PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Noble, P; Spendlove, I; Harding, S; Parsons, T; Durrant, LG				Noble, Philip; Spendlove, Ian; Harding, Stephen; Parsons, Tina; Durrant, Lindy G.			Therapeutic Targeting of Lewis(y) and Lewis(b) with a Novel Monoclonal Antibody 692/29	PLOS ONE			English	Article							BLOOD-GROUP ANTIGENS; BR96-DOXORUBICIN CONJUGATE; ANTITUMOR-ACTIVITY; COLORECTAL-CANCER; PHASE-II; X-BLOOD; EXPRESSION; TUMORS; ADENOCARCINOMA; DETERMINANTS	Background: Several monoclonal antibodies (mAbs) recognising Lewis(y), such as BR96, have reached the clinic but have failed to show good anti-tumour responses with an acceptable level of toxicity. No Lewis(b) mAbs have been trialled in patients. In this study we compare the specificity of three mAbs; BR96 (Lewis(y)), 2-25 LE (Lewis(b)) and 692/29 that recognises a unique facet of both Lewis(y) and Lewis(b). We then assessed the in vivo therapeutic effect of 692/29 using xenograft models. Methodology/Principal Findings: Using a glycan array, each mAb was shown to display a different binding pattern with only 692/29 binding to both Lewis(y) and Lewis(b). 692/29 was able to kill tumour cells over-expressing Lewis(y/b) directly, as well as by antibody and complement mediated cytotoxicity (ADCC/CDC), but failed to kill cells expressing low levels of these haptens. In contrast, BR96, directly killed cells expressing either high or low levels of Lewis(y) perhaps explaining its toxicity in patients. 2-25 LE failed to cause any direct killing but did mediate ADCC/CDC. Both 692/29 and BR96 bound to >80% of a panel of over 400 colorectal tumours whereas 2-25 LE showed lower reactivity (52%). 692/29 demonstrated more restricted normal tissue reactivity than both BR96 and 2-25 LE. 692/29 anti-Lewis(y/b) mAb also showed good in vivo killing in xenograft models. Conclusions/Significance: MAbs targeting both Lewis(y) and Lewis(b) may have a therapeutic advantage over mAbs targeting just one hapten. 692/29 has a more restricted normal tissue distribution and a higher antigen threshold for killing which should reduce its toxicity compared to a Lewis(y) specific mAb. 692/29 has an ability to directly kill tumours whereas the anti-Lewis(b) mAb does not. This suggests that Lewis(y) but not Lewis(b) are functional glycans. 692/29 showed good anti-tumour responses in vivo and is a strong therapeutic candidate.	[Noble, Philip; Spendlove, Ian; Harding, Stephen; Parsons, Tina; Durrant, Lindy G.] Univ Nottingham, Acad Dept Clin Oncol, Nottingham NG7 2RD, England	University of Nottingham	Durrant, LG (corresponding author), Univ Nottingham, Acad Dept Clin Oncol, City Hosp Campus, Nottingham NG7 2RD, England.	lindy.durrant@nottingham.ac.uk		Harding, Stephen E./0000-0002-7798-9692; Multhoff, Gabriele/0000-0002-2616-3137; Spendlove, Ian/0000-0002-7480-3768	MRC	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the MRC for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1986, CANCER RES, V46, P2639; Ajani JA, 2000, CANCER J, V6, P78; Brodin T, 1987, GLYCOCONJUGATE J, V4, P339; BROWN A, 1984, INT J CANCER, V33, P727, DOI 10.1002/ijc.2910330604; BROWN A, 1983, BIOSCIENCE REP, V3, P163, DOI 10.1007/BF01121947; Burris HA, 2010, CLIN CANCER RES, V16, P1673, DOI 10.1158/1078-0432.CCR-09-2263; Duncan Timothy J, 2007, World J Surg Oncol, V5, P31, DOI 10.1186/1477-7819-5-31; DURRANT LG, 1993, HYBRIDOMA, V12, P647, DOI 10.1089/hyb.1993.12.647; DURRANT LG, 1989, J NATL CANCER I, V81, P688, DOI 10.1093/jnci/81.9.688; GARRIGUES J, 1993, AM J PATHOL, V142, P607; HAKOMORI S, 1985, CANCER RES, V45, P2405; Hernandez AM, 2011, J IMMUNOL; ITZKOWITZ SH, 1992, J CELL BIOCHEM, P97; KIM YS, 1986, CANCER RES, V46, P5985; KITAMURA K, 1994, P NATL ACAD SCI USA, V91, P12957, DOI 10.1073/pnas.91.26.12957; Loo D, 2007, MOL CANCER THER, V6, P856, DOI 10.1158/1535-7163.MCT-06-0581; Madjd Z, 2005, BREAST CANCER RES, V7, pR780, DOI 10.1186/bcr1305; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Masayuki W, 1995, CANCER, V75, P2827; Partyka K, 2012, PROTEOMICS; Pryde JG, 2000, J BIOL CHEM, V275, P33574, DOI 10.1074/jbc.M001008200; Ramsland PA, 2004, J MOL BIOL, V340, P809, DOI 10.1016/j.jmb.2004.05.037; SAKAMOTO J, 1986, CANCER RES, V46, P1553; SAKAMOTO J, 1989, CANCER RES, V49, P745; Saleh MN, 2000, J CLIN ONCOL, V18, P2282, DOI 10.1200/JCO.2000.18.11.2282; SCHREIBER GJ, 1992, CANCER RES, V52, P3262; Scott AM, 2007, CLIN CANCER RES, V13, P3286, DOI 10.1158/1078-0432.CCR-07-0284; Simpson JAD, 2010, GUT, V59, P926, DOI 10.1136/gut.2009.194472; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tolcher AW, 1999, J CLIN ONCOL, V17, P478, DOI 10.1200/JCO.1999.17.2.478; VANDONSELAAR M, 1987, J BIOL CHEM, V262, P10848; Watson NFS, 2006, CANCER IMMUNOL IMMUN, V55, P973, DOI 10.1007/s00262-005-0055-0; Watson Nicholas F S, 2005, World J Surg Oncol, V3, P47, DOI 10.1186/1477-7819-3-47; WATSON SA, 1993, EUR J CANCER, V29A, P1740, DOI 10.1016/0959-8049(93)90117-X; Westwood JA, 2005, P NATL ACAD SCI USA, V102, P19051, DOI 10.1073/pnas.0504312102; Zhang CG, 1998, P NATL ACAD SCI USA, V95, P6290, DOI 10.1073/pnas.95.11.6290	36	14	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e54892	10.1371/journal.pone.0054892	http://dx.doi.org/10.1371/journal.pone.0054892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408949	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300006
J	Orr, WS; Denbo, JW; Saab, KR; Ng, CY; Wu, JR; Li, K; Garner, JM; Morton, CL; Du, ZY; Pfeffer, LM; Davidoff, AM				Orr, W. Shannon; Denbo, Jason W.; Saab, Karim R.; Ng, Catherine Y.; Wu, Jianrong; Li, Kui; Garner, Jo Meagan; Morton, Christopher L.; Du, Ziyun; Pfeffer, Lawrence M.; Davidoff, Andrew M.			Curcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-kappa B Activity	PLOS ONE			English	Article							GENE-PRODUCTS; CANCER CELLS; TUMOR-GROWTH; NUDE-MICE; EXPRESSION; PROLIFERATION; ACTIVATION; RADIATION; ANGIOGENESIS; METASTASIS	Ionizing radiation (IR) is an essential component of therapy for alveolar rhabdomyosarcoma. Nuclear factor-kappaB (NF-kappa B) transcription factors are upregulated by IR and have been implicated in radioresistance. We evaluated the ability of curcumin, a putative NF-kappa B inhibitor, and cells expressing genetic NF-kappa B inhibitors (I kappa B alpha and p100 super-repressor constructs) to function as a radiosensitizer. Ionizing radiation induced NF-kappa B activity in the ARMS cells in vitro in a dose-and time-dependent manner, and upregulated expression of NF-kappa B target proteins. Pretreatment of the cells with curcumin inhibited radiation-induced NF-kappa B activity and target protein expression. In vivo, the combination of curcumin and IR had synergistic antitumor activity against Rh30 and Rh41 ARMS xenografts. The greatest effect occurred when tumor-bearing mice were treated with curcumin prior to IR. Immunohistochemistry revealed that combination therapy significantly decreased tumor cell proliferation and endothelial cell count, and increased tumor cell apoptosis. Stable expression of the super-repressor, SR-I kappa B alpha, that blocks the classical NF-kappa B pathway, increased sensitivity to IR, while expression of SR-p100, that blocks the alternative pathway, did not. Our results demonstrate that curcumin can potentiate the antitumor activity of IR in ARMS xenografts by suppressing a classical NF-kappa B activation pathway induced by ionizing radiation. These data support testing of curcumin as a radiosensitizer for the clinical treatment of alveolar rhabdomyosarcoma. Impact of work: The NF-kappa B protein complex has been linked to radioresistance in several cancers. In this study, we have demonstrated that inhibiting radiation-induced NF-kappa B activity by either pharmacologic (curcumin) or genetic (SR-I kappa B alpha) means significantly enhanced the efficacy of radiation therapy in the treatment of alveolar rhabdomyosarcoma cells and xenografts. These data suggest that preventing the radiation-induced activation of the NF-kappa B pathway is a promising way to improve the antitumor efficacy of ionizing radiation and warrants clinical trials.	[Orr, W. Shannon; Denbo, Jason W.; Davidoff, Andrew M.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38103 USA; [Orr, W. Shannon; Denbo, Jason W.; Saab, Karim R.; Ng, Catherine Y.; Morton, Christopher L.; Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Wu, Jianrong] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Li, Kui] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA; [Garner, Jo Meagan; Du, Ziyun; Pfeffer, Lawrence M.; Davidoff, Andrew M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN USA; [Garner, Jo Meagan; Du, Ziyun; Pfeffer, Lawrence M.; Davidoff, Andrew M.] Univ Tennessee, Ctr Canc Res, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Davidoff, AM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38103 USA.	Andrew.davidoff@stjude.org		Pfeffer, Lawrence/0000-0003-2809-1234	Assisi Foundation of Memphis; US Public Health Service Childhood Solid Tumor Program Project [CA23099]; Cancer Center Support Grant from the National Cancer Institute [21766]; National Cancer Institute [CA133322]; United States National Institutes of Health [AI069285]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA133322, P01CA023099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069285, R01AI069285] Funding Source: NIH RePORTER	Assisi Foundation of Memphis; US Public Health Service Childhood Solid Tumor Program Project; Cancer Center Support Grant from the National Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Assisi Foundation of Memphis, the US Public Health Service Childhood Solid Tumor Program Project Grant No. CA23099, the Cancer Center Support Grant No. 21766 from the National Cancer Institute, Grant No. CA133322 from National Cancer Institute, Grant No. AI069285 from United States National Institutes of Health, and by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400; Aravindan N, 2011, INT J RADIAT ONCOL, V79, P1206, DOI 10.1016/j.ijrobp.2010.10.058; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chang YH, 2002, EXP CELL RES, V278, P166, DOI 10.1006/excr.2002.5573; Duarte VM, 2010, MOL CANCER THER, V9, P2665, DOI 10.1158/1535-7163.MCT-10-0064; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; GRECO WR, 1990, CANCER RES, V50, P5318; HANCOCK SL, 1993, JAMA-J AM MED ASSOC, V270, P1949, DOI 10.1001/jama.270.16.1949; Hull MC, 2003, JAMA-J AM MED ASSOC, V290, P2831, DOI 10.1001/jama.290.21.2831; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Kunnumakkara AB, 2008, CLIN CANCER RES, V14, P2128, DOI 10.1158/1078-0432.CCR-07-4722; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Loeb DM, 2008, SURG CLIN N AM, V88, P615, DOI 10.1016/j.suc.2008.03.008; MACHADO SG, 1994, STAT MED, V13, P2289, DOI 10.1002/sim.4780132202; Meadows A T, 1974, Semin Oncol, V1, P87; MEADOWS AT, 1981, LANCET, V2, P1015; Meadows AT, 1986, J ASS PEDIAT ONCOL N, V6, P7; Meza JL, 2006, J CLIN ONCOL, V24, P3844, DOI 10.1200/JCO.2005.05.3801; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Raney R B, 2001, Sarcoma, V5, P9, DOI 10.1080/13577140120048890; Rosati SF, 2008, MOL CANCER THER, V7, P3852, DOI 10.1158/1535-7163.MCT-08-0806; Sandur SK, 2009, INT J RADIAT ONCOL, V75, P534, DOI 10.1016/j.ijrobp.2009.06.034; Sims TL, 2010, MOL CANCER THER, V9, P761, DOI 10.1158/1535-7163.MCT-09-0800; Spurbeck WW, 2002, BLOOD, V100, P3361, DOI 10.1182/blood.V100.9.3361	27	26	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e51309	10.1371/journal.pone.0051309	http://dx.doi.org/10.1371/journal.pone.0051309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408929	gold, Green Submitted, Green Published			2022-12-27	WOS:000315157200003
J	Arsenault, D; Brochu-Gaudreau, K; Charbonneau, M; Dubois, CM				Arsenault, Dominique; Brochu-Gaudreau, Karine; Charbonneau, Martine; Dubois, Claire M.			HDAC6 Deacetylase Activity Is Required for Hypoxia-Induced Invadopodia Formation and Cell Invasion	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX DEGRADATION; SUBEROYLANILIDE HYDROXAMIC ACID; BREAST-CANCER CELLS; TGF-BETA; HISTONE DEACETYLASES; MESENCHYMAL TRANSITION; SMAD PROTEINS; TUMOR-CELLS; SIGNALING PATHWAYS; EPITHELIAL-CELLS	Despite significant progress in the cancer field, tumor cell invasion and metastasis remain a major clinical challenge. Cell invasion across tissue boundaries depends largely on extracellular matrix degradation, which can be initiated by formation of actin-rich cell structures specialized in matrix degradation called invadopodia. Although the hypoxic microenvironment within solid tumors has been increasingly recognized as an important driver of local invasion and metastasis, little is known about how hypoxia influences invadopodia biogenesis. Here, we show that histone deacetylase 6 (HDAC6), a cytoplasmic member of the histone deacetylase family, is a novel modulator of hypoxia-induced invadopodia formation. Hypoxia was found to enhance HDAC6 tubulin deacetylase activity through activation of the EGFR pathway. Activated HDAC6, in turn, triggered Smad3 phosphorylation resulting in nuclear accumulation. Inhibition of HDAC6 activity or knockdown of the protein inhibited both hypoxia-induced Smad3 activation and invadopodia formation. Our data provide evidence that hypoxia influences invadopodia formation in a biphasic manner, which involves the activation of HDAC6 deacetylase activity by EGFR, resulting in enhanced Smad phosphorylation and nuclear accumulation. The identification of HDAC6 as a key participant of hypoxia-induced cell invasion may have important therapeutic implications for the treatment of metastasis in cancer patients.	[Arsenault, Dominique; Brochu-Gaudreau, Karine; Charbonneau, Martine; Dubois, Claire M.] Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Dubois, CM (corresponding author), Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada.	Claire.Dubois@usherbrooke.ca	Brochu-Gaudreau, Karine/GWC-1767-2022; Dubois, Claire M/K-1985-2013	Brochu-Gaudreau, Karine/0000-0003-1163-2196; 	Canadian Institutes for Health Research [MOP-89810]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes for Health Research (grant MOP-89810 to C. M. Dubois). C. M. Dubois is a member of the Fonds de la Recherche en Sante du Quebec (FRSQ)-funded Centre de Recherche Clinique Etienne-LeBel. D. Arsenault is a recipient of a scolarship from the Canadian Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M., 2012, DNA CELL BIOL; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Akman HO, 2001, BLOOD, V98, P3324, DOI 10.1182/blood.V98.12.3324; Arsenault D, 2011, J CELL PHYSL; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Baldassarre M, 2006, EUR J CELL BIOL, V85, P1217, DOI 10.1016/j.ejcb.2006.08.003; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bazzaro M, 2008, CLIN CANCER RES, V14, P7340, DOI 10.1158/1078-0432.CCR-08-0642; Behzadian MA, 1998, GLIA, V24, P216, DOI 10.1002/(SICI)1098-1136(199810)24:2<216::AID-GLIA6>3.3.CO;2-D; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Bruserud O, 2007, CURR PHARM BIOTECHNO, V8, P388, DOI 10.2174/138920107783018417; Chae KS, 2011, ONCOGENE, V30, P1213, DOI 10.1038/onc.2010.498; Chen WT, 1999, ANN NY ACAD SCI, V878, P361, DOI 10.1111/j.1749-6632.1999.tb07695.x; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Dallavalle S, 2012, BIOCHEM PHARMACOL, V84, P756, DOI 10.1016/j.bcp.2012.06.014; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fukuda Hiroki, 2006, Briefings in Functional Genomics & Proteomics, V5, P190, DOI 10.1093/bfgp/ell032; Gong KZ, 2011, MOL ENDOCRINOL, V25, P1794, DOI 10.1210/me.2011-1009; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hess-Stumpp H, 2005, EUR J CELL BIOL, V84, P109, DOI 10.1016/j.ejcb.2004.12.010; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Inoue A, 2002, J MOL ENDOCRINOL, V29, P175, DOI 10.1677/jme.0.0290175; ITO N, 1991, CANCER RES, V51, P4080; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kimura F, 2010, CANCER SCI, V101, P1133, DOI 10.1111/j.1349-7006.2010.01527.x; Krasagakis K, 1998, BRIT J CANCER, V77, P1492, DOI 10.1038/bjc.1998.245; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Lin HH, 2012, MOL CELL BIOL, V32, P1124, DOI 10.1128/MCB.06053-11; Lin HY, 2006, MED RES REV, V26, P397, DOI 10.1002/med.20056; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Lucien F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028851; Luu TH, 2008, CLIN CANCER RES, V14, P7138, DOI 10.1158/1078-0432.CCR-08-0122; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mandal S, 2008, EXP CELL RES, V314, P3478, DOI 10.1016/j.yexcr.2008.09.013; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McMahon S, 2005, J BIOL CHEM, V280, P6561, DOI 10.1074/jbc.M413248200; Mishra OP, 2010, NEUROCHEM RES, V35, P1471, DOI 10.1007/s11064-010-0208-1; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Mottet D, 2005, INT J CANCER, V117, P764, DOI 10.1002/ijc.21268; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nascimento CF, 2010, MICROSC RES TECHNIQ, V73, P99, DOI 10.1002/jemt.20761; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Park SY, 2011, ONCOL REP, V25, P1677, DOI 10.3892/or.2011.1236; Piek E, 1999, J CELL SCI, V112, P4557; Rey M, 2011, EUR J CELL BIOL, V90, P128, DOI 10.1016/j.ejcb.2010.09.004; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Sakuma T, 2006, INT J ONCOL, V29, P117; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Sasseville M, 2010, J CELL SCI, V123, P3166, DOI 10.1242/jcs.063834; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Shi YF, 2007, FEBS LETT, V581, P203, DOI 10.1016/j.febslet.2006.12.010; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Tsunoda K, 2011, J INVEST DERMATOL; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wang J, 2010, INVEST OPHTH VIS SCI, V51, P2943, DOI 10.1167/iovs.09-4639; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Wang X, 2010, CARCINOGENESIS, V31, P1202, DOI 10.1093/carcin/bgq078; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wiercinska E, 2010, BREAST CANC RES TREA; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	92	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55529	10.1371/journal.pone.0055529	http://dx.doi.org/10.1371/journal.pone.0055529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405166	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400111
J	Foulkes, AS; Matthews, GJ; Das, U; Ferguson, JF; Lin, RH; Reilly, MP				Foulkes, Andrea S.; Matthews, Gregory J.; Das, Ujjwal; Ferguson, Jane F.; Lin, Rongheng; Reilly, Muredach P.			Mixed Modeling of Meta-Analysis P-Values (MixMAP) Suggests Multiple Novel Gene Loci for Low Density Lipoprotein Cholesterol	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; LIPID-LEVELS; GLUCURONOSYLTRANSFERASE 1A1; ATHEROSCLEROTIC LESIONS; DELTA GENOTYPE; ASSOCIATION; METABOLISM; POLYMORPHISMS; EXPRESSION; PROTEIN	Informing missing heritability for complex disease will likely require leveraging information across multiple SNPs within a gene region simultaneously to characterize gene and locus-level contributions to disease phenotypes. To this aim, we introduce a novel strategy, termed Mixed modeling of Meta-Analysis P-values (MixMAP), that draws on a principled statistical modeling framework and the vast array of summary data now available from genetic association studies, to test formally for locus level association. The primary inputs to this approach are: (a) single SNP level p-values for tests of association; and (b) the mapping of SNPs to genomic regions. The output of MixMAP is comprised of locus level estimates and tests of association. In application of MixMAP to summary data from the Global Lipids Gene Consortium, we suggest twelve new loci (PKN, FN1, UGT1A1, PPARG, DMDGH, PPARD, CDK6, VPS13B, GAD2, GAB2, APOH and NPC1) for low-density lipoprotein cholesterol (LDL-C), a causal risk factor for cardiovascular disease and we also demonstrate the potential utility of MixMAP in small data settings. Overall, MixMAP offers novel and complementary information as compared to SNP-based analysis approaches and is straightforward to implement with existing open-source statistical software tools.	[Foulkes, Andrea S.; Matthews, Gregory J.; Das, Ujjwal; Lin, Rongheng] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat, Amherst, MA 01003 USA; [Ferguson, Jane F.; Reilly, Muredach P.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Pennsylvania; Pennsylvania Medicine	Foulkes, AS (corresponding author), Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat, Amherst, MA 01003 USA.	foulkes@schoolph.umass.edu	Ferguson, Jane/C-7154-2011; Das, Ujjwal/GWQ-7254-2022	Ferguson, Jane/0000-0001-6896-1025; Reilly, Muredach/0000-0002-3035-9386	NIH (National Institute of Health) [R01-HL107196, R01-DK071224]; NIH [R01-HL107196, R01-DK071224, R01-DK090505, U01-HL108636, K24-HL107643]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107196, U01HL108636, K24HL107643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090505, R01DK071224] Funding Source: NIH RePORTER	NIH (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ASF and GJM are supported by NIH (National Institute of Health) R01-HL107196 and R01-DK071224; UD is supported by NIH R01-HL107196; MPR is supported by NIH R01-DK071224, R01-DK090505, U01-HL108636, K24-HL107643 and R01-HL107196. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AMOS CI, 1994, AM J HUM GENET, V54, P535; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Bae JW, 2011, EUR J CLIN PHARMACOL, V67, P39, DOI 10.1007/s00228-010-0899-x; Balding DJ, 2004, APPL LONGITUDINAL AN; Binzak BA, 2001, AM J HUM GENET, V68, P839, DOI 10.1086/319520; Burch LR, 2010, J CLIN ENDOCR METAB, V95, P1830, DOI 10.1210/jc.2009-1201; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Demissie S, 2006, ATHEROSCLEROSIS, V185, P210, DOI 10.1016/j.atherosclerosis.2005.06.008; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Devlin CM, 2002, P NATL ACAD SCI USA, V99, P6280, DOI 10.1073/pnas.092324399; Dierks T, 2009, BBA-MOL CELL RES, V1793, P710, DOI 10.1016/j.bbamcr.2008.11.015; Dietrich T, 2007, BASIC RES CARDIOL, V102, P298, DOI 10.1007/s00395-007-0652-5; Duner P, 2011, CARDIOVASC RES, V91, P528, DOI 10.1093/cvr/cvr101; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; Fan RZ, 2003, BIOSTATISTICS, V4, P75, DOI 10.1093/biostatistics/4.1.75; Ferguson JF, 2012, J AM COLL CARDIOL, V59, P764, DOI 10.1016/j.jacc.2011.11.019; Foulkes AS, 2008, BIOSTATISTICS, V9, P635, DOI 10.1093/biostatistics/kxm055; Foulkes AS, 2005, STAT MED, V24, P775, DOI 10.1002/sim.1965; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gauthier B, 1999, J LIPID RES, V40, P1284; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Hu C, 2006, DIABETIC MED, V23, P1307, DOI 10.1111/j.1464-5491.2006.02001.x; Johansson LE, 2009, INT J PEDIATR OBES, V4, P119, DOI 10.1080/17477160802263194; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kamboh MI, 1999, GENET EPIDEMIOL, V16, P205, DOI 10.1002/(SICI)1098-2272(1999)16:2<205::AID-GEPI7>3.0.CO;2-P; Kamboh MI, 2004, ANN HUM GENET, V68, P285, DOI 10.1046/j.1529-8817.2004.00097.x; Katzaki E, 2007, J HUM GENET, V52, P1011, DOI 10.1007/s10038-007-0208-4; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Klos KLE, 2008, J LIPID RES, V49, P1701, DOI 10.1194/jlr.M700490-JLR200; Lawrence R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-367; Leduc MS, 2008, J LIPID RES, V49, P2648, DOI 10.1194/jlr.M800155-JLR200; Ljung L, 2007, CLIN EXP RHEUMATOL, V25, P617; Meirhaeghe A, 2005, MOL GENET METAB, V85, P140, DOI 10.1016/j.ymgme.2005.02.004; Nackley AC, 2002, ENDOCRINOLOGY, V143, P1085, DOI 10.1210/en.143.3.1085; Osabe M, 2008, DRUG METAB DISPOS, V36, P294, DOI 10.1124/dmd.107.017731; Oswald S, 2006, CLIN PHARMACOL THER, V79, P206, DOI 10.1016/j.clpt.2005.11.004; Pou J, 2011, BBA-MOL CELL BIOL L, V1811, P556, DOI 10.1016/j.bbalip.2011.05.014; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Schroeder F, 2001, EXP BIOL MED, V226, P873, DOI 10.1177/153537020122601002; Schumacher Fredrick R, 2007, BMC Proc, V1 Suppl 1, pS112; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Searle SR., 1992, VARIANCE COMPONENTS; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sertic Jadranka, 2009, BMC Res Notes, V2, P203, DOI 10.1186/1756-0500-2-203; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Shea-Eaton W, 2001, ENDOCRINOLOGY, V142, P49, DOI 10.1210/en.142.1.49; Shearman AM, 2005, HUM MOL GENET, V14, P2405, DOI 10.1093/hmg/ddi242; Skogsberg J, 2003, ARTERIOSCL THROM VAS, V23, P637, DOI 10.1161/01.ATV.0000064383.88696.24; Skogsberg J, 2003, J INTERN MED, V254, P597, DOI 10.1111/j.1365-2796.2003.01236.x; Smiderle L, 2011, GYNECOL ENDOCRINOL, V27, P20, DOI 10.3109/09513590.2010.493248; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tsunoda K, 2002, HUM BIOL, V74, P659, DOI 10.1353/hub.2002.0058; Wang L, 2011, BIOINFORMATICS, V27, P686, DOI 10.1093/bioinformatics/btq728; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	59	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54812	10.1371/journal.pone.0054812	http://dx.doi.org/10.1371/journal.pone.0054812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405096	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400040
J	Liu, Y; Yang, XS; Guo, CY; Nie, P; Liu, Y; Ma, J				Liu, Yong; Yang, Xuesen; Guo, Chenying; Nie, Pan; Liu, Yan; Ma, Jie			Essential Role of MFG-E8 for Phagocytic Properties of Microglial Cells	PLOS ONE			English	Article							GLOBULE-EGF FACTOR-8; SYSTEMIC-LUPUS-ERYTHEMATOSUS; APOPTOTIC CELLS; NEURONAL DEATH; MACROPHAGE CLEARANCE; LENTIVIRUS VECTOR; VIABLE NEURONS; PHOSPHATIDYLSERINE; DISEASE; IDENTIFICATION	Milk fat globule factor-E8 (MFG-E8) has been regarded as a key factor involved in the phagocytosis of apoptotic cells. We induced a lentivirus into the microglial cells for the augmentation or abrogation of MFG-E8 expression in mouse microglial cells, and investigated phagocytosis of phosphatidylserine tagged human red blood cells (hRBCs) in co-cultures. Increased MFG-E8 levels were associated with a significant increase in phagocytic activity compared to the controls. Conversely, phagocytosis dramitically decreased due to the abrogation of MFG-E8. In addition, the expression of the inflammatory cytokines, TNF-alpha and IL-1 beta, also increased or decreased in the microglial cells with the augmentation or abrogation of MFG-E8, respectively. Our findings indicate that the enhanced expression of MFG-E8 could increase phagocytosis of apoptotic cells; conversely, the rate of phagocytosis and the expression of inflammatory cytokines decreased when MFG-E8 expression was knocked down. Our results confirm that MFG-E8 plays an important role in phagocytosis, and possibly serves as an essential signal molecule for microglial cells.	[Liu, Yong] Third Mil Med Univ, SW Eye Hosp, Southwest Hosp, Chongqing, Peoples R China; [Yang, Xuesen] Third Mil Med Univ, Inst Trop Med, Chongqing, Peoples R China; [Guo, Chenying; Ma, Jie] Harvard Univ, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Dept Ophthalmol,Med Sch, Boston, MA USA; [Nie, Pan; Liu, Yan] Southwest Univ, Coll Life Sci, Chongqing, Peoples R China	Army Medical University; Army Medical University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Southwest University - China	Liu, Y (corresponding author), Third Mil Med Univ, SW Eye Hosp, Southwest Hosp, Chongqing, Peoples R China.	liu_yong2012@yahoo.com			National Natural Science Foundation of China [30700931, 30970672]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30700931 to Yong Liu and No. 30970672 to Xuesen Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; Aziz M, 2011, APOPTOSIS, V16, P1077, DOI 10.1007/s10495-011-0630-0; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Fricker M, 2012, J NEUROSCI, V32, P2657, DOI 10.1523/JNEUROSCI.4837-11.2012; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Leonardi-Essmann F, 2005, J NEUROIMMUNOL, V160, P92, DOI 10.1016/j.jneuroim.2004.11.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Miksa M, 2006, SHOCK, V25, P586, DOI 10.1097/01.shk.0000209533.22941.d0; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; Tyurina YY, 2004, J BIOL CHEM, V279, P6056, DOI 10.1074/jbc.M309929200; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; Yamaguchi H, 2010, EUR J IMMUNOL, V40, P1778, DOI 10.1002/eji.200940096; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; ZHANG L, 1995, BRAIN RES, V677, P177, DOI 10.1016/0006-8993(95)00197-X; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	38	23	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55754	10.1371/journal.pone.0055754	http://dx.doi.org/10.1371/journal.pone.0055754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405209	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400154
J	Shu, MY; Wang, YH; Yu, JH; Kuo, S; Coda, A; Jiang, Y; Gallo, RL; Huang, CM				Shu, Muya; Wang, Yanhan; Yu, Jinghua; Kuo, Sherwin; Coda, Alvin; Jiang, Yong; Gallo, Richard L.; Huang, Chun-Ming			Fermentation of Propionibacterium acnes, a Commensal Bacterium in the Human Skin Microbiome, as Skin Probiotics against Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INFECTIONS; GLYCEROL; CELLS; SUSCEPTIBILITY; ANTIMICROBIALS; INTERFERENCE; INFLAMMATION; METABOLISM; PREDICTION	Bacterial interference creates an ecological competition between commensal and pathogenic bacteria. Through fermentation of milk with gut-friendly bacteria, yogurt is an excellent aid to balance the bacteriological ecosystem in the human intestine. Here, we demonstrate that fermentation of glycerol with Propionibacterium acnes (P. acnes), a skin commensal bacterium, can function as a skin probiotic for in vitro and in vivo growth suppression of USA300, the most prevalent community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). We also promote the notion that inappropriate use of antibiotics may eliminate the skin commensals, making it more difficult to fight pathogen infection. This study warrants further investigation to better understand the role of fermentation of skin commensals in infectious disease and the importance of the human skin microbiome in skin health.	[Shu, Muya; Wang, Yanhan; Kuo, Sherwin; Coda, Alvin; Gallo, Richard L.; Huang, Chun-Ming] Univ Calif San Diego, Dept Med, Div Dermatol, La Jolla, CA 92093 USA; [Yu, Jinghua] Sanford Burnham Inst Med Res, La Jolla, CA USA; [Jiang, Yong] Surface Bioadv Inc, San Diego, CA USA; [Huang, Chun-Ming] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Huang, CM (corresponding author), Univ Calif San Diego, Dept Med, Div Dermatol, La Jolla, CA 92093 USA.	chunming@ucsd.edu	Gallo, Richard L/A-8931-2009; , Chun-Ming/AAM-1856-2020	Gallo, Richard L/0000-0002-1401-7861; , Chun-Ming/0000-0002-3352-5394; Coda, Alvin/0000-0002-8509-8590	NIH [STTR, 1R21AI088147]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088147, R01AI083358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants (STTR and 1R21AI088147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CY, 1996, PLAST RECONSTR SURG, V98, P1225, DOI 10.1097/00006534-199612000-00016; Bashir A, 2007, PAK J PHARM SCI, V20, P299; Chitarra LG, 2000, J APPL MICROBIOL, V88, P809, DOI 10.1046/j.1365-2672.2000.01014.x; Cohen AL, 2007, EMERG INFECT DIS, V13, P1707, DOI 10.3201/eid1311.070148; CUMMINS CS, 1975, J CLIN MICROBIOL, V2, P104; CUMMINS CS, 1974, J GEN MICROBIOL, V80, P433, DOI 10.1099/00221287-80-2-433; Curry JL, 2003, ARCH PATHOL LAB MED, V127, P289; DEMAEREL P, 1994, LANCET, V344, P1234, DOI 10.1016/S0140-6736(94)90552-5; Dishisha T, 2012, BIORESOURCE TECHNOL, V118, P553, DOI 10.1016/j.biortech.2012.05.079; EVANS CA, 1975, J INVEST DERMATOL, V64, P42, DOI 10.1111/1523-1747.ep12540897; EVANS CA, 1984, J INVEST DERMATOL, V82, P294, DOI 10.1111/1523-1747.ep12260391; Falagas ME, 2008, INT J ANTIMICROB AG, V31, P518, DOI 10.1016/j.ijantimicag.2008.01.024; Fluhr JW, 2008, BRIT J DERMATOL, V159, P23, DOI 10.1111/j.1365-2133.2008.08643.x; Fujita T, 2011, J INVEST DERMATOL, V131, P1660, DOI 10.1038/jid.2011.123; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Gilbert M, 2006, CAN MED ASSOC J, V175, P149, DOI 10.1503/cmaj.051565; Goetghebeur M, 2007, CAN J INFECT DIS MED, V18, P27, DOI 10.1155/2007/253947; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Higaki S, 2004, INT J DERMATOL, V43, P103, DOI 10.1111/j.1365-4632.2004.01887.x; Higaki S, 1990, Nihon Hifuka Gakkai Zasshi, V100, P883; INGRAM LO, 1984, ADV MICROB PHYSIOL, V25, P253; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kidd DA, 2007, TOXICOL IN VITRO, V21, P1292, DOI 10.1016/j.tiv.2007.08.018; Kitagawa H, 2011, EXP DERMATOL, V20, P157, DOI 10.1111/j.1600-0625.2010.01180.x; Kwon YM, 1998, APPL ENVIRON MICROB, V64, P3458; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lind H., 2010, INT J MICROBIOL, V2010, DOI [10.1155/2010/430873, DOI 10.1155/2010/430873]; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Malani PN, 2008, J AM GERIATR SOC, V56, P1485, DOI 10.1111/j.1532-5415.2008.01823.x; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; Millet S, 2010, CRIT REV FOOD SCI, V50, P605, DOI 10.1080/10408390802565939; MUAMBA MLK, 1982, CAN J MICROBIOL, V28, P758, DOI 10.1139/m82-115; Odell CA, 2010, CURR OPIN PEDIATR, V22, P273, DOI 10.1097/MOP.0b013e328339421b; OSTLING CE, 1993, J APPL BACTERIOL, V75, P18, DOI 10.1111/j.1365-2672.1993.tb03402.x; Park JS, 2007, INT IMMUNOPHARMACOL, V7, P70, DOI 10.1016/j.intimp.2006.08.015; Raftari M, 2009, Open Microbiol J, V3, P121, DOI 10.2174/1874285800903010121; Ramage G, 2003, BIOMATERIALS, V24, P3221, DOI 10.1016/S0142-9612(03)00173-X; Ramstad S, 1997, J PHOTOCH PHOTOBIO B, V40, P141, DOI 10.1016/S1011-1344(97)00039-0; Ricke SC, 2003, POULTRY SCI, V82, P632, DOI 10.1093/ps/82.4.632; Saleh K, 2011, DERMATOL SURG, V37, P1014, DOI 10.1111/j.1524-4725.2011.02040.x; Slonczewski JL, 1992, ASM NEWS, V58, P140; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; USHIJIMA T, 1984, CAN J MICROBIOL, V30, P647, DOI 10.1139/m84-096; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wang ZX, 2001, BIOTECHNOL ADV, V19, P201, DOI 10.1016/S0734-9750(01)00060-X; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Wu Ling, 2009, Weishengwu Xuebao, V49, P168; Zhang H, 2009, INT J FOOD MICROBIOL, V135, P211, DOI 10.1016/j.ijfoodmicro.2009.08.015; Zheng XJ, 2003, J INVEST DERMATOL, V121, P1487, DOI 10.1111/j.1523-1747.2003.12614.x	53	164	187	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55380	10.1371/journal.pone.0055380	http://dx.doi.org/10.1371/journal.pone.0055380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405142	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400087
J	Vermeulen, C; Lejeune, P; Lisein, J; Sawadogo, P; Bouche, P				Vermeulen, Cedric; Lejeune, Philippe; Lisein, Jonathan; Sawadogo, Prosper; Bouche, Philippe			Unmanned Aerial Survey of Elephants	PLOS ONE			English	Article								The use of a UAS (Unmanned Aircraft System) was tested to survey large mammals in the Nazinga Game Ranch in the south of Burkina Faso. The Gatewing x 100 (TM) equipped with a Ricoh GR III camera was used to test animal reaction as the UAS passed, and visibility on the images. No reaction was recorded as the UAS passed at a height of 100 m. Observations, made on a set of more than 7000 images, revealed that only elephants (Loxodonta africana) were easily visible while medium and small sized mammals were not. The easy observation of elephants allows experts to enumerate them on images acquired at a height of 100 m. We, therefore, implemented an aerial strip sample count along transects used for the annual wildlife foot count. A total of 34 elephants were recorded on 4 transects, each overflown twice. The elephant density was estimated at 2.47 elephants/km(2) with a coefficient of variation (CV%) of 36.10%. The main drawback of our UAS was its low autonomy (45 min). Increased endurance of small UAS is required to replace manned aircraft survey of large areas (about 1000 km of transect per day vs 40 km for our UAS). The monitoring strategy should be adapted according to the sampling plan. Also, the UAS is as expensive as a second-hand light aircraft. However the logistic and flight implementation are easier, the running costs are lower and its use is safer. Technological evolution will make civil UAS more efficient, allowing them to compete with light aircraft for aerial wildlife surveys.	[Vermeulen, Cedric; Lejeune, Philippe; Lisein, Jonathan; Bouche, Philippe] Univ Liege Gembloux Agrobio Tech, Unite Gest Ressources Forestieres & Milieux Nat, Gembloux, Belgium; [Sawadogo, Prosper] Off Natl Aires Protegees, Ouagadougou, Burkina Faso	University of Liege	Vermeulen, C (corresponding author), Univ Liege Gembloux Agrobio Tech, Unite Gest Ressources Forestieres & Milieux Nat, Gembloux, Belgium.	cvermeulen@ulg.ac.be			Department of Forest Nature and Landscape of the University of Liege Gembloux Agro-Bio Tech.	Department of Forest Nature and Landscape of the University of Liege Gembloux Agro-Bio Tech.	This operation was funded by the Department of Forest Nature and Landscape of the University of Liege Gembloux Agro-Bio Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouche P, 2012, THESIS U LIEGE; Bouche P, 2012, ENV MONITOR IN PRESS; Bouche P, 2012, BIOTECHNOL AGRON SOC, V16, P77; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Croze H., 1972, East African Wildlife Journal, V10, P91; Dekker AJFM, 1985, DPBKF82008 PNUDFAO; Dunham KM, 2012, AFR J ECOL IN PRESS; Ferreira SM, 2009, S AFR J WILDL RES, V39, P181, DOI 10.3957/056.039.0205; Israel M, 2011, INT ARCH PHOTOGRAMME, VXXXVIII-1/C22; JACHMANN H, 1991, AFR J ECOL, V29, P188, DOI 10.1111/j.1365-2028.1991.tb01001.x; Jachmann H., 2001, ESTIMATING ABUNDANCE, DOI 10.1007/978-1-4615-1381-0; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Marchal A, 2012, BIOTECHNOL AGRON SOC, V16, P307; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038882; National Oceanic and Atmospheric Administration, 2009, NOAA UNM AIRCR HELP; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Norton-Griffiths, 1978, AWF HDB, V1; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Trimble MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026614; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; Wilkinson BE, 2009, PHOTOGRAMM ENG REM S, V75, P1415, DOI 10.14358/PERS.75.12.1415	22	165	181	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54700	10.1371/journal.pone.0054700	http://dx.doi.org/10.1371/journal.pone.0054700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405088	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400032
J	Xu, XY; Zhao, MD; Liu, XB; Jiang, YZ; Zhang, HX; Zhai, XY; Zhang, L; Hu, XM				Xu, Xiaoyan; Zhao, Mingdong; Liu, Xianbing; Jiang, Yuzhu; Zhang, Haixia; Zhai, Xiaoyu; Zhang, Ling; Hu, Xuemei			Toxoplasma gondii Infection Regulates the Balance of Activating and Inhibitory Receptors on Decidual Natural Killer Cells	PLOS ONE			English	Article							NK CELL	Inhibitory receptors and activating receptor expressed on decidual natural killer (dNK) cells are generally believed to be important in abnormal pregnancy outcomes and induced adverse pregnancy. However, if Toxoplasma gondii (T. gondii) infection induced abnormal pregnancy was related to dNK cells changes is not clear. In this study, we used human dNK cells co-cultured with human extravillous cytotrophoblast (EVT) cells following YFP-Toxoplasma gondii (YFP-T. gondii) infection in vitro and established animal pregnant infection model. Levels of inhibitory receptors KIR2DL4 and ILT-2, their ligand HLA-G, and activating receptor NKG2D in human decidua, and NKG2A and its ligand Qa-1 and NKG2D in mice uterine were analyzed by real-time PCR and flow cytometry with levels of NKG2D significantly higher than those of KIR2DL4 and ILT-2 in vitro and in invo. The level of NKG2D was positively correlated with cytotoxic activity of dNK cells in vitro. Numbers of abnormal pregnancies were significantly greater in the infected group than in the control group. This result demonstrated that the increased NKG2D expression and imbalance between inhibitory receptors of dNK cells and HLA-G may contribute to abnormal pregnancy outcomes observed upon maternal infection with T. gondii.	[Xu, Xiaoyan; Liu, Xianbing; Jiang, Yuzhu; Zhang, Haixia; Zhai, Xiaoyu; Zhang, Ling; Hu, Xuemei] Binzhou Med Univ, Dept Immunol, Binzhou, Shandong, Peoples R China; [Zhao, Mingdong] Binzhou Med Univ, Yantai Affiliated Hosp, Dept Radiol, Binzhou, Shandong, Peoples R China	Binzhou Medical University; Binzhou Medical University	Hu, XM (corresponding author), Binzhou Med Univ, Dept Immunol, Binzhou, Shandong, Peoples R China.	xue-mei-hu@163.com			National Natural Science Foundation of China [81171591, 81273243]; Science and Technology Development Planning Project of Shandong Province [2012GSF11809]; Natural Science Foundation of Shandong Province [ZR2010HM012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Project of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported in part by funds from the National Natural Science Foundation of China 81171591 and 81273243, Science and Technology Development Planning Project of Shandong Province 2012GSF11809, Natural Science Foundation of Shandong Province ZR2010HM012. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI K, 1995, LANCET, V345, P1340, DOI 10.1016/S0140-6736(95)92539-2; Biassoni R, 2003, J CELL MOL MED, V7, P376, DOI 10.1111/j.1582-4934.2003.tb00240.x; Chao KH, 1999, HUM IMMUNOL, V60, P791, DOI 10.1016/S0198-8859(99)00049-X; Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030; Emmer PM, 2002, HUM REPROD, V17, P1072, DOI 10.1093/humrep/17.4.1072; Faridi RM, 2009, HUM REPROD, V24, P1758, DOI 10.1093/humrep/dep047; Gonen-Gross T, 2003, HUM IMMUNOL, V64, P1011, DOI 10.1016/j.humimm.2003.08.355; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Leng J, 2009, PARASITE IMMUNOL, V31, P717, DOI 10.1111/j.1365-3024.2009.01122.x; Loke Y.W., 1995, HUMAN IMPLANTATION C; Moffett-King Ashley, 2002, Trends in Immunology, V23, P332, DOI 10.1016/S1471-4906(02)02261-5; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Perussia B, 2005, MOL IMMUNOL, V42, P385, DOI 10.1016/j.molimm.2004.07.017; Rajagopalan S, 2001, J IMMUNOL, V167, P1877, DOI 10.4049/jimmunol.167.4.1877; Trundley A, 2006, METH MOLEC MED, V122, P109; Vargas-Inchaustegui DA, 2011, IMMUNOLOGY, V134, P326, DOI 10.1111/j.1365-2567.2011.03493.x; Varla-Leftherioti M, 2005, CHEM IMMUNOL ALLERGY, V89, P84, DOI 10.1159/000087915; Wold ASD, 2005, CURR OPIN OBSTET GYN, V17, P237; Yamada H, 2005, MOL HUM REPROD, V11, P451, DOI 10.1093/molehr/gah181; Yamada H, 2001, AM J REPROD IMMUNOL, V46, P132, DOI 10.1111/j.8755-8920.2001.460203.x; Yang X, 2008, IMMUOLOGY, V90, P490; [杨新 Yang Xin], 2008, [现代免疫学, Current Immunology], V28, P208; YOKOYAMA WM, 1993, CURR OPIN IMMUNOL, V5, P67, DOI 10.1016/0952-7915(93)90083-5	26	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55432	10.1371/journal.pone.0055432	http://dx.doi.org/10.1371/journal.pone.0055432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393578	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800032
J	Sun, XL; Jones, HP; Dobbs, N; Bodhankar, S; Simecka, JW				Sun, Xiangle; Jones, Harlan P.; Dobbs, Nicole; Bodhankar, Sheetal; Simecka, Jerry W.			Dendritic Cells Are the Major Antigen Presenting Cells in Inflammatory Lesions of Murine Mycoplasma Respiratory Disease	PLOS ONE			English	Article							EOSINOPHILIC AIRWAY INFLAMMATION; MACROPHAGE POPULATIONS; INHALED ANTIGEN; FLOW-CYTOMETRY; TH2 RESPONSES; T-CELLS; MICE; PULMONIS; INFECTION; IMMUNITY	Mycoplasmas cause chronic respiratory diseases in animals and humans, and to date, development of vaccines have been problematic. Using a murine model of mycoplasma pneumonia, lymphocyte responses, specifically T cells, were shown to confer protection as well as promote immunopathology in mycoplasma disease. Because T cells play such a critical role, it is important to define the role of antigen presenting cells (APC) as these cells may influence either exacerbation of mycoplasma disease pathogenesis or enhancement of protective immunity. The roles of APC, such as dendritic cells and/or macrophages, and their ability to modulate adaptive immunity in mycoplasma disease are currently unknown. Therefore, the purpose of this study was to identify individual pulmonary APC populations that may contribute to the activation of T cell responses during mycoplasma disease pathogenesis. The present study indeed demonstrates increasing numbers of CD11c(-) F4/80(+) cells, which contain macrophages, and more mature/activated CD11c(+) F4/80(-) cells, containing DC, in the lungs after infection. CD11c(-) F4/80(+) macrophage-enriched cells and CD11c(+) F4/80(-) dendritic cell-enriched populations showed different patterns of cytokine mRNA expression, supporting the idea that these cells have different impacts on immunity in response to infection. In fact, DC containing CD11c(+) F4/80(-) cell populations from the lungs of infected mice were most capable of stimulating mycoplasma-specific CD4(+) Th cell responses in vitro. In vivo, these CD11c(+) F4/80(-) cells were co-localized with CD4(+) Th cells in inflammatory infiltrates in the lungs of mycoplasma-infected mice. Thus, CD11c(+)F4/80(-) dendritic cells appear to be the major APC population responsible for pulmonary T cell stimulation in mycoplasma-infected mice, and these dendritic cells likely contribute to responses impacting disease pathogenesis.	[Sun, Xiangle; Jones, Harlan P.; Dobbs, Nicole; Bodhankar, Sheetal; Simecka, Jerry W.] Univ N Texas, Hlth Sci Ctr Ft Worth, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Simecka, JW (corresponding author), Univ N Texas, Hlth Sci Ctr Ft Worth, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA.	jerry.simecka@unthsc.edu	Jones, Harlan/ABC-9920-2020		Public Health Service Grant [HL 69431, AI 55907]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055907] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grants HL 69431 and AI 55907 (to J.W.S.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bertorelli G, 2000, ALLERGY, V55, P449, DOI 10.1034/j.1398-9995.2000.055005449.x; BILYK N, 1995, IMMUNOLOGY, V86, P231; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Bodhankar S, 2010, J INFECT DIS, V202, P39, DOI 10.1086/653121; CARTNER SC, 1995, INFECT IMMUN, V63, P4138, DOI 10.1128/IAI.63.10.4138-4142.1995; Cartner SC, 1996, INFECT IMMUN, V64, P5326, DOI 10.1128/IAI.64.12.5326-5331.1996; Cartner SC, 1998, INFECT IMMUN, V66, P3485, DOI 10.1128/IAI.66.8.3485-3491.1998; CASSELL GH, 1973, ANN NY ACAD SCI, V225, P395, DOI 10.1111/j.1749-6632.1973.tb45665.x; CASSELL GH, 1982, REV INFECT DIS, V4, pS18; Cochand L, 1999, AM J RESP CELL MOL, V21, P547, DOI 10.1165/ajrcmb.21.5.3785; DAJANI AS, 1965, J EXP MED, V121, P1071, DOI 10.1084/jem.121.6.1071; DAVIDSON MK, 1988, INFECT IMMUN, V56, P2156, DOI 10.1128/IAI.56.8.2156-2162.1988; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; EVENGARD B, 1994, CLIN EXP IMMUNOL, V98, P388; Faulkner L, 2000, IMMUNOLOGY, V99, P523, DOI 10.1046/j.1365-2567.2000.00018.x; FOY HM, 1993, CLIN INFECT DIS, V17, pS37, DOI 10.1093/clinids/17.Supplement_1.S37; Hammad H, 2000, LAB INVEST, V80, P605, DOI 10.1038/labinvest.3780065; HOROWITZ SA, 1987, INFECT IMMUN, V55, P1314, DOI 10.1128/IAI.55.5.1314-1320.1987; Jones HP, 2003, FRONT BIOSCI-LANDMRK, V8, pD930, DOI 10.2741/1098; Jones HP, 2002, J IMMUNOL, V168, P3493, DOI 10.4049/jimmunol.168.7.3493; KEYSTONE EC, 1980, INFECT IMMUN, V27, P192, DOI 10.1128/IAI.27.1.192-196.1980; KRAUSE DC, 1993, MYCOPLASMAS MOL BIOL, P417; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lambrecht BN, 1999, AM J RESP CELL MOL, V20, P1165, DOI 10.1165/ajrcmb.20.6.3484; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Masten BJ, 1999, J IMMUNOL, V162, P1310; Masten BJ, 1997, AM J RESP CELL MOL, V16, P335, DOI 10.1165/ajrcmb.16.3.9070619; MCWILLIAM AS, 1995, IMMUNOL CELL BIOL, V73, P405, DOI 10.1038/icb.1995.63; Moller GM, 1996, CLIN EXP ALLERGY, V26, P517, DOI 10.1111/j.1365-2222.1996.tb00571.x; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; NICOD LP, 1987, AM REV RESPIR DIS, V136, P818, DOI 10.1164/ajrccm/136.4.818; Osterholzer JJ, 2009, INFECT IMMUN, V77, P3749, DOI 10.1128/IAI.00454-09; POLLARD AM, 1990, J EXP MED, V172, P159, DOI 10.1084/jem.172.1.159; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Sandstedt K, 1997, CLIN EXP IMMUNOL, V108, P490, DOI 10.1046/j.1365-2249.1997.3981294.x; SIMECKA J W, 1992, Regional Immunology, V4, P18; Simecka JW, 2005, MYCOPLASMAS: MOLECULAR BIOLOGY PATHOGENICITY AND STRATEGIES FOR CONTROL, P485; Simecka JW, 2003, RRD INF IMM, V1, P203; SIMECKA JW, 1987, INFECT IMMUN, V55, P731, DOI 10.1128/IAI.55.3.731-735.1987; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Sun XG, 2006, INFECT IMMUN, V74, P5943, DOI 10.1128/IAI.00082-06; Sung SSJ, 2001, J IMMUNOL, V166, P1261, DOI 10.4049/jimmunol.166.2.1261; TAYLOR G, 1974, J MED MICROBIOL, V7, P343, DOI 10.1099/00222615-7-3-343; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Woolard MD, 2004, J IMMUNOL, V172, P6875, DOI 10.4049/jimmunol.172.11.6875; Yancey AL, 2001, INFECT IMMUN, V69, P2865, DOI 10.1128/IAI.69.5.2865-2871.2001	53	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55984	10.1371/journal.pone.0055984	http://dx.doi.org/10.1371/journal.pone.0055984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390557	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100073
J	Zhou, L; Oh, SY; Zhou, YQ; Yuan, BJ; Wu, F; Oh, MH; Wang, YF; Takemoto, C; Van Rooijen, N; Zheng, T; Zhu, Z				Zhou, Li; Oh, Sun Young; Zhou, Yuqi; Yuan, Baojun; Wu, Fan; Oh, Min Hee; Wang, Yefu; Takemoto, Cliff; Van Rooijen, Nico; Zheng, Tao; Zhu, Zhou			SHP-1 Regulation of Mast Cell Function in Allergic Inflammation and Anaphylaxis	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE SHP-1; MULTIPLE-SCLEROSIS PATIENTS; AIRWAY SMOOTH-MUSCLE; IMMUNODEFICIENT MUTANT; OXIDATIVE STRESS; MOTH-EATEN; ASTHMA; EXPRESSION; LIPOPOLYSACCHARIDE; RESPONSES	Allergic inflammation and severe allergic reactions (anaphylaxis) are important in allergen induced diseases. Bacterial products such as lipopolysaccharide (LPS) are ubiquitous and can facilitate allergen induced Th2 immune responses. Phosphatase SHP-1 is critical in regulating immunological homeostasis and in allergen induced Th2 immune responses in the lung. However, the mechanisms underlying the initiation of allergic inflammation and allergen induced anaphylaxis are still not completely elucidated and it is unclear whether SHP-1 plays any role in LPS-induced airway inflammation and in allergen-induced anaphylaxis. In this study we tested the hypothesis that phosphatase SHP-1 plays an important role in allergic inflammation and anaphylaxis and determined whether its effects are through regulation of mast cell functions. SHP-1 deficient (mev/+ and mev/mev) and mast cell deficient (Kit(W-sh)) mice were examined in their responses to LPS airway stimulation and to ovalbumin (OVA) allergen induced systemic anaphylaxis. Compared to wild type mice, mev/+ mice had significantly enhanced LPS induced airway inflammation and OVA induced anaphylactic responses, including hypothermia and clinical symptoms. These changes were mast cell dependent as Kit(W-sh) mice had reduced responses whereas adoptive transfer of mast cells restored the responses. However, T and B cells were not involved and macrophages did not play a significant role in LPS induced airway inflammation. Interestingly, basophil differentiation from SHP-1 deficient bone marrow cells was significantly reduced. These findings provided evidence that through regulation of mast cell functions SHP-1 plays a critical role as a negative regulator in allergic inflammation and in allergen induced anaphylaxis. In addition, SHP-1 seems to be required for normal basophil development.	[Zhou, Li; Oh, Sun Young; Zhou, Yuqi; Yuan, Baojun; Wu, Fan; Oh, Min Hee; Zheng, Tao; Zhu, Zhou] Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD USA; [Takemoto, Cliff] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Hematol, Baltimore, MD 21205 USA; [Wang, Yefu] Wuhan Univ, Ctr Expt Anim, ABSL Lab 3, Wuhan 430072, Peoples R China; [Wang, Yefu] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Van Rooijen, Nico] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Wuhan University; Wuhan University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Zhu, Z (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD USA.	zzhu@jhmi.edu	Van Rooijen, Nico/Z-1578-2019; Takemoto, Clifford M/Y-7558-2018	Oh, Min-Hee/0000-0003-1581-4288	National Institutes of Health (NIH) [R01HL079349, P01HL107151, R01AI075025, AI 075025-03S1]; China Scholarship Council grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079349, P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075025] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council grant(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants R01HL079349 and P01HL107151 to ZZ, R01AI075025 and AI 075025-03S1 to TZ, and a China Scholarship Council grant to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias K, 2011, J ALLERGY CLIN IMMUN, V127, P1552, DOI 10.1016/j.jaci.2011.03.044; Bem RA, 2008, AM J PHYSIOL-LUNG C, V295, pL314, DOI 10.1152/ajplung.00210.2007; Branum Amy M, 2008, NCHS Data Brief, P1; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brightling CE, 2003, CLIN EXP ALLERGY, V33, P1711, DOI 10.1111/j.1365-2222.2003.01827.x; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Chiba N, 2007, J CELL PHYSIOL, V213, P126, DOI 10.1002/jcp.21101; Cho YS, 2008, AM J RESP CELL MOL, V39, P412, DOI 10.1165/rcmb.2007-0229OC; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Christophi GP, 2009, LAB INVEST, V89, P742, DOI 10.1038/labinvest.2009.32; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Jang MK, 2010, BIOCHEM BIOPH RES CO, V393, P137, DOI 10.1016/j.bbrc.2010.01.102; Kamata T, 2003, J CLIN INVEST, V111, P109, DOI 10.1172/JCI200315719; Kim YK, 2007, J IMMUNOL, V178, P5375, DOI 10.4049/jimmunol.178.8.5375; Kumagai C, 2012, J NEUROIMMUNOL, V246, P51, DOI 10.1016/j.jneuroim.2012.03.003; Masuda A, 2002, J IMMUNOL, V169, P3801, DOI 10.4049/jimmunol.169.7.3801; Matsubara S, 2006, AM J RESP CRIT CARE, V173, P56, DOI 10.1164/rccm.200503-361OC; Moorman Jeanne E., 2011, Morbidity and Mortality Weekly Report, V60, P84; National Institute of Allergy and Infectious Diseases, 2003, NIH PUBL; Oh SY, 2009, AM J RESP CELL MOL, V40, P568, DOI 10.1165/rcmb.2008-0225OC; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Reuter S, 2008, EUR RESPIR J, V31, P773, DOI 10.1183/09031936.00058907; Roongapinun S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014174; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1976, J IMMUNOL, V116, P936; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Sun JF, 2007, J IMMUNOL, V179, P6696, DOI 10.4049/jimmunol.179.10.6696; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang L, 2010, J IMMUNOL, V184, P1180, DOI 10.4049/jimmunol.0901972; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu Z, 2010, CLIN EXP ALLERGY, V40, P536, DOI 10.1111/j.1365-2222.2010.03477.x	38	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55763	10.1371/journal.pone.0055763	http://dx.doi.org/10.1371/journal.pone.0055763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390550	Green Submitted, gold, Green Published			2022-12-27	WOS:000314691100066
J	Hummitzsch, K; Irving-Rodgers, HF; Hatzirodos, N; Bonner, W; Sabatier, L; Reinhardt, DP; Sado, Y; Ninomiya, Y; Wilhelm, D; Rodgers, RJ				Hummitzsch, Katja; Irving-Rodgers, Helen F.; Hatzirodos, Nicholas; Bonner, Wendy; Sabatier, Laetitia; Reinhardt, Dieter P.; Sado, Yoshikazu; Ninomiya, Yoshifumi; Wilhelm, Dagmar; Rodgers, Raymond J.			A New Model of Development of the Mammalian Ovary and Follicles	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; HUMAN-FETAL OVARY; GERM-CELLS; DIFFERENTIAL EXPRESSION; SEX DETERMINATION; GENE-EXPRESSION; RETE OVARII; MOUSE OVARY; SURFACE; GROWTH	Ovarian follicular granulosa cells surround and nurture oocytes, and produce sex steroid hormones. It is believed that during development the ovarian surface epithelial cells penetrate into the ovary and develop into granulosa cells when associating with oogonia to form follicles. Using bovine fetal ovaries (n = 80) we identified a novel cell type, termed GREL for Gonadal Ridge Epithelial-Like. Using 26 markers for GREL and other cells and extracellular matrix we conducted immunohistochemistry and electron microscopy and chronologically tracked all somatic cell types during development. Before 70 days of gestation the gonadal ridge/ovarian primordium is formed by proliferation of GREL cells at the surface epithelium of the mesonephros. Primordial germ cells (PGCs) migrate into the ovarian primordium. After 70 days, stroma from the underlying mesonephros begins to penetrate the primordium, partitioning the developing ovary into irregularly-shaped ovigerous cords composed of GREL cells and PGCs/oogonia. Importantly we identified that the cords are always separated from the stroma by a basal lamina. Around 130 days of gestation the stroma expands laterally below the outermost layers of GREL cells forming a sub-epithelial basal lamina and establishing an epithelial-stromal interface. It is at this stage that a mature surface epithelium develops from the GREL cells on the surface of the ovary primordium. Expansion of the stroma continues to partition the ovigerous cords into smaller groups of cells eventually forming follicles containing an oogonium/oocyte surrounded by GREL cells, which become granulosa cells, all enclosed by a basal lamina. Thus in contrast to the prevailing theory, the ovarian surface epithelial cells do not penetrate into the ovary to form the granulosa cells of follicles, instead ovarian surface epithelial cells and granulosa cells have a common precursor, the GREL cell.	[Hummitzsch, Katja; Irving-Rodgers, Helen F.; Hatzirodos, Nicholas; Bonner, Wendy; Rodgers, Raymond J.] Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Inst, Adelaide, SA 5005, Australia; [Irving-Rodgers, Helen F.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Sabatier, Laetitia] McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ, Canada; [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Sado, Yoshikazu] Shigei Med Res Inst, Div Immunol, Okayama, Japan; [Ninomiya, Yoshifumi] Okayama Univ, Sch Med, Dept Mol Biol & Biochem, Okayama 700, Japan; [Wilhelm, Dagmar] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Robinson Research Institute; University of Adelaide; Queensland University of Technology (QUT); McGill University; McGill University; Okayama University; Monash University	Rodgers, RJ (corresponding author), Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Inst, Adelaide, SA 5005, Australia.	ray.rodgers@adelaide.edu.au	Hummitzsch, Katja/K-6940-2013; Reinhardt, Dieter P/A-3102-2008; Hatzirodos, Nick/K-6939-2013; Wilhelm, Dagmar/B-6915-2009; Rodgers, Raymond J/C-3476-2009	Hummitzsch, Katja/0000-0001-5023-2668; Reinhardt, Dieter P/0000-0001-6535-9872; Hatzirodos, Nick/0000-0002-1342-9741; Wilhelm, Dagmar/0000-0002-7757-4075; 	National Health and Medical Research Council of Australia; University of Adelaide; Clive and Vera Ramaciotti Foundation; Grants-in-Aid for Scientific Research [23390348] Funding Source: KAKEN	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide; Clive and Vera Ramaciotti Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the National Health and Medical Research Council of Australia, the University of Adelaide and the Clive and Vera Ramaciotti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Auersperg N, 2000, METH MOLEC MED, V39, P169; BONILLAMUSOLES F, 1975, ARCH GYNAKOL, V218, P233, DOI 10.1007/BF00667384; Burkhart MN, 2010, ANIM REPROD SCI, V117, P43, DOI 10.1016/j.anireprosci.2009.02.010; BYSKOV AG, 1973, J ANAT, V116, P207; BYSKOV AG, 1977, J ANAT, V123, P77; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; CZERNOBILSKY B, 1985, EUR J CELL BIOL, V37, P175; DeFalco T, 2011, DEV BIOL, V352, P14, DOI 10.1016/j.ydbio.2011.01.011; Duffin K, 2009, MOL HUM REPROD, V15, P771, DOI 10.1093/molehr/gap065; Erickson AC, 2001, MATRIX BIOL, V19, P769, DOI 10.1016/S0945-053X(00)00126-8; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; FRIDMACHER V, 1992, DEVELOPMENT, V115, P503; Hatzirodos N, 2012, MATRIX BIOL, V31, P45, DOI 10.1016/j.matbio.2011.10.002; Hatzirodos N, 2011, FASEB J, V25, P2256, DOI 10.1096/fj.11-181099; Honda A, 2007, P NATL ACAD SCI USA, V104, P12389, DOI 10.1073/pnas.0703787104; Hughesdon P E, 1982, Obstet Gynecol Surv, V37, P59, DOI 10.1097/00006254-198202000-00001; Irving-Rodgers HF, 2009, REPRODUCTION, V137, P825, DOI 10.1530/REP-08-0485; Irving-Rodgers HF, 2009, HUM REPROD, V24, P936, DOI 10.1093/humrep/den447; Irving-Rodgers HF, 2002, REPRODUCTION, V123, P97, DOI 10.1530/rep.0.1230097; Irving-Rodgers HF, 2002, BIOL REPROD, V66, P934, DOI 10.1095/biolreprod66.4.934; Jimenez R, 2010, SEX DEV, V3, P291, DOI 10.1159/000280584; Juengel JL, 2002, MOL CELL ENDOCRINOL, V191, P1, DOI 10.1016/S0303-7207(02)00045-X; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; Kerr JB, 2006, REPRODUCTION, V132, P95, DOI 10.1530/rep.1.01128; Kezele P, 2002, FRONT BIOSCI-LANDMRK, V7, pD1990, DOI 10.2741/kezele; KONISHI I, 1986, J ANAT, V148, P121; Kovacic JC, 2008, TRENDS CARDIOVAS MED, V18, P45, DOI 10.1016/j.tcm.2007.12.002; Loffler S, 2000, ANAT EMBRYOL, V201, P207, DOI 10.1007/s004290050019; Logan KA, 2002, BIOL REPROD, V66, P906, DOI 10.1095/biolreprod66.4.906; Maheshwari A, 2008, ZYGOTE, V16, P285, DOI 10.1017/S0967199408004802; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; McNatty KP, 2000, MOL CELL ENDOCRINOL, V163, P11, DOI 10.1016/S0303-7207(99)00235-X; Mork L, 2011, BIOL REPROD; MOTTA PM, 1986, J SUBMICR CYTOL PATH, V18, P271; MOTTA PM, 1986, EUR J OBSTET GYN R B, V22, P271, DOI 10.1016/0028-2243(86)90115-2; Murayama C, 2008, MOL CELL BIOCHEM, V314, P51, DOI 10.1007/s11010-008-9764-y; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Pannetier M, 2005, GENOMICS, V85, P715, DOI 10.1016/j.ygeno.2005.02.011; Pannetier M, 2003, CYTOGENET GENOME RES, V101, P199, DOI 10.1159/000074337; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Ramayya MS, 2010, J STEROID BIOCHEM, V119, P14, DOI 10.1016/j.jsbmb.2009.11.006; Russe I, 1983, Bibl Anat, V24, P77; Sabatier L, 2010, MATRIX BIOL, V21, P21; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Sato Y, 2003, J CLIN ENDOCR METAB, V88, P3415, DOI 10.1210/jc.2002-021723; Sawyer HR, 2002, BIOL REPROD, V66, P1134, DOI 10.1095/biolreprod66.4.1134; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; Stoop H, 2005, HUM REPROD, V20, P1466, DOI 10.1093/humrep/deh800; Takamoto N, 2005, MOL ENDOCRINOL, V19, P2299, DOI 10.1210/me.2005-0019; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Urbanek M, 2005, J CLIN ENDOCR METAB, V90, P6623, DOI 10.1210/jc.2005-0622; VANDENHURK R, 1995, MOL REPROD DEV, V41, P459, DOI 10.1002/mrd.1080410408; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Wrobel KH, 2000, ANAT EMBRYOL, V202, P475, DOI 10.1007/s004290000133; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	65	85	86	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55578	10.1371/journal.pone.0055578	http://dx.doi.org/10.1371/journal.pone.0055578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409002	gold, Green Published			2022-12-27	WOS:000315157200041
J	Zhang, GQ; Wei, HM; Lu, J; Wong, P; Shim, W				Zhang, Guang Qin; Wei, Heming; Lu, Jun; Wong, Philip; Shim, Winston			Identification and Characterization of Calcium Sparks in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							FUNCTIONAL-PROPERTIES; IN-VITRO; DIFFERENTIATION; TRANSIENTS; GRADIENTS	Introduction: Ca2+ spark constitutes the elementary units of cardiac excitation-contraction (E-C) coupling in mature cardiomyocytes. Human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes are known to have electrophysiological properties similar to mature adult cardiomyocytes. However, it is unclear if they share similar calcium handling property. We hypothesized that Ca2+ sparks in human induced pluripotent stem cell (hiPSCs)-derived cardiomyocytes (hiPSC-CMs) may display unique structural and functional properties than mature adult cardiomyocytes. Methods and results: Ca2+ sparks in hiPSC-CMs were recorded with Ca2+ imaging assay with confocal laser scanning microscopy. Those sparks were stochastic with a tendency of repetitive occurrence at the same site. Nevertheless, the spatial-temporal properties of Ca2+ spark were analogous to that of adult CMs. Inhibition of L-type Ca2+ channels by nifedipine caused a 61% reduction in calcium spark frequency without affecting amplitude of those sparks and magnitude of caffeine releasable sarcoplasmic reticulum (SR) Ca2+ content. In contrast, high extracellular Ca2+ and ryanodine increased the frequency, full width at half maximum (FWHM) and full duration at half maximum (FDHM) of spontaneous Ca2+ sparks. Conclusions: For the first time, spontaneous Ca2+ sparks were detected in hiPSC-CMs. The Ca2+ sparks are predominately triggered by L-type Ca2+ channels mediated Ca2+ influx, which is comparable to sparks detected in adult ventricular myocytes in which cardiac E-C coupling was governed by a Ca2+-induced Ca2+ release (CICR) mechanism. However, focal repetitive sparks originated from the same intracellular organelle could reflect an immature status of the hiPSC-CMs.	[Zhang, Guang Qin; Wei, Heming; Lu, Jun; Wong, Philip; Shim, Winston] Natl Heart Ctr Singapore, Res & Dev Unit, Singapore, Singapore; [Zhang, Guang Qin] China Pharmaceut Univ, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China; [Wei, Heming; Wong, Philip; Shim, Winston] DUKE NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore	National Heart Centre Singapore; China Pharmaceutical University; National University of Singapore	Shim, W (corresponding author), Natl Heart Ctr Singapore, Res & Dev Unit, Singapore, Singapore.	winston.shim.s.n@nhcs.com.sg			National Research Foundation of Singapore [NRF2008 NRF-CRP003 002]	National Research Foundation of Singapore(National Research Foundation, Singapore)	This work is supported by the National Research Foundation of Singapore (NRF2008 NRF-CRP003 002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2004, DIFFERENTIATION, V72, P224, DOI 10.1111/j.1432-0436.2004.07205005.x; Baharvand H, 2006, CELL BIOL INT, V30, P800, DOI 10.1016/j.cellbi.2006.06.002; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blatter LA, 2003, J PHYSIOL-LONDON, V546, P19, DOI 10.1113/jphysiol.2002.025239; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHENG H, 1995, CIRC RES, V76, P236, DOI 10.1161/01.RES.76.2.236; Cheng H, 1996, AM J PHYSIOL-CELL PH, V270, pC148; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Essin K, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/135249; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Huser J, 1996, J PHYSIOL-LONDON, V494, P641; Itzhaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018037; Izu LT, 2006, BIOPHYS J, V91, P95, DOI 10.1529/biophysj.105.077214; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Lee YK, 2011, STEM CELL REV REP, V7, P976, DOI 10.1007/s12015-011-9273-3; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Sauer H, 2001, AM J PHYSIOL-HEART C, V281, pH411, DOI 10.1152/ajpheart.2001.281.1.H411; Sheehan KA, 2006, J PHYSIOL-LONDON, V572, P799, DOI 10.1113/jphysiol.2005.103267; Shiels HA, 2005, AM J PHYSIOL-REG I, V288, pR1756, DOI 10.1152/ajpregu.00510.2004; Sobie EA, 2005, J PHYSIOL-LONDON, V565, P441, DOI 10.1113/jphysiol.2005.086496; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Yang Z, 2002, CIRC RES, V91, P315, DOI 10.1161/01.RES.0000030180.06028.23; Zhang GQ, 2004, SCI CHINA SER C, V47, P31, DOI 10.1360/02yc0234; Zhu WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005407; Zhu XS, 2005, CELL CALCIUM, V37, P583, DOI 10.1016/j.ceca.2005.03.002	34	29	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55266	10.1371/journal.pone.0055266	http://dx.doi.org/10.1371/journal.pone.0055266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408964	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200022
J	Arruda, D; Publio, R; Roque, AC				Arruda, Denise; Publio, Rodrigo; Roque, Antonio C.			The Periglomerular Cell of the Olfactory Bulb and its Role in Controlling Mitral Cell Spiking: A Computational Model	PLOS ONE			English	Article							CALCIUM CURRENTS; GLOMERULAR LAYER; INHIBITION; MECHANISMS; SIMULATIONS; NEUROPIL	Interneurons in the olfactory bulb are key elements of odor processing but their roles have not yet being fully understood. Two types of inhibitory interneurons, periglomerular and granule cells, act at two different levels within the olfactory bulb and may have different roles in coordinating the spiking of mitral cells, which are the principal output neurons of the olfactory bulb. In this work we introduce a reduced compartmental model of the periglomerular cell and use it to investigate its role on mitral cell spiking in a model of an elementary cell triad composed of these two cell types plus a granule cell. Our simulation results show that the periglomerular cell is more effective in inhibiting the mitral cell than the granule cell. Based on our results we predict that periglomerular and granule cells have different roles in the control of mitral cell spiking. The periglomerular cell would be the only one capable of completely inhibiting the mitral cell, and the activity decrease of the mitral cell through this inhibitory action would occur in a stepwise fashion depending on parameters of the periglomerular and granule cells as well as on the relative times of arrival of external stimuli to the three cells. The major role of the granule cell would be to facilitate the inhibitory action of the periglomerular cell by enlarging the range of parameters of the periglomerular cell which correspond to complete inhibition of the mitral cell. The combined action of the two interneurons would thus provide an efficient way of controling the instantaneous value of the firing rate of the mitral cell.	[Arruda, Denise; Publio, Rodrigo; Roque, Antonio C.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, Brazil	Universidade de Sao Paulo	Arruda, D (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, Brazil.	denisearruda84@gmail.com	Roque, Antonio C./C-2316-2011	Roque, Antonio C./0000-0003-1260-4840	CNPq MSc scholarship; FAPESP post-doc grant; CNPq research grant	CNPq MSc scholarship; FAPESP post-doc grant; CNPq research grant(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DA was supported by a CNPq (www.cnpq.br) MSc scholarship. RP is supported by a FAPESP (www.fapesp.br) post-doc grant. ACR is supported by a CNPq research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Bardoni R, 1995, BRAIN RES, V703, P19, DOI 10.1016/0006-8993(95)01039-4; Bardoni R, 1996, NEUROSCI LETT, V210, P95, DOI 10.1016/0304-3940(96)12677-X; Bathellier B, 2006, J NEUROPHYSIOL, V95, P3961; BHALLA US, 1993, J NEUROPHYSIOL, V69, P1948, DOI 10.1152/jn.1993.69.6.1948; Cadetti L, 2001, NEUROREPORT, V12, P3117, DOI 10.1097/00001756-200110080-00027; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; Cleland TA, 2005, CHEM SENSES, V30, P801, DOI 10.1093/chemse/bji072; Cleland TA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00005; Cleland TA, 2010, TRENDS NEUROSCI, V33, P130, DOI 10.1016/j.tins.2009.12.004; David F, 2008, J COMPUT NEUROSCI, V25, P25, DOI 10.1007/s10827-007-0063-5; Davison AP, 2000, BRAIN RES BULL, V51, P393, DOI 10.1016/S0361-9230(99)00256-7; Davison AP, 2003, J NEUROPHYSIOL, V90, P1921, DOI 10.1152/jn.00623.2002; Davison AP, 2000, THESIS U CAMBRIDGE C; Destexhe A, 1996, J NEUROSCI, V16, P169; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Djurisic M, 2008, J NEUROSCI, V28, P4057, DOI 10.1523/JNEUROSCI.5296-07.2008; Fletcher ML, 2010, LEARN MEMORY, V17, P561, DOI 10.1101/lm.941510; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Maher BJ, 2008, J NEUROPHYSIOL, V99, P1559, DOI 10.1152/jn.00636.2007; McQuiston AR, 2001, J NEUROPHYSIOL, V86, P1899, DOI 10.1152/jn.2001.86.4.1899; Migliore M, 2005, J COMPUT NEUROSCI, V18, P151, DOI 10.1007/s10827-005-6556-1; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; PINCHING AJ, 1971, J CELL SCI, V9, P305; PINCHING AJ, 1971, J CELL SCI, V9, P379; PINCHING AJ, 1971, J CELL SCI, V9, P347; Puopolo M, 2005, J NEUROPHYSIOL, V94, P3618, DOI 10.1152/jn.00225.2005; Puopolo M, 1998, EUR J NEUROSCI, V10, P1073, DOI 10.1046/j.1460-9568.1998.00115.x; Rubin DB, 2006, J NEUROPHYSIOL, V96, P555, DOI 10.1152/jn.00264.2006; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Shen GYY, 1999, J NEUROPHYSIOL, V82, P3006, DOI 10.1152/jn.1999.82.6.3006; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Smith TC, 2002, NAT NEUROSCI, V5, P760, DOI 10.1038/nn882; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Wiechert MT, 2010, NAT NEUROSCI, V13; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	46	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56148	10.1371/journal.pone.0056148	http://dx.doi.org/10.1371/journal.pone.0056148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405261	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400207
J	Aswendt, M; Adamczak, J; Couillard-Despres, S; Hoehn, M				Aswendt, Markus; Adamczak, Joanna; Couillard-Despres, Sebastien; Hoehn, Mathias			Boosting Bioluminescence Neuroimaging: An Optimized Protocol for Brain Studies	PLOS ONE			English	Article							FIREFLY LUCIFERASE INHIBITION; IN-VIVO; MAMMALIAN-CELLS; GENE-EXPRESSION; LIVING MICE; STEM-CELL; REPORTER GENE; LONG-TERM; ANESTHETICS; MODEL	Bioluminescence imaging is widely used for optical cell tracking approaches. However, reliable and quantitative bioluminescence of transplanted cells in the brain is highly challenging. In this study we established a new bioluminescence imaging protocol dedicated for neuroimaging, which increases sensitivity especially for noninvasive tracking of brain cell grafts. Different D-Luciferin concentrations (15, 150, 300 and 750 mg/kg), injection routes (iv, ip, sc), types of anesthesia (Isoflurane, Ketamine/Xylazine, Pentobarbital) and timing of injection were compared using DCX-Luc transgenic mice for brain specific bioluminescence. Luciferase kinetics was quantitatively evaluated for maximal photon emission, total photon emission and time-to-peak. Photon emission followed a D-Luciferin dose-dependent relation without saturation, but with delay in time-to-peak increasing for increasing concentrations. The comparison of intravenous, subcutaneous and intraperitoneal substrate injection reflects expected pharmacokinetics with fastest and highest photon emission for intravenous administration. Ketamine/Xylazine and Pentobarbital anesthesia showed no significant beneficial effect on maximal photon emission. However, a strong difference in outcome was observed by injecting the substrate pre Isoflurane anesthesia. This protocol optimization for brain specific bioluminescence imaging comprises injection of 300 mg/kg D-Luciferin pre Isoflurane anesthesia as an efficient and stable method with a signal gain of approx. 200% (compared to 150 mg/kg post Isoflurane). Gain in sensitivity by the novel imaging protocol was quantitatively assessed by signal-to-noise calculations of luciferase-expressing neural stem cells grafted into mouse brains (transplantation of 3,000-300,000 cells). The optimized imaging protocol lowered the detection limit from 6,000 to 3,000 cells by a gain in signal-to-noise ratio.	[Aswendt, Markus; Adamczak, Joanna; Hoehn, Mathias] Max Planck Inst Neurol Res, In Vivo NMR Lab, D-50931 Cologne, Germany; [Couillard-Despres, Sebastien] Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria; [Couillard-Despres, Sebastien] Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria	Max Planck Society; Paracelsus Private Medical University	Hoehn, M (corresponding author), Max Planck Inst Neurol Res, In Vivo NMR Lab, Gleueler Str 50, D-50931 Cologne, Germany.	mathias@nf.mpg.de	Aswendt, Markus/L-2743-2019	Aswendt, Markus/0000-0003-1423-0934; Hummer, Joanna/0000-0002-0329-2892; Couillard-Despres, Sebastien/0000-0002-8486-6412	Volkswagen Foundation [I/83443]; EU-FP7 program ENCITE [HEALTH-F5-2008-201842, HEALTH-F2-2012-279017]	Volkswagen Foundation(Volkswagen); EU-FP7 program ENCITE	This work was financially supported by grants from the Volkswagen Foundation (I/83443) and the EU-FP7 program ENCITE (HEALTH-F5-2008-201842) and TargetBraIn (HEALTH-F2-2012-279017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger F, 2008, EUR J NUCL MED MOL I, V35, P2275, DOI 10.1007/s00259-008-0870-6; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Couillard-Despres S, 2008, MOL IMAGING, V7, P28, DOI 10.2310/7290.2008.0004; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Edinger M, 2002, EUR J CANCER, V38, P2128, DOI 10.1016/S0959-8049(02)00410-0; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; Gerbino P. P., 2005, REMINGTON SCI PRACTI; Gissel C, 2005, THROMB HAEMOSTASIS, V94, P719, DOI 10.1160/TH05-05-0338; Hasan MT, 2001, GENESIS, V29, P116, DOI 10.1002/gene.1014; Hildebrandt IJ, 2008, ILAR J, V49, P17, DOI 10.1093/ilar.49.1.17; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2; Keyaerts M, 2012, PLOS ONE, V7, P374, DOI 10.1371/journal.pone.0030061; Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Lee KH, 2003, NUCL MED COMMUN, V24, P1003, DOI 10.1097/00006231-200309000-00009; Leitao JMM, 2010, J PHOTOCH PHOTOBIO B, V101, P1, DOI 10.1016/j.jphotobiol.2010.06.015; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; Lipshutz GS, 2001, MOL THER, V3, P284, DOI 10.1006/mthe.2001.0267; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NGUYEN VT, 1988, ANAL BIOCHEM, V171, P404, DOI 10.1016/0003-2697(88)90505-2; Pawson P, 2008, SMALL ANIMAL CLIN PH; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Pesnel S, 2011, MOL IMAGING BIOL, V13, P646, DOI 10.1007/s11307-010-0387-9; Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Sher F, 2009, STEM CELLS, V27, P1582, DOI 10.1002/stem.76; Sutton EJ, 2008, EUR RADIOL, V18, P2021, DOI 10.1007/s00330-008-0984-z; Szarecka A, 2007, BIOPHYS J, V93, P1895, DOI 10.1529/biophysj.106.102780; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Wang WG, 2003, CANCER BIOL THER, V2, P196, DOI 10.4161/cbt.2.2.347; Zuurbier CJ, 2002, AM J PHYSIOL-HEART C, V282, pH2099, DOI 10.1152/ajpheart.01002.2001	39	58	58	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55662	10.1371/journal.pone.0055662	http://dx.doi.org/10.1371/journal.pone.0055662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405190	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400135
J	Bonnefond, A; Saulnier, PJ; Stathopoulou, MG; Grarup, N; Ndiaye, NC; Roussel, R; Nezhad, MA; Dechaume, A; Lantieri, O; Hercberg, S; Lauritzen, T; Balkau, B; Moustafa, JSE; Hansen, T; Pedersen, O; Froguel, P; Charpentier, G; Marre, M; Hadjadj, S; Visvikis-Siest, S				Bonnefond, Amelie; Saulnier, Pierre-Jean; Stathopoulou, Maria G.; Grarup, Niels; Ndiaye, Ndeye Coumba; Roussel, Ronan; Nezhad, Mohsen Azimi; Dechaume, Aurelie; Lantieri, Olivier; Hercberg, Serge; Lauritzen, Torsten; Balkau, Beverley; Moustafa, Julia S. El-Sayed; Hansen, Torben; Pedersen, Oluf; Froguel, Philippe; Charpentier, Guillaume; Marre, Michel; Hadjadj, Samy; Visvikis-Siest, Sophie			What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications?	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LOCI; ASSOCIATION; HERITABILITY; ANGIOGENESIS; POPULATION; EXPRESSION; DISEASE; BIOLOGY; SERUM	Vascular endothelial growth factor (VEGF) is a key chemokine involved in tissue growth and organ repair processes, particularly angiogenesis. Elevated circulating VEGF levels are believed to play a role in type 2 diabetes (T2D) microvascular complications, especially diabetic retinopathy. Recently, a genome-wide association study identified two common single nucleotide polymorphisms (SNPs; rs6921438 and rs10738760) explaining nearly half of the variance in circulating VEGF levels. Considering the putative contribution of VEGF to T2D and its complications, we aimed to assess the effect of these VEGF- related SNPs on the risk of T2D, nephropathy and retinopathy, as well as on variation in related traits. SNPs were genotyped in several case-control studies: French and Danish T2D studies (N-cases = 6,920-N-controls = 3,875 and N-cases = 3,561-N-controls = 2,623; respectively), two French studies one for diabetic nephropathy (N-cases = 1,242-N-controls = 860) and the other for diabetic retinopathy (N-cases = 1,336-N-controls = 1,231). The effects of each SNP on quantitative traits were analyzed in a French general population- based cohort (N = 4,760) and two French T2D studies (N = 3,480). SNP associations were assessed using logistic or linear regressions. In the French population, we found an association between the G-allele of rs6921438, shown to increase circulating VEGF levels, and increased T2D risk (OR = 1.15; P = 3.7 x 10(-5)). Furthermore, the same allele was associated with higher glycated hemoglobin levels (beta = 0.02%; P = 9.2 x 10(-3)). However, these findings were not confirmed in the Danes. Conversely, the SNP rs10738760 was not associated with T2D in the French or Danish populations. Despite having adequate statistical power, we did not find any significant effects of rs6921438 or rs10738760 on diabetic microvascular complications or the variation in related traits in T2D patients. In spite of their impact on the variance in circulating VEGF, we did not find any association between SNPs rs6921438 and rs10738760, and the risk of T2D, diabetic nephropathy or retinopathy. The link between VEGF and T2D and its complications might be indirect and more complex than expected.	[Bonnefond, Amelie; Stathopoulou, Maria G.; Ndiaye, Ndeye Coumba; Nezhad, Mohsen Azimi; Visvikis-Siest, Sophie] Univ Lorraine, Cardiovasc Genet Res Unit, EA4373, Nancy, France; [Saulnier, Pierre-Jean; Hadjadj, Samy] Univ Poitiers, Dept Endocrinol & Diabetol, Ctr Hosp Univ Poitiers, Poitiers, France; [Saulnier, Pierre-Jean; Hadjadj, Samy] Clin Invest Ctr CIC0802, Poitiers, France; [Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Roussel, Ronan; Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Bonnefond, Amelie; Roussel, Ronan; Marre, Michel] Univ Paris 07, INSERM, U695, Paris, France; [Dechaume, Aurelie; Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR8199, Lille, France; [Dechaume, Aurelie; Froguel, Philippe] Lille Nord de France Univ, Lille, France; [Lantieri, Olivier] Inst Interreg Sante IRSA, La Riche, France; [Hercberg, Serge] Univ Paris 13, Ctr Rech Nutr Humaine, Inst Natl Rech Agronom INRA Unit 1125, Inserm,U557, Bobigny, France; [Hercberg, Serge] Avicenne Hosp, AP HP, Dept Publ Hlth, Bobigny, France; [Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, Aarhus, Denmark; [Balkau, Beverley] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Balkau, Beverley] Univ Paris 11, Villejuif, France; [Moustafa, Julia S. El-Sayed; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Dept Endocrinol & Diabetol, Essonnes, France; [Hadjadj, Samy] INSERM, U1082, Poitiers, France	Universite de Lorraine; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; Novo Nordisk; Hagedorn Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Imperial College London; Aarhus University; Centre Hospitalier Sud Francilien; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers	Bonnefond, A (corresponding author), Univ Paris 07, INSERM, U695, Paris, France.	amelie.bonnefond@gmail.com; sophie.visvikis-siest@inserm.fr	Visvikis-Siest, Sophie/H-2324-2014; Bonnefond, Amélie/O-2784-2017; FROGUEL, Philippe/O-6799-2017; HERCBERG, Serge/B-4429-2008; Serge, Hercberg/F-3038-2017; Pedersen, Oluf/Z-1731-2019; SAULNIER, Pierre-Jean/H-7218-2016; Pedersen, Oluf/AAG-8015-2020; Grarup, Niels/K-2807-2015; Stathopoulou, Maria/H-7324-2016	Visvikis-Siest, Sophie/0000-0001-8104-8425; Bonnefond, Amélie/0000-0001-9976-3005; FROGUEL, Philippe/0000-0003-2972-0784; HERCBERG, Serge/0000-0002-3168-1350; Serge, Hercberg/0000-0002-3168-1350; Pedersen, Oluf/0000-0002-3321-3972; SAULNIER, Pierre-Jean/0000-0003-1862-4252; Grarup, Niels/0000-0001-5526-1070; Stathopoulou, Maria/0000-0003-4376-2083; Hansen, Torben/0000-0001-8748-3831; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654; Marre, Michel/0000-0002-3071-1837	BioIntelligence project; French minister of health (PHRC-Poitiers); French minister of health (PHRC-IR); AFD (Research Grant); GEMMS (Groupe d'Etude des Maladies Metaboliques et Systemiques [Poitiers, France]); MRC [G1002084] Funding Source: UKRI; Medical Research Council [G1002084] Funding Source: researchfish	BioIntelligence project; French minister of health (PHRC-Poitiers); French minister of health (PHRC-IR); AFD (Research Grant); GEMMS (Groupe d'Etude des Maladies Metaboliques et Systemiques [Poitiers, France]); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the BioIntelligence project. The Diab2-Nephrogene study was supported by grants from French minister of health (PHRC-Poitiers 2004 and PHRC-IR 2008) and AFD (Research Grant 2003). The association GEMMS (Groupe d'Etude des Maladies Metaboliques et Systemiques [Poitiers, France]) also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bates DO, 2002, VASC PHARMACOL, V39, P225, DOI 10.1016/S1537-1891(03)00011-9; Berrahmoune H, 2007, ANN HUM GENET, V71, P54, DOI 10.1111/j.1469-1809.2006.00298.x; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Chin BSP, 2002, AM J CARDIOL, V90, P1258, DOI 10.1016/S0002-9149(02)02848-5; Debette S, 2011, CIRC RES, V109, P554, DOI 10.1161/CIRCRESAHA.111.243790; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ellis JW, 2012, HUM MOL GENET, V21, P3293, DOI 10.1093/hmg/dds138; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Hadjadj S, 2008, DIABETES CARE, V31, P1847, DOI 10.2337/dc07-2079; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Hojo Y, 2000, J AM COLL CARDIOL, V35, P968, DOI 10.1016/S0735-1097(99)00632-4; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lieb W, 2009, EUR HEART J, V30, P1121, DOI 10.1093/eurheartj/ehp007; Pantsulaia I, 2004, CYTOKINE, V27, P152, DOI 10.1016/j.cyto.2004.04.005; Schrijvers BF, 2004, KIDNEY INT, V65, P2003, DOI 10.1111/j.1523-1755.2004.00621.x; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slevin M, 2000, STROKE, V31, P1863, DOI 10.1161/01.STR.31.8.1863; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Sparso T, 2009, DIABETES; TOI M, 1994, JPN J CANCER RES, V85, P1045, DOI 10.1111/j.1349-7006.1994.tb02904.x; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wasada T, 1998, METABOLISM, V47, P27, DOI 10.1016/S0026-0495(98)90188-3; Wirostko B, 2008, PROG RETIN EYE RES, V27, P608, DOI 10.1016/j.preteyeres.2008.09.002	32	30	31	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55921	10.1371/journal.pone.0055921	http://dx.doi.org/10.1371/journal.pone.0055921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405237	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400182
J	Bibiloni, MD; Pons, A; Tur, JA				del Mar Bibiloni, Maria; Pons, Antoni; Tur, Josep A.			Defining Body Fatness in Adolescents: A Proposal of the Afad-A Classification	PLOS ONE			English	Article							TO-HEIGHT RATIO; WAIST-CIRCUMFERENCE; RISK-FACTORS; HIP-RATIO; FAT DISTRIBUTION; MASS INDEX; CHILDREN; OVERWEIGHT; OBESITY; BMI	Aims: Body mass index (BMI) shows several limitations as indicator of fatness. Using the International Obesity Task Force (IOTF) reference and the World Health Organization (WHO) standard 2007 on the same dataset yielded widely different rates. At higher levels, BMI and the BMI cut-offs may be help in informing a clinical judgement, but at levels near the norm additional criteria may be needed. This study compares the prevalence of overweight and obesity using IOTF and WHO-2007 references and interprets body composition by comparing measures of BMI and body fatness (fat mass index, FMI; and waist-to-height ratio, WHtR) among an adolescent population. Methods and Results: A random sample (n = 1231) of adolescent population (12-17 years old) was interviewed. Weight, height, waist circumference, triceps and subscapular skinfolds were used to calculate BMI, FMI, and WHtR. The prevalence of overweight and obesity were 12.3% and 15.4% (WHO standards) and 18.6% and 6.1% (IOTF definition). Despite that IOTF cut-offs misclassified less often than WHO standards, BMI categories were combined with FMI and WHtR resulting in the Adiposity & Fat Distribution for adolescents (AFAD-A) classification, which identified the following groups normal-weight normal-fat (73.2%), normal-weight overfat (2.1%), overweight normal-fat (6.7%), overweight overfat (11.9%) and obesity (6.1%), and also classified overweight at risk and obese adolescents into type-I (9.5% and 1.3%, respectively) and type-II (2.3% and 4.9%, respectively) depending if they had or not abdominal fatness. Conclusions: There are differences between IOTF and WHO-2007 international references and there is a misclassification when adiposity is considered. The BMI limitations, especially for overweight identification, could be reduced by adding an estimate of both adiposity (FMI) and fat distribution (WHtR). The AFAD-A classification could be useful in clinical and population health to identify overfat adolescent and those who have greater risk of developing weight-related cardiovascular diseases according to the BMI category.	[del Mar Bibiloni, Maria; Pons, Antoni; Tur, Josep A.] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain; [del Mar Bibiloni, Maria; Pons, Antoni; Tur, Josep A.] Inst Salud Carlos III, CIBERobn Fisiopatol Obesidad & Nutr CB12 03 30038, Madrid, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Tur, JA (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain.	pep.tur@uib.es	Tur, Josep/AAE-5748-2020; Pons, Antoni/L-4844-2014; Tur, Josep Antoni/F-5576-2014; del Mar Bibiloni, Maria/M-3123-2014; Bibiloni, Maria del Mar/H-9734-2015	Tur, Josep/0000-0002-6940-0761; Pons, Antoni/0000-0003-2447-3868; Tur, Josep Antoni/0000-0002-6940-0761; del Mar Bibiloni, Maria/0000-0001-8926-9206; 	Spanish Ministry of Health and Consumption Affairs [05/1276, 08/1259, 11/01791, RD06/0045/1004, CB12/03/30038]; Balearic Islands Gov. [35/2011]; EU FEDER funds [35/2011]; Spanish Ministry of Education and Science (FPU Programme)	Spanish Ministry of Health and Consumption Affairs(Spanish Government); Balearic Islands Gov.; EU FEDER funds(European Commission); Spanish Ministry of Education and Science (FPU Programme)(Spanish Government)	The study was supported by the Spanish Ministry of Health and Consumption Affairs (Programme of Promotion of Biomedical Research and Health Sciences, Projects 05/1276, 08/1259, and 11/01791, Red Predimed-RETIC RD06/0045/1004, and CIBERobn CB12/03/30038), Grant of support to research groups no. 35/2011 (Balearic Islands Gov. and EU FEDER funds), Spanish Ministry of Education and Science (FPU Programme, PhD fellowship to M. M. B.). The Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands belongs to the Centre Catala de la Nutricio (IEC) and Exernet Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio-Sanz J, 2011, MED ORAL PATOL ORAL, V16, pE271, DOI 10.4317/medoral.16.e271; Baumgartner RN, 1998, J APPL PHYSIOL, V84, P257, DOI 10.1152/jappl.1998.84.1.257; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2009, PEDIATRICS, V124, pS35, DOI 10.1542/peds.2008-3586F; Lorenzo A, 2006, NUTR METAB CARDIOVAS, V16, P513, DOI 10.1016/j.numecd.2005.10.010; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dencker M, 2007, CLIN PHYSIOL FUNCT I, V27, P12, DOI 10.1111/j.1475-097X.2007.00709.x; Dobbelsteyn CJ, 2001, INT J OBESITY, V25, P652, DOI 10.1038/sj.ijo.0801582; Hall DMB, 2006, ARCH DIS CHILD, V91, P283, DOI 10.1136/adc.2005.077339; Haroun D, 2010, OBESITY, V18, P1252, DOI 10.1038/oby.2009.344; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Millstein Rachel A, 2008, Medscape J Med, V10, P119; Monasta L, 2011, OBES REV, V12, P295, DOI 10.1111/j.1467-789X.2010.00748.x; Moreno LA, 1997, J PEDIATR GASTR NUTR, V25, P175, DOI 10.1097/00005176-199708000-00008; Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300; Nambiar S, 2010, PUBLIC HEALTH NUTR, V13, P1566, DOI 10.1017/S1368980009993053; Neovius M, 2005, INT J OBESITY, V29, P163, DOI 10.1038/sj.ijo.0802867; Owen PR, 2000, J APPL SOC PSYCHOL, V30, P979, DOI 10.1111/j.1559-1816.2000.tb02506.x; Ramadhani MK, 2006, ATHEROSCLEROSIS, V184, P21, DOI 10.1016/j.atherosclerosis.2005.03.022; Alvero-Cruz JR, 2010, MED CLIN-BARCELONA, V135, P8, DOI 10.1016/j.medcli.2010.01.017; Reilly JJ, 2006, INT J OBESITY, V30, P595, DOI 10.1038/sj.ijo.0803301; Rodriguez G, 2005, EUR J CLIN NUTR, V59, P1158, DOI 10.1038/sj.ejcn.1602226; Rodriguez G, 2004, INT J OBESITY, V28, pS54, DOI 10.1038/sj.ijo.0802805; Sardinha LB, 2011, INT J PEDIATR OBES, V6, pE124, DOI 10.3109/17477166.2010.490263; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Utter J, 2010, INT J PEDIATR OBES, V5, P461, DOI 10.3109/17477160903568439; Wells JCK, 2002, INT J OBESITY, V26, P947, DOI 10.1038/sj.ijo.0802027; World Health Organization Expert Committee, 1995, WHO TECHN REP SER; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743	34	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55849	10.1371/journal.pone.0055849	http://dx.doi.org/10.1371/journal.pone.0055849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405220	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400165
J	Ghirotto, S; Tassi, F; Fumagalli, E; Colonna, V; Sandionigi, A; Lari, M; Vai, S; Petiti, E; Corti, G; Rizzi, E; De Bellis, G; Caramelli, D; Barbujani, G				Ghirotto, Silvia; Tassi, Francesca; Fumagalli, Erica; Colonna, Vincenza; Sandionigi, Anna; Lari, Martina; Vai, Stefania; Petiti, Emmanuele; Corti, Giorgio; Rizzi, Ermanno; De Bellis, Gianluca; Caramelli, David; Barbujani, Guido			Origins and Evolution of the Etruscans' mtDNA	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; SEQUENCE; TIME; POPULATIONS; NEANDERTHAL; DIVERGENCE; MIGRATION; INFERENCE; MODELS	The Etruscan culture is documented in Etruria, Central Italy, from the 8th to the 1st century BC. For more than 2,000 years there has been disagreement on the Etruscans' biological origins, whether local or in Anatolia. Genetic affinities with both Tuscan and Anatolian populations have been reported, but so far all attempts have failed to fit the Etruscans' and modern populations in the same genealogy. We extracted and typed the hypervariable region of mitochondrial DNA of 14 individuals buried in two Etruscan necropoleis, analyzing them along with other Etruscan and Medieval samples, and 4,910 contemporary individuals from the Mediterranean basin. Comparing ancient (30 Etruscans, 27 Medieval individuals) and modern DNA sequences (370 Tuscans), with the results of millions of computer simulations, we show that the Etruscans can be considered ancestral, with a high degree of confidence, to the current inhabitants of Casentino and Volterra, but not to the general contemporary population of the former Etruscan homeland. By further considering two Anatolian samples (35 and 123 individuals) we could estimate that the genetic links between Tuscany and Anatolia date back to at least 5,000 years ago, strongly suggesting that the Etruscan culture developed locally, and not as an immediate consequence of immigration from the Eastern Mediterranean shores.	[Ghirotto, Silvia; Tassi, Francesca; Fumagalli, Erica; Colonna, Vincenza; Barbujani, Guido] Univ Ferrara, Dept Biol & Evolut, I-44100 Ferrara, Italy; [Tassi, Francesca] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Colonna, Vincenza] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy; [Sandionigi, Anna; Lari, Martina; Vai, Stefania; Petiti, Emmanuele; Caramelli, David] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Corti, Giorgio; Rizzi, Ermanno; De Bellis, Gianluca] CNR, Inst Biomed Technol, Milan, Italy	University of Ferrara; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Barbujani, G (corresponding author), Univ Ferrara, Dept Biol & Evolut, I-44100 Ferrara, Italy.	g.barbujani@unife.it	Sandionigi, Anna/H-8815-2016; De Bellis, Gianluca/H-9725-2013; Lari, Martina/A-4085-2009; Barbujani, Guido/ABE-9998-2020; rizzi, ermanno/Q-3399-2016; Colonna, Vincenza/H-2021-2014	Sandionigi, Anna/0000-0002-5257-0027; De Bellis, Gianluca/0000-0002-1622-4477; Barbujani, Guido/0000-0001-7854-6669; rizzi, ermanno/0000-0002-9898-2326; Colonna, Vincenza/0000-0002-3966-0474; Petiti, Emmanuele/0000-0002-4726-4172; Caramelli, David/0000-0001-6468-1675; Corti, Giorgio/0000-0001-6379-4117; tassi, francesca/0000-0001-8310-323X; VAI, STEFANIA/0000-0003-3844-5147	Italian Ministry for Universities Funds PRIN; Italian Ministry for Universities Funds FIRB [RBFR08U07M]; "Futuro in ricerca" grant [RBFR08U07M]; Fondazione Cassa di Risparmio di Ferrara; Associazione Archeologica Odysseus Casale di Pari	Italian Ministry for Universities Funds PRIN; Italian Ministry for Universities Funds FIRB; "Futuro in ricerca" grant; Fondazione Cassa di Risparmio di Ferrara(Fondazione Carife); Associazione Archeologica Odysseus Casale di Pari	Study supported by the Italian Ministry for Universities Funds PRIN 2008 to GB and DC and FIRB 2008 (RBFR08U07M) to ER, DC and GB, by the "Futuro in ricerca" grant RBFR08U07M to ML, ER, GC, GD and DC, by the Fondazione Cassa di Risparmio di Ferrara and by Associazione Archeologica Odysseus Casale di Pari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2010, R LANG ENV STAT COMP; Bandelt HJ, 2006, ANN HUM GENET, V70, P314, DOI 10.1111/j.1469-1809.2005.00234.x; Bandelt HJ, 2004, AM J HUM GENET, V75, P919, DOI 10.1086/425180; Barker G., 2006, AGR REVOLUTION PREHI; Barker G, 1998, ETRUSCANS; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2008, SIMULATIONS GENETICS, P135; Belle EMS, 2009, HEREDITY, V102, P218, DOI 10.1038/hdy.2008.103; Belle EMS, 2006, P NATL ACAD SCI USA, V103, P8012, DOI 10.1073/pnas.0509718103; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; BIRABEN JN, 1979, POPULATION, V34, P13, DOI 10.2307/1531855; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Caramelli D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002700; Claassen H, 2004, ANN ANAT, V186, P157, DOI 10.1016/S0940-9602(04)80032-3; Di Benedetto G, 2001, AM J PHYS ANTHROPOL, V115, P144, DOI 10.1002/ajpa.1064; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Gelman A., 2004, BAYESIAN DATA ANAL; Ghirotto S, 2010, MOL BIOL EVOL, V27, P875, DOI 10.1093/molbev/msp292; Guimaraes S, 2009, MOL BIOL EVOL, V26, P2157, DOI 10.1093/molbev/msp126; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Laval G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010284; Livi-Bacci M., 2007, CONCISE HIST WORLD P; Maricic T, 2009, BIOTECHNIQUES, V46, P51, DOI 10.2144/000113042; Mateiu LM, 2008, MOL BIOL EVOL, V25, P1503, DOI 10.1093/molbev/msn095; Neuenschwander S, 2008, MOL ECOL, V17, P757, DOI 10.1111/j.1365-294X.2007.03621.x; Nielsen R, 2001, GENETICS, V158, P885; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Turchi C, 2008, INT J LEGAL MED, V122, P199, DOI 10.1007/s00414-007-0207-1; Vernesi C, 2004, AM J HUM GENET, V74, P694, DOI 10.1086/383284; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102	47	22	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55519	10.1371/journal.pone.0055519	http://dx.doi.org/10.1371/journal.pone.0055519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405165	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400110
J	Hoertel, N; Le Strat, Y; Limosin, F; Dubertret, C; Gorwood, P				Hoertel, Nicolas; Le Strat, Yann; Limosin, Frederic; Dubertret, Caroline; Gorwood, Philip			Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample	PLOS ONE			English	Article							ALCOHOL-USE DISORDER; INTERVIEW SCHEDULE AUDADIS; ANTIDEPRESSANT EFFICACY TRIALS; STAR-ASTERISK-D; BIPOLAR DISORDERS; CLINICAL-TRIAL; DRUG MODULES; MEDICAL LITERATURE; USERS GUIDES; RELIABILITY	Background: Growing evidence supports the validity of distinguishing major depressive disorder (MDD) plus a lifetime history of subthreshold hypomania (D(m)) from pure MDD in psychiatric classifications. The present study sought to estimate the proportion of individuals with D(m) that would have been included in RCTs for MDD using typical eligibility criteria, and examine the potential impact of including these participants on internal validity. Methods: Data were derived from the 2001-2002 National Epidemiological Survey on Alcohol and Related Conditions (NESARC), a national representative sample of 43,093 adults of the United States population. We examined the proportion of participants with a current diagnosis of pure MDD and D(m) that would have been eligible in clinical trials for MDD with a traditional set of eligibility criteria, and compared it with that of participants with bipolar 2 disorder if the same set of eligibility criteria was applied. We considered 4 models including different definitions of subthreshold hypomania. Results: We found that more than 7 out of ten participants with pure MDD and with D(m) would have been excluded by at least one classical eligibility criterion. Prevalence rate of individuals with D(m) in RCTs for MDD with traditional eligibility criteria would have ranged from 7.98% to 22.59%. Overall exclusion rate of individuals with MDD plus at least 4 lifetime concomitant hypomanic probes significantly differ from those with pure MDD, whereas it was not significantly different in those with at least 2 lifetime concomitant hypomanic probes compared to those with bipolar 2 disorder. Conclusions: The current design of clinical trials for MDD may suffer from impaired external validity and potential impaired internal validity, due to the inclusion of a substantial proportion of individuals with subthreshold hypomania presenting with similar pattern of exclusion rates to those with bipolar 2 disorder, possibly resulting in a selection bias.	[Hoertel, Nicolas; Limosin, Frederic] Hop Corentin Celton, AP HP, Psychiat Serv, Issy Les Moulineaux, France; [Hoertel, Nicolas; Le Strat, Yann; Limosin, Frederic; Dubertret, Caroline; Gorwood, Philip] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Hoertel, Nicolas; Le Strat, Yann; Limosin, Frederic; Dubertret, Caroline; Gorwood, Philip] INSERM, U894, Ctr Psychiat & Neurosci, Paris, France; [Le Strat, Yann; Dubertret, Caroline] Hop Louis Mourier, AP HP, Serv Psychiat & Addictol, F-92701 Colombes, France; [Gorwood, Philip] Grp Hosp St Anne, CMME, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Corentin-Celton - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Hoertel, N (corresponding author), Hop Corentin Celton, AP HP, Psychiat Serv, Issy Les Moulineaux, France.	nico.hoertel@yahoo.fr	GORWOOD, Philip/M-9703-2019; , Hoertel/H-9457-2015	GORWOOD, Philip/0000-0003-1845-3676; , Hoertel/0000-0002-7890-1349	Eli Lilly; Servier	Eli Lilly(Eli Lilly); Servier(Servier)	Professor Philip Gorwood is a consultant for Eli Lilly, Janssen, Lundbeck, Roche and Servier, has received grant/research support from Eli Lilly and Servier, honoraria from AstraZeneca, Bristol-Myers Squibb, Janssen, Lundbeck, Roche and Servier, and is speaker/on advisory boards for AstraZeneca, Bristol-Myers Squibb, Janssen, Lundbeck, Roche and Servier;. Professor Frederic Limosin is speaker/on advisory boards for Bristol-Myers Squibb, Eutherapie, Janssen, and Lundbeck. All other authors declare that they have no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Angst J, 2003, J AFFECT DISORDERS, V73, P133, DOI 10.1016/S0165-0327(02)00322-1; Angst J, 2011, EUR ARCH PSYCHIAT CL; Angst J, 2007, BRIT J PSYCHIAT, V190, P189, DOI 10.1192/bjp.bp.106.030957; Angst J, 2011, ARCH GEN PSYCHIAT, V68, P791, DOI 10.1001/archgenpsychiatry.2011.87; Angst J, 2010, AM J PSYCHIAT, V167, P1194, DOI 10.1176/appi.ajp.2010.09071011; Blanco C, 2008, DRUG ALCOHOL DEPEN, V98, P123, DOI 10.1016/j.drugalcdep.2008.05.002; Blanco C, 2008, J CLIN PSYCHIAT, V69, P1276, DOI 10.4088/JCP.v69n0810; Bucher HC, 1999, JAMA-J AM MED ASSOC, V282, P771, DOI 10.1001/jama.282.8.771; Canino G, 1999, J STUD ALCOHOL, V60, P790, DOI 10.15288/jsa.1999.60.790; Chatterji S, 1997, DRUG ALCOHOL DEPEN, V47, P171, DOI 10.1016/S0376-8716(97)00088-4; Cruz N, 2010, INT J NEUROPSYCHOPH, V13, P5, DOI 10.1017/S1461145709990344; Dzewaltowski DA, 2004, HEALTH PROMOT INT, V19, P235, DOI 10.1093/heapro/dah211; Fiedorowicz JG, 2011, AM J PSYCHIAT, V168, P40, DOI 10.1176/appi.ajp.2010.10030328; Gaynes BN, 2009, PSYCHIAT SERV, V60, P1439, DOI 10.1176/ps.2009.60.11.1439; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P37, DOI 10.1016/0376-8716(95)01134-K; Hasin D, 1997, DRUG ALCOHOL DEPEN, V44, P133, DOI 10.1016/S0376-8716(97)01332-X; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hoertel N, 2013, J CLIN PSYCHIAT, V74, P265, DOI 10.4088/JCP.12m07935; Hoertel N, 2013, J AFFECT DISORDERS, V146, P383, DOI 10.1016/j.jad.2012.09.023; Hoertel N, 2013, J AFFECT DISORDERS, V146, P338, DOI 10.1016/j.jad.2012.09.016; Hoertel N, 2012, DEPRESS ANXIETY, V29, P614, DOI 10.1002/da.21937; Judd LL, 2003, J AFFECT DISORDERS, V73, P123, DOI 10.1016/S0165-0327(02)00332-4; Keck PE, 2008, J PSYCHIATR PRACT, V14, P31, DOI 10.1097/01.pra.0000320124.91799.2a; LEWINSOHN PM, 1995, J AM ACAD CHILD PSY, V34, P454, DOI 10.1097/00004583-199504000-00012; Licht RW, 2008, BIPOLAR DISORD, V10, P79, DOI 10.1111/j.1399-5618.2008.00499.x; Mavissakalian MR, 2002, COMPR PSYCHIAT, V43, P88, DOI 10.1053/comp.2002.30803; Melberg HO, 2010, DRUG ALCOHOL REV, V29, P193, DOI 10.1111/j.1465-3362.2009.00096.x; Merikangas KR, 2008, ARCH GEN PSYCHIAT, V65, P47, DOI 10.1001/archgenpsychiatry.2007.18; Ghaemi S, 2008, BIPOLAR DISORD, V10, P957, DOI 10.1111/j.1399-5618.2008.00639.x; OXMAN AD, 1993, JAMA-J AM MED ASSOC, V270, P2093; Seemuller F, 2009, ACTA PSYCHIAT SCAND, V119, P166, DOI 10.1111/j.1600-0447.2008.01328.x; Szadoczky E, 1998, J AFFECT DISORDERS, V50, P153, DOI 10.1016/S0165-0327(98)00056-1; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Zimmerman M, 2005, AM J PSYCHIAT, V162, P1370, DOI 10.1176/appi.ajp.162.7.1370; Zimmerman M, 2004, J NERV MENT DIS, V192, P87, DOI 10.1097/01.nmd.0000110279.23893.82; Zimmerman M, 2002, AM J PSYCHIAT, V159, P469, DOI 10.1176/appi.ajp.159.3.469; Zimmermann P, 2009, ARCH GEN PSYCHIAT, V66, P1341, DOI 10.1001/archgenpsychiatry.2009.158	40	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55448	10.1371/journal.pone.0055448	http://dx.doi.org/10.1371/journal.pone.0055448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405152	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400097
J	Hornung, C; Poehlein, A; Haack, FS; Schmidt, M; Dierking, K; Pohlen, A; Schulenburg, H; Blokesch, M; Plener, L; Jung, K; Bonge, A; Krohn-Molt, I; Utpatel, C; Timmermann, G; Spieck, E; Pommerening-Roser, A; Bode, E; Bode, HB; Daniel, R; Schmeisser, C; Streit, WR				Hornung, Claudia; Poehlein, Anja; Haack, Frederike S.; Schmidt, Martina; Dierking, Katja; Pohlen, Andrea; Schulenburg, Hinrich; Blokesch, Melanie; Plener, Laure; Jung, Kirsten; Bonge, Andreas; Krohn-Molt, Ines; Utpatel, Christian; Timmermann, Gabriele; Spieck, Eva; Pommerening-Roeser, Andreas; Bode, Edna; Bode, Helge B.; Daniel, Rolf; Schmeisser, Christel; Streit, Wolfgang R.			The Janthinobacterium sp HH01 Genome Encodes a Homologue of the V. cholerae CqsA and L. pneumophila LqsA Autoinducer Synthases	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; CHROMOBACTERIUM-VIOLACEUM; VIBRIO-CHOLERAE; IV PILI; TWITCHING MOTILITY; VI SECRETION; IN-VITRO; BACTERIAL; SEQUENCE; COMMUNICATION	Janthinobacteria commonly form biofilms on eukaryotic hosts and are known to synthesize antibacterial and antifungal compounds. Janthinobacterium sp. HH01 was recently isolated from an aquatic environment and its genome sequence was established. The genome consists of a single chromosome and reveals a size of 7.10 Mb, being the largest janthinobacterial genome so far known. Approximately 80% of the 5,980 coding sequences (CDSs) present in the HH01 genome could be assigned putative functions. The genome encodes a wealth of secretory functions and several large clusters for polyketide biosynthesis. HH01 also encodes a remarkable number of proteins involved in resistance to drugs or heavy metals. Interestingly, the genome of HH01 apparently lacks the N-acylhomoserine lactone (AHL)-dependent signaling system and the AI-2-dependent quorum sensing regulatory circuit. Instead it encodes a homologue of the Legionella-and Vibrio-like autoinducer (lqsA/cqsA) synthase gene which we designated jqsA. The jqsA gene is linked to a cognate sensor kinase (jqsS) which is flanked by the response regulator jqsR. Here we show that a jqsA deletion has strong impact on the violacein biosynthesis in Janthinobacterium sp. HH01 and that a jqsA deletion mutant can be functionally complemented with the V. cholerae cqsA and the L. pneumophila lqsA genes.	[Hornung, Claudia; Haack, Frederike S.; Schmidt, Martina; Bonge, Andreas; Krohn-Molt, Ines; Utpatel, Christian; Timmermann, Gabriele; Spieck, Eva; Pommerening-Roeser, Andreas; Schmeisser, Christel; Streit, Wolfgang R.] Univ Hamburg, Biozentrum Klein Flottbek, Abt Mikrobiol & Biotechnol, Hamburg, Germany; [Poehlein, Anja; Daniel, Rolf] Univ Gottingen, Inst Mikrobiol & Genet, Lab Genomanal, D-37073 Gottingen, Germany; [Dierking, Katja; Pohlen, Andrea; Schulenburg, Hinrich] Univ Kiel, Dept Evolutionary Ecol & Genet, Kiel, Germany; [Blokesch, Melanie] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Mol Microbiol Lab, Lausanne, Switzerland; [Plener, Laure; Jung, Kirsten] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biol 1, Martinsried, Germany; [Bode, Edna; Bode, Helge B.] Goethe Univ Frankfurt, Inst Mol Biowissensch, Frankfurt, Germany	University of Hamburg; University of Gottingen; University of Kiel; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Munich; Goethe University Frankfurt	Streit, WR (corresponding author), Univ Hamburg, Biozentrum Klein Flottbek, Abt Mikrobiol & Biotechnol, Hamburg, Germany.	wolfgang.streit@uni-hamburg.de	Schulenburg, Hinrich/A-3886-2009; Streit, Wolfgang R/K-1366-2012; Ziegler, Katja/GPT-0482-2022; Dierking, Katja/E-1050-2011; Daniel, Rolf/AAQ-5933-2021; Blokesch, Melanie/A-4057-2013; Bode, Helge B/F-7022-2014; Streit, Wolfgang/S-3049-2019	Dierking, Katja/0000-0002-5129-346X; Daniel, Rolf/0000-0002-8646-7925; Blokesch, Melanie/0000-0002-7024-1489; Bode, Helge B/0000-0001-6048-5909; Streit, Wolfgang/0000-0001-7617-7396; Poehlein, Anja/0000-0002-2473-6202	German Federal Ministry of Education and Research (BMBF)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was kindly funded by the German Federal Ministry of Education and Research (BMBF) within the framework GenomikTransfer and in relation to the ExpressSys and ChemBiofilm network projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Antonio Regina Vasconcellos, 2004, Genet Mol Res, V3, P85; Aranda S, 2011, MICROB ECOL, V62, P446, DOI 10.1007/s00248-011-9840-9; Audic S, 2007, PLOS GENET, V3, P1454, DOI 10.1371/journal.pgen.0030138; August PR, 2000, J MOL MICROB BIOTECH, V2, P513; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Blosser RS, 2000, J MICROBIOL METH, V40, P47, DOI 10.1016/S0167-7012(99)00136-0; BRENNER S, 1974, GENETICS, V77, P71; Bromberg N, 2005, J ENZYM INHIB MED CH, V20, P449, DOI 10.1080/14756360500273052; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cazoto LL, 2011, J ANTIBIOT, V64, P395, DOI 10.1038/ja.2011.13; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; de Carvalho DD, 2006, TOXICOL IN VITRO, V20, P1514, DOI 10.1016/j.tiv.2006.06.007; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; DELEY J, 1978, INT J SYST BACTERIOL, V28, P154, DOI 10.1099/00207713-28-2-154; Driessen AJM, 1998, CURR OPIN MICROBIOL, V1, P216, DOI 10.1016/S1369-5274(98)80014-3; DUCEY TF, 2002, EPICENTRE FORUM, V9, P6; Federle MJ, 2009, CONTRIB MICROBIOL, V16, P18, DOI 10.1159/000219371; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Galloway WRJD, 2011, CHEM REV, V111, P28, DOI 10.1021/cr100109t; Ganin H, 2012, ACS CHEM BIOL, V7, P659, DOI 10.1021/cb2004675; GONZALEZ C, 1987, CAN J MICROBIOL, V33, P1120, DOI 10.1139/m87-196; Hakvag S, 2009, MAR DRUGS, V7, P576, DOI 10.3390/md7040576; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kelly RC, 2009, NAT CHEM BIOL, V5, P891, DOI 10.1038/nchembio.237; Kim SJ, 2012, J BACTERIOL, V194, P2096, DOI 10.1128/JB.00096-12; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Lee YM, 2011, J MICROBIOL, V49, P355, DOI 10.1007/s12275-011-0232-0; Lo Scrudato M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002778; Lopes SCP, 2009, ANTIMICROB AGENTS CH, V53, P2149, DOI 10.1128/AAC.00693-08; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mashburn-Warren L, 2008, GEOBIOLOGY, V6, P214, DOI 10.1111/j.1472-4669.2008.00157.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Meiser P, 2008, CHEMBIOCHEM, V9, P1549, DOI 10.1002/cbic.200800077; Mojib N, 2011, INT J DERMATOL, V50, P1223, DOI 10.1111/j.1365-4632.2010.04825.x; Mojib N, 2010, ANTON LEEUW INT J G, V98, P531, DOI 10.1007/s10482-010-9470-0; Molnar I, 2000, CHEM BIOL, V7, P97, DOI 10.1016/S1074-5521(00)00075-2; Momen AZMR, 2000, BIOSCI BIOTECH BIOCH, V64, P539, DOI 10.1271/bbb.64.539; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Morohoshi T, 2008, FEMS MICROBIOL LETT, V279, P124, DOI 10.1111/j.1574-6968.2007.01016.x; Morohoshi T, 2010, BIOSCI BIOTECH BIOCH, V74, P2116, DOI 10.1271/bbb.100385; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ng WL, 2011, MOL MICROBIOL, V79, P1407, DOI 10.1111/j.1365-2958.2011.07548.x; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Pantanella F, 2007, J APPL MICROBIOL, V102, P992, DOI 10.1111/j.1365-2672.2006.03155.x; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Robbel L, 2010, J BIOL CHEM, V285, P27501, DOI 10.1074/jbc.R110.128181; Rodrigues AL, 2012, BIOTECHNOL LETT, V34, P717, DOI 10.1007/s10529-011-0827-x; Rossolini GM, 2001, ANTIMICROB AGENTS CH, V45, P837, DOI 10.1128/AAC.45.3.837-844.2001; Ryan KS, 2008, J BIOL CHEM, V283, P6467, DOI 10.1074/jbc.M708573200; Sambrook J., 2001, MOL CLONING LAB MANU; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Schiex T, 2003, NUCLEIC ACIDS RES, V31, P3738, DOI 10.1093/nar/gkg610; Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09; Shinoda K, 2007, CHEM COMMUN, P4140, DOI 10.1039/b705358d; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SNEATH PHA, 1956, J GEN MICROBIOL, V15, P70, DOI 10.1099/00221287-15-1-70; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; Stiernagle Theresa, 2006, WormBook, P1; Suckow G, 2011, J BACTERIOL, V193, P4914, DOI 10.1128/JB.05396-11; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tech Maike, 2003, In Silico Biology, V3, P441; Tiaden A, 2010, TRENDS MICROBIOL, V18, P288, DOI 10.1016/j.tim.2010.03.004; Tiaden A, 2010, ENVIRON MICROBIOL, V12, P1243, DOI 10.1111/j.1462-2920.2010.02167.x; Voget S, 2003, APPL ENVIRON MICROB, V69, P6235, DOI 10.1128/AEM.69.10.6235-6242.2003; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Yada S, 2008, MAR BIOTECHNOL, V10, P128, DOI 10.1007/s10126-007-9046-9; Yang LH, 2007, LETT APPL MICROBIOL, V44, P625, DOI 10.1111/j.1472-765X.2007.02125.x; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8	98	43	45	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55045	10.1371/journal.pone.0055045	http://dx.doi.org/10.1371/journal.pone.0055045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405110	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400054
J	Katsamenis, OL; Jenkins, T; Quinci, F; Michopoulou, S; Sinclair, I; Thurner, PJ				Katsamenis, Orestis L.; Jenkins, Thomas; Quinci, Federico; Michopoulou, Sofia; Sinclair, Ian; Thurner, Philipp J.			A Novel Videography Method for Generating Crack-Extension Resistance Curves in Small Bone Samples	PLOS ONE			English	Article							HUMAN CORTICAL BONE; AGE-RELATED-CHANGES; FRACTURE-TOUGHNESS; GROWTH-RESISTANCE; MICRODAMAGE; PLASTICITY; MECHANICS; BEHAVIOR; FAILURE	Assessment of bone quality is an emerging solution for quantifying the effects of bone pathology or treatment. Perhaps one of the most important parameters characterising bone quality is the toughness behaviour of bone. Particularly, fracture toughness, is becoming a popular means for evaluating bone quality. The method is moving from a single value approach that models bone as a linear-elastic material (using the stress intensity factor, K) towards full crack extension resistance curves (R-curves) using a non-linear model (the strain energy release rate in J-R curves). However, for explanted human bone or small animal bones, there are difficulties in measuring crack-extension resistance curves due to size constraints at the millimetre and sub-millimetre scale. This research proposes a novel "whitening front tracking'' method that uses videography to generate full fracture resistance curves in small bone samples where crack propagation cannot typically be observed. Here we present this method on sharp edge notched samples (<1 mmx1 mmxLength) prepared from four human femora tested in three-point bending. Each sample was loaded in a mechanical tester with the crack propagation recorded using videography and analysed using an algorithm to track the whitening (damage) zone. Using the "whitening front tracking'' method, full R-curves and J-R curves could be generated for these samples. The curves for this antiplane longitudinal orientation were similar to those found in the literature, being between the published longitudinal and transverse orientations. The proposed technique shows the ability to generate full "crack'' extension resistance curves by tracking the whitening front propagation to overcome the small size limitations and the single value approach.	[Katsamenis, Orestis L.; Jenkins, Thomas; Thurner, Philipp J.] Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England; [Quinci, Federico] Univ Southampton, Fac Engn & Environm, Natl Ctr Adv Tribol Southampton, Southampton, Hants, England; [Michopoulou, Sofia] Univ Coll London Hosp NHS Fdn Trust, Inst Nucl Med, London, England; [Sinclair, Ian] Univ Southampton, Fac Engn & Environm, Engn Mat Res Grp, Southampton, Hants, England	University of Southampton; University of Southampton; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Southampton	Katsamenis, OL (corresponding author), Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England.	O.Katsamenis@soton.ac.uk; p.thurner@soton.ac.uk	Thurner, Philipp J/A-3887-2012; Sinclair, Ian/ABB-5502-2021	Katsamenis, Orestis/0000-0003-4367-4147; Thurner, Philipp/0000-0001-7588-9041; Michopoulou, Sofia/0000-0003-1974-8388				[Anonymous], 2004, E11210 ASTM INT, V4, P1, DOI [DOI 10.1520/E0112-96R04, DOI 10.1520/E0112-10]; Chamis CC, 1974, D7572 NASA TN; EVANS AG, 1984, J AM CERAM SOC, V67, P255, DOI 10.1111/j.1151-2916.1984.tb18842.x; GOODMAN HM, 1988, BASIC MED ENDOCRINOL; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; Kruzic JJ, 2005, J BIOMED MATER RES A, V74A, P461, DOI 10.1002/jbm.a.30380; Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI [10.1146/annurev-matsci-070909-104427, 10.1146/annurev-matsci-070909-10442]; Leng HJ, 2008, J MECH BEHAV BIOMED, V1, P68, DOI 10.1016/j.jmbbm.2007.06.002; Malik CL, 2003, J BIOMECH, V36, P191, DOI 10.1016/S0021-9290(02)00362-7; Nalla RK, 2005, BIOMATERIALS, V26, P217, DOI 10.1016/j.biomaterials.2004.02.017; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; NORMAN TL, 1995, J BIOMECH, V28, P309, DOI 10.1016/0021-9290(94)00069-G; Phelps JB, 2000, J BIOMED MATER RES, V51, P735, DOI 10.1002/1097-4636(20000915)51:4<735::AID-JBM23>3.0.CO;2-G; Rau C, 2011, PHYS STATUS SOLIDI A; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Ritchie RO, 2008, BONE, V43, P798, DOI 10.1016/j.bone.2008.04.027; Ritchie RO, 2005, FATIGUE FRACT ENG M, V28, P345, DOI 10.1111/j.1460-2695.2005.00878.x; Ritchie RO, 2009, PHYS TODAY, V62, P41, DOI 10.1063/1.3156332; Sun XH, 2010, J BIOMECH, V43, P1989, DOI 10.1016/j.jbiomech.2010.03.011; Thurner PJ, 2007, ENG FRACT MECH, V74, P1928, DOI 10.1016/j.engfracmech.2006.05.024; Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8; Vashishth D, 2004, J BIOMECH, V37, P943, DOI 10.1016/j.jbiomech.2003.11.003; Vashishth D, 2007, INT J FATIGUE, V29, P1024, DOI 10.1016/j.ijfatigue.2006.09.010; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Yan JH, 2007, BONE, V40, P479, DOI 10.1016/j.bone.2006.08.013; Yang QD, 2006, BONE, V38, P878, DOI 10.1016/j.bone.2005.10.014; Zimmermann EA, 2011, P NATL ACAD SCI USA, V108, P14416, DOI 10.1073/pnas.1107966108; Zimmermann EA, 2010, BIOMATERIALS, V31, P5297, DOI 10.1016/j.biomaterials.2010.03.056; Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7	30	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55641	10.1371/journal.pone.0055641	http://dx.doi.org/10.1371/journal.pone.0055641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405186	Green Accepted, Green Published, gold			2022-12-27	WOS:000315153400131
J	Liang, HY; Luo, L; Yang, ZC; Di, B; Bai, ZJ; He, P; Jing, QL; Zheng, XL				Liang, Huiying; Luo, Lei; Yang, Zhicong; Di, Biao; Bai, Zhijun; He, Peng; Jing, Qinlong; Zheng, Xueli			Re-Emergence of Dengue Virus Type 3 in Canton, China, 2009-2010, Associated with Multiple Introductions through Different Geographical Routes	PLOS ONE			English	Article							SUBTYPE-III; GUANGDONG PROVINCE; SEROTYPE 3; EMERGENCE; GUANGZHOU; OUTBREAK; FEVER; EPIDEMIOLOGY; INFECTIONS; GENOTYPE	Background: Endemic dengue virus type 3 (DENV-3) infections have not been reported in Canton, China, since 1980. In March 2009, DENV-3 was isolated for the second time, occurring about 30 years after the previous circulation. In August, 3 other cases emerged. One much larger outbreak occurred again in 2010. To address the origin and particularly to determine whether the outbreaks were caused by the same viral genotype, we investigated the epidemiological and molecular characteristics of the introduction, spread and genetic microevolution of DENV-3 involved. Methodology/Principal Findings: Three imported cases (index-1,2,3) separately traveled back from Vietnam, India and Tanzania, resulted in 1, 3 and 60 secondary autochthonous cases, respectively. In autochthonous cases, 64.6% positive in IgM anti-DENV and 18.6% in IgG from a total of 48 submitted serum samples, accompanied by 7 DENV-3 isolates. With 99.8%, 99.7%, and 100% envelope gene nucleotidic identity, 09/GZ/1081 from index-1 and endemic strain (09/GZ/1483) belonged to genotype V; 09/GZ/10616 from index-2 and endemic strains (09/GZ/11144 and 09/GZ/11194) belonged to genotype III Clade-A; and 10/GZ/4898 from index-3 and all four 2010 endemic DENV-3 strains belonged to genotype III Clade-B, respectively. Conclusions/Significance: Both epidemiological and phylogenetic analyses showed that the 2010 outbreak of dengue was not a reemergence of the 2009 strain. Introductions of different genotypes following more than one route were important contributory factors for the 2009-2010 dengue epidemics/outbreaks in Canton. These findings underscore the importance of early detection and case management of imported case in preventing large-scale dengue epidemics among indigenous peoples of Canton.	[Liang, Huiying] Canton Ctr Dis Control & Prevent, Dept Primary Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Luo, Lei; Yang, Zhicong; Di, Biao; Bai, Zhijun; He, Peng; Jing, Qinlong] Canton Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zheng, Xueli] So Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Yang, ZC (corresponding author), Canton Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	yangzc@gzcdc.org.cn		Liang, Huiying/0000-0002-9987-8002	National Institutes of Health (NIH) [1R01A1083202-01A1]; National Natural Science Foundation of China (NSFC) [30972566]; Guangzhou Medical Science Program [20121A011120, 20121A011124]; Guangzhou Municipal Science & Technology Bureau [2009J-c161]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangzhou Medical Science Program; Guangzhou Municipal Science & Technology Bureau	This study was supported by the National Institutes of Health (NIH) Research Project (No.1R01A1083202-01A1), the National Natural Science Foundation of China (NSFC) grant (No.30972566), Guangzhou Medical Science Program grant (20121A011120 and 20121A011124), and the Guangzhou Municipal Science & Technology Bureau grant (No.2009J-c161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007299; Bitar D, 2009, EUROSURVEILLANCE, V14; Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555; Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025; Dash PK, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-55; Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Halstead SB, 2005, EMERG INFECT DIS, V11, P740, DOI 10.3201/eid1105.050346; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908; Jiang Tao, 2012, Virol J, V9, P125, DOI 10.1186/1743-422X-9-125; Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87; Jones TF, 1999, CLIN INFECT DIS, V28, P853, DOI 10.1086/515213; LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luo L, 2012, J VECTOR ECOL, V37, P230, DOI 10.1111/j.1948-7134.2012.00221.x; [罗雷 LUO Lei], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P490; Massad E, 2011, LANCET, V377, P1630, DOI 10.1016/S0140-6736(11)60470-4; McBride WJH, 2000, MICROBES INFECT, V2, P1041, DOI 10.1016/S1286-4579(00)01258-2; Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Palacio M, 1995, MMWR-MORBID MORTAL W, V44, P21; Papa A, 2002, EUR J CLIN MICROBIOL, V21, P603, DOI 10.1007/s10096-002-0770-9; Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83; QIU FX, 1993, B WORLD HEALTH ORGAN, V71, P349; Ramos MM, 2009, T ROY SOC TROP MED H, V103, P878, DOI 10.1016/j.trstmh.2008.11.009; Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753; Sharma S, 2011, J GEN VIROL, V92, P1595, DOI 10.1099/vir.0.030437-0; Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003; Shu PY, 2005, EMERG INFECT DIS, V11, P460, DOI 10.3201/eid1103.040420; Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thai KTD, 2010, EPIDEMIOL INFECT, V138, P585, DOI 10.1017/S095026880999046X; Usuku S, 2001, ARCH VIROL, V146, P1381, DOI 10.1007/s007050170098; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182; Yan Zi-qiang, 2010, Zhonghua Weisheng Shachong Yaoxie, V16, P42; Zheng K, 2009, EPIDEMIOL INFECT, V137, P73, DOI 10.1017/S0950268808000617	39	17	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55353	10.1371/journal.pone.0055353	http://dx.doi.org/10.1371/journal.pone.0055353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405138	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400083
J	Wang, L; Lv, XQ; Li, H; Zhang, M; Wang, H; Jin, B; Chen, T				Wang, Li; Lv, Xueqin; Li, Hong; Zhang, Min; Wang, Hong; Jin, Biao; Chen, Tong			Inhibition of Apoplastic Calmodulin Impairs Calcium Homeostasis and Cell Wall Modeling during Cedrus deodara Pollen Tube Growth	PLOS ONE			English	Article							EXTRACELLULAR CALMODULIN; SIGNAL-TRANSDUCTION; HIGHER-PLANTS; CARROT CELLS; GERMINATION; PROTEIN; GRADIENT; PECTIN; CA2+; POLYPEPTIDE	Calmodulin (CaM) is one of the most well-studied Ca2+ transducers in eukaryotic cells. It is known to regulate the activity of numerous proteins with diverse cellular functions; however, the functions of apoplastic CaM in plant cells are still poorly understood. By combining pharmacological analysis and microscopic techniques, we investigated the involvement of apoplastic CaM in pollen tube growth of Cedrus deodara (Roxb.) Loud. It was found that the tip-focused calcium gradient was rapidly disturbed as one of the early events after application of pharmacological agents, while the cytoplasmic organization was not significantly affected. The deposition and distribution of acidic pectins and esterified pectins were also dramatically changed, further perturbing the normal modeling of the cell wall. Several protein candidates from different functional categories may be involved in the responses to inhibition of apoplastic CaM. These results revealed that apoplastic CaM functions to maintain the tip-focused calcium gradient and to modulate the distribution/transformation of pectins during pollen tube growth.	[Wang, Li; Lv, Xueqin; Li, Hong; Zhang, Min; Wang, Hong; Chen, Tong] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Wang, Li; Zhang, Min; Jin, Biao] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Lv, Xueqin; Li, Hong] Yangzhou Univ, Coll Biol Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Yangzhou University; Yangzhou University	Chen, T (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China.	chentong@ibcas.ac.cn	Chen, Tong/C-5684-2014	Chen, Tong/0000-0002-2456-7170; Wang, Li/0000-0003-1688-064X	Natural Science Foundation of China [31000092, 31200145, 30870436]; National Natural Science Foundation of Jiangsu Province [BK2011444]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the Natural Science Foundation of China (no. 31000092, 31200145 and 30870436) and the National Natural Science Foundation of Jiangsu Province (no. BK2011444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRO RL, 1984, PLANT PHYSIOL, V75, P382, DOI 10.1104/pp.75.2.382; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; BOWLER C, 1994, PLANT CELL, V6, P1529, DOI 10.1105/tpc.6.11.1529; BOYNTON AL, 1980, BIOCHEM BIOPH RES CO, V95, P745, DOI 10.1016/0006-291X(80)90849-9; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Chen T, 2007, PLANT CELL PHYSIOL, V48, P19, DOI 10.1093/pcp/pcl036; Chen T, 2009, PLANT PHYSIOL, V149, P1111, DOI 10.1104/pp.108.127514; CROCKER G, 1988, BIOCHEM J, V253, P877, DOI 10.1042/bj2530877; Cui SJ, 2005, J BIOL CHEM, V280, P31420, DOI 10.1074/jbc.M501349200; CYR RJ, 1991, J CELL SCI, V100, P311; Derksen J, 1999, PROTOPLASMA, V208, P26, DOI 10.1007/BF01279072; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Feijo JA, 2004, CURR OPIN PLANT BIOL, V7, P589, DOI 10.1016/j.pbi.2004.07.014; Fernando DD, 2005, SEX PLANT REPROD, V18, P149, DOI 10.1007/s00497-005-0008-y; Franklin-Tong VE, 1999, PLANT CELL, V11, P727, DOI 10.1105/tpc.11.4.727; Geitmann A, 2006, PLANT CELL MONOGR, V3, P177, DOI 10.1007/7089_049; Hao HQ, 2005, NEW PHYTOL, V165, P721, DOI 10.1111/j.1469-8137.2004.01290.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; JENA PK, 1989, P NATL ACAD SCI USA, V86, P3644, DOI 10.1073/pnas.86.10.3644; Jurgen Z, 1999, PLANTA, V209, P537; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Konno H, 2002, PHYSIOL PLANTARUM, V114, P213, DOI 10.1034/j.1399-3054.2002.1140207.x; Konrad KR, 2011, CURR OPIN PLANT BIOL, V14, P721, DOI 10.1016/j.pbi.2011.09.005; Krichevsky A, 2007, DEV BIOL, V303, P405, DOI 10.1016/j.ydbio.2006.12.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazzaro MD, 2005, J EXP BOT, V56, P2619, DOI 10.1093/jxb/eri256; LI YQ, 1994, SEX PLANT REPROD, V7, P145; Ma LG, 1997, PLANTA, V202, P336, DOI 10.1007/s004250050135; Ma LG, 1999, PLANT CELL, V11, P1351, DOI 10.1105/tpc.11.7.1351; Ma LG, 2000, PLANT CELL PHYSIOL, V41, P372; Malho R, 2006, PROTOPLASMA, V228, P21, DOI 10.1007/s00709-006-0162-6; MALHO R, 1995, PLANT CELL, V7, P1173, DOI 10.1105/tpc.7.8.1173; MCCANN MC, 1993, J CELL SCI, V106, P1347; MCCANN MC, 1992, PLANT PHYSIOL, V100, P1940, DOI 10.1104/pp.100.4.1940; MILLER DD, 1992, J CELL SCI, V101, P7; MORIKAWA H, 1978, PLANT CELL PHYSIOL, V19, P1151; MORRIS ER, 1982, J MOL BIOL, V155, P507, DOI 10.1016/0022-2836(82)90484-3; Moutinho A, 1998, SEX PLANT REPROD, V11, P131, DOI 10.1007/s004970050130; OBERMEYER G, 1991, EUR J CELL BIOL, V56, P319; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; RATHORE KS, 1991, DEV BIOL, V148, P612, DOI 10.1016/0012-1606(91)90278-B; Rato C, 2004, PLANT J, V38, P887, DOI 10.1111/j.1365-313X.2004.02091.x; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; STINEMETZ CL, 1987, PLANT PHYSIOL, V84, P1337, DOI 10.1104/pp.84.4.1337; SUN DY, 1995, PLANT CELL PHYSIOL, V36, P133; Sun DY, 2001, SCI CHINA SER C, V44, P449, DOI 10.1007/BF02882387; Sun Y, 2003, PLANT CELL ENVIRON, V26, P887, DOI 10.1046/j.1365-3040.2003.01021.x; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Williams DH, 1980, SPECTROSCOPIC METHOD, P125; Yan A, 2009, P NATL ACAD SCI USA, V106, P22002, DOI 10.1073/pnas.0910811106; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yokota E, 2004, PLANTA, V218, P1008, DOI 10.1007/s00425-003-1177-2	55	8	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55411	10.1371/journal.pone.0055411	http://dx.doi.org/10.1371/journal.pone.0055411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405148	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400093
J	White, O; Diedrichsen, J				White, Olivier; Diedrichsen, Joern			Flexible Switching of Feedback Control Mechanisms Allows for Learning of Different Task Dynamics	PLOS ONE			English	Article							INTERNAL-MODELS; MOTOR; ADAPTATION; RESPONSES; MOVEMENT; SYSTEM; REACH; LIMB; CUES; ARM	To produce skilled movements, the brain flexibly adapts to different task requirements and movement contexts. Two core abilities underlie this flexibility. First, depending on the task, the motor system must rapidly switch the way it produces motor commands and how it corrects movements online, i.e. it switches between different (feedback) control policies. Second, it must also adapt to environmental changes for different tasks separately. Here we show these two abilities are related. In a bimanual movement task, we show that participants can switch on a movement-by-movement basis between two feedback control policies, depending only on a static visual cue. When this cue indicates that the hands control separate objects, reactions to force field perturbations of each arm are purely unilateral. In contrast, when the visual cue indicates a commonly controlled object, reactions are shared across hands. Participants are also able to learn different force fields associated with a visual cue. This is however only the case when the visual cue is associated with different feedback control policies. These results indicate that when the motor system can flexibly switch between different control policies, it is also able to adapt separately to the dynamics of different environmental contexts. In contrast, visual cues that are not associated with different control policies are not effective for learning different task dynamics.	[White, Olivier] INSERM, Cognit Act & Sensorimotor Plast U1093, Dijon, France; [White, Olivier] Univ Bourgogne, Unite Format & Rech Sci & Tech Act Phys & Sport, Dijon, France; [Diedrichsen, Joern] UCL, Inst Cognit Neurosci, London, England; [White, Olivier; Diedrichsen, Joern] Bangor Univ, Wolfson Ctr Clin & Cognit Neurosci, Bangor, Gwynedd, Wales	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; University of London; University College London; Bangor University	White, O (corresponding author), INSERM, Cognit Act & Sensorimotor Plast U1093, Dijon, France.	olivier.white@u-bourgogne.fr	White, Olivier/AAJ-6914-2020; Diedrichsen, Jörn/AAQ-2242-2020; Diedrichsen, Jörn/A-7789-2010	White, Olivier/0000-0002-9119-1329; Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532	Biotechnology and Biological Science Research Council [BB/J009458/1]; INSERM (Institut National de la Sante et de la Recherche Medicale); Conseil General de Bourgogne; BBSRC [BB/E009174/2, BB/J009458/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009458/1, BB/E009174/2] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Conseil General de Bourgogne; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by a grant from the Biotechnology and Biological Science Research Council (BB/J009458/1) to JD and by INSERM (Institut National de la Sante et de la Recherche Medicale) and the Conseil General de Bourgogne to OW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Cothros N, 2006, EXP BRAIN RES, V173, P689, DOI 10.1007/s00221-006-0411-0; Cothros N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001990; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Diedrichsen J, 2009, HUM MOVEMENT SCI, V28, P334, DOI 10.1016/j.humov.2008.10.003; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Hirashima M, 2012, CURR BIOL, V22, P432, DOI 10.1016/j.cub.2012.01.042; Howard IS, 2008, J NEUROSCI, V28, P10531, DOI 10.1523/JNEUROSCI.3473-08.2008; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; MARSDEN CD, 1981, BRAIN, V104, P513, DOI 10.1093/brain/104.3.513; Mutha PK, 2009, J NEUROPHYSIOL, V102, P3142, DOI 10.1152/jn.91335.2008; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Pruszynski JA, 2008, J NEUROPHYSIOL, V100, P224, DOI 10.1152/jn.90262.2008; ROTHWELL JC, 1980, NATURE, V286, P496, DOI 10.1038/286496a0; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Shadmehr R, 2004, HUM MOVEMENT SCI, V23, P543, DOI 10.1016/j.humov.2004.04.003; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Wainscott SK, 2005, J NEUROPHYSIOL, V93, P786, DOI 10.1152/jn.00240.2004	25	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54771	10.1371/journal.pone.0054771	http://dx.doi.org/10.1371/journal.pone.0054771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405093	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400037
J	Wu, M; Yu, Q; Li, XL; Zheng, J; Huang, JF; Kwoh, CK				Wu, Min; Yu, Qi; Li, Xiaoli; Zheng, Jie; Huang, Jing-Fei; Kwoh, Chee-Keong			Benchmarking Human Protein Complexes to Investigate Drug-Related Systems and Evaluate Predicted Protein Complexes	PLOS ONE			English	Article							TRANSLATIONAL BIOINFORMATICS; GENOME; DATABASE; MODULES	Protein complexes are key entities to perform cellular functions. Human diseases are also revealed to associate with some specific human protein complexes. In fact, human protein complexes are widely used for protein function annotation, inference of human protein interactome, disease gene prediction, and so on. Therefore, it is highly desired to build an up-to-date catalogue of human complexes to support the research in these applications. Protein complexes from different databases are as expected to be highly redundant. In this paper, we designed a set of concise operations to compile these redundant human complexes and built a comprehensive catalogue called CHPC2012 (Catalogue of Human Protein Complexes). CHPC2012 achieves a higher coverage for proteins and protein complexes than those individual databases. It is also verified to be a set of complexes with high quality as its co-complex protein associations have a high overlap with protein-protein interactions (PPI) in various existing PPI databases. We demonstrated two distinct applications of CHPC2012, that is, investigating the relationship between protein complexes and drug-related systems and evaluating the quality of predicted protein complexes. In particular, CHPC2012 provides more insights into drug development. For instance, proteins involved in multiple complexes (the overlapping proteins) are potential drug targets; the drug-complex network is utilized to investigate multi-target drugs and drug-drug interactions; and the disease-specific complex-drug networks will provide new clues for drug repositioning. With this up-to-date reference set of human protein complexes, we believe that the CHPC2012 catalogue is able to enhance the studies for protein interactions, protein functions, human diseases, drugs, and related fields of research. CHPC2012 complexes can be downloaded from http://www1.i2r.a-star.edu.sg/xlli/CHPC2012/CHPC2012.htm.	[Wu, Min; Zheng, Jie; Kwoh, Chee-Keong] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [Yu, Qi; Huang, Jing-Fei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Beijing 100864, Peoples R China; [Li, Xiaoli] Inst Infocomm Res, Data Min Dept, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chinese Academy of Sciences; Kunming Institute of Zoology; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Huang, JF (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Beijing 100864, Peoples R China.	huangjf@mail.kiz.ac.cn; asckkwoh@ntu.edu.sg	Wu, Min/AAB-2446-2022; Zheng, Jie/C-1356-2011; Zheng, Jie/AAX-1454-2021; Yu, Qi/I-2427-2019; Li, Xiaoli/GYQ-7384-2022; Li, Xiaoli/C-9739-2012	Wu, Min/0000-0003-0977-3600; Zheng, Jie/0000-0001-6774-9786; Yu, Qi/0000-0002-2110-244X; Li, Xiaoli/0000-0002-0762-6562	Nanyang Technological University, Singapore [M58020030]; Tier 1 AcRF Grant from Ministry of Education, Singapore [RG32/11 (M4010977.020)]; Tier 2 AcRF Grant from Ministry of Education, Singapore [MOE2008-T2-1-074]; National Basic Research Program of China [2009CB941300]; National Natural Science Foundation of China [31123005]	Nanyang Technological University, Singapore(Nanyang Technological University); Tier 1 AcRF Grant from Ministry of Education, Singapore(Ministry of Education, Singapore); Tier 2 AcRF Grant from Ministry of Education, Singapore(Ministry of Education, Singapore); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research has been supported by Startup Grant M58020030 from Nanyang Technological University, Singapore; Tier 1 AcRF Grant RG32/11 (M4010977.020) from Ministry of Education, Singapore; Tier 2 AcRF Grant MOE2008-T2-1-074 from Ministry of Education, Singapore; the National Basic Research Program of China (Grant No. 2009CB941300); and the National Natural Science Foundation of China (Grant No. 31123005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Agarwal P, 2008, BRIEF BIOINFORM, V9, P479, DOI 10.1093/bib/bbn035; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bin Goh WW, 2012, J PROTEOME RES, V11, P1571, DOI 10.1021/pr200698c; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P443, DOI 10.1177/0091270003252519; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Butte AJ, 2008, J AM MED INFORM ASSN, V15, P709, DOI 10.1197/jamia.M2824; Chua Hon Nian, 2008, Journal of Bioinformatics and Computational Biology, V6, P435, DOI 10.1142/S0219720008003497; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Cramer P, 2001, SCIENCE, V292, P1844; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu HY, 2005, BIOINFORMATICS, V21, pI213, DOI 10.1093/bioinformatics/bti1049; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lee HS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-80; Li J, 2009, PLOS COMPUTATIONAL B, V5; Li M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-398; Li Xiao-Li, 2007, Comput Syst Bioinformatics Conf, V6, P157; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Luc PV, 2004, BIOINFORMATICS, V20, P1413, DOI 10.1093/bioinformatics/bth114; Lussier YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-319; Nacher JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030028; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wegener E., 2008, V186, P237, DOI 10.1007/978-3-540-72843-6_10; Wu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S8; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169; Xie ZP, 2011, BIOINFORMATICS, V27, pI159, DOI 10.1093/bioinformatics/btr212; Yan Q, 2010, METHODS MOL BIOL, V662, P167, DOI 10.1007/978-1-60761-800-3_8; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502; Yu Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/103702	45	10	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53197	10.1371/journal.pone.0053197	http://dx.doi.org/10.1371/journal.pone.0053197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405067	Green Published, gold			2022-12-27	WOS:000315153400010
J	Rakobowchuk, M; Parsloe, ER; Gibbins, SE; Harris, E; Birch, KM				Rakobowchuk, Mark; Parsloe, Emily R.; Gibbins, Sarah E.; Harris, Emma; Birch, Karen M.			Prolonged Low Flow Reduces Reactive Hyperemia and Augments Low Flow Mediated Constriction in the Brachial Artery Independent of the Menstrual Cycle	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ATP CHANNEL ACTIVATION; HUMANS IN-VIVO; POSTCONDITIONING PROTECTS; VASCULAR FUNCTION; PROGENITOR CELLS; DILATION; INFORMATION; EXERCISE	Non-invasive forearm ischemia-reperfusion injury and low flow induced vascular dysfunction models provide methods to evaluate vascular function. The role of oestrogen, an endogenous anti-oxidant on recovery from ischemia-reperfusion injury has not been evaluated nor has the impact of prolonged low flow on vascular function been established. Eight healthy women (33610 yr) attended the lab during the follicular, ovulatory and mid-luteal phases of their menstrual cycles. After 30 minutes of rest, brachial artery vascular function was assessed by ultrasound measurements of diameter changes during 5 minutes of forearm ischemia and 3 minutes after. Subsequently, a 20-minute forearm ischemia period was completed. Further, vascular function assessments were completed 15, 30 and 45 minutes into recovery. Flow-mediated dilation, low-flow-mediated constriction, and reactive hyperaemia proximal to the area of ischemia were determined. Flow-mediated dilation was reduced at 15 minutes of recovery but recovered at 30 and 45 minutes (PRE:7.1 +/- 1.0%, POST15:4.5 +/- 0.6%, POST30:5.5 +/- 0.7% POST45:5.9 +/- 0.4%, p<0.01). Conversely, low-flow mediated constriction increased (PRE:-1.3 +/- 0.4%, POST15:-3.3 +/- 0.6%, POST30:-2.5 +/- 0.5% POST45:-1.5 +/- 0.12%, p<0.01). Reactive hyperaemia was reduced throughout recovery (p, 0.05). Data were unaffected by menstrual phase. Prolonged low flow altered vascular function and may relate as much to increased vasoconstriction as with decreased vasodilation. Reductions in anterograde shear and greater retrograde shear likely modulate the brachial artery response, but the reduced total shear also plays an important role. The data suggest substantial alterations in vascular function proximal to areas of ischemia with potential clinical implications following reperfusion.	[Rakobowchuk, Mark] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Parsloe, Emily R.] Univ Cambridge, Cambridge, England; [Gibbins, Sarah E.; Harris, Emma; Birch, Karen M.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England	University of Essex; University of Cambridge; University of Leeds	Rakobowchuk, M (corresponding author), Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England.	merako@essex.ac.uk	Harris, Emma/AAJ-8194-2020	Harris, Emma/0000-0002-7649-9763; Birch, Karen/0000-0001-7796-8640	British Heart Foundation [PG/08/060/25340]; Physiological Society summer studentship; Wellcome Trust Vacation Studentship	British Heart Foundation(British Heart Foundation); Physiological Society summer studentship; Wellcome Trust Vacation Studentship(Wellcome Trust)	This work was supported by the British Heart Foundation (PG/08/060/25340), a Physiological Society summer studentship to SG, and a Wellcome Trust Vacation Studentship to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broadhead MW, 2004, CIRCULATION, V110, P2077, DOI 10.1161/01.CIR.0000144304.91010.F0; DeVan AE, 2011, AM J PHYSIOL-HEART C, V300, pH813, DOI 10.1152/ajpheart.00845.2010; Fadini GP, 2008, ARTERIOSCL THROM VAS, V28, P997, DOI 10.1161/ATVBAHA.107.159558; Gori T, 2005, CIRCULATION, V111, P742, DOI 10.1161/01.CIR.0000155252.23933.2D; Gori T, 2010, HEART, V96, P141, DOI 10.1136/hrt.2009.167213; Gori T, 2008, J AM COLL CARDIOL, V51, P1953, DOI 10.1016/j.jacc.2008.01.049; Gori T, 2012, EUR HEART J, V33, P363, DOI 10.1093/eurheartj/ehr361; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; Jiang BY, 2011, HYPERTENSION, V57, P1145, DOI 10.1161/HYPERTENSIONAHA.110.163113; Kharbanda RK, 2001, CIRCULATION, V103, P1624, DOI 10.1161/01.CIR.103.12.1624; Loukogeorgakis SP, 2006, CIRCULATION, V113, P1015, DOI 10.1161/CIRCULATIONAHA.105.590398; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Loukogeorgakis SP, 2010, CIRCULATION, V121, P2310, DOI 10.1161/CIRCULATIONAHA.108.814731; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Okorie MI, 2011, EUR HEART J, V32, P1266, DOI 10.1093/eurheartj/ehr041; Pedersen CM, 2012, EUR HEART J, V33, P1920, DOI 10.1093/eurheartj/ehr380; Pleiner J, 2008, ATHEROSCLEROSIS, V197, P383, DOI 10.1016/j.atherosclerosis.2007.06.011; Pyke KE, 2007, J APPL PHYSIOL, V102, P1510, DOI 10.1152/japplphysiol.01024.2006; Rakobowchuk M, 2012, EXP PHYSIOL, V97, P375, DOI 10.1113/expphysiol.2011.062836; Spieker LE, 2003, J CARDIOVASC PHARM, V42, P315, DOI 10.1097/00005344-200309000-00001; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Weissgerber TL, 2010, J APPL PHYSIOL, V108, P1097, DOI 10.1152/japplphysiol.00815.2009	22	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55385	10.1371/journal.pone.0055385	http://dx.doi.org/10.1371/journal.pone.0055385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393572	Green Published, gold, Green Accepted			2022-12-27	WOS:000314692800026
J	Chujo, D; Foucat, E; Nguyen, TS; Chaussabel, D; Banchereau, J; Ueno, H				Chujo, Daisuke; Foucat, Emile; Thien-Son Nguyen; Chaussabel, Damien; Banchereau, Jacques; Ueno, Hideki			ZnT8-Specific CD4(+) T Cells Display Distinct Cytokine Expression Profiles between Type 1 Diabetes Patients and Healthy Adults	PLOS ONE			English	Article							CLASS-II TETRAMERS; GLUTAMATE-DECARBOXYLASE; PERIPHERAL-BLOOD; RESPONSES; INSULIN; AUTOANTIGEN; EPITOPE; AUTOIMMUNITY; ASSAY; IDDM	Determination of antigen-specific T cell repertoires in human blood has been a challenge. Here, we show a novel integrated approach that permits determination of multiple parameters of antigen-specific T cell repertoires. The approach consists of two assays: the Direct assay and the Cytokine-driven assay. Briefly, human PBMCs are first stimulated with overlapping peptides encoding a given antigen for 48 hours to measure cytokine secretion (Direct assay). Peptide-reactive T cells are further expanded by IL-2 for 5 days; and after overnight starvation, expanded cells are stimulated with the same peptides from the initial culture to analyze cytokine secretion (Cytokine-driven assay). We first applied this integrated approach to determine the type of islet-antigen-specific T cells in healthy adults. Out of ten donors, the Direct assay identified GAD65-specific CD4(+) T cells in three adults and zinc transporter 8 (ZnT8)-specific CD4(+) T cells in five adults. The intracytoplasmic cytokine staining assay showed that these islet-antigen-specific CD4(+) T cells belonged to the CD45RO(+) memory compartment. The Cytokine-driven assay further revealed that islet-antigen-specific CD4(+) T cells in healthy adults were capable of secreting various types of cytokines including type 1 and type 2 cytokines as well as IL-10. We next applied our integrated assay to determine whether the type of ZnT8-specific CD4(+) T cells is different between Type 1 diabetes patients and age/gender/HLA-matched healthy adults. We found that ZnT8-specific CD4(+) T cells were skewed towards Th1 cells in T1D patients, while Th2 and IL-10-producing cells were prevalent in healthy adults. In conclusion, the Direct assay and the Cytokine-driven assay complement each other, and the combination of the two assays provides information of antigen-specific T cell repertoires on the breadth, type, and avidity. This strategy is applicable to determine the differences in the quality of antigen-specific T cells between health and disease.	[Chujo, Daisuke; Foucat, Emile; Banchereau, Jacques; Ueno, Hideki] Baylor Inst Immunol Res, Dallas, TX USA; [Thien-Son Nguyen; Chaussabel, Damien] Virginia Mason, Benaroya Res Inst, Seattle, WA USA	Baylor Scott & White Health; Benaroya Research Institute; Virginia Mason Medical Center	Ueno, H (corresponding author), Baylor Inst Immunol Res, Dallas, TX USA.	HidekiU@baylorhealth.edu	Ueno, Hideki/L-1237-2016; Chaussabel, Damien/AAX-1909-2020	Ueno, Hideki/0000-0001-7747-0738; Chaussabel, Damien/0000-0002-6131-7242	Juvenile Diabetes Research Foundation [17-2010-406]; Baylor Health Care System	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Baylor Health Care System	This study was supported by funding from Juvenile Diabetes Research Foundation (grant number: 17-2010-406; http://www.jdrf.org) and Baylor Health Care System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; ATKINSON MA, 1994, J CLIN INVEST, V94, P2125, DOI 10.1172/JCI117567; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Boehm BO, 2009, MOL IMMUNOL, V46, P2576, DOI 10.1016/j.molimm.2009.05.007; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Chujo D, 2012, CELL TRANSPLANTATION; Chujo D, 2012, CELL TRANSP IN PRESS; Coppieters KT, 2012, J EXP MED; Dang M, 2011, J IMMUNOL, V186, P6056, DOI 10.4049/jimmunol.1003815; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Durinovic-Bello I, 2002, J AUTOIMMUN, V18, P55, DOI 10.1006/jaut.2001.0566; Durinovic-Bello I, 2006, P NATL ACAD SCI USA, V103, P11683, DOI 10.1073/pnas.0603682103; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gianani R, 2005, IMMUNOL REV, V204, P232, DOI 10.1111/j.0105-2896.2005.00248.x; Herold KC, 2009, DIABETES, V58, P2588, DOI 10.2337/db09-0249; Jarchum I, 2008, CLIN IMMUNOL, V127, P359, DOI 10.1016/j.clim.2008.01.015; Jasinski J M, 2005, Clin Dev Immunol, V12, P181, DOI 10.1080/17402520500078204; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Mallone R, 2007, DIABETES, V56, P613, DOI 10.2337/db06-1419; Mannering SI, 2010, CLIN EXP IMMUNOL, V162, P197, DOI 10.1111/j.1365-2249.2010.04237.x; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; Nepom GT, 2002, ARTHRITIS RHEUM, V46, P5, DOI 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Peakman M, 1999, J CLIN INVEST, V104, P1449, DOI 10.1172/JCI7936; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Reijonen H, 2004, DIABETES, V53, P1987, DOI 10.2337/diabetes.53.8.1987; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Schloot NC, 2003, J AUTOIMMUN, V21, P365, DOI 10.1016/S0896-8411(03)00111-2; Schloot NC, 1997, DIABETOLOGIA, V40, P332, DOI 10.1007/s001250050683; Seyfert-Margolis V, 2006, DIABETES, V55, P2588, DOI 10.2337/db05-1378; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tree TIM, 2010, DIABETES, V59, P1451, DOI 10.2337/db09-0503; Vence L, 2007, P NATL ACAD SCI USA, V104, P20884, DOI 10.1073/pnas.0710557105; Viglietta V, 2002, J CLIN INVEST, V109, P895, DOI 10.1172/JCI14114; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wong FS, 1999, J AUTOIMMUN, V13, P290, DOI 10.1006/jaut.1999.0322; Yang JB, 2006, J IMMUNOL, V176, P2781, DOI 10.4049/jimmunol.176.5.2781; Zaccone P, 1999, DIABETES, V48, P1522, DOI 10.2337/diabetes.48.8.1522	47	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55595	10.1371/journal.pone.0055595	http://dx.doi.org/10.1371/journal.pone.0055595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390544	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100060
J	Atorrasagasti, C; Peixoto, E; Aquino, JB; Kippes, N; Malvicini, M; Alaniz, L; Garcia, M; Piccioni, F; Fiore, EJ; Bayo, J; Bataller, R; Guruceaga, E; Corrales, F; Podhajcer, O; Mazzolini, G				Atorrasagasti, Catalina; Peixoto, Estanislao; Aquino, Jorge B.; Kippes, Nestor; Malvicini, Mariana; Alaniz, Laura; Garcia, Mariana; Piccioni, Flavia; Fiore, Esteban J.; Bayo, Juan; Bataller, Ramon; Guruceaga, Elizabeth; Corrales, Fernando; Podhajcer, Osvaldo; Mazzolini, Guillermo			Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; GROWTH-FACTOR-BETA; DNA-REPAIR GENES; HEPATOCELLULAR-CARCINOMA; HEPATOCYTE SURVIVAL; INDUCED CIRRHOSIS; HYALURONIC-ACID; MESANGIAL CELLS; DOWN-REGULATION; NULL MICE	Introduction: Secreted Protein, Acidic and Rich in Cysteine (SPARC) is a matricellular protein involved in many biological processes and found over-expressed in cirrhotic livers. By mean of a genetic approach we herein provide evidence from different in vivo liver disease models suggesting a profibrogenic role for SPARC. Methods: Two in vivo models of liver fibrosis, based on TAA administration and bile duct ligation, were developed on SPARC wild-type (SPARC(+/+)) and knock-out (SPARC(-/-)) mice. Hepatic SPARC expression was analyzed by qPCR. Fibrosis was assessed by Sirius Red staining, and the maturation state of collagen fibers was analyzed using polarized light. Necroinflammatory activity was evaluated by applying the Knodell score and liver inflammatory infiltration was characterized by immunohistochemistry. Hepatic stellate cell activation was assessed by alpha-SMA immunohistochemistry. In addition, pro-fibrogenic genes and inflammatory cytokines were measured by qPCR and/or ELISA. Liver gene expression profile was analyzed in SPARC(-/-) and SPARC(+/+) mice using Affymetrix Mouse Gene ST 1.0 array. Results: SPARC expression was found induced in fibrotic livers of mouse and human. SPARC(-/-) mice showed a reduction in the degree of inflammation, mainly CD4+ cells, and fibrosis. Consistently, collagen deposits and mRNA expression levels were decreased in SPARC(-/-) mice when compared to SPARC+/+ mice; in addition, MMP-2 expression was increased in SPARC(-/-) mice. A reduction in the number of activated myofibroblasts was observed. Moreover, TGF-beta 1 expression levels were down-regulated in the liver as well as in the serum of TAA-treated knock-out animals. Ingenuity Pathway Analysis (IPA) analysis suggested several gene networks which might involve protective mechanisms of SPARC deficiency against liver fibrogenesis and a better established machinery to repair DNA and detoxify from external chemical stimuli. Conclusions: Overall our data suggest that SPARC plays a significant role in liver fibrogenesis. Interventions to inhibit SPARC expression are suggested as promising approaches for liver fibrosis treatment.	[Atorrasagasti, Catalina; Peixoto, Estanislao; Aquino, Jorge B.; Kippes, Nestor; Malvicini, Mariana; Alaniz, Laura; Garcia, Mariana; Piccioni, Flavia; Fiore, Esteban J.; Bayo, Juan; Mazzolini, Guillermo] Austral Univ, Sch Med, Gene Therapy Lab, Buenos Aires, DF, Argentina; [Aquino, Jorge B.; Alaniz, Laura; Garcia, Mariana; Podhajcer, Osvaldo; Mazzolini, Guillermo] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Bataller, Ramon] Univ N Carolina, Dept Med & Nutr, Chapel Hill, NC USA; [Guruceaga, Elizabeth; Corrales, Fernando] Univ Navarra, Ctr Invest Med Aplicada, E-31080 Pamplona, Spain; [Podhajcer, Osvaldo] Fdn Inst Leloir, Gene Therapy Lab, Buenos Aires, DF, Argentina	Austral University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of North Carolina; University of North Carolina Chapel Hill; University of Navarra; Leloir Institute	Mazzolini, G (corresponding author), Austral Univ, Sch Med, Gene Therapy Lab, Buenos Aires, DF, Argentina.	gmazzoli@cas.austral.edu.ar	Alaniz, Laura/AAM-2676-2020; Kippes, Nestor/H-5013-2019; , Ph.D/K-4540-2019; Guruceaga, Elizabeth/B-1796-2008	Alaniz, Laura/0000-0002-6070-6078; Kippes, Nestor/0000-0002-5852-1963; Bayo Fina, Juan Miguel/0000-0003-3999-0841; Guruceaga, Elizabeth/0000-0003-0547-681X; Peixoto, Estanislao/0000-0001-5226-9747; podhajcer, osvaldo/0000-0002-6512-8553; Corrales, Fernando/0000-0002-0231-5159; Bataller, Ramon/0000-0002-1119-7799; Fiore, Esteban/0000-0003-1059-1695; Aquino, Jorge B/0000-0002-3818-5181	Austral University; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2006-1882, PICT-2005-34788, PICT 2007-00736, PICTO-CRUP 2005-31179, PICT 2008-00123]; AECI; FIMA; UTE project CIMA; Ministerio de Ciencia e Innovacion [SAF2011-29312, PIB2010AR-00474]; ISCIII-RETIC [RD06/0020];  [CTE-06]	Austral University; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); AECI; FIMA; UTE project CIMA; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ISCIII-RETIC(Instituto de Salud Carlos III); 	This work was supported by grants from Austral University, Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2006-1882, PICT-2005-34788, PICT 2007-00736, PICTO-CRUP 2005-31179, PICT 2008-00123), CTE-06 and AECI 2008, FIMA and the "UTE project CIMA'', grants Plan Nacional SAF2011-29312 and PIB2010AR-00474 from Ministerio de Ciencia e Innovacion to FJC, and ISCIII-RETIC RD06/0020 to FJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2008, TOXICOL SCI, V104, P261, DOI 10.1093/toxsci/kfn093; Aleksunes LM, 2006, TOXICOL SCI, V89, P370, DOI 10.1093/toxsci/kfi332; Atorrasagasti C, 2011, AM J PHYSL GASTROINT; Atorrasagasti C, 2011, AM J PHYSIOL-GASTR L, V300, pG739, DOI 10.1152/ajpgi.00316.2010; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Benyon RC, 1999, HEPATOLOGY, V30, P977, DOI 10.1002/hep.510300431; Blazejewski S, 1997, AM J PATHOL, V151, P651; Bolstad B, 2005, BIOINFORMATICS COMPU; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Camino AM, 2008, J GENE MED, V10, P993, DOI 10.1002/jgm.1228; Draghici S., 2003, DATA ANAL TOOLS DNA; Dubrovska A, 2005, ONCOGENE, V24, P2289, DOI 10.1038/sj.onc.1208443; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; FRIZELL E, 1995, HEPATOLOGY, V21, P847, DOI 10.1002/hep.1840210335; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; George J, 1999, P NATL ACAD SCI USA, V96, P12719, DOI 10.1073/pnas.96.22.12719; George J, 2004, INT J BIOCHEM CELL B, V36, P307, DOI 10.1016/S1357-2725(03)00253-X; Goldenberg D, 2002, MOL CARCINOGEN, V33, P113, DOI 10.1002/mc.10027.abs; Grant AJ, 2002, AM J PATHOL, V160, P1445, DOI 10.1016/S0002-9440(10)62570-9; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Haimerl F, 2009, J BIOL CHEM, V284, P495, DOI 10.1074/jbc.M803533200; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Kim DJ, 2008, BIOCHEM BIOPH RES CO, V373, P521, DOI 10.1016/j.bbrc.2008.06.071; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Lamireau T, 1999, J HEPATOL, V31, P248, DOI 10.1016/S0168-8278(99)80221-9; Lau CPY, 2006, J PATHOL, V210, P459, DOI 10.1002/path.2068; Le Bail B, 1999, J PATHOL, V189, P46; Lim YS, 2007, HISTOCHEM CELL BIOL, V127, P149, DOI 10.1007/s00418-006-0233-y; Lu S, 2005, HUM MOL GENET, V14, P3019, DOI 10.1093/hmg/ddi333; Marra F, 2002, FRONT BIOSCI, V7, pD1899, DOI 10.2741/marra; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; MULLER A, 1988, EXP PATHOL-JENA, V34, P229; Nakata K, 2006, DRUG METAB PHARMACOK, V21, P437, DOI 10.2133/dmpk.21.437; Oren R, 1996, HEPATOLOGY, V24, P419; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Piccioni F, 2012, GLYCOBIOLOGY, V22, P400, DOI 10.1093/glycob/cwr158; Qi Z, 1999, P NATL ACAD SCI USA, V96, P2345, DOI 10.1073/pnas.96.5.2345; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Radbill BD, 2011, DIGEST DIS SCI, V56, P406, DOI 10.1007/s10620-010-1296-0; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rempel SA, 2007, GENES IMMUN, V8, P262, DOI 10.1038/sj.gene.6364388; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Riccio A, 1999, NAT GENET, V23, P266, DOI 10.1038/15443; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Ronen A, 2001, ENVIRON MOL MUTAGEN, V37, P241, DOI 10.1002/em.1033; Sahin H, 2010, NAT REV GASTRO HEPAT, V7, P682, DOI 10.1038/nrgastro.2010.168; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Santamaria I, 1999, J BIOL CHEM, V274, P13800, DOI 10.1074/jbc.274.20.13800; Satterwhite DJ, 2000, BIOCHEM BIOPH RES CO, V276, P686, DOI 10.1006/bbrc.2000.3510; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Socha MJ, 2007, AM J PATHOL, V171, P1104, DOI 10.2353/ajpath.2007.061273; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Tang X, 2011, ACTA BIOCH BIOPH SIN, V43, P779, DOI 10.1093/abbs/gmr073; Wang JC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2973; Wang Y, 2000, GENE DEV, V14, P927; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; WRANA JL, 1991, EUR J BIOCHEM, V197, P519, DOI 10.1111/j.1432-1033.1991.tb15940.x; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	75	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54962	10.1371/journal.pone.0054962	http://dx.doi.org/10.1371/journal.pone.0054962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408952	Green Published, gold			2022-12-27	WOS:000315100000011
J	Tain, YL; Lee, WC; Hsu, CN; Lee, WC; Huang, LT; Lee, CT; Lin, CY				Tain, You-Lin; Lee, Wen-Chin; Hsu, Chien-Ning; Lee, Wei-Chia; Huang, Li-Tung; Lee, Chien-Te; Lin, Ching-Yuang			Asymmetric Dimethylarginine Is Associated with Developmental Programming of Adult Kidney Disease and Hypertension in Offspring of Streptozotocin-Treated Mothers	PLOS ONE			English	Article							NITRIC-OXIDE; DIABETES-MELLITUS; L-ARGININE; MATERNAL NUTRITION; BLOOD-PRESSURE; DIMETHYLAMINOHYDROLASE; ADMA; RATS; NEPHROPATHY; PATHWAY	Diabetes mellitus complicates pregnancies, leading to diseases in adult life in the offspring. Asymmetric dimethylarginine (ADMA) is increased in diabetes mellitus, kidney disease, and hypertension. We tested whether maternal diabetes causes increased ADMA in rats, resulting in kidney disease and hypertension in the adult offspring, and whether these can be prevented by maternal citrulline supplementation. Newborn female and pregnant Sprague-Dawley rats were injected with streptozotocin (STZ), which made up the nSTZ and STZ models, respectively. For the STZ model, 4 groups of male offspring were killed at age 3 months: the control, STZ, and Cit and STZ+Cit (control and STZ rats treated with 0.25% L-citrulline solution, respectively) groups. The nSTZ rats had lower nephron numbers. The renal level of ADMA was higher in the nSTZ rats than in controls. The STZ group developed kidney injury, renal hypertrophy, and elevated blood pressure at the age of 12 weeks. These conditions were found to be associated with increased ADMA levels, decreased nitric oxide (NO) production, and decreased dimethylarginine dimethylaminohydrolase (DDAH) activity in the kidney. In addition, ADMA caused a nephron deficit in cultured rat metanephroi. Maternal citrulline supplementation prevented hypertension and kidney injury, increased the renal DDAH-2 protein level, and restored the levels of ADMA and NO in the STZ+Cit group. Reduced nephron number and increased ADMA contribute to adult kidney disease and hypertension in offspring of mothers with STZ-induced diabetes. Manipulation of the ADMA-NO pathway by citrulline supplementation may be a potential approach to prevent these conditions.	[Tain, You-Lin; Huang, Li-Tung] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Lee, Wen-Chin; Lee, Chien-Te] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Nephrol, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Med Univ, Coll Pharm, Grad Inst Clin Pharm, Kaohsiung, Taiwan; [Lee, Wei-Chia] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Devis Urol, Kaohsiung, Taiwan; [Lin, Ching-Yuang] China Med Univ, Coll Med, Clin Immunol Ctr, Taichung, Taiwan; [Lin, Ching-Yuang] China Med Univ Hosp, Div Pediat Nephrol, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tain, YL (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	tainyl@hotmail.com	Tain, You-Lin/H-2827-2019; LEE, Wen-Chin/AAQ-8466-2021; Hsu, Chien-Ning/GLS-4014-2022	Tain, You-Lin/0000-0002-7059-6407; LEE, Wen-Chin/0000-0001-6172-1483; Hsu, Chien-Ning/0000-0001-7470-528X; Lee, Wei-Chia/0000-0003-0701-2285	National Science Council, Taiwan [NSC 98-2314-B-182A-006-MY3]; Chang Gung Memorial Hospital, Taiwan [CMRPG8B0171]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grant NSC 98-2314-B-182A-006-MY3 from National Science Council, Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7) and grant CMRPG8B0171 from Chang Gung Memorial Hospital, Taiwan (http://www.cgmh.org.tw/eng2002/about01.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amri R, 1999, DIABETES, V48, P2240, DOI 10.2337/diabetes.48.11.2240; Bagby SP, 2007, J NUTR, V137, P1066, DOI 10.1093/jn/137.4.1066; Baylis C, 2006, NAT CLIN PRACT NEPHR, V2, P209, DOI 10.1038/ncpneph0143; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; Cavanal MD, 2007, PEDIATR RES, V62, P145; Chen YH, 2009, EXP EYE RES, V89, P1028, DOI 10.1016/j.exer.2009.09.004; Hanai K, 2009, NEPHROL DIAL TRANSPL, V24, P1884, DOI 10.1093/ndt/gfn716; Huemer M, 2011, J PEDIATR-US, V158, P602, DOI 10.1016/j.jpeds.2010.09.058; Lee JH, 2011, DIABETES RES CLIN PR, V94, P111, DOI 10.1016/j.diabres.2011.07.005; Lee WC, 2007, BIOESSAYS, V29, P205, DOI 10.1002/bies.20541; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Lu CW, 2010, ATHEROSCLEROSIS, V209, P66, DOI 10.1016/j.atherosclerosis.2009.08.035; Malecki MT, 2007, DIABETES CARE, V30, P2899, DOI 10.2337/dc07-1138; Mihout F, 2011, J PATHOL, V223, P37, DOI 10.1002/path.2769; Mittermayer F, 2002, DIABETOLOGIA, V45, P1372, DOI 10.1070/s00125-002-0916-4; Nehiri T, 2008, DIABETES, V57, P2167, DOI 10.2337/db07-0780; Nelson RG, 1998, AM J EPIDEMIOL, V148, P650, DOI 10.1093/aje/148.7.650; Romero MJ, 2006, CARDIOVASC DRUG REV, V24, P275, DOI 10.1111/j.1527-3466.2006.00275.x; Simeoni U, 2009, SEMIN FETAL NEONAT M, V14, P119, DOI 10.1016/j.siny.2009.01.002; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Tain YL, 2007, KIDNEY INT, V72, P886, DOI 10.1038/sj.ki.5002446; Tain YL, 2012, FREE RADICAL RES, V46, P68, DOI 10.3109/10715762.2011.639069; Tain YL, 2010, J PINEAL RES, V49, P390, DOI 10.1111/j.1600-079X.2010.00806.x; Tain YL, 2010, FREE RADICAL BIO MED, V49, P1088, DOI 10.1016/j.freeradbiomed.2010.06.029; Tain YL, 2010, NITRIC OXIDE-BIOL CH, V23, P34, DOI 10.1016/j.niox.2010.03.005; Tain YL, 2010, J PINEAL RES, V48, P212, DOI 10.1111/j.1600-079X.2010.00745.x; Tarnow L, 2004, DIABETES CARE, V27, P765, DOI 10.2337/diacare.27.3.765; Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002; Tran S, 2008, J AM SOC NEPHROL, V19, P943, DOI 10.1681/ASN.2007080864; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Wichi RB, 2005, AM J PHYSIOL-REG I, V288, pR1129, DOI 10.1152/ajpregu.00366.2004; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yamagishi S, 2008, CURR PHARM DESIGN, V14, P2613, DOI 10.2174/138161208786071326	35	60	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55420	10.1371/journal.pone.0055420	http://dx.doi.org/10.1371/journal.pone.0055420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408977	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200030
J	Bohm, R; Rockenbach, B				Boehm, Robert; Rockenbach, Bettina			The Inter-Group Comparison - Intra-Group Cooperation Hypothesis: Comparisons between Groups Increase Efficiency in Public Goods Provision	PLOS ONE			English	Article							SOCIAL DILEMMAS; GROUP-SIZE; PERFORMANCE; RECIPROCITY; COMPETITION; IMPACT; EVOLUTION; ALTRUISM; DYNAMICS; IDENTITY	Identifying methods to increase cooperation and efficiency in public goods provision is of vital interest for human societies. The methods that have been proposed often incur costs that (more than) destroy the efficiency gains through increased cooperation. It has for example been shown that inter-group conflict increases intra-group cooperation, however at the cost of collective efficiency. We propose a new method that makes use of the positive effects associated with inter-group competition but avoids the detrimental (cost) effects of a structural conflict. We show that the mere comparison to another structurally independent group increases both the level of intra-group cooperation and overall efficiency. The advantage of this new method is that it directly transfers the benefits from increased cooperation into increased efficiency. In repeated public goods provision we experimentally manipulated the participants' level of contribution feedback (intra-group only vs. both intra-and inter-group) as well as the provision environment (smaller groups with higher individual benefits from cooperation vs. larger groups with lower individual benefits from cooperation). Irrespective of the provision environment groups with an inter-group comparison opportunity exhibited a significantly stronger cooperation than groups without this opportunity. Participants conditionally cooperated within their group and additionally acted to advance their group to not fall behind the other group. The individual efforts to advance the own group cushion the downward trend in the above average contributors and thus render contributions on a higher level. We discuss areas of practical application.	[Boehm, Robert] Univ Erfurt, Ctr Empir Res Econ & Behav Sci, Erfurt, Germany; [Rockenbach, Bettina] Univ Cologne, Dept Econ, D-50931 Cologne, Germany	University of Erfurt; University of Cologne	Bohm, R (corresponding author), Univ Erfurt, Ctr Empir Res Econ & Behav Sci, Erfurt, Germany.	robert.boehm@uni-erfurt.de	Rockenbach, Bettina/AAI-8072-2021; Rockenbach, Bettina/B-5447-2016	Rockenbach, Bettina/0000-0003-2624-1964; Rockenbach, Bettina/0000-0003-2624-1964; Bohm, Robert/0000-0001-6806-0374				Benard S, 2011, ADV GROUP PROCESSES, P189; Bernard S, 2012, SOC PSYCHOL Q, V75, P107; Bigoni M, 2012, J ECON BEHAV ORGAN, V82, P86, DOI 10.1016/j.jebo.2011.12.013; Blanton H, 1999, J PERS SOC PSYCHOL, V76, P420, DOI 10.1037/0022-3514.76.3.420; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Bornstein G, 2003, PERS SOC PSYCHOL REV, V7, P129, DOI 10.1207/S15327957PSPR0702_129-145; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; BREWER MB, 1994, J PERS SOC PSYCHOL, V66, P268, DOI 10.1037/0022-3514.66.2.268; BREWER MB, 1986, J PERS SOC PSYCHOL, V50, P543, DOI 10.1037/0022-3514.50.3.543; Campbell DT, 1972, J SOC ISSUES, V28, P21; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; Corcoran K, 2009, SOC PERSONAL PSYCHOL, V3, P244, DOI 10.1111/j.1751-9004.2009.00173.x; Croson RTA, 2007, ECON INQ, V45, P199, DOI 10.1111/j.1465-7295.2006.00006.x; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Gachter S, 2012, SCAND J ECON, V114, P1346, DOI 10.1111/j.1467-9442.2012.01730.x; Gould RV, 1999, AM SOCIOL REV, V64, P356, DOI 10.2307/2657491; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hogg MA, 2000, PL S SOC CL, P401; Hogg MA, 2000, EUROPEAN REV SOCIAL; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; KELLEY HH, 1970, J PERS SOC PSYCHOL, V16, P66, DOI 10.1037/h0029849; KREPS DM, 1982, J ECON THEORY, V27, P245, DOI 10.1016/0022-0531(82)90029-1; Kuhnen CM, 2012, MANAGE SCI, V58, P94, DOI 10.1287/mnsc.1110.1379; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Maner JK, 2010, J PERS SOC PSYCHOL, V99, P482, DOI 10.1037/a0018559; Messick D. M., 1983, REV PERSONALITY SOCI, V4, P11; Neugebauer T, 2009, J ECON PSYCHOL, V30, P52, DOI 10.1016/j.joep.2008.04.005; Pinheiro J., 2011, PACKAGE R SOFTWARE S, P21; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2008, LANG ENV STAT COMP; RIJSMAN JB, 1974, EUR J SOC PSYCHOL, V4, P279, DOI 10.1002/ejsp.2420040303; Saaksvuori L, 2011, P R SOC B, V2011; SETA JJ, 1982, J PERS SOC PSYCHOL, V42, P281, DOI 10.1037/0022-3514.42.2.281; Shang J, 2009, ECON J, V119, P1422, DOI 10.1111/j.1468-0297.2009.02267.x; Sherif M., 1966, COMMON PREDICAMENT S; Suls J., 2000, HDB SOCIAL COMP; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Triplett N., 1898, AM J PSYCHOL, V9, P507, DOI [10.2307/1412188, DOI 10.2307/1412188]; Turner J.C., 1987, REDISCOVERING SOCIAL; TURNER JC, 1975, EUR J SOC PSYCHOL, V5, P5, DOI 10.1002/ejsp.2420050102; WHEELER L, 1992, J PERS SOC PSYCHOL, V62, P760, DOI 10.1037/0022-3514.62.5.760	48	36	36	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56152	10.1371/journal.pone.0056152	http://dx.doi.org/10.1371/journal.pone.0056152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405262	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400208
J	Bruno, N; Bertamini, M				Bruno, Nicola; Bertamini, Marco			Self-Portraits: Smartphones Reveal a Side Bias in Non-Artists	PLOS ONE			English	Article							TURNING LEFT CHEEK; LATERALITY; PICTURES	According to surveys of art books and exhibitions, artists prefer poses showing the left side of the face when composing a portrait and the right side when composing a self-portrait. However, it is presently not known whether similar biases can be observed in individuals that lack formal artistic training. We collected self-portraits by naive photographers who used the iPhone (TM) front camera, and confirmed a right side bias in this non-artist sample and even when biomechanical constraints would have favored the opposite. This result undermines explanations based on posing conventions due to artistic training or biomechanical factors, and is consistent with the hypothesis that side biases in portraiture and self-portraiture are caused by biologically-determined asymmetries in facial expressiveness.	[Bruno, Nicola] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Bertamini, Marco] Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England	University of Parma; University of Liverpool	Bruno, N (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	nicola.bruno@unipr.it	Bertamini, Marco/H-2752-2019; Bertamini, Marco/C-2495-2011	Bertamini, Marco/0000-0001-8617-6864; Bertamini, Marco/0000-0001-8617-6864	Leverhulme Trust;  [2008RBFNLH]	Leverhulme Trust(Leverhulme Trust); 	The study was supported in part by a Leverhulme Trust Grant (M.B) and by PRIN 2008RBFNLH (N.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett KM, 2010, PERCEPTION, V39, P970, DOI 10.1068/p6624; Bruno N., 2011, I-PERCEPTION, V2, P1; Calabrese, 2010, ARTE AUTORITRATTO ST; EKMAN P, 1981, PSYCHOPHYSIOLOGY, V18, P101, DOI 10.1111/j.1469-8986.1981.tb02919.x; GORDON IE, 1974, BRIT J PSYCHOL, V65, P243, DOI 10.1111/j.2044-8295.1974.tb01398.x; Humphrey NK., 1973, NEW SCI, V59, P437; LABAR M, 1973, NATURE, V245, P338, DOI 10.1038/245338a0; Latto R, 1996, EMPIR STUD ARTS, VArts14, P89, DOI DOI 10.2190/198M-911X-PR9G-U18E; Lindell A. K., 2012, LATERALITY, DOI 10. 1080/1357650X. 2012. 673622; Maass Anne, 2007, EMPIR STUD ARTS, V25, P71, DOI DOI 10.2190/X458-8V17-5M35-5549; Mamassian P, 2008, VISION RES, V48, P2143, DOI 10.1016/j.visres.2008.06.010; McManus I.C., 1979, THESIS U CAMBRIDGE; MCMANUS IC, 1973, NATURE, V243, P271, DOI 10.1038/243271a0; Nicholls MER, 2000, SIDE BIAS: A NEUROPSYCHOLOGICAL PERSPECTIVE, P313; Nicholls MER, 1999, P ROY SOC B-BIOL SCI, V266, P1517, DOI 10.1098/rspb.1999.0809; Pendergrast M., 2003, MIRROR MIRROR HIST H; Powell WR, 2009, LATERALITY, V14, P545, DOI 10.1080/13576500802680336; Ramamurthy A., 2004, PHOTOGRAPHY CRITICAL, P193	18	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55141	10.1371/journal.pone.0055141	http://dx.doi.org/10.1371/journal.pone.0055141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405117	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400061
J	de Hoef, DLV; Coppens, I; Holowka, T; Ben Mamoun, C; Branch, O; Rodriguez, A				de Hoef, Diana L. van; Coppens, Isabelle; Holowka, Thomas; Ben Mamoun, Choukri; Branch, OraLee; Rodriguez, Ana			Plasmodium falciparum-Derived Uric Acid Precipitates Induce Maturation of Dendritic Cells	PLOS ONE			English	Article							EXPERIMENTAL CEREBRAL MALARIA; DANGER SIGNAL; ANTIGEN PRESENTATION; GALLSTONE FORMATION; URATE OXIDASE; PLASMA; RESPONSES; HEMOZOIN; IDENTIFICATION; INFLAMMASOME	Malaria is characterized by cyclical fevers and high levels of inflammation, and while an early inflammatory response contributes to parasite clearance, excessive and persistent inflammation can lead to severe forms of the disease. Here, we show that Plasmodium falciparum-infected erythrocytes contain uric acid precipitates in the cytoplasm of the parasitophorous vacuole, which are released when erythrocytes rupture. Uric acid precipitates are highly inflammatory molecules that are considered a danger signal for innate immunity and are the causative agent in gout. We determined that P. falciparum-derived uric acid precipitates induce maturation of human dendritic cells, increasing the expression of cell surface co-stimulatory molecules such as CD80 and CD86, while decreasing human leukocyte antigen-DR expression. In accordance with this, uric acid accounts for a significant proportion of the total stimulatory activity induced by parasite-infected erythrocytes. Moreover, the identification of uric acid precipitates in P. falciparum-and P. vivax-infected erythrocytes obtained directly from malaria patients underscores the in vivo and clinical relevance of our findings. Altogether, our data implicate uric acid precipitates as a potentially important contributor to the innate immune response to Plasmodium infection and may provide a novel target for adjunct therapies.	[de Hoef, Diana L. van; Branch, OraLee; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA; [Coppens, Isabelle] Johns Hopkins Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Holowka, Thomas; Ben Mamoun, Choukri] Yale Univ, Infect Dis Sect, Sch Med, New Haven, CT USA; [Holowka, Thomas; Ben Mamoun, Choukri] Yale Univ, Dept Microbial Pathogenesis, Sch Med, New Haven, CT USA	New York University; Johns Hopkins University; Yale University; Yale University	Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA.	Ana.Rodriguez@nyumc.org	Rodríguez, Ana/GQR-0554-2022	Rodriguez, Ana/0000-0002-0060-3405	Burroughs Wellcome Fund Award for Investigators in the Pathogenesis of Infectious Disease; NIH [R56-AI070907]; Irma T. Hirschl Trust Career Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007404, R56AI070907, R01AI064831] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Award for Investigators in the Pathogenesis of Infectious Disease; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Trust Career Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Burroughs Wellcome Fund Award for Investigators in the Pathogenesis of Infectious Disease (http://www.bwfund.org/pages/105/Investigators-in-the-Pathogenesis-of-Infectious-Disease/), NIH grant R56-AI070907 (http://grants.nih.gov/grants/funding/r56.htm) and the Irma T. Hirschl Trust Career Investigator Award (http://www.mssm.edu/static_files/Test2/06081716/www.mssm.edu/grants/pdfs/Hirschl_applic_guidelines.pdf) to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Becker MA, 2009, J RHEUMATOL, V36, P1273, DOI 10.3899/jrheum.080814; Bertrand Kouam Eric, 2008, Pak J Biol Sci, V11, P1646, DOI 10.3923/pjbs.2008.1646.1649; Bettiol E, MALAR J, V9, P64; BOULIEU R, 1983, ANAL BIOCHEM, V129, P398, DOI 10.1016/0003-2697(83)90568-7; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; Clark EH, 2012, INFECT IMMUN; Clark IA, 2003, PHARMACOL THERAPEUT, V99, P221, DOI 10.1016/S0163-7258(03)00060-3; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; DAS BS, 1993, AM J TROP MED HYG, V49, P720, DOI 10.4269/ajtmh.1993.49.720; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; Della Bella S, 2008, J IMMUNOL METHODS, V339, P153, DOI 10.1016/j.jim.2008.09.009; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Elandalloussi Laurence M, 2002, Malar J, V1, P6, DOI 10.1186/1475-2875-1-6; Erdman LK, 2008, MOL BIOCHEM PARASIT, V162, P105, DOI 10.1016/j.molbiopara.2008.08.006; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Gowda NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020398; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Haldar K, 2009, HEMATOL-AM SOC HEMAT, V2009, P87, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.87; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hu DE, 2004, CANCER RES, V64, P5059, DOI 10.1158/0008-5472.CAN-04-1586; Iwalokun BA, 2006, APMIS, V114, P842, DOI 10.1111/j.1600-0463.2006.apm_457.x; Iwama M, 2012, BIOL PHARM BULL, V35, P1367, DOI 10.1248/bpb.b12-00198; Johnson RJ, 2011, SEMIN NEPHROL, V31, P394, DOI 10.1016/j.semnephrol.2011.08.002; Khan SR, 2002, KIDNEY INT, V62, P2062, DOI 10.1046/j.1523-1755.2002.00676.x; Kim CC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-17; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Kono H, J CLIN INVEST, V120, P1939; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kordes M, 2011, INFECT IMMUN, V79, P3633, DOI 10.1128/IAI.05459-11; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Labbe K, 2010, J IMMUNOL, V185, P5495, DOI 10.4049/jimmunol.1002517; Lopera-Mesa T.MM-MNK, 2012, PLOS ONE, V7; Luah YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010252; Lundie RJ, 2010, EUR J IMMUNOL, V40, P1674, DOI 10.1002/eji.200939265; MCCARTY DJ, 1961, ANN INTERN MED, V54, P452, DOI 10.7326/0003-4819-54-3-452; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; MOSER AJ, 1994, DIGEST DIS SCI, V39, P1313; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Nguansangiam S, 2007, TROP MED INT HEALTH, V12, P1037, DOI 10.1111/j.1365-3156.2007.01881.x; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Orengo JM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-254; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Orengo JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005194; Overgaard-Hansen K, 1959, NATURE S8, P553; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Reimer T, 2010, EUR J IMMUNOL, V40, P764, DOI 10.1002/eji.200939996; ROSLYN JJ, 1987, DIGEST DIS SCI, V32, P609, DOI 10.1007/BF01296161; Saliba KJ, 2003, J BIOL CHEM, V278, P5605, DOI 10.1074/jbc.M208648200; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Sarma PSA, 1998, AM J TROP MED HYG, V58, P454, DOI 10.4269/ajtmh.1998.58.454; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; Selvam R., 1992, Indian Journal of Malariology, V29, P103; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; STOCKER R, 1986, BIOCHEM BIOPH RES CO, V134, P152, DOI 10.1016/0006-291X(86)90540-1; Terkeltaub R, 2007, J RHEUMATOL, V34, P1955; Urban BC, 2001, BLOOD, V98, P2859, DOI 10.1182/blood.V98.9.2859; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; ZOLG JW, 1982, J PARASITOL, V68, P1072, DOI 10.2307/3281094	72	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55584	10.1371/journal.pone.0055584	http://dx.doi.org/10.1371/journal.pone.0055584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405174	Green Published, gold			2022-12-27	WOS:000315153400119
J	Fisson, S; Ouakrim, H; Touitou, V; Baudet, S; Ben Abdelwahed, R; Donnou, S; Miloudi, A; Galand, C; Bodaghi, B; LeHoang, P; Brissard, M; Le Garff-Tavernier, M; Fridman, WH; Sautes-Fridman, C; Cassoux, N; Merle-Beral, H				Fisson, Sylvain; Ouakrim, Hanane; Touitou, Valerie; Baudet, Sylvie; Ben Abdelwahed, Rym; Donnou, Sabrina; Miloudi, Amine; Galand, Claire; Bodaghi, Bahram; Phuc LeHoang; Brissard, Martine; Le Garff-Tavernier, Magali; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Cassoux, Nathalie; Merle-Beral, Helene			Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis	PLOS ONE			English	Article							NERVOUS-SYSTEM LYMPHOMA; VITREORETINAL LYMPHOMA; AQUEOUS-HUMOR; INTERLEUKIN-10	Primary intraocular lymphoma (PIOL), also called primary vitreoretinal lymphomas, often masquerades as uveitis. This misdiagnosis can result in subsequent brain involvement and oculocerebral lymphoma (OCL). In this study, we sought to characterize the helper T-cell type 1 (Th1)/Th2 cytokine profile in vitreous samples from patients with PIOL, OCL, uveitis and controls with non-inflammatory disease. Vitreous and aqueous humor samples from 87 patients with PIOL (n = 30), OCL (n = 12), uveitis (n = 34), and retinal detachment (RD) without hemorrhage (n = 11) were analyzed and their concentrations of interleukin (IL)-2, IL-4, IL-6, IL-10, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha were determined by flow cytometric bead arrays (CBA). The IL-10 levels determined by CBA were compared with those by ELISA. IL-10 concentrations measured by CBA and ELISA were highly correlated. IL-2, IL-4, and TNF alpha were not detected in any sample. The only cytokine detected at a significant level in samples from RD vitreous was IL-6. The IL-10/IL-6 ratio, as previously reported, was slightly higher in PIOL than in uveitis samples, but not for all patients. Cytokine profiles from PIOL and OCL samples did not differ. The combination of the IL-10/IL-6 and IL-10/IFN gamma ratios was highly informative for discriminating PIOL/OCL from uveitis samples and for therapeutic follow up of PIOL. This strategy might be very helpful as an initial screening to rule out PIOL in patients thought to have uveitis.	[Fisson, Sylvain; Ouakrim, Hanane; Ben Abdelwahed, Rym; Donnou, Sabrina; Miloudi, Amine; Galand, Claire; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Merle-Beral, Helene] INSERM, UMRS872, Ctr Rech Cordeliers, Paris, France; [Fisson, Sylvain; Ouakrim, Hanane; Touitou, Valerie; Baudet, Sylvie; Ben Abdelwahed, Rym; Donnou, Sabrina; Miloudi, Amine; Galand, Claire; Bodaghi, Bahram; Phuc LeHoang; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Merle-Beral, Helene] Univ Paris 06, UMRS 872, Paris, France; [Fisson, Sylvain; Ouakrim, Hanane; Ben Abdelwahed, Rym; Donnou, Sabrina; Miloudi, Amine; Galand, Claire; Fridman, Wolf Herman; Sautes-Fridman, Catherine] Univ Paris 05, UMRS 872, Paris, France; [Fisson, Sylvain; Donnou, Sabrina] Genethon, Evry, France; [Fisson, Sylvain; Donnou, Sabrina] INSERM, U951, Evry, France; [Fisson, Sylvain; Donnou, Sabrina] Univ Evry Val dEssonne, UMRS 951, Evry, France; [Touitou, Valerie; Bodaghi, Bahram; Phuc LeHoang] Hop La Pitie Salpetriere, AP HP, Serv Ophtalmol, Paris, France; [Baudet, Sylvie; Brissard, Martine; Le Garff-Tavernier, Magali; Merle-Beral, Helene] Hop La Pitie Salpetriere, AP HP, Serv Hematol Biol, Paris, France; [Cassoux, Nathalie] Inst Curie, Serv Oncoophtalmol, Dept Oncol Chirurg, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Fisson, S (corresponding author), INSERM, UMRS872, Ctr Rech Cordeliers, Paris, France.	sylvain.fisson@univ-evry.fr	Bodaghi, Bahram/AAS-1160-2021; FISSON, Sylvain/J-8003-2013; Cassoux, Nathalie/D-6844-2015	FISSON, Sylvain/0000-0002-0057-363X; Cassoux, Nathalie/0000-0002-5535-9649; Merle-Beral, Helene/0000-0002-7430-1143; Galand, Claire/0000-0001-8005-4831; fridman, wolf herman/0000-0002-1332-0973; Le Garff-Tavernier, Magali/0000-0002-3131-3240; LeHoang, Phuc/0000-0003-4722-1831; Bodaghi, Bahram/0000-0002-0962-5301; sautes-fridman, catherine/0000-0003-1735-8722	Institut National du Cancer [RC013-C06N631-2005, C06N748-2006]; Association pour la Recherche contre le Cancer; Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre and Marie Curie; Universite Paris-Descartes; pole de competitivite Ile de France (ImmuCan project); Tunisian Direction Generale de la Recherche Scientifique; French-Tunisian CMCU "(Egide-PHC Utique)" project; DGRS-INSERM; CMCU; Institut National du Cancer; Federation des Aveugles de France; Fondation de France (Fouassier)	Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre and Marie Curie; Universite Paris-Descartes; pole de competitivite Ile de France (ImmuCan project); Tunisian Direction Generale de la Recherche Scientifique; French-Tunisian CMCU "(Egide-PHC Utique)" project; DGRS-INSERM; CMCU; Institut National du Cancer(Institut National du Cancer (INCA) France); Federation des Aveugles de France; Fondation de France (Fouassier)	This work was supported by the Institut National du Cancer (Grants RC013-C06N631-2005 and C06N748-2006), the Association pour la Recherche contre le Cancer, the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite Pierre and Marie Curie, the Universite Paris-Descartes, the pole de competitivite Ile de France (ImmuCan project), the Tunisian Direction Generale de la Recherche Scientifique, and the French-Tunisian CMCU "(Egide-PHC Utique)" project. R. B. A. was a recipient of grants from the DGRS-INSERM and the CMCU. S. D. was recipient of a grant from the Institut National du Cancer. V. T. was a beneficiary of study grants from the Federation des Aveugles de France and the Fondation de France (Fouassier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpek EK, 1999, OPHTHALMOLOGY, V106, P2291; Buggage RR, 1999, INVEST OPHTH VIS SCI, V40, P2462; Cassoux N, 2000, OCUL IMMUNOL INFLAMM, V8, P243, DOI 10.1076/ocii.8.4.243.6463; Cassoux N, 2007, INVEST OPHTH VIS SCI, V48, P3253, DOI 10.1167/iovs.06-0031; Chan Chi-Chao, 2003, Trans Am Ophthalmol Soc, V101, P275; Chan CC, 2011, ONCOLOGIST, V16, P1589, DOI 10.1634/theoncologist.2011-0210; Chan CC, 2009, OCUL IMMUNOL INFLAMM, V17, P375, DOI 10.3109/09273940903434804; Corn BW, 1997, CANCER, V79, P2409; Davis JL, 2004, OCUL IMMUNOL INFLAMM, V12, P7, DOI 10.1076/ocii.12.1.7.28072; Ecker SM, 2011, MOL VIS, V17, P2856; HOCHBERG FH, 1988, J NEUROSURG, V68, P835, DOI 10.3171/jns.1988.68.6.0835; Jahnke K, 2007, CLIN OPHTHALMOL, V1, P247; Kawamura H, 2009, OPHTHAL RES, V42, P172, DOI 10.1159/000230879; Merle-Beral H, 2004, BRIT J HAEMATOL, V124, P469, DOI 10.1046/j.1365-2141.2003.04800.x; Sen HN, 2009, OCUL IMMUNOL INFLAMM, V17, P133, DOI 10.1080/09273940903108544; Vosganian GS, 2011, J NEURO-ONCOL, V105, P127, DOI 10.1007/s11060-011-0618-1; Whitcup SM, 1997, ARCH OPHTHALMOL-CHIC, V115, P1157, DOI 10.1001/archopht.1997.01100160327010; WHITCUP SM, 1993, OPHTHALMOLOGY, V100, P1399; Wolf LA, 2003, OPHTHALMOLOGY, V110, P1671, DOI 10.1016/S0161-6420(03)00811-X	19	45	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e52385	10.1371/journal.pone.0052385	http://dx.doi.org/10.1371/journal.pone.0052385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405064	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400007
J	Hostage, CA; Choudhury, KR; Doraiswamy, PM; Petrella, JR				Hostage, Christopher A.; Choudhury, Kingshuk Roy; Doraiswamy, Pudugramam Murali; Petrella, Jeffrey R.		Alzheimer's Dis Neuroimaging Initi	Dissecting the Gene Dose-Effects of the APOE epsilon 4 and epsilon 2 Alleles on Hippocampal Volumes in Aging and Alzheimer's Disease	PLOS ONE			English	Article							NEUROIMAGING INITIATIVE ADNI; APOLIPOPROTEIN-E GENOTYPE; GRAY-MATTER VOLUME; GEOMETRICALLY ACCURATE; CORTICAL THICKNESSES; MRI; ATROPHY; LOAD; SEGMENTATION; FREQUENCY	Objective: To investigate whether there is a specific dose-dependent effect of the Apolipoprotein E (APOE) epsilon 4 and epsilon 2 alleles on hippocampal volume, across the cognitive spectrum, from normal aging to Alzheimer's Disease (AD). Materials and Methods: We analyzed MR and genetic data on 662 patients from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database-198 cognitively normal controls (CN), 321 mild-cognitive impairment (MCI) subjects, and 143 AD subjects-looking for dose-dependent effects of the epsilon 4 and epsilon 2 alleles on hippocampal volumes. Volumes were measured using a fully-automated algorithm applied to high resolution T1-weighted MR images. Statistical analysis consisted of a multivariate regression with repeated-measures model. Results: There was a dose-dependent effect of the epsilon 4 allele on hippocampal volume in AD (p = 0.04) and MCI (p = 0.02)-in both cases, each allele accounted for loss of >150 mm(3) (approximately 4%) of hippocampal volume below the mean volume for AD and MCI subjects with no such alleles (Cohen's d = -0.16 and -0.19 for AD and MCI, respectively). There was also a dose-dependent, main effect of the epsilon 2 allele (p<0.0001), suggestive of a moderate protective effect on hippocampal volume-an approximately 20% per allele volume increase as compared to CN with no epsilon 2 alleles (Cohen's d = 0.23). Conclusion: Though no effect of epsilon 4 was seen in CN subjects, our findings confirm and extend prior data on the opposing effects of the APOE epsilon 4 and epsilon 2 alleles on hippocampal morphology across the spectrum of cognitive aging.	[Hostage, Christopher A.; Choudhury, Kingshuk Roy; Petrella, Jeffrey R.] Duke Univ, Dept Radiol, Sch Med, Durham, NC 27710 USA; [Doraiswamy, Pudugramam Murali] Duke Univ, Dept Psychiat, Sch Med, Durham, NC 27706 USA; [Doraiswamy, Pudugramam Murali] Duke Univ, Sch Med, Duke Inst Brain Sci, Durham, NC USA	Duke University; Duke University; Duke University	Petrella, JR (corresponding author), Duke Univ, Dept Radiol, Sch Med, Durham, NC 27710 USA.	jeffrey.petrella@duke.edu			RSNA Research Medical Student Grant [RMS1213]; NATIONAL INSTITUTE ON AGING [U19AG010483] Funding Source: NIH RePORTER	RSNA Research Medical Student Grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a 2012 RSNA Research Medical Student Grant, grant #RMS1213 (http://www.rsna.org/Grants_and_Awards.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ADNI MRI PROTOCOLS; Barber R, 2000, NEUROLOGY, V54, P1304, DOI 10.1212/WNL.54.6.1304; Basso M, 2006, NEUROBIOL AGING, V27, P1416, DOI 10.1016/j.neurobiolaging.2005.08.002; BENJAMIN R, 1994, LANCET, V344, P473, DOI 10.1016/S0140-6736(94)91804-X; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501, DOI 10.1093/gerona/63.5.501; Chiang GC, 2010, NEUROLOGY, V75, P1976, DOI 10.1212/WNL.0b013e3181ffe4d1; Crivello F, 2010, NEUROIMAGE, V53, P1064, DOI 10.1016/j.neuroimage.2009.12.116; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Farlow MR, 1997, NEUROLOGY, V48, pS30, DOI 10.1212/WNL.48.5_Suppl_6.30S; Farlow MR, 2004, NEUROLOGY, V63, P1898, DOI 10.1212/01.WNL.0000144279.21502.B7; Filippini N, 2009, NEUROIMAGE, V44, P724, DOI 10.1016/j.neuroimage.2008.10.003; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Holland D, 2012, HUM BRAIN MAPP, V33, P2586, DOI 10.1002/hbm.21386; Holland D, 2011, MED IMAGE ANAL, V15, P489, DOI 10.1016/j.media.2011.02.005; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 1998, ANN NEUROL, V43, P303, DOI 10.1002/ana.410430307; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Lemaitre H, 2005, NEUROIMAGE, V24, P1205, DOI 10.1016/j.neuroimage.2004.10.016; Liu YW, 2010, DEMENT GERIATR COGN, V30, P229, DOI 10.1159/000320136; Liu YW, 2010, J ALZHEIMERS DIS, V21, P947, DOI 10.3233/JAD-2010-100201; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; NAGY Z, 1995, NEUROSCIENCE, V69, P757, DOI 10.1016/0306-4522(95)00331-C; Petersen R, 2008, ALZHEIMERS DIS NEURO; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Rebeck GW, 2002, J ALZHEIMERS DIS, V4, P145, DOI 10.3233/JAD-2002-4304; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Serra-Grabulosa JM, 2003, NEUROGENETICS, V4, P141, DOI 10.1007/s10048-002-0142-8; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Teter B, 2002, J ALZHEIMERS DIS, V4, P155, DOI 10.3233/JAD-2002-4305; Thompson PM, 1997, J COMPUT ASSIST TOMO, V21, P567, DOI 10.1097/00004728-199707000-00008; Tupler LA, 2007, NEUROBIOL AGING, V28, P1644, DOI 10.1016/j.neurobiolaging.2006.07.001; WEST HL, 1994, NEUROSCI LETT, V175, P46, DOI 10.1016/0304-3940(94)91074-X	45	43	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54483	10.1371/journal.pone.0054483	http://dx.doi.org/10.1371/journal.pone.0054483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405083	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400027
J	Spry, C; Macuamule, C; Lin, ZY; Virga, KG; Lee, RE; Strauss, E; Saliba, KJ				Spry, Christina; Macuamule, Cristiano; Lin, Zhiyang; Virga, Kristopher G.; Lee, Richard E.; Strauss, Erick; Saliba, Kevin J.			Pantothenamides Are Potent, On-Target Inhibitors of Plasmodium falciparum Growth When Serum Pantetheinase Is Inactivated	PLOS ONE			English	Article							N-SUBSTITUTED PANTOTHENAMIDES; COENZYME-A BIOSYNTHESIS; IN-VITRO; MALARIA; KINASE; ASSAY; ACID; DERIVATIVES; ENZYME; PENTYLPANTOTHENAMIDE	Growth of the virulent human malaria parasite Plasmodium falciparum is dependent on an extracellular supply of pantothenate (vitamin B5) and is susceptible to inhibition by pantothenate analogues that hinder pantothenate utilization. In this study, on the hunt for pantothenate analogues with increased potency relative to those reported previously, we screened a series of pantothenamides (amide analogues of pantothenate) against P. falciparum and show for the first time that analogues of this type possess antiplasmodial activity. Although the active pantothenamides in this series exhibit only modest potency under standard in vitro culture conditions, we show that the potency of pantothenamides is selectively enhanced when the parasite culture medium is pre-incubated at 37 degrees C for a prolonged period. We present evidence that this finding is linked to the presence in Albumax II (a serum-substitute routinely used for in vitro cultivation of P. falciparum) of pantetheinase activity: the activity of an enzyme that hydrolyzes the pantothenate metabolite pantetheine, for which pantothenamides also serve as substrates. Pantetheinase activity, and thereby pantothenamide degradation, is reduced following incubation of Albumax II-containing culture medium for a prolonged period at 37 degrees C, revealing the true, sub-micromolar potency of pantothenamides. Importantly we show that the potent antiplasmodial effect of pantothenamides is attenuated with pantothenate, consistent with the compounds inhibiting parasite proliferation specifically by inhibiting pantothenate and/or CoA utilization. Additionally, we show that the pantothenamides interact with P. falciparum pantothenate kinase, the first enzyme involved in converting pantothenate to coenzyme A. This is the first demonstration of on-target antiplasmodial pantothenate analogues with sub-micromolar potency, and highlights the potential of pantetheinase-resistant pantothenamides as antimalarial agents.	[Spry, Christina; Lin, Zhiyang; Saliba, Kevin J.] Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia; [Saliba, Kevin J.] Australian Natl Univ, Sch Med, Coll Med Biol & Environm, Canberra, ACT, Australia; [Macuamule, Cristiano; Strauss, Erick] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa; [Virga, Kristopher G.] Presbyterian Coll, Sch Pharm, Dept Pharmaceut & Adm Sci, Clinton, SC USA; [Virga, Kristopher G.; Lee, Richard E.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	Australian National University; Australian National University; Stellenbosch University; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Saliba, KJ (corresponding author), Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia.	kevin.saliba@anu.edu.au	Lee, Richard/J-4997-2013; Saliba, Kevin J/C-9166-2009; Strauss, Erick/G-1783-2010; Lee, Richard/AAX-3996-2021	Lee, Richard/0000-0002-2397-0443; Saliba, Kevin J/0000-0003-3345-8440; Strauss, Erick/0000-0002-9898-8226; Lee, Richard/0000-0002-2397-0443; Spry, Christina/0000-0002-8156-7070; Lin, Zhiyang Jace/0000-0003-1857-0303; MACUAMULE, Cristiano Joao/0000-0003-0551-3772	South African Malaria Initiative (SAMI); American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital	South African Malaria Initiative (SAMI); American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC))	Aspects of this work were supported by grants from the South African Malaria Initiative (SAMI) to ES and KJS and the American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital, to REL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinnusi TO, 2011, BIOORGAN MED CHEM, V19, P2696, DOI 10.1016/j.bmc.2011.02.053; Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Asahi H, 2005, EXP PARASITOL, V109, P7, DOI 10.1016/j.exppara.2004.10.002; Bracchi-Ricard V, 2000, BIOCHEM J, V347, P255, DOI 10.1042/0264-6021:3470255; Choudhry AE, 2003, ANTIMICROB AGENTS CH, V47, P2051, DOI 10.1128/AAC.47.6.2051-2055.2003; CLIFTON G, 1970, ARCH BIOCHEM BIOPHYS, V137, P523, DOI 10.1016/0003-9861(70)90470-4; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; DUPRE S, 1984, ANAL BIOCHEM, V142, P175, DOI 10.1016/0003-2697(84)90534-7; Harmse L, 2001, BIOCHEM PHARMACOL, V62, P341, DOI 10.1016/S0006-2952(01)00644-X; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Ivey RA, 2004, J BIOL CHEM, V279, P35622, DOI 10.1074/jbc.M403152200; Lamprecht DA, 2012, ORG BIOMOL CHEM, V10, P5278, DOI 10.1039/c2ob25429h; Lehane AM, 2007, J BIOL CHEM, V282, P25395, DOI 10.1074/jbc.M704610200; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Martin F, 2001, IMMUNOGENETICS, V53, P296, DOI 10.1007/s002510100327; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Mercer AC, 2008, BIOORG MED CHEM LETT, V18, P5991, DOI 10.1016/j.bmcl.2008.07.078; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Mitamura T, 2000, PARASITOL INT, V49, P219, DOI 10.1016/S1383-5769(00)00048-9; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Pace HC, 2001, GENOME BIOL, V2; Patani GA, 1996, CHEM REV, V96, P3147, DOI 10.1021/cr950066q; Perez-Sacau E, 2005, CHEM BIODIVERS, V2, P264, DOI 10.1002/cbdv.200590009; Ruan BH, 2010, ANAL BIOCHEM, V399, P284, DOI 10.1016/j.ab.2009.12.010; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Saliba KJ, 2005, MOL BIOCHEM PARASIT, V141, P129, DOI 10.1016/j.molbiopara.2005.02.003; Saliba KJ, 2005, ANTIMICROB AGENTS CH, V49, P632, DOI 10.1128/AAC.49.2.632-637.2005; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; Spry C, 2005, ANTIMICROB AGENTS CH, V49, P4649, DOI 10.1128/AAC.49.11.4649-4657.2005; Spry C., 2010, Infectious Disorders - Drug Targets, V10, P200; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; Strauss E, 2002, J BIOL CHEM, V277, P48205, DOI 10.1074/jbc.M204560200; Thomas J, 2010, ANTIMICROB AGENTS CH, V54, P1374, DOI 10.1128/AAC.01473-09; van Schalkwyk DA, 2008, J PHARMACOL EXP THER, V327, P511, DOI 10.1124/jpet.108.141929; van Wyk M, 2008, ORG BIOMOL CHEM, V6, P4348, DOI 10.1039/b811086g; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Virga KG, 2006, BIOORGAN MED CHEM, V14, P1007, DOI 10.1016/j.bmc.2005.09.021; WEIGELE M, 1972, J AM CHEM SOC, V94, P5927, DOI 10.1021/ja00771a084; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WITTWER CT, 1983, J BIOL CHEM, V258, P9733; WITTWER CT, 1989, AM J CLIN NUTR, V50, P1072, DOI 10.1093/ajcn/50.5.1072; WITTWER CT, 1985, J CLIN INVEST, V76, P1665, DOI 10.1172/JCI112152; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Zhang YM, 2004, J BIOL CHEM, V279, P50969, DOI 10.1074/jbc.M409607200	48	61	62	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54974	10.1371/journal.pone.0054974	http://dx.doi.org/10.1371/journal.pone.0054974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405100	Green Published, gold			2022-12-27	WOS:000315153400044
J	Wang, JH; Zhang, CS; Wei, XF; Blagosklonov, O; Lv, GD; Lu, XM; Mantion, G; Vuitton, DA; Wen, H; Lin, RY				Wang, Junhua; Zhang, Chuanshan; Wei, Xufa; Blagosklonov, Oleg; Lv, Guodong; Lu, Xiaomei; Mantion, Georges; Vuitton, Dominique A.; Wen, Hao; Lin, Renyong			TGF-beta and TGF-beta/Smad Signaling in the Interactions between Echinococcus multilocularis and Its Hosts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HUMAN ALVEOLAR ECHINOCOCCOSIS; HUMAN LIVER FIBROSIS; PERIPARASITIC GRANULOMA; EXTRACELLULAR-MATRIX; TNF-ALPHA; CELLS; MICE; EXPRESSION; KINASE	Alveolar echinococcosis (AE) is characterized by the development of irreversible fibrosis and of immune tolerance towards Echinococcus multilocularis (E. multilocularis). Very little is known on the presence of transforming growth factor-beta (TGF-beta) and other components of TGF-beta/Smad pathway in the liver, and on their possible influence on fibrosis, over the various stages of infection. Using Western Blot, qRT-PCR and immunohistochemistry, we measured the levels of TGF-beta 1, TGF-beta receptors, and down-stream Smads activation, as well as fibrosis marker expression in both a murine AE model from day 2 to 360 post-infection (p.i.) and in AE patients. TGF-beta 1, its receptors, and down-stream Smads were markedly expressed in the periparasitic infiltrate and also in the hepatocytes, close to and distant from AE lesions. Fibrosis was significant at 180 days p.i. in the periparasitic infiltrate and was also present in the liver parenchyma, even distant from the lesions. Over the time course after infection TGF-beta 1 expression was correlated with CD4/CD8 T-cell ratio long described as a hallmark of AE severity. The time course of the various actors of the TGF-beta/Smad system in the in vivo mouse model as well as down-regulation of Smad7 in liver areas close to the lesions in human cases highly suggest that TGF-beta plays an important role in AE both in immune tolerance against the parasite and in liver fibrosis.	[Wang, Junhua; Zhang, Chuanshan; Wei, Xufa; Lv, Guodong; Lu, Xiaomei; Wen, Hao; Lin, Renyong] Xinjiang Med Univ, State Key Lab Incubat Base Xinjiang Major Dis Res, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Wang, Junhua; Zhang, Chuanshan; Wei, Xufa; Lv, Guodong; Lu, Xiaomei; Wen, Hao; Lin, Renyong] Xinjiang Med Univ, Xinjiang Key Lab Echinococcosis, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Wang, Junhua; Blagosklonov, Oleg] Univ Franche Comte, Dept Nucl Med, F-25030 Besancon, Franche Comte, France; [Wang, Junhua; Blagosklonov, Oleg] Jean Minjoz Univ Hosp, Besancon, Franche Comte, France; [Blagosklonov, Oleg; Mantion, Georges; Vuitton, Dominique A.] Univ Franche Comte, WHO Collaborating Ctr Prevent & Treatment Human E, F-25030 Besancon, Franche Comte, France; [Blagosklonov, Oleg; Mantion, Georges; Vuitton, Dominique A.] Univ Hosp, Besancon, Franche Comte, France	Xinjiang Medical University; Xinjiang Medical University; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Wen, H (corresponding author), Xinjiang Med Univ, State Key Lab Incubat Base Xinjiang Major Dis Res, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China.	Dr.wenhao@163.com; renyongl@yahoo.com.cn	Wang, Junhua/ABB-6324-2021	Wang, Junhua/0000-0002-6110-3711	Xinjiang Young Scientist Foundation [2010211B19]; Program for Changjiang Scholars and Innovative Research Team in Universities [IRT1181]; NSFC [30960342, 81260452, 81260252]; Xinjiang Key-Lab Projects [XJDX0202-2009-03]	Xinjiang Young Scientist Foundation; Program for Changjiang Scholars and Innovative Research Team in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NSFC(National Natural Science Foundation of China (NSFC)); Xinjiang Key-Lab Projects	This work was supported by the Xinjiang Young Scientist Foundation (2010211B19), the Program for Changjiang Scholars and Innovative Research Team in Universities (IRT1181), NSFC Grant Projects (30960342, 81260452, 81260252), and Xinjiang Key-Lab Projects (XJDX0202-2009-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SS, 2008, HAEMOPHILIA, V14, P1151, DOI 10.1111/j.1365-2516.2008.01831.x; Alatorre-Carranza MD, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-81; Allen JT, 2001, RESP RES, V3, DOI 10.1186/rr162; Amiot F, 1999, PARASITE IMMUNOL, V21, P475, DOI 10.1046/j.1365-3024.1999.00245.x; Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009; Banas MC, 2007, J HISTOCHEM CYTOCHEM, V55, P275, DOI 10.1369/jhc.6A7083.2006; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Brehm K, 2006, PARASITOL INT, V55, pS15, DOI 10.1016/j.parint.2005.11.003; BRESSONHADNI S, 1994, EUR CYTOKINE NETW, V5, P461; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; Emery I, 1996, PARASITE IMMUNOL, V18, P463, DOI 10.1111/j.1365-3024.1996.tb01030.x; Feng M, 2012, INT IMMUNOPHARMACOL, V12, P189, DOI 10.1016/j.intimp.2011.11.010; Gelmedin V, 2008, BIOCHEM PHARMACOL, V76, P1068, DOI 10.1016/j.bcp.2008.08.020; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; Guerret S, 1998, PARASITOL RES, V84, P657, DOI 10.1007/s004360050466; Harraga S, 2003, ACTA TROP, V85, P231, DOI 10.1016/S0001-706X(02)00218-8; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Higashiyama H, 2007, J CLIN PATHOL, V60, P283, DOI 10.1136/jcp.2006.037606; Itoh S, 2007, MOL CANCER RES, V5, P667, DOI 10.1158/1541-7786.MCR-06-0282; JETTEN AM, 1986, EXP CELL RES, V167, P539, DOI 10.1016/0014-4827(86)90193-X; Kamiya Y, 2010, J BIOL CHEM, V285, P30804, DOI 10.1074/jbc.M110.166140; LIANCE M, 1984, EXPERIENTIA, V40, P1436, DOI 10.1007/BF01951932; Lin RY, 2009, WORLD J GASTROENTERO, V15, P2116, DOI 10.3748/wjg.15.2116; Maille E, 2011, AM J PHYSIOL-LUNG C, V301, pL945, DOI 10.1152/ajplung.00149.2011; Mondragon-De-la-Pena C, 2002, PARASITE, V9, P351, DOI 10.1051/parasite/2002094351; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nono JK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001516; Ouellette MJ, 1997, AM J REPROD IMMUNOL, V37, P125; Przybyszewska M, 2011, ARCH IMMUNOL THER EX, V59, P315, DOI 10.1007/s00005-011-0133-2; RicardBlum S, 1996, GASTROENTEROLOGY, V111, P172, DOI 10.1053/gast.1996.v111.pm8698196; RICARDBLUM S, 1992, HEPATOLOGY, V15, P599, DOI 10.1002/hep.1840150408; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Singh P, 2011, INDIAN J CANCER, V48, P351, DOI 10.4103/0019-509X.84939; Sobral LM, 2011, J PERIODONTOL, V82, P642, DOI 10.1902/jop.2010.100510; Spiliotis M, 2006, INT J PARASITOL, V36, P1097, DOI 10.1016/j.ijpara.2006.05.008; Vuitton DA, 2006, PARASITOL INT, V55, pS51, DOI 10.1016/j.parint.2005.11.007; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1986, Z PARASITENKD, V72, P97, DOI 10.1007/BF00927740; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wu Xiang-wei, 2004, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V22, P1; Yang YZ, 2010, DIABETES, V59, pA590; Zhang CS, 2012, PLOS ONE, V7, P436, DOI 10.1371/journal.pone.0030127; Zhang S, 2008, J INFECT DIS, V197, P1341, DOI 10.1086/586709; Zhou L, 2011, CANCER RES, V71, P955, DOI 10.1158/0008-5472.CAN-10-2933	45	27	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55379	10.1371/journal.pone.0055379	http://dx.doi.org/10.1371/journal.pone.0055379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405141	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400086
J	Lee, YJ; Jeong, BH; Choi, EK; Carp, RI; Kim, YS				Lee, Yun-Jung; Jeong, Byung-Hoon; Choi, Eun-Kyoung; Carp, Richard I.; Kim, Yong-Sun			Complete Genome Sequences of New Xenotropic Murine Leukemia Viruses from the Senescence-Accelerated Mouse (SAM): Molecular and Phylogenetic Analyses	PLOS ONE			English	Article							CELL-SURFACE RECEPTOR; GENE; GAMMARETROVIRUSES; INDUCTION; INFECTION; PROTEIN; MICE; XMRV	Approximately 10% of the mouse genome is constituted by endogenous retroviruses (ERVs), and a number of mouse ERVs remain active. Many copies of endogenous murine leukemia viruses (MuLVs) are detected in the genomes of inbred mouse strains. Some of these MuLVs are transcriptionally active or produce infectious virus particles. Previously, we identified partial env sequences of new xenotropic MuLVs (X-MuLVs) from a senescence-accelerated mouse (SAM) strain. In the present study, we investigated and characterized the complete sequences of the X-MuLVs. The complete genomes and open reading frames (ORFs) of two X-MuLVs, designated xmlv15 and xmlv18 (accession nos. HQ154630 and HQ154631, respectively), were molecularly cloned from the genome of the SAM mice. We confirmed that the xmlv15 and xmlv18 sequences are distinct from all known MuLV genomes and are most similar to DG-75 MuLV. Moreover, we found that common strains of laboratory mice carry our newly identified xmlvs. Additionally, the expression levels of xmlv15-related sequences were much higher in C57BL and ICR mice than in the SAM strains without any stimulators. Our findings suggest that a specific group of endogenous MuLVs is constitutively expressed in the brain and that they may participate in normal functions and/or pathogenic conditions.	[Lee, Yun-Jung; Jeong, Byung-Hoon; Choi, Eun-Kyoung; Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea; [Lee, Yun-Jung; Kim, Yong-Sun] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, Kangwon Do, South Korea; [Carp, Richard I.] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA	Hallym University; Hallym University; Institute for Basic Research in Developmental Disabilities	Kim, YS (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea.	yskim@hallym.ac.kr	Jeong, Byung-Hoon/AAA-3425-2020	Jeong, Byung-Hoon/0000-0002-4525-9994	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012-0000308]; National Research Foundation of Korea Grant; Korean Government [NRF-2011-619E0001]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean Government(Korean Government)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012-0000308) and by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2011-619E0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1971, SCIENCE, V174, P157, DOI 10.1126/science.174.4005.157; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Baliji S, 2010, J VIROL, V84, P12841, DOI 10.1128/JVI.01863-10; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; BATTINI JL, 1992, J VIROL, V66, P1468, DOI 10.1128/JVI.66.3.1468-1475.1992; Boeke JD, 1997, RETROVIRUSES; DATTA SK, 1977, VIROLOGY, V83, P449, DOI 10.1016/0042-6822(77)90193-3; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRANKEL WN, 1989, J VIROL, V63, P1763, DOI 10.1128/JVI.63.4.1763-1774.1989; GREENBERGER JS, 1975, J IMMUNOL, V115, P317; Groom HCT, 2012, J GEN VIROL, V93, P915, DOI 10.1099/vir.0.041038-0; GROSS L, 1951, P SOC EXP BIOL MED, V76, P27; HEARD JM, 1991, J VIROL, V65, P4026, DOI 10.1128/JVI.65.8.4026-4032.1991; Jeong BH, 2002, J NEUROPATH EXP NEUR, V61, P1001, DOI 10.1093/jnen/61.11.1001; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; KRIEG AM, 1988, J VIROL, V62, P3545, DOI 10.1128/JVI.62.10.3545-3550.1988; Lee KH, 2006, BIOCHEM BIOPH RES CO, V349, P122, DOI 10.1016/j.bbrc.2006.08.016; LEVY JA, 1970, SCIENCE, V170, P326, DOI 10.1126/science.170.3955.326; LOWY DR, 1971, SCIENCE, V174, P155, DOI 10.1126/science.174.4005.155; MORSE HC, 1982, J VIROL, V43, P1; Mouse Genome Sequencing Consortium, 2001, NATURE, V420, P520; ONEILL RR, 1986, J VIROL, V58, P359, DOI 10.1128/JVI.58.2.359-366.1986; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PORTIS JL, 1987, J VIROL, V61, P1037, DOI 10.1128/JVI.61.4.1037-1044.1987; RISSER R, 1983, ANNU REV GENET, V17, P85, DOI 10.1146/annurev.ge.17.120183.000505; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; SHERR CJ, 1974, CELL, V1, P55, DOI 10.1016/0092-8674(74)90155-X; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; Stoye JP, 2001, CURR BIOL, V11, pR914, DOI 10.1016/S0960-9822(01)00553-X; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; VOGT M, 1986, VIROLOGY, V154, P420, DOI 10.1016/0042-6822(86)90470-8; WEBER WJ, 1982, DIS TRANSMITTED RATS; Yang YL, 1999, NAT GENET, V21, P216, DOI 10.1038/6005	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55669	10.1371/journal.pone.0055669	http://dx.doi.org/10.1371/journal.pone.0055669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393596	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800050
J	Siljamaki, E; Rintanen, N; Kirsi, M; Upla, P; Wang, W; Karjalainen, M; Ikonen, E; Marjomaki, V				Siljamaki, Elina; Rintanen, Nina; Kirsi, Maija; Upla, Paula; Wang, Wei; Karjalainen, Mikko; Ikonen, Elina; Marjomaki, Varpu			Cholesterol Dependence of Collagen and Echovirus 1 Trafficking along the Novel alpha 2 beta 1 Integrin Internalization Pathway	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GPI-ANCHORED PROTEINS; LOW-DENSITY-LIPOPROTEIN; LIPID RAFTS; RNA REPLICATION; CELL-MEMBRANES; TRANSPORT; ENTRY; REQUIRES; BINDING	We have previously shown that soluble collagen and a human pathogen, echovirus 1 (EV1) cluster alpha 2 beta 1 integrin on the plasma membrane and cause their internalization into cytoplasmic endosomes. Here we show that cholesterol plays a major role not only in the uptake of a2b1 integrin and its ligands but also in the formation of alpha 2 integrin-specific multivesicular bodies (alpha 2-MVBs) and virus infection. EV1 infection and alpha 2 beta 1 integrin internalization were totally halted by low amounts of the cholesterol-aggregating drugs filipin or nystatin. Inhibition of cholesterol synthesis and accumulation of lanosterol after ketoconazole treatment inhibited uptake of collagen, virus and clustered integrin, and prevented formation of multivesicular bodies and virus infection. Loading of lipid starved cells with cholesterol increased infection to some extent but could not completely restore EV1 infection to control levels. Cold Triton X-100 treatment did not solubilize the alpha 2-MVBs suggesting, together with cholesterol labeling, that the cytoplasmic endosomes were enriched in detergent-resistant lipids in contrast to alpha V integrin labeled control endosomes in the clathrin pathway. Cholesterol aggregation leading to increased ion permeability caused a significant reduction in EV1 uncoating in endosomes as judged by sucrose gradient centrifugation and by neutral red-based uncoating assay. In contrast, the replication step was not dependent on cholesterol in contrast to the reports on several other viruses. In conclusion, our results showed that the integrin internalization pathway is dependent on cholesterol for uptake of collagen, EV1 and integrin, for maturation of endosomal structures and for promoting EV1 uncoating. The results thus provide novel information for developing anti-viral strategies and more insight into collagen and integrin trafficking.	[Siljamaki, Elina; Rintanen, Nina; Kirsi, Maija; Upla, Paula; Karjalainen, Mikko; Marjomaki, Varpu] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla, Finland; [Wang, Wei; Ikonen, Elina] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Wang, Wei; Ikonen, Elina] Minerva Fdn, Helsinki, Finland	University of Jyvaskyla; University of Helsinki	Marjomaki, V (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla, Finland.	varpu.s.marjomaki@jyu.fi		Marjomaki, Varpu/0000-0002-4592-5926; Ikonen, Elina/0000-0001-8382-1135	Academy of Finland [131429, 131489/Elina Ikonen, 140756, 218109/Varpu Marjomaki]; National graduate school in Nanoscience	Academy of Finland(Academy of Finland); National graduate school in Nanoscience	This work was supported by grants from Academy of Finland (http://www.aka.fi/eng, grant numbers: 131429, 131489/Elina Ikonen; 140756, 218109/Varpu Marjomaki) and National graduate school in Nanoscience (https://www.jyu.fi/science/muut_yksikot/nsc/en/studies/ngs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; ARCHER DB, 1975, J GEN MICROBIOL, V90, P187, DOI 10.1099/00221287-90-1-187; Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; BABCOCK DF, 1976, J BIOL CHEM, V251, P3881; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Beh CT, 2001, GENETICS, V157, P1117; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Chemello ME, 2002, J VIROL, V76, P13083, DOI 10.1128/JVI.76.24.13083-13087.2002; Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gopalakrishna P, 2000, J CELL BIOCHEM, V77, P517, DOI 10.1002/(SICI)1097-4644(20000615)77:4<517::AID-JCB1>3.3.CO;2-Y; Green JM, 1999, J CELL BIOL, V146, P673, DOI 10.1083/jcb.146.3.673; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Johansson M, 2003, MOL BIOL CELL, V14, P903, DOI 10.1091/mbc.E02-08-0459; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094; Karjalainen M, 2011, CELL MICROBIOL, V13, P1975, DOI 10.1111/j.1462-5822.2011.01685.x; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; KOTLERBRAJTBURG J, 1979, ANTIMICROB AGENTS CH, V15, P716, DOI 10.1128/AAC.15.5.716; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Pietiainen V, 2004, MOL BIOL CELL, V15, P4911, DOI 10.1091/mbc.E04-01-0070; Rintanen N, 2012, MOL BIOL CELL, V23, P448, DOI 10.1091/mbc.E11-06-0548; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Upla P, 2008, J VIROL, V82, P1581, DOI 10.1128/JVI.01375-07; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; WETZ K, 1991, J GEN VIROL, V72, P2541, DOI 10.1099/0022-1317-72-10-2541; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; Zerenturk EJ, 2011, BIOCH BIOPHYSICA ACT	54	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55465	10.1371/journal.pone.0055465	http://dx.doi.org/10.1371/journal.pone.0055465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393580	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800034
J	McAllister, CH; Facette, M; Holt, A; Good, AG				McAllister, Chandra H.; Facette, Michelle; Holt, Andrew; Good, Allen G.			Analysis of the Enzymatic Properties of a Broad Family of Alanine Aminotransferases	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; D-AMINO ACIDS; ARABIDOPSIS-THALIANA; CHROMATOGRAPHIC DETERMINATION; YOUNG SEEDLINGS; CDNA CLONING; ORYZA-SATIVA; RICE; EXPRESSION; PLANTS	Alanine aminotransferase (AlaAT) has been studied in a variety of organisms due to the involvement of this enzyme in mammalian processes such as non-alcoholic hepatocellular damage, and in plant processes such as C-4 photosynthesis, post-hypoxic stress response and nitrogen use efficiency. To date, very few studies have made direct comparisons of AlaAT enzymes and fewer still have made direct comparisons of this enzyme across a broad spectrum of organisms. In this study we present a direct kinetic comparison of glutamate: pyruvate aminotransferase (GPAT) activity for seven AlaATs and two glutamate: glyoxylate aminotransferases (GGAT), measuring the KM values for the enzymes analyzed. We also demonstrate that recombinant expression of AlaAT enzymes in Eschericia coli results in differences in bacterial growth inhibition, supporting previous reports of AlaAT possessing bactericidal properties, attributed to lipopolysaccharide endotoxin recognition and binding. A probable lipopolysaccharide binding region within the AlaAT enzymes, homologous to a region of a lipopolysaccharide binding protein (LBP) in humans, was also identified in this study. The AlaAT enzyme differences identified here indicate that AlaAT homologues have differentiated significantly and the roles these homologues play in vivo may also have diverged significantly. Specifically, the differing kinetics of AlaAT enzymes and how this may alter the nitrogen use efficiency in plants is discussed.	[McAllister, Chandra H.; Facette, Michelle; Holt, Andrew; Good, Allen G.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	McAllister, CH (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	chandram@ualberta.ca	Facette, Michelle/K-6603-2019; Facette, Michelle/E-6114-2015	Facette, Michelle/0000-0002-6214-9359; Facette, Michelle/0000-0002-6214-9359	NSERC [NSERC RGPIN 89739]; Alberta Crop Industry Development Fund [ACIDF2009C001R]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Crop Industry Development Fund	This research was funded by an NSERC Discovery Grant - NSERC RGPIN 89739 to the Principal Investigator, AGG (http://www.nserc-crsng.gc.ca/), and a Research grant from the Alberta Crop Industry Development Fund; ACIDF2009C001R to AGG (URL http://www.acidf.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty PH, 2009, PLANT BIOTECHNOL J, V7, P562, DOI 10.1111/j.1467-7652.2009.00424.x; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Bruckner H, 2003, AMINO ACIDS, V24, P43, DOI 10.1007/s00726-002-0322-8; BRUCKNER H, 1994, CHROMATOGRAPHIA, V39, P419, DOI 10.1007/BF02278756; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Duff SMG, 2012, ARCH BIOCHEM BIOPHYS, V528, P90, DOI 10.1016/j.abb.2012.06.006; Duff SMG, 2011, PLANT PHYSIOL BIOCH, V49, P251, DOI 10.1016/j.plaphy.2010.12.006; GOOD AG, 1992, PLANT PHYSIOL, V99, P1520, DOI 10.1104/pp.99.4.1520; Good AG, 2007, US Patent, Patent No. [#20070162995, 20070162995]; Good AG, 2007, CAN J BOT, V85, P252, DOI 10.1139/B07-019; HATCH MD, 1977, ARCH BIOCHEM BIOPHYS, V179, P361, DOI 10.1016/0003-9861(77)90123-0; Jadaho SB, 2004, HEPATOLOGY, V39, P1297, DOI 10.1002/hep.20182; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11514, DOI 10.1021/bi901158h; Jiao Z, 2010, J AGR FOOD CHEM, V58, P1746, DOI 10.1021/jf902676y; Jing XL, 2011, DEV COMP IMMUNOL, V35, P94, DOI 10.1016/j.dci.2010.08.014; Kameya M, 2010, FEBS J, V277, P1876, DOI 10.1111/j.1742-4658.2010.07604.x; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Kikuchi H, 1999, PLANT MOL BIOL, V39, P149, DOI 10.1023/A:1006156214716; Kim SH, 2010, J BACTERIOL, V192, P5304, DOI 10.1128/JB.00738-10; Liepman AH, 2003, PLANT PHYSIOL, V131, P215, DOI 10.1104/pp.011460; Lock Y-Y, 2011, THESIS U ALBERTA; Marangoni B, 2003, ENZYME KINETICS MODE; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; MUENCH DG, 1994, PLANT MOL BIOL, V24, P417, DOI 10.1007/BF00024110; Narsai R, 2009, PLANT PHYSIOL, V151, P306, DOI 10.1104/pp.109.142026; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Ricoult C, 2006, J EXP BOT, V57, P3079, DOI 10.1093/jxb/erl069; Shrawat AK, 2008, PLANT BIOTECHNOL J, V6, P722, DOI 10.1111/j.1467-7652.2008.00351.x; Singh B, 1999, PLANT AMINO ACIDS BI; Sohocki MM, 1997, GENOMICS, V40, P247, DOI 10.1006/geno.1996.4604; Uhrig RG, 2009, TRENDS PLANT SCI, V14, P505, DOI 10.1016/j.tplants.2009.07.003; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Wisniewski P, 2006, ACTA PHYSIOL PLANT, V28, P577, DOI 10.1007/s11738-006-0053-7; Wolansky MA, 2005, THESIS U ALBERTA; Wong KF, 2007, FASEB J, V21, P3231, DOI 10.1096/fj.06-7579com; Yang RZ, 2009, HEPATOLOGY, V49, P598, DOI 10.1002/hep.22657	41	21	24	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55032	10.1371/journal.pone.0055032	http://dx.doi.org/10.1371/journal.pone.0055032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408955	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200015
J	Jeon, JY; Jeong, DH; Park, MG; Lee, JW; Chu, SH; Park, JH; Lee, MK; Sato, K; Ligibel, JA; Meyerhardt, JA; Kim, NK				Jeon, Justin Y.; Jeong, Duck Hyoun; Park, Min Geun; Lee, Ji-Won; Chu, Sang Hui; Park, Ji-Hye; Lee, Mi Kyung; Sato, Kaori; Ligibel, Jennifer A.; Meyerhardt, Jeffrey A.; Kim, Nam Kyu			Impact of Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs. Rectal Cancer	PLOS ONE			English	Article							INDEPENDENT RISK-FACTOR; IGF-BINDING-PROTEINS; BODY-MASS INDEX; SERUM C-PEPTIDE; MELLITUS; TYPE-2; MORTALITY; INSULIN; SURVIVAL; METAANALYSIS	Background: To evaluate the impact of diabetes on outcomes in colorectal cancer patients and to examine whether this association varies by the location of tumor (colon vs. rectum). Patients and methods: This study includes 4,131 stage I-III colorectal cancer patients, treated between 1995 and 2007 (12.5% diabetic, 53% colon, 47% rectal) in South Korea. Cox proportional hazards modeling was used to determine the prognostic influence of DM on survival endpoints. Results: Colorectal cancer patients with DM had significantly worse disease-free survival (DFS) [hazard ratio (HR) 1.17, 95% confidence interval (CI): 1.00-1.37] compared with patients without DM. When considering colon and rectal cancer independently, DM was significantly associated with worse overall survival (OS) (HR: 1.46, 95% CI: 1.11-1.92), DFS (HR: 1.45, 95% CI: 1.15-1.84) and recurrence-free survival (RFS) (HR: 1.32, 95% CI: 0.98-1.76) in colon cancer patients. No association for OS, DFS or RFS was observed in rectal cancer patients. There was significant interaction of location of tumor (colon vs. rectal cancer) with DM on OS (P = 0.009) and DFS (P = 0.007). Conclusions: This study suggests that DM negatively impacts survival outcomes of patients with colon cancer but not rectal cancer.	[Jeong, Duck Hyoun; Park, Min Geun; Kim, Nam Kyu] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Jeon, Justin Y.; Sato, Kaori; Ligibel, Jennifer A.; Meyerhardt, Jeffrey A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jeon, Justin Y.; Park, Ji-Hye; Lee, Mi Kyung] Yonsei Univ, Sports Med Lab, Seoul 120749, South Korea; [Lee, Ji-Won] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Chu, Sang Hui] Yonsei Univ, Coll Nursing, Biobehav Res Ctr, Dept Clin Nursing Sci, Seoul 120749, South Korea; [Chu, Sang Hui] Yonsei Univ, Coll Nursing, Biobehav Res Ctr, Nursing Policy & Res Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Meyerhardt, JA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	jmeyerhardt@partners.org; namkyuk@yuhs.ac		Kim, Nam-Kyu/0000-0003-0639-5632; CHU, Sang Hui/0000-0001-6877-5599; Jeon, Justin/0000-0001-7978-4271; LEE, JI WON/0000-0002-2666-4249	NATIONAL CANCER INSTITUTE [R01CA149222] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA149222] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BACH LA, 1992, DIABETES METAB REV, V8, P229, DOI 10.1002/dmr.5610080304; Berster Jutta M., 2008, Archives of Physiology and Biochemistry, V114, P84, DOI [10.1080/13813450802008455, 10.1080/13813450802008455 ]; Bowker SL, 2010, DIABETOLOGIA, V53, P1631, DOI 10.1007/s00125-010-1750-8; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Breivik J, 1997, INT J CANCER, V74, P664, DOI 10.1002/(SICI)1097-0215(19971219)74:6<664::AID-IJC18>3.0.CO;2-5; Carmona FJ, 2011, CLIN CANCER RES, V17, P1215, DOI 10.1158/1078-0432.CCR-10-3446; Caudle AS, 2008, ANN SURG ONCOL, V15, P1931, DOI 10.1245/s10434-008-9873-6; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dehal AN, 2012, J CLIN ONCOL, V30, P53, DOI 10.1200/JCO.2011.38.0303; Dehal AN, 2011, J CLIN ONCOLOGY OFFI; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giouleme O, 2011, WORLD J GASTROENTERO, V17, P444, DOI 10.3748/wjg.v17.i4.444; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Harriss DJ, 2009, COLORECTAL DIS, V11, P547, DOI 10.1111/j.1463-1318.2009.01766.x; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Huang YC, 2011, J CANCER RES CLIN, V137, P211, DOI 10.1007/s00432-010-0879-7; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Kaczka Aleksandra, 2007, Pol Merkur Lekarski, V22, P373; Korea TS, 2010, STAT CAUSE DEATH; Larsson SC, 2006, EUR J CANCER, V42, P2590, DOI 10.1016/j.ejca.2006.04.015; Li M, 2007, ONCOLOGY-BASEL, V73, P52, DOI 10.1159/000120628; Li Q, 2011, EPIGENETICS-US, V6, P849, DOI 10.4161/epi.6.7.16314; Lim E, 2005, CANCER EPIDEM BIOMAR, V14, P1579, DOI 10.1158/1055-9965.EPI-05-0176; Limburg PJ, 2005, CANCER EPIDEM BIOMAR, V14, P133; Lindblom A, 2001, CURR OPIN ONCOL, V13, P63, DOI 10.1097/00001622-200101000-00013; Meyerhardt JA, 2004, J CLIN ONCOL, V22, P648, DOI 10.1200/JCO.2004.07.121; Meyerhardt JA, 2008, J CLIN ONCOL, V26, P4109, DOI 10.1200/JCO.2007.15.6687; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; Moore Malcolm A, 2005, Asian Pac J Cancer Prev, V6, P412; Morrison DS, 2011, J EPIDEMIOL COMMUN H, V65, P1053, DOI 10.1136/jech.2010.127555; Noh Geum Youb, 2010, J Korean Soc Coloproctol, V26, P424, DOI 10.3393/jksc.2010.26.6.424; Polednak AP, 2006, CANCER DETECT PREV, V30, P466, DOI 10.1016/j.cdp.2006.07.003; Salageanu Aurora, 2010, J Med Life, V3, P416; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Shonka NA, 2006, MED ONCOL, V23, P515, DOI 10.1385/MO:23:4:515; Song YM, 2008, J CLIN ONCOL, V26, P3395, DOI 10.1200/JCO.2007.15.7867; Sun L, 2012, DIGEST DIS SCI, V57, P1586, DOI 10.1007/s10620-012-2059-x; Tavani A, 2005, CANCER EPIDEM BIOMAR, V14, P2277, DOI 10.1158/1055-9965.EPI-05-0331; van de Poll-Franse LV, 2007, INT J CANCER, V120, P1986, DOI 10.1002/ijc.22532; WILLIAMS JC, 1984, CANCER, V54, P3070, DOI 10.1002/1097-0142(19841215)54:12<3070::AID-CNCR2820541243>3.0.CO;2-N; Xu XT, 2011, J DIGEST DIS, V12, P234, DOI 10.1111/j.1751-2980.2011.00504.x; Yu J, 2004, CLIN IMMUNOL, V113, P318, DOI 10.1016/j.clim.2004.08.009; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512	51	62	64	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55196	10.1371/journal.pone.0055196	http://dx.doi.org/10.1371/journal.pone.0055196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405123	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400068
J	McDonough, PM; Maciejewski-Lenoir, D; Hartig, SM; Hanna, RA; Whittaker, R; Heisel, A; Nicoll, JB; Buehrer, BM; Christensen, K; Mancini, MG; Mancini, MA; Edwards, DP; Price, JH				McDonough, Patrick M.; Maciejewski-Lenoir, Dominique; Hartig, Sean M.; Hanna, Rita A.; Whittaker, Ross; Heisel, Andrew; Nicoll, James B.; Buehrer, Benjamin M.; Christensen, Kurt; Mancini, Maureen G.; Mancini, Michael A.; Edwards, Dean P.; Price, Jeffrey H.			Differential Phosphorylation of Perilipin 1A at the Initiation of Lipolysis Revealed by Novel Monoclonal Antibodies and High Content Analysis	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; DEPENDENT PROTEIN-KINASE; LIPID STORAGE DROPLETS; A-STIMULATED LIPOLYSIS; PROGESTERONE-RECEPTOR; ADIPOCYTE LIPOLYSIS; BREAST-CANCER; TRANSLOCATION; ACTIVATION; REGULATOR	Lipolysis in adipocytes is regulated by phosphorylation of lipid droplet-associated proteins, including perilipin 1A and hormone-sensitive lipase (HSL). Perilipin 1A is potentially phosphorylated by cAMP(adenosine 3',5'-cyclic monophosphate)dependent protein kinase (PKA) on several sites, including conserved C-terminal residues, serine 497 (PKA-site 5) and serine 522 (PKA-site 6). To characterize perilipin 1A phosphorylation, novel monoclonal antibodies were developed, which selectively recognize perilipin 1A phosphorylation at PKA-site 5 and PKA-site 6. Utilizing these novel antibodies, as well as antibodies selectively recognizing HSL phosphorylation at serine 563 or serine 660, we used high content analysis to examine the phosphorylation of perilipin 1A and HSL in adipocytes exposed to lipolytic agents. We found that perilipin PKA-site 5 and HSL-serine 660 were phosphorylated to a similar extent in response to forskolin (FSK) and L-gamma-melanocyte stimulating hormone (L-gamma-MSH). In contrast, perilipin PKA-site 6 and HSL-serine 563 were phosphorylated more slowly and L-gamma-MSH was a stronger agonist for these sites compared to FSK. When a panel of lipolytic agents was tested, including multiple concentrations of isoproterenol, FSK, and L-gamma-MSH, the pattern of results was virtually identical for perilipin PKA-site 5 and HSL-serine 660, whereas a distinct pattern was observed for perilipin PKA-site 6 and HSL-serine 563. Notably, perilipin PKA-site 5 and HSL-serine 660 feature two arginine residues upstream from the phospho-acceptor site, which confers high affinity for PKA, whereas perilipin PKA-site 6 and HSL-serine 563 feature only a single arginine. Thus, we suggest perilipin 1A and HSL are differentially phosphorylated in a similar manner at the initiation of lipolysis and arginine residues near the target serines may influence this process.	[McDonough, Patrick M.; Maciejewski-Lenoir, Dominique; Hanna, Rita A.; Whittaker, Ross; Heisel, Andrew; Price, Jeffrey H.] Vala Sci Inc, San Diego, CA USA; [Hartig, Sean M.; Christensen, Kurt; Mancini, Maureen G.; Mancini, Michael A.; Edwards, Dean P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Nicoll, James B.; Buehrer, Benjamin M.] Zen Bio Inc, Res Triangle Pk, NC USA; [Price, Jeffrey H.] Sanford Burnham Inst Med Res, Signal Transduct Program, La Jolla, CA USA	Baylor College of Medicine; Sanford Burnham Prebys Medical Discovery Institute	McDonough, PM (corresponding author), Vala Sci Inc, San Diego, CA USA.	pmcdonough@valasciences.com		Buehrer, Benjamin/0000-0001-6654-4367	United States National Institutes of Health (NIH)/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) [5R44DK074333]; NIH/NIDDK [1F32DK85979]; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Specialized Cooperative Centers for Reproduction Grant NIH/NICHD (National Institute of Child Health and Human Development) [U54 HD-007495]; Texas Gulf Coast Digestive Diseases Center [NIH/NIDDK P30 DK-56338]; Public Health Services Cancer Center [NIH/NCI P30 CA-125123]; Dan L. Duncan Cancer Center of Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK074333, F32DK085970, P30DK056338] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); John S. Dunn Gulf Coast Consortium for Chemical Genomics; Specialized Cooperative Centers for Reproduction Grant NIH/NICHD (National Institute of Child Health and Human Development); Texas Gulf Coast Digestive Diseases Center; Public Health Services Cancer Center; Dan L. Duncan Cancer Center of Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in part, by United States National Institutes of Health (NIH)/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) 5R44DK074333 (P. M. McDonough). S. M. Hartig was supported by NIH/NIDDK 1F32DK85979. Imaging resources were supported by the John S. Dunn Gulf Coast Consortium for Chemical Genomics (M. A. Mancini), Specialized Cooperative Centers for Reproduction Grant NIH/NICHD (National Institute of Child Health and Human Development) U54 HD-007495 (B. W. O'Malley), Texas Gulf Coast Digestive Diseases Center Grant NIH/NIDDK P30 DK-56338 (M. K. Estes), Public Health Services Cancer Center Support Grant NIH/NCI P30 CA-125123 (C. K. Osborne), and the Dan L. Duncan Cancer Center of Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shimon A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002288; Bicknell KA, 2009, MOL CELL ENDOCRINOL, V300, P71, DOI 10.1016/j.mce.2008.09.032; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2010, CELL METAB, V11, P173, DOI 10.1016/j.cmet.2010.02.008; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11; Clemm DL, 2000, MOL ENDOCRINOL, V14, P52, DOI 10.1210/me.14.1.52; Galello F, 2010, J BIOL CHEM, V285, P29770, DOI 10.1074/jbc.M110.120378; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; Harmer SC, 2008, J ENDOCRINOL, V196, P149, DOI 10.1677/JOE-07-0391; Hilhorst R, 2009, ANAL BIOCHEM, V387, P150, DOI 10.1016/j.ab.2009.01.022; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martin S, 2009, J BIOL CHEM, V284, P32097, DOI 10.1074/jbc.M109.002675; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; McDonough PM, 2011, ASSAY DRUG DEV TECHN, V9, P262, DOI 10.1089/adt.2010.0302; McDonough PM, 2009, ASSAY DRUG DEV TECHN, V7, P440, DOI 10.1089/adt.2009.0196; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Press M, 2002, STEROIDS, V67, P799, DOI 10.1016/S0039-128X(02)00039-9; Rapold RA, 2012, J LIPID RES; Ruppelt A.O., 2009, HDB CELLULAR SIGNALL, P1497; Sasano H, 2005, J STEROID BIOCHEM, V95, P35, DOI 10.1016/j.jsbmb.2005.04.027; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Whittaker R, 2010, J BIOMOL SCREEN; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zhang XD, 2010, BIOCHEM BIOPH RES CO, V396, P1054, DOI 10.1016/j.bbrc.2010.05.064; Zhou DQ, 2012, FASEB J, V26, P4733, DOI 10.1096/fj.12-206862	41	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55511	10.1371/journal.pone.0055511	http://dx.doi.org/10.1371/journal.pone.0055511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405163	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400108
J	Pham, HV; Bhaduri, B; Tangella, K; Best-Popescu, C; Popescu, G				Pham, Hoa V.; Bhaduri, Basanta; Tangella, Krishnarao; Best-Popescu, Catherine; Popescu, Gabriel			Real Time Blood Testing Using Quantitative Phase Imaging	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; REFRACTIVE-INDEX; MICROSCOPY; DYNAMICS; TOMOGRAPHY; HEMOGLOBIN	We demonstrate a real-time blood testing system that can provide remote diagnosis with minimal human intervention in economically challenged areas. Our instrument combines novel advances in label-free optical imaging with parallel computing. Specifically, we use quantitative phase imaging for extracting red blood cell morphology with nanoscale sensitivity and NVIDIA's CUDA programming language to perform real time cellular-level analysis. While the blood smear is translated through focus, our system is able to segment and analyze all the cells in the one megapixel field of view, at a rate of 40 frames/s. The variety of diagnostic parameters measured from each cell (e.g., surface area, sphericity, and minimum cylindrical diameter) are currently not available with current state of the art clinical instruments. In addition, we show that our instrument correctly recovers the red blood cell volume distribution, as evidenced by the excellent agreement with the cell counter results obtained on normal patients and those with microcytic and macrocytic anemia. The final data outputted by our instrument represent arrays of numbers associated with these morphological parameters and not images. Thus, the memory necessary to store these data is of the order of kilobytes, which allows for their remote transmission via, for example, the cellular network. We envision that such a system will dramatically increase access for blood testing and furthermore, may pave the way to digital hematology.	[Pham, Hoa V.; Bhaduri, Basanta; Popescu, Gabriel] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61801 USA; [Tangella, Krishnarao] Christie Clin, Dept Pathol, Urbana, IL USA; [Tangella, Krishnarao] Univ Illinois, Urbana, IL USA; [Best-Popescu, Catherine] Univ Illinois, Coll Med, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Pham, HV (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61801 USA.	hoapham2@illinois.edu		Best-Popescu, Catherine/0000-0003-3857-5953; Bhaduri, Basanta/0000-0001-9737-0996	National Science Foundation [CBET 08-46660, CBET-1040462]; National Cancer Institute [R21 CA147967-01]; NATIONAL CANCER INSTITUTE [R21CA147967] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the National Science Foundation (grants CBET 08-46660 CAREER, CBET-1040462 MRI) and the National Cancer Institute (grant R21 CA147967-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain B. J., 2004, BEGINNERS GUIDE BLOO; BARER R, 1953, NATURE, V172, P1097, DOI 10.1038/1721097a0; BESSMAN JD, 1983, AM J CLIN PATHOL, V80, P322, DOI 10.1093/ajcp/80.3.322; Bhaduri B, 2012, OPT LETT, V37, P1094, DOI 10.1364/OL.37.001094; Bradski G, 2000, DR DOBBS J, V25, P120; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; CANHAM PB, 1968, CIRC RES, V22, P405, DOI 10.1161/01.RES.22.3.405; Charriere F, 2006, OPT EXPRESS, V14, P7005, DOI 10.1364/OE.14.007005; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Cui XQ, 2008, P NATL ACAD SCI USA, V105, P10670, DOI 10.1073/pnas.0804612105; DAVIES HG, 1954, LAB INVEST, V3, P277; Ding HF, 2011, OPT LETT, V36, P2281, DOI 10.1364/OL.36.002281; Ding HF, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238102; Dunn GA, 1998, CELL BIOL LAB HDB; Fu D, 2010, BIOMED OPT EXPRESS, V1, P347, DOI 10.1364/BOE.1.000347; Gaster B, 2012, HETEROGENEOUS COMPUT, Vxvi; Hawick KA, 2010, PARALLEL COMPUT, V36, P655, DOI 10.1016/j.parco.2010.07.002; Pham H, 2011, BIOMED OPT EXPRESS, V2, P1781, DOI 10.1364/BOE.2.001781; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Kalentev O, 2011, J PARALLEL DISTR COM, V71, P615, DOI 10.1016/j.jpdc.2010.10.012; Kaushansky K, 2016, WILLIAMS HEMATOLOGY, V9th; Kirk D, 2010, PROGRAMMING MASSIVEL; Mazarevica G, 2002, J BIOMED OPT, V7, P244, DOI 10.1117/1.1463043; Mihailescu M, 2011, APPL OPTICS, V50, P3589, DOI 10.1364/AO.50.003589; Mir M, 2011, BIOMED OPT EXPRESS, V2, P3259, DOI 10.1364/BOE.2.003259; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; MORGAN DL, 1988, AM J CLIN PATHOL, V89, P513, DOI 10.1093/ajcp/89.4.513; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; Organization. WH, 2012, BLOOD SAF AV; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Park Y, 2009, OPT LETT, V34, P3668, DOI 10.1364/OL.34.003668; Pham H, 2012, OPT LETT, V37, P3438, DOI 10.1364/OL.37.003438; Popescu G, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2149847; Popescu G., 2011, QUANTITATIVE PHASE I; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Popescu G, 2008, BLOOD CELL MOL DIS, V41, P10, DOI 10.1016/j.bcmd.2008.01.010; Pratt WK, 2007, DIGITAL IMAGE PROCES, Vxix; Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060; ROBERTS GT, 1985, AM J CLIN PATHOL, V83, P222, DOI 10.1093/ajcp/83.2.222; Safran S. A., 1994, STAT THERMODYNAMICS; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Suzuki K, 2003, COMPUT VIS IMAGE UND, V89, P1, DOI 10.1016/S1077-3142(02)00030-9; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Wang R, 2011, OPT EXPRESS, V19, P20571, DOI 10.1364/OE.19.020571; Wang R, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/37/374107; Wang Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3656732; Wang Z, 2011, OPT EXPRESS, V19, P19907, DOI 10.1364/OE.19.019907; Wang Z, 2011, OPT LETT, V36, P1215, DOI 10.1364/OL.36.001215; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Weinstein RS, 2012, APMIS, V120, P256, DOI 10.1111/j.1600-0463.2011.02866.x; Zhernovaya O, 2011, PHYS MED BIOL, V56, P4013, DOI 10.1088/0031-9155/56/13/017; Zhernovaya OS, 2008, LASER PHYS LETT, V5, P460, DOI 10.1002/lapl.200810007; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	54	68	71	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55676	10.1371/journal.pone.0055676	http://dx.doi.org/10.1371/journal.pone.0055676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405194	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400139
J	Yamazaki, T; Yamamoto, M; Ishihara, Y; Komatsu, S; Munetsuna, E; Onizaki, M; Ishida, A; Kawato, S; Mukuda, T				Yamazaki, Takeshi; Yamamoto, Megumi; Ishihara, Yasuhiro; Komatsu, Shota; Munetsuna, Eiji; Onizaki, Masahiro; Ishida, Atsuhiko; Kawato, Suguru; Mukuda, Takao			De Novo Synthesized Estradiol Protects against Methylmercury-Induced Neurotoxicity in Cultured Rat Hippocampal Slices	PLOS ONE			English	Article							SEX STEROID-HORMONES; MINAMATA DISEASE; OXIDATIVE STRESS; NEUROPROTECTIVE ACTIONS; ESTROGEN SYNTHESIS; PROPIDIUM IODIDE; NERVOUS-SYSTEM; CELL-DEATH; BRAIN; MERCURY	Background: Estrogen, a class of female sex steroids, is neuroprotective. Estrogen is synthesized in specific areas of the brain. There is a possibility that the de novo synthesized estrogen exerts protective effect in brain, although direct evidence for the neuroprotective function of brain-synthesized estrogen has not been clearly demonstrated. Methylmercury (MeHg) is a neurotoxin that induces neuronal degeneration in the central nervous system. The neurotoxicity of MeHg is region-specific, and the molecular mechanisms for the selective neurotoxicity are not well defined. In this study, the protective effect of de novo synthesized 17 beta-estradiol on MeHg-induced neurotoxicity in rat hippocampus was examined. Methodology/Principal Findings: Neurotoxic effect of MeHg on hippocampal organotypic slice culture was quantified by propidium iodide fluorescence imaging. Twenty-four-hour treatment of the slices with MeHg caused cell death in a dose-dependent manner. The toxicity of MeHg was attenuated by pre-treatment with exogenously added estradiol. The slices de novo synthesized estradiol. The estradiol synthesis was not affected by treatment with 1 mu M MeHg. The toxicity of MeHg was enhanced by inhibition of de novo estradiol synthesis, and the enhancement of toxicity was recovered by the addition of exogenous estradiol. The neuroprotective effect of estradiol was inhibited by an estrogen receptor (ER) antagonist, and mimicked by pre-treatment of the slices with agonists for ER alpha and ER beta, indicating the neuroprotective effect was mediated by ERs. Conclusions/Significance: Hippocampus de novo synthesized estradiol protected hippocampal cells from MeHg-induced neurotoxicity via ER alpha- and ER beta-mediated pathways. The self-protective function of de novo synthesized estradiol might be one of the possible mechanisms for the selective sensitivity of the brain to MeHg toxicity.	[Yamazaki, Takeshi; Ishihara, Yasuhiro; Komatsu, Shota; Munetsuna, Eiji; Onizaki, Masahiro; Ishida, Atsuhiko] Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan; [Yamamoto, Megumi] Natl Inst Minamata Dis, Physiol Sect, Dept Basic Med Sci, Minamata, Kumamoto, Japan; [Kawato, Suguru] Univ Tokyo Komaba, Dept Biophys & Life Sci, Grad Sch Arts & Sci, Tokyo, Japan; [Mukuda, Takao] Hiroshima Univ, Lab Integrat Physiol, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan	Hiroshima University; University of Tokyo; Hiroshima University	Yamazaki, T (corresponding author), Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan.	takey@hiroshima-u.ac.jp	Ishihara, Yasuhiro/U-6511-2017	Ishihara, Yasuhiro/0000-0001-9751-7660	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschner M, 2005, THER DRUG MONIT, V27, P278, DOI 10.1097/01.ftd.0000160275.85450.32; BAKIR F, 1973, SCIENCE, V181, P230, DOI 10.1126/science.181.4096.230; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Ceccatelli S, 2010, CHEM-BIOL INTERACT, V188, P301, DOI 10.1016/j.cbi.2010.04.007; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Dare E, 2000, J NEUROSCI RES, V62, P557, DOI 10.1002/1097-4547(20001115)62:4<557::AID-JNR10>3.0.CO;2-9; Eto K, 2000, NEUROPATHOLOGY, V20, pS14; Eto K, 1997, TOXICOL PATHOL, V25, P614, DOI 10.1177/019262339702500612; Falluel-Morel A, 2007, J NEUROCHEM, V103, P1968, DOI 10.1111/j.1471-4159.2007.04882.x; Fester L, 2011, CELL TISSUE RES, V345, P285, DOI 10.1007/s00441-011-1221-7; Fujimura M, 2009, NEUROTOXICOLOGY, V30, P1000, DOI 10.1016/j.neuro.2009.08.001; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Garcia-Segura LM, 2003, PROG NEUROBIOL, V71, P31, DOI 10.1016/j.pneurobio.2003.09.005; Haynes LE, 2003, NEUROSCIENCE, V120, P799, DOI 10.1016/S0306-4522(03)00167-2; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; Ishihara Y, 2012, NEUROCHEM INT, V60, P782, DOI 10.1016/j.neuint.2012.03.004; Konkle ATM, 2011, ENDOCRINOLOGY, V152, P223, DOI 10.1210/en.2010-0607; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Malagutti KS, 2009, ENVIRON TOXICOL PHAR, V27, P293, DOI 10.1016/j.etap.2008.11.005; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Munetsuna E, 2009, ENDOCRINOLOGY, V150, P4260, DOI 10.1210/en.2008-1644; Nagashima K, 1997, TOXICOL PATHOL, V25, P624, DOI 10.1177/019262339702500613; OKABE M, 1980, NEUROTOXICOLOGY, V1, P607; PARDRIDGE WM, 1979, J CLIN INVEST, V64, P145, DOI 10.1172/JCI109433; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Rune GM, 2006, NEUROCHEM RES, V31, P145, DOI 10.1007/s11064-005-9004-8; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Sarafian TA, 1999, AM J RESP CELL MOL, V20, P1286, DOI 10.1165/ajrcmb.20.6.3424; Sasano H, 1998, CLIN ENDOCRINOL, V48, P325, DOI 10.1046/j.1365-2265.1998.00390.x; Singh M, 2006, EXP BIOL MED, V231, P514; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Takeuchi T, 1982, Acta Pathol Jpn, V32 Suppl 1, P73; TAKEUCHI T, 1989, NEUROTOXICOLOGY, V10, P651; Tan SW, 2009, CRIT REV TOXICOL, V39, P228, DOI 10.1080/10408440802233259; VITALE M, 1993, HISTOCHEMISTRY, V100, P223, DOI 10.1007/BF00269095; Wakabayashi K, 1995, BRAIN RES, V705, P267, DOI 10.1016/0006-8993(95)01208-7; Yee S, 1996, NEUROTOXICOLOGY, V17, P17; Yi KD, 2009, J NEUROCHEM, V108, P732, DOI 10.1111/j.1471-4159.2008.05805.x; Zhao LQ, 2004, BRAIN RES, V1010, P22, DOI 10.1016/j.brainres.2004.02.066; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029	47	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55559	10.1371/journal.pone.0055559	http://dx.doi.org/10.1371/journal.pone.0055559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405170	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400115
J	Ji, K; Akgul, G; Wollmuth, LP; Tsirka, SE				Ji, Kyungmin; Akgul, Gulcan; Wollmuth, Lonnie P.; Tsirka, Stella E.			Microglia Actively Regulate the Number of Functional Synapses	PLOS ONE			English	Article							HIPPOCAMPAL SLICE CULTURES; IN-VIVO; BRAIN; CELLS; MACROPHAGES; STRENGTH; RECEPTOR; INJURY; ALPHA	Microglia are the immunocompetent cells of the central nervous system. In the physiological setting, their highly motile processes continually survey the local brain parenchyma and transiently contact synaptic elements. Although recent work has shown that the interaction of microglia with synapses contributes to synaptic remodeling during development, the role of microglia in synaptic physiology is just starting to get explored. To assess this question, we employed an electrophysiological approach using two methods to manipulate microglia in culture: organotypic hippocampal brain slices in which microglia were depleted using clodronate liposomes, and cultured hippocampal neurons to which microglia were added. We show here that the frequency of excitatory postsynaptic current increases in microglia-depleted brain slices, consistent with a higher synaptic density, and that this enhancement ensures from the loss of microglia since it is reversed when the microglia are replenished. Conversely, the addition of microglia to neuronal cultures decreases synaptic activity and reduces the density of synapses, spine numbers, surface expression of AMPA receptor (GluA1), and levels of synaptic adhesion molecules. Taken together, our findings demonstrate that non-activated microglia acutely modulate synaptic activity by regulating the number of functional synapses in the central nervous system.	[Ji, Kyungmin; Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Akgul, Gulcan] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA; [Akgul, Gulcan; Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wollmuth, LP (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	lwollmuth@notes.cc.sunysb.edu; stella@pharm.stonybrook.edu	Tsirka, Stella/AAD-4018-2019; Akgül, Gülcan/AAE-1418-2019	Akgül, Gülcan/0000-0003-1590-6350	 [NS42168];  [MH066892]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was partially funded by NS42168 (SET) and MH066892 (LPW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AURIAULT C, 1983, FEBS LETT, V153, P11, DOI 10.1016/0014-5793(83)80109-4; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dehghani F, 2004, EXP NEUROL, V189, P241, DOI 10.1016/j.expneurol.2004.06.010; Hailer NP, 1997, EUR J NEUROSCI, V9, P863, DOI 10.1111/j.1460-9568.1997.tb01436.x; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tyler CM, 2012, NEURON, V74, P597, DOI 10.1016/j.neuron.2012.05.002; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009	28	169	173	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e56293	10.1371/journal.pone.0056293	http://dx.doi.org/10.1371/journal.pone.0056293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393609	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800064
J	Wen, YD; Wang, H; Kho, SH; Rinkiko, S; Sheng, X; Shen, HM; Zhu, YZ				Wen, Ya-Dan; Wang, Hong; Kho, Sok-Hong; Rinkiko, Suguro; Sheng, Xiong; Shen, Han-Ming; Zhu, Yi-Zhun			Hydrogen Sulfide Protects HUVECs against Hydrogen Peroxide Induced Mitochondrial Dysfunction and Oxidative Stress	PLOS ONE			English	Article							PERMEABILITY TRANSITION; ENDOTHELIAL-CELLS; ATHEROSCLEROSIS; DISEASE; DEATH; H2S; MECHANISMS; INHIBITOR; APOPTOSIS; CYSTEINE	Background: Hydrogen sulfide (H2S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H2S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H2O2) induced endothelial cells damage. Methodology and Principal Findings: H2S, at non-cytotoxic levels, exerts a concentration dependent protective effect in human umbilical vein endothelial cells (HUVECs) exposed to H2O2. Analysis of ATP synthesis, mitochondrial membrane potential (Delta Psi m) and cytochrome c release from mitochondria indicated that mitochondrial function was preserved by pretreatment with H2S. In contrast, in H2O2 exposed endothelial cells mitochondria appeared swollen or ruptured. In additional experiments, H2S was also found to preserve the activities and protein expressions levels of the antioxidants enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione-S-transferase in H2O2 exposed cells. ROS and lipid peroxidation, as assessed by measuring H(2)DCFDA, dihydroethidium (DHE), diphenyl-l-pyrenylphosphine (DPPP) and malonaldehyde (MDA) levels, were also inhibited by H2S treatment. Interestingly, in the current model, D, L-propargylglycine (PAG), a selective inhibitor of cystathionine gamma-lyase (CSE), abolished the protective effects of H2S donors. Innovation: This study is the first to show that H2S can inhibit H2O2 mediated mitochondrial dysfunction in human endothelial cells by preserving antioxidant defences. Significance: H2S may protect against atherosclerosis by preventing H2O2 induced injury to endothelial cells. These effects appear to be mediated via the preservation of mitochondrial function and by reducing the deleterious effects of oxidative stress.	[Wen, Ya-Dan; Wang, Hong; Kho, Sok-Hong; Zhu, Yi-Zhun] Natl Univ Singapore, Sch Med, Dept Pharmacol, Singapore 117548, Singapore; [Rinkiko, Suguro; Sheng, Xiong] Jinan Univ, Inst Biomed, Guangzhou, Guangdong, Peoples R China; [Shen, Han-Ming] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	National University of Singapore; Jinan University; National University of Singapore	Zhu, YZ (corresponding author), Natl Univ Singapore, Sch Med, Dept Pharmacol, Singapore 117548, Singapore.	yizhunzhu@gmail.com	SHEN, Han-Ming/B-5942-2011; Zhu, Yi Zhun/ABG-8449-2021	SHEN, Han-Ming/0000-0001-7369-5227; Zhu, Yi Zhun/0000-0001-7700-8041	National Medical Research Council [NMRC/EDG/0053/2009]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by National Medical Research Council (http://www.nmrc.gov.sg/content/nmrc_internet/home.html), fund number NMRC/EDG/0053/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Laggner H, 2007, FREE RADICAL RES, V41, P741, DOI 10.1080/10715760701263265; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mitsuhashi H, 2005, SHOCK, V24, P529, DOI 10.1097/01.shk.0000183393.83272.de; Mourier A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001129; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Recchioni R, 2002, METABOLISM, V51, P1384, DOI 10.1053/meta.2002.35579; Singh Raja B, 2002, Exp Clin Cardiol, V7, P40; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Thorburn DR, 2004, NAT GENET, V36, P13, DOI 10.1038/ng0104-13; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; Violi F, 2007, NUTR FOOD SCI, V3, P200; Wang Q, 2010, ANTIOXID REDOX SIGN, V12, P1155, DOI 10.1089/ars.2009.2947; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao X, 2008, HYPERTENS RES, V31, P1619, DOI 10.1291/hypres.31.1619	27	138	141	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53147	10.1371/journal.pone.0053147	http://dx.doi.org/10.1371/journal.pone.0053147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393548	Green Submitted, gold, Green Published			2022-12-27	WOS:000314692800002
J	Yang, FL; Zhou, GS				Yang, Fulin; Zhou, Guangsheng			Sensitivity of Temperate Desert Steppe Carbon Exchange to Seasonal Droughts and Precipitation Variations in Inner Mongolia, China	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; GAP FILLING STRATEGIES; SOIL CO2 FLUX; DIOXIDE EXCHANGE; INTERANNUAL VARIABILITY; PRIMARY PRODUCTIVITY; ANNUAL GRASSLAND; RESPIRATION; WATER; HEAT	Arid grassland ecosystems have significant interannual variation in carbon exchange; however, it is unclear how environmental factors influence carbon exchange in different hydrological years. In this study, the eddy covariance technique was used to investigate the seasonal and interannual variability of CO2 flux over a temperate desert steppe in Inner Mongolia, China from 2008 to 2010. The amounts and times of precipitation varied significantly throughout the study period. The precipitation in 2009 (186.4 mm) was close to the long-term average (183.9 +/- 47.6 mm), while the precipitation in 2008 (136.3 mm) and 2010 (141.3 mm) was approximately a quarter below the long-term average. The temperate desert steppe showed carbon neutrality for atmospheric CO2 throughout the study period, with a net ecosystem carbon dioxide exchange (NEE) of -7.2, -22.9, and 26.0 g C m(-2) yr(-1) in 2008, 2009, and 2010, not significantly different from zero. The ecosystem gained more carbon in 2009 compared to other two relatively dry years, while there was significant difference in carbon uptake between 2008 and 2010, although both years recorded similar annual precipitation. The results suggest that summer precipitation is a key factor determining annual NEE. The apparent quantum yield and saturation value of NEE (NEEsat) and the temperature sensitivity coefficient of ecosystem respiration (R-eco) exhibited significant variations. The values of NEEsat were -2.6, -2.9, and -1.4 mu mol CO2 m(-2) s(-1) in 2008, 2009, and 2010, respectively. Drought suppressed both the gross primary production (GPP) and R-eco, and the drought sensitivity of GPP was greater than that of R-eco. The soil water content sensitivity of GPP was high during the dry year of 2008 with limited soil moisture availability. Our results suggest the carbon balance of this temperate desert steppe was not only sensitive to total annual precipitation, but also to its seasonal distribution.	[Yang, Fulin] CMA, Key Lab Arid Climat Change & Reducing Disaster Ga, Key Open Lab Arid Climat Change & Disaster Reduct, Inst Arid Meteorol, Lanzhou, Peoples R China; [Yang, Fulin; Zhou, Guangsheng] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	China Meteorological Administration; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Meteorological Sciences (CAMS)	Zhou, GS (corresponding author), Chinese Acad Meteorol Sci, Beijing, Peoples R China.	gszhou@cams.cma.gov.cn	郭, 青霞/GZH-2618-2022	Yang, Fulin/0000-0002-5530-0954	National Basic Research Program of China [2010CB951303]; National Natural Science Foundation of China [40830957]; China Postdoctoral Science Foundation [2012M512044]; Natural Science Foundation of Gansu Province [1208RJYA025]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Gansu Province	This research was jointly supported by the National Basic Research Program of China (2010CB951303), National Natural Science Foundation of China (40830957), China Postdoctoral Science Foundation (2012M512044), and Natural Science Foundation of Gansu Province (1208RJYA025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires LMI, 2008, GLOBAL CHANGE BIOL, V14, P539, DOI 10.1111/j.1365-2486.2007.01507.x; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Baldocchi D, 2011, NATURE, V476, P160, DOI 10.1038/476160a; Burba GG, 2008, GLOBAL CHANGE BIOL, V14, P1854, DOI 10.1111/j.1365-2486.2008.01606.x; Chou WW, 2008, GLOBAL CHANGE BIOL, V14, P1382, DOI 10.1111/j.1365-2486.2008.01572.x; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Craine JM, 1999, PLANT SOIL, V207, P77, DOI 10.1023/A:1004417419288; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Falge E, 2001, AGR FOREST METEOROL, V107, P71, DOI 10.1016/S0168-1923(00)00235-5; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Fu Y, 2009, BIOGEOSCIENCES, V6, P2879, DOI 10.5194/bg-6-2879-2009; Gilmanov TG, 2007, AGR ECOSYST ENVIRON, V121, P93, DOI 10.1016/j.agee.2006.12.008; Gu LH, 2005, AGR FOREST METEOROL, V128, P179, DOI 10.1016/j.agrformet.2004.11.006; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Hunt JE, 2002, AGR FOREST METEOROL, V111, P65, DOI 10.1016/S0168-1923(02)00006-0; Hussain MZ, 2011, AGR ECOSYST ENVIRON, V141, P67, DOI 10.1016/j.agee.2011.02.013; Jongen M, 2011, AGR FOREST METEOROL, V151, P595, DOI 10.1016/j.agrformet.2011.01.008; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kato T, 2006, GLOBAL CHANGE BIOL, V12, P1285, DOI 10.1111/j.1365-2486.2006.01153.x; Klumpp K, 2011, GLOBAL CHANGE BIOL, V17, P3534, DOI 10.1111/j.1365-2486.2011.02490.x; Koehler AK, 2011, GLOBAL CHANGE BIOL, V17, P309, DOI 10.1111/j.1365-2486.2010.02180.x; Krishnan P, 2012, AGR FOREST METEOROL, V153, P31, DOI 10.1016/j.agrformet.2011.09.017; Li SG, 2005, GLOBAL CHANGE BIOL, V11, P1941, DOI 10.1111/j.1365-2486.2005.01047.x; [李晓兵 Li Xiaobing], 2002, [地球科学进展, Advance in Earth Sciences], V17, P254; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Ma SY, 2007, AGR FOREST METEOROL, V147, P157, DOI 10.1016/j.agrformet.2007.07.008; Meir P, 2008, PHILOS T R SOC B, V363, P1849, DOI 10.1098/rstb.2007.0021; Meyers TP, 2001, AGR FOREST METEOROL, V106, P205, DOI 10.1016/S0168-1923(00)00213-6; Monteith J.L., 1990, PRINCIPLES ENV PHYS, V2nd; Nagy Z, 2007, AGR ECOSYST ENVIRON, V121, P21, DOI 10.1016/j.agee.2006.12.003; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Oliphant AJ, 2004, AGR FOREST METEOROL, V126, P185, DOI 10.1016/j.agrformet.2004.07.003; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; PARTON WJ, 1995, GLOBAL CHANGE BIOL, V1, P13, DOI 10.1111/j.1365-2486.1995.tb00002.x; Ping XY, 2010, GEODERMA, V155, P262, DOI 10.1016/j.geoderma.2009.12.009; Polley HW, 2008, GLOBAL CHANGE BIOL, V14, P1620, DOI 10.1111/j.1365-2486.2008.01599.x; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2002, GLOBAL CHANGE BIOL, V8, P999, DOI 10.1046/j.1365-2486.2002.00530.x; Richardson AD, 2006, AGR FOREST METEOROL, V136, P1, DOI 10.1016/j.agrformet.2006.01.007; Saigusa N, 1998, AGR FOREST METEOROL, V89, P131, DOI 10.1016/S0168-1923(97)00060-9; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Scott RL, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001348; Shen WJ, 2009, GLOBAL CHANGE BIOL, V15, P2274, DOI 10.1111/j.1365-2486.2009.01857.x; SIMS PL, 2001, AGR FOREST METEOROL, V109, P117, DOI DOI 10.1016/S0168-1923(01)00264-7; Smart AJ, 2007, RANGELAND ECOL MANAG, V60, P146, DOI 10.2111/05-099R4.1; Sottocornola M, 2010, AGR FOREST METEOROL, V150, P287, DOI 10.1016/j.agrformet.2009.11.013; Sun H., 2005, ECOSYSTEMS CHINA; Suyker AE, 2001, GLOBAL CHANGE BIOL, V7, P279, DOI 10.1046/j.1365-2486.2001.00407.x; Suyker AE, 2003, GLOBAL CHANGE BIOL, V9, P255, DOI 10.1046/j.1365-2486.2003.00567.x; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Thomey ML, 2011, GLOBAL CHANGE BIOL, V17, P1505, DOI 10.1111/j.1365-2486.2010.02363.x; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang YF, 2011, SCI TOTAL ENVIRON, V410, P182, DOI 10.1016/j.scitotenv.2011.09.067; Wang YL, 2008, AGR FOREST METEOROL, V148, P714, DOI 10.1016/j.agrformet.2008.01.013; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wolf S, 2011, GLOBAL CHANGE BIOL, V17, P2763, DOI 10.1111/j.1365-2486.2011.02460.x; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yang FL, 2011, AGR ECOSYST ENVIRON, V142, P318, DOI 10.1016/j.agee.2011.05.032; Yang FL, 2011, J HYDROL, V396, P139, DOI 10.1016/j.jhydrol.2010.11.001; Zhao L, 2006, GLOBAL CHANGE BIOL, V12, P1940, DOI 10.1111/j.1365-2486.2006.01197.x; Zhu ZL, 2006, SCI CHINA SER D, V49, P36, DOI 10.1007/s11430-006-8036-5	69	20	24	11	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55418	10.1371/journal.pone.0055418	http://dx.doi.org/10.1371/journal.pone.0055418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393576	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800030
J	Filiatrault, MJ; Tombline, G; Wagner, VE; Van Alst, N; Rumbaugh, K; Sokol, P; Schwingel, J; Iglewski, BH				Filiatrault, Melanie J.; Tombline, Gregory; Wagner, Victoria E.; Van Alst, Nadine; Rumbaugh, Kendra; Sokol, Pam; Schwingel, Johanna; Iglewski, Barbara H.			Pseudomonas aeruginosa PA1006, Which Plays a Role in Molybdenum Homeostasis, Is Required for Nitrate Utilization, Biofilm Formation, and Virulence	PLOS ONE			English	Article							METABOLIC NETWORK ANALYSIS; CYSTIC-FIBROSIS PATIENTS; QUORUM-SENSING SYSTEMS; ESCHERICHIA-COLI K-12; ANTIMICROBIAL RESISTANCE; AEROBIC DENITRIFICATION; TRANSCRIPTOME ANALYSIS; ANAEROBIC RESPIRATION; BIOSYNTHESIS GENES; TWITCHING MOTILITY	Pseudomonas aeruginosa (Pae) is a clinically important opportunistic pathogen. Herein, we demonstrate that the PA1006 protein is critical for all nitrate reductase activities, growth as a biofilm in a continuous flow system, as well as virulence in mouse burn and rat lung model systems. Microarray analysis revealed that DPA1006 cells displayed extensive alterations in gene expression including nitrate-responsive, quorum sensing (including PQS production), and iron-regulated genes, as well as molybdenum cofactor and Fe-S cluster biosynthesis factors, members of the TCA cycle, and Type VI Secretion System components. Phenotype Microarray (TM) profiles of DPA1006 aerobic cultures using Biolog plates also revealed a reduced ability to utilize a number of TCA cycle intermediates as well as a failure to utilize xanthine as a sole source of nitrogen. As a whole, these data indicate that the loss of PA1006 confers extensive changes in Pae metabolism. Based upon homology of PA1006 to the E. coli YhhP protein and data from the accompanying study, loss of PA1006 persulfuration and/or molybdenum homeostasis are likely the cause of extensive metabolic alterations that impact biofilm development and virulence in the Delta PA1006 mutant.	[Filiatrault, Melanie J.; Tombline, Gregory; Wagner, Victoria E.; Van Alst, Nadine; Schwingel, Johanna; Iglewski, Barbara H.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Rumbaugh, Kendra] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA; [Sokol, Pam] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	University of Rochester; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Calgary	Iglewski, BH (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Barbara_Iglewski@URMC.Rochester.edu			NIH [5R37AI033713]; Cystic Fibrosis Foundation Therapeutics grant [IGLEWS00V0]; American Diabetes Association [1-08-RA-165]; Canadian Institutes of Health Research [MOP 42510]; NRSA Postdoctoral fellowship from the National Institutes of Health (NIH) [F32AI056825]; Cystic Fibrosis Foundation Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033713, F32AI056825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics grant; American Diabetes Association(American Diabetes Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NRSA Postdoctoral fellowship from the National Institutes of Health (NIH); Cystic Fibrosis Foundation Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant NIH 5R37AI033713 and the Cystic Fibrosis Foundation Therapeutics grant IGLEWS00V0 to B. H. I. Mouse experiments were supported by an American Diabetes Association research grant #1-08-RA-165 to K. P. R. Rat lung experiments were supported by the Canadian Institutes of Health Research MOP 42510 to P. A. S. M. J. F. performed this work as a postdoctoral fellow at the University of Rochester and was supported by a NRSA Postdoctoral fellowship from the National Institutes of Health (NIH) (F32AI056825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank A. Brooks, K. Miller, L. Ascroft, and K. Wahowski at the Microarray Core Facility in The Functional Genomics Center at the University of Rochester for technical support and assistance, the Cystic Fibrosis Foundation Therapeutics, Inc. for subsidizing the P. aeruginosa Affymetrix GeneChip (R) Arrays, Axel Magalon (CNRS; Marseille, FR) for kindly providing alpha-NarGH antisera. We would also like to especially thank Don Woods (U. Calgary) and Virginia Clark (U. Rochester) for helpful discussions and critical reading of the manuscript.	Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09; CASH HA, 1979, AM REV RESPIR DIS, V119, P453; Chen F, 2006, BIOTECHNOL BIOENG, V93, P1069, DOI 10.1002/bit.20812; Chen F, 2003, APPL ENVIRON MICROB, V69, P6715, DOI 10.1128/AEM.69.11.6715-6722.2003; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001; Diaz-Perez AL, 2007, FEMS MICROBIOL LETT, V269, P309, DOI 10.1111/j.1574-6968.2007.00654.x; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; Filiatrault MJ, 2005, INFECT IMMUN, V73, P3764, DOI 10.1128/IAI.73.6.3764-3772.2005; Glessner A, 1999, J BACTERIOL, V181, P1623, DOI 10.1128/JB.181.5.1623-1629.1999; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hassett DJ, 1996, J BACTERIOL, V178, P7322, DOI 10.1128/jb.178.24.7322-7325.1996; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Irani VR, 1997, CURR MICROBIOL, V35, P9, DOI 10.1007/s002849900202; Kerschen EJ, 2001, J BACTERIOL, V183, P2125, DOI 10.1128/JB.183.6.2125-2131.2001; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MACGREGOR CH, 1974, J BIOL CHEM, V249, P5321; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Palmer KL, 2007, J BACTERIOL, V189, P4449, DOI 10.1128/JB.00162-07; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Platt MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Rumbaugh KP, 1999, J HOSP INFECT, V43, P211, DOI 10.1053/jhin.1999.0252; RUSSO TA, 1993, MOL MICROBIOL, V9, P357, DOI 10.1111/j.1365-2958.1993.tb01696.x; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; SIAS SR, 1979, ARCH MICROBIOL, V122, P263, DOI 10.1007/BF00411289; Silo-Suh L, 2002, P NATL ACAD SCI USA, V99, P15699, DOI 10.1073/pnas.242343999; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; STEWART V, 1988, J BACTERIOL, V170, P1589, DOI 10.1128/jb.170.4.1589-1597.1988; Stewart V, 2002, J BACTERIOL, V184, P1314, DOI 10.1128/JB.184.5.1314-1323.2002; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tombline G., 2013, PLOS ONE, V8; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Alst NE, 2007, INFECT IMMUN, V75, P3780, DOI 10.1128/IAI.00201-07; Van Alst NE, 2009, INFECT IMMUN, V77, P4446, DOI 10.1128/IAI.00822-09; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wagner VE, 2004, VACCINE, V22, pS15, DOI 10.1016/j.vaccine.2004.08.011; Wagner Victoria E., 2008, P129; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; WOODS DE, 1982, INFECT IMMUN, V36, P1223, DOI 10.1128/IAI.36.3.1223-1228.1982; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	86	27	28	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55594	10.1371/journal.pone.0055594	http://dx.doi.org/10.1371/journal.pone.0055594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409004	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300023
J	Guida, VG; Valentine, PC; Gallea, LB				Guida, Vincent G.; Valentine, Page C.; Gallea, Leslie B.			Semidiurnal Temperature Changes Caused by Tidal Front Movements in the Warm Season in Seabed Habitats on the Georges Bank Northern Margin and Their Ecological Implications	PLOS ONE			English	Article							PROGNOSTIC NUMERICAL-MODEL; HORIZONTAL TRANSPORT; CYCLIC TEMPERATURE; CONTINENTAL-SHELF; SEDIMENT; STRATIFICATION; POPULATIONS; PHYSIOLOGY; COMMUNITY; ECOSYSTEM	Georges Bank is a large, shallow feature separating the Gulf of Maine from the Atlantic Ocean. Previous studies demonstrated a strong tidal-mixing front during the warm season on the northern bank margin between thermally stratified water in the Gulf of Maine and mixed water on the bank. Tides transport warm water off the bank during flood tide and cool gulf water onto the bank during ebb tide. During 10 days in August 2009, we mapped frontal temperatures in five study areas along similar to 100 km of the bank margin. The seabed "frontal zone", where temperature changed with frontal movment, experienced semidiurnal temperature maxima and minima. The tidal excursion of the frontal boundary between stratified and mixed water ranged 6 to 10 km. This "frontal boundary zone" was narrower than the frontal zone. Along transects perpendicular to the bank margin, seabed temperature change at individual sites ranged from 7.0 degrees C in the frontal zone to 0.0 degrees C in mixed bank water. At time series in frontal zone stations, changes during tidal cycles ranged from 1.2 to 6.1 degrees C. The greatest rate of change (-2.48 degrees C hr(-1)) occurred at mid-ebb. Geographic plots of seabed temperature change allowed the mapping of up to 8 subareas in each study area. The magnitude of temperature change in a subarea depended on its location in the frontal zone. Frontal movement had the greatest effect on seabed temperature in the 40 to 80 m depth interval. Subareas experiencing maximum temperature change in the frontal zone were not in the frontal boundary zone, but rather several km gulfward (off-bank) of the frontal boundary zone. These results provide a new ecological framework for examining the effect of tidally-driven temperature variability on the distribution, food resources, and reproductive success of benthic invertebrate and demersal fish species living in tidal front habitats.	[Guida, Vincent G.] NOAA, NE Fisheries Sci Ctr, JJ Howard Lab, Natl Marine Fisheries Serv, Highlands, NJ 07732 USA; [Valentine, Page C.; Gallea, Leslie B.] US Geol Survey, Woods Hole Coastal & Marine Sci Ctr, Woods Hole, MA 02543 USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; United States Geological Survey	Guida, VG (corresponding author), NOAA, NE Fisheries Sci Ctr, JJ Howard Lab, Natl Marine Fisheries Serv, Highlands, NJ 07732 USA.	Vincent.Guida@noaa.gov			Northeast Fisheries Science Center (NEFSC); United States Geological Survey Woods Hole Coastal and Marine Science Center (USGS WH CMSC); NEFSC	Northeast Fisheries Science Center (NEFSC); United States Geological Survey Woods Hole Coastal and Marine Science Center (USGS WH CMSC); NEFSC	This study was supported by salary funds from the regular annual salary budget from Northeast Fisheries Science Center (NEFSC) and United States Geological Survey Woods Hole Coastal and Marine Science Center (USGS WH C&MSC), respectively; ship time funds from the NEFSC annual budget for days-at-sea ship operations; equipment from the NEFSC and USGS WH C&MSC annual equipment budgets. The funding offices (NEFSC and USGS WH C& MSC) played the following roles in this study: approval of research plans and allocation of assets, e.g. ship time and personnel travel and overtime payments, and review and approval of manuscript release for publication. This is standard agency practice in both cases.	Asch RG, 2008, FISH B-NOAA, V106, P438; Blackwood D, 2000, SEABED CONSERVATION; BRICKMAN D, 1993, J PHYS OCEANOGR, V23, P409, DOI 10.1175/1520-0485(1993)023<0409:EOTITO>2.0.CO;2; Brink KH, 2009, PROG OCEANOGR, V82, P191, DOI 10.1016/j.pocean.2009.07.004; BUTMAN B, 1987, GEORGES BANK, P125; Callaway R, 2002, ICES J MAR SCI, V59, P1199, DOI 10.1006/jmsc.2002.1288; Chen CS, 1998, J MAR RES, V56, P1163, DOI 10.1357/002224098765093607; Chen CS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000390; Chen CS, 2001, DEEP-SEA RES PT II, V48, P419, DOI 10.1016/S0967-0645(00)00124-7; CHRISTIANSEN ME, 1975, MAR BIOL, V32, P215, DOI 10.1007/BF00399201; CLAIREAUX G, 1995, J EXP BIOL, V198, P49; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; CREUTZBERG F, 1986, NETH J SEA RES, V20, P305, DOI 10.1016/0077-7579(86)90052-9; Dale AC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001327; Dewicke A, 2002, J SEA RES, V47, P121, DOI 10.1016/S1385-1101(02)00106-5; FEARNHEAD PG, 1975, DEEP-SEA RES, V22, P311, DOI 10.1016/0011-7471(75)90072-8; Flagg C.N., 1987, GEORGES BANK, P108; Franks PJS, 2001, DEEP-SEA RES PT II, V48, P457, DOI 10.1016/S0967-0645(00)00125-9; Hannah CG, 1997, CONT SHELF RES, V17, P1887, DOI 10.1016/S0278-4343(97)00048-4; Harris BP, 2010, CONT SHELF RES, V30, P1840, DOI 10.1016/j.csr.2010.08.011; Hermsen JM, 2003, MAR ECOL PROG SER, V260, P97, DOI 10.3354/meps260097; Horne E.P.W., 1989, Scientia Marina, V153, P145; Horne EPW, 1996, DEEP-SEA RES PT II, V43, P1683, DOI 10.1016/S0967-0645(96)00037-9; Hu S, 2008, J MARINE SYST, V74, P528, DOI 10.1016/j.jmarsys.2008.04.007; International Hydrographic Organization, 1994, SPEC PUBL INT HYDR B, V1; Ji RB, 2008, J MARINE SYST, V73, P31, DOI 10.1016/j.jmarsys.2007.08.002; JOHNS DM, 1981, MAR BIOL, V63, P301, DOI 10.1007/BF00396000; Kostylev V., 2007, SPEC PAP GEOL ASS CA, V47, P171; Kostylev VE, 2005, AM FISH S S, V41, P141; LODER JW, 1985, J MAR RES, V43, P581, DOI 10.1357/002224085788440367; LODER JW, 1992, J GEOPHYS RES-OCEANS, V97, P14331, DOI 10.1029/92JC01342; Lough RG, 2010, FISH OCEANOGR, V19, P159, DOI 10.1111/j.1365-2419.2010.00535.x; LOUGH RG, 1989, J MAR RES, V47, P343, DOI 10.1357/002224089785076334; Lough RG, 2001, DEEP-SEA RES PT II, V48, P631; Manuel JL, 1997, J PLANKTON RES, V19, P1949, DOI 10.1093/plankt/19.12.1949; MCLEESE DW, 1958, J FISH RES BOARD CAN, V15, P1345, DOI 10.1139/f58-073; National Oceanic and Atmospheric Administration, 2009, TID CURR G SHOAL; National Oceanic and Atmospheric Administration, 2009, TID CURR CURR STAT L; OREILLY JE, 1987, GEORGES BANK, P220; Packer D.B., 1999, SUMMER FLOUNDER PARA; PINGREE RD, 1978, J GEOPHYS RES-OCEANS, V83, P4615, DOI 10.1029/JC083iC09p04615; Pringle JM, 2001, LIMNOL OCEANOGR, V46, P381, DOI 10.4319/lo.2001.46.2.0381; SIMPSON JH, 1974, NATURE, V250, P404, DOI 10.1038/250404a0; SIMPSON JH, 1981, DEEP-SEA RES, V28, P727, DOI 10.1016/0198-0149(81)90132-1; SIMPSON JH, 1978, J GEOPHYS RES-OC ATM, V83, P4607, DOI 10.1029/JC083iC09p04607; SIMPSON JH, 1971, DEEP-SEA RES, V18, P309, DOI 10.1016/0011-7471(71)90036-2; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Steele JH, 2007, PROG OCEANOGR, V74, P423, DOI 10.1016/j.pocean.2007.05.003; THORP JH, 1981, ARCH ENVIRON CON TOX, V10, P69, DOI 10.1007/BF01057576; THORP JH, 1975, J EXP MAR BIOL ECOL, V18, P19, DOI 10.1016/0022-0981(75)90013-1; Tian RC, 2009, MAR ECOL PROG SER, V380, P147, DOI 10.3354/meps07916; Trimmer M, 2003, ESTUAR COAST SHELF S, V56, P1011, DOI 10.1016/S0272-7714(02)00312-8; Ullman DS, 1999, J GEOPHYS RES-OCEANS, V104, P23459, DOI 10.1029/1999JC900133; Ullman DS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001328; Ullman DS, 2001, CONT SHELF RES, V21, P1139, DOI 10.1016/S0278-4343(00)00107-2; WOLCOTT TG, 1973, BIOL BULL, V145, P389, DOI 10.2307/1540048; Yoshida J, 1996, DEEP-SEA RES PT II, V43, P1713, DOI 10.1016/S0967-0645(96)00056-2	57	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55273	10.1371/journal.pone.0055273	http://dx.doi.org/10.1371/journal.pone.0055273			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405129	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400074
J	He, P; Cheng, X; Staufenbiel, M; Li, R; Shen, Y				He, Ping; Cheng, Xin; Staufenbiel, Matthias; Li, Rena; Shen, Yong			Long-Term Treatment of Thalidomide Ameliorates Amyloid-Like Pathology through Inhibition of beta-Secretase in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TRANSGENIC TG2576 MICE; FACTOR-ALPHA; PRECURSOR PROTEIN; TNF-ALPHA; INFLAMMATORY RESPONSES; NEURONAL DEATH; MESSENGER-RNA; ANIMAL-MODEL; EXPRESSION	Thalidomide is a tumor necrosis factor alpha (TNF alpha) inhibitor which has been found to have abilities against tumor growth, angiogenesis and inflammation. Recently, it has been applied in clinic for the treatment of multiple myeloma as well as some inflammatory diseases. However, whether thalidomide has any therapeutic effects on neurodegenerative disorders, i.e. Alzheimer's disease (AD) is not clear. AD is characterized by excessive amount of amyloid beta peptides (A beta), which results in a significant release of inflammatory factors, including TNF alpha in the brain. Studies have shown that inhibition of TNF alpha reduces amyloid-associated pathology, prevents neuron loss and improves cognition. Our recent report showed that genetic inhibition of TNF alpha/TNF receptor signal transduction down-regulates beta amyloid cleavage enzyme 1 (BACE1) activity, reduces A beta generation and improves learning and memory deficits. However, the mechanism of thalidomide involving in the mitigation of AD neuropathological features remains unclear. Here, we chronically administrated thalidomide on human APPswedish mutation transgenic (APP23) mice from 9 months old (an onset of A beta deposits and early stage of AD-like changes) to 12 months old. We found that, in addition of dramatic decrease in the activation of both astrocytes and microglia, thalidomide significantly reduces Ab load and plaque formation. Furthermore, we found a significant decrease in BACE1 level and activity with long-term thalidomide application. Interestingly, these findings cannot be observed in the brains of 12-month-old APP23 mice with short-term treatment of thalidomide (3 days). These results suggest that chronic thalidomide administration is an alternative approach for AD prevention and therapeutics.	[He, Ping; Shen, Yong] Roskamp Inst, Ctr Adv Therapeut Strategies Brain Disorders, Sarasota, FL 34243 USA; [Cheng, Xin; Shen, Yong] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Cheng, Xin; Shen, Yong] Fudan Univ, Inst Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Staufenbiel, Matthias] Novartis Pharm Ltd, Nervous Syst Res, Basel, Switzerland; [Li, Rena] Roskamp Inst, Ctr Hormone Adv Sci & Educ, Sarasota, FL USA	Fudan University; Fudan University; Novartis	Shen, Y (corresponding author), Roskamp Inst, Ctr Adv Therapeut Strategies Brain Disorders, Sarasota, FL 34243 USA.	yshen@rfdn.org	Cheng, Xin/AAF-4744-2019	Cheng, Xin/0000-0001-7816-0547	National Institutes of Health [NIA025888, NIAR01AG032441]; Alzheimer Association [IIRG-09-61521, IIRG-07-59510]; AHAF [G2006-118, A2008-642]; NSFC [81100861]; NATIONAL INSTITUTE ON AGING [R01AG025888, R01AG034155, R01AG032441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); AHAF; NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by grants from National Institutes of Health: NIA025888 (YS) and NIAR01AG032441 (RL), Alzheimer Association: IIRG-09-61521 (YS) and IIRG-07-59510 (RL); AHAF: G2006-118 (RL) and A2008-642 (PH); and NSFC 81100861 (XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alkam T, 2008, BEHAV BRAIN RES, V189, P100, DOI 10.1016/j.bbr.2007.12.014; Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Aragon-Ching JB, 2007, RECENT PAT ANTI-CANC, V2, P167, DOI 10.2174/157489207780832478; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Boddapati S, 2011, J MOL BIOL, V405, P436, DOI 10.1016/j.jmb.2010.10.054; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; Cheng X, 2010, J ALZHEIMERS DIS, V19, P621, DOI 10.3233/JAD-2010-1253; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Daruwalla J, 2005, J SURG ONCOL, V91, P134, DOI 10.1002/jso.20289; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong HS, 2003, BIOCHEM BIOPH RES CO, V307, P922, DOI 10.1016/S0006-291X(03)01270-1; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Kaicker S, 2003, INT J ONCOL, V23, P1651; Kenyon BM, 1997, EXP EYE RES, V64, P971, DOI 10.1006/exer.1997.0292; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; Mazzoccoli L, 2012, BIOMED PHARMACOTHER, V66, P323, DOI 10.1016/j.biopha.2012.05.001; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; McCusker SM, 2001, LANCET, V357, P436, DOI 10.1016/S0140-6736(00)04008-3; Mehlhorn G, 2000, INT J DEV NEUROSCI, V18, P423, DOI 10.1016/S0736-5748(00)00012-5; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Munch G, 2003, J NEUROCHEM, V86, P283, DOI 10.1046/j.1471-4159.2003.01837.x; Nair RR, 2012, ADV PHARMACOL, V65, P143, DOI 10.1016/B978-0-12-397927-8.00006-3; Paganelli R, 2002, EXP GERONTOL, V37, P257, DOI 10.1016/S0531-5565(01)00191-7; Pak T, 2005, MED SCI MONITOR, V11, pBR357; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Patel NS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-9; Ryu JK, 2008, NEUROBIOL DIS, V29, P254, DOI 10.1016/j.nbd.2007.08.019; Sabbagh MN, 2010, ALZHEIMERS DEMENTIA, V6; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shen Y, 2006, TRENDS MOL MED, V12, P574, DOI 10.1016/j.molmed.2006.10.002; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sly LM, 2001, BRAIN RES BULL, V56, P581, DOI 10.1016/S0361-9230(01)00730-4; Sommer B, 1998, MOL PSYCHIATR, V3, P284, DOI 10.1038/sj.mp.4000397; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Van Dooren T, 2006, AM J PATHOL, V168, P245, DOI 10.2353/ajpath.2006.050752; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walker SL, 2007, LEPROSY REV, V78, P197; Weber D, 2003, J CLIN ONCOL, V21, P16, DOI 10.1200/JCO.2003.03.139; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Yan Q, 2003, J NEUROSCI, V23, P7504; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yang LB, 2002, J NEUROSCI, V22, P3025, DOI 10.1523/JNEUROSCI.22-08-03025.2002; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15	74	58	62	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55091	10.1371/journal.pone.0055091	http://dx.doi.org/10.1371/journal.pone.0055091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405115	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400059
J	Hsu, NC; Huang, YF; Yokoyama, KK; Chu, PY; Chen, FM; Hou, MF				Hsu, Nicholas C.; Huang, Ya-Fang; Yokoyama, Kazunari K.; Chu, Pei-Yi; Chen, Fang-Ming; Hou, Ming-Feng			Methylation of BRCA1 Promoter Region Is Associated with Unfavorable Prognosis in Women with Early-Stage Breast Cancer	PLOS ONE			English	Article							SPORADIC BREAST; GERMLINE MUTATIONS; OVARIAN-CANCER; HEREDITARY BREAST; FAMILIAL BREAST; MESSENGER-RNA; EARLY-ONSET; GENETIC-HETEROGENEITY; TUMOR CHARACTERISTICS; HYPERMETHYLATION	BRCA1-associated breast cancers are associated with particular features such as early onset, poor histological differentiation, and hormone receptor negativity. Previous studies conducted in Taiwanese population showed that the mutation of BRCA1 gene does not play a significant role in the occurrence of breast cancer. The present study explored methylation of BRCA1 promoter and its relationship to clinical features and outcome in Taiwanese breast cancer patients. Tumor specimens from a cohort of 139 early-stage breast cancer patients were obtained during surgery before adjuvant treatment for DNA extraction. Methylation of BRCA1 promoter region was determined by methylation-specific PCR and the results were related to clinical features and outcome of patients using statistical analysis. Methylation of the BRCA1 promoter was detected in 78 (56%) of the 139 tumors. Chi-square analysis indicated that BRCA1 promoter methylation correlated significantly with triple-negative (ER-/PR-/HER2-) status of breast cancer patients (p = 0.041). The Kaplan-Meier method showed that BRCA1 promoter methylation was significantly associated with poor overall survival (p = 0.026) and disease-free survival (p = 0.001). Multivariate analysis which incorporated variables of patients' age, tumor size, grade, and lymph node metastasis revealed that BRCA1 promoter methylation was associated with overall survival (p = 0.27; hazard ratio, 16.38) and disease-free survival (p = 0.003; hazard ratio, 12.19). Our findings underscore the clinical relevance of the methylation of BRCA1 promoter in Taiwanese patients with early-stage breast cancer.	[Hsu, Nicholas C.; Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Huang, Ya-Fang; Hou, Ming-Feng] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chu, Pei-Yi] St Martin De Porres Hosp, Dept Pathol, Chiayi, Taiwan; [Chen, Fang-Ming; Hou, Ming-Feng] Kaohsiung Med Univ Hosp, Dept Surg, Div Gen & Gastroenterol Surg, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Natl Sun Yat Sen Univ, Joint Res Ctr, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Chen, FM (corresponding author), Kaohsiung Med Univ Hosp, Dept Surg, Div Gen & Gastroenterol Surg, Kaohsiung, Taiwan.	fchen@kmu.edu.tw; mifeho@kmu.edu.tw		Huang, Ya-Fang/0000-0002-7790-8071; Hou, Ming-Feng/0000-0001-6030-9702; Chu, Pei-Yi/0000-0001-7336-2465	Department of Health, Taiwan [DOH101-TD-C-111-002]	Department of Health, Taiwan	This study was supported by a grant from the Department of Health, Taiwan (DOH101-TD-C-111-002). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2007, CANCER LETT, V245, P90, DOI 10.1016/j.canlet.2005.12.031; [Anonymous], 2012, CANC REG ANN REP 200; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bal A, 2012, VIRCHOWS ARCH, V461, P305, DOI 10.1007/s00428-012-1286-z; Barekati Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-244; Baylin SB, 1998, ADV CANCER RES, V72, P141; Birgisdottir V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1522; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Chen ST, 2003, BREAST CANCER RES TR, V77, P133, DOI 10.1023/A:1021386026051; Chen WQ, 2009, BREAST CANCER RES TR, V117, P55, DOI 10.1007/s10549-008-0066-6; EASTON DF, 1993, AM J HUM GENET, V52, P678; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Fong M, 2006, BREAST CANCER RES TR, V97, P57, DOI 10.1007/s10549-005-9088-5; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Honrado E, 2006, ONCOGENE, V25, P5837, DOI 10.1038/sj.onc.1209875; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(96)00469-8; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Krasteva ME, 2012, NEOPLASMA, V59, P85, DOI 10.4149/neo_2012_011; Krop I, 2003, CANCER RES, V63, P2024; Li SSL, 1999, HUM GENET, V104, P201, DOI 10.1007/s004390050936; Liede A, 2002, HUM MUTAT, V20, P413, DOI 10.1002/humu.10154; Lynch HT, 2008, BREAST J, V14, P3, DOI 10.1111/j.1524-4741.2007.00515.x; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Mehrotra J, 2004, CLIN CANCER RES, V10, P2052, DOI 10.1158/1078-0432.CCR-03-0514; Mirza S, 2007, LIFE SCI, V81, P280, DOI 10.1016/j.lfs.2007.05.012; Miyoshi Y, 2008, INT J CLIN ONCOL, V13, P395, DOI 10.1007/s10147-008-0831-x; NAROD SA, 1995, AM J HUM GENET, V56, P254; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Rice JC, 2000, CARCINOGENESIS, V21, P1761, DOI 10.1093/carcin/21.9.1761; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Sobol H, 1997, INT J ONCOL, V10, P349; Toh GT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002024; van der Groep P, 2006, J CLIN PATHOL, V59, P611, DOI 10.1136/jcp.2005.032151; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Veronesi A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-70; Wei MJ, 2005, CANCER RES, V65, P10692, DOI 10.1158/0008-5472.CAN-05-1277; XU CF, 1995, HUM MOL GENET, V4, P2259, DOI 10.1093/hmg/4.12.2259	40	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56256	10.1371/journal.pone.0056256	http://dx.doi.org/10.1371/journal.pone.0056256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405268	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400214
J	Hummler, E; Dousse, A; Rieder, A; Stehle, JC; Rubera, I; Osterheld, MC; Beermann, F; Frateschi, S; Charles, RP				Hummler, Edith; Dousse, Aline; Rieder, Audrey; Stehle, Jean-Christophe; Rubera, Isabelle; Osterheld, Maria-Chiara; Beermann, Friedrich; Frateschi, Simona; Charles, Roch-Philippe			The Channel-Activating Protease CAP1/Prss8 Is Required for Placental Labyrinth Maturation	PLOS ONE			English	Article							PROSTASIN SERINE-PROTEASE; SODIUM-CHANNEL; MESSENGER-RNA; EXPRESSION; MATRIPTASE; GROWTH; CANCER; INHIBITION; CLEARANCE; CARCINOMA	The serine protease CAP1/Prss8 is crucial for skin barrier function, lung alveolar fluid clearance and has been unveiled as diagnostic marker for specific cancer types. Here, we show that a constitutive knockout of CAP1/Prss8 leads to embryonic lethality. These embryos presented no specific defects, but it is during this period, and in particular at E13.5, that wildtype placentas show an increased expression of CAP1/Prss8, thus suggesting a placental defect in the knockout situation. The placentas of knockout embryos exhibited significantly reduced vascular development and incomplete cellular maturation. In contrary, epiblast-specific deletion of CAP1/Prss8 allowed development until birth. These CAP1/Prss8-deficient newborns presented abnormal epidermis, and died soon after birth due to impaired skin function. We thus conclude that a late placental insufficiency might be the primary cause of embryonic lethality in CAP1/Prss8 knockouts. This study highlights a novel and crucial role for CAP1/Prss8 in placental development and function.	[Hummler, Edith; Dousse, Aline; Rieder, Audrey; Rubera, Isabelle; Frateschi, Simona; Charles, Roch-Philippe] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Stehle, Jean-Christophe; Osterheld, Maria-Chiara] Univ Lausanne, Univ Inst Pathol, Lausanne, Switzerland; [Beermann, Friedrich] Ecole Polytech Fed Lausanne, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland	University of Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Hummler, E (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	Edith.Hummler@unil.ch		Charles, Roch-Philippe/0000-0002-5243-3866; RUBERA, Isabelle/0000-0002-4267-6207	Swiss National Science Foundation [3100A0-102125/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (grant 3100A0-102125/1 to EH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen LM, 2001, PROSTATE, V48, P93, DOI 10.1002/pros.1085; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Chen LM, 2002, INT J CANCER, V97, P323, DOI 10.1002/ijc.1601; Chen M, 2008, BBA-MOL CELL RES, V1783, P896, DOI 10.1016/j.bbamcr.2007.10.019; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; Cross JC, 2002, RECENT PROG HORM RES, V57, P221, DOI 10.1210/rp.57.1.221; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Forbs D, 2005, INT J ONCOL, V27, P1061; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin HY, 2006, J HISTOCHEM CYTOCHEM, V54, P1139, DOI 10.1369/jhc.6A7005.2006; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Ma XJ, 2009, HISTOCHEM CELL BIOL, V132, P639, DOI 10.1007/s00418-009-0652-7; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Rubera I, 2002, GENESIS, V32, P173, DOI 10.1002/gene.10040; Sakashita K, 2008, J SURG ONCOL, V98, P559, DOI 10.1002/jso.21158; Santin AD, 2003, CANCER, V98, P1898, DOI 10.1002/cncr.11753; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	40	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55796	10.1371/journal.pone.0055796	http://dx.doi.org/10.1371/journal.pone.0055796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405214	Green Published, gold			2022-12-27	WOS:000315153400159
J	Lin, T; Yu, YJ; Bai, XM; Feng, L; Wang, J				Lin, Tao; Yu, Yunjun; Bai, Xuemei; Feng, Ling; Wang, Jin			Greenhouse Gas Emissions Accounting of Urban Residential Consumption: A Household Survey Based Approach	PLOS ONE			English	Article							ENERGY USE; GHG EMISSIONS; CO2 EMISSION; LIFE-STYLES; CITY; OPPORTUNITIES; SCALE; CYCLE	Devising policies for a low carbon city requires a careful understanding of the characteristics of urban residential lifestyle and consumption. The production-based accounting approach based on top-down statistical data has a limited ability to reflect the total greenhouse gas (GHG) emissions from residential consumption. In this paper, we present a survey-based GHG emissions accounting methodology for urban residential consumption, and apply it in Xiamen City, a rapidly urbanizing coastal city in southeast China. Based on this, the main influencing factors determining residential GHG emissions at the household and community scale are identified, and the typical profiles of low, medium and high GHG emission households and communities are identified. Up to 70% of household GHG emissions are from regional and national activities that support household consumption including the supply of energy and building materials, while 17% are from urban level basic services and supplies such as sewage treatment and solid waste management, and only 13% are direct emissions from household consumption. Housing area and household size are the two main factors determining GHG emissions from residential consumption at the household scale, while average housing area and building height were the main factors at the community scale. Our results show a large disparity in GHG emissions profiles among different households, with high GHG emissions households emitting about five times more than low GHG emissions households. Emissions from high GHG emissions communities are about twice as high as from low GHG emissions communities. Our findings can contribute to better tailored and targeted policies aimed at reducing household GHG emissions, and developing low GHG emissions residential communities in China.	[Lin, Tao; Yu, Yunjun; Feng, Ling; Wang, Jin] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Lin, Tao; Yu, Yunjun; Feng, Ling; Wang, Jin] Xiamen Key Lab Urban Metab, Xiamen, Peoples R China; [Bai, Xuemei] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Australian National University	Lin, T (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	tlin@iue.ac.cn	CAS, KLUEH/T-5743-2019; Bai, Xuemei/A-5443-2012; Lin, Tao/B-7256-2009; yu, yunjun/AAA-6254-2022	Bai, Xuemei/0000-0001-6556-8041; Lin, Tao/0000-0002-7479-2333; 	National Natural Science Foundation of China [41201598]; Fujian Provincial department of Science and Technology [2011R0093, 2010I0014]; China Postdoctoral Science Foundation [20110490614]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial department of Science and Technology; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Funding was provided by the National Natural Science Foundation of China (41201598), http://www.nsfc.gov.cn; Fujian Provincial department of Science and Technology (2011R0093,2010I0014), http://xmgl.fjkjt.gov.cn/; and China Postdoctoral Science Foundation (20110490614), http://www.chinapostdoctor.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X. M, 2012, ENERGIZING SUSTAINAB; Bai XM, 2007, J IND ECOL, V11, P15, DOI 10.1162/jie.2007.1202; Baynes T, 2011, ENERG POLICY, V39, P7298, DOI 10.1016/j.enpol.2011.08.053; Baynes TM, 2012, CURR OPIN ENV SUST, V4, P458, DOI 10.1016/j.cosust.2012.09.003; Bin S, 2005, ENERG POLICY, V33, P197, DOI 10.1016/S0301-4215(03)00210-6; Dhakal S, 2010, CURR OPIN ENV SUST, V2, P277, DOI 10.1016/j.cosust.2010.05.007; Dhakal S, 2009, ENERG POLICY, V37, P4208, DOI 10.1016/j.enpol.2009.05.020; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Druckman A, 2008, ENERG POLICY, V36, P3177, DOI 10.1016/j.enpol.2008.03.021; Druckman A, 2009, ECOL ECON, V68, P2066, DOI 10.1016/j.ecolecon.2009.01.013; Feng L, 2011, CHINA POPUL RESOURC, V21, P93; Feng ZH, 2011, ENERGY, V36, P656, DOI 10.1016/j.energy.2010.09.049; Gao L., 2010, J GEOINFORMATION SCI, V2, P364; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grubler A., 2012, GLOBAL ENERGY ASSESS; HM Government, 2006, UK CLIM CHANG PROGR; IPCC, 2006, 2006 IPCC GUIDELINES, V3, P1; Jones CM, 2011, ENVIRON SCI TECHNOL, V45, P4088, DOI 10.1021/es102221h; Kanemoto K, 2012, ENVIRON SCI TECHNOL, V46, P172, DOI 10.1021/es202239t; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; Kennedy C, 2010, ENERG POLICY, V38, P4828, DOI 10.1016/j.enpol.2009.08.050; Lenzen M, 2006, ENERGY, V31, P181, DOI 10.1016/j.energy.2005.01.009; Lenzen M, 2011, J IND ECOL, V15, P650, DOI 10.1111/j.1530-9290.2011.00397.x; Lin JY, 2010, ENERG POLICY, V38, P5123, DOI 10.1016/j.enpol.2010.04.042; [刘晶茹 Liu Jingru], 2003, [城市环境与城市生态, Urban Environment and Urban Ecology], V16, P34; Martinsson J, 2011, ENERG POLICY, V39, P5182, DOI 10.1016/j.enpol.2011.05.046; National Development And Reform Commission, 2009, CHIN GRID BAS EM FAC; Ngnikam E, 2002, WASTE MANAGE RES, V20, P501, DOI 10.1177/0734242X0202000604; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Ramaswami A, 2008, ENVIRON SCI TECHNOL, V42, P6455, DOI 10.1021/es702992q; Ramaswami A, 2011, ENVIRON SCI TECHNOL, V45, P4205, DOI 10.1021/es201166n; Ruhl C., 2008, BP STAT REV WORLD EN; SCHIPPER L, 1989, ANNU REV ENERGY, V14, P273, DOI 10.1146/annurev.eg.14.110189.001421; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Wang J, 2002, INT J REMOTE SENS, V23, P263, DOI 10.1080/01431160010025998; Wang Y, 2009, CHIN J POPUL RESOUR, V7, P11, DOI 10.1080/10042857.2009.10684933; Wei YM, 2007, ENERG POLICY, V35, P247, DOI 10.1016/j.enpol.2005.11.020; Weisz H, 2010, CURR OPIN ENV SUST, V2, P185, DOI 10.1016/j.cosust.2010.05.010; Xiamen Statistics Bureau, 2009, YB XIAM SPEC EC ZON; Yang YX., 2009, CHINA FOOD COMPOSITI; You F, 2011, ECOL COMPLEX, V8, P201, DOI 10.1016/j.ecocom.2011.02.003; Zhao JZ, 2011, ENVIRON SCI TECHNOL, V45, P8607, DOI 10.1021/es203138c; [智静 ZHI Jing], 2009, [地理科学进展, Progress in Geography], V28, P429	43	49	51	1	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55642	10.1371/journal.pone.0055642	http://dx.doi.org/10.1371/journal.pone.0055642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405187	gold, Green Published			2022-12-27	WOS:000315153400132
J	Thornton, RB; Wiertsema, SP; Kirkham, LAS; Rigby, PJ; Vijayasekaran, S; Coates, HL; Richmond, PC				Thornton, Ruth B.; Wiertsema, Selma P.; Kirkham, Lea-Ann S.; Rigby, Paul J.; Vijayasekaran, Shyan; Coates, Harvey L.; Richmond, Peter C.			Neutrophil Extracellular Traps and Bacterial Biofilms in Middle Ear Effusion of Children with Recurrent Acute Otitis Media - A Potential Treatment Target	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CYSTIC-FIBROSIS PATIENTS; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; MORAXELLA-CATARRHALIS; RAPID IDENTIFICATION; DNA; COLONIZATION; TRACT; PATHOGENESIS	Background: Bacteria persist within biofilms on the middle ear mucosa of children with recurrent and chronic otitis media however the mechanisms by which these develop remain to be elucidated. Biopsies can be difficult to obtain from children and their small size limits analysis. Methods: In this study we aimed to investigate biofilm presence in middle ear effusion (MEE) from children with recurrent acute otitis media (rAOM) and to determine if these may represent infectious reservoirs similarly to those on the mucosa. We examined this through culture, viability staining and fluorescent in situ hybridisation (FISH) to determine bacterial species present. Most MEEs had live bacteria present using viability staining (32/36) and all effusions had bacteria present using the universal FISH probe (26/26). Of these, 70% contained 2 or more otopathogenic species. Extensive DNA stranding was also present. This DNA was largely host derived, representing neutrophil extracellular traps (NETs) within which live bacteria in biofilm formations were present. When treated with the recombinant human deoxyribonuclease 1, Dornase alfa, these strands were observed to fragment. Conclusions: Bacterial biofilms, composed of multiple live otopathogenic species can be demonstrated in the MEEs of children with rAOM and that these contain extensive DNA stranding from NETs. The NETs contribute to the viscosity of the effusion, potentially contributing to its failure to clear as well as biofilm development. Our data indicates that Dornase alfa can fragment these strands and may play a role in future chronic OM treatment.	[Thornton, Ruth B.; Wiertsema, Selma P.; Kirkham, Lea-Ann S.; Vijayasekaran, Shyan; Coates, Harvey L.; Richmond, Peter C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Thornton, Ruth B.; Wiertsema, Selma P.; Kirkham, Lea-Ann S.; Richmond, Peter C.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Rigby, Paul J.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Vijayasekaran, Shyan; Coates, Harvey L.] Princess Margaret Hosp Children, Dept Otolaryngol Head & Neck Surg, Perth, WA, Australia; [Vijayasekaran, Shyan; Coates, Harvey L.] Univ Western Australia, Dept Otolaryngol Head & Neck Surg, Perth, WA 6009, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Thornton, RB (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	ruth.thornton@uwa.edu.au	Richmond, Peter C/G-3379-2012; vijayasekaran, shyan/AAB-7538-2022; Thornton, Ruth/GOP-2314-2022; Kirkham, Lea-Ann S/A-5847-2013; Coates, Harvey Larry Charles/AAR-2846-2020	Richmond, Peter C/0000-0001-7562-7228; vijayasekaran, shyan/0000-0001-7990-6742; Kirkham, Lea-Ann S/0000-0001-5421-8126; Thornton, Ruth/0000-0001-9852-8310	GlaxoSmithKline Australia; University of Western Australia Priming Grant; University of Western Australia near miss safety net grant; Telethon Trust Research Grant	GlaxoSmithKline Australia(GlaxoSmithKline); University of Western Australia Priming Grant; University of Western Australia near miss safety net grant; Telethon Trust Research Grant	GlaxoSmithKline Australia, University of Western Australia Priming Grant, University of Western Australia near miss safety net grant and Telethon Trust Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Bluestone CD, 2003, EVIDENCE BASED OTITI, V2nd; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Casselbrant M.L., 2003, EVIDENCE BASED OTITI; Coates H, 2004, ADV THERAPY OTITIS M, P299; Coates H, 2008, OTOLARYNG HEAD NECK, V138, P778, DOI 10.1016/j.otohns.2007.02.009; Dagan R, 1998, PEDIATR INFECT DIS J, V17, P776, DOI 10.1097/00006454-199809000-00005; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Gok U, 2001, INT J PEDIATR OTORHI, V60, P49, DOI 10.1016/S0165-5876(01)00510-9; Goodman SD, 2011, MUCOSAL IMMUNOL; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Heiniger N, 2007, J INFECT DIS, V196, P1080, DOI 10.1086/521194; Henke MO, 2007, PAEDIATR RESPIR REV, V8, P24, DOI 10.1016/j.prrv.2007.02.009; Hogardt M, 2000, J CLIN MICROBIOL, V38, P818, DOI 10.1128/JCM.38.2.818-825.2000; Homoe P, 2009, EUR ARCH OTORHINOLAR; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Juneau RA, 2011, INFECT IMMUN, V79, P431, DOI 10.1128/IAI.00660-10; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Kobayashi H, 2009, J INFECT CHEMOTHER, V15, P125, DOI 10.1007/s10156-008-0691-3; Krishnamurthy A, 2009, MICROBES INFECT, V11, P545, DOI 10.1016/j.micinf.2009.03.001; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parks QM, 2009, J MED MICROBIOL, V58, P492, DOI 10.1099/jmm.0.005728-0; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Ratjen F, 2005, PEDIATR PULM, V39, P1, DOI 10.1002/ppul.20134; Ratner AJ, 2005, P NATL ACAD SCI USA, V102, P3429, DOI 10.1073/pnas.0500599102; Reid SD, 2009, J INFECT DIS; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Thornton RB, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-94; Trebesius K, 2000, MED MICROBIOL IMMUN, V188, P169, DOI 10.1007/s004300000035; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Wiertsema SP, 2011, VACCINE	45	66	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53837	10.1371/journal.pone.0053837	http://dx.doi.org/10.1371/journal.pone.0053837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393551	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800005
J	Hata, J; Arima, H; Zoungas, S; Fulcher, G; Pollock, C; Adams, M; Watson, J; Joshi, R; Kengne, AP; Ninomiya, T; Anderson, C; Woodward, M; Patel, A; Mancia, G; Poulter, N; MacMahon, S; Chalmers, J; Neal, B				Hata, Jun; Arima, Hisatomi; Zoungas, Sophia; Fulcher, Greg; Pollock, Carol; Adams, Mark; Watson, John; Joshi, Rohina; Kengne, Andre Pascal; Ninomiya, Toshiharu; Anderson, Craig; Woodward, Mark; Patel, Anushka; Mancia, Giuseppe; Poulter, Neil; MacMahon, Stephen; Chalmers, John; Neal, Bruce		ADV Collaborative Grp	Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial	PLOS ONE			English	Article							CLINICAL EVENTS COMMITTEE; MYOCARDIAL-INFARCTION; OUTCOMES; DEATH; MODE	Background: Endpoint adjudication committees (EPAC) are widely used in clinical trials. The aim of the present analysis is to assess the effects of the endpoint adjudication process on the main findings of the ADVANCE trial (Trial registration: ClinicalTrials.gov NCT00145925). Methods and Findings: The ADVANCE trial was a multicentre, 2x2 factorial randomised controlled trial of blood pressure lowering and intensive blood glucose control in 11140 patients with type 2 diabetes. Primary outcomes were major macrovascular (nonfatal myocardial infarction, nonfatal stroke and cardiovascular death) and microvascular (new or worsening nephropathy and retinopathy) events. Suspected primary outcomes were initially reported by the investigators at the 215 sites with subsequent adjudication by the EPAC. The EPAC also adjudicated upon potential events identified directly by ongoing screening of all reported events. Over a median follow-up of 5 years, the site investigators reported one or more primary outcomes among 2443 participants. After adjudication these events were confirmed for 2077 (85%) with 48 further events added through the EPAC-led database screening process. The estimated relative risk reductions (95% confidence intervals) in the primary outcome for the blood pressure lowering comparison were 8% (-1 to 15%) based on the investigator-reported events and 9% (0 to 17%) based on the EPAC-based events (P for homogeneity = 0.70). The corresponding findings for the glucose comparison were 8% (1 to 15%) and 10% (2% to 18%) (P for homogeneity = 0.60). The effect estimates were also highly comparable when studied separately for macrovascular events and microvascular events for both comparisons (all P for homogeneity >0.6). Conclusions: The endpoint adjudication process had no discernible impact on the main findings in ADVANCE. These data highlight the need for careful consideration of the likely impact of an EPAC on the findings and conclusions of clinical trials prior to their establishment.	[Hata, Jun; Arima, Hisatomi; Zoungas, Sophia; Joshi, Rohina; Kengne, Andre Pascal; Ninomiya, Toshiharu; Anderson, Craig; Woodward, Mark; Patel, Anushka; MacMahon, Stephen; Chalmers, John; Neal, Bruce] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Zoungas, Sophia] Monash Univ, Sch Publ Hlth, Clayton, Vic, Australia; [Fulcher, Greg; Pollock, Carol] Royal N Shore Hosp, Sydney, NSW, Australia; [Adams, Mark] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Watson, John] Univ Sydney, Sydney Med Sch, Sydney Adventist Hosp Clin Sch, Sydney, NSW 2006, Australia; [Mancia, Giuseppe] Univ Milano Bicocca, Milan, Italy; [Poulter, Neil] Univ London Imperial Coll Sci Technol & Med, London, England	George Institute for Global Health; University of Sydney; Monash University; Royal North Shore Hospital; University of Sydney; University of Sydney; University of Sydney; University of Milano-Bicocca; Imperial College London	Neal, B (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia.	bneal@georgeinstitute.org.au	Woodward, Mark/D-8492-2015; Woodward, Mark/L-6817-2017; Kengne, Andre Pascal/ABB-3696-2020	Patel, Anushka/0000-0003-3825-4092; Zoungas, Sophia/0000-0003-2672-0949; Woodward, Mark/0000-0001-9800-5296; MacMahon, Stephen/0000-0003-2064-7699; Chalmers, John/0000-0002-9931-0580; Anderson, Craig/0000-0002-7248-4863; Kengne, Andre Pascal/0000-0002-5183-131X; Watson, John/0000-0003-0988-2583; Joshi, Rohina/0000-0002-3374-401X; Neal, Bruce/0000-0002-0490-7465	National Health and Medical Research Council of Australia [211086, 358395]; Servier; MSD; Novartis; Novo Nordisk; Boheringer Ingelheim; Sanofi Aventis; Astra Zeneca; BMS; Roche; Pfizer; Julius Clinical Research; Gilead; Daiichi-Sankyo; Takeda; Medtronic; Jannsen; Amgen; GlaxoSmithKline; Pepsico; Pharmacy Guild of Australia; Tanabe	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Servier(Servier); MSD; Novartis(Novartis); Novo Nordisk(Novo Nordisk); Boheringer Ingelheim; Sanofi Aventis(Sanofi-Aventis); Astra Zeneca(AstraZeneca); BMS(Bristol-Myers Squibb); Roche(Roche Holding); Pfizer(Pfizer); Julius Clinical Research; Gilead(Gilead Sciences); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Takeda(Takeda Pharmaceutical Company Ltd); Medtronic(Medtronic); Jannsen; Amgen(Amgen); GlaxoSmithKline(GlaxoSmithKline); Pepsico; Pharmacy Guild of Australia; Tanabe	The ADVANCE trial was supported by grants from the National Health and Medical Research Council of Australia (211086 and 358395; http://www.nhmrc.gov.au) and Servier (http://www.servier.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: SZ reports being an advisory board member for MSD, Novo Nordisk, Sanofi Aventis, Boehringer Ingelheim, Astra Zeneca, and BMS, and receiving lecture fees from Servier, MSD, Novartis, Novo Nordisk, Boheringer Ingelheim, Sanofi Aventis, Astra Zeneca and BMS. CP reports being an advisory board member for Amgen, Boehringer Ingelheim, MSD, Janssen Cilag, Reata and Abbott, and receiving lecture fees from MSD, Boehringer Ingelheim and BMS. MW reports receiving consulting fees from Roche and lecture fees from Servier and Sonofi Aventis. NP reports receiving grant support from Pfizer, Julius Clinical Research, and Novartis, and lecture fees from Gilead, Daiichi-Sankyo, Servier, Takeda, Pfizer, Novo-Nordisk, Roche, Boehringer Ingelheim, Medtronic, and Jannsen. SM reports being an advisory board member for Servier, Pfizer, and Novartis, and receiving lecture fees from Servier and Pfizer and grant support from Servier, Pfizer, and Novartis. JC reports being a member of an advisory board for Servier and receiving lecture fees and grant support from Servier. BN reports being a board member of Roche, Takeda, and Pepsico and receiving lecture fees from Amgen, AstraZeneca, GlaxoSmithKline, Novartis, Pepsico, Pfizer, Pharmacy Guild of Australia, Sanofi Aventis, Servier, and Tanabe. This study was partly funded by Servier. There are no patents, products in development, or marketed products products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Chalmers J, 2001, DIABETOLOGIA, V44, P1118; CLELAND JGF, 1993, J CARDIOVASC PHARM, V22, pS22, DOI 10.1097/00005344-199312002-00006; Granger CB, 2008, CLIN TRIALS, V5, P56, DOI 10.1177/1740774507087972; Mahaffey KW, 2002, AM HEART J, V143, P242, DOI 10.1067/mhj.2002.120145; Mahaffey KW, 2001, CURR CONTR TRIALS C, V2, P187, DOI 10.1186/CVM-2-4-187; Mahaffey KW, 2001, CURR CONTR TRIALS C, V2, P180, DOI 10.1186/CVM-2-4-180; Naslund U, 1999, EUR HEART J, V20, P771, DOI 10.1053/euhj.1998.1351; Ninomiya T, 2009, STROKE, V40, P2111, DOI 10.1161/STROKEAHA.108.539601; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Petersen JL, 2006, CONTEMP CLIN TRIALS, V27, P260, DOI 10.1016/j.cct.2006.02.002; Pogue J, 2009, CLIN TRIALS, V6, P239, DOI 10.1177/1740774509105223; Walter SD, 1997, CONTROL CLIN TRIALS, V18, P27, DOI 10.1016/S0197-2456(96)00131-6	13	30	30	0	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55807	10.1371/journal.pone.0055807	http://dx.doi.org/10.1371/journal.pone.0055807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390553	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100069
J	Marston, C; Renedo, A; McGowan, CR; Portela, A				Marston, Cicely; Renedo, Alicia; McGowan, C. R.; Portela, Anayda			Effects of Community Participation on Improving Uptake of Skilled Care for Maternal and Newborn Health: A Systematic Review	PLOS ONE			English	Review							PUBLIC INVOLVEMENT; WOMENS GROUPS; REPRESENTATIVENESS; INTERVENTION; PSYCHOLOGY; MORTALITY; TRIALS	Background: Despite a broad consensus that communities should be actively involved in improving their own health, evidence for the effect of community participation on specific health outcomes is limited. We examine the effectiveness of community participation interventions in maternal and newborn health, asking: did participation improve outcomes? We also look at how the impact of community participation has been assessed, particularly through randomised controlled trials, and make recommendations for future research. We highlight the importance of qualitative investigation, suggesting key areas for qualitative data reporting alongside quantitative work. Methods and findings: Systematic review of published and 'grey' literature from 1990. We searched 11 databases, and followed up secondary references. Main outcome measures were the use of skilled care before/during/after birth and maternal/newborn mortality/morbidity. We included qualitative and quantitative studies from any country, and used a community participation theoretical framework to analyse the data. We found 10 interventions. Community participation had largely positive impacts on maternal/newborn health as part of a package of interventions, although not necessarily on uptake of skilled care. Interventions improving mortality or use of skilled care raised awareness, encouraged dialogue and involved communities in designing solutions-but so did those showing no effect. Discussion: There are few high-quality, quantitative studies. We also lack information about why participation interventions do/do not succeed - an area of obvious interest for programme designers. Qualitative investigation can help fill this information gap and should be at the heart of future quantitative research examining participation interventions - in maternal/newborn health, and more widely. This review illustrates the need for qualitative investigation alongside RCTs and other quantitative studies to understand complex interventions in context, describe predicted and unforeseen impacts, assess potential for generalisability, and capture the less easily measurable social/political effects of encouraging participation.	[Marston, Cicely] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Renedo, Alicia] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [McGowan, C. R.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Portela, Anayda] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Marston, C (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England.	Cicely.Marston@lshtm.ac.uk	Marston, Cicely A/T-3551-2017; Marston, Cicely/ABB-9376-2020	Marston, Cicely A/0000-0002-5529-4646; McGowan, Catherine/0000-0001-6941-6539; Portela, Anayda/0000-0001-6368-1585; Renedo, Alicia/0000-0001-7159-1723	Department of Health Policy, Development and Services of the World Health Organization (WHO); Norwegian Agency for Development Cooperation; Collaboration for Leadership in Applied Health Research and Care for Northwest London	Department of Health Policy, Development and Services of the World Health Organization (WHO); Norwegian Agency for Development Cooperation; Collaboration for Leadership in Applied Health Research and Care for Northwest London	A preliminary review, upon which this work is based, was commissioned and funded by the Department of Health Policy, Development and Services of the World Health Organization (WHO). The WHO Department of Maternal, Newborn, Child and Adolescent Health provided further financial support for the update presented here, through a grant received from the Norwegian Agency for Development Cooperation. We also received financial support from Collaboration for Leadership in Applied Health Research and Care for Northwest London. WHO staff commented on drafts of the original protocol and this paper. Other than AP, who is an author, WHO staff had no role in the data collection and analysis. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, COMMONW COMP POLIT, DOI DOI 10.1080/14662040600624460; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Baum F, 2006, J EPIDEMIOL COMMUN H, V60, P854, DOI 10.1136/jech.2004.028662; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Bonell C, 2006, BMJ-BRIT MED J, V333, P346, DOI 10.1136/bmj.333.7563.346; Bonell C, 2012, SOC SCI MED, V75, P2299, DOI 10.1016/j.socscimed.2012.08.032; Brazier E, 2009, SOC SCI MED, V69, P682, DOI 10.1016/j.socscimed.2009.06.023; Campbell C, 2000, J COMMUNITY APPL SOC, V10, P255, DOI 10.1002/1099-1298(200007/08)10:4<255::AID-CASP582>3.0.CO;2-M; Campbell C, 2004, J HEALTH PSYCHOL, V9, P187, DOI 10.1177/1359105304040886; Campbell C, 2012, AIDS BEHAV, V16, P847, DOI 10.1007/s10461-011-9966-2; Collaboration C, 2008, COCHRANE HDB SYSTEMA; Cornish F, 2006, J COMMUNITY APPL SOC, V16, P301, DOI 10.1002/casp.866; Cornwall A, 2002, 170 I DEV STUD; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; De Vos Pol, 2009, Health Hum Rights, V11, P23; Draper AK, 2010, SOC SCI MED, V71, P1102, DOI 10.1016/j.socscimed.2010.05.016; Guareschi PA, 2004, J HEALTH PSYCHOL, V9, P311, DOI 10.1177/1359105304040896; Hossain J, 2006, INT J GYNECOL OBSTET, V92, P320, DOI 10.1016/j.ijgo.2005.09.029; HOWARDGRABMAN L, 2002, WARMI PROJECT PARTIC; Jewkes R, 1998, SOC SCI MED, V46, P843, DOI 10.1016/S0277-9536(97)00209-8; Kaseje D, 2010, GLOB PUBLIC HEALTH, V5, P595, DOI 10.1080/17441690903418969; Lewycka S, 2010, THESIS U COLL LONDON; Malhotra A, 2005, NEPAL DISTRIBUTIONAL; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Marston C, 2009, 7 GLOB C HLTH PROM N; Martin GP, 2008, SOCIOL HEALTH ILL, V30, P35, DOI 10.1111/j.1467-9566.2007.01027.x; Martin GP, 2008, SOC SCI MED, V67, P1757, DOI 10.1016/j.socscimed.2008.09.024; Mathur S, 2005, 2005 ANN M POP UNPUB; Morgan LM, 2001, HEALTH POLICY PLANN, V16, P221, DOI 10.1093/heapol/16.3.221; Morrison J, 2010, INT HEALTH, V2, P25, DOI 10.1016/j.inhe.2009.11.004; Morrison J, 2005, BMC PREGNANCY CHILDB, V5, P1; Nelson N., 1995, POWER PARTICIPATORY, P1; O'Rourke K, 1998, Rev Panam Salud Publica, V3, P9; Oakley P, 1999, PUB HEAL ACT, V5, P114; Oakley P, 1999, PUB HEAL ACT, V5, P3; Oakley P., 1991, PROJECTS PEOPLE PRAC; Pence BW, 2007, SCAND J PUBLIC HEALT, V35, P599, DOI 10.1080/14034940701349225; Rath S, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-25; Renedo A, 2011, J COMMUNITY APPL SOC, V21, P268, DOI 10.1002/casp.1092; Rifkin S. B., 1986, Health Policy and Planning, V1, P240, DOI 10.1093/heapol/1.3.240; Rifkin SB, 1996, ACTA TROP, V61, P79, DOI 10.1016/0001-706X(95)00105-N; RIFKIN SB, 1988, SOC SCI MED, V26, P931, DOI 10.1016/0277-9536(88)90413-3; Rifkin SB, 1990, COMMUNITY PARTICIPAT; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Rosato M, 2010, MALAWI MED J, V22, P112; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; UNICEF, 2008, MAT PER DEATH INQ RE; United States Agency for International Development, 1993, FIN EV WARMI PROJ SA; Wade A, 2006, BMC PREGNANCY CHILDB, V6, P1; WHO, 2003, WORK IND FAM COMM IM; WHO, 2008, WORLD HLTH REP PRIM; World Health Organization, 1979, INT C PRIM HLTH CAR; World Health Organization, 2011, RIO POL DECL SOC DET; World Health Organization, 1986, OTT CHART GES; Zakus JDL, 1998, HEALTH POLICY PLANN, V13, P1, DOI 10.1093/heapol/13.1.1	56	64	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55012	10.1371/journal.pone.0055012	http://dx.doi.org/10.1371/journal.pone.0055012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086NH	23390509	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000314691100025
J	Nabte, MJ; Marino, AI; Rodriguez, MV; Monjeau, A; Saba, SL				Nabte, Marcela J.; Marino, Andrea I.; Victoria Rodriguez, Maria; Monjeau, Adrian; Saba, Sergio L.			Range Management Affects Native Ungulate Populations in Peninsula Valdes, a World Natural Heritage	PLOS ONE			English	Article							PATAGONIAN MONTE; HETEROGENEITY; SHEEP; CONSERVATION; COMPETITION; LIVESTOCK; GUANACOS	Sheep rearing is the main productive activity in Patagonian rangelands, where guanacos are the only native ungulate. Ranchers perceive a decrease in range carrying capacity as guanaco numbers increase, therefore guanaco conservation within private lands becomes a considerable challenge. This issue is particularly evident in the World Natural Heritage Peninsula Valdes (PV), where there is a need to harmonize livestock production and biodiversity conservation. While sheep rearing prevails as the primary land use in the area, some ecotourism initiatives have been implemented to complement livestock production. In order to study how land use affected guanaco distribution, we characterized PV's ranches in terms of land subdivision, primary productivity, stocking-rate and management type, and assess how these variables affected guanaco encounter rates. Smaller ranches were composed of smaller paddocks (mean size 4.8 km(2)), which showed higher values of the remote-sensing derived Enhance Vegetation Index (EVI) (mean 0.14) and held higher sheep densities (mean 108.0 sheep/km(2)), while larger management units (mean size 23.8 km(2)), showed lower EVI values (mean 0.12) and lower stocking-rates (mean 36.7 sheep/km(2)). This pattern suggests that primary productivity has been a decisive factor to determine the minimal paddock size set by ranchers in PV, apparently precluding excessive land-subdivision in less productive areas. Guanaco encounter rate, expressed as number of guanacos per travelled kilometre, was inversely related to EVI and stocking-rate. However, land subdivision was the better predictor of guanaco encounter-rate within only sheep ranches, finding more guanacos per kilometre as paddock size increased. In contrast, in ranches where ecotourism was implemented as a complementary activity, guanaco encounter-rates were greater, regardless of paddock size. Our results suggest that the implementation of an additional activity by which landowners derive benefits from wildlife has prompted a beneficial outcome for guanacos, presumably through a decrease in harassment intensity. Finally, we propose possible mechanisms by which land subdivision may affect guanaco distribution and potential alternatives for the inclusion of wildlife conservation in a context of extensive livestock production.	[Nabte, Marcela J.; Marino, Andrea I.; Victoria Rodriguez, Maria; Saba, Sergio L.] Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Nabte, Marcela J.; Saba, Sergio L.] Univ Nacl Patagonia San Juan Bosco, Fac Ciencias Nat, Puerto Madryn, Chubut, Argentina; [Monjeau, Adrian] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Monjeau, Adrian] Fdn Bariloche, Programa Ecofilosofia, Dept Filosofia, San Carlos De Bariloche, Rio Negro, Argentina	Centro Nacional Patagonico (CENPAT); Universidad Nacional de la Patagonia San Juan Bosco; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Marino, AI (corresponding author), Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina.	marino@cenpat.edu.ar			Rufford Small Grant Foundation; Universidad Nacional de la Patagonia San Juan Bosco; Administracion del Area Natural Protegida Peninsula Valdes	Rufford Small Grant Foundation; Universidad Nacional de la Patagonia San Juan Bosco; Administracion del Area Natural Protegida Peninsula Valdes	The field work was possible thanks to the financial support of The Rufford Small Grant Foundation, Universidad Nacional de la Patagonia San Juan Bosco and Administracion del Area Natural Protegida Peninsula Valdes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi R, 2004, J WILDLIFE MANAGE, V68, P924, DOI 10.2193/0022-541X(2004)068[0924:HPFCBG]2.0.CO;2; Baldi R, 2001, OECOLOGIA, V129, P561, DOI 10.1007/s004420100770; Barnes MK, 2008, RANGELAND ECOL MANAG, V61, P380, DOI 10.2111/06-155.1; Barros V, 1983, CONTRIBUCION CTR NAC; Barros VR, 1981, MAPAS PROBABILIAD PR; Bertiller MB, 1981, CONTRIBUCION CTR NAC; Bertiller Monica B., 1998, Ecologia Austral, V8, P191; Bisigato AJ, 1997, J ARID ENVIRON, V36, P639, DOI 10.1006/jare.1996.0247; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Campanella MV, 2008, J VEG SCI, V19, P75, DOI 10.3170/2007-8-18333; Chaikina N.A., 2006, RANGELANDS, V28, P8, DOI DOI 10.2111/1551-501X(2006)28[8:TEOCGO]2.0.CO;2; Cheli GH, 2009, THESIS U NACL COMAHU; Comerford E, 2004, CHOOSING INCENTIVE M; Cramps S, 1977, HDB BIRDS EUROPE MID, V1; Crawley M.J., 2007, R BOOK; de Leeuw J, 2001, BIOL CONSERV, V100, P297, DOI 10.1016/S0006-3207(01)00034-9; De Lucca ER, 2010, PRESENCIA PUMA PUMA; Derner JD, 2009, RANGELAND ECOL MANAG, V62, P111, DOI 10.2111/08-008.1; du Toit Johan T., 2010, P30, DOI 10.1002/9781444317091.ch3; Fernandez T, 2008, CUAD HIST PATAGON, V2, P17; Folch A, 1992, HDB BIRDS WORLD, V1; Fuhlendorf SD, 2006, ECOL APPL, V16, P1706, DOI 10.1890/1051-0761(2006)016[1706:SHBTBF]2.0.CO;2; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Fulbright TE, 2006, WHITE TAILED DEER HA; Gallardo Giovana, 2009, Mastozool. neotrop., V16, P59; Golluscio Rodolfo A., 1998, Ecologia Austral, V8, P265; Hobbs NT, 2008, GLOBAL ENVIRON CHANG, V18, P776, DOI 10.1016/j.gloenvcha.2008.07.011; LANGE RT, 1969, J RANGE MANAGE, V22, P396, DOI 10.2307/3895849; Menedin F, 2008, INFORME SECTORIAL SE; Nabte MJ, 2010, DESARROLLO CRITERIOS; Nebel G, 2005, FOREST POLICY ECON, V7, P175, DOI 10.1016/S1389-9341(03)00030-3; Niroula GS, 2005, LAND USE POLICY, V22, P358, DOI 10.1016/j.landusepol.2004.10.001; Novaro Andres J., 1995, Oryx, V29, P18; Ottichilo Wilber K., 2000, Conservation Biology Series (Dordrecht), V12, P203; Pedrana J, 2010, BIODIVERS CONSERV, V19, P3499, DOI 10.1007/s10531-010-9910-1; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Prins Herbert H.T., 2000, Conservation Biology Series (Dordrecht), V12, P51; Rodriguez MV, 2007, J ARID ENVIRON, V70, P137, DOI 10.1016/j.jaridenv.2006.12.010; Saba SL, 1995, NATURALIA PATAGONICA, V3, P153; Secretaria de Medio Ambiente y Desarrollo Sustentable de la Nacion, 2012, SECRETARIA MEDIO AMB; Travaini A, 2000, MASTOZOOL NEOTROP, V7, P117; Victurine R, 2010, WILD RANGELANDS CONS, P152; Burgi MV, 2012, ORYX, V46, P99, DOI 10.1017/S0030605311000214; Wrobel ML, 2010, WILD RANGELANDS CONS, P1, DOI [10.1002/9781444317091.ch1, DOI 10.1002/9781444317091.CH1]	45	21	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55655	10.1371/journal.pone.0055655	http://dx.doi.org/10.1371/journal.pone.0055655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390546	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100062
J	Porwal, C; Kaushik, A; Makkar, N; Banavaliker, JN; Hanif, M; Singla, R; Bhatnagar, AK; Behera, D; Pande, JN; Singh, UB				Porwal, Chhavi; Kaushik, Amit; Makkar, Nayani; Banavaliker, Jayant N.; Hanif, Mahmud; Singla, Rupak; Bhatnagar, Anuj K.; Behera, Digambar; Pande, Jitendra Nath; Singh, Urvashi B.			Incidence and Risk Factors for Extensively Drug-Resistant Tuberculosis in Delhi Region	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANT; 2ND-LINE DRUGS; XDR-TB; SOUTH-AFRICA; INDIA; PREVALENCE; SYSTEM	Background: India with a major burden of multidrug-resistant tuberculosis (MDR-TB) does not have national level data on this hazardous disease. Since 2006, emergence of extensively drug-resistant TB (XDR-TB) is considered a serious threat to global TB control. This study highlights the demographic and clinical risk factors associated with XDR-TB in Delhi. Methods: The study was conducted during April 2007 to May 2010. Six hundred eleven MDR-TB suspects were enrolled from four tertiary care hospitals, treating TB patients in Delhi and the demographic details recorded. Sputum samples were cultured using rapid, automated liquid culture system (MGIT 960). Drug susceptibility testing (DST) for Rifampicin (RIF) and Isoniazid (INH) was performed for all positive M. tuberculosis (M.tb) cultures. All MDR-TB isolates were tested for sensitivity to second-line drugs [Amikacin (AMK), Capreomycin (CAP), Ofloxacin (OFX), Ethionamide (ETA)]. Results/Findings: Of 611, 483 patients were infected with MDR M. tuberculosis (M. tb) strains. Eighteen MDR-TB isolates (3.7%) were XDR M.tb strains. Family history of TB (p 0.045), socioeconomic status (p 0.013), concomitant illness (p 0.001) and previous intake of 2nd line injectable drugs (p 0.001) were significantly associated with occurrence of XDR-TB. Only two of the patients enrolled were HIV seropositive, but had a negative culture for M. tuberculosis. 56/483 isolates were pre-XDR M. tuberculosis, though the occurrence of pre-XDR-TB did not show any significant demographical associations. Conclusions: The actual incidence and prevalence rate of XDR-TB in India is not available, although some scattered data is available. This study raises a concern about existence of XDR-TB in India, though small, signaling a need to strengthen the TB control program for early diagnosis of both tuberculosis and drug resistance in order to break the chains of transmission.	[Porwal, Chhavi; Kaushik, Amit; Makkar, Nayani; Singh, Urvashi B.] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Banavaliker, Jayant N.; Bhatnagar, Anuj K.] Rajan Babu Inst Pulm Med & TB, Delhi, India; [Hanif, Mahmud] New Delhi TB Ctr, New Delhi, India; [Singla, Rupak; Behera, Digambar] Lala Ram Sarup Inst TB & Resp Dis, New Delhi, India; [Pande, Jitendra Nath] Sitaram Bhartia Inst Sci & Res, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Sitaram Bhartia Institute of Science & Research	Singh, UB (corresponding author), All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India.	drurvashi@gmail.com	Kaushik, Amit/J-8836-2019	Kaushik, Amit/0000-0002-5622-1721	Indian Council of Medical Research (ICMR), New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi	Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Chhavi Porwal and Amit Kaushik gratefully acknowledge the research fellowships from the Indian Council of Medical Research (ICMR) and Council of Scientific and Industrial Research (CSIR), New Delhi respectively.	Ajbani K, 2011, J CLIN MICROBIOL, V49, P1588, DOI 10.1128/JCM.00113-11; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; [Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Balaji V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009527; Banerjee R, 2008, CLIN INFECT DIS, V47, P450, DOI 10.1086/590009; Centers for Disease Control and Prevention, 2006, JAMA J AM MED ASS AM, V296, P2792; Chan ED, 2009, CLIN INFECT DIS, V48, pE50, DOI 10.1086/597010; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Jain A, 2008, J BIOSCIENCES, V33, P605, DOI 10.1007/s12038-008-0078-8; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Kent PT, 1985, GUIDE LEVEL 3 LAB; Khanna A, 2010, ANTIMICROB AGENTS CH, V54, P4789, DOI 10.1128/AAC.00661-10; Lin SYG, 2009, J CLIN MICROBIOL, V47, P3630, DOI 10.1128/JCM.00803-09; Martin A, 2008, J CLIN MICROBIOL, V46, P3952, DOI 10.1128/JCM.01171-08; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005; Migliori GB, 2007, EUR RESPIR J, V29, P423, DOI 10.1183/09031936.00001307; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Mondal R, 2007, EMERG INFECT DIS, V13, P1429, DOI 10.3201/eid1309.070443; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P243; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Rodrigues C, 2008, INT J TUBERC LUNG D, V12, P1449; Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006; Sharma SK, 2009, INDIAN J MED RES, V130, P392; Siddiqi SH, 2006, MGIT PROCEDURE MANUA; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; Singh S, 2007, AIDS, V21, P2345, DOI 10.1097/QAD.0b013e3282f125c9; World Health Organization, 2008, WHOHTMTB2008392; World Health Organization, 2010, WHOHTMTB20103	29	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55299	10.1371/journal.pone.0055299	http://dx.doi.org/10.1371/journal.pone.0055299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390524	gold, Green Submitted, Green Published			2022-12-27	WOS:000314691100040
J	Sandvik, EL; McLeod, BR; Parker, AE; Stewart, PS				Sandvik, Elizabeth L.; McLeod, Bruce R.; Parker, Albert E.; Stewart, Philip S.			Direct Electric Current Treatment under Physiologic Saline Conditions Kills Staphylococcus epidermidis Biofilms via Electrolytic Generation of Hypochlorous Acid	PLOS ONE			English	Article							CURRENT-INDUCED DETACHMENT; SURGICAL STAINLESS-STEEL; PSEUDOMONAS-AERUGINOSA BIOFILMS; ESCHERICHIA-COLI; SALMONELLA-ENTERITIDIS; INFECTIONS; BACTERIAL; EFFICACY; ENHANCEMENT; IMPLANTS	The purpose of this study was to investigate the mechanism by which a direct electrical current reduced the viability of Staphylococcus epidermidis biofilms in conjunction with ciprofloxacin at physiologic saline conditions meant to approximate those in an infected artificial joint. Biofilms grown in CDC biofilm reactors were exposed to current for 24 hours in 1/10th strength tryptic soy broth containing 9 g/L total NaCl. Dose-dependent log reductions up to 6.7 log(10) CFU/cm(2) were observed with the application of direct current at all four levels (0.7 to 1.8 mA/cm(2)) both in the presence and absence of ciprofloxacin. There were no significant differences in log reductions for wells with ciprofloxacin compared to those without at the same current levels. When current exposures were repeated without biofilm or organics in the medium, significant generation of free chlorine was measured. Free chlorine doses equivalent to the 24 hour endpoint concentration for each current level were shown to mimic killing achieved by current application. Current exposure (1.8 mA/cm(2)) in medium lacking chloride and amended with sulfate, nitrate, or phosphate as alternative electrolytes produced diminished kills of 3, 2, and 0 log reduction, respectively. Direct current also killed Pseudomonas aeruginosa biofilms when NaCl was present. Together these results indicate that electrolysis reactions generating hypochlorous acid from chloride are likely a main contributor to the efficacy of direct current application. A physiologically relevant NaCl concentration is thus a critical parameter in experimental design if direct current is to be investigated for in vivo medical applications.	[Sandvik, Elizabeth L.; McLeod, Bruce R.; Parker, Albert E.; Stewart, Philip S.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; [Sandvik, Elizabeth L.; Stewart, Philip S.] Montana State Univ, Dept Chem & Biol Engn, Bozeman, MT 59717 USA; [McLeod, Bruce R.] Montana State Univ, Dept Elect & Comp Engn, Bozeman, MT 59717 USA; [Parker, Albert E.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Stewart, PS (corresponding author), Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA.	phil_s@erc.montana.edu		Stewart, Philip/0000-0001-7773-8570	Montana State University College of Engineering; Peter Ewing Capital Management LLC; Allegheny-Singer Research Institute; Montana Board of Research and Commercialization Technology [08-03]; M.J. Murdock Charitable Trust; NSF Major Research Instrumentation Program	Montana State University College of Engineering; Peter Ewing Capital Management LLC; Allegheny-Singer Research Institute; Montana Board of Research and Commercialization Technology; M.J. Murdock Charitable Trust; NSF Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by Montana State University College of Engineering, Peter Ewing Capital Management LLC, The Allegheny-Singer Research Institute, and The Montana Board of Research and Commercialization Technology Grant Agreement No. 08-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Betsey Pitts at the Center for Biofilm Engineering for providing expert assistance with confocal microscopy. Microscopy equipment at the facility was purchased with funds provided by the M.J. Murdock Charitable Trust and the NSF Major Research Instrumentation Program.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, E589507 ASTM INT, DOI [10.1520/E2562-07.www.astm.org, DOI 10.1520/E2562-07]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGER TJ, 1976, ANTIMICROB AGENTS CH, V9, P357, DOI 10.1128/AAC.9.2.357; BERGER TJ, 1976, ANTIMICROB AGENTS CH, V10, P856, DOI 10.1128/AAC.10.5.856; BLENKINSOPP SA, 1992, APPL ENVIRON MICROB, V58, P3770, DOI 10.1128/AEM.58.11.3770-3773.1992; Brezonik P.L., 1994, CHEM KINETICS PROCES; Buckingham-Meyer K, 2007, J MICROBIOL METH, V70, P236, DOI 10.1016/j.mimet.2007.04.010; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Chapman JS, 2003, INT BIODETER BIODEGR, V51, P133, DOI 10.1016/S0964-8305(02)00097-5; COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; DAVIS CP, 1989, ANTIMICROB AGENTS CH, V33, P442, DOI 10.1128/AAC.33.4.442; DAVIS CP, 1992, ANTIMICROB AGENTS CH, V36, P2552, DOI 10.1128/AAC.36.11.2552; DAVIS CP, 1982, J CLIN MICROBIOL, V15, P891, DOI 10.1128/JCM.15.5.891-894.1982; Davison WM, 2010, ANTIMICROB AGENTS CH, V54, P2920, DOI 10.1128/AAC.01734-09; del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P35, DOI 10.1128/AAC.00237-08; Ehrlich GD, 2004, ASM NEWS, V70, P127; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; Hong SH, 2008, BIOTECHNOL BIOENG, V100, P379, DOI 10.1002/bit.21760; Jass J, 1996, J ANTIMICROB CHEMOTH, V38, P987, DOI 10.1093/jac/38.6.987; JASS J, 1995, J IND MICROBIOL, V15, P234, DOI 10.1007/BF01569830; Khoury A E, 1992, ASAIO J, V38, pM174, DOI 10.1097/00002480-199207000-00013; King CC, 1997, J LEUKOCYTE BIOL, V61, P293, DOI 10.1002/jlb.61.3.293; Konig DP, 2001, ARCH ORTHOP TRAUM SU, V121, P297, DOI 10.1007/s004020000242; Li XY, 2004, J ENVIRON ENG, V130, P1217, DOI 10.1061/(ASCE)0733-9372(2004)130:10(1217); Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; McLeod BR, 1999, METHOD ENZYMOL, V310, P656; Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]; Pavoni GL, 2004, CLIN MICROBIOL INFEC, V10, P831, DOI 10.1111/j.1469-0691.2004.00928.x; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Poortinga AT, 2001, BIOTECHNOL BIOENG, V76, P395, DOI 10.1002/bit.10129; Poortinga AT, 2001, COLLOID SURFACE B, V20, P189, DOI 10.1016/S0927-7765(00)00184-3; Rabinovitch C, 2006, APPL ENVIRON MICROB, V72, P6364, DOI 10.1128/AEM.00442-06; Saginur R, 2006, ANTIMICROB AGENTS CH, V50, P55, DOI 10.1128/AAC.50.1.55-61.2006; Sam CH, 2009, J DENT SCI, V4, P45, DOI 10.1016/S1991-7902(09)60008-8; Secinti KD, 2008, J CLIN NEUROSCI, V15, P434, DOI 10.1016/j.jocn.2007.03.010; Shirtliff ME, 2005, APPL ENVIRON MICROB, V71, P6379, DOI 10.1128/AEM.71.10.6379-6382.2005; Stewart PS, 1999, ANTIMICROB AGENTS CH, V43, P292, DOI 10.1128/AAC.43.2.292; Stoodley P, 1997, ANTIMICROB AGENTS CH, V41, P1876, DOI 10.1128/AAC.41.9.1876; Sun JL, 2012, CAN J MICROBIOL, V58, P448, DOI 10.1139/w2012-005; Ueda Shigeko, 2007, Biocontrol Science, V12, P149; van der Borden AJ, 2005, BIOMATERIALS, V26, P6731, DOI 10.1016/j.biomaterials.2004.04.052; van der Borden AJ, 2004, APPL ENVIRON MICROB, V70, P6871, DOI 10.1128/AEM.70.11.6871-6874.2004; van der Borden AJ, 2004, J BIOMED MATER RES B, V68B, P160, DOI 10.1002/jbm.b.20015; van der Borden AJ, 2007, BIOMATERIALS, V28, P2122, DOI 10.1016/j.biomaterials.2007.01.001; Venkitanarayanan KS, 1999, APPL ENVIRON MICROB, V65, P4276; Vergidis P, 2012, INFECT DIS CLIN N AM, V26, P173, DOI 10.1016/j.idc.2011.09.012; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Wattanakaroon W, 2000, ARCH ORAL BIOL, V45, P167, DOI 10.1016/S0003-9969(99)00132-6; Wellman N, 1996, ANTIMICROB AGENTS CH, V40, P2012, DOI 10.1128/AAC.40.9.2012; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Xulu BA, 2010, BIOCHEMISTRY-US, V49, P2068, DOI 10.1021/bi902089w; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537	54	57	64	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55118	10.1371/journal.pone.0055118	http://dx.doi.org/10.1371/journal.pone.0055118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390518	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100034
J	Taipale, RS; Hakkinen, K				Taipale, Ritva S.; Hakkinen, Keijo			Acute Hormonal and Force Responses to Combined Strength and Endurance Loadings in Men and Women: The "Order Effect"	PLOS ONE			English	Article							HEAVY-RESISTANCE EXERCISE; GROWTH-HORMONE; IGF-I; NEUROMUSCULAR PERFORMANCE; CONCURRENT ENDURANCE; TRAINING SEQUENCE; STEROID-HORMONES; MAXIMAL STRENGTH; SKELETAL-MUSCLE; RUNNING ECONOMY	Purpose: To examine acute responses and recovery of serum hormones and muscle force following combined strength (S) and endurance (E) loading sessions in which the order of exercises is reversed (ES vs. SE). Methods: This cross-over study design included recreationally endurance trained men and women (age 21-45 years, n = 12 men n = 10 women) who performed both loadings. Maximal bilateral isometric strength (MVC), isometric rate of force development (RFD) and serum concentrations of testosterone (T), cortisol (C), growth hormone (GH), insulin-like growth factor 1 (IGF-1), binding protein 3 (IGFBP3) and sex hormone binding globulin (SHBG) were measured during and after both loadings. Results: Both of the present combined (ES and SE) loadings led to a greater acute decrease in MVC in men than in women, while RFD was slightly affected only in men. Recovery of MVC and RFD to baseline was complete at 24 h regardless of the order of exercises. In men, neuromuscular fatigue was accompanied by increased C concentrations observed post SE. This was followed by decreased concentrations of T at 24 h and 48 h that were significantly lower than those observed following ES. GH response in men also differed significantly post loadings. In women, only a significant difference in T between ES and SE loadings was observed at post. Conclusion: These observed differences in hormonal responses despite similarities in neuromuscular fatigue in men indicate the presence of an order effect as the body was not fully recovered at 48 h following SE. These findings may be applicable in training prescription in order to optimize specific training adaptations.	[Taipale, Ritva S.; Hakkinen, Keijo] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland	University of Jyvaskyla	Taipale, RS (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland.	ritva.taipale@jyu.fi		Mikkonen (Taipale), Ritva/0000-0002-5668-2202	Department of Biology of Physical Activity, University of Jyvaskyla	Department of Biology of Physical Activity, University of Jyvaskyla	Funding for this project was provided by the Department of Biology of Physical Activity, University of Jyvaskyla. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1986, INT J SPORTS MED, V7, P27; Ahtiainen JP, 2003, EUR J APPL PHYSIOL, V89, P555, DOI 10.1007/s00421-003-0833-3; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Bell GJ, 2000, EUR J APPL PHYSIOL, V81, P418, DOI 10.1007/s004210050063; Cadore EL, 2012, J STRENGTH CONDITION; Chtara M, 2005, BRIT J SPORT MED, V39, P555, DOI 10.1136/bjsm.2004.015248; Chtara M, 2008, J STRENGTH COND RES, V22, P1037, DOI 10.1519/JSC.0b013e31816a4419; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Copeland JL, 2002, J GERONTOL A-BIOL, V57, pB158, DOI 10.1093/gerona/57.4.B158; Daly W, 2005, EUR J APPL PHYSIOL, V93, P375, DOI 10.1007/s00421-004-1223-1; Galliven EA, 1997, J APPL PHYSIOL, V83, P1822; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; Goto K, 2005, EUR J APPL PHYSIOL, V94, P333, DOI 10.1007/s00421-004-1296-x; HAKKINEN K, 1993, INT J SPORTS MED, V14, P53, DOI 10.1055/s-2007-1021146; HAKKINEN K, 1985, EUR J APPL PHYSIOL O, V53, P287, DOI 10.1007/BF00422840; HAKKINEN K, 1993, ACTA PHYSIOL SCAND, V148, P199, DOI 10.1111/j.1748-1716.1993.tb09549.x; Hakkinen K, 1998, J APPL PHYSIOL, V84, P1341, DOI 10.1152/jappl.1998.84.4.1341; HAKKINEN K, 1986, EUR J APPL PHYSIOL O, V55, P588, DOI 10.1007/BF00423202; Hakkinen K, 1995, INT J SPORTS MED, V16, P507, DOI 10.1055/s-2007-973045; HAKKINEN K, 1993, J APPL PHYSIOL, V74, P882, DOI 10.1152/jappl.1993.74.2.882; HAKKINEN K, 1988, INT J SPORTS MED, V9, P422, DOI 10.1055/s-2007-1025044; HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333; Izquierdo M, 2004, J SPORT SCI, V22, P465, DOI 10.1080/02640410410001675342; Kanaley JA, 1997, J APPL PHYSIOL, V83, P1756, DOI 10.1152/jappl.1997.83.5.1756; Kanaley JA, 2001, J CLIN ENDOCR METAB, V86, P2881, DOI 10.1210/jc.86.6.2881; Kraemer WJ, 2010, CURR SPORT MED REP, V9, P242, DOI 10.1249/JSR.0b013e3181e976df; Kraemer WJ, 1999, J APPL PHYSIOL, V87, P982, DOI 10.1152/jappl.1999.87.3.982; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; KRAEMER WJ, 1995, J APPL PHYSIOL, V79, P1310, DOI 10.1152/jappl.1995.79.4.1310; KRAEMER WJ, 1990, J APPL PHYSIOL, V69, P1442, DOI 10.1152/jappl.1990.69.4.1442; Kraemer WJ, 1998, EUR J APPL PHYSIOL O, V78, P69, DOI 10.1007/s004210050389; Kraemer WJ, 2001, EUR J APPL PHYSIOL, V84, P13, DOI 10.1007/s004210000322; Linnamo V, 2005, J STRENGTH COND RES, V19, P566; Linnamo V, 1998, EUR J APPL PHYSIOL, V77, P176; Mauras N, 2005, GROWTH HORM IGF RES, V15, P19, DOI 10.1016/j.ghir.2004.12.003; McCaulley GO, 2009, EUR J APPL PHYSIOL, V105, P695, DOI 10.1007/s00421-008-0951-z; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; Miikola JS, 2007, J STRENGTH COND RES, V21, P613, DOI 10.1519/R-20045.1; Mikkola J, 2011, J SPORT SCI, V29, P1359, DOI 10.1080/02640414.2011.589467; Nindl BC, 2007, BRIT J SPORT MED, V41, P346, DOI 10.1136/bjsm.2006.028951; Nindl BC, 2011, GROWTH HORM IGF RES, V21, P124, DOI 10.1016/j.ghir.2011.03.001; Paavolainen L, 1999, J APPL PHYSIOL, V86, P1527; Schilling BK, 2012, J STRENGTH CONDITION; Sloniger MA, 1997, J APPL PHYSIOL, V83, P2073, DOI 10.1152/jappl.1997.83.6.2073; Storen O, 2008, MED SCI SPORT EXER, V40, P1087, DOI 10.1249/MSS.0b013e318168da2f; Tremblay MS, 2005, EUR J APPL PHYSIOL, V94, P505, DOI 10.1007/s00421-005-1380-x; Tremblay MS, 2004, J APPL PHYSIOL, V96, P531, DOI 10.1152/japplphysiol.00656.2003; VIITASALO J T, 1980, Electromyography and Clinical Neurophysiology, V20, P487; Viru AM, 2001, EUR J APPL PHYSIOL, V85, P578, DOI 10.1007/s004210100498; Vuorimaa T, 1999, EUR J APPL PHYSIOL O, V80, P575, DOI 10.1007/s004210050636; WELTMAN A, 1992, J APPL PHYSIOL, V72, P2188, DOI 10.1152/jappl.1992.72.6.2188	51	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55051	10.1371/journal.pone.0055051	http://dx.doi.org/10.1371/journal.pone.0055051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408956	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200016
J	Guillemet, E; Tran, SL; Cadot, C; Rognan, D; Lereclus, D; Ramarao, N				Guillemet, Elisabeth; Tran, Seav-Ly; Cadot, Celine; Rognan, Didier; Lereclus, Didier; Ramarao, Nalini			Glucose 6P Binds and Activates HlyIIR to Repress Bacillus cereus Haemolysin hlyII Gene Expression	PLOS ONE			English	Article							ENVIRONMENTAL-CONDITIONS; REGULATES EXPRESSION; IRON-METABOLISM; TOXIN GENE; II GENE; THURINGIENSIS; VIRULENCE; PROTEIN; BACTERIA; PORE	Bacillus cereus is a Gram-positive spore-forming bacterium causing food poisoning and serious opportunistic infections. These infections are characterized by bacterial accumulation despite the recruitment of phagocytic cells. We have previously shown that B. cereus Haemolysin II (HlyII) induces macrophage cell death by apoptosis. In this work, we investigated the regulation of the hlyII gene. We show that HlyIIR, the negative regulator of hlyII expression in B. cereus, is especially active during the early bacterial growth phase. We demonstrate that glucose 6P directly binds to HlyIIR and enhances its activity at a post-transcriptional level. Glucose 6P activates HlyIIR, increasing its capacity to bind to its DNA-box located upstream of the hlyII gene, inhibiting its expression. Thus, hlyII expression is modulated by the availability of glucose. As HlyII induces haemocyte and macrophage death, two cell types that play a role in the sequestration of nutrients upon infection, HlyII may induce host cell death to allow the bacteria to gain access to carbon sources that are essential components for bacterial growth.	[Guillemet, Elisabeth; Tran, Seav-Ly; Cadot, Celine; Lereclus, Didier; Ramarao, Nalini] INRA, Unite MICALIS UMR 1319, La Miniere, Guyancourt, France; [Rognan, Didier] CNRS, UMR 7200, Lab Therapeut Innovat, Illkirch Graffenstaden, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Ramarao, N (corresponding author), INRA, Unite MICALIS UMR 1319, La Miniere, Guyancourt, France.	nalini.ramarao@jouy.inra.fr	Rama Rao, Nalini/GRR-7800-2022; Lereclus, Didier/AAD-8293-2019; Rognan, Didier/B-9939-2014	Lereclus, Didier/0000-0001-9047-9104; Tran, Seav-ly/0000-0001-7014-6601				AGAISSE H, 1994, J BACTERIOL, V176, P4734, DOI 10.1128/JB.176.15.4734-4741.1994; Andreeva ZI, 2007, BBA-BIOMEMBRANES, V1768, P253, DOI 10.1016/j.bbamem.2006.11.004; Andreeva ZI, 2006, PROTEIN EXPRES PURIF, V47, P186, DOI 10.1016/j.pep.2005.10.030; Andreeva-Kovalevskaya ZI, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1473, DOI 10.1134/S0006297908130087; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnaout MK, 1999, J PEDIAT HEMATOL ONC, V21, P431, DOI 10.1097/00043426-199909000-00018; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Auger S, 2009, APPL ENVIRON MICROB, V75, P6616, DOI 10.1128/AEM.00155-09; Baida G, 1999, FEMS MICROBIOL LETT, V180, P7, DOI 10.1016/S0378-1097(99)00455-3; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Bouillaut L, 2005, APPL ENVIRON MICROB, V71, P8903, DOI 10.1128/AEM.71.12.8903-8910.2005; Brillard J, 2010, APPL ENVIRON MICROB, V76, P2562, DOI 10.1128/AEM.02348-09; Brillard J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-183; Budarina ZI, 2004, MICROBIOL-SGM, V150, P3691, DOI 10.1099/mic.0.27142-0; Cadot C, 2010, J CLIN MICROBIOL, V48, P1358, DOI 10.1128/JCM.02123-09; Callegan MC, 2005, INVEST OPHTH VIS SCI, V46, P3233, DOI 10.1167/iovs.05-0410; Chiang C, 2011, J BACTERIOL, V193, P52, DOI 10.1128/JB.01656-09; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Eckert DT, 2008, BIOCHEM BIOPH RES CO, V372, P131, DOI 10.1016/j.bbrc.2008.05.002; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Halbedel S, 2007, J MOL MICROB BIOTECH, V12, P147, DOI 10.1159/000096470; Harvie DR, 2005, MICROBIOL-SGM, V151, P569, DOI 10.1099/mic.0.27744-0; Hernandez E, 1998, J CLIN MICROBIOL, V36, P2138, DOI 10.1128/JCM.36.7.2138-2139.1998; Hilliard NJ, 2003, J CLIN MICROBIOL, V41, P3441, DOI 10.1128/JCM.41.7.3441-3444.2003; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Kovalevskiy OV, 2007, J MOL BIOL, V365, P825, DOI 10.1016/j.jmb.2006.10.074; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; LERECLUS D, 1992, BIO-TECHNOL, V10, P418, DOI 10.1038/nbt0492-418; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Maniatis T., 1982, MOL CLONING LAB MANU; Meugnier E, 2007, CURR OPIN CLIN NUTR, V10, P518, DOI 10.1097/MCO.0b013e3281298fef; Miles G, 2002, PROTEIN SCI, V11, P1813, DOI 10.1110/ps.0204002; Porcheron G, 2011, MOL MICROBIOL, V81, P717, DOI 10.1111/j.1365-2958.2011.07725.x; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; Ramarao N, 2006, MICROBES INFECT, V8, P1483, DOI 10.1016/j.micinf.2006.01.005; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rodikova EA, 2007, FEBS LETT, V581, P1190, DOI 10.1016/j.febslet.2007.02.035; Sanchis V, 1996, J BIOTECHNOL, V48, P81, DOI 10.1016/0168-1656(96)01404-6; Sineva E, 2012, J BACTERIOL, V194, P3327, DOI 10.1128/JB.00199-12; Sineva EV, 2009, FEMS MICROBIOL LETT, V299, P110, DOI 10.1111/j.1574-6968.2009.01742.x; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Tran SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022876; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Tran SL, 2010, J BACTERIOL, V192, P2638, DOI 10.1128/JB.01315-09; van der Voort M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-62; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; 2009, EFSA J, V271	57	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55085	10.1371/journal.pone.0055085	http://dx.doi.org/10.1371/journal.pone.0055085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405113	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400057
J	Keita, AK; Socolovschi, C; Ahuka-Mundeke, S; Ratmanov, P; Butel, C; Ayouba, A; Inogwabini, BI; Muyembe-Tamfum, JJ; Mpoudi-Ngole, E; Delaporte, E; Peeters, M; Fenollar, F; Raoult, D				Keita, Alpha Kabinet; Socolovschi, Cristina; Ahuka-Mundeke, Steve; Ratmanov, Pavel; Butel, Christelle; Ayouba, Ahidjo; Inogwabini, Bila-Isia; Muyembe-Tamfum, Jean-Jacques; Mpoudi-Ngole, Eitel; Delaporte, Eric; Peeters, Martine; Fenollar, Florence; Raoult, Didier			Molecular Evidence for the Presence of Rickettsia Felis in the Feces of Wild-living African Apes	PLOS ONE			English	Article							PHYLOGENY; FLEAS; SEQUENCES	Background: Rickettsia felis is a common emerging pathogen detected in mosquitoes in sub-Saharan Africa. We hypothesized that, as with malaria, great apes may be exposed to the infectious bite of infected mosquitoes and release R. felis DNA in their feces. Methods: We conducted a study of 17 forest sites in Central Africa, testing 1,028 fecal samples from 313 chimpanzees, 430 gorillas and 285 bonobos. The presence of rickettsial DNA was investigated by specific quantitative real-time PCR. Positive results were confirmed by a second PCR using primers and a probe targeting a specific gene for R. felis. All positive samples were sequenced. Results: Overall, 113 samples (11%) were positive for the Rickettsia-specific gltA gene, including 25 (22%) that were positive for R. felis. The citrate synthase (gltA) sequence and outer membrane protein A (ompA) sequence analysis indicated 99% identity at the nucleotide level to R. felis. The 88 other samples (78%) were negative using R. felis-specific qPCR and were compatible with R. felis-like organisms. Conclusion: For the first time, we detected R. felis in wild-living ape feces. This non invasive detection of human pathogens in endangered species opens up new possibilities in the molecular epidemiology and evolutionary analysis of infectious diseases, beside HIV and malaria.	[Keita, Alpha Kabinet; Socolovschi, Cristina; Ratmanov, Pavel; Fenollar, Florence; Raoult, Didier] Aix Marseille Univ, CNRS 7278, IRD 198, URMITE,UM63,Inserm 1095, Marseille, France; [Keita, Alpha Kabinet; Ahuka-Mundeke, Steve; Butel, Christelle; Ayouba, Ahidjo; Delaporte, Eric; Peeters, Martine] IRD, TransVIHMI, UMI 233, Montpellier, France; [Keita, Alpha Kabinet; Ahuka-Mundeke, Steve; Butel, Christelle; Ayouba, Ahidjo; Delaporte, Eric; Peeters, Martine] Univ Montpellier I, Montpellier, France; [Inogwabini, Bila-Isia] WWF, Projet Lac Tumba, Mbandaka, DEM REP CONGO; [Muyembe-Tamfum, Jean-Jacques] Clin Univ Kinshasa, Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Muyembe-Tamfum, Jean-Jacques] Clin Univ Kinshasa, Microbiol Serv, Kinshasa, DEM REP CONGO; [Mpoudi-Ngole, Eitel] Projet PRESICA, Yaounde, Cameroon; [Mpoudi-Ngole, Eitel] Virol Lab IMPM IRD, Yaounde, Cameroon	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; World Wildlife Fund; Institute Nacional de Recherche Biomedical; Universite de Kinshasa; Universite de Kinshasa	Raoult, D (corresponding author), Aix Marseille Univ, CNRS 7278, IRD 198, URMITE,UM63,Inserm 1095, Marseille, France.	didier.raoult@gmail.com	Keita, Alpha/A-9454-2015; Ayouba, Ahidjo/G-8775-2017; KEITA, Alpha Kabinet/AAR-1586-2020; Ratmanov, Pavel/K-8952-2019; Ratmanov, Pavel E/A-9301-2016; Delaporte, Eric/J-5397-2018; RAOULT, Didier/A-8434-2008	Keita, Alpha/0000-0003-4377-341X; Ayouba, Ahidjo/0000-0002-5081-1632; KEITA, Alpha Kabinet/0000-0003-4377-341X; Ratmanov, Pavel/0000-0002-6292-8758; Ratmanov, Pavel E/0000-0002-6292-8758; Delaporte, Eric/0000-0002-1822-9853; RAOULT, Didier/0000-0002-0633-5974; Inogwabini, Bila-Isia/0000-0002-6897-2477	NIAID NIH HHS [R37 AI050529] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050529] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berrelha J, 2009, CLIN MICROBIOL INFEC, V15, P251, DOI 10.1111/j.1469-0691.2008.02273.x; Bitam I, 2006, AM J TROP MED HYG, V74, P532, DOI 10.4269/ajtmh.2006.74.532; Calvignac-Spencer S, 2012, CLIN MICROBIOL INFEC, V18, P521, DOI 10.1111/j.1469-0691.2012.03816.x; Duval L, 2012, CLIN MICROBIOL INFEC, V18, P528, DOI 10.1111/j.1469-0691.2012.03825.x; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Horta MC, 2006, APPL ENVIRON MICROB, V72, P1705, DOI 10.1128/AEM.72.2.1705-1707.2006; La Scola B, 2002, INT J SYST EVOL MICR, V52, P2035, DOI [10.1099/ijs.0.02070-0, 10.1099/00207713-52-6-2035]; Li YY, 2012, J VIROL, V86, P10776, DOI 10.1128/JVI.01498-12; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Mediannikov O, 2012, COMP IMMUNOL MICROB, V35, P145, DOI 10.1016/j.cimid.2011.12.011; Mediannikov O, 2012, EMERG INFECT DIS, V18, P1385, DOI 10.3201/eid1808.111243; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Neel C, 2010, J VIROL, V84, P1464, DOI 10.1128/JVI.02129-09; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Peeters M, 2012, CLIN MICROBIOL INFEC, V18, P514, DOI 10.1111/j.1469-0691.2012.03843.x; Raoult D, 2012, CLIN MICROBIOL INFEC, V18, P513, DOI 10.1111/j.1469-0691.2012.03810.x; Richards AL, 2010, EMERG INFECT DIS, V16, P1081, DOI 10.3201/eid1607.091885; Rolain JM, 2005, EMERG INFECT DIS, V11, P1742, DOI 10.3201/eid1111.050861; Sackal C, 2008, EMERG INFECT DIS, V14, P1972, DOI 10.3201/eid1412.080610; SIBLEY CG, 1990, J MOL EVOL, V30, P202, DOI 10.1007/BF02099992; SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980; Socolovschi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048254; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1687, DOI 10.3201/eid1810.120178; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1140, DOI 10.3201/eid1607.100070; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thepparit C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016396; Van Heuverswyn Fran, 2007, Curr Infect Dis Rep, V9, P338, DOI 10.1007/s11908-007-0052-x; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111	28	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54679	10.1371/journal.pone.0054679	http://dx.doi.org/10.1371/journal.pone.0054679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405087	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400031
J	Nguyen, HD; Tomitaka, Y; Ho, SYW; Duchene, S; Vetten, HJ; Lesemann, D; Walsh, JA; Gibbs, AJ; Ohshima, K				Nguyen, Huy D.; Tomitaka, Yasuhiro; Ho, Simon Y. W.; Duchene, Sebastian; Vetten, Heinrich-Josef; Lesemann, Dietrich; Walsh, John A.; Gibbs, Adrian J.; Ohshima, Kazusato			Turnip Mosaic Potyvirus Probably First Spread to Eurasian Brassica Crops from Wild Orchids about 1000 Years Ago	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MOLECULAR CHARACTERIZATION; DNA-SEQUENCES; VIRUS; RECOMBINATION; RNA; DETERMINANT; P3; IDENTIFICATION; PHYLOGENETICS	Turnip mosaic potyvirus (TuMV) is probably the most widespread and damaging virus that infects cultivated brassicas worldwide. Previous work has indicated that the virus originated in western Eurasia, with all of its closest relatives being viruses of monocotyledonous plants. Here we report that we have identified a sister lineage of TuMV-like potyviruses (TuMV-OM) from European orchids. The isolates of TuMV-OM form a monophyletic sister lineage to the brassica-infecting TuMVs (TuMV-BIs), and are nested within a clade of monocotyledon-infecting viruses. Extensive host-range tests showed that all of the TuMV-OMs are biologically similar to, but distinct from, TuMV-BIs and do not readily infect brassicas. We conclude that it is more likely that TuMV evolved from a TuMV-OM-like ancestor than the reverse. We did Bayesian coalescent analyses using a combination of novel and published sequence data from four TuMV genes [helper component-proteinase protein (HC-Pro), protein 3(P3), nuclear inclusion b protein (NIb), and coat protein (CP)]. Three genes (HC-Pro, P3, and NIb), but not the CP gene, gave results indicating that the TuMV-BI viruses diverged from TuMV-OMs around 1000 years ago. Only 150 years later, the four lineages of the present global population of TuMV-BIs diverged from one another. These dates are congruent with historical records of the spread of agriculture in Western Europe. From about 1200 years ago, there was a warming of the climate, and agriculture and the human population of the region greatly increased. Farming replaced woodlands, fostering viruses and aphid vectors that could invade the crops, which included several brassica cultivars and weeds. Later, starting 500 years ago, inter-continental maritime trade probably spread the TuMV-BIs to the remainder of the world.	[Nguyen, Huy D.; Tomitaka, Yasuhiro; Ohshima, Kazusato] Saga Univ, Fac Agr, Lab Plant Virol, Saga 840, Japan; [Nguyen, Huy D.; Tomitaka, Yasuhiro; Ohshima, Kazusato] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Ho, Simon Y. W.; Duchene, Sebastian] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Vetten, Heinrich-Josef; Lesemann, Dietrich] Fed Res Ctr Cultivated Plants JKI, Julius Kuehn Inst, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Walsh, John A.] Univ Warwick, Wellesbourne, Warwick, England; [Gibbs, Adrian J.] Australian Natl Univ, Canberra, ACT, Australia	Saga University; Kagoshima University; University of Sydney; Julius Kuhn-Institut; University of Warwick; Australian National University	Ohshima, K (corresponding author), Saga Univ, Fac Agr, Lab Plant Virol, Saga 840, Japan.	ohshimak@cc.saga-u.ac.jp	Walsh, John/K-9791-2015; Ho, Simon YW/A-8417-2008	Ho, Simon YW/0000-0002-0361-2307; Duchene, Sebastian/0000-0002-2863-0907	Saga University; JSPS KAKENHI [18405022, 24405026]; BBSRC [BB/E00668X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00668X/1] Funding Source: researchfish	Saga University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was in part funded by Saga University and supported by JSPS KAKENHI Grant Number 18405022 and 24405026 (http://www.saga-u.ac.jp/and http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 1994, MAKING EUROPE CONQUE; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Chen CC, 2003, PLANT DIS, V87, P901, DOI 10.1094/PDIS.2003.87.8.901; Chen J, 2003, J PHYTOPATHOL, V151, P26, DOI 10.1046/j.1439-0434.2003.00674.x; Chen J, 2002, ARCH VIROL, V147, P683, DOI 10.1007/s007050200018; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Crisp P., 1995, EVOLUTION CROP PLANT, P86; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Farzadfar S, 2009, EUR J PLANT PATHOL, V124, P45, DOI 10.1007/s10658-008-9390-2; Felsenstein J, 1993, PHYLIP PHYLOGENY INT; Fuji S, 1999, ARCH VIROL, V144, P231, DOI 10.1007/s007050050500; Fuji S, 2000, ARCH VIROL, V145, P635, DOI 10.1007/s007050050052; Gardner MW, 1921, J AGRIC RES, V22, P0123; Gibbs A., 2000, AUST ORCHID REV, V65, P10; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Gibbs A, 2008, ARCH VIROL, V153, P2177, DOI 10.1007/s00705-008-0256-x; Gibbs A, 2010, ANNU REV PHYTOPATHOL, V48, P205, DOI 10.1146/annurev-phyto-073009-114404; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harlan J.R., 1998, ORIGINS AGR CROP DOM, P1; Hemingway JS, 1995, EVOLUTION CROP PLANT, P82; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Hodgkin T, 1995, EVOLUTION CROP PLANT, P76; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jenner CE, 2003, MOL PLANT MICROBE IN, V16, P777, DOI 10.1094/MPMI.2003.16.9.777; Jenner CE, 2002, VIROLOGY, V300, P50, DOI 10.1006/viro.2002.1519; Jenner CE, 2000, MOL PLANT MICROBE IN, V13, P1102, DOI 10.1094/MPMI.2000.13.10.1102; King AM, 2012, 9 REPORT INT COMMITT, P770; Korkmaz S, 2008, PLANT PATHOL, V57, P1155, DOI 10.1111/j.1365-3059.2008.01902.x; Kozubek E, 2007, J APPL GENET, V48, P295, DOI 10.1007/BF03195226; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lesemann D. E., 1985, ACTA HORTIC, V164, P45; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; MacNaughton IH, 1995, EVOLUTION CROP PLANT, P62; MacNaughton IH, 1995, EVOLUTION CROP PLANT, P68; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; NICOLAS O, 1992, J GEN VIROL, V73, P2785, DOI 10.1099/0022-1317-73-11-2785; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511; Ohshima K, 1996, ARCH VIROL, V141, P1991, DOI 10.1007/BF01718209; Ohshima K, 2007, J GEN VIROL, V88, P298, DOI 10.1099/vir.0.82335-0; Pagan I, 2010, J MOL EVOL, V71, P298, DOI 10.1007/s00239-010-9385-4; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Pallett DW, 2008, PLANT PATHOL, V57, P401, DOI 10.1111/j.1365-3059.2007.01764.x; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Sanjuan R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002685; Sawyer S, 1999, GENECONV COMPUTER PA; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Simmonds NW., 1976, EVOLUTION CROP PLANT; Simmons HE, 2008, J GEN VIROL, V89, P1081, DOI 10.1099/vir.0.83543-0; SMARRT J, 1995, EVOLUTION CROP PLANT; SMITH JM, 1992, J MOL EVOL, V34, P126; Suehiro N, 2004, J GEN VIROL, V85, P2087, DOI 10.1099/vir.0.79825-0; Tan ZY, 2005, J GEN VIROL, V86, P501, DOI 10.1099/vir.0.80540-0; Tomimura K, 2004, VIROLOGY, V330, P408, DOI 10.1016/j.virol.2004.09.040; Tomimura K, 2003, MOL ECOL, V12, P2099, DOI 10.1046/j.1365-294X.2003.01881.x; Vavilov, 1926, ORIGIN CULTIVATED PL; Wang HY, 2009, VIRUS GENES, V38, P421, DOI 10.1007/s11262-009-0335-4; Ward C. W., 1995, MOL BASIS VIRUS EVOL, P477; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929	69	79	82	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55336	10.1371/journal.pone.0055336	http://dx.doi.org/10.1371/journal.pone.0055336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405136	Green Published, gold			2022-12-27	WOS:000315153400081
J	Pombo, M; Denadai, MR; Turra, A				Pombo, Maira; Denadai, Marcia Regina; Turra, Alexander			Seasonality, Dietary Overlap and the Role of Taxonomic Resolution in the Study of the Diet of Three Congeneric Fishes from a Tropical Bay	PLOS ONE			English	Article							PLANKTONIC COPEPODS; SOUTHEASTERN BRAZIL; STELLIFER-RASTRIFER; COMMUNITY STRUCTURE; DYNAMICS; BIODIVERSITY; VARIABILITY; PERCIFORMES; SCIAENIDAE; CRUSTACEA	Not only seasonality but also taxonomic resolution of prey categories has been shown to affect diet studies. We analyzed the stomach contents of three sympatric species, Stellifer rastrifer, S. brasiliensis and S. stellifer, sampled monthly from August 2003 to October 2004 in Caraguatatuba Bay, southeastern Brazil. General characteristics and similarities among their diets were evaluated by considering high taxonomic ranks of all prey groups, and also the lower taxonomic ranks of the main prey groups. Dietary similarity was relatively high among species and low between seasons, and both evaluation criteria gave the equivalent results. The rare items, however, provided information about resource partition, and the species compositions of the most important groups were apparently good indicators of food availability.	[Pombo, Maira; Turra, Alexander] Univ Sao Paulo, Inst Oceanog, Sao Paulo, Brazil; [Denadai, Marcia Regina] Ctr Univ Modulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Pombo, M (corresponding author), Univ Sao Paulo, Inst Oceanog, Sao Paulo, Brazil.	mairapombo@gmail.com	Turra, Alexander/G-1352-2012; Pombo, Maíra/J-7791-2015; Denadai, Marcia R/P-9927-2015	Turra, Alexander/0000-0003-2225-8371; Denadai, Marcia R/0000-0002-7236-9478	Project Aware Foundation; State of Sao Paulo Research Foundation (FAPESP) [05/60041-6]	Project Aware Foundation; State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was partially supported by the Project Aware Foundation and by the State of Sao Paulo Research Foundation (FAPESP), which we also thank for the grant provided to M.R.D. (Proc. No. 05/60041-6) and the scholarship awarded to M.P. Logistical support was provided by the Instituto Costa Brasilis and the University Center of the Fundacao de Ensino Octavio Bastos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Teodoro SDA, 2012, BRAZ J OCEANOGR, V60, P245; Anger K, 1995, J EXP MAR BIOL ECOL, V193, P119, DOI 10.1016/0022-0981(95)00114-X; Araujo HMP, 2008, BRAZ J BIOL, V68, P751, DOI 10.1590/S1519-69842008000400009; Barleta-Bergan A, 2002, ESTUAR COAST SHELF S, V54, P193, DOI 10.1006/ecss.2001.0842; Branco JO, 2006, REV BRAS ZOOL, V23, P381, DOI 10.1590/S0101-81752006000200011; Bundy A, 2011, J FISH BIOL, V78, P514, DOI 10.1111/j.1095-8649.2010.02868.x; Camargo Mauricio, 2004, Rev. Bras. Zool., V21, P85, DOI 10.1590/S0101-81752004000100015; Chaves PDC, 1998, BRAZ ARCH BIOL TECHN, V41, P423; Coelho J.A.P., 1985, Boletim do Instituto de Pesca (Sao Paulo), V12, P99; COSTELLO MJ, 1990, J FISH BIOL, V36, P261, DOI 10.1111/j.1095-8649.1990.tb05601.x; DALL W, 1990, ADV MAR BIOL, V27, P1; DAUER DM, 1993, MAR POLLUT BULL, V26, P249, DOI 10.1016/0025-326X(93)90063-P; Diamond SL, 2000, CAN J FISH AQUAT SCI, V57, P2010, DOI 10.1139/cjfas-57-10-2010; Dias CD, 2008, BRAZ ARCH BIOL TECHN, V51, P731; Dias CD, 2009, ZOOLOGIA-CURITIBA, V26, P705; Eskinazi-Sant'Anna EM, 2006, HYDROBIOLOGIA, V563, P253, DOI 10.1007/s10750-006-0014-6; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Garrison LP, 2000, MAR ECOL PROG SER, V202, P231, DOI 10.3354/meps202231; Gerking SD., 2014, FEEDING ECOLOGY FISH; German DP, 2006, MAR BIOL, V148, P1123, DOI 10.1007/s00227-005-0149-4; GIANNINI R, 1990, Boletim do Instituto Oceanografico, V38, P69; Hofling Jose Claudio, 1997, Bioikos, V11, P7; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jia YJ, 2008, ENVIRON BIOL FISH, V81, P457, DOI 10.1007/s10641-007-9242-5; Jones R., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V172, P292; Jones R., 1982, ICLARM C P, V9, P195; Karachle PK, 2010, ACTA ICHTHYOL PISCAT, V40, P45, DOI 10.3750/AIP2010.40.1.06; Kawakami E., 1980, Boletim do Instituto Oceanografico, V29, P205; López-Ibarra Gladis A, 2006, Rev. biol. mar. oceanogr., V41, P63; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Menezes NA, 1980, MANUAL PEIXES MARINH, VIV; Micheletti CV, 1996, ARQ BIOL TECNOL, V39, P639; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Pauly D., 2000, TROPHLAB MANUAL; Pombo M, 2012, BRAZ J OCEANOGR, V60, P271, DOI 10.1590/S1679-87592012000300001; Rodrigues E.S., 1988, Boletim do Instituto de Pesca (Sao Paulo), V15, P135; Russo Mcircia Regina, 2004, Acta Scientiarum Biological Sciences, V26, P431; SASAKI K, 1989, Memoirs of the Faculty of Fisheries Hokkaido University, V36, P1; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; TavaresCromar AF, 1996, ECOL MONOGR, V66, P91, DOI 10.2307/2963482; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Wootton JT, 1998, AM NAT, V152, P803, DOI 10.1086/286210; Zhang Bo, 2005, Acta Zoologica Sinica, V51, P616	45	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56107	10.1371/journal.pone.0056107	http://dx.doi.org/10.1371/journal.pone.0056107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405256	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400202
J	Twomey, E; Yeager, J; Brown, JL; Morales, V; Cummings, M; Summers, K				Twomey, Evan; Yeager, Justin; Brown, Jason Lee; Morales, Victor; Cummings, Molly; Summers, Kyle			Phenotypic and Genetic Divergence among Poison Frog Populations in a Mimetic Radiation	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MULLERIAN MIMICRY; MIGRATION RATES; WARNING-COLOR; INFERENCE; SELECTION; SPECIATION; EVOLUTION; PATTERN; LOCI	The evolution of Mullerian mimicry is, paradoxically, associated with high levels of diversity in color and pattern. In a mimetic radiation, different populations of a species evolve to resemble different models, which can lead to speciation. Yet there are circumstances under which initial selection for divergence under mimicry may be reversed. Here we provide evidence for the evolution of extensive phenotypic divergence in a mimetic radiation in Ranitomeya imitator, the mimic poison frog, in Peru. Analyses of color hue (spectral reflectance) and pattern reveal substantial divergence between morphs. However, we also report that there is a "transition-zone'' with mixed phenotypes. Analyses of genetic structure using microsatellite variation reveals some differentiation between populations, but this does not strictly correspond to color pattern divergence. Analyses of gene flow between populations suggest that, while historical levels of gene flow were low, recent levels are high in some cases, including substantial gene flow between some color pattern morphs. We discuss possible explanations for these observations.	[Twomey, Evan; Yeager, Justin; Brown, Jason Lee; Summers, Kyle] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Yeager, Justin] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Brown, Jason Lee] Duke Univ, Dept Biol, Durham, NC USA; [Morales, Victor] Univ Ricardo Palma, Fac Ciencias Biol, Lima, Peru; [Cummings, Molly] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of North Carolina; East Carolina University; Tulane University; Duke University; Universidad Ricardo Palma; University of Texas System; University of Texas Austin	Summers, K (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	summersk@ecu.edu		Yeager, Justin/0000-0001-8692-6311	National Science Foundation; National Geographic Society	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society)	Work was supported by the National Science Foundation and the National Geographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli P, 1999, GENETICS, V152, P763; Brown JL, 2008, BEHAVIOUR, V145, P1139, DOI 10.1163/156853908785387647; Brown JL, 2011, ZOOTAXA, P1; Brown JL, 2009, CONSERV GENET RESOUR, V1, P149, DOI 10.1007/s12686-009-9036-5; Brown JL, 2010, AM NAT, V175, P436, DOI 10.1086/650727; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Chouteau M, 2011, AM NAT, V178, P810, DOI 10.1086/662667; Chouteau M, 2011, BIOL LETTERS, V7, P796, DOI 10.1098/rsbl.2011.0039; Cooley WW, 1971, MULTIVARIATE DATA AN; Cummings ME, 2008, ANIM BEHAV, V75, P175, DOI 10.1016/j.anbehav.2007.04.016; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Friendly M, 2007, J COMPUT GRAPH STAT, V16, P421, DOI 10.1198/106186007x208407; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Jiggins CD, 2008, BIOSCIENCE, V58, P541, DOI 10.1641/B580610; Kronforst MR, 2007, J EVOLUTION BIOL, V20, P278, DOI 10.1111/j.1420-9101.2006.01198.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Muller F., 1879, T ENTOMOL SOC LOND, V1879, P20, DOI DOI 10.1093/beheco/arw009; Naisbit RE, 2001, P ROY SOC B-BIOL SCI, V268, P1849, DOI 10.1098/rspb.2001.1753; Pritchard JK, 2000, GENETICS, V155, P945; Rasband W., 2006, IMAGEJ; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowland HM, 2010, BEHAV ECOL, V21, P851, DOI 10.1093/beheco/arq071; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SCHULTE R, 1999, PFEILGIFTFROSCHE, V2; Spande TF, 1999, J NAT PROD, V62, P5, DOI 10.1021/np980298v; Symula R, 2003, MOL PHYLOGENET EVOL, V26, P452, DOI 10.1016/S1055-7903(02)00367-6; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812; Venables WN., 2002, MODERN APPL STAT S 4; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Wilson GA, 2003, GENETICS, V163, P1177; Yeager J., 2009, THESIS E CAROLINA U; Yeager J, 2012, CURR ZOOL, V58, P668, DOI 10.1093/czoolo/58.4.668	36	24	24	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55443	10.1371/journal.pone.0055443	http://dx.doi.org/10.1371/journal.pone.0055443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405150	Green Published, gold			2022-12-27	WOS:000315153400095
J	van Vugt-Lussenburg, BMA; van der Weel, L; Hagen, WR; Hagedoorn, PL				van Vugt-Lussenburg, Barbara M. A.; van der Weel, Laura; Hagen, Wilfred R.; Hagedoorn, Peter-Leon			Biochemical Similarities and Differences between the Catalytic [4Fe-4S] Cluster Containing Fumarases FumA and FumB from Escherichia coli	PLOS ONE			English	Article							HYDRO-LYASES; IRON; EXPRESSION; GENE; PURIFICATION; PROTEIN; OXYGEN; K-12	Background: The highly homologous [4Fe-4S] containing fumarases FumA and FumB, sharing 90% amino acid sequence identity, from Escherichia coli are differentially regulated, which suggests a difference in their physiological function. The ratio of FumB over FumA expression levels increases by one to two orders of magnitude upon change from aerobic to anaerobic growth conditions. Methodology/Principal Findings: To understand this difference in terms of structure-function relations, catalytic and thermodynamic properties were determined for the two enzymes obtained from homologous overexpression systems. FumA and FumB are essentially identical in their Michaelis-Menten kinetics of the reversible fumarate to L-malate conversion; however, FumB has a significantly greater catalytic efficiency for the conversion of D-tartrate to oxaloacetate consistent with the requirement of the fumB gene for growth on D-tartrate. Reduction potentials of the [4Fe-4S](2+) Lewis acid active centre were determined in mediated bulk titrations in the presence of added substrate and were found to be approximately 2290 mV for both FumA and FumB. Conclusions/Significance: This study contradicts previously published claims that FumA and FumB exhibit different catalytic preferences for the natural substrates L-malate and fumarate. FumA and FumB differ significantly only in the catalytic efficiency for the conversion of D-tartrate, a supposedly non-natural substrate. The reduction potential of the substrate-bound [4Fe-4S] active centre is, contrary to previously reported values, close to the cellular redox potential.	[van Vugt-Lussenburg, Barbara M. A.; van der Weel, Laura; Hagen, Wilfred R.; Hagedoorn, Peter-Leon] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Delft University of Technology	Hagedoorn, PL (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	p.l.hagedoorn@tudelft.nl	Hagedoorn, Peter-Leon/C-8535-2014; Hagen, Wilfred R./H-8918-2017	Hagedoorn, Peter-Leon/0000-0001-6342-2022; Hagen, Wilfred R./0000-0002-1609-6671	Netherlands Ministry of Economic Affairs; B-Basic partner organizations through B-Basic, a public-private NWO-ACTS programme (ACTS = Advanced Chemical Technologies for Sustainability)	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations through B-Basic, a public-private NWO-ACTS programme (ACTS = Advanced Chemical Technologies for Sustainability)	This project is financially supported by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations (www.b-basic.nl) through B-Basic, a public-private NWO-ACTS programme (ACTS = Advanced Chemical Technologies for Sustainability). The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL PJ, 1989, J BACTERIOL, V171, P3494, DOI 10.1128/jb.171.6.3494-3503.1989; BOCK RM, 1953, J AM CHEM SOC, V75, P1921, DOI 10.1021/ja01104a043; Chen YP, 2012, J MICROBIOL, V50, P426, DOI 10.1007/s12275-012-1542-6; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; EMPTAGE MH, 1983, J BIOL CHEM, V258, P1106; FLINT DH, 1992, BIOCHEMISTRY-US, V31, P10331, DOI 10.1021/bi00157a022; Flint DH, 1996, CHEM REV, V96, P2315, DOI 10.1021/cr950041r; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FLINT DH, 1994, ARCH BIOCHEM BIOPHYS, V311, P509, DOI 10.1006/abbi.1994.1269; FRIEDEN C, 1955, J BIOL CHEM, V212, P859; GUEST JR, 1983, J BACTERIOL, V153, P588, DOI 10.1128/JB.153.2.588-596.1983; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; Kim OB, 2007, ARCH MICROBIOL, V188, P583, DOI 10.1007/s00203-007-0279-9; Kim OB, 2009, MICROBIOL-SGM, V155, P3632, DOI 10.1099/mic.0.031401-0; Lin HH, 2012, CURR MICROBIOL, V64, P412, DOI 10.1007/s00284-012-0087-6; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Shimoyama T, 2007, FEMS MICROBIOL LETT, V270, P207, DOI 10.1111/j.1574-6968.2007.00665.x; Telser J, 2000, J BIOL INORG CHEM, V5, P369, DOI 10.1007/PL00010666; Tseng CP, 1997, FEMS MICROBIOL LETT, V157, P67, DOI 10.1016/S0378-1097(97)00455-2; Tseng CP, 2001, J BACTERIOL, V183, P461, DOI 10.1128/JB.183.2.461-467.2001; UEDA Y, 1991, J BIOCHEM, V109, P728, DOI 10.1093/oxfordjournals.jbchem.a123448; van Vugt-Lussenburg BMA, 2009, MICROBIOL-SGM, V155, P3015, DOI 10.1099/mic.0.030320-0; WOODS SA, 1987, FEMS MICROBIOL LETT, V48, P219, DOI 10.1016/0378-1097(87)90165-0; WOODS SA, 1988, BIOCHIM BIOPHYS ACTA, V954, P14, DOI 10.1016/0167-4838(88)90050-7	25	24	25	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55549	10.1371/journal.pone.0055549	http://dx.doi.org/10.1371/journal.pone.0055549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405168	gold, Green Published			2022-12-27	WOS:000315153400113
J	Yeoman, CJ; Thomas, SM; Miller, MEB; Ulanov, AV; Torralba, M; Lucas, S; Gillis, M; Cregger, M; Gomez, A; Ho, MF; Leigh, SR; Stumpf, R; Creedon, DJ; Smith, MA; Weisbaum, JS; Nelson, KE; Wilson, BA; White, BA				Yeoman, Carl J.; Thomas, Susan M.; Miller, Margret E. Berg; Ulanov, Alexander V.; Torralba, Manolito; Lucas, Sarah; Gillis, Marcus; Cregger, Melissa; Gomez, Andres; Ho, Mengfei; Leigh, Steven R.; Stumpf, Rebecca; Creedon, Douglas J.; Smith, Michael A.; Weisbaum, Jon S.; Nelson, Karen E.; Wilson, Brenda A.; White, Bryan A.			A Multi-Omic Systems-Based Approach Reveals Metabolic Markers of Bacterial Vaginosis and Insight into the Disease	PLOS ONE			English	Article							NONSPECIFIC VAGINITIS; VAGINAL MICROBIOME; HAEMOPHILUS VAGINALIS; GARDNERELLA-VAGINALIS; BIOGENIC-AMINES; GRAM STAIN; SP-NOV.; WOMEN; ASSOCIATIONS; PREVALENCE	Background: Bacterial vaginosis (BV) is the most common vaginal disorder of reproductive-age women. Yet the cause of BV has not been established. To uncover key determinants of BV, we employed a multi-omic, systems-biology approach, including both deep 16S rRNA gene-based sequencing and metabolomics of lavage samples from 36 women. These women varied demographically, behaviorally, and in terms of health status and symptoms. Principal Findings: 16S rRNA gene-based community composition profiles reflected Nugent scores, but not Amsel criteria. In contrast, metabolomic profiles were markedly more concordant with Amsel criteria. Metabolomic profiles revealed two distinct symptomatic BV types (SBVI and SBVII) with similar characteristics that indicated disruption of epithelial integrity, but each type was correlated to the presence of different microbial taxa and metabolites, as well as to different host behaviors. The characteristic odor associated with BV was linked to increases in putrescine and cadaverine, which were both linked to Dialister spp. Additional correlations were seen with the presence of discharge, 2-methyl-2-hydroxybutanoic acid, and Mobiluncus spp., and with pain, diethylene glycol and Gardnerella spp. Conclusions: The results not only provide useful diagnostic biomarkers, but also may ultimately provide much needed insight into the determinants of BV.	[Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Yeoman, Carl J.; Thomas, Susan M.; Miller, Margret E. Berg; Cregger, Melissa; Gomez, Andres; Wilson, Brenda A.; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ulanov, Alexander V.] Univ Illinois, Ctr Biotechnol, Urbana, IL 61801 USA; [Ho, Mengfei; Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Leigh, Steven R.; Stumpf, Rebecca] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Torralba, Manolito; Lucas, Sarah; Gillis, Marcus; Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [Creedon, Douglas J.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA; [Smith, Michael A.] Christie Clin, Dept Obstet & Gynecol, Urbana, IL USA; [Weisbaum, Jon S.] Carle Clin Assoc, Dept Obstet & Gynecol, Urbana, IL USA	Montana State University System; Montana State University Bozeman; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; J. Craig Venter Institute; Mayo Clinic	Wilson, BA (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	bawilson@life.illinois.edu; bwhite44@illinois.edu	Yeoman, Carl/ABA-1906-2021; Cregger, Melissa/D-7142-2018; Ho, Mengfei/Q-6844-2019	Yeoman, Carl/0000-0002-8775-7879; Cregger, Melissa/0000-0001-8329-366X; Lucas, Sarah/0000-0003-1676-5801; Berg, Margret/0000-0002-0411-1619; LEIGH, STEVEN/0000-0001-6844-7122; Ho, Mengfei/0000-0002-8315-8158	National Institutes of Health (NIH) [R56 AI085096-01]; Carle-UIUC translational research initiative (CUTR); National Science Foundation (NSF) [08-20709]; Institute for Genomic Biology; Research Board of the University of Illinois at Urbana-Champaign; Mayo Clinic-University of Illinois alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085096] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carle-UIUC translational research initiative (CUTR); National Science Foundation (NSF)(National Science Foundation (NSF)); Institute for Genomic Biology; Research Board of the University of Illinois at Urbana-Champaign; Mayo Clinic-University of Illinois alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (NIH) grant R56 AI085096-01 (www.NIH.gov; PI: B. White), a Carle-UIUC translational research initiative (CUTR) grant (PI: B. Wilson), and a National Science Foundation (NSF) Grant #08-20709 (www.nsf.gov; PI: RS), with additional support from the Institute for Genomic Biology and the Research Board of the University of Illinois at Urbana-Champaign. Parts of this work were also funded by the Mayo Clinic-University of Illinois alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Antoine FR, 2004, J FOOD PROTECT, V67, P2255, DOI 10.4315/0362-028X-67.10.2255; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Bartlett J G, 1984, Rev Infect Dis, V6 Suppl 1, pS67; Chatwani Ashwin J, 2006, Infect Dis Obstet Gynecol, V2006, P95618; DEBRUERES J, 1985, PATHOL BIOL, V33, P687; Downes J, 2003, INT J SYST EVOL MICR, V53, P1937, DOI 10.1099/ijs.0.02640-0; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elferink SJWHO, 2001, APPL ENVIRON MICROB, V67, P125, DOI 10.1128/AEM.67.1.125-132.2001; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Hassan S, 2011, J LOW GENIT TRACT DI, V15, P128, DOI 10.1097/LGT.0b013e3181fb4270; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Izquierdo I, 2000, TETRAHEDRON-ASYMMETR, V11, P1749, DOI 10.1016/S0957-4166(00)00117-8; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Katikou P, 2006, J AGR FOOD CHEM, V54, P4277, DOI 10.1021/jf0602121; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lee J C, 2000, Curr Urol Rep, V1, P159, DOI 10.1007/s11934-000-0052-y; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Mills SC, 2011, CLIN EVID; Morotomi M, 2008, INT J SYST EVOL MICR, V58, P2716, DOI 10.1099/ijs.0.2008/000810-0; Nieto N, 2012, LIVER INT, V32, P189, DOI 10.1111/j.1478-3231.2011.02573.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Prester L, 2011, FOOD ADDIT CONTAM A, V28, P1547, DOI 10.1080/19440049.2011.600728; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rubio-Tapia A, 2009, J CLIN GASTROENTEROL, V43, P157, DOI 10.1097/MCG.0b013e3181557e67; SAUTTER RL, 1980, J CLIN MICROBIOL, V11, P479, DOI 10.1128/JCM.11.5.479-484.1980; Schweitzer L, 1999, WATER SCI TECHNOL, V40, P293, DOI 10.2166/wst.1999.0312; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; SPIEGEL CA, 1980, NEW ENGL J MED, V303, P601, DOI 10.1056/NEJM198009113031102; SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170, DOI 10.1128/JCM.18.1.170-177.1983; TOTTEN PA, 1982, J CLIN MICROBIOL, V15, P141, DOI 10.1128/JCM.15.1.141-147.1982; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WHITE AA, 1956, ARCH BIOCHEM BIOPHYS, V64, P57, DOI 10.1016/0003-9861(56)90241-7; White BA, 2011, TRENDS ENDOCRIN MET, V22, P389, DOI 10.1016/j.tem.2011.06.001; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411; Zhang S, 2011, J FOOD SCI, V76, pC127, DOI 10.1111/j.1750-3841.2010.01916.x	43	80	84	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56111	10.1371/journal.pone.0056111	http://dx.doi.org/10.1371/journal.pone.0056111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405259	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400205
J	Ziske, J; Kunz, A; Sewangi, J; Lau, I; Dugange, F; Hauser, A; Kirschner, W; Harms, G; Theuring, S				Ziske, Judith; Kunz, Andrea; Sewangi, Julius; Lau, Inga; Dugange, Festo; Hauser, Andrea; Kirschner, Wolf; Harms, Gundel; Theuring, Stefanie			Hematological Changes in Women and Infants Exposed to an AZT-Containing Regimen for Prevention of Mother-to-Child-Transmission of HIV in Tanzania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BREAST-FEEDING POPULATIONS; SINGLE-DOSE NEVIRAPINE; PERINATAL ZIDOVUDINE; FOLLOW-UP; EFFICACY; PROGRAM; SAFETY; HEMATOPOIESIS; INTERVENTIONS	Introduction: Tanzanian guidelines for prevention of mother-to-child-transmission of HIV (PMTCT) recommend an antiretroviral combination regimen involving zidovudine (AZT) during pregnancy, single-dosed nevirapine at labor onset, AZT plus Lamivudine (3TC) during delivery, and AZT/3TC for 1-4 weeks postpartum. As drug toxicities are a relevant concern, we assessed hematological alterations in AZT-exposed women and their infants. Methods and Materials: A cohort of HIV-positive women, either with AZT intake (n = 82, group 1) or without AZT intake (n = 62, group 2) for PMTCT during pregnancy, was established at Kyela District Hospital, Tanzania. The cohort also included the infants of group 1 with an in-utero AZT exposure >= 4 weeks, receiving AZT for 1 week postpartum (n = 41), and infants of group 2 without in-utero AZT exposure, receiving a prolonged 4-week AZT tail (n = 58). Complete blood counts were evaluated during pregnancy, birth, weeks 4-6 and 12. Results: For women of group 1 with antenatal AZT intake, we found a statistically significant decrease in hemoglobin level, red blood cells, white blood cells, granulocytes, as well as an increase in red cell distribution width and platelet count. At delivery, the median red blood cell count was significantly lower and the median platelet count was significantly higher in women of group 1 compared to group 2. At birth, infants from group 1 showed a lower median hemoglobin level and granulocyte count and a higher frequency of anemia and granulocytopenia. At 4-6 weeks postpartum, the mean neutrophil granulocyte count was significantly lower and neutropenia was significantly more frequent in infants of group 2. Conclusions: AZT exposure during pregnancy as well as after birth resulted in significant hematological alterations for women and their newborns, although these changes were mostly mild and transient in nature. Research involving larger cohorts is needed to further analyze the impact of AZT-containing regimens on maternal and infant health.	[Ziske, Judith; Kunz, Andrea; Lau, Inga; Hauser, Andrea; Harms, Gundel; Theuring, Stefanie] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Sewangi, Julius] Minist Hlth & Social Welf, Reg AIDS Control Program Mbeya Reg, Mbeya, Tanzania; [Dugange, Festo] Kyela Dist Hosp, Minist Hlth & Social Welf, Kyela, Tanzania; [Kirschner, Wolf] Forsch Beratung Evaluat, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Theuring, S (corresponding author), Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany.	stefanie.theuring@charite.de			German Ministry of Economic Cooperation through the GIZ Sector Project	German Ministry of Economic Cooperation through the GIZ Sector Project	The study was supported by the German Ministry of Economic Cooperation through the GIZ Sector Project "Strengthening the German Contribution to the Global AIDS Response". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Alioum A, 2001, STAT MED, V20, P3539, DOI 10.1002/sim.1076; [Anonymous], 2011, PROGRESS REPORT 2011; Briand Nelly, 2007, PLoS Clin Trials, V2, pe11, DOI 10.1371/journal.pctr.0020011; Briand N, 2010, AIDS RES HUM RETROV, V26, P1163, DOI 10.1089/aid.2010.0034; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cordoba A, 2018, ALAMBIQUE REV ACAD M, V6, P1; Dabis F, 2005, AIDS, V19, P309; Dao H, 2007, AM J OBSTET GYNECOL, V197, pS42, DOI 10.1016/j.ajog.2007.03.001; Eshleman SH, 2005, JAIDS-J ACQ IMM DEF, V39, P593; Feiterna-Sperling C, 2007, JAIDS-J ACQ IMM DEF, V45, P43, DOI 10.1097/QAI.0b013e318042d5e3; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; Le Chenadec J, 2003, AIDS, V17, P2053, DOI 10.1097/00002030-200309260-00006; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; McIntyre JA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000172; Mirkuzie AH, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-50; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; National Institute for Allergy and Infectious Disease (NIAID) Division of AIDS, 2009, TABL GRAD SEV AD PED; Pacheco SE, 2006, J INFECT DIS, V194, P1089, DOI 10.1086/507645; Shah MM, 1996, AIDS, V10, P1239, DOI 10.1097/00002030-199609000-00010; SILL PR, 1985, BRIT J OBSTET GYNAEC, V92, P480, DOI 10.1111/j.1471-0528.1985.tb01352.x; Sinha G, 2007, JAIDS-J ACQ IMM DEF, V45, P210, DOI 10.1097/QAI.0b013e3180556000; Sperling RS, 1998, AIDS, V12, P1805, DOI 10.1097/00002030-199814000-00012; Tanzania Commission for AIDS (TACAIDS) National Bureau of Statistics (NBS), 2008, TANZANIA HIV AIDS AN; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2008, UNITED REPUBLIC OF T; United Nations Development Programme, 2011, HUMAN DEVELOPMENT RE	28	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55633	10.1371/journal.pone.0055633	http://dx.doi.org/10.1371/journal.pone.0055633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405185	Green Published, gold			2022-12-27	WOS:000315153400130
J	Qian, XF; Cao, SY; Yang, GH; Pan, Y; Yin, CY; Chen, X; Zhu, Y; Zhuang, Y; Shen, YF; Hu, ZB				Qian, Xifeng; Cao, Songyu; Yang, Guohua; Pan, Yun; Yin, Chenyu; Chen, Xiang; Zhu, Ying; Zhuang, Yun; Shen, Yunfeng; Hu, Zhibin			Potentially Functional Polymorphism in IL-23 Receptor and Risk of Acute Myeloid Leukemia in a Chinese Population	PLOS ONE			English	Article							INTERLEUKIN-23 RECEPTOR; ANTITUMOR IMMUNITY; CANCER; GENE; CYTOKINE; IL23R	The interleukin-23 (IL-23) and its receptor (IL-23R) mediate the direct antitumor activities in human hematologic malignancies including pediatric acute leukemia. Two potentially functional genetic variants (IL-23R rs1884444 T > G and rs6682925 T > C) have been found to contribute to solid cancer susceptibility. In this study, we conducted a case-control study including 545 acute myeloid leukemia (AML) patients and 1,146 cancer-free controls in a Chinese population to assess the association between these two SNPs and the risk of AML. We found that IL-23R rs1884444 TG/GG and rs6682925 TC/CC variant genotypes were associated with significantly increased risk of AML [rs1884444: adjusted odds ratio (OR) = 1.28, 95% confidence interval (CI) = 1.01-1.62; rs6682925: adjusted OR = 1.30, 95% CI = 1.01-1.67], compared to their corresponding wild-type homozygotes, respectively. These findings indicated that genetic variants in IL-23R may contribute to AML risk in our Chinese population.	[Qian, Xifeng; Yang, Guohua; Zhuang, Yun; Shen, Yunfeng] Nanjing Med Univ, Dept Hematol, Wuxi Peoples Hosp, Wuxi, Peoples R China; [Cao, Songyu; Pan, Yun; Hu, Zhibin] Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Cao, Songyu; Pan, Yun; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Yin, Chenyu; Chen, Xiang; Zhu, Ying] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Peoples R China; [Qian, Xifeng; Cao, Songyu; Hu, Zhibin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China	Jiangnan University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Jiangnan University; Nanjing Medical University; Nanjing Medical University	Hu, ZB (corresponding author), Nanjing Med Univ, Dept Hematol, Wuxi Peoples Hosp, Wuxi, Peoples R China.	yfshen21cn@yahoo.com.cn; zhibin_hu@njmu.edu.cn			National Natural Science Foundation for Young Scholars of China [81200361]; Nanjing Medical University Foundation for Development of Science and Technology [2011NJMU203]	National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Nanjing Medical University Foundation for Development of Science and Technology	This work was supported in part by the National Natural Science Foundation for Young Scholars of China (81200361)(http://kjc.njmu.edu.cn/); Nanjing Medical University Foundation for Development of Science and Technology (2011NJMU203)(http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossard P, 1998, DEVELOPMENT, V125, P4909; Chen JJ, 2010, MOL CARCINOGEN, V49, P862, DOI 10.1002/mc.20661; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Chu HJ, 2012, INT J CANCER, V130, P1093, DOI 10.1002/ijc.26130; Cocco C, 2011, J LEUKOCYTE BIOL, V89, P729, DOI 10.1189/jlb.1210660; Cocco C, 2010, BLOOD, V116, P3887, DOI 10.1182/blood-2009-10-248245; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; EVANS DIK, 1972, LANCET, V2, P1322; Farago B, 2008, ANN RHEUM DIS, V67, P248, DOI 10.1136/ard.2007.072819; Ferretti E, 2010, IMMUNOL LETT, V133, P99, DOI 10.1016/j.imlet.2010.08.002; GUNZ FW, 1969, J NATL CANCER I, V42, P517; Hu JW, 2006, CANCER RES, V66, P8887, DOI 10.1158/0008-5472.CAN-05-3448; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Jiang L, 2011, CANCER SCI, V102, P1462, DOI 10.1111/j.1349-7006.2011.01965.x; Kaiga T, 2007, J IMMUNOL, V178, P7571, DOI 10.4049/jimmunol.178.12.7571; Kan SH, 2008, GENES IMMUN, V9, P631, DOI 10.1038/gene.2008.64; Kim ES, 2012, LIFE SCI, V90, P740, DOI 10.1016/j.lfs.2012.03.017; Langowski JL, 2007, TRENDS IMMUNOL, V28, P207, DOI 10.1016/j.it.2007.03.006; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; LEBEAU MM, 1986, J CLIN ONCOL, V4, P325, DOI 10.1200/JCO.1986.4.3.325; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Overwijk WW, 2006, J IMMUNOL, V176, P5213, DOI 10.4049/jimmunol.176.9.5213; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Safrany E, 2012, INFLAMM RES; Tartour E, 1999, CANCER RES, V59, P3698; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Ugai S, 2003, CANCER GENE THER, V10, P771, DOI 10.1038/sj.cgt.7700630; Xu Y, 2012, J GASTROENTEROL; Yuan XP, 2006, CANCER RES, V66, P2630, DOI 10.1158/0008-5472.CAN-05-1682	31	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55473	10.1371/journal.pone.0055473	http://dx.doi.org/10.1371/journal.pone.0055473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393581	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800035
J	Seo, JS; Koo, YJ; Jung, C; Yeu, SY; Song, JT; Kim, JK; Choi, Y; Lee, JS; Choi, YD				Seo, Jun Sung; Koo, Yeon Jong; Jung, Choonkyun; Yeu, Song Yion; Song, Jong Tae; Kim, Ju-Kon; Choi, Yeonhee; Lee, Jong Seob; Choi, Yang Do			Identification of a Novel Jasmonate-Responsive Element in the AtJMT Promoter and Its Binding Protein for AtJMT Repression	PLOS ONE			English	Article							SYNTHASE NOS PROMOTER; METHYL JASMONATE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; HISTONE ACETYLATION; ARABIDOPSIS-THALIANA; JAZ REPRESSORS; GCC-BOX; ACID; ETHYLENE	Jasmonates (JAs) are important regulators of plant biotic and abiotic stress responses and development. AtJMT in Arabidopsis thaliana and BcNTR1 in Brassica campestris encode jasmonic acid carboxyl methyltransferases, which catalyze methyl jasmonate (MeJA) biosynthesis and are involved in JA signaling. Their expression is induced by MeJA application. To understand its regulatory mechanism, here we define a novel JA-responsive cis-element (JARE), G(C)TCCTGA, in the AtJMT and BcNTR1 promoters, by promoter deletion analysis and Yeast 1-Hybrid (Y1H) assays; the JARE is distinct from other JA-responsive cis-elements previously reported. We also used Y1H screening to identify a trans-acting factor, AtBBD1, which binds to the JARE and interacts with AtJAZ1 and AtJAZ4. Knockout and overexpression analyses showed that AtBBD1 and its close homologue AtBBD2 are functionally redundant and act as negative regulators of AtJMT expression. However, AtBBD1 positively regulated the JA-responsive expression of JR2. Chromatin immunoprecipitation from knockout and overexpression plants revealed that repression of AtJMT is associated with reduced histone acetylation in the promoter region containing the JARE. These results show that AtBBD1 interacts with JAZ proteins, binds to the JARE and represses AtJMT expression.	[Seo, Jun Sung; Koo, Yeon Jong; Jung, Choonkyun; Yeu, Song Yion; Choi, Yang Do] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Song, Jong Tae] Kyungpook Natl Univ, Sch Appl Biosci, Taegu, South Korea; [Kim, Ju-Kon] Myongji Univ, Sch Biotechnol & Environm Engn, Yongin, South Korea; [Choi, Yeonhee; Lee, Jong Seob] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Seoul National University (SNU); Kyungpook National University; Myongji University; Seoul National University (SNU)	Choi, YD (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	choiyngd@snu.ac.kr	Choi, Yeonhee/AAF-5906-2020; Seo, Jun Sung/AAT-9552-2020		Next-Generation BioGreen 21 Program [PJ008053, PJ007971]; Rural Development Administration, Republic of Korea through the National Center for GM Crops	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea through the National Center for GM Crops	This work was supported by a grant from the Next-Generation BioGreen 21 Program (project nos. PJ008053 to YDC and PJ007971 to JKK), Rural Development Administration, Republic of Korea through the National Center for GM Crops. A graduate research assistantship to JSS from the Brain Korea 21 project of the MEST is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chua YL, 2003, PLANT CELL, V15, P1468, DOI 10.1105/tpc.011825; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Endt DV, 2007, PLANT PHYSIOL, V144, P1680, DOI 10.1104/pp.107.096115; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Guerineau F, 2003, J EXP BOT, V54, P1153, DOI 10.1093/jxb/erg123; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; He YH, 2001, PLANT MOL BIOL, V47, P595, DOI 10.1023/A:1012211011538; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Howe GA, 2010, PLANT PHYSIOL, V154, P471, DOI 10.1104/pp.110.161190; Ikeda M, 2009, PLANT CELL, V21, P3493, DOI 10.1105/tpc.109.069997; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kagale S, 2011, EPIGENETICS-US, V6, P141, DOI 10.4161/epi.6.2.13627; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; KIM SR, 1993, PLANT PHYSIOL, V103, P97, DOI 10.1104/pp.103.1.97; KIM SR, 1992, PLANT PHYSIOL, V99, P627, DOI 10.1104/pp.99.2.627; KIM YH, 1994, PLANT MOL BIOL, V24, P105, DOI 10.1007/BF00040578; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; Krogan NT, 2009, CURR OPIN PLANT BIOL, V12, P628, DOI 10.1016/j.pbi.2009.07.011; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; MASON HS, 1993, PLANT CELL, V5, P241, DOI 10.1105/tpc.5.3.241; Memelink J, 2009, PHYTOCHEMISTRY, V70, P1560, DOI 10.1016/j.phytochem.2009.09.004; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Seo HS, 2001, AGR CHEM BIOTECHNOL, V44, P119; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Song JT, 2000, PLANT MOL BIOL, V42, P647, DOI 10.1023/A:1006381625421; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stitz M, 2011, PLANT PHYSIOL, V157, P341, DOI 10.1104/pp.111.178582; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wu K, 2008, J EXP BOT, V59, P225, DOI 10.1093/jxb/erm300; Xu BF, 2004, PLANT MOL BIOL, V55, P743, DOI 10.1007/s11103-004-1962-8; Yamamoto YY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-39; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; You MK, 2010, PLANT PHYSIOL, V152, P1015, DOI 10.1104/pp.109.147645; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	63	10	12	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55482	10.1371/journal.pone.0055482	http://dx.doi.org/10.1371/journal.pone.0055482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393583	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800037
J	Setz, C; Friedrich, M; Hahn, S; Dorrie, J; Schaft, N; Schuler, G; Schubert, U				Setz, Christian; Friedrich, Melanie; Hahn, Sabine; Doerrie, Jan; Schaft, Niels; Schuler, Gerold; Schubert, Ulrich			Just One Position-Independent Lysine Residue Can Direct MelanA into Proteasomal Degradation following N-Terminal Fusion of Ubiquitin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; MULTIUBIQUITIN CHAIN; ANTIGEN PRESENTATION; VIRUS NUCLEOPROTEIN; CROSS-PRESENTATION; DNA IMMUNIZATION; T-LYMPHOCYTES; PROTEIN; PATHWAY	N-terminal stable in frame fusion of ubiquitin (Ub) has been shown to target the fusion protein for proteasomal degradation. This pathway, called the Ub fusion degradation (UFD), might also elevate MHC class I (MHC-I) antigen presentation of specific antigens. The UFD, mainly studied on cytosolic proteins, has been described to be mediated by polyubiquitination of specific lysine residues within the fused Ub moiety. Using the well characterized melanoma-specific antigen MelanA as a model protein, we analyzed the requirements of the UFD for ubiquitination and proteasomal degradation of a transmembrane protein. Here we show that fusion of the non-cleavable Ub(G76V) variant to the N-terminus of MelanA results in rapid proteasomal degradation via the endoplasmic reticulum-associated degradation (ERAD) pathway and, consequently, leads to an increased MHC-I antigen presentation. While lysine residues within Ub are dispensable for these effects, the presence of one single lysine residue, irrespectively of its location along the fusion protein, is sufficient to induce degradation of MelanA. These results show that the ubiquitination, ER to cytosol relocation and proteasomal degradation of a transmembrane protein can be increased by N-terminal fusion of Ub at the presence of at least one, position independent lysine residue. These findings are in contrast to the conventional wisdom concerning the UFD and indicate a new concept to target a protein into the ubiquitin-proteasome system (UPS) and thus for enhanced MHC-I antigen presentation, and might open up new possibilities in the development of tumor vaccines.	[Setz, Christian; Friedrich, Melanie; Hahn, Sabine; Schubert, Ulrich] Univ Klinikum Erlangen, Inst Clin & Mol Virol, Erlangen, Germany; [Doerrie, Jan; Schaft, Niels; Schuler, Gerold] Univ Klinikum Erlangen, Dept Dermatol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schubert, U (corresponding author), Univ Klinikum Erlangen, Inst Clin & Mol Virol, Erlangen, Germany.	ulrich.schubert@viro.med.uni-erlangen.de	Dörrie, Jan/H-3678-2011; Schaft, Niels/H-3713-2011	Dörrie, Jan/0000-0002-3478-0741; Schaft, Niels/0000-0001-8236-9298	German Human Genome Research Project [IE-S08T06]; German Research Council [SFB 643-A1]; National Institutes of Health [R01DK81553]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081553] Funding Source: NIH RePORTER	German Human Genome Research Project; German Research Council(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant IE-S08T06 from the German Human Genome Research Project, by the grant SFB 643-A1 from the German Research Council as well as by National Institutes of Health grant R01DK81553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Andersson HA, 2004, MOL THER, V10, P432, DOI 10.1016/j.ymthe.2004.05.035; Basta S, 2007, SCAND J IMMUNOL, V65, P311, DOI 10.1111/j.1365-3083.2007.01909.x; Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; De Maziere AM, 2002, TRAFFIC, V3, P678, DOI 10.1034/j.1600-0854.2002.30909.x; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Fu TM, 1998, VACCINE, V16, P1711, DOI 10.1016/S0264-410X(98)00134-0; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Goldwich A, 2008, J IMMUNOL, V180, P372, DOI 10.4049/jimmunol.180.1.372; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2007, FEBS LETT, V581, P265, DOI 10.1016/j.febslet.2006.12.024; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kohler G, 1981, CHARACTERIZATION MON; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Levy F, 2005, MOL BIOL CELL, V16, P1777, DOI 10.1091/mbc.E04-09-0803; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rimoldi D, 2001, J BIOL CHEM, V276, P43189, DOI 10.1074/jbc.M103221200; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; Saeki Y, 2004, BIOCHEM BIOPH RES CO, V320, P840, DOI 10.1016/j.bbrc.2004.05.216; Schliehe C, 2012, J VIROL, V86, P9782, DOI 10.1128/JVI.00694-12; Schlosser E, 2007, EMBO REP, V8, P945, DOI 10.1038/sj.embor.7401065; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sijts A., 2001, Current Molecular Medicine (Hilversum), V1, P665, DOI 10.2174/1566524013363230; Stack JH, 2000, NAT BIOTECHNOL, V18, P1298, DOI 10.1038/82422; Tellam J, 2003, BLOOD, V102, P4535, DOI 10.1182/blood-2003-03-0870; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Wu YQ, 1997, J IMMUNOL, V159, P6037; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zhang MX, 2004, IMMUNOLOGY, V112, P567, DOI 10.1111/j.1365-2567.2004.01916.x; Zhao G, 2009, P NATL ACAD SCI USA, V106, P16197, DOI 10.1073/pnas.0908321106	56	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55567	10.1371/journal.pone.0055567	http://dx.doi.org/10.1371/journal.pone.0055567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393593	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800047
J	Arntz, R; Rutten-Jacobs, L; Maaijwee, N; Schoonderwaldt, H; Dorresteijn, L; van Dijk, E; de Leeuw, FE				Arntz, Renate; Rutten-Jacobs, Loes; Maaijwee, Noortje; Schoonderwaldt, Hennie; Dorresteijn, Lucille; van Dijk, Ewoud; de Leeuw, Frank-Erik			Post-Stroke Epilepsy in Young Adults: A Long-Term Follow-Up Study	PLOS ONE			English	Article							ACUTE CEREBROVASCULAR-DISEASE; TRANSIENT ISCHEMIC ATTACKS; NIH STROKE SCALE; CEREBRAL INFARCTION; EARLY SEIZURES; PREDICTORS; MULTICENTER; PROGNOSIS; RATIONALE; MORTALITY	Background: Little is known about the incidence and risk of seizures after stroke in young adults. Especially in the young seizures might dramatically influence prognosis and quality of life. We therefore investigated the long-term incidence and risk of post-stroke epilepsy in young adults with a transient ischemic attack (TIA), ischemic stroke (IS) or intracerebral hemorrhage (ICH). Methods and Findings: We performed a prospective cohort study among 697 consecutive patients with a first-ever TIA, IS or ICH, aged 18-50 years, admitted to our hospital between 1-1-1980 till 1-11-2010. The occurrence of epilepsy was assessed by standardized questionnaires and verified by a neurologist. Cumulative risks were estimated with Kaplan-Meier analysis. Cox proportional hazard models were used to calculate relative risks. After mean follow-up of 9.1 years (SD 8.2), 79 (11.3%) patients developed post-stroke epilepsy and 39 patients (5.6%) developed epilepsy with recurrent seizures. Patients with an initial late seizure more often developed recurrent seizures than patients with an initial early seizure. Cumulative risk of epilepsy was 31%, 16% and 5% for patients with an ICH, IS and TIA respectively (Logrank test ICH and IS versus TIA p<0.001). Cumulative risk of epilepsy with recurrent seizures was 23%, 8% and 4% respectively (Logrank ICH versus IS p = 0.05, ICH versus TIA p<0.001, IS versus TIA p = 0.01). In addition a high NIHSS was a significant predictor of both epilepsy and epilepsy with recurrent seizures (HR 1.07, 95% CI 1.03-1.11 and 1.08, 95% CI 1.02-1.14). Conclusions: Post-stroke epilepsy is much more common than previously thought. Especially patients with an ICH and a high NIHSS are at high risk. This calls upon the question whether a subgroup could be identified which benefits from the use of prophylactic antiepileptic medication. Future studies should be executed to investigate risk factors and the effect of post-stroke epilepsy on quality of life.	[Arntz, Renate; Rutten-Jacobs, Loes; Maaijwee, Noortje; Schoonderwaldt, Hennie; van Dijk, Ewoud; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Dorresteijn, Lucille] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands	Radboud University Nijmegen; Medical Spectrum Twente	de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Dept Neurol, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	h.deleeuw@neuro.umcn.nl	van Dijk, Ewoud J/J-7951-2012; Rutten-Jacobs, Loes/C-7746-2013; de Leeuw, Frank-Erik/E-4795-2012; de Leeuw, H.F./L-4479-2015	Rutten-Jacobs, Loes/0000-0003-3223-885X; Rutten-Jacobs, Loes/0000-0001-6275-0462	Dutch Epilepsy Fund [2010-18]	Dutch Epilepsy Fund	This manuscript was supported by the "Dutch Epilepsy Fund" (grantnumber 2010-18). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, Stroke, V6, P564; [Anonymous], 1993, EPILEPSIA, V34, P592; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Arboix A, 1996, NEUROLOGY, V47, P1429, DOI 10.1212/WNL.47.6.1429; Beghi E, 2011, NEUROLOGY, V77, P1785, DOI 10.1212/WNL.0b013e3182364878; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Bousser MG, 2009, CEREBROVASC DIS, V27, P509, DOI 10.1159/000212671; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Burneo JG, 2010, EUR J NEUROL, V17, P52, DOI 10.1111/j.1468-1331.2009.02739.x; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; De Herdt V, 2011, NEUROLOGY, V77, P1794, DOI 10.1212/WNL.0b013e31823648a6; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; HANKEY GJ, 1991, J NEUROL NEUROSUR PS, V54, P793, DOI 10.1136/jnnp.54.9.793; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Kammersgaard Lars Peter, 2005, J Stroke Cerebrovasc Dis, V14, P210, DOI 10.1016/j.jstrokecerebrovasdis.2005.07.001; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; Krakow K, 2010, CEREBROVASC DIS, V30, P584, DOI 10.1159/000319777; Labovitz DL, 2001, NEUROLOGY, V57, P200, DOI 10.1212/WNL.57.2.200; Lamy C, 2003, NEUROLOGY, V60, P400, DOI 10.1212/WNL.60.3.400; Leys D, 2002, NEUROLOGY, V59, P26, DOI 10.1212/WNL.59.1.26; Lossius MI, 2005, EPILEPSIA, V46, P1246, DOI 10.1111/j.1528-1167.2005.57904.x; Luhmann HJ, 1996, PROG NEUROBIOL, V48, P131, DOI 10.1016/0301-0082(95)00042-9; Naess H, 2004, ACTA NEUROL SCAND, V110, P107, DOI 10.1111/j.1600-0404.2004.00273.x; Neau JP, 1998, CEREBROVASC DIS, V8, P296, DOI 10.1159/000015869; Paolucci S, 1997, EPILEPSIA, V38, P266, DOI 10.1111/j.1528-1157.1997.tb01115.x; Putaala J, 2010, ANN NEUROL, V68, P661, DOI 10.1002/ana.22091; Reith J, 1997, STROKE, V28, P1585, DOI 10.1161/01.STR.28.8.1585; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; Schulz UGR, 2002, POSTGRAD MED J, V78, P246, DOI 10.1136/pmj.78.918.246; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Varona JF, 2004, J NEUROL, V251, P1507, DOI 10.1007/s00415-004-0583-0; Williams LS, 2000, STROKE, V31, P858, DOI 10.1161/01.STR.31.4.858	37	62	66	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55498	10.1371/journal.pone.0055498	http://dx.doi.org/10.1371/journal.pone.0055498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390537	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100053
J	Chen, SC; Hung, CC; Kuo, MC; Lee, JJ; Chiu, YW; Chang, JM; Hwang, SJ; Chen, HC				Chen, Szu-Chia; Hung, Chi-Chih; Kuo, Mei-Chuan; Lee, Jia-Jung; Chiu, Yi-Wen; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun			Association of Dyslipidemia with Renal Outcomes in Chronic Kidney Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; FIBRONECTIN PRODUCTION; REVERSE EPIDEMIOLOGY; BLOOD-PRESSURE; CHOLESTEROL; DYSFUNCTION; PROGRESSION; PRAVASTATIN; RISK	Dyslipidemia is highly prevalent in patients with chronic kidney disease (CKD) and the relationship between dyslipidemia with renal outcomes in patients with moderate to advanced CKD remains controversial. Hence, our objective is to determine whether dyslipidemia is independently associated with rapid renal progression and progression to renal replacement therapy (RRT) in CKD patients. The study analyzed the association between lipid profile, RRT, and rapid renal progression (estimated glomerular filtration rate [eGFR] slope <-6 ml/min/1.73 m(2)/yr) in 3303 patients with stages 3 to 5 CKD. During a median 2.8-year follow-up, 1080 (32.3%) participants commenced RRT and 841 (25.5%) had rapid renal progression. In the adjusted models, the lowest quintile (hazard ratios [HR], 1.23; 95% confidence interval [Cl], 1.01 to 1.49) and the highest two quintiles of total cholesterol (HR, 1.25; 95% Cl, 1.02 to 1.52 and HR, 1.35; 95% Cl, 1.11 to 1.65 respectively) increased risks for RRT (vs. quintile 2). Besides, the highest quintile of total cholesterol was independently associated with rapid renal progression (odds ratio, 1.36; 95% Cl, 1.01 to 1.83). Our study demonstrated that certain levels of dyslipidemia were independently associated with RRT and rapid renal progression in CKD stage 3-5. Assessment of lipid profile may help identify high risk groups with adverse renal outcomes.	[Chen, Szu-Chia; Hung, Chi-Chih; Kuo, Mei-Chuan; Lee, Jia-Jung; Chiu, Yi-Wen; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Div Nephrol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chen, Szu-Chia; Chang, Jer-Ming] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung Municipal Hsiao Kang Hosp, Kaohsiung, Taiwan; [Kuo, Mei-Chuan; Chiu, Yi-Wen; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan; [Chen, Szu-Chia; Hung, Chi-Chih; Lee, Jia-Jung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chang, JM (corresponding author), Kaohsiung Med Univ, Div Nephrol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.	jemich@kmu.edu.tw	蘇, 河名/AAE-9843-2019					Abrass CK, 2004, AM J NEPHROL, V24, P46, DOI 10.1159/000075925; Atthobari J, 2006, NEPHROL DIAL TRANSPL, V21, P3106, DOI 10.1093/ndt/gfl244; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Chawla V, 2010, CLIN J AM SOC NEPHRO, V5, P1582, DOI 10.2215/CJN.01450210; Chen HC, 2002, KIDNEY BLOOD PRESS R, V25, P2, DOI 10.1159/000049428; Chen HC, 2002, ATHEROSCLEROSIS, V160, P141, DOI 10.1016/S0021-9150(01)00545-7; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P2750, DOI 10.2215/CJN.04660511; Chen SC, 2011, HYPERTENS RES, V34, P1052, DOI 10.1038/hr.2011.95; Contreras G, 2010, J AM SOC NEPHROL, V21, P2131, DOI 10.1681/ASN.2009121285; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hattori M, 1999, KIDNEY INT, V56, pS47, DOI 10.1046/j.1523-1755.1999.07112.x; Hovind P, 2001, KIDNEY INT, V60, P277, DOI 10.1046/j.1523-1755.2001.00797.x; Iseki K, 2002, KIDNEY INT, V61, P1887, DOI 10.1046/j.1523-1755.2002.00324.x; Kopple JD, 2005, AM J CLIN NUTR, V81, P1257; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin NW, 2007, SEMIN DIALYSIS, V20, P586, DOI 10.1111/j.1525-139X.2007.00366.x; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nakamura T, 2001, AM J NEPHROL, V21, P449, DOI 10.1159/000046648; Panichi V, 2001, RENAL FAILURE, V23, P551, DOI 10.1081/JDI-100104737; Rahman M, 2008, AM J KIDNEY DIS, V52, P412, DOI 10.1053/j.ajkd.2008.05.027; ROVIN BH, 1993, KIDNEY INT, V43, P218, DOI 10.1038/ki.1993.35; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Schaeffner ES, 2003, J AM SOC NEPHROL, V14, P2084, DOI 10.1681/ASN.V1482084; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Vaziri ND, 2006, INT J HAEMODIALYSIS, V10, P1; Vaziri ND, 2011, BLOOD PURIFICAT, V31, P189, DOI 10.1159/000321845; Vazquez-Perez S, 2001, NEPHROL DIAL TRANSPL, V16, P40, DOI 10.1093/ndt/16.suppl_1.40	31	27	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55643	10.1371/journal.pone.0055643	http://dx.doi.org/10.1371/journal.pone.0055643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390545	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100061
J	Martirosyan, A; Ohne, Y; Degos, C; Gorvel, L; Moriyon, I; Oh, S; Gorvel, JP				Martirosyan, Anna; Ohne, Yoichiro; Degos, Clara; Gorvel, Laurent; Moriyon, Ignacio; Oh, Sangkon; Gorvel, Jean-Pierre			Lipopolysaccharides with Acylation Defects Potentiate TLR4 Signaling and Shape T Cell Responses	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; DENDRITIC CELLS; LYMPH-NODES; IMMUNITY; ANTIGEN; SUBSETS; RECOGNITION; TOLERANCE; INFECTION; ENDOTOXIN	Lipopolysaccharides or endotoxins are components of Gram-negative enterobacteria that cause septic shock in mammals. However, a LPS carrying hexa-acyl lipid A moieties is highly endotoxic compared to a tetra-acyl LPS and the latter has been considered as an antagonist of hexa-acyl LPS-mediated TLR4 signaling. We investigated the relationship between the structure and the function of bacterial LPS in the context of human and mouse dendritic cell activation. Strikingly, LPS with acylation defects were capable of triggering a strong and early TLR4-dependent DC activation, which in turn led to the activation of the proteasome machinery dampening the pro-inflammatory cytokine secretion. Upon activation with tetraacyl LPS both mouse and human dendritic cells triggered CD4(+) T and CD8(+) T cell responses and, importantly, human myeloid dendritic cells favored the induction of regulatory T cells. Altogether, our data suggest that LPS acylation controlled by pathogenic bacteria might be an important strategy to subvert adaptive immunity.	[Martirosyan, Anna; Degos, Clara; Gorvel, Laurent; Gorvel, Jean-Pierre] Aix Marseille Univ UM 2, Ctr Immunol Marseille Luminy, Marseille, France; [Martirosyan, Anna; Degos, Clara; Gorvel, Laurent; Gorvel, Jean-Pierre] INSERM, U1104, F-13258 Marseille, France; [Martirosyan, Anna; Degos, Clara; Gorvel, Laurent; Gorvel, Jean-Pierre] CNRS, UMR 7280, Marseille, France; [Ohne, Yoichiro; Oh, Sangkon] Baylor Inst Immunol Res, Dallas, TX USA; [Moriyon, Ignacio] Univ Navarra, Inst Trop Hlth, E-31080 Pamplona, Spain; [Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Baylor Scott & White Health; University of Navarra; University of Navarra	Gorvel, JP (corresponding author), Aix Marseille Univ UM 2, Ctr Immunol Marseille Luminy, Marseille, France.	gorvel@ciml.univ-mrs.fr	Gorvel, Jean-Pierre/O-1332-2018; GORVEL, Laurent/AAB-1749-2020; Ohne, Yoichiro/AGE-6061-2022; Moriyon, Ignacio/N-4764-2016	Gorvel, Jean-Pierre/0000-0002-2829-9804; GORVEL, Laurent/0000-0001-7526-261X; Moriyon, Ignacio/0000-0002-4288-0195; Degos, Clara/0000-0002-1359-1669	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale, France; Foundation de la Recherche Medicale (FRM), France; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [U19 AI057234]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Foundation de la Recherche Medicale (FRM), France; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale, France. AM was a recipient of the Foundation de la Recherche Medicale (FRM), France. This work was also supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) - U19 AI057234. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Backhed F, 2003, MICROBES INFECT, V5, P1057, DOI 10.1016/S1286-4579(03)00207-7; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lapaque N, 2006, CELL MICROBIOL, V8, P401, DOI 10.1111/j.1462-5822.2005.00629.x; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Mills KHG, 2004, SEMIN IMMUNOL, V16, P107, DOI 10.1016/j.smim.2003.12.006; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Pierre P, 2009, CURR OPIN IMMUNOL, V21, P70, DOI 10.1016/j.coi.2009.03.003; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Seydel U, 2003, EUR J IMMUNOL, V33, P1586, DOI 10.1002/eji.200323649; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343	34	13	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55117	10.1371/journal.pone.0055117	http://dx.doi.org/10.1371/journal.pone.0055117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390517	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100033
J	Massoner, P; Kugler, KG; Unterberger, K; Kuner, R; Mueller, LAJ; Falth, M; Schafer, G; Seifarth, C; Ecker, S; Verdorfer, I; Graber, A; Sultmann, H; Klocker, H				Massoner, Petra; Kugler, Karl G.; Unterberger, Karin; Kuner, Ruprecht; Mueller, Laurin A. J.; Faelth, Maria; Schaefer, Georg; Seifarth, Christof; Ecker, Simone; Verdorfer, Irmgard; Graber, Armin; Sueltmann, Holger; Klocker, Helmut			Characterization of Transcriptional Changes in ERG Rearrangement-Positive Prostate Cancer Identifies the Regulation of Metabolic Sensors Such as Neuropeptide Y	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; ANDROGEN RECEPTOR; MICROARRAY DATA; CELL-LINES; FUSION; TMPRSS2; PROGRESSION; MODEL; METAANALYSIS; ABERRATIONS	ERG gene rearrangements are found in about one half of all prostate cancers. Functional analyses do not fully explain the selective pressure causing ERG rearrangement during the development of prostate cancer. To identify transcriptional changes in prostate cancer, including tumors with ERG gene rearrangements, we performed a meta-analysis on published gene expression data followed by validations on mRNA and protein levels as well as first functional investigations. Eight expression studies (n = 561) on human prostate tissues were included in the meta-analysis. Transcriptional changes between prostate cancer and non-cancerous prostate, as well as ERG rearrangement-positive (ERG+) and ERG rearrangement-negative (ERG-) prostate cancer, were analyzed. Detailed results can be accessed through an online database. We validated our meta-analysis using data from our own independent microarray study (n = 57). 84% and 49% (fold-change>2 and >1.5, respectively) of all transcriptional changes between ERG+ and ERG- prostate cancer determined by meta-analysis were verified in the validation study. Selected targets were confirmed by immunohistochemistry: NPY and PLA2G7 (up-regulated in ERG+ cancers), and AZGP1 and TFF3 (down-regulated in ERG+ cancers). First functional investigations for one of the most prominent ERG rearrangement-associated genes - neuropeptide Y (NPY) - revealed increased glucose uptake in vitro indicating the potential role of NPY in regulating cellular metabolism. In summary, we found robust population-independent transcriptional changes in prostate cancer and first signs of ERG rearrangements inducing metabolic changes in cancer cells by activating major metabolic signaling molecules like NPY. Our study indicates that metabolic changes possibly contribute to the selective pressure favoring ERG rearrangements in prostate cancer.	[Massoner, Petra; Schaefer, Georg; Seifarth, Christof; Klocker, Helmut] Med Univ Innsbruck, Div Expt Urol, Dept Urol, A-6020 Innsbruck, Austria; [Massoner, Petra; Unterberger, Karin; Klocker, Helmut] Ctr Personalized Canc Med GmbH, Oncotyrol, Innsbruck, Austria; [Kugler, Karl G.; Mueller, Laurin A. J.; Ecker, Simone; Graber, Armin] Univ Hlth Sci Med Informat & Technol UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria; [Kuner, Ruprecht; Faelth, Maria; Sueltmann, Holger] German Canc Res Ctr, Unit Canc Genome Res, Div Mol Genet, Heidelberg, Germany; [Kuner, Ruprecht; Faelth, Maria; Sueltmann, Holger] Natl Ctr Tumor Dis, Heidelberg, Germany; [Verdorfer, Irmgard] Med Univ Innsbruck, Div Human Genet, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Medical University of Innsbruck	Massoner, P (corresponding author), Med Univ Innsbruck, Div Expt Urol, Dept Urol, A-6020 Innsbruck, Austria.	Petra.Massoner@i.med.ac.at; Helmut.Klocker@uki.at	Kugler, Karl G/B-8406-2015; Ecker, Simone/W-8200-2019; Sültmann, Holger/E-4534-2013; Klocker, Helmut/AAI-7130-2020	Kugler, Karl G/0000-0003-2342-7472; Ecker, Simone/0000-0001-5648-1710; Sültmann, Holger/0000-0002-5257-8600; 	Comet Center Oncotyrol [3.1]; Autonomous Province of Bolzano, South Tyrol [37/40.3]; Austrian Science Fund FWF [J3201]; Tyrolean Research Fund; Oncotyrol GmbH	Comet Center Oncotyrol; Autonomous Province of Bolzano, South Tyrol; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Tyrolean Research Fund; Oncotyrol GmbH	The authors acknowledge financial support from Comet Center Oncotyrol (Project 3.1), the Autonomous Province of Bolzano, South Tyrol, (Grant 37/40.3), the Austrian Science Fund FWF (Grant J3201), and the Tyrolean Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: after discussing with Oncotyrol, Center for Personalized Cancer Medicine GmbH, the authors would like to disclose the following: PM, KU and HK conducted this work as employees/associates of Oncotyrol GmbH. The work to this project was co-funded by Oncotyrol GmbH in the context of the Austrian COMET funding program. Oncotyrol GmbH does not plan to file a patent or commercially pursue the results contained in this manuscript. Consequently no competing interest could be identified in the context of the described work. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Bartsch G, 2008, BJU INT, V101, P809, DOI 10.1111/j.1464-410X.2008.07502.x; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bermudo R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-315; Bondar OP, 2007, CLIN CHEM, V53, P673, DOI 10.1373/clinchem.2006.079681; Boormans JL, 2011, EUR UROL, V60, P183, DOI 10.1016/j.eururo.2011.03.028; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; Bu H, 2010, PROSTATE; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Descazeaud A, 2006, PROSTATE, V66, P1037, DOI 10.1002/pros.20405; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gopalan A, 2009, CANCER RES, V69, P1400, DOI 10.1158/0008-5472.CAN-08-2467; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hirsch D, 2012, CELL MOL NEUROBIOL, V32, P645, DOI 10.1007/s10571-011-9793-z; Jiang Z, 2004, AM J CLIN PATHOL, V122, P275, DOI 10.1309/EJUYUQPEX1MG68MK; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kosari F, 2002, CANCER EPIDEM BIOMAR, V11, P1419; Kugler KG, 2010, SOURCE CODE BIOL MED, V5, DOI 10.1186/1751-0473-5-3; Kuner R, 2012, J MOL MED BERL; Lapointe J, 2007, MODERN PATHOL, V20, P467, DOI 10.1038/modpathol.3800759; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Magee JA, 2001, CANCER RES, V61, P5692; Massoner P, 2011, AM J PATHOL, V179, P2905, DOI 10.1016/j.ajpath.2011.08.026; Mehra R, 2008, CANCER RES, V68, P3584, DOI 10.1158/0008-5472.CAN-07-6154; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Nagakawa O, 2001, INT J UROL, V8, P65, DOI 10.1046/j.1442-2042.2001.00250.x; Nagakawa O, 1998, CANCER LETT, V133, P27, DOI 10.1016/S0304-3835(98)00186-4; Nam RK, 2007, BRIT J CANCER, V97, P1690, DOI 10.1038/sj.bjc.6604054; Paland N, 2009, MOL CANCER RES, V7, P1212, DOI 10.1158/1541-7786.MCR-09-0073; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; Rhodes DR, 2002, CANCER RES, V62, P4427; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rickman DS, 2010, NEOPLASIA, V12, P1031, DOI 10.1593/neo.10866; Rodriguez J C, 2000, Int J Surg Investig, V2, P319; Romualdi C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-287; Ruscica M, 2006, ENDOCRINOLOGY, V147, P1466, DOI 10.1210/en.2005-0925; Saramaki OR, 2008, CLIN CANCER RES, V14, P3395, DOI 10.1158/1078-0432.CCR-07-2051; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi YC, 2012, BONE, V50, P430, DOI 10.1016/j.bone.2011.10.001; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2009, EUR UROL; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tsavachidou D, 2009, JNCI-J NATL CANCER I, V101, P306, DOI 10.1093/jnci/djn512; Tu JJ, 2007, MODERN PATHOL, V20, P921, DOI 10.1038/modpathol.3800903; Vainio P, 2011, AM J PATHOL, V178, P525, DOI 10.1016/j.ajpath.2010.10.002; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Vestergaard EM, 2006, CLIN CANCER RES, V12, P807, DOI 10.1158/1078-0432.CCR-05-1545; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Walther C, 2011, J PEPT SCI, V17, P233, DOI 10.1002/psc.1357; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang YP, 2010, CANCER RES, V70, P6448, DOI 10.1158/0008-5472.CAN-10-0021; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011; Zhang SXD, 1998, J UROLOGY, V159, P548, DOI 10.1016/S0022-5347(01)63981-8	75	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55207	10.1371/journal.pone.0055207	http://dx.doi.org/10.1371/journal.pone.0055207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390522	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100038
J	van den Brand, BT; Vermeij, EA; Waterborg, CEJ; Arntz, OJ; Kracht, M; Bennink, MB; van den Berg, WB; van de Loo, FAJ				van den Brand, Ben T.; Vermeij, Eline A.; Waterborg, Claire E. J.; Arntz, Onno J.; Kracht, Michael; Bennink, Miranda B.; van den Berg, Wim B.; van de Loo, Fons A. J.			Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+and Ly-6C+Cells in Spleen, Important Target Cells in Autoimmune Arthritis	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; IN-VIVO; IMMUNE-RESPONSE; DEFICIENT MICE; GENE DELIVERY; TH17 CELLS; EXPRESSION; HEPATOCYTES; TRANSGENE; ANTAGONIST	Antigen presenting cells (APCs) play an important role in arthritis and APC specific gene therapeutic targeting will enable intracellular modulation of cell activity. Viral mediated overexpression is a potent approach to achieve adequate transgene expression levels and lentivirus (LV) is useful for sustained expression in target cells. Therefore, we studied the feasibility of lentiviral mediated targeting of APCs in experimental arthritis. Third generation VSV-G pseudotyped self-inactivating (SIN)-LV were injected intravenously and spleen cells were analyzed with flow cytometry for green fluorescent protein (GFP) transgene expression and cell surface markers. Collagen-induced arthritis (CIA) was induced by immunization with bovine collagen type II in complete Freund's adjuvant. Effect on inflammation was monitored macroscopically and T-cell subsets in spleen were analyzed by flow cytometry. Synovium from arthritic knee joints were analyzed for proinflammatory cytokine expression. Lentiviruses injected via the tail vein preferentially infected the spleen and transduction peaks at day 10. A dose escalating study showed that 8% of all spleen cells were targeted and further analysis showed that predominantly Ly6C+ and F4/80+ cells in spleen were targeted by the LV. To study the feasibility of blocking TAK1-dependent pathways by this approach, a catalytically inactive mutant of TAK1 (TAK1-K63W) was overexpressed during CIA. LV-TAK1-K63W significantly reduced incidence and arthritis severity macroscopically. Further histological analysis showed a significant decrease in bone erosion in LV-TAK1-K63W treated animals. Moreover, systemic Th17 levels were decreased by LV-TAK1-K63W treatment in addition to diminished IL-6 and KC production in inflamed synovium. In conclusion, systemically delivered LV efficiently targets monocytes and macrophages in spleen that are involved in autoimmune arthritis. Moreover, this study confirms efficacy of TAK1 targeting in arthritis. This approach may provide a valuable tool in targeting splenic APCs, to unravel their role in autoimmune arthritis and to identify and validate APC specific therapeutic targets.	[van den Brand, Ben T.; Vermeij, Eline A.; Waterborg, Claire E. J.; Arntz, Onno J.; Bennink, Miranda B.; van den Berg, Wim B.; van de Loo, Fons A. J.] Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35390 Giessen, Germany	Radboud University Nijmegen; Justus Liebig University Giessen	van de Loo, FAJ (corresponding author), Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	a.vandeloo@reuma.umcn.nl	Arntz, Onno J/A-2354-2016; van de Loo, Fons AJ/A-3425-2014; Waterborg, Claire/P-9245-2015; van den Berg, W.B./H-8010-2014	Arntz, Onno J/0000-0001-7064-6067; van de Loo, Fons AJ/0000-0002-5851-099X; Kracht, Michael/0000-0002-8501-043X	Top Institute Pharma [D1-101]; VIDI grant from the Netherlands Organization for Scientific Research [917.46.363]; Dutch Arthritis Association [RF 11-1-409]	Top Institute Pharma; VIDI grant from the Netherlands Organization for Scientific Research; Dutch Arthritis Association	This work was supported by: Top Institute Pharma, project D1-101; VIDI grant (917.46.363) from the Netherlands Organization for Scientific Research; and Dutch Arthritis Association (RF 11-1-409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Anderson R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3089; Annoni A, 2007, BLOOD, V110, P1788, DOI 10.1182/blood-2006-11-059873; Arce F, 2009, MOL THER, V17, P1643, DOI 10.1038/mt.2009.149; Arntz OJ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2974; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Courties G, 2010, BLOOD, V116, P3505, DOI 10.1182/blood-2010-02-269605; de Vries TJ, 2009, J LEUKOCYTE BIOL, V85, P919, DOI 10.1189/jlb.0708402; Dimitrova P, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3926; Eftychi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031550; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Gjertsson I, 2009, MOL THER, V17, P632, DOI 10.1038/mt.2009.299; Hofkens W, 2011, J CONTROL RELEASE, V152, P363, DOI 10.1016/j.jconrel.2011.03.001; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kimura T, 2007, MOL THER, V15, P1390, DOI 10.1038/sj.mt.6300180; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; van Lent PLEM, 2009, INT J RADIAT BIOL, V85, P860, DOI [10.3109/09553000903072454, 10.1080/09553000903072454]; VandenDriessche T, 2002, BLOOD, V100, P813, DOI 10.1182/blood.V100.3.813; Veenbergen S, 2008, ARTHRITIS RHEUM-US, V58, P3742, DOI 10.1002/art.24072	25	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55356	10.1371/journal.pone.0055356	http://dx.doi.org/10.1371/journal.pone.0055356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390530	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100046
J	Wang, X; Liu, DM; Li, AL; Sun, XL; Zhang, RZ; Wu, L; Liang, YC; Mao, L				Wang, Xiang; Liu, Danmei; Li, Aili; Sun, Xiuli; Zhang, Rongzhi; Wu, Liang; Liang, Yanchun; Mao, Long			Transcriptome Analysis of Tomato Flower Pedicel Tissues Reveals Abscission Zone-Specific Modulation of Key Meristem Activity Genes	PLOS ONE			English	Article							FLORAL ORGAN ABSCISSION; CELL-SEPARATION; ARABIDOPSIS; ETHYLENE; EXPRESSION; JOINTLESS; ENCODES; DEHISCENCE; IDENTITY; LEAVES	Tomato flower abscises at the anatomically distinct abscission zone that separates the pedicel into basal and apical portions. During abscission, cell separation occurs only at the abscission zone indicating distinctive molecular regulation in its cells. We conducted a transcriptome analysis of tomato pedicel tissues during ethylene promoted abscission. We found that the abscission zone was the most active site with the largest set of differentially expressed genes when compared with basal and apical portions. Gene Ontology analyses revealed enriched transcription regulation and hydrolase activities in the abscission zone. We also demonstrate coordinated responses of hormone and cell wall related genes. Besides, a number of ESTs representing homologs of key Arabidopsis shoot apical meristem activity genes were found to be preferentially expressed in the abscission zone, including WUSCHEL (WUS), KNAT6, LATERAL ORGAN BOUNDARIES DOMAIN PROTEIN 1(LBD1), and BELL-like homeodomain protein 1 (BLH1), as well as tomato axillary meristem genes BLIND (Bl) and LATERAL SUPPRESSOR (Ls). More interestingly, the homologs of WUS and the potential functional partner OVATE FAMILIY PROTEIN (OFP) were subsequently down regulated during abscission while Bl and AGL12 were continuously and specifically induced in the abscission zone. The expression patterns of meristem activity genes corroborate the idea that cells of the abscission zone confer meristem-like nature and coincide with the course of abscission and post-abscission cell differentiation. Our data therefore propose a possible regulatory scheme in tomato involving meristem genes that may be required not only for the abscission zone development, but also for abscission.	[Wang, Xiang] Henan Agr Univ, Natl Ctr Wheat Res, Zhengzhou, Peoples R China; [Wang, Xiang; Liu, Danmei; Li, Aili; Sun, Xiuli; Zhang, Rongzhi; Wu, Liang; Mao, Long] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Germplasm & Biotechnol, Beijing 100193, Peoples R China; [Sun, Xiuli; Liang, Yanchun] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Henan Agricultural University; Chinese Academy of Agricultural Sciences; Jilin University	Mao, L (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Germplasm & Biotechnol, Beijing 100193, Peoples R China.	maolong@caas.net.cn			Natural Science Foundation of China [31070260]; National Transgenic Key project of MOA of China [2013ZX08009-001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Key project of MOA of China	This work is supported in part by Natural Science Foundation of China (number 31070260) and National Transgenic Key project of MOA of China (number 2013ZX08009-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; Addicott F.T, 1982, ABSCISSION; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder B. M., 2009, Stewart Postharvest Review, V5, P1, DOI 10.2212/spr.2009.1.1; Bleecker AB, 1997, PLANT CELL, V9, P1169, DOI 10.1105/tpc.9.7.1169; Butenko MA, 2012, PLANT SIGNAL BEHAV, V7, P135, DOI 10.4161/psb.7.1.18379; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; delCampillo E, 1996, PLANT PHYSIOL, V111, P813, DOI 10.1104/pp.111.3.813; GAWADI AG, 1950, AM J BOT, V37, P172, DOI 10.2307/2437968; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Hamant O, 2010, CR BIOL, V333, P371, DOI 10.1016/j.crvi.2010.01.015; Hong SB, 2000, PLANT PHYSIOL, V123, P869, DOI 10.1104/pp.123.3.869; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACKSON MB, 1970, NATURE, V225, P1019, DOI 10.1038/2251019a0; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; LASHBROOK CC, 1994, PLANT CELL, V6, P1485, DOI 10.1105/tpc.6.10.1485; Lee J, 2007, PLANT MOL BIOL, V65, P487, DOI 10.1007/s11103-007-9196-1; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; McManus MT, 2008, ANN BOT-LONDON, V101, P285, DOI 10.1093/aob/mcm269; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Muller D, 2006, PLANT CELL, V18, P586, DOI 10.1105/tpc.105.038745; Nakano T, 2012, PLANT PHYSIOL, V158, P439, DOI 10.1104/pp.111.183731; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OSBORNE DJ, 1989, CRIT REV PLANT SCI, V8, P103, DOI 10.1080/07352688909382272; OSBORNE DJ, 1976, PLANTA, V132, P197, DOI 10.1007/BF00388903; Osborne DJ, 2005, HORMONES SIGNALS TAR; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Patterson SE, 2001, PLANT PHYSIOL, V126, P494, DOI 10.1104/pp.126.2.494; Preston JC, 2010, PLANT J, V62, P704, DOI 10.1111/j.1365-313X.2010.04184.x; Quinet M, 2011, PHYSIOL PLANTARUM, V141, P166, DOI 10.1111/j.1399-3054.2010.01426.x; ROBERTS JA, 1984, PLANTA, V160, P159, DOI 10.1007/BF00392864; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Rolland-Lagan AG, 2008, CURR OPIN GENET DEV, V18, P348, DOI 10.1016/j.gde.2008.05.002; Rossini L, 2006, THEOR APPL GENET, V112, P1073, DOI 10.1007/s00122-006-0209-2; Rutjens B, 2009, PLANT J, V58, P641, DOI 10.1111/j.1365-313X.2009.03809.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Szymkowiak EJ, 2006, PLANTA, V223, P646, DOI 10.1007/s00425-005-0115-x; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; van Nocker S, 2007, PLANT REV; van Nocker SJSPR., 2009, STEWART POSTHARVEST, V5, P5, DOI DOI 10.2212/SPR.2009.1.5; Wang XQ, 2006, J INTEGR PLANT BIOL, V48, P15, DOI 10.1111/j.1744-7909.2005.00085.x-i1; Yang TJ, 2005, CHROMOSOMA, V114, P103, DOI 10.1007/s00412-005-0342-8; Zenoni S, 2011, NEW PHYTOL, V191, P662, DOI 10.1111/j.1469-8137.2011.03726.x	60	47	47	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55238	10.1371/journal.pone.0055238	http://dx.doi.org/10.1371/journal.pone.0055238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390523	Green Submitted, gold, Green Published			2022-12-27	WOS:000314691100039
J	Xi, JF; Zhu, HH; Liu, DQ; Nan, X; Zheng, W; Liu, KY; Shi, W; Chen, L; Lv, Y; Yan, F; Li, YH; Xie, XY; Wang, YF; Yue, W; Xu, X; Wei, XF; Zhu, J; Huang, XJ; Pei, XT				Xi, Jiafei; Zhu, Honghu; Liu, Daqing; Nan, Xue; Zheng, Wen; Liu, Kaiyan; Shi, Wei; Chen, Lin; Lv, Yang; Yan, Fang; Li, Yanhua; Xie, Xiaoyan; Wang, Yunfang; Yue, Wen; Xu, Xin; Wei, Xiaofei; Zhu, Jun; Huang, Xiaojun; Pei, Xuetao			Infusion of Megakaryocytic Progenitor Products Generated from Cord Blood Hematopoietic Stem/Progenitor Cells: Results of the Phase 1 Study	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EX-VIVO EXPANSION; IN-VITRO; HUMAN PLATELETS; TRANSPLANTATION; CHEMOTHERAPY	Background: Currently, a constant shortage in the supply of platelets has become an important medical and society challenge, especially in developing country, and the in vitro production of megakaryocytic progenitor cells (MPs) from cord blood could represent an effective platelet substitute. In the present study, our objective was to determine the safety and feasibility of ex vivo generated MPs in patients. Methods and Findings: MPs were produced and characterized from cord blood mononuclear cells under a serum free medium with cytokines. We investigated the feasibility of expansion and infusion of cord blood-derived MPs in 24 patients with advanced hematological malignancyes. The primary end point was the safety and tolerability of the infusion of cord blood-derived MPs. No adverse effects were observed in patients who received ex vivo-generated cells at concentrations of up to a median value of 5.45x10(6) cells/kg of body weight. With one year follow-up, acute and chronic GVHD had not been observed among patients who received MPs infusion, even without ABO blood group and HLA typing matching. Conclusions: These initial results in patients are very encouraging. They suggest that infusion of cord blood-derived MPs appears safe and feasible for treatment of thrombocytopenia.	[Xi, Jiafei; Liu, Daqing; Nan, Xue; Shi, Wei; Chen, Lin; Lv, Yang; Yan, Fang; Li, Yanhua; Xie, Xiaoyan; Wang, Yunfang; Yue, Wen; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China; [Zhu, Honghu; Liu, Kaiyan; Huang, Xiaojun] Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100871, Peoples R China; [Zheng, Wen; Zhu, Jun] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China; [Liu, Kaiyan; Xu, Xin; Wei, Xiaofei] Beijing Cord Blood Bank, Beijing, Peoples R China	Peking University; Peking University	Liu, KY (corresponding author), Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100871, Peoples R China.	liukaiyan@medmail.com.cn; xxu@chinacord.org; xfwei@chinacord.org	Huang, Xiao-Jun/HIK-3759-2022	Huang, Xiao-Jun/0000-0002-2145-6643; Xi, Jiafei/0000-0001-9751-2974	National High Technology Research and Development Program of China [2011AA020109, 2011AA020105]; Major State Basic Research Program of China [2011CB964804]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National High Technology Research and Development Program of China (Grant Nos: 2011AA020109 and 2011AA020105), the Major State Basic Research Program of China (Grant No: 2011CB964804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghideh AN, 2010, GROWTH FACTORS, V28, P409, DOI 10.3109/08977194.2010.504722; Barker JN, 2003, NAT REV CANCER, V3, P526, DOI 10.1038/nrc1125; Barker JN, 2002, CURR OPIN ONCOL, V14, P160, DOI 10.1097/00001622-200203000-00004; Bertolini F, 1997, BLOOD, V89, P2679, DOI 10.1182/blood.V89.8.2679; Chen TW, 2009, EXP HEMATOL, V37, P1330, DOI 10.1016/j.exphem.2009.07.012; De Bruyn C, 2005, STEM CELLS DEV, V14, P415, DOI 10.1089/scd.2005.14.415; Decaudin D, 2004, BONE MARROW TRANSPL, V34, P1089, DOI 10.1038/sj.bmt.1704675; Gekas C, 2010, J EXP MED, V207, P2781, DOI 10.1084/jem.20102428; Kishore V, 2011, J BIOMED MATER RES A, V96A, P682, DOI 10.1002/jbm.a.33024; Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8; Matsunaga T, 2006, STEM CELLS, V24, P2877, DOI 10.1634/stemcells.2006-0309; McNiece I, 2000, BLOOD, V96, P3001; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Pineault N, 2011, CYTOTHERAPY, V13, P467, DOI 10.3109/14653249.2010.530651; Poirault-Chassac S, 2010, BLOOD, V116, P5670, DOI 10.1182/blood-2010-05-285957; Reems JA, 2010, TRANSFUS MED REV, V24, P33, DOI 10.1016/j.tmrv.2009.09.003; Reiffers J, 1999, LANCET, V354, P1092, DOI 10.1016/S0140-6736(99)03113-X; Scheding S, 2004, HAEMATOLOGICA, V89, P630; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844	20	24	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54941	10.1371/journal.pone.0054941	http://dx.doi.org/10.1371/journal.pone.0054941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390507	Green Submitted, gold, Green Published			2022-12-27	WOS:000314691100023
J	Dreifuss, AA; Bastos-Pereira, AL; Fabossi, IA; Livero, FAD; Stolf, AM; de Souza, CEA; Gomes, LD; Constantin, RP; Furman, AEF; Strapasson, RLB; Teixeira, S; Zampronio, AR; Muscara, MN; Stefanello, MEA; Acco, A				Dreifuss, Arturo Alejandro; Bastos-Pereira, Amanda Leite; Fabossi, Isabella Aviles; dos Reis Livero, Francislaine Aparecida; Stolf, Aline Maria; Alves de Souza, Carlos Eduardo; Gomes, Liana de Oliveira; Constantin, Rodrigo Polimeni; Ferreira Furman, Aline Emmer; Batista Strapasson, Regiane Lauriano; Teixeira, Simone; Zampronio, Aleksander Roberto; Muscara, Marcelo Nicolas; Alves Stefanello, Maria Elida; Acco, Alexandra			Uncaria tomentosa Exerts Extensive Anti-Neoplastic Effects against the Walker-256 Tumour by Modulating Oxidative Stress and Not by Alkaloid Activity	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; QUINOVIC ACID GLYCOSIDES; UNA-DE-GATO; NF-KAPPA-B; OXINDOLE ALKALOIDS; CATS CLAW; ANTIINFLAMMATORY ACTIVITY; BEARING RATS; CANCER CACHEXIA; LEUKEMIA-CELLS	This study aimed to compare the anti-neoplastic effects of an Uncaria tomentosa (UT) brute hydroethanolic (BHE) extract with those of two fractions derived from it. These fractions are choroformic (CHCl3) and n-butanolic (BuOH), rich in pentacyclic oxindole alkaloids (POA) and antioxidant substances, respectively. The cancer model was the subcutaneous inoculation of Walker-256 tumour cells in the pelvic limb of male Wistar rat. Subsequently to the inoculation, gavage with BHE extract (50 mg.kg(-1)) or its fractions (as per the yield of the fractioning process) or vehicle (Control) was performed during 14 days. Baseline values, corresponding to individuals without tumour or treatment with UT, were also included. After treatment, tumour volume and mass, plasma biochemistry, oxidative stress in liver and tumour, TNF-alpha level in liver and tumour homogenates, and survival rates were analysed. Both the BHE extract and its BuOH fraction successfully reduced tumour weight and volume, and modulated anti-oxidant systems. The hepatic TNF-alpha level indicated a greater effect from the BHE extract as compared to its BuOH fraction. Importantly, both the BHE extract and its BuOH fraction increased the survival time of the tumour-bearing animals. Inversely, the CHCl3 fraction was ineffective. These data represent an in vivo demonstration of the importance of the modulation of oxidative stress as part of the anti-neoplastic activity of UT, as well as constitute evidence of the lack of activity of isolated POAs in the primary tumour of this tumour lineage. These effects are possibly resulting from a synergic combination of substances, most of them with antioxidant properties.	[Dreifuss, Arturo Alejandro; Bastos-Pereira, Amanda Leite; Fabossi, Isabella Aviles; dos Reis Livero, Francislaine Aparecida; Stolf, Aline Maria; Alves de Souza, Carlos Eduardo; Gomes, Liana de Oliveira; Zampronio, Aleksander Roberto; Acco, Alexandra] Univ Fed Parana, Dept Pharmacol, BR-80060000 Curitiba, Parana, Brazil; [Constantin, Rodrigo Polimeni] Univ Maringa, Dept Biochem, Maringa, Parana, Brazil; [Ferreira Furman, Aline Emmer] Univ Fed Parana, Training Lab, Dept Pharm, BR-80060000 Curitiba, Parana, Brazil; [Batista Strapasson, Regiane Lauriano; Alves Stefanello, Maria Elida] Univ Fed Parana, Dept Chem, BR-80060000 Curitiba, Parana, Brazil; [Teixeira, Simone; Muscara, Marcelo Nicolas] Univ Sao Paulo, Dept Pharmacol, BR-05508 Sao Paulo, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal do Parana; Universidade de Sao Paulo	Acco, A (corresponding author), Univ Fed Parana, Dept Pharmacol, BR-80060000 Curitiba, Parana, Brazil.	aleacco@ufpr.br	Muscará, Marcelo N/F-3250-2012; Acco, Alexandra/AAF-8826-2020; Bastos-Pereira, Amanda/AAQ-1375-2020; Constantin, Rodrigo P/A-4727-2016; Acco, Alexandra/K-1265-2014; Zampronio, Aleksander R/B-3915-2013; Lívero, Francislaine/AAG-6083-2019; Teixeira, Simone/K-3991-2016	Muscará, Marcelo N/0000-0002-8342-5586; Acco, Alexandra/0000-0003-3977-687X; Bastos-Pereira, Amanda/0000-0001-9416-1208; Acco, Alexandra/0000-0003-3977-687X; Lívero, Francislaine/0000-0001-6533-0850; Teixeira, Simone/0000-0002-8515-5030; Zampronio, Aleksander/0000-0002-8354-7081	REUNI/CAPES	REUNI/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to express their gratitude to Dr. Jose Luis Aguilar, from the Cayetano Heredia Peruvian University, Lima, Peru; Dr. Armando Rivero, from the National University of San Marcos, Lima, Peru; and Peruvian Heritage, S. A. C., for their generous contribution of all botanic material employed in this work. Also, all our appreciation goes to Prof. Dr. Luiz Claudio Fernandes, Federal University of Parana, for his kindness in providing us with the Walker-256 tumour cells. Finally, many thankful regards go to Jorgete Constantin, Aparecida Pinto Munhos Hermoso and Renato Polimeni Constantin, from the University of Maringa, Parana, Brazil, for their invaluable help during some experimental procedures. The authors acknowledge REUNI/CAPES for the Master degree fellowship supported to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acco A, 2007, BASIC CLIN PHARMACOL, V101, P294, DOI 10.1111/j.1742-7843.2007.00124.x; Aebi H, 1984, CATALASE IN VITRO; Aguilar JL, 2002, J ETHNOPHARMACOL, V81, P271, DOI 10.1016/S0378-8741(02)00093-4; Dreifuss AA, 2010, J ETHNOPHARMACOL, V130, P127, DOI 10.1016/j.jep.2010.04.029; Allen-Hall L, 2010, J ETHNOPHARMACOL, V127, P685, DOI 10.1016/j.jep.2009.12.004; Aquino R, 1997, PHYTOCHEMISTRY, V45, P1035, DOI 10.1016/S0031-9422(96)00716-9; AQUINO R, 1991, J NAT PROD, V54, P453, DOI 10.1021/np50074a016; AQUINO R, 1990, J NAT PROD, V53, P559, DOI 10.1021/np50069a004; Bacher N, 2006, BRIT J HAEMATOL, V132, P615, DOI 10.1111/j.1365-2141.2005.05907.x; Bastos-Pereira AL, 2010, CANCER CHEMOTH PHARM, V65, P267, DOI 10.1007/s00280-009-1031-8; Bechtel W, 2009, ANTICANCER RES, V29, P4541; Bechtel W, 2009, ANTICANCER RES, V29, P4559; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; CERRI R, 1988, J NAT PROD, V51, P257, DOI 10.1021/np50056a010; Chen Y, 1999, J AGR FOOD CHEM, V47, P2226, DOI 10.1021/jf990092f; Coelho I, 2012, LIPIDS, V47, P1031, DOI 10.1007/s11745-012-3715-9; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Martino L, 2006, J ETHNOPHARMACOL, V107, P91, DOI 10.1016/j.jep.2006.02.013; Jumes FMD, 2010, CAN J PHYSIOL PHARM, V88, P21, DOI 10.1139/Y09-111; Earle WR, 1934, AM J CANC, V24, P566; Folador A, 2009, NUTR CANCER, V61, P670, DOI 10.1080/01635580902825548; Ganzera M, 2001, PLANTA MED, V67, P447, DOI 10.1055/s-2001-15824; Gao RM, 1998, BIOELECTROCH BIOENER, V45, P41, DOI 10.1016/S0302-4598(98)00072-5; Prado EG, 2007, PHYTOMEDICINE, V14, P280, DOI 10.1016/j.phymed.2006.12.023; Gate L, 1999, BIOMED PHARMACOTHER, V53, P169, DOI 10.1016/S0753-3322(99)80086-9; Giboney PT, 2005, AM FAM PHYSICIAN, V71, P1105; Goncalves C, 2005, PHYTOCHEMISTRY, V66, P89, DOI 10.1016/j.phytochem.2004.10.025; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Heitzman ME, 2005, PHYTOCHEMISTRY, V66, P5, DOI 10.1016/j.phytochem.2004.10.022; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Kitajima Mariko, 2004, Chemical & Pharmaceutical Bulletin (Tokyo), V52, P1258, DOI 10.1248/cpb.52.1258; LAUS G, 1994, J CHROMATOGR A, V662, P243, DOI 10.1016/0021-9673(94)80511-3; Laus G, 1997, PHYTOCHEMISTRY, V45, P855, DOI 10.1016/S0031-9422(97)00061-7; Gurrola-Diaz CM, 2011, PHYTOMEDICINE, V18, P683, DOI 10.1016/j.phymed.2010.11.002; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miller M J, 2001, BMC Complement Altern Med, V1, P11, DOI 10.1186/1472-6882-1-11; Mizuno M, 1999, BIOCHEM MOL BIOL INT, V47, P707; Muhammad I, 2001, PHYTOCHEMISTRY, V57, P781, DOI 10.1016/S0031-9422(01)00043-7; Paniagua-Perez R, 2009, BASIC CLIN PHARMACOL, V104, P222, DOI 10.1111/j.1742-7843.2008.00366.x; Piffar PM, 2003, CANCER LETT, V201, P139, DOI 10.1016/S0304-3835(03)00472-5; Pilarski R, 2007, PHARMACOL REP, V59, P565; Pilarski R, 2010, PHYTOMEDICINE, V17, P1133, DOI 10.1016/j.phymed.2010.04.013; Portugal J, 2009, TUMORI J, V95, P409; Reinhard KH, 1999, J ALTERN COMPLEM MED, V5, P143, DOI 10.1089/acm.1999.5.143; Riva L, 2001, ANTICANCER RES, V21, P2457; RIZZI R, 1993, J ETHNOPHARMACOL, V38, P63, DOI 10.1016/0378-8741(93)90080-O; Sandoval M, 2000, FREE RADICAL BIO MED, V29, P71, DOI 10.1016/S0891-5849(00)00327-0; Sandoval-Chacon M, 1998, ALIMENT PHARM THER, V12, P1279, DOI 10.1046/j.1365-2036.1998.00424.x; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SEKI H, 1993, CHEM PHARM BULL, V41, P2077, DOI 10.1248/cpb.41.2077; Sheng YZ, 1998, ANTICANCER RES, V18, P3363; Sheng YZ, 2000, J ETHNOPHARMACOL, V69, P115, DOI 10.1016/S0378-8741(99)00070-7; Takayama H, 2005, CURR ORG CHEM, V9, P1445, DOI 10.2174/138527205774370559; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vicentino C, 2002, LIVER, V22, P342, DOI 10.1034/j.1600-0676.2002.01656.x; WAGNER H, 1985, PLANTA MED, V51, P419, DOI 10.1055/s-2007-969537; YAMAGUCHI Y, 1992, BIOCHEM BIOPH RES CO, V189, P1084, DOI 10.1016/0006-291X(92)92315-O; YASMINEH WG, 1991, CANCER RES, V51, P3990	61	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54618	10.1371/journal.pone.0054618	http://dx.doi.org/10.1371/journal.pone.0054618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408945	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200011
J	Hutson, CL; Gallardo-Romero, N; Carroll, DS; Clemmons, C; Salzer, JS; Nagy, T; Hughes, CM; Olson, VA; Karem, KL; Damon, IK				Hutson, Christina L.; Gallardo-Romero, Nadia; Carroll, Darin S.; Clemmons, Cody; Salzer, Johanna S.; Nagy, Tamas; Hughes, Christine M.; Olson, Victoria A.; Karem, Kevin L.; Damon, Inger K.			Transmissibility of the Monkeypox Virus Clades via Respiratory Transmission: Investigation Using the Prairie Dog-Monkeypox Virus Challenge System	PLOS ONE			English	Article							ANIMAL-MODEL; RISK-FACTORS; CONGO BASIN; DISEASE; INFECTION; PATHOLOGY; STRAINS; AFRICAN; HUMANS	Monkeypox virus (MPXV) is endemic within Africa where it sporadically is reported to cause outbreaks of human disease. In 2003, an outbreak of human MPXV occurred in the US after the importation of infected African rodents. Since the eradication of smallpox (caused by an orthopoxvirus (OPXV) related to MPXV) and cessation of routine smallpox vaccination (with the live OPXV vaccinia), there is an increasing population of people susceptible to OPXV diseases. Previous studies have shown that the prairie dog MPXV model is a functional animal model for the study of systemic human OPXV illness. Studies with this model have demonstrated that infected animals are able to transmit the virus to naive animals through multiple routes of exposure causing subsequent infection, but were not able to prove that infected animals could transmit the virus exclusively via the respiratory route. Herein we used the model system to evaluate the hypothesis that the Congo Basin clade of MPXV is more easily transmitted, via respiratory route, than the West African clade. Using a small number of test animals, we show that transmission of viruses from each of the MPXV clade was minimal via respiratory transmission. However, transmissibility of the Congo Basin clade was slightly greater than West African MXPV clade (16.7% and 0% respectively). Based on these findings, respiratory transmission appears to be less efficient than those of previous studies assessing contact as a mechanism of transmission within the prairie dog MPXV animal model.	[Hutson, Christina L.; Gallardo-Romero, Nadia; Carroll, Darin S.; Clemmons, Cody; Salzer, Johanna S.; Hughes, Christine M.; Olson, Victoria A.; Karem, Kevin L.; Damon, Inger K.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Poxvirus & Rabies Branch, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA; [Hutson, Christina L.; Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Salzer, Johanna S.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; Emory University	Hutson, CL (corresponding author), Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Poxvirus & Rabies Branch, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA.	chutson1@cdc.gov; iad7@cdc.gov						BREMAN JG, 1980, B WORLD HEALTH ORGAN, V58, P165; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; DEMKOWICZ WE, 1992, J VIROL, V66, P386, DOI 10.1128/JVI.66.1.386-398.1992; FOSTER SO, 1972, B WORLD HEALTH ORGAN, V46, P569; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028295; Hutson CL, 2010, VIROLOGY, V402, P72, DOI 10.1016/j.virol.2010.03.012; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; JEZEK Z, 1988, B WORLD HEALTH ORGAN, V66, P459; Jezek Z., 1988, MONOGRAPHS VIROLOGY, V17, P1, DOI 10.1159/000416456; Keckler MS, 2011, J VIROL, V85, P7683, DOI 10.1128/JVI.02174-10; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P681, DOI 10.1080/15459624.2012.725986; Nalca A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012880; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reynolds MG, 2007, EMERG INFECT DIS, V13, P1332, DOI 10.3201/eid1309.070175; Reynolds MG, 2012, CURR OPIN VIROL, V2, P335, DOI 10.1016/j.coviro.2012.02.004; Salzer JS, 2013, J WILDLIFE DIS, V49, P125, DOI 10.7589/2012-04-100; Sbrana E, 2007, AM J TROP MED HYG, V76, P155, DOI 10.4269/ajtmh.2007.76.155; Smith SK, 2011, J VIROL, V85, P9176, DOI 10.1128/JVI.02173-10; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	25	20	20	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55488	10.1371/journal.pone.0055488	http://dx.doi.org/10.1371/journal.pone.0055488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408990	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200033
J	Chi, XJ; Lu, YX; Zhao, P; Li, CG; Wang, XJ; Wang, M				Chi, Xiao-Jing; Lu, Yi-Xin; Zhao, Peng; Li, Chuan-Gen; Wang, Xiao-Jia; Wang, Ming			Interaction Domain of Glycoproteins gB and gH of Marek's Disease Virus and Identification of an Antiviral Peptide with Dual Functions	PLOS ONE			English	Article							VIRAL MEMBRANE-FUSION; CELL-FUSION; FUSOGENIC DOMAINS; CRYSTAL-STRUCTURE; B GB; TYPE-1; ENTRY; GL; PROTEIN; GD	Our previous study reported that both glycoproteins gB and gH of the herpesvirus Marek's disease virus (MDV) contain eleven potential heptad repeat domains. These domains overlap with a-helix-enriched hydrophobic regions, including the gH-derived HR1 (gHH1) and HR3 (gHH3) and gB-derived HR1 (gBH1) regions, which demonstrate effective antiviral activity, with 50% inhibitory concentrations (IC50) of less than 12 mu M. Plaque formation and chicken embryo infection assays confirmed these results. In this study, biochemical and biophysical analyses detected potential interactions between these peptides. gHH1, gHH3, and gBH1 were found to interact with each other in pairs. The complex formed by gHH3 and gBH1 showed the most stable interaction at a molar ratio of 1: 3, the binding between gHH1 and gBH1 was relatively weak, and no interaction was observed between the three HR peptides. These results indicate that gHH3 and gBH1 are likely the key contributors to the interaction between gB and gH. Furthermore, each HR peptide from herpesvirus glycoproteins did not effectively inhibit virus infection compared with peptides from a class I enveloped virus. In this report, the HR mimic peptide modified with a double glutamic acid (EE) or a double lysine (KK) at the non-interactive sites (i.e., solvent-accessible sites) did not noticeably affect the antiviral activity compared with the wild-type HR peptide, whereas tandem peptides from gH-derived gHH1 and gB-derived gBH1 (i.e., gBH1-Linker-gHH1) produced efficient antiviral effects, unlike the individual peptides. The proposed interpretation of inhibition of entry has been addressed. Our results support the hypothesis that the interaction domain between glycoproteins gH and gB is a critical target in the design of inhibitors of herpesvirus infection.	[Chi, Xiao-Jing; Lu, Yi-Xin; Li, Chuan-Gen; Wang, Xiao-Jia; Wang, Ming] China Agr Univ, Coll Vet Med, Minist Agricultrure, Key Lab Zoonosis, Beijing 100094, Peoples R China; [Zhao, Peng] Shandong Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Tai An, Shandong, Peoples R China	China Agricultural University; Shandong Agricultural University	Wang, XJ (corresponding author), China Agr Univ, Coll Vet Med, Minist Agricultrure, Key Lab Zoonosis, Beijing 100094, Peoples R China.	wangxj@cau.edu.cn; vetdean@cau.edu.cn	Zhao, Peng/HDO-7507-2022		National Natural Science Foundation of China [31101819]; program of Education Ministry of China for New Century Excellent Talents in University [NCET-11-0486]; Foundation for the Authors of National Excellent Doctoral Dissertations of PR China [2006079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program of Education Ministry of China for New Century Excellent Talents in University; Foundation for the Authors of National Excellent Doctoral Dissertations of PR China	This work was supported by grants from The National Natural Science Foundation of China (31101819), the program of Education Ministry of China for New Century Excellent Talents in University (NCET-11-0486), and the Foundation for the Authors of National Excellent Doctoral Dissertations of PR China (2006079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajithdoss DK, 2009, VIRUS RES, V142, P57, DOI 10.1016/j.virusres.2009.01.008; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; BISSELL MJ, 1977, J SUPRAMOL STR CELL, V6, P1, DOI 10.1002/jss.400060102; Browne HM, 2009, PROTEIN PEPTIDE LETT, V16, P760, DOI 10.2174/092986609788681850; Burgess SC, 2004, P NATL ACAD SCI USA, V101, P13879, DOI 10.1073/pnas.0305789101; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Falanga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032186; Falanga A, 2009, PROTEIN PEPTIDE LETT, V16, P751, DOI 10.2174/092986609788681760; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; FUKUCHI K, 1985, P NATL ACAD SCI USA, V82, P751, DOI 10.1073/pnas.82.3.751; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Gianni T, 2006, J VIROL, V80, P2216, DOI 10.1128/JVI.80.5.2216-2224.2006; Gianni T, 2006, J VIROL, V80, P8190, DOI 10.1128/JVI.00504-06; Gimeno IM, 2001, VET PATHOL, V38, P491, DOI 10.1354/vp.38-5-491; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Kato K, 1999, J VET MED SCI, V61, P1161, DOI 10.1292/jvms.61.1161; Lee SI, 2001, J VET MED SCI, V63, P427, DOI 10.1292/jvms.63.427; Li Yanpeng, 2010, Weishengwu Xuebao, V50, P942; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lopper M, 2004, J VIROL, V78, P8333, DOI 10.1128/jvi.78.15.8333-8341.2004; Maresova L, 2001, J VIROL, V75, P9483, DOI 10.1128/JVI.75.19.9483-9492.2001; Maurer UE, 2008, P NATL ACAD SCI USA, V105, P10559, DOI 10.1073/pnas.0801674105; Muggeridge MI, 2000, J GEN VIROL, V81, P2017, DOI 10.1099/0022-1317-81-8-2017; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Pertel PE, 2002, J VIROL, V76, P4390, DOI 10.1128/JVI.76.9.4390-4400.2002; Silva RF, 2010, AVIAN DIS, V54, P862, DOI 10.1637/9048-090409-Reg.1; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Tulman ER, 2000, J VIROL, V74, P7980, DOI 10.1128/JVI.74.17.7980-7988.2000; Wang XJ, 2011, VIROLOGY, V416, P65, DOI 10.1016/j.virol.2011.05.001; Wang XJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-190; Wu P, 1999, ACTA VIROL, V43, P152; YOSHIDA S, 1994, GENE, V150, P303, DOI 10.1016/0378-1119(94)90442-1	46	4	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54761	10.1371/journal.pone.0054761	http://dx.doi.org/10.1371/journal.pone.0054761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405092	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400036
J	Davidson, Z; Valeix, M; Van Kesteren, F; Loveridge, AJ; Hunt, JE; Murindagomo, F; Macdonald, DW				Davidson, Zeke; Valeix, Marion; Van Kesteren, Freya; Loveridge, Andrew J.; Hunt, Jane E.; Murindagomo, Felix; Macdonald, David W.			Seasonal Diet and Prey Preference of the African Lion in a Waterhole-Driven Semi-Arid Savanna	PLOS ONE			English	Article							PHOTOGRAPHIC REFERENCE SYSTEM; KRUGER-NATIONAL-PARK; POPULATION-DYNAMICS; CARNIVORE DIET; SELECTION; HAIR; SIZE; MICROSTRUCTURE; HERBIVORES; PATTERNS	Large carnivores inhabiting ecosystems with heterogeneously distributed environmental resources with strong seasonal variations frequently employ opportunistic foraging strategies, often typified by seasonal switches in diet. In semi-arid ecosystems, herbivore distribution is generally more homogeneous in the wet season, when surface water is abundant, than in the dry season when only permanent sources remain. Here, we investigate the seasonal contribution of the different herbivore species, prey preference and distribution of kills (i.e. feeding locations) of African lions in Hwange National Park, Zimbabwe, a semi-arid African savanna structured by artificial waterholes. We used data from 245 kills and 74 faecal samples. Buffalo consistently emerged as the most frequently utilised prey in all seasons by both male (56%) and female (33%) lions, contributing the most to lion dietary biomass. Jacobs' index also revealed that buffalo was the most intensively selected species throughout the year. For female lions, kudu and to a lesser extent the group "medium Bovidae" are the most important secondary prey. This study revealed seasonal patterns in secondary prey consumption by female lions partly based on prey ecology with browsers, such as giraffe and kudu, mainly consumed in the early dry season, and grazers, such as zebra and suids, contributing more to female diet in the late dry season. Further, it revealed the opportunistic hunting behaviour of lions for prey as diverse as elephants and mice, with elephants taken mostly as juveniles at the end of the dry season during droughts. Jacobs' index finally revealed a very strong preference for kills within 2 km from a waterhole for all prey species, except small antelopes, in all seasons. This suggested that surface-water resources form passive traps and contribute to the structuring of lion foraging behaviour.	[Davidson, Zeke; Valeix, Marion; Van Kesteren, Freya; Loveridge, Andrew J.; Hunt, Jane E.; Macdonald, David W.] Univ Oxford, Dept Zool, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Abingdon, Oxon, England; [Valeix, Marion] Univ Lyon 1, CNRS UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Murindagomo, Felix] Zimbabwe Parks & Wildlife Management Author, Harare, Zimbabwe	University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Davidson, Z (corresponding author), Colden Common, Marwell Wildlife, Winchester, Hants, England.	zeked@marwell.org.uk	Valeix, Marion/A-5110-2010		Darwin Initiative for Biodiversity; Disney Wildlife Conservation Foundation; SAVE Foundation; Regina B. Frankenberg Foundation; Rufford Maurice Laing Foundation; Instalite Contracting Bulawayo; Eppley Foundation; Panthera Foundation; Dete Animal Rescue Trust (DART)	Darwin Initiative for Biodiversity; Disney Wildlife Conservation Foundation; SAVE Foundation; Regina B. Frankenberg Foundation; Rufford Maurice Laing Foundation; Instalite Contracting Bulawayo; Eppley Foundation; Panthera Foundation; Dete Animal Rescue Trust (DART)	The work was supported by the Darwin Initiative for Biodiversity, Disney Wildlife Conservation Foundation, SAVE Foundation, Regina B. Frankenberg Foundation the Rufford Maurice Laing Foundation and Instalite Contracting Bulawayo. The Project was supported by the Eppley Foundation, Panthera Foundation and the kind generosity of Rivington and Joan Winant, Adrian Gardiner and the Lilian Jean Kaplan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Zimbabwe Parks and Wildlife Management Authority is acknowledged for approving this research and for permission to publish this manuscript. The field assistance of Dr. Daniel Parker, B. Stapelkamp, Nicholas Elliot, Jaelle Claypole, Agrippa Moyo, Lowani Mpofu and the rangers of the Hwange National Park was invaluable. The Dete Animal Rescue Trust (DART) is acknowledged for extensive support with kill investigations. We owe thanks to Wilderness Safaris, The Hide Safaris, Touch the Wild Safaris, Zimbabwe Sun international and the Gwaai ICA for permission to work on their concessions. We thank Matt Hayward, Craig Tambling and two anonymous reviewers for helpful comments on a previous draft.	Bacon MM, 2011, WILDLIFE SOC B, V35, P409, DOI 10.1002/wsb.85; BUYS D, 1984, S AFR J WILDL RES, V14, P111; Campbell Ken, 1995, P117; Chamaille-Jammes S, 2009, AFR J ECOL, V47, P804, DOI 10.1111/j.1365-2028.2009.01077.x; Cumming DHM, 2003, OECOLOGIA, V134, P560, DOI 10.1007/s00442-002-1149-4; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; de Boer WF, 2010, J MAMMAL, V91, P1280, DOI 10.1644/09-MAMM-A-392.1; de Leeuw J, 2001, BIOL CONSERV, V100, P297, DOI 10.1016/S0006-3207(01)00034-9; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fritz H, 2011, ECOGRAPHY, V34, P196, DOI 10.1111/j.1600-0587.2010.06537.x; Fritz Herve, 2006, Conservation Biology Series (Cambridge), V11, P19; Funston PJ, 2006, S AFR J WILDL RES, V36, P9; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2011, ACTA OECOL, V37, P314, DOI 10.1016/j.actao.2011.03.003; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Holdo RM, 2003, J TROP ECOL, V19, P189, DOI 10.1017/S0266467403003213; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; KEOGH HJ, 1985, S AFR J WILDL RES, V15, P109; KEOGH HJ, 1983, S AFR J WILDL RES, V13, P89; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge AJ, 2006, J ZOOL, V270, P523, DOI 10.1111/j.1469-7998.2006.00181.x; Loveridge AJ, 2009, ECOGRAPHY, V32, P953, DOI 10.1111/j.1600-0587.2009.05745.x; Marker LL, 2003, S AFR J WILDL RES, V33, P43; Marucco F, 2008, J MAMMAL, V89, P665, DOI 10.1644/07-MAMM-A-005R3.1; Mills M. G. L., 1995, Koedoe, V38, P95; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Owen-Smith N, 2008, ECOLOGY, V89, P1120, DOI 10.1890/07-0970.1; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; OWENSMITH N, 1982, ECOL STUD, V42, P359; PERRIN MR, 1980, S AFR J WILDL RES, V10, P1; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Rogers CML, 1993, WODDY VEGETATION SUR; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Tambling CJ, 2012, J ZOOL, V286, P102, DOI 10.1111/j.1469-7998.2011.00856.x; Tambling CJ, 2010, J WILDLIFE MANAGE, V74, P549, DOI 10.2193/2009-010; THRASH I, 1995, J ARID ENVIRON, V29, P213, DOI 10.1016/S0140-1963(05)80091-6; Valeix M, 2011, AM NAT, V178, P269, DOI 10.1086/660824; Valeix M, 2011, J TROP ECOL, V27, P163, DOI 10.1017/S0266467410000647; Valeix M, 2010, LANDSCAPE ECOL, V25, P337, DOI 10.1007/s10980-009-9425-x; Van Kesteren F, 2006, THESIS U OXFORD OXFO; WALKER BH, 1987, J APPL ECOL, V24, P381, DOI 10.2307/2403882; WESTERN D, 1975, East African Wildlife Journal, V13, P265	50	82	84	2	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55182	10.1371/journal.pone.0055182	http://dx.doi.org/10.1371/journal.pone.0055182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405121	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400065
J	Fang, XL; Finnegan, PM; Barbetti, MJ				Fang, Xiangling; Finnegan, Patrick M.; Barbetti, Martin J.			Wide Variation in Virulence and Genetic Diversity of Binucleate Rhizoctonia Isolates Associated with Root Rot of Strawberry in Western Australia	PLOS ONE			English	Article							SPP. CAUSING ROOT; ANASTOMOSIS GROUPS; FUSARIUM-OXYSPORUM; METHYL-BROMIDE; RIBOSOMAL DNA; SOLANI; PATHOGENICITY; FUNGI; DISEASES; CROWN	Strawberry (Fragariaxananassa) is one of the most important berry crops in the world. Root rot of strawberry caused by Rhizoctonia spp. is a serious threat to commercial strawberry production worldwide. However, there is no information on the genetic diversity and phylogenetic status of Rhizoctonia spp. associated with root rot of strawberry in Australia. To address this, a total of 96 Rhizoctonia spp. isolates recovered from diseased strawberry plants in Western Australia were characterized for their nuclear condition, virulence, genetic diversity and phylogenetic status. All the isolates were found to be binucleate Rhizoctonia (BNR). Sixty-five of the 96 BNR isolates were pathogenic on strawberry, but with wide variation in virulence, with 25 isolates having high virulence. Sequence analysis of the internal transcribed spacers of the ribosomal DNA separated the 65 pathogenic BNR isolates into six distinct clades. The sequence analysis also separated reference BNR isolates from strawberry or other crops across the world into clades that correspond to their respective anastomosis group (AG). Some of the pathogenic BNR isolates from this study were embedded in the clades for AG-A, AG-K and AG-I, while other isolates formed clades that were sister to the clades specific for AG-G, AG-B, AG-I and AG-C. There was no significant association between genetic diversity and virulence of these BNR isolates. This study demonstrates that pathogenic BNR isolates associated with root rot of strawberry in Western Australia have wide genetic diversity, and highlights new genetic groups not previously found to be associated with root rot of strawberry in the world (e. g., AG-B) or in Australia (e. g., AG-G). The wide variation in virulence and genetic diversity identified in this study will be of high value for strawberry breeding programs in selecting, developing and deploying new cultivars with resistance to these multi-genetic groups of BNR.	[Fang, Xiangling; Finnegan, Patrick M.; Barbetti, Martin J.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia; [Finnegan, Patrick M.; Barbetti, Martin J.] Univ Western Australia, Fac Sci, Inst Agr, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Barbetti, MJ (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia.	martin.barbetti@uwa.edu.au	Barbetti, Martin J/B-3455-2011; Finnegan, Patrick M/B-3469-2011; Fang, Xiangling/G-1075-2012	Barbetti, Martin J/0000-0002-5331-0817; Finnegan, Patrick M/0000-0001-5021-1138; 	Australia Research Council; Department of Agriculture and Food Western Australia; China Scholarship Council; University of Western Australia	Australia Research Council(Australian Research Council); Department of Agriculture and Food Western Australia; China Scholarship Council(China Scholarship Council); University of Western Australia	This work was supported by the Australia Research Council and the Department of Agriculture and Food Western Australia. XLF gratefully acknowledges the financial assistance of the China Scholarship Council and the University of Western Australia by a jointly awarded PhD Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBETTI MJ, 1987, AUST J AGR RES, V38, P317, DOI 10.1071/AR9870317; Bombarely A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-503; Botha A, 2003, AUSTRALAS PLANT PATH, V32, P195, DOI 10.1071/AP02067; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Cubeta M.A., 2000, ENCY MICROBIOLOGY, P109; Fang XL, 2011, AUSTRALAS PLANT PATH, V40, P109, DOI 10.1007/s13313-010-0019-5; Fang XL, 2012, PLANT SOIL, V358, P71, DOI 10.1007/s11104-012-1205-8; Fang XL, 2012, PHYTOPATHOL MEDITERR, V51, P69; Fang XL, 2011, SCI HORTIC-AMSTERDAM, V131, P39, DOI 10.1016/j.scienta.2011.09.025; Feng J, 2010, PLANT PATHOL, V59, P845, DOI 10.1111/j.1365-3059.2010.02313.x; Fravel D, 2003, NEW PHYTOL, V157, P493, DOI 10.1046/j.1469-8137.2003.00700.x; Gonzalez D, 2001, MYCOLOGIA, V93, P1138, DOI 10.2307/3761674; Gonzalez D, 2006, MOL PHYLOGENET EVOL, V40, P459, DOI 10.1016/j.ympev.2006.03.022; Gronberg H, 2003, MYCOL RES, V107, P428, DOI 10.1017/S0953756203007500; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Himelrick D, 1991, ADV STRAWBERRY PRODU, V10; HUA'AN Y, 1991, Australasian Plant Pathology, V20, P119, DOI 10.1071/APP9910119; Hyakumachi M, 2005, PHYTOPATHOLOGY, V95, P784, DOI 10.1094/PHYTO-95-0784; Johanson A, 1998, FEMS MICROBIOL LETT, V162, P289, DOI 10.1111/j.1574-6968.1998.tb13011.x; Katan J, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P423; Krause MS, 2001, PHYTOPATHOLOGY, V91, P1116, DOI 10.1094/PHYTO.2001.91.11.1116; Kuramae EE, 2007, EUR J PLANT PATHOL, V119, P469, DOI 10.1007/s10658-007-9175-z; Lehtonen MJ, 2008, PLANT PATHOL, V57, P141, DOI 10.1111/j.1365-3059.2007.01694.x; Manici LM, 2007, EUR J PLANT PATHOL, V118, P31, DOI 10.1007/s10658-007-9100-5; MANTEL N, 1967, CANCER RES, V27, P209; Martin FN, 2002, PHYTOPATHOLOGY, V92, P1356, DOI 10.1094/PHYTO.2002.92.12.1356; MARTIN SB, 1988, PHYTOPATHOLOGY, V78, P379, DOI 10.1094/Phyto-78-379; Martin SN, 2000, PHYTOPATHOLOGY, V90, P345, DOI 10.1094/PHYTO.2000.90.4.345; Mathew FM, 2012, PLANT DIS, V96, P666, DOI 10.1094/PDIS-02-11-0087; Matsumoto Masaru, 2006, Journal of General Plant Pathology, V72, P318, DOI 10.1007/s10327-006-0286-8; Nei M., 2000, MOL EVOLUTION PHYLOG; Ohkura M, 2009, PLANT DIS, V93, P615, DOI 10.1094/PDIS-93-6-0615; Pannecoucque J, 2008, PLANT PATHOL, V57, P737, DOI 10.1111/j.1365-3059.2007.01823.x; Particka CA, 2005, J AM SOC HORTIC SCI, V130, P688, DOI 10.21273/JASHS.130.5.688; Porter IJ, 1999, AUSTRALAS PLANT PATH, V28, P65, DOI 10.1071/AP99009; Rinehart TA, 2007, PLANT DIS, V91, P616, DOI 10.1094/PDIS-91-5-0616; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharon M, 2008, MYCOSCIENCE, V49, P93, DOI 10.1007/s10267-007-0394-0; Sharon Michal, 2006, Mycoscience, V47, P299, DOI 10.1007/s10267-006-0320-x; Sharon M, 2007, EUR J PLANT PATHOL, V117, P247, DOI 10.1007/s10658-006-9091-7; Sneh B., 1991, IDENTIFICATION RHIZO; Strausbaugh CA, 2011, CAN J PLANT PATHOL, V33, P210, DOI 10.1080/07060661.2011.558523; Subbarao KV, 2007, PLANT DIS, V91, P964, DOI 10.1094/PDIS-91-8-0964; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toda Takeshi, 2004, Journal of General Plant Pathology, V70, P270, DOI 10.1007/s10327-004-0123-x; Watanabe K, 2011, PLANT SOIL, V347, P255, DOI 10.1007/s11104-011-0843-6; WATANABE T, 1977, T MYCOL SOC JPN, V18, P251; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilhelm S., 1980, Plant Disease, V64, P264; YUEN GY, 1991, PLANT DIS, V75, P416, DOI 10.1094/PD-75-0416	52	38	41	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55877	10.1371/journal.pone.0055877	http://dx.doi.org/10.1371/journal.pone.0055877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405226	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400171
J	Hastie, AR; Dong, LL; Smith, A; Finklestein, J; Lam, ET; Huo, NX; Cao, H; Kwok, PY; Deal, KR; Dvorak, J; Luo, MC; Gu, Y; Xiao, M				Hastie, Alex R.; Dong, Lingli; Smith, Alexis; Finklestein, Jeff; Lam, Ernest T.; Huo, Naxin; Cao, Han; Kwok, Pui-Yan; Deal, Karin R.; Dvorak, Jan; Luo, Ming-Cheng; Gu, Yong; Xiao, Ming			Rapid Genome Mapping in Nanochannel Arrays for Highly Complete and Accurate De Novo Sequence Assembly of the Complex Aegilops tauschii Genome	PLOS ONE			English	Article							WHOLE-GENOME; PHYSICAL MAP; STRUCTURAL VARIATION; GENERATION; VALIDATION; RESOLUTION; CLONE; DNA	Next-generation sequencing (NGS) technologies have enabled high-throughput and low-cost generation of sequence data; however, de novo genome assembly remains a great challenge, particularly for large genomes. NGS short reads are often insufficient to create large contigs that span repeat sequences and to facilitate unambiguous assembly. Plant genomes are notorious for containing high quantities of repetitive elements, which combined with huge genome sizes, makes accurate assembly of these large and complex genomes intractable thus far. Using two-color genome mapping of tiling bacterial artificial chromosomes (BAC) clones on nanochannel arrays, we completed high-confidence assembly of a 2.1-Mb, highly repetitive region in the large and complex genome of Aegilops tauschii, the D-genome donor of hexaploid wheat (Triticum aestivum). Genome mapping is based on direct visualization of sequence motifs on single DNA molecules hundreds of kilobases in length. With the genome map as a scaffold, we anchored unplaced sequence contigs, validated the initial draft assembly, and resolved instances of misassembly, some involving contigs <2 kb long, to dramatically improve the assembly from 75% to 95% complete.	[Hastie, Alex R.; Smith, Alexis; Finklestein, Jeff; Lam, Ernest T.; Cao, Han; Xiao, Ming] BioNano Genom, San Diego, CA USA; [Dong, Lingli; Huo, Naxin; Gu, Yong] ARS, Genom & Gene Discovery Res Unit, USDA, Albany, CA 94710 USA; [Dong, Lingli; Huo, Naxin; Deal, Karin R.; Dvorak, Jan; Luo, Ming-Cheng; Gu, Yong] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California San Francisco	Gu, Y (corresponding author), ARS, Genom & Gene Discovery Res Unit, USDA, Albany, CA 94710 USA.	yong.gu@ars.usda.gov; ming.xiao@drexel.edu	Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Luo, Ming-Cheng/0000-0002-9744-5887	US National Institutes of Health (NIH) [R01 HG005946]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005946] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research is supported in part by US National Institutes of Health (NIH) award to P.-Y.K. and M. X. (R01 HG005946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Blakesley RW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-21; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; CASSIDY BG, 1991, THEOR APPL GENET, V81, P653, DOI 10.1007/BF00226733; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Das SK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq673; Dvorak J, 2009, TRITICEAE GENOME STR; Green ED, 2001, NAT REV GENET, V2, P573, DOI 10.1038/35084503; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Howden BP, 2010, J BACTERIOL, V192, P5848, DOI 10.1128/JB.00951-10; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lee H, 2012, METHODS MOL BIOL, V855, P155, DOI 10.1007/978-1-61779-582-4_5; Leroy P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00005; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Lin HC, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-189; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Mun JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-280; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Philippe R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-47; Riley MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027085; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; SMITH DB, 1975, CHROMOSOMA, V50, P223, DOI 10.1007/BF00283468; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; van Oeveren J, 2011, GENOME RES, V21, P618, DOI 10.1101/gr.112094.110; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Warren RL, 2006, GENOME RES, V16, P768, DOI 10.1101/gr.5090606; Xiao M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1044; Zhou S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-278; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	36	110	120	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55864	10.1371/journal.pone.0055864	http://dx.doi.org/10.1371/journal.pone.0055864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405223	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400168
J	Leisegang, R; Maartens, G; Hislop, M; Sargent, J; Darkoh, E; Cleary, S				Leisegang, Rory; Maartens, Gary; Hislop, Michael; Sargent, John; Darkoh, Ernest; Cleary, Susan			A Novel Markov Model Projecting Costs and Outcomes of Providing Antiretroviral Therapy to Public Patients in Private Practices versus Public Clinics in South Africa	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; HIV TREATMENT; DISEASE; STRATEGIES; EFFICIENCY; BENEFITS; CARE	Introduction: Providing private antiretroviral therapy (ART) care for public sector patients could increase access to ART in low-and middle-income countries. We compared the costs and outcomes of a private-care and a public-care ART program in South Africa. Methods: A novel Markov model was developed from the public-care program. Patients were first tunneled for 6 months in their baseline CD4 category before being distributed into a dynamic CD4 and viral load model. Patients were allowed to return to ART care from loss to follow up (LTFU). We then populated this modeling framework with estimates derived from the private-care program to externally validate the model. Results: Baseline characteristics were similar in the two programs. Clinic visit utilization was higher and death rates were lower in the first few years on ART in the public-care program. After 10 years on ART we estimated the following outcomes in the public-care and private-care programs respectively: viral load <1000 copies/ml 89% and 84%, CD4 >500 cells/ml 33% and 37%, LTFU 14% and 14%, and death 27% and 32%. Lifetime undiscounted survival estimates were 14.1 (95% CI 13.2-14.9) and (95% CI 12.7-14.5) years with costs of 18,734 (95% CI 12,588-14,022) and 13,062 (95% CI 12,077-14,047) USD in the private-care and public-care programs respectively. When clinic visit utilization in the public-care program was reduced by two thirds after the initial 6 months on ART, which is similar to their current practice, the costs were comparable between the programs. Conclusions: Using a novel Markov model, we determined that the private-care program had similar outcomes but lower costs than the public-care program, largely due to lower visit frequencies. These findings have important implications for increasing and sustaining coverage of patients in need of ART care in resource-limited settings.	[Leisegang, Rory; Maartens, Gary] Univ Cape Town, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Hislop, Michael] Medscheme Pty Ltd, Aid AIDS, Cape Town, South Africa; [Sargent, John; Darkoh, Ernest] BroadReach Healthcare, Cape Town, South Africa; [Cleary, Susan] Univ Cape Town, Hlth Econ Unit, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Maartens, G (corresponding author), Univ Cape Town, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa.	gary.maartens@uct.ac.za	Cleary, Susan/AHE-7259-2022; Maartens, Gary/F-3836-2014; Sargent, James D/I-2773-2013; Maartens, Gary/S-2788-2019	Cleary, Susan/0000-0002-9071-7958; Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606	Wellcome Trust CIDRI grant; Tibotec's Research and Education in HIV/AIDS for Resource-Poor Countries initiative; Doris Duke Charitable Foundation	Wellcome Trust CIDRI grant; Tibotec's Research and Education in HIV/AIDS for Resource-Poor Countries initiative; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This research was supported in part by the Wellcome Trust CIDRI grant, Tibotec's Research and Education in HIV/AIDS for Resource-Poor Countries initiative, and the Doris Duke Charitable Foundation. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analysis SD, 2011, STATA 11 0; Ananworanich J, 2006, LANCET, V368, P459, DOI 10.1016/S0140-6736(06)69153-8; Bachmann MO, 2006, AIDS CARE, V18, P109, DOI 10.1080/09540120500159334; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Boulle A, 2008, POSTGRAD MED J, V84, P225, DOI 10.1136/sti.2007.027748; Boulle A, 2010, AIDS; Cleary S, 2011, HEALTH POLICY, V99, P261, DOI 10.1016/j.healthpol.2010.10.016; Cleary S, 2010, CURR OPIN HIV AIDS, V5, P210, DOI 10.1097/COH.0b013e3283384a6f; Cleary SM, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327621.24232.71; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Consumer Price Index (CPI), 2010, CONS PRIC IND CPI; Dreesch Norbert, 2007, Hum Resour Health, V5, P25, DOI 10.1186/1478-4491-5-25; Freedberg K, 2007, AIDS; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kranzer K, 2011, TROP MED INT HLTH; Leisegang R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S3; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Marseille E, 2006, AIDS, V20, P907, DOI 10.1097/01.aids.0000218556.36661.47; Nachega JB, 2010, ANN INTERN MED, V152, P18, DOI 10.7326/0003-4819-152-1-201001050-00006; Ndiaye B, 2009, AIDS, V23, P1786, DOI 10.1097/QAD.0b013e32832e3469; Rosen S, 2006, MUCH DOES IT COST PR; Rosen S, 2007, SAMJ, V97; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sendi PP, 1999, J EVAL CLIN PRACT, V5, P283, DOI 10.1046/j.1365-2753.1999.00174.x; Treeage Software I, 2009, TREEAG SOFTW I; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; WHO, 2010, UNAIDS REP GLOB AIDS; WHO, 2004, COST COST EFF PUBL P; Wolf LL, 2007, JAIDS-J ACQ IMM DEF, V46, P463, DOI 10.1097/QAI.0b013e3181594c38; World Health Organization, 2003, SCAL ANT THER RES LT	35	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53570	10.1371/journal.pone.0053570	http://dx.doi.org/10.1371/journal.pone.0053570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405073	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400016
J	McCarthy, JK; Brockerhoff, EG; Didham, RK				McCarthy, James K.; Brockerhoff, Eckehard G.; Didham, Raphael K.			An Experimental Test of Insect-Mediated Colonisation of Damaged Pinus radiata Trees by Sapstain Fungi	PLOS ONE			English	Article							HYLASTES-ATER COLEOPTERA; SPHAEROPSIS-SAPINEA; BARK BEETLES; STORM DAMAGE; HOST; OPHIOSTOMA; PATHOGEN; PINES; CERATOCYSTIOPSIS; ASSOCIATION	Vector-pathogen dynamics play a central role in understanding tree health and forest dynamics. There is substantial evidence that bark beetles act as spore vectors for many species of fungi that cause 'sapstain' discolouration of damaged trees and timber. However, the direct quantitative link between vector-mediated spore dispersal and subsequent sapstain colonisation of wood is not fully understood. Here, we used caged versus uncaged experimental logs to test whether the exclusion of bark beetles quantitatively alters the distribution and intensity of sapstain fungal spread within damaged trees. Using generalised linear mixed models, we tested the effect of bark beetle exclusion on sapstain intensity within and among cut logs at two plantation forest sites. Overall, sapstain was found on all logs regardless of caging treatment, indicating that sapstain colonisation can occur (to some degree) without arthropod vectors, probably via wind, rain-splash and, potentially, latent endophytic development. This was supported by the dominance of Diplodia pinea in fungal isolations taken from trees felled at the site, as this fungal species is known to disperse independently of bark beetles. However, the intensity of sapstain within and among experimental logs was significantly greater in uncaged than in caged logs, where beetle colonisation was significantly greater. This appeared to be driven by a significant within-log association between the intensity of staining and the intensity of beetle, and other arthropod, tunnelling and feeding activities. Taken together, these results strongly suggest that the dominant mechanism underlying the role of bark beetles in sapstain development in this study system is not vector-mediated spore dispersal, per se, but rather the facilitation of spore entry and hyphal development through tunnelling and feeding activities. We discuss the implications of these findings for forest management and the effective salvage-harvest of trees damaged by stochastic climate events such as storm and fire damage.	[McCarthy, James K.; Brockerhoff, Eckehard G.] Scion New Zealand Forest Res Inst, Christchurch, New Zealand; [McCarthy, James K.; Brockerhoff, Eckehard G.; Didham, Raphael K.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] Ctr Environm & Life Sci, CSIRO Ecosyst Serv, Perth, WA, Australia	University of Canterbury; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	McCarthy, JK (corresponding author), Scion New Zealand Forest Res Inst, Christchurch, New Zealand.	james.k.mccarthy@me.com	Brockerhoff, Eckehard Gustav/C-1528-2009; McCarthy, James K./E-9801-2010; Didham, Raphael K/B-5953-2011	Brockerhoff, Eckehard Gustav/0000-0002-5962-3208; McCarthy, James K./0000-0003-3060-1678; 	Foundation for Research, Science and Technology [C04X0807]; New Zealand Forest Health Research Collaborative; Brian Mason Scientific and Technical Trust; University of Canterbury; Tertiary Education Commission Enterprise Scholarship	Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); New Zealand Forest Health Research Collaborative; Brian Mason Scientific and Technical Trust; University of Canterbury; Tertiary Education Commission Enterprise Scholarship	Funding was provided by the Foundation for Research, Science and Technology (contract C04X0807 to Scion), the New Zealand Forest Health Research Collaborative, the Brian Mason Scientific and Technical Trust, the University of Canterbury, and a Tertiary Education Commission Enterprise Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BALLARD RG, 1982, CAN J BOT, V60, P2334, DOI 10.1139/b82-285; Bates D., 2011, LINEAR MIXED EFFECTS; Bihon W, 2011, FOREST PATHOL, V41, P370, DOI 10.1111/j.1439-0329.2010.00691.x; Brockerhoff Eckehard G., 2003, New Zealand Entomologist, V26, P29; Brockerhoff EG, 2006, FOREST ECOL MANAG, V228, P234, DOI 10.1016/j.foreco.2006.02.046; BROOKHOUSER LW, 1971, PHYTOPATHOLOGY, V61, P409, DOI 10.1094/Phyto-61-409; Bueno A, 2010, SILVA FENN, V44, P387, DOI 10.14214/sf.137; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cudmore TJ, 2010, J APPL ECOL, V47, P1036, DOI 10.1111/j.1365-2664.2010.01848.x; Eagen R, 1997, CAN J MICROBIOL, V43, P592, DOI 10.1139/m97-084; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Feci E, 2003, FOREST PATHOL, V33, P7, DOI 10.1046/j.1439-0329.2003.00304.x; Grulke NE, 2011, NEW PHYTOL, V189, P8, DOI 10.1111/j.1469-8137.2010.03568.x; HARRINGTON TC, 1981, MYCOLOGIA, V73, P1123, DOI 10.2307/3759682; Hood I.A., 1997, Australian Forestry, V60, P7; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Kerr J, 2010, OLFACTORY VISUAL CUE; Leach JG, 1934, J AGRIC RES, V49, P0315; Liese W., 1984, New Zealand Journal of Forestry, V29, P119; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Luchi N, 2012, FOREST PATHOL, V42, P246, DOI 10.1111/j.1439-0329.2011.00750.x; Madar Z, 2005, PHYTOPARASITICA, V33, P28, DOI 10.1007/BF02980922; Mausel DL, 2007, CAN J FOREST RES, V37, P156, DOI 10.1139/X06-215; McCarthy JK, 2010, FOREST ECOL MANAG, V260, P1456, DOI 10.1016/j.foreco.2010.07.044; McCarthy JK, 2012, FOREST ECOL MANAG, V277, P81, DOI 10.1016/j.foreco.2012.04.018; McCarthy JK, 2011, ROLE BARK BEETLES VE; Oblinger BW, 2011, FOREST ECOL MANAG, V262, P663, DOI 10.1016/j.foreco.2011.04.038; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; PALMER MA, 1987, PHYTOPATHOLOGY, V77, P944, DOI 10.1094/Phyto-77-944; PALMER MA, 1988, PHYTOPATHOLOGY, V78, P831, DOI 10.1094/Phyto-78-831; POWELL MA, 1995, CAN J FOREST RES, V25, P1148, DOI 10.1139/x95-127; R Core Team, 2016, R FDN STAT COMP; Reay S.D., 2006, New Zealand Entomologist, V29, P21; Reay SD, 2002, FOREST ECOL MANAG, V165, P47, DOI 10.1016/S0378-1127(01)00628-4; Rornn P, 2007, CAN J MICROBIOL, V53, P756, DOI 10.1139/W07-001; Santini A, 2008, FOREST ECOL MANAG, V256, P502, DOI 10.1016/j.foreco.2008.05.010; Seifert K. A., 1999, TAXONOMY ECOLOGY PAT, P141; Stanosz GR, 2001, NEW PHYTOL, V149, P531, DOI 10.1046/j.1469-8137.2001.00052.x; Suckling DM, 1999, 2 NZ SAPST S, P117; SWART WJ, 1987, PLANT DIS, V71, P1038, DOI 10.1094/PD-71-1038; Thwaites JM, 2005, NEW ZEAL J BOT, V43, P653, DOI 10.1080/0028825X.2005.9512982; Uzunovic A, 1999, CAN J FOREST RES, V29, P242, DOI 10.1139/cjfr-29-2-242; Whitehill JGA, 2007, ENVIRON ENTOMOL, V36, P114, DOI 10.1603/0046-225X(2007)36[114:IPCSIA]2.0.CO;2; Wingfield M. J., 1980, Phytophylactica, V12, P57; Wylie F. R., 1999, Australian Forestry, V62, P148; Zeff C, 1999, FORESTRY PRACTISES M, P31; Zhou XD, 2004, FUNGAL DIVERS, V15, P261; Zimmerman WC, 1995, MYCOLOGIA, V87, P857, DOI 10.2307/3760861; Zipfel RD, 2006, STUD MYCOL, P75, DOI 10.3114/sim.55.1.75; ZWOLINSKI JB, 1995, FOREST ECOL MANAG, V72, P293, DOI 10.1016/0378-1127(94)03459-A	52	8	8	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55692	10.1371/journal.pone.0055692	http://dx.doi.org/10.1371/journal.pone.0055692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405198	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400143
J	Muth, CA; Steinl, C; Klein, G; Lee-Thedieck, C				Muth, Christine Anna; Steinl, Carolin; Klein, Gerd; Lee-Thedieck, Cornelia			Regulation of Hematopoietic Stem Cell Behavior by the Nanostructured Presentation of Extracellular Matrix Components	PLOS ONE			English	Article							COPOLYMER MICELLE NANOLITHOGRAPHY; BONE-MARROW NICHE; PROGENITOR CELLS; SUBSTRATE ELASTICITY; INTEGRIN LIGANDS; STEM/PROGENITOR CELLS; IN-VITRO; FIBRONECTIN; ADHESION; THROMBOSPONDIN-2	Hematopoietic stem cells (HSCs) are maintained in stem cell niches, which regulate stem cell fate. Extracellular matrix (ECM) molecules, which are an essential part of these niches, can actively modulate cell functions. However, only little is known on the impact of ECM ligands on HSCs in a biomimetic environment defined on the nanometer-scale level. Here, we show that human hematopoietic stem and progenitor cell (HSPC) adhesion depends on the type of ligand, i.e., the type of ECM molecule, and the lateral, nanometer-scaled distance between the ligands (while the ligand type influenced the dependency on the latter). For small fibronectin (FN)-derived peptide ligands such as RGD and LDV the critical adhesive interligand distance for HSPCs was below 45 nm. FN-derived (FN type III 7-10) and osteopontin-derived protein domains also supported cell adhesion at greater distances. We found that the expression of the ECM protein thrombospondin-2 (THBS2) in HSPCs depends on the presence of the ligand type and its nanostructured presentation. Functionally, THBS2 proved to mediate adhesion of HSPCs. In conclusion, the present study shows that HSPCs are sensitive to the nanostructure of their microenvironment and that they are able to actively modulate their environment by secreting ECM factors.	[Muth, Christine Anna; Lee-Thedieck, Cornelia] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Muth, Christine Anna; Lee-Thedieck, Cornelia] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany; [Steinl, Carolin; Klein, Gerd] Univ Tubingen, Med Res Ctr, Sect Transplantat Immunol & Immunohematol, Tubingen, Germany; [Lee-Thedieck, Cornelia] Karlsruhe Inst Technol, Inst Funct Interfaces, Eggenstein Leopoldshafen, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Helmholtz Association; Karlsruhe Institute of Technology	Lee-Thedieck, C (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	cornelia.lee-thedieck@kit.edu	Klein, Gerd/C-8499-2013; Lee-Thedieck, Cornelia/H-2835-2013	Lee-Thedieck, Cornelia/0000-0001-8863-5403; Muth, Anna Christine/0000-0001-6161-6085	Baden-Wurttemberg Stiftung [P-LS-Biomat/22]; Brigitte Schlieben-Lange-Programme; Kathe und Josef Klinz-Stiftung	Baden-Wurttemberg Stiftung; Brigitte Schlieben-Lange-Programme; Kathe und Josef Klinz-Stiftung	The project was supported by contract research 'Biomaterialien/Biokompatibilitat' of the Baden-Wurttemberg Stiftung (P-LS-Biomat/22). CL-T gratefully acknowledges support by the Brigitte Schlieben-Lange-Programme and the 'Kathe und Josef Klinz-Stiftung'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D; Alford AI, 2010, BONE, V46, P464, DOI 10.1016/j.bone.2009.08.058; Altrock E, 2012, BIOMATERIALS, V33, P3107, DOI 10.1016/j.biomaterials.2012.01.002; AOTA S, 1994, J BIOL CHEM, V269, P24756; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Aydin D, 2010, LANGMUIR, V26, P15472, DOI 10.1021/la103065x; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Bornstein P, 2000, MATRIX BIOL, V19, P557, DOI 10.1016/S0945-053X(00)00104-9; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Cavalcanti-Adam EA, 2008, HFSP J, V2, P276, DOI 10.2976/1.2976662; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Choi JS, 2012, BIOMATERIALS, V33, P4460, DOI 10.1016/j.biomaterials.2012.03.010; Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829; Franke K, 2007, BIOMATERIALS, V28, P836, DOI 10.1016/j.biomaterials.2006.09.031; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gillette Jennifer M, 2009, Commun Integr Biol, V2, P305; Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314; Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Hankenson KD, 2002, J BONE MINER RES, V17, P415, DOI 10.1359/jbmr.2002.17.3.415; Hines M, 2008, J CHEM TECHNOL BIOT, V83, P421, DOI 10.1002/jctb.1856; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Hirschfeld-Warneken VC, 2008, EUR J CELL BIOL, V87, P743, DOI 10.1016/j.ejcb.2008.03.011; Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; HURLEY RW, 1995, J CLIN INVEST, V96, P511, DOI 10.1172/JCI118063; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126; Jung Y, 2005, CYTOKINE, V32, P155, DOI 10.1016/j.cyto.2005.09.001; KERST JM, 1993, BLOOD, V81, P344; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KLEIN G, 1995, EXPERIENTIA, V51, P914, DOI 10.1007/BF01921741; Kramer A, 1999, P NATL ACAD SCI USA, V96, P2087, DOI 10.1073/pnas.96.5.2087; Kurth I, 2011, MACROMOL BIOSCI, V11, P739, DOI 10.1002/mabi.201000432; Kurth I, 2009, INTEGR BIOL-UK, V1, P427, DOI 10.1039/b903711j; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lee-Thedieck C, 2012, J CELL SCI, V125, P3765, DOI 10.1242/jcs.095596; Lee-Thedieck C, 2012, MACROMOL RAPID COMM, V33, P1432, DOI 10.1002/marc.201200219; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Lepzelter D, 2012, LANGMUIR, V28, P5379, DOI 10.1021/la203725a; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; Liao JH, 2011, J ORTHOP RES, V29, P1544, DOI 10.1002/jor.21436; Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003; Lohmuller T, 2011, BIOINTERPHASES, V6, pMR1, DOI 10.1116/1.3536839; Melikova S, 2004, EXP HEMATOL, V32, P1051, DOI 10.1016/j.exphem.2004.07.018; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MOULD AP, 1991, J BIOL CHEM, V266, P3579; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schofield KP, 1998, BLOOD, V91, P3230, DOI 10.1182/blood.V91.9.3230.3230_3230_3238; Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006; Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023; Spatz JP, 2000, LANGMUIR, V16, P407, DOI 10.1021/1a990070n; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9; WAYNER EA, 1992, J CELL BIOL, V116, P489, DOI 10.1083/jcb.116.2.489; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Wolfram T, 2007, BIOINTERPHASES, V2, P44, DOI 10.1116/1.2713991; Yokota T, 1998, BLOOD, V91, P3263, DOI 10.1182/blood.V91.9.3263.3263_3263_3272; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R	83	36	37	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54778	10.1371/journal.pone.0054778	http://dx.doi.org/10.1371/journal.pone.0054778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405094	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400038
J	Ratan, A; Miller, W; Guillory, J; Stinson, J; Seshagiri, S; Schuster, SC				Ratan, Aakrosh; Miller, Webb; Guillory, Joseph; Stinson, Jeremy; Seshagiri, Somasekar; Schuster, Stephan C.			Comparison of Sequencing Platforms for Single Nucleotide Variant Calls in a Human Sample	PLOS ONE			English	Article							GENOME SEQUENCE	Next-generation sequencings platforms coupled with advanced bioinformatic tools enable re-sequencing of the human genome at high-speed and large cost savings. We compare sequencing platforms from Roche/454(GS FLX), Illumina/HiSeq (HiSeq 2000), and Life Technologies/SOLiD (SOLiD 3 ECC) for their ability to identify single nucleotide substitutions in whole genome sequences from the same human sample. We report on significant GC-related bias observed in the data sequenced on Illumina and SOLiD platforms. The differences in the variant calls were investigated with regards to coverage, and sequencing error. Some of the variants called by only one or two of the platforms were experimentally tested using mass spectrometry; a method that is independent of DNA sequencing. We establish several causes why variants remained unreported, specific to each platform. We report the indel called using the three sequencing technologies and from the obtained results we conclude that sequencing human genomes with more than a single platform and multiple libraries is beneficial when high level of accuracy is required.	[Ratan, Aakrosh; Miller, Webb; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Guillory, Joseph; Stinson, Jeremy; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Roche Holding; Genentech	Schuster, SC (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA.	scs@bx.psu.edu			Roche [454]; Pennsylvania Department of Health	Roche(Roche Holding); Pennsylvania Department of Health	This study is based on sequencing data generated for the Southern African genomes Project [5]. The 454 data was generated at Penn State University and supported by Roche/454 via the donation of sequencing reagents. We like to thank Timothy Harkins and Kevin McCarren for making SOLiD data for the KB1 genome available to this group of investigators. The sequence data for Illumina GA IIx and HiSeq 2000 was generated at Penn State University and supported through internal funds. The funders had no role in study design, data collection (other than what has been stated above) and analysis, decision to publish, or preparation of the manuscript. This project is funded, in part, under a grant by the Pennsylvania Department of Health using Tobacco CURE Funds to AR. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Koehler R, 2011, BIOINFORMATICS, V27, P272, DOI 10.1093/bioinformatics/btq640; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lassmann T, 2011, BIOINFORMATICS, V27, P130, DOI 10.1093/bioinformatics/btq614; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Shen YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004012; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	24	57	58	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55089	10.1371/journal.pone.0055089	http://dx.doi.org/10.1371/journal.pone.0055089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405114	Green Published, gold			2022-12-27	WOS:000315153400058
J	Sawaya, S; Bagshaw, A; Buschiazzo, E; Kumar, P; Chowdhury, S; Black, MA; Gemmell, N				Sawaya, Sterling; Bagshaw, Andrew; Buschiazzo, Emmanuel; Kumar, Pankaj; Chowdhury, Shantanu; Black, Michael A.; Gemmell, Neil			Microsatellite Tandem Repeats Are Abundant in Human Promoters and Are Associated with Regulatory Elements	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; HEME OXYGENASE-1 GENE; NITRIC-OXIDE SYNTHASE; G4 DNA; G-QUADRUPLEX; DINUCLEOTIDE REPEATS; GENOME; POLYMORPHISM; EXPRESSION; TRANSCRIPTION	Tandem repeats are genomic elements that are prone to changes in repeat number and are thus often polymorphic. These sequences are found at a high density at the start of human genes, in the gene's promoter. Increasing empirical evidence suggests that length variation in these tandem repeats can affect gene regulation. One class of tandem repeats, known as microsatellites, rapidly alter in repeat number. Some of the genetic variation induced by microsatellites is known to result in phenotypic variation. Recently, our group developed a novel method for measuring the evolutionary conservation of microsatellites, and with it we discovered that human microsatellites near transcription start sites are often highly conserved. In this study, we examined the properties of microsatellites found in promoters. We found a high density of microsatellites at the start of genes. We showed that microsatellites are statistically associated with promoters using a wavelet analysis, which allowed us to test for associations on multiple scales and to control for other promoter related elements. Because promoter microsatellites tend to be G/C rich, we hypothesized that G/C rich regulatory elements may drive the association between microsatellites and promoters. Our results indicate that CpG islands, G-quadruplexes (G4) and untranslated regulatory regions have highly significant associations with microsatellites, but controlling for these elements in the analysis does not remove the association between microsatellites and promoters. Due to their intrinsic lability and their overlap with predicted functional elements, these results suggest that many promoter microsatellites have the potential to affect human phenotypes by generating mutations in regulatory elements, which may ultimately result in disease. We discuss the potential functions of human promoter microsatellites in this context.	[Sawaya, Sterling; Gemmell, Neil] Univ Otago, Dept Anat, Ctr Reprod & Genom, Dunedin, New Zealand; [Sawaya, Sterling; Gemmell, Neil] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand; [Bagshaw, Andrew] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Buschiazzo, Emmanuel] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Kumar, Pankaj; Chowdhury, Shantanu] GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Chowdhury, Shantanu] CSIR, Inst Genom & Integrat Biol, Prote & Struct Biol Unit, Delhi, India; [Black, Michael A.] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of California System; University of California Merced; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Otago	Sawaya, S (corresponding author), Univ Otago, Dept Anat, Ctr Reprod & Genom, Dunedin, New Zealand.	sterlingsawaya@gmail.com	Gemmell, Neil J/C-6774-2009; Black, Michael/F-1484-2010	Gemmell, Neil J/0000-0003-0671-3637; Black, Michael/0000-0003-1174-6054; Bagshaw, Andrew/0000-0002-2930-7298; KUMAR, PANKAJ/0000-0002-8411-1634	Royal Society of New Zealand Marsden [UOO 0721, UOO 085]; Minority Health International Research Training grant (National Institutes of Health); Indian Council of Medical Research	Royal Society of New Zealand Marsden(Royal Society of New ZealandMarsden Fund (NZ)); Minority Health International Research Training grant (National Institutes of Health); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	SS and NG were partially funded by Royal Society of New Zealand Marsden Grant (UOO 0721) and Minority Health International Research Training grant (National Institutes of Health). AB was funded by a Royal Society of New Zealand Marsden Grant (UOO 085). PK was funded by a Sr. Research Fellowship from the Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2000, HYPERTENSION, V36, P187, DOI 10.1161/01.HYP.36.2.187; Akai J, 1999, GENE, V239, P65, DOI 10.1016/S0378-1119(99)00380-7; Allayee H, 2008, AM J CLIN NUTR, V88, P934, DOI 10.1093/ajcn/88.4.934; Arneodo A, 1996, PHYSICA D, V96, P291, DOI 10.1016/0167-2789(96)00029-2; Bacolla A, 2001, J BIOL CHEM, V276, P18605, DOI 10.1074/jbc.M100404200; Bacolla A, 2008, GENOME RES, V18, P1545, DOI 10.1101/gr.078303.108; Baral A, 2012, NUCLEIC ACIDS RES, V40, P3800, DOI 10.1093/nar/gkr1258; Beaulieu M, 1997, ANTISENSE NUCLEIC A, V7, P125, DOI 10.1089/oli.1.1997.7.125; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Borel C, 2012, HUM MUTAT, V33, P1302, DOI 10.1002/humu.22115; BRAHMACHARI SK, 1995, ELECTROPHORESIS, V16, P1705, DOI 10.1002/elps.11501601283; Brandstrom M, 2008, MOL BIOL EVOL, V25, P2579, DOI 10.1093/molbev/msn201; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Buschiazzo E, 2010, GENOME BIOL EVOL, V2, P153, DOI 10.1093/gbe/evq007; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Darlow JM, 1998, J MOL BIOL, V275, P3, DOI 10.1006/jmbi.1997.1453; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dodin G, 2000, J THEOR BIOL, V206, P323, DOI 10.1006/jtbi.2000.2127; Domart MC, 2012, ADDICT BIOL, V17, P783, DOI 10.1111/j.1369-1600.2011.00321.x; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Du Z, 2009, NUCLEIC ACIDS RES, V37, P6784, DOI 10.1093/nar/gkp710; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Eddy J, 2011, NUCLEIC ACIDS RES, V39, P4975, DOI 10.1093/nar/gkr079; Eddy J, 2009, MOL CARCINOGEN, V48, P319, DOI 10.1002/mc.20496; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fujita P. A., 2010, NUCL ACIDS RES; Funke-Kaiser H, 2003, J HYPERTENS, V21, P2111, DOI 10.1097/00004872-200311000-00021; Gao PS, 2004, J MED GENET, V41, P535, DOI 10.1136/jmg.2003.015842; Gebhardt F, 1999, J BIOL CHEM, V274, P13176, DOI 10.1074/jbc.274.19.13176; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Halder R, 2010, MOL BIOSYST, V6, P2439, DOI 10.1039/c0mb00009d; Han YJ, 2008, MOL CELL BIOL, V28, P863, DOI 10.1128/MCB.00960-07; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Herdewyn S., 2012, HUMAN MOL GENETICS; Hough C, 2008, J THROMB HAEMOST, V6, P1183, DOI 10.1111/j.1538-7836.2008.03011.x; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Itokawa M, 2003, PHARMACOGENETICS, V13, P271, DOI 10.1097/00008571-200305000-00006; Kelkar YD, 2011, GENOME RES; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; King DG, 2007, HEREDITY, V99, P123, DOI 10.1038/sj.hdy.6800998; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kopf J, 2011, NEUROIMAGE, V57, P1617, DOI 10.1016/j.neuroimage.2011.05.034; Koren S, 2012, NAT BIOTECHNOL; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lawson MJ, 2008, GENE, V407, P54, DOI 10.1016/j.gene.2007.09.017; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; McIver LJ, 2011, GENOMICS, V97, P193, DOI 10.1016/j.ygeno.2011.01.001; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nason GP, 2008, USE R, P1; Ng TK, 2009, MOL VIS, V15, P2239; Nithianantharajah J, 2007, BIOESSAYS, V29, P525, DOI 10.1002/bies.20589; Okladnova O, 1998, BIOCHEM BIOPH RES CO, V248, P402, DOI 10.1006/bbrc.1998.8972; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Reif A, 2009, ARCH GEN PSYCHIAT, V66, P41, DOI 10.1001/archgenpsychiatry.2008.510; Rife T, 2009, J NEUROSCI RES, V87, P2319, DOI 10.1002/jnr.22045; Riley DE, 2009, GENE, V429, P74, DOI 10.1016/j.gene.2008.09.025; Riley DE, 2009, GENE, V429, P80, DOI 10.1016/j.gene.2008.09.030; Roberts RL, 2008, PHARMACOGENET GENOM, V18, P434, DOI 10.1097/FPC.0b013e3282f85e47; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Rothenburg S, 2001, IMMUNOL REV, V184, P286, DOI 10.1034/j.1600-065x.2001.1840125.x; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Sawaya S, 2012, TANDEM REPEAT POLYMO; Sawaya SM, 2012, GENOME BIOL EVOL, V4, P748, DOI 10.1093/gbe/evs050; Searle S, 1999, J MED GENET, V36, P295; Shimajiri S, 1999, FEBS LETT, V455, P70, DOI 10.1016/S0014-5793(99)00863-7; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Todd AK, 2008, NUCLEIC ACIDS RES, V36, P2700, DOI 10.1093/nar/gkn078; Todur SP, 2012, CLIN TRANSLATIONAL S; Tracey M, 2001, CROAT MED J, V42, P233; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Valverde P, 1999, CIRC RES, V84, P937; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wang BS, 2005, ONCOGENE, V24, P3999, DOI 10.1038/sj.onc.1208550; Wang GL, 2007, FRONT BIOSCI-LANDMRK, V12, P4424, DOI 10.2741/2399; Wang SY, 2008, MUTAT RES-FUND MOL M, V638, P26, DOI 10.1016/j.mrfmmm.2007.08.011; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Whetstine JR, 2002, J BIOL CHEM, V277, P43873, DOI 10.1074/jbc.M208296200; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Xu G, 1998, ARCH BIOCHEM BIOPHYS, V358, P83, DOI 10.1006/abbi.1998.0852; Yadav VK, 2008, NUCLEIC ACIDS RES, V36, pD381, DOI 10.1093/nar/gkm781; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	97	97	104	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54710	10.1371/journal.pone.0054710	http://dx.doi.org/10.1371/journal.pone.0054710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405090	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400034
J	Zhao, A; Tsechansky, M; Swaminathan, J; Cook, L; Ellington, AD; Marcotte, EM				Zhao, Alice; Tsechansky, Mark; Swaminathan, Jagannath; Cook, Lindsey; Ellington, Andrew D.; Marcotte, Edward M.			Transiently Transfected Purine Biosynthetic Enzymes Form Stress Bodies	PLOS ONE			English	Article							MULTIENZYME COMPLEX; ALPHA-SYNUCLEIN; CELL-GROWTH; AGGREGATION; PROTEINS	It has been hypothesized that components of enzymatic pathways might organize into intracellular assemblies to improve their catalytic efficiency or lead to coordinate regulation. Accordingly, de novo purine biosynthesis enzymes may form a purinosome in the absence of purines, and a punctate intracellular body has been identified as the purinosome. We investigated the mechanism by which human de novo purine biosynthetic enzymes might be organized into purinosomes, especially under differing cellular conditions. Irregardless of the activity of bodies formed by endogenous enzymes, we demonstrate that intracellular bodies formed by transiently transfected, fluorescently tagged human purine biosynthesis proteins are best explained as protein aggregation.	[Zhao, Alice; Tsechansky, Mark; Swaminathan, Jagannath; Cook, Lindsey; Ellington, Andrew D.; Marcotte, Edward M.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Marcotte, EM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu	Zhao, Alice/J-8115-2016	Zhao, Alice/0000-0001-5845-8071; Fox, Lindsey/0000-0001-7558-618X; Marcotte, Edward/0000-0001-8808-180X	United States National Institutes of Health, National Science Foundation, and Welch [F1515]; Packard Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076536] Funding Source: NIH RePORTER	United States National Institutes of Health, National Science Foundation, and Welch; Packard Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the United States National Institutes of Health, National Science Foundation, and Welch (F1515) and Packard Foundations to EMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Baresova V, 2012, HUM MOL GENET, V21, P1534, DOI 10.1093/hmg/ddr591; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gooljarsingh LT, 2001, P NATL ACAD SCI USA, V98, P6565, DOI 10.1073/pnas.121182998; Howard RA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-32; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Lewers JC, 2008, NEUROSCIENCE, V152, P761, DOI 10.1016/j.neuroscience.2007.10.065; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Proctor CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022038; Sagot I, 2006, MOL BIOL CELL, V17, P4645, DOI 10.1091/mbc.E06-04-0282; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Verrier F, 2011, NAT CHEM BIOL, V7, P909, DOI [10.1038/NCHEMBIO.690, 10.1038/nchembio.690]; Yamaoka T, 1997, J BIOL CHEM, V272, P17719, DOI 10.1074/jbc.272.28.17719; Yamaoka T, 2001, J BIOL CHEM, V276, P21285, DOI 10.1074/jbc.M011103200	20	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56203	10.1371/journal.pone.0056203	http://dx.doi.org/10.1371/journal.pone.0056203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405267	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400213
J	Becker, D; Wimmers, K; Luther, H; Hofer, A; Leeb, T				Becker, Doreen; Wimmers, Klaus; Luther, Henning; Hofer, Andreas; Leeb, Tosso			A Genome-Wide Association Study to Detect QTL for Commercially Important Traits in Swiss Large White Boars	PLOS ONE			English	Article							QUANTITATIVE TRAIT; CARCASS COMPOSITION; GENETIC-PARAMETERS; MEAT QUALITY; WILD BOAR; REPRODUCTION TRAITS; LOCI; PIG; GROWTH; IDENTIFICATION	The improvement of meat quality and production traits has high priority in the pork industry. Many of these traits show a low to moderate heritability and are difficult and expensive to measure. Their improvement by targeted breeding programs is challenging and requires knowledge of the genetic and molecular background. For this study we genotyped 192 artificial insemination boars of a commercial line derived from the Swiss Large White breed using the PorcineSNP60 BeadChip with 62,163 evenly spaced SNPs across the pig genome. We obtained 26 estimated breeding values (EBVs) for various traits including exterior, meat quality, reproduction, and production. The subsequent genome-wide association analysis allowed us to identify four QTL with suggestive significance for three of these traits (p-values ranging from 4.99 x 10(-6) to 2.73 x 10(-5)). Single QTL for the EBVs pH one hour post mortem (pH1) and carcass length were on pig chromosome (SSC) 14 and SSC 2, respectively. Two QTL for the EBV rear view hind legs were on SSC 10 and SSC 16.	[Becker, Doreen; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Wimmers, Klaus] Leibniz Inst Farm Anim Biol, Dummerstorf, Germany; [Luther, Henning; Hofer, Andreas] SUISAG, Sempach, Switzerland	University of Bern; Forschungsinstitut fur Nutztierbiologie (FBN)	Leeb, T (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Becker, Doreen/AAF-9108-2020; Leeb, Tosso/G-3187-2014; Wimmers, Klaus/AAF-9434-2020	Becker, Doreen/0000-0003-0425-6284; Leeb, Tosso/0000-0003-0553-4880; Wimmers, Klaus/0000-0002-9523-6790	German Research Council (DFG) [LE 1032/23-1]	German Research Council (DFG)(German Research Foundation (DFG))	This study was funded by a grant from the German Research Council (DFG LE 1032/23-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson-Eklund L, 1998, J ANIM SCI, V76, P694; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Koning DJ, 2001, LIVEST PROD SCI, V72, P185, DOI 10.1016/S0301-6226(01)00226-3; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Evans GJ, 2003, GENETICS, V164, P621; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Fontanesi L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-583; Geldermann H, 2003, J ANIM BREED GENET, V120, P363, DOI 10.1046/j.0931-2668.2003.00408.x; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gregersen VR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-22; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hermesch S, 2000, LIVEST PROD SCI, V65, P239, DOI 10.1016/S0301-6226(00)00150-0; Karlskov-Mortensen P, 2006, ANIM GENET, V37, P156, DOI 10.1111/j.1365-2052.2005.01405.x; Knott SA, 1998, GENETICS, V149, P1069; Lee GJ, 2003, ANIM SCI, V76, P155, DOI 10.1017/S1357729800053418; Lee SS, 2003, J ANIM BREED GENET, V120, P11, DOI 10.1046/j.0931-2668.2003.00419.x; Malek M, 2001, MAMM GENOME, V12, P630, DOI 10.1007/s003350020018; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Nezer C, 2002, GENET SEL EVOL, V34, P371, DOI [10.1051/gse:2002013, 10.1186/1297-9686-34-3-371]; Onteru SK, 2012, ANIM GENET, V43, P18, DOI 10.1111/j.1365-2052.2011.02213.x; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rohrer GA, 1998, J ANIM SCI, V76, P2255; Schneider JF, 2012, J ANIM SCI, V90, P3360, DOI 10.2527/jas.2011-4759; Sonesson AK, 1998, LIVEST PROD SCI, V57, P23, DOI 10.1016/S0301-6226(98)00163-8; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Uemoto Y, 2010, ANIM SCI J, V81, P28, DOI 10.1111/j.1740-0929.2009.00713.x; Uimari P, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-42; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; van Wijk HJ, 2005, J ANIM SCI, V83, P324; Wang JY, 2013, ANIM GENET, V44, P34, DOI 10.1111/j.1365-2052.2012.02366.x; Wilson K, 2012, J APPL GENET, V53, P449, DOI 10.1007/s13353-012-0112-2	37	27	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55951	10.1371/journal.pone.0055951	http://dx.doi.org/10.1371/journal.pone.0055951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393604	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800059
J	Bull, SC; Muldoon, MR; Doig, AJ				Bull, Simon C.; Muldoon, Mark R.; Doig, Andrew J.			Maximising the Size of Non-Redundant Protein Datasets Using Graph Theory	PLOS ONE			English	Article							MAXIMUM CLIQUE PROBLEM	Analysis of protein data sets often requires prior removal of redundancy, so that data is not biased by containing similar proteins. This is usually achieved by pairwise comparison of sequences, followed by purging so that no two pairs have similarities above a chosen threshold. From a starting set, such as the PDB or a genome, one should remove as few sequences as possible, to give the largest possible non-redundant set for subsequent analysis. Protein redundancy can be represented as a graph, with proteins as nodes connected by undirected edges, if they have a pairwise similarity above the chosen threshold. The problem is then equivalent to finding the maximum independent set (MIS), where as few nodes are removed as possible to remove all edges. We tested seven MIS algorithms, three of which are new. We applied the methods to the PDB, subsets of the PDB, various genomes and the BHOLSIB benchmark datasets. For PDB subsets of up to 1000 proteins, we could compare to the exact MIS, found by the Cliquer algorithm. The best algorithm was the new method, Leaf. This works by adding clique members that have no edges to nodes outside the clique to the MIS, starting with the smallest cliques. For PDB subsets of up to 1000 members, it usually finds the MIS and is fast enough to apply to data sets of tens of thousands of proteins. Leaf gives sets that are around 10% larger than the commonly used PISCES algorithm, that are of identical quality. We therefore suggest that Leaf should be the method of choice for generating non-redundant protein data sets, though it is ineffective on dense graphs, such as the BHOLSIB benchmarks. The Leaf algorithm is available at: https://github.com/SimonCB765/Leaf, and sets from genomes and the PDB are available at: http://www.bioinf.manchester.ac.uk/leaf/.	[Bull, Simon C.; Doig, Andrew J.] Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester, Lancs, England; [Muldoon, Mark R.] Univ Manchester, Sch Math, Manchester, Lancs, England	University of Manchester; University of Manchester	Doig, AJ (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester, Lancs, England.	andrew.doig@manchester.ac.uk	Muldoon, Mark/T-9192-2019; Muldoon, Mark R/C-7505-2009; Doig, Andrew/AAD-7456-2019	Doig, Andrew/0000-0003-0346-2270; Muldoon, Mark/0000-0002-5004-7195	BBSRC (UK)	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The BBSRC (UK) supported this work with a PhD studentship to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Balaji S., 2010, ADV MODEL OPTIM, V12, P107; Barton GJ, 1996, PROTEIN STRUCTURE PR; Grosso A, 2008, J HEURISTICS, V14, P587, DOI 10.1007/s10732-007-9055-x; HOBOHM U, 1994, PROTEIN SCI, V3, P522; Liu P, 2009, BIOINFORMATICS BIOME, P1; Niskanen S, 2003, CLIQUER USERS GUIDE; Ostergard PRJ, 2002, DISCRETE APPL MATH, V120, P197, DOI 10.1016/S0166-218X(01)00290-6; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224	11	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55484	10.1371/journal.pone.0055484	http://dx.doi.org/10.1371/journal.pone.0055484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393584	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000314692800038
J	Hodul, PJ; Dong, YB; Husain, K; Pimiento, JM; Chen, JD; Zhang, AY; Francois, R; Pledger, WJ; Coppola, D; Sebti, SM; Chen, DT; Malafa, MP				Hodul, Pamela J.; Dong, Yanbin; Husain, Kazim; Pimiento, Jose M.; Chen, Jiandong; Zhang, Anying; Francois, Rony; Pledger, Warren J.; Coppola, Domenico; Sebti, Said M.; Chen, Dung-Tsa; Malafa, Mokenge P.			Vitamin E delta-Tocotrienol Induces p27(Kip1) -Dependent Cell-Cycle Arrest in Pancreatic Cancer Cells via an E2F-1-Dependent Mechanism	PLOS ONE			English	Article							P27 EXPRESSION; POOR-PROGNOSIS; PROLIFERATION; RAS; PHOSPHORYLATION; LOCALIZATION; MUTATIONS; P21(CIP1); TUMOR; CHEMOPREVENTION	Vitamin E delta-tocotrienol has been shown to have antitumor activity, but the precise molecular mechanism by which it inhibits the proliferation of cancer cells remains unclear. Here, we demonstrated that delta-tocotrienol exerted significant cell growth inhibition pancreatic ductal cancer (PDCA) cells without affecting normal human pancreatic ductal epithelial cell growth. We also showed that delta-tocotrienol-induced growth inhibition occurred concomitantly with G(1) cell-cycle arrest and increased p27(Kip1) nuclear accumulation. This finding is significant considering that loss of nuclear p27(Kip1) expression is a well-established adverse prognostic factor in PDCA. Furthermore, delta-tocotrienol inactivated RAF-MEK-ERK signaling, a pathway known to suppress p27(Kip1) expression. To determine whether p27(Kip1) induction is required for delta-tocotrienol inhibition of PDCA cell proliferation, we stably silenced the CDKN1B gene, encoding p27(Kip1), in MIAPaCa-2 PDCA cells and demonstrated that p27(Kip1) silencing suppressed cell-cycle arrest induced by delta-tocotrienol. Furthermore, delta-tocotrienol induced p27(Kip1) mRNA expression but not its protein degradation. p27(Kip1) gene promoter activity was induced by delta-tocotrienol through the promoter's E2F-1 binding site, and this activity was attenuated by E2F-1 depletion using E2F-1 small interfering RNA. Finally, decreased proliferation, mediated by Ki67 and p27(Kip1) expression by delta-tocotrienol, was confirmed in vivo in a nude mouse xenograft pancreatic cancer model. Our findings reveal a new mechanism, dependent on p27(Kip1) induction, by which delta-tocotrienol can inhibit proliferation in PDCA cells, providing a new rationale for p27(Kip1) as a biomarker for delta-tocotrienol efficacy in pancreatic cancer prevention and therapy.	[Hodul, Pamela J.; Dong, Yanbin; Husain, Kazim; Pimiento, Jose M.; Malafa, Mokenge P.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA; [Chen, Jiandong; Pledger, Warren J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA; [Sebti, Said M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Chen, Dung-Tsa] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Biostat Core, Tampa, FL 33612 USA; [Zhang, Anying] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Francois, Rony] Univ Florida, Coll Med, Gainesville, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Electronic Science & Technology of China; State University System of Florida; University of Florida	Malafa, MP (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA.	mokenge.malafa@moffitt.org	Zhang, An/GRS-5852-2022; Pimiento, Jose M./AAA-8284-2021	Francois, Rony/0000-0003-4699-6336	National Institutes of Health (NIH) [1R01 CA-129227-01A1, 5RO1 CA-098473-05, DAVOS 69-15099-99-01, Bankhead-Coley 08BR-02]; Moffitt Foundation [Kurtz Pledge 09-33412-06-01, GI Cancer Research 09-33412-07-01, Steinmann Family Foundation 09-33412-08-05]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA098473, R01CA129227] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health (NIH) grant K12 Clinical Scholar in Oncology grant (to PJ Hodul) and by Moffitt Foundation grants (Kurtz Pledge 09-33412-06-01, GI Cancer Research 09-33412-07-01, and Steinmann Family Foundation 09-33412-08-05). This work was also supported by NIH grants 1R01 CA-129227-01A1, 5RO1 CA-098473-05, DAVOS 69-15099-99-01 (to MP Malafa), and Bankhead-Coley 08BR-02. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Bagui TK, 2003, MOL CELL BIOL, V23, P7285, DOI 10.1128/MCB.23.20.7285-7290.2003; Bagui TK, 2000, MOL CELL BIOL, V20, P8748, DOI 10.1128/MCB.20.23.8748-8757.2000; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Chan JM, 2005, CANCER EPIDEM BIOMAR, V14, P2093, DOI 10.1158/1055-9965.EPI-05-0226; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; ELSON CE, 1995, J NUTR, V125, pS1666; ELSON CE, 1994, J NUTR, V124, P607, DOI 10.1093/jn/124.5.607; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Furukawa T, 1996, AM J PATHOL, V148, P1763; GOULD MN, 1991, AM J CLIN NUTR, V53, pS1068, DOI 10.1093/ajcn/53.4.1068S; GRUNEWALD K, 1989, INT J CANCER, V43, P1037, DOI 10.1002/ijc.2910430614; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hu YX, 2000, PANCREAS, V21, P226, DOI 10.1097/00006676-200010000-00002; Husain K, 2011, MOL CANCER THER, V10, P2363, DOI 10.1158/1535-7163.MCT-11-0424; Husain K, 2009, PHARMACOLOGY, V83, P157, DOI 10.1159/000190792; Hussein D, 2009, PANCREAS, V38, pE124, DOI 10.1097/MPA.0b013e3181a20f9c; Ishimura N, 2003, CANCER LETT, V199, P169, DOI 10.1016/S0304-3835(03)00384-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Juuti A, 2003, ONCOLOGY-BASEL, V65, P371, DOI 10.1159/000074651; Kawa S, 2005, J STEROID BIOCHEM, V97, P173, DOI 10.1016/j.jsbmb.2005.06.021; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lu CD, 1999, CANCER, V85, P1250, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1250::AID-CNCR6>3.3.CO;2-R; MILLS PK, 1988, CANCER-AM CANCER SOC, V61, P2578, DOI 10.1002/1097-0142(19880615)61:12&lt;2578::AID-CNCR2820611232&gt;3.0.CO;2-0; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; MOTOJIMA K, 1993, ANN SURG, V217, P138, DOI 10.1097/00000658-199302000-00007; NGAH WZW, 1991, AM J CLIN NUTR, V53, pS1076, DOI 10.1093/ajcn/53.4.1076S; Orend G, 1998, ONCOGENE, V16, P2575, DOI 10.1038/sj.onc.1201791; PARKER RA, 1993, J BIOL CHEM, V268, P11230; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Sen CK, 2007, MOL ASPECTS MED, V28, P692, DOI 10.1016/j.mam.2007.03.001; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P5039, DOI 10.2741/2446; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; Springett GM, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-1299; Sylvester PW, 2005, FRONT BIOSCI, V10, P699, DOI 10.2741/1565; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Wada S, 2005, CANCER LETT, V229, P181, DOI 10.1016/j.canlet.2005.06.036; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Wiseman DA, 2007, J PHARMACOL EXP THER, V320, P1163, DOI 10.1124/jpet.106.111666; Xu WL, 2009, NUTRITION, V25, P555, DOI 10.1016/j.nut.2008.10.019; Zhou XH, 2009, ANAT REC, V292, P1122, DOI 10.1002/ar.20938	50	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e52526	10.1371/journal.pone.0052526	http://dx.doi.org/10.1371/journal.pone.0052526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393547	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800001
J	Jetha, NN; Semenchenko, V; Wishart, DS; Cashman, NR; Marziali, A				Jetha, Nahid N.; Semenchenko, Valentyna; Wishart, David S.; Cashman, Neil R.; Marziali, Andre			Nanopore Analysis of Wild-Type and Mutant Prion Protein (PrPC): Single Molecule Discrimination and PrPC Kinetics	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; HIDDEN MARKOV-MODELS; FATAL FAMILIAL INSOMNIA; DNA HAIRPIN MOLECULES; CONFORMATIONAL CONVERSION; DYNAMICS SIMULATIONS; ION-CHANNEL; SCRAPIE; PORE; POLYMORPHISM	Prion diseases are fatal neurodegenerative diseases associated with the conversion of cellular prion protein (PrPC) in the central nervous system into the infectious isoform (PrPSc). The mechanics of conversion are almost entirely unknown, with understanding stymied by the lack of an atomic-level structure for PrPSc. A number of pathogenic PrPC mutants exist that are characterized by an increased propensity for conversion into PrPSc and that differ from wild-type by only a single amino-acid point mutation in their primary structure. These mutations are known to perturb the stability and conformational dynamics of the protein. Understanding of how this occurs may provide insight into the mechanism of PrPC conversion. In this work we sought to explore wild-type and pathogenic mutant prion protein structure and dynamics by analysis of the current fluctuations through an organic alpha-hemolysin nanometer-scale pore (nanopore) in which a single prion protein has been captured electrophoretically. In doing this, we find that wild-type and D178N mutant PrPC, (a PrPC mutant associated with both Fatal Familial Insomnia and Creutzfeldt-Jakob disease), exhibit easily distinguishable current signatures and kinetics inside the pore and we further demonstrate, with the use of Hidden Markov Model signal processing, accurate discrimination between these two proteins at the single molecule level based on the kinetics of a single PrPC capture event. Moreover, we present a four-state model to describe wild-type PrPC kinetics in the pore as a first step in our investigation on characterizing the differences in kinetics and conformational dynamics between wild-type and D178N mutant PrPC. These results demonstrate the potential of nanopore analysis for highly sensitive, real-time protein and small molecule detection based on single molecule kinetics inside a nanopore, and show the utility of this technique as an assay to probe differences in stability between wild-type and mutant prion proteins at the single molecule level.	[Jetha, Nahid N.; Marziali, Andre] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada; [Semenchenko, Valentyna; Wishart, David S.] Natl Inst Nanotechnol, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Cashman, Neil R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; National Research Council Canada; University of Alberta; University of Alberta; University of British Columbia	Jetha, NN (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada.	nahid@phas.ubc.ca	Wishart, David Scott/ABI-3181-2020	Wishart, David S/0000-0002-3207-2434	PrioNet Canada; Natural Sciences and Engineering Research Council of Canada	PrioNet Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by PrioNet Canada (http://www.prionetcanada.ca/). NNJ received scholarship funding from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Alonso DOV, 2001, P NATL ACAD SCI USA, V98, P2985, DOI 10.1073/pnas.061555898; Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Barducci A, 2005, BIOPHYS J, V88, P1334, DOI 10.1529/biophysj.104.049882; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Caughey B, 1997, J VIROL, V71, P4107, DOI 10.1128/JVI.71.5.4107-4110.1997; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; CHUNG SH, 1990, PHILOS T R SOC B, V329, P265, DOI 10.1098/rstb.1990.0170; Churbanov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S13; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Coulthart MB, 2001, CAN MED ASSOC J, V165, P51; DeGuzman VS, 2006, NUCLEIC ACIDS RES, V34, P6425, DOI 10.1093/nar/gkl754; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Hatlo MM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.068101; Jetha NN, 2009, METHODS MOL BIOL, V544, P129, DOI 10.1007/978-1-59745-483-4_10; Jetha NN, 2009, METHODS MOL BIOL, V544, P113, DOI 10.1007/978-1-59745-483-4_9; Julien O, 2011, BIOCHEMISTRY-US, V50, P7536, DOI 10.1021/bi200731e; Lin JX, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158101; Ma L, 2010, CHEMBIOCHEM, V11, P25, DOI 10.1002/cbic.200900526; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Meli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019093; Merstorf C, 2012, ACS CHEM BIOL, V7, P652, DOI 10.1021/cb2004737; Mohammad MM, 2008, EUR BIOPHYS J BIOPHY, V37, P913, DOI 10.1007/s00249-008-0309-9; Mohammad MM, 2008, J AM CHEM SOC, V130, P4081, DOI 10.1021/ja710787a; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; Nandi PK, 2002, BIOCHEMISTRY-US, V41, P11017, DOI 10.1021/bi025886t; Pastoriza-Gallego M, 2011, J AM CHEM SOC, V133, P2923, DOI 10.1021/ja1073245; Payet L, 2012, ANAL CHEM, V84, P4071, DOI 10.1021/ac300129e; Perez-Pineiro R, 2011, FEBS J, V278, P4002, DOI 10.1111/j.1742-4658.2011.08304.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Soskine M, 2012, NANO LETT, V12, P4895, DOI 10.1021/nl3024438; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200; Venkataramanan L, 2002, BIOPHYS J, V82, P1930, DOI 10.1016/S0006-3495(02)75542-2; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Vercoutere WA, 2003, NUCLEIC ACIDS RES, V31, P1311, DOI 10.1093/nar/gkg218; Wanunu M, 2010, NAT NANOTECHNOL, V5, P160, DOI [10.1038/nnano.2009.379, 10.1038/NNANO.2009.379]; Winters-Hilt S, 2003, BIOPHYS J, V84, P967, DOI 10.1016/S0006-3495(03)74913-3; Zuegg J, 1999, BIOCHEMISTRY-US, V38, P13862, DOI 10.1021/bi991469d	45	12	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54982	10.1371/journal.pone.0054982	http://dx.doi.org/10.1371/journal.pone.0054982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393562	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800016
J	Kaur, K; Zarzoso, M; Ponce-Balbuena, D; Guerrero-Serna, G; Hou, LQ; Musa, H; Jalife, J				Kaur, Kuljeet; Zarzoso, Manuel; Ponce-Balbuena, Daniela; Guerrero-Serna, Guadalupe; Hou, Luqia; Musa, Hassan; Jalife, Jose			TGF-beta 1, Released by Myofibroblasts, Differentially Regulates Transcription and Function of Sodium and Potassium Channels in Adult Rat Ventricular Myocytes	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CARDIAC FIBROBLASTS; MYOCARDIAL-INFARCTION; ANGIOTENSIN-II; IN-VITRO; EXPRESSION; CELL; HYPERTROPHY; PHENOTYPE; CARDIOMYOCYTES	Cardiac injury promotes fibroblasts activation and differentiation into myofibroblasts, which are hypersecretory of multiple cytokines. It is unknown whether any of such cytokines are involved in the electrophysiological remodeling of adult cardiomyocytes. We cultured adult cardiomyocytes for 3 days in cardiac fibroblast conditioned medium (FCM) from adult rats. In whole-cell voltage-clamp experiments, FCM-treated myocytes had 41% more peak inward sodium current (I-Na) density at -40 mV than myocytes in control medium (p<0.01). In contrast, peak transient outward current (I-to) was decreased by similar to 55% at 60 mV (p<0.001). Protein analysis of FCM demonstrated that the concentration of TGF-beta 1 was >3 fold greater in FCM than control, which suggested that FCM effects could be mediated by TGF-beta 1. This was confirmed by pre-treatment with TGF-beta 1 neutralizing antibody, which abolished the FCM-induced changes in both I-Na and I-to. In current-clamp experiments TGF-beta 1 (10 ng/ml) prolonged the action potential duration at 30, 50, and 90 repolarization (p<0.05); at 50 ng/ml it gave rise to early afterdepolarizations. In voltage-clamp experiments, TGF-beta 1 increased I-Na density in a dose-dependent manner without affecting voltage dependence of activation or inactivation. I-Na density was -36.25 +/- 2.8 pA/pF in control, -59.17 +/- 6.2 pA/pF at 0.1 ng/ml (p<0.01), and -58.22 +/- 6.6 pA/pF at 1 ng/ml (p<0.01). In sharp contrast, I-to density decreased from 22.2 +/- 1.2 pA/pF to 12.7 +/- 0.98 pA/pF (p<0.001) at 10 ng/ml. At 1 ng/ml TGF-beta 1 significantly increased SCN5A (Na(V)1.5) (+73%; p<0.01), while reducing KCNIP2 (Kchip2; -77%; p<0.01) and KCND2 (K(V)4.2; -50% p<0.05) mRNA levels. Further, the TGF-beta 1-induced increase in I-Na was mediated through activation of the PI3K-AKT pathway via phosphorylation of FOXO1 (a negative regulator of SCN5A). TGF-beta 1 released by myofibroblasts differentially regulates transcription and function of the main cardiac sodium channel and of the channel responsible for the transient outward current. The results provide new mechanistic insight into the electrical remodeling associated with myocardial injury.	[Kaur, Kuljeet; Zarzoso, Manuel; Ponce-Balbuena, Daniela; Guerrero-Serna, Guadalupe; Hou, Luqia; Musa, Hassan; Jalife, Jose] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jalife, J (corresponding author), Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA.	jjalife@umich.edu	Jalife, Jose/L-4833-2015; Musa, Hassan/AAQ-1548-2021; Kaur, Kuljeet/R-4564-2017; Jalife, Jose/AAJ-9156-2021; Zarzoso, Manuel/AAA-6129-2019	Jalife, Jose/0000-0003-0080-3500; Kaur, Kuljeet/0000-0002-8075-5678; Jalife, Jose/0000-0003-0080-3500; Zarzoso, Manuel/0000-0003-3372-4497	National Institutes of Health Heart, Blood, and Lung Institute (NHLBI) [P01HL039707, P01HL087226]; Fondation Leducq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087226, P01HL039707] Funding Source: NIH RePORTER	National Institutes of Health Heart, Blood, and Lung Institute (NHLBI); Fondation Leducq(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Heart, Blood, and Lung Institute (NHLBI) Grants P01HL039707, P01HL087226, and by a Transatlantic Network of Excellence Program grant from Fondation Leducq (http://www.fondationleducq.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Azhar M, 2003, CYTOKINE GROWTH F R, V14, P391, DOI 10.1016/S1359-6101(03)00044-3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; Dobaczewski Marcin, 2009, Front Biosci (Schol Ed), V1, P391, DOI 10.2741/e33; Duffy HS, 2011, J CARDIOVASC PHARM, V57, P373, DOI 10.1097/FJC.0b013e3182155a38; EGHBALI M, 1991, CIRC RES, V69, P483, DOI 10.1161/01.RES.69.2.483; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Guo W, 1999, CARDIOVASC RES, V41, P157, DOI 10.1016/S0008-6363(98)00157-6; Harada M, 1997, CIRCULATION, V96, P3737; HEIMER R, 1995, J MOL CELL CARDIOL, V27, P2191, DOI 10.1016/S0022-2828(95)91479-X; Horio T, 2005, REGUL PEPTIDES, V124, P65, DOI 10.1016/j.regpep.2004.06.029; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Jia Y, 2006, CIRC RES, V98, P386, DOI 10.1161/01.RES.0000201956.86258.e1; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; King KL, 1996, ENDOCRINE, V5, P85, DOI 10.1007/BF02738660; Kupershmidt S, 1998, CIRC RES, V83, P441, DOI 10.1161/01.RES.83.4.441; LaFramboise WA, 2007, AM J PHYSIOL-CELL PH, V292, pC1799, DOI 10.1152/ajpcell.00166.2006; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li X, 2008, AM J PHYSIOL-HEART C, V295, pH416, DOI 10.1152/ajpheart.91446.2007; Mann DL, 2003, NEW ENGL J MED, V349, P1963, DOI 10.1056/NEJMe038163; Mao WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032738; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Nakazato Kazuhiko, 2010, Fukushima J Med Sci, V56, P1, DOI 10.5387/fms.56.1; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Panama BK, 2011, CIRC RES, V108, P537, DOI 10.1161/CIRCRESAHA.110.229112; Pathak M, 2001, HYPERTENSION, V37, P833, DOI 10.1161/01.HYP.37.3.833; Pedrotty DM, 2009, CARDIOVASC RES, V83, P688, DOI 10.1093/cvr/cvp164; Ramos-Mondragon R, 2011, PFLUG ARCH EUR J PHY, V461, P235, DOI 10.1007/s00424-010-0912-3; Ramos-Mondragon R, 2008, VASC HEALTH RISK MAN, V4, P1289; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shang LL, 2008, AM J PHYSIOL-CELL PH, V294, pC372, DOI 10.1152/ajpcell.00186.2007; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Trepanier-Boulay V, 2004, CARDIOVASC RES, V64, P84, DOI 10.1016/j.cardiores.2004.06.002; Vasquez C, 2010, CIRC RES, V107, P1011, DOI 10.1161/CIRCRESAHA.110.227421; Villarreal FJ, 1996, J MOL CELL CARDIOL, V28, P735, DOI 10.1006/jmcc.1996.0068; Wang JG, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-38; Zhang TT, 2001, CIRC RES, V88, P476, DOI 10.1161/01.RES.88.5.476	46	46	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55391	10.1371/journal.pone.0055391	http://dx.doi.org/10.1371/journal.pone.0055391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393573	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800027
J	Kim, HJ; Woo, HM; Ryu, J; Bok, J; Kim, JW; Choi, SB; Park, MH; Park, HY; Koo, SK				Kim, Hyung Jin; Woo, Hae-Mi; Ryu, Jihee; Bok, Jinwoong; Kim, Jin Woo; Choi, Sang Back; Park, Mi-Hyun; Park, Hyun-Young; Koo, Soo Kyung			Conditional Deletion of Pten Leads to Defects in Nerve Innervation and Neuronal Survival in Inner Ear Development	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; TUMOR-SUPPRESSOR; SENSORY NEURONS; OTIC PLACODE; GROWTH; MOUSE; MICE; PROLIFERATION; COCHLEA; BRAIN	All cellular phenomena and developmental events, including inner ear development, are modulated through harmonized signaling networks. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a tumor suppressor, is a major signaling component involved in cross talk with key regulators of development; i.e., Wnt, Notch, and bone morphogenetic proteins. Although Pten function has been studied in various systems, its role in inner ear development is poorly understood. Here, we used inner ear-specific Pten conditional knockout mice and examined the characteristics of the inner ear. In a detailed analysis of the phenotype, reduced cochlear turning and widened epithelia were observed. Phalloidin staining of sensory epithelium revealed that hair cell patterns were disturbed; i.e., additional rows of hair cells were discovered. The neural abnormality revealed a reduction in and disorganization of nerve fibers, including apoptosis at the neural precursor stage. Pten deficiency induced increased phosphorylation of Akt at Ser473. The elevation of inhibitory glycogen synthase kinase 3 beta Ser9 phosphorylation (pGSK3 beta) was sustained until the neuronal differentiation stage at embryonic day 14.5, instead of pGSK3 beta downregulation. This is the first report on the influence of Pten/Akt/GSK3 beta signaling on the development of spiral ganglia. These results suggest that Pten is required for the maintenance of neuroblast number, neural precursors, and differentiation in the inner ear.	[Kim, Hyung Jin; Woo, Hae-Mi; Ryu, Jihee; Choi, Sang Back; Park, Mi-Hyun; Park, Hyun-Young; Koo, Soo Kyung] Natl Inst Hlth, Ctr Biomed Sci, Cheongwon Gun, Chungcheongbuk, South Korea; [Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, Project Med Sci BK21, Seoul, South Korea; [Kim, Jin Woo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST)	Koo, SK (corresponding author), Natl Inst Hlth, Ctr Biomed Sci, Osong Hlth Technol Adm Complex 643, Cheongwon Gun, Chungcheongbuk, South Korea.	skkoo@nih.go.kr	KIM, JIN WOO/C-1655-2011; Bok, Jinwoong/M-2834-2019	KIM, JIN WOO/0000-0003-0767-1918; Bok, Jinwoong/0000-0003-1958-1872; Park, Hyun-Young/0000-0002-6698-7368	Korea National Institute of Health [4800-4845-300-210, 2100-N63005-00, 4800-4845-302-210, 2012-N61001-00]	Korea National Institute of Health	This study was supported by a Korea National Institute of Health intramural research grant 4800-4845-300-210 (no. 2100-N63005-00) and 4800-4845-302-210 (no. 2012-N61001-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030790; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Chang W, 2002, DEV BIOL, V251, P380, DOI 10.1006/dbio.2002.0822; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dong YY, 2010, NEUROREPORT, V21, P731, DOI 10.1097/WNR.0b013e32833bfb5e; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; Fritzsch B, 1997, J NEUROSCI, V17, P6213; FRITZSCH B, 1993, HEARING RES, V65, P51, DOI 10.1016/0378-5955(93)90200-K; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Iwata T, 2009, DEV GROWTH DIFFER, V51, P299, DOI 10.1111/j.1440-169X.2009.01104.x; Kazdoba TM, 2012, DEV NEUROSCI-BASEL, V34, P198, DOI 10.1159/000337229; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kim WY, 2001, DEVELOPMENT, V128, P417; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; Liu B, 2009, BBA-BIOMEMBRANES, V1788, P2174, DOI 10.1016/j.bbamem.2009.07.016; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marino S, 2002, DEVELOPMENT, V129, P3513; Monet M, 2012, J BIOL CHEM, V287, P17672, DOI 10.1074/jbc.M112.341354; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Morsli H, 1998, J NEUROSCI, V18, P3327; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Okano T, 2011, J NEUROSCI, V31, P18104, DOI 10.1523/JNEUROSCI.3619-11.2011; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sha SH, 2010, HEARING RES, V264, P86, DOI 10.1016/j.heares.2009.09.002; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Wangemann P, 2011, CELL PHYSIOL BIOCHEM, V28, P527, DOI 10.1159/000335113; Wu DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008409; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55609	10.1371/journal.pone.0055609	http://dx.doi.org/10.1371/journal.pone.0055609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393595	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800049
J	Schechter, SP; Bruns, TD				Schechter, Shannon P.; Bruns, Thomas D.			A Common Garden Test of Host-Symbiont Specificity Supports a Dominant Role for Soil Type in Determining AMF Assemblage Structure in Collinsia sparsiflora	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; EVOLUTIONARY ECOLOGY; LOCAL ADAPTATION; PLANT HOST; SERPENTINE; DIVERSITY; COMMUNITIES; POPULATION; MUTUALISTS; SELECTION	Specialization in plant host-symbiont-soil interactions may help mediate plant adaptation to edaphic stress. Our previous field study showed ecological evidence for host-symbiont specificity between serpentine and non-serpentine adapted ecotypes of Collinsia sparsiflora and arbuscular mycorrrhizal fungi (AMF). To test for adapted plant ecotype-AMF specificity between C. sparsiflora ecotypes and field AMF taxa, we conducted an AMF common garden greenhouse experiment. We grew C. sparsiflora ecotypes individually in a common pool of serpentine and non-serpentine AMF then identified the root AMF by amplifying rDNA, cloning, and sequencing and compared common garden AMF associates to serpentine and non-serpentine AMF controls. Mixing of serpentine and non-serpentine AMF soil inoculum resulted in an intermediate soil classified as non-serpentine soil type. Within this common garden both host ecotypes associated with AMF assemblages that resembled those seen in a non-serpentine soil. ANOSIM analysis and MDS ordination showed that common garden AMF assemblages differed significantly from those in the serpentine-only controls (R = 0.643, P < 0.001), but were similar the non-serpentine-only control AMF assemblages (R = 0.081, P < 0.31). There was no evidence of adapted host ecotype-AMF specificity. Instead soil type accounted for most of the variation AM fungi association patterns, and some differences between field and greenhouse behavior of individual AM fungi were found.	[Schechter, Shannon P.; Bruns, Thomas D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schechter, SP (corresponding author), US EPA, Robert S Kerr Environm Res Ctr, Ada, OK USA.	Schechter.Shannon@epa.gov			U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program; University of California Natural Reserve System; Mycological Society of San Francisco; NSF [2036096]	U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program(United States Environmental Protection Agency); University of California Natural Reserve System; Mycological Society of San Francisco; NSF(National Science Foundation (NSF))	This research has been supported by a grant from the U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program (http://www.epa.gov/ncer/rfa/2012/2012_star_gradfellow.html), by a grant from the University of California Natural Reserve System (http://nrs.ucop.edu/), a grant from the Mycological Society of San Francisco (http://www.mssf.org/), and NSF Grant #2036096 (T.D. Bruns). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Bidartondo MI, 2002, NATURE, V419, P389, DOI 10.1038/nature01054; Bonfante P, 2008, TRENDS PLANT SCI, V13, P492, DOI 10.1016/j.tplants.2008.07.001; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Clarke K. R., 2001, CHANGES MARINE COMMU; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Croll D, 2008, NEW PHYTOL, V178, P672, DOI 10.1111/j.1469-8137.2008.02381.x; Douds DD, 1998, NEW PHYTOL, V138, P27, DOI 10.1046/j.1469-8137.1998.00876.x; Ehinger M, 2009, NEW PHYTOL, V184, P412, DOI 10.1111/j.1469-8137.2009.02983.x; Gonzalez-Chavez C, 2002, NEW PHYTOL, V155, P163, DOI 10.1046/j.1469-8137.2002.00430.x; Hausmann NT, 2010, ECOLOGY, V91, P2333, DOI 10.1890/09-0924.1; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Helgason T, 2002, J ECOL, V90, P371, DOI 10.1046/j.1365-2745.2001.00674.x; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Ji BM, 2010, ECOLOGY, V91, P3037, DOI 10.1890/09-1451.1; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kruckeberg A.R., 1984, CALIFORNIA SERPENTIN; Linderman RG, 2004, SCI HORTIC-AMSTERDAM, V99, P67, DOI 10.1016/S0304-4238(03)00081-5; MADDISON D, 2005, MACCLADE ANAL PHYLOG; Mangan SA, 2010, ECOLOGY, V91, P2594, DOI 10.1890/09-0396.1; Merckx V, 2008, P ROY SOC B-BIOL SCI, V275, P1029, DOI 10.1098/rspb.2007.1622; Peters SM, 2001, ARID LAND RES MANAG, V15, P359, DOI 10.1080/153249801753127642; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Pringle A, 2002, AM J BOT, V89, P1439, DOI 10.3732/ajb.89.9.1439; Rajakaruna N, 2004, INT GEOL REV, V46, P471, DOI 10.2747/0020-6814.46.5.471; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Renker C, 2006, MYCORRHIZA, V16, P525, DOI 10.1007/s00572-006-0067-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Schechter SP, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00059.1; Schultz PA, 2001, AM J BOT, V88, P1650, DOI 10.2307/3558410; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sykorova Z, 2007, MYCORRHIZA, V18, P1, DOI 10.1007/s00572-007-0147-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thrall PH, 2008, J ECOL, V96, P746, DOI 10.1111/j.1365-2745.2008.01381.x; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Walker C, 2007, MYCOL RES, V111, P137, DOI 10.1016/j.mycres.2006.11.008; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wright JW, 2007, NEW PHYTOL, V173, P354, DOI 10.1111/j.1469-8137.2006.01925.x; Wright JW, 2006, ECOLOGY, V87, P2433, DOI 10.1890/0012-9658(2006)87[2433:EVOENM]2.0.CO;2; Wright JW, 2006, EVOL ECOL RES, V8, P1; Zwickl D. J, 2006, GENETIC ALGORITHM AP	48	18	18	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55507	10.1371/journal.pone.0055507	http://dx.doi.org/10.1371/journal.pone.0055507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393588	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800042
J	Stefanaki, I; Panagiotou, OA; Kodela, E; Gogas, H; Kypreou, KP; Chatzinasiou, F; Nikolaou, V; Plaka, M; Kalfa, I; Antoniou, C; Ioannidis, JPA; Evangelou, E; Stratigos, AJ				Stefanaki, Irene; Panagiotou, Orestis A.; Kodela, Elisavet; Gogas, Helen; Kypreou, Katerina P.; Chatzinasiou, Foteini; Nikolaou, Vasiliki; Plaka, Michaela; Kalfa, Iro; Antoniou, Christina; Ioannidis, John P. A.; Evangelou, Evangelos; Stratigos, Alexander J.			Replication and Predictive Value of SNPs Associated with Melanoma and Pigmentation Traits in a Southern European Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR MC1R GENE; CUTANEOUS MALIGNANT-MELANOMA; MELANOCORTIN-1 RECEPTOR; RISK-FACTORS; SKIN-CANCER; SUSCEPTIBILITY GENES; SEQUENCE VARIANTS; GREEK PATIENTS; IDENTIFIES 3	Background: Genetic association studies have revealed numerous polymorphisms conferring susceptibility to melanoma. We aimed to replicate previously discovered melanoma-associated single-nucleotide polymorphisms (SNPs) in a Greek case-control population, and examine their predictive value. Methods: Based on a field synopsis of genetic variants of melanoma (MelGene), we genotyped 284 patients and 284 controls at 34 melanoma-associated SNPs of which 19 derived from GWAS. We tested each one of the 33 SNPs passing quality control for association with melanoma both with and without accounting for the presence of well-established phenotypic risk factors. We compared the risk allele frequencies between the Greek population and the HapMap CEU sample. Finally, we evaluated the predictive ability of the replicated SNPs. Results: Risk allele frequencies were significantly lower compared to the HapMap CEU for eight SNPs (rs16891982 - SLC45A2, rs12203592 - IRF4, rs258322 - CDK10, rs1805007 - MC1R, rs1805008 - MC1R, rs910873 - PIGU, rs17305573 - PIGU, and rs1885120 - MTAP) and higher for one SNP (rs6001027 - PLA2G6) indicating a different profile of genetic susceptibility in the studied population. Previously identified effect estimates modestly correlated with those found in our population (r = 0.72, P<0.0001). The strongest associations were observed for rs401681-T in CLPTM1L (odds ratio [OR] 1.60, 95% CI 1.22-2.10; P = 0.001), rs16891982-C in SCL45A2 (OR 0.51, 95% CI 0.34-0.76; P = 0.001), and rs1805007-T in MC1R (OR 4.38, 95% CI 2.03-9.43; P = 2610 25). Nominally statistically significant associations were seen also for another 5 variants (rs258322-T in CDK10, rs1805005-T in MC1R, rs1885120-C in MYH7B, rs2218220-T in MTAP and rs4911442-G in the ASIP region). The addition of all SNPs with nominal significance to a clinical non-genetic model did not substantially improve melanoma risk prediction (AUC for clinical model 83.3% versus 83.9%, p = 0.66). Conclusion: Overall, our study has validated genetic variants that are likely to contribute to melanoma susceptibility in the Greek population.	[Stefanaki, Irene; Kodela, Elisavet; Kypreou, Katerina P.; Chatzinasiou, Foteini; Nikolaou, Vasiliki; Plaka, Michaela; Antoniou, Christina; Stratigos, Alexander J.] Univ Athens, Sch Med, Andreas Sygros Hosp, Dept Dermatol, GR-11527 Athens, Greece; [Panagiotou, Orestis A.; Ioannidis, John P. A.; Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Gogas, Helen] Univ Athens, Laikon Hosp, Dept Internal Med, Athens, Greece; [Kalfa, Iro] Laikon Gen Hosp, Blood Donat Unit, Athens, Greece; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Evangelou, Evangelos] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England	Athens Medical School; National & Kapodistrian University of Athens; University of Ioannina; Laiko General Hospital; National & Kapodistrian University of Athens; Laiko General Hospital; Stanford University; Stanford University; Stanford University; University of London; King's College London	Stratigos, AJ (corresponding author), Univ Athens, Sch Med, Andreas Sygros Hosp, Dept Dermatol, GR-11527 Athens, Greece.	alstrat@hol.gr	Stefanaki, Irene/AAT-2771-2021; Evangelou, Evangelos/C-3033-2013; Ioannidis, John P. A./G-9836-2011; Panagiotou, Orestis A/I-5934-2015; Panagiotou, Orestis/AAI-1268-2021; Nikolaou, Vasiliki/AAQ-7874-2021	Stefanaki, Irene/0000-0002-2964-370X; Evangelou, Evangelos/0000-0002-5488-2999; Panagiotou, Orestis A/0000-0001-9604-8380; Nikolaou, Vasiliki/0000-0001-9340-9152	Aristeia Program; European Social Fund and National Resources [1094]	Aristeia Program; European Social Fund and National Resources(European Social Fund (ESF))	The present work was funded by Aristeia Program. This Program is co-funded by the European Social Fund and National Resources (Project code: 1094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bastiaens M, 2001, HUM MOL GENET, V10, P1701, DOI 10.1093/hmg/10.16.1701; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Bataille V, 2003, EUR J CANCER, V39, P1341, DOI 10.1016/S0959-8049(03)00313-7; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Berwick M, 2006, CANCER EPIDEM BIOMAR, V15, P1520, DOI 10.1158/1055-9965.EPI-06-0270; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Chatzinasiou F, 2011, JNCI-J NATL CANCER I, V103, P1227, DOI 10.1093/jnci/djr219; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Fargnoli MC, 2006, EXPERT REV ANTICANC, V6, P657, DOI 10.1586/14737140.6.5.657; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Ioannidis JPA, 2012, ARCH INTERN MED, V172, P744, DOI 10.1001/archinternmed.2012.931; Kefford RF, 1999, J CLIN ONCOL, V17, P3245, DOI 10.1200/JCO.1999.17.10.3245; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Lasithiotakis K, 2006, INT J DERMATOL, V45, P397, DOI 10.1111/j.1365-4632.2006.02492.x; Lasithiotakis K, 2004, EUR J CANCER, V40, P2502, DOI 10.1016/j.ejca.2004.06.032; Law MH, 2012, J INVEST DERMATOL, V132, P1763, DOI 10.1038/jid.2012.75; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Matichard E, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011536; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Nikolaou V, 2011, BRIT J DERMATOL, V165, P1219, DOI 10.1111/j.1365-2133.2011.10551.x; Nikolaou VA, 2008, CANCER CAUSE CONTROL, V19, P671, DOI 10.1007/s10552-008-9130-0; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Shekar SN, 2009, J INVEST DERMATOL, V129, P2211, DOI 10.1038/jid.2009.48; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Stratigos AJ, 2006, J INVEST DERMATOL, V126, P399, DOI 10.1038/sj.jid.5700078; Stratigos AJ, 2006, J INVEST DERMATOL, V126, P1842, DOI 10.1038/sj.jid.5700292; Titus-Ernstoff L, 2005, INT J CANCER, V116, P144, DOI 10.1002/ijc.21001; Tucker MA, 2003, ONCOGENE, V22, P3042, DOI 10.1038/sj.onc.1206444; Wacholder S, 2012, AM J EPIDEMIOL, V176, P495, DOI 10.1093/aje/kws255; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630	51	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55712	10.1371/journal.pone.0055712	http://dx.doi.org/10.1371/journal.pone.0055712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393597	gold, Green Submitted, Green Published			2022-12-27	WOS:000314692800051
J	Takasaki, K; Miura, T; Kanno, M; Tamaki, H; Hanada, S; Kamagata, Y; Kimura, N				Takasaki, Kazuto; Miura, Takamasa; Kanno, Manabu; Tamaki, Hideyuki; Hanada, Satoshi; Kamagata, Yoichi; Kimura, Nobutada			Discovery of Glycoside Hydrolase Enzymes in an AvicelAdapted Forest Soil Fungal Community by a Metatranscriptomic Approach	PLOS ONE			English	Article							CELL-WALLS; DIVERSITY; EXPANSIN; GENES; RNA; HYDROLYSIS; DISRUPTION; PROTEIN	To discover the structural and functional novel glycoside hydrolase enzymes from soil fungal communities that decompose cellulosic biomass, transcripts of functional genes in a forest soil were analyzed. Pyrosequencing of the Avicel and wheat-amended soil cDNAs produced 56,084 putative protein-coding sequence (CDS) fragments, and the most dominant group of putative CDSs based on the taxonomic analysis was assigned to the domain Eukarya, which accounted for 99% of the total number of the putative CDSs. Of 9,449 eukaryotic CDSs whose functions could be categorized, approximately 40% of the putative CDSs corresponded to metabolism-related genes, including genes involved in carbohydrate, amino acid, and energy metabolism. Among the carbohydrate-metabolism genes, 129 sequences encoded glycoside hydrolase enzymes, with 47 sequences being putative cellulases belonging to 13 GH families. To characterize the function of glycoside hydrolase enzymes, we synthesized the putative CelA gene with codon optimization for heterologous expression in Escherichia coli, which was shown to be similar to the structure of plant expansins, and observed stimulation for cellulase activity on Avicel degradation. This study demonstrated that fungal communities adapt to Avicel and wheat decomposition and that metatranscriptomic sequence data can be reference data for identifying a novel gene.	[Takasaki, Kazuto; Miura, Takamasa; Kanno, Manabu; Tamaki, Hideyuki; Hanada, Satoshi; Kamagata, Yoichi; Kimura, Nobutada] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kimura, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.	n-kimura@aist.go.jp	Tamaki, Hideyuki/M-9863-2016; Kanno, Manabu/M-4244-2016	Kanno, Manabu/0000-0003-2410-8756	New Energy and industrial technology Development Organization (NEDO) in Japan	New Energy and industrial technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported by the New Energy and industrial technology Development Organization (NEDO) in Japan (http://www.nedo.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Botero LM, 2005, APPL ENVIRON MICROB, V71, P1267, DOI 10.1128/AEM.71.3.1267-1275.2005; Bouzarelou D, 2008, FUNGAL GENET BIOL, V45, P839, DOI 10.1016/j.fgb.2008.03.001; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Cowan DA, 2000, TRENDS BIOTECHNOL, V18, P14, DOI 10.1016/S0167-7799(99)01395-5; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; GOODAY GW, 1977, J GEN MICROBIOL, V99, P1; Grant S, 2006, APPL ENVIRON MICROB, V72, P135, DOI 10.1128/AEM.72.1.135-143.2006; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Lara E, 2007, FEMS MICROBIOL ECOL, V62, P365, DOI 10.1111/j.1574-6941.2007.00387.x; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; McGrath KC, 2008, J MICROBIOL METH, V75, P172, DOI 10.1016/j.mimet.2008.05.019; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Moon-van der Staay SY, 2006, FEMS MICROBIOL ECOL, V57, P420, DOI 10.1111/j.1574-6941.2006.00130.x; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Voget S, 2003, APPL ENVIRON MICROB, V69, P6235, DOI 10.1128/AEM.69.10.6235-6242.2003; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zachow C, 2009, ISME J, V3, P79, DOI 10.1038/ismej.2008.87	37	23	24	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55485	10.1371/journal.pone.0055485	http://dx.doi.org/10.1371/journal.pone.0055485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393585	Green Submitted, gold, Green Published			2022-12-27	WOS:000314692800039
J	Uchida, Y; Maezawa, Y; Uchida, Y; Hiruta, N; Shimoyama, E; Kawai, S				Uchida, Yasumi; Maezawa, Yuko; Uchida, Yasuto; Hiruta, Nobuyuki; Shimoyama, Ei; Kawai, Seiji			Localization of Oxidized Low-Density Lipoprotein and Its Relation to Plaque Morphology in Human Coronary Artery	PLOS ONE			English	Article							ATHEROSCLEROTIC LESIONS; MACROPHAGES; LDL; OXIDATION; VISUALIZATION; ACCUMULATION; CELLS	Objectives: Oxidized low-density lipoprotein (oxLDL) plays a key role in the formation of atherosclerotic plaques. However, its localization in human coronary arterial wall is not well understood. The present study was performed to visualize deposition sites and patterns of native oxLDL and their relation to plaque morphology in human coronary artery. Methods: Evans blue dye (EB) elicits a violet fluorescence by excitation at 345-nm and emission at 420-nm, and a reddish-brown fluorescence by excitation at 470-nm and emission at 515-nm characteristic of oxLDL only. Therefore, native oxLDL in excised human coronary artery were investigated by color fluorescent microscopy (CFM) using EB as a biomarker. Results: (1) By luminal surface scan with CFM, the % incidence of oxLDL in 38 normal segments, 41 white plaques and 32 yellow plaques that were classified by conventional angioscopy, was respectively 26, 44 and 94, indicating significantly (p<0.05) higher incidence in the latter than the former two groups. Distribution pattern was classified as patchy, diffuse and web-like. Web-like pattern was observed only in yellow plaques with necrotic core. (2) By transected surface scan, oxLDL deposited within superficial layer in normal segments and diffusely within both superficial and deep layers in white and yellow plaques. In yellow plaques with necrotic core, oxLDL deposited not only in the marginal zone of the necrotic core but also in the fibrous cap. Conclusion: Taken into consideration of the well-known process of coronary plaque growth, the results suggest that oxLDL begins to deposit in human coronary artery wall before plaque formation and increasingly deposits with plaque growth, exhibiting different deposition sites and patterns depending on morphological changes.	[Uchida, Yasumi] Japan Fdn Cardiovasc Res, Funabashi, Chiba, Japan; [Maezawa, Yuko] Chiba Univ, Dept Cellular Therapy, Chiba, Japan; [Uchida, Yasuto] Toho Univ, Ohmori Hosp, Dept Cardiol, Tokyo, Japan; [Hiruta, Nobuyuki] Toho Univ, Sakura Hosp, Dept Pathol, Sakura, Japan; [Shimoyama, Ei] Funabashi Futawa Hosp, Dept Pathol, Funabashi, Chiba, Japan; [Kawai, Seiji] Chiba Kensei Hosp, Dept Surg, Chiba, Japan	Chiba University; Toho University; Toho University	Uchida, Y (corresponding author), Japan Fdn Cardiovasc Res, Funabashi, Chiba, Japan.	uchiy@ta2.so-net.ne.jp		Maezawa, Yoshiro/0000-0001-5567-9901				Al Gadban MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012534; BALL RY, 1995, ATHEROSCLEROSIS, V114, P45, DOI 10.1016/0021-9150(94)05463-S; Briley-Saebo KC, 2008, CIRCULATION, V117, P3206, DOI 10.1161/CIRCULATIONAHA.107.757120; Chen JH, 2009, ARTERIOSCL THROM VAS, V29, P92, DOI 10.1161/ATVBAHA.108.174599; Fang LH, 2011, J CLIN INVEST, V121, P4861, DOI 10.1172/JCI57755; Fukuchi M, 2002, LAB INVEST, V82, P1437, DOI 10.1097/01.LAB.0000032546.01658.5D; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Harvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183; Itabe H, 2000, BBA-MOL CELL BIOL L, V1487, P233, DOI 10.1016/S1388-1981(00)00098-6; Iuliano L, 1996, ATHEROSCLEROSIS, V126, P131; Kayo S, 2004, AM HEART J, V148, P818, DOI 10.1016/j.ahj.2004.05.042; Li W, 1998, ARTERIOSCL THROM VAS, V18, P177, DOI 10.1161/01.ATV.18.2.177; Matsuura E, 2008, AUTOIMMUN REV, V7, P558, DOI 10.1016/j.autrev.2008.04.018; Okura Y, 2000, CIRCULATION, V102, P2680, DOI 10.1161/01.CIR.102.22.2680; Ovchinnikova O, 2009, ARTERIOSCL THROM VAS, V29, P1478, DOI 10.1161/ATVBAHA.109.188185; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; SHAH PK, 1995, CIRCULATION, V92, P1565; Shah PK, 2009, CARDIOVASC DRUG THER, V23, P31, DOI 10.1007/s10557-008-6147-2; Sigala F, 2010, J VASC SURG, V52, P704, DOI 10.1016/j.jvs.2010.03.047; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; TERASAWA K, 2000, J JPN COLL ANGIOL, V40, P159; Tsimikas S, 1999, J NUCL CARDIOL, V6, P41, DOI 10.1016/S1071-3581(99)90064-8; UCHIDA Y, 1995, AM HEART J, V130, P1114, DOI 10.1016/0002-8703(95)90216-3; UCHIDA Y, 2006, Patent No. 7025981; Uchida Y, 2001, CORONARY ANGIOSCOPY, P71; Uchida Y, 2012, MOL IMAGING, P247; Uchida Y, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/JOURNAL.PONE.0031530; Uchida Y, 2001, CORONARY ANGIOSCOPY, P51; Uchida Y, 2001, CORONARY ANGIOSCOPY, P14; Uchida Y, 2011, CIRC J, V75, P1913, DOI 10.1253/circj.CJ-10-1286; Uchida Y, 2011, ARTERIOSCL THROM VAS, V31, P1452, DOI 10.1161/ATVBAHA.110.221671; Uchida Y, 2010, CIRC J, V74, P2181, DOI 10.1253/circj.CJ-10-0451; Uchida Y, 2010, JACC-CARDIOVASC IMAG, V3, P398, DOI 10.1016/j.jcmg.2009.09.030; Vickers KC, 2009, J LIPID RES, V50, P1735, DOI 10.1194/jlr.M800342-JLR200; Yamada Nobuhiro, 2002, Nihon Rinsho, V60 Suppl 10, P87; Yancey PG, 1998, J LIPID RES, V39, P1349; Zaima N, 2011, ATHEROSCLEROSIS, V217, P427, DOI 10.1016/j.atherosclerosis.2011.03.044	37	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55188	10.1371/journal.pone.0055188	http://dx.doi.org/10.1371/journal.pone.0055188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393566	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800020
J	Gao, XN; Lin, J; Ning, QY; Gao, L; Yao, YS; Zhou, JH; Li, YH; Wang, LL; Yu, L				Gao, Xiao-ning; Lin, Ji; Ning, Qiao-yang; Gao, Li; Yao, Yu-shi; Zhou, Ji-hao; Li, Yong-hui; Wang, Li-li; Yu, Li			A Histone Acetyltransferase p300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MONOCYTIC LEUKEMIA; G1/S TRANSITION; FUSION PROTEIN; AML1-ETO; CBP/P300; AML1/ETO; TRANSCRIPTION; PATHWAYS; KINASE	AML1-ETO fusion protein (AE) is generated by t(8;21)(q22;q22) chromosomal translocation, which is one of the most frequently observed structural abnormalities in acute myeloid leukemia (AML) and displays a pivotal role in leukemogenesis. The histone acetyltransferase p300 promotes self-renewal of leukemia cells by acetylating AE and facilitating its downstream gene expression as a transcriptional coactivator, suggesting that p300 may be a potential therapeutic target for AE-positive AML. However, the effects of p300 inhibitors on leukemia cells and the underlying mechanisms have not been extensively investigated. In the current study, we analyzed the anti-leukemia effects of C646, a selective and competitive p300 inhibitor, on AML cells. Results showed that C646 inhibited cellular proliferation, reduced colony formation, evoked partial cell cycle arrest in G1 phase, and induced apoptosis in AE-positive AML cell lines and primary blasts isolated from leukemic mice and AML patients. Nevertheless, no significant inhibitory effects were observed in granulocyte colony-stimulating factor-mobilized normal peripheral blood stem cells. Notably, AE-positive AML cells were more sensitive to lower C646 doses than AE-negative ones. And C646-induced growth inhibition on AE-positive AML cells was associated with reduced global histone H3 acetylation and declined c-kit and bcl-2 levels. Therefore, C646 may be a potential candidate for treating AE-positive AML.	[Gao, Xiao-ning; Ning, Qiao-yang; Gao, Li; Yao, Yu-shi; Zhou, Ji-hao; Li, Yong-hui; Wang, Li-li; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Lin, Ji] Chinese Peoples Liberat Army Gen Hosp, Cent Lab, Hainan Branch, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China.	chunhuiliyu@yahoo.com	wang, lili/HDL-7210-2022	Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [81000221, 81171820, 90919044, 30971297]; Beijing Natural Science Foundation [7122169, 7112126]; Beijing New Stars Program of Science and Technology [2010B075]; National Public Health Grand Research Foundation [201202017]; Capital Public Health Project [Z111107067311070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing New Stars Program of Science and Technology; National Public Health Grand Research Foundation; Capital Public Health Project	This work was supported by the National Natural Science Foundation of China (No. 81000221, No. 81171820, No. 90919044 and No. 30971297), the Beijing Natural Science Foundation (No. 7122169, No. 7112126), the Beijing New Stars Program of Science and Technology (No. 2010B075), the National Public Health Grand Research Foundation (No. 201202017) and the Capital Public Health Project (No. Z111107067311070). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Chan HM, 2001, J CELL SCI, V114, P2363; Elagib KE, 2007, CANCER LETT, V251, P179, DOI 10.1016/j.canlet.2006.10.010; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Fazi F, 2007, BLOOD, V109, P4432, DOI 10.1182/blood-2006-09-045781; Feng LX, 2000, J BIOL CHEM, V275, P25572, DOI 10.1074/jbc.M002218200; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goodman RH, 2000, GENE DEV, V14, P1553; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Grisolano JL, 2003, P NATL ACAD SCI USA, V100, P9506, DOI 10.1073/pnas.1531730100; Iyer NG, 2007, ONCOGENE, V26, P21, DOI 10.1038/sj.onc.1209771; Katsumoto T, 2008, CANCER SCI, V99, P1523, DOI 10.1111/j.1349-7006.2008.00865.x; Kitabayashi I, 2001, LEUKEMIA, V15, P89, DOI 10.1038/sj.leu.2401983; Klampfer L, 1996, P NATL ACAD SCI USA, V93, P14059, DOI 10.1073/pnas.93.24.14059; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Santer FR, 2011, MOL CANCER THER, V10, P1644, DOI 10.1158/1535-7163.MCT-11-0182; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662; Wang YY, 2011, P NATL ACAD SCI USA, V108, P2450, DOI 10.1073/pnas.1019625108; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443	22	72	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55481	10.1371/journal.pone.0055481	http://dx.doi.org/10.1371/journal.pone.0055481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390536	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100052
J	Hou, JY; Rodriguez-Gabin, A; Samaweera, L; Hazan, R; Goldberg, GL; Horwitz, SB; McDaid, HM				Hou, June Y.; Rodriguez-Gabin, Alicia; Samaweera, Leleesha; Hazan, Rachel; Goldberg, Gary L.; Horwitz, Susan Band; McDaid, Hayley M.			Exploiting MEK Inhibitor-Mediated Activation of ER alpha for Therapeutic Intervention in ER-Positive Ovarian Carcinoma	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; TREFOIL FACTOR-1; LOW-GRADE; PROGESTERONE-RECEPTOR; SEROUS CARCINOMA; PHASE-II; PHOSPHORYLATION; EXPRESSION; LETROZOLE	While the clinical benefit of MEK inhibitor (MEKi)-based therapy is well established in Raf mutant malignancies, its utility as a suppressor of hyperactive MAPK signaling in the absence of mutated Raf or Ras, is an area of ongoing research. MAPK activation is associated with loss of ER alpha expression and hormonal resistance in numerous malignancies. Herein, we demonstrate that MEKi induces a feedback response that results in ER alpha overexpression, phosphorylation and transcriptional activation of ER-regulated genes. Mechanistically, MEKi-mediated ER alpha overexpression is largely independent of erbB2 and AKT feedback activation, but is ERK-dependent. We subsequently exploit this phenomenon therapeutically by combining the ER-antagonist, fulvestrant with MEKi. This results in synergistic suppression of tumor growth, in vitro and potentiation of single agent activity in vivo in nude mice bearing xenografts. Thus, we demonstrate that exploiting adaptive feedback after MEKi can be used to sensitize ER alpha-positive tumors to hormonal therapy, and propose that this strategy may have broader clinical utility in ER alpha-positive ovarian carcinoma.	[Hou, June Y.; Goldberg, Gary L.] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Obstet & Gynecol & Womens Hlth, Div Gynecol Oncol, Bronx, NY 10467 USA; [Rodriguez-Gabin, Alicia; Samaweera, Leleesha; Horwitz, Susan Band] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Hazan, Rachel] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [McDaid, Hayley M.] Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McDaid, HM (corresponding author), Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA.	hayley.mcdaid@einstein.yu.edu	Hou, June/L-6992-2019		National Cancer Institute Grant [CA077263]; Breast Cancer Research Foundation; National Foundation for Cancer Research; National Institutes of Health Grant [K12CA132783-01A1]; Young Clinical Investigators award from Montefiore Medical Center; NATIONAL CANCER INSTITUTE [K12CA132783, R01CA135061, R01CA136854, R01CA077263] Funding Source: NIH RePORTER	National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; National Foundation for Cancer Research; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Young Clinical Investigators award from Montefiore Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grant CA077263, the Breast Cancer Research Foundation (HMD and SBH), the National Foundation for Cancer Research (SBH), National Institutes of Health Grant K12CA132783-01A1 (HMD and JYH). JYH was the recipient of a Young Clinical Investigators award from Montefiore Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenta PA, 2009, GYNECOL ONCOL, V113, P205, DOI 10.1016/j.ygyno.2009.01.012; Arias-Pulido H, 2009, GYNECOL ONCOL, V114, P480, DOI 10.1016/j.ygyno.2009.05.045; Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Ayhan A, 2009, AM J SURG PATHOL, V33, P1220, DOI 10.1097/PAS.0b013e3181a24354; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Bindels EMJ, 2002, ONCOGENE, V21, P8158, DOI 10.1038/sj.onc.1206012; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bowman A, 2002, CLIN CANCER RES, V8, P2233; Buache E, 2011, ONCOGENE, V30, P3261, DOI 10.1038/onc.2011.41; Clarkl DE, 2001, EMBO J, V20, P3484, DOI 10.1093/emboj/20.13.3484; Covens AL, 2011, GYNECOL ONCOL, V120, P185, DOI 10.1016/j.ygyno.2010.10.015; Cunat S, 2004, GYNECOL ONCOL, V94, P25, DOI 10.1016/j.ygyno.2004.03.026; de Leeuw R., 2012, ONCOGENE; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Gross AL, 2010, J ONCOL, V2010, DOI 10.1155/2010/126295; Ho CL, 2004, CANCER RES, V64, P6915, DOI 10.1158/0008-5472.CAN-04-2067; Houtman R, 2012, MOL CANCER THER, V11, P805, DOI 10.1158/1535-7163.MCT-11-0855; Howlader NNA, 2011, SEER CANC STAT REV, P1975; Hsu CY, 2004, CLIN CANCER RES, V10, P6432, DOI 10.1158/1078-0432.CCR-04-0893; Huang GS, 2006, CLIN CANCER RES, V12, P298, DOI 10.1158/1078-0432.CCR-05-0229; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; Karam SM, 2008, CELL PROLIFERAT, V41, P923, DOI 10.1111/j.1365-2184.2008.00562.x; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; LANGDON SP, 1993, INT J CANCER, V55, P459, DOI 10.1002/ijc.2910550323; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lau KM, 1999, P NATL ACAD SCI USA, V96, P5722, DOI 10.1073/pnas.96.10.5722; Legrier M-E, 2007, P 98 ANN M AM ASS CA; Legrier ME, 2007, CANCER RES, V67, P11300, DOI 10.1158/0008-5472.CAN-07-0702; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Markman M, 1996, GYNECOL ONCOL, V62, P4, DOI 10.1006/gyno.1996.0181; O'Donnell AJM, 2005, ENDOCR-RELAT CANCER, V12, P851, DOI 10.1677/erc.1.01039; Papadimitriou CA, 2004, ONCOLOGY-BASEL, V66, P112, DOI 10.1159/000077436; PETRANGELI E, 1994, J STEROID BIOCHEM, V49, P327, DOI 10.1016/0960-0760(94)90275-5; RAO BR, 1991, ENDOCR REV, V12, P14, DOI 10.1210/edrv-12-1-14; Regalo G, 2005, CELL MOL LIFE SCI, V62, P2910, DOI 10.1007/s00018-005-5478-4; Ribieras S, 1998, BBA-REV CANCER, V1378, pF61, DOI 10.1016/S0304-419X(98)00016-X; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schmeler KM, 2008, GYNECOL ONCOL, V108, P510, DOI 10.1016/j.ygyno.2007.11.013; Seidman JD, 2006, GYNECOL ONCOL, V103, P703, DOI 10.1016/j.ygyno.2006.05.030; SHELLING AN, 1995, BRIT J CANCER, V72, P521, DOI 10.1038/bjc.1995.367; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smyth JF, 2007, CLIN CANCER RES, V13, P3617, DOI 10.1158/1078-0432.CCR-06-2878; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Song RXD, 2010, J STEROID BIOCHEM, V118, P219, DOI 10.1016/j.jsbmb.2009.09.018; Suga S, 2007, GYNECOL ONCOL, V105, P341, DOI 10.1016/j.ygyno.2006.12.030; Vereczkey I, 2011, PATHOL ONCOL RES, V17, P551, DOI 10.1007/s12253-010-9345-8; Walker G, 2007, GYNECOL ONCOL, V106, P461, DOI 10.1016/j.ygyno.2007.05.009; Yamnik RL, 2010, FEBS LETT, V584, P124, DOI 10.1016/j.febslet.2009.11.041; Yan L, 2009, 100 AACR ANN M; Yoon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004560; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300	54	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54103	10.1371/journal.pone.0054103	http://dx.doi.org/10.1371/journal.pone.0054103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390495	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100011
J	Seo, HJ; Kim, HC; Klein, TA; Ramey, AM; Lee, JH; Kyung, SG; Park, JY; Cho, YS; Cho, IS; Yeh, JY				Seo, Hyun-Ji; Kim, Heung Chul; Klein, Terry A.; Ramey, Andrew M.; Lee, Ji-Hye; Kyung, Soon-Goo; Park, Jee-Yong; Cho, Yun Sang; Cho, In-Soo; Yeh, Jung-Yong			Molecular Detection and Genotyping of Japanese Encephalitis Virus in Mosquitoes during a 2010 Outbreak in the Republic of Korea	PLOS ONE			English	Article							WEST-NILE-VIRUS; LABORATORY TRANSMISSION; FREQUENT INTRODUCTIONS; SOUTH-KOREA; EAST-ASIA; CHINA; CULICIDAE; DIPTERA; IDENTIFICATION; IMMUNIZATION	Japanese encephalitis virus (JEV), a mosquito-borne zoonotic pathogen, is one of the major causes of viral encephalitis. To reduce the impact of Japanese encephalitis among children in the Republic of Korea (ROK), the government established a mandatory vaccination program in 1967. Through the efforts of this program only 0-7 (mean 2.1) cases of Japanese encephalitis were reported annually in the ROK during the period of 1984-2009. However, in 2010 there was an outbreak of 26 confirmed cases of Japanese encephalitis, including 7 deaths. This represented a >12-fold increase in the number of confirmed cases of Japanese encephalitis in the ROK as compared to the mean number reported over the last 26 years and a 3.7-fold increase over the highest annual number of cases during this same period (7 cases). Surveillance of adult mosquitoes was conducted during the 2010 outbreak of Japanese encephalitis in the ROK. A total of 6,328 culicine mosquitoes belonging to 12 species from 5 genera were collected at 6 survey sites from June through October 2010 and assayed by reverse-transcription polymerase chain reaction (RT-PCR) for the presence of JEV. A total of 34/371 pooled samples tested positive for JEV (29/121 Culex tritaeniorhynchus, 4/64 Cx. pipiens, and 1/26 Cx. bitaeniorhynchus) as confirmed by sequencing of the pre-membrane and envelope protein coding genes. The maximum likelihood estimates of JEV positive individuals per 1,000 culicine vectors for Cx. tritaeniorhynchus, Cx. pipiens, and Cx. bitaeniorhynchus were 11.8, 5.6, and 2.8, respectively. Sequences of the JEV pre-membrane and envelope protein coding genes amplified from the culicine mosquitoes by RT-PCR were compared with those of JEV genotypes I-V. Phylogenetic analyses support the detection of a single genotype (I) among samples collected from the ROK in 2010.	[Seo, Hyun-Ji; Lee, Ji-Hye; Park, Jee-Yong; Cho, Yun Sang; Cho, In-Soo; Yeh, Jung-Yong] Anim Plant & Fisheries Quarantine & Inspect Agcy, Foreign Anim Dis Div, Anyang Si, South Korea; [Kim, Heung Chul] 5th Med Detachment, Unit 15247, Multifunct Med Battal 168, Med Brigade 65, Seoul, South Korea; [Klein, Terry A.] Force Hlth Protect & Prevent Med, Med Brigade USAMEDDAC Korea 65, Unit 15281, Seoul, South Korea; [Ramey, Andrew M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Kyung, Soon-Goo] Korea Racing Author, Gwacheon, South Korea; [Yeh, Jung-Yong] Univ Incheon, Div Life Sci, Coll Life Sci & Bioengn, Inchon, South Korea	Animal & Plant Quarantine Agency; United States Department of the Interior; United States Geological Survey; Incheon National University	Yeh, JY (corresponding author), Anim Plant & Fisheries Quarantine & Inspect Agcy, Foreign Anim Dis Div, Anyang Si, South Korea.	malvab2848@gmail.com		Cho, Yun Sang/0000-0003-1346-7067; Ramey, Andrew/0000-0002-3601-8400; Yeh, Jung-Yong/0000-0002-0939-7783	Korea National Veterinary Research and Quarantine Service (NVRQS) [N-AD13-2011-13-01]; Korean Horse Racing Authority, Seoul, ROK; Uniformed Services University, Bethesda, MD; Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD; National Center for Medical Intelligence	Korea National Veterinary Research and Quarantine Service (NVRQS); Korean Horse Racing Authority, Seoul, ROK; Uniformed Services University, Bethesda, MD; Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD; National Center for Medical Intelligence	This work was supported by Korea National Veterinary Research and Quarantine Service (NVRQS) grant N-AD13-2011-13-01. This work was also supported through a joint partnership between the Korean Horse Racing Authority, Seoul, ROK; the Uniformed Services University, Bethesda, MD; the Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD; and the National Center for Medical Intelligence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE K, 1978, INDIAN J MED RES, V67, P889; BHATTACHARYA S, 1986, TROP GEOGR MED, V38, P46; Cao QS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-472; CHEN WR, 1992, AM J TROP MED HYG, V47, P61, DOI 10.4269/ajtmh.1992.47.61; CHEN WR, 1990, J GEN VIROL, V71, P2915, DOI 10.1099/0022-1317-71-12-2915; Cho YJ, 2007, J BACTERIOLOGY VIROL, V37, P161; GRASCENKOV N. I., 1964, BULL WORLD HLTH ORGAN, V30, P161; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; IGARASHI A, 1994, MICROBIOL IMMUNOL, V38, P827, DOI 10.1111/j.1348-0421.1994.tb01866.x; Jeong YE, 2011, ACTIVITY JAPANESE EN; Johansen CA, 2002, AM J TROP MED HYG, V67, P656, DOI 10.4269/ajtmh.2002.67.656; K-CDC, 2010, INF DIS SURV YB REP, P51; Kim HC, 2011, J MED ENTOMOL, V48, P1250, DOI 10.1603/ME11091; Kim Heung Chul, 2007, Entomological Research, V37, P267, DOI 10.1111/j.1748-5967.2007.00124.x; Kim JO, 2009, ESTABLISHMENT IN VIT; Lee H.W., 1971, J KOREAN MED ASSOC, V14, P871; LEWIS L, 1947, ARCH NEURO PSYCHIATR, V57, P430, DOI 10.1001/archneurpsyc.1947.02300270048004; Li YX, 2011, EMERG INFECT DIS, V17, P934, DOI 10.3201/eid1705.101417; Nabeshima T, 2009, J GEN VIROL, V90, P827, DOI 10.1099/vir.0.007617-0; Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0; Nitatpattana N, 2008, EMERG INFECT DIS, V14, P1762, DOI 10.3201/eid1411.080542; ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143; Saito M, 2007, AM J TROP MED HYG, V77, P737, DOI 10.4269/ajtmh.2007.77.737; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; SUCHARIT S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P611; Takasaki T, 2003, VACCINE, V21, P4514, DOI 10.1016/S0264-410X(03)00507-3; Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449; Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2; Turell MJ, 2006, J MED ENTOMOL, V43, P1076, DOI 10.1603/0022-2585(2006)43[1076:LTOJEW]2.0.CO;2; Turell MJ, 2006, J MED ENTOMOL, V43, P296, DOI 10.1603/0022-2585(2006)043[0296:LTOJEA]2.0.CO;2; Turell MJ, 2003, J MED ENTOMOL, V40, P580, DOI 10.1603/0022-2585-40.4.580; United Nations, 2005, UN URB PROSP 2005 RE; VYTHILINGAM I, 1995, J AM MOSQUITO CONTR, V11, P94; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Wang HY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-73; Wang LH, 2007, EMERG INFECT DIS, V13, P1123, DOI 10.3201/eid1307.070010; Wang LH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-345; Weng MH, 2000, J MED ENTOMOL, V37, P780, DOI 10.1603/0022-2585-37.5.780; Williams DT, 2001, AM J TROP MED HYG, V65, P379, DOI 10.4269/ajtmh.2001.65.379; World Health Organization, 2008, WORLD HLTH REP YEARS; Yamshchikov G, 2005, VACCINE, V23, P4785, DOI 10.1016/j.vaccine.2005.04.036; Yang Dong Kun, 2004, J Vet Sci, V5, P125; Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127; Zhang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016418; Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710	46	53	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55165	10.1371/journal.pone.0055165	http://dx.doi.org/10.1371/journal.pone.0055165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390520	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100036
J	Teich, AF; Patel, M; Arancio, O				Teich, Andrew F.; Patel, Mitesh; Arancio, Ottavio			A Reliable Way to Detect Endogenous Murine beta-Amyloid	PLOS ONE			English	Article							IN-VIVO; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; WILD-TYPE; MEMORY; BRAIN; MICE; PEPTIDE; CELLS	Unraveling the normal physiologic role of beta-amyloid is likely crucial to understanding the pathogenesis of Alzheimer's disease. However, progress on this question is currently limited by the high background of many ELISAs for murine beta-amyloid. Here, we examine the background signal of several murine beta-amyloid ELISAs, and conclude that the majority of the background is from non-APP derived proteins. Most importantly, we identify ELISAs that eliminate this background signal.	[Teich, Andrew F.; Patel, Mitesh; Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA	Columbia University	Teich, AF (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	aft25@columbia.edu	Patel, Mitesh/AAD-5925-2022; arancio, ottavio/AAB-7959-2019	Patel, Mitesh/0000-0001-6724-9183; Teich, Andrew/0000-0002-1916-8490; arancio, ottavio/0000-0001-6335-164X	National Institutes of Health [AG034248]; Alzheimer's Association [NIRG-11-203583]; Louis V. Gerstner, Jr. Scholars Program; NATIONAL INSTITUTE ON AGING [R01AG034248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Louis V. Gerstner, Jr. Scholars Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants to OA by the National Institutes of Health (AG034248), and by grants to AFT from the Alzheimer's Association (NIRG-11-203583) and the Louis V. Gerstner, Jr. Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Anderson JJ, 2005, BIOCHEM PHARMACOL, V69, P689, DOI 10.1016/j.bcp.2004.11.015; Best JD, 2005, J PHARMACOL EXP THER, V313, P902, DOI 10.1124/jpet.104.081174; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Lanz TA, 2008, J NEUROSCI METH, V169, P16, DOI 10.1016/j.jneumeth.2007.11.009; Lanz TA, 2006, J NEUROSCI METH, V157, P71, DOI 10.1016/j.jneumeth.2006.03.023; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Morales-Corraliza J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007134; Plant LD, 2003, J NEUROSCI, V23, P5531; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Venezia V, 2004, J NEUROCHEM, V90, P1359, DOI 10.1111/j.1471-4159.2004.02618.x; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	17	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55647	10.1371/journal.pone.0055647	http://dx.doi.org/10.1371/journal.pone.0055647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383341	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900048
J	Kubanek, J; Brunner, P; Gunduz, A; Poeppel, D; Schalk, G				Kubanek, Jan; Brunner, Peter; Gunduz, Aysegul; Poeppel, David; Schalk, Gerwin			The Tracking of Speech Envelope in the Human Cortex	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; TEMPORAL ENVELOPE; INTELLIGIBLE SPEECH; FIRING RATE; REPRESENTATION; LOCALIZATION; VOCALIZATIONS; ORGANIZATION; HEMISPHERE; RESPONSES	Humans are highly adept at processing speech. Recently, it has been shown that slow temporal information in speech (i.e., the envelope of speech) is critical for speech comprehension. Furthermore, it has been found that evoked electric potentials in human cortex are correlated with the speech envelope. However, it has been unclear whether this essential linguistic feature is encoded differentially in specific regions, or whether it is represented throughout the auditory system. To answer this question, we recorded neural data with high temporal resolution directly from the cortex while human subjects listened to a spoken story. We found that the gamma activity in human auditory cortex robustly tracks the speech envelope. The effect is so marked that it is observed during a single presentation of the spoken story to each subject. The effect is stronger in regions situated relatively early in the auditory pathway (belt areas) compared to other regions involved in speech processing, including the superior temporal gyrus (STG) and the posterior inferior frontal gyrus (Broca's region). To further distinguish whether speech envelope is encoded in the auditory system as a phonological (speech-related), or instead as a more general acoustic feature, we also probed the auditory system with a melodic stimulus. We found that belt areas track melody envelope weakly, and as the only region considered. Together, our data provide the first direct electrophysiological evidence that the envelope of speech is robustly tracked in non-primary auditory cortex (belt areas in particular), and suggest that the considered higher-order regions (STG and Broca's region) partake in a more abstract linguistic analysis.	[Kubanek, Jan] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Kubanek, Jan] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Brunner, Peter; Gunduz, Aysegul; Schalk, Gerwin] Albany Med Coll, Dept Neurol, Albany, NY 12208 USA; [Brunner, Peter; Gunduz, Aysegul; Schalk, Gerwin] New York State Dept Hlth, Wadsworth Ctr, Brain Comp Interface Res & Dev Program, Albany, NY USA; [Poeppel, David] NYU, Dept Psychol, New York, NY 10003 USA	Washington University (WUSTL); Washington University (WUSTL); Albany Medical College; State University of New York (SUNY) System; Wadsworth Center; New York University	Kubanek, J (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	kubanek@wustl.edu	Gunduz, Aysegul/Q-2336-2016	Gunduz, Aysegul/0000-0001-7925-0747; Brunner, Peter/0000-0002-2588-2754; Schalk, Gerwin/0000-0003-3443-9487; Kubanek, Jan/0000-0003-0527-5559	National Institutes of Health [EB006356, EB000856]; United States Army Research Office [W911NF-07-1-0415, W911NF-08-1-0216]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000856, R01EB006356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Research Office; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the National Institutes of Health (EB006356 and EB000856) and the United States Army Research Office (W911NF-07-1-0415 and W911NF-08-1-0216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Abrams DA, 2009, J NEUROSCI, V29, P7686, DOI 10.1523/JNEUROSCI.5242-08.2009; Acharya S, 2010, J NEURAL ENG, V7, DOI [10.1088/1741-2560/7/4/046002, 10.2202/1553-3840.1324]; Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Broca P, 1861, B SOC ANAT, V6; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Goodglass H., 2001, BOSTON DIAGNOSTIC AP, VThird; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P144, DOI 10.1152/jn.00807.2006; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; Miller KJ, 2007, J NEUROSCI METH, V162, P303, DOI 10.1016/j.jneumeth.2007.01.019; Miller KJ, 2010, J NEUROSCI, V30, P6477, DOI 10.1523/JNEUROSCI.6401-09.2010; Mukamel R, 2011, HUM BRAIN MAPP, V32, P1181, DOI 10.1002/hbm.21100; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Nourski KV, 2009, J NEUROSCI, V29, P15564, DOI 10.1523/JNEUROSCI.3065-09.2009; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Schalk G, 2010, PRACTICAL GUIDE TO BRAIN-COMPUTER INTERFACING WITH BCI2000, P1, DOI 10.1007/978-1-84996-092-2; Schwartz DA, 2003, J NEUROSCI, V23, P7160, DOI 10.1523/JNEUROSCI.23-18-07160.2003; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Stevens K. N, 2000, ACOUSTIC PHONETICS, V30; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wechsler D., 1997, WECHSLER ADULT INTEL; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Williams D, 1938, NEW ENGL J MED, V218, P998, DOI 10.1056/NEJM193806162182402; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zeng FG, 1999, NEUROREPORT, V10, P3429, DOI 10.1097/00001756-199911080-00031	45	78	78	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53398	10.1371/journal.pone.0053398	http://dx.doi.org/10.1371/journal.pone.0053398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23408924	Green Submitted, gold, Green Published			2022-12-27	WOS:000313552400023
J	Fajen, BR; Matthis, JS				Fajen, Brett R.; Matthis, Jonathan S.			Visual and Non-Visual Contributions to the Perception of Object Motion during Self-Motion	PLOS ONE			English	Article							RETINAL MOTION; CUES; INTERCEPTION; INFORMATION; GUIDANCE; PURSUIT; TIME; FLOW	Many locomotor tasks involve interactions with moving objects. When observer (i.e., self-)motion is accompanied by object motion, the optic flow field includes a component due to self-motion and a component due to object motion. For moving observers to perceive the movement of other objects relative to the stationary environment, the visual system could recover the object-motion component - that is, it could factor out the influence of self-motion. In principle, this could be achieved using visual self-motion information, non-visual self-motion information, or a combination of both. In this study, we report evidence that visual information about the speed (Experiment 1) and direction (Experiment 2) of self-motion plays a role in recovering the object-motion component even when non-visual self-motion information is also available. However, the magnitude of the effect was less than one would expect if subjects relied entirely on visual self-motion information. Taken together with previous studies, we conclude that when self-motion is real and actively generated, both visual and non-visual self-motion information contribute to the perception of object motion. We also consider the possible role of this process in visually guided interception and avoidance of moving objects.	[Fajen, Brett R.; Matthis, Jonathan S.] Rensselaer Polytech Inst, Dept Cognit Sci, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Fajen, BR (corresponding author), Rensselaer Polytech Inst, Dept Cognit Sci, Troy, NY 12180 USA.	fajenb@rpi.edu			United States National Institutes of Health [1R01EY019317]; NATIONAL EYE INSTITUTE [R01EY019317] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by a grant from the United States National Institutes of Health (1R01EY019317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin J, 2010, EXP BRAIN RES, V201, P763, DOI 10.1007/s00221-009-2092-y; Bootsma RJ, 2002, PERCEPTION, V31, P901, DOI 10.1068/p3230; Calabro FJ, 2012, EXP BRAIN RES, V221, P177, DOI 10.1007/s00221-012-3159-8; Campos JL, 2010, EUR J NEUROSCI, V31, P1889, DOI 10.1111/j.1460-9568.2010.07212.x; Chardenon A, 2004, EXP BRAIN RES, V158, P100, DOI 10.1007/s00221-004-1880-7; Dyde RT, 2008, J VISION, V8, DOI 10.1167/8.14.5; Fajen BR, 2004, PERCEPTION, V33, P689, DOI 10.1068/p5236; Fajen BR, 2007, EXP BRAIN RES, V180, P303, DOI 10.1007/s00221-007-0859-6; Fajen BR, 2011, J EXP PSYCHOL HUMAN, V37, P1442, DOI 10.1037/a0023510; Fajen BR, 2011, HUM MOVEMENT SCI, V30, P504, DOI 10.1016/j.humov.2010.07.016; Ghose K, 2006, PLOS BIOL, V4, P865, DOI 10.1371/journal.pbio.0040108; Gibson JJ, 1950, PERCEPTION VISUAL WO; Harris L. R., 2002, Virtual Reality, V6, P75, DOI 10.1007/s100550200008; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; LANCHESTER BS, 1975, J EXP BIOL, V63, P627; LARISH JF, 1990, J EXP PSYCHOL HUMAN, V16, P295, DOI 10.1037/0096-1523.16.2.295; Lee D.N., 1980, TUTORIALS MOTOR BEHA, P281; Lenoir M, 1999, J MOTOR BEHAV, V31, P55, DOI 10.1080/00222899909601891; MacNeilage PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040264; Matsumiya K, 2009, J VISION, V9, DOI 10.1167/9.1.15; Niehorster DC, 2012, J VISION, V12, P244, DOI DOI 10.1167/12.9.244; Olberg RM, 2000, J COMP PHYSIOL A, V186, P155, DOI 10.1007/s003590050015; Royden CS, 2010, VISION RES, V50, P1014, DOI 10.1016/j.visres.2010.03.008; Rushton SK, 2007, COGNITION, V105, P237, DOI 10.1016/j.cognition.2006.09.004; Rushton SK, 2005, CURR BIOL, V15, pR542, DOI 10.1016/j.cub.2005.07.020; Sedgwick H. A., 1980, PERCEPTION PICTURES, V1, P33; Shaffer DM, 2009, OPEN SPORTS SCI J, V2, P29, DOI DOI 10.2174/1875399X00902010029; Tcheang L, 2005, VISION RES, V45, P2177, DOI 10.1016/j.visres.2005.02.006; WALLACH H, 1987, ANNU REV PSYCHOL, V38, P1, DOI 10.1146/annurev.ps.38.020187.000245; Warren PA, 2008, VISION RES, V48, P655, DOI 10.1016/j.visres.2007.10.023; Warren PA, 2007, J VISION, V7, DOI 10.1167/7.11.2; Warren PA, 2009, CURR BIOL, V19, P1555, DOI 10.1016/j.cub.2009.07.057; Warren PA, 2009, VISION RES, V49, P1406, DOI 10.1016/j.visres.2009.01.016; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Wexler M, 2001, NATURE, V409, P85, DOI 10.1038/35051081	36	31	31	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55446	10.1371/journal.pone.0055446	http://dx.doi.org/10.1371/journal.pone.0055446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23408983	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200031
J	Kazuno, A; Ohtawa, K; Otsuki, K; Usui, M; Sugawara, H; Okazaki, Y; Kato, T				Kazuno, An-a; Ohtawa, Kenji; Otsuki, Kaori; Usui, Masaya; Sugawara, Hiroko; Okazaki, Yuji; Kato, Tadafumi			Proteomic Analysis of Lymphoblastoid Cells Derived from Monozygotic Twins Discordant for Bipolar Disorder: A Preliminary Study	PLOS ONE			English	Article							GENE-EXPRESSION; VALPROIC ACID; PSYCHIATRIC-DISORDERS; POSTMORTEM CHANGES; MOOD STABILIZERS; BRAIN PROTEINS; SCHIZOPHRENIA; CORTEX; DISEASE; ILLNESS	Bipolar disorder is a severe mental illness characterized by recurrent manic and depressive episodes. In bipolar disorder, family and twin studies suggest contributions from genetic and environmental factors; however, the detailed molecular pathogenesis is yet unknown. Thus, identification of biomarkers may contribute to the clinical diagnosis of bipolar disorder. Monozygotic twins discordant for bipolar disorder are relatively rare but have been reported. Here we performed a comparative proteomic analysis of whole cell lysate derived from lymphoblastoid cells of monozygotic twins discordant for bipolar disorder by using two-dimensional differential in-gel electrophoresis (2D-DIGE). We found approximately 200 protein spots to be significantly differentially expressed between the patient and the co-twin (t test, p<0.05). Some of the proteins were subsequently identified by liquid chromatography tandem mass spectrometry and included proteins involved in cell death and glycolysis. To examine whether these proteins could serve as biomarkers of bipolar disorder, we performed Western blot analysis using case-control samples. Expression of phosphoglycerate mutase 1 (PGAM1), which is involved in glycolysis, was significantly up-regulated in patients with bipolar disorder (t test, p<0.05). Although PGAM1 cannot be regarded as a qualified biomarker of bipolar disorder from this preliminary finding, it could be one of the candidates for further study to identify biomarkers of bipolar disorder.	[Kazuno, An-a; Sugawara, Hiroko; Kato, Tadafumi] RIKEN, Lab Mol Dynam Mental Disorders, Brain Sci Inst, Saitama, Japan; [Ohtawa, Kenji; Otsuki, Kaori; Usui, Masaya] RIKEN, Res Resources Ctr, Brain Sci Inst, Saitama, Japan; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo, Japan	RIKEN; RIKEN	Kato, T (corresponding author), RIKEN, Lab Mol Dynam Mental Disorders, Brain Sci Inst, Saitama, Japan.	kato@brain.riken.jp	Kato, Tadafumi/J-3583-2014	Kato, Tadafumi/0000-0001-7856-3952	Japanese Ministry of Health, Labour and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grant-in-aid from Japanese Ministry of Health, Labour and Welfare, and a grant from Japanese Ministry of Education, Culture, Sports, Science and Technology to AK and TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MG, 1976, ARCH GEN PSYCHIAT, V33, P1476; Altamura AC, 2010, EUR ARCH PSY CLIN N, V260, P385, DOI 10.1007/s00406-009-0085-2; Benes FM, 2006, MOL PSYCHIATR, V11, P241, DOI 10.1038/sj.mp.4001758; Benes FM, 2001, BIOL PSYCHIAT, V50, P395, DOI 10.1016/S0006-3223(01)01084-8; BERTELSEN A, 1977, BRIT J PSYCHIAT, V130, P330, DOI 10.1192/bjp.130.4.330; Bora E, 2010, BIOL PSYCHIAT, V67, P1097, DOI 10.1016/j.biopsych.2010.01.020; BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P483; CAMPBELL JW, 1974, NATURE, V250, P301, DOI 10.1038/250301a0; Cannell GR, 2002, LIFE SCI, V71, P2633, DOI 10.1016/S0024-3205(02)02107-0; Chuang DM, 2002, BIPOLAR DISORD, V4, P129, DOI 10.1034/j.1399-5618.2002.01179.x; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Corena-McLeod MD, 2008, BRAIN RES, V1233, P8, DOI 10.1016/j.brainres.2008.07.021; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; English JA, 2011, BIOL PSYCHIAT, V69, P163, DOI 10.1016/j.biopsych.2010.06.031; English JA, 2009, PROTEOMICS, V9, P3368, DOI 10.1002/pmic.200900015; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; Franzen B, 2003, PROTEOMICS, V3, P1920, DOI 10.1002/pmic.200300535; GERSHON ES, 1994, GENETIC APPROACHES M; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Herberth M, 2011, PROTEOMICS, V11, P94, DOI 10.1002/pmic.201000291; HOLLANDER BA, 1991, J NEUROSCI RES, V28, P332, DOI 10.1002/jnr.490280304; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Kapczinski Flavio, 2008, Expert Rev Neurother, V8, P1101, DOI 10.1586/14737175.8.7.1101; Kato T, 2005, MOL PSYCHIATR, V10, P622, DOI 10.1038/sj.mp.4001662; Kato T, 2003, INT J NEUROPSYCHOPH, V6, P379, DOI 10.1017/S1461145703003717; Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Li JL, 2003, NEUROPSYCHOPHARMACOL, V28, P1017, DOI 10.1038/sj.npp.1300112; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Manji HK, 2000, MOL PSYCHIATR, V5, P578, DOI 10.1038/sj.mp.4000811; Manji HK, 2000, BIOL PSYCHIAT, V48, P740, DOI 10.1016/S0006-3223(00)00979-3; Manji HK, 2002, MOL PSYCHIATR, V7, pS46, DOI 10.1038/sj.mp.4001018; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Matigian N, 2007, MOL PSYCHIATR, V12, P815, DOI 10.1038/sj.mp.4001998; Meltzer H, 1989, BR J PSYCHIAT S, V8, P25; Novikova SI, 2006, NEUROBIOL DIS, V23, P61, DOI 10.1016/j.nbd.2006.02.002; Pennington K, 2008, MOL PSYCHIATR, V13, P1102, DOI 10.1038/sj.mp.4002098; Scheffler IE, 1999, MITOCHONDRIA; Schwarz E, 2008, BRIT J PHARMACOL, V153, pS133, DOI 10.1038/sj.bjp.0707658; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sugawara H, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.26; Sussulini A, 2011, PROTEOMICS, V11, P261, DOI 10.1002/pmic.201000371; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Vercauteren FGG, 2004, EUR J PHARMACOL, V500, P385, DOI 10.1016/j.ejphar.2004.07.039; VILLARPA.C, 1970, ANNU REV BIOCHEM, V39, P639, DOI 10.1146/annurev.bi.39.070170.003231; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200	53	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e53855	10.1371/journal.pone.0053855	http://dx.doi.org/10.1371/journal.pone.0053855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408933	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200006
J	Benenson, JF; Markovits, H; Hultgren, B; Nguyen, T; Bullock, G; Wrangham, R				Benenson, Joyce F.; Markovits, Henry; Hultgren, Brittney; Tuyet Nguyen; Bullock, Grace; Wrangham, Richard			Social Exclusion: More Important to Human Females Than Males	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; KIBALE-NATIONAL-PARK; SEX-DIFFERENCES; WILD CHIMPANZEES; INTRASEXUAL AGGRESSION; REJECTION; SELECTION; GENDER; COOPERATION; EVOLUTION	Theoretical models based on primate evidence suggest that social structure determines the costs and benefits of particular aggressive strategies. In humans, males more than females interact in groups of unrelated same-sex peers, and larger group size predicts success in inter-group contests. In marked contrast, human females form isolated one-on-one relationships with fewer instrumental benefits, so social exclusion constitutes a more useful strategy. If this model is accurate, then human social exclusion should be utilized by females more than males and females should be more sensitive to its occurrence. Here we present four studies supporting this model. In Study 1, using a computerized game with fictitious opponents, we demonstrate that females are more willing than males to socially exclude a temporary ally. In Study 2, females report more actual incidents of social exclusion than males do. In Study 3, females perceive cues revealing social exclusion more rapidly than males do. Finally, in Study 4, females' heart rate increases more than males' in response to social exclusion. Together, results indicate that social exclusion is a strategy well-tailored to human females' social structure.	[Benenson, Joyce F.; Wrangham, Richard] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Benenson, Joyce F.; Hultgren, Brittney; Tuyet Nguyen; Bullock, Grace] Emmanuel Coll, Dept Psychol, Boston, MA USA; [Markovits, Henry] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada	Harvard University; University of Quebec; University of Quebec Montreal	Markovits, H (corresponding author), Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada.	Joyce.Benenson@gmail.com		Hultgren, Brittney/0000-0002-7181-5050	Social Sciences and Humanities Council of Canada	Social Sciences and Humanities Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	These studies were supported by a grant from the Social Sciences and Humanities Council of Canada to HM and JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2009, HORM BEHAV, V56, P498, DOI 10.1016/j.yhbeh.2009.08.003; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Archer J, 2009, BEHAV BRAIN SCI, V32, P292, DOI 10.1017/S0140525X09990963; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Bakan D ., 1966, DUALITY HUMAN EXISTE; Baumeister RF, 2004, PERS SOC PSYCHOL REV, V8, P339, DOI 10.1207/s15327957pspr0804_2; Benenson JF, 2006, DEV PSYCHOL, V42, P272, DOI 10.1037/0012-1649.42.2.272; Benenson JF, 2004, INFANT BEHAV DEV, V27, P173, DOI 10.1016/j.infbeh.2003.09.008; Benenson JF, 2011, PSYCHOL SCI, V22, P538, DOI 10.1177/0956797611402511; Benenson JF, 2009, BEHAV BRAIN SCI, V32, P268, DOI 10.1017/S0140525X0999046X; Benenson JF, 2008, EVOL PSYCHOL, V6, P13; Benenson JF, 2009, P ROY SOC B-BIOL SCI, V276, P2589, DOI 10.1098/rspb.2009.0314; BERCOVITCH FB, 1988, ANIM BEHAV, V36, P1198, DOI 10.1016/S0003-3472(88)80079-4; BJORKQVIST K, 1994, SEX ROLES, V30, P177, DOI 10.1007/BF01420988; Blackhart GC, 2007, BIOL PSYCHOL, V75, P267, DOI 10.1016/j.biopsycho.2007.03.005; Blackhart GC, 2009, PERS SOC PSYCHOL REV, V13, P269, DOI 10.1177/1088868309346065; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Campbell A, 1999, BEHAV BRAIN SCI, V22, P203, DOI 10.1017/S0140525X99001818; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; CRICK NR, 1995, CHILD DEV, V66, P710, DOI 10.1111/j.1467-8624.1995.tb00900.x; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fine GA, 1980, FRIENDSHIP SOCIAL RE, P291; Gabriel S, 1999, J PERS SOC PSYCHOL, V77, P642, DOI 10.1037/0022-3514.77.3.642; Gilby IC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1831, DOI 10.1007/s00265-008-0612-6; Goodall J., 1986, CHIMPANZEES GOMBE PA; Kahlenberg SM, 2008, INT J PRIMATOL, V29, P931, DOI 10.1007/s10764-008-9276-3; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; LeBlanc Steven A., 2003, CONSTANT BATTLES MYT, V1st; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Markovits H, 2001, CHILD DEV, V72, P879, DOI 10.1111/1467-8624.00321; Markovits H, GENDER DIFFERE UNPUB; Markovits H, 2006, J EXP SOC PSYCHOL, V42, P662, DOI 10.1016/j.jesp.2005.09.003; Pusey A, 2008, INT J PRIMATOL, V29, P949, DOI 10.1007/s10764-008-9281-6; Sacco DF, 2012, EVOL PSYCHOL-US, V10, P573; Savinwilliams R.C., 1980, FRIENDSHIP SOCIAL RE, P343; Simmons R, 2003, ODD GIRL OUR HIDDEN; Stroud LR, 2002, BIOL PSYCHIAT, V52, P318, DOI 10.1016/S0006-3223(02)01333-1; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; Townsend SW, 2007, CURR BIOL, V17, pR355, DOI 10.1016/j.cub.2007.03.020; Tracy, 1991, SECRET US COMPETITIO; Underwood M.K., 2003, SOCIAL AGGRESSION GI; Underwood MK, 2003, MERRILL PALMER QUART, V49, P373, DOI 10.1353/mpq.2003.0016; Weik U, 2010, HORM BEHAV, V58, P891, DOI 10.1016/j.yhbeh.2010.08.018; Winstead B., 2001, ENCY WOMEN GENDER, P481; Wiseman R, 2003, QUEEN BEES WANNABES; Wrangham R W, 1980, J Reprod Fertil Suppl, VSuppl 28, P13; Wrangham R.W., 1987, P282; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1	53	67	67	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55851	10.1371/journal.pone.0055851	http://dx.doi.org/10.1371/journal.pone.0055851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405221	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400166
J	Falagas, ME; Zarkali, A; Karageorgopoulos, DE; Bardakas, V; Mavros, MN				Falagas, Matthew E.; Zarkali, Angeliki; Karageorgopoulos, Drosos E.; Bardakas, Vangelis; Mavros, Michael N.			The Impact of Article Length on the Number of Future Citations: A Bibliometric Analysis of General Medicine Journals	PLOS ONE			English	Article							COUNTS; PUBLICATION; RATES	Background: The number of citations received is considered an index of study quality and impact. We aimed to examine the factors associated with the number of citations of published articles, focusing on the article length. Methods: Original human studies published in the first trimester of 2006 in 5 major General Medicine journals were analyzed with regard to the number of authors and of author-affiliated institutions, title and abstract word count, article length (number of print pages), number of bibliographic references, study design, and 2006 journal impact factor (JIF). A multiple linear regression model was employed to identify the variables independently associated with the number of article citations received through January 2012. Results: On univariate analysis the JIF, number of authors, article length, study design (interventional/observational and prospective/retrospective), title and abstract word count, number of author-affiliated institutions, and number of references were all associated with the number of citations received. On multivariate analysis with the logarithm of citations as the dependent variable, only article length [regression coefficient: 14.64 (95% confidence intervals: (5.76-23.50)] and JIF [3.37 (1.80-4.948)] independently predicted the number of citations. The variance of citations explained by these parameters was 51.2%. Conclusion: In a sample of articles published in major General Medicine journals, in addition to journal impact factors, article length and number of authors independently predicted the number of citations. This may reflect a higher complexity level and quality of longer and multi-authored studies.	[Falagas, Matthew E.; Zarkali, Angeliki; Karageorgopoulos, Drosos E.; Bardakas, Vangelis; Mavros, Michael N.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.] Mitera Gen Hosp, Dept Med & Infect Dis, Hygeia Grp, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Karageorgopoulos, Drosos E.] Hygeia Hosp, Dept Med, Athens, Greece; [Karageorgopoulos, Drosos E.] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Bardakas, Vangelis] Natl Tech Univ Athens, Dept Appl Math & Phys Sci, Athens, Greece	Alfa Institute Of Biomedical Sciences; Tufts University; Hygeia Hospital; National Technical University of Athens	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018; Mavros, M/AAS-3154-2020	Karageorgopoulos, Drosos/0000-0002-9959-9978; Zarkali, Angeliki/0000-0003-2808-072X				Ball P, 2008, NATURE, V455, P274, DOI 10.1038/455274a; Bhandari M, 2007, CAN J SURG, V50, P119; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Cheek J, 2006, QUAL HEALTH RES, V16, P423, DOI 10.1177/1049732305285701; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Etter JF, 2009, J CLIN EPIDEMIOL, V62, P831, DOI 10.1016/j.jclinepi.2008.09.015; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Falagas ME, 2010, INTERN MED J, V40, P587, DOI 10.1111/j.1445-5994.2010.02247.x; Falagas ME, 2008, ARCH IMMUNOL THER EX, V56, P223, DOI 10.1007/s00005-008-0024-5; Falagas ME, 2008, FASEB J, V22, P2623, DOI 10.1096/fj.08-107938; Figg WD, 2006, PHARMACOTHERAPY, V26, P759, DOI 10.1592/phco.26.6.759; Filion Kristian B, 2008, Epidemiol Perspect Innov, V5, P3, DOI 10.1186/1742-5573-5-3; Garfield E, 1996, BRIT MED J, V313, P411, DOI 10.1136/bmj.313.7054.411; Habibzadeh F, 2010, CROAT MED J, V51, P165, DOI 10.3325/cmj.2010.51.165; Jacques Thomas S, 2010, JRSM Short Rep, V1, P2, DOI 10.1258/shorts.2009.100020; Kim HE, 2011, J AM MED INFORM ASSN, V18, pI166, DOI 10.1136/amiajnl-2011-000706; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Lansingh VC, 2009, OPHTHALMOLOGY, V116, P1425, DOI 10.1016/j.ophtha.2008.12.052; Lokker C, 2008, BMJ-BRIT MED J, V336, P655, DOI 10.1136/bmj.39482.526713.BE; Mavros MN, 2013, SCIENTOMETRICS, V94, P203, DOI 10.1007/s11192-012-0752-3; Montori VM, 2003, BMC MED, V1, DOI 10.1186/1741-7015-1-2; Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42; Okike K, 2011, J CLIN EPIDEMIOL, V64, P331, DOI 10.1016/j.jclinepi.2010.03.019; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Perneger TV, 2010, J CLIN EPIDEMIOL, V63, P660, DOI 10.1016/j.jclinepi.2009.09.012; Perneger TV, 2004, BRIT MED J, V329, P546, DOI 10.1136/bmj.329.7465.546; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Willis DL, 2011, BJU INT, V107, P1876, DOI 10.1111/j.1464-410X.2010.10028.x	28	75	80	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e49476	10.1371/journal.pone.0049476	http://dx.doi.org/10.1371/journal.pone.0049476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405060	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400003
J	Kujala, H; Moilanen, A; Araujo, MB; Cabeza, M				Kujala, Heini; Moilanen, Atte; Araujo, Miguel B.; Cabeza, Mar			Conservation Planning with Uncertain Climate Change Projections	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; DISPERSAL CORRIDORS; RESERVE NETWORKS; PROTECTED AREAS; CHANGE IMPACTS; GLOBAL CHANGE; BIODIVERSITY; VULNERABILITY; PERSISTENCE; SCENARIOS	Climate change is affecting biodiversity worldwide, but conservation responses are constrained by considerable uncertainty regarding the magnitude, rate and ecological consequences of expected climate change. Here we propose a framework to account for several sources of uncertainty in conservation prioritization. Within this framework we account for uncertainties arising from (i) species distributions that shift following climate change, (ii) basic connectivity requirements of species, (iii) alternative climate change scenarios and their impacts, (iv) in the modelling of species distributions, and (v) different levels of confidence about present and future. When future impacts of climate change are uncertain, robustness of decision-making can be improved by quantifying the risks and trade-offs associated with climate scenarios. Sensible prioritization that accounts simultaneously for the present and potential future distributions of species is achievable without overly jeopardising present-day conservation values. Doing so requires systematic treatment of uncertainties and testing of the sensitivity of results to assumptions about climate. We illustrate the proposed framework by identifying priority areas for amphibians and reptiles in Europe.	[Kujala, Heini; Moilanen, Atte; Cabeza, Mar] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [Araujo, Miguel B.] CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid, Spain; [Araujo, Miguel B.] Univ Evora, Rui Nabeiro Biodivers Chair, Ctr Invest Biodiversidade & Recursos Genet, Evora, Portugal; [Araujo, Miguel B.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	University of Helsinki; Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora; University of Copenhagen	Cabeza, M (corresponding author), Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland.	cabeza@cc.helsinki.fi	Moilanen, Atte/A-5005-2011; Cabeza, Mar/ABC-4297-2020; Araújo, Miguel B/B-6117-2008	Cabeza, Mar/0000-0002-7410-7631; Araújo, Miguel B/0000-0002-5107-7265; KUJALA, HEINI/0000-0001-9772-3202	Academy of Finland Centre of Excellence Programme [213457, 129636]; Luonnonvaraisten elioiden kestavan kayton ja suojelun tutkijakoulu Graduate School fellowship; Finnish Cultural Foundation [SKR-00070832]; ERC-StG (European Research Council Starting Grant) [260393]; European Commission [244092]; Spanish Research Council; 'Rui Nabeiro' Biodiversity Chair; Danish National Research Foundation	Academy of Finland Centre of Excellence Programme(Academy of Finland); Luonnonvaraisten elioiden kestavan kayton ja suojelun tutkijakoulu Graduate School fellowship; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); ERC-StG (European Research Council Starting Grant); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Research Council; 'Rui Nabeiro' Biodiversity Chair; Danish National Research Foundation(Danmarks Grundforskningsfond)	For financial support HK and AM thank the Academy of Finland Centre of Excellence Programme 2006-2011, grants 213457 and 129636 (URL: http://www.aka.fi/en-GB/A/Centres-of-Excellence-/). HK was also funded by a Luonnonvaraisten elioiden kestavan kayton ja suojelun tutkijakoulu Graduate School fellowship (URL: http://www.helsinki.fi/luova) and by Finnish Cultural Foundation, grant SKR-00070832 (URL: http://www.skr.fi). AM acknowledges the support by the ERC-StG (European Research Council Starting Grant, URL: http://erc.europa.eu/starting-grants) project Global Environmental Decision Analysis (GEDA), grant 260393. MC and MBA were funded by the European Commission Seventh Framework Program project European RESPONSES to climate change (grant agreement number 244092, URL: http://www.responsesproject.eu/). MBA also acknowledges the Spanish Research Council (URL: http://www.csic.es/web/guest/home), the 'Rui Nabeiro' Biodiversity Chair (URL: http://www.catedra.uevora.pt/rui-nabeiro/), and the Danish National Research Foundation (URL: http://www.dg.dk/en/) for support of his research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasyan A, 2009, IUCN 2011 IUCN RED L; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2004, BIOL CONSERV, V118, P533, DOI 10.1016/j.biocon.2003.10.006; Araujo MB, 2009, CONSERV BIOL, V23, P1332; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P3, DOI 10.1016/j.gloenvcha.2003.10.004; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Ben-Haim Y., 2006, INFO GAP DECISION TH, V2; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Burns CE, 2003, P NATL ACAD SCI USA, V100, P11474, DOI 10.1073/pnas.1635115100; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Carr LW, 2001, CONSERV BIOL, V15, P1071, DOI 10.1046/j.1523-1739.2001.0150041071.x; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Gasc J.P., 1997, P1; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Hannah L, 2002, CONSERV BIOL, V16, P264, DOI 10.1046/j.1523-1739.2002.00465.x; Hastie T., 1986, STAT SCI, V1, P297; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Henle K, 2010, BIODIVERSITY CLIMATE, P225; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; IPCC, 2000, SPECIAL REPORT EMISS; IUCN, 2008, AN AMPH 2008 IUCN RE; Kharouba HM, 2010, BIOL CONSERV, V143, P1094, DOI 10.1016/j.biocon.2010.02.002; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kujala H, 2011, BIOL CONSERV, V144, P2450, DOI 10.1016/j.biocon.2011.06.023; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Lek S, 1996, ECOL MODEL, V90, P39, DOI 10.1016/0304-3800(95)00142-5; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mitchell TD, 2003, COMPREHENSIVE SET HI, V55, P55; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A, 2008, ZONATION SOFTWARE SP; Moilanen A, 2006, CONSERV BIOL, V20, P1688, DOI 10.1111/j.1523-1739.2006.00560.x; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; O'Neill BC, 2004, INT STAT REV, V72, P167; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2008, ECOL APPL, V18, P1200, DOI 10.1890/07-0507.1; Porter KR, 1972, HERPETOLOGY; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; PRESSEY RL, 1994, BIODIVERS CONSERV, V3, P242, DOI 10.1007/BF00055941; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Rayfield B, 2009, ECOL MODEL, V220, P725, DOI 10.1016/j.ecolmodel.2008.11.016; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; SINSCH U, 1990, ETHOL ECOL EVOL, V2, P65, DOI 10.1080/08927014.1990.9525494; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Thomson JR, 2009, ECOL APPL, V19, P817, DOI 10.1890/08-0915.1; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P759, DOI 10.1111/j.1365-2486.2006.01140.x; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9; Wintle BA, 2011, NAT CLIM CHANGE, V1, P355, DOI 10.1038/NCLIMATE1227	73	108	109	1	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53315	10.1371/journal.pone.0053315	http://dx.doi.org/10.1371/journal.pone.0053315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405068	Green Published, gold			2022-12-27	WOS:000315153400011
J	Thomas, M; Kienast, Y; Scheuer, W; Bahner, M; Kaluza, K; Gassner, C; Herting, F; Brinkmann, U; Seeber, S; Kavlie, A; Welschof, M; Ries, S; Weidner, KM; Regula, JT; Klein, C				Thomas, Markus; Kienast, Yvonne; Scheuer, Werner; Baehner, Monika; Kaluza, Klaus; Gassner, Christian; Herting, Frank; Brinkmann, Ulrich; Seeber, Stefan; Kavlie, Anita; Welschof, Martin; Ries, Stefan; Weidner, K. Michael; Regula, Joerg T.; Klein, Christian			A Novel Angiopoietin-2 Selective Fully Human Antibody with Potent Anti-Tumoral and Anti-Angiogenic Efficacy and Superior Side Effect Profile Compared to Pan-Angiopoietin-1/-2 Inhibitors	PLOS ONE			English	Article							ENDOTHELIAL-CELL SURVIVAL; ADVANCED SOLID TUMORS; AMG 386; OVARIAN-CANCER; TIE2 RECEPTOR; IN-VIVO; OCULAR ANGIOGENESIS; ANTITUMOR-ACTIVITY; BLOOD-VESSELS; SHORT-TERM	There is increasing experimental evidence for an important role of Angiopoietin-2 (Ang-2) in tumor angiogenesis and progression. In addition, Ang-2 is up-regulated in many cancer types and correlated with poor prognosis. To investigate the functional role of Ang-2 inhibition in tumor development and progression, we generated novel fully human antibodies that neutralize specifically the binding of Ang-2 to its receptor Tie2. The selected antibodies LC06 and LC08 recognize both rodent and human Ang-2 with high affinity, but LC06 shows a higher selectivity for Ang-2 over Ang-1 compared to LC08 which can be considered an Ang-2/Ang-1 cross-reactive antibody. Our data demonstrate that Ang-2 blockade results in potent tumor growth inhibition and pronounced tumor necrosis in subcutaneous and orthotopic tumor models. These effects are attended with a reduction of intratumoral microvessel density and tumor vessels characterized by fewer branches and increased pericyte coverage. Furthermore, anti-Ang-2 treatment strongly inhibits the dissemination of tumor cells to the lungs. Interestingly, in contrast to the Ang-2/Ang-1 cross-reactive antibody LC08 that leads to a regression of physiological vessels in the mouse trachea, the inhibition with the selective anti-Ang-2 antibody LC06 appears to be largely restricted to tumor vasculature without obvious effects on normal vasculature. Taken together, these data provide strong evidence for the selective Ang-2 antibody LC06 as promising new therapeutic agent for the treatment of various cancers.	[Thomas, Markus; Kienast, Yvonne; Scheuer, Werner; Herting, Frank; Weidner, K. Michael; Klein, Christian] Roche Diagnost GmbH, Pharma Res & Early Dev, Discovery Oncol, Penzberg, Germany; [Baehner, Monika; Kaluza, Klaus; Gassner, Christian; Brinkmann, Ulrich; Seeber, Stefan; Ries, Stefan; Regula, Joerg T.] Roche Diagnost GmbH, Pharma Res & Early Dev, Biol Res, Penzberg, Germany; [Kavlie, Anita; Welschof, Martin] Affitech Res AS, Oslo, Norway	Roche Holding; Roche Holding	Thomas, M (corresponding author), Roche Diagnost GmbH, Pharma Res & Early Dev, Discovery Oncol, Penzberg, Germany.	markus.thomas@roche.com	Brinkmann, Ulrich/AAF-8216-2019; Klein, Christian/G-1336-2010	Brinkmann, Ulrich/0000-0002-5558-0212; Klein, Christian/0000-0001-7594-7280; Regula, Joerg Thomas/0000-0002-7343-1077				Ahmad SA, 2001, CANCER, V92, P1138, DOI 10.1002/1097-0142(20010901)92:5<1138::AID-CNCR1431>3.0.CO;2-L; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Brown JL, 2010, MOL CANCER THER, V9, P145, DOI 10.1158/1535-7163.MCT-09-0554; Burger RA, 2012, GYNECOL ONCOL, V124, P5, DOI 10.1016/j.ygyno.2011.11.011; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Franco M, 2006, CANCER RES, V66, P3639, DOI 10.1158/0008-5472.CAN-05-3295; Hatfield KJ, 2008, LEUKEMIA, V22, P287, DOI 10.1038/sj.leu.2404985; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Herbst RS, 2009, J CLIN ONCOL, V27, P3557, DOI 10.1200/JCO.2008.19.6683; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hu B, 2003, P NATL ACAD SCI USA, V100, P8904, DOI 10.1073/pnas.1533394100; Huang H, 2011, CLIN CANC RES; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Joussen AM, 2001, GRAEF ARCH CLIN EXP, V239, P972, DOI 10.1007/s004170100365; Karlan BY, 2012, J CLIN ONCOL, V30, P362, DOI 10.1200/JCO.2010.34.3178; Kesisis G, 2007, CURR PHARM DESIGN, V13, P2795, DOI 10.2174/138161207781757033; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kurebayashi J, 1999, BRIT J CANCER, V79, P707, DOI 10.1038/sj.bjc.6690114; Leow CC, 2012, INT J ONCOL, V40, P1321, DOI 10.3892/ijo.2012.1366; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Mita AC, 2010, CLIN CANCER RES, V16, P3044, DOI 10.1158/1078-0432.CCR-09-3368; Mochizuki Y, 2002, J CELL SCI, V115, P175; Nasarre P, 2009, CANCER RES, V69, P1324, DOI 10.1158/0008-5472.CAN-08-3030; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park JH, 2007, CHEST, V132, P200, DOI 10.1378/chest.06-2915; Pfaff D, 2006, J LEUKOCYTE BIOL, V80, P719, DOI 10.1189/jlb.1105652; Pietila R, 2012, J CELL SCI, V125, P2212, DOI 10.1242/jcs.098020; Rennel ES, 2011, MICROCIRCULATION, V18, P598, DOI 10.1111/j.1549-8719.2011.00120.x; Rini B, 2012, CANCER; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sarraf-Yazdi S, 2008, J SURG RES, V146, P16, DOI 10.1016/j.jss.2007.04.028; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Schneider T, 2002, CLIN EXP METASTAS, V19, P571, DOI 10.1023/A:1020992411420; Stoeltzing O, 2003, CANCER RES, V63, P3370; Stratmann A, 1998, AM J PATHOL, V153, P1459, DOI 10.1016/S0002-9440(10)65733-1; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tsutsui S, 2006, BREAST CANCER RES TR, V98, P261, DOI 10.1007/s10549-005-9157-9; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wurmbach JH, 2000, ANTICANCER RES, V20, P5217; Zagzag D, 1999, EXP NEUROL, V159, P391, DOI 10.1006/exnr.1999.7162; Zhang L, 2003, CANCER RES, V63, P3403	55	50	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54923	10.1371/journal.pone.0054923	http://dx.doi.org/10.1371/journal.pone.0054923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405099	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400043
J	Wang, W; Collinger, JL; Degenhart, AD; Tyler-Kabara, EC; Schwartz, AB; Moran, DW; Weber, DJ; Wodlinger, B; Vinjamuri, RK; Ashmore, RC; Kelly, JW; Boninger, ML				Wang, Wei; Collinger, Jennifer L.; Degenhart, Alan D.; Tyler-Kabara, Elizabeth C.; Schwartz, Andrew B.; Moran, Daniel W.; Weber, Douglas J.; Wodlinger, Brian; Vinjamuri, Ramana K.; Ashmore, Robin C.; Kelly, John W.; Boninger, Michael L.			An Electrocorticographic Brain Interface in an Individual with Tetraplegia	PLOS ONE			English	Article							MOTOR CORTICAL REPRESENTATION; MOVEMENT TRAJECTORIES; COMPUTER INTERFACE; CORTEX; SIGNALS; EXECUTION; DIRECTION; IMAGERY; ARM	Brain-computer interface (BCI) technology aims to help individuals with disability to control assistive devices and reanimate paralyzed limbs. Our study investigated the feasibility of an electrocorticography (ECoG)-based BCI system in an individual with tetraplegia caused by C4 level spinal cord injury. ECoG signals were recorded with a high-density 32-electrode grid over the hand and arm area of the left sensorimotor cortex. The participant was able to voluntarily activate his sensorimotor cortex using attempted movements, with distinct cortical activity patterns for different segments of the upper limb. Using only brain activity, the participant achieved robust control of 3D cursor movement. The ECoG grid was explanted 28 days post-implantation with no adverse effect. This study demonstrates that ECoG signals recorded from the sensorimotor cortex can be used for real-time device control in paralyzed individuals.	[Wang, Wei; Collinger, Jennifer L.; Tyler-Kabara, Elizabeth C.; Schwartz, Andrew B.; Weber, Douglas J.; Wodlinger, Brian; Vinjamuri, Ramana K.; Ashmore, Robin C.; Boninger, Michael L.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Wang, Wei; Collinger, Jennifer L.; Degenhart, Alan D.; Tyler-Kabara, Elizabeth C.; Schwartz, Andrew B.; Weber, Douglas J.; Boninger, Michael L.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Wang, Wei; Boninger, Michael L.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Wang, Wei; Degenhart, Alan D.; Schwartz, Andrew B.; Weber, Douglas J.; Wodlinger, Brian] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Wang, Wei; Degenhart, Alan D.; Schwartz, Andrew B.; Weber, Douglas J.; Wodlinger, Brian] Univ Pittsburgh, Pittsburgh, PA USA; [Collinger, Jennifer L.; Weber, Douglas J.; Boninger, Michael L.] Dept Vet Affairs, Human Engn Res Labs, Pittsburgh, PA USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Schwartz, Andrew B.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Moran, Daniel W.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Moran, Daniel W.] Washington Univ, Dept Neurobiol, St Louis, MO USA; [Kelly, John W.] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Washington University (WUSTL); Carnegie Mellon University	Wang, W (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.	wangwei3@pitt.edu	Tyler-Kabara, Elizabeth/H-4930-2013	Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Degenhart, Alan/0000-0002-8369-8517; Wodlinger, Brian/0000-0001-6808-4448; Vinjamuri, Ramana Kumar/0000-0003-1650-5524; Collinger, Jennifer/0000-0002-4517-5395; Boninger, Michael/0000-0001-6966-919X	University of Pittsburgh Medical Center (UPMC); UPMC Rehabilitation Institute; National Institutes of Health (NIH) [3R01NS050256-05S1, 1R01EB009103-01, 8KL2TR000146-07]; SPAWAR [N66001-10-C-4056 20100630]; Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command Agreement [W81XWH-07-1-0716]; Craig H. Neilsen Foundation; Office of Research and Development, Rehabilitation Research & Development Service, VA Center of Excellence in Wheelchairs and Associated Rehab Engineering [B6789C]; Hopkins University Applied Physics Laboratory; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050256] Funding Source: NIH RePORTER	University of Pittsburgh Medical Center (UPMC); UPMC Rehabilitation Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPAWAR; Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command Agreement; Craig H. Neilsen Foundation; Office of Research and Development, Rehabilitation Research & Development Service, VA Center of Excellence in Wheelchairs and Associated Rehab Engineering; Hopkins University Applied Physics Laboratory; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the University of Pittsburgh Medical Center (UPMC) (www.upmc.com), UPMC Rehabilitation Institute (www.upmc.com/Services/rehab/rehab-institute), and the National Institutes of Health (NIH)(www.nih.gov) Grants 3R01NS050256-05S1, 1R01EB009103-01, and 8KL2TR000146-07. This material is based upon work supported by the SPAWAR (www.spawar.navy.mil) under Contract No. N66001-10-C-4056 20100630, Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command Agreement (www.tatrc.org) W81XWH-07-1-0716, and the Craig H. Neilsen Foundation (chnfoundation.org). This material is supported in part by the Office of Research and Development, Rehabilitation Research & Development Service, VA Center of Excellence in Wheelchairs and Associated Rehab Engineering (www.herl.research.va.gov), Grant# B6789C. The contents of this publication do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participant for his commitment and effort for this study and for his insightful discussion with the study team. We thank the contribution and support from clinicians and researchers at the University of Pittsburgh and University of Pittsburgh Medical Center (UPMC). Specifically, we thank Dr. Joseph Ricker at Department of Physical Medicine and Rehabilitation (PM&R) for conducting presurgical neuropsychological screening with the study participant, Dr. Timothy Verstynen at the Learning Research and Development Center for his help with presurgical fMRI protocol development, Dr. Donald Crammond at the Department of Neurological Surgery for intra-operative neurophysiology monitoring, Dr. Ferenc Gyulai at the Department of Anesthesiology for directing general anesthesia for the grid implantation surgery, and Dr. Richard Barbara at the Department of PM&R for post-BCI-experiment neuropsychological consultation with the participant. We thank Ms. Elizabeth (Betsy) Harchick at the Department of PM&R for helping with regulatory compliance, subject recruitment, presurgical functional neuroimaging studies, and BCI sessions. We thank Dr. Stephen Foldes at the Department of PM&R and Ms. Leah Helou at the Department of communication science and disorders for helping with BCI sessions. We thank the University of Pittsburgh Clinical and Translational Science Institute for important help with human subject protocol development and regulatory approval and compliance. We thank Mr. Jesse Wheeler at the Department of Biomedical Engineering, Washington University in St. Louis, for pre-clinical testing of the custom ECoG array and discussions on neural decoding schemes. We thank the Johns Hopkins University Applied Physics Laboratory for their support of the project, especially the prosthetic arm control experiment.	Acharya S, 2010, J NEURAL ENG, V7, DOI [10.1088/1741-2560/7/4/046002, 10.2202/1553-3840.1324]; American Spinal Injury Association/International Medical Society of Paraplegia, 2001, INT STAND NEUR FUNCT; Ashmore RC, 2012, STABLE ONLINE CONTRO; Blakely T, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0977; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao ZC, 2011, FRONT NEUROENGINEERI, V3, P3; Christensen MS, 2007, PREMOTOR CORTEX MODU; Crapse TB, 2008, CURR OPIN NEUROBIOL, V18, P552, DOI 10.1016/j.conb.2008.09.017; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Degenhart AD, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/363565; Donoghue JP, 2008, NEURON, V60, P511, DOI 10.1016/j.neuron.2008.10.037; Edwards E, 2009, NEUROIMAGE; Felton EA, 2007, ELECTROCORTICOGRAPHI; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gritsenko V, 2007, AFFERENT INPUT EFFER; Harris A, 2011, IEEE SYS MAN CYBERN, P2877, DOI 10.1109/ICSMC.2011.6084102; Hermes D, 2010, J NEUROSCI METH, V185, P293, DOI 10.1016/j.jneumeth.2009.10.005; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Kellis S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056007; Kennedy PR, 2004, IEEE T NEUR SYS REH, V12, P339, DOI 10.1109/TNSRE.2004.834629; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Miller KJ, 2007, J NEUROSCI METH, V162, P303, DOI 10.1016/j.jneumeth.2007.01.019; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Porro CA, 1996, PRIMARY MOTOR SENSOR; Ray S, 2008, CLIN NEUROPHYSIOL, V119, P116, DOI 10.1016/j.clinph.2007.09.136; Rouse AG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036018; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Schalk G, 2012, BRAIN COMPUTER INTER, P251; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shoham S, 2001, NATURE, V413, P793, DOI 10.1038/35101651; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Stoica P., 1997, SPECTRAL ANAL SIGNAL; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wang W, 2009, HUMAN MOTOR CORTICAL; Wang W, 2007, J NEUROPHYSIOL, V97, P4258, DOI 10.1152/jn.01180.2006; Wang Wei, 2010, Phys Med Rehabil Clin N Am, V21, P157, DOI 10.1016/j.pmr.2009.07.003; Wheeler JJ, 2011, PERSONAL COMMUNICATI; Wodlinger B, 2012, CLIN NEUROP IN PRESS, P3083; Yanagisawa T, 2011, ANN NEUROL	54	223	224	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55344	10.1371/journal.pone.0055344	http://dx.doi.org/10.1371/journal.pone.0055344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405137	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000315153400082
J	Yeh, CY; Yeh, TH; Jung, CJ; Chen, PL; Lien, HT; Chia, JS				Yeh, Chiou-Yueh; Yeh, Te-Huei; Jung, Chiau-Jing; Chen, Pei-Lin; Lien, Huei-Ting; Chia, Jean-San			Activated Human Nasal Epithelial Cells Modulate Specific Antibody Response against Bacterial or Viral Antigens	PLOS ONE			English	Article							IN-VITRO IMMUNIZATION; NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; GEM PARTICLES; STREPTOCOCCUS-MUTANS; LACTOCOCCUS-LACTIS; B-CELLS; EXPRESSION; INDUCE; INTERFACE	Nasal mucosa is an immune responsive organ evidenced by eliciting both specific local secretory IgA and systemic IgG antibody responses with intra-nasal administration of antigens. Nevertheless, the role of nasal epithelial cells in modulating such responses is unclear. Human nasal epithelial cells (hNECs) obtained from sinus mucosa of patients with chronic rhinosinusitis were cultured in vitro and firstly were stimulated by Lactococcus lactis bacterium-like particles (BLPs) in order to examine their role on antibody production. Secondly, both antigens of immunodominant protein IDG60 from oral Streptococcus mutans and hemagglutinin (HA) from influenza virus were tested to evaluate the specific antibody response. Stimulated hNECs by BLPs exhibited a significant increase in the production of interleukin-6 (IL-6), and thymic stromal lymphopoietin (TSLP). Conditioned medium of stimulated hNECs has effects on enhancing the proliferation of CD4+ T cells together with interferon-gamma and IL-5 production, increasing the costimulatory molecules on dendritic cells and augmenting the production of IDG60 specific IgA, HA specific IgG, IgA by human peripheral blood lymphocytes. Such production of antigen specific IgG and IgA is significantly counteracted in the presence of IL-6 and TSLP neutralizing antibodies. In conclusion, properly stimulated hNECs may impart immuno-modulatory effects on the antigen-specific antibody response at least through the production of IL-6 and TSLP.	[Yeh, Chiou-Yueh; Lien, Huei-Ting; Chia, Jean-San] Natl Taiwan Univ, Grad Inst Immunol, Coll Med, Taipei 10764, Taiwan; [Yeh, Te-Huei] Natl Taiwan Univ, Dept Otolaryngol, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Jung, Chiau-Jing; Chen, Pei-Lin; Chia, Jean-San] Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chia, JS (corresponding author), Natl Taiwan Univ, Grad Inst Immunol, Coll Med, Taipei 10764, Taiwan.	chiajs@ntu.edu.tw		CHIA, JEAN-SAN/0000-0002-5431-0712	National Science Council [NSC 95-2320-B-002-086-MY3, NSC 97-2314-B-002-091-MY3, 98-2320-B-002-047-MY3, NSC 100-2314-B-002-044, NSC 101-2321-B-002-074, NSC 101-2321-B-002-016]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council (NSC 95-2320-B-002-086-MY3, NSC 97-2314-B-002-091-MY3, 98-2320-B-002-047-MY3, NSC 100-2314-B-002-044, NSC 101-2321-B-002-074 and NSC 101-2321-B-002-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audouy SAL, 2006, VACCINE, V24, P5434, DOI 10.1016/j.vaccine.2006.03.054; BORREBAECK CAK, 1987, BIOCHEM BIOPH RES CO, V148, P941, DOI 10.1016/S0006-291X(87)80223-1; Bosma T, 2006, APPL ENVIRON MICROB, V72, P880, DOI 10.1128/AEM.72.1.880-889.2006; Brandtzaeg P, 2011, AM J RESP CRIT CARE, V183, P1595, DOI 10.1164/rccm.201011-1783OC; BROMANDER A, 1991, J IMMUNOL, V146, P2908; BROMANDER AK, 1993, SCAND J IMMUNOL, V37, P452, DOI 10.1111/j.1365-3083.1993.tb03318.x; Chia JS, 2000, ORAL MICROBIOL IMMUN, V15, P131, DOI 10.1034/j.1399-302x.2000.150210.x; Chia JS, 2001, INFECT IMMUN, V69, P6987, DOI 10.1128/IAI.69.11.6987-6998.2001; Chua BY, 2011, J IMMUNOL, V187, P1692, DOI 10.4049/jimmunol.1100486; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Fujiki T, 2010, BIOSCI BIOTECH BIOCH, V74, P1836, DOI 10.1271/bbb.100243; GASSON MJ, 1983, J BACTERIOL, V154, P1; Ichikawa A, 1999, CYTOTECHNOLOGY, V31, P131, DOI 10.1023/A:1008063903946; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kalinski P, 2000, J IMMUNOL, V165, P1877, DOI 10.4049/jimmunol.165.4.1877; Kamekura R, 2008, INFLAMMATION REGENER, V28, P160; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Krzysiek R, 2000, BLOOD, V96, P2338, DOI 10.1182/blood.V96.7.2338.h8002338_2338_2345; Lin CF, 2007, ACTA OTO-LARYNGOL, V127, P395, DOI 10.1080/00016480601089416; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Matsumoto S, 2006, CYTOTECHNOLOGY, V52, P227, DOI 10.1007/s10616-006-9003-x; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Ramasamy R, 2006, VACCINE, V24, P3900, DOI 10.1016/j.vaccine.2006.02.040; Ramirez K, 2010, MUCOSAL IMMUNOL, V3, P159, DOI 10.1038/mi.2009.131; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saluja V, 2010, EUR J PHARM BIOPHARM, V76, P470, DOI 10.1016/j.ejpb.2010.08.003; Saluja V, 2010, VACCINE, V28, P7963, DOI 10.1016/j.vaccine.2010.09.066; Saluja V, 2010, AAPS J, V12, P109, DOI 10.1208/s12248-009-9168-2; Tanaka J, 2010, DIGEST DIS SCI, V55, P1896, DOI 10.1007/s10620-009-0979-x; van Roosmalen ML, 2006, METHODS, V38, P144, DOI 10.1016/j.ymeth.2005.09.015; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Yeh CY, 2006, INFECT IMMUN, V74, P1273, DOI 10.1128/IAI.74.2.1273-1283.2006; Yeh TH, 2007, LARYNGOSCOPE, V117, P1439, DOI 10.1097/MLG.0b013e318063e84f; Yeh TH, 2005, ACTA OTO-LARYNGOL, V125, P1091, DOI 10.1080/00016480510037906; Zeng WG, 2012, VACCINE, V30, P4800, DOI 10.1016/j.vaccine.2012.05.017	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55472	10.1371/journal.pone.0055472	http://dx.doi.org/10.1371/journal.pone.0055472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405156	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400101
J	Ishikawa, T; Sakaguchi, Y				Ishikawa, Takumi; Sakaguchi, Yutaka			Both Movement-End and Task-End Are Critical for Error Feedback in Visuomotor Adaptation: A Behavioral Experiment	PLOS ONE			English	Article							PRISM ADAPTATION; SENSORY PREDICTION; BASAL GANGLIA; CEREBELLUM; SPECIFICITY; DEPRESSION; SIGNALS; LOOKING; LESIONS; CORTEX	An important issue in motor learning/adaptation research is how the brain accepts the error information necessary for maintaining and improving task performance in a changing environment. The present study focuses on the effect of timing of error feedback. Previous research has demonstrated that adaptation to displacement of the visual field by prisms in a manual reaching task is significantly slowed by delayed visual feedback of the endpoint, suggesting that error feedback is most effective when given at the end of a movement. To further elucidate the brain mechanism by which error information is accepted in visuomotor adaptation, we tested whether error acceptance is linked to the end of a given task or to the end of an executed movement. We conducted a behavioral experiment using a virtual shooting task in which subjects controlled their wrist movements to meet a target with a cursor as accurately as possible. We manipulated the timing of visual feedback of the impact position so that it occurred either ahead of or behind the true time of impact. In another condition, the impact timing was explicitly indicated by an additional cue. The magnitude of the aftereffect significantly varied depending on the timing of feedback (p < 0.05, Friedman's Test). Interestingly, two distinct peaks of aftereffect were observed around movement-end and around task-end, irrespective of the existence of the timing cue. However, the peak around task-end was sharper when the timing cue was given. Our results demonstrate that the brain efficiently accepts error information at both movement-end and task-end, suggesting that two different learning mechanisms may underlie visuomotor transformation.	[Ishikawa, Takumi; Sakaguchi, Yutaka] Univ Electrocommun, Dept Informat Media Syst, Tokyo, Japan	University of Electro-Communications - Japan	Ishikawa, T (corresponding author), Univ Electrocommun, Dept Informat Media Syst, Tokyo, Japan.	g.burafuma@gmail.com		Sakaguchi, Yutaka/0000-0002-5573-8462	Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This research was partially supported by Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST) (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; BINGHAM GP, 1989, J EXP PSYCHOL HUMAN, V15, P507, DOI 10.1037/0096-1523.15.3.507; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Cressman EK, 2010, J NEUROPHYSIOL, V103, P1888, DOI 10.1152/jn.01002.2009; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Fernandez-Ruiz J, 2004, COGNITIVE BRAIN RES, V20, P92, DOI 10.1016/j.cogbrainres.2004.01.007; Fernandez-Ruiz J, 1999, LEARN MEMORY, V6, P47; Fernandez-Ruiz J, 2006, J NEUROSCI, V26, P1986, DOI 10.1523/JNEUROSCI.4023-05.2006; Fernandez-Ruiz J, 2003, EUR J NEUROSCI, V18, P689, DOI 10.1046/j.1460-9568.2003.02785.x; Fernandez-Ruiz J, 2007, NEUROPSYCHOLOGIA, V45, P2692, DOI 10.1016/j.neuropsychologia.2007.04.006; Honda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037900; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; Ishikawa T, 2010, NEURO2010; Ishikawa T, 2011, LECT NOTES COMPU III, P95; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Kawato M., 1990, ADV NEURAL COMPUTERS, V6, P365; Kitazawa S, 1997, J NEUROSCI, V17, P1481; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; Kitazawa S, 2002, EXP BRAIN RES, V144, P258, DOI 10.1007/s00221-002-1089-6; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Newport R, 2006, NEUROPSYCHOLOGIA, V44, P2757, DOI 10.1016/j.neuropsychologia.2006.01.007; Rao SM, 1997, J NEUROSCI, V17, P5528; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Stratton GM, 1896, PSYCHOL REV, V3, P611, DOI DOI 10.1037/H0072918; Tanaka H, 2011, EXP BRAIN RES, V208, P257, DOI 10.1007/s00221-010-2476-z; Thach WT, 1998, NEUROBIOL LEARN MEM, V70, P177, DOI 10.1006/nlme.1998.3846; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Yin PB, 2001, EXP BRAIN RES, V141, P250, DOI 10.1007/s002210100892	38	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55801	10.1371/journal.pone.0055801	http://dx.doi.org/10.1371/journal.pone.0055801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086NV	23393602	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800057
J	Wallrabenstein, I; Kuklan, J; Weber, L; Zborala, S; Werner, M; Altmuller, J; Becker, C; Schmidt, A; Hatt, H; Hummel, T; Gisselmann, G				Wallrabenstein, Ivonne; Kuklan, Jonas; Weber, Lea; Zborala, Sandra; Werner, Markus; Altmueller, Janine; Becker, Christian; Schmidt, Anna; Hatt, Hanns; Hummel, Thomas; Gisselmann, Guenter			Human Trace Amine-Associated Receptor TAAR5 Can Be Activated by Trimethylamine	PLOS ONE			English	Article							MAMMALIAN ODORANT RECEPTORS; FUNCTIONAL EXPRESSION; OLFACTORY SUBSYSTEM; IDENTIFICATION; SENSITIVITY; EXCRETION; AGONISTS; ANOSMIA; STRESS; FAMILY	In addition to the canonical olfactory receptors, TAARs were currently suggested to be a second class of chemosensory receptors in the olfactory epithelium of vertebrates. In contrast to several deorphanized murine TAARs, agonists for the intact human TAAR genes 2, 5, 6, 8 and 9 that are potentially expressed in the human olfactory epithelium have not been determined so far. Moreover, the physiological relevance of TAARs still remains elusive. We present the first successful functional expression of a human TAAR and agonists of human TAAR5. We performed a ligand screening using recombinantly expressed human TAAR5 in HANA3A cells and Xenopus laevis oocytes. In order to measure receptor activity, we used a cAMP-dependent reporter gene assay and two-electrode voltage clamp technique. As a result, human TAAR5 can be activated in a concentration-dependent manner by trimethylamine and with less efficacy by dimethylethylamine. It could neither be activated by any other of the tested single amines with a related chemical structure (42 in total), nor by any of the tested odorant mixtures. The hypothesis that Single Nucleotide Polymorphisms (SNP) within the reading frame of an olfactory receptor gene can cause a specific anosmia, formed the basis for clarifying the question, if anosmia for trimethylamine is caused by a SNP in a TAAR coding sequence. All functional human TAAR gene reading frames of subjects with specific anosmia for trimethylamine were amplified and products analyzed regarding SNP distribution. We demonstrated that the observed specific anosmia for trimethylamine is not correlated with a SNP in the coding sequence of one of the putatively functional human TAAR genes.	[Wallrabenstein, Ivonne; Kuklan, Jonas; Weber, Lea; Zborala, Sandra; Werner, Markus; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Bochum, Germany; [Schmidt, Anna; Hummel, Thomas] Tech Univ Dresden, Univ Dresden Med Sch, Dept Otorhinolaryngol, Smell & Taste Clin, D-01062 Dresden, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	Ruhr University Bochum; Technische Universitat Dresden; University of Cologne	Wallrabenstein, I (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	Ivonne.Wallrabenstein@rub.de		Altmuller, Janine/0000-0003-4372-1521	Deutsche Forschungsgemeinschaft [SPP1393]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (SPP1393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; AMOORE JE, 1977, CHEM SENS FLAV, V2, P267, DOI 10.1093/chemse/2.3.267; AMOORE JE, 1979, CHEM SENS FLAV, V4, P153, DOI 10.1093/chemse/4.2.153; Amoore JE, 1976, J CHEM ECOL, V2, P49, DOI 10.1007/BF00988023; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Carnicelli V, 2010, CHEMOSENS PERCEPT, V3, P99, DOI 10.1007/s12078-010-9075-z; Ferrero DM, 2012, ACS CHEM BIOL, V7, P1184, DOI 10.1021/cb300111e; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Johnson MA, 2012, P NATL ACAD SCI USA, V109, P13410, DOI 10.1073/pnas.1206724109; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keydar I, 2012, HUM MUTAT; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; McKee CLG, 2006, J PROTEOME RES, V5, P378, DOI 10.1021/pr050255h; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P517; Navarrete-Palacios E, 2003, BIOL PSYCHOL, V63, P269, DOI 10.1016/S0301-0511(03)00076-0; NISHIMURA K, 1989, J EXP ZOOL, V251, P300, DOI 10.1002/jez.1402510306; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; PAULOS MA, 1982, SCIENCE, V215, P1127, DOI 10.1126/science.7063846; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Shimizu M, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-2; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; SNODDY AM, 1985, PHARMACOL BIOCHEM BE, V22, P497, DOI 10.1016/0091-3057(85)90054-1; Staubert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011133; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zucchi R, 2006, BRIT J PHARMACOL, V149, P967, DOI 10.1038/sj.bjp.0706948	37	81	83	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54950	10.1371/journal.pone.0054950	http://dx.doi.org/10.1371/journal.pone.0054950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393561	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800015
J	Alvarez-Lacalle, E; Cantalapiedra, IR; Penaranda, A; Cinca, J; Hove-Madsen, L; Echebarria, B				Alvarez-Lacalle, Enric; Cantalapiedra, Inma R.; Penaranda, Angelina; Cinca, Juan; Hove-Madsen, Leif; Echebarria, Blas			Dependency of Calcium Alternans on Ryanodine Receptor Refractoriness	PLOS ONE			English	Article							CA2+-INDUCED CA2+ RELEASE; SARCOPLASMIC-RETICULUM; TERMINATION; MECHANISMS; FIBRILLATION; ACTIVATION; MUTATIONS; STABILITY; TRANSIENT; DYNAMICS	Background: Rapid pacing rates induce alternations in the cytosolic calcium concentration caused by fluctuations in calcium released from the sarcoplasmic reticulum (SR). However, the relationship between calcium alternans and refractoriness of the SR calcium release channel (RyR2) remains elusive. Methodology/Principal Findings: To investigate how ryanodine receptor (RyR2) refractoriness modulates calcium handling on a beat-to-beat basis using a numerical rabbit cardiomyocyte model. We used a mathematical rabbit cardiomyocyte model to study the beat-to-beat calcium response as a function of RyR2 activation and inactivation. Bi-dimensional maps were constructed depicting the beat-to-beat response. When alternans was observed, a novel numerical clamping protocol was used to determine whether alternans was caused by oscillations in SR calcium loading or by RyR2 refractoriness. Using this protocol, we identified regions of RyR2 gating parameters where SR calcium loading or RyR2 refractoriness underlie the induction of calcium alternans, and we found that at the onset of alternans both mechanisms contribute. At low inactivation rates of the RyR2, calcium alternans was caused by alternation in SR calcium loading, while at low activation rates it was caused by alternation in the level of available RyR2s. Conclusions/Significance: We have mapped cardiomyocyte beat-to-beat responses as a function of RyR2 activation and inactivation, identifying domains where SR calcium load or RyR2 refractoriness underlie the induction of calcium alternans. A corollary of this work is that RyR2 refractoriness due to slow recovery from inactivation can be the cause of calcium alternans even when alternation in SR calcium load is present.	[Alvarez-Lacalle, Enric; Cantalapiedra, Inma R.; Penaranda, Angelina; Echebarria, Blas] Univ Politecn Catalunya Barcelona Tech, Dept Fis Aplicada, Barcelona, Spain; [Cinca, Juan] Hosp Santa Creu & Sant Pau, Cardiol Serv IIB St Pau, Barcelona, Spain; [Hove-Madsen, Leif] Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain	Universitat Politecnica de Catalunya; Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Echebarria, B (corresponding author), Univ Politecn Catalunya Barcelona Tech, Dept Fis Aplicada, Barcelona, Spain.	blas.echebarria@upc.edu	Alvarez Lacalle, Enrique/M-1031-2014; Echebarria, Blas/K-5247-2014; Alvarez-Lacalle, Enrique/ADA-6394-2022; Rodriguez Cantalapiedra, Inmaculada/L-6394-2014; Echebarria, Blas/AAE-4135-2021; echebarria, blas/ABD-6811-2020; Peñaranda, Angelina/L-5120-2014	Alvarez Lacalle, Enrique/0000-0001-6824-6857; Echebarria, Blas/0000-0003-0503-1781; Alvarez-Lacalle, Enrique/0000-0001-6824-6857; Rodriguez Cantalapiedra, Inmaculada/0000-0002-0070-8979; Peñaranda, Angelina/0000-0002-0162-2851; Hove-Madsen, Leif/0000-0001-5493-3998	Spanish Ministry of Science and Innovation [CNIC-2007-12, FIS2008-06335-C02-01, FIS2011-28820-C02-01, FIS2009-13360-C03-03, SAF2011-30312]; Redes de Investigacion corporative, Instituto de Salud Carlos III, red REDINSCOR [RD06-0003-0000]; Generalitat of Catalonia [2009SGR878]; Spanish Ministry of Health and Consume	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Redes de Investigacion corporative, Instituto de Salud Carlos III, red REDINSCOR; Generalitat of Catalonia; Spanish Ministry of Health and Consume	Financial support from the Spanish Ministry of Science and Innovation is acknowledged CNIC-2007-12 (to BE, JC, and LHM), FIS2008-06335-C02-01 and FIS2011-28820-C02-01 (to BE), FIS2009-13360-C03-03 and SAF2011-30312 (to LHM). L. Hove-Madsen and J. Cinca were also supported by the Spanish Ministry of Health and Consume; Redes de Investigacion corporative, Instituto de Salud Carlos III, red REDINSCOR [RD06-0003-0000]. IRC also acknowledges financial support from the Generalitat of Catalonia under Project 2009SGR878. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belevych AE, 2009, CARDIOVASC RES, V84, P387, DOI 10.1093/cvr/cvp246; Chudin E, 1999, BIOPHYS J, V77, P2930, DOI 10.1016/S0006-3495(99)77126-2; Diaz ME, 2004, CIRC RES, V94, P650, DOI 10.1161/01.RES.0000119923.64774.72; Diaz ME, 2002, CIRC RES, V91, P585, DOI 10.1161/01.RES.0000035527.53514.C2; Diaz ME, 1997, J PHYSIOL-LONDON, V501, P3, DOI 10.1111/j.1469-7793.1997.003bo.x; Domeier TL, 2009, J PHYSIOL-LONDON, V587, P5197, DOI 10.1113/jphysiol.2009.177576; Dumitrescu C, 2002, AM J PHYSIOL-HEART C, V282, pH1320, DOI 10.1152/ajpheart.00466.2001; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; Huser J, 2000, J PHYSIOL-LONDON, V524, P795, DOI 10.1111/j.1469-7793.2000.00795.x; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Kameyama M, 2003, J ELECTROCARDIOL, V36, P125, DOI 10.1054/jelc.2003.50021; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Laver DR, 2011, J MOL CELL CARDIOL, V51, P357, DOI 10.1016/j.yjmcc.2011.05.009; Lehnart SE, 2004, CIRCULATION, V109, P3208, DOI 10.1161/01.CIR.0000132472.98675.EC; Llach A, 2011, J PHYSIOL-LONDON, V589, P3247, DOI 10.1113/jphysiol.2010.197715; Lukyanenko V, 1998, J PHYSIOL-LONDON, V507, P667, DOI 10.1111/j.1469-7793.1998.667bs.x; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; MATTIAZZI A, 1994, AM J PHYSIOL, V267, pH812, DOI 10.1152/ajpheart.1994.267.2.H812; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; Penaranda A, 2012, COMPUT CARDIOL CONF, V39, P297; Picht E, 2006, CIRC RES, V99, P740, DOI 10.1161/01.RES.0000244002.88813.91; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Restrepo JG, 2008, BIOPHYS J, V95, P3767, DOI 10.1529/biophysj.108.130419; Rovetti R, 2010, CIRC RES, V106, P1582, DOI 10.1161/CIRCRESAHA.109.213975; Sham JSK, 1998, P NATL ACAD SCI USA, V95, P15096, DOI 10.1073/pnas.95.25.15096; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shiferaw Y, 2003, BIOPHYS J, V85, P3666, DOI 10.1016/S0006-3495(03)74784-5; Shkryl VM, 2012, AM J PHYSIOL-HEART C, V302, pH2310, DOI 10.1152/ajpheart.00079.2012; Sobie EA, 2005, J PHYSIOL-LONDON, V565, P441, DOI 10.1113/jphysiol.2005.086496; Szentesi P, 2004, CIRC RES, V95, P807, DOI 10.1161/01.RES.0000146029.80463.7d; Terentyev D, 2002, CIRC RES, V91, P414, DOI 10.1161/01.RES.0000032490.04207.BD; Thomas NL, 2005, BIOCHEM BIOPH RES CO, V331, P231, DOI 10.1016/j.bbrc.2005.02.194; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	38	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55042	10.1371/journal.pone.0055042	http://dx.doi.org/10.1371/journal.pone.0055042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390511	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100027
J	Findlay, B; Mookherjee, N; Schweizer, F				Findlay, Brandon; Mookherjee, Neeloffer; Schweizer, Frank			Ultrashort Cationic Lipopeptides and Lipopeptoids Selectively Induce Cytokine Production in Macrophages	PLOS ONE			English	Article							DEFENSE PEPTIDE LL-37; ANTIMICROBIAL PEPTIDES; BACTERIAL-INFECTIONS; IMMUNE-RESPONSES; HUMAN CAP18; IN-VITRO; RECEPTOR; RESISTANCE; DISCOVERY; DISEASE	A series of ultrashort lipopeptides and lipopeptoids were tested for their ability to induce cytokine production in macrophages. Fourteen compounds were found to strongly induce production of chemokines Gro alpha and IL-8, with a structural bias that was absent from previous antibacterial activity investigations. Compounds based on LysGlyLys and NLysGlyNLys sequences did not induce cytokine production, whereas those based on LysLysLys and NLysNLysNLys were active only when linked to a lipid tail at least sixteen carbons long. Three lipopeptides induced high levels of IL-8 production, above that of equivalent concentrations of cathelicidin LL-37, while no compound induced production of the pro-inflammatory cytokine TNF-alpha at or below 100 mu M. Two compounds, peptoids C16OH-NLysNLysNLys and C16OH-NHarNHarNHar, were selective for IL-8 production and did not induce TNF-alpha or IL-1 beta. These compounds may prove beneficial for in vivo treatment of infectious disease, with improved bioavailability over LL-37 due to their protease-resistant scaffold.	[Findlay, Brandon; Schweizer, Frank] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Mookherjee, Neeloffer] Univ Manitoba, Dept Internal Med & Immunol, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada; [Schweizer, Frank] Univ Manitoba, Dept Med Microbiol, Hlth Sci Ctr, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Mookherjee, N (corresponding author), Univ Manitoba, Dept Internal Med & Immunol, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada.	mookherj@cc.umanitoba.ca; schweize@cc.umanitoba.ca		Mookherjee, Neeloffer/0000-0002-9350-4157	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri G, 2011, J MED CHEM, V54, P8148, DOI 10.1021/jm201071e; Baker TJ, 2000, J ORG CHEM, V65, P9054, DOI 10.1021/jo001142e; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Choi KY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00149; Czihal P, 2012, ACS CHEM BIOL, V7, P1281, DOI 10.1021/cb300063v; Findlay B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041141; Findlay B, 2012, INT J ANTIMICROB AG, V40, P36, DOI 10.1016/j.ijantimicag.2012.03.013; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Hammerum AM, 2007, EMERG INFECT DIS, V13, P1632, DOI 10.3201/eid1311.070421; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; Kaoud TS, 2011, ACS CHEM BIOL, V6, P658, DOI 10.1021/cb200017n; Khandelia H, 2008, BBA-BIOMEMBRANES, V1778, P1528, DOI 10.1016/j.bbamem.2008.02.009; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; LARRICK JW, 1995, IMMUNOTECHNOLOGY, V1, P65, DOI 10.1016/1380-2933(95)00006-2; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Mookherjee N, 2009, MOL BIOSYST, V5, P483, DOI 10.1039/b813787k; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Thaker HD, 2012, J AM CHEM SOC, V134, P11088, DOI 10.1021/ja303304j; Thwaite JE, 2006, ANTIMICROB AGENTS CH, V50, P2316, DOI 10.1128/AAC.01488-05; Turner-Brannen E, 2011, J IMMUNOL, V186, P7127, DOI 10.4049/jimmunol.1002306; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang LH, 2008, P NATL ACAD SCI USA, V105, P20595, DOI 10.1073/pnas.0806456105; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yu J, 2007, J IMMUNOL, V179, P7684, DOI 10.4049/jimmunol.179.11.7684; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	40	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54280	10.1371/journal.pone.0054280	http://dx.doi.org/10.1371/journal.pone.0054280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390497	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100013
J	Lin, CT; Chen, YC; Jinn, TR; Wu, CC; Hong, YM; Wu, WH				Lin, Ching-Ting; Chen, Yu-Ching; Jinn, Tzyy-Rong; Wu, Chien-Chen; Hong, Yi-Ming; Wu, Wen-Hao			Role of the cAMP-Dependent Carbon Catabolite Repression in Capsular Polysaccharide Biosynthesis in Klebsiella pneumoniae	PLOS ONE			English	Article							AMP RECEPTOR PROTEIN; CYCLIC-AMP; ESCHERICHIA-COLI; ACTIVATOR PROTEIN; LIVER-ABSCESS; TRANSCRIPTION ACTIVATION; COMMON INFECTIONS; EMERGING DISEASE; GENE-EXPRESSION; HIGH PREVALENCE	K. pneumoniae is the predominant pathogen isolated from liver abscesses of diabetic patients in Asian countries. Although elevated blood glucose levels cause various immune problems, its effects on K. pneumoniae virulence are unknown. This study investigated the regulation of capsular polysaccharide (CPS) biosynthesis, a major determinant for K. pneumoniae virulence, in response to exogenous glucose. We found that K. pneumoniae produce more CPS in glucose-rich medium via reduction in cyclic AMP (cAMP) levels. Individual deletion of cyaA or crp, which respectively encode adenylate cyclase and cAMP receptor protein in K. pneumoniae, markedly increased CPS production, while deletion of cpdA, which encodes cAMP phosphodiesterase, decreased CPS production. These results indicate that K. pneumoniae CPS biosynthesis is controlled by the cAMP-dependent carbon catabolite repression (CCR). To investigate the underlying mechanism, quantitative real-time PCR and promoter-reporter assays were used to verify that the transcription of CPS biosynthesis genes, which are organized into 3 transcription units (orf1-2, orf3-15, and orf16-17), were activated by the deletion of crp. Sequence analysis revealed putative CRP binding sites located on Porf3-15 and Porf16-17, suggesting direct CRP-cAMP regulation on the promoters. These results were then confirmed by electrophoretic mobility shift assay. In addition, we found putative CRP binding sites located in the promoter region of rcsA, which encodes a cps transcriptional activator, demonstrating a direct repression of CRP-cAMP and P-rcsA. The deletion of rcsA in mutation of crp partially reduced CPS biosynthesis and the transcription of orf1-2 but not of orf3-15 or orf16-17. These results suggest that RcsA participates in the CRP-cAMP regulation of orf1-2 transcription and influences CPS biosynthesis. Finally, the effect of glucose and CCR proteins on CPS biosynthesis also reflects bacterial resistance to serum killing. We here provide evidence that K. pneumoniae increases CPS biosynthesis for successful infection in response to exogenous glucose via cAMP-dependent CCR.	[Lin, Ching-Ting; Jinn, Tzyy-Rong; Hong, Yi-Ming; Wu, Wen-Hao] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Chen, Yu-Ching] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Wu, Chien-Chen] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	China Medical University Taiwan; Asia University Taiwan; National Yang Ming Chiao Tung University	Lin, CT (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	gingting@mail.cmu.edu.tw			National Science Council [NSC 99-2320-B-039-002-MY3]; China Medical University [CMU100-ASIA-12]	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	The work is supported by the grants from National Science Council (NSC 99-2320-B-039-002-MY3) and China Medical University (CMU100-ASIA-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA Y, 1995, J BACTERIOL, V177, P1788, DOI 10.1128/jb.177.7.1788-1796.1995; BAGA M, 1985, EMBO J, V4, P3887, DOI 10.1002/j.1460-2075.1985.tb04162.x; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Chen SL, 2009, J UROLOGY, V182, pS51, DOI 10.1016/j.juro.2009.07.090; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; DELORENZO V, 1988, EUR J BIOCHEM, V173, P537; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; Endoh T, 2009, J BACTERIOL, V191, P7193, DOI 10.1128/JB.00970-09; Fuchs EL, 2010, J BACTERIOL; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Geerlings SE, 2000, ADV EXP MED BIOL, V485, P309; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; HAN SHB, 1995, WESTERN J MED, V162, P220; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; Inada T, 1996, MOL GEN GENET, V253, P198, DOI 10.1007/s004380050313; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim HS, 2009, J BACTERIOL, V191, P922, DOI 10.1128/JB.01350-08; Lai YC, 2001, INFECT IMMUN, V69, P7140, DOI 10.1128/IAI.69.11.7140-7145.2001; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Lau YJ, 2000, J CLIN MICROBIOL, V38, P412; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lin CT, 2006, J BIOCHEM, V140, P429, DOI 10.1093/jb/mvj168; Lin CT, 2011, MICROBIOL-SGM, V157, P419, DOI 10.1099/mic.0.044065-0; Lin HH, 2011, J BACTERIOL, V193, P5833, DOI 10.1128/JB.05359-11; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Lory S, 2004, INT J MED MICROBIOL, V293, P479, DOI 10.1078/1438-4221-00297; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mendez M, 2008, J BACTERIOL, V190, P48, DOI 10.1128/JB.01407-07; Meyer M, 2001, J BACTERIOL, V183, P5248, DOI 10.1128/JB.183.18.5248-5256.2001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; NASSIF X, 1989, MOL MICROBIOL, V3, P1349, DOI 10.1111/j.1365-2958.1989.tb00116.x; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; Patterson JE, 1997, INFECT DIS CLIN N AM, V11, P735, DOI 10.1016/S0891-5520(05)70383-4; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; PETERKOFSKY A, 1971, P NATL ACAD SCI USA, V68, P2794, DOI 10.1073/pnas.68.11.2794; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Sahly H, 2000, INFECT IMMUN, V68, P6744, DOI 10.1128/IAI.68.12.6744-6749.2000; Saier MH, 1996, FEMS MICROBIOL LETT, V138, P97; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Stella NA, 2008, RES MICROBIOL, V159, P562, DOI 10.1016/j.resmic.2008.07.003; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vecerek B, 2003, MOL MICROBIOL, V50, P897, DOI 10.1046/j.1365-2958.2003.03727.x; Warren JW, 2001, INT J ANTIMICROB AG, V17, P299, DOI 10.1016/S0924-8579(00)00359-9; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; WEST SEH, 1994, J BACTERIOL, V176, P7532, DOI 10.1128/JB.176.24.7532-7542.1994; Wu CC, 2012, MICROBIOL-SGM, V158, P1045, DOI 10.1099/mic.0.053801-0; Wu JH, 2005, EXP BIOL MED, V230, P757, DOI 10.1177/153537020523001009; Yang YS, 2009, J CLIN MICROBIOL, V47, P3336, DOI 10.1128/JCM.00918-09; Zhang ZG, 2005, J BACTERIOL, V187, P980, DOI 10.1128/JB.187.3.980-990.2005; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	72	61	69	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54430	10.1371/journal.pone.0054430	http://dx.doi.org/10.1371/journal.pone.0054430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408939	gold, Green Submitted, Green Published			2022-12-27	WOS:000315100000003
J	Deng, YH; Hassan, MM; Mo, JW; Lin, EH				Deng, Yanhong; Hassan, Manal M.; Mo, Jianwen; Lin, Edward H.			Peripheral Blood Mononuclear CD133 mRNA Levels Correlates with Response to Treatment in Patients with Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							CANCER STEM-CELLS; SOLID TUMORS; EXPRESSION; MARKER; SARCOMA	Background: CD133 is a marker that identifies/enriches cancer stem cell implicated in tumor initiation. We hypothesize that changes in the CD133 mRNA expression levels and vascular endothelial growth factor (VEGF) may correlate tumor response in GIST. Methodology/Principal Findings: After informed consent, we obtained peripheral blood samples from 24 evaluable patients with gastrointestinal stromal tumors (GIST). There were 7 -paired samples before and after treatment, We measured CD133 mRNA levels by real time RT-PCR method and vascular endothelial growth factor (VEGF) levels by ELISA. All measurements were done in duplicates in two separate experiments. The treatment resulted in significant reduction of CD133 mRNA expression (p = 0.048) as well as the level of VEGF (p = 0.003). The mean CD133 mRNA levels for GIST patients was 615. We found no correlation between the CD133 mRNA levels and VEGF levels. (p = 0.826). Logistic regression analysis suggested a relationship between elevated CD133 mRNA levels and fitted probability of eventual progressive disease (PD) and mixed response at 37% for CD133 mRNA of 2.25, and the probability of eventual PD/MR is 84% for a CD133 of 2072 (p = 0.08). Conclusions/Significance: CD133 mRNA expression levels in GIST patients measured by real time RT-PCR assay appeared to correlate with tumor response to surgery or imatinib and may be used to predict tumor progression. Additional prospective studies are warranted.	[Lin, Edward H.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA; [Deng, Yanhong; Mo, Jianwen] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Hassan, Manal M.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center	Deng, YH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.	dengyanh@mail.sysu.edu.cn; elin@seattlecca.org			National Natural Science Foundation [81101669]; Sun Yatsen University	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Sun Yatsen University	This study was supported by the National Natural Science Foundation (No. 81101669) and the Young Investigator Training Program of Sun Yatsen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arne G, 2011, INT J CANCER, V129, P1149, DOI 10.1002/ijc.25755; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bozzi F, 2011, CYTOM PART B-CLIN CY, V80B, P238, DOI 10.1002/cyto.b.20589; Chen JW, 2012, GENE CHROMOSOME CANC, V51, P186, DOI 10.1002/gcc.20942; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Lin EH, 2007, CANCER-AM CANCER SOC, V110, P534, DOI 10.1002/cncr.22774; Mehra N, 2006, CLIN CANCER RES, V12, P4859, DOI 10.1158/1078-0432.CCR-06-0422; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Terry J, 2010, APPL IMMUNOHISTO M M, V18, P159, DOI 10.1097/PAI.0b013e3181b77451; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012	18	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55520	10.1371/journal.pone.0055520	http://dx.doi.org/10.1371/journal.pone.0055520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408993	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200034
J	Alemayehu, M; Dragan, M; Pape, C; Siddiqui, I; Sacks, DB; Di Guglielmo, GM; Babwah, AV; Bhattacharya, M				Alemayehu, Mistre; Dragan, Magdalena; Pape, Cynthia; Siddiqui, Iram; Sacks, David B.; Di Guglielmo, Gianni M.; Babwah, Andy V.; Bhattacharya, Moshmi			beta-Arrestin2 Regulates Lysophosphatidic Acid-Induced Human Breast Tumor Cell Migration and Invasion via Rap1 and IQGAP1	PLOS ONE			English	Article							STRESS FIBER FORMATION; BETA-ARRESTIN; CANCER METASTASIS; EPITHELIAL-CELLS; PROSTATE-CANCER; LEADING-EDGE; ACTIVATION; RECEPTOR; PROTEINS; ADHESION	beta-arrestins play critical roles in chemotaxis and cytoskeletal reorganization downstream of several receptor types, including G protein-coupled receptors (GPCRs), which are targets for greater than 50% of all pharmaceuticals. Among them, receptors for lysophosphatidic acid (LPA), namely LPA(1) are overexpressed in breast cancer and promote metastatic spread. We have recently reported that beta-arrestin2 regulates LPA(1)-mediated breast cancer cell migration and invasion, although the underlying molecular mechanisms are not clearly understood. We show here that LPA induces activity of the small G protein, Rap1 in breast cancer cells in a beta-arrestin2-dependent manner, but fails to activate Rap1 in non-malignant mammary epithelial cells. We found that Rap1A mRNA levels are higher in human breast tumors compared to healthy patient samples and Rap1A is robustly expressed in human ductal carcinoma in situ and invasive tumors, in contrast to the normal mammary ducts. Rap1A protein expression is also higher in aggressive breast cancer cells (MDA-MB-231 and Hs578t) relative to the weakly invasive MCF-7 cells or non-malignant MCF10A mammary cells. Depletion of Rap1A expression significantly impaired LPA-stimulated migration of breast cancer cells and invasiveness in three-dimensional Matrigel cultures. Furthermore, we found that beta-arrestin2 associates with the actin binding protein IQGAP1 in breast cancer cells, and is necessary for the recruitment of IQGAP1 to the leading edge of migratory cells. Depletion of IQGAP1 blocked LPA-stimulated breast cancer cell invasion. Finally, we have identified that LPA enhances the binding of endogenous Rap1A to beta-arrestin2, and also stimulates Rap1A and IQGAP1 to associate with LPA1. Thus our data establish novel roles for Rap1A and IQGAP1 as critical regulators of LPA-induced breast cancer cell migration and invasion.	[Alemayehu, Mistre; Dragan, Magdalena; Pape, Cynthia; Di Guglielmo, Gianni M.; Babwah, Andy V.; Bhattacharya, Moshmi] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Siddiqui, Iram] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Babwah, Andy V.] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada; [Babwah, Andy V.] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada; [Babwah, Andy V.] Univ Western Ontario, Dept Obstet & Gynecol, London, ON, Canada; [Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); National Institutes of Health (NIH) - USA	Bhattacharya, M (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	moshmi.bhattacharya@schulich.uwo.ca		Sacks, David/0000-0003-3100-0735	Canadian Institutes of Health Research (CIHR) [MOP 107972]; National Institutes of Health; CIHR Strategic Training Program/Translational Breast Cancer Research Unit; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR Strategic Training Program/Translational Breast Cancer Research Unit(Canadian Institutes of Health Research (CIHR)); CLINICAL CENTER	This study was supported by a grant awarded to MB by the Canadian Institutes of Health Research (CIHR) MOP 107972. DS is supported by the Intramural Research Program of the National Institutes of Health. The following are recipients of salary awards and studentships: MB and AB, CIHR Canadian Institute of Health Research New Investigator Awards; MA, CIHR Strategic Training Program/Translational Breast Cancer Research Unit studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Dorfleutner A, 2007, J CELL PHYSIOL, V213, P740, DOI 10.1002/jcp.21143; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Fang XJ, 2004, J BIOL CHEM, V279, P9653, DOI 10.1074/jbc.M306662200; Frische EW, 2010, DEV BIOL, V340, P1, DOI 10.1016/j.ydbio.2009.12.043; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Furstenau DK, 2011, BREAST CANCER RES TR, V129, P361, DOI 10.1007/s10549-010-1227-y; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Goto M, 2010, CLIN CANCER RES, V16, P65, DOI 10.1158/1078-0432.CCR-09-1122; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Hsieh SM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-331; Itoh M, 2007, CANCER RES, V67, P4759, DOI 10.1158/0008-5472.CAN-06-4246; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Kimura T, 2011, CARDIOVASC RES, V92, P149, DOI 10.1093/cvr/cvr154; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li JJ, 2009, ENVIRON HEALTH PERSP, V117, P400, DOI 10.1289/ehp.0800311; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Logue JS, 2010, FEBS J, V277, P4370, DOI 10.1111/j.1742-4658.2010.07866.x; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Matsubayashi I, 2008, J PATHOL, V216, P317, DOI 10.1002/path.2414; McSherry EA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2853; Michal AM, 2011, BREAST CANCER RES TR, V130, P791, DOI 10.1007/s10549-011-1374-9; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Min JA, 2011, MOL PHARMACOL, V80, P760, DOI 10.1124/mol.111.072470; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Raghuwanshi SK, 2008, J IMMUNOL, V180, P5699, DOI 10.4049/jimmunol.180.8.5699; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Shenoy SK, 2011, ONCOGENE, V22, P256; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Urs NM, 2005, J CELL SCI, V118, P5291, DOI 10.1242/jcs.02634; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; White CD, 2011, CELL SIGNALLING; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zajac M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021599; Zou L, 2008, FASEB J, V22, P355, DOI 10.1096/fj.07-9046com; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	62	48	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56174	10.1371/journal.pone.0056174	http://dx.doi.org/10.1371/journal.pone.0056174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405264	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400210
J	Grijalva-Eternod, CS; Lawlor, DA; Wells, JCK				Grijalva-Eternod, Carlos S.; Lawlor, Debbie A.; Wells, Jonathan C. K.			Testing a Capacity-Load Model for Hypertension: Disentangling Early and Late Growth Effects on Childhood Blood Pressure in a Prospective Birth Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; FETAL ORIGINS; CARDIOVASCULAR RISK; THRIFTY PHENOTYPE; CENTRAL ADIPOSITY; GESTATIONAL-AGE; ADULT OBESITY; WEIGHT-GAIN; FAT MASS; SIZE	Background: In -005, it was estimated that hypertension affected 26.4% of the adult population worldwide. By -025, it is predicted that it will affect about 60% of adults, a total of 1.56 billion. Both pre- and postnatal growth patterns have been associated with later blood pressure (BP), but in contrasting directions. These inconsistent associations of growth during different developmental periods merit elucidation. We tested a theoretical model treating birth weight as a marker of homeostatic metabolic capacity, and childhood height, lean mass and fat mass as independent indices of metabolic load. We predicted that decreased capacity and increased load would be independently associated with increased BP. Methods and Findings: Data from the ALSPAC cohort on growth from birth to 7 years, and body composition by dual-energy X-ray absorptiometry and BP at 9 years, were analysed (n = 6579). Data were expressed as standard deviation scores (SDS) or standardised regression residuals (SRR). BP was independently and positively associated with each of height, lean mass and fat mass. In a joint model systolic BP was positively associated with conditional weight velocity [males 0.40 (95% CI: 0.37-0.44) & females 0.44 (95% CI: 0.40-0.47) SDS/SRR], but not birth weight [0.00 (95% CI: -0.03-0.04) & 0.03 (95% CI: -0.01-0.07) SDS/SDS]. Adjusting for height, lean mass and fat mass, the association of systolic BP and conditional weight velocity attenuated [0.00(95% CI: -0.09-0.08) & -0.06(95% CI: -0.14-0.03) SDS/SRR], whereas that with birth weight became negative [-0.10 (95% CI: -0.14-0.06) & -0.09 (95% CI: -0.13-0.05) SDS/SDS]. Similar results were obtained for diastolic BP and pulse pressure. Conclusions: Consistent with our theoretical model, high metabolic load relative to metabolic capacity is associated with increased BP. Our data demonstrate the contribution of different growth and body composition components to BP variance, and clarify the developmental aetiology of hypertension.	[Grijalva-Eternod, Carlos S.] UCL Inst Global Hlth, London, England; [Lawlor, Debbie A.] Univ Bristol, Dept Social Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Wells, Jonathan C. K.] UCL Inst Child Hlth, MRC Childhood Nutr Res Ctr, London, England	University of London; University College London; University of Bristol; University of London; University College London	Grijalva-Eternod, CS (corresponding author), UCL Inst Global Hlth, London, England.	c.eternod@ucl.ac.uk	Wells, Jonathan/A-4604-2009; Grijalva-Eternod, Carlos S/A-2809-2010	Wells, Jonathan/0000-0003-0411-8025; Grijalva-Eternod, Carlos S/0000-0002-2461-9954; Lawlor, Debbie A/0000-0002-6793-2262	The UK Medical Research Council; Wellcome Trust [092731]; University of Bristol; MRC [G0600705, MC_UU_12013/5] Funding Source: UKRI; Medical Research Council [MC_UU_12013/5, G0600705, G9815508] Funding Source: researchfish	The UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC (Avon Longitudinal Study of Parents and Children). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Blacher J, 2000, ARCH INTERN MED, V160, P1085, DOI 10.1001/archinte.160.8.1085; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; BRANDON LJ, 1993, AM J PREV MED, V9, P34, DOI 10.1016/S0749-3797(18)30765-7; Brion MA, 2007, J HUM HYPERTENS, V21, P283, DOI 10.1038/sj.jhh.1002152; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; de Chantemele EJB, 2011, HYPERTENSION, V58, P271, DOI 10.1161/HYPERTENSIONAHA.110.168427; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Falkner B, 2004, HYPERTENSION, V43, P203, DOI 10.1161/01.HYP.0000109322.72948.24; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; GARBY L, 1988, EUR J CLIN NUTR, V42, P301; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; HADI AS, 1994, J ROY STAT SOC B MET, V56, P393; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Howe LD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015186; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Jackson LV, 2007, ARCH DIS CHILD, V92, P298, DOI 10.1136/adc.2005.081216; Julius S, 2002, AM J HYPERTENS, V15, P258, DOI 10.1016/S0895-7061(01)02282-8; Karaolis-Danckert N, 2006, AM J CLIN NUTR, V84, P1449, DOI 10.1093/ajcn/84.6.1449; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Law CM, 1996, J HYPERTENS, V14, P935; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P1405, DOI 10.1093/aje/kwm028; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Leon DA, 1996, BRIT MED J, V312, P401, DOI 10.1136/bmj.312.7028.401; Li HJ, 2003, AM J CLIN NUTR, V77, P1498, DOI 10.1093/ajcn/77.6.1498; Li ZB, 2009, HYPERTENS RES, V32, P404, DOI 10.1038/hr.2009.32; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; MACKENZIE HS, 1995, AM J KIDNEY DIS, V26, P91, DOI 10.1016/0272-6386(95)90161-2; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; Martin RM, 2003, AM J CLIN NUTR, V77, P1489, DOI 10.1093/ajcn/77.6.1489; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Samaras TT, 2004, MED SCI MONITOR, V10, pRA63; Samaras TT, 2007, HUMAN BODY SIZE LAWS; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; Sobotka PA, 2011, CLIN RES CARDIOL, V100, P1049, DOI 10.1007/s00392-011-0335-y; Stettler N, 2002, INT J OBESITY, V26, P214, DOI 10.1038/sj.ijo.0801860; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang ZM, 2012, AM J HUM BIOL, V24, P648, DOI 10.1002/ajhb.22286; WEDER AB, 1994, HYPERTENSION, V24, P145, DOI 10.1161/01.HYP.24.2.145; Weder AB, 2007, HYPERTENSION, V49, P260, DOI 10.1161/01.HYP.0000255165.84684.9d; Wells J. C. K., 2010, EVOLUTIONARY BIOL HU; Wells JCK, 2002, INT J OBESITY, V26, P947, DOI 10.1038/sj.ijo.0802027; Wells JCK, 2005, INT J OBESITY, V29, P483, DOI 10.1038/sj.ijo.0802899; Wells JCK, 2000, INT J OBESITY, V24, P325, DOI 10.1038/sj.ijo.0801132; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; Wells JCK, 2009, P NUTR SOC, V68, P179, DOI 10.1017/S0029665109001086; Williams JE, 2006, AM J CLIN NUTR, V83, P1047, DOI 10.1093/ajcn/83.5.1047; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x	57	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56078	10.1371/journal.pone.0056078	http://dx.doi.org/10.1371/journal.pone.0056078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405253	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400198
J	Ting, WC; Chen, LM; Pao, JB; Yang, YP; You, BJ; Chang, TY; Lan, YH; Lee, HZ; Bao, BY				Ting, Wen-Chien; Chen, Lu-Min; Pao, Jiunn-Bey; Yang, Ying-Pi; You, Bang-Jau; Chang, Ta-Yuan; Lan, Yu-Hsuan; Lee, Hong-Zin; Bao, Bo-Ying			Common Genetic Variants in Wnt Signaling Pathway Genes as Potential Prognostic Biomarkers for Colorectal Cancer	PLOS ONE			English	Article							ANTIGEN RECURRENCE; DATABASE	Compelling evidence has implicated the Wnt signaling pathway in the pathogenesis of colorectal cancer. We assessed the use of tag single nucleotide polymorphisms (tSNPs) in adenomatous polyposis coli (APC)/beta-catenin (CTNNB1) genes to predict outcomes in patients with colorectal cancer. We selected and genotyped 10 tSNP to predict common variants across entire APC and CTNNB1 genes in 282 colorectal cancer patients. The associations of these tSNPs with distant metastasis-free survival and overall survival were evaluated by Kaplan-Meier analysis, Cox regression model, and survival tree analysis. The 5-year overall survival rate was 68.3%. Survival tree analysis identified a higher-order genetic interaction profile consisting of the APC rs565453, CTNNB1 2293303, and APC rs1816769 that was significantly associated with overall survival. The 5-year survival overall rates were 89.2%, 66.1%, and 58.8% for the low-, medium-, and high-risk genetic profiles, respectively (log-rank P = 0.001). After adjusting for possible confounders, including age, gender, carcinoembryonic antigen levels, tumor differentiation, stage, lymphovascular invasion, perineural invasion, and lymph node involvement, the genetic interaction profile remained significant. None of the studied SNPs were individually associated with distant metastasis-free survival and overall survival. Our results suggest that the genetic interaction profile among Wnt pathway SNPs might potentially increase the prognostic value in outcome prediction for colorectal cancer.	[Ting, Wen-Chien] China Med Univ Hosp, Dept Colorectal Surg, Taichung, Taiwan; [Ting, Wen-Chien] Chung Shan Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taichung, Taiwan; [Ting, Wen-Chien] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chen, Lu-Min] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Pao, Jiunn-Bey; Yang, Ying-Pi] Taipei City Hosp, Yangming Branch, Dept Pharm, Taipei, Taiwan; [You, Bang-Jau] China Med Univ, Dept Chinese Med Resources, Taichung, Taiwan; [Chang, Ta-Yuan] China Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Lan, Yu-Hsuan; Lee, Hong-Zin; Bao, Bo-Ying] China Med Univ, Dept Pharm, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei City Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Bao, BY (corresponding author), China Med Univ, Dept Pharm, Taichung, Taiwan.	bao@mail.cmu.edu.tw	Chang, Ta-Yuan/P-3126-2015; Bao, Bo-Ying/H-4589-2019; Bao, Bo-Ying/D-1789-2012	Chang, Ta-Yuan/0000-0001-5664-4559; Bao, Bo-Ying/0000-0001-5510-6513; Bao, Bo-Ying/0000-0001-5510-6513	National Science Council, Taiwan [NSC-98-2320-B-039-019-MY3, NSC-100-2314-B-039-009-MY3]; China Medical University [CMU98-N1-21, CMU98-C-12]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	This work was supported by the National Science Council, Taiwan (grant number: grants NSC-98-2320-B-039-019-MY3 and NSC-100-2314-B-039-009-MY3), and China Medical University (grant number: CMU98-N1-21 and CMU98-C-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Huang SP, 2010, ANN SURG ONCOL, V17, P312, DOI 10.1245/s10434-009-0698-8; Huang SP, 2009, CANCER EPIDEM BIOMAR, V18, P3068, DOI 10.1158/1055-9965.EPI-09-0665; Kines KJ, 2012, FRONT BIOSCI-LANDMRK, V17, P1329, DOI 10.2741/3990; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; WANEBO HJ, 1978, NEW ENGL J MED, V299, P448, DOI 10.1056/NEJM197808312990904; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	15	34	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56196	10.1371/journal.pone.0056196	http://dx.doi.org/10.1371/journal.pone.0056196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405266	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400212
J	Vallabhaneni, S; McConnell, JJ; Loeb, L; Hartogensis, W; Hecht, FM; Grant, RM; Pilcher, CD				Vallabhaneni, Snigdha; McConnell, J. Jeff; Loeb, Lisa; Hartogensis, Wendy; Hecht, Fredrick M.; Grant, Robert M.; Pilcher, Christopher D.			Changes in Seroadaptive Practices from before to after Diagnosis of Recent HIV Infection among Men Who Have Sex with Men	PLOS ONE			English	Article							TRANSMISSION RISK BEHAVIORS; UNPROTECTED ANAL INTERCOURSE; POSITIVE MEN; UNITED-STATES; PREVENTION; PREVALENCE; INCREASE; DISEASE; COHORT	Objective: We assessed changes in sexual behavior among men who have sex with men (MSM), before and for several years after HIV diagnosis, accounting for adoption of a variety of seroadaptive practices. Methods: We collected self-reported sexual behavior data every 3 months from HIV-positive MSM at various stages of HIV infection. To establish population level trends in sexual behavior, we used negative binomial regression to model the relationship between time since diagnosis and several sexual behavior variables: numbers of (a) total partners, (b) potentially discordant partners (PDP; i.e., HIV-negative or unknown-status partners), (c) PDPs with whom unprotected anal intercourse (UAI) occurred, and (d) PDPs with whom unprotected insertive anal intercourse (uIAI) occurred. Results: A total of 237 HIV-positive MSM contributed 502 interviews. UAI with PDPs occurred with a mean of 4.2 partners in the 3 months before diagnosis. This declined to 0.9 partners/3 months at 12 months after diagnosis, and subsequently rose to 1.7 partners/3 months at 48 months, before falling again to 1.0 partners/3 months at 60 months. The number of PDPs with whom uIAI occurred dropped from 2.4 in the pre-diagnosis period to 0.3 partners/3 months (an 87.5% reduction) by 12 months after enrollment, and continued to decline over time. Conclusion: Within months after being diagnosed with HIV, MSM adopted seroadaptive practices, especially seropositioning, where the HIV-positive partner was not in the insertive position during UAI, resulting in a sustained decline in the sexual activity associated with the highest risk of HIV transmission.	[Vallabhaneni, Snigdha] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [McConnell, J. Jeff; Grant, Robert M.] Gladstone Inst, San Francisco, CA USA; [Loeb, Lisa; Hartogensis, Wendy; Hecht, Fredrick M.; Grant, Robert M.; Pilcher, Christopher D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Vallabhaneni, S (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	snigdhav@gmail.com		Loeb Stanga, Lisa/0000-0001-7471-5381; Grant, Robert/0000-0002-0851-7085; Hecht, Frederick/0000-0002-5782-1171	NIH NIAID [5 P01 A1071713]; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, T32MH019105, R34MH096606] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from NIH NIAID 5 P01 A1071713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidala AA, 2006, AIDS EDUC PREV, V18, P12, DOI 10.1521/aeap.2006.18.1.12; Bachmann LH, 2005, SEX TRANSM DIS, V32, P20, DOI 10.1097/01.olq.0000148293.81774.e4; Butler DM, 2007, AIDS, V21, P1218, DOI 10.1097/QAD.0b013e32814db7bf; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; Denning PH, 2005, AM J PUBLIC HEALTH, V95, P152, DOI 10.2105/AJPH.2003.017814; Eaton LA, 2009, J ASSOC NURSE AIDS C, V20, P39, DOI 10.1016/j.jana.2008.10.005; Gates GJ., MANY PEOPLE ARE LESB; Glick SN, 2012, JAIDS-J ACQ IMM DEF, V60, P83, DOI 10.1097/QAI.0b013e318247925e; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Gorbach PM, 2006, JAIDS-J ACQ IMM DEF, V42, P80, DOI 10.1097/01.qai.0000196665.78497.f1; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harrell FE, 2001, REGRESSION MODELING; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Kalichman SC, 2010, AM J PUBLIC HEALTH, V100, P714, DOI 10.2105/AJPH.2009.162602; Le Talec J, SEROADAPTATION INSTE; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McConnell JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008831; McFarland W, 2012, AIDS BEHAV, V16, P121, DOI 10.1007/s10461-011-9936-8; McGowan JP, 2004, CLIN INFECT DIS, V38, P122, DOI 10.1086/380128; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; Morin SF, 2005, JAIDS-J ACQ IMM DEF, V40, P226, DOI 10.1097/01.qai.0000166375.16222.eb; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pinkerton SD, 2008, AM J PREV MED, V35, P184, DOI 10.1016/j.amepre.2008.04.012; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	30	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55397	10.1371/journal.pone.0055397	http://dx.doi.org/10.1371/journal.pone.0055397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405145	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400090
J	Bruun, CS; Jaderlund, KH; Berendt, M; Jensen, KB; Spodsberg, EH; Gredal, H; Shelton, GD; Mickelson, JR; Minor, KM; Lohi, H; Bjerkas, I; Stigen, O; Espenes, A; Rohdin, C; Edlund, R; Ohlsson, J; Cizinauskas, S; Leifsson, PS; Drogemuller, C; Moe, L; Cirera, S; Fredholm, M				Bruun, Camilla S.; Jaderlund, Karin H.; Berendt, Mette; Jensen, Kristine B.; Spodsberg, Eva H.; Gredal, Hanne; Shelton, G. Diane; Mickelson, James R.; Minor, Katie M.; Lohi, Hannes; Bjerkas, Inge; Stigen, Oyvind; Espenes, Arild; Rohdin, Cecilia; Edlund, Rebecca; Ohlsson, Jennie; Cizinauskas, Sigitas; Leifsson, Pall S.; Droegemueller, Cord; Moe, Lars; Cirera, Susanna; Fredholm, Merete			A Gly98Val Mutation in the N-Myc Downstream Regulated Gene 1 (NDRG1) in Alaskan Malamutes with Polyneuropathy	PLOS ONE			English	Article							MARIE-TOOTH DISEASE; SENSORY NEUROPATHY-LOM; HEREDITARY MOTOR; DEMYELINATING NEUROPATHY; GYPSIES; BRAIN	The first cases of early-onset progressive polyneuropathy appeared in the Alaskan Malamute population in Norway in the late 1970s. Affected dogs were of both sexes and were ambulatory paraparetic, progressing to non-ambulatory tetraparesis. On neurologic examination, affected dogs displayed predominantly laryngeal paresis, decreased postural reactions, decreased spinal reflexes and muscle atrophy. The disease was considered eradicated through breeding programmes but recently new cases have occurred in the Nordic countries and the USA. The N-myc downstream-regulated gene (NDRG1) is implicated in neuropathies with comparable symptoms or clinical signs both in humans and in Greyhound dogs. This gene was therefore considered a candidate gene for the polyneuropathy in Alaskan Malamutes. The coding sequence of the NDRG1 gene derived from one healthy and one affected Alaskan Malamute revealed a non-synonymous G>T mutation in exon 4 in the affected dog that causes a Gly98Val amino acid substitution. This substitution was categorized to be "probably damaging'' to the protein function by PolyPhen2 (score: 1.000). Subsequently, 102 Alaskan Malamutes from the Nordic countries and the USA known to be either affected (n = 22), obligate carriers (n = 7) or healthy (n = 73) were genotyped for the SNP using TaqMan. All affected dogs had the T/T genotype, the obligate carriers had the G/T genotype and the healthy dogs had the G/G genotype except for 13 who had the G/T genotype. A protein alignment showed that residue 98 is conserved in mammals and also that the entire NDRG1 protein is highly conserved (94.7%) in mammals. We conclude that the G>T substitution is most likely the mutation that causes polyneuropathy in Alaskan Malamutes. Our characterization of a novel candidate causative mutation for polyneuropathy offers a new canine model that can provide further insight into pathobiology and therapy of human polyneuropathy. Furthermore, selection against this mutation can now be used to eliminate the disease in Alaskan Malamutes.	[Bruun, Camilla S.; Berendt, Mette; Jensen, Kristine B.; Spodsberg, Eva H.; Gredal, Hanne; Edlund, Rebecca; Ohlsson, Jennie; Cirera, Susanna; Fredholm, Merete] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark; [Jaderlund, Karin H.; Stigen, Oyvind; Moe, Lars] Norwegian Sch Vet Sci, Dept Compan Anim Clin Sci, Oslo, Norway; [Shelton, G. Diane] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Mickelson, James R.; Minor, Katie M.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Lohi, Hannes; Cizinauskas, Sigitas] Univ Helsinki, Res Programs Unit, Dept Vet Biosci, Helsinki, Finland; [Lohi, Hannes; Cizinauskas, Sigitas] Folkhalsen Res Ctr, Helsinki, Finland; [Espenes, Arild] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Rohdin, Cecilia] Swedish Univ Agr Sci, Univ Anim Hosp, Uppsala, Sweden; [Leifsson, Pall S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Droegemueller, Cord] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland	University of Copenhagen; Norwegian University of Life Sciences; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of Helsinki; Folkhalsan Research Center; Norwegian University of Life Sciences; Swedish University of Agricultural Sciences; University of Copenhagen; University of Bern	Bruun, CS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark.	cvb@sund.ku.dk; mf@sund.ku.dk	Lohi, Hannes/F-4596-2011; Cirera, Susanna/K-8540-2017; Jäderlund, Karin Hultin/AAL-8211-2020; Rohdin, Cecilia/E-5590-2016	Lohi, Hannes/0000-0003-1087-5532; Rohdin, Cecilia/0000-0002-7698-550X; Leifsson, Pall S/0000-0003-1539-9491; Fredholm, Merete/0000-0002-3563-7648; Minor, Katie/0000-0002-5472-5088; Berendt, Mette/0000-0003-0636-449X; Gredal, Hanne/0000-0001-5582-1816; Mickelson, James/0000-0001-6951-0234; Drogemuller, Cord/0000-0001-9773-522X; Cirera, Susanna/0000-0001-8105-1579	Agria Insurance Foundation for Research; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; European Commission [LUPA-GA-201370]	Agria Insurance Foundation for Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	Agria Insurance Foundation for Research (http://www.agria.se) has financially supported investigations performed in Norway and Sweden. Veterinarian Peter Juul Kristensen has financially supported the diagnostic tests in one Danish dog. The Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation) and the Jane and Aatos Erkko Foundation (http://www.jaes.fi) have financially supported work in HL's laboratory. Work in MF's laboratory was supported by European Commission (LUPA-GA-201370) (http://www.eurolupa.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Berger P, 2004, NEUROBIOL DIS, V17, P290, DOI 10.1016/j.nbd.2004.07.014; Braund KG, 1997, J VET INTERN MED, V11, P243, DOI 10.1111/j.1939-1676.1997.tb00098.x; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Drogemuller C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011258; Dubowitz V, 2007, MUSCLE BIOPSY PRACTI, P21; Granger N, 2011, VET J, V188, P274, DOI 10.1016/j.tvjl.2010.06.003; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kalaydjieva L, 1998, BRAIN, V121, P399, DOI 10.1093/brain/121.3.399; King RHM, 2011, NEUROBIOL DIS, V42, P368, DOI 10.1016/j.nbd.2011.01.030; Matiasek K, 2011, VET J, V188, P254, DOI 10.1016/j.tvjl.2011.03.002; Moe, 1989, P 3 ANN S EUR SOC VE, P28; Moe L., 1982, Proceedings of the 14th Nordic Veterinary Congress, 6-9 July, 1982, Copenhagen, Denmark., P171; Moe L., 1992, KIRKS CURRENT VET TH, P1038; Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7; Reilly MM, 2011, J PERIPHER NERV SYST, V16, P1, DOI 10.1111/j.1529-8027.2011.00324.x; Rentmeister K, 2012, TIERAERZTL PRAX K H, V40, P26; Rozen S, 2000, Methods Mol Biol, V132, P365; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	21	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54547	10.1371/journal.pone.0054547	http://dx.doi.org/10.1371/journal.pone.0054547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393557	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800011
J	Hou, LQ; Hu, B; Jalife, J				Hou, Luqia; Hu, Bin; Jalife, Jose			Genetically Engineered Excitable Cardiac Myofibroblasts Coupled to Cardiomyocytes Rescue Normal Propagation and Reduce Arrhythmia Complexity in Heterocellular Monolayers	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BIOLOGICAL PACEMAKER; PURKINJE NEURONS; FIBROBLASTS; CHANNELS; MODULATION; EXPRESSION; CONDUCTION; MYOCYTES; THERAPY	Rationale and Objective: The use of genetic engineering of unexcitable cells to enable expression of gap junctions and inward rectifier potassium channels has suggested that cell therapies aimed at establishing electrical coupling of unexcitable donor cells to host cardiomyocytes may be arrhythmogenic. Whether similar considerations apply when the donor cells are electrically excitable has not been investigated. Here we tested the hypothesis that adenoviral transfer of genes coding Kir2.1 (I-K1), Na(V)1.5 (I-Na) and connexin-43 (Cx43) proteins into neonatal rat ventricular myofibroblasts (NRVF) will convert them into fully excitable cells, rescue rapid conduction velocity (CV) and reduce the incidence of complex reentry arrhythmias in an in vitro model. Methods and Results: We used adenoviral (Ad-) constructs encoding Kir2.1, Na(V)1.5 and Cx43 in NRVF. In single NRVF, Ad-Kir2.1 or Ad- Na(V)1.5 infection enabled us to regulate the densities of I-K1 and I-Na, respectively. At varying MOI ratios of 10/10, 5/10 and 5/20, NRVF co-infected with Ad-Kir2.1+ Na(V)1.5 were hyperpolarized and generated action potentials (APs) with upstroke velocities >100 V/s. However, when forming monolayers only the addition of Ad-Cx43 made the excitable NRVF capable of conducting electrical impulses (CV = 20.71 +/- 0.79 cm/s). When genetically engineered excitable NRVF overexpressing Kir2.1, Na(V)1.5 and Cx43 were used to replace normal NRVF in heterocellular monolayers that included neonatal rat ventricular myocytes (NRVM), CV was significantly increased (27.59 +/- 0.76 cm/s vs. 21.18 +/- 0.65 cm/s, p<0.05), reaching values similar to those of pure myocytes monolayers (27.27 +/- 0.72 cm/s). Moreover, during reentry, propagation was faster and more organized, with a significantly lower number of wavebreaks in heterocellular monolayers formed by excitable compared with unexcitable NRVF. Conclusion: Viral transfer of genes coding Kir2.1, Na(V)1.5 and Cx43 to cardiac myofibroblasts endows them with the ability to generate and propagate APs. The results provide proof of concept that cell therapies with excitable donor cells increase safety and reduce arrhythmogenic potential.	[Hou, Luqia; Hu, Bin; Jalife, Jose] Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Hou, Luqia; Jalife, Jose] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jalife, J (corresponding author), Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA.	jjalife@umich.edu	Jalife, Jose/L-4833-2015; Jalife, Jose/AAJ-9156-2021	Jalife, Jose/0000-0003-0080-3500; Jalife, Jose/0000-0003-0080-3500	National Heart, Lung and Blood Institute [P01-HL039707, P01-HL087226]; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL039707, P01HL087226] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by P01-HL039707 and P01-HL087226 from the National Heart, Lung and Blood Institute and by the Leducq Foundation (JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaci Muriel, 2007, Biotechnology Journal, V2, P50, DOI 10.1002/biot.200600092; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Cho HC, 2007, CIRC RES, V100, P1112, DOI 10.1161/01.RES.0000265845.04439.78; Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936; Choudry Fizzah Aziz, 2011, Regen Med, V6, P17, DOI 10.2217/rme.11.57; DELMAR M, 1989, CIRC RES, V65, P775, DOI 10.1161/01.RES.65.3.775; DEMAZIERE AMGL, 1992, J MOL CELL CARDIOL, V24, P567, DOI 10.1016/0022-2828(92)91041-3; Feld Y, 2002, CIRCULATION, V105, P522, DOI 10.1161/hc0402.102661; Fozzard HA, 1996, PHYSIOL REV, V76, P887, DOI 10.1152/physrev.1996.76.3.887; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Greener I, 2011, J MOL CELL CARDIOL, V50, P759, DOI 10.1016/j.yjmcc.2010.07.022; He YS, 2008, FEBS LETT, V582, P2338, DOI 10.1016/j.febslet.2008.05.023; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kirkton RD, 2012, EUROPACE, V14, pV40, DOI 10.1093/europace/eus269; Kirkton RD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1302; Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096; KOHL P, 1994, EXP PHYSIOL, V79, P943, DOI 10.1113/expphysiol.1994.sp003819; McSpadden LC, 2012, CIRC ARRHYTHM ELECTR; Milstein ML, 2012, P NATL ACAD SCI US; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Munoz V, 2007, CIRC RES, V101, P475, DOI 10.1161/CIRCRESAHA.107.149617; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; Plotnikov AN, 2007, CIRCULATION, V116, P706, DOI 10.1161/CIRCULATIONAHA.107.703231; Potapova I, 2004, CIRC RES, V94, P952, DOI 10.1161/01.RES.0000123827.60210.72; Raizman JE, 2007, J CELL PHYSIOL, V213, P540, DOI 10.1002/jcp.21134; Rosker C, 2011, CIRC RES, V109, P1120, DOI 10.1161/CIRCRESAHA.111.244798; Walsh KB, 2008, AM J PHYSIOL-HEART C, V294, pH1010, DOI 10.1152/ajpheart.01195.2007; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yankelson L, 2008, CIRCULATION, V117, P720, DOI 10.1161/CIRCULATIONAHA.106.671776; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	35	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55400	10.1371/journal.pone.0055400	http://dx.doi.org/10.1371/journal.pone.0055400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393574	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800028
J	Engle, JR; Tinling, S; Recanzone, GH				Engle, James R.; Tinling, Steve; Recanzone, Gregg H.			Age-Related Hearing Loss in Rhesus Monkeys Is Correlated with Cochlear Histopathologies	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; AUDITORY BRAIN-STEM; HUMAN TEMPORAL BONE; MACACA-MULATTA; AUDIOMETRIC PATTERNS; HAIR-CELLS; PRESBYCUSIS; DEGENERATION; PATHOLOGY; NOISE	Audiometric hearing deficits are a common symptom of age-related hearing loss (ARHL), as are specific histopathological changes in the cochlea; however, very little data have been collected in non-human primates. To examine this relationship further, we collected auditory brainstem responses (ABRs) from rhesus monkeys spanning in age from 10 to 35 years old, and examined four different morphological features of their cochleae. We found significant correlations between ABR thresholds and the loss of outer hair cells and spiral ganglion cells, but not with the loss of inner hair cells or a reduced thickness of the stria vascularis. The strongest correlation with ABR thresholds was the number of different pathologies present. These findings show that while aged rhesus monkeys experience audiometric hearing deficits similar to that seen in humans, they are not correlated with a single peripheral deficit, but instead with a number of different underlying cochlear histopathologies, indicating that similar histopathologies may exist in geriatric humans as well.	[Engle, James R.] Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ USA; [Engle, James R.] Univ Arizona, ARL Div Neural Syst Memory & Aging, Tucson, AZ USA; [Tinling, Steve] Univ Calif Davis, Dept Otolaryngol, Davis, CA 95616 USA; [Engle, James R.; Recanzone, Gregg H.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Recanzone, Gregg H.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of Arizona; University of Arizona; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Recanzone, GH (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	ghrecanzone@ucdavis.edu			National Institute on Aging (NIA) [R21AG024372, R01AG034137]; National Institute on Deafness and Other Communication Disorders (NIDCD) [T32DC008072, R01DC008649]; NATIONAL INSTITUTE ON AGING [R21AG024372, R01AG034137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008649, T32DC008072] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funded by National Institute on Aging (NIA) R21AG024372, R01AG034137 (GHR), and National Institute on Deafness and Other Communication Disorders (NIDCD) T32DC008072 (JRE) and R01DC008649 (ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel SM, 2000, J ACOUST SOC AM, V108, P743, DOI 10.1121/1.429607; ALLEN AR, 1978, ELECTROEN CLIN NEURO, V45, P53, DOI 10.1016/0013-4694(78)90341-3; Bao JX, 2010, HEARING RES, V264, P93, DOI 10.1016/j.heares.2009.10.009; BENNETT CL, 1983, BEHAV NEUROSCI, V97, P602, DOI 10.1037/0735-7044.97.4.602; Chen MA, 2006, OTOL NEUROTOL, V27, P316, DOI 10.1097/00129492-200604000-00005; Clark J G, 1981, ASHA, V23, P493; Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Fowler CG, 2002, HEARING RES, V169, P24, DOI 10.1016/S0378-5955(02)00335-0; Fowler CG, 2010, HEARING RES, V261, P75, DOI 10.1016/j.heares.2010.01.006; Frisina DR, 1997, HEARING RES, V106, P95, DOI 10.1016/S0378-5955(97)00006-3; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; HAWKINS JE, 1976, ACTA OTO-LARYNGOL, V81, P337, DOI 10.3109/00016487609119971; HAWKINS JE, 1968, ANN OTO RHINOL LARYN, V77, P608, DOI 10.1177/000348946807700403; Hawkins JE, 1986, BEHAV PATHOLOGY AGIN; Heffner RS, 2004, ANAT REC PART A, V281A, P1111, DOI 10.1002/ar.a.20117; Juarez-Salinas DL, 2010, J NEUROSCI, V30, P14795, DOI 10.1523/JNEUROSCI.3393-10.2010; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Linthicum FH, 2009, OTOL NEUROTOL, V30, P418, DOI 10.1097/MAO.0b013e31819a8827; Miller LM, 2009, P NATL ACAD SCI USA, V106, P5931, DOI 10.1073/pnas.0901023106; MOODY DB, 1978, ARCH OTO-RHINO-LARYN, V220, P47, DOI 10.1007/BF00456301; Navarro XO, 2008, SOC NEUR ABSTR, V34; Nelson EG, 2003, LARYNGOSCOPE, V113, P1672, DOI 10.1097/00005537-200310000-00006; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Ohlemiller KK, 2008, HEARING RES, V244, P85, DOI 10.1016/j.heares.2008.08.001; Ohlemiller KK, 2004, J COMP NEUROL, V479, P103, DOI 10.1002/cne.20326; RAMADAN HH, 1989, OTOLARYNG HEAD NECK, V100, P30, DOI 10.1177/019459988910000105; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Recanzone GH, 2011, HEARING RES, V271, P115, DOI 10.1016/j.heares.2010.03.084; SCHUKNECHT H F, 1955, Laryngoscope, V65, P402; SCHUKNECHT HF, 1964, ARCHIV OTOLARYNGOL, V80, P369; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; SUGA F, 1976, ANN OTO RHINOL LARYN, V85, P169, DOI 10.1177/000348947608500201; SUZUKA Y, 1988, ACTA OTO-LARYNGOL, P1; Tinling SP, 2004, J MICROSC-OXFORD, V215, P230, DOI 10.1111/j.0022-2720.2004.01382.x; Torre P, 2004, NEUROBIOL AGING, V25, P945, DOI 10.1016/j.neurobiolaging.2003.09.006; Torre P, 2000, HEARING RES, V142, P131, DOI 10.1016/S0378-5955(00)00025-3; WILLOTT JF, 1988, EXP NEUROL, V99, P615, DOI 10.1016/0014-4886(88)90178-1; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Xing YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034500; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012	43	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55092	10.1371/journal.pone.0055092	http://dx.doi.org/10.1371/journal.pone.0055092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390514	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100030
J	Slayton, RB; Turabelidze, G; Bennett, SD; Schwensohn, CA; Yaffee, AQ; Khan, F; Butler, C; Trees, E; Ayers, TL; Davis, ML; Laufer, AS; Gladbach, S; Williams, I; Gieraltowski, LB				Slayton, Rachel B.; Turabelidze, George; Bennett, Sarah D.; Schwensohn, Colin A.; Yaffee, Anna Q.; Khan, Faisal; Butler, Cindy; Trees, Eija; Ayers, Tracy L.; Davis, Marjorie L.; Laufer, Alison S.; Gladbach, Stephen; Williams, Ian; Gieraltowski, Laura B.			Outbreak of Shiga Toxin-Producing Escherichia coli (STEC) O157:H7 Associated with Romaine Lettuce Consumption, 2011	PLOS ONE			English	Article							FOODBORNE ILLNESS; UNITED-STATES; CALIFORNIA; O157-H7	Background: Shiga toxin-producing Escherichia coli (STEC) O157:H7 is the causal agent for more than 96,000 cases of diarrheal illness and 3,200 infection-attributable hospitalizations annually in the United States. Materials and Methods: We defined a confirmed case as a compatible illness in a person with the outbreak strain during 10/07/2011-11/30/2011. Investigation included hypothesis generation, a case-control study utilizing geographically-matched controls, and a case series investigation. Environmental inspections and tracebacks were conducted. Results: We identified 58 cases in 10 states; 67% were hospitalized and 6.4% developed hemolytic uremic syndrome. Any romaine consumption was significantly associated with illness (matched Odds Ratio (mOR) = 10.0, 95% Confidence Interval (CI) = 2.1-97.0). Grocery Store Chain A salad bar was significantly associated with illness (mOR = 18.9, 95% CI = 4.5-176.8). Two separate traceback investigations for romaine lettuce converged on Farm A. Case series results indicate that cases (64.9%) were more likely than the FoodNet population (47%) to eat romaine lettuce (p-value = 0.013); 61.3% of cases reported consuming romaine lettuce from the Grocery Store Chain A salad bar. Conclusions: This multistate outbreak of STEC O157:H7 infections was associated with consumption of romaine lettuce. Traceback analysis determined that a single common lot of romaine lettuce harvested from Farm A was used to supply Grocery Store Chain A and a university campus linked to a case with the outbreak strain. An investigation at Farm A did not identify the source of contamination. Improved ability to trace produce from the growing fields to the point of consumption will allow more timely prevention and control measures to be implemented.	[Slayton, Rachel B.; Bennett, Sarah D.; Laufer, Alison S.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Slayton, Rachel B.; Bennett, Sarah D.; Schwensohn, Colin A.; Yaffee, Anna Q.; Trees, Eija; Ayers, Tracy L.; Laufer, Alison S.; Williams, Ian; Gieraltowski, Laura B.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Turabelidze, George; Butler, Cindy; Gladbach, Stephen] Missouri Dept Hlth & Senior Serv, Eastern Dist Off, St Louis, MO USA; [Khan, Faisal] St Louis Cty Dept Hlth, Communicable Dis Control Serv, St Louis, MO USA; [Davis, Marjorie L.] US FDA, Coordinated Outbreak Response & Evaluat Team, College Pk, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Slayton, RB (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	RSlayton@cdc.gov	Yaffee, Anna/AAQ-3559-2021; Trees, Eija/AAY-7538-2020	Trees, Eija/0000-0001-6694-2445; Ayers, Tracy/0000-0003-4140-3263; Slayton, Rachel/0000-0003-4699-8040; Yaffee, Anna/0000-0002-4495-6587				Aruscavage D, 2008, J FOOD PROTECT, V71, P2384, DOI 10.4315/0362-028X-71.12.2384; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Ethelberg S., 2010, EURO SURVEILL, V15; Friesema I, 2008, EURO SURVEILL, V13; Hyytia-Trees E, 2010, FOODBORNE PATHOG DIS, V7, P129, DOI 10.1089/fpd.2009.0371; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Soderstrom A, 2008, FOODBORNE PATHOG DIS, V5, P339, DOI 10.1089/fpd.2007.0065; Sodha SV, 2011, EPIDEMIOL INFECT, V139, P309, DOI 10.1017/S0950268810000920; U.S. Centers for Disease Control and Prevention, 2007, FOODB DIS ACT SURV N	12	56	56	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55300	10.1371/journal.pone.0055300	http://dx.doi.org/10.1371/journal.pone.0055300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390525	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100041
J	Chaparro, JM; Badri, DV; Bakker, MG; Sugiyama, A; Manter, DK; Vivanco, JM				Chaparro, Jacqueline M.; Badri, Dayakar V.; Bakker, Matthew G.; Sugiyama, Akifumi; Manter, Daniel K.; Vivanco, Jorge M.			Root Exudation of Phytochemicals in Arabidopsis Follows Specific Patterns That Are Developmentally Programmed and Correlate with Soil Microbial Functions	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS; GENE-EXPRESSION; PSEUDOMONAS-FLUORESCENS; SINORHIZOBIUM-MELILOTI; RHIZOSPHERE MICROBIOME; SECONDARY METABOLITES; BACILLUS-SUBTILIS; CHEMOTAXIS; ACID; SECRETION	Plant roots constantly secrete compounds into the soil to interact with neighboring organisms presumably to gain certain functional advantages at different stages of development. Accordingly, it has been hypothesized that the phytochemical composition present in the root exudates changes over the course of the lifespan of a plant. Here, root exudates of in vitro grown Arabidopsis plants were collected at different developmental stages and analyzed using GC-MS. Principle component analysis revealed that the composition of root exudates varied at each developmental stage. Cumulative secretion levels of sugars and sugar alcohols were higher in early time points and decreased through development. In contrast, the cumulative secretion levels of amino acids and phenolics increased over time. The expression in roots of genes involved in biosynthesis and transportation of compounds represented in the root exudates were consistent with patterns of root exudation. Correlation analyses were performed of the in vitro root exudation patterns with the functional capacity of the rhizosphere microbiome to metabolize these compounds at different developmental stages of Arabidopsis grown in natural soils. Pyrosequencing of rhizosphere mRNA revealed strong correlations (p<0.05) between microbial functional genes involved in the metabolism of carbohydrates, amino acids and secondary metabolites with the corresponding compounds released by the roots at particular stages of plant development. In summary, our results suggest that the root exudation process of phytochemicals follows a developmental pattern that is genetically programmed.	[Chaparro, Jacqueline M.; Badri, Dayakar V.; Bakker, Matthew G.; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Sugiyama, Akifumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Manter, Daniel K.] USDA ARS, Soil Plant Nutrient Res Unit, Ft Collins, CO 80522 USA	Colorado State University; Kyoto University; United States Department of Agriculture (USDA)	Vivanco, JM (corresponding author), Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA.	j.vivanco@colostate.edu	Bakker, Matthew/B-8610-2013	Bakker, Matthew/0000-0003-0345-0587; Sugiyama, Akifumi/0000-0002-9643-6639	National Science Foundation [MCB-0950857]; Div Of Molecular and Cellular Bioscience [0950857] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Work was supported by a grant from the National Science Foundation to J.M.V. (MCB-0950857). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Nada Y, 2007, EUR J PLANT PATHOL, V118, P375, DOI 10.1007/s10658-007-9150-8; [Anonymous], 2010, COMMUN INTEGR BIOL, DOI DOI 10.4161/CIB.3.1.10118; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Badri Dayakar V, 2012, Front Plant Sci, V3, P149, DOI 10.3389/fpls.2012.00149; Badri DV, 2010, MOL PLANT, V3, P491, DOI 10.1093/mp/ssq004; Badri DV, 2009, PLANT PHYSIOL, V151, P2006, DOI 10.1104/pp.109.147462; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; BEHERA B, 1974, SOIL SCI SOC AM J, V38, P591, DOI 10.2136/sssaj1974.03615995003800040021x; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Blencke HM, 2003, METAB ENG, V5, P133, DOI 10.1016/S1096-7176(03)00009-0; BOWRA BJ, 1981, J GEN MICROBIOL, V126, P231; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; De-la-Pena C, 2010, J BIOL CHEM, V285, P30654, DOI 10.1074/jbc.M110.119040; Edreva A., 2008, General and Applied Plant Physiology, V34, P67; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Flores HE, 1999, TRENDS PLANT SCI, V4, P220, DOI 10.1016/S1360-1385(99)01411-9; Hamer U, 2005, SOIL BIOL BIOCHEM, V37, P445, DOI 10.1016/j.soilbio.2004.07.037; Haudecoeur E, 2009, P NATL ACAD SCI USA, V106, P14587, DOI 10.1073/pnas.0808005106; Horiuchi J, 2005, PLANTA, V222, P848, DOI 10.1007/s00425-005-0025-y; JimenezZurdo JI, 1997, MOL MICROBIOL, V23, P85, DOI 10.1046/j.1365-2958.1997.1861555.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Y, 2009, APPL ENVIRON MICROB, V75, P1223, DOI 10.1128/AEM.02015-08; LOAKE GJ, 1988, J GEN MICROBIOL, V134, P1427; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Micallef SA, 2009, PLANT SIGNAL BEHAV, V4, P777, DOI 10.1093/jxb/erp053; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naher U. A., 2008, Research Journal of Microbiology, V3, P580; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Oku S, 2012, MICROBES ENV; Omrane S, 2009, PLANT SIGNAL BEHAV, V4, P1066, DOI 10.4161/psb.4.11.9735; ORDAL GW, 1979, J GEN MICROBIOL, V115, P167, DOI 10.1099/00221287-115-1-167; Ortiz-Castro R, 2009, PLANT SIGNAL BEHAV, V4, P701, DOI 10.4161/psb.4.8.9047; Phillips DA, 2004, PLANT PHYSIOL, V136, P2887, DOI 10.1104/pp.104.044222; Pillai BVS, 2002, APPL ENVIRON MICROB, V68, P143, DOI 10.1128/AEM.68.1.143-151.2002; Poysti NJ, 2007, MICROBIOL-SGM, V153, P727, DOI 10.1099/mic.0.29148-0; Ramos-Gonzalez MI, 2005, J BACTERIOL, V187, P4033, DOI 10.1128/JB.187.12.4033-4041.2005; ROVIRA AD, 1969, BOT REV, V35, P35, DOI 10.1007/BF02859887; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Sana TR, 2010, METABOLOMICS, V6, P451, DOI 10.1007/s11306-010-0218-7; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHMULLING T, 1988, EMBO J, V7, P2621, DOI 10.1002/j.1460-2075.1988.tb03114.x; Selvakumar G., 2012, BACTERIAL MEDIATED A, P205; SHAW CH, 1991, BIOESSAYS, V13, P25, DOI 10.1002/bies.950130105; Shcheglov Alex S., 2007, P97, DOI 10.1007/978-1-4020-6040-3_5; Simons M, 1997, MOL PLANT MICROBE IN, V10, P102, DOI 10.1094/MPMI.1997.10.1.102; Steinkellner S, 2007, MOLECULES, V12, P1290, DOI 10.3390/12071290; TANG CS, 1995, ACS SYM SER, V582, P142; Volkers RJM, 2009, EXTREMOPHILES, V13, P283, DOI 10.1007/s00792-008-0216-0; Williams MA, 2010, SOIL BIOL BIOCHEM, V42, P1148, DOI 10.1016/j.soilbio.2010.03.021; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313; Zamioudis C, 2012, MOL PLANT MICROBE IN, V25, P139, DOI 10.1094/MPMI-06-11-0179; Zhang J, 2009, PLANT J, V57, P171, DOI 10.1111/j.1365-313X.2008.03676.x	68	361	386	18	402	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55731	10.1371/journal.pone.0055731	http://dx.doi.org/10.1371/journal.pone.0055731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383346	Green Submitted, Green Published, gold			2022-12-27	WOS:000314597900053
J	Ko, SC; Huang, CR; Shieh, JM; Yang, JH; Chang, WC; Chen, BK				Ko, Shian-Chin; Huang, Chi-Ruei; Shieh, Jiunn-Min; Yang, Jhen-Hong; Chang, Wen-Chang; Chen, Ben-Kuen			Epidermal Growth Factor Protects Squamous Cell Carcinoma against Cisplatin-Induced Cytotoxicity through Increased Interleukin-1 beta Expression	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN BREAST-CANCER; FACTOR-RECEPTOR; PROINFLAMMATORY CYTOKINE; DYNAMIC REGULATION; SUPPRESSOR-CELLS; EPITHELIAL-CELLS; ENDOTOXIC-SHOCK; MESSENGER-RNA; FACTOR-ALPHA	The expression of cytokines, such as IL-1 beta, and the activation of the epidermal growth factor receptor (EGFR) are crucial regulators in the process of carcinogenesis. The correlation between growth factor and activated cytokine signals in the control of tumor development is a critical issue to be clarified. In our study, we found that the IL-1 beta gene and protein expression were induced by EGF in squamous cell carcinoma. To clarify the mechanism involved in EGF-regulated IL-1 beta expression, we examined the transcriptional activity and mRNA stability of IL-1 beta in EGF-treated cells. We found that EGF induced the expression of IL-1 beta and was mediated through transcriptional activation, but not through mRNA stability. The involvement of Akt and NF-kappa B signaling pathways in the EGF-induced IL-1 beta gene expression was confirmed by knockdown of RelA and Akt in cells or treating cells with Akt and NF-kappa B inhibitors, LY294002 and parthenolide, respectively. The expression of dominant negative I kappa B also repressed the activation of NF-kappa B and inhibited EGF-induced IL-1 beta expression. Using immunofluorescence staining assay, the EGF-stimulated nuclear translocation of NF-kappa B (p65) was inhibited by pretreating cells with LY294002 and parthenolide. Furthermore, EGF increased the binding of NF-kappa B to the NF-kappa B binding site of the IL-1 beta promoter through the activation of the Akt/NF-kappa B pathway, which resulted in activating IL-1 beta promoter activity. The expression and secretion of IL-1 beta induced by EGF considerably reduced chemotherapeutic drug cisplatin-induced cell death. These results showed that EGF enhanced the expression of IL-1 beta, which was mediated by the Akt/NF-kappa B pathway. The activation of EGF signaling and increase of IL-1 beta contributed to chemotherapeutic resistance of cancer cells, suggesting that the expression of IL-1 beta may be used as a biomarker to evaluate successful cancer treatment.	[Ko, Shian-Chin; Shieh, Jiunn-Min] Chi Mei Med Ctr, Dept Chest Med, Tainan, Taiwan; [Huang, Chi-Ruei; Chen, Ben-Kuen] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan; [Yang, Jhen-Hong; Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Chang, Wen-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Chen, BK (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan.	bkchen58@mail.ncku.edu.tw		Huang, Chi-Ruei/0000-0001-9646-8852	National Science Council of the Republic of China [NSC 99-2320-B-006-006-MY3]; National Cheng Kung University Project of Promoting Academic Excellence and Developing World-Class Research Centers	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); National Cheng Kung University Project of Promoting Academic Excellence and Developing World-Class Research Centers	This work was supported by grant NSC 99-2320-B-006-006-MY3 from the National Science Council of the Republic of China and by the National Cheng Kung University Project of Promoting Academic Excellence and Developing World-Class Research Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2003, J BIOL CHEM, V278, P20077, DOI 10.1074/jbc.M208619200; Ahsan A, 2010, CANCER RES, V70, P2862, DOI 10.1158/0008-5472.CAN-09-4294; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Apte RN, 2002, ADV EXP MED BIOL, P277; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Cenni B, 2001, CANCER CHEMOTH PHARM, V47, P397, DOI 10.1007/s002800000244; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chang KY, 2009, J BIOL CHEM, V284, P9908, DOI 10.1074/jbc.M806210200; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gao HW, 2007, EXPERT OPIN THER TAR, V11, P869, DOI 10.1517/14728222.11.7.869; Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X; GRANDIS JR, 1993, CANCER RES, V53, P3579; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kerpedjieva SS, 2012, STEM CELLS DEV; KONDO Y, 1994, J PHARMACOL EXP THER, V270, P1313; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Liu YW, 1997, BIOCHEM J, V324, P133, DOI 10.1042/bj3240133; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Miller LJ, 2000, CANCER INVEST, V18, P293, DOI 10.3109/07357900009012171; Molina-Holgado E, 2000, BRIT J PHARMACOL, V131, P152, DOI 10.1038/sj.bjp.0703557; Nakamura H, 2007, CLIN EXP RHEUMATOL, V25, P831; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; NETA R, 1986, J IMMUNOL, V136, P2483; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Noordhuis MG, 2009, CLIN CANCER RES, V15, P7389, DOI 10.1158/1078-0432.CCR-09-1149; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Poppenborg H, 1999, CYTOKINE, V11, P689, DOI 10.1006/cyto.1998.0473; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schlosser S, 1999, CANCER RES, V59, P4551; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Sheehan M, 2002, MOL PHARMACOL, V61, P953, DOI 10.1124/mol.61.5.953; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Sriuranpong V, 2003, CANCER RES, V63, P2948; Watkins LR, 1999, LIFE SCI, V65, P449, DOI 10.1016/S0024-3205(99)00095-8; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	51	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55795	10.1371/journal.pone.0055795	http://dx.doi.org/10.1371/journal.pone.0055795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383347	gold, Green Published, Green Submitted			2022-12-27	WOS:000314597900054
J	Foerch, C; Rosidi, NL; Schlunk, F; Lauer, A; Cianchetti, FA; Mandeville, E; Arai, K; Yigitkanli, K; Fan, X; Wang, X; van Leyen, K; Steinmetz, H; Schaffer, CB; Lo, EH				Foerch, Christian; Rosidi, Nathanael L.; Schlunk, Frieder; Lauer, Arne; Cianchetti, Flor A.; Mandeville, Emiri; Arai, Ken; Yigitkanli, Kazim; Fan, Xiang; Wang, Xiaoying; van Leyen, Klaus; Steinmetz, Helmuth; Schaffer, Chris B.; Lo, Eng H.			Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; SUBARACHNOID HEMORRHAGE; RAT MODEL; STROKE; THROMBOLYSIS; INHIBITION; PROTEIN; INJURY	Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH). Surprisingly, however, the assumption that tPA will worsen ICH has never been biologically tested. Here, we assessed the effects of tPA in two models of ICH. In a mouse model of collagenase-induced ICH, hemorrhage volumes and neurological deficits after 24 hrs were similar in saline controls and tPA-treated mice, whereas heparin-treated mice had 3-fold larger hematomas. In a model of laser-induced vessel rupture, tPA also did not worsen hemorrhage volumes, while heparin did. tPA is known to worsen neurovascular injury by amplifying matrix metalloproteinases during cerebral ischemia. In contrast, tPA did not upregulate matrix metalloproteinases in our mouse ICH models. In summary, our experimental data do not support the assumption that intravenous tPA has a deleterious effect in acute ICH. However, due to potential species differences and the inability of models to fully capture the dynamics of human ICH, caution is warranted when considering the implications of these findings for human therapy.	[Foerch, Christian; Schlunk, Frieder; Lauer, Arne; Mandeville, Emiri; Arai, Ken; Yigitkanli, Kazim; Fan, Xiang; Wang, Xiaoying; van Leyen, Klaus; Lo, Eng H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroprotect Res Lab, Boston, MA 02114 USA; [Foerch, Christian; Schlunk, Frieder; Lauer, Arne; Steinmetz, Helmuth] Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany; [Rosidi, Nathanael L.; Cianchetti, Flor A.; Schaffer, Chris B.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Goethe University Frankfurt; Cornell University	Foerch, C (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroprotect Res Lab, Boston, MA 02114 USA.	foerch@em.uni-frankfurt.de	yigitkanli, kazım/AAK-6184-2021; van Leyen, Klaus/C-9126-2013; Schaffer, Chris B./A-7409-2008	van Leyen, Klaus/0000-0003-1032-3754; Schaffer, Chris B./0000-0002-7800-9596	National Institutes of Health [R37-NS37074, R01-NS56458, P01-NS55104]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037074, R01NS049430, R01NS069939, R01NS056458, P01NS055104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health grants R37-NS37074, R01-NS56458 and P01-NS55104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Ducruet AF, 2010, NEUROSURGERY, V66, P648, DOI 10.1227/01.NEU.0000360374.59435.60; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Foerch C, 2008, STROKE, V39, P3397, DOI 10.1161/STROKEAHA.108.517482; Hayakawa K, 2010, J CEREBR BLOOD F MET, V30, P871, DOI 10.1038/jcbfm.2009.257; Hogan KA, 2002, THROMB HAEMOSTASIS, V87, P563, DOI 10.1055/s-0037-1613050; Ishii H, 2001, CIRC RES, V89, P1240, DOI 10.1161/hh2401.101066; Ishikawa T, 2006, SURG NEUROL, V66, P269, DOI 10.1016/j.surneu.2006.03.030; JANG IK, 1989, CIRCULATION, V79, P920, DOI 10.1161/01.CIR.79.4.920; Kahles T, 2005, VASC PHARMACOL, V43, P254, DOI 10.1016/j.vph.2005.07.008; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Mihara K, 2005, J NEUROTRAUM, V22, P1362, DOI 10.1089/neu.2005.22.1362; Montagne A, 2012, STROKE, V43, P2774, DOI 10.1161/STROKEAHA.112.669374; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Murray V, 1989, J INTERN MED, V267, P191; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Thiex R, 2004, EXP NEUROL, V189, P25, DOI 10.1016/j.expneurol.2004.05.021; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Xue MZ, 2009, STROKE, V40, P2199, DOI 10.1161/STROKEAHA.108.540393; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhu HH, 2010, J CEREBR BLOOD F MET, V30, P1137, DOI 10.1038/jcbfm.2009.279; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e54203	10.1371/journal.pone.0054203	http://dx.doi.org/10.1371/journal.pone.0054203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408937	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300005
J	Mukherjee, R; Evans, P; Singh, LN; Hannenhalli, S				Mukherjee, Rithun; Evans, Perry; Singh, Larry N.; Hannenhalli, Sridhar			Correlated Evolution of Positions within Mammalian cis Elements	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; COMPENSATORY EVOLUTION; MAXIMUM-LIKELIHOOD; RESPONSE ELEMENTS; DNA; SITES; SEQUENCE; GENE; CONSERVATION; SPECIFICITY	Transcriptional regulation critically depends on proper interactions between transcription factors (TF) and their cognate DNA binding sites. The widely used model of TF-DNA binding - the Positional Weight Matrix (PWM) - presumes independence between positions within the binding site. However, there is evidence to show that the independence assumption may not always hold, and the extent of interposition dependence is not completely known. We hypothesize that the interposition dependence should partly be manifested as correlated evolution at the positions. We report a Maximum-Likelihood (ML) approach to infer correlated evolution at any two positions within a PWM, based on a multiple alignment of 5 mammalian genomes. Application to a genome-wide set of putative cis elements in human promoters reveals a prevalence of correlated evolution within cis elements. We found that the interdependence between two positions decreases with increasing distance between the positions. The interdependent positions tend to be evolutionarily more constrained and moreover, the dependence patterns are relatively similar across structurally related transcription factors. Although some of the detected mutational dependencies may be due to context-dependent genomic hyper-mutation, notably CG to TG, the majority is likely due to context-dependent preferences for specific nucleotide combinations within the cis elements. Patterns of evolution at individual nucleotide positions within mammalian TF binding sites are often significantly correlated, suggesting interposition dependence. The proposed methodology is also applicable to other classes of non-coding functional elements. A detailed investigation of mutational dependencies within specific motifs could reveal preferred nucleotide combinations that may help refine the DNA binding models.	[Mukherjee, Rithun] Fred Hutchinson Canc Res Ctr, Computat Biol Program, Seattle, WA 98104 USA; [Evans, Perry] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Singh, Larry N.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Hannenhalli, Sridhar] Univ Maryland, Dept Cell & Mol Biol, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Fred Hutchinson Cancer Center; Yale University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University System of Maryland; University of Maryland College Park	Mukherjee, R (corresponding author), Fred Hutchinson Canc Res Ctr, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA.	rmukherj@fhcrc.org; sridhar@umiacs.umd.edu	Singh, Larry N./AAG-6880-2021	Singh, Larry N./0000-0002-2478-5864	NIH [GM085226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085226] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Source of funding: The work was supported by NIH GM085226 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 1998, DETECTING NONADJOINI, P2; Baines JF, 2002, MOL BIOL EVOL, V19, P989, DOI 10.1093/oxfordjournals.molbev.a004179; Barash Y., 2003, MODELING DEPENDENCIE, P28; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Evans P, 2006, LECT NOTES COMPUT SC, V4205, P186; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2004, INFERRING PHYLOGENIE; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kaneko S, 2006, GENETICS, V172, P2421, DOI 10.1534/genetics.105.052910; Kim E, 2003, BIOCHEM CELL BIOL, V81, P141, DOI 10.1139/o03-046; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Ordoukhanian P, 1999, CHEM BIOL, V6, P881, DOI 10.1016/S1074-5521(00)80007-1; Osada R, 2004, BIOINFORMATICS, V20, P3516, DOI 10.1093/bioinformatics/bth438; Pischedda A, 2005, J EVOLUTION BIOL, V18, P1115, DOI 10.1111/j.1420-9101.2005.00915.x; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; PTASHNE M, 2004, GENETIC SWITCH; Raviscioni M, 2005, J MOL BIOL, V350, P402, DOI 10.1016/j.jmb.2005.04.054; Reynolds MG, 2000, GENETICS, V156, P1471; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Williams EJB, 2000, GENE, V253, P313, DOI 10.1016/S0378-1119(00)00233-X; YANG Z, 2007, MOL BIOL EVOL; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55521	10.1371/journal.pone.0055521	http://dx.doi.org/10.1371/journal.pone.0055521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408994	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300020
J	van der Plas, H; Meintjes, G; Schutz, C; Goliath, R; Myer, L; Baatjie, D; Wilkinson, RJ; Maartens, G; Mendelson, M				van der Plas, Helen; Meintjes, Graeme; Schutz, Charlotte; Goliath, Rene; Myer, Landon; Baatjie, Dorothea; Wilkinson, Robert J.; Maartens, Gary; Mendelson, Marc			Complications of Antiretroviral Therapy Initiation in Hospitalised Patients with HIV-Associated Tuberculosis	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; CLINICAL DETERIORATION; INFECTION; AFRICA	Background: HIV-associated tuberculosis is a common coinfection in Sub-Saharan Africa, which causes high morbidity and mortality. A sub-set of HIV-associated tuberculosis patients require prolonged hospital admission, during which antiretroviral therapy initiation may be required. The aim of this study was to document the causes of clinical deterioration of hospitalised patients with HIV-associated tuberculosis starting antiretroviral therapy in order to inform healthcare practice in low-to middle-income countries. Methods: Prospective, observational cohort study of adult inpatients with HIV-associated tuberculosis starting antiretroviral therapy in a dedicated tuberculosis hospital in Cape Town, South Africa. Causes of clinical deterioration and outcome were recorded in the first 12 weeks of antiretroviral therapy. Patients with rifampicin-resistant tuberculosis were excluded. Results: Between May 2009 and November 2010, 112 patients (60% female), with a median age of 32 years were enrolled. At baseline the median CD4 count was 55 cells/mm(3) (IQR 31-106) and HIV viral load 5.6 log copies/mL. All patients had significant comorbidity: 82% were bed-bound, 65% had disseminated tuberculosis and 27% had central nervous system tuberculosis. Seventy six patients (68%) developed 144 clinical events after starting antiretroviral therapy. TB-IRIS, hospital-acquired infections and significant drug toxicities occurred in 42%, 20.5% and 15% of patients respectively. A new opportunistic disease occurred in 15% of patients and a thromboembolic event in 8%. Mortality during the 12 week period was 10.6%. Conclusions: High rates of TB-IRIS, hospital-acquired infections and drug toxicities complicate the course of patients with HIV-associated tuberculosis starting antiretroviral therapy in hospital. Despite the high morbidity, mortality was relatively low. Careful clinical management and adequate resources are needed in hospitalised HIV-TB patients in the 1st three months following ART initiation.	[van der Plas, Helen; Meintjes, Graeme; Wilkinson, Robert J.; Maartens, Gary; Mendelson, Marc] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme; Schutz, Charlotte; Goliath, Rene; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme; Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol Res, ZA-7925 Cape Town, South Africa; [Baatjie, Dorothea] Brooklyn Chest Hosp, Cape Town, South Africa; [Wilkinson, Robert J.] Natl Inst Med Res, MRC, London NW7 1AA, England	University of Cape Town; University of Cape Town; Imperial College London; University of Cape Town; MRC National Institute for Medical Research	van der Plas, H (corresponding author), Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa.	Helenvanderplas@gmail.com	Maartens, Gary/F-3836-2014; Schutz, Charlotte/G-6864-2016; Maartens, Gary/S-2788-2019	Maartens, Gary/0000-0003-3080-6606; Schutz, Charlotte/0000-0001-8329-6158; Maartens, Gary/0000-0003-3080-6606; Mendelson, Marc/0000-0001-6668-3893; Wilkinson, Robert/0000-0002-2753-1800; Meintjes, Graeme/0000-0003-1196-4414	United States President's Emergency Plan for AIDS Relief (PEPFAR)/United States Agency for International Development (USAID) through the Anova Health Institute; Fogarty International Center [U2RTW007970/3 ICORTA]; Wellcome Trust [081667, 088316]; Fogarty International Center South Africa TB/AIDS Training Award [NIH/FIC 1U2RTW007373-01A1, U2RTW007373 ICORTA]; MRC [U.1175.02.002.00014.01]	United States President's Emergency Plan for AIDS Relief (PEPFAR)/United States Agency for International Development (USAID) through the Anova Health Institute(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); Fogarty International Center South Africa TB/AIDS Training Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	HvdP, GrM and MM were supported by funding from United States President's Emergency Plan for AIDS Relief (PEPFAR)/United States Agency for International Development (USAID) through the Anova Health Institute. HvdP received research training support from the South African Tuberculosis HIV Training that was funded by the Fogarty International Center grant number U2RTW007970/3 ICORTA. Graeme Meintjes (GrM) received support from the Wellcome Trust (081667) and a Fogarty International Center South Africa TB/AIDS Training Award (NIH/FIC 1U2RTW007373-01A1 and U2RTW007373 ICORTA). RJW received support from Welcome Trust (088316) and MRC (U.1175.02.002.00014.01). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Haddow LJ, 2011, AIDS, V25, P1163, DOI 10.1097/QAD.0b013e3283477d67; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Pepper DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004520; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; van der Plas H, 2011, SAMJ S AFR MED J, V101, P529; Waitt CJ, 2011, J INFECT DIS, V204, P358, DOI 10.1093/infdis/jir265; WHO, GLOB TUB CONTR 2011; World Health Organization, IMPR DIAGN TREATM SM	17	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e54145	10.1371/journal.pone.0054145	http://dx.doi.org/10.1371/journal.pone.0054145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408935	gold, Green Published, Green Submitted			2022-12-27	WOS:000314660300003
J	Willeit, P; Thompson, A; Aspelund, T; Rumley, A; Eiriksdottir, G; Lowe, G; Gudnason, V; Di Angelantonio, E				Willeit, Peter; Thompson, Alexander; Aspelund, Thor; Rumley, Ann; Eiriksdottir, Gudny; Lowe, Gordon; Gudnason, Vilmundur; Di Angelantonio, Emanuele			Hemostatic Factors and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Updated Meta-Analyses	PLOS ONE			English	Article							FIBRIN D-DIMER; VON-WILLEBRAND-FACTOR; TISSUE-PLASMINOGEN ACTIVATOR; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; PLASMA-LEVELS; FACTOR-VIII; ASSOCIATIONS	Background: Activation of blood coagulation and fibrinolysis may be associated with increased risk of coronary heart disease. We aimed to assess associations of circulating tissue plasminogen activator (t-PA) antigen, D-dimer and von Willebrand factor (VWF) with coronary heart disease risk. Design: Prospective case-control study, systematic review and meta-analyses. Methods: Measurements were made in 1925 people who had a first-ever nonfatal myocardial infarction or died of coronary heart disease during follow-up (median 19.4 years) and in 3616 controls nested within the prospective population-based Reykjavik Study. Results: Age and sex-adjusted odds ratios for coronary heart disease per 1 standard deviation higher baseline level were 1.25 (1.18, 1.33) for t-PA antigen, 1.01 (0.95, 1.07) for D-dimer and 1.11 (1.05, 1.18) for VWF. After additional adjustment for conventional cardiovascular risk factors, corresponding odds ratios were 1.07 (0.99, 1.14) for t-PA antigen, 1.06 (1.00, 1.13) for D-dimer and 1.08 (1.02, 1.15) for VWF. When combined with the results from previous prospective studies in a random-effects meta-analysis, overall adjusted odds ratios were 1.13 (1.06, 1.21) for t-PA antigen (13 studies, 5494 cases), 1.23 (1.16, 1.32) with D-dimer (18 studies, 6799 cases) and 1.16 (1.10, 1.22) with VWF (15 studies, 6556 cases). Conclusions: Concentrations of t-PA antigen, D-dimer and VWF may be more modestly associated with first-ever CHD events than previously reported. More detailed analysis is required to clarify whether these markers are causal risk factors or simply correlates of coronary heart disease.	[Willeit, Peter; Thompson, Alexander; Di Angelantonio, Emanuele] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Thompson, Alexander] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England; [Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Rumley, Ann; Lowe, Gordon] Univ Glasgow, Cardiovasc& Med Div, Glasgow, Lanark, Scotland	University of Cambridge; Roche Holding; Icelandic Heart Association; University of Iceland; University of Glasgow	Di Angelantonio, E (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	ed303@medschl.cam.ac.uk	Gudnason, Vilmundur/AAE-7126-2019; DiAngelantonio, Emanuele/ABE-6852-2020; Aspelund, Thor/K-7022-2019; Willeit, Peter/HCI-7091-2022; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/K-6885-2015	Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Willeit, Peter/0000-0002-1866-7159; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Di Angelantonio, Emanuele/0000-0001-8776-6719	British Heart Foundation [RG/08/014, FS/10/37/28413]; GlaxoSmithKline; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); GlaxoSmithKline(GlaxoSmithKline); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was underpinned by a program grant from the British Heart Foundation (RG/08/014) and an unrestricted educational grant from GlaxoSmithKline. PW was supported by a British Heart Foundation 3-year PhD Studentship (FS/10/37/28413). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arnett DK, 2011, INT J MOL EPIDEMIOL, V2, P391; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Carcaillon L, 2009, J THROMB HAEMOST, V7, P1972, DOI 10.1111/j.1538-7836.2009.03603.x; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493; Danesh J, 2001, CIRCULATION, V103, P2323; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eichinger S, 2008, CLIN CHEM, V54, P2042, DOI 10.1373/clinchem.2008.112243; Empana JP, 2008, EUR HEART J, V29, P1966, DOI 10.1093/eurheartj/ehn331; Folsom AR, 2009, AM J HEMATOL, V84, P349, DOI 10.1002/ajh.21429; Folsom AR, 2001, ARTERIOSCL THROM VAS, V21, P611, DOI 10.1161/01.ATV.21.4.611; Ghebre MA, 2012, J THROMB HAEMOST, V10, P352, DOI 10.1111/j.1538-7836.2012.04617.x; Gong LL, 2012, THROMB RES, V130, pE43, DOI 10.1016/j.thromres.2012.06.015; Gram J, 2000, J INTERN MED, V247, P205, DOI 10.1046/j.1365-2796.2000.00604.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang J, 2012, BLOOD; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; Kucharska-Newton AM, 2009, ARTERIOSCL THROM VAS, V29, P2182, DOI 10.1161/ATVBAHA.109.192740; LIP GYH, 1995, CLIN SCI, V89, P205, DOI 10.1042/cs0890205; Lowe GDO, 2006, BRIT J HAEMATOL, V133, P232, DOI 10.1111/j.1365-2141.2006.06021.x; Lowe GDO, 2005, J THROMB HAEMOST, V3, P1618, DOI 10.1111/j.1538-7836.2005.01416.x; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1529, DOI 10.1161/01.ATV.0000135995.39488.6c; Lowe GDO, 2004, EUR HEART J, V25, P252, DOI 10.1016/j.ehj.2003.11.004; May M, 2007, EUR J CARDIOV PREV R, V14, P638, DOI 10.1097/HJR.0b013e3280e129d0; McCann CJ, 2009, AM J CARDIOL, V103, P22, DOI 10.1016/j.amjcard.2008.08.026; MEADE TW, 1994, BRIT J HAEMATOL, V88, P601, DOI 10.1111/j.1365-2141.1994.tb05079.x; Nordenhem A, 1998, SCAND J CLIN LAB INV, V58, P475, DOI 10.1080/00365519850186274; PLOW EF, 1991, THROMB HAEMOSTASIS, V66, P32; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Pradhan AD, 2004, CIRCULATION, V110, P292, DOI 10.1161/01.CIR.0000134965.73212.A6; RIDKER PM, 1993, LANCET, V341, P1165, DOI 10.1016/0140-6736(93)90998-V; RIDKER PM, 1994, CIRCULATION, V90, P2236, DOI 10.1161/01.CIR.90.5.2236; Rudnicka AR, 2007, CIRCULATION, V115, P996, DOI 10.1161/CIRCULATIONAHA.106.635169; Rumley A, 2009, J THROMB HAEMOST S2, V7, P214; Smith A, 2005, CIRCULATION, V112, P3080, DOI 10.1161/CIRCULATIONAHA.105.557132; Smith NL, 2011, CIRCULATION, V123, P1864, DOI 10.1161/CIRCULATIONAHA.110.009480; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; van Loon JE, 2012, J THROMB HAEMOST, V10, P1262, DOI 10.1111/j.1538-7836.2012.04771.x; Van Loon JE, 2011, J THROMB HAEMOST, V9, P1415, DOI 10.1111/j.1538-7836.2011.04314.x; van Schie MC, 2011, BLOOD, V117, P1393, DOI 10.1182/blood-2010-03-273961; Vischer UM, 2006, J THROMB HAEMOST, V4, P1186, DOI 10.1111/j.1538-7836.2006.01949.x; Wannamethee SG, 2009, J THROMB HAEMOST, V7, P1605, DOI 10.1111/j.1538-7836.2009.03574.x; Wennberg P, 2012, THROMB RES, V129, P68, DOI 10.1016/j.thromres.2011.05.015; Wennberg P, 2010, EUR J CARDIOV PREV R, V17, P56, DOI 10.1097/HJR.0b013e32832f3b11; Whincup RH, 2002, EUR HEART J, V23, P1764, DOI 10.1053/euhj.2001.3237; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Woodward M, 2007, J THROMB HAEMOST, V5, P1795, DOI 10.1111/j.1538-7836.2007.02677.x; Wu O, 2008, J THROMB HAEMOST, V6, P62; Yarnell J, 2005, EUR HEART J, V26, P332, DOI 10.1093/eurheartj/ehi052	57	78	81	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55175	10.1371/journal.pone.0055175	http://dx.doi.org/10.1371/journal.pone.0055175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408959	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000315157200019
J	Ghosh, S; DeCoffe, D; Brown, K; Rajendiran, E; Estaki, M; Dai, CB; Yip, A; Gibson, DL				Ghosh, Sanjoy; DeCoffe, Daniella; Brown, Kirsty; Rajendiran, Ethendhar; Estaki, Mehrbod; Dai, Chuanbin; Yip, Ashley; Gibson, Deanna L.			Fish Oil Attenuates Omega-6 Polyunsaturated Fatty Acid-Induced Dysbiosis and Infectious Colitis but Impairs LPS Dephosphorylation Activity Causing Sepsis	PLOS ONE			English	Article							INTESTINAL ALKALINE-PHOSPHATASE; ULCERATIVE-COLITIS; ESCHERICHIA-COLI; CROHNS-DISEASE; LINOLEIC-ACID; LIPOPOLYSACCHARIDE; INFLAMMATION; MICROBIOTA; DEFENSE; SUSCEPTIBILITY	Clinically, excessive omega-6 polyunsaturated fatty acid (PUFA) and inadequate omega-3 PUFA have been associated with enhanced risks for developing ulcerative colitis. In rodent models, omega-3 PUFAs have been shown to either attenuate or exacerbate colitis in different studies. We hypothesized that a high omega-6: omega-3 PUFA ratio would increase colitis susceptibility through the microbe-immunity nexus. To address this, we fed post-weaned mice diets rich in omega-6 PUFA (corn oil) and diets supplemented with omega-3 PUFA (corn oil+fish oil) for 5 weeks. We evaluated the intestinal microbiota, induced colitis with Citrobacter rodentium and followed disease progression. We found that omega-6 PUFA enriched the microbiota with Enterobacteriaceae, Segmented Filamentous Bacteria and Clostridia spp., all known to induce inflammation. During infection-induced colitis, omega-6 PUFA fed mice had exacerbated intestinal damage, immune cell infiltration, prostaglandin E2 expression and C. rodentium translocation across the intestinal mucosae. Addition of omega-3 PUFA on a high omega-6 PUFA diet, reversed inflammatory-inducing microbial blooms and enriched beneficial microbes like Lactobacillus and Bifidobacteria, reduced immune cell infiltration and impaired cytokine/chemokine induction during infection. While, omega-3 PUFA supplementation protected against severe colitis, these mice suffered greater mortality associated with sepsis-related serum factors such as LPS binding protein, IL-15 and TNF-alpha. These mice also demonstrated decreased expression of intestinal alkaline phosphatase and an inability to dephosphorylate LPS. Thus, the colonic microbiota is altered differentially through varying PUFA composition, conferring altered susceptibility to colitis. Overall, omega-6 PUFA enriches pro-inflammatory microbes and augments colitis; but prevents infection-induced systemic inflammation. In contrast, omega-3 PUFA supplementation reverses the effects of the omega-6 PUFA diet but impairs infection-induced responses resulting in sepsis. We conclude that as an anti-inflammatory agent, omega-3 PUFA supplementation during infection may prove detrimental when host inflammatory responses are critical for survival.	[Ghosh, Sanjoy; DeCoffe, Daniella; Brown, Kirsty; Rajendiran, Ethendhar; Estaki, Mehrbod; Dai, Chuanbin; Yip, Ashley; Gibson, Deanna L.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada	University of British Columbia; University of British Columbia Okanagan	Gibson, DL (corresponding author), Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada.	deanna.gibson@ubc.ca	Gibson, Deanna L/CAF-4166-2022	Gibson, Deanna L/0000-0003-0052-7550; Brown, Kirsty/0000-0003-1410-4532	Intestinal Disease Education and Awareness Society; Bill & Melinda Gates Foundation; Crohn's and Colitis Foundation of Canada; Canadian Association of Gastroenterology	Intestinal Disease Education and Awareness Society; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Crohn's and Colitis Foundation of Canada; Canadian Association of Gastroenterology	Grant Support was provided by the Intestinal Disease Education and Awareness Society; Bill & Melinda Gates Foundation; and Crohn's and Colitis Foundation of Canada. D. D. and K. B were funded through scholarships from the Canadian Association of Gastroenterology. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andoh A, 2003, INT J MOL MED, V12, P721; Baker J, 2012, AM J PHYSIOL-GASTR L, V303, pG825, DOI 10.1152/ajpgi.00327.2011; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2002, CLIN NUTR, V21, P451, DOI 10.1054/clnu.2002.0594; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Belluzzi A, 2004, Eur Rev Med Pharmacol Sci, V8, P225; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Brown K, 2012, NUTRIENTS, V4, P1552, DOI [10.3390/nu4081095, 10.3390/nu4111552]; Chapkin RS, 2007, J NUTR, V137, p200S, DOI 10.1093/jn/137.1.200S; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; Dong L, 2011, J GASTROENTEROL HEPA; Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; GALLAY P, 1993, INFECT IMMUN, V61, P378, DOI 10.1128/IAI.61.2.378-383.1993; Gareau MG, 2010, J INFECT DIS, V201, P81, DOI 10.1086/648614; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Ghosh S, 2011, AM J PHYSIOL-GASTR L, V301, pG39, DOI 10.1152/ajpgi.00509.2010; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Gibson DL, 2010, GASTROENTEROLOGY, V139, P1277, DOI 10.1053/j.gastro.2010.06.057; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Gravaghi C, 2011, J NUTR BIOCHEM, V22, P360, DOI 10.1016/j.jnutbio.2010.03.003; Gray-Donald K, 2000, CAN J PUBLIC HEALTH, V91, P381, DOI 10.1007/BF03404812; Hummel S, 2012, APPL ENVIRON MICROB, V78, P1140, DOI 10.1128/AEM.06983-11; Innis SM, 2010, AM J PHYSIOL-GASTR L, V299, pG1376, DOI 10.1152/ajpgi.00258.2010; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ma CX, 2006, CELL MICROBIOL, V8, P1669, DOI 10.1111/j.1462-5822.2006.00741.x; Ma X, 2008, CLIN EXP IMMUNOL, V151, P130, DOI 10.1111/j.1365-2249.2007.03530.x; Mane J, 2009, J NUTR, V139, P603, DOI 10.3945/jn.108.101170; Matsunaga H, 2008, INFLAMM BOWEL DIS, V14, P1348, DOI 10.1002/ibd.20491; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Monteleone I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-122; Natividad JMM, 2012, INFLAMM BOWEL DIS, V18, P1434, DOI 10.1002/ibd.22848; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Ramsden CE, 2010, BRIT J NUTR, V104, P1586, DOI 10.1017/S0007114510004010; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos Artemis P., 1999, Annals of Nutrition and Metabolism, V43, P127, DOI 10.1159/000012777; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Statistics C, 2006, FOOD STAT 2005; Tjonneland A, 2009, GUT, V58, P1606, DOI 10.1136/gut.2008.169078; Todorov SD, 2011, J APPL MICROBIOL; Uchiyama K, 2010, INFLAMM BOWEL DIS, V16, P1696, DOI 10.1002/ibd.21251; Villar J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006818; WAN JM, 1987, CLIN SCI, V72, P383, DOI 10.1042/cs0720383; Ward PA, 2007, NAT MED, V13, P903, DOI 10.1038/nm0807-903; Woodworth HL, 2010, CANCER RES, V70, P7960, DOI 10.1158/0008-5472.CAN-10-1396	49	131	133	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55468	10.1371/journal.pone.0055468	http://dx.doi.org/10.1371/journal.pone.0055468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405155	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400100
J	Kriticos, DJ; Leriche, A; Palmer, DJ; Cook, DC; Brockerhoff, EG; Stephens, AEA; Watt, MS				Kriticos, Darren J.; Leriche, Agathe; Palmer, David J.; Cook, David C.; Brockerhoff, Eckehard G.; Stephens, Andrea E. A.; Watt, Michael S.			Linking Climate Suitability, Spread Rates and Host-Impact When Estimating the Potential Costs of Invasive Pests	PLOS ONE			English	Article							PINE PROCESSIONARY MOTH; THAUMETOPOEA-PITYOCAMPA DEN.; GEOGRAPHIC RANGE; SCHIFF. LEP.; ECONOMIC-IMPACT; FRUIT-FLY; TEMPERATURE; DEFOLIATION; SURVIVAL; FOREST	Biosecurity agencies need robust bioeconomic tools to help inform policy and allocate scarce management resources. They need to estimate the potential for each invasive alien species (IAS) to create negative impacts, so that relative and absolute comparisons can be made. Using pine processionary moth (Thaumetopoea pityocampa sensu lato) as an example, these needs were met by combining species niche modelling, dispersal modelling, host impact and economic modelling. Within its native range (the Mediterranean Basin and adjacent areas), T. pityocampa causes significant defoliation of pines and serious urticating injuries to humans. Such severe impacts overseas have fuelled concerns about its potential impacts, should it be introduced to New Zealand. A stochastic bioeconomic model was used to estimate the impact of PPM invasion in terms of pine production value lost due to a hypothetical invasion of New Zealand by T. pityocampa. The bioeconomic model combines a semi-mechanistic niche model to develop a climate-related damage function, a climate-related forest growth model, and a stochastic spread model to estimate the present value (PV) of an invasion. Simulated invasions indicate that Thaumetopoea pityocampa could reduce New Zealand's merchantable and total pine stem volume production by 30%, reducing forest production by between NZ$1,550 M to NZ$2,560 M if left untreated. Where T. pityocampa is controlled using aerial application of an insecticide, projected losses in PV were reduced, but still significant (NZ$30 M to NZ$2,210 M). The PV estimates were more sensitive to the efficacy of the spray program than the potential rate of spread of the moth. Our novel bioeconomic method provides a refined means of estimating potential impacts of invasive alien species, taking into account climatic effects on asset values, the potential for pest impacts, and pest spread rates.	[Kriticos, Darren J.; Leriche, Agathe; Cook, David C.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Kriticos, Darren J.; Leriche, Agathe] Univ Minnesota, Dept Appl Econ, InSTePP, St Paul, MN 55108 USA; [Kriticos, Darren J.; Leriche, Agathe; Cook, David C.] CRC Natl Plant Biosecur, Bruce, Australia; [Kriticos, Darren J.; Palmer, David J.] Scion New Zealand Forest Res Inst, Rotorua, New Zealand; [Cook, David C.] Dept Agr & Food Western Australia, Bunbury, Australia; [Cook, David C.] Univ Western Australia, Crawley, Australia; [Brockerhoff, Eckehard G.; Watt, Michael S.] Scion New Zealand Forest Res Inst, Christchurch, New Zealand; [Stephens, Andrea E. A.] HortResearch, Lincoln, New Zealand	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Minnesota System; University of Minnesota Twin Cities; University of Western Australia; New Zealand Institute for Plant & Food Research Ltd	Kriticos, DJ (corresponding author), CSIRO Ecosyst Sci, Canberra, ACT, Australia.	Darren.Kriticos@csiro.au	Brockerhoff, Eckehard Gustav/C-1528-2009; Leriche, Agathe/C-3151-2008; Watt, Michael S/C-3813-2009; Kriticos, Darren J/A-4170-2008; Cook, David C/C-1064-2009	Brockerhoff, Eckehard Gustav/0000-0002-5962-3208; Leriche, Agathe/0000-0001-9646-5344; Kriticos, Darren J/0000-0003-2599-8105; Cook, David C/0000-0002-2954-7697; Stephens, Andrea/0000-0003-0595-4623; Watt, Michael/0000-0001-6752-9134	New Zealand Foundation for Research, Science Technology [C02X0501, C09X0905]; New Zealand Ministry of Agriculture and Forestry	New Zealand Foundation for Research, Science Technology(New Zealand Foundation for Research, Science and Technology); New Zealand Ministry of Agriculture and Forestry	This work was partly funded by the New Zealand Foundation for Research, Science & Technology through contract C02X0501 [the Better Border Biosecurity (B3) programme (www.b3nz.org)], and contract C09X0905 (Beating Environmental Weeds II) and the New Zealand Ministry of Agriculture and Forestry. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOW DA, 1990, LANDSCAPE ECOL, V4, P177, DOI 10.1007/BF00132860; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Astiaso Gallart F, 1992, B SERVICIO PLAGAS FO, V4, P122; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; BREUER M, 1990, J APPL ENTOMOL, V109, P331, DOI 10.1111/j.1439-0418.1990.tb00060.x; Brockerhoff EG, 2007, 12216 NZ FOR HLTH RE; Buffo E, 2007, AGR FOREST ENTOMOL, V9, P65, DOI 10.1111/j.1461-9563.2006.00321.x; BUXTON RD, 1983, OUTLOOK AGR, V12, P34, DOI 10.1177/003072708301200106; Carus S, 2004, PHYTOPARASITICA, V32, P459, DOI 10.1007/BF02980440; Cobos Suarez J. M., 1990, Boletin de Sanidad Vegetal, Plagas, V16, P37; Cook DC, 2008, AUST FORESTRY, V71, P107, DOI 10.1080/00049158.2008.10676277; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; CTGREF-INRA, 1980, CHEN PROC PIN ORG SU; De Villiers M., 2012, B ENTOMOLOGICAL RES; De Wolf ED, 2007, ANNU REV PHYTOPATHOL, V45, P203, DOI 10.1146/annurev.phyto.44.070505.143329; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; EPPO/CABI, 1996, THAUM PIT, P532; FAO, 2006, INT STAND PHYT MEAS; Fraser RW, 2006, INT J PEST MANAGE, V52, P261, DOI 10.1080/09670870600795930; Gatto P, 2009, J ENVIRON MANAGE, V90, P683, DOI 10.1016/j.jenvman.2008.01.007; Hengeveld R., 1989, DYNAMICS BIOL INVASI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoch G, 2009, AGR FOREST ENTOMOL, V11, P313, DOI 10.1111/j.1461-9563.2009.00431.x; Hodar JA, 2004, ACTA OECOL, V26, P203, DOI 10.1016/j.actao.2004.05.004; Huchon H, 1970, REV FORESTIERE FRANC, P220; Kanat M, 2005, ANN FOREST SCI, V62, P91, DOI 10.1051/forest:2004095; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kerdelhue C, 2006, HEREDITY, V97, P38, DOI 10.1038/sj.hdy.6800836; Kimberley Mark, 2005, New Zealand Journal of Forestry, V50, P13; Kriticos D. J., 2005, New Zealand Plant Protection, V58, P1; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; LAURENTHERVOUET N, 1986, ANN SCI FOREST, V43, P239, DOI 10.1051/forest:19860209; LEMOINE B, 1977, ANN SCI FOREST, V34, P205, DOI 10.1051/forest/19770302; Lewis M., 1997, SPATIAL ECOLOGY ROLE, P46; Markalas S, 1998, POPULATION DYNAMICS, IMPACTS, AND INTEGRATED MANAGEMENT OF FOREST DEFOLIATING INSECTS - PROCEEDINGS, P292; Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138; Ministry for Environment, LAND COV DAT VERS 2; Ministry of Agriculture and Forestry, 2010, NAT EX FOR DESCR; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Palmer DJ, 2009, FOREST ECOL MANAG, V258, P2046, DOI 10.1016/j.foreco.2009.07.057; Palmeri V, 2005, FOREST, V2, P345; Pimentel C, 2006, FOREST ECOL MANAG, V233, P108, DOI 10.1016/j.foreco.2006.06.005; Pimentel C, 2010, BIOL J LINN SOC, V100, P224, DOI 10.1111/j.1095-8312.2010.01413.x; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pitt JPW, 2011, ECOL MODEL, V222, P1880, DOI 10.1016/j.ecolmodel.2011.03.023; Plant Health Australia, 2009, PLANTPLAN AUSTR EM P; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Robinet C, 2008, J ANIM ECOL, V77, P966, DOI 10.1111/j.1365-2656.2008.01417.x; Robinet C, 2007, GLOBAL ECOL BIOGEOGR, V16, P460, DOI 10.1111/j.1466-8238.2006.00302.x; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; Schmidt GH, 1997, PHYTOPARASITICA, V25, P275; Sharov AA, 2004, RISK ANAL, V24, P879, DOI 10.1111/j.0272-4332.2004.00486.x; Shigesada N., 1997, BIOL INVASIONS THEOR; Standards Australia, 2006, NAT POSTB WEED RISK; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Waggoner PE, 1950, PLANT DIS REP      S, V190, P19; Watt MS, 2009, WEED RES, V49, P381, DOI 10.1111/j.1365-3180.2009.00704.x; Watt MS, 2009, FOREST ECOL MANAG, V257, P1505, DOI 10.1016/j.foreco.2008.12.026; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wilby, 2005, NEW AGENDA BIOSECURI; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152; Zhang QH, 1998, J APPL ENTOMOL, V122, P353, DOI 10.1111/j.1439-0418.1998.tb01512.x	69	25	26	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54861	10.1371/journal.pone.0054861	http://dx.doi.org/10.1371/journal.pone.0054861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405097	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400041
J	Onorato, M; Proment, D; Clauss, G; Klein, M				Onorato, Miguel; Proment, Davide; Clauss, Guenther; Klein, Marco			Rogue Waves: From Nonlinear Schrodinger Breather Solutions to Sea-Keeping Test	PLOS ONE			English	Article							WATER; EQUATION	Under suitable assumptions, the nonlinear dynamics of surface gravity waves can be modeled by the one-dimensional nonlinear Schrodinger equation. Besides traveling wave solutions like solitons, this model admits also breather solutions that are now considered as prototypes of rogue waves in ocean. We propose a novel technique to study the interaction between waves and ships/structures during extreme ocean conditions using such breather solutions. In particular, we discuss a state of the art sea-keeping test in a 90-meter long wave tank by creating a Peregrine breather solution hitting a scaled chemical tanker and we discuss its potential devastating effects on the ship.	[Onorato, Miguel] Univ Turin, Dipartimento Fis, Turin, Italy; [Onorato, Miguel] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy; [Proment, Davide] Univ E Anglia, Sch Math, Norwich NR4 7TJ, Norfolk, England; [Clauss, Guenther; Klein, Marco] Tech Univ Berlin, Ocean Engn Div, Berlin, Germany	University of Turin; Istituto Nazionale di Fisica Nucleare (INFN); University of East Anglia; Technical University of Berlin	Proment, D (corresponding author), Univ E Anglia, Sch Math, Norwich NR4 7TJ, Norfolk, England.	davideproment@gmail.com	Proment, Davide/R-2463-2017; Onorato, Miguel/AAE-8793-2021; Onorato, Miguel/G-7104-2012	Proment, Davide/0000-0002-9472-0097; Onorato, Miguel/0000-0001-9141-2147; Onorato, Miguel/0000-0001-9141-2147; Klein, Marco/0000-0003-2867-7534	E.U. project EXTREME SEAS [SCP8-GA-2009-234175]	E.U. project EXTREME SEAS	The authors were supported by the E.U. project EXTREME SEAS (SCP8-GA-2009-234175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHMEDIEV NN, 1987, THEOR MATH PHYS+, V72, P809, DOI 10.1007/BF01017105; AKHMEDIEV NN, 1985, ZH EKSP TEOR FIZ+, V89, P1542; Baldock TE, 1996, PHILOS T R SOC A, V354, P649, DOI 10.1098/rsta.1996.0022; Bludov YV, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033610; Chabchoub A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016311; Chabchoub A, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007636; Chabchoub A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.204502; Clauss G., 2011, P ASME 2011 30 INT C, P1; Clauss GF, 2002, APPL OCEAN RES, V24, P147, DOI 10.1016/S0141-1187(02)00026-3; Clauss GF, 2005, 24 INT C OFFSH MECH, V129, P61; Clauss GF, 1996, 96552 OMAE, V1, P41; Dysthe KB, 1999, PHYS SCRIPTA, VT82, P48, DOI 10.1238/Physica.Topical.082a00048; Haver S, 2004, P ROG WAV 2004; Kharif C, 2009, ADV GEOPHYS ENV MECH, P1, DOI 10.1007/978-3-540-88419-4_1; Kibler B, 2010, NAT PHYS, V6, P790, DOI 10.1038/NPHYS1740; Kuznetsov E A, 1977, AKAD NAUK SSSR DOKLA, V236, P575; MA YC, 1979, STUD APPL MATH, V60, P43; Mei C. C., 1989, APPL DYNAMICS OCEAN, V1; Newell A.C., 1992, NONLINEAR OPTICS; Osborne AR, 2000, PHYS LETT A, V275, P386, DOI 10.1016/S0375-9601(00)00575-2; PEREGRINE DH, 1983, J AUST MATH SOC B, V25, P16, DOI 10.1017/S0334270000003891; Sulem P.-L., 1999, NONLINEAR SCHRODINGE, V139; Toffoli A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041771; Zakharov V.E., 1968, J APPL MECH TECH PH+, V9, P190, DOI [DOI 10.1007/BF00913182, 10.1007/BF00913182]	24	93	95	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54629	10.1371/journal.pone.0054629	http://dx.doi.org/10.1371/journal.pone.0054629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405086	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000315153400030
J	Schappin, R; Wijnroks, L; Venema, MMATU; Jongmans, MJ				Schappin, Renske; Wijnroks, Lex; Venema, Monica M. A. T. Uniken; Jongmans, Marian J.			Rethinking Stress in Parents of Preterm Infants: A Meta-Analysis	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; NEONATAL INTENSIVE-CARE; GESTATIONAL-AGE INFANTS; INDIVIDUALIZED DEVELOPMENTAL CARE; EARLY-INTERVENTION PROGRAM; FAMILY-BASED INTERVENTION; KANGAROO MOTHER CARE; FULL-TERM INFANTS; TO-SKIN CONTACT; PREMATURE-INFANTS	Background: With improved medical outcome in preterm infants, the psychosocial situation of their families is receiving increasing attention. For parents, the birth of a preterm infant is generally regarded as a stressful experience, and therefore many interventions are based on reducing parental stress. Nevertheless, it remains unclear whether parents of children born preterm experience more stress than parents of term-born children, which would justify these interventions. This meta-analysis provides a comprehensive account of parental stress in parents of preterm infants, from birth of the infant through to their adolescence. Mean levels of stress in specific domains of family functioning were investigated, and stress levels in parents of preterm and term infants, and fathers and mothers of preterm infants, were compared. Furthermore, we investigated moderators of parental stress. Methods and Findings: A random-effects meta-analysis was conducted including 38 studies describing 3025 parents of preterm (<37 wk) and low birth weight (<2500 g) infants. Parental stress was measured with two parent-reported questionnaires, the Parenting Stress Index and the Parental Stressor Scale: Neonatal Intensive Care Unit. The results indicate that parents of preterm-born children experience only slightly more stress than parents of term-born children, with small effect sizes. Furthermore, mothers have slightly more stress than fathers, but these effect sizes are also small. Parents report more stress for infants with lower gestational ages and lower birth weights. There is a strong effect for infant birth year, with decreasing parental stress from the 1980s onward, probably due to increased quality of care for preterm infants. Conclusions: Based on our findings we argue that prematurity can best be regarded as one of the possible complications of birth, and not as a source of stress in itself.	[Schappin, Renske; Venema, Monica M. A. T. Uniken] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Med Psychol & Social Work, Utrecht, Netherlands; [Wijnroks, Lex; Jongmans, Marian J.] Univ Utrecht, Dept Special Educ, Fac Social & Behav Sci, Utrecht, Netherlands; [Jongmans, Marian J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Schappin, R (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Med Psychol & Social Work, Utrecht, Netherlands.	r.schappin@umcutrecht.nl	Jongmans, Marian/G-5922-2010	Schappin, Renske/0000-0002-5727-5852	Netherlands Organization for Health Research and Development (ZonMw) [157001023]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This research was supported by the Netherlands Organization for Health Research and Development (ZonMw; www.zonmw.nl) grant 157001023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin R.R., 1986, PARENTING STRESS IND; Abidin R.R., 1990, PARENTING STRESS IND; Abidin RR., 1995, PSYCHOL ASSESSMENT R; Abidin RR., 1983, PARENTING STRESS IND; Als H, 2003, J DEV BEHAV PEDIATR, V24, P399, DOI 10.1097/00004703-200312000-00001; [Anonymous], HDB STRESS THEORETIC; Askie LM, 2003, NEW ENGL J MED, V349, P959, DOI 10.1056/NEJMoa023080; Badr LK, 2009, EARLY HUM DEV, V85, P279, DOI 10.1016/j.earlhumdev.2008.11.005; Badr LK, 2001, APPL NURS RES, V14, P125, DOI 10.1053/apnr.2001.24411; Baker BL, 2003, J INTELL DISABIL RES, V47, P217, DOI 10.1046/j.1365-2788.2003.00484.x; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Bardin C, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.2.e4; BARRERA ME, 1991, TOP EARLY CHILD SPEC, V10, P14, DOI 10.1177/027112149101000403; BECK SJ, 1990, J AM ACAD CHILD PSY, V29, P558, DOI 10.1097/00004583-199007000-00008; BECKMAN PJ, 1988, J SPEC EDUC, V22, P55, DOI 10.1177/002246698802200108; Bell PL, 1997, J PERINAT NEONAT NUR, V11, P77; Bendell D, 1987, INFANT MENT HEALTH J, V8, P28; Benzies KM, 2004, PUBLIC HEALTH NURS, V21, P111, DOI 10.1111/j.0737-1209.2004.021204.x; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Blanch D'Souza SR., 2009, J NEONATAL NURS, V15, P152, DOI [10.1016/j.jnn.2009.07.003, DOI 10.1016/J.JNN.2009.07.003]; Borenstein M., 2005, COMPREHENSIVE META A; Borenstein M, 2009, INTRO META ANAL; Branum AM, 2002, PAEDIATR PERINAT EP, V16, P8, DOI 10.1046/j.1365-3016.2002.00394.x; Browne JV, 2005, J PEDIATR PSYCHOL, V30, P667, DOI 10.1093/jpepsy/jsi053; Cameron S. J., 1989, CAN J REHABIL, V2, P134; Candelaria MA, 2006, J APPL DEV PSYCHOL, V27, P588, DOI 10.1016/j.appdev.2006.08.006; Carter JD, 2007, PERSONAL MENT HEALTH, V1, P40, DOI 10.1002/pmh.4; Carter JD, 2005, ARCH DIS CHILD-FETAL, V90, P109, DOI 10.1136/adc.2003.031641; Charpak N, 2005, ACTA PAEDIATR, V94, P514, DOI 10.1080/08035250510027381; Cobiella C W, 1990, Child Health Care, V19, P93, DOI 10.1207/s15326888chc1902_4; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Colpin H, 1999, HUM REPROD, V14, P3133, DOI 10.1093/humrep/14.12.3133; Crnic K. A., 1986, INFANT MENT HEALTH J, V7, P19, DOI DOI 10.1002/1097-0355(198621)7:; CRNIC KA, 1983, CHILD DEV, V54, P209, DOI 10.2307/1129878; Davis L, 2003, EARLY HUM DEV, V73, P61, DOI 10.1016/S0378-3782(03)00073-2; De Brock A.J.L.L., 1992, NIJMEEGSE OUDERLIJKE; de Groot FM, 2011, J MANIP PHYSIOL THER, V34, P297, DOI 10.1016/j.jmpt.2011.04.007; Denney MK, 2006, RES PRACT PERS SEV D, V31, P255, DOI 10.1177/154079690603100305; DoussardRoosevelt JA, 1997, CHILD DEV, V68, P173, DOI 10.2307/1131844; Dudek-Shriber L, 2004, AM J OCCUP THER, V58, P509, DOI 10.5014/ajot.58.5.509; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elgen I, 2002, ACTA PAEDIATR, V91, P939, DOI 10.1080/080352502760148676; Elgen I, 2002, ARCH DIS CHILD-FETAL, V87, pF128, DOI 10.1136/fn.87.2.F128; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; Erdeve O, 2009, AM J PERINAT, V26, P159, DOI 10.1055/s-0028-1095186; Farel A, 1998, PSYCHOL REP, V83, P173, DOI 10.2466/PR0.83.5.173-174; Farel AM, 1998, J LEARN DISABIL, V31, P118, DOI 10.1177/002221949803100202; Feldman R, 2003, J FAM PSYCHOL, V17, P94, DOI 10.1037/0893-3200.17.1.94; Foster J, 2008, J ADV NURS, V61, P522, DOI 10.1111/j.1365-2648.2007.04547.x; Franck LS, 2005, J ADV NURS, V49, P608, DOI 10.1111/j.1365-2648.2004.03336.x; Franck LS, 2004, ARCH DIS CHILD-FETAL, V89, pF71, DOI 10.1136/fn.89.1.F71; Geva R, 2005, INFANT MENT HEALTH J, V26, P481, DOI 10.1002/imhj.20063; Glazebrook C, 2004, FERTIL STERIL, V81, P505, DOI 10.1016/j.fertnstert.2003.10.020; Glazebrook C, 2007, ARCH DIS CHILD-FETAL, V92, P438, DOI 10.1136/adc.2006.103135; GOLDBERG S, 1990, J PEDIATR PSYCHOL, V15, P347, DOI 10.1093/jpepsy/15.3.347; Goldberg S, 1995, HDB PARENTING CHILDR; GOTTS G, 1988, STRESS AROUSAL CHECK; Greco LA, 2005, BEHAV THER, V36, P177, DOI 10.1016/S0005-7894(05)80066-8; Grunau RE, 2009, PAIN, V143, P138, DOI 10.1016/j.pain.2009.02.014; Halpern LF, 2001, J PEDIATR PSYCHOL, V26, P93, DOI 10.1093/jpepsy/26.2.93; HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993; Harrison MJ, 1996, RES NURS HEALTH, V19, P451, DOI 10.1002/(SICI)1098-240X(199612)19:6<451::AID-NUR1>3.0.CO;2-N; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOLDEN GW, 1991, CHILD DEV, V62, P311, DOI 10.2307/1131005; Holditch-Davis D, 2003, JOGNN, V32, P161, DOI 10.1177/0884217503252035; Holditch-Davis D, 2007, RES NURS HEALTH, V30, P333, DOI 10.1002/nur.20190; Holditch-Davis D, 2009, J DEV BEHAV PEDIATR, V30, P193, DOI 10.1097/DBP.0b013e3181a7ee53; Holroyd J., 1974, J COMMUNITY PSYCHOL, V2, P92; HORBAR JD, 1993, PEDIATRICS, V92, P191; Ichijima E, 2011, J PEDIATR NURS, V26, P206, DOI 10.1016/j.pedn.2009.10.003; INNOCENTI MS, 1992, TOP EARLY CHILD SPEC, V12, P403, DOI 10.1177/027112149201200310; Jackson K, 2003, J ADV NURS, V43, P120, DOI 10.1046/j.1365-2648.2003.02686.x; JENSEN AM, 1991, J PEDIATR PSYCHOL, V16, P429, DOI 10.1093/jpepsy/16.4.429; JOHNSON BH, 2000, FAMILIES SYSTEMS HLT, V18, P137, DOI DOI 10.1037/H0091843; Kaaresen PI, 2008, EARLY HUM DEV, V84, P201, DOI 10.1016/j.earlhumdev.2007.07.003; Kaaresen PI, 2006, PEDIATRICS, V118, pE9, DOI 10.1542/peds.2005-1491; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; KAPLAN DM, 1960, AM J ORTHOPSYCHIAT, V30, P539, DOI 10.1111/j.1939-0025.1960.tb02069.x; Khan NZ, 2008, CHILD CARE HLTH DEV, V34, P657, DOI 10.1111/j.1365-2214.2008.00873.x; Klebanoff MA, 2011, CLIN PERINATOL, V38, P339, DOI 10.1016/j.clp.2011.06.006; Kok JH, 1998, BRIT J OBSTET GYNAEC, V105, P162, DOI 10.1111/j.1471-0528.1998.tb10046.x; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Lau C, 2007, J PERINATOL, V27, P399, DOI 10.1038/sj.jp.7211770; Lau R, 2003, STRESS HEALTH, V19, P69, DOI 10.1002/smi.964; Lee CF, 2009, FAM COMMUNITY HEALTH, V32, P228, DOI 10.1097/FCH.0b013e3181ab3b6a; Linhart Y, 2000, EUR J OBSTET GYN R B, V90, P43, DOI 10.1016/S0301-2115(99)00196-7; Liu CH, 2010, J CLIN NURS, V19, P1729, DOI 10.1111/j.1365-2702.2009.03082.x; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lundqvist-Persson C, 2011, ACTA PAEDIAT; Mackley Amy B, 2010, Adv Neonatal Care, V10, P200, DOI 10.1097/ANC.0b013e3181e946f0; Magill-Evans J, 2001, CHILD HEALTH CARE, V30, P135, DOI 10.1207/S15326888CHC3002_4; Melnyk BM, 2006, PEDIATRICS, V118, pE1414, DOI 10.1542/peds.2005-2580; Melnyk BM, 2008, NURS RES, V57, P383, DOI 10.1097/NNR.0b013e3181906f59; Melnyk Bernadette Mazurek, 2009, Nurs Adm Q, V33, P32, DOI 10.1097/01.NAQ.0000343346.47795.13; Melnyk BM, 2001, RES NURS HEALTH, V24, P373, DOI 10.1002/nur.1038; Meyer EC, 1995, J DEV BEHAV PEDIATR, V16, P412; MEYER EC, 1994, PEDIATRICS, V93, P241; Miceli PJ, 2000, J PEDIATR PSYCHOL, V25, P353, DOI 10.1093/jpepsy/25.5.353; MILES M S, 1989, Critical Care Nursing Quarterly, V12, P69; Miles M S, 1991, AACN Clin Issues Crit Care Nurs, V2, P346; Miles Margaret Shandor, 2003, Adv Neonatal Care, V3, P189, DOI 10.1016/S1536-0903(03)00138-3; Miles MS, 2007, J DEV BEHAV PEDIATR, V28, P36, DOI 10.1097/01.DBP.0000257517.52459.7a; MILES MS, 1993, NURS RES, V42, P148; MILES MS, 1992, RES NURS HEALTH, V15, P261, DOI 10.1002/nur.4770150405; Miles R, 2006, EARLY HUM DEV, V82, P447, DOI 10.1016/j.earlhumdev.2005.11.008; Newnham CA, 2009, INFANT BEHAV DEV, V32, P17, DOI 10.1016/j.infbeh.2008.09.004; Olafsen KS, 2008, INFANT BEHAV DEV, V31, P408, DOI 10.1016/j.infbeh.2007.12.005; Olafsen KS, 2007, SCAND J PSYCHOL, V48, P499, DOI 10.1111/j.1467-9450.2007.00619.x; Ong LC, 2001, J PAEDIATR CHILD H, V37, P363, DOI 10.1046/j.1440-1754.2001.00694.x; Ong LC, 2001, ACTA PAEDIATR, V90, P1464; ONUFRAK B, 1995, J PEDIATR PSYCHOL, V20, P587, DOI 10.1093/jpepsy/20.5.587; Ostberg M, 1997, SCAND J PSYCHOL, V38, P199, DOI 10.1111/1467-9450.00028; PEACOCK EJ, 1990, STRESS MEDICINE, V6, P227, DOI 10.1002/smi.2460060308; Petrou S, 2001, CHILD CARE HLTH DEV, V27, P97, DOI 10.1046/j.1365-2214.2001.00203.x; Power N, 2008, J ADV NURS, V62, P622, DOI 10.1111/j.1365-2648.2008.04643.x; Preyde M, 2003, CAN MED ASSOC J, V168, P969; Raley S, 2006, ANNU REV SOCIOL, V32, P401, DOI 10.1146/annurev.soc.32.061604.123106; Reichman SRF, 2000, CHILD HEALTH CARE, V29, P279, DOI 10.1207/S15326888CHC2904_4; Reid T, 2003, J REPROD INFANT PSYC, V21, P279, DOI 10.1080/02646830310001622114; Reid T, 2007, J REPROD INFANT PSYC, V25, P66, DOI 10.1080/02646830601117258; Reijneveld SA, 2006, ARCH DIS CHILD-FETAL, V91, pF423, DOI 10.1136/adc.2006.093674; Rimmerman A., 2001, CHILD FAM SOC WORK, V6, P261, DOI DOI 10.1046/J.1365-2206.2001.00201.X; Roberts K L, 2000, Neonatal Netw, V19, P31; Robson AL, 1997, J PEDIATR PSYCHOL, V22, P297, DOI 10.1093/jpepsy/22.3.297; Rowe J., 2010, J NEONATAL NURSING, V16, P258, DOI [DOI 10.1016/J.JNN.2010.07.018, 10.1016/j.jnn.2010.07.018]; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Saisto T, 2008, J PSYCHOSOM OBST GYN, V29, P213, DOI 10.1080/01674820802000467; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Saylor CF, 1996, J PEDIATR PSYCHOL, V21, P869, DOI 10.1093/jpepsy/21.6.869; Saylor CF, 2003, CHILD PSYCHIAT HUM D, V33, P175, DOI 10.1023/A:1021402012924; Schraeder BD, 1996, CHILD HEALTH CARE, V25, P117, DOI 10.1207/s15326888chc2502_4; Secco ML, 2006, COMPR CHILD ADOLES N, V29, P131, DOI 10.1080/01460860600846867; Shaw RJ, 2006, PSYCHOSOMATICS, V47, P206, DOI 10.1176/appi.psy.47.3.206; Shields-Poe D, 1997, Neonatal Netw, V16, P29; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Singer LT, 1996, FAM RELAT, V45, P343, DOI 10.2307/585507; Singer LT, 2007, J PEDIATR-US, V151, P463, DOI 10.1016/j.jpeds.2007.04.012; Singer LT, 2010, ARCH PEDIAT ADOL MED, V164, P518, DOI 10.1001/archpediatrics.2010.81; Sisk PM, 2006, PEDIATRICS, V117, pE67, DOI 10.1542/peds.2005-0267; Sloan K, 2008, J NEONATAL NURS, V14, P108, DOI DOI 10.1016/J.JNN.2007.12.009; SOLIS ML, 1991, J CLIN CHILD PSYCHOL, V20, P372, DOI 10.1207/s15374424jccp2004_5; Spear ML, 2002, AM J PERINAT, V19, P205, DOI 10.1055/s-2002-28484; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; Swaminathan S, 2006, MATERN CHILD HLTH J, V10, P473, DOI 10.1007/s10995-006-0146-3; Tallandini MA, 2006, INFANT MENT HEALTH J, V27, P251, DOI 10.1002/imhj.20091; Tarsitani L., 1999, MED PSICOSOMATICA, V44, P163; Taylor HG, 2001, ARCH PEDIAT ADOL MED, V155, P155, DOI 10.1001/archpedi.155.2.155; Thomas Karen A, 2004, Adv Neonatal Care, V4, P33, DOI 10.1016/j.adnc.2003.11.012; THOMPSON RJ, 1994, J DEV BEHAV PEDIATR, V15, P232; TOBEY GY, 1990, NURS RES, V39, P84; Tommiska V, 2002, ARCH DIS CHILD-FETAL, V86, P161, DOI 10.1136/fn.86.3.F161; TRAUSE MA, 1983, DEV MED CHILD NEUROL, V25, P459; Treyvaud K, 2010, INFANT MENT HEALTH J, V31, P58, DOI 10.1002/imhj.20242; Trombini E, 2008, ACTA PAEDIATR, V97, P894, DOI 10.1111/j.1651-2227.2008.00849.x; Turan T, 2008, J CLIN NURS, V17, P2856, DOI 10.1111/j.1365-2702.2008.02307.x; van Beek Y, 2006, INFANT CHILD DEV, V15, P41, DOI 10.1002/icd.428; van der Pal SM, 2007, ACTA PAEDIATR, V96, P1611, DOI 10.1111/j.1651-2227.2007.00487.x; van der Pal S, 2008, J EARLY INTERVENTION, V30, P102, DOI 10.1177/1053815107313485; van der Pal SM, 2008, BRIT J DEV PSYCHOL, V26, P103, DOI 10.1348/026151007X205290; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Veddovi M, 2004, INFANT MENT HEALTH J, V25, P580, DOI 10.1002/imhj.20026; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Wijnroks L, 1999, INF MENTAL HLTH J, V20, P393, DOI 10.1002/(SICI)1097-0355(199924)20:4<393::AID-IMHJ3>3.0.CO;2-I; Young Seideman R, 1997, J Pediatr Nurs, V12, P169, DOI 10.1016/S0882-5963(97)80074-7; Youngblut JM, 1998, NURS RES, V47, P114, DOI 10.1097/00006199-199803000-00010; Youngblut JM, 1997, PSYCHOL WOMEN QUART, V21, P247, DOI 10.1111/j.1471-6402.1997.tb00111.x; Zahr LK, 2000, INFANT MENT HEALTH J, V21, P448, DOI 10.1002/1097-0355(200011/12)21:6<448::AID-IMHJ4>3.0.CO;2-#	167	124	127	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54992	10.1371/journal.pone.0054992	http://dx.doi.org/10.1371/journal.pone.0054992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405105	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400049
J	Williams, SA; Jasarevic, E; Vandas, GM; Warzak, DA; Geary, DC; Ellersieck, MR; Roberts, RM; Rosenfeld, CS				Williams, Scott A.; Jasarevic, Eldin; Vandas, Gregory M.; Warzak, Denise A.; Geary, David C.; Ellersieck, Mark R.; Roberts, R. Michael; Rosenfeld, Cheryl S.			Effects of Developmental Bisphenol A Exposure on Reproductive-Related Behaviors in California Mice (Peromyscus californicus): A Monogamous Animal Model	PLOS ONE			English	Article							TERRITORIAL MARKING; SEX-DIFFERENCES; SOCIAL STRESS; URINE-MARKING; TESTOSTERONE; ENDOCRINE; ESTRADIOL; DIFFERENTIATION; EXPLORATION; INTERFERES	Bisphenol A (BPA), a pervasive, endocrine disrupting compound (EDC), acts as a mixed agonist-antagonist with respect to estrogens and other steroid hormones. We hypothesized that sexually selected traits would be particularly sensitive to EDC. Consistent with this concept, developmental exposure of males from the polygynous deer mouse, Peromyscus maniculatus, to BPA resulted in compromised spatial navigational ability and exploratory behaviors, while there was little effect on females. Here, we have examined a related, monogamous species, the California mouse (Peromyscus californicus), where we predicted that males would be less sensitive to BPA in terms of navigational and exploratory behaviors, while displaying other traits related to interactions with females and territorial marking that might be vulnerable to disruption. As in the deer mouse experiments, females were fed either a phytoestrogen-free CTL diet through pregnancy and lactation or the same diet supplemented with BPA (50 mg/kg feed weight) or ethinyl estradiol (EE) (0.1 part per billion) to provide a "pure'' estrogen control. After weaning, pups were maintained on CTL diet until they had reached sexual maturity, at which time behaviors were evaluated. In addition, territorial marking was assessed in BPA-exposed males housed alone and when a control male was visible in the testing arena. In contrast to deer mice, BPA and EE exposure had no effect on spatial navigational skills in either male or female California mice. While CTL females exhibited greater exploratory behavior than CTL males, BPA exposure abolished this sex difference. BPA-exposed males, however, engaged in less territorial marking when CTL males were present. These studies demonstrate that developmental BPA exposure can disrupt adult behaviors in a sex- and species-dependent manner and are consistent with the hypothesis that sexually selected traits are particularly vulnerable to endocrine disruption and should be a consideration in risk assessment studies.	[Williams, Scott A.; Vandas, Gregory M.; Warzak, Denise A.; Roberts, R. Michael; Rosenfeld, Cheryl S.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65212 USA; [Williams, Scott A.; Jasarevic, Eldin; Vandas, Gregory M.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Jasarevic, Eldin; Geary, David C.] Univ Missouri, Ctr Translat Neurosci, Interdisciplinary Neurosci Program, Columbia, MO USA; [Jasarevic, Eldin; Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA; [Jasarevic, Eldin] Univ Missouri, Thompson Ctr Autism & Neurodev Disorder, Columbia, MO USA; [Warzak, Denise A.; Roberts, R. Michael] Univ Missouri, Dept Anim Sci, Columbia, MO USA; [Ellersieck, Mark R.] Univ Missouri, Coll Agr Food & Nat Resources Statistician, Columbia, MO USA; [Roberts, R. Michael] Univ Missouri, Dept Biochem, Columbia, MO USA; [Roberts, R. Michael; Rosenfeld, Cheryl S.] Univ Missouri, Genet Area Program, Columbia, MO USA; [Rosenfeld, Cheryl S.] Univ Missouri, Dept Biomed Sci, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Rosenfeld, CS (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65212 USA.	rosenfeldc@missouri.edu		Jasarevic, Eldin/0000-0001-8174-0710	National Institutes of Health Challenge Grant [RC1 ES018195]; Mizzou Advantage grant; Food for the 21th Century Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC1ES018195] Funding Source: NIH RePORTER	National Institutes of Health Challenge Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizzou Advantage grant; Food for the 21th Century Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a National Institutes of Health Challenge Grant RC1 ES018195 (to CSR), a Mizzou Advantage grant (to CSR, DCG and RMR), and support from Food for the 21th Century Program to RMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ARNOLD AP, 1985, HORM BEHAV, V19, P469, DOI 10.1016/0018-506X(85)90042-X; ASA CS, 1990, HORM BEHAV, V24, P497, DOI 10.1016/0018-506X(90)90038-Y; Bailin P.D., 2008, PUBLIC AWARENESS DRI, P37; Balakrishnan B, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.025; Bartolomucci A, 2001, PHYSIOL BEHAV, V73, P401, DOI 10.1016/S0031-9384(01)00453-X; Becker EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032002; Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Chang YM, 2000, J COMP PSYCHOL, V114, P401, DOI 10.1037/0735-7036.114.4.401; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cox KH, 2010, HORM BEHAV, V58, P754, DOI 10.1016/j.yhbeh.2010.07.008; D'Amato FR, 2001, PHYSIOL BEHAV, V73, P421, DOI 10.1016/S0031-9384(01)00460-7; Darwin C., 1871, P423; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Eichmann F, 1999, PHYSIOL BEHAV, V65, P785; EISENBERG JOHN F., 1962, BEHAVIOUR, V19, P177, DOI 10.1163/156853962X00014; Fountain ED, 2008, BIOL REPROD, V78, P211, DOI 10.1095/biolreprod.107.065003; Frazier CRM, 2006, HORM BEHAV, V50, P699, DOI 10.1016/j.yhbeh.2006.06.035; Frye CA, 2012, J NEUROENDOCRINOL, V24, P144, DOI 10.1111/j.1365-2826.2011.02229.x; Galea LAM, 1996, J EXP BIOL, V199, P195; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Galloway T, 2010, ENV HLTH PERSPECT; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Gleason ED, 2009, FRONT NEUROENDOCRIN, V30, P460, DOI 10.1016/j.yfrne.2009.04.009; GUBERNICK DJ, 1987, J COMP PSYCHOL, V101, P169, DOI 10.1037/0735-7036.101.2.169; Gubernick DJ, 2000, P ROY SOC B-BIOL SCI, V267, P147, DOI 10.1098/rspb.2000.0979; Hajszan T, 2010, FRONT NEUROENDOCRIN, V31, P519, DOI 10.1016/j.yfrne.2010.06.004; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; He YH, 2009, ENVIRON RES, V109, P629, DOI 10.1016/j.envres.2009.04.003; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; JACOBS LF, 1990, P NATL ACAD SCI USA, V87, P6349, DOI 10.1073/pnas.87.16.6349; Jasarevic E, 2012, J COMP PSYCHOL; Jasarevic E, 2013, HORM BEHAV, V63, P180, DOI 10.1016/j.yhbeh.2012.09.009; Jasarevic E, 2012, ANIM BEHAV, V84, P1141, DOI 10.1016/j.anbehav.2012.08.015; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Kawamoto Y, 2007, TOXICOL APPL PHARM, V224, P182, DOI 10.1016/j.taap.2007.06.023; Kim ME, 2011, FOOD CHEM TOXICOL, V49, P3383, DOI 10.1016/j.fct.2011.09.017; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; Lambert KG, 2011, BRAIN BEHAV EVOLUT, V77, P159, DOI 10.1159/000326054; Layne JN, 1968, BIOL PEROMYSCUS RODE; Leranth C, 2008, P NATL ACAD SCI USA, V105, P14187, DOI 10.1073/pnas.0806139105; Leranth C, 2008, ENDOCRINOLOGY, V149, P988, DOI 10.1210/en.2007-1053; Littell RC, 1998, J ANIM SCI, V76, P1216; Marler CA, 2008, NEUROBIOLOGY OF THE PARENTAL BRAIN, P435, DOI 10.1016/B978-012374285-8.00028-7; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Nakamura K, 2012, BRAIN DEV-JPN, V34, P57, DOI 10.1016/j.braindev.2010.12.011; Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575; Perera F, 2012, ENVIRON HEALTH PERSP, V120, P1190, DOI 10.1289/ehp.1104492; Pyter LM, 2006, EUR J NEUROSCI, V23, P3056, DOI 10.1111/j.1460-9568.2006.04821.x; Pyter LM, 2005, J NEUROSCI, V25, P4521, DOI 10.1523/JNEUROSCI.0795-05.2005; Razzoli M, 2005, BRAIN RES BULL, V65, P249, DOI 10.1016/j.brainresbull.2004.11.013; Ribble DO, 1990, POPULATION SOCIAL DY; Rubin BS, 2011, J STEROID BIOCH MOL; Ryan BC, 2010, TOXICOL SCI, V114, P133, DOI 10.1093/toxsci/kfp266; Saal FSV, 2005, BIRTH DEFECTS RES A, V73, P140, DOI 10.1002/bdra.20120; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Stump DG, 2010, TOXICOL SCI, V115, P167, DOI 10.1093/toxsci/kfq025; THIESSEN DD, 1971, J COMP PHYSIOL PSYCH, V77, P38, DOI 10.1037/h0031570; THIESSEN DD, 1968, SCIENCE, V160, P432, DOI 10.1126/science.160.3826.432; TURNER JW, 1979, PHYSIOL BEHAV, V23, P845, DOI 10.1016/0031-9384(79)90188-4; TURNER JW, 1984, PHYSIOL BEHAV, V33, P173, DOI 10.1016/0031-9384(84)90096-9; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; VOMSAAL FS, 1995, TOXICOL LETT, V77, P343, DOI 10.1016/0378-4274(95)03316-5; Walton JC, 2011, NEUROSCIENCE, V175, P127, DOI 10.1016/j.neuroscience.2010.12.004; Yamaguchi H, 2005, HORM BEHAV, V47, P549, DOI 10.1016/j.yhbeh.2004.12.009	70	56	57	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55698	10.1371/journal.pone.0055698	http://dx.doi.org/10.1371/journal.pone.0055698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405200	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400145
J	Breme, C; Heslot, F				Breme, Camille; Heslot, Francois			Mapping of Single-Base Differences between Two DNA Strands in a Single Molecule Using Holliday Junction Nanomechanics	PLOS ONE			English	Article							FORCE SPECTROSCOPY; HELICAL JUNCTIONS; BRANCH MIGRATION; ELASTICITY; TWEEZERS; TORQUE	Objective: The aim of this work is to demonstrate a novel single-molecule DNA sequence comparison assay that is purely based on DNA mechanics. Methods: A molecular construct that contained the two homologous but non-identical DNA sequences that were to be compared was prepared such that a four-way (Holliday) junction could be formed by the formation of heteroduplexes through the inter-recombination of the strands. Magnetic tweezers were used to manipulate the force and the winding applied to this construct for inducing both the formation and the migration of a Holliday junction. The end-to-end distance of the construct was measured as a function of the winding and was used to monitor the behavior of the Holliday junction in different regions of the intra-molecular recombination. Main Results: In the appropriate buffer, the magnet rotation induces the migration of the Holliday junction in the regions where there is no sequence difference between the recombining sequences. In contrast, even a single-base difference between the recombining sequences leads to a long-lasting blockage of the migration in the same buffer; this effect was obtained when the junction was positioned near this locus (the site of the single-base difference) and forced toward the formation of heteroduplexes that comprise the locus. The migration blockages were detected through the identification of the formation of plectonemes. The detection of the presence of sequence differences and their respective mappings were obtained from the series of blockages that were detected. Significance: This work presents a novel single-molecule sequence comparison assay that is based on the use of a Holliday junction as an ultra-sensitive nanomechanism; the mismatches act as blocking grains of sand in the Holliday "DNA gearbox''. This approach will potentially have future applications in biotechnology.	[Breme, Camille; Heslot, Francois] Ecole Normale Super, Lab Pierre Aigrain, UMR 8551, F-75231 Paris, France; [Breme, Camille; Heslot, Francois] Univ Paris 06, Lab Pierre Aigrain, Paris, France; [Breme, Camille; Heslot, Francois] Univ Paris 07, Lab Pierre Aigrain, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Heslot, F (corresponding author), Ecole Normale Super, Lab Pierre Aigrain, UMR 8551, 24 Rue Lhomond, F-75231 Paris, France.	heslot@lpa.ens.fr	heslot, françois/AAF-9406-2021		Centre national de la recherche scientifique (CNRS); Universite Pierre et Marie Curie (UPMC)	Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie (UPMC)	The funders for the study were Centre national de la recherche scientifique (CNRS) and Universite Pierre et Marie Curie (UPMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas I, 1998, J MOL BIOL, V279, P795, DOI 10.1006/jmbi.1998.1769; Bockelmann U, 2002, BIOPHYS J, V82, P1537, DOI 10.1016/S0006-3495(02)75506-9; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Dawid A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188102; De Vlaminck I, 2011, NANO LETT, V11, P5489, DOI 10.1021/nl203299e; Forth S, 2011, BIOPHYS J, V101, pL5, DOI 10.1016/j.bpj.2011.05.066; Gomez A, 2005, APPL ENVIRON MICROB, V71, P7607, DOI 10.1128/AEM.71.11.7607-7609.2005; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Lilley DMJ, 2009, IMA VOL MATH APPL, V150, P213, DOI 10.1007/978-1-4419-0670-0_11; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; Marko JF, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021926; McKinney SA, 2005, P NATL ACAD SCI USA, V102, P5715, DOI 10.1073/pnas.0409328102; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Moroz JD, 1998, MACROMOLECULES, V31, P6333, DOI 10.1021/ma971804a; Mosconi F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.078301; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; PANYUTIN IG, 1995, EMBO J, V14, P1819, DOI 10.1002/j.1460-2075.1995.tb07170.x; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Ramreddy T, 2011, NUCLEIC ACIDS RES, V39, P4275, DOI 10.1093/nar/gkr008; SCOULICA E, 1995, ANTIMICROB AGENTS CH, V39, P1379, DOI 10.1128/AAC.39.6.1379; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAYLOR WH, 1990, J MOL BIOL, V212, P363, DOI 10.1016/0022-2836(90)90131-5; Treffer R, 2010, CURR OPIN BIOTECH, V21, P4, DOI 10.1016/j.copbio.2010.02.009; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; VIOVY JL, 1994, CR ACAD SCI III-VIE, V317, P795; Voulgarakis NK, 2006, NANO LETT, V6, P1483, DOI 10.1021/nl0608801; Zhao Q, 2007, NANO LETT, V7, P1680, DOI 10.1021/nl070668c	31	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55154	10.1371/journal.pone.0055154	http://dx.doi.org/10.1371/journal.pone.0055154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393565	gold, Green Submitted, Green Published			2022-12-27	WOS:000314692800019
J	Papadimitriou, KI; Stan, GBV; Drakakis, EM				Papadimitriou, Konstantinos I.; Stan, Guy-Bart V.; Drakakis, Emmanuel M.			Systematic Computation of Nonlinear Cellular and Molecular Dynamics with Low-Power CytoMimetic Circuits: A Simulation Study	PLOS ONE			English	Article							CA2+-INDUCED CA2+ RELEASE; CALCIUM OSCILLATIONS; PROTEIN-PHOSPHORYLATION; INTRACELLULAR CALCIUM; MODEL; VLSI	This paper presents a novel method for the systematic implementation of low-power microelectronic circuits aimed at computing nonlinear cellular and molecular dynamics. The method proposed is based on the Nonlinear Bernoulli Cell Formalism (NBCF), an advanced mathematical framework stemming from the Bernoulli Cell Formalism (BCF) originally exploited for the modular synthesis and analysis of linear, time-invariant, high dynamic range, logarithmic filters. Our approach identifies and exploits the striking similarities existing between the NBCF and coupled nonlinear ordinary differential equations (ODEs) typically appearing in models of naturally encountered biochemical systems. The resulting continuous-time, continuous-value, low-power CytoMimetic electronic circuits succeed in simulating fast and with good accuracy cellular and molecular dynamics. The application of the method is illustrated by synthesising for the first time microelectronic CytoMimetic topologies which simulate successfully: 1) a nonlinear intracellular calcium oscillations model for several Hill coefficient values and 2) a gene-protein regulatory system model. The dynamic behaviours generated by the proposed CytoMimetic circuits are compared and found to be in very good agreement with their biological counterparts. The circuits exploit the exponential law codifying the low-power subthreshold operation regime and have been simulated with realistic parameters from a commercially available CMOS process. They occupy an area of a fraction of a square-millimetre, while consuming between 1 and 12 microwatts of power. Simulations of fabrication-related variability results are also presented.	[Papadimitriou, Konstantinos I.; Stan, Guy-Bart V.; Drakakis, Emmanuel M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Stan, Guy-Bart V.] Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England	Imperial College London; Imperial College London	Drakakis, EM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, S Kensington Campus, London, England.	e.drakakis@imperial.ac.uk	Papadimitriou, Konstantinos/G-1214-2013	Stan, Guy-Bart/0000-0002-5560-902X; Papadimitriou, Konstantinos I./0000-0002-0995-4834	Engineering and Physical Sciences Research Council [EP/G036004/1] Funding Source: researchfish; EPSRC [EP/G036004/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Andreou AG, 1996, ANALOG INTEGR CIRC S, V9, P141, DOI 10.1007/BF00166411; Andronov A.A, 1973, THEORY BIFURCATIONS; Ascoli A, 2007, INT J CIRC THEOR APP, V35, P33, DOI 10.1002/cta.379; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; CAPOGROSSI MC, 1987, CIRC RES, V61, P498, DOI 10.1161/01.RES.61.4.498; Carafoli E., 1978, CURR TOP MEMBR TRANS, V10, P151; Cauwenberghs G, 1997, ANALOG INTEGR CIRC S, V13, P195, DOI 10.1023/A:1008252532342; Chen H, 2010, IEEE T NEURAL NETWOR, V21, P1511, DOI 10.1109/TNN.2010.2049028; Chen LN, 2002, IEEE T CIRCUITS-I, V49, P1429, DOI 10.1109/TCSI.2002.803354; Drakakis EM, 1999, IEEE T CIRCUITS-I, V46, P559, DOI 10.1109/81.762921; Drakakis EM, 1999, IEEE T CIRCUITS-II, V46, P290, DOI 10.1109/82.754862; Drakakis EM, 1997, ISCAS '97 - PROCEEDINGS OF 1997 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS I - IV, P501, DOI 10.1109/ISCAS.1997.608784; Drazin P, 1992, NONLINEAR SYSTEMS, V10; DUPONT G, 1994, BIOPHYS J, V67, P2191, DOI 10.1016/S0006-3495(94)80705-2; DUPONT G, 1991, CELL CALCIUM, V12, P73, DOI 10.1016/0143-4160(91)90010-C; DUPONT G, 1992, BIOPHYS CHEM, V42, P257, DOI 10.1016/0301-4622(92)80018-Z; DUPONT G, 1993, CELL CALCIUM, V14, P311, DOI 10.1016/0143-4160(93)90052-8; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Enz C, 1999, IEEE T CIRCUITS-II, V46, P279, DOI 10.1109/82.754861; GOLDBETER A, 1990, BIOPHYS CHEM, V37, P341, DOI 10.1016/0301-4622(90)88033-O; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; Goldbeter A., 1996, BIOCH OSCILLATIONS B; Guckenheimer J, 1997, NONLINEAR OSCILLATIO, V42; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Indiveri G., 2011, FRONTIERS NEUROSCIEN, V5; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Marhl M, 1997, BIOPHYS CHEM, V63, P221, DOI 10.1016/S0301-4622(96)02248-X; Marsden J.E., 1976, HOPF BIFURCATION ITS, V19; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; Mees A.I., 1981, DYNAMICS FEEDBACK SY; Panasonic Industry, 2022, ULTRA LOW POWER BIOE, DOI 10.1017/CBO9780511841446; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Reissig R, 1967, ZAMM-Z ANGEW MATH ME, V4, P480; ROONEY TA, 1990, J BIOL CHEM, V265, P10792; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Serrano-Gotarredona T, 1998, CIRC SYST 1998 ISCAS, V2, P466; Serrano-Gotarredona T, 2003, SOL STAT CIRC C 2003, P627; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Takahashi K, 2002, IEEE INTELL SYST, V17, P64, DOI 10.1109/MIS.2002.1039834; Tenore F, 2004, CIRC SYST 2004 ISCAS, V5, pV; Toth L, 2000, IEEE T CIRCUITS-II, V47, P1365, DOI 10.1109/82.899629; Tsividis Y, 1997, IEEE T CIRCUITS-II, V44, P65, DOI 10.1109/82.554425; Zhang W.L., 2011, SYST BIOL ISB 2011 I, P190, DOI [10.1109/ISB.2011.6033154, DOI 10.1109/ISB.2011.6033154]	45	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53591	10.1371/journal.pone.0053591	http://dx.doi.org/10.1371/journal.pone.0053591			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393550	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000314692800004
J	Andersson, K; Pokrzywa, M; Dacklin, I; Lundgren, E				Andersson, Karin; Pokrzywa, Malgorzata; Dacklin, Ingrid; Lundgren, Erik			Inhibition of TTR Aggregation-Induced Cell Death-A New Role for Serum Amyloid P Component	PLOS ONE			English	Article							DNA-BINDING PROTEIN; C-REACTIVE PROTEIN; SYSTEMIC AMYLOIDOSIS; ALZHEIMERS-DISEASE; APOPTOTIC CELLS; IN-VITRO; TRANSTHYRETIN; TOXICITY; PEPTIDE; POLYNEUROPATHY	Background: Serum amyloid P component (SAP) is a glycoprotein that is universally found associated with different types of amyloid deposits. It has been suggested that it stabilizes amyloid fibrils and therefore protects them from proteolytic degradation. Methodology/Principal Findings: In this paper, we show that SAP binds not only to mature amyloid fibrils but also to early aggregates of amyloidogenic mutants of the plasma protein transthyretin (TTR). It does not inhibit fibril formation of TTR mutants, which spontaneously form amyloid in vitro at physiological pH. We found that SAP prevents cell death induced by mutant TTR, while several other molecules that are also known to decorate amyloid fibrils do not have such effect. Using a Drosophila model for TTR-associated amyloidosis, we found a new role for SAP as a protective factor in inhibition of TTR-induced toxicity. Overexpression of mutated TTR leads to a neurological phenotype with changes in wing posture. SAP-transgenic flies were crossed with mutated TTR-expressing flies and the results clearly confirmed a protective effect of SAP on TTR-induced phenotype, with an almost complete reduction in abnormal wing posture. Furthermore, we found in vivo that binding of SAP to mutated TTR counteracts the otherwise detrimental effects of aggregation of amyloidogenic TTR on retinal structure. Conclusions/Significance: Together, these two approaches firmly establish the protective effect of SAP on TTR-induced cell death and degenerative phenotypes, and suggest a novel role for SAP through which the toxicity of early amyloidogenic aggregates is attenuated.	[Andersson, Karin; Dacklin, Ingrid; Lundgren, Erik] Umea Univ, Dept Mol Biol, Umea, Sweden; [Pokrzywa, Malgorzata] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden	Umea University; University of Gothenburg	Pokrzywa, M (corresponding author), Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.	malgorzata.pokrzywa@gu.se; Erik.Lundgren@molbiol.umu.se	Pokrzywa, Małgorzata/GQA-6257-2022		European Commission (EURAMY); European Commission (Systemic Amyloidosis Network); Swedish Research Council; Swedish Agency for Animal Protection; Medical Faculty of Umea University; Swedish Society for Medical Research; Lennander Foundation; FAMY patient associations; Amyl Foundation, Norrbotten, Sweden	European Commission (EURAMY)(European CommissionEuropean Commission Joint Research Centre); European Commission (Systemic Amyloidosis Network)(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Agency for Animal Protection; Medical Faculty of Umea University; Swedish Society for Medical Research; Lennander Foundation; FAMY patient associations; Amyl Foundation, Norrbotten, Sweden	This work was supported by grants from the European Commission (EURAMY, Systemic Amyloidosis Network), the Swedish Research Council, the Swedish Agency for Animal Protection, the Medical Faculty of Umea University, the Swedish Society for Medical Research, the Lennander Foundation, the FAMY patient associations, and the Amyl Foundation, Norrbotten, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JK, 1982, ANN NY ACAD SCI, V389, P216, DOI 10.1111/j.1749-6632.1982.tb22139.x; Andersson K, 2002, BIOCHEM BIOPH RES CO, V294, P309, DOI 10.1016/S0006-291X(02)00465-5; Aslund Andreas, 2009, J Chem Biol, V2, P161, DOI 10.1007/s12154-009-0024-8; BARTALENA L, 1993, CLIN LAB MED, V13, P583, DOI 10.1016/S0272-2712(18)30427-X; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Benson MD, 1996, AMYLOID, V3, P44, DOI 10.3109/13506129609014354; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bijl M, 2003, ARTHRITIS RHEUM, V48, P248, DOI 10.1002/art.10737; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BUTLER PJG, 1990, J EXP MED, V172, P13, DOI 10.1084/jem.172.1.13; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Cohen A S, 1993, Curr Opin Rheumatol, V5, P62; Colon W, 1996, CIBA F SYMP, V199, P228; ELLIS MC, 1993, DEVELOPMENT, V119, P855; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Familian A, 2001, J IMMUNOL, V167, P647, DOI 10.4049/jimmunol.167.2.647; Goldsteins G, 1997, BIOCHEMISTRY-US, V36, P5346, DOI 10.1021/bi961649c; Goldsteins G, 1999, P NATL ACAD SCI USA, V96, P3108, DOI 10.1073/pnas.96.6.3108; HAMAZAKI H, 1995, BIOCHEM BIOPH RES CO, V211, P349, DOI 10.1006/bbrc.1995.1819; HAWKINS PN, 1995, EUR J NUCL MED, V22, P595, DOI 10.1007/BF01254559; JANCIAUSKIENE S, 1995, J BIOL CHEM, V270, P26041, DOI 10.1074/jbc.270.44.26041; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kruman I, 1997, J NEUROSCI, V17, P5089; Lundgren E, 1999, METHOD ENZYMOL, V309, P591; MURAKAMI T, 1992, AM J PATHOL, V141, P451; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Olofsson A, 2002, CLIN CHEM LAB MED, V40, P1266, DOI 10.1515/CCLM.2002.219; Olofsson A, 2001, J BIOL CHEM, V276, P39592, DOI 10.1074/jbc.M103599200; OSMAND AP, 1977, P NATL ACAD SCI USA, V74, P739, DOI 10.1073/pnas.74.2.739; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; PEPYS MB, 1987, BIOCHEM BIOPH RES CO, V148, P308, DOI 10.1016/0006-291X(87)91111-9; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; PITKANEN P, 1984, AM J PATHOL, V117, P391; Pokrzywa M, 2007, EUR J NEUROSCI, V26, P913, DOI 10.1111/j.1460-9568.2007.05728.x; Pokrzywa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014343; Rapezzi C, 2010, NAT REV CARDIOL, V7, P398, DOI 10.1038/nrcardio.2010.67; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Schreiber G, 1997, COMP BIOCHEM PHYS B, V116, P137, DOI 10.1016/S0305-0491(96)00212-X; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; SNOW AD, 1987, LAB INVEST, V56, P120; Soma M, 2001, BIOCHEM BIOPH RES CO, V286, P200, DOI 10.1006/bbrc.2001.5364; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Sousa MM, 2000, LAB INVEST, V80, P1101, DOI 10.1038/labinvest.3780116; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; Suhr OB, 2001, SCAND J CLIN LAB INV, V61, P11; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Veerhuis R, 2003, ACTA NEUROPATHOL, V105, P135, DOI 10.1007/s00401-002-0624-7; Webster S, 1996, J NEUROSCI RES, V46, P58, DOI 10.1002/(SICI)1097-4547(19961001)46:1<58::AID-JNR8>3.0.CO;2-E; Wiseman RL, 2005, BIOCHEMISTRY-US, V44, P16612, DOI 10.1021/bi0511484	61	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55766	10.1371/journal.pone.0055766	http://dx.doi.org/10.1371/journal.pone.0055766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390551	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100067
J	Rodriguez-Jato, S; Shan, JX; Khadake, J; Heggestad, AD; Ma, XJ; Johnstone, KA; Resnick, JL; Yang, TP				Rodriguez-Jato, Sara; Shan, Jixiu; Khadake, Jyoti; Heggestad, Arnold D.; Ma, Xiaojie; Johnstone, Karen A.; Resnick, James L.; Yang, Thomas P.			Regulatory Elements Associated with Paternally-Expressed Genes in the Imprinted Murine Angelman/Prader-Willi Syndrome Domain	PLOS ONE			English	Article							BETA-GLOBIN LOCUS; MAMMALIAN MITOCHONDRIAL BIOGENESIS; TRANSCRIPTION FACTOR GABP; SNRPN MINIMAL PROMOTER; DELETION MOUSE MODEL; PRADER-WILLI; IN-VIVO; CONTROL REGION; CHROMOSOME CONFORMATION; SPATIAL-ORGANIZATION	The Angelman/Prader-Willi syndrome (AS/PWS) domain contains at least 8 imprinted genes regulated by a bipartite imprinting center (IC) associated with the SNRPN gene. One component of the IC, the PWS-IC, governs the paternal epigenotype and expression of paternal genes. The mechanisms by which imprinting and expression of paternal genes within the AS/PWS domain-such as MKRN3 and NDN-are regulated by the PWS-IC are unclear. The syntenic region in the mouse is organized and imprinted similarly to the human domain with the murine PWS-IC defined by a 6 kb interval within the Snrpn locus that includes the promoter. To identify regulatory elements that may mediate PWS-IC function, we mapped the location and allele-specificity of DNase I hypersensitive (DH) sites within the PWS-IC in brain cells, then identified transcription factor binding sites within a subset of these DH sites. Six major paternal-specific DH sites were detected in the Snrpn gene, five of which map within the 6 kb PWS-IC. We postulate these five DH sites represent functional components of the murine PWS-IC. Analysis of transcription factor binding within multiple DH sites detected nuclear respiratory factors (NRF's) and YY1 specifically on the paternal allele. NRF's and YY1 were also detected in the paternal promoter region of the murine Mrkn3 and Ndn genes. These results suggest that NRF's and YY1 may facilitate PWS-IC function and coordinately regulate expression of paternal genes. The presence of NRF's also suggests a link between transcriptional regulation within the AS/PWS domain and regulation of respiration. 3C analyses indicated Mkrn3 lies in close proximity to the PWS-IC on the paternal chromosome, evidence that the PWS-IC functions by allele-specific interaction with its distal target genes. This could occur by allele-specific co-localization of the PWS-IC and its target genes to transcription factories containing NRF's and YY1.	[Rodriguez-Jato, Sara; Shan, Jixiu; Khadake, Jyoti; Heggestad, Arnold D.; Ma, Xiaojie; Yang, Thomas P.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Johnstone, Karen A.; Resnick, James L.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Yang, Thomas P.] Univ Florida, Coll Med, Ctr Epigenet, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Yang, TP (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	tpyang@ufl.edu			National Institutes of Health [HD057026, HD037872]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057026, R01HD037872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health grants HD057026 to TPY and HD037872 JLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR JA, 1995, MAMM GENOME, V6, P405, DOI 10.1007/BF00355641; Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; Bittel DC, 2007, AM J MED GENET A, V143A, P422, DOI 10.1002/ajmg.a.31504; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Buiting K, 1999, HUM GENET, V105, P665, DOI 10.1007/s004390051160; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chen C, 2001, MOL CELL BIOL, V21, P7682, DOI 10.1128/MCB.21.22.7682-7695.2001; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dhar SS, 2009, J BIOL CHEM, V284, P18644, DOI 10.1074/jbc.M109.019976; Do Kim J, 2006, GENOME RES, V16, P901, DOI 10.1101/gr.5091406; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Dubose AJ, 2011, HUM MOL GENET; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Eskiw CH, 2010, COLD SH Q B, V75, P501, DOI 10.1101/sqb.2010.75.046; Finberg YG, 2003, GENE, V304, P201, DOI 10.1016/S0378-1119(02)01212-X; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Glenn CC, 1996, AM J HUM GENET, V58, P335; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Greally JM, 1999, P NATL ACAD SCI USA, V96, P14430, DOI 10.1073/pnas.96.25.14430; Hanel ML, 2005, J CELL BIOCHEM, V94, P1046, DOI 10.1002/jcb.20365; Hershko AY, 2001, GENES CELLS, V6, P967, DOI 10.1046/j.1365-2443.2001.00474.x; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; HORNSTRA IK, 1993, ANAL BIOCHEM, V213, P179, DOI 10.1006/abio.1993.1407; HORNSTRA IK, 1993, HUM MOL GENET, V2, P1659; HORNSTRA IK, 1992, MOL CELL BIOL, V12, P5345, DOI 10.1128/MCB.12.12.5345; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jong MTC, 1999, HUM MOL GENET, V8, P795, DOI 10.1093/hmg/8.5.795; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Kang SHL, 2003, MOL CELL BIOL, V23, P4150, DOI 10.1128/MCB.23.12.4150-4161.2003; Kantor B, 2004, HUM MOL GENET, V13, P751, DOI 10.1093/hmg/ddh085; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; LAMARCO KL, 1989, GENE DEV, V3, P1372, DOI 10.1101/gad.3.9.1372; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lee S, 2003, GENE EXPR PATTERNS, V3, P599, DOI 10.1016/S1567-133X(03)00113-3; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Murrell A, 2011, BIOCHEM CELL BIOL, V89, P469, DOI [10.1139/o11-043, 10.1139/O11-043]; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; O'Leary DA, 2007, MOL CELL BIOL, V27, P3470, DOI 10.1128/MCB.00659-06; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Perk J, 2002, EMBO J, V21, P5807, DOI 10.1093/emboj/cdf570; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rabinovitz S, 2012, P NATL ACAD SCI US; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Rodriguez-Jato S, 2005, NUCLEIC ACIDS RES, V33, P4740, DOI 10.1093/nar/gki786; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Saitoh S, 2000, AM J HUM GENET, V66, P1958, DOI 10.1086/302917; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schweizer J, 1999, HUM MOL GENET, V8, P555, DOI 10.1093/hmg/8.4.555; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Smith KT, 2006, NUCLEIC ACIDS RES, V34, P1205, DOI 10.1093/nar/gkj521; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stefan M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-157; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034348; Xin ZH, 2001, AM J HUM GENET, V69, P1389, DOI 10.1086/324469; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548	75	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e52390	10.1371/journal.pone.0052390	http://dx.doi.org/10.1371/journal.pone.0052390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390487	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100003
J	Ronholm, J; van Faassen, H; MacKenzie, R; Zhang, ZY; Cao, XD; Lin, M				Ronholm, Jennifer; van Faassen, Henk; MacKenzie, Roger; Zhang, Zhiyi; Cao, Xudong; Lin, Min			Monoclonal Antibodies Recognizing the Surface Autolysin IspC of Listeria monocytogenes Serotype 4b: Epitope Localization, Kinetic Characterization, and Cross-Reaction Studies	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; GRAM-POSITIVE BACTERIA; PEPTIDOGLYCAN HYDROLASE; ESCHERICHIA-COLI; PROTEINS; VIRULENCE; EXPRESSION; CHALLENGE; INFECTION; AFFINITY	Listeria monocytogenes serotype 4b is responsible for a high percentage of fatal cases of food-borne infection. In a previous study, we created 15 monoclonal antibodies (MAbs) against a similar to 77 kDa antigen that is associated with the cell surface of live L. monocytogenes serotype 4b cells. Here we report an extensive characterization of these MAbs to further their development as diagnostic reagents. The similar to 77 kDa target antigen was identified by mass spectrometry and N-terminal sequencing to be IspC, a novel surface associated autolysin. Epitope localization experiments revealed that each of the 15 MAbs recognized the C-terminal cell-wall binding domain of IspC. The presence of IspC was shown to be highly conserved within L. monocytogenes serotype 4b, as evidenced by a strong reaction between anti-IspC MAbs and all 4b isolates. To determine the range of cross-reactivity with other L. monocytogenes serotypes ELISA was used to test each MAb against multiple isolates from each of the L. monocytogenes serotypes. Of the 15 MAbs, five: M2774, M2775, M2780, M2790 and M2797, showed specificity for L. monocytogenes serotype 4b and only cross reacted with serotype 4ab isolates. The kinetics of the interaction between each of the MAbs and IspC was measured using surface plasmon resonance. The MAbs M2773, M2792, M2775, M2797 and M2781 each had very low dissociation constants (4.5 x 10(-9) to 1.2 x 10(-8) M). While several of these antibodies have properties which could be useful in diagnostic tests, the combined high fidelity and affinity of M2775 for the IspC protein and serotype 4b isolates, makes it a particularly promising candidate for use in the development of a specific L. monocytogenes serotype 4b diagnostic test.	[Ronholm, Jennifer; Lin, Min] Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Ottawa, ON, Canada; [Ronholm, Jennifer; Lin, Min] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [van Faassen, Henk; MacKenzie, Roger] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [MacKenzie, Roger] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Zhang, Zhiyi] Natl Res Council Canada, Inst Microstruct Sci, Ottawa, ON, Canada; [Cao, Xudong] Univ Ottawa, Dept Chem & Biol Engn, Ottawa, ON, Canada	Canadian Food Inspection Agency; University of Ottawa; National Research Council Canada; University of Guelph; National Research Council Canada; University of Ottawa	Lin, M (corresponding author), Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Ottawa, ON, Canada.	Min.Lin@inspection.gc.ca	Ronholm, Jennifer/ABD-6240-2020		Canadian Institutes of Health Research (CIHR) through a Banting and Best Doctoral Canadian Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR) through a Banting and Best Doctoral Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	JR is supported by the Canadian Institutes of Health Research (CIHR) through a Banting and Best Doctoral Canadian Graduate Scholarship (http://www.cihr-irsc.gc.ca/). This study is supported, in part, by a Strategic Grant from Natural Sciences and Engineering Research Council of Canada (NSERC) to XC and ML (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhunia AK, 1997, CRIT REV MICROBIOL, V23, P77, DOI 10.3109/10408419709115131; Donnelly CW, 2001, NUTR REV, V59, P183, DOI 10.1111/j.1753-4887.2001.tb07011.x; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Gerner-Smidt P, 2005, CLIN MICROBIOL INFEC, V11, P618, DOI 10.1111/j.1469-0691.2005.01171.x; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Jung YS, 2003, J FOOD PROTECT, V66, P1283, DOI 10.4315/0362-028X-66.7.1283; KATHARIOU S, 1994, APPL ENVIRON MICROB, V60, P3548, DOI 10.1128/AEM.60.10.3548-3552.1994; Kerdahi KF, 2000, J AOAC INT, V83, P86; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li GX, 2010, HYBRIDOMA, V29, P283, DOI 10.1089/hyb.2010.0021; Lin M, 2006, J MED MICROBIOL, V55, P291, DOI 10.1099/jmm.0.46305-0; Lin M, 2009, J APPL MICROBIOL, V106, P1705, DOI 10.1111/j.1365-2672.2008.04140.x; Makino S, 1998, MICROB PATHOGENESIS, V25, P101, DOI 10.1006/mpat.1998.0216; Milohanic E, 2004, INFECT IMMUN, V72, P4401, DOI 10.1128/IAI.72.8.4401-4409.2004; Monte LG, 2011, COMP IMMUNOL MICROB, V34, P441, DOI 10.1016/j.cimid.2011.08.003; NIMMO GR, 1984, J IMMUNOL METHODS, V72, P177, DOI 10.1016/0022-1759(84)90446-0; Norton DM, 2002, J AOAC INT, V85, P505; Nuttall SD, 2011, PROTEINS, V79, P1306, DOI 10.1002/prot.22971; Paton JC, 1998, TRENDS MICROBIOL, V6, P85, DOI 10.1016/S0966-842X(98)01220-7; Ralovich B., 1993, Acta Microbiologica Hungarica, V40, P3; Ronholm J, 2012, APPL ENVIRON MICROB, V78, P7833, DOI 10.1128/AEM.02065-12; Ronholm J, 2012, GLYCOBIOLOGY, V22, P1311, DOI 10.1093/glycob/cws100; Sambrook J. G., 2001, MOL CLONING LAB MANU; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Seeliger H.P.R., 1986, BERGEYS MANUAL SYSTE, P1235; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Van Blarcom TJ, 2010, GENE THER, V17, P913, DOI 10.1038/gt.2010.42; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wang LR, 2008, MICROBIOL-SGM, V154, P1900, DOI 10.1099/mic.0.2007/015172-0; Wang LR, 2007, J BACTERIOL, V189, P2046, DOI 10.1128/JB.01375-06; Wang L, 2007, BIOCHEM BIOPH RES CO, V354, P403, DOI 10.1016/j.bbrc.2006.12.218; Yu WL, 2007, J MED MICROBIOL, V56, P888, DOI 10.1099/jmm.0.46977-0	33	11	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55098	10.1371/journal.pone.0055098	http://dx.doi.org/10.1371/journal.pone.0055098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390515	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100031
J	Storm, P; Tibiletti, T; Hall, M; Funk, C				Storm, Patrik; Tibiletti, Tania; Hall, Michael; Funk, Christiane			Refolding and Enzyme Kinetic Studies on the Ferrochelatase of the Cyanobacterium Synechocystis sp. PCC 6803	PLOS ONE			English	Article							CAB-LIKE-PROTEINS; TETRAPYRROLE BIOSYNTHESIS; SUBCELLULAR-LOCALIZATION; CHLOROPHYLL SYNTHESIS; GENE-EXPRESSION; SP PCC-6803; METAL-ION; ARABIDOPSIS; HEME; PATHWAY	Heme is a cofactor for proteins participating in many important cellular processes, including respiration, oxygen metabolism and oxygen binding. The key enzyme in the heme biosynthesis pathway is ferrochelatase (protohaem ferrolyase, EC 4.99.1.1), which catalyzes the insertion of ferrous iron into protoporphyrin IX. In higher plants, the ferrochelatase enzyme is localized not only in mitochondria, but also in chloroplasts. The plastidic type II ferrochelatase contains a C-terminal chlorophyll a/b (CAB) motif, a conserved hydrophobic stretch homologous to the CAB domain of plant light harvesting proteins and light-harvesting like proteins. This type II ferrochelatase, found in all photosynthetic organisms, is presumed to have evolved from the cyanobacterial ferrochelatase. Here we describe a detailed enzymological study on recombinant, refolded and functionally active type II ferrochelatase (FeCh) from the cyanobacterium Synechocystis sp. PCC 6803. A protocol was developed for the functional refolding and purification of the recombinant enzyme from inclusion bodies, without truncation products or soluble aggregates. The refolded FeCh is active in its monomeric form, however, addition of an N-terminal His(6)-tag has significant effects on its enzyme kinetics. Strikingly, removal of the C-terminal CAB-domain led to a greatly increased turnover number, k(cat), compared to the full length protein. While pigments isolated from photosynthetic membranes decrease the activity of FeCh, direct pigment binding to the CAB domain of FeCh was not evident.	[Funk, Christiane] Umea Univ, Deptartment Chem, Umea, Sweden; Umea Univ, Umea Plant Sci Ctr, Umea, Sweden	Umea University; Umea University	Funk, C (corresponding author), Umea Univ, Deptartment Chem, Umea, Sweden.	Christiane.Funk@chem.umu.se	Funk, Christiane/AAO-6041-2021	Funk, Christiane/0000-0002-7897-4038; Tibiletti, Tania/0000-0002-1875-798X	Swedish Energy Agency; Umea University	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Umea University	The authors are thankful to the Royal Swedish Academy (to C.F.) and the Kempe foundation (to P.S.) for granting their positions. The work was supported by the Swedish Energy Agency and Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS A, 1993, J BIOL CHEM, V268, P8541; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; CAMADRO JM, 1988, J BIOL CHEM, V263, P11675; CASTELFRANCO PA, 1975, PLANT PHYSIOL, V55, P485, DOI 10.1104/pp.55.3.485; Chow KS, 1997, J BIOL CHEM, V272, P27565, DOI 10.1074/jbc.272.44.27565; Chow KS, 1998, PLANT J, V15, P531, DOI 10.1046/j.1365-313X.1998.00235.x; Cornah JE, 2002, BIOCHEM J, V362, P423, DOI 10.1042/0264-6021:3620423; Dailey HA, 2002, BIOCHEM SOC T, V30, P590, DOI 10.1042/bst0300590; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Dupuy C, 1997, LANGMUIR, V13, P3965, DOI 10.1021/la9604285; Evers TH, 2008, PROTEIN ENG DES SEL, V21, P529, DOI 10.1093/protein/gzn029; Falk JE, 1964, PORPHYRINS METALLOPO, P236; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Hansson MD, 2007, BIOCHEMISTRY-US, V46, P87, DOI 10.1021/bi061760a; Hansson MD, 2006, J BIOL INORG CHEM, V11, P325, DOI 10.1007/s00775-006-0080-2; Hernandez-Prieto MA, 2011, BBA-BIOENERGETICS, V1807, P1143, DOI 10.1016/j.bbabio.2011.05.002; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hunter GA, 2008, J BIOL CHEM, V283, P23685, DOI 10.1074/jbc.M803372200; Iyer JK, 2003, MOL MED, V9, P175, DOI 10.1007/BF03402182; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Lipfert J, 2007, J PHYS CHEM B, V111, P12427, DOI 10.1021/jp073016l; Lister R, 2001, FEBS LETT, V506, P291, DOI 10.1016/S0014-5793(01)02925-8; Masuda T, 2003, PLANTA, V217, P602, DOI 10.1007/s00425-003-1019-2; Matsumoto F, 2004, PLANT PHYSIOL, V135, P2379, DOI 10.1104/pp.104.042408; Moulin M, 2005, BIOCHEM SOC T, V33, P737, DOI 10.1042/BST0330737; Papenbrock J, 1999, PLANTA, V208, P264, DOI 10.1007/s004250050558; Shi Z, 2004, J BIOL CHEM, V279, P19977, DOI 10.1074/jbc.M313821200; Shi Z, 2003, ANAL BIOCHEM, V318, P18, DOI 10.1016/S0003-2697(03)00175-1; Singh DP, 2002, PLANT MOL BIOL, V50, P773, DOI 10.1023/A:1019959224271; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sobotka R, 2011, PLANT PHYSIOL, V155, P1735, DOI 10.1104/pp.110.167528; Stephenson PG, 2008, PHOTOCH PHOTOBIO SCI, V7, P1243, DOI 10.1039/b802596g; Storm P, 2008, PHOTOSYNTH RES, V98, P479, DOI 10.1007/s11120-008-9368-0; Suzuki T, 2002, J BIOL CHEM, V277, P4731, DOI 10.1074/jbc.M105613200; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; van Lis R, 2005, PLANT PHYSIOL, V139, P1946, DOI 10.1104/pp.105.069732; Vavilin DV, 2002, PHYSIOL PLANTARUM, V115, P9, DOI 10.1034/j.1399-3054.2002.1150102.x; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Yao DCI, 2012, J BIOL CHEM, V287, P682, DOI 10.1074/jbc.M111.320994	42	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55569	10.1371/journal.pone.0055569	http://dx.doi.org/10.1371/journal.pone.0055569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390541	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100057
J	Park, JW; Piknova, B; Huang, PL; Noguchi, CT; Schechter, AN				Park, Ji Won; Piknova, Barbora; Huang, Paul L.; Noguchi, Constance T.; Schechter, Alan N.			Effect of Blood Nitrite and Nitrate Levels on Murine Platelet Function	PLOS ONE			English	Article							OXIDE SYNTHASE; XANTHINE OXIDOREDUCTASE; DIETARY NITRATE; HYPOXIC CONDITIONS; RELAXING FACTOR; REDUCTION; ENDOTHELIUM; AGGREGATION; HUMANS; MICE	Nitric oxide (NO) appears to play an important role in the regulation of thrombosis and hemostasis by inhibiting platelet function. The discovery of NO generation by reduction of nitrite (NO2-) and nitrate (NO3-) in mammals has led to increased attention to these anions with respect to potential beneficial effects in cardiovascular diseases. We have previously shown that nitrite anions at 0.1 mu M inhibit aggregation and activation of human platelet preparations in vitro in the presence of red blood cells and this effect was enhanced by deoxygenation, an effect likely due to NO generation. In the present study, we hypothesized that nitrite and nitrate derived from the diet could also alter platelet function upon their conversion to NO in vivo. To manipulate the levels of nitrite and nitrate in mouse blood, we used antibiotics, NOS inhibitors, low nitrite/nitrate (NOx) diets, endothelial NOS knock-out mice and also supplementation with high levels of nitrite or nitrate in the drinking water. We found that all of these perturbations affected nitrite and nitrate levels but that the lowest whole blood values were obtained by dietary restriction. Platelet aggregation and ATP release were measured in whole blood and the results show an inverse correlation between nitrite/nitrate levels and platelet activity in aggregation and ATP release. Furthermore, we demonstrated that nitrite-supplemented group has a prolonged bleeding time compared with control or low NOx diet group. These results show that diet restriction contributes greatly to blood nitrite and nitrate levels and that platelet reactivity can be significantly affected by these manipulations. Our study suggests that endogenous levels of nitrite and nitrate may be used as a biomarker for predicting platelet function and that dietary manipulation may affect thrombotic processes.	[Park, Ji Won; Piknova, Barbora; Noguchi, Constance T.; Schechter, Alan N.] NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Huang, Paul L.] Massachusetts Gen Hosp, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Massachusetts General Hospital	Schechter, AN (corresponding author), NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	alans@intra.niddk.nih.gov		Schechter, Alan N/0000-0002-5235-9408; Huang, Paul/0000-0002-5436-8658	National Institue of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025093, ZIADK025104, ZIADK025061, ZIADK025021] Funding Source: NIH RePORTER	National Institue of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the intramural program of the National Institue of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID U, 1987, THROMB RES, V47, P561, DOI 10.1016/0049-3848(87)90361-6; AZUMA H, 1986, BRIT J PHARMACOL, V88, P411, DOI 10.1111/j.1476-5381.1986.tb10218.x; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Bryan NS, 2008, FREE RADICAL BIO MED, V45, P468, DOI 10.1016/j.freeradbiomed.2008.04.040; Bryan NS, 2007, P NATL ACAD SCI USA, V104, P19144, DOI 10.1073/pnas.0706579104; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; BULT H, 1988, BRIT J PHARMACOL, V95, P1308, DOI 10.1111/j.1476-5381.1988.tb11769.x; Carlsson S, 2001, NITRIC OXIDE-BIOL CH, V5, P580, DOI 10.1006/niox.2001.0371; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Freedman JE, 1999, CIRC RES, V84, P1416; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Govoni M, 2008, NITRIC OXIDE-BIOL CH, V19, P333, DOI 10.1016/j.niox.2008.08.003; Huang LY, 2010, NITRIC OXIDE-BIOL CH, V22, P191, DOI 10.1016/j.niox.2010.01.004; Jansson EA, 2008, NAT CHEM BIOL, V4, P411, DOI 10.1038/nchembio.92; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; LUNDBERG JON, 1994, GUT, V35, P1543, DOI 10.1136/gut.35.11.1543; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2010, BIOCHEM BIOPH RES CO, V396, P39, DOI 10.1016/j.bbrc.2010.02.136; Lundberg JO, 2010, NITRIC OXIDE-BIOL CH, V22, P61, DOI 10.1016/j.niox.2009.11.004; Machha A, 2011, EUR J NUTR, V50, P293, DOI 10.1007/s00394-011-0192-5; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Milsom AB, 2012, ANTIOXID REDOX SIGN, V17, P422, DOI 10.1089/ars.2011.4156; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Naseem KM, 2011, PLATELETS, V22, P148, DOI 10.3109/09537104.2010.522629; Raat NJH, 2009, FREE RADICAL BIO MED, V47, P510, DOI 10.1016/j.freeradbiomed.2009.05.015; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Richardson G, 2002, NITRIC OXIDE-BIOL CH, V7, P24, DOI 10.1016/S1089-8603(02)00010-1; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Tymvios C, 2009, BRIT J PHARMACOL, V158, P1735, DOI 10.1111/j.1476-5381.2009.00408.x; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Weitzberg E, 1998, NITRIC OXIDE-BIOL CH, V2, P1, DOI 10.1006/niox.1997.0162; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Zhang Zhi, 1997, Biochemical Society Transactions, V25, p524S; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3	42	52	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55699	10.1371/journal.pone.0055699	http://dx.doi.org/10.1371/journal.pone.0055699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383344	Green Submitted, gold, Green Published			2022-12-27	WOS:000314597900051
J	Varghese, B; Supply, P; Allix-Beguec, C; Shoukri, M; Al-Omari, R; Herbawi, M; Al-Hajoj, S				Varghese, Bright; Supply, Philip; Allix-Beguec, Caroline; Shoukri, Mohammed; Al-Omari, Ruba; Herbawi, Mais; Al-Hajoj, Sahal			Admixed Phylogenetic Distribution of Drug Resistant Mycobacterium tuberculosis in Saudi Arabia	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; BEIJING GENOTYPE; HAJJ PILGRIMAGE; MIRU-VNTRPLUS; STRAINS; INFECTION; PATTERNS; IDENTIFICATION; IMMIGRATION; DIVERSITY	Background: The phylogeographical structure of Mycobacterium tuberculosis is generally bimodal in low tuberculosis (TB) incidence countries, where genetic lineages of the isolates generally differ with little strain clustering between autochthonous and foreign-born TB patients. However, less is known on this structure in Saudi Arabia-the most important hub of human migration as it hosts a total population of expatriates and pilgrims from all over the world which is equal to that of its citizens. Methodology: We explored the mycobacterial phylogenetic structure and strain molecular clustering in Saudi Arabia by genotyping 322 drug-resistant clinical isolates collected over a 12-month period in a national drug surveillance survey, using 24 locus-based MIRU-VNTR typing and spoligotyping. Principal Findings: In contrast to the cosmopolitan population of the country, almost all the known phylogeographic lineages of M. tuberculosis complex (with noticeable exception of Mycobacterium africanum/West-African 1 and 2) were detected, with Delhi/CAS (21.1%), EAI (11.2%), Beijing (11.2%) and main branches of the Euro-American super-lineage such as Ghana (14.9%), Haarlem (10.6%) and Cameroon (7.8%) being represented. Statistically significant associations of strain lineages were observed with poly-drug resistance and multi drug resistance especially among previously treated cases (p value of < = 0.001 for both types of resistance), with relative over-representation of Beijing strains in the latter category. However, there was no significant difference among Saudi and non-Saudi TB patients regarding distribution of phylogenetic lineages (p = 0.311). Moreover, 59.5% (22/37) of the strain molecular clusters were shared between the Saudi born and immigrant TB patients. Conclusions: Specific distribution of M. tuberculosis phylogeographic lineages is not observed between the autochthonous and foreign-born populations. These observations might reflect both socially favored ongoing TB transmission between the two population groups, and historically deep-rooted, prolonged contacts and trade relations of the peninsula with other world regions. More vigorous surveillance and strict adherence to tuberculosis control policies are urgently needed in the country.	[Varghese, Bright; Al-Omari, Ruba; Herbawi, Mais; Al-Hajoj, Sahal] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Supply, Philip; Allix-Beguec, Caroline] Genoscreen, Lille, France; [Supply, Philip] INSERM, U1019, F-59045 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Supply, Philip] Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France; [Supply, Philip] Univ Lille Nord France, Lille, France; [Shoukri, Mohammed] King Faisal Specialist Hosp & Res Ctr, Natl Biotechnol Ctr, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; King Faisal Specialist Hospital & Research Center	Al-Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	hajoj@kfshrc.edu.sa	Allix-Béguec, Caroline/AAI-4645-2021; Supply, Philip/A-9580-2019	Allix-Béguec, Caroline/0000-0001-7642-4844; Supply, Philip/0000-0003-3690-3853	Institute (King Faisal Specialist Hospital and Research Center) [RAC 2030017]	Institute (King Faisal Specialist Hospital and Research Center)	The authors received no current external funding sources for this study. This study was supported by the authors' Institute (King Faisal Specialist Hospital and Research Center) under project: RAC #2030017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, as the authors received an institutional fund.	Abouzeid MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039478; Al-Hajoj SAM, 2007, J CLIN MICROBIOL, V45, P2467, DOI 10.1128/JCM.02293-06; Al-Jasser FS, 2012, SAUDI MED J, V33, P879; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Alothman AF, 2011, BMC P S6, V5, P252, DOI 10,1186/1753-6561-5-S6-P252; Alrabiaah AA, 2012, ANN SAUDI MED, V32, P4, DOI 10.5144/0256-4947.2012.4; Alzeer A, 1998, J INFECTION, V36, P303, DOI 10.1016/S0163-4453(98)94315-8; Alzeer AH, 2009, ANN THORAC MED, V4, P50, DOI 10.4103/1817-1737.49412; [Anonymous], 2009, GUID SURV DRUG RES T; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Arora J, 2009, INFECT GENET EVOL, V9, P832, DOI 10.1016/j.meegid.2009.05.008; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Curtin P., 1984, CROSS CULTURAL TRADE; Dale JW, 1999, J CLIN MICROBIOL, V37, P1265, DOI 10.1128/JCM.37.5.1265-1268.1999; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garzelli C, 2010, CLIN MICROBIOL INFEC, V16, P1691, DOI [10.1111/j.1469-0691.2009.03149.x, 10.1111/j.1469-0691.2010.03149.x]; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Mandourah Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-117; Omran A R, 1993, Popul Today, V21, P1; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Parwati I, 2010, J INFECT DIS, V201, P553, DOI 10.1086/650311; Rajapaksa US, 2008, T ROY SOC TROP MED H, V102, P997, DOI 10.1016/j.trstmh.2008.04.025; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Ritz N, 2009, ANTIMICROB AGENTS CH, V53, P316, DOI 10.1128/AAC.01302-08; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tanveer M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-171; Weniger T, 2012, INFECT GENET EVOL, V12, P748, DOI 10.1016/j.meegid.2012.01.021; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2011, WHO GLOBAL TUBERCULO; Wilder-Smith A, 2005, TROP MED INT HEALTH, V10, P336, DOI 10.1111/j.1365-3156.2005.01395.x	40	20	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55598	10.1371/journal.pone.0055598	http://dx.doi.org/10.1371/journal.pone.0055598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383340	Green Submitted, Green Published, gold			2022-12-27	WOS:000314597900047
J	Zhao, Y; Ling, F; Wang, HC; Sun, XH				Zhao, Ying; Ling, Flora; Wang, Hong-Cheng; Sun, Xiao-Hong			Chronic TLR Signaling Impairs the Long-Term Repopulating Potential of Hematopoietic Stem Cells of Wild Type but Not Id1 Deficient Mice	PLOS ONE			English	Article							PROGENITOR CELLS; SELF-RENEWAL; E2A PROTEINS; IN-VIVO; BONE-MARROW; DNA-BINDING; C-MYC; TRANSCRIPTION; EXPRESSION; PROMOTE	Hematopoietic stem cells (HSCs) maintain life-long blood supply but are inevitably exposed to various inflammatory stimuli, which have been shown to be harmful for HSC integrity but the mediators of the deleterious effects have not been fully identified. Here, we show that daily injection of mice with 1 mu g of LPS for 30 days triggers a storm of inflammatory cytokines. LPS injection also stimulated the transcription of the Id1 gene in HSCs in vivo but not in vitro, suggesting an indirect effect. To determine the effects of LPS treatment on HSC function and to evaluate the significance of Id1 expression, we assess the repopulating potential of wild type and Id1 deficient mice, which were subjected to a 30 day regimen of LPS treatment. We found that LPS caused dramatic reduction in the long-term but not short-term repopulating activity of wild type but not Id1 deficient HSC. This treatment also led to increases in HSC counts, decreases in BrdU-label retention and disturbance of quiescence detected by Ki67 staining in wild type but not Id1 deficient mice. Together, it appears that Id1, at least in part, plays a role in LPS-induced damage of HSC integrity.	[Zhao, Ying; Ling, Flora; Wang, Hong-Cheng; Sun, Xiao-Hong] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; [Ling, Flora; Sun, Xiao-Hong] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Sun, XH (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sunx@omrf.org			National Institute of Health [AI56129]; Oklahoma Center for Adult Stem Cell Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056129] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for Adult Stem Cell Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grants to XHS from the National Institute of Health (AI56129) and Oklahoma Center for Adult Stem Cell Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bryder D, 2001, J EXP MED, V194, P941, DOI 10.1084/jem.194.7.941; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Cochrane SW, 2009, BLOOD, V113, P1016, DOI 10.1182/blood-2008-06-164996; Curtis DJ, 2004, BLOOD, V103, P3342, DOI 10.1182/blood-2003-09-3202; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; ESSERS MAG, 2009, NATURE; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Jankovic V, 2007, P NATL ACAD SCI US; Kang YJ, 2007, STEM CELLS, V25, P1814, DOI 10.1634/stemcells.2007-0002; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maeda Y, 2004, J CELL BIOCHEM, V93, P337, DOI 10.1002/jcb.20154; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Megias J, 2012, STEM CELLS, V30, P1486, DOI 10.1002/stem.1110; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Park ST, 1998, J BIOL CHEM, V273, P7030, DOI 10.1074/jbc.273.12.7030; PATCHEN ML, 1991, BLOOD, V77, P472; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Suh HC, 2009, BLOOD, V114, P1186, DOI 10.1182/blood-2008-09-179788; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885; Yang Q, 2011, BLOOD, V117, P3529, DOI 10.1182/blood-2010-07-297689; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	50	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55552	10.1371/journal.pone.0055552	http://dx.doi.org/10.1371/journal.pone.0055552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383338	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900045
J	Johnson, LE; Larsen, M; Perez, MT				Johnson, Leif E.; Larsen, Michael; Perez, Maria-Thereza			Retinal Adaptation to Changing Glycemic Levels in a Rat Model of Type 2 Diabetes	PLOS ONE			English	Article							SCOTOPIC ELECTRORETINOGRAM; PHOTORECEPTOR SENSITIVITY; TRANSIENT HYPERGLYCEMIA; ALTERED EXPRESSION; A-WAVE; RETINOPATHY; INSULIN; ERG; GLUCOSE; ELECTROPHYSIOLOGY	Purpose: Glucose concentrations are elevated in retinal cells in undiagnosed and in undertreated diabetes. Studies of diabetic patients suggest that retinal function adapts, to some extent, to this increased supply of glucose. The aim of the present study was to examine such adaptation in a model of type 2 diabetes and assess how the retina responds to the subsequent institution of glycemic control. Methods: Electroretinography (ERG) was conducted on untreated Zucker diabetic fatty (ZDF) rats and congenic controls from 8-22 weeks of age and on ZDFs treated with daily insulin from 16-22 weeks of age. Retinal sections from various ages were prepared and compared histologically and by immunocytochemistry. Principal Findings/Conclusions: Acute hyperglycemia did not have an effect on control rats while chronic hyperglycemia in the ZDF was associated with scotopic ERG amplitudes which were up to 20% higher than those of age-matched controls. This change followed the onset of hyperglycemia with a delay of over one month, supporting that habituation to hyperglycemia is a slow process. When glycemia was lowered, an immediate decrease in ZDF photoreceptoral activity was induced as seen by a reduction in a-wave amplitudes and maximum slopes of about 30%. A direct effect of insulin on the ERG was unlikely since the expression of phosphorylated Akt kinase was not affected by treatment. The electrophysiological differences between untreated ZDFs and controls preceded an activation of Muller cells in the ZDFs (up-regulation of glial fibrillary acidic protein), which was attenuated by insulin treatment. There were otherwise no signs of cell death or morphological alterations in any of the experimental groups. These data show that under chronic hyperglycemia, the ZDF retina became abnormally sensitive to variations in substrate supply. In diabetes, a similar inability to cope with intensive glucose lowering could render the retina susceptible to damage.	[Johnson, Leif E.; Larsen, Michael; Perez, Maria-Thereza] Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark; [Larsen, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Perez, Maria-Thereza] Lund Univ, Div Ophthalmol, Dept Clin Sci, Lund, Sweden	University of Copenhagen; University of Copenhagen; Lund University	Johnson, LE (corresponding author), Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark.	leif.johnson@regionh.dk	Larsen, Michael/E-9620-2010	Larsen, Michael/0000-0002-5172-5891	Novo Nordisk Foundation; Danish Council for Independent Research, Medical Sciences [09-071219]; Stiftelsen for synskadade i fd malmohus lan; Kronprisessan Margarettas Arbetsnamnd for synskadade Stiftelser; Ogonfonden Stiftelser; Gun och Bertil Stohnes Stiftelser; Greta och Johan Kocks Stiftelser; Magnus Bergvalls Stiftelser	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Stiftelsen for synskadade i fd malmohus lan; Kronprisessan Margarettas Arbetsnamnd for synskadade Stiftelser; Ogonfonden Stiftelser; Gun och Bertil Stohnes Stiftelser; Greta och Johan Kocks Stiftelser; Magnus Bergvalls Stiftelser	The study was supported by the Novo Nordisk Foundation (www.novonordiskfonden.dk/en/index.asp), the Danish Council for Independent Research, Medical Sciences (09-071219; en.fi.dk/councils-commissions/the-danish-council-forindependent-research/scientific-research-councils/medical-sciences), Stiftelsen for synskadade i fd malmohus lan (www.stiftelsenkma.com/), the Kronprisessan Margarettas Arbetsnamnd for synskadade (www.stiftelsenkma.com/), Ogonfonden (www.ogonfonden.se), and the Gun och Bertil Stohnes (web.comhem.se/stohnes-stiftelse), Greta och Johan Kocks (www.kockskastiftelsen.se/) and Magnus Bergvalls (www.magnbergvallsstiftelse.nu/) Stiftelser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko T, 2003, DIABETES, V52, P829, DOI 10.2337/diabetes.52.3.829; AMOUZADEH HR, 1990, VET HUM TOXICOL, V32, P19; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Behl Y, 2008, AM J PATHOL, V172, P1411, DOI 10.2353/ajpath.2008.071070; Bui BV, 2003, DIABETOLOGIA, V46, P401, DOI 10.1007/s00125-003-1042-7; Charng J, 2011, INVEST OPHTH VIS SCI, V52, P8891, DOI 10.1167/iovs.11-7602; Chung N H, 1993, Korean J Ophthalmol, V7, P43; Dang TM, 2011, DOC OPHTHALMOL, V122, P149, DOI 10.1007/s10633-011-9269-y; DANIS RP, 1993, INVEST OPHTH VIS SCI, V34, P2367; Dawson William W., 2000, Documenta Ophthalmologica, V101, P155, DOI 10.1023/A:1026569701949; Derwent JJK, 2001, VISUAL NEUROSCI, V18, P983, DOI 10.1017/S0952523801186153; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Fox DA, 2011, TOXICOL APPL PHARM, V256, P258, DOI 10.1016/j.taap.2011.05.021; GJOTTERBERG M, 1974, ACTA OPHTHALMOL, V52, P521; Goncalves A, 2012, DIABETES OBES METAB, V14, P454, DOI 10.1111/j.1463-1326.2011.01548.x; Gosbell A, 1996, CURR EYE RES, V15, P1132, DOI 10.3109/02713689608995145; HAHN I, 1989, ACTA OPHTHALMOL, V67, P131; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; HARDY KJ, 1995, BRIT J OPHTHALMOL, V79, P35, DOI 10.1136/bjo.79.1.35; HIRSCHHOFFMANN C, 1993, CLIN VISION SCI, V8, P489; Holfort SK, 2011, DIABETOLOGIA, V54, P1853, DOI 10.1007/s00125-011-2149-x; Holfort SK, 2010, EXP EYE RES, V91, P710, DOI 10.1016/j.exer.2010.08.017; Holfort SK, 2010, INVEST OPHTH VIS SCI, V51, P2790, DOI 10.1167/iovs.09-4891; HORSBURGH GM, 1987, J COMP NEUROL, V263, P553, DOI 10.1002/cne.902630407; Huber M, 2011, HYPERTENS RES, V34, P103, DOI 10.1038/hr.2010.168; HUSSAIN AA, 1992, VISION RES, V32, P29, DOI 10.1016/0042-6989(92)90109-V; Iandiev I, 2007, NEUROSCI LETT, V421, P132, DOI 10.1016/j.neulet.2007.04.076; Jamison JA, 2001, VISUAL NEUROSCI, V18, P445, DOI 10.1017/S0952523801183112; JENKINS TCA, 1990, BRIT J OPHTHALMOL, V74, P681, DOI 10.1136/bjo.74.11.681; Kappelgaard P, 2012, DOC OPHTHALMOL, V124, P49, DOI 10.1007/s10633-011-9303-0; Kern TS, 2010, MOL VIS, V16, P1629; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Klemp K, 2005, INVEST OPHTH VIS SCI, V46, P2620, DOI 10.1167/iovs.04-1254; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818; Kurtenbach A, 2006, VISUAL NEUROSCI, V23, P651, DOI 10.1017/S095252380623339X; Lansel N, 1997, INVEST OPHTH VIS SCI, V38, P792; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; Matsubara H, 2006, JPN J OPHTHALMOL, V50, P211, DOI 10.1007/s10384-005-0315-8; Misra GP, 2009, BIOMATERIALS, V30, P6541, DOI 10.1016/j.biomaterials.2009.08.025; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Ola MS, 2006, AM J PHYSIOL-ENDOC M, V290, pE1057, DOI 10.1152/ajpendo.00323.2005; Papakostopoulos D, 1996, INT J PSYCHOPHYSIOL, V21, P33, DOI 10.1016/0167-8760(95)00040-2; PARMER R, 1982, COMP BIOCHEM PHYS C, V72, P109, DOI 10.1016/0306-4492(82)90213-1; Paulsen SJ, 2010, J ANAT, V217, P624, DOI 10.1111/j.1469-7580.2010.01285.x; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Puchowicz MA, 2004, J CEREBR BLOOD F MET, V24, P449, DOI 10.1097/00004647-200404000-00010; Reiter CEN, 2003, AM J PHYSIOL-ENDOC M, V285, pE763, DOI 10.1152/ajpendo.00507.2002; RIMMER T, 1993, INVEST OPHTH VIS SCI, V34, P3246; Rothenberg SJ, 2002, INVEST OPHTH VIS SCI, V43, P2036; SAKAI H, 1995, OPHTHALMIC RES, V27, P57, DOI 10.1159/000267571; SANDBERG MA, 1991, INVEST OPHTH VIS SCI, V32, P1508; Santos JM, 2011, FREE RADICAL BIO MED, V51, P1849, DOI 10.1016/j.freeradbiomed.2011.08.017; SCHNEIDER T, 1986, INVEST OPHTH VIS SCI, V27, P1395; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tyrberg M, 2011, DOC OPHTHALMOL, V123, P193, DOI 10.1007/s10633-011-9298-6; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Wright WS, 2010, EXP EYE RES, V90, P405, DOI 10.1016/j.exer.2009.12.002; Wunderlich KA, 2010, INVEST OPHTH VIS SCI, V51, P4809, DOI 10.1167/iovs.09-5073; Yoshida Y, 2009, DIABETES-METAB RES, V25, P678, DOI 10.1002/dmrr.1007; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9	65	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55456	10.1371/journal.pone.0055456	http://dx.doi.org/10.1371/journal.pone.0055456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408985	gold, Green Published, Green Submitted			2022-12-27	WOS:000314660300016
J	Tamborero, D; Lopez-Bigas, N; Gonzalez-Perez, A				Tamborero, David; Lopez-Bigas, Nuria; Gonzalez-Perez, Abel			Oncodrive-CIS: A Method to Reveal Likely Driver Genes Based on the Impact of Their Copy Number Changes on Expression	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER; ALGORITHMS; PATHWAYS; GROWTH; STAGE	A well-established approach for detecting genes involved in tumorigenesis due to copy number alterations (CNAs) is to assess the recurrence of the alteration across multiple samples. Expression data can be used to filter this list of candidates by assessing whether the gene expression significantly differs between tumors depending on the copy number status. A drawback of this approach is that it may fail to detect low-recurrent drivers. Furthermore, this analysis does not provide information about expression changes for each gene as compared to the whole data set and does not take into consideration the expression of normal samples. Here we describe a novel method (Oncodrive-CIS) aimed at ranking genes according to the expression impact caused by the CNAs. The rationale of Oncodrive-CIS is based on the hypothesis that genes involved in cancer due to copy number changes are more biased towards misregulation than are bystanders. Moreover, to gain insight into the expression changes caused by gene dosage, the expression of samples with CNAs is compared to that of tumor samples with diploid genotype and also to that of normal samples. Oncodrive-CIS demonstrated better performance in detecting putative associations between copy-number and expression in simulated data sets as compared to other methods aimed to this purpose, and picked up genes likely to be related with tumorigenesis when applied to real cancer samples. In summary, Oncodrive-CIS provides a statistical framework to evaluate the in cis effect of CNAs that may be useful to elucidate the role of these aberrations in driving oncogenesis. An implementation of this method and the corresponding user guide are freely available at http://bg.upf.edu/oncodrivecis.	[Tamborero, David; Lopez-Bigas, Nuria; Gonzalez-Perez, Abel] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain; [Lopez-Bigas, Nuria] ICREA, Barcelona, Spain	Pompeu Fabra University; ICREA	Lopez-Bigas, N (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain.	nuria.lopez@upf.edu; abel.gonzalez@upf.edu	tamborero, david/M-5283-2015; Gasull, Martina/J-4076-2019; Lopez-Bigas, Nuria/F-6193-2011	tamborero, david/0000-0002-7218-2806; Lopez-Bigas, Nuria/0000-0003-4925-8988; Gonzalez-Perez, Abel/0000-0002-8582-4660	Spanish Ministry of Science and Technology [SAF2009-06954]; Spanish National Institute of Bioinformatics (INB); ICREA Funding Source: Custom	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute of Bioinformatics (INB); ICREA(ICREA)	The authors acknowledge funding from the Spanish Ministry of Science and Technology (grant number SAF2009-06954) and the Spanish National Institute of Bioinformatics (INB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NATURE, V474, P609; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cowin PA, 2010, ANNU REV GENOM HUM G, V11, P133, DOI 10.1146/annurev-genom-082509-141536; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Ghosh AK, 1999, MOL CELL BIOL, V19, P2880; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Louhimo R, 2012, NAT METHODS, V9, P351, DOI [10.1038/NMETH.1893, 10.1038/nmeth.1893]; Louhimo R, 2011, BIOINFORMATICS, V27, P887, DOI 10.1093/bioinformatics/btr019; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Taunk NK, 2012, CANCER-AM CANCER SOC, V118, P888, DOI 10.1002/cncr.26352; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Wang Y, 2000, GENE DEV, V14, P927; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Zou JX, 2007, P NATL ACAD SCI USA, V104, P18067, DOI 10.1073/pnas.0705814104	24	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55489	10.1371/journal.pone.0055489	http://dx.doi.org/10.1371/journal.pone.0055489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408991	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300019
J	Romano, M; Osborne, LA; Truzoli, R; Reed, P				Romano, Michela; Osborne, Lisa A.; Truzoli, Roberto; Reed, Phil			Differential Psychological Impact of Internet Exposure on Internet Addicts	PLOS ONE			English	Article							SYMPTOMS	The study explored the immediate impact of internet exposure on the mood and psychological states of internet addicts and low internet-users. Participants were given a battery of psychological tests to explore levels of internet addiction, mood, anxiety, depression, schizotypy, and autism traits. They were then given exposure to the internet for 15 min, and re-tested for mood and current anxiety. Internet addiction was associated with long-standing depression, impulsive nonconformity, and autism traits. High internet-users also showed a pronounced decrease in mood following internet use compared to the low internet-users. The immediate negative impact of exposure to the internet on the mood of internet addicts may contribute to increased usage by those individuals attempting to reduce their low mood by re-engaging rapidly in internet use.	[Romano, Michela; Truzoli, Roberto] Univ Milan, Milan, Italy; [Osborne, Lisa A.; Reed, Phil] Swansea Univ, Swansea, W Glam, Wales	University of Milan; Swansea University	Reed, P (corresponding author), Swansea Univ, Swansea, W Glam, Wales.	p.reed@swansea.ac.uk	Reed, Phil/H-7999-2019; truzoli, roberto/K-8735-2015; TRUZOLI, ROBERTO/Q-1928-2019	Reed, Phil/0000-0002-8157-0747; truzoli, roberto/0000-0001-7420-7053; TRUZOLI, ROBERTO/0000-0001-7420-7053				Aboujaoude E, 2006, CNS SPECTRUMS, V11, P750, DOI 10.1017/S1092852900014875; Alizadeh Sahraee O, 2011, EUROPEAN PSYCHIAT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; Greenfield DN, 2012, VIRTUAL ADDICTION; Griffiths MD, 2012, ADDICT RES THEORY, V20, P111, DOI 10.3109/16066359.2011.588351; Gundogar A., 2012, EUROPEAN PSYCHIAT, V2, P271, DOI [10.1089/cyber.2014.0568, DOI 10.1089/CYBER.2014.0568]; Hardie E, 2007, AUST J EMERG TECH SO, V5, P34, DOI DOI 10.1016/S0092-6566(03)00046-1; Israelashvili M, 2012, J ADOLESCENCE, V35, P417, DOI 10.1016/j.adolescence.2011.07.015; Jiang QL, 2012, SOC SCI COMPUT REV, V30, P170, DOI 10.1177/0894439311398440; Kim J, 2009, J COMPUT-MEDIAT COMM, V14, P988, DOI 10.1111/j.1083-6101.2009.01478.x; King DL, 2011, CLIN PSYCHOL REV, V31, P1110, DOI 10.1016/j.cpr.2011.06.009; Ko CH, 2010, PSYCHIAT RES, V175, P121, DOI 10.1016/j.psychres.2008.10.004; Ko CH, 2009, J ADOLESCENT HEALTH, V44, P598, DOI 10.1016/j.jadohealth.2008.11.011; Kugler T, 2012, J BEHAV DECIS MAKING, V25, P123, DOI 10.1002/bdm.724; Kuss DJ, 2012, INT J MENT HEALTH AD, V10, P278, DOI 10.1007/s11469-011-9318-5; Lee HW, 2012, CYBERPSYCH BEH SOC N, V15, P373, DOI 10.1089/cyber.2012.0063; Leung L, 2012, SOC SCI COMPUT REV, V30, P403, DOI 10.1177/0894439311435217; Ma H, 2012, INT J CHILD HLTH HUM, V5, P123; Mason O, 2005, SCHIZOPHR RES, V78, P293, DOI 10.1016/j.schres.2005.06.020; Mitchell P, 2000, LANCET, V355, P632, DOI 10.1016/S0140-6736(05)72500-9; Park S, 2012, PERSONALITY INDIVIDU; Spielberger C. D., 1983, MIND GARDEN; Tonioni F, 2012, GEN HOSP PSYCHIAT, V34, P80, DOI 10.1016/j.genhosppsych.2011.09.013; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wolfling KJ, 2012, EUR PSYCHIAT, V27; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Yen JY, 2007, J ADOLESCENT HEALTH, V41, P93, DOI 10.1016/j.jadohealth.2007.02.002; Young K.S., 1998, CAUGHT NET; Young KS., 1998, CYBERPSYCHOL BEHAV, V1, P25, DOI [10.1089/cpb.1998.1.25, DOI 10.1089/CPB.1998.1.25]	34	56	56	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55162	10.1371/journal.pone.0055162	http://dx.doi.org/10.1371/journal.pone.0055162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23408958	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200018
J	Audet, GN; Fulks, D; Stricker, JC; Olfert, IM				Audet, Gerald N.; Fulks, Daniel; Stricker, Janelle C.; Olfert, I. Mark			Chronic Delivery of a Thrombospondin-1 Mimetic Decreases Skeletal Muscle Capillarity in Mice	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; LOW-DENSITY-LIPOPROTEIN; NITRIC-OXIDE; TUMOR-GROWTH; ANGIOGENESIS; ABT-510; PEPTIDE; CD36; INFLAMMATION; ACTIVATION	Angiogenesis is an essential process for normal skeletal muscle function. There is a growing body of evidence suggesting that thrombospondin-1 (TSP-1), a potent antiangiogenic protein in tumorigenesis, is an important regulator of both physiological and pathological skeletal muscle angiogenesis. We tested the hypothesis that chronic exposure to a TSP-1 mimetic (ABT-510), which targets the CD36 TSP-1 receptor, would decrease skeletal muscle capillarity as well as alter the balance between positive and negative angiogenic proteins under basal conditions. Osmotic minipumps with either ABT-510 or vehicle (5% dextrose) were implanted subcutaneously in the subscapular region of C57/BL6 mice for 14 days. When compared to the vehicle treated mice, the ABT-510 group had a 20% decrease in capillarity in the superficial region of the gastrocnemius (GA), 11% decrease in the plantaris (PLT), and a 35% decrease in the soleus (SOL). ABT-510 also decreased muscle protein expression of vascular endothelial growth factor (VEGF) in both the GA (-140%) and SOL (-62%); however there was no change in VEGF in the PLT. Serum VEGF was not altered in ABT-510 treated animals. Endogenous TSP-1 protein expression in all muscles remained unaltered. Tunnel staining revealed no difference in muscle apoptosis between ABT-510 and vehicle treated groups. These data provide evidence that the anti-angiogenic effects of TSP-1 are mediated, at least in part, via the CD36 receptor. It also suggests that under physiologic conditions the TSP-1/CD36 axis plays a role in regulating basal skeletal muscle microvessel density.	[Audet, Gerald N.; Fulks, Daniel; Stricker, Janelle C.; Olfert, I. Mark] W Virginia Univ, Sch Med, Ctr Cardiovasc & Resp Sci, Div Exercise Physiol, Morgantown, WV 26506 USA	West Virginia University	Olfert, IM (corresponding author), W Virginia Univ, Sch Med, Ctr Cardiovasc & Resp Sci, Div Exercise Physiol, Morgantown, WV 26506 USA.	molfert@hsc.wvu.edu			National Institutes of Health T32 student training grant [NIH5T32HL090610]; American Heart Association [AHA10BGIA3630002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL090610] Funding Source: NIH RePORTER	National Institutes of Health T32 student training grant; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by funding from the National Institutes of Health T32 student training grant NIH5T32HL090610 (GNA) and by the American Heart Association AHA10BGIA3630002 (IMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; Anderson JC, 2007, CANCER BIOL THER, V6, P454, DOI 10.4161/cbt.6.3.3630; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Breen EC, 1996, J APPL PHYSIOL, V81, P355, DOI 10.1152/jappl.1996.81.1.355; Campbell NE, THROMBOSPONDIN 1 MIM; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Dalla Libera L, 1999, AM J PHYSIOL-CELL PH, V277, pC982, DOI 10.1152/ajpcell.1999.277.5.C982; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Degens H, 2006, INT J SPORTS MED, V27, P94, DOI 10.1055/s-2005-837571; Dimmeler S, 2000, CIRC RES, V87, P434; Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003; Duscha BD, 1999, J AM COLL CARDIOL, V33, P1956, DOI 10.1016/S0735-1097(99)00101-1; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Frazier EP, 2011, MATRIX BIOL; Friedl P, 2002, CELL MOL LIFE SCI, V59, P1347, DOI 10.1007/s00018-002-8512-9; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Greenaway J, 2009, MOL CANCER THER, V8, P64, DOI 10.1158/1535-7163.MCT-08-0864; Guo NH, 1997, CANCER RES, V57, P1735; Gupta K, 1999, Angiogenesis, V3, P147, DOI 10.1023/A:1009018702832; Hasina R, 2009, CANCER PREV RES, V2, P385, DOI 10.1158/1940-6207.CAPR-08-0211; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; Hoekstra R, 2005, J CLIN ONCOL, V23, P5188, DOI 10.1200/JCO.2005.05.013; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Isenberg JS, 2008, BIOCHEM PHARMACOL, V75, P875, DOI 10.1016/j.bcp.2007.10.025; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Joyce D, 2006, J CLIN ONCOL S, V24, P13545; Kaur S, 2010, J BIOL CHEM, V285, P38923, DOI 10.1074/jbc.M110.172304; Kivela R, 2006, FASEB J, V20, P1570, DOI 10.1096/fj.05-4780fje; Kivela R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-13; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Lange-Asschenfeldt B, 2002, BLOOD, V99, P538, DOI 10.1182/blood.V99.2.538; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; LOJDA Z, 1979, HISTOCHEMISTRY, V59, P153, DOI 10.1007/BF00495663; Malek MH, 2009, EXP PHYSIOL, V94, P749, DOI 10.1113/expphysiol.2008.045989; Meeson A, 1996, DEVELOPMENT, V122, P3929; Meeson AP, 1999, DEVELOPMENT, V126, P1407; Miao WM, 2001, CANCER RES, V61, P7830; MRAZKOVA O, 1986, AM J ANAT, V177, P141, DOI 10.1002/aja.1001770203; Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733; Olfert IM, 2006, GROWTH FACTORS, V24, P253, DOI 10.1080/08977190601000111; Olfert IM, 2011, MICROCIRCULATION, V18, P316, DOI 10.1111/j.1549-8719.2011.00092.x; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Olfert IM, 2012, UNPUB; Primo L, 2005, FASEB J, V19, P1713, DOI 10.1096/fj.05-3697fje; Reiher FK, 2002, INT J CANCER, V98, P682, DOI 10.1002/ijc.10247; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Roudier E, 2010, J PHYSIOL-LONDON, V588, P4579, DOI 10.1113/jphysiol.2010.193243; Rusk A, 2006, CLIN CANCER RES, V12, P7444, DOI 10.1158/1078-0432.CCR-06-0109; Simons M, 2012, PHYSIOLOGY, V27, P213, DOI 10.1152/physiol.00016.2012; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004; Sun JF, 2009, AM J PHYSIOL-HEART C, V296, pH1344, DOI 10.1152/ajpheart.01246.2008; Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Wintergerst ES, 2000, EUR J BIOCHEM, V267, P6050, DOI 10.1046/j.1432-1327.2000.01682.x; Yap R, 2005, CLIN CANCER RES, V11, P6678, DOI 10.1158/1078-0432.CCR-05-0621; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649	63	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55953	10.1371/journal.pone.0055953	http://dx.doi.org/10.1371/journal.pone.0055953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405239	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400184
J	O'Halloran, LR; Borer, ET; Seabloom, EW; MacDougall, AS; Cleland, EE; McCulley, RL; Hobbie, S; Harpole, WS; DeCrappeo, NM; Chu, CJ; Bakker, JD; Davies, KF; Du, GZ; Firn, J; Hagenah, N; Hofmockel, KS; Knops, JMH; Li, W; Melbourne, BA; Morgan, JW; Orrock, JL; Prober, SM; Stevens, CJ				O'Halloran, Lydia R.; Borer, Elizabeth T.; Seabloom, Eric W.; MacDougall, Andrew S.; Cleland, Elsa E.; McCulley, Rebecca L.; Hobbie, Sarah; Harpole, W. Stan; DeCrappeo, Nicole M.; Chu, Chengjin; Bakker, Jonathan D.; Davies, Kendi F.; Du, Guozhen; Firn, Jennifer; Hagenah, Nicole; Hofmockel, Kirsten S.; Knops, Johannes M. H.; Li, Wei; Melbourne, Brett A.; Morgan, John W.; Orrock, John L.; Prober, Suzanne M.; Stevens, Carly J.			Regional Contingencies in the Relationship between Aboveground Biomass and Litter in the World's Grasslands	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; NET PRIMARY PRODUCTIVITY; DECOMPOSITION RATES; TERRESTRIAL ECOSYSTEMS; LEAF-LITTER; CARBON SEQUESTRATION; ROOT DECOMPOSITION; NITROGEN RELEASE; GLOBAL PATTERNS; GREAT-PLAINS	Based on regional-scale studies, aboveground production and litter decomposition are thought to positively covary, because they are driven by shared biotic and climatic factors. Until now we have been unable to test whether production and decomposition are generally coupled across climatically dissimilar regions, because we lacked replicated data collected within a single vegetation type across multiple regions, obfuscating the drivers and generality of the association between production and decomposition. Furthermore, our understanding of the relationships between production and decomposition rests heavily on separate meta-analyses of each response, because no studies have simultaneously measured production and the accumulation or decomposition of litter using consistent methods at globally relevant scales. Here, we use a multi-country grassland dataset collected using a standardized protocol to show that live plant biomass (an estimate of aboveground net primary production) and litter disappearance (represented by mass loss of aboveground litter) do not strongly covary. Live biomass and litter disappearance varied at different spatial scales. There was substantial variation in live biomass among continents, sites and plots whereas among continent differences accounted for most of the variation in litter disappearance rates. Although there were strong associations among aboveground biomass, litter disappearance and climatic factors in some regions (e. g. U. S. Great Plains), these relationships were inconsistent within and among the regions represented by this study. These results highlight the importance of replication among regions and continents when characterizing the correlations between ecosystem processes and interpreting their global-scale implications for carbon flux. We must exercise caution in parameterizing litter decomposition and aboveground production in future regional and global carbon models as their relationship is complex.	[O'Halloran, Lydia R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Borer, Elizabeth T.; Seabloom, Eric W.; Hobbie, Sarah] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [MacDougall, Andrew S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Cleland, Elsa E.] Univ Calif San Diego, Ecol Behav & Evolut Sect, La Jolla, CA 92093 USA; [McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Harpole, W. Stan; Hofmockel, Kirsten S.; Li, Wei] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [DeCrappeo, Nicole M.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Chu, Chengjin; Du, Guozhen] Lanzhou Univ, Sch Life Sci, MOE Key Lab Arid & Grassland Ecol, Lanzhou 730000, Peoples R China; [Bakker, Jonathan D.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Davies, Kendi F.; Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Firn, Jennifer] Queensland Univ Technol, Fac Sci & Engn, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Hagenah, Nicole] Univ KwaZulu Natal, Sch Life Sci, Scottsville, South Africa; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Morgan, John W.] La Trobe Univ, Dept Bot, Bundoora, Vic 3083, Australia; [Orrock, John L.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Prober, Suzanne M.] CSIRO Ecosyst Sci, Wembley, WA, Australia; [Stevens, Carly J.] Open Univ, Dept Environm Earth & Ecosyst, Milton Keynes MK7 6AA, Bucks, England; [Hagenah, Nicole] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Stevens, Carly J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Oregon State University; University of Minnesota System; University of Minnesota Twin Cities; University of Guelph; University of California System; University of California San Diego; University of Kentucky; Iowa State University; United States Department of the Interior; United States Geological Survey; Lanzhou University; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; Queensland University of Technology (QUT); University of Kwazulu Natal; University of Nebraska System; University of Nebraska Lincoln; La Trobe University; University of Wisconsin System; University of Wisconsin Madison; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Open University - UK; Yale University; Lancaster University	O'Halloran, LR (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	riesl@science.oregonstate.edu	Chu, Chu/T-6038-2019; Bakker, Jonathan/I-6960-2013; MacDougall, Andrew S/F-2037-2011; Harpole, William S/C-2814-2013; Knops, Johannes/AAA-8546-2020; Prober, Suzanne/G-6465-2010	Bakker, Jonathan/0000-0002-8973-2771; Harpole, William S/0000-0002-3404-9174; Prober, Suzanne/0000-0002-6518-239X; MELBOURNE, BRETT/0000-0002-8843-4131; Firn, Jennifer/0000-0001-6026-8912; Chu, Chengjin/0000-0002-0606-449X; Hofmockel, Kirsten/0000-0003-1586-2167; Stevens, Carly/0000-0002-2390-1763; Borer, Elizabeth/0000-0003-2259-5853; Hobbie, Sarah/0000-0001-5159-031X; Seabloom, Eric/0000-0001-6780-9259	National Science Foundation (NSF) [NSF-DEB-1042132]; Division Of Environmental Biology [1042132, 0823380, 1234162] Funding Source: National Science Foundation; Natural Environment Research Council [ceh010010] Funding Source: researchfish	National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was generated using data from the Nutrient Network collaborative experiment, funded at the site-scale by individual researchers and coordinated through Research Coordination Network funding from National Science Foundation (NSF) to ETB and EWS (NSF-DEB-1042132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2008, GLOBAL CHANGE BIOL, V14, P2636, DOI 10.1111/j.1365-2486.2008.01674.x; Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, AR4 CLIM CHANG 2007; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Bagchi S, 2010, OECOLOGIA, V164, P1075, DOI 10.1007/s00442-010-1690-5; Burke IC, 1997, SOIL ORGANIC MATTER, P85; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen H, 2001, CAN J FOREST RES, V31, P246, DOI 10.1139/cjfr-31-2-246; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Crawley M.J., 2007, R BOOK; Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1; Derner JD, 2007, J SOIL WATER CONSERV, V62, P77; Dormaar J.E, 1992, ECOSYSTEMS WORLD, V8, P121; Epstein HE, 2002, ECOLOGY, V83, P320, DOI 10.1890/0012-9658(2002)083[0320:RPODAP]2.0.CO;2; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Frank DA, 2002, ECOLOGY, V83, P602, DOI 10.1890/0012-9658(2002)083[0602:CCOGPP]2.0.CO;2; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Holdsworth AR, 2012, ECOSYSTEMS, V15, P913, DOI 10.1007/s10021-012-9554-y; KERN JS, 1993, SOIL SCI SOC AM J, V57, P200, DOI 10.2136/sssaj1993.03615995005700010036x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lauenroth W. K., 1979, Perspectives in grassland ecology., P3; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liski J, 2003, GLOBAL CHANGE BIOL, V9, P575, DOI 10.1046/j.1365-2486.2003.00605.x; McCulley RL, 2005, ECOSYSTEMS, V8, P106, DOI 10.1007/s10021-004-0117-8; McLauchlan KK, 2006, ECOL APPL, V16, P143, DOI 10.1890/04-1650; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; Metherall AK, 1993, 4 USDAARS GREAT PLAI; Murray S., 2000, PILOT ANAL GLOBAL EC; Niklinska M, 1999, BIOGEOCHEMISTRY, V44, P239, DOI 10.1023/A:1006049204600; Noy-Meir I., 1973, ANNU REV ECOL SYST, V4, P23; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Pinheiro J, 2001, MIXED EFFECTS MODELS; Risser P.G., 1981, TRUE PRAIRIE ECOSYST; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Wolkovich EM, 2010, GLOBAL CHANGE BIOL, V16, P1351, DOI 10.1111/j.1365-2486.2009.02001.x; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Ziter C, 2013, ECOLOGY IN PRESS	60	24	25	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54988	10.1371/journal.pone.0054988	http://dx.doi.org/10.1371/journal.pone.0054988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405103	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000315153400047
J	Pascu, ML; Danko, B; Martins, A; Jedlinszki, N; Alexandru, T; Nastasa, V; Boni, M; Militaru, A; Andrei, IR; Staicu, A; Hunyadi, A; Fanning, S; Amaral, L				Pascu, Mihail Lucian; Danko, Balazs; Martins, Ana; Jedlinszki, Nikoletta; Alexandru, Tatiana; Nastasa, Viorel; Boni, Mihai; Militaru, Andra; Andrei, Ionut Relu; Staicu, Angela; Hunyadi, Attila; Fanning, Seamus; Amaral, Leonard			Exposure of Chlorpromazine to 266 nm Laser Beam Generates New Species with Antibacterial Properties: Contributions to Development of a New Process for Drug Discovery	PLOS ONE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL EFFLUX PUMPS; CLINICAL CONCENTRATIONS; STAPHYLOCOCCUS-AUREUS; FLASH-PHOTOLYSIS; SELF-ASSOCIATION; NON-ANTIBIOTICS; POTENTIAL USE; THIORIDAZINE; PHENOTHIAZINES	Introduction: Phenothiazines when exposed to white light or to UV radiation undergo a variety of reactions that result in degradation of parental compound and formation of new species. This process is slow and may be sped up with exposure to high energy light such as that produced by a laser. Methods: Varying concentrations of Chlorpromazine Hydrochloride (CPZ) (2-20 mg/mL in distilled water) were exposed to 266 nm laser beam (time intervals: 1-24 hrs). At distinct intervals the irradiation products were evaluated by spectrophotometry between 200-1500 nm, Thin Layer Chromatography, High Pressure Liquid Chromatography (HPLC) Diode Array Detection, HPLC tandem mass spectrometry, and for activity against the CPZ sensitive test organism Staphylococcus aureus ATCC 25923. Results: CPZ exposure to 266 nm laser beam of given energy levels yielded species, whose number increased with duration of exposure. Although the major species produced were Promazine (PZ), hydroxypromazine or PZ sulfoxide, and CPZ sulfoxide, over 200 compounds were generated with exposure of 20 mg/mL of CPZ for 24 hrs. Evaluation of the irradiation products indicated that the bioactivity against the test organism increased despite the total disappearance of CPZ, that is due, most probably, to one or more new species that remain yet unidentified. Conclusions: Exposure of CPZ to a high energy (6.5 mJ) 266 nm laser beam yields rapidly a large number of new and stable species. For biological grade phenothiazines (in other words knowing the impurities in the samples: solvent and solute) this process may be reproducible because one can control within reasonably low experimental errors: the concentration of the parent compound, the laser beam wavelength and average energy, as well as the duration of the exposure time. Because the process is "clean'' and rapid, it may offer advantages over the pyrogenically based methods for the production of derivatives.	[Pascu, Mihail Lucian; Alexandru, Tatiana; Nastasa, Viorel; Boni, Mihai; Militaru, Andra; Andrei, Ionut Relu; Staicu, Angela] Natl Inst Laser Plasma & Radiat Phys, Laser Dept, Magurele Ilfov, Romania; [Danko, Balazs; Martins, Ana; Jedlinszki, Nikoletta; Hunyadi, Attila] Univ Szeged, Fac Pharm, Inst Pharmacognosy, Szeged, Hungary; [Fanning, Seamus] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Ctr Food Safety, Dublin 2, Ireland; [Fanning, Seamus] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Ctr Food Borne Zoon, Dublin 2, Ireland; [Amaral, Leonard] Univ Nova Lisboa, Inst Hyg & Trop Med, Microbiol Unit, Grp Mycobacteria, P-1200 Lisbon, Portugal; [Pascu, Mihail Lucian; Alexandru, Tatiana; Nastasa, Viorel; Boni, Mihai; Militaru, Andra] Univ Bucharest, Fac Phys, Magurele Ilfov, Romania	National Institute for Laser, Plasma & Radiation Physics - Romania; Szeged University; University College Dublin; University College Dublin; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University of Bucharest	Pascu, ML (corresponding author), Natl Inst Laser Plasma & Radiat Phys, Laser Dept, Magurele Ilfov, Romania.	mihai.pascu@inflpr.ro	Boni, Mihai/U-2458-2019; Tozar, Tatiana/P-3856-2019; Amaral, Leonard/I-2112-2012; Pascu, Mihail Lucian/U-3601-2019; Staicu, Angela/B-6741-2011; Nastasa, Viorel V/A-3881-2012; Pascu, Mihail Lucian M/C-4495-2011; Viveiros, Miguel/A-7326-2008; Andrei, Ionut Relu/GMW-7389-2022; Tozar (Alexandru), Tatiana/E-6369-2016; Dinache, Andra Cristina/A-2927-2017; Boni, Mihai/A-3915-2012	Boni, Mihai/0000-0003-3010-3003; Tozar, Tatiana/0000-0002-5953-9241; Amaral, Leonard/0000-0003-3127-1295; Pascu, Mihail Lucian/0000-0003-1151-9345; Staicu, Angela/0000-0003-0630-0314; Nastasa, Viorel V/0000-0002-9235-4492; Pascu, Mihail Lucian M/0000-0003-1151-9345; Viveiros, Miguel/0000-0001-9676-6251; Andrei, Ionut Relu/0000-0002-0952-8480; Tozar (Alexandru), Tatiana/0000-0002-5953-9241; Dinache, Andra Cristina/0000-0001-6107-7675; Boni, Mihai/0000-0003-3010-3003; Fanning, Seamus/0000-0002-1922-8836; Martins, Ana/0000-0002-8541-7440; Hunyadi, Attila/0000-0003-0074-3472	New Hungary Development Plan [TAMOP-4.2.1/B-09/1/KONV-2010-0005]; Baross Gabor Program [MFB-00339/2010]; Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal [EU-FSE / FEDERPOCI / SAU - MMO/59370/2004, EU-FSE / FEDER - PTDC/ BIAMIC / 71280/2006, SFRH/BCC/51099/2010]; ANCS (RO) project [LAPLAS 3-PN 09 33]; STSM (Short Term Scientific Mission) [CM0804, BM0701];  [PTDC/SAU-FCF/102807/2008];  [POSDRU 107/1.5/S/80765];  [POSDRU/88/1.5/S/56668]	New Hungary Development Plan; Baross Gabor Program; Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal(Portuguese Foundation for Science and Technology); ANCS (RO) project; STSM (Short Term Scientific Mission); ; ; 	This work was supported by the New Hungary Development Plan (TAMOP-4.2.1/B-09/1/KONV-2010-0005), the Baross Gabor Program (MFB-00339/2010) and partially supported by grants EU-FSE / FEDERPOCI / SAU - MMO/59370/2004 and EU-FSE / FEDER - PTDC/ BIAMIC / 71280/2006 provided by the Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal. Leonard Amaral was supported by BCC grant SFRH/BCC/51099/2010 provided by the Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal and PTDC/SAU-FCF/102807/2008. It was also supported by the ANCS (RO) project LAPLAS 3-PN 09 33. Attila Hunyadi was supported by an STSM (Short Term Scientific Mission) within the COST Action CM0804 and Balazs Danko was supported by an STSM (Short Term Scientific Mission) within the COST Action BM0701. Andra Militaru and Viorel Nastasa were supported by projects POSDRU 107/1.5/S/80765 and POSDRU/88/1.5/S/56668, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral L, 2008, CURR DRUG TARGETS, V9, P816, DOI 10.2174/138945008785747798; Amaral L, 1996, J ANTIMICROB CHEMOTH, V38, P1049, DOI 10.1093/jac/38.6.1049; Amaral L, 2000, INT J ANTIMICROB AG, V14, P173, DOI 10.1016/S0924-8579(99)00153-3; Amaral L, 2001, TROP MED INT HEALTH, V6, P1016, DOI 10.1046/j.1365-3156.2001.00804.x; Amaral L, 2001, J ANTIMICROB CHEMOTH, V47, P505, DOI 10.1093/jac/47.5.505; Amaral L, 2011, RECENT PATENTS ANTII, V6, P284; Amaral L, 2006, CURR DRUG TARGETS, V7, P887, DOI 10.2174/138945006777709539; Amaral L, 2010, IN VIVO, V24, P409; Arakaki AK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-315; Arce R, 2003, J PHOTOCH PHOTOBIO A, V154, P245, DOI 10.1016/S1010-6030(02)00353-2; Beijersbergen Van Henegouwen GMJ, 1997, ADV DRUG RES, V29, P119; BINFORD JS, 1994, BIOPHYS J, V66, P2024, DOI 10.1016/S0006-3495(94)80995-6; BUETTNER GR, 1986, PHOTOCHEM PHOTOBIOL, V44, P5, DOI 10.1111/j.1751-1097.1986.tb03556.x; BUETTNER GR, 1989, PHOTOCHEM PHOTOBIOL, V49, P249, DOI 10.1111/j.1751-1097.1989.tb04103.x; Caber-Ud-Din M, 2009, COLLOID J RUSS ACAD+, V71, P498, DOI [10.1134/S1061933X09040115, DOI 10.1134/S1061933X09040115]; CHIGNELL CF, 1985, ENVIRON HEALTH PERSP, V64, P103, DOI 10.2307/3430002; Ciamician G, 1908, CHEM BER, V41, P1928, DOI 10.1002/cber.19080410272; DAVIES AK, 1976, J CHEM SOC PERK T 2, P25, DOI 10.1039/p29760000025; Drucker AM, 2011, DRUG SAFETY, V34, P821, DOI 10.2165/11592780-000000000-00000; Ehrlich P, 1959, 1913 CHEMO THERAPY, VIII, P505; FELMEISTER A, 1964, J PHARM SCI, V53, P756, DOI 10.1002/jps.2600530712; Garcia C, 2005, J PHYS CHEM A, V109, P3360, DOI 10.1021/jp044530j; GARCIA C, 1995, J AM CHEM SOC, V117, P10871, DOI 10.1021/ja00149a010; Garcia C, 2002, J PHYS CHEM B, V106, P9794, DOI 10.1021/jp0257855; Garcia C, 2008, J PHYS CHEM B, V112, P168, DOI 10.1021/jp0710739; Garcia C, 2009, PHOTOCHEM PHOTOBIOL, V85, P160, DOI 10.1111/j.1751-1097.2008.00412.x; GRANT FW, 1972, TOXICOL APPL PHARM, V23, P71, DOI 10.1016/0041-008X(72)90205-0; HUANG C L, 1962, Psychopharmacol Serv Cent Bull, V2, P54; Itou H, 2005, J BIOL CHEM, V280, P38711, DOI 10.1074/jbc.M505999200; Kochevar IE, 1998, PHOTOCHEM PHOTOBIOL, V68, P692, DOI 10.1562/0031-8655(1998)068<0692:PTDBNC>2.3.CO;2; KOCHEVAR IE, 1979, PHOTOCHEM PHOTOBIOL, V29, P791, DOI 10.1111/j.1751-1097.1979.tb07768.x; KOCHEVAR IE, 1984, CHEM-BIOL INTERACT, V51, P273, DOI 10.1016/0009-2797(84)90153-4; KOCHEVAR IE, 1983, PHOTOCHEM PHOTOBIOL, V37, P163, DOI 10.1111/j.1751-1097.1983.tb04452.x; KOCHEVAR IE, 1980, TOXICOL APPL PHARM, V54, P258, DOI 10.1016/0041-008X(80)90195-7; Koenig J.L., 1999, SPECTROSCOPY POLYM; Kristiansen JE, 1997, J ANTIMICROB CHEMOTH, V40, P319, DOI 10.1093/jac/40.3.319; KYLE DE, 1993, AM J TROP MED HYG, V48, P126, DOI 10.4269/ajtmh.1993.48.126; Martins M, 2004, IN VIVO, V18, P787; Martins M, 2007, IN VIVO, V21, P771; McIntosh MP, 2010, J PHARM SCI-US, V99, P2999, DOI 10.1002/jps.22064; MINDER R, 1971, N-S ARCH PHARMAKOL, V268, P334, DOI 10.1007/BF00997266; Motten AG, 1983, PHOTOCHEM PHOTOBIOL, V42, P9; Nalecz-Jawecki G, 2008, ENVIRON TOXICOL, V23, P52, DOI 10.1002/tox.20310; Nalecz-Jawecki G, 2008, ECOTOXICOLOGY, V17, P13, DOI 10.1007/s10646-007-0171-z; NAVARATNAM S, 1978, J CHEM SOC FARAD T 1, V74, P1811, DOI 10.1039/f19787401811; Odian G., 2004, PRINCIPLES POLYM, P352; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Pascu Mihail-Lucian, 2011, Recent Pat Antiinfect Drug Discov, V6, P147; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pinero LE, 2009, PHOTOCHEM PHOTOBIOL, V85, P895, DOI 10.1111/j.1751-1097.2009.00584.x; PREMA K, 1974, BIOCHEM J, V137, P119, DOI 10.1042/bj1370119; Ray RS, 2008, TOXICOL IN VITRO, V22, P1775, DOI 10.1016/j.tiv.2008.06.015; Sala C, 2009, MOL MICROBIOL, V71, P1102, DOI 10.1111/j.1365-2958.2008.06583.x; Schreier S, 2000, BBA-BIOMEMBRANES, V1508, P210, DOI 10.1016/S0304-4157(00)00012-5; Spengler G, 2011, ANTICANCER RES, V31, P4201; Viveiros M, 2005, IN VIVO, V19, P733; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Yde CW, 2009, ANTI-CANCER DRUG, V20, P723, DOI 10.1097/CAD.0b013e32832ec041	59	35	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55767	10.1371/journal.pone.0055767	http://dx.doi.org/10.1371/journal.pone.0055767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405212	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400157
J	Szabo, A; Gogolak, P; Pazmandi, K; Kis-Toth, K; Riedl, K; Wizel, B; Lingnau, K; Bacsi, A; Rethi, B; Rajnavolgyi, E				Szabo, Attila; Gogolak, Peter; Pazmandi, Kitti; Kis-Toth, Katalin; Riedl, Karin; Wizel, Benjamin; Lingnau, Karen; Bacsi, Attila; Rethi, Bence; Rajnavolgyi, Eva			The Two-Component Adjuvant IC31 (R) Boosts Type I Interferon Production of Human Monocyte-Derived Dendritic Cells via Ligation of Endosomal TLRs	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; ANTIMYCOBACTERIAL T-CELL; ADAPTIVE IMMUNITY; VACCINE ADJUVANTS; RESPONSES; VIVO; INDUCTION; AG85B-ESAT-6; ACTIVATION; SUBTYPES	The aim of this study was to characterize and identify the mode of action of IC31 (R), a two-component vaccine adjuvant. We found that IC31 (R) was accumulated in human peripheral blood monocytes, MHC class II positive cells and monocyte-derived DCs (moDCs) but not in plasmacytoid DCs (pDCs). In the presence of IC31 (R) the differentiation of inflammatory CD1a(+) moDCs and the secretion of chemokines, TNF-alpha and IL-6 cytokines was inhibited but the production of IFN beta was increased. Sustained addition of IC31 (R) to differentiating moDCs interfered with I kappa B alpha phosphorylation, while the level of phospho-IRF3 increased. We also showed that both IC31 (R) and its KLK component exhibited a booster effect on type I IFN responses induced by the specific ligands of TLR3 or TLR7/8, whereas TLR9 ligand induces type I IFN production only in the presence of IC31 (R) or ODN1. Furthermore, long term incubation of moDCs with IC31 (R) caused significantly higher expression of IRF and IFN genes than a single 24 hr treatment. The adjuvant activity of IC31 (R) on the IFN response was shown to be exerted through TLRs residing in the vesicular compartment of moDCs. Based on these results IC31 (R) was identified as a moDC modulatory adjuvant that sets the balance of the NF-kappa B and IRF3 mediated signaling pathways to the production of IFN beta. Thus IC31 (R) is emerging as a potent adjuvant to increase immune responses against intracellular pathogens and cancer in future vaccination strategies.	[Szabo, Attila; Gogolak, Peter; Pazmandi, Kitti; Kis-Toth, Katalin; Bacsi, Attila; Rajnavolgyi, Eva] Univ Debrecen, Med & Hlth Sci Ctr, Dept Immunol, H-4012 Debrecen, Hungary; [Kis-Toth, Katalin] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Rheumatol, Boston, MA 02215 USA; [Riedl, Karin; Wizel, Benjamin; Lingnau, Karen] Intercell AG, Vienna, Austria; [Rethi, Bence] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	University of Debrecen; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Intercell; Karolinska Institutet	Rajnavolgyi, E (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Immunol, H-4012 Debrecen, Hungary.	evaraj@dote.hu	Rethi, Bence/C-5770-2013; Rajnavölgyi, Éva/D-4384-2013	Rethi, Bence/0000-0001-8220-5015; Bacsi, Attila/0000-0002-2311-2975; Gogolak, Peter/0000-0001-9411-9587; Pazmandi, Kitti Linda/0000-0001-7709-6707; Szabo, Attila/0000-0001-7833-8894	National Scientific Research grant OTKA [NK-10-15-38]; TAMOP [4.2.1./B-09/1/KONV-2010-0007]	National Scientific Research grant OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP	The experimental work was supported by the National Scientific Research grant OTKA NK-10-15-38 and TAMOP 4.2.1./B-09/1/KONV-2010-0007 both to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Aichinger MC, 2008, CELL BIOL INT, V32, P1449, DOI 10.1016/j.cellbi.2008.08.024; Aichinger MC, 2011, VACCINE, V29, P426, DOI 10.1016/j.vaccine.2010.11.003; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Benko S, 2008, BIOL CHEM, V389, P469, DOI 10.1515/BC.2008.054; Berghofer B, 2007, J IMMUNOL, V178, P4072, DOI 10.4049/jimmunol.178.7.4072; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Dustin ML, 2011, NAT REV IMMUNOL, V11, P672, DOI 10.1038/nri3066; Fritz JH, 2004, VACCINE, V22, P3274, DOI 10.1016/j.vaccine.2004.03.007; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Gogolak P, 2007, BLOOD, V109, P643, DOI 10.1182/blood-2006-04-016840; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kaisho T, 2010, VACCINE, V28, P8046, DOI 10.1016/j.vaccine.2010.09.025; Kamath AT, 2008, EUR J IMMUNOL, V38, P1247, DOI 10.1002/eji.200737889; Kamath AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003683; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kritsch CE, 2005, J CHROMATOGR B, V822, P263, DOI 10.1016/j.jchromb.2005.06.013; Lingnau K, 2007, EXPERT REV VACCINES, V6, P741, DOI 10.1586/14760584.6.5.741; Magyarics Z, 2008, CYTOM PART A, V73A, P254, DOI 10.1002/cyto.a.20529; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pilz A, 2009, J IMMUNOL, V183, P2286, DOI 10.4049/jimmunol.0901383; Prchal M, 2009, VACCINE, V27, pG17, DOI 10.1016/j.vaccine.2009.10.016; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Szabo A, 2012, J LEUKOCYTE BIOL, V92, P159, DOI 10.1189/jlb.0711360; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Xiao HB, 2012, GENE THER, V19, P1030, DOI 10.1038/gt.2011.171	44	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55264	10.1371/journal.pone.0055264	http://dx.doi.org/10.1371/journal.pone.0055264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405128	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400073
J	Teh, MY; Morona, R				Teh, Min Yan; Morona, Renato			Identification of Shigella flexneri IcsA Residues Affecting Interaction with N-WASP, and Evidence for IcsA-IcsA Co-Operative Interaction	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; ALDRICH-SYNDROME PROTEIN; ANTIGEN CHAIN-LENGTH; FAMILY PROTEINS; ARP2/3 COMPLEX; VIRG PROTEIN; IN-VITRO; AUTOTRANSPORTER; SECRETION; VIRULENCE	The Shigella flexneri IcsA (VirG) protein is a polarly distributed outer membrane protein that is a fundamental virulence factor which interacts with neural Wiskott-Aldrich syndrome protein (N-WASP). The activated N-WASP then activates the Arp2/3 complex which initiates de novo actin nucleation and polymerisation to form F-actin comet tails and allows bacterial cell-to-cell spreading. In a previous study, IcsA was found to have three N-WASP interacting regions (IRs): IR I (aa 185-312), IR II (aa 330-382) and IR III (aa 508-730). The aim of this study was to more clearly define N-WASP interacting regions II and III by site-directed mutagenesis of specific amino acids. Mutant IcsA proteins were expressed in both smooth lipopolysaccharide (S-LPS) and rough LPS (R-LPS) S. flexneri strains and characterised for IcsA production level, N-WASP recruitment and F-actin comet tail formation. We have successfully identified new amino acids involved in N-WASP recruitment within different N-WASP interacting regions, and report for the first time using co-expression of mutant IcsA proteins, that N-WASP activation involves interactions with different regions on different IcsA molecules as shown by Arp3 recruitment. In addition, our findings suggest that autochaperone (AC) mutant protein production was not rescued by another AC region provided in trans, differing to that reported for two other autotransporters, PrtS and BrkA autotransporters.	[Teh, Min Yan; Morona, Renato] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Microbiol & Immunol, Adelaide, SA, Australia	University of Adelaide	Morona, R (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Discipline Microbiol & Immunol, Adelaide, SA, Australia.	renato.morona@adelaide.edu.au	Morona, Renato/B-7746-2013	Morona, Renato/0000-0001-7009-7440	National Health and Medical Research Council (NHMRC) of Australia [565526]; University of Adelaide	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide	This work is supported by a Program Grant (565526) from the National Health and Medical Research Council (NHMRC) of Australia. MYT was the recipient of a Faculty of Science Postgraduate Scholarship from the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SJ, 1999, MICROBIOL-SGM, V145, P367, DOI 10.1099/13500872-145-2-367; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; BOLIVAR F, 1977, GENE, V2, P75, DOI 10.1016/0378-1119(77)90074-9; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07; Klemm P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/j.ijmm.2005.10.002; Kuhnel K, 2011, J BACTERIOL, V193, P2042, DOI 10.1128/JB.00790-10; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; May KL, 2012, MICROBIOL-SGM, V158, P1874, DOI 10.1099/mic.0.056465-0; Meng GY, 2011, EMBO J, V30, P3864, DOI 10.1038/emboj.2011.279; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; OHNISHI Y, 1994, J BIOL CHEM, V269, P32800; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pallen MJ, 2003, CURR OPIN MICROBIOL, V6, P519, DOI 10.1016/j.mib.2003.09.005; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Philpott DJ, 2000, PHILOS T R SOC B, V355, P575, DOI 10.1098/rstb.2000.0599; SANSONETTI PJ, 1991, VACCINE, V9, P416, DOI 10.1016/0264-410X(91)90128-S; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Suzuki T, 2002, CELL MICROBIOL, V4, P223, DOI 10.1046/j.1462-5822.2002.00185.x; Suzuki T, 2001, INFECT IMMUN, V69, P5959, DOI 10.1128/IAI.69.10.5959-5966.2001; Teh MY, 2012, MICROBIOL-SGM, V158, P2835, DOI 10.1099/mic.0.062471-0; Van Den Bosch L, 2003, MICROB PATHOGENESIS, V35, P11, DOI 10.1016/S0882-4010(03)00064-0; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Wells TJ, 2010, MICROBIOL-SGM, V156, P2459, DOI 10.1099/mic.0.039024-0; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7	45	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55152	10.1371/journal.pone.0055152	http://dx.doi.org/10.1371/journal.pone.0055152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405119	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400063
J	Kwiatek, JM; Owen, DM; Abu-Siniyeh, A; Yan, P; Loew, LM; Gaus, K				Kwiatek, Joanna M.; Owen, Dylan M.; Abu-Siniyeh, Ahmed; Yan, Ping; Loew, Leslie M.; Gaus, Katharina			Characterization of a New Series of Fluorescent Probes for Imaging Membrane Order	PLOS ONE			English	Article							LIPID RAFTS; GENERALIZED POLARIZATION; PLASMA-MEMBRANE; LAURDAN FLUORESCENCE; CELL-MEMBRANES; LIVING CELLS; DOMAINS; MICROSCOPY; DI-4-ANEPPDHQ; MODEL	Visualization and quantification of lipid order is an important tool in membrane biophysics and cell biology, but the availability of environmentally sensitive fluorescent membrane probes is limited. Here, we present the characterization of the novel fluorescent dyes PY3304, PY3174 and PY3184, whose fluorescence properties are sensitive to membrane lipid order. In artificial bilayers, the fluorescence emission spectra are red-shifted between the liquid-ordered and liquid-disordered phases. Using ratiometric imaging we demonstrate that the degree of membrane order can be quantitatively determined in artificial liposomes as well as live cells and intact, live zebrafish embryos. Finally, we show that the fluorescence lifetime of the dyes is also dependent on bilayer order. These probes expand the current palate of lipid excitation/emission wavelengths and possibly new opportunities in membrane biology.	[Kwiatek, Joanna M.; Owen, Dylan M.; Abu-Siniyeh, Ahmed; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Kwiatek, Joanna M.; Owen, Dylan M.; Abu-Siniyeh, Ahmed; Gaus, Katharina] Univ New S Wales, Australian Ctr Nanomed, Sydney, NSW, Australia; [Yan, Ping; Loew, Leslie M.] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modelling, Farmington, CT USA	University of New South Wales Sydney; University of New South Wales Sydney; University of Connecticut	Owen, DM (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	dylan.owen@unsw.edu.au; les@volt.uchc.edu; k.gaus@unsw.edu.au	Zdilla, Michael J/B-4145-2011; Abu siniyeh, Ahmed/M-5591-2019; Wunder, Stephanie L/B-5066-2012	Abu siniyeh, Ahmed/0000-0002-1175-5017; Gaus, Katharina/0000-0002-8009-9658; Kwiatek, Joanna/0000-0001-8934-0922; Loew, Leslie/0000-0002-1851-4646; Yan, Ping/0000-0001-6472-150X	Australian Research Council (ARC) [DE130100251]; National Institutes of Health (NIH) [R01 EB001963]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001963] Funding Source: NIH RePORTER	Australian Research Council (ARC)(Australian Research Council); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	DMO and KG acknowledge funding from the Australian Research Council (ARC), grant DE130100251. LML and PY acknowledge support from the National Institutes of Health (NIH) grant R01 EB001963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Demchenko AP, 2009, BIOPHYS J, V96, P3461, DOI 10.1016/j.bpj.2009.02.012; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, V89, pL4, DOI 10.1529/biophysj.105.064816; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Miguel L, 2011, J IMMUNOL, V186, P3505, DOI 10.4049/jimmunol.1002980; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Owen DM, 2007, SEMIN CELL DEV BIOL, V18, P591, DOI 10.1016/j.semcdb.2007.07.011; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Owen DM, 2010, MOL MEMBR BIOL, V27, P178, DOI 10.3109/09687688.2010.495353; Owen DM, 2010, BIOPHYS J, V99, pL7, DOI 10.1016/j.bpj.2010.04.022; Owen DM, 2010, MICROSC RES TECHNIQ, V73, P618, DOI 10.1002/jemt.20801; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Weber P, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470446	34	51	52	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e52960	10.1371/journal.pone.0052960	http://dx.doi.org/10.1371/journal.pone.0052960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390489	Green Submitted, gold, Green Published			2022-12-27	WOS:000314691100005
J	Xu, J; Ishikawa, H; Wollstein, G; Bilonick, RA; Folio, LS; Nadler, Z; Kagemann, L; Schuman, JS				Xu, Juan; Ishikawa, Hiroshi; Wollstein, Gadi; Bilonick, Richard A.; Folio, Lindsey S.; Nadler, Zach; Kagemann, Larry; Schuman, Joel S.			Three-Dimensional Spectral-Domain Optical Coherence Tomography Data Analysis for Glaucoma Detection	PLOS ONE			English	Article							NERVE-FIBER-LAYER; OPERATING CHARACTERISTIC CURVES; SEGMENTATION; AREAS	Purpose: To develop a new three-dimensional (3D) spectral-domain optical coherence tomography (SD-OCT) data analysis method using a machine learning technique based on variable-size super pixel segmentation that efficiently utilizes full 3D dataset to improve the discrimination between early glaucomatous and healthy eyes. Methods: 192 eyes of 96 subjects (44 healthy, 59 glaucoma suspect and 89 glaucomatous eyes) were scanned with SD-OCT. Each SD-OCT cube dataset was first converted into 2D feature map based on retinal nerve fiber layer (RNFL) segmentation and then divided into various number of super pixels. Unlike the conventional super pixel having a fixed number of points, this newly developed variable-size super pixel is defined as a cluster of homogeneous adjacent pixels with variable size, shape and number. Features of super pixel map were extracted and used as inputs to machine classifier (LogitBoost adaptive boosting) to automatically identify diseased eyes. For discriminating performance assessment, area under the curve (AUC) of the receiver operating characteristics of the machine classifier outputs were compared with the conventional circumpapillary RNFL (cpRNFL) thickness measurements. Results: The super pixel analysis showed statistically significantly higher AUC than the cpRNFL (0.855 vs. 0.707, respectively, p = 0.031, Jackknife test) when glaucoma suspects were discriminated from healthy, while no significant difference was found when confirmed glaucoma eyes were discriminated from healthy eyes. Conclusions: A novel 3D OCT analysis technique performed at least as well as the cpRNFL in glaucoma discrimination and even better at glaucoma suspect discrimination. This new method has the potential to improve early detection of glaucomatous damage.	[Xu, Juan; Ishikawa, Hiroshi; Wollstein, Gadi; Bilonick, Richard A.; Folio, Lindsey S.; Nadler, Zach; Kagemann, Larry; Schuman, Joel S.] Univ Pittsburgh, Sch Med, Dept Ophthalmol,UPMC, Ophthalmol & Visual Sci Res Ctr,Eye Ctr,Eye & Ear, Pittsburgh, PA 15261 USA; [Ishikawa, Hiroshi; Folio, Lindsey S.; Kagemann, Larry; Schuman, Joel S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wollstein, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol,UPMC, Ophthalmol & Visual Sci Res Ctr,Eye Ctr,Eye & Ear, Pittsburgh, PA 15261 USA.	wollsteing@upmc.edu	Schuman, Joel S/K-7304-2012; Schuman, Joel S/M-2389-2019; Ishikawa, Hiroshi/ABC-6293-2020; Ishikawa, Hiroshi/D-6370-2014	Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; Ishikawa, Hiroshi/0000-0001-6310-5748; Ishikawa, Hiroshi/0000-0001-6310-5748; Kagemann, Larry/0000-0001-8961-0187	National Institutes of Health [NIH R01-EY013178, R01-EY011289, P30-EY008098]; Eye and Ear Foundation (Pittsburgh, Pennsylvania, United States of America); Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY008098, R01EY011289, R01EY013178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye and Ear Foundation (Pittsburgh, Pennsylvania, United States of America); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH R01-EY013178; R01-EY011289; P30-EY008098), http://grants.nih.gov/grants/oer.htm; and the Eye and Ear Foundation (Pittsburgh, Pennsylvania, United States of America), http://www.eyeandear.org/; and Research to Prevent Blindness (http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajtony C, 2007, INVEST OPHTH VIS SCI, V48, P258, DOI 10.1167/iovs.06-0410; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589; Folio LS, 2012, OPTOMETRY VISION SCI, V89, pE554, DOI 10.1097/OPX.0b013e31824eeb43; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Gabriele ML, 2010, PROG RETIN EYE RES, V29, P556, DOI 10.1016/j.preteyeres.2010.05.005; Hanley JA, 1997, ACAD RADIOL, V4, P49, DOI 10.1016/S1076-6332(97)80161-4; Hee MR, 1998, OPHTHALMOLOGY, V105, P360, DOI 10.1016/S0161-6420(98)93601-6; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P325, DOI 10.1001/archopht.1995.01100030081025; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Leung CKS, 2010, OPHTHALMOLOGY, V117, P1684, DOI 10.1016/j.ophtha.2010.01.026; Pons ME, 2000, ARCH OPHTHALMOL-CHIC, V118, P1044, DOI 10.1001/archopht.118.8.1044; PULIAFITO CA, 1995, OPTICAL COHERENCE TO; Schuman Joel S, 2008, Trans Am Ophthalmol Soc, V106, P426; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Townsend KA, 2009, BRIT J OPHTHALMOL, V93, P139, DOI 10.1136/bjo.2008.145540; Xu J, 2007, IEEE T BIO-MED ENG, V54, P473, DOI 10.1109/TBME.2006.888831; Xu JA, 2009, IFMBE PROC, V25, P179	19	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55476	10.1371/journal.pone.0055476	http://dx.doi.org/10.1371/journal.pone.0055476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408988	gold, Green Published, Green Accepted			2022-12-27	WOS:000315100000016
J	Herkul, K; Kotta, J; Kutser, T; Vahtmae, E				Herkuel, Kristjan; Kotta, Jonne; Kutser, Tiit; Vahtmaee, Ele			Relating Remotely Sensed Optical Variability to Marine Benthic Biodiversity	PLOS ONE			English	Article							DIVERSITY; MACROALGAE; COMMUNITIES; PREFERENCES; REGRESSION; VEGETATION; ECOLOGY; BIOMASS; ISOPOD; ALPHA	Biodiversity is important in maintaining ecosystem viability, and the availability of adequate biodiversity data is a prerequisite for the sustainable management of natural resources. As such, there is a clear need to map biodiversity at high spatial resolutions across large areas. Airborne and spaceborne optical remote sensing is a potential tool to provide such biodiversity data. The spectral variation hypothesis (SVH) predicts a positive correlation between spectral variability (SV) of a remotely sensed image and biodiversity. The SVH has only been tested on a few terrestrial plant communities. Our study is the first attempt to apply the SVH in the marine environment using hyperspectral imagery recorded by Compact Airborne Spectrographic Imager (CASI). All coverage-based diversity measures of benthic macrophytes and invertebrates showed low but statistically significant positive correlations with SV whereas the relationship between biomass-based diversity measures and SV were weak or lacking. The observed relationships did not vary with spatial scale. SV had the highest independent effect among predictor variables in the statistical models of coverage-derived total benthic species richness and Shannon index. Thus, the relevance of SVH in marine benthic habitats was proved and this forms a prerequisite for the future use of SV in benthic biodiversity assessments.	[Herkuel, Kristjan; Kotta, Jonne; Kutser, Tiit; Vahtmaee, Ele] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia	University of Tartu; Estonian Marine Institute	Herkul, K (corresponding author), Univ Tartu, Estonian Marine Inst, Tallinn, Estonia.	kristjan.herkyl@sea.ee	Kutser, Tiit/H-1304-2015; Herkül, Kristjan/G-5791-2016; Kotta, Jonne/B-5542-2009	Herkül, Kristjan/0000-0002-4356-8152; Kotta, Jonne/0000-0002-4970-6755; Kutser, Tiit/0000-0001-9679-1422	Central Baltic Interreg IVa Programme HISPARES; Estonian Research Council [IUT02-20]; Estonian Science Foundation [7813, 8254]; Environmental protection and technology programme of European Regional Fund [3.2.0802.11-0029]	Central Baltic Interreg IVa Programme HISPARES; Estonian Research Council(Estonian Research Council); Estonian Science Foundation; Environmental protection and technology programme of European Regional Fund	This work was funded by the Central Baltic Interreg IVa Programme HISPARES. The study was additionally supported by Institutional research funding IUT02-20 of the Estonian Research Council and by the Estonian Science Foundation grants 7813 and 8254. The study has been partly supported by the project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" 3.2.0802.11-0029 of Environmental protection and technology programme of European Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrefouet S, 2004, MAR ECOL PROG SER, V283, P161, DOI 10.3354/meps283161; Asner GP, 2009, FRONT ECOL ENVIRON, V7, P269, DOI 10.1890/070152; Begin C, 2004, MAR ECOL PROG SER, V271, P121, DOI 10.3354/meps271121; Boero F, 2007, MAR ECOL-EVOL PERSP, V28, P134, DOI 10.1111/j.1439-0485.2007.00171.x; Carlson KM, 2007, ECOSYSTEMS, V10, P536, DOI 10.1007/s10021-007-9041-z; Ellis J, 2006, MAR ECOL PROG SER, V316, P69, DOI 10.3354/meps316069; Feilhauer H, 2009, APPL VEG SCI, V12, P429, DOI 10.1111/j.1654-109X.2009.01037.x; Foody GM, 2003, J BIOGEOGR, V30, P1053, DOI 10.1046/j.1365-2699.2003.00887.x; Gogina M, 2010, J MARINE SYST, V80, P57, DOI 10.1016/j.jmarsys.2009.10.001; Gustafsson C, 2011, OIKOS, V120, P1037, DOI 10.1111/j.1600-0706.2010.19008.x; Hansen JP, 2008, ESTUAR COAST SHELF S, V77, P535, DOI 10.1016/j.ecss.2007.10.013; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Helsinki Commission (HELCOM), 2008, MAN MAR MON COMBINE; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Innes JL, 1998, GLOBAL ECOL BIOGEOGR, V7, P397, DOI 10.2307/2997712; Isuus M., 2008, WAVE EXPOSURE CALCUL; Jormalainen V, 2001, MAR ECOL PROG SER, V220, P219, DOI 10.3354/meps220219; Knudby A, 2010, REMOTE SENS ENVIRON, V114, P1230, DOI 10.1016/j.rse.2010.01.007; Kotta J, 2000, INT REV HYDROBIOL, V85, P697; Kotta J, 2001, ANN ZOOL FENN, V38, P163; Kotta J., 2008, V197, P217, DOI 10.1007/978-3-540-73524-3_10; Kutser T, 2006, ESTUAR COAST SHELF S, V67, P521, DOI 10.1016/j.ecss.2005.12.004; Kutser Tiit, 2006, Proceedings of the Estonian Academy of Sciences Biology Ecology, V55, P329; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Mac Nally R, 1996, AUST J ECOL, V21, P224; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McCullagh P., 1989, GEN LINEAR MODELS; Mumby PJ, 1999, J ENVIRON MANAGE, V55, P157, DOI 10.1006/jema.1998.0255; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Oldeland J, 2010, ECOL INDIC, V10, P390, DOI 10.1016/j.ecolind.2009.07.012; Orav-Kotta H, 2004, HYDROBIOLOGIA, V514, P79, DOI 10.1023/B:hydr.0000018208.72394.09; Palmer M.W., 2000, COOPERATION LONG TER, P123; Palmer MW, 2002, ENVIRONMETRICS, V13, P121, DOI 10.1002/env.516; Parker JD, 2001, MAR ECOL PROG SER, V224, P55, DOI 10.3354/meps224055; Purkis SJ, 2008, CORAL REEFS, V27, P167, DOI 10.1007/s00338-007-0306-y; R Foundation for Statistical Computing, 2010, R VERS 2 11 1; Ricotta C, 1999, INT J REMOTE SENS, V20, P3367, DOI 10.1080/014311699211381; Rocchini D, 2007, REMOTE SENS ENVIRON, V111, P423, DOI 10.1016/j.rse.2007.03.018; Sandman A, 2008, J MARINE SYST, V74, pS86, DOI 10.1016/j.jmarsys.2008.03.028; Silva TSF, 2008, ENVIRON MONIT ASSESS, V140, P131, DOI 10.1007/s10661-007-9855-3; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Vis C, 2003, AQUAT BOT, V77, P187, DOI 10.1016/S0304-3770(03)00105-0; White JC, 2010, REMOTE SENS ENVIRON, V114, P1576, DOI 10.1016/j.rse.2010.02.012; Willems W, 2008, ECOL MODEL, V212, P74, DOI 10.1016/j.ecolmodel.2007.10.017; Young MA, 2010, MAR ECOL PROG SER, V415, P247, DOI 10.3354/meps08760	46	20	21	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55624	10.1371/journal.pone.0055624	http://dx.doi.org/10.1371/journal.pone.0055624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405180	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400125
J	Li, L; Mori, S; Sakamoto, M; Takahashi, S; Kodama, T				Li, Li; Mori, Shiro; Sakamoto, Maya; Takahashi, Shoki; Kodama, Tetsuya			Mouse Model of Lymph Node Metastasis via Afferent Lymphatic Vessels for Development of Imaging Modalities	PLOS ONE			English	Article							HIGH-FREQUENCY ULTRASOUND; ISOLATED TUMOR-CELLS; BREAST-CANCER; IN-VIVO; PRECLINICAL MODELS; FAS LIGAND; MICE; MICROMETASTASES; CARCINOMA; ANGIOGENESIS	Animal studies of lymph node metastasis are constrained by limitations in the techniques available for noninvasive monitoring of the progression of lymph node metastasis, as well as difficulties in the establishment of appropriate animal models. To overcome these challenges, this study has developed a mouse model of inter-lymph-node metastasis via afferent lymphatic vessels for use in the development of imaging modalities. We used 14- to 18-week-old MRL/MpJ-/lpr/lpr (MRL/lpr) mice exhibiting remarkable systemic lymphadenopathy, with proper axillary lymph nodes (proper-ALNs) and subiliac lymph nodes (SiLNs) that are 6 to 12 mm in diameter (similar in size to human lymph nodes). When KM-Luc/GFP malignant fibrous histiocytoma-like cells stably expressing the firefly luciferase gene were injected into the SiLN, metastasis could be detected in the proper-ALN within 3 to 9 days, using in vivo bioluminescence imaging. The metastasis route was found to be via the efferent lymphatic vessels of the SiLN, and metastasis incidence depended on the number of cells injected, the injection duration and the SiLN volume. Three-dimensional contrast-enhanced high-frequency ultrasound imaging showed that the blood vessel volume and density in the metastasized proper-ALN significantly increased at 14 days after tumor cell inoculation into the SiLN. The present metastasis model, with lymph nodes similar in size to those of humans, has potential use in the development of ultrasound imaging with high-precision and high-sensitivity as well as other imaging modalities for the detection of blood vessels in lymph nodes during the progression of metastasis.	[Li, Li; Kodama, Tetsuya] Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi 980, Japan; [Li, Li; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 980, Japan; [Mori, Shiro] Tohoku Univ Hosp, Dept Oral & Maxillofacial Surg, Sendai, Miyagi, Japan; [Sakamoto, Maya] Tohoku Univ, Grad Sch Dent, Dept Oral Diag, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kodama, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi 980, Japan.	kodama@bme.tohoku.ac.jp	Kodama, Tetsuya/T-2246-2019	Kodama, Tetsuya/0000-0003-4727-9558	 [22390378];  [24659884];  [21390500];  [24659834];  [23300183];  [24650286]; Grants-in-Aid for Scientific Research [23300183] Funding Source: KAKEN	; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.jsps.go.jp/english/e-grants/grants01.html Grant-in-Aid for Scientific Research (B) (22390378) Grant-in-Aid for Challenging Exploratory Research (24659884) Grant-in-Aid for Scientific Research (B) (21390500) Grant-in-Aid for Challenging Exploratory Research (24659834) Grant-in-Aid for Scientific Research (B) (23300183) Grant-in-Aid for Challenging Exploratory Research (24650286)	Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Castelijns JA, 2001, AM J NEURORADIOL, V22, P3; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; Dickson PV, 2007, J PEDIATR SURG, V42, P1172, DOI 10.1016/j.jpedsurg.2007.02.027; Dieter M, 2003, LYMPHOLOGY, V36, P39; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; du Toit LC, 2011, PHARM RES-DORDR, V28, P494, DOI 10.1007/s11095-010-0247-y; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Furukawa H, 2009, AM J IMMUNOL, V5, P89; Graham KC, 2005, CANCER RES, V65, P5231, DOI 10.1158/0008-5472.CAN-05-0440; GYOTOKU Y, 1987, J IMMUNOL, V138, P3785; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hansen NM, 2009, J CLIN ONCOL, V27, P4679, DOI 10.1200/JCO.2008.19.0686; Hasegawa H, 2003, ARTHRITIS RHEUM, V48, P2555, DOI 10.1002/art.11231; Hayashi K, 2007, CANCER RES, V67, P8223, DOI 10.1158/0008-5472.CAN-07-1237; Huyn ST, 2009, CLIN CANCER RES, V15, P3126, DOI 10.1158/1078-0432.CCR-08-2666; Ito Y, 2010, CANCER SCI, V101, P1853, DOI 10.1111/j.1349-7006.2010.01607.x; Kasuya H, 2005, CANCER RES, V65, P3823, DOI 10.1158/0008-5472.CAN-04-2631; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Kiessling F, 2005, EUR RADIOL, V15, P1079, DOI 10.1007/s00330-005-2701-5; Kodama T, 2011, CANCER RES, V71, P6957, DOI 10.1158/0008-5472.CAN-11-2389; Kodama T, 2010, ULTRASOUND MED BIOL, V36, P1196, DOI 10.1016/j.ultrasmedbio.2010.04.016; Kodama T, 2010, J ELECTRON MICROSC, V59, P187, DOI 10.1093/jmicro/dfp056; Kozaki K, 2000, CANCER RES, V60, P2535; Loveless ME, 2008, J ULTRAS MED, V27, P1699, DOI 10.7863/jum.2008.27.12.1699; Lutman CV, 2006, GYNECOL ONCOL, V102, P92, DOI 10.1016/j.ygyno.2005.11.032; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Murphy ED, 1978, AUTOIMMUNIY LYMPHOPR, P207; NAGATA S, 1994, PHILOS T ROY SOC B, V345, P281, DOI 10.1098/rstb.1994.0107; Nathanson SD, 2007, CANCER TREAT RES, P129; Poon RTP, 2002, J CLIN ONCOL, V20, P1775, DOI 10.1200/JCO.2002.07.089; Ran S, 2010, PATHOPHYSIOLOGY, V17, P229, DOI DOI 10.1016/J.PATH0PHYS.2009.11.003; Rofstad EK, 2002, CANCER RES, V62, P661; Roitt I., 2001, IMMUNOLOGY, V6th; Servais EL, 2011, J MOL MED, V89, P753, DOI 10.1007/s00109-011-0764-0; Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055; Swirski FK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001075; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; THOMPSON SC, 1974, BRIT J CANCER, V30, P332, DOI 10.1038/bjc.1974.201; TOKER C, 1963, CANCER, V16, P364, DOI 10.1002/1097-0142(196303)16:3<364::AID-CNCR2820160311>3.0.CO;2-K; Unno N, 2008, EUR J VASC ENDOVASC, V35, P205, DOI 10.1016/j.ejvs.2007.09.001; Uribarrena-Amezaga R, 2010, REV ESP ENFERM DIG, V102, P176, DOI 10.4321/s1130-01082010000300004; Vakoc BJ, 2012, NAT REV CANCER, V12, P363, DOI 10.1038/nrc3235; van den Brekel MWM, 1998, AM J NEURORADIOL, V19, P695; van Deurzen CHM, 2008, J NATL CANCER I, V100, P1574, DOI 10.1093/jnci/djn343; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Williams AD, 2001, AM J ROENTGENOL, V177, P343, DOI 10.2214/ajr.177.2.1770343; Williams Peter L, 1973, ANGIOLOGY, P588	52	60	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55797	10.1371/journal.pone.0055797	http://dx.doi.org/10.1371/journal.pone.0055797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405215	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400160
J	Pomschar, A; Koerte, I; Lee, S; Laubender, RP; Straube, A; Heinen, F; Ertl-Wagner, B; Alperin, N				Pomschar, Andreas; Koerte, Inga; Lee, Sang; Laubender, Ruediger P.; Straube, Andreas; Heinen, Florian; Ertl-Wagner, Birgit; Alperin, Noam			MRI Evidence for Altered Venous Drainage and Intracranial Compliance in Mild Traumatic Brain Injury	PLOS ONE			English	Article							PHASE-CONTRAST MRI; HEAD-INJURY; BLOOD-FLOW; PHYSIOLOGY; OUTFLOW; HUMANS; SYSTEM; ICP	Purpose: To compare venous drainage patterns and associated intracranial hydrodynamics between subjects who experienced mild traumatic brain injury (mTBI) and age-and gender-matched controls. Methods: Thirty adult subjects (15 with mTBI and 15 age- and gender-matched controls) were investigated using a 3T MR scanner. Time since trauma was 0.5 to 29 years (mean 11.4 years). A 2D-time-of-flight MR-venography of the upper neck was performed to visualize the cervical venous vasculature. Cerebral venous drainage through primary and secondary channels, and intracranial compliance index and pressure were derived using cine-phase contrast imaging of the cerebral arterial inflow, venous outflow, and the craniospinal CSF flow. The intracranial compliance index is the defined as the ratio of maximal intracranial volume and pressure changes during the cardiac cycle. MR estimated ICP was then obtained through the inverse relationship between compliance and ICP. Results: Compared to the controls, subjects with mTBI demonstrated a significantly smaller percentage of venous outflow through internal jugular veins (60.9+/-21% vs. controls: 76.8+/-10%; p=0.01) compensated by an increased drainage through secondary veins (12.3+/-10.9% vs. 5.5+/-3.3%; p<0.03). Mean intracranial compliance index was significantly lower in the mTBI cohort (5.8+/-1.4 vs. controls 8.4+/-1.9; p<0.0007). Consequently, MR estimate of intracranial pressure was significantly higher in the mTBI cohort (12.5+/-2.9 mmHg vs. 8.8+/-2.0 mmHg; p<0.0007). Conclusions: mTBI is associated with increased venous drainage through secondary pathways. This reflects higher outflow impedance, which may explain the finding of reduced intracranial compliance. These results suggest that hemodynamic and hydrodynamic changes following mTBI persist even in the absence of clinical symptoms and abnormal findings in conventional MR imaging.	[Pomschar, Andreas; Koerte, Inga; Ertl-Wagner, Birgit] Univ Munich, Inst Clin Radiol, Munich, Germany; [Lee, Sang; Alperin, Noam] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA; [Laubender, Ruediger P.] Univ Munich, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Straube, Andreas] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Heinen, Florian] Univ Munich, Dept Pediat Neurol Dev Med, Dr von Hauners Childrens Hosp, Munich, Germany	University of Munich; University of Miami; University of Munich; University of Munich; University of Munich	Alperin, N (corresponding author), Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA.	nalperin@med.miami.edu	Heinen, Florian/B-6594-2015; Ertl-Wagner, Birgit/AAD-5708-2020; Koerte, Inga Katharina/AAW-3031-2021	Heinen, Florian/0000-0002-3872-6136; Ertl-Wagner, Birgit/0000-0002-7896-7049	National Institutes of Health [R01 NS05212]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health award R01 NS05212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin N, 2005, ACTA NEUROCHIR SUPPL, V95, P191; Alperin N, 2005, ACT NEUR S, V95, P129; Alperin N, 2005, J MAGN RESON IMAGING, V22, P591, DOI 10.1002/jmri.20427; Alperin N, 2003, MAGNET RESON MED, V49, P934, DOI 10.1002/mrm.10455; Alperin N, 2002, P INT SOC MAG RESON, P2; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Bailey DM, 2012, CLIN SCI LOND; BATSON OV, 1957, AMER J ROENTGENOL RA, V78, P195; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Doepp F, 2004, NEURORADIOLOGY, V46, P565, DOI 10.1007/s00234-004-1213-3; Ertl-Wagner B, 2012, MULT SCLER J, V18, P1000, DOI 10.1177/1352458511432742; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kivioja J, 2001, J CLIN IMMUNOL, V21, P272, DOI 10.1023/A:1010931309088; Koerte IK, 2011, INVEST RADIOL; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miyati T, 2007, J MAGN RESON IMAGING, V26, P274, DOI 10.1002/jmri.20999; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Piccio L, 2005, J IMMUNOL, V174, P5805, DOI 10.4049/jimmunol.174.9.5805; Piechnik SK, 2001, NEUROSURGERY, V49, P1214, DOI 10.1097/00006123-200111000-00034; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Stoquart-ElSankari S, 2009, J CEREBR BLOOD F MET, V29, P1208, DOI [10.1038/sj.jcbfm.jcbfm200929, 10.1038/jcbfm.2009.29]; Tain RW, 2009, J MAGN RESON IMAGING, V30, P878, DOI 10.1002/jmri.21925; Tain RW, 2009, IEEE T BIO-MED ENG, V56, P544, DOI 10.1109/TBME.2008.2006010; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Zhang K, 2010, EXP BRAIN RES	37	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55447	10.1371/journal.pone.0055447	http://dx.doi.org/10.1371/journal.pone.0055447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405151	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400096
J	Tang, J; Agrawal, T; Cheng, Q; Qu, LK; Brewer, MD; Chen, JD; Yang, XL				Tang, Jun; Agrawal, Trisha; Cheng, Qian; Qu, Like; Brewer, Michael D.; Chen, Jiandong; Yang, Xiaolu			Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation	PLOS ONE			English	Article							REGULATING MDM2; PROTEIN; OLIGOMERIZATION; CHECKPOINT; PROMOTES; KINASES; COMPLEX; MICE	p53 plays a central role in tumor suppression. It does so by inducing anti-proliferative processes as a response to various tumor-promoting stresses. p53 is regulated by the ubiquitin ligase Mdm2. The optimal function of Mdm2 requires Daxx, which stabilizes Mdm2 through the deubiquitinase Hausp/USP7 and also directly promotes Mdm2's ubiquitin ligase activity towards p53. The Daxx-Mdm2 interaction is disrupted upon DNA damage. However, both the mechanisms and the consequence of the Daxx-Mdm2 dissociation are not understood. Here we show that upon DNA damage Daxx is phosphorylated in a manner that is dependent on ATM, a member of the PI 3-kinase family that orchestrates the DNA damage response. The main phosphorylation site of Daxx is identified to be Ser564, which is a direct target of ATM. Phosphorylation of endogenous Daxx at Ser564 occurs rapidly during the DNA damage response and precedes p53 activation. Blockage of this phosphorylation event prevents the separation of Daxx from Mdm2, stabilizes Mdm2, and inhibits DNA damage-induced p53 activation. These results suggest that phosphorylation of Daxx by ATM upon DNA damage disrupts the Daxx-Mdm2 interaction and facilitates p53 activation.	[Tang, Jun; Agrawal, Trisha; Qu, Like; Brewer, Michael D.; Yang, Xiaolu] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Tang, Jun; Agrawal, Trisha; Qu, Like; Brewer, Michael D.; Yang, Xiaolu] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Cheng, Qian; Chen, Jiandong] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Mol Oncol, Tampa, FL 33682 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Yang, XL (corresponding author), Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA.	xyang@mail.med.upenn.edu			National Institutes of Health [CA088868]; Department of Defense [W81XWH-07-1-0336]; NATIONAL CANCER INSTITUTE [T32CA009140, R01CA088868, P30CA016520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health (CA088868) and Department of Defense (W81XWH-07-1-0336) grants to XY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Chehab NH, 2000, GENE DEV, V14, P278; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Shieh SY, 2000, GENE DEV, V14, P289; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	27	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55813	10.1371/journal.pone.0055813	http://dx.doi.org/10.1371/journal.pone.0055813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405218	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400163
J	Tarandovskiy, ID; Artemenko, EO; Panteleev, MA; Sinauridze, EI; Ataullakhanov, FI				Tarandovskiy, Ivan D.; Artemenko, Elena O.; Panteleev, Mikhail A.; Sinauridze, Elena I.; Ataullakhanov, Fazoil I.			Antiplatelet Agents Can Promote Two-Peaked Thrombin Generation in Platelet Rich Plasma: Mechanism and Possible Applications	PLOS ONE			English	Article							PROCOAGULANT ACTIVITY; ACTIVATED PLATELETS; DIMETHYL-SULFOXIDE; BLOOD-COAGULATION; SEVERE HEMOPHILIA; WHOLE-BLOOD; THROMBOGRAM; CELLS; DIMETHYLSULFOXIDE; SUBPOPULATIONS	Background: Thrombin generation assay is a convenient and widely used method for analysis of the blood coagulation system status. Thrombin generation curve (TGC) is usually bell-shaped with a single peak, but there are exceptions. In particular, TGC in platelet-rich plasma (PRP) can sometimes have two peaks. Objective: We sought to understand the mechanism underlying the occurrence of two peaks in the PRP thrombin generation curve. Methods: Tissue factor-induced thrombin generation in PRP and platelet-poor plasma (PPP) was monitored using continuous measurement of the hydrolysis rate of the thrombin-specific fluorogenic substrate Z-Gly-Gly-Arg-AMC. Expression of phosphatidylserine (PS) and CD62P on the surface of activated platelets was measured by flow cytometry using corresponding fluorescently labeled markers. Results: The addition of the P2Y12 receptor antagonist MeS-AMP (160 mu M), 83 nM prostaglandin E-1 (PGE(1)), or 1.6% DMSO to PRP caused the appearance of two peaks in the TGC. The PS exposure after thrombin activation on washed platelets in a suspension supplemented with DMSO, PGE(1) or MeS-AMP was delayed, which could indicate mechanism of the second peak formation. Supplementation of PRP with 1.6% DMSO plus 830 nM PGE(1) mediated the disappearance of the second peak and decreased the amplitude of the first peak. Increasing the platelet concentration in the PRP promoted the consolidation of the two peaks into one. Conclusions: Procoagulant tenase and prothrombinase complexes in PRP assemble on phospholipid surfaces containing PS of two types - plasma lipoproteins and the surface of activated platelets. Thrombin generation in the PRP can be two-peaked. The second peak appears in the presence of platelet antagonists as a result of delayed PS expression on platelets, which leads to delayed assembly of the membrane-dependent procoagulant complexes and a second wave of thrombin generation.	[Tarandovskiy, Ivan D.; Artemenko, Elena O.; Panteleev, Mikhail A.; Sinauridze, Elena I.; Ataullakhanov, Fazoil I.] Ctr Theoret Problems Physicochem Pharmacol RAS, Lab Mol Mech Hemostasis, Moscow, Russia; [Panteleev, Mikhail A.; Sinauridze, Elena I.; Ataullakhanov, Fazoil I.] Natl Res Ctr Hematol, Lab Phys Biochem Blood, Moscow, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Biophys Lab, Moscow, Russia	Russian Academy of Sciences; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Lomonosov Moscow State University; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology	Tarandovskiy, ID (corresponding author), Ctr Theoret Problems Physicochem Pharmacol RAS, Lab Mol Mech Hemostasis, Moscow, Russia.	taran_@list.ru	Panteleev, Mikhail A/H-5491-2012; Ataullakhanov, Fazoil/O-3458-2019; Sinauridze, Elena Ivanovna/E-4058-2014; Ataullakhanov, Fazoil/J-8076-2012	Panteleev, Mikhail A/0000-0002-8128-7757; Sinauridze, Elena Ivanovna/0000-0002-5948-3444; 	Russian Foundation for Basic Research (RFBR) [10-01-91055, 11-04-00303, 11-04-12080]; Fundamental Research Programs of the Presidium of the Russian Academy of Sciences "Molecular and cellular biology'' and "Fundamental sciences for medicine''	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Fundamental Research Programs of the Presidium of the Russian Academy of Sciences "Molecular and cellular biology'' and "Fundamental sciences for medicine''	This work was supported in part by the Russian Foundation for Basic Research (RFBR) grants 10-01-91055, 11-04-00303, and 11-04-12080, as well as by the Fundamental Research Programs of the Presidium of the Russian Academy of Sciences "Molecular and cellular biology'' and "Fundamental sciences for medicine''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2003, CIRCULATION, V108, P2697, DOI 10.1161/01.CIR.0000093279.36628.12; Asmis L, 2010, BIOCHEM BIOPH RES CO, V391, P1629, DOI 10.1016/j.bbrc.2009.12.102; Baglin T, 2011, J THROMB HAEMOST, V9, P1859, DOI 10.1111/j.1538-7836.2011.04427.x; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; BRAMMER JP, 1984, BRIT J PHARMACOL, V82, P61, DOI 10.1111/j.1476-5381.1984.tb16442.x; Butenas S, 2001, BLOOD, V97, P2314, DOI 10.1182/blood.V97.8.2314; CAWELLO W, 1995, BRIT J CLIN PHARMACO, V40, P273, DOI 10.1111/j.1365-2125.1995.tb05784.x; Chatziioannou A, 2012, SCI WORLD J, DOI 10.1100/2012/803678; Chen-Plotkin AS, 2007, NEUROLOGY, V68, P859, DOI 10.1212/01.wnl.0000256716.04218.5b; Gerotziafas GT, 2004, THROMB HAEMOSTASIS, V91, P531, DOI 10.1160/TH03-07-0483; Gumbel E. J., 1954, STAT THEORY EXTREME; Hemker HC, 2000, THROMB HAEMOSTASIS, V83, P589; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hoang Ba X, 2011, J Pain Palliat Care Pharmacother, V25, P19, DOI 10.3109/15360288.2010.536306; HOLTZ GC, 1972, P SOC EXP BIOL MED, V141, P244; Iyu D, 2011, PROSTAG OTH LIPID M, V94, P9, DOI 10.1016/j.prostaglandins.2010.11.001; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; KALAFATIS M, 1994, BBA-MOL BASIS DIS, V1227, P113, DOI 10.1016/0925-4439(94)90086-8; Kotova YN, 2008, J THROMB HAEMOST, V6, P1603, DOI 10.1111/j.1538-7836.2008.03052.x; Kozek-Langenecker SA, 1998, ANESTH ANALG, V87, P985, DOI 10.1097/00000539-199811000-00001; Kreutz RP, 2012, PLATELETS; Maloney SF, 2010, INTEGR BIOL-UK, V2, P183, DOI 10.1039/b919728a; Martin-Henao GA, 2010, VOX SANG, V99, P267, DOI 10.1111/j.1423-0410.2010.01341.x; Mueller LP, 2007, EUR J HAEMATOL, V78, P527, DOI 10.1111/j.1600-0609.2007.00851.x; Neubauer H, 2008, THROMB HAEMOSTASIS, V99, P357, DOI 10.1160/TH07-10-0624; Panteleev MA, 2005, J THROMB HAEMOST, V3, P2545, DOI 10.1111/j.1538-7836.2005.01616.x; Roberts W, 2010, BLOOD, V116, P4297, DOI 10.1182/blood-2010-01-265561; Rugeri L, 2007, HAEMATOLOGICA, V92, P1639, DOI 10.3324/haematol.11460; Santagostino E, 2010, J THROMB HAEMOST, V8, P737, DOI 10.1111/j.1538-7836.2010.03767.x; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Siegemund T, 2003, THROMB HAEMOSTASIS, V90, P781, DOI 10.1160/TH03-01-0027; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Tappenden KA, 2007, BRIT J HAEMATOL, V139, P106, DOI 10.1111/j.1365-2141.2007.06732.x; Tardy-Poncet B, 2009, J THROMB HAEMOST, V7, P1474, DOI 10.1111/j.1538-7836.2009.03514.x; Topalov NN, 2012, BRIT J HAEMATOL, V157, P105, DOI 10.1111/j.1365-2141.2011.09021.x; van der Meijden PEJ, 2005, THROMB HAEMOSTASIS, V93, P1128, DOI 10.1160/TH04-09-0597; Vanschoonbeek K, 2004, J THROMB HAEMOST, V2, P476, DOI 10.1111/j.1538-7933.2004.00618.x; Wagenvoord R, 2006, J THROMB HAEMOST, V4, P1331, DOI 10.1111/j.1538-7836.2006.01967.x	39	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55688	10.1371/journal.pone.0055688	http://dx.doi.org/10.1371/journal.pone.0055688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405196	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400141
J	Zhu, ZX; Shi, ZX; Yan, WJ; Wei, JC; Shao, DH; Deng, XF; Wang, SH; Li, BB; Tong, GZ; Ma, ZY				Zhu, Zixiang; Shi, Zixue; Yan, Wenjun; Wei, Jianchao; Shao, Donghua; Deng, Xufang; Wang, Shaohui; Li, Beibei; Tong, Guangzhi; Ma, Zhiyong			Nonstructural Protein 1 of Influenza A Virus Interacts with Human Guanylate-Binding Protein 1 to Antagonize Antiviral Activity	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; NS1 PROTEIN; FLUORESCENCE COMPLEMENTATION; INTRACELLULAR PATHOGENS; HOST-DEFENSE; INTERFERON; INHIBITION; GTPASE; ACTIVATION; GAMMA	Human guanylate-binding protein 1 (hGBP1) is an interferon-inducible protein involved in the host immune response against viral infection. In response to infection by influenza A virus (IAV), hGBP1 transcript and protein were significantly upregulated. Overexpression of hGBP1 inhibited IAV replication in a dose-dependent manner in vitro. The lysine residue at position 51 (K51) of hGBP1 was essential for inhibition of IAV replication. Mutation of K51 resulted in an hGBP1 that was unable to inhibit IAV replication. The viral nonstructural protein 1 (NS1) was found to interact directly with hGBP1. K51 of hGBP1 and a region between residues 123 and 144 in NS1 were demonstrated to be essential for the interaction between NS1 and hGBP1. Binding of NS1 to hGBP1 resulted in a significant reduction in both GTPase activity and the anti-IAV activity of hGBP1. These findings indicated that hGBP1 contributed to the host immune response against IAV replication and that hGBP1-mediated antiviral activity was antagonized by NS1 via binding to hGBP1.	[Zhu, Zixiang; Shi, Zixue; Yan, Wenjun; Wei, Jianchao; Shao, Donghua; Deng, Xufang; Wang, Shaohui; Li, Beibei; Ma, Zhiyong] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Vet Publ Hlth, Shanghai, Peoples R China; [Tong, Guangzhi] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Swine Infect Dis, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Ma, ZY (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Vet Publ Hlth, Shanghai, Peoples R China.	zhiyongma@shvri.ac.cn	Deng, Xufang/I-3001-2013	Deng, Xufang/0000-0002-7604-3627; Shi, Zixue/0000-0001-5357-1171	National Natural Science Foundation of China [30970141, 81171547]; Natural Science Foundation of Shanghai [10JC1417300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was sponsored by the National Natural Science Foundation of China (no. 30970141 and no. 81171547) and the Natural Science Foundation of Shanghai (no. 10JC1417300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CHENG YSE, 1985, J BIOL CHEM, V260, P5834; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Ducatez MF, 2008, VACCINE, V26, pD67, DOI 10.1016/j.vaccine.2008.07.064; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Li G, 2009, MOL BIOL EVOL, V26, P1619, DOI 10.1093/molbev/msp074; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li YT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-398; Lu Yin-ping, 2007, Virologica Sinica, V22, P193, DOI 10.1007/s12250-007-0021-4; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nordmann A, 2012, FASEB J, V26, P1290, DOI 10.1096/fj.11-189886; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ronni T, 1997, J IMMUNOL, V158, P2363; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SCHWEMMLE M, 1994, J BIOL CHEM, V269, P11299; Shyu YJ, 2008, TRENDS BIOTECHNOL, V26, P622, DOI 10.1016/j.tibtech.2008.07.006; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tripal P, 2007, J INTERF CYTOK RES, V27, P44, DOI 10.1089/jir.2007.0086; Uetani K, 2008, EUR J IMMUNOL, V38, P1559, DOI 10.1002/eji.200737045; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Virreira WS, 2011, PLOS ONE, V6; Wang XD, 2012, J BIOL CHEM, V287, P18366, DOI 10.1074/jbc.M111.335422; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhao YO, 2009, MEM I OSWALDO CRUZ, V104, P234, DOI 10.1590/S0074-02762009000200016	42	67	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55920	10.1371/journal.pone.0055920	http://dx.doi.org/10.1371/journal.pone.0055920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405236	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400181
J	Mattsson, BJ; Zipkin, EF; Gardner, B; Blank, PJ; Sauer, JR; Royle, JA				Mattsson, Brady J.; Zipkin, Elise F.; Gardner, Beth; Blank, Peter J.; Sauer, John R.; Royle, J. Andrew			Explaining Local-Scale Species Distributions: Relative Contributions of Spatial Autocorrelation and Landscape Heterogeneity for an Avian Assemblage	PLOS ONE			English	Article							FOREST FRAGMENTATION; OCCUPANCY MODELS; BIRDS; INFERENCE; RICHNESS	Understanding interactions between mobile species distributions and landcover characteristics remains an outstanding challenge in ecology. Multiple factors could explain species distributions including endogenous evolutionary traits leading to conspecific clustering and endogenous habitat features that support life history requirements. Birds are a useful taxon for examining hypotheses about the relative importance of these factors among species in a community. We developed a hierarchical Bayes approach to model the relationships between bird species occupancy and local landcover variables accounting for spatial autocorrelation, species similarities, and partial observability. We fit alternative occupancy models to detections of 90 bird species observed during repeat visits to 316 point-counts forming a 400-m grid throughout the Patuxent Wildlife Research Refuge in Maryland, USA. Models with landcover variables performed significantly better than our autologistic and null models, supporting the hypothesis that local landcover heterogeneity is important as an exogenous driver for species distributions. Conspecific clustering alone was a comparatively poor descriptor of local community composition, but there was evidence for spatial autocorrelation in all species. Considerable uncertainty remains whether landcover combined with spatial autocorrelation is most parsimonious for describing bird species distributions at a local scale. Spatial structuring may be weaker at intermediate scales within which dispersal is less frequent, information flows are localized, and landcover types become spatially diversified and therefore exhibit little aggregation. Examining such hypotheses across species assemblages contributes to our understanding of community-level associations with conspecifics and landscape composition.	[Mattsson, Brady J.] US Geol Survey, Western Ecol Res Ctr, Sacramento, CA USA; [Zipkin, Elise F.; Blank, Peter J.; Sauer, John R.; Royle, J. Andrew] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Gardner, Beth] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of North Carolina; North Carolina State University	Mattsson, BJ (corresponding author), Univ Nat Resources & Life Sci, Dept Forest & Soil Sci, Vienna, Austria.	brady.mattsson@gmail.com	Mattsson, Brady/K-1688-2015	Mattsson, Brady/0000-0002-3182-9538; Royle, Jeffrey/0000-0003-3135-2167; Zipkin, Elise/0000-0003-4155-6139				Ando T, 2007, BIOMETRIKA, V94, P443, DOI 10.1093/biomet/asm017; Bahn V, 2006, ECOGRAPHY, V29, P835, DOI 10.1111/j.2006.0906-7590.04621.x; Betts MG, 2006, ECOL MODEL, V191, P197, DOI 10.1016/j.ecolmodel.2005.04.027; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Boulinier T, 2001, ECOLOGY, V82, P1159, DOI 10.1890/0012-9658(2001)082[1159:FFABCD]2.0.CO;2; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Bull EL, 1995, BIRDS N AM, V148, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campomizzi AJ, 2008, J WILDLIFE MANAGE, V72, P331, DOI 10.2193/2007-204; Carroll C, 2010, CONSERV BIOL, V24, P1538, DOI 10.1111/j.1523-1739.2010.01528.x; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; De Wan AA, 2009, BIOL CONSERV, V142, P982, DOI 10.1016/j.biocon.2008.12.032; Doherty PF, 2003, P NATL ACAD SCI USA, V100, P5858, DOI 10.1073/pnas.0836953100; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dorazio RM, 2010, ECOLOGY, V91, P2466, DOI 10.1890/09-1033.1; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hahn BA, 2007, ANIM CONSERV, V10, P436, DOI 10.1111/j.1469-1795.2007.00128.x; Hartley S, 2004, P ROY SOC B-BIOL SCI, V271, P81, DOI 10.1098/rspb.2003.2531; Kearney R. F., 2003, PARTNERS FLIGHT LAND; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maryland Department of Natural Resources, 2007, NAT AGR IM PROGR NAI; Mattsson BJ, 2009, P 4 INT PARTN FLIGHT, P617; Mcgowan KJ, 2001, BIRDS N AM ONLINE; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; O'Connell TJ, 2000, ECOL APPL, V10, P1706, DOI 10.2307/2641233; Proches S, 2010, ECOGRAPHY, V33, P128, DOI 10.1111/j.1600-0587.2009.06035.x; ROBBINS CS, 1989, WILDLIFE MONOGR, P1; Roberge JM, 2006, BIOL CONSERV, V130, P134, DOI 10.1016/j.biocon.2005.12.008; Rodewald AD, 2003, WILDLIFE SOC B, V31, P586; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2007, ECOL MONOGR, V77, P465, DOI 10.1890/06-0912.1; Sauer JR, 2012, J WILDLIFE IN PRESS; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thogmartin WE, 2007, LANDSCAPE ECOL, V22, P61, DOI 10.1007/s10980-006-9005-2; Verbeek N. A., 2002, BIRDS N AM ONLINE; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; Wagner HH, 2005, ECOLOGY, V86, P1975, DOI 10.1890/04-0914; Wiebe K. L., 2008, BIRDS N AM ONLINE; Zipkin EF, 2012, ECOL APPL, V22, P1962, DOI 10.1890/11-1936.1; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	53	22	24	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55097	10.1371/journal.pone.0055097	http://dx.doi.org/10.1371/journal.pone.0055097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393564	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800018
J	Nawijn, MC; Motta, AC; Gras, R; Shirinbak, S; Maazi, H; van Oosterhout, AJM				Nawijn, Martijn C.; Motta, Alexandre C.; Gras, Renee; Shirinbak, Soheila; Maazi, Hadi; van Oosterhout, Antoon J. M.			TLR-2 Activation Induces Regulatory T Cells and Long-Term Suppression of Asthma Manifestations in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ALLERGIC AIRWAY INFLAMMATION; DENDRITIC CELLS; IMMUNE REGULATION; EPITHELIAL-CELLS; PROTEIN-KINASE; CUTTING EDGE; C-FOS; RESPONSES; TOLL-LIKE-RECEPTOR-2	Asthma is a chronic inflammatory disease of the airways characterized by variable airway obstruction and airway hyperresponsiveness (AHR). The T regulatory (Treg) cell subset is critically important for the regulation of immune responses. Adoptive transfer of Treg cells has been shown to be sufficient for the suppression of airway inflammation in experimental allergic asthma. Intervention strategies aimed at expanding the Treg cell population locally in the airways of sensitized individuals are therefore of high interest as a potential therapeutic treatment for allergic airway disease. Here, we aim to test whether long-term suppression of asthma manifestations can be achieved by locally expanding the Treg cell subset via intranasal administration of a TLR-2 agonist. To model therapeutic intervention aimed at expanding the endogenous Treg population in a sensitized host, we challenged OVA-sensitized mice by OVA inhalation with concomitant intranasal instillation of the TLR-2 agonist Pam3Cys, followed by an additional series of OVA challenges. Pam3Cys treatment induced an acute but transient aggravation of asthma manifestations, followed by a reduction or loss of AHR to methacholine, depending on the time between Pam3Cys treatment and OVA challenges. In addition, Pam3Cys-treatment induced significant reductions of eosinophils and increased numbers of Treg cells in the lung infiltrates. Our data show that, despite having adverse acute effects, TLR2 agonist treatment as a therapeutic intervention induces an expansion of the Treg cell population in the lungs and results in long-term protection against manifestation of allergic asthma upon subsequent allergen provocation. Our data indicate that local expansion of Tregs in allergic airway disease is an interesting therapeutic approach that warrants further investigation.	[Nawijn, Martijn C.; Motta, Alexandre C.; Gras, Renee; Shirinbak, Soheila; Maazi, Hadi; van Oosterhout, Antoon J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis,GRIAC Res Inst, Groningen, Netherlands	University of Groningen	Nawijn, MC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis,GRIAC Res Inst, Groningen, Netherlands.	m.c.nawijn@umcg.nl		Maazi, Hadi/0000-0002-8979-3769; Nawijn, Martijn/0000-0003-3372-6521	Netherlands Asthma Foundation [NAF 03.54]	Netherlands Asthma Foundation	This study was financially supported by the Netherlands Asthma Foundation (NAF 03.54). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Armstrong L, 2004, AM J RESP CELL MOL, V31, P241, DOI 10.1165/rcmb.2004-0078OC; Baru AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047102; Boudousquie C, 2009, CLIN EXP ALLERGY, V39, P1415, DOI 10.1111/j.1365-2222.2009.03314.x; Burchell JT, 2009, AM J PHYSIOL-LUNG C, V296, pL307, DOI 10.1152/ajplung.00521.2007; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Fuchs Barbara, 2008, J Occup Med Toxicol, V3 Suppl 1, pS5, DOI 10.1186/1745-6673-3-S1-S5; Gomez MI, 2008, PEDIATR PULM, V43, P11, DOI 10.1002/ppul.20735; Inman MD, 2010, CLIN EXP ALLERGY, V40, P524, DOI 10.1111/j.1365-2222.2010.03485.x; Issa R, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-30; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Kearley J, 2008, J ALLERGY CLIN IMMUN, V122, P617, DOI 10.1016/j.jaci.2008.05.048; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Luhrmann A, 2005, VACCINE, V23, P4721, DOI 10.1016/j.vaccine.2005.05.009; Maazi H, 2012, CLIN EXP ALLERGY, V42, P1519, DOI 10.1111/j.1365-2222.2012.04064.x; Motta AC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-93; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Nawijn MC, 2011, AM J RESP CELL MOL, V45, P295, DOI 10.1165/rcmb.2009-0369OC; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Ryanna K, 2009, ALLERGY, V64, P335, DOI 10.1111/j.1398-9995.2009.01972.x; Shirinbak S, 2010, J IMMUNOL, V185, P3857, DOI 10.4049/jimmunol.0903909; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Ueno K, 2008, AM J RESP CELL MOL, V38, P263, DOI 10.1165/rcmb.2007-0336RC; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Wong CK, 2007, AM J RESP CELL MOL, V37, P85, DOI 10.1165/rcmb.2006-0457OC; Xystrakis E, 2007, CURR OPIN ALLERGY CL, V7, P535, DOI 10.1097/ACI.0b013e3282f14d7c	40	39	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55307	10.1371/journal.pone.0055307	http://dx.doi.org/10.1371/journal.pone.0055307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393567	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800021
J	Latronico, T; Brana, MT; Gramegna, P; Fasano, A; Di Bari, G; Liuzzi, GM				Latronico, Tiziana; Brana, Maria Teresa; Gramegna, Pasqua; Fasano, Anna; Di Bari, Gaetano; Liuzzi, Grazia Maria			Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; MATRIX METALLOPROTEINASES; CELL-CULTURES; BASIC-PROTEIN; IFN-BETA; EXPRESSION; TISSUE; MATRIX-METALLOPROTEINASE-9; ENCEPHALOMYELITIS	Background: Proteolytic enzymes have been implicated in the pathogenesis of Multiple Sclerosis (MS) for both their ability to degrade myelin proteins and for their presence in MS plaques. In this study we investigated whether interferon-beta (IFN-beta) could differently modulate the activity and the expression of proteolytic activities against myelin basic protein (MBP) present in lipopolysaccharide (LPS)-activated astrocytes. Methodology/Principal Findings: Rat astrocyte cultures were activated with LPS and simultaneously treated with different doses of IFN-beta. To assess the presence of MBP-cleaving proteolytic activity, culture supernatants and cellular extracts collected from astrocytes were incubated with exogenous MBP. A MBP-degrading activity was found in both lysates and supernatants from LPS-activated astrocytes and was dose-dependently inhibited by IFN-beta. The use of protease inhibitors as well as the zymographic analysis indicated the presence of calpain II (CANP-2) in cell lysates and gelatinases A (MMP-2) and B (MMP-9) in cell supernatants. RT-PCR revealed that the expression of CANP-2 as well as of MMP-2 and MMP-9 was increased in LPS-activated astrocytes and was dose-dependently inhibited by IFN-beta treatment. The expression of calpastatin, the natural inhibitor of CANPs, was not affected by IFN-beta treatment. By contrast, decreased expression of TIMP-1 and TIMP-2, the natural inhibitors of MMP-9 and MMP-2, respectively, was observed in IFN-beta-treated astrocytes compared to LPS-treated cells. The ratio enzyme/inhibitor indicated that the effect of IFN-beta treatment is more relevant to CANP-2 than on MMPs. Conclusions/Significance: These results suggest that the neuroinflammatory damage during MS involves altered balance between multiple proteases and their inhibitors and indicate that IFN-beta is effective in regulating different enzymatic systems involved in MS pathogenesis.	[Latronico, Tiziana; Brana, Maria Teresa; Gramegna, Pasqua; Fasano, Anna; Di Bari, Gaetano; Liuzzi, Grazia Maria] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Liuzzi, GM (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	graziamaria.liuzzi@uniba.it	Branà, Maria Teresa/P-6874-2018; Liuzzi, Grazia Maria/GVR-7164-2022	Branà, Maria Teresa/0000-0002-0878-9363; Liuzzi, Grazia Maria/0000-0001-5692-9335; Latronico, Tiziana/0000-0001-6971-5416	Italian Foundation for Multiple Sclerosis (FISM) [2005/R/13, 2009/R/16]	Italian Foundation for Multiple Sclerosis (FISM)(Fondazione Italiana Sclerosi Multipla (FISM))	This work was supported by funding from the Italian Foundation for Multiple Sclerosis (FISM) (grants numbers 2005/R/13 and 2009/R/16 to G. M. L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Bartholome EJ, 2001, J INTERF CYTOK RES, V21, P495, DOI 10.1089/10799900152434367; BARTUS RT, 1995, NEUROL RES, V17, P249, DOI 10.1080/01616412.1995.11740322; Benjelloun N, 1998, CELL MOL BIOL, V44, P579; Benveniste EN, 1995, FASEB J, V9, P1577, DOI 10.1096/fasebj.9.15.8529837; Chandler S, 1995, NEUROSCI LETT, V201, P223, DOI 10.1016/0304-3940(95)12173-0; Croall DE, 2002, ANAL BIOCHEM, V304, P129, DOI 10.1006/abio.2001.5606; Cuzner ML, 1996, J NEUROPATH EXP NEUR, V55, P1194, DOI 10.1097/00005072-199612000-00002; DEIBLER GE, 1972, PREP BIOCHEM, V2, P139, DOI 10.1080/00327487208061467; DESHPANDE RV, 1995, J NEUROSCI RES, V42, P259, DOI 10.1002/jnr.490420214; Diaz-Sanchez M, 2006, ACTA NEUROPATHOL, V111, P289, DOI 10.1007/s00401-006-0045-0; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; GIJBELS K, 1992, J NEUROIMMUNOL, V41, P29, DOI 10.1016/0165-5728(92)90192-N; GIJBELS K, 1994, J CELL BIOCHEM, P143; Gilli F, 2004, BRAIN, V127, P259, DOI 10.1093/brain/awh028; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Guyton MK, 2010, J NEUROSCI RES, V88, P2398, DOI 10.1002/jnr.22408; Guyton MK, 2009, J NEUROCHEM, V110, P1895, DOI 10.1111/j.1471-4159.2009.06287.x; Guyton MK, 2005, J NEUROSCI RES, V81, P53, DOI 10.1002/jnr.20470; Gveric D, 2001, BRAIN, V124, P1978, DOI 10.1093/brain/124.10.1978; Hassen GW, 2006, J NEUROIMMUNOL, V180, P135, DOI 10.1016/j.jneuroim.2006.08.005; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Liuzzi GM, 2004, MULT SCLER, V10, P290, DOI 10.1191/1352458504ms1016oa; Liuzzi GM, 2004, BRAIN, V127, P398, DOI 10.1093/brain/awh049; LIUZZI GM, 1995, J NEUROIMMUNOL, V62, P91, DOI 10.1016/0165-5728(95)00110-N; Liuzzi GM, 2002, MULT SCLER, V8, P222, DOI 10.1191/1352458502ms800oa; Mastroianni M.C., 2002, HIV CLIN TRIALS, V3, P310, DOI [10.1310/u9lj-mff9-are1-257h, DOI 10.1310/U9LJ-MFF9-ARE1-257H]; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; NAKAJIMA K, 1989, BIOMED RES-TOKYO, V10, P411; Opdenakker G, 2003, LANCET NEUROL, V2, P747, DOI 10.1016/S1474-4422(03)00587-8; Opdenakker G, 2011, CYTOKINE GROWTH F R, V22, P359, DOI 10.1016/j.cytogfr.2011.11.005; PROOST P, 1993, BIOCHEM BIOPH RES CO, V192, P1175, DOI 10.1006/bbrc.1993.1540; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; ROSENBERG GA, 1992, BRAIN RES, V576, P203, DOI 10.1016/0006-8993(92)90681-X; Schaecher K, 2002, J NEUROIMMUNOL, V129, P1, DOI 10.1016/S0165-5728(02)00142-X; Shields DC, 1999, J NEUROSCI RES, V55, P533, DOI 10.1002/(SICI)1097-4547(19990301)55:5<533::AID-JNR1>3.0.CO;2-8; Shields DC, 1999, P NATL ACAD SCI USA, V96, P11486, DOI 10.1073/pnas.96.20.11486; Shields DC, 1998, P NATL ACAD SCI USA, V95, P5768, DOI 10.1073/pnas.95.10.5768; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Trojano M, 1999, NEUROLOGY, V53, P1402, DOI 10.1212/WNL.53.7.1402; Waubant E, 2003, NEUROLOGY, V60, P52, DOI 10.1212/WNL.60.1.52; Yong VW, 2007, J NEUROL SCI, V259, P79, DOI 10.1016/j.jns.2006.11.021	43	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e49656	10.1371/journal.pone.0049656	http://dx.doi.org/10.1371/journal.pone.0049656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390485	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100001
J	Merkx, MAG; Huberts, W; Bosboom, EMH; Bode, AS; Bescos, JO; Tordoir, JHM; Breeuwer, M; van de Vosse, FN				Merkx, Maarten A. G.; Huberts, Wouter; Bosboom, E. Marielle H.; Bode, Aron S.; Bescos, Javier Olivan; Tordoir, Jan H. M.; Breeuwer, Marcel; van de Vosse, Frans N.			The Benefit of Non Contrast-Enhanced Magnetic Resonance Angiography for Predicting Vascular Access Surgery Outcome: A Computer Model Perspective	PLOS ONE			English	Article							PULSE-WAVE PROPAGATION; STAGE RENAL-DISEASE; BLOOD-FLOW; EXPERIMENTAL VALIDATION; ARTERIOVENOUS-FISTULAS; HEMODYNAMICS; ACCURACY; VESSELS	Introduction: Vascular access (VA) surgery, a prerequisite for hemodialysis treatment of end-stage renal-disease (ESRD) patients, is hampered by complication rates, which are frequently related to flow enhancement. To assist in VA surgery planning, a patient-specific computer model for postoperative flow enhancement was developed. The purpose of this study is to assess the benefit of non contrast-enhanced magnetic resonance angiography (NCE-MRA) data as patient-specific geometrical input for the model-based prediction of surgery outcome. Methods: 25 ESRD patients were included in this study. All patients received a NCE-MRA examination of the upper extremity blood vessels in addition to routine ultrasound (US). Local arterial radii were assessed from NCE-MRA and converted to model input using a linear fit per artery. Venous radii were determined with US. The effect of radius measurement uncertainty on model predictions was accounted for by performing Monte-Carlo simulations. The resulting flow prediction interval of the computer model was compared with the postoperative flow obtained from US. Patients with no overlap between model-based prediction and postoperative measurement were further analyzed to determine whether an increase in geometrical detail improved computer model prediction. Results: Overlap between postoperative flows and model-based predictions was obtained for 71% of patients. Detailed inspection of non-overlapping cases revealed that the geometrical details that could be assessed from NCE-MRA explained most of the differences, and moreover, upon addition of these details in the computer model the flow predictions improved. Conclusions: The results demonstrate clearly that NCE-MRA does provide valuable geometrical information for VA surgery planning. Therefore, it is recommended to use this modality, at least for patients at risk for local or global narrowing of the blood vessels as well as for patients for whom an US-based model prediction would not overlap with surgical choice, as the geometrical details are crucial for obtaining accurate flow predictions.	[Merkx, Maarten A. G.; Bosboom, E. Marielle H.] Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands; [Huberts, Wouter; Breeuwer, Marcel; van de Vosse, Frans N.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Bode, Aron S.; Tordoir, Jan H. M.] Maastricht Univ, Med Ctr, Dept Vasc Surg, Maastricht, Netherlands; [Bescos, Javier Olivan] Philips Healthcare, Dept Intervent Xray, Best, Netherlands; [Breeuwer, Marcel] Philips Healthcare, Dept MR Clin Sci, Best, Netherlands	Maastricht University; Eindhoven University of Technology; Maastricht University; Philips; Philips Healthcare; Philips; Philips Healthcare	Merkx, MAG (corresponding author), Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands.	m.a.g.merkx@alumnus.tue.nl	van de Vosse, Frans N/I-4006-2013; Tordoir, Jan/AAE-4083-2020	van de Vosse, Frans N/0000-0002-4084-2064; Huberts, Wouter/0000-0002-0779-4785	ARCH project [ICT-224390]; European Commission	ARCH project; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was carried out in the context of the ARCH project (ICT-224390) funded by the 7th Framework programme of the European Commission (http://ec.europa.eu/information_society/activities/health/research/fp7vph/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; [Anonymous], 2006, AM J KIDNEY DIS, V48, pS4, DOI 10.1053/j.ajkd.2006.07.015; Bessems D., 2007, THESIS EINDHOVEN U T; Bessems D, 2007, J FLUID MECH, V580, P145, DOI 10.1017/S0022112007005344; Bode A, 2011, J VASC ACCESS, V12, P369, DOI 10.5301/JVA.2011.8382; Bode AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034491; Bode AS, 2011, EUR J VASC ENDOVASC, P88; Dammers R, 2005, ULTRASOUND MED BIOL, V31, P1327, DOI 10.1016/j.ultrasmedbio.2005.03.017; Deschamps T., 2001, THESIS U PARIS 9 DAU; Gjesdal KI, 2009, EUR RADIOL, V19, P110, DOI 10.1007/s00330-008-1113-8; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Grassmann A, 2006, ARTIF ORGANS, V30, P895, DOI 10.1111/j.1525-1594.2006.00321.x; HAACKE EM, 1990, RADIOLOGY, V175, P545, DOI 10.1148/radiology.175.2.2326480; Hoogeveen RM, 1998, JMRI-J MAGN RESON IM, V8, P1228, DOI 10.1002/jmri.1880080608; Huberts W, 2012, J BIOMECH, V45, P1684, DOI 10.1016/j.jbiomech.2012.03.028; Huberts W, 2012, MED ENG PHYS UNPUB; Huberts W, 2011, MED ENG PHYS; HUDSON DJ, 1966, J AM STAT ASSOC, V61, P1097, DOI 10.2307/2283203; Kroon JW, 2012, COMPUTATION IN PRESS; Kumar V, 2007, ROBBINS BASIC PATHOL; Lotz J, 2002, RADIOGRAPHICS, V22, P651, DOI 10.1148/radiographics.22.3.g02ma11651; Malovrh M, 1998, NEPHROL DIAL TRANSPL, V13, P125, DOI 10.1093/ndt/13.1.125; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Merkx M, 2012, ASSISTING VASC UNPUB; Merkx M, 2012, J VASCULAR IN PRESS; Merkx MAG, 2012, J MAGN RESON IMAGING, V36, P1186, DOI 10.1002/jmri.23752; Mulder G, 2011, MED ENG PHYS, V33, P195, DOI 10.1016/j.medengphy.2010.09.021; Olufsen MS, 2000, ANN BIOMED ENG, V28, P1281, DOI 10.1114/1.1326031; Planken RN, 2006, J VASC SURG, V44, P353, DOI 10.1016/j.jvs.2006.04.038; Planken RN, 2006, NEPHROL DIAL TRANSPL, V21, P802, DOI 10.1093/ndt/gfi340; Shemesh D, 2007, ULTRASOUND MED BIOL, V33, P727, DOI 10.1016/j.ultrasmedbio.2006.11.019; Tordoir J H, 1990, Eur J Vasc Surg, V4, P179, DOI 10.1016/S0950-821X(05)80434-7; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; Tordoir JHM, 2003, NEPHROL DIAL TRANSPL, V18, P378, DOI 10.1093/ndt/18.2.378; Tordoir JHM, 2004, EUR J VASC ENDOVASC, V27, P1, DOI 10.1016/j.ejvs.2003.10.007; van de Vosse FN, 2011, ANNU REV FLUID MECH, V43, P467, DOI 10.1146/annurev-fluid-122109-160730; WESTERHOF N, 1973, MED BIOL ENG, V11, P710, DOI 10.1007/BF02478659; Wijnen E, 2005, ARTIF ORGANS, V29, P960, DOI 10.1111/j.1525-1594.2005.00165.x; Wolters BJBM, 2007, MED ENG PHYS, V29, P1106, DOI 10.1016/j.medengphy.2006.11.008	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e53615	10.1371/journal.pone.0053615	http://dx.doi.org/10.1371/journal.pone.0053615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390490	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100006
J	Premanand, B; Prabakaran, M; Kiener, TK; Kwang, J				Premanand, Balraj; Prabakaran, Mookkan; Kiener, Tanja K.; Kwang, Jimmy			Recombinant Baculovirus Associated with Bilosomes as an Oral Vaccine Candidate against HEV71 Infection in Mice	PLOS ONE			English	Article							LETHAL ENTEROVIRUS-71 INFECTION; T-CELL RESPONSES; TOXIN B-SUBUNIT; INFLUENZA-VIRUS; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; GENE-DELIVERY; NEWBORN MICE; IMMUNIZATION; PROTECTION	Background: Human enterovirus 71 (HEV71) is one of the major pathogen responsible for hand, foot and mouth disease (HFMD). Currently no effective vaccine or antiviral drugs are available. Like poliovirus, EV71 is transmitted mainly by the feco-oral route. To date the majority of the studied EV71 vaccine candidates are administered parenterally. Injectable vaccines induce good systemic immunity but mucosal responses are often unsatisfactory, whereas mucosal vaccines provide both systemic and mucosal immunity. Therefore, oral immunization appears to be an attractive alternative to parenteral immunization. Methodology/Principal Findings: In this report, we studied the efficacy of an orally administered vaccine candidate developed using recombinant baculovirus displaying VP1 (Bac-VP1) in a murine model. Gastrointestinal delivery of Bac-VP1 significantly induced VP1-specific humoral (IgG) and mucosal (IgA) immune responses. Further, we studied the efficacy of the Bac-VP1 associated with bilosomes and observed that the Bac-VP1 associated with bilosomes elicited significantly higher immune responses compared to bilosomes non-associated with Bac-VP1. However, mice immunized subcutaneously with live Bac-VP1 had significantly enhanced VP1 specific serum IgG levels and higher neutralizing antibody titers compared with mice orally immunized with live Bac-VP1 alone or associated with bilosomes. Conclusion: Bilosomes have been shown to possess inherent adjuvant properties when associated with antigen. Therefore Bac-VP1 with bilosomes could be a promising oral vaccine candidate against EV71 infections. Thus, Bac-VP1 loaded bilosomes may provide a needle free, painless approach for immunization against EV71, thereby increasing patient compliance and consequently increasing vaccination coverage.	[Premanand, Balraj; Prabakaran, Mookkan; Kiener, Tanja K.; Kwang, Jimmy] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Kwang, Jimmy] Natl Univ Singapore, Fac Med, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Kwang, J (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	kwang@tll.org.sg		Prabakaran, Mookkan/0000-0002-9816-5908	Temasek Life Sciences Laboratory	Temasek Life Sciences Laboratory(National University of Singapore)	This project is funded by Temasek Life Sciences Laboratory (http://www.tll.org.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarthi D, 2004, BIOLOGICALS, V32, P153, DOI 10.1016/j.biologicals.2004.09.001; Allaoui-Attarki K, 1998, VACCINE, V16, P685, DOI 10.1016/S0264-410X(97)00261-2; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; BREWER JM, 1995, VACCINE, V13, P1441, DOI 10.1016/0264-410X(95)00065-9; Chen SC, 1998, J VIROL, V72, P5757, DOI 10.1128/JVI.72.7.5757-5761.1998; Cheng XJ, 2001, PARASITOL RES, V87, P126, DOI 10.1007/s004360000323; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Conacher M, 2001, VACCINE, V19, P2965, DOI 10.1016/S0264-410X(00)00537-5; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; FRY DW, 1978, ANAL BIOCHEM, V90, P809, DOI 10.1016/0003-2697(78)90172-0; GHAZI HO, 1995, J MED MICROBIOL, V42, P53, DOI 10.1099/00222615-42-1-53; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Hu YC, 2003, ENZYME MICROB TECH, V33, P445, DOI 10.1016/S0141-0229(03)00143-1; Isaka M, 2001, VACCINE, V19, P1460, DOI 10.1016/S0264-410X(00)00348-0; Kinnunen K, 2009, J GENE MED, V11, P382, DOI 10.1002/jgm.1311; Kolpe AB, 2012, VIRUS RES, V168, P64, DOI 10.1016/j.virusres.2012.06.014; Kost TA, 2002, TRENDS BIOTECHNOL, V20, P173, DOI 10.1016/S0167-7799(01)01911-4; LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0; Lavelle Ed C, 2006, Expert Opin Drug Deliv, V3, P747, DOI 10.1517/17425247.3.6.747; Li XL, 2009, BIOCHEM BIOPH RES CO, V390, P1126, DOI 10.1016/j.bbrc.2009.09.103; Liu JN, 2010, VACCINE, V28, P7444, DOI 10.1016/j.vaccine.2010.08.080; Lotter H, 2004, INFECT IMMUN, V72, P7318, DOI 10.1128/IAI.72.12.7318-7321.2004; Lotter H, 2008, INT J MED MICROBIOL, V298, P79, DOI 10.1016/j.ijmm.2007.07.001; MALOY KJ, 1995, EUR J IMMUNOL, V25, P2835, DOI 10.1002/eji.1830251019; Mann BJ, 1997, VACCINE, V15, P659, DOI 10.1016/S0264-410X(96)00236-8; Mann JFS, 2009, VACCINE, V27, P3643, DOI 10.1016/j.vaccine.2009.03.040; Mann JFS, 2006, METHODS, V38, P90, DOI 10.1016/j.ymeth.2005.11.002; Mann JFS, 2004, VACCINE, V22, P2425, DOI 10.1016/j.vaccine.2003.11.067; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Meng T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021757; MOLDOVEANU Z, 1993, J INFECT DIS, V167, P84, DOI 10.1093/infdis/167.1.84; Musthaq SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026428; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI, P60; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Pauletti GM, 1996, J CONTROL RELEASE, V41, P3, DOI 10.1016/0168-3659(96)01352-1; PFAFF E, 1988, J VIROL, V62, P2033, DOI 10.1128/JVI.62.6.2033-2040.1988; Prabakaran M, 2010, J VIROL, V84, P3201, DOI 10.1128/JVI.02175-09; Premanand B, 2012, ANTIVIR RES, V95, P311, DOI 10.1016/j.antiviral.2012.05.017; RUECKERT R R, 1990, P507; Rueda P, 2000, VACCINE, V19, P726, DOI 10.1016/S0264-410X(00)00259-0; SHALABY WSW, 1995, CLIN IMMUNOL IMMUNOP, V74, P127, DOI 10.1006/clin.1995.1019; Shoji I, 1997, J GEN VIROL, V78, P2657, DOI 10.1099/0022-1317-78-10-2657; Singh P, 2004, INT J PHARMACEUT, V278, P379, DOI 10.1016/j.ijpharm.2004.03.014; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Tan CS, 2007, ARCH VIROL, V152, P1069, DOI 10.1007/s00705-007-0941-1; Tani H, 2003, J VIROL, V77, P9799, DOI 10.1128/JVI.77.18.9799-9808.2003; TJIA ST, 1983, VIROLOGY, V125, P107; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Watarai S, 1998, J VET MED SCI, V60, P1047, DOI 10.1292/jvms.60.1047; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1	52	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55536	10.1371/journal.pone.0055536	http://dx.doi.org/10.1371/journal.pone.0055536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390538	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100054
J	Li, B; Ze, YG; Sun, QQ; Zhang, T; Sang, XZ; Cui, YL; Wang, XC; Gui, SX; Tan, DL; Zhu, M; Zhao, XY; Sheng, L; Wang, L; Hong, FS; Tang, M				Li, Bing; Ze, Yuguan; Sun, Qingqing; Zhang, Ting; Sang, Xuezi; Cui, Yaling; Wang, Xiaochun; Gui, Suxin; Tan, Danlin; Zhu, Min; Zhao, Xiaoyang; Sheng, Lei; Wang, Ling; Hong, Fashui; Tang, Meng			Molecular Mechanisms of Nanosized Titanium Dioxide-Induced Pulmonary Injury in Mice	PLOS ONE			English	Article							INHALATION EXPOSURE; QUANTITATIVE PCR; IMMUNE-RESPONSES; NANOPARTICLES; EXPRESSION; LUNG; IDENTIFICATION; INFLAMMATION; VALIDATION; PARTICLES	The pulmonary damage induced by nanosized titanium dioxide (nano-TiO2) is of great concern, but the mechanism of how this damage may be incurred has yet to be elucidated. Here, we examined how multiple genes may be affected by nano-TiO2 exposure to contribute to the observed damage. The results suggest that long-term exposure to nano-TiO2 led to significant increases in inflammatory cells, and levels of lactate dehydrogenase, alkaline phosphate, and total protein, and promoted production of reactive oxygen species and peroxidation of lipid, protein and DNA in mouse lung tissue. We also observed nano-TiO2 deposition in lung tissue via light and confocal Raman microscopy, which in turn led to severe pulmonary inflammation and pneumonocytic apoptosis in mice. Specifically, microarray analysis showed significant alterations in the expression of 847 genes in the nano-TiO2-exposed lung tissues. Of 521 genes with known functions, 361 were up-regulated and 160 down-regulated, which were associated with the immune/inflammatory responses, apoptosis, oxidative stress, the cell cycle, stress responses, cell proliferation, the cytoskeleton, signal transduction, and metabolic processes. Therefore, the application of nano-TiO2 should be carried out cautiously, especially in humans.	[Li, Bing; Ze, Yuguan; Sun, Qingqing; Sang, Xuezi; Cui, Yaling; Wang, Xiaochun; Gui, Suxin; Tan, Danlin; Zhu, Min; Zhao, Xiaoyang; Sheng, Lei; Wang, Ling; Hong, Fashui] Soochow Univ, Coll Med, Suzhou, Peoples R China; [Zhang, Ting; Tang, Meng] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med & Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, Ting; Tang, Meng] Southeast Univ, Jiangsu Key Lab Biomat & Devices, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Southeast University - China; Southeast University - China	Hong, FS (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	Hongfsh_cn@sina.com; tm@seu.ecu.cn	li, bing/GWQ-9617-2022		National Natural Science Foundation of China [81273036, 30901218, 81172697, 30671782, 30972504]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Major State Basic Research Development Program of China (973 Program) [2006CB705602]; National Important Project on Scientific Research of China [2011CB933404]; National Ideas Foundation of Student of Soochow University [111028534]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Important Project on Scientific Research of China; National Ideas Foundation of Student of Soochow University	This work was supported by the National Natural Science Foundation of China (grant numbers 81273036, 30901218, 81172697), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Major State Basic Research Development Program of China (973 Program) (grant number 2006CB705602), National Important Project on Scientific Research of China (grant number 2011CB933404), National Natural Science Foundation of China (grant numbers 30671782, 30972504) and the National Ideas Foundation of Student of Soochow University (grant number 111028534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque W, 2004, J PEDIATR-US, V144, P278, DOI 10.1016/j.jpeds.2003.10.055; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Cai YP, 2009, J IMMUNOL, V182, P5393, DOI 10.4049/jimmunol.0803874; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chen HW, 2006, FASEB J, V20, P2393, DOI 10.1096/fj.06-6485fje; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; Donaldson K, 2001, OCCUP ENVIRON MED, V58, P211, DOI 10.1136/oem.58.3.211; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fozard JR, 1999, PULM PHARMACOL THER, V12, P111, DOI 10.1006/pupt.1999.0191; Fujita K, 2009, TOXICOLOGY, V258, P47, DOI 10.1016/j.tox.2009.01.005; Grassian VH, 2007, ENVIRON HEALTH PERSP, V115, P397, DOI 10.1289/ehp.9469; Hirschorn R, 2006, PRIMARY IMMUNODEFICI, P169; Hoyt VW, 2008, J CHEM HEALTH SAF, V15, P10, DOI 10.1016/j.jchas.2007.07.015; Hu RP, 2011, J HAZARD MATER, V191, P32, DOI 10.1016/j.jhazmat.2011.04.027; Inoue K, 2009, TOXICOL APPL PHARM, V234, P68, DOI 10.1016/j.taap.2008.09.012; Ito Y, 2002, INT J MOL MED, V9, P373; Jacobson Marlene A., 1997, P315; Jortner J, 2002, PURE APPL CHEM, V74, P1491, DOI 10.1351/pac200274091491; Kacharmina JE, 1999, METHOD ENZYMOL, V303, P3; Kajimoto K, 2005, CIRC J, V69, P1029, DOI 10.1253/circj.69.1029; Kaminski Naftali, 2006, Proc Am Thorac Soc, V3, P339, DOI 10.1513/pats.200601-011TK; Katsuma S, 2001, BIOCHEM BIOPH RES CO, V288, P747, DOI 10.1006/bbrc.2001.5853; Ke LD, 2000, MOL CELL PROBE, V14, P127, DOI 10.1006/mcpr.2000.0288; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Li JA, 2007, ENVIRON TOXICOL PHAR, V24, P239, DOI 10.1016/j.etap.2007.06.004; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Liu R, 2009, PROG NAT SCI-MATER, V19, P573, DOI 10.1016/j.pnsc.2008.06.020; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; McDowell SA, 2003, AM J RESP CELL MOL, V28, P188, DOI 10.1165/rcmb.2002-0077OC; Mohsenin A, 2007, AM J PHYSIOL-LUNG C, V293, pL753, DOI 10.1152/ajplung.00187.2007; Monteiller C, 2007, OCCUP ENVIRON MED, V64, P609, DOI 10.1136/oem.2005.024802; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Pan Z, 2009, SMALL, V5, P511, DOI 10.1002/smll.200800798; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Roco M. C., 2001, SOC IMPLICATIONS NAN; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Studer Sean M, 2007, Proc Am Thorac Soc, V4, P85, DOI 10.1513/pats.200607-139JG; Sun QQ, 2012, J HAZARD MATER, V235, P47, DOI 10.1016/j.jhazmat.2012.05.072; Sun QQ, 2012, J BIOMED MATER RES A, V100A, P2554, DOI 10.1002/jbm.a.34190; Thurn KT, 2011, NANOMED-NANOTECHNOL, V7, P123, DOI 10.1016/j.nano.2010.09.004; Whiston EA, 2008, INFECT IMMUN, V76, P1781, DOI 10.1128/IAI.01285-07; Yang P, 2002, MATER LETT, V57, P794, DOI 10.1016/S0167-577X(02)00875-3	48	47	47	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55563	10.1371/journal.pone.0055563	http://dx.doi.org/10.1371/journal.pone.0055563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409001	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200040
J	Malizia, N				Malizia, Nicholas			Inaccuracy, Uncertainty and the Space-Time Permutation Scan Statistic	PLOS ONE			English	Article							POSITIONAL ACCURACY; SPATIOTEMPORAL ANALYSIS; CRIME; CONFIDENTIALITY; INFLUENZA; DIFFUSION; CLUSTERS; CANCER; POINT	The space-time permutation scan statistic (STPSS) is designed to identify hot (and cool) spots of space-time interaction within patterns of spatio-temporal events. While the method has been adopted widely in practice, there has been little consideration of the effect inaccurate and/or incomplete input data may have on its results. Given the pervasiveness of inaccuracy, uncertainty and incompleteness within spatio-temporal datasets and the popularity of the method, this issue warrants further investigation. Here, a series of simulation experiments using both synthetic and real-world data are carried out to better understand how deficiencies in the spatial and temporal accuracy as well as the completeness of the input data may affect results of the STPSS. The findings, while specific to the parameters employed here, reveal a surprising robustness of the method's results in the face of these deficiencies. As expected, the experiments illustrate that greater degradation of input data quality leads to greater variability in the results. Additionally, they show that weaker signals of space-time interaction are those most affected by the introduced deficiencies. However, in stark contrast to previous investigations into the impact of these input data problems on global tests of space-time interaction, this local metric is revealed to be only minimally affected by the degree of inaccuracy and incompleteness introduced in these experiments.	Arizona State Univ, GeoDa Ctr Geospatial Anal & Computat, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Malizia, N (corresponding author), Arizona State Univ, GeoDa Ctr Geospatial Anal & Computat, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA.	nmalizia@asu.edu			U.S. National Science Foundation through a Graduate Research Fellowship; National Institute of Justice, Office of Justice Programs, U.S. Department of Justice;  [2009-SQ-B9-K101]	U.S. National Science Foundation through a Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Justice, Office of Justice Programs, U.S. Department of Justice; 	This work was supported by the U.S. National Science Foundation through a Graduate Research Fellowship to Nicholas Malizia. Additionally, the work was supported by Award No. 2009-SQ-B9-K101 awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication are those of the author and do not necessarily reflect those of the Department of Justice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WD, 2007, SOUTH ECON J, V73, P623, DOI 10.2307/20111915; Armstrong MP, 1999, STAT MED, V18, P497, DOI 10.1002/(SICI)1097-0258(19990315)18:5<497::AID-SIM45>3.3.CO;2-R; Bonner MR, 2003, EPIDEMIOLOGY, V14, P408, DOI 10.1097/01.EDE.0000073121.63254.c5; Burra T, 2002, CAN GEOGR-GEOGR CAN, V46, P160, DOI 10.1111/j.1541-0064.2002.tb00737.x; Carcach Carlos A., 1997, TRENDS ISSUES CRIME, V68; Cayo Michael R, 2003, Int J Health Geogr, V2, P10, DOI 10.1186/1476-072X-2-10; Cooper DL, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-16; Curriero FC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008998; DeLuca PF, 2008, J SPAT SCI, V53, P131, DOI 10.1080/14498596.2008.9635141; Diggle P J, 1995, Stat Methods Med Res, V4, P124, DOI 10.1177/096228029500400203; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; Duffy KJ, 2011, CONSERV BIOL, V25, P392, DOI 10.1111/j.1523-1739.2010.01612.x; Eterno JA, 2012, ADV POLIC THEOR PRAC, P1, DOI 10.1201/b11477; Fefferman NH, 2005, J PUBLIC HEALTH POL, V26, P430, DOI 10.1057/palgrave.jphp.3200029; Fischer EAJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-126; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Goldberg D W, 2007, URISA J, V19, P33, DOI DOI 10.1079/9781780640891.0051; GOODCHILD MF, 1989, ACCURACY OF SPATIAL DATABASES, P107; Haas AJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-22; Hagerstrand T., 1970, PAPERS REGIONAL SCI, VXXIV, P6, DOI [DOI 10.1007/BF01936872, 10/bkqqfc]; Hyder K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-14; Jacquez Geoffrey M, 2004, Int J Health Geogr, V3, P22, DOI 10.1186/1476-072X-3-22; Jacquez GM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-60; Jacquez GM, 1996, STAT MED, V15, P1935, DOI 10.1002/(SICI)1097-0258(19960930)15:18<1935::AID-SIM406>3.0.CO;2-I; Jacquez GM, 2000, QUANTIFYING SPATIAL, P53; Jeffery C, 2009, J AM MED INFORM ASSN, V16, P847, DOI 10.1197/jamia.M2788; KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25; Kravets N, 2007, HEALTH PLACE, V13, P293, DOI 10.1016/j.healthplace.2005.08.006; Krieger N, 2001, AM J PUBLIC HEALTH, V91, P1114, DOI 10.2105/AJPH.91.7.1114; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2010, SATSCAN V9 0 SOFTWAR; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kwan M, 2004, CARTOGRAPHICA, V39, P15, DOI DOI 10.3138/X204-4223-57MK-8273; Malizia N, 2012, T GIS IN PRESS; MANTEL N, 1967, CANCER RES, V27, P209; Mazumdar S, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-13; McNally RJQ, 2009, HEPATOLOGY, V50, P1169, DOI 10.1002/hep.23139; Miller H, 2007, GEOGR COMPASS, V1, P503, DOI 10.1111/j.1749-8198.2007.00025.x; Mosher C.J., 2010, MISMEASURE CRIME; O'Loughlin J, 2011, ANN ASSOC AM GEOGR, V101, P178, DOI 10.1080/00045608.2010.534713; O'Loughlin J, 2010, EURASIAN GEOGR ECON, V51, P437, DOI 10.2747/1539-7216.51.4.437; Ozonoff A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-52; Poljak Z, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-59; Ratcliffe J, 1998, INT J GEOGR INF SCI, V12, P751, DOI 10.1080/136588198241644; Ratcliffe JH, 2000, INT J GEOGR INF SCI, V14, P669, DOI 10.1080/136588100424963; Ratcliffe JH, 2002, J QUANT CRIMINOL, V18, P23, DOI 10.1023/A:1013240828824; Ratcliffe JH, 2004, INT J GEOGR INF SCI, V18, P61, DOI 10.1080/13658810310001596076; Ratcliffe JH, 2001, INT J GEOGR INF SCI, V15, P473, DOI 10.1080/13658810110047221; Recuenco S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-14; Rushton G, 2006, AM J PREV MED, V30, pS16, DOI 10.1016/j.amepre.2005.09.011; Seidman D, 1973, LAW SOC REV, V8, P457; Takahashi K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-14; Tango T, 2010, STAT METHODS DIS CLU; Tarling R, 2010, BRIT J CRIMINOL, V50, P474, DOI 10.1093/bjc/azq011; Tuia D, 2008, COMMUN NONLINEAR SCI, V13, P1689, DOI 10.1016/j.cnsns.2007.03.004; Unwin DJ, 1995, PROG HUM GEOG, V19, P549, DOI 10.1177/030913259501900408; VanWey LK, 2005, P NATL ACAD SCI USA, V102, P15337, DOI 10.1073/pnas.0507804102; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Ward MH, 2005, EPIDEMIOLOGY, V16, P542, DOI 10.1097/01.ede.0000165364.54925.f3; Ward MP, 2008, VET RES, V39, DOI 10.1051/vetres:2007063; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; Whitsel Eric A, 2006, Epidemiol Perspect Innov, V3, P8, DOI 10.1186/1742-5573-3-8; Wieland SC, 2008, P NATL ACAD SCI USA, V105, P17608, DOI 10.1073/pnas.0801021105; Zandbergen PA, 2008, COMPUT ENVIRON URBAN, V32, P214, DOI 10.1016/j.compenvurbsys.2007.11.006; Zandbergen PA, 2011, T GIS, V15, P495, DOI 10.1111/j.1467-9671.2011.01277.x; Zandbergen PA, 2011, GEOCARTO INT, V26, P35, DOI 10.1080/10106049.2010.537374; Zandbergen Paul A., 2009, CRIMINAL JUSTICE POL, V20, P62, DOI DOI 10.1177/0887403408323690; Zhan FB, 2006, ANN EPIDEMIOL, V16, P842, DOI 10.1016/j.annepidem.2006.08.001; Zhang J., 2002, UNCERTAINTY GEOGRAPH; Zimmerman DL, 2008, STAT MED, V27, P4254, DOI 10.1002/sim.3288; Zinszer K, 2010, SPAT SPATIO-TEMPORAL, V1, P163, DOI 10.1016/j.sste.2010.03.002	73	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e52034	10.1371/journal.pone.0052034	http://dx.doi.org/10.1371/journal.pone.0052034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408930	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200004
J	Ainley, V; Tsakiris, M				Ainley, Vivien; Tsakiris, Manos			Body Conscious? Interoceptive Awareness, Measured by Heartbeat Perception, Is Negatively Correlated with Self-Objectification	PLOS ONE			English	Article							FOCUSED ATTENTION; CARDIAC AWARENESS; ANOREXIA-NERVOSA; BEAT PERCEPTION; PRIVATE; ALEXITHYMIA; SENSITIVITY; VALIDATION; REACTIVITY; EXPERIENCE	Background: 'Self-objectification' is the tendency to experience one's body principally as an object, to be evaluated for its appearance rather than for its effectiveness. Within objectification theory, it has been proposed that self-objectification accounts for the poorer interoceptive awareness observed in women, as measured by heartbeat perception. Our study is, we believe, the first specifically to test this relationship. Methodology/Principal Findings: Using a well-validated and reliable heartbeat perception task, we measured interoceptive awareness in women and compared this with their scores on the Self-Objectification Questionnaire, the Self-Consciousness Scale and the Body Consciousness Questionnaire. Interoceptive awareness was negatively correlated with self-objectification. Interoceptive awareness, public body consciousness and private body consciousness together explained 31% of the variance in self-objectification. However, private body consciousness was not significantly correlated with interoceptive awareness, which may explain the many nonsignificant results in self-objectification studies that have used private body consciousness as a measure of body awareness. Conclusions/Significance: We propose interoceptive awareness, assessed by heartbeat perception, as a measure of body awareness in self-objectification studies. Our findings have implications for those clinical conditions, in women, which are characterised by self-objectification and low interoceptive awareness, such as eating disorders.	[Ainley, Vivien; Tsakiris, Manos] Royal Holloway Univ London, Dept Psychol, London, England	University of London; Royal Holloway University London	Ainley, V (corresponding author), Royal Holloway Univ London, Dept Psychol, London, England.	Vivien.Ainley.2008@live.rhul.ac.uk	TSAKIRIS, MANOS/C-1529-2008	TSAKIRIS, MANOS/0000-0001-7753-7576; Ainley, Vivien/0000-0003-0373-0079	European Platform for Life Sciences, Mind Sciences and Humanities, Volkswagen Foundation [II/85 064]	European Platform for Life Sciences, Mind Sciences and Humanities, Volkswagen Foundation	This study was funded by the European Platform for Life Sciences, Mind Sciences and Humanities, Volkswagen Foundation (II/85 064) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley V, 2012, PSYCHOPHYSIOLOGY, V49, P1672, DOI 10.1111/j.1469-8986.2012.01468.x; Anderson EM, 1996, J PERS ASSESS, V66, P144, DOI 10.1207/s15327752jpa6601_11; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; BLASCOVICH J, 1992, J PERS SOC PSYCHOL, V63, P164, DOI 10.1037/0022-3514.63.1.164; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Buss A. H., 1975, TEMPERAMENT THEORY P; Cameron O.G., 2002, VISCERAL SENSORY NEU; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; CARVER CS, 1978, J PERS SOC PSYCHOL, V36, P324, DOI 10.1037/0022-3514.36.3.324; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Damasio Antonio, 2010, SELF COMES MIND CONS; Dunn BD, 2007, J ABNORM PSYCHOL, V116, P1, DOI 10.1037/0021-843X.116.1.1; Duval S., 1972, THEORY OBJECTIVE SEL; EHLERS A, 1992, J ABNORM PSYCHOL, V101, P371, DOI 10.1037/0021-843X.101.3.371; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Fairclough SH, 2007, J PSYCHOSOM RES, V62, P289, DOI 10.1016/j.jpsychores.2006.10.017; Fejfar MC, 2000, PERS SOC PSYCHOL REV, V4, P132, DOI 10.1207/S15327957PSPR0402_02; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Fredrickson BL, 1998, J PERS SOC PSYCHOL, V75, P269, DOI 10.1037/0022-3514.75.1.269; Fredrickson BL, 1997, PSYCHOL WOMEN QUART, V21, P173, DOI 10.1111/j.1471-6402.1997.tb00108.x; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; GARNER DM, 1976, PSYCHOSOM MED, V38, P327, DOI 10.1097/00006842-197609000-00005; HARVER A, 1993, PSYCHOPHYSIOLOGY, V30, P223, DOI 10.1111/j.1469-8986.1993.tb03347.x; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036646; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; JENNINGS JR, 1981, PSYCHOPHYSIOLOGY, V18, P226, DOI 10.1111/j.1469-8986.1981.tb03023.x; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Khalsa SS, 2008, PSYCHOPHYSIOLOGY, V45, P671, DOI 10.1111/j.1469-8986.2008.00666.x; Knapp-Kline K, 2005, BIOL PSYCHOL, V69, P387, DOI 10.1016/j.biopsycho.2004.09.002; KNOLL JF, 1992, PSYCHOPHYSIOLOGY, V29, P218, DOI 10.1111/j.1469-8986.1992.tb01689.x; Matthias E, 2009, INT J PSYCHOPHYSIOL, V72, P154, DOI 10.1016/j.ijpsycho.2008.12.001; McKinley NM, 1996, PSYCHOL WOMEN QUART, V20, P181, DOI 10.1111/j.1471-6402.1996.tb00467.x; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; MILLER LC, 1981, J PERS SOC PSYCHOL, V41, P397, DOI 10.1037/0022-3514.41.2.397; Miner-Rubino K, 2002, J RES PERS, V36, P147, DOI 10.1006/jrpe.2001.2343; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Moradi B, 2008, PSYCHOL WOMEN QUART, V32, P377, DOI 10.1111/j.1471-6402.2008.00452.x; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Muehlenkamp JJ, 2002, PSYCHOL WOMEN QUART, V26, P371, DOI 10.1111/1471-6402.t01-1-00076; Mussap AJ, 2006, J HEALTH PSYCHOL, V11, P627, DOI 10.1177/1359105306065022; Mussgay L, 1999, J PSYCHOPHYSIOL, V13, P27, DOI 10.1027//0269-8803.13.1.27; Myers TA, 2008, PSYCHOL WOMEN QUART, V32, P172, DOI 10.1111/j.1471-6402.2008.00421.x; Peat CM, 2011, PSYCHOL WOMEN QUART, V35, P441, DOI 10.1177/0361684311400389; Pennebaker J.W., 1982, PSYCHOL PHYS SYMPTOM; PENNEBAKER JW, 1980, J PERS SOC PSYCHOL, V39, P165, DOI 10.1037/0022-3514.39.1.165; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Pollatos O, 2007, J ANXIETY DISORD, V21, P931, DOI 10.1016/j.janxdis.2006.12.004; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V63, P117, DOI 10.1016/j.ijpsycho.2006.09.003; Pollatos O, 2011, PAIN, V152, P2157, DOI 10.1016/j.pain.2011.05.024; RING C, 1992, PSYCHOPHYSIOLOGY, V29, P535, DOI 10.1111/j.1469-8986.1992.tb02027.x; Rochat P, 2011, CONSCIOUS COGN, V20, P204, DOI 10.1016/j.concog.2010.06.007; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Silvia PJ, 2004, BEHAV RES METH INS C, V36, P325, DOI 10.3758/BF03195578; Silvia PJ, 2001, PERS SOC PSYCHOL REV, V5, P230, DOI 10.1207/S15327957PSPR0503_4; Szymanski DM, 2007, SEX ROLES, V56, P45, DOI 10.1007/s11199-006-9147-3; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Tiggemann M, 2004, BRIT J CLIN PSYCHOL, V43, P299, DOI 10.1348/0144665031752925; Tiggemann M, 2001, PSYCHOL WOMEN QUART, V25, P57, DOI 10.1111/1471-6402.00007; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Vaitl D, 1996, BIOL PSYCHOL, V42, P1, DOI 10.1016/0301-0511(95)05144-9; WEISZ J, 1988, PSYCHOPHYSIOLOGY, V25, P193, DOI 10.1111/j.1469-8986.1988.tb00987.x; WHITEHEAD WE, 1980, PSYCHOPHYSIOLOGY, V17, P552, DOI 10.1111/j.1469-8986.1980.tb02296.x; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905	69	84	84	7	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55568	10.1371/journal.pone.0055568	http://dx.doi.org/10.1371/journal.pone.0055568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405173	Green Published, gold			2022-12-27	WOS:000315153400118
J	Bagchi, DP; Yu, LH; Perlmutter, JS; Xu, JB; Mach, RH; Tu, ZD; Kotzbauer, PT				Bagchi, Devika P.; Yu, Lihai; Perlmutter, Joel S.; Xu, Jinbin; Mach, Robert H.; Tu, Zhude; Kotzbauer, Paul T.			Binding of the Radioligand SIL23 to alpha-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; LEWY BODIES; IN-VITRO; CLINICAL-DIAGNOSIS; DEMENTIA; TAU; NEURODEGENERATION; PATHOLOGY	Accumulation of alpha-synuclein (alpha-syn) fibrils in Lewy bodies and Lewy neurites is the pathological hallmark of Parkinson disease (PD). Ligands that bind alpha-syn fibrils could be utilized as imaging agents to improve the diagnosis of PD and to monitor disease progression. However, ligands for alpha-syn fibrils in PD brain tissue have not been previously identified and the feasibility of quantifying alpha-syn fibrils in brain tissue is unknown. We report the identification of the I-125-labeled alpha-syn radioligand SIL23. [I-125]SIL23 binds alpha-syn fibrils in postmortem brain tissue from PD patients as well as an alpha-syn transgenic mouse model for PD. The density of SIL23 binding sites correlates with the level of fibrillar alpha-syn in PD brain tissue, and [I-125] SIL23 binding site densities in brain tissue are sufficiently high to enable in vivo imaging with high affinity ligands. These results identify a SIL23 binding site on alpha-syn fibrils that is a feasible target for development of an alpha-syn imaging agent. The affinity of SIL23 for alpha-syn and its selectivity for alpha-syn versus Ab and tau fibrils is not optimal for imaging fibrillar alpha-syn in vivo, but we show that SIL23 competitive binding assays can be used to screen additional ligands for suitable affinity and selectivity, which will accelerate the development of an alpha-syn imaging agent for PD.	[Bagchi, Devika P.; Perlmutter, Joel S.; Kotzbauer, Paul T.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Bagchi, Devika P.; Kotzbauer, Paul T.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Bagchi, Devika P.; Yu, Lihai; Perlmutter, Joel S.; Xu, Jinbin; Mach, Robert H.; Tu, Zhude; Kotzbauer, Paul T.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Yu, Lihai; Perlmutter, Joel S.; Xu, Jinbin; Mach, Robert H.; Tu, Zhude] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Program Occupat Therapy, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kotzbauer, PT (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	kotzbauerp@neuro.wustl.edu	Xu, Jinbin/ABG-1280-2020	Xu, Jinbin/0000-0002-2120-8287; Mach, Robert/0000-0002-7645-2869; Tu, Zhude/0000-0003-0325-835X	Michael J. Fox Foundation; Washington University Institute of Clinical and Translational Sciences [CTSA406]; American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA; Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund for PD Research & the Jack Buck Research Fund); NIH/NINDS [NS075321, NS058714, NS41509]; NIH [NS061025, NS075527, MH092797]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH092797, R21MH092797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041509, R01NS058714, R21NS061025, R01NS075527, R03NS090214, R01NS075321] Funding Source: NIH RePORTER	Michael J. Fox Foundation; Washington University Institute of Clinical and Translational Sciences; American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA; Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund for PD Research & the Jack Buck Research Fund); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Michael J. Fox Foundation grant supporting a Consortium to Develop an Alpha-Synuclein Imaging Agent (RHM, ZT, PTK), Washington University Institute of Clinical and Translational Sciences Grant CTSA406 (PTK, ZT), American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA (JSP); the Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund for PD Research & the Jack Buck Research Fund) (JSP), NIH/NINDS grants NS075321, NS058714 and NS41509 (JSP), and NIH grants NS061025, NS075527, and MH092797 (ZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burack MA, 2010, NEUROLOGY, V74, P77, DOI 10.1212/WNL.0b013e3181c7da8e; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Engel LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012897; Fodero-Tavoletti MT, 2007, J NEUROSCI, V27, P10365, DOI 10.1523/JNEUROSCI.0630-07.2007; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Fodero-Tavoletti MT, 2009, EUR J PHARMACOL, V617, P54, DOI 10.1016/j.ejphar.2009.06.042; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Fujishiro H, 2008, ACTA NEUROPATHOL, V116, P269, DOI 10.1007/s00401-008-0398-7; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hou C, 2006, NUCL MED BIOL, V33, P203, DOI 10.1016/j.nucmedbio.2005.10.001; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Jankovic J, 2000, ARCH NEUROL-CHICAGO, V57, P369, DOI 10.1001/archneur.57.3.369; Jensen JR, 2011, J ALZHEIMERS DIS, V26, P147, DOI 10.3233/JAD-2011-0003; Josephs KA, 2011, ACTA NEUROPATHOL, V122, P137, DOI 10.1007/s00401-011-0839-6; Klunk WE, 2005, J NEUROSCI, V25, P10598, DOI 10.1523/JNEUROSCI.2990-05.2005; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; KUNG MP, 1990, J NUCL MED, V31, P648; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; MURPHY RA, 1990, J MED CHEM, V33, P171, DOI 10.1021/jm00163a029; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; Paisan-Ruiz C, 2010, NEUROBIOL AGING; Parkkinen L, 2007, CLIN NEUROPATHOL, V26, P276; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Villemagne VL, 2011, J NUCL MED, V52, P1210, DOI 10.2967/jnumed.111.089730; Wakabayashi K, 2005, ACTA NEUROPATHOL, V110, P185, DOI 10.1007/s00401-005-1029-1; Ye L, 2008, J NEUROCHEM, V105, P1428, DOI 10.1111/j.1471-4159.2008.05245.x; Yu L, 2012, BIOORG MED IN PRESS	44	80	83	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55031	10.1371/journal.pone.0055031	http://dx.doi.org/10.1371/journal.pone.0055031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405108	gold, Green Published			2022-12-27	WOS:000315153400052
J	Desender, K; Van Lierde, E; Van den Bussche, E				Desender, Kobe; Van Lierde, Elke; Van den Bussche, Eva			Comparing Conscious and Unconscious Conflict Adaptation	PLOS ONE			English	Article							SEQUENTIAL MODULATIONS; STRATEGIC CONTROL; TASK; ACTIVATION; MECHANISMS; PROPORTION; ATTENTION; PURSUIT; CORTEX; GOALS	Recently, researchers have been trying to unravel the function of consciousness by exploring whether unconscious information is ( in) capable of exerting cognitive control. Theoretically, cognitive control functions, such as conflict adaptation, have often been assumed to require consciousness. However, empirical evidence on conscious versus unconscious conflict adaptation is highly contradictory and hitherto, only one study reliably demonstrated adaptation to unconscious conflict. Therefore, the current study wanted to shed further light on this debated issue. A masked and unmasked version of the priming paradigm were used to create unconscious and conscious conflict trials (i.e., when prime and target trigger opposite responses). In contrast to previous studies, the Stimulus Onset Asynchrony was kept constant in both conditions and neutral trials were added to the design in order to investigate the origin of the adaptation and to investigate the specific adaptation effects. Our results showed robust conflict adaptation effects following conscious and unconscious conflict. Furthermore, our results suggest that the adaptation elicited by the conflict, is mainly an adaptation of interference, not of facilitation. We can conclude that conflict adaptation can occur after unconscious conflict, which indicates that this expression of cognitive control is most likely not an exclusive function of consciousness.	[Desender, Kobe; Van Lierde, Elke; Van den Bussche, Eva] Vrije Univ Brussel, Dept Psychol, Brussels, Belgium	Vrije Universiteit Brussel	Desender, K (corresponding author), Vrije Univ Brussel, Dept Psychol, Brussels, Belgium.	Kobe.Desender@vub.ac.be	Van den Bussche, Eva/AFU-0195-2022; Van den Bussche, Eva/E-7977-2010; Desender, Kobe/F-6624-2018	Van den Bussche, Eva/0000-0003-1894-9380; Desender, Kobe/0000-0002-5462-4260	Research Foundation Flanders, Belgium [FWOTM635]	Research Foundation Flanders, Belgium(FWO)	KD received a PhD grant of the Research Foundation Flanders, Belgium (Grant number FWOTM635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge U, 2011, PSYCHOL RES-PSYCH FO, V75, P351, DOI 10.1007/s00426-010-0313-4; Baars B.J., 1993, COGNITIVE THEORY CON; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Bodner GE, 2010, EXP PSYCHOL, V57, P360, DOI 10.1027/1618-3169/a000043; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S., 2008, BETTER CONSCIOUS DEC, P22; Desender K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00003; Dijksterhuis A, 2010, ANNU REV PSYCHOL, V61, P467, DOI 10.1146/annurev.psych.093008.100445; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Francken JC, 2011, CONSCIOUS COGN, V20, P1793, DOI 10.1016/j.concog.2011.04.005; Frings C, 2008, ACTA PSYCHOL, V128, P318, DOI 10.1016/j.actpsy.2008.03.004; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Haynes JD, 2005, NEURON, V46, P811, DOI 10.1016/j.neuron.2005.05.012; Jack AI, 2001, COGNITION, V79, P161, DOI 10.1016/S0010-0277(00)00128-1; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Kinoshita S, 2008, MEM COGNITION, V36, P1324, DOI 10.3758/MC.36.7.1324; Kinoshita S, 2011, J EXP PSYCHOL GEN, V140, P622, DOI 10.1037/a0024230; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kunde W, 2003, COGNITION, V88, P223, DOI 10.1016/S0010-0277(03)00023-4; Kunde W, 2003, PSYCHON B REV, V10, P198, DOI 10.3758/BF03196485; Kunde W, 2006, MEM COGNITION, V34, P356, DOI 10.3758/BF03193413; Kunde W, 2012, ADV COGN PSYCHOL, V8, P9, DOI [10.2478/v10053-008-0097-x, 10.5709/acp-0097-x]; Lamers MJM, 2011, Q J EXP PSYCHOL, V64, P1056, DOI 10.1080/17470218.2010.523792; Lau HC, 2009, UNDERST COMPLEX SYST, P153, DOI 10.1007/978-3-642-03205-9_9; Lupker SJ, 1997, J EXP PSYCHOL LEARN, V23, P570, DOI 10.1037/0278-7393.23.3.570; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Norman D.A., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Notebaert W, 2007, J EXP PSYCHOL HUMAN, V33, P1256, DOI 10.1037/0096-1523.33.5.1256; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Schlaghecken F, 2012, J EXP PSYCHOL HUMAN, V38, P272, DOI 10.1037/a0025791; Schmidt Filipp, 2011, Adv Cogn Psychol, V7, P120, DOI 10.2478/v10053-008-0092-2; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Van den Bussche E, 2010, CONSCIOUS COGN, V19, P86, DOI 10.1016/j.concog.2009.12.019; Van den Bussche E, 2008, CONSCIOUS COGN, V17, P1345, DOI 10.1016/j.concog.2007.08.005; Van den Bussche E, 2009, EXP PSYCHOL, V56, P295, DOI 10.1027/1618-3169.56.5.295; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; van Gaal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011508; Verguts T, 2011, PSYCHON B REV, V18, P76, DOI 10.3758/s13423-010-0016-2	44	35	36	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55976	10.1371/journal.pone.0055976	http://dx.doi.org/10.1371/journal.pone.0055976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405242	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400187
J	Jittawuttipoka, T; Planchon, M; Spalla, O; Benzerara, K; Guyot, F; Cassier-Chauvat, C; Chauvat, F				Jittawuttipoka, Thichakorn; Planchon, Mariane; Spalla, Olivier; Benzerara, Karim; Guyot, Francois; Cassier-Chauvat, Corinne; Chauvat, Franck			Multidisciplinary Evidences that Synechocystis PCC6803 Exopolysaccharides Operate in Cell Sedimentation and Protection against Salt and Metal Stresses	PLOS ONE			English	Article							SP PCC 6803; BIOFILM FORMATION; ESCHERICHIA-COLI; GENES; CYANOBACTERIA; MUTAGENESIS; EXPRESSION; RESISTANCE; TOXICITY; GENOME	Little is known about the production of exopolysaccharides (EPS) in cyanobacteria, and there are no genetic and physiological evidences that EPS are involved in cell protection against the frequently encountered environmental stresses caused by salt and metals. We studied four presumptive EPS production genes, sll0923, sll1581, slr1875 and sll5052, in the model cyanobacterium Synechocystis PCC6803, which produces copious amounts of EPS attached to cells (CPS) and released in the culture medium (RPS) as shown here. We show that sll0923, sll1581, slr1875 and sll5052 are all dispensable to the growth of all corresponding single and double deletion mutants in absence of stress. Furthermore, we report that sll0923, sll1581 and slr1875 unambiguously operate in the production of both CPS and RPS. Both sll1581 and slr1875 are more important than sll0923 for CPS production, whereas the contrary is true for RPS production. We show that the most EPS-depleted mutant, doubly deleted for sll1581 and slr1875, lacks the EPS mantle that surrounds WT cells and sorbs iron in their vicinity. Using this mutant, we demonstrate for the first time that cyanobacterial EPS directly operate in cell protection against NaCl, CoCl2, CdSO4 and Fe-starvation. We believe that our EPS-depleted mutants will be useful tools to investigate the role of EPS in cell-to-cell aggregation, biofilm formation, biomineralization and tolerance to environmental stresses. We also suggest using the fast sedimenting mutants as biotechnological cell factories to facilitate the otherwise expensive harvest of the producer cell biomass and/or its separation from products excreted in the growth media.	[Jittawuttipoka, Thichakorn; Cassier-Chauvat, Corinne; Chauvat, Franck] Univ Paris 11, UMR8221, CEA, CNRS,iBiTec S,LBBC,CEA Saclay, F-91191 Gif Sur Yvette, France; [Planchon, Mariane; Spalla, Olivier] CEA, DSM IRAMIS LIONS SIS2M, UMR CEA CNRS 3299, F-91191 Gif Sur Yvette, France; [Benzerara, Karim; Guyot, Francois] Univ Paris 06, UMR 7590, CNRS, IPGP,Inst Mineral & Phys Milieux Condenses, F-75252 Paris 05, France; [Benzerara, Karim; Guyot, Francois] Univ Paris 07, UMR 7590, CNRS, IPGP,Inst Mineral & Phys Milieux Condenses, F-75252 Paris 05, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris Cite	Cassier-Chauvat, C (corresponding author), Univ Paris 11, UMR8221, CEA, CNRS,iBiTec S,LBBC,CEA Saclay, Bat 142, F-91191 Gif Sur Yvette, France.	corinne-cassier.chauvat@cea.fr; franck.chauvat@cea.fr	CASSIER-CHAUVAT, Corinne/E-7505-2010; GUYOT, François J/C-3824-2016; Chauvat, Franck/E-7394-2010; Cassier-Chauvat, Corinnne/ABB-4815-2021; Benzerara, Karim/J-1532-2016	CASSIER-CHAUVAT, Corinne/0000-0001-6901-5559; GUYOT, François J/0000-0003-4622-2218; Chauvat, Franck/0000-0002-9151-7667; Cassier-Chauvat, Corinnne/0000-0001-6901-5559; Benzerara, Karim/0000-0002-0553-0137	french C'Nano programme (Enseine project); Region Ile de France [SESAME 2006 NuI-07-593/R]	french C'Nano programme (Enseine project); Region Ile de France(Region Ile-de-France)	The french C'Nano programme (Enseine project) for the postdoc and PhD fellowships to T.J and M. P, respectively. The Scanning Electron Microscope (SEM) facility at the Institut de Mineralogie et de Physique des Milieux Condenses is supported by Region Ile de France grant SESAME 2006 NuI-07-593/R, INSU-CNRS, INP-CNRS, Universite Pierre et Marie Curie - Paris 6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barras F, 2011, METALLOMICS, V3, P1130, DOI 10.1039/c1mt00099c; Cerantola S, 2000, FEMS MICROBIOL LETT, V185, P243, DOI 10.1016/S0378-1097(00)00099-9; Conover MS, 2012, J BACTERIOL, V194, P233, DOI 10.1128/JB.06020-11; De Philippis R, 2011, APPL MICROBIOL BIOT, V92, P697, DOI 10.1007/s00253-011-3601-z; Domain F, 2004, MOL MICROBIOL, V53, P65, DOI 10.1111/j.1365-2958.2004.04100.x; Foster JS, 2009, FEMS MICROBIOL LETT, V293, P298, DOI 10.1111/j.1574-6968.2009.01548.x; Freitas F, 2011, TRENDS BIOTECHNOL, V29, P388, DOI 10.1016/j.tibtech.2011.03.008; Griese M, 2011, FEMS MICROBIOL LETT, V323, P124, DOI 10.1111/j.1574-6968.2011.02368.x; GRIGORIEVA G, 1982, FEMS MICROBIOL LETT, V13, P367, DOI 10.1111/j.1574-6968.1982.tb08289.x; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Houot L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-350; Jansson C, 2010, CURR OPIN BIOTECH, V21, P365, DOI 10.1016/j.copbio.2010.03.017; LABARRE J, 1989, J BACTERIOL, V171, P3449, DOI 10.1128/jb.171.6.3449-3457.1989; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Mazouni K, 2004, MOL MICROBIOL, V52, P1145, DOI 10.1111/j.1365-2958.2004.04042.x; Mazouni K, 1998, MOL MICROBIOL, V30, P1113, DOI 10.1046/j.1365-2958.1998.01145.x; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Nilsson M, 2011, ENVIRON MICROBIOL, V13, P1357, DOI 10.1111/j.1462-2920.2011.02447.x; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Poncelet M, 1998, MOL MICROBIOL, V28, P813, DOI 10.1046/j.1365-2958.1998.00844.x; REED JW, 1991, J BACTERIOL, V173, P664, DOI 10.1128/jb.173.2.664-677.1991; Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Souza LCA, 2006, FEMS MICROBIOL LETT, V257, P236, DOI 10.1111/j.1574-6968.2006.00176.x; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Yoshida T, 2003, MICROBIOL-SGM, V149, P431, DOI 10.1099/mic.0.25913-0; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zeyons O, 2009, NANOTOXICOLOGY, V3, P284, DOI 10.3109/17435390903305260	31	97	100	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55564	10.1371/journal.pone.0055564	http://dx.doi.org/10.1371/journal.pone.0055564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405172	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400117
J	Kiriazis, A; Vahakoski, RL; Santio, NM; Arnaudova, R; Eerola, SK; Rainio, EM; Aumuller, IB; Yli-Kauhaluoma, J; Koskinen, PJ				Kiriazis, Alexandros; Vahakoski, Riitta L.; Santio, Niina M.; Arnaudova, Ralica; Eerola, Sini K.; Rainio, Eeva-Marja; Aumuller, Ingo B.; Yli-Kauhaluoma, Jari; Koskinen, Paivi J.			Tricyclic Benzo[cd]azulenes Selectively Inhibit Activities of Pim Kinases and Restrict Growth of Epstein-Barr Virus-Transformed Cells	PLOS ONE			English	Article							C-MYC; EXPRESSION; SURVIVAL; CANCER; BAD; TRICARBONYL(TROPONE)IRON; TRANSCRIPTION; CARCINOMA; PATHWAY; BINDING	Oncogenic Pim family kinases are often overexpressed in human hematopoietic malignancies as well as in solid tumours. These kinases contribute to tumorigenesis by promoting cell survival and by enhancing resistance against chemotherapy and radiation therapy. Furthermore, we have recently shown that they increase the metastatic potential of adherent cancer cells. Here we describe identification of tricyclic benzo[cd]azulenes and their derivatives as effective and selective inhibitors of Pim kinases. These compounds inhibit Pim autophosphorylation and abrogate the anti-apoptotic effects of Pim kinases. They also reduce cancer cell motility and suppress proliferation of lymphoblastoid cell lines infected and immortalized by the Epstein-Barr virus. Thus, these novel Pim-selective inhibitors provide promising compounds for both research and therapeutic purposes.	[Kiriazis, Alexandros; Arnaudova, Ralica; Aumuller, Ingo B.; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, FIN-00014 Helsinki, Finland; [Vahakoski, Riitta L.; Santio, Niina M.; Arnaudova, Ralica; Eerola, Sini K.; Rainio, Eeva-Marja; Koskinen, Paivi J.] Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Helsinki; University of Turku	Yli-Kauhaluoma, J (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, FIN-00014 Helsinki, Finland.	jari.yli-kauhaluoma@helsinki.fi; paivi.koskinen@utu.fi	Koskinen, Päivi J/G-8939-2014	Arnaudova, Ralica Zhorova/0000-0002-4907-9229; Koskinen, Paivi/0000-0002-6864-4457; Rainio, Eeva/0000-0002-5632-0455; Yli-Kauhaluoma, Jari/0000-0003-0370-7653	Academy of Finland [108376, 111820, 121533]; Graduate School in Pharmaceutical Research; Walter och Lisi Wahls Stiftelse for Naturvetenskaplig Forskning; Drug Discovery Graduate School; Turku University Foundation; Orion-Farmos Research Foundation; Cancer Society of Finland; Maud Kuistila Foundation; CIMO exchange programme;  [LSHB-CT-2004-503467]	Academy of Finland(Academy of Finland); Graduate School in Pharmaceutical Research; Walter och Lisi Wahls Stiftelse for Naturvetenskaplig Forskning; Drug Discovery Graduate School; Turku University Foundation; Orion-Farmos Research Foundation; Cancer Society of Finland; Maud Kuistila Foundation; CIMO exchange programme; 	LSHB-CT-2004-503467 to J.Y.K.), the Academy of Finland (grant 108376 to J.Y.K), Graduate School in Pharmaceutical Research (A.K.) and Walter och Lisi Wahls Stiftelse for Naturvetenskaplig Forskning (J.Y.K.). The biological experiments were supported by the Academy of Finland (grants 111820 and 121533 to P.J.K.), the Drug Discovery Graduate School (R.L.V., N.M.S.), Turku University Foundation (N.M.S.), the Orion-Farmos Research Foundation (R.L.V.), the Cancer Society of Finland (R.L.V.), the Maud Kuistila Foundation (R.L.V.) and the CIMO exchange programme (R. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho TL, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-21; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; AMSON R, 1989, P NATL ACAD SCI USA, V86, P8857, DOI 10.1073/pnas.86.22.8857; Anizon F, 2010, CURR MED CHEM, V17, P4114, DOI 10.2174/092986710793348554; Aumuller IB, 2011, ORG LETT, V13, P1670, DOI 10.1021/ol2001528; Aumuller IB, 2009, ORG LETT, V11, P5363, DOI 10.1021/ol902283q; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BERGMANN ED, 1968, CHEM REV, V68, P41, DOI 10.1021/cr60251a002; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Cheng F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000324; Coquerel Y, 2002, J ORGANOMET CHEM, V659, P176, DOI 10.1016/S0022-328X(02)01725-4; DAUTRY F, 1988, J BIOL CHEM, V263, P17615; Eichmann A, 2000, ONCOGENE, V19, P1215, DOI 10.1038/sj.onc.1203355; Heslop HE, 2009, BLOOD, V114, P4002, DOI 10.1182/blood-2009-07-143545; Kiriazis A, 2011, TETRAHEDRON LETT, V52, P1151, DOI 10.1016/j.tetlet.2011.01.016; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; LEVINE SG, 1958, J AM CHEM SOC, V80, P6150, DOI 10.1021/ja01555a068; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; LILLY M, 1992, ONCOGENE, V7, P727; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Matikainen S, 1999, BLOOD, V93, P1980, DOI 10.1182/blood.V93.6.1980.406k20_1980_1991; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Morwick T, 2010, EXPERT OPIN THER PAT, V20, P193, DOI 10.1517/13543770903496442; PAUSON PL, 1955, CHEM REV, V55, P9, DOI 10.1021/cr50001a002; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Rainio EM, 2005, VIROLOGY, V333, P201, DOI 10.1016/j.virol.2005.01.001; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; RIGBY JH, 1990, TETRAHEDRON LETT, V31, P3385, DOI 10.1016/S0040-4039(00)97403-3; Santio NM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-279; Schenone S, 2010, CURR PHARM DESIGN, V16, P3964, DOI 10.2174/138161210794454996; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang J, 2011, ONCOGENE, V12, P1; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200	38	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55409	10.1371/journal.pone.0055409	http://dx.doi.org/10.1371/journal.pone.0055409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405147	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400092
J	Park, MS; Kim, BK; Cheong, JY; Kim, DJ; Park, JY; Kim, DY; Ahn, SH; Han, KH; Chon, CY; Kim, SU				Park, Mi Sung; Kim, Beom Kyung; Cheong, Jae Yoeun; Kim, Dong Joon; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Kim, Seung Up			Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B	PLOS ONE			English	Article							C VIRUS-INFECTION; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; CIRRHOSIS; ACCURACY; DIAGNOSIS; MARKERS	Background and Aims: The FibroTest (FT) demonstrated excellent diagnostic performance in the prediction of liver fibrosis in patients with chronic hepatitis B (CHB). Here, we aimed to identify predictors of discordance between FT and liver biopsy (LB) in Asian patients with CHB. Methods: Consecutive patients with CHB who underwent both LB and FT on the same day between 2007 and 2010 were recruited from three medical institutes. Laboratory evaluations including specific parameters for calculating FT score, such as alpha 2-macroglobulin, apolipoprotein A1, haptoglobin, gamma-glutamyl transpeptidase, and total bilirubin levels, were obtained. The Batts and Ludwig scoring system was used for histological analysis. Results: A total of 330 patients (200 male and 130 female) were analyzed. Discordances of at least two fibrosis stages between FT and LB were observed in 30 (9.1%) patients; using FT, fibrosis was underestimated in 25 patients and overestimated in 5 patients with reference to LB. Patients with discordance had a higher proportion of F3-4 (P<0.001) and F4 (P=0.012) compared with those with nondiscordance. The discordance rate was significantly higher in those with F3-4 than those with F1-2 (15.4% vs. 3.0%, P<0.001). Multivariate analysis demonstrated F3-4 at LB as the only independent factor for discordance (P<0.001; odds ratio 5.95). After adjusting fibrosis stages, neither necroinflammatory activity on histology nor serum ALT level influenced FT values independently. Conclusion: Advanced fibrosis stage (F3-4) is the sole factor of discordance between FT and LB in Asian patients with CHB.	[Park, Mi Sung; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Kim, Seung Up] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Kim, Seung Up] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Kim, Seung Up] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Cheong, Jae Yoeun] Ajou Univ, Sch Med, Dept Gastroenterol, Suwon 441749, South Korea; [Kim, Dong Joon] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Ahn, Sang Hoon; Han, Kwang-Hyub] Brain Korea 21 Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ajou University; Hallym University	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ksukorea@yuhs.ac		Ahn, Sang Hoon/0000-0002-3629-4624; Park, Jun Yong/0000-0001-6324-2224; Han, Kwang-Hyub/0000-0003-3960-6539; Kim, Beom Kyung/0000-0002-5363-2496; Kim, Seung Up/0000-0002-9658-8050	Liver Cirrhosis Clinical Research Center; Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea [A102065]; Yonsei Liver Blood Bank (YLBB); Sanofi-Aventis Korea; BioPredictive	Liver Cirrhosis Clinical Research Center; Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea; Yonsei Liver Blood Bank (YLBB); Sanofi-Aventis Korea(Sanofi-Aventis); BioPredictive	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea (no. A102065), and by the Yonsei Liver Blood Bank (YLBB), in part by a grant from Sanofi-Aventis Korea. BioPredictive kindly provided the complimentary service for calculation of FT score. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from commercial sources, Sanofi-Aventis Korea and BioPredictive; this study was supported by the Yonsei Liver Blood Bank (YLBB) in part by a grant from Sanofi-Aventis Korea and BioPredictive kindly provided the complimentary service for calculation of FT score. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Furthermore, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Fontaine H, 2007, GASTROEN CLIN BIOL, V31, P504, DOI 10.1016/S0399-8320(07)89420-6; Halfon P, 2008, GASTROEN CLIN BIOL, V32, P22, DOI 10.1016/S0399-8320(08)73991-5; Han KH, 2008, INTERVIROLOGY, V51, P11, DOI 10.1159/000122594; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kim BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035825; Kim SU, 2010, ALIMENT PHARM THER, V32, P498, DOI 10.1111/j.1365-2036.2010.04353.x; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032233; Kim SU, 2011, J GASTROEN HEPATOL, V26, P937, DOI 10.1111/j.1440-1746.2011.06741.x; Kim SU, 2010, WORLD J GASTROENTERO, V16, P5173, DOI 10.3748/wjg.v16.i41.5173; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Park H, 2012, J CLIN GASTROENTEROL, V46, P602, DOI 10.1097/MCG.0b013e3182582a31; Poynard T, 2007, ALIMENT PHARM THER, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yoon KT, 2012, DIGEST DIS SCI, V57, P1682, DOI 10.1007/s10620-012-2044-4	22	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55759	10.1371/journal.pone.0055759	http://dx.doi.org/10.1371/journal.pone.0055759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405210	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400155
J	Scheer, S; Nakelsky, S; Bingham, T; Damesyn, M; Sun, D; Chin, CS; Buckman, A; Mark, KE				Scheer, Susan; Nakelsky, Shoshanna; Bingham, Trista; Damesyn, Mark; Sun, Dan; Chin, Chi-Sheng; Buckman, Anthony; Mark, Karen E.			Estimated HIV Incidence in California, 2006-2009	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; UNITED-STATES; TRANSMISSION; PREVENTION	Introduction: Accurate estimates of HIV incidence are crucial for prioritizing, targeting, and evaluating HIV prevention efforts. Using the methodology the CDC used to estimate national HIV incidence, we estimated HIV incidence in Los Angeles County (LAC), San Francisco (SF), and California's remaining counties. Methods: We estimated new HIV infections in 2006-2009 among adults and adolescents in LAC, SF and the remaining California counties using the Serologic Testing Algorithm for Recent Seroconversion (STARHS). STARHS methodology uses the BED HIV-1 capture enzyme immunoassay to determine recent HIV infections by testing remnant serum from persons newly diagnosed with HIV. A population-based incidence estimate is calculated using HIV testing data from newly diagnosed cases and imputing for persons unaware of their HIV infection. Results: For years 2007-2009, respectively, we estimated new infections in LAC to be 2426 (95% CI 1871-2982), 1669 (CI 1309-2029) and 1898 (CI 1452-2344) (p < 0.01); in SF for 2006-2009, 492 (CI 327-657), 490 (CI 335-646), 458 (CI 342-574) and 367 (CI 261-473) (p = 0.14); and in the remaining California counties in 2008-2009, 2526 (CI 1688-3364) and 2993 (CI 2141-3846) respectively. HIV infection rates among men who have sex with men (MSM) in LAC were 100 times higher than other risk populations; the SF MSM rate was 3 to 18 times higher than other demographic groups. In LAC, incidence rates among African-Americans were twice those of whites and Latinos; persons 40 years or older had lower rates of infection than younger persons. Discussion: We report the first HIV incidence estimates for California, highlighting geographic disparities in HIV incidence and confirming national findings that MSM and African-Americans are disproportionately impacted by HIV. HIV incidence estimates can and should be used to target prevention efforts towards populations at highest risk of acquiring new HIV infections, focusing on geographic, racial and risk group disparities.	[Scheer, Susan; Chin, Chi-Sheng; Buckman, Anthony] San Francisco Dept Publ Hlth, HIV Epidemiol Sect, San Francisco, CA 94102 USA; [Nakelsky, Shoshanna; Bingham, Trista] Los Angeles Cty Dept Publ Hlth, Div HIV & STD Programs, Los Angeles, CA USA; [Damesyn, Mark; Sun, Dan; Mark, Karen E.] Calif Dept Publ Hlth, Off AIDS, Sacramento, CA USA	San Francisco Department of Public Health; Los Angeles County Department of Public Health; California Department of Public Health	Scheer, S (corresponding author), San Francisco Dept Publ Hlth, HIV Epidemiol Sect, San Francisco, CA 94102 USA.	susan.scheer@sfdph.org			Centers for Disease Control and Prevention (CDC); CDC [3U62PS001000, U62PSD001045]; Office of AIDS in Sacramento the CDC [5U62PS001024]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of AIDS in Sacramento the CDC	This study was funded by the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In San Francisco, the CDC grant number was 3U62PS001000, in Los Angeles the CDC grant number was U62PSD001045, and at the Office of AIDS in Sacramento the CDC grant number was 5U62PS001024. The url for the CDC is www.cdc.gov.	California Department of Public Health. Office of AIDS, 2010, HIV AIDS SURV Q REP; Centers for Disease Control and Prevention, 1981, MMWR-MORBID MORTAL W, V21, P1; Centers for Disease Control and Prevention, 2009, HIV SURV REP, V21; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; HIV Epidemiology Program Los Angeles County Department of Public Health, 2010, HIV AIDS SURV SUMM; Huizenga HM, 2011, BRIT J MATH STAT PSY, V64, P1, DOI 10.1348/000711010X522687; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; Lieb S, 2011, PUBLIC HEALTH REP, V126, P60, DOI 10.1177/003335491112600110; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Office of National AIDS Policy, 2010, NATL HIV AIDS STRAT; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; San Francisco Department of Public Health HIV Epidemiology Section, 2010, HIV AIDS EP ANN REP; Scheer S, 2009, AIDS, V23, P533, DOI 10.1097/QAD.0b013e328322432b; State of California Department of Finance, 2007, RAC ETHN POP AG SEX	20	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55002	10.1371/journal.pone.0055002	http://dx.doi.org/10.1371/journal.pone.0055002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405106	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400050
J	Sejdic, E; Kalika, D; Czarnek, N				Sejdic, Ervin; Kalika, Dmitry; Czarnek, Nicholas			An Analysis of Resting-State Functional Transcranial Doppler Recordings from Middle Cerebral Arteries	PLOS ONE			English	Article							FLOW-VELOCITY; LANGUAGE LATERALIZATION; SONOGRAPHY; VARIABILITY; ULTRASOUND; COMPLEXITY; HEMODYNAMICS; HANDEDNESS	Functional transcrannial Doppler (fTCD) is used for monitoring the hemodynamics characteristics of major cerebral arteries. Its resting-state characteristics are known only when considering the maximal velocity corresponding to the highest Doppler shift (so called the envelope signals). Significantly more information about the resting-state fTCD can be gained when considering the raw cerebral blood flow velocity (CBFV) recordings. In this paper, we considered simultaneously acquired envelope and raw CBFV signals. Specifically, we collected bilateral CBFV recordings from left and right middle cerebral arteries using 20 healthy subjects (10 females). The data collection lasted for 15 minutes. The subjects were asked to remain awake, stay silent, and try to remain thought-free during the data collection. Time, frequency and time-frequency features were extracted from both the raw and the envelope CBFV signals. The effects of age, sex and body-mass index were examined on the extracted features. The results showed that the raw CBFV signals had a higher frequency content, and its temporal structures were almost uncorrelated. The information-theoretic features showed that the raw recordings from left and right middle cerebral arteries had higher content of mutual information than the envelope signals. Age and body-mass index did not have statistically significant effects on the extracted features. Sex-based differences were observed in all three domains and for both, the envelope signals and the raw CBFV signals. These findings indicate that the raw CBFV signals provide valuable information about the cerebral blood flow which can be utilized in further validation of fTCD as a clinical tool.	[Sejdic, Ervin; Kalika, Dmitry; Czarnek, Nicholas] Univ Pittsburgh, Dept Elect & Comp Engn, Swanson Sch Engn, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sejdic, E (corresponding author), Univ Pittsburgh, Dept Elect & Comp Engn, Swanson Sch Engn, Pittsburgh, PA 15260 USA.	esejdic@ieee.org		Sejdic, Ervin/0000-0003-4987-8298; Czarnek, Nicholas/0000-0002-7889-0184	University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	The authors would like to thank the University of Pittsburgh for funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Deppe M, 2004, NEUROIMAGE, V21, P1124, DOI 10.1016/j.neuroimage.2003.10.016; Duschek S, 2003, PSYCHOPHYSIOLOGY, V40, P436, DOI 10.1111/1469-8986.00046; KELLEY RE, 1992, STROKE, V23, P9, DOI 10.1161/01.STR.23.1.9; Knake S, 2003, NEUROIMAGE, V19, P1228, DOI 10.1016/S1053-8119(03)00174-5; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Krejza J, 1999, AM J ROENTGENOL, V172, P213, DOI 10.2214/ajr.172.1.9888770; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee J, 2010, BIOMEDICAL ENG ONLIN, V9; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lohmann H, 2005, NEUROIMAGE, V24, P780, DOI 10.1016/j.neuroimage.2004.08.053; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marinoni M, 1998, ACTA NEUROL SCAND, V97, P324, DOI 10.1111/j.1600-0404.1998.tb05961.x; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MARTIN PJ, 1994, STROKE, V25, P390, DOI 10.1161/01.STR.25.2.390; Matteis M, 2001, J NEUROL, V248, P104, DOI 10.1007/s004150170243; Moody M, 2005, AM J PHYSIOL-REG I, V288, pR1581, DOI 10.1152/ajpregu.00837.2004; Myrden AJB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024170; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papoulis A., 1991, PROBABILITY RANDOM V; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Rey B, 2010, VIRTUAL REAL-LONDON, V14, P55, DOI 10.1007/s10055-009-0141-2; Rey B, 2010, ULTRASOUND MED BIOL, V36, P383, DOI 10.1016/j.ultrasmedbio.2009.11.001; Salinet ASM, 2012, ULTRASOUND MED BIOL, V38, P997, DOI 10.1016/j.ultrasmedbio.2012.02.016; Sejdic E., 2010, BMC RES NOTES, V3, P269; Sejdic E, 2009, DIGIT SIGNAL PROCESS, V19, P153, DOI 10.1016/j.dsp.2007.12.004; Stroobant N, 2000, NEUROPSYCHOL REV, V10, P213, DOI 10.1023/A:1026412811036; VRIENS EM, 1988, ULTRASOUND MED BIOL, V15, P1	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55405	10.1371/journal.pone.0055405	http://dx.doi.org/10.1371/journal.pone.0055405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405146	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315153400091
J	Yin, Q; Fu, BB; Li, BY; Shi, XC; Inagaki, F; Zhang, XH				Yin, Qi; Fu, Bingbing; Li, Bingyu; Shi, Xiaochong; Inagaki, Fumio; Zhang, Xiao-Hua			Spatial Variations in Microbial Community Composition in Surface Seawater from the Ultra-Oligotrophic Center to Rim of the South Pacific Gyre	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; RIBOSOMAL-RNA GENES; IN-SITU; OLIGONUCLEOTIDE PROBES; MARINE-SEDIMENTS; CLONE LIBRARIES; SEA-ICE; BACTERIA; DIVERSITY; OCEAN	Surface seawater in the South Pacific Gyre (SPG) is one of the cleanest oceanic environments on earth, and the photosynthetic primary production is extremely low. Despite the ecological significance of the largest aquatic desert on our planet, microbial community composition in the ultra-oligotrophic seawater remain largely unknown. In this study, we collected surface seawater along a southern transect of the SPG during the Integrated Ocean Drilling Program (IODP) Expedition 329. Samples from four distinct sites (Sites U1368, U1369, U1370 and U1371) were examined, representing similar to 5400 kilometers of transect line from the gyre heart to the edge area. Real-time PCR analysis showed 16S rRNA gene abundance in the gyre seawater, ranging from 5.96x10(5) to 2.55x10(6) copies ml(-1) for Bacteria and 1.17x10(3) to 1.90x10(4) copies ml(-1) for Archaea. The results obtained by statistic analyses of 16S rRNA gene clone libraries revealed the community composition in the southern SPG area: diversity richness estimators in the gyre center (Sites U1368 & U1369) are generally lower than those at sites in the gyre edge (Sites U1370 & U1371) and their community structures are clearly distinguishable. Phylogenetic analysis showed the predominance of Proteobacteria (especially Alphaproteobacteria) and Cyanobacteria in bacterial 16S rRNA gene clone libraries, whereas phylotypes of Betaproteobacteria were only detected in the central gyre. Archaeal 16S rRNA genes in the clone libraries were predominated by the sequences of Marine Group II within the Euryarchaeota, and the Crenarchaeota sequences were rarely detected, which is consistent with the real-time PCR data (only 9.9 to 22.1 copies ml(-1)). We also performed cultivation of heterotrophic microbes onboard, resulting in 18.9% of phylogenetically distinct bacterial isolates at least at the species level. Our results suggest that the distribution and diversity of microbial communities in the SPG surface seawater are closely related to the ultra-oligotrophic oceanographic features in the Pacific Ocean.	[Yin, Qi; Fu, Bingbing; Li, Bingyu; Shi, Xiaochong; Zhang, Xiao-Hua] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Nankoku, Kochi, Japan	Ocean University of China; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Zhang, XH (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.	xhzhang@ouc.edu.cn	Inagaki, Fumio/AAI-1156-2019	Inagaki, Fumio/0000-0003-2887-6525	National Natural Science Foundation of China [41276141]; National Natural Science Foundation for Creative Research Groups [41221004]; National High Technology Research & Development Program of China (863 Programs) [2012AA091605]; IODP China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Creative Research Groups(Science Fund for Creative Research Groups); National High Technology Research & Development Program of China (863 Programs)(National High Technology Research and Development Program of China); IODP China	This research used samples and data provided by the Integrated Ocean Drilling Program (IODP). We thank all of the crews and technical staffs on the JOIDES Resolution during the IODP Expedition 329 for their great efforts and help in sample collection. This work was supported by the National Natural Science Foundation of China (No. 41276141), the National Natural Science Foundation for Creative Research Groups (No. 41221004), the National High Technology Research & Development Program of China (863 Programs, No. 2012AA091605) and the IODP China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Busse HJ, 2005, BERGEYS MANUAL SYSTE, P658, DOI DOI 10.1007/0-387-29298-5_; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Claustre H, 2003, SCIENCE, V302, P1514, DOI 10.1126/science.1092704; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S., 2011, P IODP; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Halm H, 2012, ISME J, V6, P1238, DOI 10.1038/ismej.2011.182; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirchman DL, 2005, LIMNOL OCEANOGR, V50, P1697, DOI 10.4319/lo.2005.50.5.1697; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kwon KK, 2005, INT J SYST EVOL MICR, V55, P2033, DOI 10.1099/ijs.0.63684-0; Labrenz M, 2004, APPL ENVIRON MICROB, V70, P4971, DOI 10.1128/AEM.70.8.4971-4979.2004; Lami R, 2007, APPL ENVIRON MICROB, V73, P4198, DOI 10.1128/AEM.02652-06; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Meier H, 1999, SYST APPL MICROBIOL, V22, P186, DOI 10.1016/S0723-2020(99)80065-4; Moissl C, 2003, ARCH MICROBIOL, V180, P211, DOI 10.1007/s00203-003-0580-1; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Morel A, 2007, LIMNOL OCEANOGR, V52, P217, DOI 10.4319/lo.2007.52.1.0217; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Overmann J, 1999, ARCH MICROBIOL, V172, P83, DOI 10.1007/s002030050744; Park M, 2005, MICROBIOL RES, V160, P127, DOI 10.1016/j.micres.2004.10.003; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Ras J, 2008, BIOGEOSCIENCES, V5, P353, DOI 10.5194/bg-5-353-2008; Sahm K, 1998, MAR ECOL PROG SER, V165, P71, DOI 10.3354/meps165071; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Vetriani C, 2003, APPL ENVIRON MICROB, V69, P6481, DOI 10.1128/AEM.69.11.6481-6488.2003; Voss M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020127; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang W, 2008, ESTUAR COAST SHELF S, V76, P668, DOI 10.1016/j.ecss.2007.07.040; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	55	67	72	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55148	10.1371/journal.pone.0055148	http://dx.doi.org/10.1371/journal.pone.0055148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405118	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400062
J	Davies, A; Singh, KP; Shubber, Z; duCros, P; Mills, EJ; Cooke, G; Ford, N				Davies, Anna; Singh, Kasha P.; Shubber, Zara; duCros, Philipp; Mills, Edward J.; Cooke, Graham; Ford, Nathan			Treatment Outcomes of Treatment-Naive Hepatitis C Patients Co-Infected with HIV: A Systematic Review and Meta-Analysis of Observational Cohorts	PLOS ONE			English	Review							SUSTAINED VIROLOGICAL RESPONSE; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV/HCV COINFECTED PATIENTS; INTERFERON PLUS RIBAVIRIN; PEGYLATED INTERFERON; VIRAL RESPONSE; HCV TREATMENT; THERAPY; INDIVIDUALS; GENOTYPE	Introduction: Co-infection with Hepatitis C (HCV) and HIV is common and HIV accelerates hepatic disease progression due to HCV. However, access to HCV treatment is limited and success rates are generally poor. Methods: We conducted a systematic review and meta-analysis to assess HCV treatment outcomes in observational cohorts. Two databases (Medline and EMBASE) were searched using a compound search strategy for cohort studies reporting HCV treatment outcomes (as determined by a sustained virological response, SVR) in HIV-positive patients initiating HCV treatment for the first time. Results: 40 studies were included for review, providing outcomes on 5339 patients from 17 countries. The pooled proportion of patients achieving SVR was 38%. Significantly poorer outcomes were observed for patients infected with HCV genotypes 1 or 4 (pooled SVR 24.5%), compared to genotypes 2 or 3 (pooled SVR 59.8%). The pooled proportion of patients who discontinued treatment due to drug toxicities (reported by 33 studies) was low, at 4.3% (3.3-5.3%). Defaulting from treatment, reported by 33 studies, was also low (5.1%, 3.5-6.6%), as was on-treatment mortality (35 studies, 0.1% (0-0.2%)). Conclusions: These results, reported under programmatic conditions, are comparable to those reported in randomised clinical trials, and show that although HCV treatment outcomes are generally poor in HIV co-infected patients, those infected with HCV genotypes 2 or 3 have outcomes comparable to HIV-negative patients.	[Davies, Anna; Cooke, Graham; Ford, Nathan] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, London, England; [Singh, Kasha P.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Singh, Kasha P.] Univ Coll Hosp, Div Infect & Immun, London, England; [Shubber, Zara] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London, England; [duCros, Philipp; Ford, Nathan] Manson Unit, London, England; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	Imperial College London; Monash University; University of London; University College London; Imperial College London; University of Ottawa; University of Cape Town	Ford, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, London, England.	nathan.ford@msf.org		Cooke, Graham/0000-0001-6475-5056				Amorosa VK, 2010, ANTIVIR THER, V15, P91, DOI 10.3851/IMP1492; Araujo ESA, 2011, J VIRAL HEPATITIS, V18, pe52, DOI 10.1111/j.1365-2893.2010.01358.x; Avidan NU, 2009, JAIDS-J ACQ IMM DEF, V52, P452, DOI 10.1097/QAI.0b013e3181be7249; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Berenguer J, 2011, J ANTIMICROB CHEMOTH, V66, P2843, DOI 10.1093/jac/dkr362; Burbelo PD, 2010, J INFECT DIS, V202, P894, DOI 10.1086/655780; Cesari M, 2009, HIV MED, V10, P580, DOI 10.1111/j.1468-1293.2009.00729.x; Chung RT, 2002, AIDS, V16, P1915, DOI 10.1097/00002030-200209270-00008; Cooper CL, 2010, THER CLIN RISK MANAG, V6, P207; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Durier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034548; Fleming CA, 2005, CLIN INFECT DIS, V40, pS349, DOI 10.1086/427452; Ford N, 2012, B WORLD HEALTH ORGAN, V90, P540, DOI 10.2471/BLT.11.097147; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Gluud LL, 2009, AM J GASTROENTEROL, V104, P2335, DOI 10.1038/ajg.2009.311; Gonvers JJ, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13055; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iorio A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004888.pub2; James PD, 2008, CANADIAN J INFECT DI, V23, P31; Kieran J, 2011, INT J STD AIDS, V22, P571, DOI 10.1258/ijsa.2011.010416; Laufer N, 2011, ANTIVIR RES, V90, P92, DOI 10.1016/j.antiviral.2011.02.013; de Almeida PRL, 2010, ANN HEPATOL, V9, P150, DOI 10.1016/S1665-2681(19)31653-9; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Lopez-Cortes LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028115; Macias J, 2010, J ANTIMICROB CHEMOTH, V65, P2204, DOI 10.1093/jac/dkq272; Marchetti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032028; Maru DSR, 2008, CLIN INFECT DIS, V47, P952, DOI 10.1086/591707; Marucco DA, 2008, J ANTIMICROB CHEMOTH, V61, P919, DOI 10.1093/jac/dkn013; Medrano J, 2009, CLIN INFECT DIS, V49, P1397, DOI 10.1086/630205; Mehta SH, 2006, AIDS, V20, P2361, DOI 10.1097/QAD.0b013e32801086da; Michielsen P, 2009, ACTA GASTRO-ENT BELG, V72, P389; Mira JA, 2009, CLIN INFECT DIS, V49, pE84, DOI 10.1086/605677; Mitchell AE, 2010, HEPATOLOGY, V51, P729, DOI 10.1002/hep.23561; Murray MCM, 2011, EUR J GASTROEN HEPAT, V23, P45, DOI 10.1097/MEG.0b013e328341ef54; Nasti G, 2001, AIDS, V15, P1783, DOI 10.1097/00002030-200109280-00006; Neukam K, 2012, J HEPATOL, V56, P788, DOI 10.1016/j.jhep.2011.11.008; Nicot F, 2008, J MED VIROL, V80, P1523, DOI 10.1002/jmv.21227; Nischalke HD, 2010, AIDS, V24, P2001, DOI 10.1097/QAD.0b013e32833bedc8; Olle K, 2008, AIDS, V22, P899, DOI 10.1097/QAD.0b013e3282f7067e; Poizot-Martin I, 2003, HIV CLIN TRIALS, V4, P262, DOI 10.1310/50JB-VNBB-7HRG-7GUR; Reiberger T, 2011, ANTIVIR THER, V16, P815, DOI 10.3851/IMP1831; Reiberger T, 2008, ANTIVIR THER, V13, P969; Righi E, 2008, INFECTION, V36, P358, DOI 10.1007/s15010-008-7319-5; Rockstroh J, 2004, 11 C RETR OPP INF SA; Sacchi A, 2011, CLIN IMMUNOL, V138, P178, DOI 10.1016/j.clim.2010.11.001; Santin M, 2006, AIDS RES HUM RETROV, V22, P315, DOI 10.1089/aid.2006.22.315; Sarmento-Castro R, 2007, J INFECTION, V54, P609, DOI 10.1016/j.jinf.2006.11.010; Scaglione SJ, 2012, GASTROENTEROLOGY, V142, P1360, DOI 10.1053/j.gastro.2012.01.044; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Taylor LE, 2011, DRUG ALCOHOL DEPEN, V116, P233, DOI 10.1016/j.drugalcdep.2010.11.016; Thein HH, 2007, HIV MED, V8, P520, DOI 10.1111/j.1468-1293.2007.00505.x; Van den Eynde E, 2010, AIDS, V24, P975, DOI 10.1097/QAD.0b013e3283350f7c; Vandenbroucke JP, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7020; Wagner G, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/903480; Yotsuyanagi H, 2009, HEPATOL RES, V39, P657, DOI 10.1111/j.1872-034X.2009.00517.x; Zinkernagel AS, 2006, ANTIVIR THER, V11, P131	58	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55373	10.1371/journal.pone.0055373	http://dx.doi.org/10.1371/journal.pone.0055373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393570	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800024
J	Liu, L; Nie, J; Chen, L; Dong, GL; Du, XH; Wu, X; Tang, Y; Han, WD				Liu, Lin; Nie, Jing; Chen, Lin; Dong, Guanglong; Du, Xiaohui; Wu, Xin; Tang, Yun; Han, Weidong			The Oncogenic Role of microRNA-130a/301a/454 in Human Colorectal Cancer via Targeting Smad4 Expression	PLOS ONE			English	Article							CELL-PROLIFERATION; PROMOTES APOPTOSIS; MICRORNA; GENE; PLURIPOTENCY; METASTASIS; MIRNA-130A	Transforming growth factor (TGF)-beta/Smad signaling plays an important role in colon cancer development, progression and metastasis. In this study we demonstrated that the microRNA-130a/301a/454 family is up-regulated in colon cancer tissues compared to paired adjacent normal mucosa, which share the same 3'-untranslational region (3'-UTR) binding seed sequence and are predicated to target Smad4. In colorectal cancer HCT116 and SW480 cells, overexpression of miRNA-130a/301a/454 mimics enhances cell proliferation and migration, while inhibitors of these miRNAs affect cell survival. The biological function of miRNA-130a/301a/454 on colon cancer cells is likely mediated by suppression of Smad4, and the up-regulation of the miRNAs is correlated with Smad4 down-regulation in human colon cancers. Collectively, these results suggest that miRNA-130a/301a/454 are novel oncogenic miRNAs contributing to colon tumorigenesis by regulating TGF-beta/Smad signaling, which may have potential application in cancer therapy.	[Liu, Lin; Chen, Lin; Dong, Guanglong; Du, Xiaohui; Wu, Xin; Tang, Yun] Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China; [Nie, Jing; Han, Weidong] Peoples Liberat Army Gen Hosp, Dept Mol Biol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Tang, Y (corresponding author), Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China.	tangyun_301@163.com; hanwdrsw@sina.com		Dong, Guanglong/0000-0002-5545-1912	National Basic Research Programs [2012CB518103]; National Natural Science Foundation of China [31100554, 31270820, 81230061, 81121004]; Nursery Foundation of PLA General Hospital [12KMM48]; Beijing Nova Program [Z12111000250000]	National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nursery Foundation of PLA General Hospital; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This project is supported by grants from the National Basic Research Programs (2012CB518103), National Natural Science Foundation of China (31100554, 31270820, 81230061, and 81121004), Nursery Foundation of PLA General Hospital (12KMM48), and Beijing Nova Program (Z12111000250000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chen Z, 2012, J CELL BIOCHEM, V113, P3229, DOI 10.1002/jcb.24200; Genovese G, 2012, CANCER DISCOV, V2, P736, DOI 10.1158/2159-8290.CD-12-0111; Hahn SA, 1998, CANCER RES, V58, P1124; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kovaleva V, 2012, CANCER RES, V72, P1763, DOI 10.1158/0008-5472.CAN-11-3671; Lee YH, 2011, BIOCELL, V35, pB43; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Mycko MP, 2012, P NATL ACAD SCI USA, V109, pE1248, DOI 10.1073/pnas.1114325109; Nie J, 2012, CARCINOGENESIS, V33, P220, DOI 10.1093/carcin/bgr245; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Pfaff N, 2011, EMBO REP, V12, P1153, DOI 10.1038/embor.2011.176; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Suresh S, 2011, J CELL COMMUN SIGNAL, V5, P183, DOI 10.1007/s12079-011-0139-x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Wang XC, 2010, AM J MED SCI, V340, P385, DOI 10.1097/MAJ.0b013e3181e892a0; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Xiao B, 2012, ONCOL REP, V27, P559, DOI 10.3892/or.2011.1514; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zhang Y, 2012, NUCLEIC ACIDS RES, V40, P9286, DOI 10.1093/nar/gks667; Zhou P, 2012, DIGEST DIS SCI, V57, P1171, DOI 10.1007/s10620-012-2099-2	40	84	88	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55532	10.1371/journal.pone.0055532	http://dx.doi.org/10.1371/journal.pone.0055532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393589	gold, Green Submitted, Green Published			2022-12-27	WOS:000314692800043
J	Junk, DJ; Cipriano, R; Stampfer, M; Jackson, MW				Junk, Damian J.; Cipriano, Rocky; Stampfer, Martha; Jackson, Mark W.			Constitutive CCND1/CDK2 Activity Substitutes for p53 Loss, or MYC or Oncogenic RAS Expression in the Transformation of Human Mammary Epithelial Cells	PLOS ONE			English	Article							BREAST-CANCER; CYCLIN D1; INDUCED SENESCENCE; GROWTH; AMPLIFICATION; GENES; CDK2; PHOSPHORYLATION; OVEREXPRESSION; PROLIFERATION	Cancer develops following the accumulation of genetic and epigenetic alterations that inactivate tumor suppressor genes and activate proto-oncogenes. Dysregulated cyclin-dependent kinase (CDK) activity has oncogenic potential in breast cancer due to its ability to inactivate key tumor suppressor networks and drive aberrant proliferation. Accumulation or over-expression of cyclin D1 (CCND1) occurs in a majority of breast cancers and over-expression of CCND1 leads to accumulation of activated CCND1/CDK2 complexes in breast cancer cells. We describe here the role of constitutively active CCND1/CDK2 complexes in human mammary epithelial cell (HMEC) transformation. A genetically-defined, stepwise HMEC transformation model was generated by inhibiting p16 and p53 with shRNA, and expressing exogenous MYC and mutant RAS. By replacing components of this model, we demonstrate that constitutive CCND1/CDK2 activity effectively confers anchorage independent growth by inhibiting p53 or replacing MYC or oncogenic RAS expression. These findings are consistent with several clinical observations of luminal breast cancer sub-types that show elevated CCND1 typically occurs in specimens that retain wild-type p53, do not amplify MYC, and contain no RAS mutations. Taken together, these data suggest that targeted inhibition of constitutive CCND1/CDK2 activity may enhance the effectiveness of current treatments for luminal breast cancer.	[Junk, Damian J.; Cipriano, Rocky; Jackson, Mark W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Stampfer, Martha] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Jackson, Mark W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Case Western Reserve University	Jackson, MW (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	mark.w.jackson@case.edu		Junk, Damian/0000-0002-9251-3799	U.S. Department of Energy [DE-AC02-05CH11231]; NIH [T32 CA059366]; NATIONAL CANCER INSTITUTE [T32CA059366] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Martha Stampfer was supported under the U.S. Department of Energy contract No. DE-AC02-05CH11231. Damian Junk was supported by NIH T32 CA059366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chytil A, 2004, J BIOL CHEM, V279, P47688, DOI 10.1074/jbc.M405938200; Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108; Corsino P, 2007, CANCER RES, V67, P3135, DOI 10.1158/0008-5472.CAN-06-3815; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Cuny M, 2000, CANCER RES, V60, P1077; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; FILMUS J, 1994, ONCOGENE, V9, P3627; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Garrett MD, 1999, CURR OPIN GENET DEV, V9, P104, DOI 10.1016/S0959-437X(99)80015-X; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; GILLETT C, 1994, CANCER RES, V54, P1812; Guedj M, 2011, ONCOGENE; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hydbring P, 2010, CANCER RES, V70, P6687, DOI 10.1158/0008-5472.CAN-10-1383; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Kan CE, 2007, CANCER RES, V67, P9862, DOI 10.1158/0008-5472.CAN-07-0259; KATO J, 1993, GENE DEV, V7, P331; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Mani S, 2000, EXPERT OPIN INV DRUG, V9, P1849, DOI 10.1517/13543784.9.8.1849; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; Sweeney KJ, 1998, ONCOGENE, V16, P2865, DOI 10.1038/sj.onc.1201814	39	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e53776	10.1371/journal.pone.0053776	http://dx.doi.org/10.1371/journal.pone.0053776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390492	gold, Green Submitted, Green Published			2022-12-27	WOS:000314691100008
J	Rachow, S; Zorn-Kruppa, M; Ohnemus, U; Kirschner, N; Vidal-y-Sy, S; von den Driesch, P; Bornchen, C; Eberle, J; Mildner, M; Vettorazzi, E; Rosenthal, R; Moll, I; Brandner, JM				Rachow, Susanne; Zorn-Kruppa, Michaela; Ohnemus, Ulrich; Kirschner, Nina; Vidal-y-Sy, Sabine; von den Driesch, Peter; Boernchen, Christian; Eberle, Juergen; Mildner, Michael; Vettorazzi, Eik; Rosenthal, Rita; Moll, Ingrid; Brandner, Johanna M.			Occludin Is Involved in Adhesion, Apoptosis, Differentiation and Ca2+-Homeostasis of Human Keratinocytes: Implications for Tumorigenesis	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; CELL-CELL ADHESION; EPITHELIAL-MESENCHYMAL TRANSITION; INVOLUCRIN EXPRESSION; EPIDERMAL BARRIER; TUMOR INVASION; SKIN; CLAUDINS; PROGRESSION; COMPLEX	Tight junction (TJ) proteins are involved in a number of cellular functions, including paracellular barrier formation, cell polarization, differentiation, and proliferation. Altered expression of TJ proteins was reported in various epithelial tumors. Here, we used tissue samples of human cutaneous squamous cell carcinoma (SCC), its precursor tumors, as well as sun-exposed and non-sun-exposed skin as a model system to investigate TJ protein alteration at various stages of tumorigenesis. We identified that a broader localization of zonula occludens protein (ZO)-1 and claudin-4 (Cldn-4) as well as downregulation of Cldn-1 in deeper epidermal layers is a frequent event in all the tumor entities as well as in sun-exposed skin, suggesting that these changes result from chronic UV irradiation. In contrast, SCC could be distinguished from the precursor tumors and sun-exposed skin by a frequent complete loss of occludin (Ocln). To elucidate the impact of downregulation of Ocln, we performed Ocln siRNA experiments in human keratinocytes and uncovered that Ocln downregulation results in decreased epithelial cell-cell adhesion and reduced susceptibility to apoptosis induction by UVB or TNF-related apoptosis-inducing ligand (TRAIL), cellular characteristics for tumorigenesis. Furthermore, an influence on epidermal differentiation was observed, while there was no change of E-cadherin and vimentin, markers for epithelial-mesenchymal transition. Ocln knock-down altered Ca2+-homeostasis which may contribute to alterations of cell-cell adhesion and differentiation. As downregulation of Ocln is also seen in SCC derived from other tissues, as well as in other carcinomas, we suggest this as a common principle in tumor pathogenesis, which may be used as a target for therapeutic intervention.	[Rachow, Susanne; Zorn-Kruppa, Michaela; Ohnemus, Ulrich; Kirschner, Nina; Vidal-y-Sy, Sabine; Boernchen, Christian; Moll, Ingrid; Brandner, Johanna M.] Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany; [Rachow, Susanne] Tabea Clin GmbH, Hamburg, Germany; [von den Driesch, Peter] Klinikum Stuttgart, Dermatol Ctr, Stuttgart, Germany; [Eberle, Juergen] Charite, Skin Canc Ctr, Dept Dermatol Venerol & Allergol, Berlin, Germany; [Mildner, Michael] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Vettorazzi, Eik] Univ Hosp Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Rosenthal, Rita] Charite, Inst Clin Physiol, D-13353 Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Klinikum Stuttgart; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Vienna; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brandner, JM (corresponding author), Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany.	brandner@uke.de	Rosenthal, Rita/M-5652-2014; Vettorazzi, Eik/B-8130-2019	Vettorazzi, Eik/0000-0002-3737-6402; Eberle, Jurgen/0000-0001-8533-1519; Mildner, Michael/0000-0002-6892-925X	Deutsche Forschungsgemeinschaft [Forschergruppe 721/2, TP9]; Johann und Anny Thomas Stiftung; COST Action [BM 0903]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Johann und Anny Thomas Stiftung; COST Action(European Cooperation in Science and Technology (COST))	Deutsche Forschungsgemeinschaft, Forschergruppe 721/2, TP9, Johann und Anny Thomas Stiftung, COST Action BM 0903 SkinBAD STSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Arabzadeh A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-196; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Beeman N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.14; Beeman NE, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-85; Behne MJ, 2012, ADV EXP MED BIOL, V740, P945, DOI 10.1007/978-94-007-2888-2_43; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; BRUSSELBACH S, 1995, ONCOGENE, V10, P79; BRYNE M, 1989, J ORAL PATHOL MED, V18, P432, DOI 10.1111/j.1600-0714.1989.tb01339.x; Caldwell CJ, 1997, CLIN EXP DERMATOL, V22, P11, DOI 10.1046/j.1365-2230.1997.d01-232.x; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; DUVIC M, 1994, J INVEST DERMATOL, V102, P462, DOI 10.1111/1523-1747.ep12373021; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gao Y, 2008, INT J PHARM, V359, P70, DOI 10.1016/j.ijpharm.2008.03.016; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Iseri OD, 2011, BIOMED PHARMACOTHER, V65, P40, DOI 10.1016/j.biopha.2010.10.004; Jansen BJH, 2003, J INVEST DERMATOL, V121, P1433, DOI 10.1046/j.1523-1747.2003.12636.x; Kirschner N, 2013, J INVEST DERMATOL, V133, P1161, DOI 10.1038/jid.2012.507; Kirschner N, 2012, EXP DERMATOL, V21, P171, DOI 10.1111/j.1600-0625.2011.01431.x; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; Lanigan F, 2009, INT J CANCER, V124, P2088, DOI 10.1002/ijc.24159; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Martin TA, 2011, FRONT BIOSCI-LANDMRK, V16, P898, DOI 10.2741/3726; Martin TA, 2010, INT J MOL MED, V26, P721, DOI 10.3892/ijmm_00000519; Martinet N, 2003, AM J RESP CELL MOL, V28, P428, DOI 10.1165/rcmb.2002-0114OC; Mildner M, 2006, BIOCHEM BIOPH RES CO, V348, P76, DOI 10.1016/j.bbrc.2006.07.035; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Morita K, 2004, BRIT J DERMATOL, V151, P328, DOI 10.1111/j.1365-2133.2004.06029.x; Murata M, 2005, EXP CELL RES, V310, P140, DOI 10.1016/j.yexcr.2005.07.017; Nemeth Z, 2009, PATHOL ONCOL RES, V15, P533, DOI 10.1007/s12253-009-9150-4; Oliveira SS, 2007, CELL MOL LIFE SCI, V64, P17, DOI 10.1007/s00018-006-6314-1; Orban E, 2008, PATHOL ONCOL RES, V14, P299, DOI 10.1007/s12253-008-9031-2; Osanai M, 2006, CANCER RES, V66, P9125, DOI 10.1158/0008-5472.CAN-06-1864; Ouban A, 2011, INT J SURG PATHOL; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Paschoud S, 2007, MODERN PATHOL, V20, P947, DOI 10.1038/modpathol.3800835; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Sayers TJ, 2011, CANCER IMMUNOL IMMUN, V60, P1173, DOI 10.1007/s00262-011-1008-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Sehrawat A, 2011, CANCER PREV RES, V4, P1107, DOI 10.1158/1940-6207.CAPR-10-0306; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; SOBER AJ, 1995, CANCER, V75, P645, DOI 10.1002/1097-0142(19950115)75:2+<645::AID-CNCR2820751405>3.0.CO;2-1; SUMITOMO S, 1986, ORAL SURG ORAL MED O, V62, P155, DOI 10.1016/0030-4220(86)90038-1; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tobioka H, 2004, VIRCHOWS ARCH, V445, P472, DOI 10.1007/s00428-004-1054-9; Tobioka H, 2004, HUM PATHOL, V35, P159, DOI 10.1016/j.humpath.2003.09.013; Troyanovsky SM, 1999, CURR OPIN CELL BIOL, V11, P561, DOI 10.1016/S0955-0674(99)00021-6; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; VanItallie CM, 1997, J CELL SCI, V110, P1113; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Vicanova J, 1998, J INVEST DERMATOL, V111, P97, DOI 10.1046/j.1523-1747.1998.00251.x; Viloria-Petit AM, 2010, CELL CYCLE, V9, P623, DOI 10.4161/cc.9.4.10779; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; WATANABE S, 1995, BRIT J DERMATOL, V132, P730; Weedon D., 2006, WHO CLASSIFICATION T, P20; Yamamoto T, 2008, ARCH DERMATOL RES, V300, P61, DOI 10.1007/s00403-007-0817-y; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Yuki T, 2011, J INVEST DERMATOL, V131, P744, DOI 10.1038/jid.2010.385	78	55	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55116	10.1371/journal.pone.0055116	http://dx.doi.org/10.1371/journal.pone.0055116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390516	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100032
J	Rispens, T; Derksen, NIL; Commins, SP; Platts-Mills, TA; Aalberse, RC				Rispens, Theo; Derksen, Ninotska I. L.; Commins, Scott P.; Platts-Mills, Thomas A.; Aalberse, Rob C.			IgE Production to alpha-Gal Is Accompanied by Elevated Levels of Specific IgG1 Antibodies and Low Amounts of IgE to Blood Group B	PLOS ONE			English	Article							NATURAL ANTI-GAL; ANTI-GALACTOSE-ALPHA-1,3-GALACTOSE IGE; INDUCED ANAPHYLAXIS; CROSS-REACTIVITY; CARBOHYDRATE; BACTERIAL; EPITOPE; ACTIVATION; CETUXIMAB	IgE antibodies to gal-alpha-1,3-gal-beta-1,4-GlcNAc(alpha-gal) can mediate a novel form of delayed anaphylaxis to red meat. Although IgG antibodies to alpha-gal ( anti-alpha-gal or anti-Gal) are widely expressed in humans, IgE anti-alpha-gal is not. We explored the relationship between the IgG and IgE responses to both alpha-gal and the related blood group B antigen. Contradicting previous reports, antibodies to alpha-gal were found to be significantly less abundant in individuals with blood group B or AB. Importantly, we established a connection between IgE and IgG responses to alpha-gal: elevated titers of IgG anti-alpha-gal were found in IgE-positive subjects. In particular, proportionally more IgG1 anti-alpha-gal was found in IgE-positive subjects against a background of IgG2 production specific for alpha-gal. Thus, two types of immune response to alpha-gal epitopes can be distinguished: a 'typical' IgG2 response, presumably in response to gut bacteria, and an 'atypical', Th2-like response leading to IgG1 and IgE in addition to IgG2. These results suggest that IgE to a carbohydrate antigen can be formed (probably as part of a glycoprotein or glycolipid) even against a background of bacterial immune stimulation with essentially the same antigen.	[Rispens, Theo; Derksen, Ninotska I. L.; Aalberse, Rob C.] Univ Amsterdam, Acad Med Ctr, Sanquin Res, NL-1012 WX Amsterdam, Netherlands; [Rispens, Theo; Derksen, Ninotska I. L.; Aalberse, Rob C.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1012 WX Amsterdam, Netherlands; [Commins, Scott P.; Platts-Mills, Thomas A.] Univ Virginia, Div Allergy & Immunol, Charlottesville, VA USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Virginia	Rispens, T (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res, NL-1012 WX Amsterdam, Netherlands.	t.rispens@sanquin.nl		Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020565, T32AI007496] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007496, R01 AI020565, R37 AI020565] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; AALBERSE RC, 1993, ALLERGY, V48, P559, DOI 10.1111/j.1398-9995.1993.tb00749.x; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Arkestal K, 2011, J ALLERGY CLIN IMMUN, V127, P1024, DOI 10.1016/j.jaci.2011.01.033; AVILA JL, 1989, J IMMUNOL, V142, P2828; BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127; Bernth-Jensen JM, 2011, J IMMUNOL METHODS, V373, P26, DOI 10.1016/j.jim.2011.07.017; Buonomano R, 1999, XENOTRANSPLANTATION, V6, P173, DOI 10.1034/j.1399-3089.1999.00023.x; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Cornmins SP, 2012, AM J RESP CRIT CARE, V185, P723, DOI 10.1164/rccm.201111-2017OC; FERRANTE A, 1990, PEDIATR INFECT DIS J, V9, pS16; GALILI U, 1993, BLOOD, V82, P2485, DOI 10.1182/blood.V82.8.2485.bloodjournal8282485; GALILI U, 1987, J EXP MED, V165, P693, DOI 10.1084/jem.165.3.693; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; HAMADEH RM, 1992, J CLIN INVEST, V89, P1223, DOI 10.1172/JCI115706; Jacquenet S, 2009, J ALLERGY CLIN IMMUN, V124, P603, DOI 10.1016/j.jaci.2009.06.014; Krop EJM, 2011, ALLERGY, V66, P517, DOI 10.1111/j.1398-9995.2010.02508.x; Landsteiner K, 1925, J EXP MED, V42, P863, DOI 10.1084/jem.42.6.863; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Malandain H, 2005, Eur Ann Allergy Clin Immunol, V37, P122; McMorrow IM, 1997, TRANSPLANTATION, V64, P546, DOI 10.1097/00007890-199708150-00032; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Milland J, 2007, IMMUNOL CELL BIOL, V85, P623, DOI 10.1038/sj.icb.7100111; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Plum M, 2011, J BIOL CHEM, V286, P43103, DOI 10.1074/jbc.M111.291823; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; RAVINDRAN B, 1988, IMMUNOL LETT, V19, P137, DOI 10.1016/0165-2478(88)90133-2; Saleh Hana, 2012, Clin Mol Allergy, V10, P5, DOI 10.1186/1476-7961-10-5; SIBER GR, 1980, NEW ENGL J MED, V303, P178, DOI 10.1056/NEJM198007243030402; Tomlinson S, 1997, J IMMUNOL, V159, P5606; van Bueren JJL, 2011, NAT BIOTECHNOL, V29, P574, DOI 10.1038/nbt.1912; Yu PB, 1996, J IMMUNOL, V157, P5163	33	83	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55566	10.1371/journal.pone.0055566	http://dx.doi.org/10.1371/journal.pone.0055566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390540	Green Submitted, gold, Green Published			2022-12-27	WOS:000314691100056
J	Bangirana, P; Menk, J; John, CC; Boivin, MJ; Hodges, JS				Bangirana, Paul; Menk, Jeremiah; John, Chandy C.; Boivin, Michael J.; Hodges, James S.			The Association between Cognition and Academic Performance in Ugandan Children Surviving Malaria with Neurological Involvement	PLOS ONE			English	Article							WORKING-MEMORY; CEREBRAL MALARIA; SKILLS; REHABILITATION; ACHIEVEMENT; PREDICTORS; COMPONENTS; SENEGALESE; ABILITY	Background: The contribution of different cognitive abilities to academic performance in children surviving cerebral insult can guide the choice of interventions to improve cognitive and academic outcomes. This study's objective was to identify which cognitive abilities are associated with academic performance in children after malaria with neurological involvement. Methods: 62 Ugandan children with a history of malaria with neurological involvement were assessed for cognitive ability (working memory, reasoning, learning, visual spatial skills, attention) and academic performance (reading, spelling, arithmetic) three months after the illness. Linear regressions were fit for each academic score with the five cognitive outcomes entered as predictors. Adjusters in the analysis were age, sex, education, nutrition, and home environment. Exploratory factor analysis (EFA) and structural equation models (SEM) were used to determine the nature of the association between cognition and academic performance. Predictive residual sum of squares was used to determine which combination of cognitive scores was needed to predict academic performance. Results: In regressions of a single academic score on all five cognitive outcomes and adjusters, only Working Memory was associated with Reading (coefficient estimate=0.36, 95% confidence interval=0.10 to 0.63, p<0.01) and Spelling (0.46, 0.13 to 0.78, p<0.01), Visual Spatial Skills was associated with Arithmetic (0.15, 0.03 to 0.26, p<0.05), and Learning was associated with Reading (0.06, 0.00 to 0.11, p<0.05). One latent cognitive factor was identified using EFA. The SEM found a strong association between this latent cognitive ability and each academic performance measure (P<0.0001). Working memory, visual spatial ability and learning were the best predictors of academic performance. Conclusion: Academic performance is strongly associated with the latent variable labelled "cognitive ability'' which captures most of the variation in the individual specific cognitive outcome measures. Working memory, visual spatial skills, and learning together stood out as the best combination to predict academic performance.	[Bangirana, Paul] Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda; [Menk, Jeremiah; Hodges, James S.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [John, Chandy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Boivin, Michael J.] Michigan State Univ, Dept Psychiat & Neurol Ophthalmol, E Lansing, MI 48824 USA; [Boivin, Michael J.] Univ Michigan, Dept Psychiat, Neuropsychol Sect, Ann Arbor, MI 48109 USA	Makerere University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University; University of Michigan System; University of Michigan	Bangirana, P (corresponding author), Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda.	pbangirana@yahoo.com	John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411; Bangirana, Paul/0000-0002-7136-0594	Swedish Institute; Michigan State University Department of Psychiatry; Neurology/Ophthalmology faculty start-up; National Institute of Neurological Disorders and Stroke award [5R01NS055349]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055349, D43NS078280] Funding Source: NIH RePORTER	Swedish Institute; Michigan State University Department of Psychiatry; Neurology/Ophthalmology faculty start-up; National Institute of Neurological Disorders and Stroke award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded in part by grants from The Swedish Institute to Paul Bangirana for the Joint Makerere University/Karolinska Institutet PhD Program; Michigan State University Department of Psychiatry and Neurology/Ophthalmology faculty start-up funding to Michael J Boivin and National Institute of Neurological Disorders and Stroke award (5R01NS055349) to Chandy C. John. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagenda D, 2006, PEDIATRICS, V117, P729, DOI 10.1542/peds.2004-2699; Bangirana P, 2009, AFR HEALTH SCI, V9, P186; Bangirana P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-334; Bangirana P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-96; Bangirana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007898; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; Barrouillet P, 2005, J EXP CHILD PSYCHOL, V91, P183, DOI 10.1016/j.jecp.2005.03.002; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008914; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; Caldwell B. M., 2001, HOME INVENTORY ADM M; de Hevia MD, 2008, NEUROSCI BIOBEHAV R, V32, P1361, DOI 10.1016/j.neubiorev.2008.05.015; Dupuy TR, 2005, TOVA MANUAL IBM PERS; Fernando D, 2003, T ROY SOC TROP MED H, V97, P161, DOI 10.1016/S0035-9203(03)90107-6; Forrest LF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-895; Holding PA, 1999, T ROY SOC TROP MED H, V93, P529, DOI 10.1016/S0035-9203(99)90368-1; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; Iglesias-Sarmiento V, 2011, J LEARN DISABIL-US, V44, P570, DOI 10.1177/0022219411400749; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Knoop A, 2004, REHABILITATION COUNS, V47, P184; Lin RT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-85; McLean JF, 1999, J EXP CHILD PSYCHOL, V74, P240, DOI 10.1006/jecp.1999.2516; Polderman TJC, 2010, ACTA PSYCHIAT SCAND, V122, P271, DOI 10.1111/j.1600-0447.2010.01568.x; Rasmussen C, 2005, J EXP CHILD PSYCHOL, V91, P137, DOI 10.1016/j.jecp.2005.01.004; Sesma HW, 2009, CHILD NEUROPSYCHOL, V15, P232, DOI 10.1080/09297040802220029; Silva-Pereyra J, 2010, NEUROREPORT, V21, P34, DOI 10.1097/WNR.0b013e328332c566; Simmons FR, 2012, J EXP CHILD PSYCHOL, V111, P139, DOI 10.1016/j.jecp.2011.08.011; Weisberg S., 1980, APPL LINEAR REGRESSI; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Zheng XH, 2011, J EXP CHILD PSYCHOL, V110, P481, DOI 10.1016/j.jecp.2011.06.001	32	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55653	10.1371/journal.pone.0055653	http://dx.doi.org/10.1371/journal.pone.0055653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085EU	23383342	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900049
J	Mitra, A; Palaniyandi, S; Herren, CD; Zhu, XP; Mukhopadhyay, S				Mitra, Arindam; Palaniyandi, Senthilkumar; Herren, Christopher D.; Zhu, Xiaoping; Mukhopadhyay, Suman			Pleiotropic Roles of uvrY on Biofilm Formation, Motility and Virulence in Uropathogenic Escherichia coli CFT073	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; RNA-BINDING PROTEIN; INTRACELLULAR BACTERIAL COMMUNITIES; TYPE-1 FIMBRIAE; PHASE VARIATION; 2-COMPONENT SYSTEM; GENETIC-REGULATION; EPITHELIAL-CELLS; CSRA; REGULATOR	Urinary tract infections primarily caused by uropathogenic strains of Escherichia coli (E. coli) remain a significant public health problem in both developed and developing countries. An important virulence determinant in uropathogenesis is biofilm formation which requires expression of fimbriae, flagella, and other surface components such as lipopolysaccharides. In this study, we explored the regulation of uvrY and csrA genes in biofilm formation, motility and virulence determinants in uropathogenic E. coli. We found that mutation in uvrY suppressed biofilm formation on abiotic surfaces such as polyvinyl chloride, polystyrene and glass, and complementation of uvrY in the mutant restored the biofilm phenotype. We further evaluated the role of uvrY gene in expression of type 1 fimbriae, an important adhesin that facilitates adhesion to various abiotic surfaces. We found that phase variation of type 1 fimbriae between fimbriated and afimbriated mode was modulated by uvrY at its transcriptional level. Deletion mutant of uvrY lowered expression of fimbrial recombinase genes, such as fimB, fimE, and fimA, a gene encoding major fimbrial subunit. Furthermore, transcription of virulence specific genes such as papA, hlyB and galU was also reduced in the deletion mutant. Swarming motility and expression of flhD and flhC was also diminished in the mutant. Taken together, our findings unravel a possible mechanism in which uvrY facilitates biofilm formation, persistence and virulence of uropathogenic E. coli.	[Mitra, Arindam; Palaniyandi, Senthilkumar; Herren, Christopher D.; Zhu, Xiaoping; Mukhopadhyay, Suman] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Palaniyandi, Senthilkumar; Zhu, Xiaoping] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Mukhopadhyay, S (corresponding author), NIAID, Div Microbiol & Infect Dis, NIH, HHS, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mukhopadhyays@mail.nih.gov	Mitra, Arindam/A-1379-2013; Palaniyandi, Senthilkumar/B-9575-2016	Mitra, Arindam/0000-0002-1591-6164; 	USDA-NRI-CSREES Competitive Grant [2004-35204-14749]; USDA-Animal Health [2002-1106-0195318]; Maryland Agriculture Experimental Station grant from the University of Maryland; National Institutes of Health [R01 AI65892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065892] Funding Source: NIH RePORTER	USDA-NRI-CSREES Competitive Grant; USDA-Animal Health; Maryland Agriculture Experimental Station grant from the University of Maryland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by USDA-NRI-CSREES Competitive Grant 2004-35204-14749, USDA-Animal Health 2002-1106-0195318 and Maryland Agriculture Experimental Station grant from the University of Maryland (to S. M.) and a National Institutes of Health Grant R01 AI65892 (to X.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22; Bahrani-Mougeot FK, 2002, MOL MICROBIOL, V45, P1079, DOI 10.1046/j.1365-2958.2002.03078.x; Belanger L, 2011, FEMS IMMUNOL MED MIC, V62, P1, DOI 10.1111/j.1574-695X.2011.00797.x; Blumer C, 2005, MICROBIOL-SGM, V151, P3287, DOI 10.1099/mic.0.28098-0; Bower JM, 2005, TRAFFIC, V6, P18, DOI 10.1111/j.1600-0854.2004.00251.x; Bryan A, 2006, INFECT IMMUN, V74, P1072, DOI 10.1128/IAI.74.2.1072-1083.2006; Chatterjee A, 2010, MOL PLANT MICROBE IN, V23, P1316, DOI 10.1094/MPMI-01-10-0017; Chenoweth CE, 2011, INFECT DIS CLIN N AM, V25, P103, DOI 10.1016/j.idc.2010.11.005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; EISENSTEIN BI, 1981, SCIENCE, V214, P337, DOI 10.1126/science.6116279; EISENSTEIN BI, 1988, REV INFECT DIS, V10, pS341; Ferrieres L, 2007, FEMS IMMUNOL MED MIC, V51, P212, DOI 10.1111/j.1574-695X.2007.00296.x; Foxman B, 2002, AM J MED, V113, p5S; GALLY DL, 1993, J BACTERIOL, V175, P6186, DOI 10.1128/JB.175.19.6186-6193.1993; Goller CC, 2010, VIRULENCE, V1, P333, DOI 10.4161/viru.1.4.12388; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213; HARSHEY RM, 1994, MOL MICROBIOL, V13, P389, DOI 10.1111/j.1365-2958.1994.tb00433.x; Hatt JK, 2008, CURR TOP MICROBIOL, V322, P163; Herren CD, 2006, INFECT IMMUN, V74, P4900, DOI 10.1128/IAI.00412-06; Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kariyawasam S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-81; Katouli M, 2010, IRAN J MICROBIOL, V2, P59; KLEMM P, 1986, EMBO J, V5, P1389, DOI 10.1002/j.1460-2075.1986.tb04372.x; Lane MC, 2007, KIDNEY INT, V72, P19, DOI 10.1038/sj.ki.5002230; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lim JK, 1998, INFECT IMMUN, V66, P3303, DOI 10.1128/IAI.66.7.3303-3310.1998; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; MCCLAIN MS, 1991, J BACTERIOL, V173, P5308, DOI 10.1128/jb.173.17.5308-5314.1991; Melican K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001298; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mitra A, 2008, TOXICOGENOMICS POWER, P199; Mizuno T, 1998, J BIOCHEM, V123, P555; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Palaniyandi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031348; Pernestig AK, 2003, J BACTERIOL, V185, P843, DOI 10.1128/JB.185.3.843-853.2003; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Schwan WR, 2008, INT J MED MICROBIOL, V298, P441, DOI 10.1016/j.ijmm.2007.05.009; Schwan WR, 2002, INFECT IMMUN, V70, P1391, DOI 10.1128/IAI.70.3.1391-1402.2002; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; STAMM WE, 1991, AM J MED, V91, pS65, DOI 10.1016/0002-9343(91)90345-X; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Teplitski M, 2006, MICROBIOL-SGM, V152, P3411, DOI 10.1099/mic.0.29118-0; Timmermans J, 2010, CELL MOL LIFE SCI, V67, P2897, DOI 10.1007/s00018-010-0381-z; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BD, 2000, J BACTERIOL, V182, P1632, DOI 10.1128/JB.182.6.1632-1640.2000; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Wright KJ, 2006, FUTURE MICROBIOL, V1, P75, DOI 10.2217/17460913.1.1.75; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Yang HH, 1996, J BACTERIOL, V178, P1012, DOI 10.1128/jb.178.4.1012-1017.1996	64	37	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55492	10.1371/journal.pone.0055492	http://dx.doi.org/10.1371/journal.pone.0055492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383333	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900040
J	Fujikura, D; Chiba, S; Muramatsu, D; Kazumata, M; Nakayama, Y; Kawai, T; Akira, S; Kida, H; Miyazaki, T				Fujikura, Daisuke; Chiba, Satoko; Muramatsu, Daisuke; Kazumata, Mika; Nakayama, Yosuke; Kawai, Taro; Akira, Shizuo; Kida, Hiroshi; Miyazaki, Tadaaki			Type-I Interferon is Critical for FasL Expression on Lung Cells to Determine the Severity of Influenza	PLOS ONE			English	Article							DENDRITIC CELLS; LIGAND; INFECTION; RESPONSES; IMMUNE; MACROPHAGES; RECEPTORS; APOPTOSIS; EFFECTOR; FAMILY	Infection of influenza A virus in mammals induces hyper lung pneumonia, which often causes lethal diseases. FasL is a specific ligand of Fas, which is a type-I transmembrane protein to induce cell death. Previously, it has been reported that the hyper induction of gene expression associated with Fas signal is observed in lethal influenza A virus infection. More importantly, it was also reported that functional mutation of the FasL gene protects the host against influenza A virus infection. These observations suggest that induction of FasL signal is functionally associated with the severity of influenza. However, regulation of the induction of FasL or Fas by influenza A virus infection is still unknown. Here, we demonstrated that FasL is induced after the viral infection, and inhibition of the Fas/FasL signal by treatment with a recombinant decoy receptor for FasL (Fas-Fc) increases the survival rate of mice after lethal infection of influenza A virus as well as functional mutation of the FasL gene in gld/gld mice. In addition, the induction level of FasL gene expression in the lung was correlated with the severity of influenza. We also showed that a variety of types of cells in the lung express FasL after the viral infection. Furthermore, type-I interferon induced by the viral infection was shown to be critical for induction of FasL protein expression in the lung. These findings suggested that expression of FasL protein induced by type-I IFN on the lung cell surface is critical to determine the severity of influenza.	[Fujikura, Daisuke; Chiba, Satoko; Muramatsu, Daisuke; Kazumata, Mika; Nakayama, Yosuke; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Kita Ku, Sapporo, Hokkaido, Japan; [Fujikura, Daisuke; Kida, Hiroshi; Miyazaki, Tadaaki] Japan Sci & Technol Agcy, Innovat Plaza Hokkaido, Kita Ku, Sapporo, Hokkaido, Japan; [Muramatsu, Daisuke; Kazumata, Mika] Aureo Sci Co Ltd, Kita Ku, Sapporo, Hokkaido, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 565, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Kita Ku, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] OIE, Reference Lab Highly Pathogen Avian Influenza, Sapporo, Hokkaido, Japan	Hokkaido University; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Hokkaido University; Hokkaido University	Miyazaki, T (corresponding author), Hokkaido Univ, Inst Med Genet, Dept Probiot Immunol, Kita Ku, Sapporo, Hokkaido, Japan.	miyazaki@pop.med.hokudai.ac.jp	Akira, Shizuo/C-3134-2009	Kawai, Taro/0000-0001-7510-4662	Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Science and Technology Agency	Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and by a grant from the Japan Science and Technology Agency. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Fujimoto I, 1998, CELL DEATH DIFFER, V5, P426, DOI 10.1038/sj.cdd.4400362; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Isaacs JD, 1998, J IMMUNOL, V161, P3862; Kaser A, 1999, CYTOKINE, V11, P736, DOI 10.1006/cyto.1998.0484; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Langlois RA, 2010, J IMMUNOL, V184, P4440, DOI 10.4049/jimmunol.0902984; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; Matute-Bello G, 2005, J IMMUNOL, V175, P4069, DOI 10.4049/jimmunol.175.6.4069; Matute-Bello G, 2001, AM J PHYSIOL-LUNG C, V281, pL328, DOI 10.1152/ajplung.2001.281.2.L328; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sivaraman V, 2011, J VIROL, V85, P9243, DOI 10.1128/JVI.00457-11; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	26	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55321	10.1371/journal.pone.0055321	http://dx.doi.org/10.1371/journal.pone.0055321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408968	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300011
J	Kitano, A; Shimasaki, T; Chikano, Y; Nakada, M; Hirose, M; Higashi, T; Ishigaki, Y; Endo, Y; Takino, T; Sato, H; Sai, Y; Miyamoto, K; Motoo, Y; Kawakami, K; Minamoto, T				Kitano, Ayako; Shimasaki, Takeo; Chikano, Yuri; Nakada, Mitsutoshi; Hirose, Mayumi; Higashi, Tomomi; Ishigaki, Yasuhito; Endo, Yoshio; Takino, Takahisa; Sato, Hiroshi; Sai, Yoshimichi; Miyamoto, Ken-ichi; Motoo, Yoshiharu; Kawakami, Kazuyuki; Minamoto, Toshinari			Aberrant Glycogen Synthase Kinase 3 beta Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy	PLOS ONE			English	Article							FACTOR-KAPPA-B; INHIBITION; GSK3-BETA; SURVIVAL; PHOSPHORYLATION; KINASE-3-BETA; MAINTENANCE; GSK-3-BETA; IQGAP1; OVEREXPRESSION	Background and Purpose: The major obstacles to treatment of pancreatic cancer are the highly invasive capacity and resistance to chemo-and radiotherapy. Glycogen synthase kinase 3 beta (GSK3 beta) regulates multiple cellular pathways and is implicated in various diseases including cancer. Here we investigate a pathological role for GSK3 beta in the invasive and treatment resistant phenotype of pancreatic cancer. Methods: Pancreatic cancer cells were examined for GSK3 beta expression, phosphorylation and activity using Western blotting and in vitro kinase assay. The effects of GSK3 beta inhibition on cancer cell survival, proliferation, invasive ability and susceptibility to gemcitabine and radiation were examined following treatment with a pharmacological inhibitor or by RNA interference. Effects of GSK3 beta inhibition on cancer cell xenografts were also examined. Results: Pancreatic cancer cells showed higher expression and activity of GSK3 beta than non-neoplastic cells, which were associated with changes in its differential phosphorylation. Inhibition of GSK3 beta significantly reduced the proliferation and survival of cancer cells, sensitized them to gemcitabine and ionizing radiation, and attenuated their migration and invasion. These effects were associated with decreases in cyclin D1 expression and Rb phosphorylation. Inhibition of GSK3 beta also altered the subcellular localization of Rac1 and F-actin and the cellular microarchitecture, including lamellipodia. Coincident with these changes were the reduced secretion of matrix metalloproteinase-2 (MMP-2) and decreased phosphorylation of focal adhesion kinase (FAK). The effects of GSK3 beta inhibition on tumor invasion, susceptibility to gemcitabine, MMP-2 expression and FAK phosphorylation were observed in tumor xenografts. Conclusion: The targeting of GSK3 beta represents an effective strategy to overcome the dual challenges of invasiveness and treatment resistance in pancreatic cancer.	[Kitano, Ayako; Shimasaki, Takeo; Chikano, Yuri; Hirose, Mayumi; Higashi, Tomomi; Kawakami, Kazuyuki; Minamoto, Toshinari] Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa 920, Japan; [Takino, Takahisa; Sato, Hiroshi] Kanazawa Univ, Canc Res Inst, Div Mol Virol & Oncol, Kanazawa, Ishikawa 920, Japan; [Endo, Yoshio] Kanazawa Univ, Canc Res Inst, Cent Lab, Kanazawa, Ishikawa 920, Japan; [Kitano, Ayako; Chikano, Yuri; Sai, Yoshimichi; Miyamoto, Ken-ichi] Kanazawa Univ, Grad Sch Med Sci, Dept Hosp Pharm, Kanazawa, Ishikawa, Japan; [Nakada, Mitsutoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Neurosurg, Kanazawa, Ishikawa, Japan; [Higashi, Tomomi] Kanazawa Univ, Grad Sch Med Sci, Dept Hyg, Kanazawa, Ishikawa, Japan; [Shimasaki, Takeo; Motoo, Yoshiharu] Kanazawa Med Univ, Dept Med Oncol, Uchinada, Ishikawa 92002, Japan; [Shimasaki, Takeo; Ishigaki, Yasuhito] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa 92002, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa Medical University; Kanazawa Medical University	Minamoto, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa 920, Japan.	minamoto@staff.kanazawa-u.ac.jp	SATO, Hiroshi/D-8454-2015; Motoo, Yoshiharu/E-8277-2011; ENDO, Yoshio/D-8428-2015; SAI, Yoshimichi/L-3828-2015; まゆみ, 廣瀬/AAK-5735-2020; TAKINO, Takahisa/D-8460-2015; Nakada, Mitsutoshi/B-2790-2012	ENDO, Yoshio/0000-0003-0785-2006; SAI, Yoshimichi/0000-0003-2954-1532; Nakada, Mitsutoshi/0000-0001-9419-6101	Japanese Ministry of Education, Science, Sports, Technology and Culture; Japan Society for the Promotion of Science; Japan Society for Technology; Kanazawa University Cancer Research Institute; Grants-in-Aid for Scientific Research [25460793, 23659643] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports, Technology and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for Technology; Kanazawa University Cancer Research Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, Technology and Culture; the Japan Society for the Promotion of Science (to KK, TM); the Japan Society for Technology (to KK, TM); the Extramural Collaborative Research Grant of Kanazawa University Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chico LK, 2009, NAT REV DRUG DISCOV, V8, P892, DOI 10.1038/nrd2999; Dong PX, 2006, CANCER LETT, V243, P120, DOI 10.1016/j.canlet.2005.11.024; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Furukawa T, 2008, J GASTROENTEROL, V43, P905, DOI 10.1007/s00535-008-2226-1; Hage B, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-23; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holcom B, 2008, PANCREAS, V36, P225, DOI 10.1097/MPA.0b013e31815b3207; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Korur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007443; Kudo T, 2007, CANCER SCI, V98, P563, DOI 10.1111/j.1349-7006.2007.00426.x; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mai W, 2006, ONCOLOGY-BASEL, V71, P297, DOI 10.1159/000106429; Mai W, 2009, CLIN CANCER RES, V15, P6810, DOI 10.1158/1078-0432.CCR-09-0973; Mamaghani S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-132; McDonald KL, 2007, J NEUROPATH EXP NEUR, V66, P405, DOI 10.1097/nen.0b013e31804567d7; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Miyashita K, 2009, ANTI-CANCER AGENT ME, V9, P1114, DOI 10.2174/187152009789734982; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Morgan MA, 2008, CLIN CANCER RES, V14, P6744, DOI 10.1158/1078-0432.CCR-08-1032; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Shimasaki T, 2012, J GASTROENTEROL, V47, P321, DOI 10.1007/s00535-011-0484-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spalding AC, 2010, NEOPLASIA, V12, P357, DOI 10.1593/neo.92112; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	52	55	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55289	10.1371/journal.pone.0055289	http://dx.doi.org/10.1371/journal.pone.0055289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408967	gold, Green Published, Green Submitted			2022-12-27	WOS:000314660300010
J	Gareau, C; Houssin, E; Martel, D; Coudert, L; Mellaoui, S; Huot, ME; Laprise, P; Mazroui, R				Gareau, Cristina; Houssin, Elise; Martel, David; Coudert, Laetitia; Mellaoui, Samia; Huot, Marc-Etienne; Laprise, Patrick; Mazroui, Rachid			Characterization of Fragile X Mental Retardation Protein Recruitment and Dynamics in Drosophila Stress Granules	PLOS ONE			English	Article							CELL-FREE FORMATION; MESSENGER-RNA; BINDING; PHOSPHORYLATION; NUCLEAR; FMR1; LOCALIZATION; POLYRIBOSOMES; AGGREGATION; ASSOCIATION	The RNA-binding protein Fragile X Mental Retardation (FMRP) is an evolutionarily conserved protein that is particularly abundant in the brain due to its high expression in neurons. FMRP deficiency causes fragile X mental retardation syndrome. In neurons, FMRP controls the translation of target mRNAs in part by promoting dynamic transport in and out neuronal RNA granules. We and others have previously shown that upon stress, mammalian FMRP dissociates from translating polysomes to localize into neuronal-like granules termed stress granules (SG). This localization of FMRP in SG is conserved in Drosophila. Whether FMRP plays a key role in SG formation, how FMRP is recruited into SG, and whether its association with SG is dynamic are currently unknown. In contrast with mammalian FMRP, which has two paralog proteins, Drosophila FMR1 (dFMRP) is encoded by a single gene that has no paralog. Using this genetically simple model, we assessed the role of dFMRP in SG formation and defined the determinants required for its recruitment in SG as well as its dynamics in SG. We show that dFMRP is dispensable for SG formation in vitro and ex vivo. FRAP experiments showed that dFMRP shuttles in and out SG. The shuttling activity of dFMRP is mediated by a protein-protein interaction domain located at the N-terminus of the protein. This domain is, however, dispensable for the localization of dFMRP in SG. This localization of dFMRP in SG requires the KH and RGG motifs which are known to mediate RNA binding, as well as the C-terminal glutamine/asparagine rich domain. Our studies thus suggest that the mechanisms controlling the recruitment of FMRP into SG and those that promote its shuttling between granules and the cytosol are uncoupled. To our knowledge, this is the first demonstration of the regulated shuttling activity of a SG component between RNA granules and the cytosol.	[Gareau, Cristina; Houssin, Elise; Martel, David; Coudert, Laetitia; Mellaoui, Samia; Huot, Marc-Etienne; Laprise, Patrick; Mazroui, Rachid] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Ctr Rech,CHU Quebec, Quebec City, PQ G1K 7P4, Canada	Laval University	Mazroui, R (corresponding author), Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Ctr Rech,CHU Quebec, Quebec City, PQ G1K 7P4, Canada.	rachid.mazroui@crsfa.ulaval.ca			Canadian Institute Health Research (CIHR) [MOP-199572-CP-CFBA]; Natural Sciences and Engineering Research Council of Canada [MOP-CG095386]; Canadian Foundation for Innovation [MOP-GF091050]; Faculty of Medicine at Laval University; CIHR	Canadian Institute Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Faculty of Medicine at Laval University; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institute Health Research (CIHR) grant (MOP-199572-CP-CFBA) to P. Laprise, the Natural Sciences and Engineering Research Council of Canada (MOP-CG095386) and by a Canadian Foundation for Innovation grant (MOP-GF091050) to R. Mazroui. C. Gareau is recipient of a scholarship from the Faculty of Medicine at Laval University. P. Laprise and R. Mazroui are both recipients of a CIHR New investigator Scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Banerjee P, 2010, J NEUROSCI, V30, P6782, DOI 10.1523/JNEUROSCI.6369-09.2010; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Chakraborty P, 2006, METHODS, V39, P363, DOI 10.1016/j.ymeth.2006.07.002; Cheever A, 2009, RNA BIOL, V6, P175, DOI 10.4161/rna.6.2.8196; Cheever A, 2009, RNA, V15, P362, DOI 10.1261/rna.1500809; Coffee RL, 2012, HUM MOL GENET, V21, P900, DOI 10.1093/hmg/ddr527; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Didiot MC, 2009, MOL BIOL CELL, V20, P428, DOI 10.1091/mbc.E08-07-0737; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Estes PS, 2008, MOL CELL NEUROSCI, V39, P170, DOI 10.1016/j.mcn.2008.06.012; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khandjian EW, 1999, BIOCHEM CELL BIOL, V77, P331, DOI 10.1139/bcb-77-4-331; KHANDJIAN EW, 1995, HUM MOL GENET, V4, P783, DOI 10.1093/hmg/4.5.783; Kim SH, 2006, J NEUROSCI, V26, P2413, DOI 10.1523/JNEUROSCI.3680-05.2006; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McLennan Y, 2011, CURR GENOMICS, V12, P216, DOI 10.2174/138920211795677886; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Roy G, 2004, MOL CELL BIOL, V24, P1143, DOI 10.1128/MCB.24.3.1143-1154.2004; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wang CY, 2012, RNA, V18, P694, DOI 10.1261/rna.030270.111; XU T, 1994, METHOD CELL BIOL, V44, P655, DOI 10.1016/S0091-679X(08)60937-1; Zurla C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019727	51	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55342	10.1371/journal.pone.0055342	http://dx.doi.org/10.1371/journal.pone.0055342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408971	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200025
J	Bouwense, SAW; Olesen, SS; Drewes, AM; Frokjaer, JB; van Goor, H; Wilder-Smith, OHG				Bouwense, Stefan A. W.; Olesen, Soren S.; Drewes, Asbjorn M.; Frokjaer, Jens B.; van Goor, Harry; Wilder-Smith, Oliver H. G.			Is Altered Central Pain Processing Related to Disease Stage in Chronic Pancreatitis Patients with Pain? An Exploratory Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; OPIOID-INDUCED HYPERALGESIA; CENTRAL SENSITIZATION; ULCERATIVE-COLITIS; VISCERAL PAIN; MECHANISMS; MANAGEMENT; RESPONSES; NEUROPLASTICITY; MODULATION	Background: The most dominant feature in chronic pancreatitis is intense abdominal pain. Changes in spinal and/or supraspinal central nervous system pain processing due to visceral nociceptive input play an important role in this pain. How altered pain processing is related to disease stage still needs study. Methodology/Principal Findings: Sixty chronic pancreatitis patients were compared to 15 healthy controls. Two subgroups of pancreatitis patients were defined based on the M-ANNHEIM severity index of chronic pancreatitis; i.e. moderate and severe. Pain detection and tolerance thresholds for pressure and electric stimuli were measured in six selected dermatomes (C5, T4, T10, L1, L4 and T10BACK). In addition, the conditioned pain modulation response to cold pressor task was determined. These measures were compared between the healthy controls and chronic pancreatitis patients. Severe pancreatitis patients showed lower pain thresholds than moderate pancreatitis patients or healthy volunteers. Healthy controls showed a significantly larger conditioned pain modulation response compared to all chronic pancreatitis patients taken together. Conclusions/Significance: The present study confirms that chronic pancreatitis patients show signs of altered central processing of nociception compared to healthy controls. The study further suggests that these changes, i.e. central sensitization, may be influenced by disease stage. These findings underline the need to take altered central pain processing into account when managing the pain of chronic pancreatitis.	[Bouwense, Stefan A. W.; van Goor, Harry] Radboud Univ Nijmegen, Pain & Nocicept Neurosci Res Grp, Dept Surg, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Olesen, Soren S.; Drewes, Asbjorn M.; Frokjaer, Jens B.] Aarhus Univ Hosp, Aalborg Hosp, Dept Gastroenterol, Mech Sense, Aalborg, Denmark; [Olesen, Soren S.; Drewes, Asbjorn M.; Frokjaer, Jens B.] Aarhus Univ Hosp, Aalborg Hosp, Dept Radiol, Aalborg, Denmark; [Drewes, Asbjorn M.] Aalborg Univ, Ctr Sensory Motor Interact SMI, Dept Hlth Sci & Technol, Aalborg, Denmark; [Wilder-Smith, Oliver H. G.] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Care, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Radboud University Nijmegen	Wilder-Smith, OHG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Care, NL-6525 ED Nijmegen, Netherlands.	o.wildersmith@anes.umcn.nl	van Goor, H./H-8035-2014; Drewes, Asbjørn/AAR-7479-2021; Wilder-Smith, Oliver H.G./E-7541-2012; Frøkjær, Jens Brøndum/F-5938-2017; Bouwense, Stefan/P-6468-2015	van Goor, H./0000-0003-0323-4876; Drewes, Asbjørn/0000-0001-7465-964X; Wilder-Smith, Oliver H.G./0000-0003-4390-2381; Frøkjær, Jens Brøndum/0000-0001-8722-0070; Bouwense, Stefan/0000-0002-7600-9429; Schou Olesen, Soren/0000-0003-3916-3168	Pfizer Research and Development; Hertha Christensen's Foundation; Christenson-Ceson's Family Foundation	Pfizer Research and Development; Hertha Christensen's Foundation; Christenson-Ceson's Family Foundation	Pfizer donated capsules of pregabalin and placebo. This study was supported by a free grant from Pfizer Research and Development, Hertha Christensen's Foundation, and Christenson-Ceson's Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren-Sandberg A, 2002, EUR J GASTROEN HEPAT, V14, P957, DOI 10.1097/00042737-200209000-00006; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Bajaj P, 2003, J PAIN, V4, P372, DOI 10.1016/S1526-5900(03)00720-X; Bernstein CN, 1996, PAIN, V66, P151, DOI 10.1016/0304-3959(96)03062-X; Bielefeldt K, 2009, INFLAMM BOWEL DIS, V15, P778, DOI 10.1002/ibd.20848; Bouwense SA, 2011, REG ANESTH PAIN MED; Brinkert W, 2007, PAIN, V132, pS46, DOI 10.1016/j.pain.2006.12.011; Buscher HCJL, 2008, SURGERY, V143, P715, DOI 10.1016/j.surg.2008.03.001; Buscher HG, 2006, EUR J PAIN, V10, P363, DOI 10.1016/j.ejpain.2005.06.006; Cervero F, 2000, GUT, V47, P56; CERVERO F, 1995, ANN MED, V27, P235, DOI 10.3109/07853899509031965; Chang L, 2000, GUT, V47, P497, DOI 10.1136/gut.47.4.497; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; Cole LJ, 2010, NEUROBIOL AGING, V31, P494, DOI 10.1016/j.neurobiolaging.2008.04.012; DENIS P, 1979, GASTROENTEROLOGY, V77, P45; Diener MK, 2008, ANN SURG, V247, P950, DOI 10.1097/SLA.0b013e3181724ee7; Dimcevski G, 2007, GASTROENTEROLOGY, V132, P1546, DOI 10.1053/j.gastro.2007.01.037; Drewes AM, 2008, GUT, V57, P1616, DOI 10.1136/gut.2007.146621; Drewes AM, 2008, WORLD J GASTROENTERO, V14, P4020, DOI 10.3748/wjg.14.4020; Edwards RR, 2006, ANESTHESIOLOGY, V104, P1243, DOI 10.1097/00000542-200606000-00020; Finnerup Nanna B, 2007, MedGenMed, V9, P36; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Frokjaer JB, 2011, GUT, V60, P1554, DOI 10.1136/gut.2010.236620; Giamberardino MA, 2005, PAIN, V114, P239, DOI 10.1016/j.pain.2004.12.024; LAYER P, 1994, GASTROENTEROLOGY, V107, P1481, DOI 10.1016/0016-5085(94)90553-3; Liu XG, 1998, NEUROSCIENCE, V86, P1209, DOI 10.1016/S0306-4522(98)00107-9; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Mayer EA, 2005, PAIN, V115, P398, DOI 10.1016/j.pain.2005.03.023; NESS TJ, 1991, J NEUROPHYSIOL, V66, P20, DOI 10.1152/jn.1991.66.1.20; Nir RR, 2010, EUR J PAIN; Olesen SS, 2011, ALIMENT PHARM THER, V34, P878, DOI 10.1111/j.1365-2036.2011.04802.x; Olesen SS, 2012, REGION ANESTH PAIN M, V37, P530, DOI 10.1097/AAP.0b013e3182632c40; Olesen SS, 2011, GASTROENTEROLOGY, V141, P536, DOI 10.1053/j.gastro.2011.04.003; Olesen SS, 2010, CLIN GASTROENTEROL H, V8, P724, DOI 10.1016/j.cgh.2010.03.005; Parsi MA, 2010, PANCREAS, V39, P153, DOI 10.1097/MPA.0b013e3181bb1733; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; RAO SSC, 1987, GASTROENTEROLOGY, V93, P1270, DOI 10.1016/0016-5085(87)90255-1; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rossel P, 1999, SCAND J GASTROENTERO, V34, P1001; Schneider A, 2007, J GASTROENTEROL, V42, P101, DOI 10.1007/s00535-006-1945-4; Simonnet G, 2003, NEUROREPORT, V14, P1, DOI 10.1097/00001756-200301200-00001; van Esch AAJ, 2006, DIGEST LIVER DIS, V38, P518, DOI 10.1016/j.dld.2006.02.002; Vaneker M, 2005, PAIN, V115, P204, DOI 10.1016/j.pain.2005.02.031; Vera-Portocarrero LP, 2006, NEUROSCIENCE, V140, P1311, DOI 10.1016/j.neuroscience.2006.03.016; Wilder-Smith CH, 2004, GUT, V53, P1595, DOI 10.1136/gut.2003.028514; Wilder-Smith OHG, 2003, ANESTHESIOLOGY, V98, P1214, DOI 10.1097/00000542-200305000-00025; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b	47	41	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55460	10.1371/journal.pone.0055460	http://dx.doi.org/10.1371/journal.pone.0055460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405154	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400099
J	Flegel, C; Manteniotis, S; Osthold, S; Hatt, H; Gisselmann, G				Flegel, Caroline; Manteniotis, Stavros; Osthold, Sandra; Hatt, Hanns; Gisselmann, Guenter			Expression Profile of Ectopic Olfactory Receptors Determined by Deep Sequencing	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; MAMMALIAN ODORANT RECEPTOR; BITTER TASTE RECEPTORS; LONG NONCODING RNAS; FUNCTIONAL EXPRESSION; PROSTATE-CANCER; GENE-EXPRESSION; ENTEROCHROMAFFIN CELLS; GENOMIC STRUCTURE; HUMAN SPERM	Olfactory receptors (ORs) provide the molecular basis for the detection of volatile odorant molecules by olfactory sensory neurons. The OR supergene family encodes G-protein coupled proteins that belong to the seven-transmembrane-domain receptor family. It was initially postulated that ORs are exclusively expressed in the olfactory epithelium. However, recent studies have demonstrated ectopic expression of some ORs in a variety of other tissues. In the present study, we conducted a comprehensive expression analysis of ORs using an extended panel of human tissues. This analysis made use of recent dramatic technical developments of the so-called Next Generation Sequencing (NGS) technique, which encouraged us to use open access data for the first comprehensive RNA-Seq expression analysis of ectopically expressed ORs in multiple human tissues. We analyzed mRNA-Seq data obtained by Illumina sequencing of 16 human tissues available from Illumina Body Map project 2.0 and from an additional study of OR expression in testis. At least some ORs were expressed in all the tissues analyzed. In several tissues, we could detect broadly expressed ORs such as OR2W3 and OR51E1. We also identified ORs that showed exclusive expression in one investigated tissue, such as OR4N4 in testis. For some ORs, the coding exon was found to be part of a transcript of upstream genes. In total, 111 of 400 OR genes were expressed with an FPKM (fragments per kilobase of exon per million fragments mapped) higher than 0.1 in at least one tissue. For several ORs, mRNA expression was verified by RT-PCR. Our results support the idea that ORs are broadly expressed in a variety of tissues and provide the basis for further functional studies.	[Flegel, Caroline; Manteniotis, Stavros; Osthold, Sandra; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany	Ruhr University Bochum	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	Guenter.Gisselmann@rub.de			Heinrich und Alma Vogelsang Stiftung; DFG [Sonderforschungsbereich 642]	Heinrich und Alma Vogelsang Stiftung; DFG(German Research Foundation (DFG))	Caroline Flegel was funded by the Heinrich und Alma Vogelsang Stiftung. Hanns Hatt was funded by the DFG-Sonderforschungsbereich 642 "GTP- and ATP dependent membrane processes''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; Bonigk W, 1999, J NEUROSCI, V19, P5332; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Branscomb A, 2000, GENETICS, V156, P785; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chiu IM, 2001, PROG NUCLEIC ACID RE, V70, P155, DOI 10.1016/S0079-6603(01)70016-5; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; Cunha AC, 2006, CANCER LETT, V236, P229, DOI 10.1016/j.canlet.2005.05.021; De la Cruz O, 2009, MOL BIOL EVOL, V26, P491, DOI 10.1093/molbev/msn294; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Durzynski L, 2005, BIOCHEM BIOPH RES CO, V333, P264, DOI 10.1016/j.bbrc.2005.05.085; Feingold EA, 1999, GENOMICS, V61, P15, DOI 10.1006/geno.1999.5935; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Frenkel-Morgenstern M, 2012, GENOME RES, V22, P1231, DOI 10.1101/gr.130062.111; Fujita Y, 2007, J RECEPT SIG TRANSD, V27, P323, DOI 10.1080/10799890701534180; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gaudin JC, 2001, CHEM SENSES, V26, P1157, DOI 10.1093/chemse/26.9.1157; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Illumina, 2011, RNA SEQ DAT COMP GEN; Itakura S, 2006, PLACENTA, V27, P103, DOI 10.1016/j.placenta.2004.12.006; Iwatsuki K, 2010, BIOCHEM BIOPH RES CO, V402, P495, DOI 10.1016/j.bbrc.2010.10.057; Kohli Utkarsh, 2009, Arch Drug Inf, V2, P41; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, CELL CYCLE, V8, P218, DOI 10.4161/cc.8.2.7358; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Markovets AA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S8; Meyer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032354; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Otaki JM, 2004, J NEUROBIOL, V58, P315, DOI 10.1002/neu.10272; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez-Martinez A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-80; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; Salzberg Steven L, 2010, F1000 Biol Rep, V2, P64, DOI 10.3410/B2-64; Shiao MS, 2012, GENOME BIOL EVOL, V4, P703, DOI 10.1093/gbe/evs039; Shirokova E, 2008, FASEB J, V22, P1416, DOI 10.1096/fj.07-9233com; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; Spehr J, 2011, J BIOL CHEM, V286, P13184, DOI 10.1074/jbc.M110.183525; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Vanderhaeghen P, 1997, BIOCHEM BIOPH RES CO, V237, P283, DOI 10.1006/bbrc.1997.7043; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524; Volz A, 2003, J BIOL CHEM, V278, P19691, DOI 10.1074/jbc.M212424200; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Walensky LD, 1998, J BIOL CHEM, V273, P9378, DOI 10.1074/jbc.273.16.9378; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber M, 2002, J NEUROSCI RES, V68, P176, DOI 10.1002/jnr.10164; Weng JS, 2006, INT J CANCER, V118, P1471, DOI 10.1002/ijc.21527; Xia CZ, 2001, ONCOGENE, V20, P5903, DOI 10.1038/sj.onc.1204803; Xie LL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S4; Xu LL, 2000, CANCER RES, V60, P6568; Younger RM, 2001, GENOME RES, V11, P519, DOI 10.1101/gr.GR-1603R; Yue Y, 2006, CYTOGENET GENOME RES, V112, P6, DOI 10.1159/000087507; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Ziegler A, 2002, AM J REPROD IMMUNOL, V48, P34, DOI 10.1034/j.1600-0897.2002.01097.x	83	169	182	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55368	10.1371/journal.pone.0055368	http://dx.doi.org/10.1371/journal.pone.0055368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405139	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400084
J	Konschake, M; Lentz, HHK; Conraths, FJ; Hovel, P; Selhorst, T				Konschake, Mario; Lentz, Hartmut H. K.; Conraths, Franz J.; Hoevel, Philipp; Selhorst, Thomas			On the Robustness of In- and Out-Components in a Temporal Network	PLOS ONE			English	Article							TRADE PATTERNS; MOUTH-DISEASE; MOVEMENTS; CATTLE	Background: Many networks exhibit time-dependent topologies, where an edge only exists during a certain period of time. The first measurements of such networks are very recent so that a profound theoretical understanding is still lacking. In this work, we focus on the propagation properties of infectious diseases in time-dependent networks. In particular, we analyze a dataset containing livestock trade movements. The corresponding networks are known to be a major route for the spread of animal diseases. In this context chronology is crucial. A disease can only spread if the temporal sequence of trade contacts forms a chain of causality. Therefore, the identification of relevant nodes under time-varying network topologies is of great interest for the implementation of counteractions. Methodology/Findings: We find that a time-aggregated approach might fail to identify epidemiologically relevant nodes. Hence, we explore the adaptability of the concept of centrality of nodes to temporal networks using a data-driven approach on the example of animal trade. We utilize the size of the in-and out-component of nodes as centrality measures. Both measures are refined to gain full awareness of the time-dependent topology and finite infectious periods. We show that the size of the components exhibit strong temporal heterogeneities. In particular, we find that the size of the components is overestimated in time-aggregated networks. For disease control, however, a risk assessment independent of time and specific disease properties is usually favored. We therefore explore the disease parameter range, in which a time-independent identification of central nodes remains possible. Conclusions: We find a ranking of nodes according to their component sizes reasonably stable for a wide range of infectious periods. Samples based on this ranking are robust enough against varying disease parameters and hence are promising tools for disease control.	[Konschake, Mario; Lentz, Hartmut H. K.; Conraths, Franz J.; Selhorst, Thomas] Friedrich Loeffler Inst, Inst Epidemiol, Wusterhausen, Germany; [Konschake, Mario; Hoevel, Philipp] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Lentz, Hartmut H. K.] Humboldt Univ, Inst Phys, D-10099 Berlin, Germany; [Hoevel, Philipp] Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10099 Berlin, Germany; [Hoevel, Philipp] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA	Friedrich Loeffler Institute; Technical University of Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Northeastern University	Selhorst, T (corresponding author), Friedrich Loeffler Inst, Inst Epidemiol, Wusterhausen, Germany.	thomas.selhorst@fli.bund.de		Conraths, Franz/0000-0002-7400-9409; Selhorst, Thomas/0000-0003-0969-1533; Lentz, Hartmut/0000-0002-1713-9506; Hoevel, Philipp/0000-0002-1370-4272	Friedrich-Loeffler-Institut: Forschungs-Sofort-Programm [A/H1N1-1.3]; German Academic Exchange Service (DAAD); Federal Ministry for Food, Agriculture and Consumer Protection: Forschungs-Sofort-Programm [A/H1N1-1.3]	Friedrich-Loeffler-Institut: Forschungs-Sofort-Programm; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Federal Ministry for Food, Agriculture and Consumer Protection: Forschungs-Sofort-Programm	MK is funded by The Friedrich-Loeffler-Institut: Forschungs-Sofort-Programm A/H1N1-1.3. PH is funded by German Academic Exchange Service (DAAD) via a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. R. Carmanns, Bavarian State Ministry for Nutrition, Agriculture and Forestry for providing data. This work was supported by the Federal Ministry for Food, Agriculture and Consumer Protection: Forschungs-Sofort-Programm A/H1N1-1.3. PH acknowledges support of the German Academic Exchange Service (DAAD) via a postdoctoral fellowship. We also thank two anonymous reviewers for helpful comments.	Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Basu P, 2010, ARXIV1012026011, P11; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; Casteigts A, 2012, INT J PARALLEL EMERG, V27, P387, DOI [10.1080/17445760.2012.668546, 10.1007/978-3-642-22450-8_27]; Christley R. M., 2005, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at Nairn, Inverness, Scotland, 30th March-1st April 2005, P234; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; Dorogovtsev SN, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025101; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Grindrod P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046120; Holme P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046119; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Horst H, 1998, RISK EC CONSEQUENCES; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Kim H, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026107; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kivela M, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/03/P03005; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036439; Lentz HHK, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066111; Lentz HHK, 2012, ARXIV12102283; Liu S, 2012, ARXIV12102776; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Miritello G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.045102; Natale F, 2011, PREV VET MED, V98, P111, DOI 10.1016/j.prevetmed.2010.11.013; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Nicosia V, 2012, CHAOS, V22, DOI 10.1063/1.3697996; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Riolo CS, 2001, J URBAN HEALTH, V78, P446, DOI 10.1093/jurban/78.3.446; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Rocha LEC, 2012, ARXIV12045421; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rushton J, 2011, EC ANIMAL HLTH PRODU; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Tang J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055101; Tang JP, 2010, PROCEEDINGS OF INTERNATIONAL FORUM OF KNOWLEDGE AS A SERVICE, P1, DOI 10.1145/1852658.1852661; UK Department for Environment Food and Rural Affairs (DEFRA), OR UK FOOT MOUTH DIS; Vazquez A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158702; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009	44	37	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55223	10.1371/journal.pone.0055223	http://dx.doi.org/10.1371/journal.pone.0055223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405124	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400069
J	Perez-Huerta, A; Etayo-Cadavid, MF; Andrus, CFT; Jeffries, TE; Watkins, C; Street, SC; Sandweiss, DH				Perez-Huerta, Alberto; Etayo-Cadavid, Miguel F.; Andrus, C. Fred T.; Jeffries, Teresa E.; Watkins, Clifton; Street, Shane C.; Sandweiss, Daniel H.			El Nino Impact on Mollusk Biomineralization-Implications for Trace Element Proxy Reconstructions and the Paleo-Archeological Record	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; ARAGONITIC BIVALVE SHELLS; SR/CA RATIOS; BIOLOGICAL-CONTROLS; RAMAN; OSCILLATION; VARIABILITY; VATERITE; PIGMENTS; CLIMATE	Marine macroinvertebrates are ideal sentinel organisms to monitor rapid environmental changes associated with climatic phenomena. These organisms build up protective exoskeletons incrementally by biologically-controlled mineralization, which is deeply rooted in long-term evolutionary processes. Recent studies relating potential rapid environmental fluctuations to climate change, such as ocean acidification, suggest modifications on carbonate biominerals of marine invertebrates. However, the influence of known, and recurrent, climatic events on these biological processes during active mineralization is still insufficiently understood. Analysis of Peruvian cockles from the 1982-83 large magnitude El Nino event shows significant alterations of the chemico-structure of carbonate biominerals. Here, we show that bivalves modify the main biomineralization mechanism during the event to continue shell secretion. As a result, magnesium content increases to stabilize amorphous calcium carbonate (ACC), inducing a rise in Mg/Ca unrelated to the associated increase in sea-surface temperature. Analysis of variations in Sr/Ca also suggests that this proxy should not be used in these bivalves to detect the temperature anomaly, while Ba/Ca peaks are recorded in shells in response to an increase in productivity, or dissolved barium in seawater, after the event. Presented data contribute to a better understanding of the effects of abrupt climate change on shell biomineralization, while also offering an alternative view of bivalve elemental proxy reconstructions. Furthermore, biomineralization changes in mollusk shells can be used as a novel potential proxy to provide a more nuanced historical record of El Nino and similar rapid environmental change events.	[Perez-Huerta, Alberto; Etayo-Cadavid, Miguel F.; Andrus, C. Fred T.] Univ Alabama, Dept Geol Sci, Tuscaloosa, AL 35401 USA; [Jeffries, Teresa E.] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Watkins, Clifton; Street, Shane C.] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA; [Sandweiss, Daniel H.] Univ Maine, Dept Anthropol, Climate Change Inst, Orono, ME USA	University of Alabama System; University of Alabama Tuscaloosa; Natural History Museum London; University of Alabama System; University of Alabama Tuscaloosa; University of Maine System; University of Maine Orono	Perez-Huerta, A (corresponding author), Univ Alabama, Dept Geol Sci, Tuscaloosa, AL 35401 USA.	aphuerta@as.ua.edu	Perez-Huerta, Alberto/A-6925-2015; Jeffries, Teresa/F-4415-2014; Sandweiss, Daniel/K-5808-2019	Jeffries, Teresa/0000-0001-6417-1704; Andrus, Fred/0000-0002-4075-8380	National Science Foundation [ESH-OCE-0502533]	National Science Foundation(National Science Foundation (NSF))	Funding by National Science Foundation grant ESH-OCE-0502533 to CFTA is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NJ, 2009, QUATERNARY SCI REV, V28, P2794, DOI 10.1016/j.quascirev.2009.07.006; Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Andrus CFT, 2005, GEOL SOC AM SPEC PAP, V395, P13, DOI 10.1130/2005.2395(02); Bandaranayake WM, 2006, NAT PROD REP, V23, P223, DOI 10.1039/b307612c; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Batenburg SJ, 2011, PALAEOGEOGR PALAEOCL, V306, P75, DOI 10.1016/j.palaeo.2011.03.031; Carre M, 2005, HOLOCENE, V15, P42, DOI 10.1191/0959683605h1782rp; Carre M, 2006, GEOCHIM COSMOCHIM AC, V70, P4906, DOI 10.1016/j.gca.2006.07.019; Carre M, 2012, QUATERN INT, V253, P55, DOI 10.1016/j.quaint.2011.02.004; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; CUSACK M, 1992, COMP BIOCHEM PHYS B, V102, P93, DOI 10.1016/0305-0491(92)90278-Y; Dauphin Y, 2000, COMP BIOCHEM PHYS A, V126, P367, DOI 10.1016/S1095-6433(00)00213-0; dePaula SM, 2010, MICRON, V41, P983, DOI 10.1016/j.micron.2010.06.014; Edwards HGM, 2005, SPECTROCHIM ACTA A, V61, P2273, DOI 10.1016/j.saa.2005.02.026; Etayo-Cadavid MF, 2010, THESIS U ALABAMA; Foster LC, 2008, CHEM GEOL, V254, P113, DOI 10.1016/j.chemgeo.2008.06.007; Freitas PS, 2006, GEOCHIM COSMOCHIM AC, V70, P5119, DOI 10.1016/j.gca.2006.07.029; Gillikin DP, 2008, GEO-MAR LETT, V28, P351, DOI 10.1007/s00367-008-0111-9; Gillikin DP, 2006, GEOCHIM COSMOCHIM AC, V70, P395, DOI 10.1016/j.gca.2005.09.015; Gillikin DP, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000874; GRIFFITH WP, 1970, J CHEM SOC A, P286, DOI 10.1039/j19700000286; Guzman N., 1998, ESTUD OCEANOL, V17, P17; Guzman N, 2007, MICROSC MICROANAL, V13, P397, DOI 10.1017/S1431927607070705; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Lorrain A, 2005, GEOLOGY, V33, P965, DOI 10.1130/G22048.1; Menadakis M, 2009, J MATH CHEM, V46, P484, DOI 10.1007/s10910-008-9490-4; Nebel H, 2008, Z ANORG ALLG CHEM, V634, P1439, DOI 10.1002/zaac.200800134; Olsson AA, 1961, MOLLUSKS TROPICAL E; Pokroy B, 2004, NAT MATER, V3, P900, DOI 10.1038/nmat1263; Purton LMA, 1999, GEOLOGY, V27, P1083, DOI 10.1130/0091-7613(1999)027<1083:MCSCRI>2.3.CO;2; ROLLINS HB, 1986, NATL GEOGR RES, V2, P106; ROLLINS HB, 1987, GEOARCHAEOLOGY, V2, P181; Sadler J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003595; Sandweiss D.H., 2007, CLIMATE CHANGE CULTU, P25, DOI DOI 10.1016/B978-012088390-5.50007-8; Sandweiss DH, 2003, PALAEOGEOGR PALAEOCL, V194, P23, DOI 10.1016/S0031-0182(03)00270-0; Schone BR, 2011, PALAEOGEOGR PALAEOCL, V302, P52, DOI 10.1016/j.palaeo.2010.03.016; Soldati AL, 2008, MINERAL MAG, V72, P579, DOI 10.1180/minmag.2008.072.2.579; Soldati AL, 2008, J RAMAN SPECTROSC, V39, P525, DOI 10.1002/jrs.1873; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; URBAN HJ, 1994, MAR ECOL PROG SER, V107, P139, DOI 10.3354/meps107139	42	16	16	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54274	10.1371/journal.pone.0054274	http://dx.doi.org/10.1371/journal.pone.0054274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405078	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400022
J	Duan, JZ; Lee, Y; Jania, C; Gong, JC; Rojas, M; Burk, L; Willis, M; Homeister, J; Tilley, S; Rubin, J; Deb, A				Duan, JinZhu; Lee, Yueh; Jania, Corey; Gong, Jucheng; Rojas, Mauricio; Burk, Laurel; Willis, Monte; Homeister, Jonathon; Tilley, Stephen; Rubin, Janet; Deb, Arjun			Rib Fractures and Death from Deletion of Osteoblast beta catenin in Adult Mice Is Rescued by Corticosteroids	PLOS ONE			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; BONE-RESORPTION; RANKL; FIBROBLASTS; BISPHOSPHONATES; LYMPHOCYTES; INHIBITION; EXPRESSION; CELLS	Ribs are primarily made of cortical bone and are necessary for chest expansion and ventilation. Rib fractures represent the most common type of non-traumatic fractures in the elderly yet few studies have focused on the biology of rib fragility. Here, we show that deletion of beta catenin in Col1a2 expressing osteoblasts of adult mice leads to aggressive osteoclastogenesis with increased serum levels of the osteoclastogenic cytokine RANKL, extensive rib resorption, multiple spontaneous rib fractures and chest wall deformities. Within days of osteoblast specific bcatenin deletion, animals die from respiratory failure with a vanishing rib cage that is unable to sustain ventilation. Increased bone resorption is also observed in the vertebrae and femur. Treatment with the bisphosphonate pamidronate delayed but did not prevent death or associated rib fractures. In contrast, administration of the glucocorticoid dexamethasone decreased serum RANKL and slowed osteoclastogenesis. Dexamethasone preserved rib structure, prevented respiratory compromise and strikingly increased survival. Our findings provide a novel model of accelerated osteoclastogenesis, where deletion of osteoblast bcatenin in adults leads to rapid development of destructive rib fractures. We demonstrate the role of bcatenin dependent mechanisms in rib fractures and suggest that glucocorticoids, by suppressing RANKL, may have a role in treating bone loss due to aggressive osteoclastogenesis.	[Duan, JinZhu; Jania, Corey; Gong, Jucheng; Rojas, Mauricio; Tilley, Stephen; Rubin, Janet; Deb, Arjun] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Duan, JinZhu; Gong, Jucheng; Deb, Arjun] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Lee, Yueh; Burk, Laurel] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC USA; [Lee, Yueh] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Willis, Monte; Homeister, Jonathon] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Deb, Arjun] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA; [Rubin, Janet] Univ N Carolina, Div Endocrinol, Chapel Hill, NC USA; [Jania, Corey; Tilley, Stephen] Univ N Carolina, Div Pulmonol, Chapel Hill, NC USA; [Deb, Arjun] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Duan, JinZhu; Gong, Jucheng; Rojas, Mauricio; Willis, Monte; Homeister, Jonathon; Rubin, Janet; Deb, Arjun] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC USA; [Duan, JinZhu; Gong, Jucheng; Deb, Arjun] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Deb, A (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	arjundeb@med.unc.edu	Willis, Monte S/J-9994-2015; Lee, Yueh/AAF-1430-2021; , BRIC Small Animal Imaging Facility/AEV-1023-2022	Willis, Monte S/0000-0002-0769-5816; Lee, Yueh/0000-0003-1846-7680; , BRIC Small Animal Imaging Facility/0000-0002-0535-3214	National Institutes of Health [HL104129, HL090823, AR56655, HL102190]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104129, R01HL102190, R01HL090823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	MW (HL104129), JH (HL090823) and JR (AR56655) were supported by respective grants from the National Institutes of Health. This study was supported by grants from the National Institutes of Health (HL102190) and Ellison Medical Foundation to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett-Connor E, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1069; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brault V, 2001, DEVELOPMENT, V128, P1253; Cao G, 2009, PHYS MED BIOL, V54, P2323, DOI 10.1088/0031-9155/54/8/005; Case N, 2010, J CELL BIOCHEM, V110, P545, DOI 10.1002/jcb.22574; Colucci S, 2007, J PATHOL, V212, P47, DOI 10.1002/path.2153; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Humphrey EL, 2006, BONE, V38, P652, DOI 10.1016/j.bone.2005.10.004; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kim YH, 2002, EXP MOL MED, V34, P145, DOI 10.1038/emm.2002.21; LoMauro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035965; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Makrygiannakis D, 2006, ARTHRITIS RHEUM-US, V54, P1463, DOI 10.1002/art.21767; Matzelle MM, 2012, ARTHRITIS RHEUM-US, V64, P1540, DOI 10.1002/art.33504; Morony S, 2005, ENDOCRINOLOGY, V146, P3235, DOI 10.1210/en.2004-1583; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Gradaigh D, 2004, ANN RHEUM DIS, V63, P354, DOI 10.1136/ard.2003.008458; Onal M, 2012, J BIOL CHEM, V287, P29851, DOI 10.1074/jbc.M112.377945; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Rousseau D, 1998, EUR CYTOKINE NETW, V9, P655; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Spiro AS, 2010, J TRAUMA, V69, P1473, DOI 10.1097/TA.0b013e3181dc59e4; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619; Wuermser LA, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/457591; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yeo L, 2011, ANN RHEUM DIS, V70, P2022, DOI 10.1136/ard.2011.153312; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55757	10.1371/journal.pone.0055757	http://dx.doi.org/10.1371/journal.pone.0055757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393600	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800054
J	Morin, L; Paini, DR; Randall, RP				Morin, Louise; Paini, Dean R.; Randall, Roderick P.			Can Global Weed Assemblages Be Used to Predict Future Weeds?	PLOS ONE			English	Article							RISK-ASSESSMENT SYSTEM; INVASION SUCCESS; SPECIES TRAITS; ALIEN PLANTS; INVASIVENESS; COMMUNITIES; ECOSYSTEMS; PATTERNS; IMPACTS; PESTS	Predicting which plant taxa are more likely to become weeds in a region presents significant challenges to both researchers and government agencies. Often it is done in a qualitative or semi-quantitative way. In this study, we explored the potential of using the quantitative self-organising map (SOM) approach to analyse global weed assemblages and estimate likelihoods of plant taxa becoming weeds before and after they have been moved to a new region. The SOM approach examines plant taxa associations by analysing where a taxon is recorded as a weed and what other taxa are recorded as weeds in those regions. The dataset analysed was extracted from a pre-existing, extensive worldwide database of plant taxa recorded as weeds or other related status and, following reformatting, included 187 regions and 6690 plant taxa. To assess the value of the SOM approach we selected Australia as a case study. We found that the key and most important limitation in using such analytical approach lies with the dataset used. The classification of a taxon as a weed in the literature is not often based on actual data that document the economic, environmental and/or social impact of the taxon, but mostly based on human perceptions that the taxon is troublesome or simply not wanted in a particular situation. The adoption of consistent and objective criteria that incorporate a standardized approach for impact assessment of plant taxa will be necessary to develop a new global database suitable to make predictions regarding weediness using methods like SOM. It may however, be more realistic to opt for a classification system that focuses on the invasive characteristics of plant taxa without any inference to impacts, which to be defined would require some level of research to avoid bias from human perceptions and value systems.	[Morin, Louise; Paini, Dean R.] CSIRO, Ecosyst Sci, Biosecur Flagship, Canberra, ACT, Australia; [Randall, Roderick P.] Dept Agr & Food Western Australia, Perth, WA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Morin, L (corresponding author), CSIRO, Ecosyst Sci, Biosecur Flagship, Canberra, ACT, Australia.	louise.morin@csiro.au	Paini, Dean R/C-2341-2009; Morin, Louise/B-4822-2009	Morin, Louise/0000-0002-9515-2255				Binns JA, 2001, LAND DEGRAD DEV, V12, P341, DOI 10.1002/ldr.455; Burgman M., 2005, RISKS DECISIONS CONS; Caley P, 2006, BIOL INVASIONS, V8, P1595, DOI 10.1007/s10530-004-0010-6; Caley P, 2006, AUSTRAL ECOL, V31, P647, DOI 10.1111/j.1442-9993.2006.01617.x; Categorisation Working Group, 2011, NAT CAT INV SPEC; Cereghino R, 2005, BIOL CONSERV, V125, P459, DOI 10.1016/j.biocon.2005.04.018; Cousens R, 2008, WEED SCI, V56, P873, DOI 10.1614/WS-08-047.1; Cunningham DC, 2004, WEED TECHNOL, V18, P1189, DOI 10.1614/0890-037X(2004)018[1189:AFFPSW]2.0.CO;2; DAEHLER CC, 2000, BIOL INVASIONS, V2, P93, DOI DOI 10.1023/A:1010002005024; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Gordon DR, 2008, DIVERS DISTRIB, V14, P234, DOI 10.1111/j.1472-4642.2007.00460.x; Groves RH, 2006, EUPHYTICA, V148, P111, DOI 10.1007/s10681-006-5945-5; Groves R.H., 2003, WEED CATEGORIES NATU; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Heikkila J, 2011, AGR FOOD SCI, V20, P15, DOI 10.2137/145960611795163088; HOCKING PJ, 1986, J AUST I AGR SCI, V52, P191; Hulme PE, 2012, J APPL ECOL, V49, P10, DOI 10.1111/j.1365-2664.2011.02069.x; Hulme PE, 2011, DIVERS DISTRIB, V17, P1152, DOI 10.1111/j.1472-4642.2011.00800.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; Lambdon PW, 2008, PRESLIA, V80, P101; Lonsdale WM, 2011, CURR OPIN ENV SUST, V3, P31, DOI 10.1016/j.cosust.2010.12.008; LOVE DORIS, 1959, CANADIAN JOUR BOT, V37, P173; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mack RN, 2001, BIOSCIENCE, V51, P95, DOI 10.1641/0006-3568(2001)051[0095:HAGPDG]2.0.CO;2; Mathworks, 2007, MATLAB VERS 7 4; McClay A, 2010, BIOL INVASIONS, V12, P4085, DOI 10.1007/s10530-010-9819-3; National Weed Risk Assessment System Review Group, 2006, REV NAT WEED RISK AS; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Paini DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025695; Paini DR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1118; Paini DR, 2010, J APPL ECOL, V47, P290, DOI 10.1111/j.1365-2664.2010.01782.x; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Randall R.P., 2012, GLOBAL COMPENDIUM WE; Randall R. P., 2007, INTRO FLORA AUSTR IT; Randall RP, 2009, PLANTS DATABAS UNPUB; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Roberts W, 2011, CURR OPIN ENV SUST, V3, P60, DOI 10.1016/j.cosust.2010.11.007; Sinden Jack, 2005, Plant Protection Quarterly, V20, P25; Smith C.S., 1999, Biological Invasions, V1, P89, DOI 10.1023/A:1010091918466; Standards Australia Standards New Zealand CRC Australian Weed Management, 2006, HB 294 2006 NAT POST; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; United Nations Statistics Division, 2011, COMP MACR CONT REG G; Vesanto J., 2000, SOM TOOLBOX MATLAB, V5; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Virtue J. G., 2008, Plant Protection Quarterly, V23, P166; Weber J, 2009, J ENVIRON MANAGE, V90, P798, DOI 10.1016/j.jenvman.2008.01.012; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x	56	10	11	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55547	10.1371/journal.pone.0055547	http://dx.doi.org/10.1371/journal.pone.0055547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393591	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800045
J	Lorenz, J; Paetzel, F; Schweitzer, F				Lorenz, Jan; Paetzel, Fabian; Schweitzer, Frank			Redistribution Spurs Growth by Using a Portfolio Effect on Risky Human Capital	PLOS ONE			English	Article							STATISTICAL-MECHANICS; SAVING PROPENSITY; WEALTH; INEQUALITY; INFORMATION; INCOME; MONEY; MODEL	We demonstrate by mathematical analysis and systematic computer simulations that redistribution can lead to sustainable growth in a society. In accordance with economic models of risky human capital, we assume that dynamics of human capital is modeled as a multiplicative stochastic process which, in the long run, leads to the destruction of individual human capital. When agents are linked by fully redistributive taxation the situation might turn to individual growth in the long run. We consider that a government collects a proportion of income and reduces it by a fraction as costs for administration (efficiency losses). The remaining public good is equally redistributed to all agents. Sustainable growth is induced by redistribution despite the losses from the random growth process and despite administrative costs. Growth results from a portfolio effect. The findings are verified for three different tax schemes: proportional tax, taking proportionally more from the rich, and proportionally more from the poor. We discuss which of these tax schemes performs better with respect to maximize growth under a fixed rate of administrative costs, and the governmental income. This leads us to general conclusions about governmental decisions, the relation to public good games with free riding, and the function of taxation in a risk-taking society.	[Lorenz, Jan; Schweitzer, Frank] ETH, Chair Syst Design, Zurich, Switzerland; [Lorenz, Jan] Univ Bremen, Sch Humanities & Social Sci, D-28359 Bremen, Germany; [Paetzel, Fabian] Univ Bremen, Ctr Social Policy Res, D-28359 Bremen, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bremen; University of Bremen	Lorenz, J (corresponding author), ETH, Chair Syst Design, Zurich, Switzerland.	post@janlo.de	Schweitzer, Frank/B-2127-2012; Lorenz, Jan/D-1806-2010	Schweitzer, Frank/0000-0003-1551-6491; Lorenz, Jan/0000-0002-5547-7848	Swiss State Secretariat for Education and Research [C09.0055]; European Commission's 7th Framework Programme Project CYBEREMOTIONS [231323];  [COST-MP0801]	Swiss State Secretariat for Education and Research; European Commission's 7th Framework Programme Project CYBEREMOTIONS; 	The work was partly financed within the COST-MP0801 action with the title "Evolving Networks of Agents Competing For Centrality" (http://www.sg.ethz.ch/projects/physics_of_competition_cooperation_and_conflicts) supported by a grant of the Swiss State Secretariat for Education and Research under number C09.0055, and the European Commission's 7th Framework Programme Project CYBEREMOTIONS (No. 231323, http://www.sg.ethz.ch/projects/cyberemotions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acemoglu D, 2005, HANDB ECON, V22, P385; Aghion P, 1997, REV ECON STUD, V64, P151, DOI 10.2307/2971707; Barro RJ, 2000, J ECON GROWTH, V5, P5, DOI 10.1023/A:1009850119329; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Bouchaud JP, 2000, PHYSICA A, V282, P536, DOI 10.1016/S0378-4371(00)00205-3; Chakraborti A, 2000, EUR PHYS J B, V17, P167, DOI 10.1007/s100510070173; Chatterjee A, 2007, EUR PHYS J B, V60, P135, DOI 10.1140/epjb/e2007-00343-8; Dragulescu A, 2000, EUR PHYS J B, V17, P723, DOI 10.1007/s100510070114; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Forbes KJ, 2000, AM ECON REV, V90, P869, DOI 10.1257/aer.90.4.869; Glaeser E, 2003, J MONETARY ECON, V50, P199, DOI 10.1016/S0304-3932(02)00204-0; Grochulski B, 2010, J ECON THEORY, V145, P908, DOI 10.1016/j.jet.2009.09.003; Guala S, 2009, INTERDISCIP DESCR CO, V7, P1; KELLY JL, 1956, IRE T INFORM THEOR, V2, P185, DOI 10.1109/TIT.1956.1056803; LUCAS RE, 1988, J MONETARY ECON, V22, P3, DOI 10.1016/0304-3932(88)90168-7; LUENBERGER DG, 1998, INVESTMENT SCI; Malcai O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031102; Marsili M, 1998, PHYSICA A, V253, P403, DOI 10.1016/S0378-4371(98)00075-2; Medo M, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02014; Medo M, 2008, PHYSICA A, V387, P6151, DOI 10.1016/j.physa.2008.07.007; MELTZER AH, 1981, J POLIT ECON, V89, P914, DOI 10.1086/261013; MIRRLEES JA, 1971, REV ECON STUD, V38, P175, DOI 10.2307/2296779; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Patriarca M, 2006, PHYSICA A, V369, P723, DOI 10.1016/j.physa.2006.01.091; Perotti Roberto, 1996, J ECON GROWTH, V1, P149, DOI DOI 10.1007/BF00138861; PERSSON T, 1994, AM ECON REV, V84, P600; REDNER S, 1990, AM J PHYS, V58, P267, DOI 10.1119/1.16497; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Slanina F, 1999, PHYSICA A, V269, P554, DOI 10.1016/S0378-4371(99)00180-6; Slanina F, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046102; Yaari G, 2010, EUR PHYS J B, V73, P625, DOI 10.1140/epjb/e2010-00027-4; Yaari G, 2009, ENCY COMPLEXITY SYST, P4920; Yakovenko VM, 2009, REV MOD PHYS, V81, P1703, DOI 10.1103/RevModPhys.81.1703	33	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54904	10.1371/journal.pone.0054904	http://dx.doi.org/10.1371/journal.pone.0054904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086NH	23390505	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100021
J	Yu, ZL; Zhou, N; Zhao, CT; Qiu, JP				Yu, Zhiliang; Zhou, Ning; Zhao, Chuntian; Qiu, Juanping			In-Gel Determination of L-Amino Acid Oxidase Activity Based on the Visualization of Prussian Blue-Forming Reaction	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; EXPRESSION; VENOM	L-amino acid oxidase (LAAO) is attracting increasing attention due to its important functions. Diverse detection methods with their own properties have been developed for characterization of LAAO. In the present study, a simple, rapid, sensitive, cost-effective and reproducible method for quantitative in-gel determination of LAAO activity based on the visualization of Prussian blue-forming reaction is described. Coupled with SDS-PAGE, this Prussian blue agar assay can be directly used to determine the numbers and approximate molecular weights of LAAO in one step, allowing straightforward application for purification and sequence identification of LAAO from diverse samples.	[Yu, Zhiliang; Zhou, Ning; Zhao, Chuntian; Qiu, Juanping] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology	Yu, ZL (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China.	zhiliangyu76@gmail.com; qiujping@zjut.edu.cn			Natural Science Foundation of Zhejiang Province, China [Y5100153]; Science and Technology Planning Project of Zhejiang Province, China (Welfare Technology Applied Research Project of Zhejiang Province) [2011C23007]	Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Science and Technology Planning Project of Zhejiang Province, China (Welfare Technology Applied Research Project of Zhejiang Province)	This work was supported by Natural Science Foundation of Zhejiang Province, China (Y5100153) (http://www.zjnsf.gov.cn/), and Science and Technology Planning Project of Zhejiang Province, China (Welfare Technology Applied Research Project of Zhejiang Province, Grant No.: 2011C23007) (http://www.zjkjt.gov.cn/), to ZY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WM, 2010, ENZYME MICROB TECH, V47, P52, DOI 10.1016/j.enzmictec.2010.03.008; Davis MA, 2005, APPL ENVIRON MICROB, V71, P3551, DOI 10.1128/AEM.71.7.3551-3555.2005; Ehara T, 2002, FEBS LETT, V531, P509, DOI 10.1016/S0014-5793(02)03608-6; Gomez D, 2008, APPL MICROBIOL BIOT, V79, P925, DOI 10.1007/s00253-008-1499-x; Huang YL, 2011, BIOFOULING, V27, P287, DOI 10.1080/08927014.2011.562978; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Karyakin AA, 2001, ELECTROANAL, V13, P813, DOI 10.1002/1521-4109(200106)13:10<813::AID-ELAN813>3.0.CO;2-Z; Kitani Y, 2007, FISH SHELLFISH IMMUN, V23, P1178, DOI 10.1016/j.fsi.2007.04.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lucas-Elio P, 2006, J BACTERIOL, V188, P2493, DOI 10.1128/JB.188.7.2493-2501.2006; Okubo BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033639; Ralph EC, 2006, BIOCHEMISTRY-US, V45, P15844, DOI 10.1021/bi061894o; Rau JE, 2011, J MICROBIOL METH, V85, P228, DOI 10.1016/j.mimet.2011.03.002; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; Saito M, 2007, MICROBIOL IMMUNOL, V51, P889, DOI 10.1111/j.1348-0421.2007.tb03971.x; Sakurai Y, 2001, TOXICON, V39, P1827, DOI 10.1016/S0041-0101(01)00133-7; Singh S, 2009, CAN J MICROBIOL, V55, P1096, DOI [10.1139/W09-068, 10.1139/w09-068]; Timmer B, 2005, SENSOR ACTUAT B-CHEM, V107, P666, DOI 10.1016/j.snb.2004.11.054; VALLON O, 1993, EUR J BIOCHEM, V215, P351, DOI 10.1111/j.1432-1033.1993.tb18041.x; Yang HC, 2005, J EXP BIOL, V208, P3609, DOI 10.1242/jeb.01795; Yu ZL, 2012, APPL BIOCHEM BIOTECH, V167, P1, DOI 10.1007/s12010-012-9611-1	21	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55548	10.1371/journal.pone.0055548	http://dx.doi.org/10.1371/journal.pone.0055548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383337	Green Submitted, Green Published, gold			2022-12-27	WOS:000314597900044
J	Mukhopadhyay, P; Lakshmanan, I; Ponnusamy, MP; Chakraborty, S; Jain, M; Pai, P; Smith, LM; Lele, SM; Batra, SK				Mukhopadhyay, Partha; Lakshmanan, Imayavaramban; Ponnusamy, Moorthy P.; Chakraborty, Subhankar; Jain, Maneesh; Pai, Priya; Smith, Lynette M.; Lele, Subodh M.; Batra, Surinder K.			MUC4 Overexpression Augments Cell Migration and Metastasis through EGFR Family Proteins in Triple Negative Breast Cancer Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PANCREATIC-CANCER; MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; TUMOR INVASION; EXPRESSION; PROLIFERATION; KINASE; CARCINOMAS; SURVIVAL	Introduction: Current studies indicate that triple negative breast cancer (TNBC), an aggressive breast cancer subtype, is associated with poor prognosis and an early pattern of metastasis. Emerging evidence suggests that MUC4 mucin is associated with metastasis of various cancers, including breast cancer. However, the functional role of MUC4 remains unclear in breast cancers, especially in TNBCs. Method: In the present study, we investigated the functional and mechanistic roles of MUC4 in potentiating pathogenic signals including EGFR family proteins to promote TNBC aggressiveness using in vitro and in vivo studies. Further, we studied the expression of MUC4 in invasive TNBC tissue and normal breast tissue by immunostaining. Results: MUC4 promotes proliferation, anchorage-dependent and-independent growth of TNBC cells, augments TNBC cell migratory and invasive potential in vitro, and enhances tumorigenicity and metastasis in vivo. In addition, our studies demonstrated that MUC4 up-regulates the EGFR family of proteins, and augments downstream Erk1/2, PKC-gamma, and FAK mediated oncogenic signaling. Moreover, our studies also showed that knockdown of MUC4 in TNBC cells induced molecular changes suggestive of mesenchymal to epithelial transition. We also demonstrated in this study, for the first time, that knockdown of MUC4 was associated with reduced expression of EGFR and ErbB3 (EGFR family proteins) in TNBC cells, suggesting that MUC4 uses an alternative to ErbB2 mechanism to promote aggressiveness. We further demonstrate that MUC4 is differentially over-expressed in invasive TNBC tissues compared to normal breast tissue. Conclusions: MUC4 mucin expression is associated with TNBC pathobiology, and its knockdown reduced aggressiveness in vitro, and tumorigenesis and metastasis in vivo. Overall, our findings suggest that MUC4 mucin promotes invasive activities of TNBC cells by altering the expression of EGFR, ErbB2, and ErbB3 molecules and their downstream signaling.	[Mukhopadhyay, Partha; Lakshmanan, Imayavaramban; Ponnusamy, Moorthy P.; Chakraborty, Subhankar; Jain, Maneesh; Pai, Priya; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Smith, Lynette M.] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Lele, Subodh M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	sbatra@unmc.edu		Mukhopadhyay, Partha/0000-0001-5817-0174; lakshmanan, Imayavaramban/0000-0003-1733-2223; Palanimuthu Ponnusamy, Moorthy/0000-0001-5744-193X	Department of Defense [BC074639, BC083295, BC09742]; Susan Komen Foundation [KG070826]	Department of Defense(United States Department of Defense); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by grants from the Department of Defense (BC074639, BC083295, and BC09742) and the Susan Komen Foundation (KG070826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim DM, 2004, BRIT J CANCER, V91, P1532, DOI 10.1038/sj.bjc.6602184; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Bafna S, 2009, BRIT J CANCER, V101, P1155, DOI 10.1038/sj.bjc.6605285; Bafna S, 2008, CANCER RES, V68, P9231, DOI 10.1158/0008-5472.CAN-08-3135; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; Bakin AV, 2002, J CELL SCI, V115, P3193; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dixit M, 1997, J NATL CANCER I, V89, P365, DOI 10.1093/jnci/89.5.365; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulkes WD, 2003, CANCER, V98, P1569, DOI 10.1002/cncr.11688; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ilg EC, 1996, INT J CANCER, V68, P325, DOI 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7; Inman Jamie L, 2010, J Biol, V9, P2, DOI 10.1186/jbiol213; Jain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023344; Kaplan HG, 2009, BREAST J, V15, P454, DOI 10.1111/j.1524-4741.2009.00789.x; Leibl S, 2005, J CLIN PATHOL, V58, P700, DOI 10.1136/jcp.2004.025163; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Masuda A, 1997, CANCER RES, V57, P4898; Mimeault M, 2010, CANCER LETT, V295, P69, DOI 10.1016/j.canlet.2010.02.015; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; Nofech-Mozes S, 2009, BREAST CANCER RES TR, V118, P131, DOI 10.1007/s10549-008-0295-8; Ponnusamy MP, 2008, BRIT J CANCER, V99, P520, DOI 10.1038/sj.bjc.6604517; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Pinilla SMR, 2006, BREAST CANCER RES TR, V99, P85, DOI 10.1007/s10549-006-9184-1; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Simian M, 2001, DEVELOPMENT, V128, P3117; Simon R, 2007, CANCER INFORM, V3, P11; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Siziopikou KP, 2007, BREAST, V16, P104, DOI 10.1016/j.breast.2006.09.003; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Suo ZH, 2000, ULTRASTRUCT PATHOL, V24, P371; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Walker RA, 1999, BREAST CANCER RES TR, V53, P167, DOI 10.1023/A:1006194700667; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Workman HC, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2364; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yang G, 1998, CLIN CANCER RES, V4, P1873	61	47	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54455	10.1371/journal.pone.0054455	http://dx.doi.org/10.1371/journal.pone.0054455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408941	Green Submitted, gold, Green Published			2022-12-27	WOS:000315100000005
J	Hatten, JR; Batt, TR; Scoppettone, GG; Dixon, CJ				Hatten, James R.; Batt, Thomas R.; Scoppettone, Gary G.; Dixon, Christopher J.			An Ecohydraulic Model to Identify and Monitor Moapa Dace Habitat	PLOS ONE			English	Article							MUDDY RIVER; CLARK COUNTY; FISHES; SELECTION; CLIMATE; SYSTEM	Moapa dace (Moapa coriacea) is a critically endangered thermophilic minnow native to the Muddy River ecosystem in southeastern Nevada, USA. Restricted to temperatures between 26.0 and 32.0 degrees C, these fish are constrained to the upper two km of the Muddy River and several small tributaries fed by warm springs. Habitat alterations, nonnative species invasion, and water withdrawals during the 20th century resulted in a drastic decline in the dace population and in 1979 the Moapa Valley National Wildlife Refuge (Refuge) was created to protect them. The goal of our study was to determine the potential effects of reduced surface flows that might result from groundwater pumping or water diversions on Moapa dace habitat inside the Refuge. We accomplished our goal in several steps. First, we conducted snorkel surveys to determine the locations of Moapa dace on three warm-spring tributaries of the Muddy River. Second, we conducted hydraulic simulations over a range of flows with a two-dimensional hydrodynamic model. Third, we developed a set of Moapa dace habitat models with logistic regression and a geographic information system. Fourth, we estimated Moapa dace habitat over a range of flows (plus or minus 30% of base flow). Our spatially explicit habitat models achieved classification accuracies between 85% and 91%, depending on the snorkel survey and creek. Water depth was the most significant covariate in our models, followed by substrate, Froude number, velocity, and water temperature. Hydraulic simulations showed 2-11% gains in dace habitat when flows were increased by 30%, and 8-32% losses when flows were reduced by 30%. To ensure the health and survival of Moapa dace and the Muddy River ecosystem, groundwater and surface-water withdrawals and diversions need to be carefully monitored, while fully implementing a proactive conservation strategy.	[Hatten, James R.; Batt, Thomas R.; Dixon, Christopher J.] US Geol Survey, Western Fisheries Res Ctr, Columbia River Res Lab, Cook, WA 98605 USA; [Scoppettone, Gary G.] US Geol Survey, Western Fisheries Res Ctr, Reno Field Stn, Reno, NV USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Hatten, JR (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Columbia River Res Lab, Cook, WA 98605 USA.	jhatten@usgs.gov			U.S. Fish and Wildlife Service (Nevada Fish and Wildlife Office) [85320-7-H437, F11RG00507]; Conservation Initiatives portion of the Southern Nevada Public Lands Management Act; Southern Nevada Water Authority	U.S. Fish and Wildlife Service (Nevada Fish and Wildlife Office); Conservation Initiatives portion of the Southern Nevada Public Lands Management Act; Southern Nevada Water Authority	Funding was provided by U.S. Fish and Wildlife Service (Nevada Fish and Wildlife Office) Interagency agreements 85320-7-H437 and F11RG00507; the Conservation Initiatives portion of the Southern Nevada Public Lands Management Act; and the Southern Nevada Water Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; DEACON JE, 1972, T AM FISH SOC, V101, P408, DOI 10.1577/1548-8659(1972)101<408:EDOFOM>2.0.CO;2; EAKIN TE, 1966, WATER RESOUR RES, V2, P251, DOI 10.1029/WR002i002p00251; Egan J.P., 1975, SIGNAL DETECTION THE; Environmental Systems Research Institute (ESRI), 1992, CELL BAS MOD GRID; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Galati L, 2011, WARM SPRINGS NATURAL; Garside LJ, 1979, NEVADA BUREAU MINES, V91; Ghanem A, 1996, REGUL RIVER, V12, P185, DOI 10.1002/(SICI)1099-1646(199603)12:2/3<185::AID-RRR389>3.0.CO;2-4; Ghanem AH, 1995, P 12 CAN HYDR C OTT; Glencross Brett D., 2006, Aquaculture Research, V37, P1055, DOI 10.1111/j.1365-2109.2006.01526.x; Groom M.J., 2006, PRINCIPLES CONSERVAT; Grossman GD, 2002, ECOL FRESHW FISH, V11, P2, DOI 10.1034/j.1600-0633.2002.110102.x; Guthrie CG, 2002, OIKOS, V97, P184, DOI 10.1034/j.1600-0706.2002.970204.x; Hatten JR, 2010, NORTHWEST SCI, V84, P207, DOI 10.3955/046.084.0301; Hatten JR, 2009, N AM J FISH MANAGE, V29, P1379, DOI 10.1577/M08-053.1; Hatten JR, 2003, J WILDLIFE MANAGE, V67, P774, DOI 10.2307/3802685; Hauer F. R., 2006, METHODS STREAM ECOLO; Hauer F. Richard, 2007, P103; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUBBS CARL L., 1948, OCCAS PAPERS MUS ZOOL UNIV MICHIGAN, V507, P1; JOWETT IG, 1991, NEW ZEAL J MAR FRESH, V25, P187, DOI 10.1080/00288330.1991.9516470; JOWETT IG, 1993, NEW ZEAL J MAR FRESH, V27, P241, DOI 10.1080/00288330.1993.9516563; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; KVAMME KL, 1985, CONCORDANCE ARCHAEOL, P208; Lamouroux N, 2006, RIVER RES APPL, V22, P727, DOI 10.1002/rra.931; Lane SN, 2006, PROC MONOGR ENG WATE, P2043; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; LOBB MD, 1991, T AM FISH SOC, V120, P65, DOI 10.1577/1548-8659(1991)120<0065:HUBAAO>2.3.CO;2; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mayer TD, 2008, GROUND WATER, V46, P212, DOI 10.1111/j.1745-6584.2007.00381.x; Minckley WL., 1991, BATTLE EXTINCTION NA; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; Scoppettone GG, 1998, SOUTHWEST NAT, V43, P115; SCOPPETTONE GG, 1992, GREAT BASIN NAT, V52, P216; Scoppettone GG, 2005, WEST N AM NATURALIST, V65, P410; Scoppettone GG, 2005, RESTOR ECOL, V13, P247, DOI 10.1111/j.1526-100X.2005.00032.x; SCOPPETTONE GG, 1993, T AM FISH SOC, V122, P599, DOI 10.1577/1548-8659(1993)122<0599:IBNANF>2.3.CO;2; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Stearns S.C., 1992, pi; Steffler P., 2002, RIVER2D 2 DIMENSIONA; Stoddard J. L., 2005, 620R05005 EPA; Stonestrom D., 2007, GROUND WATER RECHARG; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Subhrendu G., 2011, 8668210201101 US DEP; Tiffan KF, 2002, N AM J FISH MANAGE, V22, P713, DOI 10.1577/1548-8675(2002)022<0713:QFDCIS>2.0.CO;2; U.S. Department of the Interior, 1973, US BUR SPORT FISH WI, V114; U.S. Fish and Wildlife Service, 1995, REC PLAN RAR AQ SPEC; Waddle T, 1996, EC 2000 C QUEB CIT J; Waddle T, 2010, RIVER RES APPL, V26, P730, DOI 10.1002/rra.1278; Williams B. K., 2002, ANAL MANAGEMENT ANIM	54	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55551	10.1371/journal.pone.0055551	http://dx.doi.org/10.1371/journal.pone.0055551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408999	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200038
J	Bolognesi, A; Chatgilialoglu, A; Polito, L; Ferreri, C				Bolognesi, Andrea; Chatgilialoglu, Alexandros; Polito, Letizia; Ferreri, Carla			Membrane Lipidome Reorganization Correlates with the Fate of Neuroblastoma Cells Supplemented with Fatty Acids	PLOS ONE			English	Article							ARACHIDONIC-ACID; INDUCE APOPTOSIS; UP-REGULATION; GROWTH; ACTIVATION; BRAIN; STRESS	Palmitic acid is known to be apoptotic for nervous cells but no data are available on membrane lipidome transformations occurring during its supplementation, although membrane lipids are clearly involved in the apoptotic signaling cascade. NB100 neuroblastoma cells were supplemented with palmitic acid and membrane fatty acids were isolated, derivatized and analysed by gas chromatography at defined time intervals. Parallely, cell viability, morphology, apoptosis, cPLA2 and caspase activations were checked. Interestingly, under 150 mu M supplementation the incorporation of palmitic acid was accompanied by the specific release of arachidonic acid. This event was timely correlated with cPLA2 and caspases activations, and the time window of 60 minutes was envisaged for crucial membrane lipidome changes. The simultaneous addition of 50 mu M oleic, 50 mu M arachidonic and 150 mu M palmitic acids to the cell cultures influenced membrane changes with suppression of caspase activation and maintenance of cell viability. These results highlight the role of the membrane asset with fatty acid remodeling and suggest the potential of lipid-based strategies for influencing cell response and fate in human diseases, such as neurodegenerative disorders or tumours.	[Bolognesi, Andrea; Chatgilialoglu, Alexandros; Polito, Letizia] Alma Mater Studiorum Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy; [Chatgilialoglu, Alexandros; Ferreri, Carla] CNR, Ist Sintesi Organ & Fotoreattivita, Bologna, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR)	Bolognesi, A (corresponding author), Alma Mater Studiorum Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy.	andrea.bolognesi@unibo.it; carla.ferreri@isof.cnr.it	Polito, Letizia/H-2877-2019; FERRERI, CARLA/G-6821-2013; Bolognesi, Andrea/Q-6526-2017	Polito, Letizia/0000-0001-8051-4981; FERRERI, CARLA/0000-0002-1359-0869; Bolognesi, Andrea/0000-0001-7497-4586	University of Bologna; Pallotti's Legacies for Cancer Research	University of Bologna; Pallotti's Legacies for Cancer Research	This study was supported by the University of Bologna and the Pallotti's Legacies for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1989, ANN NY ACAD SCI, V559, P259; Andoh A, 2000, J NUTR, V130, P2636, DOI 10.1093/jn/130.11.2636; [Anonymous], 2002, NEW COMPREHENSIVE BI, DOI [DOI 10.1016/S0167-7306(02)36009-5, 10.1016/S0167-7306(02)36009-5]; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Brand A, 2010, J NEUROCHEM, V113, P465, DOI 10.1111/j.1471-4159.2010.06611.x; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cevc G., 1993, PHOSPHOLIPIDS HDB, V2ZxaucDNWHcC; Chatgilialoglu C, 2005, ACCOUNTS CHEM RES, V38, P441, DOI 10.1021/ar0400847; Christie W. W., 2007, LIPID HDB, P426; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; Dowhan W., 2002, NEW COMPR BIOCH, P1, DOI DOI 10.1016/50167-7306(02)36003-4; du Bois TM, 2005, PROG NEURO-PSYCHOPH, V29, P878, DOI 10.1016/j.pnpbp.2005.04.034; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Ferreri C, 2005, LIPIDS, V40, P661, DOI 10.1007/s11745-005-1428-7; Ferreri C, 2005, FREE RADICAL BIO MED, V38, P1180, DOI 10.1016/j.freeradbiomed.2004.12.026; Girotti AW, 1998, J LIPID RES, V39, P1529; Golomb BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032175; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Hammond EW., 1993, CHROMATOGRAPHY ANAL; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Kondoh Y, 2007, BBA-MOL CELL BIOL L, V1771, P500, DOI 10.1016/j.bbalip.2007.01.012; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Landau Z, 2006, APOPTOSIS, V11, P717, DOI 10.1007/s10495-006-5425-3; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; MANGOLD HK, 1960, J AM OIL CHEM SOC, V37, P383, DOI 10.1007/BF02672641; Matsuyama M, 2005, ONCOL REP, V14, P73; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; MCKENZIE KE, 1994, PROSTAG LEUKOTR ESS, V51, P437, DOI 10.1016/0952-3278(94)90062-0; Moghaddami N, 2003, J IMMUNOL, V171, P2616, DOI 10.4049/jimmunol.171.5.2616; Mozaffarian D, 2006, ATHEROSCLEROSIS SUPP, V7, P29, DOI 10.1016/j.atherosclerosissup.2006.04.007; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; Nano JL, 2003, PROSTAG LEUKOTR ESS, V69, P207, DOI 10.1016/S0952-3278(03)00083-8; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Puca AA, 2008, REJUV RES, V11, P63, DOI 10.1089/rej.2007.0566; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Spener F, 2003, EUR J LIPID SCI TECH, V105, P481, DOI 10.1002/ejlt.200390101; SUGIMOTO T, 1984, J NATL CANCER I, V73, P51; Ulloth JE, 2003, J NEUROCHEM, V84, P655, DOI 10.1046/j.1471-4159.2003.01571.x; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Yang X, 2007, FASEB J, V21, P943; Zambonin L, 2006, FREE RADICAL BIO MED, V40, P1549, DOI 10.1016/j.freeradbiomed.2005.12.021; ZHANG JP, 1995, J NEUROCHEM, V64, P1688; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	49	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55537	10.1371/journal.pone.0055537	http://dx.doi.org/10.1371/journal.pone.0055537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405167	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400112
J	Cascione, L; Gasparini, P; Lovat, F; Carasi, S; Pulvirenti, A; Ferro, A; Alder, H; He, G; Vecchione, A; Croce, CM; Shapiro, CL; Huebner, K				Cascione, Luciano; Gasparini, Pierluigi; Lovat, Francesca; Carasi, Stefania; Pulvirenti, Alfredo; Ferro, Alfredo; Alder, Hansjuerg; He, Gang; Vecchione, Andrea; Croce, Carlo M.; Shapiro, Charles L.; Huebner, Kay			Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; SOLID TUMORS; C-MYC; METASTASIS; GROWTH; CHEMOSENSITIVITY; IDENTIFICATION; CHEMOTHERAPY; SUPPRESSION; INVASION	Triple negative breast cancer (TNBC) is a heterogeneous disease at the molecular, pathologic and clinical levels. To stratify TNBCs, we determined microRNA (miRNA) expression profiles, as well as expression profiles of a cancer-focused mRNA panel, in tumor, adjacent non-tumor (normal) and lymph node metastatic lesion (mets) tissues, from 173 women with TNBCs; we linked specific miRNA signatures to patient survival and used miRNA/mRNA anti-correlations to identify clinically and genetically different TNBC subclasses. We also assessed miRNA signatures as potential regulators of TNBC subclass-specific gene expression networks defined by expression of canonical signal pathways. Tissue specific miRNAs and mRNAs were identified for normal vs tumor vs mets comparisons. miRNA signatures correlated with prognosis were identified and predicted anti-correlated targets within the mRNA profile were defined. Two miRNA signatures (miR-16, 155, 125b, 374a and miR-16, 125b, 374a, 374b, 421, 655, 497) predictive of overall survival (P = 0.05) and distant-disease free survival (P = 0.009), respectively, were identified for patients 50 yrs of age or younger. By multivariate analysis the risk signatures were independent predictors for overall survival and distant-disease free survival. mRNA expression profiling, using the cancer-focused mRNA panel, resulted in clustering of TNBCs into 4 molecular subclasses with different expression signatures anti-correlated with the prognostic miRNAs. Our findings suggest that miRNAs play a key role in triple negative breast cancer through their ability to regulate fundamental pathways such as: cellular growth and proliferation, cellular movement and migration, Extra Cellular Matrix degradation. The results define miRNA expression signatures that characterize and contribute to the phenotypic diversity of TNBC and its metastasis.	[Cascione, Luciano; Gasparini, Pierluigi; Lovat, Francesca; Carasi, Stefania; Alder, Hansjuerg; Vecchione, Andrea; Croce, Carlo M.; Huebner, Kay] Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Cascione, Luciano; Gasparini, Pierluigi; Lovat, Francesca; Carasi, Stefania; Alder, Hansjuerg; Vecchione, Andrea; Croce, Carlo M.; Shapiro, Charles L.; Huebner, Kay] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Cascione, Luciano; Pulvirenti, Alfredo; Ferro, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [He, Gang] Ohio State Univ, Dept Pathol, Wexner Med Ctr, Div Pathol 2, Columbus, OH 43210 USA; [Vecchione, Andrea] Univ Roma La Sapienza, Osped Santo Andrea, Rome, Italy; [Shapiro, Charles L.] James Canc Hosp, Div Med Oncol, Columbus, OH USA; [Shapiro, Charles L.] James Canc Hosp, Breast Program, Columbus, OH USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Catania; University System of Ohio; Ohio State University; Sapienza University Rome; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Huebner, K (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	kay.huebner@osumc.edu	Young, Richard A/F-6495-2012; Gasparini, Pierluigi/ABA-2811-2021; Pulvirenti, Alfredo/I-7272-2018; Cascione, Luciano/X-3115-2019	Young, Richard A/0000-0001-8855-8647; Gasparini, Pierluigi/0000-0001-8311-8845; Pulvirenti, Alfredo/0000-0002-9764-0295; Cascione, Luciano/0000-0002-4606-0637; Vecchione, Andrea/0000-0002-5497-6856	United States Public Health Service, National Cancer Institute [CA154200, CA120516, CA152758]; Stephanie Spielman Foundation for Breast Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA120516, U01CA152758, U01CA154200] Funding Source: NIH RePORTER	United States Public Health Service, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); Stephanie Spielman Foundation for Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Public Health Service, National Cancer Institute grants, CA154200, CA120516, CA152758, and the Stephanie Spielman Foundation for Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Daves MH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-56; Di Leva G, 2012, UPSALA J MED SCI, V117, P202, DOI 10.3109/03009734.2012.660551; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; Garimella SV, 2012, MOL CANCER RES, V10, P75, DOI 10.1158/1541-7786.MCR-11-0500; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gravgaard KH, 2012, BREAST CANCER RES TR, V134, P207, DOI 10.1007/s10549-012-1969-9; Greenwood C, 2012, J PROTEOMICS, V75, P3031, DOI 10.1016/j.jprot.2011.11.033; Howe EN, 2012, J MAMMARY GLAND BIOL, V17, P65, DOI 10.1007/s10911-012-9244-6; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Knopfova L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-15; Konecny GE, 2010, BREAST CANCER RES TR, V120, P481, DOI 10.1007/s10549-010-0744-z; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Martin M, 2011, BREAST CANCER RES TR, V128, P127, DOI 10.1007/s10549-011-1461-y; McInnes N, 2012, ONCOGENE, V31, P1045, DOI 10.1038/onc.2011.293; Mendoza M, 2009, INT J BIOCHEM CELL B, V41, P1452, DOI 10.1016/j.biocel.2009.01.015; Nass SJ, 1997, BREAST CANCER RES TR, V44, P1, DOI 10.1023/A:1005858611585; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Paz-Priel I, 2005, MOL CANCER RES, V3, P585, DOI 10.1158/1541-7786.MCR-05-0111; Psaila B, 2001, NAT REV CANCER, V9, P285; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Simon R, 2007, CANCER INFORM, V3, P11; Singh B, 2006, J SURG RES, V134, P44, DOI 10.1016/j.jss.2006.03.018; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Snoussi K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-283; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Trojanec R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3030; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Vosa U, 2011, GENE CHROMOSOME CANC, V50, P812, DOI 10.1002/gcc.20902; Wang L, 2012, ONCOGENE, V31, P2499, DOI 10.1038/onc.2011.444; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Xu J., 2012, ONCOGENE; Yoon S, 2010, FEBS LETT, V584, P4048, DOI 10.1016/j.febslet.2010.08.025; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	50	134	138	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55910	10.1371/journal.pone.0055910	http://dx.doi.org/10.1371/journal.pone.0055910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405235	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400180
J	Delogu, F; Tiest, WMB; Nijboer, TCW; Kappers, AML; Postma, A				Delogu, Franco; Tiest, Wouter M. Bergmann; Nijboer, Tanja C. W.; Kappers, Astrid M. L.; Postma, Albert			Binding in Haptics: Integration of "What" and "Where" Information in Working Memory for Active Touch	PLOS ONE			English	Article							LOCATION; PATHWAYS; VISION; BRAIN; TASK; FMRI	Information about the identity and the location of perceptual objects can be automatically integrated in perception and working memory (WM). Contrasting results in visual and auditory WM studies indicate that the characteristics of feature-to-location binding can vary according to the sensory modality of the input. The present study provides first evidence of binding between "what" and "where" information in WM for haptic stimuli. In an old-new recognition task, blindfolded participants were presented in their peripersonal space with sequences of three haptic stimuli varying in texture and location. They were then required to judge if a single probe stimulus was previously included in the sequence. Recall was measured both in a condition in which both texture and location were relevant for the task (Experiment 1) and in two conditions where only one feature had to be recalled (Experiment 2). Results showed that when both features were task-relevant, even if the association of location and texture was neither necessary nor required to perform the task, participants exhibited a recall advantage in conditions in which the location and the texture of the target probe was kept unaltered between encoding and recall. By contrast, when only one feature was task-relevant, the concurrent feature did not influence the recall of the target feature. We conclude that attention to feature binding is not necessary for the emergence of feature integration in haptic WM. For binding to take place, however, it is necessary to encode and maintain in memory both the identity and the location of items.	[Delogu, Franco; Nijboer, Tanja C. W.; Postma, Albert] Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands; [Delogu, Franco] Lawrence Technol Univ, Dept Humanities Social Sci & Commun, Southfield, MI USA; [Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr, Dept Neurol, Utrecht, Netherlands; [Nijboer, Tanja C. W.; Postma, Albert] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Nijboer, Tanja C. W.; Postma, Albert] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Nijboer, Tanja C. W.; Postma, Albert] Rehabil Ctr De Hoogstraat, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Delogu, F (corresponding author), Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands.	fdelogu@ltu.edu	Tiest, Wouter M Bergmann/N-8535-2013	Nijboer, Tanja/0000-0001-6683-0267	Intra-European Fellowships for career development (IEF) Marie Curie Actions [254446]; Netherlands Organization for Scientific Research (NWO) [451-10-013]	Intra-European Fellowships for career development (IEF) Marie Curie Actions; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the grant 254446 from the Intra-European Fellowships for career development (IEF) Marie Curie Actions to Franco Delogu and by the grant 451-10-013 from the Netherlands Organization for Scientific Research (NWO) to Tanja C. W. Nijboer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan JS, 2008, PERCEPT PSYCHOPHYS, V70, P36, DOI 10.3758/PP.70.1.36; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Kaas AL, 2007, CEREB CORTEX, V17, P1637, DOI 10.1093/cercor/bhl074; Kohler S, 2001, MEM COGNITION, V29, P948, DOI 10.3758/BF03195757; KUBOVY M, 1988, J EXP PSYCHOL HUMAN, V14, P318, DOI 10.1037/0096-1523.14.2.318; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Maybery MT, 2009, J MEM LANG, V61, P112, DOI 10.1016/j.jml.2009.03.001; Millar S, 2004, PERCEPT PSYCHOPHYS, V66, P51, DOI 10.3758/BF03194860; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Munk MHJ, 2002, CEREB CORTEX, V12, P866, DOI 10.1093/cercor/12.8.866; Olson IR, 2005, PERCEPT PSYCHOPHYS, V67, P185, DOI 10.3758/BF03206483; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Purdy KA, 2004, CAN J EXP PSYCHOL, V58, P32, DOI 10.1037/h0087438; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Reed CL, 2005, NEUROIMAGE, V25, P718, DOI 10.1016/j.neuroimage.2004.11.044; Ricciardi E, 2006, NEUROSCIENCE, V139, P339, DOI 10.1016/j.neuroscience.2005.08.045; Tiest WMB, 2006, ACTA PSYCHOL, V121, P1, DOI 10.1016/j.actpsy.2005.04.005; Treisman A., 1999, ATTENTION SPACE ACTI, P91; Van Boven RW, 2005, P NATL ACAD SCI USA, V102, P12601, DOI 10.1073/pnas.0505907102; Zuidhoek S, 2003, EXP BRAIN RES, V149, P320, DOI 10.1007/s00221-002-1365-5	21	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55606	10.1371/journal.pone.0055606	http://dx.doi.org/10.1371/journal.pone.0055606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405177	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400122
J	Donovan, C; Schauss, A; Kramer, R; Bramkamp, M				Donovan, Catriona; Schauss, Astrid; Kraemer, Reinhard; Bramkamp, Marc			Chromosome Segregation Impacts on Cell Growth and Division Site Selection in Corynebacterium glutamicum	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; POLE OSCILLATION; INHIBITOR MINC; WALL SYNTHESIS; PROTEIN; SYSTEM; CYCLE; LOCALIZATION; PLACEMENT	Spatial and temporal regulation of bacterial cell division is imperative for the production of viable offspring. In many rod-shaped bacteria, regulatory systems such as the Min system and nucleoid occlusion ensure the high fidelity of midcell divisome positioning. However, regulation of division site selection in bacteria lacking recognizable Min and nucleoid occlusion remains less well understood. Here, we describe one such rod-shaped organism, Corynebacterium glutamicum, which does not always place the division septum precisely at midcell. Here we now show at single cell level that cell growth and division site selection are spatially and temporally regulated by chromosome segregation. Mutants defective in chromosome segregation have more variable cell growth and aberrant placement of the division site. In these mutants, division septa constrict over and often guillotine the nucleoid, leading to nonviable, DNA-free cells. Our results suggest that chromosome segregation or some nucleoid associated factor influences growth and division site selection in C. glutamicum. Understanding growth and regulation of C. glutamicum cells will also be of importance to develop strains for industrial production of biomolecules, such as amino acids.	[Donovan, Catriona; Bramkamp, Marc] Univ Munich, Dept Biol 1, Planegg Martinsried, Germany; [Donovan, Catriona; Kraemer, Reinhard; Bramkamp, Marc] Univ Cologne, Inst Biochem, D-50931 Cologne, Germany; [Schauss, Astrid] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Munich; University of Cologne; University of Cologne	Bramkamp, M (corresponding author), Univ Munich, Dept Biol 1, Planegg Martinsried, Germany.	marc.bramkamp@lmu.de		Bramkamp, Marc/0000-0002-7704-3266				Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; Collier J, 2012, PLASMID, V67, P76, DOI 10.1016/j.plasmid.2011.12.007; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Donovan C, 2012, MOL MICROBIOL, V84, P105, DOI 10.1111/j.1365-2958.2012.08011.x; Donovan C, 2010, J BACTERIOL, V192, P3441, DOI 10.1128/JB.00214-10; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; FUNNELL BE, 1988, J BACTERIOL, V170, P954, DOI 10.1128/JB.170.2.954-960.1988; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Grover NB, 2001, MICROBIOL-SGM, V147, P171, DOI 10.1099/00221287-147-1-171; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kiekebusch D, 2012, MOL CELL, V46, P245, DOI 10.1016/j.molcel.2012.03.004; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Lesterlin C, 2004, MOL MICROBIOL, V54, P1151, DOI 10.1111/j.1365-2958.2004.04356.x; Letek M, 2008, ANTON LEEUW INT J G, V94, P99, DOI 10.1007/s10482-008-9224-4; Letek M, 2008, J BACTERIOL, V190, P3283, DOI 10.1128/JB.01934-07; Lutkenhaus J, 2002, CURR OPIN MICROBIOL, V5, P548, DOI 10.1016/S1369-5274(02)00376-4; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Migocki MD, 2002, EMBO REP, V3, P1163, DOI 10.1093/embo-reports/kvf233; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Moriya S, 2010, MOL MICROBIOL, V76, P634, DOI 10.1111/j.1365-2958.2010.07102.x; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Ramos A, 2005, MICROBIOL-SGM, V151, P2563, DOI 10.1099/mic.0.28036-0; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Rodrigues CDA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002561; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Siegal-Gaskins D, 2008, BIOPHYS J, V95, P2063, DOI 10.1529/biophysj.108.128785; Sveiczer A, 1996, J CELL SCI, V109, P2947; Tauch A, 2002, CURR MICROBIOL, V45, P362, DOI 10.1007/s00284-002-3728-3; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; van Baarle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009850; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Wu LJ, 2009, EMBO J, V28, P1940, DOI 10.1038/emboj.2009.144; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002	54	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55078	10.1371/journal.pone.0055078	http://dx.doi.org/10.1371/journal.pone.0055078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405112	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400056
J	Goheen, JR; Palmer, TM; Charles, GK; Helgen, KM; Kinyua, SN; Maclean, JE; Turner, BL; Young, HS; Pringle, RM				Goheen, Jacob R.; Palmer, Todd M.; Charles, Grace K.; Helgen, Kristofer M.; Kinyua, Stephen N.; Maclean, Janet E.; Turner, Benjamin L.; Young, Hillary S.; Pringle, Robert M.			Piecewise Disassembly of a Large-Herbivore Community across a Rainfall Gradient: The UHURU Experiment	PLOS ONE			English	Article							SEMIARID SAVANNA; WOODY COVER; PRODUCTIVITY; POPULATION; EXTINCTION; ECOSYSTEM; PREFERENCES; DIVERSITY; DYNAMICS; RODENTS	Large mammalian herbivores (LMH) strongly influence plant communities, and these effects can propagate indirectly throughout food webs. Most existing large-scale manipulations of LMH presence/absence consist of a single exclusion treatment, and few are replicated across environmental gradients. Thus, important questions remain about the functional roles of different LMH, and how these roles depend on abiotic context. In September 2008, we constructed a series of 1-ha herbivore-exclusion plots across a 20-km rainfall gradient in central Kenya. Dubbed "UHURU" (Ungulate Herbivory Under Rainfall Uncertainty), this experiment aims to illuminate the ecological effects of three size classes of LMH, and how rainfall regimes shape the direction and magnitude of these effects. UHURU consists of four treatments: total-exclusion (all ungulate herbivores), mesoherbivore-exclusion (LMH >120-cm tall), megaherbivore-exclusion (elephants and giraffes), and unfenced open plots. Each treatment is replicated three times at three locations ("sites") along the rainfall gradient: low (440 mm/year), intermediate (580 mm/year), and high (640 mm/year). There was limited variation across sites in soil attributes and LMH activity levels. Understory-plant cover was greater in plots without mesoherbivores, but did not respond strongly to the exclusion of megaherbivores, or to the additional exclusion of dik-dik and warthog. Eleven of the thirteen understory plant species that responded significantly to exclusion treatment were more common in exclusion plots than open ones. Significant interactions between site and treatment on plant communities, although uncommon, suggested that differences between treatments may be greater at sites with lower rainfall. Browsers reduced densities of several common overstory species, along with growth rates of the three dominant Acacia species. Small-mammal densities were 2-3 times greater in total-exclusion than in open plots at all sites. Although we expect patterns to become clearer with time, results from 2008-2012 show that the effects of excluding successively smaller-bodied subsets of the LMH community are generally non-additive for a given response variable, and inconsistent across response variables, indicating that the different LMH size classes are not functionally redundant. Several response variables showed significant treatment-by-site interactions, suggesting that the nature of plant-herbivore interactions can vary across restricted spatial scales.	[Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Goheen, Jacob R.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Goheen, Jacob R.; Palmer, Todd M.; Charles, Grace K.; Kinyua, Stephen N.; Maclean, Janet E.; Young, Hillary S.; Pringle, Robert M.] Mpala Res Ctr, Nanyuki, Kenya; [Palmer, Todd M.] Univ Florida, Dept Biol, Gainesville, FL USA; [Helgen, Kristofer M.] Natl Museum Nat Hist, Div Mammals, Washington, DE USA; [Kinyua, Stephen N.] Moi Univ, Dept Wildlife Management, Eldoret, Kenya; [Maclean, Janet E.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Turner, Benjamin L.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Young, Hillary S.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Pringle, Robert M.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Wyoming; University of Wyoming; State University System of Florida; University of Florida; Moi University; University of British Columbia; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Princeton University	Pringle, RM (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	rpringle@princeton.edu	Palmer, Todd/GRS-0639-2022; Helgen, Kristofer M./AAB-8348-2019; Turner, Benjamin L/E-5940-2011; Young, Hillary/S-1514-2017	Helgen, Kristofer M./0000-0002-8776-4040; Turner, Benjamin L/0000-0002-6585-0722; Palmer, Todd/0000-0001-5710-9750; Charles, Grace/0000-0003-2080-878X	Sherwood Family Foundation; National Sciences and Engineering Research Council of Canada; University of Florida; University of British Columbia; US National Science Foundation [DEB-0709880, OISE-0852961, DEB-0444071]; National Geographic Society; Stanford University's Woods Institute for the Environment; University of Wyoming; Harvard University	Sherwood Family Foundation; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Florida(University of Florida); University of British Columbia; US National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Stanford University's Woods Institute for the Environment; University of Wyoming; Harvard University	The UHURU experiment was built with seed funding from the Sherwood Family Foundation, by grants from the National Sciences and Engineering Research Council of Canada (to JRG), and by the Universities of Florida, and British Columbia. Support for various portions of this study was contributed by the US National Science Foundation (DEB-0709880 and OISE-0852961 to RMP and DEB-0444071 to TMP), the National Geographic Society, Stanford University's Woods Institute for the Environment, the University of Wyoming, and the William F. Milton Fund of Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Ahn P. M., 1987, SOILS LAIKIPIA DISTR; Anderson TM, 2007, ECOLOGY, V88, P1191, DOI 10.1890/06-0399; [Anonymous], 1993, USDA HDB; Augustine David J., 2011, Smithsonian Contributions to Zoology, P55; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Augustine DJ, 2003, PLANT ECOL, V167, P319, DOI 10.1023/A:1023927512590; Augustine DJ, 2002, THESIS SYRACUSE U NE; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Belyea LR, 1999, OIKOS, V86, P402, DOI 10.2307/3546646; Blundell M., 1982, WILD FLOWERS KENYA; Bogdan AV, 1976, REVISED LIST KENYA G; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Brady N.C., 1999, NATURE PROPERTIES SO; Brook BW, 2005, POPUL ECOL, V47, P137, DOI 10.1007/s10144-005-0213-4; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chase JM, 2000, ECOLOGY, V81, P2485, DOI 10.1890/0012-9658(2000)081[2485:TEOPHA]2.0.CO;2; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; COUGHENOUR MB, 1991, J RANGE MANAGE, V44, P530, DOI 10.2307/4003033; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Dharani N., 2006, FIELD GUIDE ACACIAS; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; DUTOIT JT, 1990, AFR J ECOL, V28, P55, DOI 10.1111/j.1365-2028.1990.tb01136.x; Ernest SKM, 2000, OIKOS, V88, P470, DOI 10.1034/j.1600-0706.2000.880302.x; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Frank DA, 2011, GLOBAL CHANGE BIOL, V17, P495, DOI 10.1111/j.1365-2486.2010.02219.x; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gee G.W., 2002, METHODS SOIL ANAL PA, V5, P255, DOI [DOI 10.2136/SSSABOOKSER5.4.C12, 10.2136/sssabookser5.4.c12]; Gillett JB, 1970, NUMBERED CHECK LIST; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Goheen JR, 2010, J ANIM ECOL, V79, P372, DOI 10.1111/j.1365-2656.2009.01644.x; Grossman R.B., 2002, METHODS SOIL ANAL 4, P201, DOI DOI 10.2136/SSSABOOKSER5.4.C9; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Hagenah N, 2009, J TROP ECOL, V25, P483, DOI 10.1017/S0266467409990046; Haynes RJ, 2001, NUTR CYCL AGROECOSYS, V59, P47, DOI 10.1023/A:1009823600950; Heady H.F., 1960, RANGE MANAGEMENT E A; Hendershot W.H., 2008, SOIL SAMPLING METHOD, P173, DOI DOI 10.1111/1365-2745.12546; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Ims RA, 2007, ECOSYSTEMS, V10, P607, DOI 10.1007/s10021-007-9060-9; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kareiva P., 1988, Lecture Notes in Biomathematics, V77, P35; Keesing F, 1998, OECOLOGIA, V116, P381, DOI 10.1007/s004420050601; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Lagendijk G, 2012, BIOTROPICA, V44, P63, DOI 10.1111/j.1744-7429.2011.00776.x; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; Maclean JE, 2011, ECOLOGY, V92, P1626, DOI 10.1890/10-2097.1; McCauley DJ, 2006, ECOLOGY, V87, P2657, DOI 10.1890/0012-9658(2006)87[2657:IEOLHO]2.0.CO;2; McLaren JR, 2010, J ECOL, V98, P459, DOI 10.1111/j.1365-2745.2009.01630.x; McNaughton SJ, 1996, ECOLOGY, V77, P974, DOI 10.2307/2265518; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1983, ECOL MONOGR, V53, P291, DOI 10.2307/1942533; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Osem Y, 2004, J ECOL, V92, P297, DOI 10.1111/j.0022-0477.2004.00859.x; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; Pringle R. M., 2011, CONSERVING WILDLIFE, P55; Pringle RM, 2008, ECOLOGY, V89, P26, DOI 10.1890/07-0776.1; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; Pringle RM, 2012, AM SCI, V100, P30; Riginos C, PASTORALISM IN PRESS; RODGERS WA, 1976, E AFR WILDL J, V14, P331; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Schmitz OJ., 2010, RESOLVING ECOSYSTEM; Smit R, 2001, PLANT ECOL, V155, P119, DOI 10.1023/A:1013239805915; SOIL SURVEY STAFF, 1999, SOIL TAX BAS SYST SO, V2nd; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; STEWART DRM, 1971, J WILDLIFE MANAGE, V35, P86, DOI 10.2307/3799875; Stuart C., 2000, FIELD GUIDE TRACKS S; Vagen T.-G., 2010, LAND DEGRADATION SUR; Van Oudtshoorn F., 2009, GUIDE GRASSES SO AFR; Vaughn KJ, 2010, RESTOR ECOL, V18, P59, DOI 10.1111/j.1526-100X.2010.00714.x; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Young TP, 2005, BIOL CONSERV, V122, P351, DOI 10.1016/j.biocon.2004.08.007	88	72	72	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55192	10.1371/journal.pone.0055192	http://dx.doi.org/10.1371/journal.pone.0055192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405122	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400067
J	Simonelli, L; Pedotti, M; Beltramello, M; Livoti, E; Calzolai, L; Sallusto, F; Lanzavecchia, A; Varani, L				Simonelli, Luca; Pedotti, Mattia; Beltramello, Martina; Livoti, Elsa; Calzolai, Luigi; Sallusto, Federica; Lanzavecchia, Antonio; Varani, Luca			Rational Engineering of a Human Anti-Dengue Antibody through Experimentally Validated Computational Docking	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; VIRUS ENVELOPE PROTEIN; DOMAIN-III; NEUTRALIZING ANTIBODY; CROSS-REACTIVITY; E-GLYCOPROTEIN; BINDING; DESIGN; ASSIGNMENTS; REVEALS	Antibodies play an increasing pivotal role in both basic research and the biopharmaceutical sector, therefore technology for characterizing and improving their properties through rational engineering is desirable. This is a difficult task thought to require high-resolution x-ray structures, which are not always available. We, instead, use a combination of solution NMR epitope mapping and computational docking to investigate the structure of a human antibody in complex with the four Dengue virus serotypes. Analysis of the resulting models allows us to design several antibody mutants altering its properties in a predictable manner, changing its binding selectivity and ultimately improving its ability to neutralize the virus by up to 40 fold. The successful rational design of antibody mutants is a testament to the accuracy achievable by combining experimental NMR epitope mapping with computational docking and to the possibility of applying it to study antibody/pathogen interactions.	[Simonelli, Luca; Pedotti, Mattia; Beltramello, Martina; Livoti, Elsa; Sallusto, Federica; Lanzavecchia, Antonio; Varani, Luca] Biomed Res Inst, Bellinzona, Switzerland; [Calzolai, Luigi] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Italy; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	Universita della Svizzera Italiana; European Commission Joint Research Centre; EC JRC ISPRA Site; Swiss Federal Institutes of Technology Domain; ETH Zurich	Varani, L (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	luca.varani@irb.usi.ch		Simonelli, Luca/0000-0001-6331-7716; Varani, Luca/0000-0002-0963-0987	Canton Ticino; Swiss Vaccine Research Institute; European Union (EU-NMR) [RII3- 622 026145]	Canton Ticino; Swiss Vaccine Research Institute; European Union (EU-NMR)(European Commission)	Funding was provided by Canton Ticino, Swiss Vaccine Research Institute, and European Union (EU-NMR, Contract #RII3- 622 026145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Chaudhury S, 2008, J MOL BIOL, V381, P1068, DOI 10.1016/j.jmb.2008.05.042; Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Huang KC, 2008, PROTEINS, V70, P1116, DOI 10.1002/prot.21806; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Morea V, 2000, METHODS, V20, P267, DOI 10.1006/meth.1999.0921; Park M-S, 2011, PLOS ONE, V6; Pedotti M, 2011, INT J MOL SCI, V12, P226, DOI 10.3390/ijms12010226; Simonelli L, 2010, J MOL BIOL, V396, P1491, DOI 10.1016/j.jmb.2009.12.053; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Varani L, 2000, NAT STRUCT BIOL, V7, P329; Varani L, 2007, P NATL ACAD SCI USA, V104, P13080, DOI 10.1073/pnas.0703702104; Volk DE, 2007, VIROLOGY, V364, P147, DOI 10.1016/j.virol.2007.02.023; Volk DE, 2006, J BIOMOL NMR, V36, P62, DOI 10.1007/s10858-006-9048-3; Volk DE, 2008, BIOMOL NMR ASSIGN, V2, P155, DOI 10.1007/s12104-008-9109-5; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; WHO, 2009, DENG DENG HAEM FEV; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	33	29	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55561	10.1371/journal.pone.0055561	http://dx.doi.org/10.1371/journal.pone.0055561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405171	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400116
J	Sun, BY; Ma, L; Yan, XW; Lee, D; Alexander, V; Hohmann, LJ; Lorang, C; Chandrasena, L; Tian, Q; Hood, L				Sun, Bingyun; Ma, Li; Yan, Xiaowei; Lee, Denis; Alexander, Vinita; Hohmann, Laura J.; Lorang, Cynthia; Chandrasena, Lalangi; Tian, Qiang; Hood, Leroy			N-Glycoproteome of E14.Tg2a Mouse Embryonic Stem Cells	PLOS ONE			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; RECEPTOR TYROSINE KINASES; RED-BLOOD-CELLS; MASS-SPECTROMETRY; MEMBRANE-PROTEINS; LYSOSOMAL MEMBRANE; STATISTICAL-MODEL; SURFACE; PROTEOMICS; GLYCOSYLATION	E14.Tg2a mouse embryonic stem (mES) cells are a widely used host in gene trap and gene targeting techniques. Molecular characterization of host cells will provide background information for a better understanding of functions of the knockout genes. Using a highly selective glycopeptide-capture approach but ordinary liquid chromatography coupled mass spectrometry (LC-MS), we characterized the N-glycoproteins of E14.Tg2a cells and analyzed the close relationship between the obtained N-glycoproteome and cell-surface proteomes. Our results provide a global view of cell surface protein molecular properties, in which receptors seem to be much more diverse but lower in abundance than transporters on average. In addition, our results provide a systematic view of the E14.Tg2a N-glycosylation, from which we discovered some striking patterns, including an evolutionarily preserved and maybe functionally selected complementarity between Nglycosylation and the transmembrane structure in protein sequences. We also observed an environmentally influenced Nglycosylation pattern among glycoenzymes and extracellular matrix proteins. We hope that the acquired information enhances our molecular understanding of mES E14.Tg2a as well as the biological roles played by N-glycosylation in cell biology in general.	[Sun, Bingyun; Ma, Li; Yan, Xiaowei; Lee, Denis; Alexander, Vinita; Hohmann, Laura J.; Lorang, Cynthia; Tian, Qiang; Hood, Leroy] Inst Syst Biol, Seattle, WA 98109 USA; [Sun, Bingyun; Chandrasena, Lalangi] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Institute for Systems Biology (ISB); Simon Fraser University	Sun, BY (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	bingyun_sun@sfu.ca; lhood@systemsbiology.org		Alexander, Vinita/0000-0003-1843-5398	NIH (National Institutes of Health) [1U54DA021519, 1U54CA119347]; NIH/NIGMS (National Institute of General Medical Sciences) [1P50GM076547]; NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) [P01 DK53074]; Startup fund from Simon Fraser University; NATIONAL CANCER INSTITUTE [U54CA119347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS (National Institute of General Medical Sciences); NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases); Startup fund from Simon Fraser University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This publication was made possible by Grant Numbers 1U54DA021519 and 1U54CA119347 from NIH (National Institutes of Health), 1P50GM076547 from NIH/NIGMS (National Institute of General Medical Sciences), P01 DK53074 from NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases), and LC is supported by the Startup fund from Simon Fraser University. The contents here are solely the responsibility of the authors and do not necessarily represent the official views of the NIH and Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 1998, JPN J PHARMACOL, V78, P113, DOI 10.1254/jjp.78.113; Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Araki R, 2006, STEM CELLS, V24, P2522, DOI 10.1634/stemcells.2006-0005; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bond MR, 2007, CURR OPIN CHEM BIOL, V11, P52, DOI 10.1016/j.cbpa.2006.11.032; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burnstock G, 2002, CLIN MED, V2, P45, DOI 10.7861/clinmedicine.2-1-45; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; CARR SA, 1986, ANAL BIOCHEM, V157, P396, DOI 10.1016/0003-2697(86)90643-3; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; CRIMAUDO C, 1987, EMBO J, V6, P75, DOI 10.1002/j.1460-2075.1987.tb04721.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Dodds ED, 2012, MASS SPECTROM REV; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dormeyer W, 2008, PROTEOMICS, V8, P4036, DOI 10.1002/pmic.200800143; Downing GJ, 2004, STEM CELLS, V22, P1168, DOI 10.1634/stemcells.2004-0101; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fisher CE, 2006, DEV BIOL, V296, P279, DOI 10.1016/j.ydbio.2006.06.007; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Gajera CR, 2010, J CELL SCI, V123, P1922, DOI 10.1242/jcs.065912; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Gundry RL, 2011, PROTEOMICS, V11, P3947, DOI 10.1002/pmic.201100100; Haffner C, 2004, EMBO J, V23, P3041, DOI 10.1038/sj.emboj.7600307; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; HILTON DJ, 1992, J BIOL CHEM, V267, P10238; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hsu VW, 2010, CURR OPIN CELL BIOL, V22, P528, DOI 10.1016/j.ceb.2010.05.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jank H, 2011, THESCIENTIFICWORLDJO, V11, P173, DOI 10.1100/tsw.2011.25; JENNINGS ML, 1989, ANNU REV BIOPHYS BIO, V18, P397, DOI 10.1146/annurev.bb.18.060189.002145; Jensen ON, 2000, MODIFICATION SPECIFI; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lauc G, 2010, MOL BIOSYST, V6, P329, DOI 10.1039/b910377e; Lazar IM, 2011, ELECTROPHORESIS, V32, P3, DOI 10.1002/elps.201000393; Ledermann B, 2000, EXP PHYSIOL, V85, P603, DOI 10.1017/S0958067000021059; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001; Li QR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001750; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma L, 2007, CLIN CHIM ACTA, V378, P24, DOI 10.1016/j.cca.2006.12.016; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Mastrangelo L, 2012, P NATL ACAD SCI USA, V109, P3377, DOI 10.1073/pnas.1118067109; Mataftsi A, 2007, INVEST OPHTH VIS SCI, V48, P5160, DOI 10.1167/iovs.06-1013; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; NEISS WF, 1984, HISTOCHEMISTRY, V80, P603, DOI 10.1007/BF00553724; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; NILSSON I, 1993, J BIOL CHEM, V268, P5798; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Nunomura K, 2005, MOL CELL PROTEOMICS, V4, P1968, DOI 10.1074/mcp.M500216-MCP200; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Ponten F, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.93; Ramos H, 2008, BIOINFORMATICS, V24, P2110, DOI 10.1093/bioinformatics/btn363; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith KA, 2011, DEVELOPMENT, V138, P4193, DOI 10.1242/dev.065375; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Sun BY, 2007, MOL CELL PROTEOMICS, V6, P141, DOI 10.1074/mcp.T600046-MCP200; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Tissot B, 2009, FEBS LETT, V583, P1728, DOI 10.1016/j.febslet.2009.03.049; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Willekens FLA, 2005, BLOOD, V105, P2141, DOI 10.1182/blood-2004-04-1578; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Yamamoto-Katayama S, 2001, BIOCHEM J, V357, P385, DOI 10.1042/0264-6021:3570385	89	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55722	10.1371/journal.pone.0055722	http://dx.doi.org/10.1371/journal.pone.0055722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405203	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400148
J	Xiao, SJ; Hu, PP; Chen, LQ; Zhen, SJ; Peng, L; Li, YF; Huang, CZ				Xiao, Sai Jin; Hu, Ping Ping; Chen, Li Qiang; Zhen, Shu Jun; Peng, Li; Li, Yuan Fang; Huang, Cheng Zhi			A Visual Dual-Aptamer Logic Gate for Sensitive Discrimination of Prion Diseases-Associated Isoform with Reusable Magnetic Microparticles and Fluorescence Quantum Dots	PLOS ONE			English	Article							PROTEIN; CONFORMATION; RECOGNITION	Molecular logic gates, which have attracted increasing research interest and are crucial for the development of molecular-scale computers, simplify the results of measurements and detections, leaving the diagnosis of disease either "yes'' or "no''. Prion diseases are a group of fatal neurodegenerative disorders that happen in human and animals. The main problem with a diagnosis of prion diseases is how to sensitively and selectively discriminate and detection of the minute amount of PrPRes in biological samples. Our previous work had demonstrated that dual-aptamer strategy could achieve highly sensitive and selective discrimination and detection of prion protein (cellular prion protein, PrPC, and the diseases associated isoform, PrPRes) in serum and brain. Inspired by the advantages of molecular logic gate, we further conceived a new concept for dual-aptamer logic gate that responds to two chemical input signals (PrPC or PrPRes and Gdn-HCl) and generates a change in fluorescence intensity as the output signal. It was found that PrPRes performs the "OR'' logic operation while PrPC performs "XOR'' logic operation when they get through the gate consisted of aptamer modified reusable magnetic microparticles (MMPs-Apt1) and quantum dots (QDs-Apt2). The dual-aptamer logic gate simplifies the discrimination results of PrPRes, leaving the detection of PrPRes either "yes'' or "no''. The development of OR logic gate based on dual-aptamer strategy and two chemical input signals (PrPRes and Gdn-HCl) is an important step toward the design of prion diseases diagnosis and therapy systems.	[Xiao, Sai Jin; Zhen, Shu Jun; Li, Yuan Fang; Huang, Cheng Zhi] Southwest Univ, Coll Chem & Chem Engn, Educ Minist, Key Lab Luminescence & Real Time Anal, Chongqing, Peoples R China; [Xiao, Sai Jin] E China Inst Technol, Dept Appl Chem, Jiangxi Key Lab Mass Spectrometry & Instrumentat, Nanchang, Jiangxi, Peoples R China; [Hu, Ping Ping; Chen, Li Qiang; Peng, Li] Southwest Univ, Coll Life Sci, Chongqing, Peoples R China; [Huang, Cheng Zhi] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China	Southwest University - China; East China University of Technology; Southwest University - China; Southwest University - China	Huang, CZ (corresponding author), Southwest Univ, Coll Chem & Chem Engn, Educ Minist, Key Lab Luminescence & Real Time Anal, Chongqing, Peoples R China.	chengzhi@swu.edu.cn	Li, Yuan/GXV-1310-2022	Chen, Liqiang/0000-0001-5430-4585	Ministry of Science and Technology of the People's Republic of China [2011CB933600]; National Natural Science Foundation of China (NSFC) [21035005]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Ministry of Science and Technology of the People's Republic of China (No. 2011CB933600) and the National Natural Science Foundation of China (NSFC, 21035005). The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	Benenson Y, 2009, CURR OPIN BIOTECH, V20, P471, DOI 10.1016/j.copbio.2009.08.002; Bibby DF, 2010, J VIROL METHODS, V151, P107; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Chang BG, 2008, J NEUROIMMUNOL, V205, P94, DOI 10.1016/j.jneuroim.2008.09.013; Chen LQ, 2012, ANAL CHEM, V84, P3099, DOI 10.1021/ac202810b; Chen LQ, 2010, J PHYS CHEM B, V114, P3655, DOI 10.1021/jp9104618; Chen X, 2006, ANGEW CHEM INT EDIT, V45, P1759, DOI 10.1002/anie.200502511; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; Deng Y, 2008, J AM CHEM SOC, V130, P28, DOI 10.1021/ja0777584; Deonarine AS, 2003, FUTURE GENER COMP SY, V19, P87, DOI 10.1016/S0167-739X(02)00110-3; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Fujii F, 2007, ANAL BIOCHEM, V370, P131, DOI 10.1016/j.ab.2007.07.018; Gilch S, 2009, CELL MOL LIFE SCI, V66, P2445, DOI 10.1007/s00018-009-0031-5; Goulko AA, 2009, TRAC-TREND ANAL CHEM, V28, P878, DOI 10.1016/j.trac.2009.03.014; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Heyduk E, 2005, ANAL CHEM, V77, P1147, DOI 10.1021/ac0487449; Hu P, 2008, ANAL CHEM, V80, P1819, DOI 10.1021/ac702187y; Huang CC, 2009, ANAL CHEM, V81, P875, DOI 10.1021/ac8010654; Koneracka M, 1999, J MAGN MAGN MATER, V201, P427, DOI 10.1016/S0304-8853(99)00005-0; Konry T, 2009, J AM CHEM SOC, V131, P13232, DOI 10.1021/ja905125b; Krafft C, 2009, J BIOPHOTONICS, V2, P13, DOI 10.1002/jbio.200810024; Leliveld SR, 2007, J NEUROSCI RES, V85, P2285, DOI 10.1002/jnr.21353; Li CX, 2011, CHEM COMMUN, V47, P4442, DOI 10.1039/c1cc10544b; Liu ZL, 2002, J MATER SYNTH PROCES, V10, P83, DOI 10.1023/A:1021231527095; Margulies D, 2005, NAT MATER, V4, P768, DOI 10.1038/nmat1469; Miyoshi D, 2006, ANGEW CHEM INT EDIT, V45, P7716, DOI 10.1002/anie.200602404; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; Qu DH, 2005, ANGEW CHEM INT EDIT, V44, P5296, DOI 10.1002/anie.200501215; Silva-Rocha R, 2008, FEBS LETT, V582, P1237, DOI 10.1016/j.febslet.2008.01.060; Soto C, 2004, NAT REV MICROBIOL, V2, P809, DOI 10.1038/nrmicro1003; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Takemura K, 2006, EXP BIOL MED, V231, P204; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Xiao SJ, 2010, ANAL CHEM, V82, P9736, DOI 10.1021/ac101865s; Yu SL, 2004, EUR J HUM GENET, V12, P867, DOI 10.1038/sj.ejhg.5201245; Zhang YL, 2007, J AM CHEM SOC, V129, P15448, DOI 10.1021/ja0773047; Zichel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031948	39	14	14	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53935	10.1371/journal.pone.0053935	http://dx.doi.org/10.1371/journal.pone.0053935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393552	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800006
J	Xu, CL; Iuliano, AD; Chen, M; Cheng, PY; Chen, T; Shi, JH; Yang, J; Wang, LJ; Yuan, F; Widdowson, MA; Shu, YL				Xu, Cuiling; Iuliano, A. Danielle; Chen, Min; Cheng, Po-Yung; Chen, Tao; Shi, Jinghong; Yang, Jing; Wang, Lijie; Yuan, Fan; Widdowson, Marc-Alain; Shu, Yuelong			Characteristics of Hospitalized Cases with Influenza A (H1N1) pdm09 Infection during First Winter Season of Post-Pandemic in China	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; RISK-FACTORS; A(H1N1); MORTALITY; OBESITY; DEATH	Background: Influenza A (H1N1)pdm09 (2009 H1N1) re-circulated as the predominant virus from January through February 2011 in China. National surveillance of 2009 H1N1 as a notifiable disease was maintained to monitor potential changes in disease severity from the previous season. Methodology/Principal Findings: To describe the characteristics of hospitalized cases with 2009 H1N1 infection and analyze risk factors for severe illness during the 2010-2011winter season in China, we obtained surveillance data from hospitalized cases with 2009 H1N1 infection from November 2010 through May 2011, and reviewed medical records from 701 hospitalized cases. Age-standardized risk ratios were used to compare the age distribution of patients that were hospitalized and died due to 2009 H1N1 between the 2010-2011winter season to those during the 2009-2010 pandemic period. During the 2010-2011 winter season, children less than 5 years of age had the highest relative risk of hospitalization and death, followed by adults aged 65 years or older. Additionally, the relative risk of hospitalized cases aged 5-14 and 15-24 years was lower compared to children less than 5 years of age. During the winter season of 2010-2011, the proportions of adults aged 25 years or older for hospitalization and death were significantly higher than those during the 2009-2010 pandemic period. Being male, having a chronic medical condition, delayed hospital admission (>= 3 days from onset) or delayed initiation of antiviral treatment (>= 5 days from onset) were associated with severe illness among non-pregnant patients >= 2 years of age. Conclusions/Significance: We observed a change in high risk groups for hospitalization for 2009 H1N1 during the winter months immediately following the pandemic period compared to the high risk groups identified during the pandemic period. Our nationally notifiable disease surveillance system enabled us to understand the evolving epidemiology of 2009 H1N1 infection after the pandemic period.	[Xu, Cuiling; Chen, Min; Chen, Tao; Shi, Jinghong; Yang, Jing; Wang, Lijie; Yuan, Fan; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, Beijing, Peoples R China; [Iuliano, A. Danielle; Cheng, Po-Yung; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA	Shu, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, Beijing, Peoples R China.	yshu@cnic.org.cn		Widdowson, Marc-Alain/0000-0002-0682-6933	Ministry of Health, China	Ministry of Health, China	We thank the participating hospitals, local health departments and Centers for Disease Control and Prevention in China for assistance in coordinating data collection, and the Ministry of Health, China for supporting this study.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P222; Athanasiou M, 2011, EUROSURVEILLANCE, V16, P14; Bolotin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030279; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chinese National Influenza Center, 2011, CHINESE INFLUENZA WE; Choi Won-Il, 2011, BMC Res Notes, V4, P351, DOI 10.1186/1756-0500-4-351; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; EuroFlu, 2011, EUROFLU WEEKLY ELECT, V2; Fuhrman C, 2010, EUROSURVEILLANCE, V15, P17; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hanslik T., 2010, PLOS CURR-TREE LIFE, V2, DOI [10.1371/currents.RRN1150, DOI 10.1371/CURRENTS.RRN1150]; Health Protection Agency, 2011, WEEKLY NATIONAL INFL; Hong Kong Center for Health Protection, 2011, FLU EXPRESS, V8; Jeon MH, 2011, DIAGN MICR INFEC DIS, V70, P230, DOI 10.1016/j.diagmicrobio.2011.01.005; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Li Hui, 2009, Zhonghua Er Ke Za Zhi, V47, P493; Liu B, 2002, CHINA PUBLIC HLTH, V18, P890; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; National Bureau of Statistics of China, 2009, CHINA STATISTICAL YE; National Institute of Infectious Diseases, 2011, INFECT AGENTS SURVEI; Pebody RG, 2010, EUROSURVEILLANCE, V15; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wang LD, 2005, COMPREHENSIVE REPORT, P50; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, 2010, EVOLUTION OF A PANDE; World Health Organization (WHO), 2010, WORLD NOW START 2009; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55016	10.1371/journal.pone.0055016	http://dx.doi.org/10.1371/journal.pone.0055016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393563	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800017
J	Stirbat, TV; Mgharbel, A; Bodennec, S; Ferri, K; Mertani, HC; Rieu, JP; Delanoe-Ayari, H				Stirbat, Tomita Vasilica; Mgharbel, Abbas; Bodennec, Selena; Ferri, Karine; Mertani, Hichem C.; Rieu, Jean-Paul; Delanoe-Ayari, Helene			Fine Tuning of Tissues' Viscosity and Surface Tension through Contractility Suggests a New Role for alpha-Catenin	PLOS ONE			English	Article							CELL-CELL; E-CADHERIN; EMBRYONIC-TISSUES; LOCAL CONCENTRATION; ADHERENS JUNCTIONS; BETA-CATENIN; ADHESION; ACTIN; MECHANISM; RHO	What governs tissue organization and movement? If molecular and genetic approaches are able to give some answers on these issues, more and more works are now giving a real importance to mechanics as a key component eventually triggering further signaling events. We chose embryonic cell aggregates as model systems for tissue organization and movement in order to investigate the origin of some mechanical constraints arising from cells organization. Steinberg et al. proposed a long time ago an analogy between liquids and tissues and showed that indeed tissues possess a measurable tissue surface tension and viscosity. We question here the molecular origin of these parameters and give a quantitative measurement of adhesion versus contractility in the framework of the differential interfacial tension hypothesis. Accompanying surface tension measurements by angle measurements (at vertexes of cell-cell contacts) at the cell/medium interface, we are able to extract the full parameters of this model: cortical tensions and adhesion energy. We show that a tunable surface tension and viscosity can be achieved easily through the control of cell-cell contractility compared to cell-medium one. Moreover we show that alpha-catenin is crucial for this regulation to occur: these molecules appear as a catalyser for the remodeling of the actin cytoskeleton underneath cell-cell contact, enabling a differential contractility between the cell-medium and cell-cell interface to take place.	[Stirbat, Tomita Vasilica; Mgharbel, Abbas; Bodennec, Selena; Ferri, Karine; Rieu, Jean-Paul; Delanoe-Ayari, Helene] Univ Lyon 1, CNRS, UMR5306, Inst Lumiere Mat, F-69365 Lyon, France; [Mertani, Hichem C.] Univ Lyon 1, CNRS, INSERM U1052,UMR 5286, Ctr Rech Cancerol Lyon,Ctr Leon Berard, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Delanoe-Ayari, H (corresponding author), Univ Lyon 1, CNRS, UMR5306, Inst Lumiere Mat, F-69365 Lyon, France.	helene.ayari@univ-lyon1.fr	MERTANI, Hichem-Claude/AAR-6415-2020; Delanoe-ayari, Helene/A-2085-2013	Delanoe-ayari, Helene/0000-0002-8658-3942	Agence Nationale de la Recherche [ANR JCJC 2005]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche (ANR JCJC 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Brevier J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.268101; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Evans EA, 1995, HDB BIOL PHYS A&B, V1, P723; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Foty RA, 1996, DEVELOPMENT, V122, P1611; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Frenkel J., 1945, J PHYS, V9, P385; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; GORDON R, 1972, J THEOR BIOL, V37, P43, DOI 10.1016/0022-5193(72)90114-2; Guevorkian K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218101; HARRIS AK, 1976, J THEOR BIOL, V61, P267, DOI 10.1016/0022-5193(76)90019-9; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Jakab K, 2008, DEV DYNAM, V237, P2438, DOI 10.1002/dvdy.21684; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Kafer J, 2008, THESIS; Kalantarian A, 2009, BIOPHYS J, V96, P1606, DOI 10.1016/j.bpj.2008.10.064; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Li ZX, 2010, J PHYS CHEM B, V114, P2894, DOI 10.1021/jp906737q; Loomis WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042033; Maeno Y, 1999, AM J PATHOL, V154, P1323, DOI 10.1016/S0002-9440(10)65385-0; Maitre JL, 2012, SCIENCE NEW YORK NY, V253; Marmottant P, 2009, P NATL ACAD SCI USA, V106, P17271, DOI 10.1073/pnas.0902085106; Mgharbel A, 2009, HFSP J, V3, P213, DOI 10.2976/1.3116822; Miyaguchi K, 2000, J STRUCT BIOL, V132, P169, DOI 10.1006/jsbi.2000.4244; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Pokluda O, 1997, AICHE J, V43, P3253, DOI 10.1002/aic.690431213; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; Rauzi M, 2011, CURR TOP DEV BIOL, V95, P93, DOI 10.1016/B978-0-12-385065-2.00004-9; Shaler A, 1949, METALS T, V185, P796; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shi QM, 2008, J BIOL CHEM, V283, P28454, DOI 10.1074/jbc.M802563200; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yonemura S, 2011, CURRENT OPINION CELL; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639	51	53	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e52554	10.1371/journal.pone.0052554	http://dx.doi.org/10.1371/journal.pone.0052554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390488	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100004
J	Wood, NI; McAllister, CJ; Cuesta, M; Aungier, J; Fraenkel, E; Morton, AJ				Wood, Nigel I.; McAllister, Catherine J.; Cuesta, Marc; Aungier, Juliet; Fraenkel, Eloise; Morton, A. Jennifer			Adaptation to Experimental Jet-Lag in R6/2 Mice despite Circadian Dysrhythmia	PLOS ONE			English	Article							HUNTINGTONS-DISEASE MUTATION; TRANSGENIC MOUSE MODEL; SLEEP DISTURBANCES; GENE-EXPRESSION; CLOCK; DYSREGULATION; DISRUPTION; RESPONSES; DEFICITS; LIGHT	The R6/2 transgenic mouse model of Huntington's disease (HD) shows a disintegration of circadian rhythms that can be delayed by pharmacological and non-pharmacological means. Since the molecular machinery underlying the circadian clocks is intact, albeit progressively dysfunctional, we wondered if light phase shifts could modulate the deterioration in daily rhythms in R6/2 mice. Mice were subjected to four x 4 hour advances in light onset. R6/2 mice adapted to phase advances, although angles of entrainment increased with age. A second cohort was subjected to a jet-lag paradigm (6 hour delay or advance in light onset, then reversal after 2 weeks). R6/2 mice adapted to the original shift, but could not adjust accurately to the reversal. Interestingly, phase shifts ameliorated the circadian rhythm breakdown seen in R6/2 mice under normal LD conditions. Our previous finding that the circadian period (tau) of 16 week old R6/2 mice shortens to approximately 23 hours may explain how they adapt to phase advances and maintain regular circadian rhythms. We tested this using a 23 hour period light/dark cycle. R6/2 mice entrained to this cycle, but onsets of activity continued to advance, and circadian rhythms still disintegrated. Therefore, the beneficial effects of phase-shifting are not due solely to the light cycle being closer to the tau of the mice. Our data show that R6/2 mice can adapt to changes in the LD schedule, even beyond the age when their circadian rhythms would normally disintegrate. Nevertheless, they show abnormal responses to changes in light cycles. These might be caused by a shortened tau, impaired photic re-synchronization, impaired light detection and/or reduced masking by evening light. If similar abnormalities are present in HD patients, they may suffer exaggerated jet-lag. Since the underlying molecular clock mechanism remains intact, light may be a useful treatment for circadian dysfunction in HD.	[Wood, Nigel I.; McAllister, Catherine J.; Cuesta, Marc; Aungier, Juliet; Fraenkel, Eloise; Morton, A. Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge	Morton, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	ajm41@cam.ac.uk	Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346; McAllister, Catherine/0000-0001-6147-6449; Aungier, Juliet/0000-0002-9144-5026	CHDI Foundation, Inc.	CHDI Foundation, Inc.	This work was supported by a grant to AJM from CHDI Foundation, Inc. (http://www.highqfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHOFF J, 1984, ANN NY ACAD SCI, V423, P442, DOI 10.1111/j.1749-6632.1984.tb23452.x; Aziz NA, 2009, J NEUROL, V256, P1961, DOI 10.1007/s00415-009-5196-1; Carter RJ, 1999, J NEUROSCI, V19, P3248; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Christofides J, 2006, J NEUROCHEM, V97, P1078, DOI 10.1111/j.1471-4159.2006.03807.x; Ciarnei A, 2008, NEUROBIOL LEARN MEM, V89, P533, DOI 10.1016/j.nlm.2007.10.009; Cuesta M, 2012, NEUROBIOL DIS, V45, P145, DOI 10.1016/j.nbd.2011.07.016; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Dodson ER, 2010, SLEEP MED CLIN, V5, DOI 10.1016/j.jsmc.2010.08.001; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Harrington M, 2010, J CLIN INVEST, V120, P2265, DOI 10.1172/JCI43632; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Kudo T, 2011, EXP NEUROL, V228, P80, DOI 10.1016/j.expneurol.2010.12.011; Lione LA, 1999, J NEUROSCI, V19, P10428; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Maywood ES, 2010, J NEUROSCI, V30, P10199, DOI 10.1523/JNEUROSCI.1694-10.2010; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Most EIS, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-19; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Pallier PN, 2007, J NEUROSCI, V27, P7869, DOI 10.1523/JNEUROSCI.0649-07.2007; Penev PD, 1998, AM J PHYSIOL-HEART C, V275, pH2334; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Reddy AB, 2002, J NEUROSCI, V22, P7326; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; SIEGEL PV, 1969, SCIENCE, V164, P1249, DOI 10.1126/science.164.3885.1249; Vitiello MV, 2001, CNS DRUGS, V15, P777, DOI 10.2165/00023210-200115100-00004	30	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55036	10.1371/journal.pone.0055036	http://dx.doi.org/10.1371/journal.pone.0055036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390510	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100026
J	Wissner-Gross, ZD; Scott, MA; Steinmeyer, JD; Yanik, MF				Wissner-Gross, Zachary D.; Scott, Mark A.; Steinmeyer, Joseph D.; Yanik, Mehmet Fatih			Synchronous Symmetry Breaking in Neurons with Different Neurite Counts	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; AXON FORMATION; CELL-CULTURE; POLARITY; ESTABLISHMENT; POLARIZATION; MICROTUBULE; MECHANISMS; PROTEIN; LENGTH	As neurons develop, several immature processes (i.e., neurites) grow out of the cell body. Over time, each neuron breaks symmetry when only one of its neurites grows much longer than the rest, becoming an axon. This symmetry breaking is an important step in neurodevelopment, and aberrant symmetry breaking is associated with several neuropsychiatric diseases, including schizophrenia and autism. However, the effects of neurite count in neuronal symmetry breaking have never been studied. Existing models for neuronal polarization disagree: some predict that neurons with more neurites polarize up to several days later than neurons with fewer neurites, while others predict that neurons with different neurite counts polarize synchronously. We experimentally find that neurons with different neurite counts polarize synchronously. We also show that despite the significant differences among the previously proposed models, they all agree with our experimental findings when the expression levels of the proteins responsible for symmetry breaking increase with neurite count. Consistent with these results, we observe that the expression levels of two of these proteins, HRas and shootin1, significantly correlate with neurite count. This coordinated symmetry breaking we observed among neurons with different neurite counts may be important for synchronized polarization of neurons in developing organisms.	[Wissner-Gross, Zachary D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Wissner-Gross, Zachary D.; Scott, Mark A.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Scott, Mark A.; Steinmeyer, Joseph D.; Yanik, Mehmet Fatih] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Yanik, Mehmet Fatih] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yanik, MF (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	yanik@mit.edu		Yanik, Mehmet/0000-0002-8963-2893; Skylar-Scott, Mark/0000-0003-3496-7124	National Institutes of Health (NIH) EUREKA Award [1-R01-NS066352-01]; Packard Fellowship in Science and Engineering; Fannie and John Hertz Foundation/Myhrvold Family fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066352] Funding Source: NIH RePORTER	National Institutes of Health (NIH) EUREKA Award; Packard Fellowship in Science and Engineering; Fannie and John Hertz Foundation/Myhrvold Family fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health (NIH) R01 EUREKA Award Grant 1-R01-NS066352-01 (MFY), a Packard Fellowship in Science and Engineering (MFY), and a Fannie and John Hertz Foundation/Myhrvold Family fellowship (ZWG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bellon A, 2007, MOL PSYCHIATR, V12, P620, DOI 10.1038/sj.mp.4001985; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kempf M, 1996, J NEUROSCI, V16, P5583; Khanin K, 2001, J MATH BIOL, V42, P26, DOI 10.1007/PL00000071; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mori T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/jbc.M700770200; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Samuels DC, 1996, PHILOS T ROY SOC B, V351, P1147, DOI 10.1098/rstb.1996.0099; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Toriyama M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.51; Wissner-Gross ZD, 2011, INTEGR BIOL-UK, V3, P65, DOI 10.1039/c0ib00058b; YU WQ, 1994, J NEUROSCI, V14, P2818	23	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54905	10.1371/journal.pone.0054905	http://dx.doi.org/10.1371/journal.pone.0054905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408951	Green Published, gold, Green Submitted			2022-12-27	WOS:000315100000010
J	Dam, G; Kording, K; Wei, KL				Dam, Gregory; Kording, Konrad; Wei, Kunlin			Credit Assignment during Movement Reinforcement Learning	PLOS ONE			English	Article							COORDINATION; ADAPTATION; VARIABILITY; TASK	We often need to learn how to move based on a single performance measure that reflects the overall success of our movements. However, movements have many properties, such as their trajectories, speeds and timing of end-points, thus the brain needs to decide which properties of movements should be improved; it needs to solve the credit assignment problem. Currently, little is known about how humans solve credit assignment problems in the context of reinforcement learning. Here we tested how human participants solve such problems during a trajectory-learning task. Without an explicitly-defined target movement, participants made hand reaches and received monetary rewards as feedback on a trial-by-trial basis. The curvature and direction of the attempted reach trajectories determined the monetary rewards received in a manner that can be manipulated experimentally. Based on the history of action-reward pairs, participants quickly solved the credit assignment problem and learned the implicit payoff function. A Bayesian credit-assignment model with built-in forgetting accurately predicts their trial-by-trial learning.	[Dam, Gregory] Univ Rio Grande, Dept Behav Sci, Rio Grande, OH USA; [Kording, Konrad] Northwestern Univ, Dept Phys Med & Rehabil, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Wei, Kunlin] Peking Univ, Beijing Engn Res Ctr Intelligent Rehabil Engn, Minist Educ, Dept Psychol,Key Lab Machine Percept, Beijing 100871, Peoples R China	University of Rio Grande; Northwestern University; Shirley Ryan AbilityLab; Peking University	Wei, KL (corresponding author), Peking Univ, Beijing Engn Res Ctr Intelligent Rehabil Engn, Minist Educ, Dept Psychol,Key Lab Machine Percept, Beijing 100871, Peoples R China.	wei.kunlin@pku.edu.cn	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Dam, Gregory/0000-0002-8370-1632	NIH [R01NS-063399, R01NS-057814]; National Natural Science Foundation of China [31000456, 61020106005]; Fundamental Research Funds for the Central Universities; Beijing Municipal Education Commission; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399, R01NS057814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Municipal Education Commission(Beijing Municipal Commission of Education); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been funded by NIH Grants R01NS-063399 and R01NS-057814, the National Natural Science Foundation of China (No. 31000456, and 61020106005), the Fundamental Research Funds for the Central Universities, and the Collaboration Funds from Beijing Municipal Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Bernstein N, 1967, COORDINATION REGULAT; Fu WT, 2008, PSYCHOL RES-PSYCH FO, V72, P321, DOI 10.1007/s00426-007-0113-7; Fu WT, 2006, J EXP PSYCHOL GEN, V135, P184, DOI 10.1037/0096-3445.135.2.184; Gordon D, 1994, USERS GUIDE NAVIGATI; Gullapalli V, 1992, REINFORCEMENT LEARNI; Houk JC, 1996, BEHAV BRAIN SCI, V19, P368, DOI 10.1017/S0140525X00081474; Kaelbling L. P., 1996, CS9605103 ARXIV; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kudo K, 2000, J MOTOR BEHAV, V32, P337, DOI 10.1080/00222890009601384; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Martin TA, 2002, J NEUROPHYSIOL, V88, P1685, DOI 10.1152/jn.2002.88.4.1685; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; PENNINGTON N, 1988, J EXP PSYCHOL LEARN, V14, P521, DOI 10.1037/0278-7393.14.3.521; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sternad D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002159; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tolman E.C., 1930, U CALIFORNIA PUBLICA; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	25	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55352	10.1371/journal.pone.0055352	http://dx.doi.org/10.1371/journal.pone.0055352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23408972	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300012
J	Albergaria, A; Resende, C; Nobre, AR; Ribeiro, AS; Sousa, B; Machado, JC; Seruca, R; Paredes, J; Schmitt, F				Albergaria, Andre; Resende, Carlos; Nobre, Ana Rita; Ribeiro, Ana Sofia; Sousa, Barbara; Machado, Jose Carlos; Seruca, Raquel; Paredes, Joana; Schmitt, Fernando			CCAAT/Enhancer Binding Protein beta (C/EBP beta) Isoforms as Transcriptional Regulators of the Pro-Invasive CDH3/P-Cadherin Gene in Human Breast Cancer Cells	PLOS ONE			English	Article							P-CADHERIN EXPRESSION; CARCINOMA CELLS; MAMMARY-GLAND; OVEREXPRESSION; ACTIVATION; INDICATOR; ADHESION; BEHAVIOR; FAMILY; ALPHA	P-cadherin is a cell-cell adhesion molecule codified by the CDH3 gene, which expression is highly associated with undifferentiated cells in normal adult epithelial tissues, as well as with poorly differentiated carcinomas. In breast cancer, P-cadherin is frequently overexpressed in high-grade tumours and is a well-established indicator of aggressive tumour behaviour and poor patient prognosis. However, till now, the mechanisms controlling CDH3 gene activation have been poorly explored. Since we recently described the existence of several CCAAT/Enhancer Binding Protein beta (C/EBP beta) transcription factor binding sites at the CDH3 promoter, the aim of this study was to assess if the distinct C/EBP beta isoforms were directly involved in the transcriptional activation of the CDH3 gene in breast cancer cells. DNA-protein interactions, mutation analysis and luciferase reporter assay studies have been performed. We demonstrated that C/EBP beta is co-expressed with P-cadherin in breast cancer cells and all the three isoforms function as transcriptional regulators of the CDH3 gene, directly interacting with specific regions of its promoter. Interestingly, this transcriptional activation was only reflected at the P-cadherin protein level concerning the LIP isoform. Taken together, our data show that CDH3 is a newly defined transcriptional target gene of C/EBPb isoforms in breast cancer, and we also identified the binding sites that are relevant for this activation.	[Albergaria, Andre; Resende, Carlos; Nobre, Ana Rita; Ribeiro, Ana Sofia; Sousa, Barbara; Machado, Jose Carlos; Seruca, Raquel; Paredes, Joana; Schmitt, Fernando] Porto Univ IPATIMUP, Inst Mol Pathol & Immunol, Canc Genet Grp, Oporto, Portugal; [Albergaria, Andre; Machado, Jose Carlos; Seruca, Raquel; Paredes, Joana; Schmitt, Fernando] Univ Porto, Fac Med, Dept Pathol, P-4100 Oporto, Portugal; [Nobre, Ana Rita; Sousa, Barbara] Inst Biomed Sci Abel Salazar ICBAS, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Schmitt, F (corresponding author), Porto Univ IPATIMUP, Inst Mol Pathol & Immunol, Canc Genet Grp, Oporto, Portugal.	fschmitt@ipatimup.pt	Paredes, Joana/F-8224-2011; Ribeiro, Ana/J-7334-2013; Sousa, Bárbara/K-8854-2014; Albergaria, André/J-6162-2013; seruca, raquel/F-8187-2011; Schmitt, Fernando/A-5270-2008; Machado, Jose Carlos/C-5907-2009	Paredes, Joana/0000-0002-1076-1343; Ribeiro, Ana/0000-0002-9698-9233; Sousa, Bárbara/0000-0002-0990-022X; Albergaria, André/0000-0002-2315-2360; Schmitt, Fernando/0000-0002-3711-8681; Machado, Jose Carlos/0000-0003-4741-8415; Schmitt, Fernando/0000-0003-1006-6946; Seruca, Raquel/0000-0002-8851-4166; Nobre, Ana Rita/0000-0002-5509-904X; Resende, Carlos/0000-0001-7143-7099	Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/73247/2010, SFRH/BD/46504/2008, SFRH/BPD/75705/2011, SFRH/BD/69353/2010]; Programa Ciencia (POPH - QREN); FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Programa Ciencia (POPH - QREN); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by research grants (SFRH/BPD/73247/2010 to A. A., SFRH/BD/46504/2008 to C. R., SFRH/BPD/75705/2011 to A. S. R. and SFRH/BD/69353/2010 to B. S.), from the Portuguese Foundation for Science and Technology (FCT). J.P. is supported by Programa Ciencia 2007 (POPH - QREN - Tipology 4.2). Institute of Molecular Pathology and Immunology of Porto University (IPATIMUP) is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albergaria A, 2011, INT J DEV BIOL, V55, P811, DOI 10.1387/ijdb.113382aa; Albergaria A, 2010, HUM MOL GENET, V19, P2554, DOI 10.1093/hmg/ddq134; BRACKE ME, 1991, BRIT J CANCER, V63, P867, DOI 10.1038/bjc.1991.191; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cheung LWT, 2010, ONCOGENE, V29, P2427, DOI 10.1038/onc.2009.523; Faraldo MM, 2007, FEBS LETT, V581, P831, DOI 10.1016/j.febslet.2007.01.053; Gamallo C, 2001, MODERN PATHOL, V14, P650, DOI 10.1038/modpathol.3880367; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Mandeville JA, 2008, BJU INT, V102, P1707, DOI 10.1111/j.1464-410X.2008.08115.x; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Paredes J, 2005, CLIN CANCER RES, V11, P5869, DOI 10.1158/1078-0432.CCR-05-0059; Paredes J, 2004, CANCER RES, V64, P8309, DOI 10.1158/0008-5472.CAN-04-0795; Paredes J, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1774; Paredes J, 2007, VIRCHOWS ARCH, V450, P73, DOI 10.1007/s00428-006-0334-y; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Ribeiro AS, 2010, ONCOGENE, V29, P392, DOI 10.1038/onc.2009.338; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Soler AP, 1999, CANCER-AM CANCER SOC, V86, P1263, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1263::AID-CNCR23>3.3.CO;2-U; Sousa B, 2010, HISTOL HISTOPATHOL, V25, P963, DOI 10.14670/HH-25.963; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Taniuchi K, 2005, CANCER RES, V65, P3092, DOI 10.1158/0008.5472.CAN-04-3646; Turashvili G, 2011, MODERN PATHOL, V24, P64, DOI 10.1038/modpathol.2010.189; Van Marck V, 2005, CANCER RES, V65, P8774, DOI 10.1158/0008-5472.CAN-04-4414; Van Marck V, 2011, INT J CANCER, V128, P1031, DOI 10.1002/ijc.25427; Vieira AF, 2012, STEM CELLS; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55749	10.1371/journal.pone.0055749	http://dx.doi.org/10.1371/journal.pone.0055749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405208	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400153
J	Cronican, AA; Fitz, NF; Carter, A; Saleem, M; Shiva, S; Barchowsky, A; Koldamova, R; Schug, J; Lefterov, I				Cronican, Andrea A.; Fitz, Nicholas F.; Carter, Alexis; Saleem, Muzamil; Shiva, Sruti; Barchowsky, Aaron; Koldamova, Radosveta; Schug, Jonathan; Lefterov, Iliya			Genome-Wide Alteration of Histone H3K9 Acetylation Pattern in Mouse Offspring Prenatally Exposed to Arsenic	PLOS ONE			English	Article							CHILDRENS INTELLECTUAL FUNCTION; CENTRAL-NERVOUS-SYSTEM; REPRESSOR DOMAIN; DRINKING-WATER; NOX ENZYMES; PHOSPHOACETYLATION; METABOLISM; RESOLUTION; EXPRESSION; CHROMATIN	Chronic exposure to arsenic in drinking water, especially in utero or perinatal exposure, can initiate neurological and cognitive dysfunction, as well as memory impairment. Several epidemiological studies have demonstrated cognitive and learning deficits in children with early exposure to low to moderate levels of arsenic, but pathogenic mechanisms or etiology for these deficits are poorly understood. Since in vivo studies show a role for histone acetylation in cognitive performance and memory formation, we examined if prenatal exposure to arsenic causes changes in the epigenomic landscape. We exposed C57Bl6/J mice to 100 mu g/L arsenic in the drinking water starting 1 week before conception till birth and applied chromatin immunoprecipitation followed by high-throughput massive parallel sequencing (ChIP-seq) to evaluate H3K9 acetylation pattern in the offspring of exposed and control mice. Arsenic exposure during embryonic life caused global hypo-acetylation at H3K9 and changes in functional annotation with highly significant representation of Kruppel associated box (KRAB) transcription factors in brain samples from exposed pups. We also found that arsenic exposure of adult mice impaired spatial and episodic memory, as well as fear conditioning performance. This is the first study to demonstrate: a) genome wide changes in H3K9 acetylation pattern in an offspring prenatally exposed to arsenic, and b) a connection between moderate arsenic exposure and cognitive impairment in adult mice. The results also emphasize the applicability of Next Generation Sequencing methodology in studies aiming to reveal the role of environmental factors, other than dietary restriction, in developmental reprogramming through histone modifications during embryonic development.	[Cronican, Andrea A.; Fitz, Nicholas F.; Carter, Alexis; Saleem, Muzamil; Barchowsky, Aaron; Koldamova, Radosveta; Lefterov, Iliya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Schug, Jonathan] Univ Penn, Perelman Sch Med, Funct Genom & Next Generat Sequencing Core, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine	Schug, J (corresponding author), Univ Penn, Perelman Sch Med, Funct Genom & Next Generat Sequencing Core, Philadelphia, PA 19104 USA.	jschug@upenn.edu; iliyal@pitt.edu	Lefterov, Iliya/B-4767-2008; Saleem, Muzamil/AAC-9192-2019	Saleem, Muzamil/0000-0001-9910-136X; Fitz, Nicholas/0000-0001-6938-6536; Lefterov, Iliya/0000-0002-0249-0280; Koldamova, Radosveta/0000-0002-6761-0984	National Institute on Aging [AG027973, AG037919]; National Institute of Environmental Health Sciences [ES021243]; NIA [F32AG034031]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG034031, R01AG027973, R01AG037919] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the following awards: AG027973 (RK) and AG037919 (IL and JS) from the National Institute on Aging and ES021243 (IL and AB) from the National Institute of Environmental Health Sciences. NFF is supported by NIA F32AG034031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Arita A, 2012, J TRACE ELEM MED BIO, V26, P174, DOI 10.1016/j.jtemb.2012.03.012; ARRIGO AP, 1983, NUCLEIC ACIDS RES, V11, P1389, DOI 10.1093/nar/11.5.1389; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106; Cheng T.F., 2012, J APPL TOXICOL; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Cui X, 2006, TOXICOL SCI, V91, P372, DOI 10.1093/toxsci/kfj159; Curtis E, 2012, ANTIOXID REDOX SIGN, V17, P951, DOI 10.1089/ars.2011.4242; Day JJ, 2012, NEUROPSYCHOPHARMACOL, V37, P247, DOI 10.1038/npp.2011.85; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Garelick H, 2008, REV ENVIRON CONTAM T, V197, P17, DOI 10.1007/978-0-387-79284-2_2; Gong G, 2010, ARSENIC EXPOSURE HYP; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Jensen TJ, 2008, CARCINOGENESIS, V29, P1500, DOI 10.1093/carcin/bgn102; Jin YP, 2004, TOXICOL APPL PHARM, V196, P396, DOI 10.1016/j.taap.2004.01.015; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Koldamova R, 2010, BBA-MOL CELL BIOL L, V1801, P824, DOI 10.1016/j.bbalip.2010.02.010; Lee BM, 2009, J CELL BIOCHEM, V108, P22, DOI 10.1002/jcb.22250; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Lefterov I, 2009, ASN NEURO, V1, DOI 10.1042/AN20090015; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lester BM, 2011, ANN NY ACAD SCI, V1226, P14, DOI 10.1111/j.1749-6632.2011.06037.x; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Li J, 2002, J BIOL CHEM, V277, P49504, DOI 10.1074/jbc.M207836200; Luo JH, 2012, TOXICOL LETT, V211, P39, DOI 10.1016/j.toxlet.2012.02.021; Luo JH, 2009, TOXICOL LETT, V184, P121, DOI 10.1016/j.toxlet.2008.10.029; Martinez EJ, 2008, NEUROTOXICOLOGY, V29, P647, DOI 10.1016/j.neuro.2008.05.004; Martinez L, 2011, NEUROCHEM INT, V58, P574, DOI 10.1016/j.neuint.2011.01.020; Martinez-Finley EJ, 2009, PHARMACOL BIOCHEM BE, V94, P271, DOI 10.1016/j.pbb.2009.09.006; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; O'Bryant SE, 2011, INT J ENV RES PUB HE, V8, P861, DOI 10.3390/ijerph8030861; Padovani AMS, 2010, ARTERIOSCL THROM VAS, V30, P1228, DOI 10.1161/ATVBAHA.110.205500; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Pilsner JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037147; Rahman M, 2006, J EPIDEMIOL COMMUN H, V60, P242, DOI 10.1136/jech.2005.040212; Rahman MM, 2009, ENVIRON GEOCHEM HLTH, V31, P9, DOI 10.1007/s10653-008-9233-2; Rai A, 2010, TOXICOL SCI, V118, P586, DOI 10.1093/toxsci/kfq266; Ramirez T, 2008, CHROMOSOMA, V117, P147, DOI 10.1007/s00412-007-0133-5; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Rodriguez VM, 2001, BRAIN RES BULL, V55, P301, DOI 10.1016/S0361-9230(01)00477-4; Rosado JL, 2007, ENVIRON HEALTH PERSP, V115, P1371, DOI 10.1289/ehp.9961; Schatz MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-474; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Sorce S, 2012, CELL MOL LIFE SCI, V69, P2387, DOI 10.1007/s00018-012-1014-5; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; von Ehrenstein OS, 2007, EPIDEMIOLOGY, V18, P44, DOI 10.1097/01.ede.0000248900.65613.a9; Waalkes MP, 2004, JNCI-J NATL CANCER I, V96, P466, DOI 10.1093/jnci/djh070; Waalkes MP, 2003, TOXICOL APPL PHARM, V186, P7, DOI 10.1016/S0041-008X(02)00022-4; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wehner Jeanne M, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805cs27; Xi SH, 2009, ARCH TOXICOL, V83, P549, DOI 10.1007/s00204-009-0403-5; Zhao FH, 2012, TOXICOL IN VITRO, V26, P24, DOI 10.1016/j.tiv.2011.10.003	66	60	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53478	10.1371/journal.pone.0053478	http://dx.doi.org/10.1371/journal.pone.0053478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405071	Green Published, gold			2022-12-27	WOS:000315153400014
J	Hsu, CN; Chang, CH; Lin, YS; Lin, JW; Caffrey, JL				Hsu, Chih-Neng; Chang, Chia-Hsuin; Lin, Yu-Sheng; Lin, Jou-Wei; Caffrey, James L.			Association of Serum C-Peptide Concentrations with Cancer Mortality Risk in Pre-Diabetes or Undiagnosed Diabetes	PLOS ONE			English	Article							GROWTH-FACTOR-I; NUTRITION EXAMINATION SURVEY; IGF BINDING PROTEIN-3; 3RD NATIONAL-HEALTH; METABOLIC SYNDROME; LIFE-STYLE; INSULIN; COHORT; DETERMINANTS; SUPPRESSION	Background: Known associations between diabetes and cancer could logically be attributed to hyperglycemia, hypersecretion of insulin, and/or insulin resistance. This study examined the relationship between initial glycemic biomarkers among men and women with impaired fasting glucose or undiagnosed diabetes and cancer mortality during follow up. Methods: The cohort included subjects aged 40 years and above from the Third National Health and Nutrition Examination Survey (NHANES III) with fasted serum glucose >100 mg/dl without the aid of pharmaceutical intervention (insulin or oral hypoglycemics). Cancer mortality was obtained from the NHANES III-linked follow-up database (up to December 31, 2006). A Cox regression model was applied to test for the associations between cancer mortality and fasting serum glucose, insulin, glycosylated hemoglobin (HbA1c), C-peptide, insulin like growth factor (IGF-1), IGF binding protein 3 (IGFBP3) and estimated insulin resistance. Results: A total of 158 and 100 cancer deaths were recorded respectively from 1,348 men and 1,161 women during the mean 134-month follow-up. After adjusting for the effect of age and smoking in women, all-cause cancer deaths (HR: 1.96 per pmol/ml, 95% CI: 1.02-3.77) and lung cancer deaths (HR: 2.65 per pmol/ml, 95% CI: 1.31-5.36) were specifically associated with serum C-peptide concentrations. Similar associations in men were not statistically significant. Serum glucose, HbA1c, IGF-1, IGFBP3 and HOMA were not independently related to long-term cancer mortality. Conclusion: C-peptide analyses suggest a modest association with both all-cause and lung cancer mortality in women but not in men. Further studies will be required to explore the mechanisms.	[Hsu, Chih-Neng; Lin, Jou-Wei] Natl Taiwan Univ Hosp, Yun Lin Branch, Ctr Cardiovasc, Dou Liou City, Yun Lin County, Taiwan; [Chang, Chia-Hsuin; Lin, Jou-Wei] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan; [Chang, Chia-Hsuin] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Yu-Sheng] Univ N Texas, Hlth Sci Ctr, Dept Environm & Occupat Hlth, Ft Worth, TX USA; [Caffrey, James L.] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX USA; [Caffrey, James L.] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Ft Worth, TX USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Lin, JW (corresponding author), Natl Taiwan Univ Hosp, Yun Lin Branch, Ctr Cardiovasc, Dou Liou City, Yun Lin County, Taiwan.	jouweilin@yahoo.com		CHANG, CHIA-HSUIN/0000-0003-0024-6177				Allen NE, 2003, CANCER CAUSE CONTROL, V14, P65, DOI 10.1023/A:1022518321634; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Carpentier A, 2002, DIABETES, V51, P1867, DOI 10.2337/diabetes.51.6.1867; CDC. National Center for Health Statistics (NCHS), 2010, 3 NAT HLTH NUTR EX S; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2009, NHANES3 LINK MORT FI; Chan JM, 2002, J NATL CANCER I, V94, P1099; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0021368]; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Chang KW, 2010, INT J CANCER, V127, P9, DOI 10.1002/ijc.25220; Faupel-Badger JM, 2009, ANN EPIDEMIOL, V19, P841, DOI 10.1016/j.annepidem.2009.08.005; Friis S, 2005, INT J CANCER, V114, P643, DOI 10.1002/ijc.20758; Gallagher EJ, 2010, ENDOCR PRACT, V16, P864, DOI 10.4158/EP10098.RA; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Hwang JJ, 2008, NUTR METAB CARDIOVAS, V18, P671, DOI 10.1016/j.numecd.2007.11.006; Irwin ML, 2011, J CLIN ONCOL, V29, P47, DOI 10.1200/JCO.2010.28.4752; Johnson JA, 2011, DIABETOLOGIA, V54, P25, DOI 10.1007/s00125-010-1933-3; Lin JW, 2010, J CLIN ENDOCR METAB, V95, P4258, DOI 10.1210/jc.2010-0332; Lin YS, 2010, CANCER EPIDEM BIOMAR, V19, P2950, DOI 10.1158/1055-9965.EPI-10-0617; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Parekh N, 2010, ANN EPIDEMIOL, V20, P182, DOI 10.1016/j.annepidem.2009.11.008; Parekh N, 2010, CANCER CAUSE CONTROL, V21, P631, DOI 10.1007/s10552-009-9492-y; Ruiter R, 2012, DIABETES CARE, V35, P119, DOI 10.2337/dc11-0857; Sarafidis Pantelis A, 2006, Curr Diab Rep, V6, P219, DOI 10.1007/s11892-006-0038-3; Vogeser M, 2007, CLIN BIOCHEM, V40, P964, DOI 10.1016/j.clinbiochem.2007.05.009; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759; Wei W, 2001, AM J PUBLIC HEALTH, V91, P258, DOI 10.2105/AJPH.91.2.258; Wild SH, 2011, DIABETOLOGIA, V54, P1589, DOI 10.1007/s00125-011-2169-6; Wu TJ, 2004, ANN EPIDEMIOL, V14, P195, DOI 10.1016/S1047-2797(03)00119-4; Yang XL, 2010, DIABETES, V59, P1254, DOI 10.2337/db09-1371	32	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55625	10.1371/journal.pone.0055625	http://dx.doi.org/10.1371/journal.pone.0055625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405181	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400126
J	Jalali, S; Bhartiya, D; Lalwani, MK; Sivasubbu, S; Scaria, V				Jalali, Saakshi; Bhartiya, Deeksha; Lalwani, Mukesh Kumar; Sivasubbu, Sridhar; Scaria, Vinod			Systematic Transcriptome Wide Analysis of lncRNA-miRNA Interactions	PLOS ONE			English	Article							LONG NONCODING RNA; MICRORNA TARGET SITES; BINDING PROTEIN; NETWORK; IDENTIFICATION; EXPRESSION; PROMOTE	Background: Long noncoding RNAs (lncRNAs) are a recently discovered class of non-protein coding RNAs, which have now increasingly been shown to be involved in a wide variety of biological processes as regulatory molecules. The functional role of many of the members of this class has been an enigma, except a few of them like Malat and HOTAIR. Little is known regarding the regulatory interactions between noncoding RNA classes. Recent reports have suggested that lncRNAs could potentially interact with other classes of non-coding RNAs including microRNAs (miRNAs) and modulate their regulatory role through interactions. We hypothesized that lncRNAs could participate as a layer of regulatory interactions with miRNAs. The availability of genome-scale datasets for Argonaute targets across human transcriptome has prompted us to reconstruct a genome-scale network of interactions between miRNAs and lncRNAs. Results: We used well characterized experimental Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP) datasets and the recent genome-wide annotations for lncRNAs in public domain to construct a comprehensive transcriptome-wide map of miRNA regulatory elements. Comparative analysis revealed that in addition to targeting protein-coding transcripts, miRNAs could also potentially target lncRNAs, thus participating in a novel layer of regulatory interactions between noncoding RNA classes. Furthermore, we have modeled one example of miRNA-lncRNA interaction using a zebrafish model. We have also found that the miRNA regulatory elements have a positional preference, clustering towards the mid regions and 39 ends of the long noncoding transcripts. We also further reconstruct a genome-wide map of miRNA interactions with lncRNAs as well as messenger RNAs. Conclusions: This analysis suggests widespread regulatory interactions between noncoding RNAs classes and suggests a novel functional role for lncRNAs. We also present the first transcriptome scale study on miRNA-lncRNA interactions and the first report of a genome-scale reconstruction of a noncoding RNA regulatory interactome involving lncRNAs.	[Jalali, Saakshi; Bhartiya, Deeksha; Scaria, Vinod] IGIB, CSIR, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Lalwani, Mukesh Kumar; Sivasubbu, Sridhar] IGIB, CSIR, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sivasubbu, S (corresponding author), IGIB, CSIR, Delhi, India.	s.sivasubbu@igib.res.in; vinods@igib.res.in	Scaria, Vinod/B-2819-2008; Scaria, Vinod/AAS-3151-2021	Scaria, Vinod/0000-0001-7644-7181	Council of Scientific and Industrial Research (CSIR), India [NWP0036, FAC002]; CSIR, India	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge funding from the Council of Scientific and Industrial Research (CSIR), India through the NWP0036 and FAC002 Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank Dr. Chetana Sachidanandan for scientific inputs, which helped in formulating the study and preparation of the manuscript. DB and MKL acknowledge Senior Research Fellowship from CSIR, India.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Bhartiya D, 2012, EXPERT OPIN DRUG DIS, V7, P503, DOI 10.1517/17460441.2012.682055; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Collins LJ, 2011, ADV EXP MED BIOL, V722, P1, DOI 10.1007/978-1-4614-0332-6_1; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fiore R, 2011, PROG MOL BIOL TRANSL, V102, P47, DOI 10.1016/B978-0-12-415795-8.00004-0; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Hollox EJ, 2012, METHODS MOL BIOL, V838, P187, DOI 10.1007/978-1-61779-507-7_9; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Iwasaki S, 2009, FLY, V3, P204; Jalali S, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-25; Janga SC, 2011, ADV EXP MED BIOL, V722, P59, DOI 10.1007/978-1-4614-0332-6_4; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jungkamp AC, 2011, MOL CELL, V44, P828, DOI 10.1016/j.molcel.2011.11.009; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lalwani MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052588; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nagele P, 2011, BEST PRACT RES-CLIN, V25, P549, DOI 10.1016/j.bpa.2011.09.001; Pase Luke, 2009, V546, P227, DOI 10.1007/978-1-60327-977-2_14; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pontier DB, 2011, HUM GENET, V130, P223, DOI 10.1007/s00439-011-1008-7; Rederstorff M, 2010, CURR OPIN MOL THER, V12, P684; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sati S, 2012, NUCL ACIDS RES; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Scaria V, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-82; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Severin AJ, 2010, PLANT PHYSIOL, V154, P3, DOI 10.1104/pp.110.158949; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Wan Y, 2010, CELL CYCLE, V9, P3391, DOI 10.4161/cc.9.17.13122; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang R, 2009, J GENET GENOMICS, V36, P1, DOI 10.1016/S1673-8527(09)60001-1; Zhao Y, 2008, TRENDS GENET, V24, P323, DOI 10.1016/j.tig.2008.04.004; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	66	339	356	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53823	10.1371/journal.pone.0053823	http://dx.doi.org/10.1371/journal.pone.0053823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405074	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400018
J	Kretzschmar, F; Pleimling, D; Hosemann, J; Fussel, S; Bornkessel-Schlesewsky, I; Schlesewsky, M				Kretzschmar, Franziska; Pleimling, Dominique; Hosemann, Jana; Fuessel, Stephan; Bornkessel-Schlesewsky, Ina; Schlesewsky, Matthias			Subjective Impressions Do Not Mirror Online Reading Effort: Concurrent EEG-Eyetracking Evidence from the Reading of Books and Digital Media	PLOS ONE			English	Article							EYE-MOVEMENTS; LANGUAGE COMPREHENSION; BRAIN; PARAFOVEAL; MODEL; OSCILLATIONS; INFORMATION; POTENTIALS; FREQUENCY; ALPHA	In the rapidly changing circumstances of our increasingly digital world, reading is also becoming an increasingly digital experience: electronic books (e-books) are now outselling print books in the United States and the United Kingdom. Nevertheless, many readers still view e-books as less readable than print books. The present study thus used combined EEG and eyetracking measures in order to test whether reading from digital media requires higher cognitive effort than reading conventional books. Young and elderly adults read short texts on three different reading devices: a paper page, an e-reader and a tablet computer and answered comprehension questions about them while their eye movements and EEG were recorded. The results of a debriefing questionnaire replicated previous findings in that participants overwhelmingly chose the paper page over the two electronic devices as their preferred reading medium. Online measures, by contrast, showed shorter mean fixation durations and lower EEG theta band voltage density - known to covary with memory encoding and retrieval - for the older adults when reading from a tablet computer in comparison to the other two devices. Young adults showed comparable fixation durations and theta activity for all three devices. Comprehension accuracy did not differ across the three media for either group. We argue that these results can be explained in terms of the better text discriminability (higher contrast) produced by the backlit display of the tablet computer. Contrast sensitivity decreases with age and degraded contrast conditions lead to longer reading times, thus supporting the conclusion that older readers may benefit particularly from the enhanced contrast of the tablet. Our findings thus indicate that people's subjective evaluation of digital reading media must be dissociated from the cognitive and neural effort expended in online information processing while reading from such devices.	[Kretzschmar, Franziska; Schlesewsky, Matthias] Johannes Gutenberg Univ Mainz, Dept English & Linguist, D-55122 Mainz, Germany; [Pleimling, Dominique; Fuessel, Stephan] Johannes Gutenberg Univ Mainz, Inst Book & Media Studies, D-55122 Mainz, Germany; [Hosemann, Jana] Univ Gottingen, Dept German Philol, D-37073 Gottingen, Germany; [Bornkessel-Schlesewsky, Ina] Univ Marburg, Dept German Linguist, Marburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Gottingen; Philipps University Marburg	Schlesewsky, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept English & Linguist, D-55122 Mainz, Germany.	schlesew@uni-mainz.de		Bornkessel-Schlesewsky, Ina/0000-0002-3238-6492	German Research Foundation [SCHL544/6-1]; Research Unit Media Convergence at the Johannes Gutenberg-University Mainz; MVB (Marketing- und Verlagsservice des Buchhandels GmbH) of the German Publishers and Booksellers Association, Frankfurt/Main	German Research Foundation(German Research Foundation (DFG)); Research Unit Media Convergence at the Johannes Gutenberg-University Mainz; MVB (Marketing- und Verlagsservice des Buchhandels GmbH) of the German Publishers and Booksellers Association, Frankfurt/Main	Parts of the research reported here were supported by the German Research Foundation (www.dfg.de; grant SCHL544/6-1), the Research Unit Media Convergence at the Johannes Gutenberg-University Mainz (www.medienkonvergenz.uni-mainz.de) and the MVB (Marketing- und Verlagsservice des Buchhandels GmbH) of the German Publishers and Booksellers Association, Frankfurt/Main (www.mvb-online.de). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baccino T, 2005, J PSYCHOPHYSIOL, V19, P204, DOI 10.1027/0269-8803.19.3.204; Bastiaansen M, 2006, PROG BRAIN RES, V159, P179, DOI 10.1016/S0079-6123(06)59012-0; Bastiaansen MCM, 2002, NEUROIMAGE, V17, P1479, DOI 10.1006/nimg.2002.1275; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bornkessel I, 2004, J MEM LANG, V51, P495, DOI 10.1016/j.jml.2004.06.011; Bornkessel ID, 2004, EXP PSYCHOL, V51, P279, DOI 10.1027/1618-3169.51.4.279; Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Bornkessel Ina, 2006, J GER LINGUIST, V18, P1, DOI [10.1017/S1470542706000018, DOI 10.1017/S1470542706000018]; Bornkessel-Schlesewsky I, 2009, LANG LINGUIST COMPAS, V3, P19, DOI 10.1111/j.1749-818x.2008.00099.x; Crawley M.J., 2007, R BOOK; Dehaene S, 2010, LESE GROSSTE ERFINDU; Demiral SB, 2008, COGNITION, V106, P484, DOI 10.1016/j.cognition.2007.01.008; Dimigen O, 2012, NEUROIMAGE, V62, P381, DOI 10.1016/j.neuroimage.2012.04.006; Dimigen O, 2011, J EXP PSYCHOL GEN, V140, P552, DOI 10.1037/a0023885; Drieghe D, 2008, PSYCHON B REV, V15, P856, DOI 10.3758/PBR.15.4.856; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Fozard J. L., 2001, HDB PSYCHOL AGING, V5, P241; FRAZIER L, 1987, ATTENTION PERFORM, P559; Frazier L., 1996, CONSTRUAL; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Genette G., 2001, PARATEXTE BUCH BEIWE; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Haupt FS, 2008, J MEM LANG, V59, P54, DOI 10.1016/j.jml.2008.02.003; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kretzschmar F, 2009, NEUROREPORT, V20, P1613, DOI 10.1097/WNR.0b013e328332c4f4; Kuhn T. S., 2001, STRUKTUR WISSENSCHAF; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Laubrock J, 2006, NEUROSCI BIOBEHAV R, V30, P872, DOI 10.1016/j.neubiorev.2006.06.013; LEGGE GE, 1987, VISION RES, V27, P1165, DOI 10.1016/0042-6989(87)90028-9; Liversedge SP, 2007, LANG LINGUIST COMPAS, V1, P17, DOI 10.1111/j.1749-818x.2007.00003.x; Luhmann Niklas, 2009, LEGITIMATION DURCH V, V4; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; Meinunger Andre, 2008, SICK SICK STREIFZUG; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1983, J VERB LEARN VERB BE, V22, P358, DOI 10.1016/S0022-5371(83)90236-0; Rayner K, 2006, PSYCHOL SCI, V17, P192, DOI 10.1111/j.1467-9280.2006.01684.x; Rayner K, 2006, PSYCHOL AGING, V21, P448, DOI 10.1037/0882-7974.21.3.448; Rayner K, 2009, BIOL PSYCHOL, V80, P4, DOI 10.1016/j.biopsycho.2008.05.002; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Reilly RG, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P429, DOI 10.1016/B978-044451020-4/50024-4; Reingold EM, 2006, PSYCHOL SCI, V17, P742, DOI 10.1111/j.1467-9280.2006.01775.x; Roehm D, 2004, NEUROREPORT, V15, P409, DOI 10.1097/00001756-200403010-00005; Roehm D., 2007, CHAOS COMPLEX LETT, V2, P365; Rohm D, 2001, NEUROSCI LETT, V310, P137, DOI 10.1016/S0304-3940(01)02106-1; Rolke B, 2001, PSYCHOPHYSIOLOGY, V38, P165, DOI 10.1017/S0048577201991504; Rowlands I, 2007, ASLIB PROC, V59, P489, DOI 10.1108/00012530710839588; Schnabel Ulrich, 2010, MUSSE GLUCK NICHTSTU; Sereno SC, 2003, TRENDS COGN SCI, V7, P489, DOI 10.1016/j.tics.2003.09.010; Sick B, 2004, DATIV GENITIV TOD; Simola J, 2009, BRAIN LANG, V111, P101, DOI 10.1016/j.bandl.2009.08.004; Trueswell J., 1994, PERSPECTIVES SENTENC; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Weischedel W, 2005, PHILOS HINTERTREPPE; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	60	57	58	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56178	10.1371/journal.pone.0056178	http://dx.doi.org/10.1371/journal.pone.0056178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405265	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400211
J	Rink, WJ; Mercier, N; Mihailovic, D; Morley, MW; Thompson, JW; Roksandic, M				Rink, William J.; Mercier, Norbert; Mihailovic, Dusan; Morley, Mike W.; Thompson, Jeroen W.; Roksandic, Mirjana			New Radiometric Ages for the BH-1 Hominin from Balanica (Serbia): Implications for Understanding the Role of the Balkans in Middle Pleistocene Human Evolution	PLOS ONE			English	Article							U-SERIES DATES; PHYLOGENETIC POSITION; HOMO-HEIDELBERGENSIS; HUMAN REMAINS; SITE; CEPRANO; SIMA; VISOGLIANO; ATAPUERCA; TRIESTE	Newly obtained ages, based on electron spin resonance combined with uranium series isotopic analysis, and infrared/post-infrared luminescence dating, provide a minimum age that lies between 397 and 525 ka for the hominin mandible BH-1 from Mala Balanica cave, Serbia. This confirms it as the easternmost hominin specimen in Europe dated to the Middle Pleistocene. Inferences drawn from the morphology of the mandible BH-1 place it outside currently observed variation of European Homo heidelbergensis. The lack of derived Neandertal traits in BH-1 and its contemporary specimens in Southeast Europe, such as Kocabas, Vasogliano and Ceprano, coupled with Middle Pleistocene synapomorphies, suggests different evolutionary forces acting in the east of the continent where isolation did not play such an important role during glaciations.	[Rink, William J.] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada; [Mercier, Norbert] Ctr Rech Phys Appl Archeol, Inst Rech Archeomat, Pessac, France; [Mihailovic, Dusan] Univ Belgrade, Dept Archaeol, Fac Philosophy, Belgrade, Serbia; [Morley, Mike W.] Oxford Brookes Univ, Dept Social Sci, Human Origins & Palaeoenvironm HOPE Res Grp, Oxford OX3 0BP, England; [Thompson, Jeroen W.] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON, Canada; [Roksandic, Mirjana] Univ Winnipeg, Dept Anthropol, Winnipeg, MB R3B 2E9, Canada	McMaster University; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); University of Belgrade; Oxford Brookes University; McMaster University; University of Winnipeg	Rink, WJ (corresponding author), McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada.	rinkwj@mcmaster.ca; m.roksandic@uwinnipeg.ca	; Roksandic, Mirjana/B-1812-2019	Mihailovic, Dusan/0000-0002-8607-8196; Morley, Mike/0000-0001-7730-9637; Roksandic, Mirjana/0000-0003-0291-6357; Mercier, Norbert/0000-0002-6375-9108	Natural Sciences and Engineering Council of Canada	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Council of Canada to WJR and MR (grant numbers not disclosed). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiec G., 1998, ANCIENT TL, V16, P37, DOI DOI 10.1016/S0277-3791(03)00021-0; Aitken MJ, 1985, THERMOLUMINESCENCE D; Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Brennan BJ, 2000, RADIAT MEAS, V32, P759, DOI 10.1016/S1350-4487(00)00107-4; BRUMBY S, 1992, NUCL TRACKS RAD MEAS, V20, P595; Bruner E, 2007, AM J PHYS ANTHROPOL, V132, P355, DOI 10.1002/ajpa.20545; Buylaert JP, 2009, RADIAT MEAS, V44, P560, DOI 10.1016/j.radmeas.2009.02.007; CARTMILL M, 2009, HUMAN LINEAGE; CATTANI L, 1991, ANTHROPOLOGIE, V95, P9; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Engin B, 1999, APPL RADIAT ISOTOPES, V51, P689, DOI 10.1016/S0969-8043(99)00090-1; Falgueres C, 2004, J ARCHAEOL SCI, V31, P941, DOI 10.1016/j.jas.2003.12.008; Falgueres C, 2008, QUAT GEOCHRONOL, V3, P390, DOI 10.1016/j.quageo.2008.01.007; Gran R., 2000, ANCIENT TL, V18, P1; Grun R, 1996, J HUM EVOL, V30, P227, DOI 10.1006/jhev.1996.0020; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Grun R, 2009, QUAT GEOCHRONOL, V4, P231, DOI 10.1016/j.quageo.2008.12.005; Guerin G, 2011, ANCIENT TL, V29, P5; Harvati K, 2011, J HUM EVOL, V60, P246, DOI 10.1016/j.jhevol.2010.09.008; Howell F.C., 1996, CONT ISSUES HUMAN EV, P1; Lamothe M, 2003, RADIAT MEAS, V37, P493, DOI 10.1016/S1350-4487(03)00016-7; Lebel S, 2001, P NATL ACAD SCI USA, V98, P11097, DOI 10.1073/pnas.181353998; Lowick SE, 2012, QUAT GEOCHRONOL, V8, P33, DOI 10.1016/j.quageo.2011.12.003; Mallegni F, 2001, HOMO, V52, P233; Manzi G, 2001, P NATL ACAD SCI USA, V98, P10011, DOI 10.1073/pnas.151259998; de Castro JMB, 2013, QUATERN INT, V295, P102, DOI 10.1016/j.quaint.2012.02.036; MARSH R, 1999, THESIS MCMASTER U HA; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Mihailovic D, 2008, PALAEOLITHIC BALKANS, V1819, P93; Mounier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018821; Nomade S, 2011, QUAT GEOCHRONOL, V6, P453, DOI 10.1016/j.quageo.2011.03.008; Rightmire GP, 2008, EVOL ANTHROPOL, V6, P218; RINK WJ, 1995, NATURE, V378, P24, DOI 10.1038/378024a0; RINK WJ, 1994, J ARCHAEOL SCI, V21, P839, DOI 10.1006/jasc.1994.1081; Roksandic M, 2011, J HUM EVOL, V61, P186, DOI 10.1016/j.jhevol.2011.03.003; Schoetensack O., 1908, UNTERKIEFER HOMOHEID; Schwarcz HP, 1997, ADV ARC MUS, V2, P159; Schwartz JH, 2010, AM J PHYS ANTHROPOL, P94, DOI 10.1002/ajpa.21443; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Thomsen KJ, 2008, RADIAT MEAS, V24, P473; Vialet A, 2012, CR PALEVOL, V11, P89, DOI 10.1016/j.crpv.2011.06.005; Wagner GA, 2010, P NATL ACAD SCI USA, V107, P19726, DOI 10.1073/pnas.1012722107	45	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54608	10.1371/journal.pone.0054608	http://dx.doi.org/10.1371/journal.pone.0054608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405085	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400029
J	Schulz, E; Piotrowski, V; Clauss, M; Mau, M; Merceron, G; Kaiser, TM				Schulz, Ellen; Piotrowski, Vanessa; Clauss, Marcus; Mau, Marcus; Merceron, Gildas; Kaiser, Thomas M.			Dietary Abrasiveness Is Associated with Variability of Microwear and Dental Surface Texture in Rabbits	PLOS ONE			English	Article							WESTERN CAPE PROVINCE; SOUTH-AFRICA; MAKAPANSGAT-LIMEWORKS; POPULATION VARIANCES; TOOTH MICROWEAR; MAMMALIAN TEETH; EARLY PLIOCENE; LATE MIOCENE; WEAR; PRIMATES	Dental microwear and 3D surface texture analyses are useful in reconstructing herbivore diets, with scratches usually interpreted as indicators of grass dominated diets and pits as indicators of browse. We conducted feeding experiments with four groups of rabbits (Oryctolagus cuniculus) each fed a different uniform, pelleted diet (lucerne, lucerne & oats, grass & oats, grass). The lowest silica content was measured in the lucerne and the highest in the grass diet. After 25 weeks of exposure to the diets, dental castings were made of the rabbit's lower molars. Occlusal surfaces were then investigated using dental microwear and 3D areal surface texture analysis. In terms of traditional microwear, we found our hypothesis supported, as the grass group showed a high proportion of (long) "scratches'' and the lucerne group a high proportion of "pits''. Regardless of the uniform diets, variability of microwear and surface textures was higher when silica content was low. A high variability in microwear and texture analysis thus need not represent dietary diversity, but can also be related to a uniform, low-abrasion diet. The uniformity or variability of microwear/texture analysis results thus might represent varying degrees of abrasion and attrition rather than a variety of diet items per se.	[Schulz, Ellen; Piotrowski, Vanessa; Kaiser, Thomas M.] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Schulz, Ellen; Piotrowski, Vanessa; Kaiser, Thomas M.] Univ Hamburg, Zool Museum, Hamburg, Germany; [Clauss, Marcus] Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland; [Mau, Marcus] Kings Coll London, Inst Dent, Guys Hosp, London WC2R 2LS, England; [Merceron, Gildas] Univ Poitiers, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, Unite Mixte Rech Ctr Nacl Rech Sci 7262, Poitiers, France	University of Hamburg; University of Hamburg; University of Zurich; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Universite de Poitiers	Schulz, E (corresponding author), Univ Hamburg, Bioctr Grindel, Hamburg, Germany.	ellen.schulz@uni-hamburg.de	Clauss, Marcus/M-8702-2019; Clauss, Marcus/A-4710-2008; Schulz-Kornas, Ellen/B-8505-2013; Clauss, Marcus/GRR-7996-2022; Merceron, Gildas/C-8648-2012; Kaiser, Thomas/G-8883-2015	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Schulz-Kornas, Ellen/0000-0003-1657-8256; Clauss, Marcus/0000-0003-3841-6207; Merceron, Gildas/0000-0001-5777-7126; Kaiser, Thomas/0000-0002-8154-1751	DFG [KA 1525/8-1]; Humboldt research fellowship for postdoctoral researchers	DFG(German Research Foundation (DFG)); Humboldt research fellowship for postdoctoral researchers	This work was funded by DFG KA 1525/8-1 and a Humboldt research fellowship for postdoctoral researchers (to GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; BAKER G, 1959, NATURE, V184, P1583, DOI 10.1038/1841583b0; BUTLER PM, 1972, EVOLUTION, V26, P474, DOI 10.1111/j.1558-5646.1972.tb01951.x; Calandra I, 2008, NATURWISSENSCHAFTEN, V95, P831, DOI 10.1007/s00114-008-0391-y; Calandra I, 2012, J HUM EVOL, V63, P85, DOI 10.1016/j.jhevol.2012.05.001; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P796, DOI 10.2307/2287161; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; Gidenne T, 2006, FEEDING IN DOMESTIC VERTEBRATES: FROM STRUCTURE TO BEHAVIOUR, P179, DOI 10.1079/9781845930639.0179; Golenishev FN, 1979, J MAMMAL, V60, P397; HEALY W. B., 1965, NEW ZEAL J AGR RES, V8, P737; Hopley PJ, 2006, PALAEOGEOGR PALAEOCL, V233, P235, DOI 10.1016/j.palaeo.2005.09.011; International Organization for Standardization, 2010, 251782 ISOFDIS; Kaiser TM, 2006, PALAEOGEOGR PALAEOCL, V239, P221, DOI 10.1016/j.palaeo.2006.01.013; Kaiser TM, 2011, MAMMAL REV; Leiber F, 2008, LIPIDS, V43, P853, DOI 10.1007/s11745-008-3210-5; Massey FP, 2007, J ECOL, V95, P414, DOI 10.1111/j.1365-2745.2007.01223.x; Massey FP, 2006, P R SOC B, V273, P2299, DOI 10.1098/rspb.2006.3586; MAYLAND HF, 1977, J RANGE MANAGE, V30, P264, DOI 10.2307/3897301; MCNAUGHTON SJ, 1983, P NATL ACAD SCI-BIOL, V80, P790, DOI 10.1073/pnas.80.3.790; Merceron G, 2005, S AFR J SCI, V101, P365; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2004, SMALL RUMINANT RES, V53, P125, DOI [10.1016/j.smallrumres.2003.10.002, 10.1016/j.smallrumers.2003.10.002]; Merceron G, 2007, J HUM EVOL, V53, P331, DOI 10.1016/j.jhevol.2007.04.008; Merceron G, 2012, J HUM EVOL, V63, P150, DOI 10.1016/j.jhevol.2012.04.006; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Nelson S, 2005, PALAEONTOL ELECTRON, V8; Parr JF, 2001, J ARCHAEOL SCI, V28, P875, DOI 10.1006/jasc.2000.0623; Purnell MA, 2012, J R SOC INTERFACE, V9, P2225, DOI 10.1098/rsif.2012.0140; Rensberger J.M., 1978, P415; Rivals F, 2005, J ARCHAEOL SCI, V32, P1603, DOI 10.1016/j.jas.2005.04.014; Rodrigues HG, 2009, NATURWISSENSCHAFTEN, V96, P537, DOI 10.1007/s00114-008-0501-x; Rogers AM, 1994, EUROPEAN RABBIT HIST, P22; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schubert BW, 2006, PALAEOGEOGR PALAEOCL, V241, P301, DOI 10.1016/j.palaeo.2006.04.004; Schulz E, 2010, SCANNING, V32, P162, DOI 10.1002/sca.20181; Scott JR, 2009, J HUM EVOL, V56, P405, DOI 10.1016/j.jhevol.2008.11.003; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2012, AM J PHYS ANTHROPOL, V147, P551, DOI 10.1002/ajpa.22007; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semprebon GM, 2004, J HUM EVOL, V47, P115, DOI 10.1016/j.jhevol.2004.06.004; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1988, PALAEOGEOGR PALAEOCL, V65, P149, DOI 10.1016/0031-0182(88)90021-1; SOLOUNIAS N, 1993, LETHAIA, V26, P261, DOI 10.1111/j.1502-3931.1993.tb01529.x; Stones HH, 1948, ORAL DENT DIS; TEAFORD MF, 1983, ARCH ORAL BIOL, V28, P1077, DOI 10.1016/0003-9969(83)90067-5; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1149; Townsend KEB, 2008, J MAMMAL, V89, P730, DOI 10.1644/06-MAMM-A-336R1.1; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; Williams J.A., 2005, ENG TRIBOLOGY; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141; Winkler DE, 2012, GEOBIOS IN PRESS; YUEN KK, 1974, BIOMETRIKA, V61, P165, DOI 10.2307/2334299	55	110	115	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56167	10.1371/journal.pone.0056167	http://dx.doi.org/10.1371/journal.pone.0056167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405263	Green Published, Green Accepted, gold			2022-12-27	WOS:000315153400209
J	Sudhinaraset, M; Ingram, M; Lofthouse, HK; Montagu, D				Sudhinaraset, May; Ingram, Matthew; Lofthouse, Heather Kinlaw; Montagu, Dominic			What Is the Role of Informal Healthcare Providers in Developing Countries? A Systematic Review	PLOS ONE			English	Review							TRADITIONAL BIRTH ATTENDANT; SEXUALLY-TRANSMITTED-DISEASES; MIDDLE-INCOME COUNTRIES; CHI-MINH-CITY; PRIVATE PHARMACIES; MALARIA TREATMENT; TUBERCULOSIS-CONTROL; MULTICOMPONENT INTERVENTION; SECTOR PROVIDERS; MEDICINE SELLERS	Informal health care providers (IPs) comprise a significant component of health systems in developing nations. Yet little is known about the most basic characteristics of performance, cost, quality, utilization, and size of this sector. To address this gap we conducted a comprehensive literature review on the informal health care sector in developing countries. We searched for studies published since 2000 through electronic databases PubMed, Google Scholar, and relevant grey literature from The New York Academy of Medicine, The World Bank, The Center for Global Development, USAID, SHOPS (formerly PSP-One), The World Health Organization, DFID, Human Resources for Health Global Resource Center. In total, 334 articles were retrieved, and 122 met inclusion criteria and chosen for data abstraction. Results indicate that IPs make up a significant portion of the healthcare sector globally, with almost half of studies (48%) from Sub-Saharan Africa. Utilization estimates from 24 studies in the literature of IP for healthcare services ranged from 9% to 90% of all healthcare interactions, depending on the country, the disease in question, and methods of measurement. IPs operate in a variety of health areas, although baseline information on quality is notably incomplete and poor quality of care is generally assumed. There was a wide variation in how quality of care is measured. The review found that IPs reported inadequate drug provision, poor adherence to clinical national guidelines, and that there were gaps in knowledge and provider practice; however, studies also found that the formal sector also reported poor provider practices. Reasons for using IPs included convenience, affordability, and social and cultural effects. Recommendations from the literature amount to a call for more engagement with the IP sector. IPs are a large component of nearly all developing country health systems. Research and policies of engagement are needed.	[Sudhinaraset, May; Montagu, Dominic] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ingram, Matthew] Metta Fund, Corte Madera, CA USA; [Lofthouse, Heather Kinlaw] Absolute Return Kids US, New York, NY USA	University of California System; University of California San Francisco	Sudhinaraset, M (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	sudhinarasetm@globalhealth.ucsf.edu			Results for Development	Results for Development	Results for Development provided funds to complete this systematic review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya T, 2009, AM J TROP MED HYG, V80, P905, DOI 10.4269/ajtmh.2009.80.905; Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; Adu-Sarkodie Y, 2000, SEX TRANSM INFECT, V76, P439, DOI 10.1136/sti.76.6.439; Ahmed SM, 2003, HEALTH POLICY PLANN, V18, P306, DOI 10.1093/heapol/czg037; Ahmed SM, 2007, HEALTH POLICY, V84, P332, DOI 10.1016/j.healthpol.2007.05.011; Ahmed SM, 2009, HEALTH POLICY PLANN, V24, P467, DOI 10.1093/heapol/czp037; Ali A, 2007, J PUBLIC HEALTH MAN, V13, P278; Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x; Amzat J, 2008, STUD ETHNO-MED, V2, P153, DOI 10.1080/09735070.2008.11886328; Attanayake N, 2009, WORKING PAPERS; Bailey Patricia E., 2002, Rev Panam Salud Publica, V11, P15, DOI 10.1590/S1020-49892002000100003; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS82, DOI 10.1038/sj.jp.7211275; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS72, DOI 10.1038/sj.jp.7211276; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Barun Kanjilal SM., 2007, PARALLEL HLTH CARE M; Battersby A, 2003, IMPROVING SUPPLY DIS; Benjarattanaporn P, 1997, AIDS, V11, pS87; Bhuiya A., 2009, HLTH RURAL MASSES IN; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; Brieger WR, 2002, INT Q COMMUNITY HLTH, V21, P19; Brugha R, 2003, BRIT MED J, V326, P1382, DOI 10.1136/bmj.326.7403.1382; Bryant J, 2001, Asia Pac J Public Health, V13, P91, DOI 10.1177/101053950101300206; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; Chalker J, 2002, TROP MED INT HEALTH, V7, P803, DOI 10.1046/j.1365-3156.2002.00934.x; Chalker J, 2000, SEX TRANSM INFECT, V76, P299, DOI 10.1136/sti.76.4.299; Chuc NTK, 2001, ANN PHARMACOTHER, V35, P1283, DOI 10.1345/aph.10313; Collumbien M, 2003, J BIOSOC SCI, V35, P41, DOI 10.1017/S0021932003000415; Colvin M, 2003, INT J TUBERC LUNG D, V7, pS86; Corno L, 2008, SWITCHING NOT HLTH S; Cross J, 2009, IDS WORKING PAPERS, P01; Cross J, 2010, SOC SCI MED, V71, P1593, DOI 10.1016/j.socscimed.2010.07.040; De Costa A, 2008, QUAL HEALTH RES, V18, P756, DOI 10.1177/1049732308318504; de Costa A, 2007, HEALTH POLICY, V84, P269, DOI 10.1016/j.healthpol.2007.04.004; De Costa A, 2009, HEALTH POLICY, V93, P41, DOI 10.1016/j.healthpol.2009.03.015; Dzator J, 2004, HEALTH POLICY, V69, P389, DOI 10.1016/j.healthpol.2004.01.005; Ecks S, 2009, TRANSCULT PSYCHIATRY, V46, P86, DOI 10.1177/1363461509102289; Enato EFO, 2006, SCAND J INFECT DIS, V38, P474, DOI 10.1080/00365540500525153; Ene-Obong HN, 2000, J HEALTH POPUL NUTR, V18, P97; Ensor T, 2001, HEALTH POLICY, V57, P1, DOI 10.1016/S0168-8510(01)00125-7; Gai RY, 2008, BIOSCI TRENDS, V2, P181; Garcia P, 2003, B WORLD HEALTH ORGAN, V81, P806; Gloyd S, 2001, J MIDWIFERY WOM HEAL, V46, P210, DOI 10.1016/S1526-9523(01)00142-8; Goldman N, 2003, SOC SCI MED, V56, P685, DOI 10.1016/S0277-9536(02)00065-5; Goodman CA, 2006, HEALTH POLICY PLANN, V21, P275, DOI 10.1093/heapol/czl011; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Greer G, 2004, IMPROVING MANAGEMENT; Hamel MJ, 2001, B WORLD HEALTH ORGAN, V79, P1014; Hill AG, 2000, TROP MED INT HEALTH, V5, P107, DOI 10.1046/j.1365-3156.2000.00528.x; Homan R, 2005, EXPLORING ROLE FAMIL; Homsy J, 2004, J ALTERN COMPLEM MED, V10, P905; Homsy J, 2004, AIDS, V18, P1723, DOI 10.1097/01.aids.0000131380.30479.16; Hosain G M, 2005, Mymensingh Med J, V14, P160; ICDDR B, 2009, COSTS UT HEALTHC SER; Izugbara CO, 2005, J URBAN HEALTH, V82, P111, DOI 10.1093/jurban/jti013; Jacobs B, 2004, SEX TRANSM DIS, V31, P650, DOI 10.1097/01.olq.0000143087.08185.17; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kaboru Berthollet Bwira, 2006, Hum Resour Health, V4, P16, DOI 10.1186/1478-4491-4-16; Kanjilal B, 2007, FUTURE HLTH SYSTEMS, V2, P4; Kayombo EJ, 2005, J ETHNOBIOL ETHNOMED, V1, DOI 10.1186/1746-4269-1-3; Kayombo EJ, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-6; Khan M, 2011, J HLTH POPULATION NU, V20, P42; Kiapi-Iwa L, 2004, AIDS CARE, V16, P339, DOI 10.1080/09540120410001665349; King R., 2000, COLLABORATION TRADIT; Konde-Lule J, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-29; Kruske S, 2004, J MIDWIFERY WOM HEAL, V49, P306, DOI 10.1016/j.jmwh.2004.01.005; Kumar R, 2007, HEALTH CARE ANAL, V15, P223, DOI 10.1007/s10728-007-0060-x; Levin A, 2001, INT J HEALTH PLAN M, V16, P179, DOI 10.1002/hpm.630; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Lonnroth K, 2003, INT J TUBERC LUNG D, V7, P1147; Lonnroth K, 2000, INT J TUBERC LUNG D, V4, P1052; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; MidwifCcrt HC, 2007, NURS HEALTH SCI, V9, P263, DOI 10.1111/j.1442-2018.2007.00321.x; Mignone J, 2007, AIDS CARE, V19, P152, DOI 10.1080/09540120600780542; Mills Anne, 2002, World Hosp Health Serv, V38, P24; Nshakira N, 2002, TROP MED INT HEALTH, V7, P309, DOI 10.1046/j.1365-3156.2002.00858.x; Nsimba Stephen E D, 2007, East Afr J Public Health, V4, P5; Okeke TA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-97; Oladepo O, 2007, FUTURS HLTH SYSTEMS; Onwujekwe O, 2010, HEALTH POLICY, V96, P72, DOI 10.1016/j.healthpol.2009.12.014; Onwujekwe O, 2010, HEALTH POLICY, V94, P144, DOI 10.1016/j.healthpol.2009.09.010; Onwujekwe O, 2010, TROP MED INT HEALTH, V15, P18, DOI 10.1111/j.1365-3156.2009.02418.x; Parkhurst JO, 2007, HEALTH POLICY PLANN, V22, P149, DOI 10.1093/heapol/czm011; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Peltzer K, 2006, AIDS BEHAV, V10, P683, DOI 10.1007/s10461-006-9110-x; Peltzer K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-255; Peu M D, 2001, Curationis, V24, P49; Poudyal AK, 2003, TROP MED INT HEALTH, V8, P956, DOI 10.1046/j.1365-3156.2003.01094.x; Rahman A, 2007, ARCH WOMEN MENT HLTH, V10, P211, DOI 10.1007/s00737-007-0193-9; Ram PK, 2007, AM J PUBLIC HEALTH, V97, P398, DOI 10.2105/AJPH.2005.073460; Rao P. H., 2005, Health and Population - Perspectives and Issues, V28, P40; Rowen T, 2009, MIDWIFERY; Rutta Edmund, 2009, Prog Community Health Partnersh, V3, P145, DOI 10.1353/cpr.0.0063; Salako LA, 2001, J TROP PEDIATRICS, V47, P230, DOI 10.1093/tropej/47.4.230; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Shah NM, 2011, HEALTH POLICY PLANN, V26, P275, DOI 10.1093/heapol/czq074; Sibley L, 2004, SOC SCI MED, V59, P1757, DOI 10.1016/j.socscimed.2004.02.009; Sibley L, 2004, MIDWIFERY, V20, P51, DOI 10.1016/S0266-6138(03)00053-6; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Sibley LM, 2004, J MIDWIFERY WOM HEAL, V49, P298, DOI 10.1016/j.jmwh.2004.03.009; Singhal N, 2001, Health Care Women Int, V22, P569, DOI 10.1080/07399330127196; Smith F, 2004, HEALTH POLICY PLANN, V19, P234, DOI 10.1093/heapol/czh028; Smith F, 2009, TROP MED INT HEALTH, V14, P362, DOI 10.1111/j.1365-3156.2009.02232.x; Smith JB, 2000, HEALTH POLICY PLANN, V15, P326, DOI 10.1093/heapol/15.3.326; Stenson B, 2001, INT J TECHNOL ASSESS, V17, P579, DOI 10.1017/S0266462301107129; Sychareun V, 2004, REPROD HEALTH MATTER, V12, P155, DOI 10.1016/S0968-8080(04)23117-2; Sydara K, 2005, COMPLEMENT THER MED, V13, P199, DOI 10.1016/j.ctim.2005.05.004; Syhakhang L, 2004, PHARM WORLD SCI, V26, P333, DOI 10.1007/s11096-004-0558-3; Syhakhang L, 2004, HEALTH POLICY PLANN, V19, P391, DOI 10.1093/heapol/czh054; Tavrow P, 2003, MALARIA J, V2, P7; TAWFIK Y, 2002, UTILIZING POTENTIAL; Tawfik Y, 2006, TROP MED INT HEALTH, V11, P967, DOI 10.1111/j.1365-3156.2006.01622.x; Taylor RB, 2001, LANCET, V357, P1933, DOI 10.1016/S0140-6736(00)05065-0; Tipke M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-266; Twabeze D., 2001, LIT REV CARE SEEKING; van den Boogaard Jossy, 2008, World Health Popul, V10, P34; van Roosmalen J, 2005, TROP MED INT HEALTH, V10, P393, DOI 10.1111/j.1365-3156.2005.01411.x; Van Sickle D, 2006, INT J TUBERC LUNG D, V10, P1386; Viberg N, 2009, SEX TRANSM INFECT, V85, P300, DOI 10.1136/sti.2008.032888; Walker D, 2001, HEALTH POLICY PLANN, V16, P35, DOI 10.1093/heapol/16.1.35; Walsh LV, 2006, J TRANSCULT NURS, V17, P148, DOI 10.1177/1043659605285412; WARREN DM, 1982, SOC SCI MED, V16, P1873, DOI 10.1016/0277-9536(82)90448-8; Waters H, 2003, HEALTH POLICY PLANN, V18, P127, DOI 10.1093/heapol/czg017; Wolfe K, 2005, YOUTH FRIENDLY PHARM	125	165	166	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54978	10.1371/journal.pone.0054978	http://dx.doi.org/10.1371/journal.pone.0054978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405101	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400045
J	Uzsak, A; Schal, C				Uzsak, Adrienn; Schal, Coby			Sensory Cues Involved in Social Facilitation of Reproduction in Blattella germanica Females	PLOS ONE			English	Article							JUVENILE-HORMONE BIOSYNTHESIS; BEHAVIORAL PHASE STATE; OOCYTE DEVELOPMENT; DESERT LOCUST; SEX-PHEROMONE; CALLING BEHAVIOR; AMERICAN COCKROACH; CIRCADIAN-RHYTHM; SCHISTOCERCA; DICTYOPTERA	Cockroaches, like many other animal species, form aggregations in which social stimuli from conspecifics can alter the physiology, morphology, or behavior of individuals. In adult females of the German cockroach, Blattella germanica, social isolation slows oocyte development, sexual maturation, and sexual receptivity, whereas social interactions as minimal as between just two females accelerate reproduction; however, the sensory modalities and pathways that mediate these physiological and behavioral changes are poorly understood. We explored the roles of visual, olfactory, and tactile cues in the reproductive physiology of German cockroach females, and whether their effects are species-specific and related to circadian time. Our results show that tactile cues are the primary sensory input associated with social conditions-with no evidence for involvement of the visual and olfactory systems-and that the antennae play an important role in the reception of these tactile cues. This conclusion is supported by the observation that interactions with other insect species of similar or larger size and with similar antennal morphology also stimulate oocyte development in B. germanica. Social facilitation of reproduction is expected to be influenced by the circadian timing system, as females engage in more social contact during the day when they shelter in aggregations with conspecifics. Surprisingly, however, the female's reproductive rate was unresponsive to social interactions during the photophase, whereas social interactions as short as two hours during the scotophase were sufficient to induce faster reproduction. We discuss the adaptive significance of these sensory-neuroendocrine responses in the German cockroach.	[Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Schal, C (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	coby_schal@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358	North Carolina Pest Management Association; Structural Pest Management Training and Research Facility; Blanton J. Whitmire endowment at North Carolina State University	North Carolina Pest Management Association; Structural Pest Management Training and Research Facility; Blanton J. Whitmire endowment at North Carolina State University	This project was supported by the Blanton J. Whitmire endowment at North Carolina State University and scholarships from the North Carolina Pest Management Association and the Structural Pest Management Training and Research Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, INSECT SOC; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; BELLES X, 1987, INSECT BIOCHEM, V17, P1007, DOI 10.1016/0020-1790(87)90111-9; Bloch G, 2012, J INSECT PH IN PRESS; Boroczky K, P NAT ACAD IN PRESS; BRADLEY JT, 1985, ENTOMOL EXP APPL, V38, P249, DOI 10.1007/BF00295258; BURNS EL, 1991, J INSECT PHYSIOL, V37, P401, DOI 10.1016/0022-1910(91)90049-6; CHAUVIN R, 1946, B SOC ZOOL FRANCE, V71, P39; CHON TS, 1990, ENVIRON ENTOMOL, V19, P1716, DOI 10.1093/ee/19.6.1716; CREWS D, 1975, SCIENCE, V189, P1059, DOI 10.1126/science.1172294; Cullen DA, 2010, J INSECT PHYSIOL, V56, P937, DOI 10.1016/j.jinsphys.2010.04.023; DAMBACH M, 1994, ENTOMOL GEN, V19, P129; Eliyahu D, 2008, J CHEM ECOL, V34, P229, DOI 10.1007/s10886-007-9409-8; GADOT M, 1989, J INSECT PHYSIOL, V35, P537, DOI 10.1016/0022-1910(89)90141-8; GADOT M, 1989, ARCH INSECT BIOCHEM, V11, P189, DOI 10.1002/arch.940110306; Gemeno C, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P179, DOI 10.1017/CBO9780511542664.007; Gervet J, 1968, NETH J ZOOL, V18, P205; GRASSE PP, 1946, EXPERIENTIA, V2, P77, DOI 10.1007/BF02172562; Hagele BF, 2000, J INSECT PHYSIOL, V46, P1295, DOI 10.1016/S0022-1910(00)00051-2; Heifetz Y, 1996, J CHEM ECOL, V22, P1717, DOI 10.1007/BF02272410; HIGHNAM KC, 1964, J INSECT PHYSIOL, V10, P849, DOI 10.1016/0022-1910(64)90077-0; Holbrook GL, 1998, PHYSIOL ENTOMOL, V23, P121, DOI 10.1046/j.1365-3032.1998.232077.x; Holbrook GL, 2000, J INSECT PHYSIOL, V46, P941, DOI 10.1016/S0022-1910(99)00201-2; ISHII S, 1967, Applied Entomology and Zoology, V2, P203; ISHII S, 1971, Applied Entomology and Zoology, V6, P192; IWANAGA K, 1986, J INSECT PHYSIOL, V32, P585, DOI 10.1016/0022-1910(86)90076-4; IZUTSU M, 1970, Applied Entomology and Zoology, V5, P159; JOHNSON BRUCE, 1965, ENTOMOL EXP APPL, V8, P49, DOI 10.1007/BF00304538; Knadler JJ, 2009, CHRONOBIOL INT, V26, P415, DOI 10.1080/07420520902876634; Krause J, 2002, LIVING GROUPS; KURTTI TJ, 1976, IN VITRO CELL DEV B, V12, P141; LEES AD, 1967, J INSECT PHYSIOL, V13, P289, DOI 10.1016/0022-1910(67)90155-2; Lester RL, 2005, J INSECT PHYSIOL, V51, P737, DOI 10.1016/j.jinsphys.2005.03.015; LIANG DS, 1994, J INSECT PHYSIOL, V40, P251, DOI 10.1016/0022-1910(94)90048-5; LIANG DS, 1993, J INSECT BEHAV, V6, P603, DOI 10.1007/BF01048126; LIANG DS, 1990, PHYSIOL ENTOMOL, V15, P355, DOI 10.1111/j.1365-3032.1990.tb00523.x; Lihoreau M, 2008, ANIM BEHAV, V75, P1965, DOI 10.1016/j.anbehav.2007.12.006; LONG D. B., 1953, TRANS ROY ENT SOC LONDON, V104, P543; Maeno K, 2011, J INSECT PHYSIOL, V57, P74, DOI 10.1016/j.jinsphys.2010.09.009; MCFARLANE JE, 1984, J INSECT PHYSIOL, V30, P103, DOI 10.1016/0022-1910(84)90112-4; NAKAI Y, 1986, JPN J APPL ENTOMOL Z, V30, P1, DOI 10.1303/jjaez.30.1; Nojima S, 1999, J INSECT BEHAV, V12, P627, DOI 10.1023/A:1020975619618; Nojima S, 2005, SCIENCE, V307, P1104, DOI 10.1126/science.1107163; Norris M.J., 1950, ANTILOCUST B, V6, P1; Norris M. J., 1952, ANTILOCUST B, V13, P1; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Roth L. M., 1960, BIOTIC ASS COCKROACH; Rust MK, 1995, UNDERSTANDING CONTRO; Rymer J, 2007, J BIOL RHYTHM, V22, P43, DOI 10.1177/0748730406295462; Saunders D.S., 2002, INSECT CLOCKS, P7, DOI DOI 10.1016/B978-044450407-4/50003-3; SCHAL C, 1995, EXPERIENTIA, V51, P994, DOI 10.1007/BF01921755; Schal C, 1997, ARCH INSECT BIOCHEM, V35, P405, DOI 10.1002/(SICI)1520-6327(1997)35:4<405::AID-ARCH5>3.3.CO;2-3; SCHAL C, 1993, J INSECT PHYSIOL, V39, P303, DOI 10.1016/0022-1910(93)90061-U; Seelinger G., 1981, P217; Sevala V, 1999, J INSECT PHYSIOL, V45, P431, DOI 10.1016/S0022-1910(98)00142-5; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; SMITH AF, 1991, J INSECT BEHAV, V4, P1, DOI 10.1007/BF01092546; Stay B, 2010, J INSECT PHYSIOL, V56, P266, DOI 10.1016/j.jinsphys.2009.10.012; STEVENS EF, 1994, ZOO BIOL, V13, P501, DOI 10.1002/zoo.1430130512; SUTHERLAND OR, 1969, J INSECT PHYSIOL, V15, P1385, DOI 10.1016/0022-1910(69)90199-1; Treiblmayr K, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.4301; Uzsak A, 2012, J EXP BIOL, V215, P3037, DOI 10.1242/jeb.069997; WEAVER DK, 1990, J INSECT PHYSIOL, V36, P531, DOI 10.1016/0022-1910(90)90105-O; WHARTON DRA, 1968, J INSECT PHYSIOL, V14, P637, DOI 10.1016/0022-1910(68)90224-2; Wijenberg R, 2008, ENTOMOL EXP APPL, V129, P124, DOI 10.1111/j.1570-7458.2008.00758.x; WILEYTO EP, 1984, ENVIRON ENTOMOL, V13, P1557, DOI 10.1093/ee/13.6.1557; WOODHEAD AP, 1983, J INSECT PHYSIOL, V29, P665, DOI 10.1016/0022-1910(83)90040-9; ZERA AJ, 1988, J INSECT PHYSIOL, V34, P489, DOI 10.1016/0022-1910(88)90190-4; ZHUKOVSKAYA MI, 1995, J INSECT PHYSIOL, V41, P941, DOI 10.1016/0022-1910(95)00060-8	73	7	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55678	10.1371/journal.pone.0055678	http://dx.doi.org/10.1371/journal.pone.0055678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405195	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400140
J	Xing, H; Ruan, YH; Li, JY; Shang, H; Zhong, P; Wang, X; Liao, LJ; Li, HP; Zhang, M; Xue, YL; Wang, Z; Su, B; Liu, W; Dong, YH; Ma, YL; Li, HQ; Qin, GM; Chen, L; Pan, XH; Chen, X; Peng, G; Fu, JH; Chen, RY; Kang, LY; Shao, YM				Xing, Hui; Ruan, Yuhua; Li, Jingyun; Shang, Hong; Zhong, Ping; Wang, Xia; Liao, Lingjie; Li, Hanping; Zhang, Min; Xue, Yile; Wang, Zhe; Su, Bin; Liu, Wei; Dong, Yonghui; Ma, Yanling; Li, Huiqin; Qin, Guangming; Chen, Lin; Pan, Xiaohong; Chen, Xi; Peng, Guoping; Fu, Jihua; Chen, Ray Y.; Kang, Laiyi; Shao, Yiming		Chinese Natl HIVDR Surveillance Mo	HIV Drug Resistance and Its Impact on Antiretroviral Therapy in Chinese HIV-Infected Patients	PLOS ONE			English	Article							ZIDOVUDINE; OUTCOMES	Background: Highly active antiretroviral therapy (HAART) has significantly decreased mortality among Chinese HIV patients. However, emerging HIV drug resistance (HIVDR) poses a growing threat to the long-term success and durability of HAART. Methods: Three cross-sectional surveys were conducted across the country from 2004 to 2006, respectively. Patients completed a questionnaire and provided blood for CD4 cell count, HIV viral load (VL), and HIV resistance genotyping. Factors associated with HIVDR were identified by logistic regression. Results: 3667 unique patients were included across the three surveys. Among 2826 treatment-experienced patients, median duration of treatment was 17.4 (IQR 8.6-28.4) months and HIVDR was identified in 543 (19.2%). Factors significantly associated with HIVDR included ART drug distribution location, CD4 cell count, initial HAART regimen, self-reported medication adherence, and province. Conclusions: Virologic failure increased over time on therapy but a significant proportion of patients in failure had no resistance mutations identified, suggesting that treatment adherence is suboptimal and must be emphasized. Due to the significantly higher risk of HIVDR in certain provinces, additional steps to reduce HIVDR should be taken.	[Xing, Hui; Ruan, Yuhua; Wang, Xia; Liao, Lingjie; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xing, Hui; Ruan, Yuhua; Wang, Xia; Liao, Lingjie; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Li, Jingyun; Li, Hanping] Acad Mil Med Sci, Inst Microbiol & Epidemiol, AIDS Res Dept, Beijing, Peoples R China; [Shang, Hong; Zhang, Min] China Med Univ, Affiliated Hosp 1, Minist Hlth, Key Lab Immunol AIDS, Shenyang, Peoples R China; [Zhong, Ping; Xue, Yile; Kang, Laiyi] Shanghai Municipal Ctr Dis Control & Prevent, Dept AIDS & STD, Shanghai, Peoples R China; [Wang, Zhe] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Su, Bin] Anhui Ctr Dis Control & Prevent, Hefei, Peoples R China; [Liu, Wei] Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China; [Dong, Yonghui] Xinjiang Ctr Dis Control & Prevent, Urumqi, Peoples R China; [Ma, Yanling] Yunnan Ctr Dis Control & Prevent, Kunming, Peoples R China; [Li, Huiqin] Yunnan Infect Dis Hosp, Kunming, Peoples R China; [Qin, Guangming] Sichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Chen, Lin] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Pan, Xiaohong] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Chen, Xi] Hunan Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Peng, Guoping] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Fu, Jihua] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Chen, Ray Y.] US Embassy Beijing, Natl Inst Allergy & Infect Dis, US Natl Inst Hlth, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Academy of Military Medical Sciences - China; China Medical University; Shanghai Center for Disease Control & Prevention; Shenzhen Center for Disease Control & Prevention (SZCDC)	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao08@gmail.com	Wang, Xia/C-3298-2018; Chen, Ray/T-5102-2019; Chen, Ray/GRJ-6736-2022; MA, YAN/HHN-2912-2022	Wang, Xia/0000-0002-1684-7076; Chen, Ray/0000-0001-6344-1442	Ministry of Science and Technology of China [2012ZX10001-002, 2009DFB30420]; International Development Research Center of Canada [104519-010]; Chinese State Key Laboratory for Infectious Disease Develop Grant [2011SKLID102]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); International Development Research Center of Canada; Chinese State Key Laboratory for Infectious Disease Develop Grant	The Ministry of Science and Technology of China (2012ZX10001-002 and 2009DFB30420) and the International Development Research Center of Canada (#104519-010), and Chinese State Key Laboratory for Infectious Disease Develop Grant (2011SKLID102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Casado JL, 2000, AIDS, V14, pF1, DOI 10.1097/00002030-200001280-00001; DAQUILA RT, 1995, ANN INTERN MED, V122, P401, DOI 10.7326/0003-4819-122-6-199503150-00001; DeGruttola V, 2000, ANTIVIR THER, V5, P41; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Joly V, 2000, ANTIMICROB AGENTS CH, V44, P3155, DOI 10.1128/AAC.44.11.3155-3157.2000; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; Ruan YH, 2010, TROP MED INT HEALTH, V15, P1357, DOI 10.1111/j.1365-3156.2010.02621.x; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Zhang F, 2008, NATL FREE HIV ANTIRE; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003	19	32	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54917	10.1371/journal.pone.0054917	http://dx.doi.org/10.1371/journal.pone.0054917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405098	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400042
J	Zhao, NB; Yang, K; Yang, GL; Chen, D; Tang, H; Zhao, D; Zhao, CR				Zhao, Ningbo; Yang, Kai; Yang, Genling; Chen, Dan; Tang, Hong; Zhao, Dan; Zhao, Chunrong			Aberrant Expression of Clock Gene Period1 and Its Correlations with the Growth, Proliferation and Metastasis of Buccal Squamous Cell Carcinoma	PLOS ONE			English	Article							HUMAN ORAL-MUCOSA; CIRCADIAN EXPRESSION; CANCER; PER1; REGULATOR; RHYTHMS; PLAYS	Period1 (PER1) is an important core clock gene, which regulates normal cell proliferations and physiological rhythms of human beings. Recent studies have showed aberrant expressions and altered rhythms of PER1 were highly correlated to the carcinogenesis and development of malignant tumors. However, there is no study on the correlation of aberrant expressions and altered rhythms of PER1 with the growth, proliferation and metastasis of buccal squamous cell carcinoma (BSCC). In this study, PER1 and MMP-2 expression in the cancerous and adjacent noncancerous tissues of 38 patients with BSCC and its correlations with patients' clinical pathologic characteristics were investigated. A mouse model of BSCC was also established and mice were sacrificed at 4 different time points in a period of 24 hours. Xenografted tumor weight, proliferation index (PI), and mitotic index (MI) of tumors in the 4 time groups were detected. Results showed that PER1 expression was significantly down-regulated in cancerous tissues of patients with BSCC (P<0.05). PER1 expression was significantly down-regulated in patients of T3 similar to T4 staging and those with lymph node metastasis compared to that of T1 similar to T2 staging and those without lymph node metastasis (P<0.05), respectively. PER1 mRNA expression, MI and tumor weight had significant differences among the 4 time groups, which PI all confirmed to circadian rhythms. MI, PI, MMP-2 mRNA and tumor weight had negative correlation with PER1 mRNA expression. Peak value of PER1 mRNA expression and trough values of MI, PI and tumor weight all appeared in middle activity phase, whereas trough value of PER1 mRNA expression and peak values of MI, PI and tumor weight all occurred in middle rest phase. Our study suggested that aberrant expression of PER1 had significant correlation with the growth, proliferation and metastasis of BSCC and it might act as an anti-oncogene.	[Zhao, Ningbo; Yang, Kai; Chen, Dan; Tang, Hong; Zhao, Dan; Zhao, Chunrong] Chongqing Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Chongqing, Peoples R China; [Yang, Genling] Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Yang, K (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Chongqing, Peoples R China.	cqfyyk@yahoo.com.cn						Badiu C, 2003, J CELL MOL MED, V7, P408, DOI 10.1111/j.1582-4934.2003.tb00243.x; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Cao Q, 2009, CANCER RES, V69, P7619, DOI 10.1158/0008-5472.CAN-08-4199; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Davidson AJ, 2006, INT J CANCER, V118, P1623, DOI 10.1002/ijc.21591; Eismann EA, 2010, PSYCHONEUROENDOCRINO, V35, P963, DOI 10.1016/j.psyneuen.2009.12.011; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Hara Y, 2009, NUCLEIC ACIDS RES, V37, P1115, DOI 10.1093/nar/gkn1013; Hsu CM, 2012, TUMOR BIOL, V33, P149, DOI 10.1007/s13277-011-0258-2; Innominato PF, 2010, ADV DRUG DELIVER REV, V62, P979, DOI 10.1016/j.addr.2010.06.002; Johnson N W, 2011, Adv Dent Res, V23, P237, DOI 10.1177/0022034511402082; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Koyanagi S, 2003, CANCER RES, V63, P7277; Mostafaie N, 2009, MOL CARCINOGEN, V48, P642, DOI 10.1002/mc.20510; Mullenders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004798; Murphy PJ, 1996, J CLIN NEUROPHYSIOL, V13, P2, DOI 10.1097/00004691-199601000-00002; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sato F, 2009, J BIOCHEM, V146, P833, DOI 10.1093/jb/mvp126; Smolensky MH, 2007, ADV DRUG DELIVER REV, V59, P828, DOI 10.1016/j.addr.2007.07.001; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yang MY, 2011, J BIOL RHYTHM, V26, P136, DOI 10.1177/0748730410395527; Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301; Yeh KT, 2005, J PATHOL, V206, P111, DOI 10.1002/path.1756; Yoshizaki T, 2002, ONCOL REP, V9, P607; Zieker D, 2010, CELL PHYSIOL BIOCHEM, V26, P155, DOI 10.1159/000320547	28	25	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55894	10.1371/journal.pone.0055894	http://dx.doi.org/10.1371/journal.pone.0055894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405233	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400178
J	Herrera, VLM; Pasion, KA; Moran, AM; Ruiz-Opazo, N				Herrera, Victoria L. M.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson			Worse Renal Disease in Postmenopausal F2[Dahl S x R]-Intercross Rats: Detection of Novel QTLs Affecting Hypertensive Kidney Disease	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; SALT; PROGRESSION; THERAPY; CREATININE; MYELOMA; WOMEN; MAP	The prevalence of hypertension increases after menopause with 75% of postmenopausal women developing hypertension in the United States, along with hypertensive end organ diseases. While human and animal model studies have indicated a protective role for estrogen against cardiovascular disease and glomerulosclerosis, clinical studies of hormone replacement therapy in postmenopausal women have shown polar results with some improvement in hypertension but worsening of hypertensive kidney disease, or no effect at all. These observations suggest that the pathogenesis of postmenopausal hypertension and its target organ complications is more complex than projected, and that loss of endogenous estrogens induces epigenetic changes that alter genetic susceptibility to end-organ complications per se resulting in pathogenetic mechanisms beyond correction by hormone replacement. We studied postmenopausal-induced changes in renal disease and performed a total genome scan for quantitative trait loci (QTLs) affecting kidney disease in postmenopausal 16m-old F2[Dahl S x R]-intercross female rats. We used glomerular injury score (GIS) as quantitative trait. We compared QTLs amongst premenopausal, ovariectomized and postmenopausal F2[Dahl S x R]-intercross rats using identical phenotype characterization. Postmenopausal F2[Dahl S x R]-intercross rats exhibited increased hypertensive glomerulosclerosis (P<0.01) and equivalent levels of kidney disease when compared to premenopausal and ovariectomized F2[Dahl S x R]-intercross rats respectively. We detected three significant to highly significant GIS-QTLs (GIS-pm1 on chromosome 4, LOD 3.54; GIS-pm2 on chromosome 3, LOD 2.72; GIS-pm3 on chromosome 5, LOD 2.37) and two suggestive GIS-QTLs (GIS-pm4 on chromosome 2, LOD 1.70; GIS-pm5 on chromosome 7, LOD 1.28), all of which were unique to this postmenopausal population. Detection of increased renal disease phenotype in postmenopausal and ovariectomized subjects suggests a protective role of ovarian hormones. Furthermore, the detection of distinct GIS-QTLs in postmenopausal intercross female rats suggests that distinct genetic mechanisms underlie hypertensive glomerulosclerosis in premenopausal and postmenopausal states.	[Herrera, Victoria L. M.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA	Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA.	nruizo@bu.edu		Herrera, Victoria/0000-0001-8991-2134; Ruiz-Opazo, Nelson/0000-0001-8234-1332	NIH [HL086532]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086532] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the NIH: HL086532 to NR-O. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2005, AM J KIDNEY DIS, V45, P1019, DOI 10.1053/j.ajkd.2005.02.025; Ahmed SB, 2008, KIDNEY INT, V74, P370, DOI 10.1038/ki.2008.205; Arimura A, 2006, BLOOD, V107, P661, DOI 10.1182/blood-2005-03-1186; Bolignano D, 2010, CURR OPIN NEPHROL HY, V19, P499, DOI 10.1097/MNH.0b013e32833d35cf; Brubel R, 2011, TRANSPL P, V43, P1297, DOI 10.1016/j.transproceed.2011.03.081; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Fortepiani LA, 2003, HYPERTENSION, V41, P640, DOI 10.1161/01.HYP.0000046924.94886.EF; Fung MM, 2011, MENOPAUSE, V18, P629, DOI 10.1097/gme.0b013e3181fca9c4; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Herrera VL, 2012, J HYPERTENS, V30, P1572, DOI 10.1097/HJH.0b013e3283550eb8; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043160; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; Hocher B, 1996, HYPERTENSION, V28, P196, DOI 10.1161/01.HYP.28.2.196; Hovind P, 2004, BRIT MED J, V328, P1105, DOI 10.1136/bmj.38070.450891.FE; Iseki K, 1997, KIDNEY INT, V51, P850, DOI 10.1038/ki.1997.119; Jafar TH, 2003, NEPHROL DIAL TRANSPL, V18, P2047, DOI 10.1093/ndt/gfg317; LEFEVRE J, 1988, BIOL REPROD, V38, P780, DOI 10.1095/biolreprod38.4.780; Li M, 2008, REGUL PEPTIDES, V145, P24, DOI 10.1016/j.regpep.2007.09.012; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Maric C, 2008, GENDER MED, V5, P147, DOI 10.1016/j.genm.2008.05.002; Monster TBM, 2001, ARCH INTERN MED, V161, P2000, DOI 10.1001/archinte.161.16.2000; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Pechere-Bertschi A, 2004, AM J HYPERTENS, V17, P994, DOI 10.1016/j.amjhyper.2004.08.009; Pimenta E, 2012, HYPERTENS RES, V35, P148, DOI 10.1038/hr.2011.190; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Schulman IH, 2006, HYPERTENSION, V47, P1168, DOI 10.1161/01.HYP.0000218857.67880.75; Szakaly P, 2008, J MOL NEUROSCI, V36, P89, DOI 10.1007/s12031-008-9064-8; Szekacs B, 2000, BRIT J OBSTET GYNAEC, V107, P1017, DOI 10.1111/j.1471-0528.2000.tb10406.x; Uchide T, 2006, EXP BIOL MED, V231, P997; Williams JM, 2008, AM J PHYSIOL-RENAL, V295, pF1764, DOI 10.1152/ajprenal.90525.2008	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e56096	10.1371/journal.pone.0056096	http://dx.doi.org/10.1371/journal.pone.0056096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393608	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800063
J	Jensen, RA; Sim, XL; Li, XH; Cotch, MF; Ikram, MK; Holliday, EG; Eiriksdottir, G; Harris, TB; Jonasson, F; Klein, BEK; Launer, LJ; Smith, AV; Boerwinkle, E; Cheung, N; Hewitt, AW; Liew, G; Mitchell, P; Wang, JJ; Attia, J; Scott, R; Glazer, NL; Lumley, T; McKnight, B; Psaty, BM; Taylor, K; Hofman, A; de Jong, PTVM; Rivadeneira, F; Uitterlinden, AG; Tay, WT; Teo, YY; Seielstad, M; Liu, JJ; Cheng, CY; Saw, SM; Aung, T; Ganesh, SK; O'Donnell, CJ; Nalls, MA; Wiggins, KL; Kuo, JZ; van Duijn, CM; Gudnason, V; Klein, R; Siscovick, DS; Rotter, JI; Tai, ES; Vingerling, J; Wong, TY				Jensen, Richard A.; Sim, Xueling; Li, Xiaohui; Cotch, Mary Frances; Ikram, M. Kamran; Holliday, Elizabeth G.; Eiriksdottir, Gudny; Harris, Tamara B.; Jonasson, Fridbert; Klein, Barbara E. K.; Launer, Lenore J.; Smith, Albert Vernon; Boerwinkle, Eric; Cheung, Ning; Hewitt, Alex W.; Liew, Gerald; Mitchell, Paul; Wang, Jie Jin; Attia, John; Scott, Rodney; Glazer, Nicole L.; Lumley, Thomas; McKnight, Barbara; Psaty, Bruce M.; Taylor, Kent; Hofman, Albert; de Jong, Paulus T. V. M.; Rivadeneira, Fernando; Uitterlinden, Andre G.; Tay, Wan-Ting; Teo, Yik Ying; Seielstad, Mark; Liu, Jianjun; Cheng, Ching-Yu; Saw, Seang-Mei; Aung, Tin; Ganesh, Santhi K.; O'Donnell, Christopher J.; Nalls, Mike A.; Wiggins, Kerri L.; Kuo, Jane Z.; van Duijn, Cornelia M.; Gudnason, Vilmundur; Klein, Ronald; Siscovick, David S.; Rotter, Jerome I.; Tai, E. Shong; Vingerling, Johannes; Wong, Tien Y.		Blue Mt Eye Study GWAS Team; CKDGen Consortium	Genome-Wide Association Study of Retinopathy in Individuals without Diabetes	PLOS ONE			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; ANTIHYPERTENSIVE DRUG THERAPIES; ATHEROSCLEROSIS RISK; BLOOD-PRESSURE; CARDIOVASCULAR HEALTH; HYPERTENSION; COMMUNITIES; MORTALITY; DESIGN; STROKE	Background: Mild retinopathy (microaneurysms or dot-blot hemorrhages) is observed in persons without diabetes or hypertension and may reflect microvascular disease in other organs. We conducted a genome-wide association study (GWAS) of mild retinopathy in persons without diabetes. Methods: A working group agreed on phenotype harmonization, covariate selection and analytic plans for within-cohort GWAS. An inverse-variance weighted fixed effects meta-analysis was performed with GWAS results from six cohorts of 19,411 Caucasians. The primary analysis included individuals without diabetes and secondary analyses were stratified by hypertension status. We also singled out the results from single nucleotide polymorphisms (SNPs) previously shown to be associated with diabetes and hypertension, the two most common causes of retinopathy. Results: No SNPs reached genome-wide significance in the primary analysis or the secondary analysis of participants with hypertension. SNP, rs12155400, in the histone deacetylase 9 gene (HDAC9) on chromosome 7, was associated with retinopathy in analysis of participants without hypertension, -1.3 +/- 0.23 (beta +/- standard error), p=6.6x10(-9). Evidence suggests this was a false positive finding. The minor allele frequency was low (similar to 2%), the quality of the imputation was moderate (r(2) similar to 0.7), and no other common variants in the HDAC9 gene were associated with the outcome. SNPs found to be associated with diabetes and hypertension in other GWAS were not associated with retinopathy in persons without diabetes or in subgroups with or without hypertension. Conclusions: This GWAS of retinopathy in individuals without diabetes showed little evidence of genetic associations. Further studies are needed to identify genes associated with these signs in order to help unravel novel pathways and determinants of microvascular diseases.	[Jensen, Richard A.; Lumley, Thomas; McKnight, Barbara; Psaty, Bruce M.; Wiggins, Kerri L.; Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Jensen, Richard A.; Psaty, Bruce M.; Wiggins, Kerri L.; Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Sim, Xueling; Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Li, Xiaohui; Taylor, Kent; Kuo, Jane Z.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Ikram, M. Kamran; Tay, Wan-Ting; Cheng, Ching-Yu; Saw, Seang-Mei; Aung, Tin; Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Ikram, M. Kamran; Vingerling, Johannes] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Holliday, Elizabeth G.; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Eiriksdottir, Gudny; Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Jonasson, Fridbert; Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Dept Med, Reykjavik, Iceland; [Jonasson, Fridbert] Landspitalinn Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland; [Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Cheung, Ning; Hewitt, Alex W.; Liew, Gerald; Wang, Jie Jin; Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Liew, Gerald; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Liew, Gerald; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Attia, John] John Hunter Hosp, Dept Med, Newcastle, NSW, Australia; [Attia, John] Hunter Med Res Inst, Newcastle, NSW, Australia; [Scott, Rodney] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2300, Australia; [Glazer, Nicole L.] Boston Univ, Sch Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Psaty, Bruce M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Vingerling, Johannes] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [de Jong, Paulus T. V. M.] Netherlands Inst Neurosci, Amsterdam, Netherlands; [de Jong, Paulus T. V. M.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Teo, Yik Ying; Cheng, Ching-Yu; Saw, Seang-Mei; Tai, E. Shong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying; Liu, Jianjun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Cheng, Ching-Yu; Saw, Seang-Mei; Aung, Tin; Wong, Tien Y.] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Ganesh, Santhi K.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [O'Donnell, Christopher J.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Nalls, Mike A.] NIA, Neurogenet Lab, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Tai, E. Shong] Natl Univ Singapore, Singapore 117548, Singapore; [Tai, E. Shong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National University of Singapore; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National University of Singapore; Singapore National Eye Center; Erasmus University Rotterdam; Erasmus MC; University of Newcastle; Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Iceland; Landspitali National University Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Centre for Eye Research Australia; University of Melbourne; University of Sydney; University of Sydney; Westmead Institute for Medical Research; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Boston University; University of Auckland; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California San Francisco; National University of Singapore; University of Michigan System; University of Michigan; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National University of Singapore; National University of Singapore	Jensen, RA (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.	richaj@uw.edu	Hewitt, Alex W/D-1936-2013; Attia, John R/F-5376-2013; Gudnason, Vilmundur/AAE-7126-2019; Rotter, Jerome/AAY-6598-2021; Mitchell, Paul/P-1498-2014; Sim, Xueling/AAZ-6652-2020; Cheng, Ching-Yu/K-7017-2013; Rivadeneira, Fernando/O-5385-2015; Wong, Tien Yin/AAC-9724-2020; Liew, Gerald/AAB-6870-2022; Jonasson, Fridbert/ABA-9889-2021; Cheng, Ching-Yu/Y-2229-2019; Tai, E Shyong/J-9831-2013; Wang, Jie Jin/P-1499-2014; Liu, Jianjun/AAK-4989-2020; wang, jie/GRS-0942-2022; Smith, Albert Vernon/K-5150-2015; Gudnason, Vilmundur/K-6885-2015; Cheung, Ning Danny/F-2043-2013; Seielstad, Mark/T-7841-2019; Scott, Rodney/B-2827-2013	Hewitt, Alex W/0000-0002-5123-5999; Attia, John R/0000-0001-9800-1308; Gudnason, Vilmundur/0000-0001-5696-0084; Sim, Xueling/0000-0002-1233-7642; Cheng, Ching-Yu/0000-0003-0655-885X; Rivadeneira, Fernando/0000-0001-9435-9441; Wong, Tien Yin/0000-0002-8448-1264; Cheng, Ching-Yu/0000-0003-0655-885X; Wang, Jie Jin/0000-0001-9491-4898; Liu, Jianjun/0000-0002-3255-3019; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Tai, E Shyong/0000-0003-2929-8966; Baird, Paul/0000-0002-1305-3502; Cotch, Mary Frances/0000-0002-2046-4350; Scott, Rodney/0000-0001-7724-3404; Klein, Ronald/0000-0002-4428-6237; Van Duijn, Cornelia/0000-0002-2374-9204; Ikram, Mohammad Kamran/0000-0003-0173-9571; Wiggins, Kerri L/0000-0003-2749-1279; Glazer, Nicole/0000-0002-6397-609X; Seielstad, Mark/0000-0001-5783-1401	National Institutes of Health (NIH) [N01-AG-12100]; National Institute on Aging Intramural Research Program at the NIH [ZIAAG007380, ZIAEY000401]; National Eye Institute Intramural Research Program at the NIH [ZIAAG007380, ZIAEY000401]; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C]; National Institutes of Health and NIH Roadmap for Medical Research [UL1RR025005]; Australian National Health & Medical Research Council (NHMRC) [974159, 991407, 211069, 457349]; NHMRC [512423, 475604, 529912, 590204]; Wellcome Trust, UK as part of Wellcome Trust Case Control Consortium; genotyping costs of the entire BMES population [085475/B/08/Z, 085475/08/Z]; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133]; NHLBI [HL080295, HL075366, HL087652, HL105756, N02-HL-6-4278]; National Institute on Aging [AG-023629, AG-15928, AG-20098, AG-027058]; Clinical Translational Science Institute [UL1RR033176]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR); Netherlands Organization of Scientific Research NWO [175.010.2005.011]; Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for Scientific Research; Netherlands Organization for Health Research and Development; Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII) the Netherlands; Municipality of Rotterdam; Lijf en Leven, Krimpen a/d Lek the Netherlands; MD Fonds, Utrecht the Netherlands; Oogfonds Nederland, Utrecht the Netherlands; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam the Netherlands; Swart van Essen, Rotterdam the Netherlands; Netherlands Organisation for Scientific Research the Netherlands; Bevordering van Volkskracht, Rotterdam the Netherlands; Blindenhulp, The Hague the Netherlands; Rotterdamse Vereniging Blindenbelangen, Rotterdam the Netherlands; OOG, The Hague the Netherlands; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn the Netherlands; Blinden-Penning, Amsterdam the Netherlands; Blindenhulp, 's Gravenzande the Netherlands; Henkes Stichting, Rotterdam the Netherlands; Topcon Europe BV, Capelle aan de IJssel the Netherlands; Medical Workshop BV, Groningen the Netherlands;  [N01 HC-95159];  [N01-HC-95169];  [RR-024156]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085086, N01HC095159, N01HC095169, N01HC035129, N01HC085079, N01HC015103, N01HC075150, N01HC045133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176, UL1RR025005, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000403, ZIAEY000401, ZIAEY000426] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, R01HL105756, R01HL087641, R01HL080295, R01HL086694, U01HL080295, R01HL075366, R01HL059367, R01HL064278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000, R01AG023629, R56AG020098, N01AG012100, R01AG020098, R01AG027058, R01AG015928, ZIAAG007420, ZIAAG007270, R56AG023629, ZIAAG007380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging Intramural Research Program at the NIH; National Eye Institute Intramural Research Program at the NIH; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK as part of Wellcome Trust Case Control Consortium; genotyping costs of the entire BMES population; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Clinical Translational Science Institute; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII) the Netherlands; Municipality of Rotterdam; Lijf en Leven, Krimpen a/d Lek the Netherlands; MD Fonds, Utrecht the Netherlands(Netherlands Government); Oogfonds Nederland, Utrecht the Netherlands; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam the Netherlands(Netherlands Government); Swart van Essen, Rotterdam the Netherlands; Netherlands Organisation for Scientific Research the Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Bevordering van Volkskracht, Rotterdam the Netherlands(Netherlands Government); Blindenhulp, The Hague the Netherlands(Netherlands Government); Rotterdamse Vereniging Blindenbelangen, Rotterdam the Netherlands(Netherlands Government); OOG, The Hague the Netherlands; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn the Netherlands(Netherlands Government); Blinden-Penning, Amsterdam the Netherlands(Netherlands Government); Blindenhulp, 's Gravenzande the Netherlands(Netherlands Government); Henkes Stichting, Rotterdam the Netherlands; Topcon Europe BV, Capelle aan de IJssel the Netherlands(Netherlands Government); Medical Workshop BV, Groningen the Netherlands; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors declare that they have no relevant financial interests. Age, Gene/Environment Susceptibility-Reykjavik Study has been funded by National Institutes of Health (NIH) contract N01-AG-12100, the National Institute on Aging and National Eye Institute Intramural Research Programs at the NIH (ZIAAG007380 and ZIAEY000401), Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The Blue Mountains Eye Study (BMES) was supported by the Australian National Health & Medical Research Council (NHMRC) grants (IDs 974159, 991407, 211069 and 457349). The genome-wide association study was supported by the following grants: NHMRC project grants IDs 512423, 475604, 529912 and 590204, and funding by the Wellcome Trust, UK as part of Wellcome Trust Case Control Consortium 2 (A Viswanathan, P McGuffin, P Mitchell, F Topouzis, P Foster), which supported the genotyping costs of the entire BMES population (Grant numbers 085475/B/08/Z and 085475/08/Z). The Cardiovascular Health Study research was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086; N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133 and NHLBI grants HL080295, HL075366, HL087652, HL105756 with additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the National Institute on Aging. See also http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by the Clinical Translational Science Institute grant UL1RR033176 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Additional funding was provided by the Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR). The Multi-Ethnic Study of Atherosclerosis (MESA) and MESA SNP Health Association Resource (SHARe) are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support is provided by grants and contracts N01 HC-95159 through N01-HC-95169 and RR-024156. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-6-4278. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. The GWA database of the Rotterdam Study was funded through the Netherlands Organization of Scientific Research NWO (nr. 175.010.2005.011).; The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Scientific Research, the Netherlands Organization for Health Research and Development, the Research Institute for Diseases in the Elderly, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The ophthalmologic part of the Rotterdam Study was supported by Lijf en Leven, Krimpen a/d Lek; MD Fonds, Utrecht. Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam; Swart van Essen, Rotterdam; Netherlands Organisation for Scientific Research; Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Rotterdamse Vereniging Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn; Blinden-Penning, Amsterdam; Blindenhulp, 's Gravenzande; Henkes Stichting, Rotterdam; Topcon Europe BV, Capelle aan de IJssel; Medical Workshop BV, Groningen; all in the Netherlands; Heidelberg Engineering, Dossenheim, Germany. The Singapore Indian Eye Study was funded by grants from the Biomedical Research Council of Singapore (BMRC 09/1/35/19/616 and BMRC 08/1/35/19/550) and the National Medical Research Council of Singapore (NMRC/STaR/0003/2008). The Singapore BioBank and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cooper LS, 2006, STROKE, V37, P82, DOI 10.1161/01.STR.0000195134.04355.e5; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; Fossdal R, 2004, HUM MOL GENET, V13, P975, DOI 10.1093/hmg/ddh106; Franceschini N, 2011, AM J HYPERTENS, V24, P392, DOI 10.1038/ajh.2010.218; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grosso A, 2011, J HYPERTENS, V29, P1667, DOI 10.1097/HJH.0b013e3283496655; Gunnlaugsdottir E, 2011, RETINOPATHY OLD PERS; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Izzedine H, 2003, J AM SOC NEPHROL, V14, P516, DOI 10.1097/01.ASN.0000051705.97966.AD; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Klein Ronald, 2006, Trans Am Ophthalmol Soc, V104, P98; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P1568, DOI 10.1001/archophthalmol.2010.298; Klungel OH, 2001, ARCH INTERN MED, V161, P37, DOI 10.1001/archinte.161.1.37; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Longstreth WT, 2007, AM J EPIDEMIOL, V165, P78, DOI 10.1093/aje/kwj350; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mitchell P, 2005, NEUROLOGY, V65, P1005, DOI 10.1212/01.wnl.0000179177.15900.ca; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Perronnet C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/849426; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Singleton JR, 2003, DIABETES, V52, P2867, DOI 10.2337/diabetes.52.12.2867; Sobrin L, 2011, INVEST OPHTH VIS SCI, V52, P7593, DOI 10.1167/iovs.11-7510; van Hecke MV, 2005, DIABETOLOGIA, V48, P1300, DOI 10.1007/s00125-005-1799-y; van Hecke MV, 2003, DIABETES CARE, V26, P2958, DOI 10.2337/diacare.26.10.2958; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Vassy JL, 2012, BEST PRACT RES CL EN, V26, P189, DOI 10.1016/j.beem.2011.09.002; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2002, JAMA-J AM MED ASSOC, V288, P67, DOI 10.1001/jama.288.1.67; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P301, DOI 10.1136/bjo.2005.084400; Wong TY, 2005, AM J OPHTHALMOL, V140, P1157, DOI 10.1016/j.ajo.2005.07.030; Wong TY, 2005, JAMA-J AM MED ASSOC, V293, P63, DOI 10.1001/jama.293.1.63; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Wong TY, 2004, J AM SOC NEPHROL, V15, P2469, DOI 10.1097/01.ASN.0000136133.28194.E4; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	52	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54232	10.1371/journal.pone.0054232	http://dx.doi.org/10.1371/journal.pone.0054232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393555	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800009
J	Maurer, M; Aberer, W; Bouillet, L; Caballero, T; Fabien, V; Kanny, G; Kaplan, A; Longhurst, H; Zanichelli, A				Maurer, Marcus; Aberer, Werner; Bouillet, Laurence; Caballero, Teresa; Fabien, Vincent; Kanny, Gisele; Kaplan, Allen; Longhurst, Hilary; Zanichelli, Andrea		I O S Investigators	Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment	PLOS ONE			English	Article							C1-INHIBITOR CONCENTRATE; ANTAGONIST ICATIBANT; RECEPTOR ANTAGONIST; HAGEMAN-FACTOR; BRADYKININ; PLASMA; EDEMA; PREKALLIKREIN; DEFICIENCY; ACTIVATION	Background: Attacks of hereditary angioedema (HAE) are unpredictable and, if affecting the upper airway, can be lethal. Icatibant is used for physician- or patient self-administered symptomatic treatment of HAE attacks in adults. Its mode of action includes disruption of the bradykinin pathway via blockade of the bradykinin B-2 receptor. Early treatment is believed to shorten attack duration and prevent severe outcomes; however, evidence to support these benefits is lacking. Objective: To examine the impact of timing of icatibant administration on the duration and resolution of HAE type I and II attacks. Methods: The Icatibant Outcome Survey is an international, prospective, observational study for patients treated with icatibant. Data on timings and outcomes of icatibant treatment for HAE attacks were collected between July 2009-February 2012. A mixed-model of repeated measures was performed for 426 attacks in 136 HAE type I and II patients. Results: Attack duration was significantly shorter in patients treated < 1 hour of attack onset compared with those treated >= 1 hour (6.1 hours versus 16.8 hours [p < 0.001]). Similar significant effects were observed for < 2 hours versus >= 2 hours (7.2 hours versus 20.2 hours [p < 0.001]) and < 5 hours versus >= 5 hours (8.0 hours versus 23.5 hours [p < 0.001]). Treatment within 1 hour of attack onset also significantly reduced time to attack resolution (5.8 hours versus 8.8 hours [p < 0.05]). Self-administrators were more likely to treat early and experience shorter attacks than those treated by a healthcare professional. Conclusion: Early blockade of the bradykinin B-2 receptor with icatibant, particularly within the first hour of attack onset, significantly reduced attack duration and time to attack resolution.	[Maurer, Marcus] Charite Univ Med Berlin, Allergie Ctr Charite, Dept Dermatol & Allergy, Berlin, Germany; [Aberer, Werner] Med Univ Graz, Dept Dermatol & Venerol, Graz, Austria; [Bouillet, Laurence] Grenoble Univ Hosp, Dept Internal Med, Natl Reference Ctr Angioedema, Grenoble, France; [Caballero, Teresa] Hosp La Paz, Hlth Res Inst IdiPaz, Biomed Res Network Rare Dis, CIBERER,U754, Madrid, Spain; [Fabien, Vincent] Shire Human Genet Therapies, Eysins, Switzerland; [Kanny, Gisele] Univ Lorraine, Fac Med, Allerg Dis Diag & Therapeut EA3999, Vandoeuvre Les Nancy, France; [Kaplan, Allen] Med Univ S Carolina, Charleston, SC 29425 USA; [Longhurst, Hilary] Barts & London Hosp, Dept Immunol, London, England; [Zanichelli, Andrea] Luigi Sacco Univ Milan, Osped Luigi Sacco Milano, Dept Clin Sci, Milan, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Graz; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Shire Pharmaceuticals Limited; Universite de Lorraine; Medical University of South Carolina; University of London; Queen Mary University London; University of Milan; Luigi Sacco Hospital	Maurer, M (corresponding author), Charite Univ Med Berlin, Allergie Ctr Charite, Dept Dermatol & Allergy, Berlin, Germany.	Marcus.Maurer@charite.de	Caballero, Teresa/H-6454-2014; Kanny, Gisèle/AHA-8910-2022; Maurer, Marcus/ABG-2174-2020; Caballero, Teresa/AAU-3982-2020	Caballero, Teresa/0000-0003-3005-9858; Maurer, Marcus/0000-0002-4121-481X; Caballero, Teresa/0000-0003-3005-9858; zanichelli, andrea/0000-0002-7512-4644	Biocryst; ViroPharma; Dyax; Shire HGT, Inc.; CSL Behring; Pharming; Shire HGT, Inc./Jerini AG; Shire Human Genetic Therapies (HGT), Eysins, Switzerland	Biocryst; ViroPharma; Dyax; Shire HGT, Inc.; CSL Behring; Pharming; Shire HGT, Inc./Jerini AG; Shire Human Genetic Therapies (HGT), Eysins, Switzerland	Marcus Maurer has received speaker/consultancy fees from Biocryst, Shire HGT, Inc./Jerini AG and ViroPharma. Werner Aberer has acted as a medical advisor and speaker for Shire HGT, Inc. and CSL Behring; received funding to attend conferences and other educational events; received donations to his departmental fund, and participated in clinical trials for Shire HGT, Inc. Laurence Bouillet has received honoraria from Shire HGT, Inc., CSL Behring, Pharming and ViroPharma. Teresa Caballero has received speaker fees from Shire HGT, Inc./Jerini AG and ViroPharma; consultancy fees from Shire HGT, Inc./Jerini AG, ViroPharma and CSL Behring; funding for travel and meeting attendance from CSL Behring and Shire HGT, Inc.; and has participated in clinical trials for Dyax, Pharming, CSL Behring and Shire HGT, Inc./Jerini AG. Vincent Fabien is an employee of Shire Human Genetic Therapies, Eysins, Switzerland. Gisele Kanny has received donations to her Research Unit and participated in clinical trials for Shire HGT, Inc. Allen Kaplan has received consultancy fees from CSL Behring and Dyax; research grants from Shire HGT, Inc. and Dyax; and has received payment for lectures including service on speakers bureaus from ViroPharma and CSL Behring. Hilary Longhurst has received funding for research and staff support from CSL Behring, Shire HGT, Inc., and Pharming; is a consultant for CSL Behring, Shire HGT Inc. and Swedish Orphan; and a speaker for CSL Behring, Shire HGT, Inc., Swedish Orphan and ViroPharma. Andrea Zanichelli is an advisor for Shire HGT, Inc. and has been an invited speaker for CSL Behring and Shire HGT, Inc. The authors confirm that the above Conflicts of Interest do not alter their adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Icatibant Outcome Survey is funded and supported by Shire Human Genetic Therapies (HGT), Eysins, Switzerland. The funders, HGT, were involved in the study design and analysis and provided funding support for medical writing services to aid the preparation of this manuscript. The listed authors were responsible for the decision to publish and have been fully involved with the preparation of this manuscript. The following listed authors comprise the Icatibant Outcome Survey (IOS) Executive Committee: Marcus Maurer (Chair), Werner Aberer, Laurence Bouillet, Teresa Caballero, Gisele Kanny, Hilary Longhurst and Andrea Zanichelli. These authors were responsible for data collection and analysis.	Aberer W, 2012, ANN MED, V44, P523, DOI 10.3109/07853890.2012.687833; Bork K, 2008, ALLERGY, V63, P751, DOI 10.1111/j.1398-9995.2007.01577.x; Bork K, 2005, TRANSFUSION, V45, P1774, DOI 10.1111/j.1537-2995.2005.00602.x; Bork K, 2007, J ALLERGY CLIN IMMUN, V119, P1497, DOI 10.1016/j.jaci.2007.02.012; Cicardi M, 2012, ALLERGY, V67, P147, DOI 10.1111/j.1398-9995.2011.02751.x; Cicardi M, 2010, NEW ENGL J MED, V363, P532, DOI 10.1056/NEJMoa0906393; Cochrane CG, 1973, J EXP MED, V138, P1568; DUNN JT, 1982, J CLIN INVEST, V70, P627, DOI 10.1172/JCI110656; FIELDS T, 1983, J ALLERGY CLIN IMMUN, V72, P54, DOI 10.1016/0091-6749(83)90052-0; Joseph K, 2002, P NATL ACAD SCI USA, V99, P896, DOI 10.1073/pnas.022626899; Joseph K, 2008, ANN ALLERG ASTHMA IM, V101, P279, DOI 10.1016/S1081-1206(10)60493-0; Kaplan AP, 2010, ANN ALLERG ASTHMA IM, V104, P193, DOI 10.1016/j.anai.2010.01.007; KAPLAN AP, 1971, J EXP MED, V133, P696, DOI 10.1084/jem.133.4.696; Kreuz W, 2012, TRANSFUSION, V52, P100, DOI 10.1111/j.1537-2995.2011.03240.x; Levi M, 2006, J ALLERGY CLIN IMMUN, V117, P904, DOI 10.1016/j.jaci.2006.01.002; Lumry WR, 2011, ANN ALLERG ASTHMA IM, V107, P529, DOI 10.1016/j.anai.2011.08.015; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; Zhao YQ, 2001, AM J PHYSIOL-HEART C, V280, pH1821, DOI 10.1152/ajpheart.2001.280.4.H1821	18	113	115	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e53773	10.1371/journal.pone.0053773	http://dx.doi.org/10.1371/journal.pone.0053773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390491	gold, Green Published			2022-12-27	WOS:000314691100007
J	Tobon, C; Ruiz-Villa, CA; Heidenreich, E; Romero, L; Hornero, F; Saiz, J				Tobon, Catalina; Ruiz-Villa, Carlos A.; Heidenreich, Elvio; Romero, Lucia; Hornero, Fernando; Saiz, Javier			A Three-Dimensional Human Atrial Model with Fiber Orientation. Electrograms and Arrhythmic Activation Patterns Relationship	PLOS ONE			English	Article							ISOLATED SHEEP HEART; PULMONARY VEINS; CATHETER ABLATION; RADIOFREQUENCY ABLATION; CARDIAC TISSUE; SINUS RHYTHM; INTRACARDIAC ECHOCARDIOGRAPHY; MATHEMATICAL-MODEL; IONIC MECHANISMS; TERMINAL CREST	The most common sustained cardiac arrhythmias in humans are atrial tachyarrhythmias, mainly atrial fibrillation. Areas of complex fractionated atrial electrograms and high dominant frequency have been proposed as critical regions for maintaining atrial fibrillation; however, there is a paucity of data on the relationship between the characteristics of electrograms and the propagation pattern underlying them. In this study, a realistic 3D computer model of the human atria has been developed to investigate this relationship. The model includes a realistic geometry with fiber orientation, anisotropic conductivity and electrophysiological heterogeneity. We simulated different tachyarrhythmic episodes applying both transient and continuous ectopic activity. Electrograms and their dominant frequency and organization index values were calculated over the entire atrial surface. Our simulations show electrograms with simple potentials, with little or no cycle length variations, narrow frequency peaks and high organization index values during stable and regular activity as the observed in atrial flutter, atrial tachycardia (except in areas of conduction block) and in areas closer to ectopic activity during focal atrial fibrillation. By contrast, cycle length variations and polymorphic electrograms with single, double and fragmented potentials were observed in areas of irregular and unstable activity during atrial fibrillation episodes. Our results also show: 1) electrograms with potentials without negative deflection related to spiral or curved wavefronts that pass over the recording point and move away, 2) potentials with a much greater proportion of positive deflection than negative in areas of wave collisions, 3) double potentials related with wave fragmentations or blocking lines and 4) fragmented electrograms associated with pivot points. Our model is the first human atrial model with realistic fiber orientation used to investigate the relationship between different atrial arrhythmic propagation patterns and the electrograms observed at more than 43000 points on the atrial surface.	[Tobon, Catalina; Romero, Lucia; Saiz, Javier] Univ Politecn Valencia, Inst Interuniv Invest Bioingn & Tecnol Orientada, E-46071 Valencia, Spain; [Ruiz-Villa, Carlos A.] Univ Caldas, Dept Sistemas, Manizales, Caldas, Colombia; [Heidenreich, Elvio] Univ Nacl Lomas de Zamora, Buenos Aires, DF, Argentina; [Hornero, Fernando] Hosp Gen Valencia, Serv Cirugia Cardiaca, Valencia, Spain; [Ruiz-Villa, Carlos A.] Univ Nacl Colombia, Dept Informat & Comp, Manizales, Caldas, Colombia	Universitat Politecnica de Valencia; Universidad de Caldas; National University of Lomas de Zamora; Universidad Nacional de Colombia	Saiz, J (corresponding author), Univ Politecn Valencia, Inst Interuniv Invest Bioingn & Tecnol Orientada, E-46071 Valencia, Spain.	jsaiz@gbio.i3bh.es	Saiz, Javier/I-1295-2015; Romero, Lucia/H-6815-2015	Saiz, Javier/0000-0002-9850-0825; Romero, Lucia/0000-0003-4605-8630; Tobon, Catalina/0000-0002-0578-329X	Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Ministerio de Ciencia e Innovacion of Spain [TEC2008-02090]; Plan Avanza (Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion), Ministerio de Industria Turismo y Comercio of Spain [TSI-020100-2010-469]; Programa Prometeo of the Generalitat Valenciana; Programa de Apoyo a la Investigacion y Desarrollo de la Universitat Politecnica de Valencia [PAID-06-11-2002]	Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Ministerio de Ciencia e Innovacion of Spain; Plan Avanza (Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion), Ministerio de Industria Turismo y Comercio of Spain; Programa Prometeo of the Generalitat Valenciana; Programa de Apoyo a la Investigacion y Desarrollo de la Universitat Politecnica de Valencia	This work was partially supported by the Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Ministerio de Ciencia e Innovacion of Spain (TEC2008-02090), by the Plan Avanza (Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion), Ministerio de Industria Turismo y Comercio of Spain (TSI-020100-2010-469), by the Programa Prometeo 2012 of the Generalitat Valenciana and by the Programa de Apoyo a la Investigacion y Desarrollo de la Universitat Politecnica de Valencia (PAID-06-11-2002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLESSIE MA, 1977, CIRC RES, V41, P9, DOI 10.1161/01.RES.41.1.9; Antz M, 1998, CIRCULATION, V98, P1790, DOI 10.1161/01.CIR.98.17.1790; Arora R, 2003, CIRCULATION, V107, P1816, DOI 10.1161/01.CIR.0000058461.86339.7E; Ashihara T, 2012, CIRC RES, V110, P275, DOI 10.1161/CIRCRESAHA.111.255026; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Becker R, 2001, CIRCULATION, V103, P2521, DOI 10.1161/01.CIR.103.20.2521; Berenfeld O, 2000, J CARDIOVASC ELECTR, V11, P869, DOI 10.1111/j.1540-8167.2000.tb00066.x; Berenfeld O, 2002, CIRC RES, V90, P1173, DOI 10.1161/01.RES.0000022854.95998.5C; BOINEAU JP, 1988, CIRCULATION, V77, P1221, DOI 10.1161/01.CIR.77.6.1221; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Cabrera JA, 1998, J CARDIOVASC ELECTR, V9, P1186, DOI 10.1111/j.1540-8167.1998.tb00091.x; CANAVAN TE, 1988, ANN THORAC SURG, V46, P232, DOI 10.1016/S0003-4975(10)65904-8; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Chorro FJ, 2003, PACE, V26, P1262, DOI 10.1046/j.1460-9592.2003.t01-1-00178.x; Clayton RH, 2004, PROG BIOPHYS MOL BIO, V85, P473, DOI 10.1016/j.pbiomolbio.2003.12.002; Cohen G I, 1995, J Am Soc Echocardiogr, V8, P221, DOI 10.1016/S0894-7317(05)80031-8; Courtemanche M, 1999, CARDIOVASC RES, V42, P477, DOI 10.1016/S0008-6363(99)00034-6; Derejko P, 2010, PACE, V33, P1518, DOI 10.1111/j.1540-8159.2010.02847.x; Dossel O, 2012, MED BIOL ENG COMPUT, V50, P773, DOI 10.1007/s11517-012-0924-6; DOLBER PC, 1989, AM J PHYSIOL, V257, pH1446, DOI 10.1152/ajpheart.1989.257.5.H1446; DURRER D, 1970, CIRCULATION, V41, P899, DOI 10.1161/01.CIR.41.6.899; Everett TH, 2001, IEEE T BIO-MED ENG, V48, P969, DOI 10.1109/10.942586; Everett TH, 2006, AM J PHYSIOL-HEART C, V291, pH2911, DOI 10.1152/ajpheart.01128.2005; Feng JL, 1998, CIRC RES, V83, P541, DOI 10.1161/01.RES.83.5.541; Franz MR, 1997, J AM COLL CARDIOL, V30, P1785, DOI 10.1016/S0735-1097(97)00385-9; Friedman PA, 2000, CIRCULATION, V101, P1568, DOI 10.1161/01.CIR.101.13.1568; Gaspo R, 1997, CIRCULATION, V96, P4027; Gima K, 2002, CIRC RES, V90, P889, DOI 10.1161/01.RES.0000016960.61087.86; Gong YF, 2007, CIRCULATION, V115, P2094, DOI 10.1161/CIRCULATIONAHA.106.656504; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Grimm RA, 1996, AM HEART J, V132, P286, DOI 10.1016/S0002-8703(96)90424-X; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hansson A, 1998, EUR HEART J, V19, P293, DOI 10.1053/euhj.1997.0742; Harrild DM, 2000, CIRC RES, V87, pE25; HAYASHI H, 1982, AM J PHYSIOL, V242, pH421, DOI 10.1152/ajpheart.1982.242.3.H421; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; Henriquez CS, 1996, P IEEE, V84, P334, DOI 10.1109/5.486738; Ho SY, 2009, CLIN ANAT, V22, P52, DOI 10.1002/ca.20634; Ho SY, 2002, CARDIOVASC RES, V54, P325, DOI 10.1016/S0008-6363(02)00226-2; Ho SY, 1999, J CARDIOVASC ELECTR, V10, P1525; Ho SY, 1998, INT WORKSH COMP SIM, P77; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jalife J, 2003, J CARDIOVASC ELECTR, V14, P776, DOI 10.1046/j.1540-8167.2003.03136.x; Kalifa JM, 2006, CIRCULATION, V113, P626, DOI 10.1161/CIRCULATIONAHA.105.575340; Kalman JM, 1998, J AM COLL CARDIOL, V31, P451, DOI 10.1016/S0735-1097(97)00492-0; Kholova I, 2004, CIRCULATION, V110, P483, DOI 10.1161/01.CIR.0000137117.87589.88; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Konings KTS, 1997, CIRCULATION, V95, P1231; Krogh-Madsen T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002390; Krueger MW, 2011, LECT NOTES COMPUT SC, V6666, P223, DOI 10.1007/978-3-642-21028-0_28; Lazar S, 2004, CIRCULATION, V110, P3181, DOI 10.1161/01.CIR.0000147279.91094.5E; Lemery R, 2003, AM J CARDIOL, V91, P1482, DOI 10.1016/S0002-9149(03)00405-3; Lemery R, 2007, J CARDIOVASC ELECTR, V18, P402, DOI 10.1111/j.1540-8167.2007.00762.x; Lesh MD, 1996, J ELECTROCARDIOL, V29, P101, DOI 10.1016/S0022-0736(96)80039-2; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Lin YJ, 2006, J CARDIOVASC ELECTR, V17, pS44, DOI 10.1111/j.1540-8167.2006.00632.x; Maleckar MM, 2009, BIOPHYS J, V97, P2179, DOI [10.1016/j.bpj.2009.07.054, 10.1016/j.bpj.2009.07.0.54]; Maleckar MM, 2009, AM J PHYSIOL-HEART C, V297, pH1398, DOI 10.1152/ajpheart.00411.2009; Mandapati R, 2000, CIRCULATION, V101, P194, DOI 10.1161/01.CIR.101.2.194; Mansour M, 2001, CIRCULATION, V103, P2631; Marom EM, 2004, RADIOLOGY, V230, P824, DOI 10.1148/radiol.2303030315; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Nademanee K, 2010, J CARDIOL, V55, P1, DOI 10.1016/j.jjcc.2009.11.002; NATHAN H, 1966, CIRCULATION, V34, P412, DOI 10.1161/01.CIR.34.3.412; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Niederer SA, 2011, PHILOS T R SOC A, V369, P4331, DOI 10.1098/rsta.2011.0139; Nygren A, 1998, CIRC RES, V82, P63; OLSHANSKY B, 1992, PACE, V15, P2308, DOI 10.1111/j.1540-8159.1992.tb04174.x; Pan NH, 2008, CHEST, V133, P190, DOI 10.1378/chest.07-1769; ROGERS JM, 1994, IEEE T BIO-MED ENG, V41, P743, DOI 10.1109/10.310090; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Ruiz C, 2010, THESIS U POLITECNICA; Ryu K, 2006, J CARDIOVASC ELECTR, V17, P198, DOI 10.1111/j.1540-8167.2005.00320.x; Sahadevan J, 2004, CIRCULATION, V110, P3293, DOI 10.1161/01.CIR.0000147781.02738.13; Saiz J, 2011, IEEE T BIO-MED ENG, V58, P43, DOI 10.1109/TBME.2010.2077292; Sanchez C, 2012, AM J PHYSIOL-HEART C, V302, pH1146, DOI 10.1152/ajpheart.00668.2011; Sanchez-Quintana D, 2002, HEART, V88, P406, DOI 10.1136/heart.88.4.406; Sanders P, 2005, CIRCULATION, V112, P789, DOI 10.1161/CIRCULATIONAHA.104.517011; Sanders P, 2006, J CARDIOVASC ELECTR, V17, P965, DOI 10.1111/j.1540-8167.2006.00546.x; Saoudi N, 2001, EUR HEART J, V22, P1162, DOI 10.1053/euhj.2001.2658; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Skanes AC, 1998, CIRCULATION, V98, P1236, DOI 10.1161/01.CIR.98.12.1236; STRANG G, 1968, SIAM J NUMER ANAL, V5, P506, DOI 10.1137/0705041; Takahashi Y, 2006, J CARDIOVASC ELECTR, V17, P382, DOI 10.1111/j.1540-8167.2005.00414.x; Tobon C, 2010, THESIS U POLITECNICA; Tobon C, 2009, THESIS U POLITECNICA; WANG K, 1995, BRIT HEART J, V73, P559; Weigner MJ, 1999, HEART, V82, P555, DOI 10.1136/hrt.82.5.555; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wilders R, 2000, PFLUG ARCH EUR J PHY, V441, P301, DOI 10.1007/s004240000413; Wolf PA, 1996, AM HEART J, V131, P790, DOI 10.1016/S0002-8703(96)90288-4; Workman AJ, 2001, CARDIOVASC RES, V52, P226, DOI 10.1016/S0008-6363(01)00380-7; Zhang HG, 2005, CARDIOVASC RES, V66, P493, DOI 10.1016/j.cardiores.2005.01.020; Zhao JC, 2012, CIRC-ARRHYTHMIA ELEC, V5, P361, DOI 10.1161/CIRCEP.111.967950; Zlochiver S, 2008, HEART RHYTHM, V5, P846, DOI 10.1016/j.hrthm.2008.03.010	97	66	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e50883	10.1371/journal.pone.0050883	http://dx.doi.org/10.1371/journal.pone.0050883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408928	Green Published, gold			2022-12-27	WOS:000315100000002
J	Hofstra, JJ; Cornet, AD; Declerck, PJ; Dixon, B; Aslami, H; Vlaar, APJ; Roelofs, JJ; van der Poll, T; Levi, M; Schultz, MJ				Hofstra, Jorrit J.; Cornet, Alexander D.; Declerck, Paul J.; Dixon, Barry; Aslami, Hamid; Vlaar, Alexander P. J.; Roelofs, Joris J.; van der Poll, Tom; Levi, Marcel; Schultz, Marcus J.			Nebulized Fibrinolytic Agents Improve Pulmonary Fibrinolysis but Not Inflammation in Rat Models of Direct and Indirect Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PSEUDOMONAS-AERUGINOSA PNEUMONIA; ACTIVATED PROTEIN-C; PLASMINOGEN-ACTIVATOR; COAGULATION; LIPOPOLYSACCHARIDE; ABNORMALITIES; INTERLEUKIN-1; COAGULOPATHY; REPERFUSION	Background: Critically ill patients frequently develop acute lung injury (ALI). Disturbed alveolar fibrin turnover, a characteristic feature of ALI, is the result of both activation of coagulation and inhibition of fibrinolysis. Nebulized fibrinolytic agents could exert lung-protective effects, via promotion of fibrinolysis as well as anti-inflammation. Methods: Rats were challenged intratracheally with Pseudomonas aeruginosa, resulting in pneumonia as a model for direct ALI, or received an intravenous bolus infusion of lipopolysaccharide, as a model for indirect ALI. Rats were randomized to nebulization of normal saline (placebo), recombinant tissue plasminogen activator (rtPA), or monoclonal antibodies against plasminogen activator inhibitor-type 1 (anti-PAI-1). Results: Nebulized rtPA or anti-PAI-1 enhanced the bronchoalveolar fibrinolytic system, as reflected by a significant reduction of PAI-1 activity levels in bronchoalveolar lavage fluid, and a consequent increase in plasminogen activator activity (PAA) levels to supranormal values. Both treatments also significantly affected systemic fibrinolysis as reflected by a significant increase in PAA levels in plasma to supranormal levels. Neither nebulized rtPA nor anti-PA1-1 affected pulmonary inflammation. Neither treatment affected bacterial clearance of P. aeruginosa from the lungs in case of pneumonia. Conclusions: Local treatment with rtPA or anti-PA1-1 affects pulmonary fibrinolysis but not inflammation in models of direct or indirect ALI in rats.	[Hofstra, Jorrit J.; Cornet, Alexander D.; Aslami, Hamid; Vlaar, Alexander P. J.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Hofstra, Jorrit J.; Aslami, Hamid; Vlaar, Alexander P. J.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands; [Hofstra, Jorrit J.] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Hofstra, Jorrit J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Declerck, Paul J.] Univ Leuven, Lab Pharmaceut Biol & Pharmacol, Fac Pharmaceut Sci, Louvain, Belgium; [Dixon, Barry] St Vincents Hosp, Dept Intens Care Med, Melbourne, Vic, Australia; [Vlaar, Alexander P. J.; Levi, Marcel] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Roelofs, Joris J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Schultz, Marcus J.] HERMES Crit Care Grp, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; St Vincent's Hospital Melbourne; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hofstra, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.hofstra@amc.uva.nl	Schultz, Marcus/AAB-6379-2021; Levi, Marcel/AAZ-8559-2020; Declerck, Paul J/A-2330-2017	Schultz, Marcus/0000-0003-3969-7792; Declerck, Paul J/0000-0003-1259-9105; Roelofs, Joris/0000-0001-9595-6571; Cornet, Alexander/0000-0002-9917-5251; Vlaar, Alexander/0000-0002-3453-7186	Academic Medical Centre of the University of Amsterdam	Academic Medical Centre of the University of Amsterdam	This research was funded by the Academic Medical Centre of the University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GB, 2009, AM J PHYSIOL-LUNG C, V296, pL277, DOI 10.1152/ajplung.90475.2008; [Anonymous], 1997, NEW ENGL J MED, V337, P1118, DOI [10.1056/NEJM199710163371603, DOI 10.1056/NEJM199710163371603]; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Choi G, 2007, EUR RESPIR J, V30, P423, DOI 10.1183/09031936.00165606; Choi G, 2006, SWISS MED WKLY, V136, P139; Choi G, 2008, CRIT CARE MED, V36, P204, DOI 10.1097/01.CCM.0000292012.87482.F4; Choi G, 2007, CRIT CARE MED, V35, P1362, DOI 10.1097/01.CCM.0000261888.32654.6D; Dahlem P, 2006, EUR RESPIR J, V28, P992, DOI 10.1183/09031936.06.00133104; Debrock S, 1997, BBA-PROTEIN STRUCT M, V1337, P257, DOI 10.1016/S0167-4838(96)00173-2; Dixon B, 2010, CRIT CARE, V14, DOI 10.1186/cc9286; Dixon B, 2008, CRIT CARE, V12, DOI 10.1186/cc6894; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Gunther A, 2000, AM J RESP CRIT CARE, V161, P454; HARDAWAY RM, 1990, CRIT CARE MED, V18, P1413, DOI 10.1097/00003246-199012000-00021; Hofstra JJ, 2010, J AEROSOL MED PULM D, V23, P105, DOI 10.1089/jamp.2009.0779; Hua F, 2011, BLOOD COAGUL FIBRIN, V22, P480, DOI 10.1097/MBC.0b013e328346ef56; IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240; IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217; Kipnis E, 2004, SHOCK, V21, P444, DOI 10.1097/00024382-200405000-00008; Renckens R, 2008, J THROMB HAEMOST, V6, P660, DOI 10.1111/j.1538-7836.2008.02892.x; Robriquet L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-41; SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440; Schoots IG, 2004, THROMB HAEMOSTASIS, V91, P497, DOI 10.1160/TH03-08-0529; Schultz MJ, 2006, CRIT CARE MED, V34, P871, DOI 10.1097/01.CCM.0000202136.91651.34; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; SEEGER W, 1992, AM J PHYSIOL, V262, pL286, DOI 10.1152/ajplung.1992.262.3.L286; SEEGER W, 1985, J APPL PHYSIOL, V58, P326, DOI 10.1152/jappl.1985.58.2.326; Stringer KA, 1998, FREE RADICAL BIO MED, V25, P184, DOI 10.1016/S0891-5849(98)00047-1; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Welty-Wolf KE, 2002, THROMB HAEMOSTASIS, V88, P17; Zhao YG, 2011, AM J PHYSIOL-LUNG C, V300, pL718, DOI 10.1152/ajplung.00227.2010	32	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55262	10.1371/journal.pone.0055262	http://dx.doi.org/10.1371/journal.pone.0055262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408962	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200020
J	Park, S; Nam, BH; Yang, HR; Lee, JA; Lim, H; Han, JT; Park, IS; Shin, HR; Lee, JS				Park, Sohee; Nam, Byung-Ho; Yang, Hye-Ryung; Lee, Ji An; Lim, Hyunsun; Han, Jun Tae; Park, Il Su; Shin, Hai-Rim; Lee, Jin Soo			Individualized Risk Prediction Model for Lung Cancer in Korean Men	PLOS ONE			English	Article							TOBACCO SMOKING; PREVENTION; EXPLANATIONS; STATISTICS; AMERICAN; PARADOX; TRIAL; JAPAN	Purpose: Lung cancer is the leading cause of cancer deaths in Korea. The objective of the present study was to develop an individualized risk prediction model for lung cancer in Korean men using population-based cohort data. Methods: From a population-based cohort study of 1,324,804 Korean men free of cancer at baseline, the individualized absolute risk of developing lung cancer was estimated using the Cox proportional hazards model. We checked the validity of the model using C statistics and the Hosmer-Lemeshow chi-square test on an external validation dataset. Results: The risk prediction model for lung cancer in Korean men included smoking exposure, age at smoking initiation, body mass index, physical activity, and fasting glucose levels. The model showed excellent performance (C statistic = 0.871, 95% CI = 0.867-0.876). Smoking was significantly associated with the risk of lung cancer in Korean men, with a four-fold increased risk in current smokers consuming more than one pack a day relative to non-smokers. Age at smoking initiation was also a significant predictor for developing lung cancer; a younger age at initiation was associated with a higher risk of developing lung cancer. Conclusion: This is the first study to provide an individualized risk prediction model for lung cancer in an Asian population with very good model performance. In addition to current smoking status, earlier exposure to smoking was a very important factor for developing lung cancer. Since most of the risk factors are modifiable, this model can be used to identify those who are at a higher risk and who can subsequently modify their lifestyle choices to lower their risk of lung cancer.	[Park, Sohee; Nam, Byung-Ho; Yang, Hye-Ryung; Lee, Ji An] Natl Canc Ctr, Biometr Res Branch, Goyang, South Korea; [Park, Sohee] Yonsei Univ, Dept Epidemiol & Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Lim, Hyunsun] Yonsei Univ, Coll Med, Gangnam Biomed Res Ctr, Seoul, South Korea; [Han, Jun Tae] Minist Patriots & Vet Affairs, Informat Team, Seoul, South Korea; [Park, Il Su] Uiduk Univ, Dept Hlth, Gyeongju, South Korea; [Shin, Hai-Rim] Natl Canc Ctr, Div Canc Registrat & Surveillance, Goyang, South Korea; [Shin, Hai-Rim] WHO, Western Pacific Reg Off, Manila, Philippines; [Lee, Jin Soo] Natl Canc Ctr, Ctr Lung Canc, Goyang, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); WHO Western Pacific Regional Office; World Health Organization; National Cancer Center - Korea (NCC)	Nam, BH (corresponding author), Natl Canc Ctr, Biometr Res Branch, Goyang, South Korea.	byunghonam@ncc.re.kr			National Cancer Center Grant [NCC-0810190]	National Cancer Center Grant	This study was supported by the National Cancer Center Grant (NCC-0810190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2009, TOBACCO ATLAS; [Anonymous], ASIAN PACIFIC PERSPE; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Colditz GA, 2000, CANCER CAUSE CONTROL, V11, P477, DOI 10.1023/A:1008984432272; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Ells L, 2007, FOOD NUTR PHYS ACT P; Etzel CJ, 2008, CANCER PREV RES, V1, P255, DOI 10.1158/1940-6207.CAPR-08-0082; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Kushi LH, 2006, CA-CANCER J CLIN, V56, P254, DOI 10.3322/canjclin.56.5.254; Marugame T, 2005, CANCER SCI, V96, P120, DOI 10.1111/j.1349-7006.2005.00013.x; Ministry of Health Welfare and Family Affairs, 2009, NAT SURV SMOK PREV B; Nakaji S, 2003, EUR J EPIDEMIOL, V18, P381; Nam B, 2000, THESIS; Omenn GS, 2007, EUR J CANCER PREV, V16, P184, DOI 10.1097/01.cej.0000215612.98132.18; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Statistics Korea, 2010, CAUS DEATHS KOR 2010; Stellman SD, 2001, CANCER EPIDEM BIOMAR, V10, P1193; Takahashi I, 2008, PUBLIC HEALTH, V122, P891, DOI 10.1016/j.puhe.2007.10.004; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Thun MJ, 1996, SMOKING TOBACCO CONT, V8; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Health Organization, 1994, INT CLASS DIS REL HL; Yun YH, 2005, CANCER EPIDEM BIOMAR, V14, P2125, DOI 10.1158/1055-9965.EPI-05-0236	30	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54823	10.1371/journal.pone.0054823	http://dx.doi.org/10.1371/journal.pone.0054823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408946	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200012
J	Antonioni, A; Cacault, MP; Lalive, R; Tomassini, M				Antonioni, Alberto; Cacault, Maria Paula; Lalive, Rafael; Tomassini, Marco			Coordination on Networks: Does Topology Matter?	PLOS ONE			English	Article							LOCAL INTERACTION; COOPERATION	Effective coordination is key to many situations that affect the well-being of two or more humans. Social coordination can be studied in coordination games between individuals located on networks of contacts. We study the behavior of humans in the laboratory when they play the Stag Hunt game - a game that has a risky but socially efficient equilibrium and an inefficient but safe equilibrium. We contrast behavior on a cliquish network to behavior on a random network. The cliquish network is highly clustered and resembles more closely to actual social networks than the random network. In contrast to simulations, we find that human players dynamics do not converge to the efficient outcome more often in the cliquish network than in the random network. Subjects do not use pure myopic best-reply as an individual update rule. Numerical simulations agree with laboratory results once we implement the actual individual updating rule that human subjects use in our laboratory experiments.	[Antonioni, Alberto; Cacault, Maria Paula; Lalive, Rafael; Tomassini, Marco] Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland	University of Lausanne	Antonioni, A (corresponding author), Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland.	alberto.antonioni@unil.ch	Antonioni, Alberto/B-9686-2014; Tomassini, Marco/D-6312-2013; Antonioni, Alberto/U-6497-2018	Antonioni, Alberto/0000-0002-5788-3348; Antonioni, Alberto/0000-0002-5788-3348; Cacault, Maria Paula/0000-0001-9241-2368; Lalive, Rafael/0000-0003-1938-692X	Swiss National Scientific Foundation [200021-132802/1]	Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF))	For A. Antonioni the project is funded by the Swiss National Scientific Foundation under grant n. 200021-132802/1 (http://www.snf.ch/F/Pages/default.aspx). This support was also used to pay the experimental subjects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battalio R, 2001, ECONOMETRICA, V61, P989; Berninghaus SK, 2002, GAME ECON BEHAV, V39, P177, DOI 10.1006/game.2001.0897; Camerer C, 2003, BEHAV GAME THEORY; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; COOPER R, 1992, Q J ECON, V107, P739, DOI 10.2307/2118488; Easley D, 2010, NETWORKS CROWDS MARK; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; ELLISON G, 1993, ECONOMETRICA, V61, P1047, DOI 10.2307/2951493; Ellison G, 2000, REV ECON STUD, V67, P17, DOI 10.1111/1467-937X.00119; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frey V, 2012, REV NETW ECON, V11, DOI 10.1515/1446-9022.1365; Goyal Sanjeev, 2007, CONNECTIONS INTRO EC; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Keser C, 1998, ECON LETT, V58, P269, DOI 10.1016/S0165-1765(97)00289-9; Luthi L, 2008, PHYSICA A, V387, P955, DOI 10.1016/j.physa.2007.09.046; Morris S, 2000, REV ECON STUD, V67, P57, DOI 10.1111/1467-937X.00121; My KB, 1999, WORKING PAPERS BETA; Roca CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015210; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Samuelson L., 1997, EVOLUTIONARY GAMES E; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tomassini M, 2010, INT J MOD PHYS C, V21, P1277, DOI 10.1142/S012918311001583X; VANHUYCK JB, 1993, GAME ECON BEHAV, V5, P485, DOI 10.1006/game.1993.1026; VANHUYCK JB, 1990, AM ECON REV, V80, P234; Vega-Redondo F., 2003, EC THEORY GAMES, P1, DOI [10.1017/CBO9780511753954, DOI 10.1017/CBO9780511753954]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weidenholzer S, 2010, GAMES-BASEL, V1, P551; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252	33	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55033	10.1371/journal.pone.0055033	http://dx.doi.org/10.1371/journal.pone.0055033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405109	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400053
J	Arachiche, A; de la Fuente, M; Nieman, MT				Arachiche, Amal; de la Fuente, Maria; Nieman, Marvin T.			Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets	PLOS ONE			English	Article							THROMBIN; PATHWAYS; AGGREGATION; INHIBITION; GENERATION; EXPOSURE; G(12/13); RELEASE; ABSENCE; ADP	Thrombin activates platelets through protease activated receptors (PARs). Mouse platelets express PAR3 and PAR4. PAR3 does not signal in platelets. However, PAR4 is a relatively poor thrombin substrate and requires PAR3 as a cofactor at low thrombin concentrations. In this study we show that PAR3 also regulates PAR4 signaling. In response to thrombin (30-100 nM) or PAR4 activating peptide (AYPGKF), platelets from PAR3(-/-) mice had increased Gq signaling compared to wild type mice as demonstrated by a 1.6-fold increase in the maximum intracellular calcium (Ca2+) mobilization, an increase in phosphorylation level of protein kinase C (PKC) substrates, and a 2-fold increase of Ca2+ release from intracellular stores. Moreover, platelets from heterozygous mice (PAR3(+/-)) had an intermediate increase in maximum Ca2+ mobilization. Treatment of PAR3(-/-) mice platelets with P2Y(12) antagonist (2MeSAMP) did not affect Ca2+ mobilization from PAR4 in response to thrombin or AYPGKF. The activation of RhoA-GTP downstream G(12/13) signaling in response to thrombin was not significantly different between wild type and PAR3(-/-) mice. Since PAR3 influenced PAR4 signaling independent of agonist, we examined the direct interaction between PAR3 and PAR4 with bioluminescence resonance energy transfer (BRET). PAR3 and PAR4 form constitutive homodimers and heterodimers. In summary, our results demonstrate that in addition to enhancing PAR4 activation at low thrombin concentrations, PAR3 negatively regulates PAR4-mediated maximum Ca2+ mobilization and PKC activation in mouse platelets by physical interaction.	[Arachiche, Amal; de la Fuente, Maria; Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Nieman, MT (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	nieman@case.edu			American Society for Hematology (Scholar Award); National Institutes of Health [R01 HL098217]; Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER	American Society for Hematology (Scholar Award); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the American Society for Hematology (Scholar Award) and the National Institutes of Health (R01 HL098217) to MN. This research was also supported by the Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arachiche A, 2009, ARTERIOSCL THROM VAS, V29, P1883, DOI 10.1161/ATVBAHA.109.190926; Bachelot-Loza C, 2006, BRIT J HAEMATOL, V133, P419, DOI 10.1111/j.1365-2141.2006.06031.x; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; de la Fuente M, 2012, J BIOL CHEM, V287, P10414, DOI 10.1074/jbc.M112.341438; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harper MT, 2011, J THROMB HAEMOST, V9, P1599, DOI 10.1111/j.1538-7836.2011.04393.x; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Ishihara H, 1998, BLOOD, V91, P4152, DOI 10.1182/blood.V91.11.4152.411k22_4152_4157; Jantzen HM, 2001, J CLIN INVEST, V108, P477; Jardin I, 2007, BIOCHEM J, V401, P167, DOI 10.1042/BJ20060888; Jin JG, 2009, BIOCHEM PHARMACOL, V77, P835, DOI 10.1016/j.bcp.2008.11.017; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Madhusudhan T, 2012, BLOOD, V119, P874, DOI 10.1182/blood-2011-07-365973; Mao YY, 2009, PLATELETS, V20, P191, DOI 10.1080/09537100902803635; McCoy KL, 2012, CELL SIGNAL, V24, P1351, DOI 10.1016/j.cellsig.2012.01.011; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; NANEVICZ T, 1995, J BIOL CHEM, V270, P21619, DOI 10.1074/jbc.270.37.21619; Nieman MT, 2008, BIOCHEMISTRY-US, V47, P13279, DOI 10.1021/bi801334s; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Rosado JA, 2011, CELL CALCIUM, V50, P168, DOI 10.1016/j.ceca.2010.11.011; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Wolberg AS, 2008, TRANSFUS APHER SCI, V38, P15, DOI 10.1016/j.transci.2007.12.005	36	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55740	10.1371/journal.pone.0055740	http://dx.doi.org/10.1371/journal.pone.0055740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405206	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400151
J	Ballhorn, DJ; Kautz, S; Heil, M				Ballhorn, Daniel J.; Kautz, Stefanie; Heil, Martin			Distance and Sex Determine Host Plant Choice by Herbivorous Beetles	PLOS ONE			English	Article							BEAN PHASEOLUS-LUNATUS; COLORADO-POTATO-BEETLE; LEAF BEETLE; PHYTOPHAGOUS INSECTS; SPECIALIST HERBIVORE; INDIRECT DEFENSES; NATURAL ENEMIES; CYDIA-POMONELLA; MATE LOCATION; VOLATILES	Background: Plants respond to herbivore damage with the release of volatile organic compounds (VOCs). This indirect defense can cause ecological costs when herbivores themselves use VOCs as cues to localize suitable host plants. Can VOCs reliably indicate food plant quality to herbivores? Methodology: We determined the choice behavior of herbivorous beetles (Chrysomelidae: Gynandrobrotica guerreroensis and Cerotoma ruficornis) when facing lima bean plants (Fabaceae: Phaseolus lunatus) with different cyanogenic potential, which is an important constitutive direct defense. Expression of inducible indirect defenses was experimentally manipulated by jasmonic acid treatment at different concentrations. The long-distance responses of male and female beetles to the resulting induced plant volatiles were investigated in olfactometer and free-flight experiments and compared to the shortdistance decisions of the same beetles in feeding trials. Conclusion: Female beetles of both species were repelled by VOCs released from all induced plants independent of the level of induction. In contrast, male beetles were repelled by strongly induced plants, showed no significant differences in choice behavior towards moderately induced plants, but responded positively to VOCs released from little induced plants. Thus, beetle sex and plant VOCs had a significant effect on host searching behavior. By contrast, feeding behavior of both sexes was strongly determined by the cyanogenic potential of leaves, although females again responded more sensitively than males. Apparently, VOCs mainly provide information to these beetles that are not directly related to food quality. Being induced by herbivory and involved in indirect plant defense, such VOCs might indicate the presence of competitors and predators to herbivores. We conclude that plant quality as a food source and finding a potentially enemy-free space is more important for female than for male insect herbivores, whereas the presence of a slightly damaged plant can help males to localize putative mating partners.	[Ballhorn, Daniel J.; Kautz, Stefanie; Heil, Martin] Univ Duisburg Essen, Dept Bot Plant Ecol, Essen, Germany	University of Duisburg Essen	Ballhorn, DJ (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.	ballhorn@pdx.edu	Heil, Martin/I-1797-2012; Heil, Martin/T-3960-2019; Heil, Martin/AAC-2730-2022	Heil, Martin/0000-0001-8036-8697; 	German Science Foundation (DFG) [He 3169/4-2, Ba 3966/1-1]; Deutscher Akademischer Austauschdienst (DAAD); German Academy of Sciences Leopoldina [LPDS 2009-29]	German Science Foundation (DFG)(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Academy of Sciences Leopoldina	This work was supported by the German Science Foundation (DFG) (:http://www.dfg.de/foerderung/index.html), grant numbers He 3169/4-2 and Ba 3966/1-1. The DFG provided equipment and consumables (He 3169/4-2) and salary to DJB (Ba 3966/1-1). The Deutscher Akademischer Austauschdienst (DAAD) (http://www.daad.de/de/index.html) provided salary to SK (no specific project number). The German Academy of Sciences Leopoldina (http://www.leopoldinahalle.de) provided salary to SK (grant number LPDS 2009-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; Agrawal AA, 2003, J ECOL, V91, P1049, DOI 10.1046/j.1365-2745.2003.00831.x; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Ballhorn DJ, 2007, J CHEM ECOL, V33, P2195, DOI 10.1007/s10886-007-9380-4; Ballhorn DJ, 2010, ENTOMOL EXP APPL, V134, P245, DOI 10.1111/j.1570-7458.2009.00961.x; Ballhorn DJ, 2008, J CHEM ECOL, V34, P1298, DOI 10.1007/s10886-008-9540-1; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Ballhorn DJ, 2006, J CHEM ECOL, V32, P1861, DOI 10.1007/s10886-006-9114-z; Ballhorn DJ, 2013, OECOLOGIA, V172, P833, DOI 10.1007/s00442-012-2539-x; Ballhorn DJ, 2011, J APPL BOT FOOD QUAL, V84, P65; Ballhorn DJ, 2011, J CHEM ECOL, V37, P141, DOI 10.1007/s10886-010-9905-0; Ballhorn DJ, 2009, PLANT SIGNAL BEHAV, V4, P743, DOI 10.4161/psb.4.8.9088; Ballhorn DJ, 2010, J ECOL, V98, P226, DOI 10.1111/j.1365-2745.2009.01591.x; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; Ballhorn DJ, 2006, J CHEM ECOL, V32, P261, DOI 10.1007/s10886-005-9001-z; Ballhorn DJ, 2005, J CHEM ECOL, V31, P1445, DOI 10.1007/s10886-005-5791-2; Bolter CJ, 1997, J CHEM ECOL, V23, P1003, DOI 10.1023/B:JOEC.0000006385.70652.5e; Bonte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011174; Brilli F, 2009, PLANT CELL ENVIRON, V32, P542, DOI 10.1111/j.1365-3040.2009.01948.x; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Carroll MJ, 2008, J CHEM ECOL, V34, P291, DOI 10.1007/s10886-007-9414-y; Clark KE, 2011, ECOL ENTOMOL, V36, P117, DOI 10.1111/j.1365-2311.2010.01248.x; Cornelius ML, 2001, J ENTOMOL SCI, V36, P259, DOI 10.18474/0749-8004-36.3.259; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; DONATH J, 1994, J PLANT PHYSIOL, V143, P473, DOI 10.1016/S0176-1617(11)81809-2; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Ehrlich PR, 1964, EVOLUTION, V76, P1483; Fernandez P, 2007, BASIC APPL ECOL, V8, P97, DOI 10.1016/j.baae.2006.05.001; Frati F, 2008, PHYSIOL ENTOMOL, V33, P129, DOI 10.1111/j.1365-3032.2008.00614.x; Frati F, 2009, J CHEM ECOL, V35, P505, DOI 10.1007/s10886-009-9625-5; Ginzel MD, 2005, J CHEM ECOL, V31, P213, DOI 10.1007/s10886-005-6735-6; Hanks LM, 1996, J INSECT BEHAV, V9, P383, DOI 10.1007/BF02214017; Heil M, 2004, J ECOL, V92, P527, DOI 10.1111/j.0022-0477.2004.00890.x; Heil M, 2004, J CHEM ECOL, V30, P1289, DOI 10.1023/B:JOEC.0000030299.59863.69; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Hern A, 1999, ENTOMOL EXP APPL, V92, P63, DOI 10.1023/A:1003756428631; Hern A, 2004, NATURWISSENSCHAFTEN, V91, P77, DOI 10.1007/s00114-003-0484-6; Ikonen A, 2002, CHEMOECOLOGY, V12, P23, DOI 10.1007/s00049-002-8323-3; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; JERMY T, 1988, ENTOMOL EXP APPL, V49, P83, DOI 10.1007/BF00188242; Johnson SN, 2006, ECOL ENTOMOL, V31, P395, DOI 10.1111/j.1365-2311.2006.00776.x; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kessler A, 2009, FUNCT ECOL, V23, P901, DOI 10.1111/j.1365-2435.2009.01639.x; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; Kost C, 2005, BASIC APPL ECOL, V6, P237, DOI 10.1016/j.baae.2004.11.002; Lill JT, 2001, OECOLOGIA, V126, P418, DOI 10.1007/s004420000557; Meiners T, 2005, ENTOMOL EXP APPL, V115, P171, DOI 10.1111/j.1570-7458.2005.00280.x; MIGUEL AA, 2005, J CHEM ECOL, V31, P315; Miyamoto Y, 2004, ENTOMOL SCI, V7, P315, DOI 10.1111/j.1479-8298.2004.00079.x; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; Nahrung HF, 2003, AGRIC FOR ENTOMOL, V5, P155, DOI 10.1046/j.1461-9563.2003.00172.x; Natale D, 2003, B ENTOMOL RES, V93, P335, DOI 10.1079/BER2003250; Nieminen M, 2003, J CHEM ECOL, V29, P823, DOI 10.1023/A:1022923514534; PALANISWAMY P, 1993, CAN ENTOMOL, V125, P903, DOI 10.4039/Ent125903-5; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; RANK NE, 1992, OECOLOGIA, V90, P95, DOI 10.1007/BF00317814; Rausher MD, 1996, TRENDS GENET, V12, P212, DOI 10.1016/0168-9525(96)10020-2; Rostas M, 2003, BASIC APPL ECOL, V4, P43, DOI 10.1078/1439-1791-00132; Rudgers JA, 2006, J ECOL, V94, P1249, DOI 10.1111/j.1365-2745.2006.01161.x; Schutz S, 1997, NATURWISSENSCHAFTEN, V84, P212, DOI 10.1007/s001140050381; Sokal R.R., 2012, BIOMETRY; Strong DR, 1984, INSECTS ON PLANTS; Sun XL, 2010, J CHEM ECOL, V36, P388, DOI 10.1007/s10886-010-9771-9; Szentesi A, 2002, ENTOMOL EXP APPL, V105, P141, DOI 10.1023/A:1022194408297; Tanaka M, 2002, POPUL ECOL, V44, P1, DOI 10.1007/s101440200000; Thaler JS, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P319; Wybouw N, 2012, INSECT BIOCHEM MOLEC, V42, P881, DOI 10.1016/j.ibmb.2012.08.002; Yi HS, 2009, PLANT PHYSIOL, V151, P2152, DOI 10.1104/pp.109.144782; ZEHNDER G, 1987, ENVIRON ENTOMOL, V16, P1199, DOI 10.1093/ee/16.5.1199	74	23	26	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55602	10.1371/journal.pone.0055602	http://dx.doi.org/10.1371/journal.pone.0055602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405176	Green Published, gold			2022-12-27	WOS:000315153400121
J	Fallah, A; Guyatt, GH; Snead, OC; Ebrahim, S; Ibrahim, GM; Mansouri, A; Reddy, D; Walter, SD; Kulkarni, AV; Bhandari, M; Banfield, L; Bhatnagar, N; Liang, SL; Teutonico, F; Liao, JX; Rutka, JT				Fallah, Aria; Guyatt, Gordon H.; Snead, O. Carter, III; Ebrahim, Shanil; Ibrahim, George M.; Mansouri, Alireza; Reddy, Deven; Walter, Stephen D.; Kulkarni, Abhaya V.; Bhandari, Mohit; Banfield, Laura; Bhatnagar, Neera; Liang, Shuli; Teutonico, Federica; Liao, Jianxiang; Rutka, James T.			Predictors of Seizure Outcomes in Children with Tuberous Sclerosis Complex and Intractable Epilepsy Undergoing Resective Epilepsy Surgery: An Individual Participant Data Meta-Analysis	PLOS ONE			English	Article							SURGICAL-TREATMENT; EXPERIENCE; IDENTIFICATION	Objective: To perform a systematic review and individual participant data meta-analysis to identify preoperative factors associated with a good seizure outcome in children with Tuberous Sclerosis Complex undergoing resective epilepsy surgery. Data Sources: Electronic databases (MEDLINE, EMBASE, CINAHL and Web of Science), archives of major epilepsy and neurosurgery meetings, and bibliographies of relevant articles, with no language or date restrictions. Study Selection: We included case-control or cohort studies of consecutive participants undergoing resective epilepsy surgery that reported seizure outcomes. We performed title and abstract and full text screening independently and in duplicate. We resolved disagreements through discussion. Data Extraction: One author performed data extraction which was verified by a second author using predefined data fields including study quality assessment using a risk of bias instrument we developed. We recorded all preoperative factors that may plausibly predict seizure outcomes. Data Synthesis: To identify predictors of a good seizure outcome (i.e. Engel Class I or II) we used logistic regression adjusting for length of follow-up for each preoperative variable. Results: Of 9863 citations, 20 articles reporting on 181 participants were eligible. Good seizure outcomes were observed in 126 (69%) participants (Engel Class I: 102(56%); Engel class II: 24(13%)). In univariable analyses, absence of generalized seizure semiology (OR = 3.1, 95%CI = 1.2-8.2, p = 0.022), no or mild developmental delay (OR = 7.3, 95%CI = 2.1-24.7, p = 0.001), unifocal ictal scalp electroencephalographic (EEG) abnormality (OR = 3.2, 95%CI = 1.4-7.6, p = 0.008) and EEG/Magnetic resonance imaging concordance (OR = 4.9, 95%CI = 1.8-13.5, p = 0.002) were associated with a good postoperative seizure outcome. Conclusions: Small retrospective cohort studies are inherently prone to bias, some of which are overcome using individual participant data. The best available evidence suggests four preoperative factors predictive of good seizure outcomes following resective epilepsy surgery. Large long-term prospective multicenter observational studies are required to further evaluate the risk factors identified in this review.	[Fallah, Aria; Ibrahim, George M.; Mansouri, Alireza; Kulkarni, Abhaya V.; Rutka, James T.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Fallah, Aria; Guyatt, Gordon H.; Ebrahim, Shanil; Reddy, Deven; Walter, Stephen D.; Bhandari, Mohit] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Snead, O. Carter, III] Hosp Sick Children, Dept Med, Div Neurol, Toronto, ON M5G 1X8, Canada; [Snead, O. Carter, III; Kulkarni, Abhaya V.; Rutka, James T.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Snead, O. Carter, III; Ibrahim, George M.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Reddy, Deven] McMaster Univ, Dept Surg, Div Neurosurg, Hamilton, ON L8S 4L8, Canada; [Bhandari, Mohit] McMaster Univ, Dept Surg, Div Orthoped Surg, Hamilton, ON L8S 4L8, Canada; [Banfield, Laura; Bhatnagar, Neera] McMaster Univ, Hlth Sci Lib, Hamilton, ON, Canada; [Liang, Shuli] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurosurg, Beijing, Peoples R China; [Teutonico, Federica] Univ Pavia, Dept Child Neurol & Psychiat, I-27100 Pavia, Italy; [Liao, Jianxiang] Shenzhen Childrens Hosp, Dept Pediat Neurol, Shenzhen, Peoples R China	University of Toronto; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McMaster University; McMaster University; McMaster University; Chinese People's Liberation Army General Hospital; University of Pavia	Fallah, A (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada.	aria.fallah@mail.utoronto.ca	Liang, Shuli/GWC-5028-2022; Banfield, Laura E/M-3621-2016; Walter, Stephen/AAB-5548-2022; Liao, Jian/GRX-4579-2022; Bhandari, Mohit/AAQ-1675-2021; Bhatnagar, Neera/B-8004-2013	Banfield, Laura E/0000-0001-6123-1476; Walter, Stephen/0000-0003-4157-8928; Bhatnagar, Neera/0000-0002-5060-5257; Fallah, Aria/0000-0002-9703-0964; Mansouri, Alireza/0000-0002-7442-7539	Smith and Nephew; Stryker; DePuy; Amgen; Moximed	Smith and Nephew; Stryker; DePuy; Amgen(Amgen); Moximed	Dr. Bhandari receives research funding from Smith and Nephew, Stryker, DePuy, Amgen and Moximed. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. All other authors report no disclosures.	Aboian MS, 2011, PEDIATR NEUROL, V45, P83, DOI 10.1016/j.pediatrneurol.2011.05.001; Asano E, 2000, NEUROLOGY, V54, P1976, DOI 10.1212/WNL.54.10.1976; Avellino AM, 1997, J NEUROSURG, V87, P391, DOI 10.3171/jns.1997.87.3.0391; Baumgartner JE, 1997, PEDIATR NEUROSURG, V27, P311, DOI 10.1159/000121276; BEBIN EM, 1993, EPILEPSIA, V34, P651, DOI 10.1111/j.1528-1157.1993.tb00442.x; Behrens E, 1997, NEUROSURGERY, V41, P1, DOI 10.1097/00006123-199707000-00004; CAHAN LD, 1984, CLEVELAND CLIN Q, V51, P313, DOI 10.3949/ccjm.51.2.313; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Guerreiro MM, 1998, NEUROLOGY, V51, P1263, DOI 10.1212/WNL.51.5.1263; Jansen FE, 2007, SEIZURE-EUR J EPILEP, V16, P445, DOI 10.1016/j.seizure.2007.03.001; Jansen FE, 2006, EPILEPSIA, V47, P108, DOI 10.1111/j.1528-1167.2006.00373.x; Jansen FE, 2007, EPILEPSIA, V48, P1477, DOI 10.1111/j.1528-1167.2007.01117.x; Kagawa K, 2005, J CHILD NEUROL, V20, P429, DOI 10.1177/08830738050200050701; Kamimura T, 2006, EPILEPSIA, V47, P991, DOI 10.1111/j.1528-1167.2006.00511.x; Karenfort M, 2002, NEUROPEDIATRICS, V33, P255, DOI 10.1055/s-2002-36740; Koh S, 2000, EPILEPSIA, V41, P1206, DOI 10.1111/j.1528-1157.2000.tb00327.x; Lachhwani DK, 2005, NEUROLOGY, V64, P1651, DOI 10.1212/01.WNL.0000160389.93984.53; Liang SL, 2010, EPILEPSIA, V51, P2316, DOI 10.1111/j.1528-1167.2010.02669.x; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Major P, 2009, EPILEPSIA, V50, P147, DOI 10.1111/j.1528-1167.2008.01814.x; NASHEF L, 1995, EPILEPSIA, V36, P1187, DOI 10.1111/j.1528-1157.1995.tb01061.x; PEROT P, 1966, ARCH NEUROL-CHICAGO, V15, P498, DOI 10.1001/archneur.1966.00470170052005; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Teutonico F, 2008, CHILD NERV SYST, V24, P1437, DOI 10.1007/s00381-008-0679-4; Tonini C, 2004, EPILEPSY RES, V62, P75, DOI 10.1016/j.eplepsyres.2004.08.006; van der Heide A, 2010, CLIN NEUROPHYSIOL, V121, P842, DOI 10.1016/j.clinph.2010.01.010; Vining EPG, 1997, PEDIATRICS, V100, P163, DOI 10.1542/peds.100.2.163; Weiner HL, 2006, PEDIATRICS, V117, P1494, DOI 10.1542/peds.2005-1206; Wen Jia-Lun, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P996; WIEDERHOLT WC, 1985, NEUROLOGY, V35, P600, DOI 10.1212/WNL.35.4.600; Wyllie E, 1998, ANN NEUROL, V44, P740, DOI 10.1002/ana.410440507	33	60	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53565	10.1371/journal.pone.0053565	http://dx.doi.org/10.1371/journal.pone.0053565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405072	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400015
J	Nguyen, THO; Westall, GP; Bull, TE; Meehan, AC; Mifsud, NA; Kotsimbos, TC				Nguyen, Thi H. O.; Westall, Glen P.; Bull, Tara E.; Meehan, Aislin C.; Mifsud, Nicole A.; Kotsimbos, Tom C.			Cross-Reactive Anti-Viral T Cells Increase Prior to an Episode of Viral Reactivation Post Human Lung Transplantation	PLOS ONE			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; VERSUS-HOST-DISEASE; ALLOGRAFT-REJECTION; CYTOMEGALOVIRUS; RESPONSES; MEMORY; LYMPHOCYTES; REPERTOIRE; IMPACT; RECIPIENTS	Human Cytomegalovirus (CMV) reactivation continues to influence lung transplant outcomes. Cross-reactivity of anti-viral memory T cells against donor human leukocyte antigens (HLA) may be a contributing factor. We identified cross-reactive HLA-A*02:01-restricted CMV-specific cytotoxic T lymphocytes (CTL) co-recognizing the NLVPMVATV (NLV) epitope and HLA-B27. NLV-specific CD8+ T cells were expanded for 13 days from 14 HLA-A*02:01/CMV seropositive healthy donors and 11 lung transplant recipients (LTR) then assessed for the production of IFN-gamma and CD107a expression in response to 19 cell lines expressing either single HLA-A or -B class I molecules. In one healthy individual, we observed functional and proliferative cross-reactivity in response to B*27:05 alloantigen, representing approximately 5% of the NLV-specific CTL population. Similar patterns were also observed in one LTR receiving a B27 allograft, revealing that the cross-reactive NLV-specific CTL gradually increased (days 13-193 post-transplant) before a CMV reactivation event (day 270) and reduced to basal levels following viral clearance (day 909). Lung function remained stable with no acute rejection episodes being reported up to 3 years post-transplant. Individualized immunological monitoring of cross-reactive anti-viral T cells will provide further insights into their effects on the allograft and an opportunity to predict sub-clinical CMV reactivation events and immunopathological complications.	[Nguyen, Thi H. O.; Westall, Glen P.; Bull, Tara E.; Meehan, Aislin C.; Mifsud, Nicole A.; Kotsimbos, Tom C.] Monash Univ, Alfred Ctr, Dept Med, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Nguyen, Thi H. O.; Westall, Glen P.; Bull, Tara E.; Meehan, Aislin C.; Mifsud, Nicole A.; Kotsimbos, Tom C.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health	Mifsud, NA (corresponding author), Monash Univ, Alfred Ctr, Dept Med, Cent Clin Sch, Melbourne, Vic 3004, Australia.	nicole.mifsud@monash.edu	Nguyen, Thi Hoang Oanh/AAM-6827-2021	Nguyen, Thi Hoang Oanh/0000-0002-9294-7693; Westall, Glen/0000-0002-3711-068X; Mifsud, Nicole/0000-0001-8647-2102	National Health and Medical Research Council of Australia (NHMRC); The Margaret Pratt Foundation; Peter Doherty NHMRC postdoctoral fellowship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); The Margaret Pratt Foundation; Peter Doherty NHMRC postdoctoral fellowship	This study was funded by the National Health and Medical Research Council of Australia (NHMRC) and The Margaret Pratt Foundation. N.A.M was supported by a Peter Doherty NHMRC postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; Bendjelloul F, 2004, TRANSPL IMMUNOL, V12, P167, DOI 10.1016/j.trim.2003.08.003; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Brehm MA, 2010, AM J TRANSPLANT, V10, P1738, DOI 10.1111/j.1600-6143.2010.03161.x; Brugiere O, 2008, J HEART LUNG TRANSPL, V27, P628, DOI 10.1016/j.healun.2008.02.013; Burrows SR, 1997, EUR J IMMUNOL, V27, P178, DOI 10.1002/eji.1830270126; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Cainelli F, 2002, LANCET INFECT DIS, V2, P539, DOI 10.1016/S1473-3099(02)00370-5; Chalermskulrat W, 2003, CHEST, V123, P1825, DOI 10.1378/chest.123.6.1825; D'Orsogna LJ, 2009, TISSUE ANTIGENS, V74, P290, DOI 10.1111/j.1399-0039.2009.01311.x; D'Orsogna LJA, 2011, TRANSPLANTATION, V91, P645, DOI 10.1097/TP.0b013e318208c071; Elkington R, 2005, BLOOD, V105, P1362, DOI 10.1182/blood-2004-07-2602; Estenne M, 2002, AM J RESP CRIT CARE, V166, P440, DOI 10.1164/rccm.200201-003PP; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; FLEISCHHAUER K, 1990, NEW ENGL J MED, V323, P1818, DOI 10.1056/NEJM199012273232607; Gamadia LE, 2004, TRANSPLANTATION, V77, P1879, DOI 10.1097/01.tp.0000131158.81346.64; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Heeger PS, 1999, J IMMUNOL, V163, P2267; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; KEEVER CA, 1994, BONE MARROW TRANSPL, V14, P137; Khan N, 2002, J INFECT DIS, V185, P1025, DOI 10.1086/339963; Koelle DM, 2002, BLOOD, V99, P3844, DOI 10.1182/blood.V99.10.3844; LOMBARDI G, 1990, INT IMMUNOL, V2, P9, DOI 10.1093/intimm/2.1.9; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Maecker HT, 2004, HUM IMMUNOL, V65, P493, DOI 10.1016/j.humimm.2004.02.004; Mannering SI, 2003, J IMMUNOL METHODS, V283, P173, DOI 10.1016/j.jim.2003.09.004; Melenhorst JJ, 2010, BLOOD, V116, P4700, DOI 10.1182/blood-2010-06-289991; MERKENSCHLAGER M, 1988, EUR J IMMUNOL, V18, P1653, DOI 10.1002/eji.1830181102; Michaelides A, 2003, J CLIN VIROL, V28, P111, DOI 10.1016/S1386-6532(02)00272-X; Mifsud NA, 2008, AM J TRANSPLANT, V8, P121, DOI 10.1111/j.1600-6143.2007.02044.x; Mifsud NA, 2010, TRANSPLANTATION, V90, P1439, DOI 10.1097/TP.0b013e3181ff4ff3; Morice A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012120; Nguyen THO, 2010, IMMUNOL CELL BIOL, V88, P676, DOI 10.1038/icb.2010.20; Paraskeva M, 2011, AM J TRANSPLANT, V11, P2190, DOI 10.1111/j.1600-6143.2011.03663.x; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Rist M, 2009, BLOOD, V114, P2244, DOI 10.1182/blood-2009-05-222596; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Venturi V, 2008, J IMMUNOL, V181, P7853, DOI 10.4049/jimmunol.181.11.7853; Westall G, 2006, AM J TRANSPLANT, V6, P577, DOI 10.1111/j.1600-6143.2005.01212.x; Westall GP, 2008, AM J TRANSPLANT, V8, P1749, DOI 10.1111/j.1600-6143.2008.02294.x; Westall GP, 2007, TRANSPL IMMUNOL, V18, P186, DOI 10.1016/j.trim.2007.07.002; Westall GP, 2003, TRANSPLANTATION, V75, P2064, DOI 10.1097/01.TP.0000069234.04901.A3; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Wong JY, 2004, TRANSPLANTATION, V78, P205, DOI 10.1097/01.tp.0000128611.71038.0c; WREGHITT T, 1989, J ANTIMICROB CHEMOTH, V23, P49, DOI 10.1093/jac/23.suppl_E.49; Wynn KK, 2008, BLOOD, V111, P4283, DOI 10.1182/blood-2007-11-122622; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56042	10.1371/journal.pone.0056042	http://dx.doi.org/10.1371/journal.pone.0056042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405250	Green Published, gold			2022-12-27	WOS:000315153400195
J	Rodriguez-Raecke, R; Niemeier, A; Ihle, K; Ruether, W; May, A				Rodriguez-Raecke, Rea; Niemeier, Andreas; Ihle, Kristin; Ruether, Wolfgang; May, Arne			Structural Brain Changes in Chronic Pain Reflect Probably Neither Damage Nor Atrophy	PLOS ONE			English	Article							GRAY-MATTER DECREASE; CHRONIC BACK-PAIN; MOTOR CORTEX; SOMATOSENSORY CORTEX; GREY-MATTER; REORGANIZATION; FIBROMYALGIA; PLASTICITY; STIMULATION; MORPHOMETRY	Chronic pain appears to be associated with brain gray matter reduction in areas ascribable to the transmission of pain. The morphological processes underlying these structural changes, probably following functional reorganisation and central plasticity in the brain, remain unclear. The pain in hip osteoarthritis is one of the few chronic pain syndromes which are principally curable. We investigated 20 patients with chronic pain due to unilateral coxarthrosis (mean age 63.25 +/- 9.46 (SD) years, 10 female) before hip joint endoprosthetic surgery (pain state) and monitored brain structural changes up to 1 year after surgery: 6-8 weeks, 12-18 weeks and 10-14 month when completely pain free. Patients with chronic pain due to unilateral coxarthrosis had significantly less gray matter compared to controls in the anterior cingulate cortex (ACC), insular cortex and operculum, dorsolateral prefrontal cortex (DLPFC) and orbitofrontal cortex. These regions function as multi-integrative structures during the experience and the anticipation of pain. When the patients were pain free after recovery from endoprosthetic surgery, a gray matter increase in nearly the same areas was found. We also found a progressive increase of brain gray matter in the premotor cortex and the supplementary motor area (SMA). We conclude that gray matter abnormalities in chronic pain are not the cause, but secondary to the disease and are at least in part due to changes in motor function and bodily integration.	[Rodriguez-Raecke, Rea; Ihle, Kristin; May, Arne] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Niemeier, Andreas; Ruether, Wolfgang] Univ Med Ctr Hamburg Eppendorf, Dept Orthopaed, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	May, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	a.may@uke.uni-hamburg.de	Rodriguez-Raecke, Rea/AAU-8948-2020		DFG (German Research Foundation) [MA 1862/2-3]; BMBF (The Federal Ministry of Education and Research) [371 57 01]	DFG (German Research Foundation)(German Research Foundation (DFG)); BMBF (The Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the DFG (German Research Foundation) (MA 1862/2-3) and BMBF (The Federal Ministry of Education and Research) (371 57 01 and NeuroImage Nord). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Antal A, 2008, CLIN J PAIN, V24, P56, DOI 10.1097/AJP.0b013e318157233b; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2006, NEUROIMAGE, V31, P951, DOI 10.1016/j.neuroimage.2006.01.018; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Duerden EG, 2008, J NEUROSCI, V28, P8655, DOI 10.1523/JNEUROSCI.2650-08.2008; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Fontaine D, 2009, J NEUROSURG, V110, P251, DOI 10.3171/2008.6.17602; Franke G, 2002, SYMPTOM CHECKLISTE N; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Geissner E, 1995, Rehabilitation (Stuttg), V34, pXXXV; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gwilym SE, 2010, ARTHRITIS RHEUM; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Levy R, 2010, PAIN PHYSICIAN, V13, P157; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2009, MORPHING VOXELS HYPE; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; May A, 2009, BRAIN, V132, P1419, DOI 10.1093/brain/awp116; Nikolajsen L, 2006, ACTA ANAESTH SCAND, V50, P495, DOI 10.1111/j.1399-6576.2006.00976.x; O'Connell NE, 2011, EUR J PHYS REHAB MED, V47, P309; Puri BK, 2010, J INT MED RES, V38, P1468, DOI 10.1177/147323001003800429; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schmidt-Wilcke T, 2010, HEADACHE; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Swart CMA, 2009, EUR J PAIN, V13, P902, DOI 10.1016/j.ejpain.2008.11.010; Teepker M, 2010, CEPHALALGIA, V30, P137, DOI 10.1111/j.1468-2982.2009.01911.x; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072	49	93	94	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54475	10.1371/journal.pone.0054475	http://dx.doi.org/10.1371/journal.pone.0054475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405082	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400026
J	Smid, JH; Gras, LM; de Boer, AG; French, NP; Havelaar, AH; Wagenaar, JA; van Pelt, W				Smid, Joost H.; Gras, Lapo Mughini; de Boer, Albert G.; French, Nigel P.; Havelaar, Arie H.; Wagenaar, Jaap A.; van Pelt, Wilfrid			Practicalities of Using Non-Local or Non-Recent Multilocus Sequence Typing Data for Source Attribution in Space and Time of Human Campylobacteriosis	PLOS ONE			English	Article							HOST ASSOCIATION; JEJUNI; GENOTYPES; RECOMBINATION; POPULATION; RESISTANCE; CLONES	In this study, 1208 Campylobacter jejuni and C. coli isolates from humans and 400 isolates from chicken, collected in two separate periods over 12 years in The Netherlands, were typed using multilocus sequence typing (MLST). Statistical evidence was found for a shift of ST frequencies in human isolates over time. The human MLST data were also compared to published data from other countries to determine geographical variation. Because only MLST typed data from chicken, taken from the same time point and spatial location, were available in addition to the human data, MLST datasets for other Campylobacter reservoirs from selected countries were used. The selection was based on the degree of similarity of the human isolates between countries. The main aim of this study was to better understand the consequences of using non-local or non-recent MLST data for attributing domestically acquired human Campylobacter infections to specific sources of origin when applying the asymmetric island model for source attribution. In addition, a power-analysis was done to find the minimum number of source isolates needed to perform source attribution using an asymmetric island model. This study showed that using source data from other countries can have a significant biasing effect on the attribution results so it is important to carefully select data if the available local data lack in quality and/or quantity. Methods aimed at reducing this bias were proposed.	[Smid, Joost H.; Havelaar, Arie H.; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands; [Smid, Joost H.; Havelaar, Arie H.] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Gras, Lapo Mughini] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Gras, Lapo Mughini] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [de Boer, Albert G.; Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [French, Nigel P.] Massey Univ, Palmerston North, New Zealand; [Wagenaar, Jaap A.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] WHO, Collaborating Ctr Reference & Res Campylobacter, OIE Reference Lab Campylobacteriosis, Lelystad, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Istituto Superiore di Sanita (ISS); University of Bologna; Wageningen University & Research; Massey University; Utrecht University; World Health Organization	Gras, LM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands.	lapo.mughinigras2@unibo.it	French, Nigel/F-5725-2011; Havelaar, Arie H./P-8495-2014	French, Nigel/0000-0002-6334-0657; Havelaar, Arie H./0000-0002-6456-5460	Dutch ministery of Health, Welfare and Sports	Dutch ministery of Health, Welfare and Sports	This study was funded by Dutch ministery of Health, Welfare and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EFSA J, V8, P1437, DOI DOI 10.2903/J.EFSA.2010.1437; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; de Haan CPA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-200; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Doorduyn Y., 2010, EPIDEMIOL INFECT, V12, P1; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Ercsey-Ravasz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037810; FAOSTAT, FAOSTAT FOOD BAL SHE; Fearnbead P, 2005, J MOL EVOL, V61, P333, DOI 10.1007/s00239-004-0316-0; Fitch BR, 2005, J CLIN MICROBIOL, V43, P4221, DOI 10.1128/JCM.43.8.4221-4224.2005; Garrett N, 2007, J APPL MICROBIOL, V103, P2113, DOI 10.1111/j.1365-2672.2007.03437.x; Gormley FJ, 2008, APPL ENVIRON MICROB, V74, P383, DOI 10.1128/AEM.01455-07; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P148, DOI 10.1128/AEM.01488-06; Kittl S, 2011, J APPL MICROBIOL, V110, P513, DOI 10.1111/j.1365-2672.2010.04906.x; Korczak BM, 2009, J CLIN MICROBIOL, V47, P1996, DOI 10.1128/JCM.00237-09; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; McTavish SM, 2008, EPIDEMIOL INFECT, V136, P1244, DOI 10.1017/S0950268807009892; Mickan L, 2007, J APPL MICROBIOL, V102, P144, DOI 10.1111/j.1365-2672.2006.03049.x; Mughini-Gras L., 2012, PLOS ONE, V7; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Niederer L, 2012, APPL ENVIRON MICROB, V78, P288, DOI 10.1128/AEM.06194-11; Olson KE, 2008, EPIDEMIOLOGY CAMPYLO, P163; Oporto B, 2011, ZOONOSES PUBLIC HLTH, V58, P365, DOI 10.1111/j.1863-2378.2010.01373.x; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Sproston EL, 2011, APPL ENVIRON MICROB, V77, P6579, DOI 10.1128/AEM.00428-11; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Venegas S. A., 1997, MANUAL EOF SVD ANAL; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203	32	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55029	10.1371/journal.pone.0055029	http://dx.doi.org/10.1371/journal.pone.0055029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405107	Green Published, gold			2022-12-27	WOS:000315153400051
J	Wang, XJ; Li, Y; Huang, H; Zhang, XJ; Xie, PW; Hu, W; Li, DD; Wang, SQ				Wang, Xue-jun; Li, Ying; Huang, Hai; Zhang, Xiu-juan; Xie, Pei-wen; Hu, Wei; Li, Dan-dan; Wang, Sheng-qi			A Simple and Robust Vector-Based shRNA Expression System Used for RNA Interference	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; MAMMALIAN-CELLS; HAIRPIN RNA; KNOCKDOWN; LIBRARY; LENGTH; MICE	Background: RNA interference (RNAi) mediated by small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) has become a powerful genetic tool for conducting functional studies. Previously, vector-based shRNA-expression strategies capable of inducing RNAi in viable cells have been developed, however, these vector systems have some disadvantages, either because they were error-prone or cost prohibitive. Results: In this report we described the development of a simple, robust shRNA expression system utilizing 1 long oligonucleotide or 2 short oligonucleotides for half the cost of conventional shRNA construction methods and with a>95% cloning success rate. The shRNA loop sequence and stem structure were also compared and carefully selected for better RNAi efficiency. Furthermore, an easier strategy was developed based on isocaudomers which permit rapid combination of the most efficient promoter-shRNA cassettes. Finally, using this method, the conservative target sites for hepatitis B virus (HBV) knockdown were systemically screened and HBV antigen expression shown to be successfully suppressed in the presence of connected multiple shRNAs both in vitro and in vivo. Conclusion: This novel design describes an inexpensive and effective way to clone and express single or multiple shRNAs from the same vector with the capacity for potent and effective silencing of target genes.	[Wang, Xue-jun; Li, Ying; Huang, Hai; Zhang, Xiu-juan; Xie, Pei-wen; Hu, Wei; Li, Dan-dan; Wang, Sheng-qi] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Wang, SQ (corresponding author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China.	sqwang@bmi.ac.cn		Wang, Xue-jun/0000-0001-5895-936X	National Natural Science Foundation of China [81202562, 81230089]; Chinese Science and Technology Key Projects [2012ZX10004503-011, 2012ZX09103301-044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Science and Technology Key Projects	This work was financially supported by the National Natural Science Foundation of China 81202562 and 81230089, and the Chinese Science and Technology Key Projects grants 2012ZX10004503-011 and 2012ZX09103301-044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Chen CC, 2007, GENE THER, V14, P11, DOI 10.1038/sj.gt.3302846; Chen YC, 2010, J VIROL, V84, P7983, DOI 10.1128/JVI.00068-10; Chumakov SP, 2010, PLASMID, V63, P143, DOI 10.1016/j.plasmid.2009.12.003; Flores-Jasso CF, 2005, ACTA PHARMACOL SIN, V26, P1467, DOI 10.1111/j.1745-7254.2005.00230.x; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034165; Jun C, 2007, PROG BIOCHEM BIOPHYS, V34, P389; Khurana A, 2012, MOL CARCINOGEN, V51, P565, DOI 10.1002/mc.20824; Li LM, 2007, RNA, V13, P1765, DOI 10.1261/rna.599107; Li XX, 2008, ANAL BIOCHEM, V381, P163, DOI 10.1016/j.ab.2008.06.011; Mcintyre GJ, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-34; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; Wu HL, 2005, GASTROENTEROLOGY, V128, P708, DOI 10.1053/j.gastro.2004.12.007; Xu XM, 2009, NAT PROTOC, V4, P1338, DOI 10.1038/nprot.2009.145; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031	24	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56110	10.1371/journal.pone.0056110	http://dx.doi.org/10.1371/journal.pone.0056110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405258	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400204
J	Wu, SJ; Luo, J; Li, QQ; Wang, YQ; Murphy, RW; Blair, C; Wu, SF; Yue, BS; Zhang, YP				Wu, Shan-Jin; Luo, Jing; Li, Qing-Qing; Wang, Yan-Qin; Murphy, Robert W.; Blair, Christopher; Wu, Shi-Fang; Yue, Bi-Song; Zhang, Ya-Ping			Ecological Genetics of Chinese Rhesus Macaque in Response to Mountain Building: All Things Are Not Equal	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISMS SNPS; MAXIMUM-LIKELIHOOD-ESTIMATION; MACACA-MULATTA; PHYLOGENETIC-RELATIONSHIPS; POPULATION-GENETICS; MIGRATION RATES; INDIAN-ORIGIN; SOFTWARE; INFERENCE; EVOLUTION	Background: Pliocene uplifting of the Qinghai-Tibetan Plateau (QTP) and Quaternary glaciation may have impacted the Asian biota more than any other events. Little is documented with respect to how the geological and climatological events influenced speciation as well as spatial and genetic structuring, especially in vertebrate endotherms. Macaca mulatta is the most widely distributed non-human primate. It may be the most suitable model to test hypotheses regarding the genetic consequences of orogenesis on an endotherm. Methodology and Principal Findings: Using a large dataset of maternally inherited mitochondrial DNA gene sequences and nuclear microsatellite DNA data, we discovered two maternal super-haplogroups exist, one in western China and the other in eastern China. M. mulatta formed around 2.31 Ma (1.51-3.15, 95%), and divergence of the two major matrilines was estimated at 1.15 Ma (0.78-1.55, 95%). The western super-haplogroup exhibits significant geographic structure. In contrast, the eastern super-haplogroup has far greater haplotypic variability with little structure based on analyses of six variable microsatellite loci using STRUCTURE and GENELAND. Analysis using MIGRATE detected greater gene flow from WEST to EAST than vice versa. We did not detect signals of bottlenecking in most populations. Conclusions: Analyses of the nuclear and mitochondrial datasets obtained large differences in genetic patterns for M. mulatta. The difference likely reflects inheritance mechanisms of the maternally inherited mtDNA genome versus nuclear biparentally inherited STRs and male-mediated gene flow. Dramatic environmental changes may be responsible for shaping the matrilineal history of macaques. The timing of events, the formation of M. mulatta, and the divergence of the super-haplogroups, corresponds to both the uplifting of the QTP and Quaternary climatic oscillations. Orogenesis likely drove divergence of western populations in China, and Pleistocene glaciations are likely responsible for genetic structuring in the eastern super-haplogroup via geographic isolation and secondary contact.	[Wu, Shan-Jin; Luo, Jing; Wang, Yan-Qin] Yunnan Univ, Sch Life Sci, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Wu, Shan-Jin; Yue, Bi-Song] Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Wu, Shan-Jin; Murphy, Robert W.; Wu, Shi-Fang; Zhang, Ya-Ping] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China; [Li, Qing-Qing] Yunnan Normal Univ, Sch Life Sci, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Blair, Christopher] Duke Univ, Dept Biol, Durham, NC USA	Yunnan University; Sichuan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan Normal University; Royal Ontario Museum; Duke University	Yue, BS (corresponding author), Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China.	bsyue@yahoo.com; zhangyp@mail.kiz.ac.cn		Murphy, Robert/0000-0001-8555-2338	National Basic Research Program of China (973 Program) [2007CB411600, 2007CB109106]; National Natural Science Foundation of China; Bureau of Science and Technology of Yunnan Province; Chinese Academy of Sciences; Natural Sciences and Engineering Research Council [A3148]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province; Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the National Basic Research Program of China (973 Program, 2007CB411600 and 2007CB109106), National Natural Science Foundation of China, and Bureau of Science and Technology of Yunnan Province, and by a Visiting Professorship for Senior International Scientists from the Chinese Academy of Sciences and a Natural Sciences and Engineering Research Council Discovery Grant (A3148) to R.W. Murphy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg C, 2002, BIOL J LINN SOC, V75, P555, DOI 10.1046/j.1095-8312.2002.00045.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Blair C, 2013, J HERED, V104, P72, DOI 10.1093/jhered/ess079; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Chatterji S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r29; Chu JH, 2007, MOL PHYLOGENET EVOL, V43, P418, DOI 10.1016/j.ympev.2006.11.022; Cornuet JM, 1996, GENETICS, V144, P2001; DAUGHERTY CH, 1990, NATURE, V347, P177, DOI 10.1038/347177a0; Deinard A, 2001, J HUM EVOL, V41, P45, DOI 10.1006/jhev.2001.0480; Deinard AS, 2002, J MED PRIMATOL, V31, P8, DOI 10.1034/j.1600-0684.2002.1o022.x; Delson E., 1980, P10; Doxiadis GGM, 2003, IMMUNOGENETICS, V55, P540, DOI 10.1007/s00251-003-0590-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Fooden J, 1999, INT J PRIMATOL, V20, P431, DOI 10.1023/A:1020556922189; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; FRENZEL B, 1968, SCIENCE, V161, P637, DOI 10.1126/science.161.3842.637; Fu YX, 1997, GENETICS, V147, P915; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Groves C.P., 2001, PRIMATE TAXONOMY; GU YM, 1980, VERTEBRAT PALASIATIC, V18, P324; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Harrison T, 2002, J HUM EVOL, V43, P207, DOI 10.1006/jhev.2002.0570; Hayaishi S, 2006, PRIMATES, V47, P158, DOI 10.1007/s10329-005-0169-1; Hayasaka K, 1996, MOL BIOL EVOL, V13, P1044, DOI 10.1093/oxfordjournals.molbev.a025655; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Kanthaswamy S, 2004, COMPARATIVE MED, V54, P193; Kayser M, 1996, MOL ECOL, V5, P157, DOI 10.1111/j.1365-294X.1996.tb00302.x; Kyes RC, 2006, AM J PRIMATOL, V68, P445, DOI 10.1002/ajp.20240; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Li DY, 2011, AM J PRIMATOL, V73, P883, DOI 10.1002/ajp.20956; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Li Qing-qing, 2004, Zoological Research, V25, P385; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; Melnick D. J., 1996, P413; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Morales JC, 1998, J HUM EVOL, V34, P1, DOI 10.1006/jhev.1997.0171; Morin PA, 1997, AM J PRIMATOL, V42, P199, DOI 10.1002/(SICI)1098-2345(1997)42:3<199::AID-AJP3>3.0.CO;2-S; Nurnberg P, 1998, AM J PRIMATOL, V44, P1; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2009, FIGTREE TREE FIGURE; RAMBAUT A, 2005, TRACER V1 3 MCMC TRA; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rollins LA, 2009, MOL ECOL, V18, P1560, DOI 10.1111/j.1365-294X.2009.04132.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SADE DS, 1972, FUNCTION EVOLUTIONAR; Satkoski J, 2008, J MED PRIMATOL, V37, P67, DOI 10.1111/j.1600-0684.2007.00228.x; Satkoski JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-256; SLATKIN M, 1991, GENETICS, V129, P555; Smith DG, 2006, INT J PRIMATOL, V27, P881, DOI 10.1007/s10764-006-9026-3; Smith DG, 2005, COMPARATIVE MED, V55, P227; Smith DG, 2005, AM J PRIMATOL, V65, P1, DOI 10.1002/ajp.20094; Smith DG, 2000, AM J PRIMATOL, V50, P1; Street SL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-480; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tosi AJ, 2000, MOL PHYLOGENET EVOL, V17, P133, DOI 10.1006/mpev.2000.0834; Tosi AJ, 2003, EVOLUTION, V57, P1419; Vallet D, 2008, CONSERV GENET, V9, P677, DOI 10.1007/s10592-007-9361-8; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wolfheim J, 1983, PRIMATES WORLD DISTR; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21; ZHANG R, 1991, Acta Theriologica Sinica, V11, P171; Zhang Ying-Qi, 2010, Vertebrata Palasiatica, V48, P275; ZHANG YP, 1993, INT J PRIMATOL, V14, P587, DOI 10.1007/BF02215449; [No title captured]	92	5	8	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55315	10.1371/journal.pone.0055315	http://dx.doi.org/10.1371/journal.pone.0055315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405134	Green Published, gold			2022-12-27	WOS:000315153400079
J	Kim, BW; Koppula, S; Hong, SS; Jeon, SB; Kwon, JH; Hwang, BY; Park, EJ; Choi, DK				Kim, Byung-Wook; Koppula, Sushruta; Hong, Seong-Su; Jeon, Sae-Bom; Kwon, Ji-Hye; Hwang, Bang-Yeon; Park, Eun-Jung; Choi, Dong-Kug			Regulation of Microglia Activity by Glaucocalyxin-A: Attenuation of Lipopolysaccharide-Stimulated Neuroinflammation through NF-kappa B and p38 MAPK Signaling Pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; LIPOCALIN 2 REGULATION; TNF-ALPHA RELEASE; INFLAMMATORY RESPONSE; KAURANE DITERPENOIDS; PARKINSONS-DISEASE; INTERFERON-GAMMA; ISODON-JAPONICUS; GLIAL-CELLS	Microglial cells are the resident macrophages and intrinsic arm of the central nervous system innate immune defense. Microglial cells become activated in response to injury, infection, environmental toxins, and other stimuli that threaten neuronal survival. Therefore, regulating microglial activation may have therapeutic benefits that lead to alleviating the progression of inflammatory-mediated neurodegeneration. In the present study, we investigated the effect of glaucocalyxin A (GLA) isolated from Rabdosia japonica on the production of pro-inflammatory mediators in lipopolysaccharide (LPS)-stimulated primary microglia and BV-2 cells. GLA significantly inhibited LPS-induced production of nitric oxide and reversed the morphological changes in primary microglia. Further, GLA suppressed expression of inducible nitric oxide synthase and cyclooxygenase-2 dose-dependently at the mRNA and protein levels. The production of proinflammatory cytokines such as tumor necrosis factor-alpha, interleukin-1 beta (IL)-1 beta, and IL-6 were inhibited by suppressing their transcriptional activity. Furthermore, GLA suppressed nuclear factor-kappa B activation by blocking degradation of I kappa B-alpha and inhibited the induction of lipocalin-2 expression in LPS-stimulated BV-2 cells. Mechanistic study revealed that the inhibitory effects of GLA were accompanied by blocking the p38 mitogen activated protein kinase signaling pathway in activated microglia. In conclusion, given that microglial activation contributes to the pathogenesis of neurodegenerative diseases, GLA could be developed as a potential therapeutic agent for treating microglia-mediated neuroinflammatory diseases.	[Kim, Byung-Wook; Koppula, Sushruta; Kwon, Ji-Hye; Choi, Dong-Kug] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea; [Hong, Seong-Su; Hwang, Bang-Yeon] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea; [Hong, Seong-Su; Hwang, Bang-Yeon] Chungbuk Natl Univ, Med Res Ctr CICT, Cheongju, South Korea; [Jeon, Sae-Bom; Park, Eun-Jung] Natl Canc Ctr, Branch Immune Therapy, Goyang, South Korea; [Jeon, Sae-Bom; Park, Eun-Jung] Natl Canc Ctr, Branch Cell Therapy, Goyang, South Korea	Konkuk University; Chungbuk National University; Chungbuk National University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Choi, DK (corresponding author), Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea.	choidk@kku.ac.kr	Koppula, Sushruta/F-2817-2013; KIM, Byungwook/U-2187-2017	Koppula, Sushruta/0000-0002-8597-7763; KIM, Byungwook/0000-0001-8390-7713; Choi, Dong-Kug/0000-0001-7041-1524	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0014923]; Regional Innovation Center (RIC) Program of the Ministry of Knowledge Economy through the Bio-Food & Drug Research Center at Konkuk University, Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Regional Innovation Center (RIC) Program of the Ministry of Knowledge Economy through the Bio-Food & Drug Research Center at Konkuk University, Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0014923) and also supported by the Regional Innovation Center (RIC) Program of the Ministry of Knowledge Economy through the Bio-Food & Drug Research Center at Konkuk University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner F, 2007, AM J TRANSPLANT, V7, P779, DOI 10.1111/j.1600-6143.2006.01723.x; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Boche D, 2003, J CEREBR BLOOD F MET, V23, P1174, DOI 10.1097/01.WCB.0000090080.64176.44; Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016/j.nbd.2006.01.004; Bonaiuto C, 1997, J NEUROIMMUNOL, V77, P51, DOI 10.1016/S0165-5728(97)00054-4; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Brenneman DE, 1996, J CLIN INVEST, V97, P2299, DOI 10.1172/JCI118672; Caivano M, 1998, FEBS LETT, V429, P249, DOI 10.1016/S0014-5793(98)00578-X; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Choi Y, 2008, INT IMMUNOPHARMACOL, V8, P548, DOI 10.1016/j.intimp.2007.12.010; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; Couch Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-166; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; DaSilva J, 1997, J BIOL CHEM, V272, P28373, DOI 10.1074/jbc.272.45.28373; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hong SS, 2008, J NAT PROD, V71, P1055, DOI 10.1021/np0705965; Hong SS, 2007, J NAT PROD, V70, P632, DOI 10.1021/np060638+; Ip JPK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-124; Jeohn GH, 2002, NEUROSCIENCE, V114, P689, DOI 10.1016/S0306-4522(02)00356-1; Jung WK, 2009, FOOD CHEM TOXICOL, V47, P410, DOI 10.1016/j.fct.2008.11.041; Kim BW, 2011, J PHARMACOL SCI, V116, P296, DOI 10.1254/jphs.10324FP; KIM DS, 1992, PHYTOCHEMISTRY, V31, P697, DOI 10.1016/0031-9422(92)90064-W; Le WD, 2001, J NEUROSCI, V21, P8447, DOI 10.1523/JNEUROSCI.21-21-08447.2001; LEE SC, 1993, J IMMUNOL, V150, P2659; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Li C, 2011, CYTOKINE, V56, P435, DOI 10.1016/j.cyto.2011.07.021; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Miharada K, 2008, J CELL PHYSIOL, V215, P526, DOI 10.1002/jcp.21334; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Oh YT, 2009, NEUROSCI LETT, V464, P93, DOI 10.1016/j.neulet.2009.08.040; Qin LY, 2005, ANN NY ACAD SCI, V1053, P107, DOI 10.1196/annals.1344.009; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rivest S, 2006, NEURON, V49, P4, DOI 10.1016/j.neuron.2005.12.004; Roudkenar MH, 2009, EXP CELL RES, V315, P3140, DOI 10.1016/j.yexcr.2009.08.019; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; St-Onge M, 2007, BBA-MOL CELL BIOL L, V1771, P1235, DOI 10.1016/j.bbalip.2007.06.002; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x; Teismann P, 2003, MOVEMENT DISORD, V18, P121, DOI 10.1002/mds.10332; Wang W, 2003, J NEUROCHEM, V84, P189, DOI 10.1046/j.1471-4159.2003.01544.x; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	54	81	83	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55792	10.1371/journal.pone.0055792	http://dx.doi.org/10.1371/journal.pone.0055792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393601	Green Submitted, gold, Green Published			2022-12-27	WOS:000314692800056
J	Hulme, MF; Vickery, JA; Green, RE; Phalan, B; Chamberlain, DE; Pomeroy, DE; Nalwanga, D; Mushabe, D; Katebaka, R; Bolwig, S; Atkinson, PW				Hulme, Mark F.; Vickery, Juliet A.; Green, Rhys E.; Phalan, Ben; Chamberlain, Dan E.; Pomeroy, Derek E.; Nalwanga, Dianah; Mushabe, David; Katebaka, Raymond; Bolwig, Simon; Atkinson, Philip W.			Conserving the Birds of Uganda's Banana-Coffee Arc: Land Sparing and Land Sharing Compared	PLOS ONE			English	Article							LOWLAND FARMLAND BIRDS; BIODIVERSITY CONSERVATION; AGRICULTURAL INTENSIFICATION; FOOD SECURITY; IMPACT; YIELD	Reconciling the aims of feeding an ever more demanding human population and conserving biodiversity is a difficult challenge. Here, we explore potential solutions by assessing whether land sparing (farming for high yield, potentially enabling the protection of non-farmland habitat), land sharing (lower yielding farming with more biodiversity within farmland) or a mixed strategy would result in better bird conservation outcomes for a specified level of agricultural production. We surveyed forest and farmland study areas in southern Uganda, measuring the population density of 256 bird species and agricultural yield: food energy and gross income. Parametric non-linear functions relating density to yield were fitted. Species were identified as "winners" (total population size always at least as great with agriculture present as without it) or "losers" (total population sometimes or always reduced with agriculture present) for a range of targets for total agricultural production. For each target we determined whether each species would be predicted to have a higher total population with land sparing, land sharing or with any intermediate level of sparing at an intermediate yield. We found that most species were expected to have their highest total populations with land sparing, particularly loser species and species with small global range sizes. Hence, more species would benefit from high-yield farming if used as part of a strategy to reduce forest loss than from low-yield farming and land sharing, as has been found in Ghana and India in a previous study. We caution against advocacy for high-yield farming alone as a means to deliver land sparing if it is done without strong protection for natural habitats, other ecosystem services and social welfare. Instead, we suggest that conservationists explore how conservation and agricultural policies can be better integrated to deliver land sparing by, for example, combining land-use planning and agronomic support for small farmers.	[Hulme, Mark F.; Atkinson, Philip W.] British Trust Ornithol, Thetford, Norfolk, England; [Vickery, Juliet A.; Green, Rhys E.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Green, Rhys E.; Phalan, Ben] Univ Cambridge, Dept Zool, Cambridge, England; [Chamberlain, Dan E.] Univ Turin, Dipartimento Biol Anim & Uomo, Turin, Italy; [Pomeroy, Derek E.; Katebaka, Raymond] Makerere Univ, Dept Biol Sci, Kampala, Uganda; [Nalwanga, Dianah; Mushabe, David] NatureUganda, Kampala, Uganda; [Bolwig, Simon] Tech Univ Denmark, Dept Engn Management, Copenhagen, Denmark	British Trust for Ornithology; Royal Society for Protection of Birds; University of Cambridge; University of Turin; Makerere University; Technical University of Denmark	Hulme, MF (corresponding author), British Trust Ornithol, Thetford, Norfolk, England.	mark.hulme@bto.org	Bolwig, Simon/N-7880-2019; Hulme, Mark/AAT-2651-2020; Atkinson, Philip/B-8975-2009; Phalan, Ben/A-5783-2009; Bolwig, Simon/O-7237-2017; Chamberlain, Dan/K-1809-2015	Bolwig, Simon/0000-0003-1537-7938; Hulme, Mark/0000-0002-7211-3464; Phalan, Ben/0000-0001-7876-7226; Bolwig, Simon/0000-0003-1537-7938; Chamberlain, Dan/0000-0002-5381-2024; Atkinson, Philip/0000-0002-0838-557X	The Darwin Initiative [14-032]; Cambridge Conservation Initiative [CCI 05/10/006]; The Leverhulme Trust [F/01 503/B]	The Darwin Initiative; Cambridge Conservation Initiative; The Leverhulme Trust(Leverhulme Trust)	This work was supported by grants from The Darwin Initiative (14-032), the Cambridge Conservation Initiative (CCI 05/10/006) and The Leverhulme Trust (F/01 503/B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; Balmford A, 2005, GLOBAL CHANGE BIOL, V11, P1594, DOI 10.1111/j.1365-2486.2005.001035.x; Balmford A, 2012, P ROY SOC B-BIOL SCI, V279, P2714, DOI 10.1098/rspb.2012.0515; BARNES RFW, 1990, AFR J ECOL, V28, P161, DOI 10.1111/j.1365-2028.1990.tb01150.x; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Brink AB, 2009, APPL GEOGR, V29, P501, DOI 10.1016/j.apgeog.2008.10.004; Buckland S.T., 2001, pi; Carswell M., 2005, BIRD ATLAS UGANDA; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Davey CM, 2010, IBIS, V152, P459, DOI 10.1111/j.1474-919X.2009.01001.x; Dranzoa Christine, 2011, Scopus, V31, P1; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; Ewers RM, 2009, GLOBAL CHANGE BIOL, V15, P1716, DOI 10.1111/j.1365-2486.2009.01849.x; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Fischer J, 2011, SCIENCE, V334, P593, DOI 10.1126/science.334.6056.593-a; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Godfray HCJ, 2011, SCIENCE, V333, P1231, DOI 10.1126/science.1211815; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; NEMA (National Environmental Management Authority), 2002, STAT ENV REP UG; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Phalan B, 2011, SCIENCE, V334, P594, DOI 10.1126/science.334.6056.594-a; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phalan B, 2011, FOOD POLICY, V36, pS62, DOI 10.1016/j.foodpol.2010.11.008; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Ranganathan J, 2008, P NATL ACAD SCI USA, V105, P17852, DOI 10.1073/pnas.0808874105; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Snow D.W., 1998, BIRDS W PALEARCTIC; Speedy AW, 1991, LIVESTOCK RES RURAL, V3, P1; Thies C, 2011, ECOL APPL, V21, P2187, DOI 10.1890/10-0929.1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Uganda Forest Department, 1999, UG FOR BIOD DAT VERS; United States Department of Agriculture, 2011, COMP FOODS RAW PROC; Urban EK, 1993, BIRDS AFRICA; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8; Waltert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016238; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x	47	80	82	4	216	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54597	10.1371/journal.pone.0054597	http://dx.doi.org/10.1371/journal.pone.0054597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390501	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100017
J	Munro, KM; Dixon, KJ; Gresle, MM; Jonas, A; Kemper, D; Doherty, W; Fabri, LJ; Owczarek, CM; Pearse, M; Boyd, AW; Kilpatrick, TJ; Butzkueven, H; Turnley, AM				Munro, Kathryn M.; Dixon, Kirsty J.; Gresle, Melissa M.; Jonas, Anna; Kemper, Dennis; Doherty, William; Fabri, Louis J.; Owczarek, Catherine M.; Pearse, Martin; Boyd, Andrew W.; Kilpatrick, Trevor J.; Butzkueven, Helmut; Turnley, Ann M.			EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE)	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; EPHA4-DEFICIENT MICE; STIMULATES MIGRATION; AXONAL INJURY; PATHOGENESIS; DEMYELINATION; INFLAMMATION; MICROGLIA; LESIONS; IMMUNE	The EphA4 receptor tyrosine kinase is a major regulator of axonal growth and astrocyte reactivity and is a possible inflammatory mediator. Given that multiple sclerosis (MS) is primarily an inflammatory demyelinating disease and in mouse models of MS, such as experimental autoimmune encephalomyelitis (EAE), axonal degeneration and reactive gliosis are prominent clinical features, we hypothesised that endogenous EphA4 could play a role in modulating EAE. EAE was induced in EphA4 knockout and wildtype mice using MOG peptide immunisation and clinical severity and histological features of the disease were then compared in lumbar spinal cord sections. EphA4 knockout mice exhibited a markedly less severe clinical course than wildtype mice, with a lower maximum disease grade and a slightly later onset of clinical symptoms. Numbers of infiltrating T cells and macrophages, the number and size of the lesions, and the extent of astrocytic gliosis were similar in both genotypes; however, EphA4 knockout mice appeared to have decreased axonal pathology. Blocking of EphA4 in wildtype mice by administration of soluble EphA4 (EphA4-Fc) as a decoy receptor following induction of EAE produced a delay in onset of clinical symptoms; however, most mice had clinical symptoms of similar severity by 22 days, indicating that EphA4 blocking treatment slowed early EAE disease evolution. Again there were no apparent differences in histopathology. To determine whether the role of EphA4 in modulating EAE was CNS mediated or due to an altered immune response, MOG primed T cells from wildtype and EphA4 knockout mice were passively transferred into naive recipient mice and both were shown to induce disease of equivalent severity. These results are consistent with a non-inflammatory, CNS specific, deleterious effect of EphA4 during neuroinflammation that results in axonal pathology.	[Munro, Kathryn M.; Dixon, Kirsty J.; Kilpatrick, Trevor J.; Turnley, Ann M.] Univ Melbourne, Neurosci Res Ctr, Melbourne, Vic 3010, Australia; [Munro, Kathryn M.; Kilpatrick, Trevor J.; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Gresle, Melissa M.; Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne Brain Ctr, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia; [Jonas, Anna; Kemper, Dennis; Doherty, William; Kilpatrick, Trevor J.] Florey Neurosci Inst, MS Div, Melbourne, Vic, Australia; [Fabri, Louis J.; Owczarek, Catherine M.; Pearse, Martin] CSL Ltd, Parkville, Vic, Australia; [Boyd, Andrew W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; CSL; QIMR Berghofer Medical Research Institute	Turnley, AM (corresponding author), Univ Melbourne, Neurosci Res Ctr, Melbourne, Vic 3010, Australia.	turnley@unimelb.edu.au		Turnley, Ann/0000-0002-8442-127X; fabri, louis/0000-0003-4033-3304; gresle, melissa/0000-0003-0738-1136; Kilpatrick, Trevor/0000-0003-3999-085X; Butzkueven, Helmut/0000-0003-3940-8727	NHMRC [1045125]; Multiple Sclerosis Research Australia grant; CRE fellowship through the Melbourne Brain Centre	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia grant; CRE fellowship through the Melbourne Brain Centre	This work was supported by a NH&MRC Project Grant #1045125 and a Multiple Sclerosis Research Australia grant. AMT is supported by an NH&MRC Fellowship, HB by an NH&MRC career development fellowship, MG by a CRE fellowship through the Melbourne Brain Centre, and KMM was supported by an NH&MRC Australian Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Coonan JR, 2001, J COMP NEUROL, V436, P248; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gresle MM, 2008, J NEUROSCI RES, V86, P3548, DOI 10.1002/jnr.21803; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Herz J, 2010, EXP NEUROL, V225, P9, DOI 10.1016/j.expneurol.2009.11.019; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Jones MV, 2008, J NEUROIMMUNOL, V199, P83, DOI 10.1016/j.jneuroim.2008.05.013; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804; Munro KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037635; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Parmentier-Batteur S, 2011, J NEUROCHEM, V118, P1016, DOI 10.1111/j.1471-4159.2011.07375.x; Puschmann TB, 2010, J NEUROCHEM, V113, P881, DOI 10.1111/j.1471-4159.2010.06655.x; Sobel RA, 2005, BRAIN PATHOL, V15, P35; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Xu LY, 2003, IMMUNOLOGY, V110, P141, DOI 10.1046/j.1365-2567.2003.01713.x	32	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55948	10.1371/journal.pone.0055948	http://dx.doi.org/10.1371/journal.pone.0055948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390555	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100071
J	Shelby, SJ; Colwill, K; Dhe-Paganon, S; Pawson, T; Thompson, DA				Shelby, Shameka J.; Colwill, Karen; Dhe-Paganon, Sirano; Pawson, Tony; Thompson, Debra A.			MERTK Interactions with SH2-Domain Proteins in the Retinal Pigment Epithelium	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; FOCAL ADHESION KINASE; ROD-CONE DYSTROPHY; NF-KAPPA-B; OUTER SEGMENTS; ALPHA-V-BETA-5 INTEGRIN; APOPTOTIC CELLS; C-MER; MEDIATED PHAGOCYTOSIS; RETINITIS-PIGMENTOSA	The receptor tyrosine kinase MERTK plays an essential role in the phagocytic uptake of shed photoreceptor membranes by the retinal pigment epithelium (RPE). A fundamental aspect of signal transduction by receptor tyrosine kinases involves autophosphorylation of tyrosine residues that recruit Src-homology 2 (SH2)-domain proteins to the receptor intracellular domain. The goal of the current study was to evaluate the interactions of human MERTK with SH2-domain proteins present in the RPE. The MERTK intracellular domain was expressed as a 6xHis-fusion protein (6xHis-rMERTK(571-999)), purified and phosphorylated. Ni2+-NTA pull downs were performed using 6xHis-rMERTK(571-999) in incubations with recombinant phosphotyrosine-recognition sequences expressed as GST-fusion proteins. In addition, pull downs of native SH2-domain proteins were performed using 6xHis-rMERTK(571-999) and protein homogenates from rat RPE/choroid. For both recombinant and native proteins, western analysis detected MERTK interactions with GRB2, PIK3R1 (P85 alpha), VAV3, and SRC. Immunohistochemical analysis localized each protein to mouse RPE. In cultured RPE-J cells incubated with rod outer segments (OS), siRNA knockdown of Grb2 had no effect on OS binding, but significantly reduced OS uptake. Pik3r1 localized to early phagosomes along with Rab5 and Eea1. Phosphorylation and activation of Src was detected downstream of phagocytosis and Mertk activation. These findings suggest that MERTK signaling in the RPE involves a cohort of SH2-domain proteins with the potential to regulate both cytoskeletal rearrangement and membrane movement. Identification of the SH2-domain signaling partners of MERTK is an important step toward further defining the mechanism of RPE phagocytosis that is central to the function and survival of the retina.	[Shelby, Shameka J.; Thompson, Debra A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Colwill, Karen; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Pawson, Tony] Univ Toronto, Dept Med Genet, Toronto, ON, Canada; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University of Michigan System; University of Michigan	Thompson, DA (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	dathom@umich.edu	Colwill, Karen/K-5101-2012; Pawson, Tony J/E-4578-2013	Colwill, Karen/0000-0002-8979-1659; Thompson, Debra/0000-0003-3485-0794	National Institutes of Health [P30-EY007003, P60-DK-020572, T32-EY13934]; Midwest Eye Bank & Transplantation Center; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Research to Prevent Blindness; University of Michigan Rackham School of Graduate Studies Merit Fellowship; King-Chavez-Parks Future Faculty Program Fellowship; NATIONAL EYE INSTITUTE [T32EY013934, P30EY007003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Eye Bank & Transplantation Center; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); University of Michigan Rackham School of Graduate Studies Merit Fellowship; King-Chavez-Parks Future Faculty Program Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from National Institutes of Health (P30-EY007003, P60-DK-020572, T32-EY13934), The Midwest Eye Bank & Transplantation Center. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. DAT is a recipient of a Senior Scientific Investigator Award from Research to Prevent Blindness. SJS is a recipient of a University of Michigan Rackham School of Graduate Studies Merit Fellowship, and a King-Chavez-Parks Future Faculty Program Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brea-Fernandez AJ, 2008, BRIT J OPHTHALMOL, V92, P1419, DOI 10.1136/bjo.2008.139204; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Fujikawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009050; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Georgescu MM, 1999, MOL CELL BIOL, V19, P1171; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Hall MO, 2003, ADV EXP MED BIOL, V533, P331; Hed J, 1986, Methods Enzymol, V132, P198; Huang XD, 2009, J STRUCT BIOL, V165, P88, DOI 10.1016/j.jsb.2008.10.003; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jeong SJ, 2006, ACTA BIOCH BIOPH SIN, V38, P556, DOI 10.1111/j.1745-7270.2006.00193.x; LaVail M M, 2001, Prog Brain Res, V131, P617; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1981, INVEST OPHTH VIS SCI, V20, P671; LAVAIL MM, 1975, J HERED, V66, P242, DOI 10.1093/oxfordjournals.jhered.a108621; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Mackay DS, 2010, MOL VIS, V16, P369; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; Mao YY, 2012, MOL BIOL CELL, V23, P1104, DOI 10.1091/mbc.E11-10-0840; May RC, 2001, J CELL SCI, V114, P1061; McHenry CL, 2004, INVEST OPHTH VIS SCI, V45, P1456, DOI 10.1167/iovs.03-0909; Nandrot EF, 2012, BIOL CELL, V104, P326, DOI 10.1111/boc.201100076; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Qin SF, 2012, EXP EYE RES, V94, P63, DOI 10.1016/j.exer.2011.11.007; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strick DJ, 2009, INVEST OPHTH VIS SCI, V50, P2427, DOI 10.1167/iovs.08-3058; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Tschernutter M, 2006, BRIT J OPHTHALMOL, V90, P718, DOI 10.1136/bjo.2005.084897; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Yi ZA, 2009, BLOOD, V114, P3191, DOI 10.1182/blood-2009-03-207522; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	53	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e53964	10.1371/journal.pone.0053964	http://dx.doi.org/10.1371/journal.pone.0053964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390493	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100009
J	Suwannasai, N; Martin, MP; Phosri, C; Sihanonth, P; Whalley, AJS; Spouge, JL				Suwannasai, Nuttika; Martin, Maria P.; Phosri, Cherdchai; Sihanonth, Prakitsin; Whalley, Anthony J. S.; Spouge, John L.			Fungi in Thailand: A Case Study of the Efficacy of an ITS Barcode for Automatically Identifying Species within the Annulohypoxylon and Hypoxylon Genera	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; DNA BARCODES; PHYLOGENETIC-RELATIONSHIPS; LAND PLANTS; SEQUENCE; IDENTIFICATION; XYLARIACEAE; TAXONOMY; NUCLEAR; ALGORITHMS	Thailand, a part of the Indo-Burma biodiversity hotspot, has many endemic animals and plants. Some of its fungal species are difficult to recognize and separate, complicating assessments of biodiversity. We assessed species diversity within the fungal genera Annulohypoxylon and Hypoxylon, which produce biologically active and potentially therapeutic compounds, by applying classical taxonomic methods to 552 teleomorphs collected from across Thailand. Using probability of correct identification (PCI), we also assessed the efficacy of automated species identification with a fungal barcode marker, ITS, in the model system of Annulohypoxylon and Hypoxylon. The 552 teleomorphs yielded 137 ITS sequences; in addition, we examined 128 GenBank ITS sequences, to assess biases in evaluating a DNA barcode with GenBank data. The use of multiple sequence alignment in a barcode database like BOLD raises some concerns about non-protein barcode markers like ITS, so we also compared species identification using different alignment methods. Our results suggest the following. (1) Multiple sequence alignment of ITS sequences is competitive with pairwise alignment when identifying species, so BOLD should be able to preserve its present bioinformatics workflow for species identification for ITS, and possibly therefore with at least some other non-protein barcode markers. (2) Automated species identification is insensitive to a specific choice of evolutionary distance, contributing to resolution of a current debate in DNA barcoding. (3) Statistical methods are available to address, at least partially, the possibility of expert misidentification of species. Phylogenetic trees discovered a cryptic species and strongly supported monophyletic clades for many Annulohypoxylon and Hypoxylon species, suggesting that ITS can contribute usefully to a barcode for these fungi. The PCIs here, derived solely from ITS, suggest that a fungal barcode will require secondary markers in Annulohypoxylon and Hypoxylon, however. The URL http://tinyurl.com/spouge-barcode contains computer programs and other supplementary material relevant to this article.	[Suwannasai, Nuttika] Srinakharinwirot Univ, Fac Sci, Dept Biol, Bangkok, Thailand; [Martin, Maria P.] Real Jardin Botan CSIC, Dept Mycol, Madrid, Spain; [Phosri, Cherdchai] Pibulsongkram Rajabhat Univ, Fac Sci & Technol, Microbiol Programme, Phitsanulok, Thailand; [Sihanonth, Prakitsin] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Whalley, Anthony J. S.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 5UX, Merseyside, England; [Spouge, John L.] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	Srinakharinwirot University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Pibulsongkram Rajabhat University; Chulalongkorn University; Liverpool John Moores University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Spouge, JL (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.	spouge@ncbi.nlm.nih.gov	Martín, María/HDL-9512-2022; Martín, María/H-8069-2012; phosri, Cherdchai/H-2747-2014; Spouge, John/AAI-2769-2020	Martín, María/0000-0002-1235-4418; Phosri, Cherdchai/0000-0003-3963-752X	Royal Golden Jubilee Ph.D. Program (RGJ); National Research Council of Thailand; International Foundation for Science (IFS); British Council; Liverpool John Moores University; British Mycological Society; Plan Nacional I+D+I (Ministerio de Ciencia y Tecnologia, Spain) [REN2002-04068-CO2-01GLO]; Intramural Research Program of the National Institutes of Health (NIH) (National Library of Medicine, USA); NATIONAL LIBRARY OF MEDICINE [ZIALM200883] Funding Source: NIH RePORTER	Royal Golden Jubilee Ph.D. Program (RGJ)(Thailand Research Fund (TRF)); National Research Council of Thailand(National Research Council of Thailand (NRCT)); International Foundation for Science (IFS)(International Foundation for Science); British Council(The British Council in India); Liverpool John Moores University; British Mycological Society; Plan Nacional I+D+I (Ministerio de Ciencia y Tecnologia, Spain); Intramural Research Program of the National Institutes of Health (NIH) (National Library of Medicine, USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported in part by the Royal Golden Jubilee Ph.D. Program (RGJ), National Research Council of Thailand, International Foundation for Science (IFS), the British Council, Liverpool John Moores University, the British Mycological Society, the Plan Nacional I+D+I (REN2002-04068-CO2-01GLO, Ministerio de Ciencia y Tecnologia, Spain), and the Intramural Research Program of the National Institutes of Health (NIH) (National Library of Medicine, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul S, 1999, SCIENTIST, V13, P15; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARRATIA R, 1985, ANN PROBAB, V13, P1236, DOI 10.1214/aop/1176992808; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Brock PM, 2009, NEW PHYTOL, V181, P719, DOI 10.1111/j.1469-8137.2008.02703.x; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Collins RA, 2012, METHODS ECOLOGY EVOL; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Karkouri K, 2007, APPL ENVIRON MICROB, V73, P5320, DOI 10.1128/AEM.00530-07; Erickson DL, 2008, TAXON, V57, P1304, DOI 10.1002/tax.574020; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; Feau N, 2009, MYCOL RES, V113, P713, DOI 10.1016/j.mycres.2009.02.007; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Fournier J, 2010, FUNGAL DIVERS, V40, P23, DOI 10.1007/s13225-010-0026-4; Fregin S, 2012, MOL PHYLOGENET EVOL, V62, P319, DOI 10.1016/j.ympev.2011.10.003; GARDES M, 1991, CAN J BOT, V69, P180, DOI 10.1139/b91-026; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HOLM S, 1979, SCAND J STAT, V6, P65; Hsieh HM, 2005, MYCOLOGIA, V97, P844, DOI 10.3852/mycologia.97.4.844; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Ju YM, 2002, NOVA HEDWIGIA, V74, P75, DOI 10.1127/0029-5035/2002/0074-0075; Ju YM, 1996, MYCOL MEM, V20, P1; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kuksa P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S9; Kwong S, 2012, MOL PHYLOGENET EVOL, V62, P1009, DOI 10.1016/j.ympev.2011.11.034; LAESSOE T, 1989, MYCOL RES, V93, P121, DOI 10.1016/S0953-7562(89)80111-X; Laessoe T, 2010, FUNGAL BIOL-UK, V114, P481, DOI 10.1016/j.funbio.2010.03.010; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lee JS, 2000, FEMS MICROBIOL LETT, V187, P89; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lumbsch T, 2010, FIELDIANA LIFE EARTH, P1; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nguyen HDT, 2008, PERSOONIA, V21, P57, DOI 10.3767/003158508X361334; Ogden TH, 2007, MOL PHYLOGENET EVOL, V42, P817, DOI 10.1016/j.ympev.2006.07.021; Okane I, 2008, MYCOSCIENCE, V49, P359, DOI 10.1007/s10267-008-0440-6; Pelaez F, 2008, FUNGAL DIVERS, V31, P111; Pinnoi A, 2010, MYCOSPHERE, V1, P1; ROGERS JD, 1994, NATO ADV SCI INST SE, V269, P321; ROGERS JD, 1977, CAN J BOT, V55, P2394, DOI 10.1139/b77-272; Rogers JD, 2000, MYCOL RES, V104, P1412, DOI 10.1017/S0953756200003464; Sanchez-Ballesteros J, 2000, MYCOLOGIA, V92, P964, DOI 10.2307/3761591; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stadler Marc, 2006, Revista Iberoamericana de Micologia, V23, P160; Stadler M, 2005, RRD PHYTOCHEM, V9, P41; Suwannasai N, 2005, MYCOTAXON, V94, P303; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tang AMC, 2009, FUNGAL DIVERS, V34, P127; Tantichareon M, 2004, THAI FUNGAL DIVERSIT, P1; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Thienhirun S, 1997, PRELIMINARY ACCOUNT; Thienhirun S, 2004, THAI FUNGAL DIVERSIT, P71; Triebel D, 2005, NOVA HEDWIGIA, V80, P25, DOI 10.1127/0029-5035/2005/0080-0025; Whalley AJS, 1996, MYCOL RES, V100, P897, DOI 10.1016/S0953-7562(96)80042-6; Whalley AJS, 2012, RAJABHAT J S HUMANIT, V13, P9; Whalley Margaret, 1996, Mycologist, V10, P149; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	67	21	21	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54529	10.1371/journal.pone.0054529	http://dx.doi.org/10.1371/journal.pone.0054529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390499	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100015
J	Deneke, C; Lipowsky, R; Valleriani, A				Deneke, Carlus; Lipowsky, Reinhard; Valleriani, Angelo			Complex Degradation Processes Lead to Non-Exponential Decay Patterns and Age-Dependent Decay Rates of Messenger RNA	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN ABUNDANCE; GLOBAL ANALYSIS; STABILITY; TRANSCRIPTOME; DISTRIBUTIONS; LIFE	Experimental studies on mRNA stability have established several, qualitatively distinct decay patterns for the amount of mRNA within the living cell. Furthermore, a variety of different and complex biochemical pathways for mRNA degradation have been identified. The central aim of this paper is to bring together both the experimental evidence about the decay patterns and the biochemical knowledge about the multi-step nature of mRNA degradation in a coherent mathematical theory. We first introduce a mathematical relationship between the mRNA decay pattern and the lifetime distribution of individual mRNA molecules. This relationship reveals that the mRNA decay patterns at steady state expression level must obey a general convexity condition, which applies to any degradation mechanism. Next, we develop a theory, formulated as a Markov chain model, that recapitulates some aspects of the multi-step nature of mRNA degradation. We apply our theory to experimental data for yeast and explicitly derive the lifetime distribution of the corresponding mRNAs. Thereby, we show how to extract single-molecule properties of an mRNA, such as the age-dependent decay rate and the residual lifetime. Finally, we analyze the decay patterns of the whole translatome of yeast cells and show that yeast mRNAs can be grouped into three broad classes that exhibit three distinct decay patterns. This paper provides both a method to accurately analyze non-exponential mRNA decay patterns and a tool to validate different models of degradation using decay data.	[Deneke, Carlus; Lipowsky, Reinhard; Valleriani, Angelo] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany	Max Planck Society	Valleriani, A (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.	angelo.valleriani@mpikg.mpg.de		Deneke, Carlus/0000-0002-2509-4950; Valleriani, Angelo/0000-0001-6591-5824; Lipowsky, Reinhard/0000-0001-8417-8567				Andersson AF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r99; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Berger F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208101; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Condon C, 2010, RNA BIOL, V7, P316, DOI 10.4161/rna.7.3.11913; Deneke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035044; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Elgart V, 2010, BIOPHYS J, V98, P2780, DOI 10.1016/j.bpj.2010.03.022; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Keller P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747337; KEPES A, 1963, BIOCHIM BIOPHYS ACTA, V76, P293; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Liou JJ, 1997, CHEM ENG SCI, V52, P1529, DOI 10.1016/S0009-2509(96)00510-6; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Nagar A, 2011, J STAT PHYS, V145, P1385, DOI 10.1007/s10955-011-0347-z; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; PETERSEN C, 1987, MOL GEN GENET, V209, P179, DOI 10.1007/BF00329856; Rading MM, 2011, J STAT PHYS, V145, P1, DOI 10.1007/s10955-011-0305-9; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; TAYLOR H., 1998, INTRO STOCHASTIC MOD; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Valleriani A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58003; Valleriani A, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28011; Valleriani A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042903; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Xie SN, 2001, SINGLE MOL, V2, P229, DOI 10.1002/1438-5171(200112)2:4<229::AID-SIMO229>3.0.CO;2-9; Zimmer SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037639	44	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55442	10.1371/journal.pone.0055442	http://dx.doi.org/10.1371/journal.pone.0055442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408982	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000014
J	Esser, D; Oosterink, E; 't Roodt, JO; Henry, RMA; Stehouwer, CDA; Muller, M; Afman, LA				Esser, Diederik; Oosterink, Els; 't Roodt, Jos Op; Henry, Ronald M. A.; Stehouwer, Coen D. A.; Muller, Michael; Afman, Lydia A.			Vascular and Inflammatory High Fat Meal Responses in Young Healthy Men; A Discriminative Role of IL-8 Observed in a Randomized Trial	PLOS ONE			English	Article							POSTPRANDIAL ENDOTHELIAL FUNCTION; FLOW-MEDIATED VASODILATION; OXIDATIVE STRESS; ARTERIAL STIFFNESS; NORMAL-WEIGHT; HUMANS; DYSFUNCTION; REACTIVITY; INTERLEUKIN-8; ACTIVATION	Background: High fat meal challenges are known to induce postprandial low-grade inflammation and endothelial dysfunction. This assumption is largely based on studies performed in older populations or in populations with a progressed disease state and an appropriate control meal is often lacking. Young healthy individuals might be more resilient to such challenges. We therefore aimed to characterize the vascular and inflammatory response after a high fat meal in young healthy individuals. Methods: In a double-blind randomized cross-over intervention study, we used a comprehensive phenotyping approach to determine the vascular and inflammatory response after consumption of a high fat shake and after an average breakfast shake in 20 young healthy subjects. Both interventions were performed three times. Results: Many features of the vascular postprandial response, such as FMD, arterial stiffness and micro-vascular skin blood flow were not different between shakes. High fat/high energy shake consumption was associated with a more pronounced increase in blood pressure, heart rate, plasma concentrations of IL-8 and PBMCs gene expression of IL-8 and CD54 (ICAM-1), whereas plasma concentrations of sVCAM1 were decreased compared to an average breakfast. Conclusion: Whereas no difference in postprandial response were observed on classical markers of endothelial function, we did observe differences between consumption of a HF/HE and an average breakfast meal on blood pressure and IL-8 in young healthy volunteers. IL-8 might play an important role in dealing with high fat challenges and might be an early marker for endothelial stress, a stage preceding endothelial dysfunction.	[Esser, Diederik; Oosterink, Els; 't Roodt, Jos Op; Henry, Ronald M. A.; Stehouwer, Coen D. A.; Muller, Michael; Afman, Lydia A.] Top Inst Food & Nutr, Wageningen, Netherlands; [Esser, Diederik; Oosterink, Els; Muller, Michael; Afman, Lydia A.] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; ['t Roodt, Jos Op; Henry, Ronald M. A.; Stehouwer, Coen D. A.] Maastricht Univ, Dept Internal Med, Maastricht, Netherlands; ['t Roodt, Jos Op; Henry, Ronald M. A.; Stehouwer, Coen D. A.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Maastricht University; Maastricht University	Afman, LA (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	lydia.afman@wur.nl	Muller, Michael/B-5795-2008; Muller, Michael/M-5724-2019; Stehouwer, Coen/AAB-3435-2021	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Stehouwer, Coen/0000-0001-8752-3223; op 't Roodt, Jos/0000-0003-3535-6894	TI Food and Nutrition [A-1004]	TI Food and Nutrition	This study was solely funded by TI Food and Nutrition (A-1004) (http://www.tifn.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja KDK, 2009, AM J CLIN NUTR, V90, P298, DOI 10.3945/ajcn.2009.27771; Ayer JG, 2010, OBESITY, V18, P945, DOI 10.1038/oby.2009.331; BAGGIOLINI M, 1994, CHEST, V105, pS95, DOI 10.1378/chest.105.3_Supplement.95S; Bell David S H, 2008, Endocr Pract, V14, P112; Berry SEE, 2008, J NUTR, V138, P1910, DOI 10.1093/jn/138.10.1910; Biston P, 1996, HYPERTENSION, V28, P863, DOI 10.1161/01.HYP.28.5.863; Blendea MC, 2005, METABOLISM, V54, P1337, DOI 10.1016/j.metabol.2005.04.023; Burdge GC, 2005, BRIT J NUTR, V93, P3, DOI 10.1079/BJN20041282; Ceriello A, 2004, DIABETES, V53, P701, DOI 10.2337/diabetes.53.3.701; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Cortes B, 2006, J AM COLL CARDIOL, V48, P1666, DOI 10.1016/j.jacc.2006.06.057; Datta D, 2007, ATHEROSCLEROSIS, V192, P391, DOI 10.1016/j.atherosclerosis.2006.05.034; de Roos NM, 2002, EUR J CLIN NUTR, V56, P674, DOI 10.1038/sj.ejcn.1601377; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; Denniss SG, 2008, VASC HEALTH RISK MAN, V4, P213, DOI 10.2147/vhrm.2008.04.01.213; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Holmer-Jensen J, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-115; Jackson KG, 2007, BIOCHEM SOC T, V35, P451, DOI 10.1042/BST0350451; Jackson KG, 2009, BRIT J NUTR, V102, P1414, DOI 10.1017/S0007114509990742; KEARNEY MT, 1995, EXP PHYSIOL, V80, P683, DOI 10.1113/expphysiol.1995.sp003878; Keogh JB, 2005, ARTERIOSCL THROM VAS, V25, P1274, DOI 10.1161/01.ATV.0000163185.28245.a1; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lekstrom-Himes JA, 2005, J IMMUNOL, V174, P411, DOI 10.4049/jimmunol.174.1.411; Lundman P, 2007, NUTR METAB CARDIOVAS, V17, P195, DOI 10.1016/j.numecd.2005.11.009; MacEneaney OJ, 2009, EUR J APPL PHYSIOL, V106, P721, DOI 10.1007/s00421-009-1073-y; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; NetherlandsNutritionCentre, 2003, DUTCH NAT FOOD CONS; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Ong PJL, 1999, LANCET, V354, P2134, DOI 10.1016/S0140-6736(99)03374-7; Raitakari OT, 2000, J AM COLL CARDIOL, V36, P417, DOI 10.1016/S0735-1097(00)00758-0; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Rubin D, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-32; Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969; Steer P, 2003, CLIN SCI, V105, P81, DOI 10.1042/CS20020327; Tsai WC, 2004, CLIN SCI, V106, P315, DOI 10.1042/CS20030227; Valensi P, 2006, DIABETES METAB, V32, p2S37; van Bussel BC, 2011, HYPERTENSION, V58, P588, DOI 10.1161/HYPERTENSIONAHA.111.174557; van Oostrom AJHHM, 2003, J LIPID RES, V44, P576, DOI 10.1194/jlr.M200419-JLR200; West S G, 2001, Curr Atheroscler Rep, V3, P446, DOI 10.1007/s11883-001-0034-7; Westphal S, 2006, ATHEROSCLEROSIS, V185, P313, DOI 10.1016/j.atherosclerosis.2005.06.004	43	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53474	10.1371/journal.pone.0053474	http://dx.doi.org/10.1371/journal.pone.0053474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405070	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400013
J	Luo, Y; Zhang, YH; Liu, T; Rutherford, S; Xu, YJ; Xu, XJ; Wu, W; Xiao, JP; Zeng, WL; Chu, C; Ma, WJ				Luo, Yuan; Zhang, Yonghui; Liu, Tao; Rutherford, Shannon; Xu, Yanjun; Xu, Xiaojun; Wu, Wei; Xiao, Jianpeng; Zeng, Weilin; Chu, Cordia; Ma, Wenjun			Lagged Effect of Diurnal Temperature Range on Mortality in a Subtropical Megacity of China	PLOS ONE			English	Article							HIGH AMBIENT-TEMPERATURE; AIR-POLLUTION; DISTRIBUTED LAG; RISK-FACTOR; EUROPEAN CITIES; UNITED-STATES; HEAT WAVES; US CITIES; WEATHER; COLD	Background: Many studies have found extreme temperature can increase the risk of mortality. However, it is not clear whether extreme diurnal temperature range (DTR) is associated with daily disease-specific mortality, and how season might modify any association. Objectives: To better understand the acute effect of DTR on mortality and identify whether season is a modifier of the DTR effect. Methods: The distributed lag nonlinear model (DLNM) was applied to assess the non-linear and delayed effects of DTR on deaths (non-accidental mortality (NAD), cardiovascular disease (CVD), respiratory disease (RD) and cerebrovascular disease (CBD)) in the full year, the cold season and the warm season. Results: A non-linear relationship was consistently found between extreme DTR and mortality. Immediate effects of extreme low DTR on all types of mortality were stronger than those of extreme high DTR in the full year. The cumulative effects of extreme DTRs increased with the increment of lag days for all types of mortality in cold season, and they were greater for extreme high DTRs than those of extreme low DTRs. In hot season, the cumulative effects for extreme low DTRs increased with the increment of lag days, but for extreme high DTR they reached maxima at a lag of 13 days for all types of mortality except for CBD(at lag6 days), and then decreased. Conclusions: Our findings suggest that extreme DTR is an independent risk factor of daily mortality, and season is a modifier of the association of DTR with daily mortality.	[Luo, Yuan; Liu, Tao; Wu, Wei; Xiao, Jianpeng; Zeng, Weilin; Ma, Wenjun] Guangdong Prov Inst Publ Hlth, Dept Environm & Hlth, Guangzhou, Guangdong, Peoples R China; [Luo, Yuan; Zhang, Yonghui; Liu, Tao; Xu, Yanjun; Xu, Xiaojun; Wu, Wei; Xiao, Jianpeng; Zeng, Weilin; Ma, Wenjun] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Rutherford, Shannon; Chu, Cordia] Griffith Univ, Sch Environm, Ctr Environm & Populat Hlth, Brisbane, Qld 4111, Australia	Griffith University	Ma, WJ (corresponding author), Guangdong Prov Inst Publ Hlth, Dept Environm & Hlth, Guangzhou, Guangdong, Peoples R China.	mwj68@tom.com	Xiao, Jianpeng/GRY-5231-2022; 马, 文军/GQQ-7852-2022; Xiao, Jian/GYU-4351-2022	Chu, Cordia/0000-0002-3683-5638	 [ACCC/20100528]		Funding was provided by http://www.ccadaptation.org.cn/, grant number ACCC/20100528. The funders had no role in study design, data collection and analysis, desicion to publish, or preparation of the manuscript.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2011, ENVIRON RES, V111, P1286, DOI 10.1016/j.envres.2011.09.006; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Brazdil R, 1996, INT J CLIMATOL, V16, P765, DOI 10.1002/(SICI)1097-0088(199607)16:7<765::AID-JOC46>3.0.CO;2-O; Cao JY, 2009, J EPIDEMIOL, V19, P328, DOI 10.2188/jea.JE20080074; Carder M, 2005, OCCUP ENVIRON MED, V62, P702, DOI 10.1136/oem.2004.016394; Chen GH, 2007, INT J CARDIOL, V116, P408, DOI 10.1016/j.ijcard.2006.03.067; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; D'Ippoliti Daniela MP, 2010, ENV HLTH, V9, P37; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Guo YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016511; Ha J, 2011, SCI TOTAL ENV; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Kan HD, 2007, ENVIRON RES, V103, P424, DOI 10.1016/j.envres.2006.11.009; Karl TR, 1993, PAPERS NATURAL RESOU, P185; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Leung M.K.H., 2004, FEASIBILITY STUDY RE; Li Q, 2008, P 16 IAHR APD C 3 S; Liang WM, 2009, INT J BIOMETEOROL, V53, P17, DOI 10.1007/s00484-008-0187-y; Lim YH, 2012, INT J BIOMETEOROL, V56, P33, DOI 10.1007/s00484-010-0395-0; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; McMicheal A, 2003, CLIMATE CHANGES HUMA; Medina-Ramon M, 2007, OCCUP ENV MED; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Roberts S, 2007, ENVIRON RES, V104, P193, DOI 10.1016/j.envres.2007.01.009; Rocklov J, 2008, SCAND J PUBLIC HEALT, V36, P516, DOI 10.1177/1403494807088458; Rocklov J, 2010, INT J ENV RES PUB HE, V7, P2607, DOI 10.3390/ijerph7062607; Schneider A, 2008, INT J BIOMETEOROL, V52, P535, DOI 10.1007/s00484-008-0144-9; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; Schwartz J, 2000, AM J EPIDEMIOL, V151, P440, DOI 10.1093/oxfordjournals.aje.a010228; Song GX, 2008, RESPIROLOGY, V13, P1066, DOI 10.1111/j.1440-1843.2008.01401.x; Tam WWS, 2009, ARCH ENVIRON OCCUP H, V64, P202, DOI 10.1080/19338240903241192; Tank AMGK, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006316; Tong SL, 2010, INT J BIOMETEOROL, V54, P393, DOI 10.1007/s00484-009-0290-8; Vose RS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024379; WHO, 2008, PROT HLTH CLIM CHANG; WHO, 2010, INT STAT CLASS DIS R; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015	44	68	70	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55280	10.1371/journal.pone.0055280	http://dx.doi.org/10.1371/journal.pone.0055280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405130	Green Published, gold			2022-12-27	WOS:000315153400075
J	Espinosa, AM; Alfaro, A; Roman-Basaure, E; Guardado-Estrada, M; Palma, I; Serralde, C; Medina, I; Juarez, E; Bermudez, M; Marquez, E; Borges-Ibanez, M; Munoz-Cortez, S; Alcantara-Vazquez, A; Alonso, P; Curiel-Valdez, J; Kofman, S; Villegas, N; Berumen, J				Maria Espinosa, Ana; Alfaro, Ana; Roman-Basaure, Edgar; Guardado-Estrada, Mariano; Palma, Icela; Serralde, Cyntia; Medina, Ingrid; Juarez, Eligia; Bermudez, Miriam; Marquez, Edna; Borges-Ibanez, Manuel; Munoz-Cortez, Sergio; Alcantara-Vazquez, Avissai; Alonso, Patricia; Curiel-Valdez, Jose; Kofman, Susana; Villegas, Nicolas; Berumen, Jaime			Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; GENE-EXPRESSION; INTRAEPITHELIAL NEOPLASIA; MICROTUBULE-BINDING; MOLECULAR MARKERS; GENOMIC APPROACH; MITOTIC PATHWAY; IDENTIFICATION; VACCINE; PRC1	The effect of preventive human papillomavirus (HPV) vaccination on the reduction of the cervical cancer (CC) burden will not be known for 30 years. Therefore, it's still necessary to improve the procedures for CC screening and treatment. The objective of this study was to identify and characterize cellular targets that could be considered potential markers for screening or therapeutic targets. A pyramidal strategy was used. Initially the expression of 8,638 genes was compared between 43 HPV16-positive CCs and 12 healthy cervical epitheliums using microarrays. A total of 997 genes were deregulated, and 21 genes that showed the greatest deregulation were validated using qRT-PCR. The 6 most upregulated genes (CCNB2, CDC20, PRC1, SYCP2, NUSAP1, CDKN3) belong to the mitosis pathway. They were further explored in 29 low-grade cervical intraepithelial neoplasias (CIN1) and 21 high-grade CIN (CIN2/3) to investigate whether they could differentiate CC and CIN2/3 (CIN2+) from CIN1 and controls. CCNB2, PRC1, and SYCP2 were mostly associated with CC and CDC20, NUSAP1, and CDKN3 were also associated with CIN2/3. The sensitivity and specificity of CDKN3 and NUSAP1 to detect CIN2+ was approximately 90%. The proteins encoded by all 6 genes were shown upregulated in CC by immunohistochemistry. The association of these markers with survival was investigated in 42 CC patients followed up for at least 42 months. Only CDKN3 was associated with poor survival and it was independent from clinical stage (HR = 5.9, 95% CI = 1.4-23.8, p = 0.01). CDKN3 and NUSAP1 may be potential targets for the development of screening methods. Nevertheless, further studies with larger samples are needed to define the optimal sensitivity and specificity. Inhibition of mitosis is a well-known strategy to combat cancers. Therefore, CDKN3 may be not only a screening and survival marker but a potential therapeutic target in CC. However, whether it's indispensable for tumor growth remains to be demonstrated.	[Maria Espinosa, Ana; Alfaro, Ana; Medina, Ingrid; Kofman, Susana; Berumen, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Maria Espinosa, Ana; Alfaro, Ana; Guardado-Estrada, Mariano; Serralde, Cyntia; Medina, Ingrid; Juarez, Eligia; Bermudez, Miriam; Curiel-Valdez, Jose; Berumen, Jaime] Hosp Gen Mexico City, Unidad Med Genom, Mexico City, DF, Mexico; [Roman-Basaure, Edgar] Hosp Gen Mexico City, Serv Oncol, Mexico City, DF, Mexico; [Palma, Icela] Inst Politecn Nacl, Escuela Super Med, Mexico City, DF, Mexico; [Marquez, Edna] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas, Mexico City 04510, DF, Mexico; [Borges-Ibanez, Manuel; Munoz-Cortez, Sergio] Hosp Gen Mexico City, Serv Ginecobstet, Mexico City, DF, Mexico; [Alcantara-Vazquez, Avissai; Alonso, Patricia] Hosp Gen Mexico City, Serv Patol, Mexico City, DF, Mexico; [Kofman, Susana] Hosp Gen Mexico City, Serv Genet, Mexico City, DF, Mexico; [Villegas, Nicolas] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Hospital General de Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Hospital General de Mexico; Hospital General de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Berumen, J (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico.	jaimeberumen@hotmail.com	Berumen, Jaime/AAL-5577-2020; Berumen, Jaime/F-7914-2018	Berumen, Jaime/0000-0001-6707-3317; Berumen, Jaime/0000-0001-6707-3317; ESPINOSA GARCIA, ANA MARIA/0000-0003-3255-4051; PALMA LARA, ICELA/0000-0003-0756-8427; Villegas-Sepulveda, Nicolas/0000-0001-9489-2545	National Council of Science and Technology (CONACYT) [8135/A1, 24341, 80680]; National University of Mexico [SDI.PTID.05.2]; CONACYT	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Council of Science and Technology (CONACYT, www.conacyt.mx), grant numbers 8135/A1, 24341 (to JB) and 80680 (to SK), and the National University of Mexico (www.unam.mx), grant number SDI.PTID.05.2 (to JB). AME, AA and IMM were recipients of a scholarship from CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e900; Baleriola C, 2008, J CLIN VIROL, V42, P22, DOI 10.1016/j.jcv.2007.12.008; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Biewenga P, 2008, GYNECOL ONCOL, V108, P520, DOI 10.1016/j.ygyno.2007.11.024; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Chen Y, 2003, CANCER RES, V63, P1927; Cuzick J, 2010, GYNECOL ONCOL, V117, pS11, DOI 10.1016/j.ygyno.2010.01.025; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dehn D, 2007, CANCER CYTOPATHOL, V111, P1, DOI 10.1002/cncr.22425; DEMETRICK DJ, 1995, CYTOGENET CELL GENET, V69, P190, DOI 10.1159/000133960; Draviam VM, 2001, J CELL BIOL, V152, P945, DOI 10.1083/jcb.152.5.945; Fan Jerome, 2006, CJEM, V8, P19; Ferlay J, 2008, IARC CANC BASE, V10; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; Giorgi-Rossi P, 2012, INT J CANCER, V130, P1387, DOI 10.1002/ijc.26147; Gius D, 2007, CANCER RES, V67, P7113, DOI 10.1158/0008-5472.CAN-07-0260; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Gupta N, 2010, DIAGN CYTOPATHOL, V38, P618, DOI 10.1002/dc.21270; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang SJ, 2012, J ONCOL, V2012, DOI 10.1155/2012/507286; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li C, 2004, ONCOGENE, V23, P9336, DOI 10.1038/sj.onc.1208114; Li XCL, 2011, GENETICS, V189, P71, DOI 10.1534/genetics.111.130674; MacDermed DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-16; Manos MM, 1989, USE POLYMERASE CHAIN, P209; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; McCrory DC, 2009, EVID REP TECHNOL ASS, V1999, P1; Mo ML, 2010, INT J BIOL MARKER, V25, P236, DOI 10.5301/JBM.2010.6088; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Natunen Kari, 2011, Infect Dis Obstet Gynecol, V2011, P675858, DOI 10.1155/2011/675858; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Park SH, 2007, CLIN CANCER RES, V13, P858, DOI 10.1158/1078-0432.CCR-06-1461; Patel D, 2010, J VIROL, V84, P10956, DOI 10.1128/JVI.00259-10; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pyeon D, 2007, CANCER RES, V67, P10163; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; Saxena R, 2012, MED RES REV, V32, P166, DOI 10.1002/med.20209; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Taylor KJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2593; Teissier S, 2007, J VIROL, V81, P9368, DOI 10.1128/JVI.00427-07; Thierry F, 2004, CANCER RES, V64, P895, DOI 10.1158/0008-5472.CAN-03-2349; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDENBRULE AJC, 1990, J CLIN MICROBIOL, V28, P2739, DOI 10.1128/JCM.28.12.2739-2743.1990; Vazquez-Mena O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032667; Wang SM, 2011, CLIN CANCER RES, V17, P6040, DOI 10.1158/1078-0432.CCR-11-0557; Wentzensen N, 2006, CANCER-AM CANCER SOC, V107, P2307, DOI 10.1002/cncr.22247; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Wright TC, 2007, CLIN OBSTET GYNECOL, V50, P313, DOI 10.1097/GRF.0b013e31804a8285; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524, DOI 10.1111/j.1349-7006.1991.tb01882.x; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056	76	57	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55975	10.1371/journal.pone.0055975	http://dx.doi.org/10.1371/journal.pone.0055975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405241	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400186
J	Sousa, MML; Zub, KA; Aas, PA; Hanssen-Bauer, A; Demirovic, A; Sarno, A; Tian, EM; Liabakk, NB; Slupphaug, G				Sousa, Mirta M. L.; Zub, Kamila Anna; Aas, Per Arne; Hanssen-Bauer, Audun; Demirovic, Aida; Sarno, Antonio; Tian, Erming; Liabakk, Nina B.; Slupphaug, Geir			An Inverse Switch in DNA Base Excision and Strand Break Repair Contributes to Melphalan Resistance in Multiple Myeloma Cells	PLOS ONE			English	Article							INTERSTRAND CROSS-LINK; CYCLE REGULATION; DRUG-RESISTANCE; DAMAGE; PROTEIN; APOPTOSIS; PATHWAY; CANCER; URACIL; GLYCOSYLASE	Alterations in checkpoint and DNA repair pathways may provide adaptive mechanisms contributing to acquired drug resistance. Here, we investigated the levels of proteins mediating DNA damage signaling and -repair in RPMI8226 multiple myeloma cells and its Melphalan-resistant derivative 8226-LR5. We observed markedly reduced steady-state levels of DNA glycosylases UNG2, NEIL1 and MPG in the resistant cells and cross-resistance to agents inducing their respective DNA base lesions. Conversely, repair of alkali-labile sites was apparently enhanced in the resistant cells, as substantiated by alkaline comet assay, autoribosylation of PARP-1, and increased sensitivity to PARP-1 inhibition by 4-AN or KU58684. Reduced base-excision and enhanced single-strand break repair would both contribute to the observed reduction in genomic alkali-labile sites, which could jeopardize productive processing of the more cytotoxic Melphalan-induced interstrand DNA crosslinks (ICLs). Furthermore, we found a marked upregulation of proteins in the non-homologous end-joining (NHEJ) pathway of double-strand break (DSB) repair, likely contributing to the observed increase in DSB repair kinetics in the resistant cells. Finally, we observed apparent upregulation of ATR-signaling and downregulation of ATM-signaling in the resistant cells. This was accompanied by markedly increased sensitivity towards Melphalan in the presence of ATR-, DNA-PK, or CHK1/2 inhibitors whereas no sensitizing effect was observed subsequent to ATM inhibition, suggesting that replication blocking lesions are primary triggers of the DNA damage response in the Melphalan resistant cells. In conclusion, Melphalan resistance is apparently contributed by modulation of the DNA damage response at multiple levels, including downregulation of specific repair pathways to avoid repair intermediates that could impair efficient processing of cytotoxic ICLs and ICL-induced DSBs. This study has revealed several novel candidate biomarkers for Melphalan sensitivity that will be included in targeted quantitation studies in larger patient cohorts to validate their value in prognosis as well as targets for replacement-or adjuvant therapies.	[Sousa, Mirta M. L.; Zub, Kamila Anna; Aas, Per Arne; Hanssen-Bauer, Audun; Demirovic, Aida; Sarno, Antonio; Tian, Erming; Liabakk, Nina B.; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Sousa, Mirta M. L.; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, Prote & Metabol Core Facil PROMEC, Trondheim, Norway; [Zub, Kamila Anna; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, KG Jebsen Ctr Myeloma Res, Trondheim, Norway; [Tian, Erming] Univ Arkansas Med Sci, Lab Myeloma Genet, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Arkansas System; University of Arkansas Medical Sciences	Slupphaug, G (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway.	geir.slupphaug@ntnu.no	Slupphaug, Geir/AAN-3794-2020	Slupphaug, Geir/0000-0002-7498-3500; Sarno, Antonio/0000-0002-9308-8018	Research Council of Norway [183423, 183432]; Norwegian Cancer Society [TS-02-2008-0185]; Cancer Fund at St. Olavs Hospital, Trondheim [47063403]; Central Norway Regional Health Authority (RHA) [81133200]; Norwegian University of Science and Technology (NTNU) [81133200]; Familien Blix fond til fremme av medisinsk forskning; NATIONAL CANCER INSTITUTE [P01CA055819] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Cancer Fund at St. Olavs Hospital, Trondheim; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); Familien Blix fond til fremme av medisinsk forskning; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906), grant no. 183423 and 183432; the Norwegian Cancer Society (https://kreftforeningen.no/en/), grant no. TS-02-2008-0185; the Cancer Fund at St. Olavs Hospital, Trondheim (http://www.stolav.no/en/), grant no. 47063403; the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (http://www.ntnu.no/dmf/rad/samorg), grant no. 81133200; and Familien Blix fond til fremme av medisinsk forskning (http://www.legatsiden.no/innhold/visettlegat.php?id=1017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS DS, 1979, CLIN PHARMACOL THER, V26, P737; ALEXANIAN R, 1969, J AMER MED ASSOC, V208, P1680, DOI 10.1001/jama.208.9.1680; Audebert M, 2008, BIOCHEM BIOPH RES CO, V369, P982, DOI 10.1016/j.bbrc.2007.11.132; Balcome S, 2004, CHEM RES TOXICOL, V17, P950, DOI 10.1021/tx0499463; Bauer GB, 1997, NUCLEIC ACIDS RES, V25, P1211, DOI 10.1093/nar/25.6.1211; BELLAMY WT, 1991, CANCER RES, V51, P995; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; BERGSAGEL DE, 1962, CANCER CHEMOTH REP, P87; Boldogh I, 2003, TOXICOLOGY, V193, P137, DOI 10.1016/j.tox.2003.08.013; BOSANQUET AG, 1988, CANCER CHEMOTH PHARM, V21, P211; BOSANQUET AG, 1985, J PHARM SCI, V74, P348, DOI 10.1002/jps.2600740329; BRAVO R, 1980, J CELL BIOL, V84, P795, DOI 10.1083/jcb.84.3.795; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Clingen PH, 2008, BIOCHEM PHARMACOL, V76, P19, DOI 10.1016/j.bcp.2008.03.025; Coste F, 1999, NUCLEIC ACIDS RES, V27, P1837, DOI 10.1093/nar/27.8.1837; Couve S, 2009, J BIOL CHEM, V284, P11963, DOI 10.1074/jbc.M900746200; DALTON WS, 1989, J CLIN ONCOL, V7, P415, DOI 10.1200/JCO.1989.7.4.415; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Dannenberg JH, 2010, CELL, V141, P18, DOI 10.1016/j.cell.2010.03.020; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dvorakova K, 2002, MOL CANCER THER, V1, P185; Edler M, 2006, J MASS SPECTROM, V41, P507, DOI 10.1002/jms.1009; EHRSSON H, 1990, CLIN PHARMACOL THER, V47, P86, DOI 10.1038/clpt.1990.13; FERNBERG JO, 1991, EUR J HAEMATOL, V47, P161; Fishel ML, 2003, CANCER RES, V63, P608; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Goncalves TL, 2009, PHARMACOL RES, V59, P279, DOI 10.1016/j.phrs.2008.12.005; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hazlehurst LA, 2003, CANCER RES, V63, P7900; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Kim DK, 2001, BIOCHEM BIOPH RES CO, V289, P34; Kothandapani A, 2011, J BIOL CHEM; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kumar A, 2011, AM J HEMATOL, V86, P18, DOI 10.1002/ajh.21904; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Lukamowicz M, 2011, MUTAGENESIS, V26, P763, DOI 10.1093/mutage/ger044; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; Ma WJ, 2012, P NATL ACAD SCI USA, V109, P6590, DOI 10.1073/pnas.1118078109; Mace-Aime G, 2010, ENVIRON MOL MUTAGEN, V51, P508, DOI 10.1002/em.20548; Merchionne F, 2007, CLIN EXP MED, V7, P83, DOI 10.1007/s10238-007-0134-y; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Oancea M, 2004, INT J HEMATOL, V80, P224, DOI 10.1532/IJH97.04107; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Palumbo A, 2009, LEUKEMIA, V23, P449, DOI 10.1038/leu.2008.325; POVIRK LF, 1994, MUTAT RES-REV GENET, V318, P205, DOI 10.1016/0165-1110(94)90015-9; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rothbarth J, 2002, CHEM-BIOL INTERACT, V140, P93, DOI 10.1016/S0009-2797(02)00014-5; Sabbioneda S, 2007, DNA REPAIR, V6, P121, DOI 10.1016/j.dnarep.2006.09.002; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SLUPPHAUG G, 1991, NUCLEIC ACIDS RES, V19, P5131, DOI 10.1093/nar/19.19.5131; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Sousa MML, 2007, MOL ASPECTS MED, V28, P276, DOI 10.1016/j.mam.2007.04.006; Spanswick VJ, 2002, BLOOD, V100, P224, DOI 10.1182/blood.V100.1.224; Stolz A, 2011, CLIN CANCER RES, V17, P401, DOI 10.1158/1078-0432.CCR-10-1215; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Tsvetkov LM, 2005, CELL CYCLE, V4, P609; Vasquez KM, 2010, ENVIRON MOL MUTAGEN, V51, P527, DOI 10.1002/em.20557; Wang D, 2009, LUNG CANCER, V66, P298, DOI 10.1016/j.lungcan.2009.02.019; Wang Dong, 2006, Zhonghua Bing Li Xue Za Zhi, V35, P352; Wang LC, 2010, CRIT REV BIOCHEM MOL, V45, P424, DOI 10.3109/10409238.2010.502166; WANG P, 1991, BIOCHEMISTRY-US, V30, P11515, DOI 10.1021/bi00113a005; WANG Z, 1989, J BIOL CHEM, V264, P1163; Wilson DM, 2010, TRENDS BIOCHEM SCI, V35, P247, DOI 10.1016/j.tibs.2010.01.003; Xiang Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005520; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616; Zhang Y, 2009, INT J ONCOL, V35, P1069, DOI 10.3892/ijo_00000422; Zhu GY, 2010, BIOCHEMISTRY-US, V49, P6177, DOI 10.1021/bi100775t	79	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55493	10.1371/journal.pone.0055493	http://dx.doi.org/10.1371/journal.pone.0055493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405159	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400104
J	Szasz, T; Davis, RP; Garver, HS; Burnett, RJ; Fink, GD; Watts, SW				Szasz, Theodora; Davis, Robert Patrick; Garver, Hannah S.; Burnett, Robert J.; Fink, Gregory D.; Watts, Stephanie W.			Long-Term Inhibition of Xanthine Oxidase by Febuxostat Does Not Decrease Blood Pressure in Deoxycorticosterone Acetate (DOCA)-Salt Hypertensive Rats	PLOS ONE			English	Article							URIC-ACID; ALLOPURINOL; GOUT; HYPERURICEMIA; PREVENTS; URATE; OXIDOREDUCTASE; EFFICACY; INJURY; SAFETY	Xanthine oxidase and its products, uric acid and ROS, have been implicated in the pathogenesis of cardiovascular disease, such as hypertension. We have previously reported that allopurinol inhibition of XO does not alter the progression of deoxycorticosterone acetate (DOCA)-salt hypertension in rats. However other researchers have observed a reduction in blood pressure after allopurinol treatment in the same model. To resolve this controversy, in this study we used the newer and more effective XO inhibitor febuxostat, and hypothesized that a more complete XO blockade might impair hypertension development and its end-organ consequences. We used DOCA-salt hypertensive rats and administered vehicle (salt water) or febuxostat (orally, 5 mg/kg/day in salt water) in a short-term "reversal" experiment (2 weeks of treatment 3 weeks after DOCA-salt beginning) and a long-term "prevention" experiment (treatment throughout 4 weeks of DOCA-salt). We confirmed XO inhibition by febuxostat by measuring circulating and tissue levels of XO metabolites. We found an overall increase in hypoxanthine (XO substrate) and decrease in uric acid (XO product) levels following febuxostat treatment. However, despite a trend for reduced blood pressure in the last week of long-term febuxostat treatment, no statistically significant difference in hemodynamic parameters was observed in either study. Additionally, no change was observed in relative heart and kidney weight. Aortic media/lumen ratio was minimally improved by long-term febuxostat treatment. Additionally, febuxostat incubation in vitro did not modify contraction of aorta or vena cava to norepinephrine, angiotensin II or endothelin-1. We conclude that XO inhibition is insufficient to attenuate hypertension in the rat DOCA-salt model, although beneficial vascular effects are possible.	[Szasz, Theodora] Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA; [Davis, Robert Patrick; Garver, Hannah S.; Burnett, Robert J.; Fink, Gregory D.; Watts, Stephanie W.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA	University System of Georgia; Augusta University; Michigan State University	Szasz, T (corresponding author), Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA.	iszasz@georgiahealth.edu			Takeda Pharmaceuticals U.S.A., Inc. [MSA-FEB-134]; study drug (febuxostat)	Takeda Pharmaceuticals U.S.A., Inc.; study drug (febuxostat)	Financial support was provided by Takeda Pharmaceuticals U.S.A., Inc. in the form of a research grant (#MSA-FEB-134) and the study drug (febuxostat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided by Takeda Pharmaceuticals U.S.A., Inc. in the form of a research grant(#MSA-FEB-134) and the study drug (febuxostat). Febuxostat is a product of Takeda Pharmaceuticals U.S.A., Inc. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Callera GE, 2006, CLIN SCI, V110, P243, DOI 10.1042/CS20050307; Chohan S, 2012, ARTHRIT CARE RES, V64, P256, DOI 10.1002/acr.20680; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Hair PI, 2008, DRUGS, V68, P1865, DOI 10.2165/00003495-200868130-00006; Hamburger M, 2011, PHYSICIAN SPORTSMED, V39, P98, DOI 10.3810/psm.2011.11.1946; Ho WJ, 2010, RHEUMATOLOGY, V49, P1929, DOI 10.1093/rheumatology/keq184; Jackson RL, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-11; Jin L, 2006, J PHYSIOL PHARMACOL, V57, P343; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kasal DAB, 2008, HISTOL HISTOPATHOL, V23, P1241, DOI 10.14670/HH-23.1241; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Laakso JT, 2004, J HYPERTENS, V22, P1333, DOI 10.1097/01.hjh.0000125441.28861.9f; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Minami M, 2005, BLOOD PRESSURE, V14, P120, DOI 10.1080/08037050510008878; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; Ong SLH, 2007, CLIN EXP PHARMACOL P, V34, P517, DOI 10.1111/j.1440-1681.2007.04605.x; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Sahan-Firat S, 2010, AM J PHYSIOL-HEART C, V299, pH1891, DOI 10.1152/ajpheart.00655.2010; Sanchez-Lozada LG, 2008, NEPHRON PHYSIOL, V108, P69, DOI 10.1159/000127837; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V294, pF710, DOI 10.1152/ajprenal.00454.2007; Sanchez-Lozada LG, 2008, NEPHROL DIAL TRANSPL, V23, P1179, DOI 10.1093/ndt/gfm783; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Suzuki H, 1998, P NATL ACAD SCI USA, V95, P4754, DOI 10.1073/pnas.95.8.4754; Szasz T, 2010, J CARDIOVASC PHARM, V56, P627, DOI 10.1097/FJC.0b013e3181f80194; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Tian N, 2005, HYPERTENSION, V45, P934, DOI 10.1161/01.HYP.0000160404.08866.5a; Viel EC, 2008, AM J PHYSIOL-HEART C, V295, pH281, DOI 10.1152/ajpheart.00304.2008; Xu H, 2004, HYPERTENSION, V43, P329, DOI 10.1161/01.HYP.0000112304.26158.5c; Yamamoto Y, 2006, HYPERTENS RES, V29, P915, DOI 10.1291/hypres.29.915; Yang J, 2008, HYPERTENS RES, V31, P931, DOI 10.1291/hypres.31.931; Zhang Y, 2005, AM J HYPERTENS, V18, P910, DOI 10.1016/j.amjhyper.2005.02.017	35	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e56046	10.1371/journal.pone.0056046	http://dx.doi.org/10.1371/journal.pone.0056046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393607	Green Submitted, gold, Green Published			2022-12-27	WOS:000314692800062
J	Redshaw, N; Camps, C; Sharma, V; Motallebipour, M; Guzman-Ayala, M; Oikonomopoulos, S; Thymiakou, E; Ragoussis, J; Episkopou, V				Redshaw, Nicholas; Camps, Carme; Sharma, Vikas; Motallebipour, Mehdi; Guzman-Ayala, Marcela; Oikonomopoulos, Spyros; Thymiakou, Efstathia; Ragoussis, Jiannis; Episkopou, Vasso			TGF-beta/Smad2/3 Signaling Directly Regulates Several miRNAs in Mouse ES Cells and Early Embryos	PLOS ONE			English	Article							TGF-BETA; MICRORNA EXPRESSION; STEM-CELLS; PRIMITIVE STREAK; GENE-EXPRESSION; ENZYME DICER; GROWTH; DIFFERENTIATION; PROFILES; FOXH1	The Transforming Growth Factor-beta (TGF-beta) signaling pathway is one of the major pathways essential for normal embryonic development and tissue homeostasis, with anti-tumor but also pro-metastatic properties in cancer. This pathway directly regulates several target genes that mediate its downstream functions, however very few microRNAs (miRNAs) have been identified as targets. miRNAs are modulators of gene expression with essential roles in development and a clear association with diseases including cancer. Little is known about the transcriptional regulation of the primary transcripts (pri-miRNA, pri-miR) from which several mature miRNAs are often derived. Here we present the identification of miRNAs regulated by TGF-beta signaling in mouse embryonic stem (ES) cells and early embryos. We used an inducible ES cell system to maintain high levels of the TGF-beta activated/phosphorylated Smad2/3 effectors, which are the transcription factors of the pathway, and a specific inhibitor that blocks their activation. By performing short RNA deep-sequencing after 12 hours Smad2/3 activation and after 16 hours inhibition, we generated a database of responsive miRNAs. Promoter/enhancer analysis of a subset of these miRNAs revealed that the transcription of pri-miR-181c/d and the pri-miR-341 similar to 3072 cluster were found to depend on activated Smad2/3. Several of these miRNAs are expressed in early mouse embryos, when the pathway is known to play an essential role. Treatment of embryos with TGF-beta inhibitor caused a reduction of their levels confirming that they are targets of this pathway in vivo. Furthermore, we showed that pri-miR-341 similar to 3072 transcription also depends on FoxH1, a known Smad2/3 transcription partner during early development. Together, our data show that miRNAs are regulated directly by the TGF-beta/Smad2/3 pathway in ES cells and early embryos. As somatic abnormalities in functions known to be regulated by the TGF-beta/Smad2/3 pathway underlie tumor suppression and metastasis, this research also provides a resource for miRNAs involved in cancer.	[Redshaw, Nicholas; Sharma, Vikas; Motallebipour, Mehdi; Guzman-Ayala, Marcela; Thymiakou, Efstathia; Episkopou, Vasso] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, London, England; [Camps, Carme; Oikonomopoulos, Spyros; Ragoussis, Jiannis] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics	Episkopou, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, London, England.	vasso.episkopou@imperial.ac.uk	Ragoussis, Ioannis/AAD-9790-2022	Ragoussis, Ioannis/0000-0002-8515-0934; Thymiakou, Efstathia/0000-0003-0204-5141	Medical Research Council, UK; Cancer Research UK; BBSRC; FP7 ITN programme InteGer; The Wellcome Trust [090532/Z/09/Z, 075491/Z/04]; Biotechnology and Biological Sciences Research Council [BB/G00577X/1, BB/G00577X/2] Funding Source: researchfish; Medical Research Council [MC_U120074332, MR/J013331/1] Funding Source: researchfish; BBSRC [BB/G00577X/1, BB/G00577X/2] Funding Source: UKRI; MRC [MR/J013331/1, MC_U120074332] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FP7 ITN programme InteGer; The Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NR, MGA and VE were supported by the Medical Research Council, UK. VS and ET were supported by Cancer Research UK and the BBSRC respectively. MM was a Swedish Research Council postdoctoral fellow. SO is a fellow funded by the FP7 ITN programme InteGer. JR and CC are supported by The Wellcome Trust grants 090532/Z/09/Z and 075491/Z/04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attisano L, 2001, MOL CELL ENDOCRINOL, V180, P3, DOI 10.1016/S0303-7207(01)00524-X; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998b; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Derynck R., 2008, TGF BETA FAMILY; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Enright AJ, 2004, GENOME BIOL, V5; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fu SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027965; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Garmire LX, 2012, RNA, V18, P1279, DOI 10.1261/rna.030916.111; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iwatsuki M, 2010, ANN SURG ONCOL, V17, P2526, DOI 10.1245/s10434-010-1041-0; Ji JF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-4; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kriegel AJ, 2010, NUCLEIC ACIDS RES, V38, P8338, DOI 10.1093/nar/gkq718; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson RA, 2010, CHEM-BIOL INTERACT, V184, P21, DOI 10.1016/j.cbi.2009.10.002; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu HQ, 2005, BIOINFORMATICS, V21, P671, DOI 10.1093/bioinformatics/bth437; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Meng FY, 2012, J CELL MOL MED, V16, P160, DOI 10.1111/j.1582-4934.2011.01282.x; Mian C, 2012, THYROID, V22, P890, DOI 10.1089/thy.2012.0045; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Norris DP, 2002, DEVELOPMENT, V129, P3455; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Qi YH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/915980; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roccaro AM, 2009, BLOOD, V113, P6669, DOI 10.1182/blood-2009-01-198408; Rodriguez TA, 2001, DEV BIOL, V234, P304, DOI 10.1006/dbio.2001.0265; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schanen BC, 2011, GENOMICS, V97, P1, DOI 10.1016/j.ygeno.2010.10.005; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Tombol Z, 2010, MODERN PATHOL, V23, P1583, DOI 10.1038/modpathol.2010.164; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang H, 2012, ONCOL LETT, V3, P229, DOI 10.3892/ol.2011.448; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Weisberg E, 1998, MECH DEVELOP, V79, P17, DOI 10.1016/S0925-4773(98)00160-9; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yabushita S, 2012, PANCREAS, V41, P1013, DOI 10.1097/MPA.0b013e31824ac3a5; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	94	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55186	10.1371/journal.pone.0055186	http://dx.doi.org/10.1371/journal.pone.0055186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23390484	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800126
J	Koyama, MS; Di Martino, A; Kelly, C; Jutagir, DR; Sunshine, J; Schwartz, SJ; Castellanos, FX; Milham, MP				Koyama, Maki S.; Di Martino, Adriana; Kelly, Clare; Jutagir, Devika R.; Sunshine, Jessica; Schwartz, Susan J.; Castellanos, Francisco X.; Milham, Michael P.			Cortical Signatures of Dyslexia and Remediation: An Intrinsic Functional Connectivity Approach	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; RESTING-STATE FMRI; WORD FORM AREA; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; SPATIAL ATTENTION; DEFAULT NETWORK; NEURAL SYSTEMS; BRAIN NETWORKS; GLOBAL SIGNAL	This observational, cross-sectional study investigates cortical signatures of developmental dyslexia, particularly from the perspective of behavioral remediation. We employed resting-state fMRI, and compared intrinsic functional connectivity (iFC) patterns of known reading regions (seeds) among three dyslexia groups characterized by (a) no remediation (current reading and spelling deficits), (b) partial remediation (only reading deficit remediated), and (c) full remediation (both reading and spelling deficits remediated), and a group of age-and IQ-matched typically developing children (TDC) (total N = 44, age range = 7-15 years). We observed significant group differences in iFC of two seeds located in the left posterior reading network - left intraparietal sulcus (L.IPS) and left fusiform gyrus (L.FFG). Specifically, iFC between L.IPS and left middle frontal gyrus was significantly weaker in all dyslexia groups, irrespective of remediation status/literacy competence, suggesting that persistent dysfunction in the fronto-parietal attention network characterizes dyslexia. Additionally, relative to both TDC and the no remediation group, the remediation groups exhibited stronger iFC between L.FFG and right middle occipital gyrus (R.MOG). The full remediation group also exhibited stronger negative iFC between the same L.FFG seed and right medial prefrontal cortex (R.MPFC), a core region of the default network These results suggest that behavioral remediation may be associated with compensatory changes anchored in L.FFG, which reflect atypically stronger coupling between posterior visual regions (L.FFG-R.MOG) and greater functional segregation between task-positive and task-negative regions (L.FFG-R.MPFC). These findings were bolstered by significant relationships between the strength of the identified functional connections and literacy scores. We conclude that examining iFC can reveal cortical signatures of dyslexia with particular promise for monitoring neural changes associated with behavioral remediation.	[Koyama, Maki S.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Koyama, Maki S.; Di Martino, Adriana; Kelly, Clare; Jutagir, Devika R.; Sunshine, Jessica; Castellanos, Francisco X.] NYU, Ctr Child Study, NYU Langone Med Ctr, Phyllis Green & Randolph Cowen Inst Pediat Neuros, New York, NY USA; [Schwartz, Susan J.; Milham, Michael P.] Child Mind Inst, Ctr Developing Brain, New York, NY USA; [Castellanos, Francisco X.; Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	Rutgers State University Newark; Rutgers State University New Brunswick; New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research	Koyama, MS (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	makisophiakoyama@gmail.com	Milham, Michael P./Y-3160-2019; Kelly, Clare/H-4629-2016; Milham, Michael P/K-9501-2014; Castellanos, Francisco Xavier/K-1892-2014; Di Martino, Adriana/X-5030-2019; Di Martino, Adriana/L-2497-2014	Kelly, Clare/0000-0001-8253-357X; Castellanos, Francisco Xavier/0000-0001-9192-9437; Di Martino, Adriana/0000-0001-6927-290X	NIMH [R01MH081218, K23MH087770]; Stavros Niarchos Foundation; Leon Levy Foundation	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stavros Niarchos Foundation; Leon Levy Foundation	This study was supported by grants from NIMH [R01MH081218, K23MH087770], the Stavros Niarchos Foundation, and the Leon Levy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersson JLR, 2007, NONLINEAR REGISTRATI; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blau V, 2010, BRAIN, V133, P868, DOI 10.1093/brain/awp308; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Carp J., 2011, NEUROIMAGE; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Chabernaud C, 2012, BIOL PSYCHIAT, V71, P434, DOI 10.1016/j.biopsych.2011.08.013; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Conners C.K., 1997, CONNERS RATING SCALE; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davis N, 2011, DEV NEUROPSYCHOL, V36, P288, DOI 10.1080/87565641.2010.549875; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Demb JB, 1998, J NEUROSCI, V18, P6939; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Duff FJ, 2011, J CHILD PSYCHOL PSYC, V52, P3, DOI 10.1111/j.1469-7610.2010.02310.x; Eden GF, 2004, NEURON, V44, P411, DOI 10.1016/j.neuron.2004.10.019; Eden GF, 1996, NEUROIMAGE, V4, pS108, DOI 10.1006/nimg.1996.0061; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Farrant E, 2011, RSC DRUG DISCOV, V11, P1, DOI 10.1039/9781849733052-00001; Ferrer E, 2010, PSYCHOL SCI, V21, P93, DOI 10.1177/0956797609354084; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Gaab N, 2007, RESTOR NEUROL NEUROS, V25, P295; Georgiou GK, 2012, DYSLEXIA, V18, P110, DOI 10.1002/dys.1439; Goswami U, 2002, P NATL ACAD SCI USA, V99, P10911, DOI 10.1073/pnas.122368599; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hamalainen J., 2012, J LEARNING DISABILIT, DOI http://dx.doi.org/10.1177/0022219411436213; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Hoeft F, 2006, J NEUROSCI, V26, P10700, DOI 10.1523/JNEUROSCI.4931-05.2006; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kaufman J, 1996, SCHEDULE AFFECTIVE D; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; KRAEMER HC, 1991, PSYCHOPHARMACOL BULL, V27, P217; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; McCloskey M, 2000, J EXP PSYCHOL HUMAN, V26, P917, DOI 10.1037/0096-1523.26.3.917; Moats LC, 1996, READ WRIT, V8, P105, DOI 10.1007/BF00423928; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nicolson RI, 2005, J NEURAL TRANSM-SUPP, P19; Odegard TN, 2008, ANN DYSLEXIA, V58, P1, DOI 10.1007/s11881-008-0014-5; Pennington BF, 2012, J ABNORM PSYCHOL, V121, P212, DOI 10.1037/a0025823; Pessoa L, 2009, BRAIN RES, V1247, P149, DOI 10.1016/j.brainres.2008.10.010; Peyrin C, 2012, BRAIN LANG, V120, P381, DOI 10.1016/j.bandl.2011.12.015; Peyrin C, 2011, BRAIN LANG, V118, P128, DOI 10.1016/j.bandl.2010.06.005; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Richlan F, 2011, NEUROIMAGE, V56, P1735, DOI 10.1016/j.neuroimage.2011.02.040; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sarkari Shirin, 2002, Semin Pediatr Neurol, V9, P229, DOI 10.1053/spen.2002.35506; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shaywitz BA, 2004, BIOL PSYCHIAT, V55, P926, DOI 10.1016/j.biopsych.2003.12.019; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Simos PG, 2007, NEUROPSYCHOLOGY, V21, P485, DOI 10.1037/0894-4105.21.4.485; Snowling M., 1998, CHILD PSYCHOL PSYCHI, V3, P4, DOI [10.1111/1475-3588.00201, DOI 10.1017/S1360641797001366, DOI 10.1111/1475-3588.00201]; STANOVICH KE, 1988, J LEARN DISABIL-US, V21, P590, DOI 10.1177/002221948802101003; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Stoodley CJ, 2011, CORTEX, V47, P101, DOI 10.1016/j.cortex.2009.10.005; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tanaka H, 2011, PSYCHOL SCI, V22, P1442, DOI 10.1177/0956797611419521; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Torgesen J.K., 1999, TOWRE TEST WORD READ; Torgesen JK, 2001, J LEARN DISABIL-US, V34, P33, DOI 10.1177/002221940103400104; Valdois S, 2011, CORTEX, V47, P1197, DOI 10.1016/j.cortex.2011.05.011; van der Mark S, 2011, NEUROIMAGE, V54, P2426, DOI 10.1016/j.neuroimage.2010.10.002; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; von dem Hagen EA, 2012, SOCIAL COGNITIVE AFF; Wagner R, 1999, CTOPP COMPREHENSIVE; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D, 2001, WECHSLER INDIVIDUAL, Vsecond; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; Willcutt EG, 2007, AM J MED GENET B, V144B, P709, DOI 10.1002/ajmg.b.30310; Wolf M, 2000, J LEARN DISABIL-US, V33, P387, DOI 10.1177/002221940003300409; Zorzi M., 2012, P NATL ACAD SCI US	107	80	81	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55454	10.1371/journal.pone.0055454	http://dx.doi.org/10.1371/journal.pone.0055454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092DU	23408984	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000015
J	Lourenco, AB; Roque, FC; Teixeira, MC; Ascenso, JR; Sa-Correia, I				Lourenco, Artur B.; Roque, Filipa C.; Teixeira, Miguel C.; Ascenso, Jose R.; Sa-Correia, Isabel			Quantitative H-1-NMR-Metabolomics Reveals Extensive Metabolic Reprogramming and the Effect of the Aquaglyceroporin FPS1 in Ethanol-Stressed Yeast Cells	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; IN-VIVO ACTIVATION; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; GENE-EXPRESSION; LIPID-COMPOSITION; BUDDING YEAST; H+-ATPASE; TOLERANCE; GLYCEROL	A metabolomic analysis using high resolution H-1 NMR spectroscopy coupled with multivariate statistical analysis was used to characterize the alterations in the endo-and exo-metabolome of S. cerevisiae BY4741 during the exponential phase of growth in minimal medium supplemented with different ethanol concentrations (0, 2, 4 and 6% v/v). This study provides evidence that supports the notion that ethanol stress induces reductive stress in yeast cells, which, in turn, appears to be counteracted by the increase in the rate of NAD(+) regenerating bioreactions. Metabolomics data also shows increased intra-and extra-cellular accumulation of most amino acids and TCA cycle intermediates in yeast cells growing under ethanol stress suggesting a state of overflow metabolism in turn of the pyruvate branch-point. Given its previous implication in ethanol stress resistance in yeast, this study also focused on the effect of the expression of the aquaglyceroporin encoded by FPS1 in the yeast metabolome, in the absence or presence of ethanol stress. The metabolomics data collected herein shows that the deletion of the FPS1 gene in the absence of ethanol stress partially mimics the effect of ethanol stress in the parental strain. Moreover, the results obtained suggest that the reported action of Fps1 in mediating the passive diffusion of glycerol is a key factor in the maintenance of redox balance, an important feature for ethanol stress resistance, and may interfere with the ability of the yeast cell to accumulate trehalose. Overall, the obtained results corroborate the idea that metabolomic approaches may be crucial tools to understand the function and/or the effect of membrane transporters/porins, such as Fps1, and may be an important tool for the clear-cut design of improved process conditions and more robust yeast strains aiming to optimize industrial fermentation performance.	[Lourenco, Artur B.; Roque, Filipa C.; Teixeira, Miguel C.; Sa-Correia, Isabel] Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, IBB, P-1096 Lisbon, Portugal; [Ascenso, Jose R.] Univ Tecn Lisboa, Inst Super Tecn, Ctr Quim Estrutural, P-1096 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Sa-Correia, I (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, IBB, P-1096 Lisbon, Portugal.	isacorreia@ist.utl.pt	Sá-Correia, Isabel/H-4054-2011; Bastos Lourenço, Artur/AEN-1450-2022; Teixeira, Miguel Cacho/A-3870-2008	Sá-Correia, Isabel/0000-0003-2208-5183; Bastos Lourenço, Artur/0000-0002-9379-9231; Teixeira, Miguel Cacho/0000-0002-5676-6174; Ascenso, Jose/0000-0002-5535-2500	FEDER, Fundacao para a Ciencia e a Tecnologia (FCT) [ERA-IB/0002/2010]	FEDER, Fundacao para a Ciencia e a Tecnologia (FCT)	This research was supported by FEDER, Fundacao para a Ciencia e a Tecnologia (FCT) (ERA-IB/0002/2010 and PhD grants to ABL and FCR). The Portuguese National NMR Network is acknowledged for providing the authors with the NMR facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera F, 2006, INT J FOOD MICROBIOL, V110, P34, DOI 10.1016/j.ijfoodmicro.2006.02.002; Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Ansanay-Geleote V, 2001, BIOTECHNOL LETT, V23, P677, DOI 10.1023/A:1010396232420; Baerends RJS, 2009, APPL ENVIRON MICROB, V75, P6055, DOI 10.1128/AEM.00989-09; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; BOLES E, 1993, EUR J BIOCHEM, V217, P469, DOI 10.1111/j.1432-1033.1993.tb18266.x; Cabrito TR, 2011, BIOCHEM J, V440, P195, DOI 10.1042/BJ20110876; Camarasa C, 2003, MICROBIOL-SGM, V149, P2669, DOI 10.1099/mic.0.26007-0; CASEY GP, 1986, CRC CR REV MICROBIOL, V13, P219, DOI 10.3109/10408418609108739; Chandler M, 2004, ANN MICROBIOL, V54, P427; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cheraiti N, 2005, APPL ENVIRON MICROB, V71, P255, DOI 10.1128/AEM.71.1.255-260.2005; Chi Z, 1999, J APPL MICROBIOL, V86, P1047, DOI 10.1046/j.1365-2672.1999.00793.x; DAMORE T, 1987, ENZYME MICROB TECH, V9, P322, DOI 10.1016/0141-0229(87)90053-6; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Devantier R, 2005, BIOTECHNOL BIOENG, V90, P703, DOI 10.1002/bit.20457; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Ding MZ, 2010, OMICS, V14, P553, DOI 10.1089/omi.2010.0015; dos Santos MM, 2003, FEMS YEAST RES, V4, P59, DOI 10.1016/S1567-1356(03)00155-7; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Fujita K, 2004, J APPL MICROBIOL, V97, P57, DOI 10.1111/j.1365-2672.2004.02290.x; Fujita K, 2006, FEMS YEAST RES, V6, P744, DOI 10.1111/j.1567-1364.2006.00040.x; Gawel R, 2007, AUST J GRAPE WINE R, V13, P38, DOI 10.1111/j.1755-0238.2007.tb00070.x; Gawel R, 2007, J AGR FOOD CHEM, V55, P2683, DOI 10.1021/jf0633950; Gibson BR, 2007, FEMS MICROBIOL REV, V31, P535, DOI 10.1111/j.1574-6976.2007.00076.x; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Guillamon JM, 2001, FEMS YEAST RES, V1, P169, DOI 10.1111/j.1567-1364.2001.tb00031.x; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; Jain VK, 2012, APPL MICROBIOL BIOT, V93, P131, DOI 10.1007/s00253-011-3431-z; Kaino T, 2008, APPL MICROBIOL BIOT, V79, P273, DOI 10.1007/s00253-008-1431-4; Kubota S, 2004, BIOSCI BIOTECH BIOCH, V68, P968, DOI 10.1271/bbb.68.968; Kutyna DR, 2010, TRENDS FOOD SCI TECH, V21, P293, DOI 10.1016/j.tifs.2010.03.004; Leskovac V, 2002, FEMS YEAST RES, V2, P481, DOI 10.1016/S1567-1356(02)00157-5; Li H, 2012, INT J BIOCHEM CELL B, V44, P1087, DOI 10.1016/j.biocel.2012.03.017; Lourenc AB, 2011, METABOLOMICS, V7, P457, DOI 10.1007/s11306-010-0264-1; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Ma MG, 2010, APPL MICROBIOL BIOT, V87, P829, DOI 10.1007/s00253-010-2594-3; Martini S, 2006, BIOPHYS CHEM, V120, P135, DOI 10.1016/j.bpc.2005.10.010; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Monteiro GA, 1998, BBA-BIOMEMBRANES, V1370, P310, DOI 10.1016/S0005-2736(97)00281-2; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; Ogawa Y, 2000, J BIOSCI BIOENG, V90, P313, DOI 10.1016/S1389-1723(00)80087-0; ROSA MF, 1991, APPL ENVIRON MICROB, V57, P830, DOI 10.1128/AEM.57.3.830-835.1991; Rosa MF, 1996, FEMS MICROBIOL LETT, V135, P271, DOI 10.1016/0378-1097(95)00465-3; SALGUEIRO SP, 1988, APPL ENVIRON MICROB, V54, P903, DOI 10.1128/AEM.54.4.903-909.1988; Schoondermark-Stolk SA, 2005, FEMS YEAST RES, V5, P757, DOI 10.1016/j.femsyr.2005.02.005; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Stanley D, 2010, APPL MICROBIOL BIOT, V88, P231, DOI 10.1007/s00253-010-2760-7; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Takagi H, 2005, APPL ENVIRON MICROB, V71, P8656, DOI 10.1128/AEM.71.12.8656-8662.2005; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Teixeira MC, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-98; Teixeira MC, 2009, APPL ENVIRON MICROB, V75, P5761, DOI 10.1128/AEM.00845-09; Toh TH, 2001, FEMS YEAST RES, V1, P205, DOI 10.1111/j.1567-1364.2001.tb00035.x; van Uden N., 1985, THES U AD, V8, P11; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359; VANDIJKEN JP, 1986, FEMS MICROBIOL LETT, V32, P199, DOI 10.1016/0378-1097(86)90291-0; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Vriesekoop F, 2007, BIOTECHNOL LETT, V29, P1099, DOI 10.1007/s10529-007-9367-9; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yoshikawa K, 2009, FEMS YEAST RES, V9, P32, DOI 10.1111/j.1567-1364.2008.00456.x	66	18	21	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55439	10.1371/journal.pone.0055439	http://dx.doi.org/10.1371/journal.pone.0055439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408980	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300014
J	Absood, A; Gandomani, B; Zaki, A; Nasta, V; Michail, A; Habib, PMW; Hodish, I				Absood, Afaf; Gandomani, Benjamin; Zaki, Anthony; Nasta, Vlad; Michail, Andrew; Habib, Peter M. W.; Hodish, Israel			Insulin Therapy for Pre-Hyperglycemic Beta-Cell Endoplasmic Reticulum Crowding	PLOS ONE			English	Article							DIABETIC MUTANT MOUSE; IMPAIRED GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; PANCREATIC ISLETS; METABOLIC-CONTROL; FASTING GLUCOSE; ER STRESS; US ADULTS; MICE; PROINSULIN	Insulin therapy improves beta-cell function in early stages of diabetes by mechanisms that may exceed alleviation of glucotoxicity. In advance type 2 diabetes, hyperglycemia causes beta-cell damage and ultimately beta-cell loss. At such an advanced stage, therapeutic modalities are often inadequate. Growing evidence indicates that in early stages of type-2 diabetes and some types of monogenic diabetes linked with malfunctioning endoplasmic-reticulum (ER), the beta-cell ER fails to process sufficient proinsulin once it becomes overloaded. These changes manifest with ER distention (ER-crowding) and deficiency of secretory granules. We hypothesize that insulin therapy may improves beta-cell function by alleviating ER-crowding. To support this hypothesis, we investigated pre-diabetic beta-cell changes in hProC(A7)Y-CpepGFP transgenic mice that develop prolonged pre-diabetes due to proinsulin dysmaturation and ER-crowding. We attenuated the beta-cell ER proinsulin synthesis with a treat-to-target insulin therapy while avoiding hypoglycemia and weight gain. Alleviation of ER-crowding resulted in temporary improvement in proinsulin maturation, insulin secretion and glucose tolerance. Our observations suggest that alleviation of pre-diabetic ER-crowding using a treat-to-target insulin therapy may improve b-cell function and may prevent further metabolic deterioration.	[Absood, Afaf; Gandomani, Benjamin; Zaki, Anthony; Nasta, Vlad; Hodish, Israel] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Michail, Andrew; Habib, Peter M. W.] Wayne State Univ, Detroit, MI USA	University of Michigan System; University of Michigan; Wayne State University	Hodish, I (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	ihodish@umich.edu		Michail, Andrew/0000-0002-5744-2067; Zaki, Anthony/0000-0001-8190-7939	National Institutes of Health [R00 DK077441A]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported primarily by National Institutes of Health R00 DK077441A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Alvarsson M, 2003, DIABETES CARE, V26, P2231, DOI 10.2337/diacare.26.8.2231; Bache I, 1997, DIABETES RES CLIN PR, V37, P9, DOI 10.1016/S0168-8227(97)00056-9; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bo S, 2000, ACTA DIABETOL, V37, P125, DOI 10.1007/s005920070014; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chen HS, 2008, DIABETES CARE, V31, P1927, DOI 10.2337/dc08-0075; CHICK WL, 1970, DIABETOLOGIA, V6, P243, DOI 10.1007/BF01212233; Despa F, 2009, BIOPHYS CHEM, V140, P115, DOI 10.1016/j.bpc.2008.12.003; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; ESCHWEGE E, 1985, HORM METAB RES, V15, P41; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; FLAX H, 1991, DIABETOLOGIA, V34, P570, DOI 10.1007/BF00400275; Florez JC, 2007, CURR OPIN CLIN NUTR, V10, P391, DOI 10.1097/MCO.0b013e3281e2c9be; FREYCHET P, 1974, J CLIN INVEST, V54, P1020, DOI 10.1172/JCI107845; Garcia-Estevez DA, 2002, METABOLISM, V51, P1047, DOI 10.1053/meta.2002.33340; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Han BG, 2008, AM J PHYSIOL-ENDOC M, V295, pE981, DOI 10.1152/ajpendo.90283.2008; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hatanaka M, 2011, HUM MOL GENET, V20, P1274, DOI 10.1093/hmg/ddq568; Hodish I, 2011, DIABETES, V60, P2092, DOI 10.2337/db10-1671; Hodish I, 2010, J BIOL CHEM, V285, P685, DOI 10.1074/jbc.M109.038042; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x; Junger E, 2002, LAB INVEST, V82, P843, DOI 10.1097/01.LAB.0000018917.69993.BA; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Karve A, 2010, DIABETES CARE, V33, P2355, DOI 10.2337/dc09-1957; Kautz S, 2012, DIABETOLOGIA, V55, P382, DOI 10.1007/s00125-011-2362-7; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LEAHY JL, 1988, J CLIN INVEST, V81, P1407, DOI 10.1172/JCI113470; LEITER EH, 1989, FASEB J, V3, P2231, DOI 10.1096/fasebj.3.11.2673897; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Li HQ, 2011, METABOLISM, V60, P1566, DOI 10.1016/j.metabol.2011.01.018; Li YB, 2004, DIABETES CARE, V27, P2597, DOI 10.2337/diacare.27.11.2597; LIKE AA, 1970, DIABETOLOGIA, V6, P207, DOI 10.1007/BF01212231; LIKE AA, 1970, DIABETOLOGIA, V6, P216, DOI 10.1007/BF01212232; Magami Y, 2002, PANCREAS, V24, P153, DOI 10.1097/00006676-200203000-00006; Manzella D, 2003, CLIN SCI, V105, P113, DOI 10.1042/CS20020291; Manzella D, 2002, CLIN ENDOCRINOL, V57, P259, DOI 10.1046/j.1365-2265.2002.01596.x; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Panero F, 2009, DIABETES CARE, V32, P301, DOI 10.2337/dc08-1241; Porcellati F, 2011, DIABETES TECHNOL THE, V13, DOI 10.1089/dia.2011.0038; Rosenthal EB, 2011, J DIABETES IN PRESS; Ryan EA, 2004, DIABETES CARE, V27, P1028, DOI 10.2337/diacare.27.5.1028; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Sandefur CI, 2011, BIOPHYS J, V100, P1864, DOI 10.1016/j.bpj.2011.03.006; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	54	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54351	10.1371/journal.pone.0054351	http://dx.doi.org/10.1371/journal.pone.0054351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408938	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200008
J	Huang, WS; Pike, DA				Huang, Wen-San; Pike, David A.			Testing Cost-Benefit Models of Parental Care Evolution Using Lizard Populations Differing in the Expression of Maternal Care	PLOS ONE			English	Article							LIFE-HISTORY CHANGES; MABUYA-LONGICAUDATA; BEHAVIOR; PREDATION; SKINK	Parents are expected to evolve tactics to care for eggs or offspring when providing such care increases fitness above the costs incurred by this behavior. Costs to the parent include the energetic demands of protecting offspring, delaying future fecundity, and increased risk of predation. We used cost-benefit models to test the ecological conditions favoring the evolution of parental care, using lizard populations that differ in whether or not they express maternal care. We found that predators play an important role in the evolution of maternal care because: (1) evolving maternal care is unlikely when care increases predation pressure on the parents; (2) maternal care cannot evolve under low levels of predation pressure on both parents and offspring; and (3) maternal care evolves only when parents are able to successfully defend offspring from predators without increasing predation risk to themselves. Our studies of one of the only known vertebrate species to exhibit interpopulation differences in the expression of maternal care provide clear support for some of the hypothesized circumstances under which maternal care should evolve (e.g., when nests are in exposed locations, parents are able to defend the eggs from predators, and egg incubation periods are brief), but do not support others (e.g., when nest-sites are scarce, life history strategies are "risky", reproductive frequency is low, and environmental conditions are harsh). We conclude that multiple pathways can lead to the evolution of parental care from a non-caring state, even in a single population of a widespread species.	[Huang, Wen-San] Natl Museum Nat Sci, Dept Zool, Taichung, Taiwan; [Huang, Wen-San] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Pike, David A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	National Chung Hsing University; James Cook University	Huang, WS (corresponding author), Natl Museum Nat Sci, Dept Zool, Taichung, Taiwan.	wshuang@mail.nmns.edu.tw	Pike, David A/B-2032-2012	Huang, Wen-San/0000-0003-0073-3557	Kuo Wu Hsiu Luan Culture and Education Foundation; National Science Council of Taiwan [NSC 99-2621-B-178-001-MY3]	Kuo Wu Hsiu Luan Culture and Education Foundation; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding was provided by the Kuo Wu Hsiu Luan Culture and Education Foundation and the National Science Council of Taiwan (NSC 99-2621-B-178-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 1996, ECOLOGY, V77, P1116, DOI 10.2307/2265580; Besnard A, 2002, EVOL ECOL, V16, P489, DOI 10.1023/A:1020809528816; BULL JJ, 1979, AM NAT, V114, P296, DOI 10.1086/283476; Chivers DP, 2001, OIKOS, V92, P135, DOI 10.1034/j.1600-0706.2001.920116.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; deFraipont M, 1996, EVOLUTION, V50, P391, DOI 10.1111/j.1558-5646.1996.tb04501.x; Girondot M, 2002, ANIM CONSERV, V5, P75, DOI 10.1017/S1367943002001099; Greene Harry W., 2002, P179; Huang WS, 2007, ECOL RES, V22, P659, DOI 10.1007/s11284-006-0068-y; Huang WS, 2006, ANIM BEHAV, V72, P791, DOI 10.1016/j.anbehav.2005.12.011; Huang Wen-San, 1994, Journal of Taiwan Museum, V47, P45; Huang WS, 2006, COPEIA, P293; Huang WS, 2011, FUNCT ECOL, V25, P1125, DOI 10.1111/j.1365-2435.2011.01855.x; Huang WS, 2011, P NATL ACAD SCI USA, V108, P7455, DOI 10.1073/pnas.1101804108; Huang WS, 2010, ZOOLOGY, V113, P85, DOI 10.1016/j.zool.2009.06.003; Huang WS, 2004, THESIS CORNELL U NY; Huang WS, J ANIM ECOL IN PRESS; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Maynard-Smith J, 1977, ANIM BEHAV, V25, P1, DOI [10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8)]; NOBLE G. K., 1933, AMER MUS NOVITATES, V619, P1; RAND AS, 1968, COPEIA, P552, DOI 10.2307/1442024; Reguera P, 1999, BEHAV ECOL, V10, P541, DOI 10.1093/beheco/10.5.541; REYNOLDS JD, 1990, AM NAT, V136, P230, DOI 10.1086/285093; Rosenheim JA, 1999, EVOL ECOL, V13, P141, DOI 10.1023/A:1006612519265; Schmitz OJ, 1998, EVOL ECOL, V12, P73, DOI 10.1023/A:1006559007590; Shine R., 1988, BIOL REPTILIA, P275; Stearns S.C., 1992, pi; Tinkle D.W, 1977, Miscellaneous Publs Mus Zool Univ Michigan, VNo. 154, P1; TINKLE DW, 1969, AM NAT, V103, P501, DOI 10.1086/282617; Tseng Hui-Yun, 2012, Herpetological Review, V43, P141; Williams G. C., 1966, P307; WINKLER DW, 1987, AM NAT, V130, P526, DOI 10.1086/284729	33	6	6	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54065	10.1371/journal.pone.0054065	http://dx.doi.org/10.1371/journal.pone.0054065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408934	Green Accepted, gold, Green Published			2022-12-27	WOS:000315157200007
J	Ma, B; Liu, JN; Zhang, Q; Ying, HJ; Jiye, A; Sun, JG; Wu, D; Wang, YL; Li, J; Liu, YH				Ma, Bo; Liu, Jiannan; Zhang, Qi; Ying, Hanjie; Jiye, A.; Sun, Jianguo; Wu, Di; Wang, Yonglu; Li, Jing; Liu, Yinhui			Metabolomic Profiles Delineate Signature Metabolic Shifts during Estrogen Deficiency-Induced Bone Loss in Rat by GC-TOF/MS	PLOS ONE			English	Article							MINERAL DENSITY; POSTMENOPAUSAL WOMEN; ARACHIDONIC-ACID; OLDER WOMEN; OVARIECTOMIZED RATS; BIOCHEMICAL MARKERS; BLOOD-PLASMA; FATTY-ACIDS; OSTEOPOROSIS; TURNOVER	Postmenopausal osteoporosis is a complicated and multi-factorial disease. To study the metabolic profiles and pathways activated in osteoporosis, Eight rats were oophorectomized (OVX group) to represent postmenopausal osteoporosis and the other eight rats were sham operated (Sham group) to be the control. The biochemical changes were assessed with metabolomics using a gas chromatography/time-of-flight mass spectrometry. Metabolomic profile using serial blood samples obtained prior to and at different time intervals after OVX were analyzed by principal component analysis (PCA) and Partial least squares-discriminant analysis (PLS-DA). The conventional indicators (bone mineral density, serum Bone alkaline phosphatase (B-ALP) and N-telopeptide of type I collagen (NTx) of osteoporosis in rats were also determined simultaneously. In OVX group, the metabolomics method could describe the endogenous changes of the disease more sensitively and systematically than the conventional criteria during the progression of osteoporosis. Significant metabolomic difference was also observed between the OVX and Sham groups. The metabolomic analyses of rat plasma showed that levels of arachidonic acid, octadecadienoic acid, branched-chain amino acids (valine, leucine and isoleucine), homocysteine, hydroxyproline and ketone bodies (3-Hydroxybutyric Acid) significantly elevated, while levels of docosahexaenoic acid, dodecanoic acid and lysine significantly decreased in OVX group compared with those in the homeochronous Sham group. Considering such metabolites are closely related to the pathology of the postmenopausal osteoporosis, the results suggest that potential biomarkers for the early diagnosis or the pathogenesis of osteoporosis might be identified via metabolomic study.	[Ma, Bo; Zhang, Qi; Wang, Yonglu; Li, Jing; Liu, Yinhui] Nanjing Univ Technol, Sch Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China; [Liu, Jiannan] Jiangsu Geriatr Hosp, Dept Respirat, Nanjing, Jiangsu, Peoples R China; [Ying, Hanjie] Nanjing Univ Technol, Sch Life Sci & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Jiye, A.; Sun, Jianguo] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Wu, Di] Childrens Hosp Philadelphia, Lab Syst Biol, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA; [Wu, Di] Univ Penn, Kinet Modeling & Simulat KMAS Core, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	Nanjing Tech University; Nanjing Tech University; China Pharmaceutical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Zhang, Q (corresponding author), Nanjing Univ Technol, Sch Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China.	nancyzhang03@hotmail.com; yinghanjie134@163.com		Ying, Hanjie/0000-0002-4061-0001	"333 High Level Talent Cultivation Project'' of Jiangsu Province	"333 High Level Talent Cultivation Project'' of Jiangsu Province	The study was supported by a grant from the "333 High Level Talent Cultivation Project'' of Jiangsu Province (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, TOHOKU J EXP MED, V214, P51, DOI 10.1620/tjem.214.51; Abrahamsen B, 2000, J BONE MINER RES, V15, P1545, DOI 10.1359/jbmr.2000.15.8.1545; Bayhan I, 2009, RHEUMATOL INT, V29, P263, DOI 10.1007/s00296-008-0693-6; Bhattacharyya S, 2008, J BONE MINER RES, V23, P1106, DOI 10.1359/JBMR.080235; Bonnelye E, 2005, J CLIN ENDOCR METAB, V90, P3115, DOI 10.1210/jc.2004-2168; Chen C, 2008, CELL METAB, V7, P135, DOI 10.1016/j.cmet.2007.12.003; Coetzee M, 2007, J NUTR BIOCHEM, V18, P54, DOI 10.1016/j.jnutbio.2006.03.002; De Leo V, 2001, AM J OBSTET GYNECOL, V184, P350, DOI 10.1067/mob.2001.111065; Dimitrova KR, 2002, CARDIOVASC RES, V53, P577, DOI 10.1016/S0008-6363(01)00462-X; FERRANDEZ L, 1990, ARCH ORTHOP TRAUM SU, V109, P181, DOI 10.1007/BF00453137; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Jinno Y, 2009, CLIN ORAL IMPLAN RES, V20, P756, DOI 10.1111/j.1600-0501.2008.01665.x; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kahl KG, 2005, AM J PSYCHIAT, V162, P168, DOI 10.1176/appi.ajp.162.1.168; Koh JM, 2006, J BONE MINER RES, V21, P1003, DOI [10.1359/jbmr.060406, 10.1359/JBMR.060406]; Leslie RD, 2011, DIABETES, V60, P2688, DOI 10.2337/db11-1177; Liu LS, 2010, ANAL BIOCHEM, V406, P105, DOI 10.1016/j.ab.2010.07.015; Lu YH, 2008, RAPID COMMUN MASS SP, V22, P2882, DOI 10.1002/rcm.3670; Ma B, 2012, ACTA PHARMACOL SIN, V33, P479, DOI 10.1038/aps.2011.177; Ma B, 2011, ACTA PHARMACOL SIN, V32, P270, DOI 10.1038/aps.2010.196; Ma YFL, 2002, J BONE MINER RES, V17, P2256, DOI 10.1359/jbmr.2002.17.12.2256; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Omoigui S, 2005, MED HYPOTHESES, V65, P559, DOI 10.1016/j.mehy.2005.03.012; PACIFICI R, 1987, P NATL ACAD SCI USA, V84, P4616, DOI 10.1073/pnas.84.13.4616; PACIFICI R, 1993, J CLIN ENDOCR METAB, V77, P1135, DOI 10.1210/jc.77.5.1135; Parhami F, 2002, J BONE MINER RES, V17, P1997, DOI 10.1359/jbmr.2002.17.11.1997; Patel MI, 2008, J UROLOGY, V179, P1668, DOI 10.1016/j.juro.2007.12.037; Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Qian S, 2010, PLOS ONE, V5; Reginster JY, 2008, BONE, V42, P832, DOI 10.1016/j.bone.2008.01.021; Schmolke B, 2001, ORTHOPADE, V30, P425, DOI 10.1007/s001320170073; Shi XL, 2012, J BIOL CHEM, V287, P6336, DOI 10.1074/jbc.M111.312199; Spencer TA, 2004, J SURG RES, V118, P83, DOI 10.1016/j.jss.2004.01.021; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Trygg J., 2005, ANAL CHEM, V77, P8086; Vasikaran SD, 2008, CRIT REV CL LAB SCI, V45, P221, DOI [10.1080/10408360801949442, 10.1080/10408360801949442 ]; Villareal DT, 2001, JAMA-J AM MED ASSOC, V286, P815, DOI 10.1001/jama.286.7.815; Watkins BA, 2000, J NUTR, V130, P2274, DOI 10.1093/jn/130.9.2274; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; Weiss LA, 2005, AM J CLIN NUTR, V81, P934, DOI 10.1093/ajcn/81.4.934; Whitney C, 2004, SPORTS MED, V34, P779, DOI 10.2165/00007256-200434120-00001; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; You L, 2011, ACTA PHARMACOL SIN, V32, P1498, DOI 10.1038/aps.2011.135; Zhang Q, 2010, BIOMARKERS, V15, P205, DOI 10.3109/13547500903419049; Zordoky BNM, 2010, PHARMACOL THERAPEUT, V125, P446, DOI 10.1016/j.pharmthera.2009.12.002	53	28	33	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54965	10.1371/journal.pone.0054965	http://dx.doi.org/10.1371/journal.pone.0054965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408954	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200014
J	Zheng, YW; Wilson, G; Stiles, L; Smith, PF				Zheng, Yiwen; Wilson, Georgina; Stiles, Lucy; Smith, Paul F.			Glutamate Receptor Subunit and Calmodulin Kinase II Expression, with and without T Maze Training, in the Rat Hippocampus following Bilateral Vestibular Deafferentation	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; LONG-TERM CHANGES; NMDA RECEPTORS; FORAGING TASK; C57BL/6J MICE; THETA-RHYTHM; BETA-IMAGER; NEURONS; LESIONS; MEMORY	Many previous studies have shown that lesions of the peripheral vestibular system result in spatial memory deficits and electrophysiological dysfunction in the hippocampus. Given the importance of glutamate as a neurotransmitter in the hippocampus, it was predicted that bilateral vestibular deafferentation (BVD) would alter the expression of NMDA and AMPA receptors in this area of the brain. Methods: The expression of the NR1, NR2A, NR2B, GluR1, GluR2, GluR3 and GluR 4 glutamate receptor subunits, as well as calmodulin kinase II alpha (CaMKII alpha) and phosphorylated CaMKII alpha (pCaMKII alpha), was measured in the rat CA1, CA2/3 and dentate gyrus (DG) subregions of the hippocampus, at 24 h, 72 h, 1 week, 1 month and 6 months following BVD, using western blotting. In the 6 month group, half of the animals underwent spatial forced alternating training in a T-maze. Results and Discussion: For the 24 h, 72 h, 1 week and 1 month data, there was no significant effect of surgery for any hippocampal subregion. However, for the 6 month data set, T maze training had a significant effect independently of surgery. The results of these experiments suggest that BVD is not associated with large changes in glutamate receptor subunit or CaMKII alpha expression in the rat hippocampus, at least in terms of both the intra-cytoplasmic and membrane receptor subunits together, that western blotting can measure. However, spatial training-associated increases in glutamate receptor and CaMKII alpha expression can be induced in BVD rats with impaired spatial performance. Therefore, the neurophysiological changes underlying BVD-induced spatial learning and memory deficits are more likely to be due to up and down regulation or changes in affinity/efficacy of glutamate receptors at the membrane level than changes in subunit transcription and transduction at the intra-cytoplasmic level.	[Smith, Paul F.] Univ Otago, Sch Med, Dept Pharmacol & Toxicol, Sch Med Sci, Dunedin, New Zealand; Univ Otago, Brain Hlth Res Ctr, Sch Med, Dunedin, New Zealand	University of Otago; University of Otago	Smith, PF (corresponding author), Univ Otago, Sch Med, Dept Pharmacol & Toxicol, Sch Med Sci, Dunedin, New Zealand.	paul.smith@stonebow.otago.ac.nz		Zheng, Yiwen/0000-0002-2439-0715	Sir Charles Hercus Research Fellowship; Jean Cathie Estate	Sir Charles Hercus Research Fellowship; Jean Cathie Estate	This research was supported by a Sir Charles Hercus Research Fellowship to YZ. LS was supported by a grant from the Jean Cathie Estate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2010, NEUROBIOL LEARN MEM, V94, P402, DOI 10.1016/j.nlm.2010.08.007; Bakshi K, 2009, J NEUROSCI, V29, P6308, DOI 10.1523/JNEUROSCI.5485-08.2009; Bannerman DM, 2003, BEHAV NEUROSCI, V117, P866, DOI 10.1037/0735-7044.117.4.866; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Besnard S, 2012, HIPPOCAMPUS, V22, P814, DOI 10.1002/hipo.20942; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dhar SS, 2009, J NEUROCHEM, V108, P1595, DOI 10.1111/j.1471-4159.2009.05929.x; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Ghafari M, 2012, BRAIN STRUCT FUNCT, V217, P353, DOI 10.1007/s00429-011-0335-8; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goddard M, 2008, BEHAV NEUROSCI, V122, P448, DOI 10.1037/0735-7044.122.2.448; Han X, 2008, J NEUROCHEM, V107, P1566, DOI 10.1111/j.1471-4159.2008.05729.x; Heo S, 2012, BRAIN STRUCT FUNCT, V217, P363, DOI 10.1007/s00429-011-0362-5; Hitier M, 2010, SURG RADIOL ANAT, V32, P835, DOI 10.1007/s00276-010-0690-9; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kennard JTT, 2011, NEUROBIOL DIS, V42, P48, DOI 10.1016/j.nbd.2011.01.003; Kojundzic SL, 2010, J COMP NEUROL, V518, P64, DOI 10.1002/cne.22209; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Langlois X, 2001, J PHARMACOL EXP THER, V299, P712; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Little GH, 2009, J BIOL CHEM, V284, P24857, DOI 10.1074/jbc.M109.003186; Liu P, 2003, NEUROSCIENCE, V117, P965, DOI 10.1016/S0306-4522(02)00878-3; Manly B. F. J., 2005, MULTIVARIATE STAT ME; Marcoulides GA, 1997, MULTIVARIATE STAT ME; McHugh SB, 2008, BEHAV BRAIN RES, V186, P41, DOI 10.1016/j.bbr.2007.07.021; Neo P, 2012, HIPPOCAMPUS, V22, P1176, DOI 10.1002/hipo.20963; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Poisnel G, 2006, J NEUROSCI METH, V154, P60, DOI 10.1016/j.jneumeth.2005.11.012; Roscioli E, 2012, J CELL BIOL, V196, P435, DOI 10.1083/jcb.201109104; Russell NA, 2003, J VESTIBUL RES-EQUIL, V13, P9; Russell NA, 2003, J NEUROSCI, V23, P6490; Russell NA, 2006, J NEUROPHYSIOL, V96, P4, DOI 10.1152/jn.00953.2005; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Stackman RW, 2002, BEHAV BRAIN RES, V128, P27, DOI 10.1016/S0166-4328(01)00270-4; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tai SK, 2012, HIPPOCAMPUS, V22, P914, DOI 10.1002/hipo.20955; Vignaux G, 2012, TOXICOL APPL PHARM, V258, P61, DOI 10.1016/j.taap.2011.10.008; Wallace DG, 2002, J NEUROSCI, V22, P10009; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WILLIAMS K, 1994, MOL PHARMACOL, V45, P803; Yun-Hong Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007138; Zheng Y, 2001, NEUROSCIENCE, V105, P1, DOI 10.1016/S0306-4522(01)00217-2; Zheng YW, 2007, HIPPOCAMPUS, V17, P253, DOI 10.1002/hipo.20266; Zheng YW, 2010, HIPPOCAMPUS, V20, P461, DOI 10.1002/hipo.20645; Zheng YW, 2009, HIPPOCAMPUS, V19, P480, DOI 10.1002/hipo.20533; Zheng YJ, 2012, MATH PROBL ENG, V2012, DOI [10.3389/fneur.2012.00020, 10.1155/2012/207318]; Zheng YW, 2006, HIPPOCAMPUS, V16, P368, DOI 10.1002/hipo.20149; Zheng YW, 2003, HIPPOCAMPUS, V13, P873, DOI 10.1002/hipo.10174	53	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54527	10.1371/journal.pone.0054527	http://dx.doi.org/10.1371/journal.pone.0054527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408944	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200010
J	Bartley, SN; Tzeng, YL; Heel, K; Lee, CW; Mowlaboccus, S; Seemann, T; Lu, W; Lin, YH; Ryan, CS; Peacock, C; Stephens, DS; Davies, JK; Kahler, CM				Bartley, Stephanie N.; Tzeng, Yih-Ling; Heel, Kathryn; Lee, Chiang W.; Mowlaboccus, Shakeel; Seemann, Torsten; Lu, Wei; Lin, Ya-Hsun; Ryan, Catherine S.; Peacock, Christopher; Stephens, David S.; Davies, John K.; Kahler, Charlene M.			Attachment and Invasion of Neisseria meningitidis to Host Cells Is Related to Surface Hydrophobicity, Bacterial Cell Size and Capsule	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; POLYSIALIC ACID CAPSULE; OUTER-MEMBRANE PROTEIN; INNER-CORE STRUCTURE; SEROGROUP-B; PILIN GLYCOSYLATION; ENDOTHELIAL-CELLS; PHASE VARIATION; SIALIC-ACID; LIPOOLIGOSACCHARIDE STRUCTURE	We compared exemplar strains from two hypervirulent clonal complexes, strain NMB-CDC from ST-8/11 cc and strain MC58 from ST-32/269 cc, in host cell attachment and invasion. Strain NMB-CDC attached to and invaded host cells at a significantly greater frequency than strain MC58. Type IV pili retained the primary role for initial attachment to host cells for both isolates regardless of pilin class and glycosylation pattern. In strain MC58, the serogroup B capsule was the major inhibitory determinant affecting both bacterial attachment to and invasion of host cells. Removal of terminal sialylation of lipooligosaccharide (LOS) in the presence of capsule did not influence rates of attachment or invasion for strain MC58. However, removal of either serogroup B capsule or LOS sialylation in strain NMB-CDC increased bacterial attachment to host cells to the same extent. Although the level of inhibition of attachment by capsule was different between these strains, the regulation of the capsule synthesis locus by the two-component response regulator MisR, and the level of surface capsule determined by flow cytometry were not significantly different. However, the diplococci of strain NMB-CDC were shown to have a 1.89-fold greater surface area than strain MC58 by flow cytometry. It was proposed that the increase in surface area without changing the amount of anchored glycolipid capsule in the outer membrane would result in a sparser capsule and increase surface hydrophobicity. Strain NMB-CDC was shown to be more hydrophobic than strain MC58 using hydrophobicity interaction chromatography and microbial adhesion-to-solvents assays. In conclusion, improved levels of adherence of strain NMB-CDC to cell lines was associated with increased bacterial cell surface and surface hydrophobicity. This study shows that there is diversity in bacterial cell surface area and surface hydrophobicity within N. meningitidis which influence steps in meningococcal pathogenesis.	[Bartley, Stephanie N.; Lee, Chiang W.; Mowlaboccus, Shakeel; Lu, Wei; Peacock, Christopher; Kahler, Charlene M.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Tzeng, Yih-Ling; Stephens, David S.] Vet Affairs Med Ctr, Atlanta, GA 30033 USA; [Tzeng, Yih-Ling; Stephens, David S.] Emory Univ, Sch Med, Atlanta, GA USA; [Heel, Kathryn] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Heel, Kathryn] Univ Western Australia, Sch Pathol & Lab Med, Translat Canc Pathol Lab, Perth, WA 6009, Australia; [Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Melbourne, Vic 3004, Australia; [Lin, Ya-Hsun; Ryan, Catherine S.; Davies, John K.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia	University of Western Australia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; University of Western Australia; University of Western Australia; Monash University; Monash University	Kahler, CM (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia.	Charlene.Kahler@uwa.edu.au	Fuller, Kathy A/C-5454-2011; Fuller, Kathy A/GWZ-2885-2022; Seemann, Torsten/B-2318-2010; Kahler, Charlene M/H-5159-2014	Fuller, Kathy A/0000-0002-3462-7501; Fuller, Kathy A/0000-0002-3462-7501; Seemann, Torsten/0000-0001-6046-610X; Kahler, Charlene M/0000-0003-4322-3055; Mowlaboccus, Shakeel/0000-0001-9408-6068	Amanda Young Foundation; National Health and Medical Research Council [APP546003]; National Institutes of Health [R01-AI061031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI061031, R01AI061031] Funding Source: NIH RePORTER	Amanda Young Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SB was supported by a PhD scholarship from the Amanda Young Foundation (http://www.amandayoungfoundation.org.au/). CMK and JKD are supported by the National Health and Medical Research Council (APP546003). YT and DSS are supported by the National Institutes of Health (R01-AI061031 to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APICELLA MA, 1981, INFECT IMMUN, V34, P751, DOI 10.1128/IAI.34.3.751-756.1981; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; BARRETT SJ, 1994, MICROBIOL-UK, V140, P2867, DOI 10.1099/00221287-140-10-2867; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bille E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003885; Bogdan JA, 2002, J MICROBIOL METH, V49, P97, DOI 10.1016/S0167-7012(01)00364-5; Bonifait L, 2010, FEMS MICROBIOL LETT, V311, P160, DOI 10.1111/j.1574-6968.2010.02086.x; Borud B, 2011, P NATL ACAD SCI USA, V108, P9643, DOI 10.1073/pnas.1103321108; Boyer RR, 2007, J FOOD PROTECT, V70, P1339, DOI 10.4315/0362-028X-70.6.1339; Boyer RR, 2011, INT J FOOD MICROBIOL, V147, P228, DOI 10.1016/j.ijfoodmicro.2011.04.016; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Callaghan MJ, 2006, INFECT IMMUN, V74, P5085, DOI 10.1128/IAI.00293-06; Calvert MEK, 2008, CYTOM PART A, V73A, P825, DOI 10.1002/cyto.a.20609; Carbonnelle E, 2009, VACCINE, V27, pB78, DOI 10.1016/j.vaccine.2009.04.069; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Cehovin A, 2010, VACCINE, V28, P4817, DOI 10.1016/j.vaccine.2010.04.065; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Chen HT, 2009, MICROFLUID NANOFLUID, V6, P529, DOI 10.1007/s10404-008-0335-z; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Dalia AB, 2011, CELL HOST MICROBE, V10, P486, DOI 10.1016/j.chom.2011.09.009; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; deVries FP, 1996, INFECT IMMUN, V64, P2998, DOI 10.1128/IAI.64.8.2998-3006.1996; Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740; FROSCH M, 1989, P NATL ACAD SCI USA, V86, P1669, DOI 10.1073/pnas.86.5.1669; GOTSCHLICH EC, 1981, J BIOL CHEM, V256, P8915; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Hassan AN, 2004, INT J FOOD MICROBIOL, V96, P103, DOI 10.1016/S0168-1605(03)00160-0; Helm RA, 2010, J BACTERIOL, V192, P3822, DOI 10.1128/JB.00280-10; Hill NS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002549; Hobb RI, 2010, MICROBES INFECT, V12, P476, DOI 10.1016/j.micinf.2010.02.009; JANIK A, 1976, J CLIN MICROBIOL, V4, P71; Jennings MP, 2011, CELL MICROBIOL, V13, P885, DOI 10.1111/j.1462-5822.2011.01586.x; Joseph B, 2012, PLOS ONE, V6; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; Kahler CM, 1996, J BACTERIOL, V178, P6677, DOI 10.1128/jb.178.23.6677-6684.1996; Kahler CM, 2005, GLYCOBIOLOGY, V15, P409, DOI 10.1093/glycob/cwi018; Kahler CM, 2001, INFECT IMMUN, V69, P3597, DOI 10.1128/IAI.69.6.3597-3604.2001; Kahler CM, 1996, J BACTERIOL, V178, P1265, DOI 10.1128/jb.178.5.1265-1273.1996; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Kempf M, 2012, CAN J MICROBIOL, V58, P311, DOI [10.1139/W11-131, 10.1139/w11-131]; Koch AL, 1994, GEN MOL BACTERIOLOGY; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; Kumar P, 2011, MOL MICROBIOL, V79, P1557, DOI 10.1111/j.1365-2958.2011.07546.x; Langsrud S, 1996, J APPL BACTERIOL, V81, P411; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li MS, 2009, MED MICROBIOL IMMUN, V198, P57, DOI 10.1007/s00430-008-0105-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LJUNGH A, 1985, INFECT IMMUN, V47, P522, DOI 10.1128/IAI.47.2.522-526.1985; Ly MH, 2006, COLLOID SURFACE B, V52, P149, DOI 10.1016/j.colsurfb.2006.04.015; Marceau M, 1998, MOL MICROBIOL, V27, P705, DOI 10.1046/j.1365-2958.1998.00706.x; MENARD R, 1993, J BACTERIOL, V175, P5899; Moore J, 2005, J BIOL CHEM, V280, P31489, DOI 10.1074/jbc.M506354200; Morand PC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006834; Nagele V, 2011, J BIOL CHEM, V286, P20536, DOI 10.1074/jbc.M110.188326; Naessan CL, 2008, J BACTERIOL, V190, P387, DOI 10.1128/JB.00765-07; Nassif X, 1999, Int Microbiol, V2, P133; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Nassif X, 1997, GENE, V192, P149, DOI 10.1016/S0378-1119(96)00802-5; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Neil RB, 2009, MICROBES INFECT, V11, P281, DOI 10.1016/j.micinf.2008.12.001; Plant L, 2006, INFECT IMMUN, V74, P1360, DOI 10.1128/IAI.74.2.1360-1367.2006; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Rahman MM, 1997, CARBOHYD RES, V301, P213; Rahman MM, 2001, GLYCOBIOLOGY, V11, P703, DOI 10.1093/glycob/11.8.703; Read RC, 1996, INFECT IMMUN, V64, P3210, DOI 10.1128/IAI.64.8.3210-3217.1996; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Rosenberg M., 1990, MICROBIAL CELL SURFA, P1; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; RUDEL T, 1992, MOL MICROBIOL, V6, P3439, DOI 10.1111/j.1365-2958.1992.tb02211.x; Schoen C, 2009, VACCINE, V27, pB103, DOI 10.1016/j.vaccine.2009.04.064; Serruto D, 2003, MOL MICROBIOL, V48, P323, DOI 10.1046/j.1365-2958.2003.03420.x; Sjolinder H, 2008, INFECT IMMUN, V76, P5412, DOI 10.1128/IAI.00478-08; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STEPHENS DS, 1991, INFECT IMMUN, V59, P4097, DOI 10.1128/IAI.59.11.4097-4102.1991; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Swartley JS, 1996, J BACTERIOL, V178, P4052, DOI 10.1128/jb.178.14.4052-4059.1996; Takahashi H, 2008, FEMS IMMUNOL MED MIC, V52, P36, DOI 10.1111/j.1574-695X.2007.00342.x; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; TINSLEY CR, 1986, J GEN MICROBIOL, V132, P2483; TRUST TJ, 1983, INFECT IMMUN, V41, P106, DOI 10.1128/IAI.41.1.106-113.1983; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; Tzeng YL, 2008, INFECT IMMUN, V76, P704, DOI 10.1128/IAI.01007-07; Tzeng YL, 2005, INFECT IMMUN, V73, P1491, DOI 10.1128/IAI.73.3.1491-1505.2005; Tzeng YL, 2004, J BIOL CHEM, V279, P35053, DOI 10.1074/jbc.M401433200; Tzeng YL, 2002, J BIOL CHEM, V277, P24103, DOI 10.1074/jbc.M200931200; Tzeng YL, 2001, INFECT IMMUN, V69, P2502, DOI 10.1128/IAI.69.4.2502-2511.2001; Unkmeir A, 2002, INFECT IMMUN, V70, P2454, DOI 10.1128/IAI.70.5.2454-2462.2002; VIRJI M, 1983, J GEN MICROBIOL, V129, P2761; VIRJI M, 1993, MOL MICROBIOL, V10, P1013, DOI 10.1111/j.1365-2958.1993.tb00972.x; VIRJI M, 1992, MOL MICROBIOL, V6, P2785, DOI 10.1111/j.1365-2958.1992.tb01458.x; Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x; VIRJI M, 1992, MOL MICROBIOL, V6, P1271, DOI 10.1111/j.1365-2958.1992.tb00848.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Warren MJ, 2004, FEMS IMMUNOL MED MIC, V41, P43, DOI 10.1016/j.femsim.2004.01.002; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Zhou DG, 1996, GENE, V171, P133, DOI 10.1016/0378-1119(96)00103-5; ZOLLINGER WD, 1983, INFECT IMMUN, V40, P257, DOI 10.1128/IAI.40.1.257-264.1983	112	43	43	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55798	10.1371/journal.pone.0055798	http://dx.doi.org/10.1371/journal.pone.0055798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405216	Green Published, gold			2022-12-27	WOS:000315153400161
J	Beversdorf, LJ; Miller, TR; McMahon, KD				Beversdorf, Lucas J.; Miller, Todd R.; McMahon, Katherine D.			The Role of Nitrogen Fixation in Cyanobacterial Bloom Toxicity in a Temperate, Eutrophic Lake	PLOS ONE			English	Article							LIMITED MICROCYSTIS-AERUGINOSA; ENVIRONMENTAL-FACTORS; GENETIC DIVERSITY; GROWTH; PHOSPHORUS; WATERS; LR; COMMUNITY; STRAINS; MENDOTA	Toxic cyanobacterial blooms threaten freshwaters worldwide but have proven difficult to predict because the mechanisms of bloom formation and toxin production are unknown, especially on weekly time scales. Water quality management continues to focus on aggregated metrics, such as chlorophyll and total nutrients, which may not be sufficient to explain complex community changes and functions such as toxin production. For example, nitrogen (N) speciation and cycling play an important role, on daily time scales, in shaping cyanobacterial communities because declining N has been shown to select for N fixers. In addition, subsequent N pulses from N-2 fixation may stimulate and sustain toxic cyanobacterial growth. Herein, we describe how rapid early summer declines in N followed by bursts of N fixation have shaped cyanobacterial communities in a eutrophic lake (Lake Mendota, Wisconsin, USA), possibly driving toxic Microcystis blooms throughout the growing season. On weekly time scales in 2010 and 2011, we monitored the cyanobacterial community in a eutrophic lake using the phycocyanin intergenic spacer (PC-IGS) region to determine population dynamics. In parallel, we measured microcystin concentrations, N-2 fixation rates, and potential environmental drivers that contribute to structuring the community. In both years, cyanobacterial community change was strongly correlated with dissolved inorganic nitrogen (DIN) concentrations, and Aphanizomenon and Microcystis alternated dominance throughout the pre-toxic, toxic, and post-toxic phases of the lake. Microcystin concentrations increased a few days after the first significant N-2 fixation rates were observed. Then, following large early summer N-2 fixation events, Microcystis increased and became most abundant. Maximum microcystin concentrations coincided with Microcystis dominance. In both years, DIN concentrations dropped again in late summer, and N-2 fixation rates and Aphanizomenon abundance increased before the lake mixed in the fall. Estimated N inputs from N-2 fixation were large enough to supplement, or even support, the toxic Microcystis blooms.	[Beversdorf, Lucas J.; McMahon, Katherine D.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [McMahon, Katherine D.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Miller, Todd R.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Milwaukee	Beversdorf, LJ (corresponding author), Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA.	lbeversdorf@wisc.edu	Miller, Todd/Y-3612-2019	Miller, Todd/0000-0002-2113-1662; McMahon, Katherine D./0000-0002-7038-026X	UW-Madison Biotechnology Training Program (BTP); National Institutes of Health [NIH 5 T32 GM08349]; Wisconsin SeaGrant [R/BT-24]; National Science Foundation [CAREER CBET-0644949]; NTL-Microbial Observatory [MCB-0702395]; NTL-LTER [DEB-0822700]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	UW-Madison Biotechnology Training Program (BTP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin SeaGrant; National Science Foundation(National Science Foundation (NSF)); NTL-Microbial Observatory; NTL-LTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by the UW-Madison Biotechnology Training Program (BTP), a National Institutes of Health training grant (NIH 5 T32 GM08349; http://www.nih.gov/), a Wisconsin SeaGrant (R/BT-24; http://www.seagrant.wisc.edu/home/), and the National Science Foundation (CAREER CBET-0644949; NTL-Microbial Observatory MCB-0702395; NTL-LTER DEB-0822700; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2007, LIMNOL OCEANOGR, V52, P2233, DOI 10.4319/lo.2007.52.5.2233; Alexova R, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003749; Birge EA, 1922, INLAND LAKES WISCONS, P222; Brock TD, 1985, EUTROPHIC LAKE MENDO; CAPONE DG, 1994, APPL ENVIRON MICROB, V60, P3989, DOI 10.1128/AEM.60.11.3989-3995.1994; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Carpenter SR, 1998, AUST J ECOL, V23, P68, DOI 10.1111/j.1442-9993.1998.tb00706.x; Clarke K.R., 2006, PRIMER V6 USER MANUA; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; DEMARSAC NT, 1988, METHOD ENZYMOL, V167, P318; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dolman Andrew M, 2012, PLoS One, V7, pe38757, DOI 10.1371/journal.pone.0038757; Downing TG, 2005, ENVIRON TOXICOL, V20, P257, DOI 10.1002/tox.20106; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Eaglesham GK, 1999, ENVIRON TOXICOL, V14, P151, DOI 10.1002/(SICI)1522-7278(199902)14:1<151::AID-TOX19>3.3.CO;2-4; FALLON RD, 1980, LIMNOL OCEANOGR, V25, P72, DOI 10.4319/lo.1980.25.1.0072; Flowers JJ, 2009, ENV MICROBIOL REP, V1, P583, DOI 10.1111/j.1758-2229.2009.00090.x; GARDNER WS, 1975, LIMNOL OCEANOGR, V20, P379, DOI 10.4319/lo.1975.20.3.0379; GERLOFF GC, 1957, ECOLOGY, V38, P556, DOI 10.2307/1943119; Ginn HP, 2010, APPL ENVIRON MICROB, V76, P4362, DOI 10.1128/AEM.01862-09; Glibert PM, 2011, CHIN J OCEANOL LIMN, V29, P724, DOI 10.1007/s00343-011-0502-z; GLIBERT PM, 1994, APPL ENVIRON MICROB, V60, P3996, DOI 10.1128/AEM.60.11.3996-4000.1994; Gondwe MJ, 2008, HYDROBIOLOGIA, V596, P251, DOI 10.1007/s10750-007-9101-6; Greenberg A.E., 1992, STANDARD METHODS EXA, V18; HARADA KI, 1988, J CHROMATOGR, V448, P275, DOI 10.1016/S0021-9673(01)84589-1; Jahnichen S, 2011, HARMFUL ALGAE, V12, P95, DOI 10.1016/j.hal.2011.09.002; JENSEN BB, 1983, APPL ENVIRON MICROB, V45, P1331, DOI 10.1128/AEM.45.4.1331-1337.1983; Jones SE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00318; Jones SE, 2009, ENVIRON MICROBIOL, V11, P905, DOI 10.1111/j.1462-2920.2008.01814.x; Kotak BG, 1996, CAN J FISH AQUAT SCI, V53, P1974, DOI 10.1139/cjfas-53-9-1974; KOTAK BG, 1995, J PHYCOL, V31, P248, DOI 10.1111/j.0022-3646.1995.00248.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 1998, DEV ENV MODELLING, V20; Lenes JM, 2010, J PLANKTON RES, V32, P1421, DOI 10.1093/plankt/fbq061; Li JH, 2003, MICROBIOL-SGM, V149, P3257, DOI 10.1099/mic.0.26462-0; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; Miller TR, 2011, FEMS MICROBIOL ECOL, V78, P336, DOI 10.1111/j.1574-6941.2011.01162.x; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P3875, DOI 10.1128/AEM.61.11.3875-3883.1995; Oh HM, 2000, APPL ENVIRON MICROB, V66, P176, DOI 10.1128/AEM.66.1.176-179.2000; Oh HM, 2001, APPL ENVIRON MICROB, V67, P1484, DOI 10.1128/AEM.67.4.1484-1489.2001; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; PAERL HW, 1988, LIMNOL OCEANOGR, V33, P823, DOI 10.4319/lo.1988.33.4_part_2.0823; Palmer MA, 2012, SCIENCE, V336, P1393, DOI 10.1126/science.1223250; Pattanaik B, 2010, HARMFUL ALGAE, V10, P30, DOI 10.1016/j.hal.2010.06.001; Read JS, 2011, ENVIRON MODELL SOFTW, V26, P1325, DOI 10.1016/j.envsoft.2011.05.006; Redfield A. C., 1934, P176; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; SIVONEN K, 1990, APPL ENVIRON MICROB, V56, P2658, DOI 10.1128/AEM.56.9.2658-2666.1990; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; STEWART WDP, 1967, P NATL ACAD SCI USA, V58, P2071, DOI 10.1073/pnas.58.5.2071; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; TETT P, 1975, LIMNOL OCEANOGR, V20, P887, DOI 10.4319/lo.1975.20.5.0887; TORREY MS, 1976, LIMNOL OCEANOGR, V21, P365, DOI 10.4319/lo.1976.21.3.0365; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; Vezie C, 2002, MICROB ECOL, V43, P443, DOI 10.1007/s00248-001-0041-9; Vezie C, 1998, MICROBIAL ECOL, V35, P126, DOI 10.1007/s002489900067; WATANABE MF, 1985, APPL ENVIRON MICROB, V49, P1342, DOI 10.1128/AEM.49.5.1342-1344.1985; White A, 2010, LIBR J, V135, P101; WHO, 1996, GUID DRINK WAT QUAL; WICKS RJ, 1990, ENVIRON SCI TECHNOL, V24, P1413, DOI 10.1021/es00079a017; Wilhelm SW, 2011, HARMFUL ALGAE, V10, P207, DOI 10.1016/j.hal.2010.10.001; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Xu Y, 2010, ENVIRON SCI POLLUT R, V17, P1581, DOI 10.1007/s11356-010-0345-8; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9	68	106	111	3	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56103	10.1371/journal.pone.0056103	http://dx.doi.org/10.1371/journal.pone.0056103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405255	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400201
J	Liang, WB; Chikritzhs, T				Liang, Wenbin; Chikritzhs, Tanya			The Association between Alcohol Exposure and Self-Reported Health Status: The Effect of Separating Former and Current Drinkers	PLOS ONE			English	Article							REDUCED MORTALITY RISK; ISCHEMIC-HEART-DISEASE; CIGARETTE-SMOKING; SYSTEMATIC-ERROR; FOLLOW-UP; CONSUMPTION; METAANALYSIS; REDUCTION; INTENTION; DRINKING	Aims: To investigate the direction and degree of potential bias introduced to analyses of drinking and health status which exclude former drinkers from exposure groups. Design: Pooled analysis of 14 waves (1997-2010) of the U. S. National Health Interview Survey (NHIS). Setting: General population-based study. Participants: 404,462 participants, from 14 waves of the NHIS, who had knownself-reported health status and alcohol consumption status. Measurements: Self-reported health status was used as the indicator of health. Two approaches were used to classify alcohol consumption: (i) separation of former drinkers and current drinkers, and (ii) combined former and current drinkers. The prevalence of fair/poor health by alcohol use, gender and age with 95% confidence intervals was estimated. The difference in prevalence of fair/poor health status for lifetime abstainers, former drinkers, current drinkers and drinkers (former drinkers and current drinkers combined) were compared using Poisson regression with robust estimations of variance. Findings: Excluding former drinkers from drinker groups exaggerates the difference in health status between abstainers and drinkers, especially for males. Conclusions: In cohort study analyses, former drinkers should be assigned to a drinking category based on their previous alcohol consumption patterns and not treated as a discrete exposure group.	[Liang, Wenbin; Chikritzhs, Tanya] Curtin Univ Technol, Natl Drug Res Inst, Perth, WA, Australia	Curtin University	Liang, WB (corresponding author), Curtin Univ Technol, Natl Drug Res Inst, Perth, WA, Australia.	w.liang@curtin.edu.au	liang, wenbin/M-2454-2013	Chikritzhs, Tanya/0000-0001-8871-3205	Australian GovernmentDepartment of Health and Ageing under the National Drug Research Institute; US National Institutes ofHealth [RC1 AA018907-01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC1AA018907] Funding Source: NIH RePORTER	Australian GovernmentDepartment of Health and Ageing under the National Drug Research Institute(Australian Government); US National Institutes ofHealth(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Australian GovernmentDepartment of Health and Ageing under the National Drug Strategy's fundingof the National Drug Research Institute and the US National Institutes ofHealth [grant number RC1 AA018907-01]. The funders had norole in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	CDC, 2000, 1998NHIS SURV DESCR; CDC, 2000, 1997NHIS SURV DESCR; CDC, 2010, 2009NHIS SURV DESCR; CDC, 2009, 2008NHIS SURV DESCR; CDC, 2011, 2010NHIS SURV DESCR; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983; Godtfredsen NS, 2002, AM J EPIDEMIOL, V156, P994, DOI 10.1093/aje/kwf150; Harriss LR, 2007, ADDICTION, V102, P1574, DOI 10.1111/j.1360-0443.2007.01947.x; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; Jackson R, 2005, LANCET, V366, P1911, DOI 10.1016/S0140-6736(05)67770-7; Klatsky AL, 2007, ANN EPIDEMIOL, V17, pS63, DOI 10.1016/j.annepidem.2007.01.014; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Liang WB, 2007, EVID-BASED COMPL ALT, V4, P17, DOI 10.1093/ecam/nel066; Liang WB, 2011, ADDICTION, V106, P75, DOI 10.1111/j.1360-0443.2010.03164.x; Liao YL, 2000, AM J EPIDEMIOL, V151, P651, DOI 10.1093/oxfordjournals.aje.a010259; Mizoue T, 2000, INT J EPIDEMIOL, V29, P232, DOI 10.1093/ije/29.2.232; Montori VM, 2001, CAN MED ASSOC J, V165, P1339; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Rehm J, 2008, AM J EPIDEMIOL, V168, P866, DOI 10.1093/aje/kwn093; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Roerecke M, 2011, INT J EPIDEMIOL; Roerecke M, 2011, AM J EPIDEMIOL, V173, P245, DOI 10.1093/aje/kwq364; Ronksley P.E., 2011, BMJ, V342; SHAPER AG, 1993, AM J PUBLIC HEALTH, V83, P799, DOI 10.2105/AJPH.83.6.799; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789	30	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55881	10.1371/journal.pone.0055881	http://dx.doi.org/10.1371/journal.pone.0055881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405228	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400173
J	Marom, N; Bar-Oz, G				Marom, Nimrod; Bar-Oz, Guy			The Prey Pathway: A Regional History of Cattle (Bos taurus) and Pig (Sus scrofa) Domestication in the Northern Jordan Valley, Israel	PLOS ONE			English	Article							HUNTING PRESSURE; FORAGING MODELS; LATE HOLOCENE; DNA ANALYSIS; WILD BOAR; BODY-SIZE; TERRITORIALITY; SURVIVORSHIP; CALIFORNIA; BEHAVIOR	The faunal assemblage from the 9th-8th millennium BP site at Sha'ar Hagolan, Israel, is used to study human interaction with wild suids and cattle in a time period just before the appearance of domesticated animals of these species in the Jordan Valley. Our results, based on demographic and osteometric data, indicate that full domestication of both cattle and suids occurred at the site during the 8th millennium. Importantly, domestication was preceded in both taxa by demographic and metric population parameters indicating severe overhunting. The possible role of overhunting in shaping the characteristics of domesticated animals and the social infrastructure to ownership of herds is then explored.	[Marom, Nimrod; Bar-Oz, Guy] Univ Haifa, Lab Archaeozool, IL-31999 Haifa, Israel	University of Haifa	Marom, N (corresponding author), Univ Haifa, Lab Archaeozool, IL-31999 Haifa, Israel.	nmarom02@campus.haifa.ac.il	BarOz, Guy/ABF-6518-2020	BarOz, Guy/0000-0002-1009-5619; Marom, Nimrod/0000-0002-1057-154X	Irene Levi Sala Care Archaeological Foundation: "Taphonomy and Subsistence Economy at the Yarmukian Site of Sha'ar Hagolan''; Israeli Council for Higher Education through a Rotenstreich Fellowship for Outstanding Doctoral Students in the Humanities	Irene Levi Sala Care Archaeological Foundation: "Taphonomy and Subsistence Economy at the Yarmukian Site of Sha'ar Hagolan''; Israeli Council for Higher Education through a Rotenstreich Fellowship for Outstanding Doctoral Students in the Humanities	This work was supported by a research grant from the 1) Irene Levi Sala Care Archaeological Foundation: "Taphonomy and Subsistence Economy at the Yarmukian Site of Sha'ar Hagolan''; 2) The Israeli Council for Higher Education through a Rotenstreich Fellowship for Outstanding Doctoral Students in the Humanities (http://che.org.il/en/?page_id=9074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvard MS, 2001, AM ANTHROPOL, V103, P295, DOI 10.1525/aa.2001.103.2.295; [Anonymous], [No title captured]; Barzilai O, 2011, STATE STONE TERMINOL, P305; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BocquetAppel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P1, DOI 10.1007/978-1-4020-8539-0; Broughton JM, 2010, J ARCHAEOL METHOD TH, V17, P371, DOI 10.1007/s10816-010-9095-7; BROUGHTON JM, 1994, J ARCHAEOL SCI, V21, P501, DOI 10.1006/jasc.1994.1050; BROUGHTON JM, 1994, J ANTHROPOL ARCHAEOL, V13, P371, DOI 10.1006/jaar.1994.1019; Broughton JM, 2002, WORLD ARCHAEOL, V34, P60, DOI 10.1080/00438240220134269; Clutton-Brock J, 1999, NATURAL HIST DOMESTI, P32; Dahl G, 1976, STUDIES SOCIAL ANTHR; Davis S., 1982, PALEORIENT, V8, P5; Davis SJM., 2012, VILLAGE COMMUNITIES, VIII, P1258; Demsetz H, 1967, AM ECON REV, V57, P347; Ducos P, 1969, DOMESTICATION EXPLOI, P265; DYSONHUDSON R, 1978, AM ANTHROPOL, V80, P21, DOI 10.1525/aa.1978.80.1.02a00020; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Edwards CJ, 2004, J ARCHAEOL SCI, V31, P695, DOI 10.1016/j.jas.2003.11.001; Gamelon M, 2011, EVOLUTION, V65, P3100, DOI 10.1111/j.1558-5646.2011.01366.x; Goring-Morris AN, 2011, CURR ANTHROPOL, V52, pS195, DOI 10.1086/658860; GRAVES HB, 1984, J ANIM SCI, V58, P482, DOI 10.2527/jas1984.582482x; Grigson C., 1989, BAR International Series, P77; Haber A, 2004, J ARCHAEOL SCI, V31, P1587, DOI 10.1016/j.jas.2004.04.001; Hall SJG, 2008, ECOGRAPHY, V31, P187, DOI 10.1111/j.0906-7590.2008.5193.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hongo H., 1998, MASCA RES PAPERS SCI, V15, P77; Horwitz Liora Kolska, 2000, Paleorient, V25, P63; Horwitz Liora Kolska, 2005, Revue de Paleobiologie, P209; Jarman M.R., 1972, PAPERS EC PREHISTORY, P83; Klein R.G., 1984, ANAL ANIMAL BONES AR; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Leacock E., 1954, MONTAGNAIS HUNTING T, DOI 10.5962/bhl.title.35991; LINARES OF, 1976, HUM ECOL, V4, P331, DOI 10.1007/BF01557917; Lupo KD, 2007, J ARCHAEOL RES, V15, P143, DOI 10.1007/s10814-007-9011-1; LYMAN RL, 1984, J ANTHROPOL ARCHAEOL, V3, P259, DOI 10.1016/0278-4165(84)90004-7; LYMAN RL, 1987, AM ANTIQUITY, V52, P125, DOI 10.2307/281064; Marom N, 2009, FARMING, V2009, P1; Marom N, 2012, J ANTHROPOL ARCHAEOL, V31, P573, DOI 10.1016/j.jaa.2012.06.002; Munro ND, 2004, CURR ANTHROPOL, V45, pS5, DOI 10.1086/422084; Munson PJ, 2003, J ARCHAEOL SCI, V30, P405, DOI 10.1006/jasc.2002.0850; Redding Richard W., 2005, P41; Rosenberg M, 1998, CURR ANTHROPOL, V39, P653, DOI 10.1086/204787; Russell N, 2012, SOCIAL ZOOARCHAEOLOG, P174; Silver I.A, 1969, SCI ARCHAEOLOGY SURV, V2nd, P283; Smith Bruce D., 2011, Biology Theory, V6, P260, DOI 10.1007/s13752-012-0028-4; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stephens D.W., 1986, pi; TCHERNOV E, 1991, J ANTHROPOL ARCHAEOL, V10, P54, DOI 10.1016/0278-4165(91)90021-O; Vigne J-D., 2005, 1 STEPS ANIMAL DOMES; Vigne JD, 2011, CURR ANTHROPOL, V52, pS255, DOI 10.1086/659306; Von Den Driesch A., 1976, GUIDE MEASUREMENT AN; Wolverton S, 2008, AM ANTIQUITY, V73, P179, DOI 10.2307/25470475; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P171; Zeder MA, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P227; Zeuner FE, 1963, HIST DOMESTICATED AN, P54; Zeuner FE, 1963, HIST DOMESTICATED AN, P17	58	34	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55958	10.1371/journal.pone.0055958	http://dx.doi.org/10.1371/journal.pone.0055958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	092WJ	23405240	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400185
J	Peroval, MY; Boyd, AC; Young, JR; Smith, AL				Peroval, Marylene Y.; Boyd, Amy C.; Young, John R.; Smith, Adrian L.			A Critical Role for MAPK Signalling Pathways in the Transcriptional Regulation of Toll Like Receptors	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE PRODUCTION; FACTOR-KAPPA-B; DIFFERENT GENETIC BACKGROUNDS; MURINE ALVEOLAR MACROPHAGES; HUMAN DENDRITIC CELLS; NEGATIVE REGULATION; PHOSPHOINOSITIDE 3-KINASE; CPG-OLIGODEOXYNUCLEOTIDE; DIFFERENTIAL EXPRESSION	Toll-like Receptors (TLR) are phylogenetically conserved transmembrane proteins responsible for detection of pathogens and activation of immune responses in diverse animal species. The stimulation of TLR by pathogen-derived molecules leads to the production of pro-inflammatory mediators including cytokines and nitric oxide. Although TLR-induced events are critical for immune induction, uncontrolled inflammation can be life threatening and regulation is a critical feature of TLR biology. We used an avian macrophage cell line (HD11) to determine the relationship between TLR agonist-induced activation of inflammatory responses and the transcriptional regulation of TLR. Exposure of macrophages to specific TLR agonists induced upregulation of cytokine and nitric oxide pathways that were inhibited by blocking various components of the TLR signalling pathways. TLR activation also led to changes in the levels of mRNA encoding the TLR responsible for recognising the inducing agonist (cognate regulation) and cross-regulation of other TLR (non-cognate regulation). Interestingly, in most cases, regulation of TLR mRNA was independent of NFkB activity but dependent on one or more of the MAPK pathway components. Moreover, the relative importance of ERK, JNK and p38 was dependent upon both the stimulating agonist and the target TLR. These results provide a framework for understanding the complex pathways involved in transcriptional regulation of TLR, immune induction and inflammation. Manipulation of these pathways during vaccination or management of acute inflammatory disease may lead to improved clinical outcome or enhanced vaccine efficacy.	[Peroval, Marylene Y.; Young, John R.] Inst Anim Hlth, Compton, Berks, England; [Boyd, Amy C.] Univ Oxford, Nuffield Dept Clin Med, Jenner Inst, Oxford, England; [Smith, Adrian L.] Univ Oxford, Dept Zool, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford; Jenner Institute; University of Oxford	Smith, AL (corresponding author), Univ Oxford, Dept Zool, Tinbergen Bldg, Oxford, England.	adrian.smith@zoo.ox.ac.uk		Smith, Adrian/0000-0002-7657-6191	Department for Environment, Food and Rural Affairs [OD0547]; Institute for Animal Health doctoral training account; University of Oxford; BBSRC [BB/K004468/1] Funding Source: UKRI	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Institute for Animal Health doctoral training account; University of Oxford; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Department for Environment, Food and Rural Affairs project number OD0547 with further funds from the Institute for Animal Health doctoral training account and the University of Oxford (John Fell Fund and the Jenner Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-69; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boyd A, 2007, BIOCHEM SOC T, V35, P1504, DOI 10.1042/BST0351504; Briscoe J, 1996, PHILOS T ROY SOC B, V351, P167, DOI 10.1098/rstb.1996.0013; Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Bryn T, 2006, J IMMUNOL, V176, P7361, DOI 10.4049/jimmunol.176.12.7361; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; Cabral ES, 2006, J INFECT DIS, V193, P849, DOI 10.1086/500467; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Chen S, 2007, J ENDOTOXIN RES, V13, P281, DOI 10.1177/0968051907085096; Cormican P, 2009, DEV COMP IMMUNOL, V33, P967, DOI 10.1016/j.dci.2009.04.001; Crippen TL, 2006, VET IMMUNOL IMMUNOP, V109, P127, DOI 10.1016/j.vetimm.2005.08.024; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dalpke AH, 2005, IMMUNOLOGY, V116, P203, DOI 10.1111/j.1365-2567.2005.02211.x; De Nardo D, 2009, J IMMUNOL, V183, P8110, DOI 10.4049/jimmunol.0901031; de Zoete MR, 2011, P NATL ACAD SCI USA, V108, P4968, DOI 10.1073/pnas.1018135108; Dil N, 2002, VET IMMUNOL IMMUNOP, V84, P191, DOI 10.1016/S0165-2427(01)00402-0; Dil N, 2002, VET IMMUNOL IMMUNOP, V88, P149, DOI 10.1016/S0165-2427(02)00153-8; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fuku A, 2001, J BIOL CHEM, V276, P47143, DOI 10.1074/jbc.M103902200; Fukuzono S, 2010, ARCH BIOCH BIOPHYS; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Gillespie M, 2011, MAMM GENOME, V22, P130, DOI 10.1007/s00335-010-9296-0; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; Hazeki K, 2006, MOL PHARMACOL, V69, P1717, DOI 10.1124/mol.105.021162; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; He HQ, 2007, MOL IMMUNOL, V44, P3234, DOI 10.1016/j.molimm.2007.01.034; He HQ, 2005, DEV COMP IMMUNOL, V29, P255, DOI 10.1016/j.dci.2004.07.005; He HQ, 2003, CELL SIGNAL, V15, P911, DOI 10.1016/S0898-6568(03)00100-1; He HQ, 2003, DEV COMP IMMUNOL, V27, P621, DOI 10.1016/S0145-305X(03)00013-2; Higgs R, 2006, INFECT IMMUN, V74, P1692, DOI 10.1128/IAI.74.3.1692-1698.2006; Higuchi M, 2007, DEV COMP IMMUNOL; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Izadi H, 2007, INFECT IMMUN, V75, P5027, DOI 10.1128/IAI.00492-07; Jenkins KA, 2009, DEV COMP IMMUNOL, V33, P660, DOI 10.1016/j.dci.2008.11.009; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Juarez E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-2; Karpala AJ, 2008, DEV COMP IMMUNOL, V32, P435, DOI 10.1016/j.dci.2007.08.004; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Keestra AM, 2008, MOL IMMUNOL, V45, P1298, DOI 10.1016/j.molimm.2007.09.013; Keestra AM, 2007, J IMMUNOL, V178, P7110, DOI 10.4049/jimmunol.178.11.7110; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Kogut MH, 2005, DEV COMP IMMUNOL, V29, P791, DOI 10.1016/j.dci.2005.02.002; Kogut MH, 2008, INNATE IMMUN-LONDON, V14, P213, DOI 10.1177/1753425908094416; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Lynn DJ, 2003, VET IMMUNOL IMMUNOP, V93, P177, DOI 10.1016/S0165-2427(03)00058-8; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marshall JD, 2007, J LEUKOCYTE BIOL, V82, P497, DOI 10.1189/jlb.0906575; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; McCartney-Francis N, 2004, J IMMUNOL, V172, P3814, DOI 10.4049/jimmunol.172.6.3814; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Miyake Kensuke, 2004, Current Drug Targets - Inflammation and Allergy, V3, P291, DOI 10.2174/1568010043343633; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nerren JR, 2009, IMMUNOGENETICS, V61, P71, DOI 10.1007/s00251-008-0340-0; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Oshikawa K, 2003, EXP LUNG RES, V29, P401, DOI 10.1080/01902140303756; Palazzo M, 2008, INT IMMUNOL, V20, P709, DOI 10.1093/intimm/dxn027; Philbin VJ, 2005, IMMUNOLOGY, V114, P507, DOI 10.1111/j.1365-2567.2005.02125.x; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Robinson-White A, 2002, ANN NY ACAD SCI, V968, P256, DOI 10.1111/j.1749-6632.2002.tb04340.x; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Schwarz H, 2007, J INTERF CYTOK RES, V27, P97, DOI 10.1089/jir.2006.0098; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; Tsukamoto K, 2008, J IMMUNOL, V180, P2054, DOI 10.4049/jimmunol.180.4.2054; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Uto T, 2005, BIOCHEM PHARMACOL, V70, P1211, DOI 10.1016/j.bcp.2005.07.011; Utsugi M, 2009, J IMMUNOL, V182, P5225, DOI 10.4049/jimmunol.0801352; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Yang HT, 2011, J IMMUNOL, V186, P1989, DOI 10.4049/jimmunol.1001003	99	79	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e51243	10.1371/journal.pone.0051243	http://dx.doi.org/10.1371/journal.pone.0051243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405061	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400004
J	Scheler, G				Scheler, Gabriele			Transfer Functions for Protein Signal Transduction: Application to a Model of Striatal Neural Plasticity	PLOS ONE			English	Article							DYNAMICS; DARPP-32; SIMULATION; EQUATIONS	We present a novel formulation for biochemical reaction networks in the context of protein signal transduction. The model consists of input-output transfer functions, which are derived from differential equations, using stable equilibria. We select a set of "source'' species, which are interpreted as input signals. Signals are transmitted to all other species in the system (the "target'' species) with a specific delay and with a specific transmission strength. The delay is computed as the maximal reaction time until a stable equilibrium for the target species is reached, in the context of all other reactions in the system. The transmission strength is the concentration change of the target species. The computed input-output transfer functions can be stored in a matrix, fitted with parameters, and even recalled to build dynamical models on the basis of state changes. By separating the temporal and the magnitudinal domain we can greatly simplify the computational model, circumventing typical problems of complex dynamical systems. The transfer function transformation of biochemical reaction systems can be applied to mass-action kinetic models of signal transduction. The paper shows that this approach yields significant novel insights while remaining a fully testable and executable dynamical model for signal transduction. In particular we can deconstruct the complex system into local transfer functions between individual species. As an example, we examine modularity and signal integration using a published model of striatal neural plasticity. The modularizations that emerge correspond to a known biological distinction between calcium-dependent and cAMP-dependent pathways. Remarkably, we found that overall interconnectedness depends on the magnitude of inputs, with higher connectivity at low input concentrations and significant modularization at moderate to high input concentrations. This general result, which directly follows from the properties of individual transfer functions, contradicts notions of ubiquitous complexity by showing input-dependent signal transmission inactivation.			Scheler, G (corresponding author), Carl Correns Fdn Math Biol, Mountain View, CA 94040 USA.	gscheler@gmail.com	Scheler, Gabriele/N-2939-2017	Scheler, Gabriele/0000-0002-7425-4404				Bandara S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000558; Barbano PE, 2007, P NATL ACAD SCI USA, V104, P19169, DOI 10.1073/pnas.0709955104; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Cepeda Carlos, 2006, Sci STKE, V2006, ppe20, DOI 10.1126/stke.3332006pe20; Deng JM, 2011, APPL MECH MATER, V43, P1, DOI 10.4028/www.scientific.net/AMM.43.1; Erhard F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-356; Eriksson O, 2009, IET SYST BIOL, V3, P113, DOI 10.1049/iet-syb.2007.0028; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Gilbert D, 2006, BRIEF BIOINFORM, V7, P339, DOI 10.1093/bib/bbl043; Hughey JJ, 2010, WIRES SYST BIOL MED, V2, P194, DOI 10.1002/wsbm.52; Kim M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000691; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Kraeutler MJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-157; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Le Novere N, 2008, CELL MOL LIFE SCI, V65, P2125, DOI 10.1007/s00018-008-8150-y; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Lindskog M, 2006, PLOS COMPUT BIOL, V2, P1045, DOI 10.1371/journal.pcbi.0020119; Manninen T, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00152; Maslov S, 2007, P NATL ACAD SCI USA, V104, P13655, DOI 10.1073/pnas.0702905104; Maslov S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/273; Nakano T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000670; Oliveira RF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002383; Pepke S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000675; Purvis JE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000298; Qi Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-26; Qi Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002444; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Srividhya J, 2007, BIOPHYS CHEM, V125, P286, DOI 10.1016/j.bpc.2006.09.001; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Theis F, 2011, B MATH BIOL, V73, P978, DOI 10.1007/s11538-010-9548-x; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Woo NH, 2003, HIPPOCAMPUS, V13, P293, DOI 10.1002/hipo.10086; Wu JL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-187; Yger M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00056; Yu RC, 2008, IET SYST BIOL, V2, P222, DOI 10.1049/iet-syb:20080127	36	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55762	10.1371/journal.pone.0055762	http://dx.doi.org/10.1371/journal.pone.0055762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405211	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400156
J	Ciaccioli, G; Martins, A; Rodrigues, C; Vieira, H; Calado, P				Ciaccioli, Gianmario; Martins, Ana; Rodrigues, Catia; Vieira, Helena; Calado, Patricia			A Powerful Yeast Model to Investigate the Synergistic Interaction of alpha-Synuclein and Tau in Neurodegeneration	PLOS ONE			English	Article							PROTEIN-TAU; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; NEURONAL LOSS; PHOSPHORYLATION; AGGREGATION; TOXICITY; MUTATION; HYPERPHOSPHORYLATION; ACCUMULATION	Several studies revealed consistent overlap between synucleinopathies and tauopathies, demonstrating that alpha-synuclein (ASYN) and tau co-localize in neurofibrillary tangles and in Lewy bodies from Alzheimer's and Parkinson's disease patients and corresponding animal models. Additionally, it has been shown that ASYN can act as an initiator of tau aggregation and phosphorylation and that these two proteins directly interact. Despite these evidences, the cellular pathway implicated in this synergistic interaction remains to be clarified. The aim of this study was to create a yeast model where the concomitant expression of ASYN and tau can be used to perform genome wide screenings for the identification of genes that modulate this interaction, in order to shed light into the pathological mechanism of cell dysfunction and to provide new targets for future therapeutic intervention. We started by validating the synergistic toxicity of tau and ASYN co-expression in yeast, by developing episomal and integrative strains expressing WT and mutant forms of both proteins, alone or in combination. The episomal strains showed no differences in growth delay upon expression of ASYN isoforms (WT or A53T) alone or in combination with tau 2N/4R isoforms (WT or P301L). However, in these strains, the presence of ASYN led to increased tau insolubility and correlated with increased tau phosphorylation in S396/404, which is mainly mediated by RIM11, the human homolog of GSK3 beta in yeast. On the other hand, the integrative strains showed a strong synergistic toxic effect upon co-expression of ASYN WT and tau WT, which was related to high levels of intracellular ASYN inclusions and increased tau phosphorylation and aggregation. Taken together, the strains described in the present study are able to mimic relevant pathogenic features involved in neurodegeneration and are powerful tools to identify potential target genes able to modulate the synergistic pathway driven by ASYN and tau interaction.	[Ciaccioli, Gianmario; Martins, Ana; Rodrigues, Catia; Vieira, Helena; Calado, Patricia] Biotecnologia SA, Serv Invest & Desenvolvimento, BIOALVO, Campo Grande, Edificio ICAT,Campus FCUL, Lisbon, Portugal; [Ciaccioli, Gianmario; Vieira, Helena] Univ Lisbon, Fac Sci, DEIO, P-1699 Lisbon, Portugal; [Ciaccioli, Gianmario; Vieira, Helena] Univ Lisbon, Fac Sci, BIOFig Ctr, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Calado, P (corresponding author), Biotecnologia SA, Serv Invest & Desenvolvimento, BIOALVO, Campo Grande, Edificio ICAT,Campus FCUL, Lisbon, Portugal.	patricia.calado@bioalvo.com	Vieira, Helena/GWC-5973-2022; Vieira, Helena/M-1623-2017	Vieira, Helena/0000-0002-3663-289X	European Community's Seventh Framework Programme FP7 [238316]; FCT (Fundacao para a Ciencia e a Tecnologia) [SFRH/BI/51091/2010]	European Community's Seventh Framework Programme FP7; FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology)	The work leading to this publication has received funding from the European Community's Seventh Framework Programme FP7/2009 under grant agreement no. 238316 and from the FCT (Fundacao para a Ciencia e a Tecnologia) under grant agreement no. SFRH/BI/51091/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2011, AM J PATHOL, V178, P803, DOI 10.1016/j.ajpath.2010.10.034; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P228, DOI 10.1177/0891988710383572; Benussi L, 2005, EXP CELL RES, V308, P78, DOI 10.1016/j.yexcr.2005.04.021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BueeScherrer V, 1996, MOL BRAIN RES, V39, P79, DOI 10.1016/0169-328X(96)00003-4; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; De Vos Ann, 2011, Int J Alzheimers Dis, V2011, P428970, DOI 10.4061/2011/428970; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Ferrer I, 2003, ACTA NEUROPATHOL, V106, P419, DOI 10.1007/s00401-003-0756-4; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Franssens V, 2010, CELL DEATH DIFFER, V17, P746, DOI 10.1038/cdd.2009.203; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Fujishiro H, 2009, ACTA NEUROPATHOL, V117, P151, DOI 10.1007/s00401-008-0463-2; Fushimi K, 2011, PROTEIN CELL, V2, P141, DOI 10.1007/s13238-011-1014-5; Giasson BI, 2003, NEUROMOL MED, V4, P49, DOI 10.1385/NMM:4:1-2:49; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Girish V, 2004, Indian J Cancer, V41, P47; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; Griffioen G, 2006, BBA-MOL BASIS DIS, V1762, P312, DOI 10.1016/j.bbadis.2005.11.009; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Karakaya T, 2012, CURR TREAT OPTION NE, V14, P126, DOI 10.1007/s11940-012-0168-7; Kassir Y, 2006, CURR DRUG TARGETS, V7, P1455, DOI 10.2174/1389450110607011455; Kawakami F, 2011, FEBS J, V278, P4895, DOI 10.1111/j.1742-4658.2011.08389.x; Kiakos K, 2002, J BIOL CHEM, V277, P44576, DOI 10.1074/jbc.M208169200; Kimura T, 2010, J BIOL CHEM, V285, P38692, DOI 10.1074/jbc.M110.136630; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; Klucken J, 2006, ACTA NEUROPATHOL, V111, P101, DOI 10.1007/s00401-005-0027-7; Ko LW, 2008, J NEUROPATH EXP NEUR, V67, P1084, DOI 10.1097/NEN.0b013e31818c3618; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; Morris M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029257; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Popescu A, 2004, ARCH NEUROL-CHICAGO, V61, P1915, DOI 10.1001/archneur.61.12.1915; Pritchard SM, 2011, J CELL MOL MED, V15, P1621, DOI 10.1111/j.1582-4934.2011.01273.x; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Sellbach AN, 2006, PARKINSONISM RELAT D, V12, P399, DOI 10.1016/j.parkreldis.2006.03.002; Sharma N, 2006, J MOL NEUROSCI, V28, P161, DOI 10.1385/JMN:28:2:161; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014; Vandebroek T, 2006, J BIOL CHEM, V281, P25388, DOI 10.1074/jbc.M602792200; Vanhelmont T, 2010, FEMS YEAST RES, V10, P992, DOI 10.1111/j.1567-1364.2010.00662.x; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; WENNING GK, 1995, J NEUROL NEUROSUR PS, V58, P160, DOI 10.1136/jnnp.58.2.160; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	74	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55848	10.1371/journal.pone.0055848	http://dx.doi.org/10.1371/journal.pone.0055848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393603	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800058
J	Wang, C; Zhang, J; Liu, X; Li, CC; Ye, ZC; Peng, H; Chen, ZJ; Lou, TQ				Wang, Cheng; Zhang, Jun; Liu, Xun; Li, Cuicui; Ye, Zengchun; Peng, Hui; Chen, Zhujiang; Lou, Tanqi			Reversed Dipper Blood-Pressure Pattern Is Closely Related to Severe Renal and Cardiovascular Damage in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; DECLINE	Background: A non-dipper blood pressure (BP) pattern is very common in chronic kidney disease (CKD) patients and affects the progression and development of cardiovascular disease. However, data on the reversed dipper BP pattern on target-organ damage in Chinese CKD patients are lacking. Methods: A total of 540 CKD patients were enrolled. Ambulatory blood pressure monitoring (ABPM), clinical BP, ultrasonographic assessment and other clinical data were collected. Univariate and multivariate analyses were used to ascertain the relationship between ABPM results and clinical parameters. Results: A total of 21.9% CKD patients had a reversed dipper BP pattern, 42% of patients had a non-dipper BP pattern and 36.1% of patients had a dipper BP pattern. Patients with reversed dipper BP pattern had the worst renal function and most severe cardiovascular damages among these CKD patients (p < 0.05). The estimated glomerular filtration rate (eGFR) and left ventricular mass index (LVMI) correlated significantly with the rate of decline of nocturnal BP. A reversed dipper BP pattern was an independent factor affecting kidney damage and left ventricular hypertrophy. Age, lower hemoglobin level, higher 24-h systolic BP from ABPM, and higher serum phosphate levels were independent associated with a reversed dipper BP pattern after multivariate logistic regression analyses. Conclusion: The reversed dipper BP pattern is closely related to severe renal damage and cardiovascular injuries in CKD patients, and special attention should be given to these CKD patients.	[Wang, Cheng; Zhang, Jun; Liu, Xun; Li, Cuicui; Ye, Zengchun; Peng, Hui; Chen, Zhujiang; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lou, TQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	lou.tq@163.com	wang, cheng/A-4225-2017					Bakris GL, 2009, J CLIN HYPERTENS, V11, P144, DOI 10.1111/j.1751-7176.2009.00092.x; Black HR, 1997, ARCH INTERN MED, V157, P2413; Brotman DJ, 2008, AM J HYPERTENS, V21, P92, DOI 10.1038/ajh.2007.7; Crespo JJ, 2012, CHRONOBIOL INT; Davidson MB, 2006, ARCH INTERN MED, V166, P846, DOI 10.1001/archinte.166.8.846; Drawz PE, 2010, RENAL FAILURE, V32, P1036, DOI 10.3109/0886022X.2010.510615; Dudeja SK, 2009, NEW ENGL J MED, V360, P2034; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Fukuda M, 2008, HYPERTENSION, V52, P1155, DOI 10.1161/HYPERTENSIONAHA.108.115329; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Gonzalez Rodriguez E, 2012, Rev Med Suisse, V8, P1709; Hermida RC, 2011, J AM SOC NEPHROL, V22, P2313, DOI 10.1681/ASN.2011040361; Hermida RC, 2005, HYPERTENSION, V46, P960, DOI 10.1161/01.HYP.0000174616.36290.fa; Kanbay M, 2007, AM J NEPHROL, V27, P516, DOI 10.1159/000107489; Khattar R S, 2001, J Clin Hypertens (Greenwich), V3, P90, DOI 10.1111/j.1524-6175.2001.00445.x; Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410; OBRIEN E, 1988, LANCET, V2, P397; Ommen SR, 2003, HEART, V89, P18; Pogue V, 2009, HYPERTENSION, V53, P20, DOI 10.1161/HYPERTENSIONAHA.108.115154; Ptinopoulou AG, 2013, HYPERTENS RES, V36, P91, DOI 10.1038/hr.2012.157; Sarafidis PA, 2012, AM J NEPHROL, V35, P238, DOI 10.1159/000336111; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Wadei HM, 2011, J AM SOC HYPERTENS, V5, P39, DOI 10.1016/j.jash.2010.11.004; Wang C, 2012, J CLIN HYPE IN PRESS; Zoccali C, 2001, J AM SOC NEPHROL, V12, P2768, DOI 10.1681/ASN.V12122768	26	16	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55419	10.1371/journal.pone.0055419	http://dx.doi.org/10.1371/journal.pone.0055419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393577	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800031
J	Garcia-Rates, S; Lewis, M; Worrall, R; Greenfield, S				Garcia-Rates, Sara; Lewis, Matthew; Worrall, Rosemary; Greenfield, Susan			Additive Toxicity of beta-Amyloid by a Novel Bioactive Peptide In Vitro: Possible Implications for Alzheimer's Disease	PLOS ONE			English	Article							ACETYLCHOLINESTERASE PROMOTES; NEUROFIBRILLARY TANGLES; PHEOCHROMOCYTOMA CELLS; CHROMAFFIN CELLS; BRAIN; RECEPTORS; BUTYRYLCHOLINESTERASE; INVOLVEMENT; RELEASE; PLAQUES	Background: beta-amyloid is regarded as a significant factor in Alzheimer's disease: but inefficient therapies based on this rationale suggests that additional signalling molecules or intermediary mechanisms must be involved in the actual initiation of the characteristic degeneration of neurons. One clue could be that acetylcholinesterase, also present in amyloid plaques, is aberrant in peripheral tissues such as blood and adrenal medulla that can be implicated in Alzheimer's disease. The aim of this study was to assess the bioactivity of a fragment of acetylcholinesterase responsible for its non-enzymatic functions, a thirty amino acid peptide ("T30") which has homologies with beta-amyloid. Methods: Cell viability was measured by sulforhodamine B assay and also lactate dehydrogenase assay: meanwhile, changes in the status of living cells was monitored by measuring release of acetylcholinesterase in cell perfusates using the Ellman reagent. Findings: T30 peptide and beta-amyloid each have toxic effects on PC12 cells, comparable to hydrogen peroxide. However only the two peptides selectively then evoke a subsequent, enhanced release in acetylcholinesterase that could only be derived from the extant cells. Moreover, unlike hydrogen peroxide, the T30 peptide selectively shifted a sub-threshold dose of beta-amyloid to a toxic effect, which also resulted in a comparable enhanced release of acetylcholinesterase. Interpretation: This is the first study comparing directly the bioactivity of beta-amyloid with a peptide derived from acetylcholinesterase: the similarity in action suggests that the sequence homology between the two compounds might have a functional and/or pathological relevance. The subsequent enhanced release of acetylcholinesterase from the extant cells could reflect a primary 'compensatory' response of cells prone to degeneration, paradoxically providing further availability of the toxic C-terminal peptide to modulate the potency of beta-amyloid. Such a cycle of events may provide new insights into the mechanism of continuing selective cell loss in Alzheimer's disease and related degenerative disorders.	[Garcia-Rates, Sara; Lewis, Matthew; Worrall, Rosemary; Greenfield, Susan] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Garcia-Rates, S (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	sara.garciarates@pharm.ox.ac.uk			The Sharp Foundation (USA)	The Sharp Foundation (USA)	This work was supported by The Sharp Foundation (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez A, 1997, J MOL BIOL, V272, P348, DOI 10.1006/jmbi.1997.1245; APPLEYARD ME, 1991, LANCET, V338, P1085, DOI 10.1016/0140-6736(91)91947-S; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ATACK JR, 1985, J NEUROL SCI, V70, P1, DOI 10.1016/0022-510X(85)90182-0; AVERBACK P, 1983, LANCET, V2, P1203; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Bond CE, 2007, GLIA, V55, P1348, DOI 10.1002/glia.20547; Bond CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004846; Bornstein SR, 2012, MOL PSYCHIATR, V17, P354, DOI 10.1038/mp.2011.176; Carvajal FJ, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00019; Day T, 2004, EXP BRAIN RES, V155, P500, DOI 10.1007/s00221-003-1757-1; DAYAN AD, 1970, ACTA NEUROPATHOL, V16, P85, DOI 10.1007/BF00687663; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emery VOB, 2011, J NEURAL TRANSM, V118, P1361, DOI 10.1007/s00702-011-0663-0; Emmett SR, 2004, NEUROSCI LETT, V358, P210, DOI 10.1016/j.neulet.2003.12.078; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Fodero LR, 2004, J NEUROCHEM, V88, P1186, DOI 10.1046/j.1471-4159.2003.02296.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greenfield S, 2002, NEUROSCIENCE, V113, P485, DOI 10.1016/S0306-4522(02)00194-X; Greenfield S, 1996, NEUROCHEM INT, V28, P485, DOI 10.1016/0197-0186(95)00100-X; Greenfield SA, 2004, J NEUROCHEM, V90, P325, DOI 10.1111/j.1471-4159.2004.02494.x; Greenfield SA, 2008, FEBS J, V275, P604, DOI 10.1111/j.1742-4658.2007.06235.x; IZUMIYAMA N, 1990, ACTA NEUROPATHOL, V81, P213, DOI 10.1007/BF00334510; MIZRACHI Y, 1990, P NATL ACAD SCI USA, V87, P6161, DOI 10.1073/pnas.87.16.6161; Nithianantharajah J, 2011, PROG NEURO-PSYCHOPH, V35, P331, DOI 10.1016/j.pnpbp.2010.10.026; Onganer PU, 2006, BBA-GEN SUBJECTS, V1760, P415, DOI 10.1016/j.bbagen.2005.12.016; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; SOMOGYI P, 1975, PROC R SOC SER B-BIO, V191, P271, DOI 10.1098/rspb.1975.0128; TAKEDA M, 1994, NEUROSCI LETT, V168, P57, DOI 10.1016/0304-3940(94)90415-4; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Zbarsky V, 2004, NEUROBIOL DIS, V16, P283, DOI 10.1016/j.nbd.2004.02.009; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040; Zimmerman G, 2006, CELL TISSUE RES, V326, P655, DOI 10.1007/s00441-006-0239-8	37	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54864	10.1371/journal.pone.0054864	http://dx.doi.org/10.1371/journal.pone.0054864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390503	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100019
J	Lombardi, G; Lanteri, P; Porcelli, S; Mauri, C; Colombini, A; Grasso, D; Zani, V; Bonomi, FG; Melegati, G; Banfi, G				Lombardi, Giovanni; Lanteri, Patrizia; Porcelli, Simone; Mauri, Clara; Colombini, Alessandra; Grasso, Dalila; Zani, Viviana; Bonomi, Felice Giulio; Melegati, Gianluca; Banfi, Giuseppe			Hematological Profile and Martial Status in Rugby Players during Whole Body Cryostimulation	PLOS ONE			English	Article							IRON-DEFICIENCY; BLOOD; CRYOTHERAPY; INFLAMMATION	Cold-based therapies are commonly applied to alleviate pain symptoms secondary to inflammatory diseases, but also to treat injuries or overuse, as done in sports rehabilitation. Whole body cryotherapy, a relatively new form of cold therapy, consists of short whole-body exposure to extremely cold air (-110 degrees C to -140 degrees C). Cryostimulation is gaining wider acceptance as an effective part of physical therapy to accelerate muscle recovery in rugby players. The aim of this study was to evaluate the effect of repeated cryostimulation sessions on the hematological profile and martial status markers in professional rugby players. Twenty-seven professional rugby players received 2 daily cryostimulation treatments for 7 consecutive days. Blood samples were collected before and after administration of the cryotherapic protocol and hematological profiles were obtained. No changes in the leukocyte count or composition were seen. There was a decrease in the values for erythrocytes, hematocrit, hemoglobin and mean corpuscular hemoglobin content, and an increase in mean corpuscular volume and red cell distribution width. Platelet count and mean volume remained unchanged. Serum transferrin and ferritin decreased, while soluble transferrin receptor increased. Serum iron and transferrin saturation were unchanged, as was reticulocyte count, whereas the immature reticulocyte fraction decreased substantially. In conclusion, in this sample of professional rugby players, cryostimulation modified the hematological profile, with a reduction in erythrocyte count and hemoglobinization paralleled by a change in martial status markers.	[Lombardi, Giovanni; Lanteri, Patrizia; Colombini, Alessandra; Grasso, Dalila; Banfi, Giuseppe] IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy; [Porcelli, Simone] CNR, Inst Bioimaging & Mol Physiol, Milan, Italy; [Mauri, Clara; Melegati, Gianluca] IRCCS Ist Ortoped Galeazzi, Dept Multifunct Rehabil, Milan, Italy; [Zani, Viviana; Bonomi, Felice Giulio] Poliambulatorio Bongi, Ctr Syst Cryotherapy, Orzinuovi, Italy; [Bonomi, Felice Giulio] Humanitas Gavazzeni, Cardiovasc Dept, OU Cardiol, Bergamo, Italy; [Banfi, Giuseppe] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; Consiglio Nazionale delle Ricerche (CNR); IRCCS Istituto Ortopedico Galeazzi; Istituto Clinico Humanitas Gavazzeni; University of Milan	Lombardi, G (corresponding author), IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy.	giovanni.lombardi@grupposandonato.it	Mauri, Chiara/GXN-0766-2022; Lombardi, Giovanni/I-2414-2012; Colombini, Alessandra/I-2441-2012; Banfi, Giuseppe/K-6585-2015; porcelli, simone/A-1977-2016	Lombardi, Giovanni/0000-0002-8365-985X; Colombini, Alessandra/0000-0002-1800-3424; Mauri, Claudia/0000-0001-9761-2625; Banfi, Giuseppe/0000-0001-9578-5338; porcelli, simone/0000-0002-9494-0858	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banffi G, 2008, BRIT J SPORT MED, V42, P858; Banfi G, 2006, CLIN LAB HAEMATOL, V28, P183, DOI 10.1111/j.1365-2257.2006.00771.x; Banfi G, 2003, J SPORT MED PHYS FIT, V43, P223; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Banfi G, 2009, J SCI MED SPORT, V12, P609, DOI [10.1016/j.jsams.2008.06.004, 10.1016/j.jsams.2008.02.004]; Banfi G, 2009, J THERM BIOL, V34, P55, DOI 10.1016/j.jtherbio.2008.10.003; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Hallberg L, 2003, AM J CLIN NUTR, V78, P1225, DOI 10.1093/ajcn/78.6.1225; HARRISON MH, 1985, PHYSIOL REV, V65, P149, DOI 10.1152/physrev.1985.65.1.149; Hausswirth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027749; Lubkowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046352; Lubkowska A, 2010, INT J OCCUP MED ENV, V23, P367, DOI 10.2478/v10001-010-0037-0; Lubkowska A, 2010, CRYOBIOLOGY, V61, P22, DOI 10.1016/j.cryobiol.2010.03.010; Lubkowska A, 2010, EUR J APPL PHYSIOL, V109, P67, DOI 10.1007/s00421-009-1207-2; Munoz M, 2009, WORLD J GASTROENTERO, V15, P4617, DOI 10.3748/wjg.15.4617; Nachtigall D, 1996, INT J SPORTS MED, V17, P473, DOI 10.1055/s-2007-972881; Peeling P, 2008, EUR J APPL PHYSIOL, V103, P381, DOI 10.1007/s00421-008-0726-6; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Robinson N, 2011, INT J LAB HEMATOL, V33, P146, DOI 10.1111/j.1751-553X.2010.01256.x; Sottas Pierre-Edouard, 2010, Handb Exp Pharmacol, P305, DOI 10.1007/978-3-540-79088-4_14; Suedekum Natalie A, 2005, Curr Sports Med Rep, V4, P199, DOI 10.1097/01.CSMR.0000306207.79809.7f; Tomkins A, 2003, J NUTR, V133, p1649S, DOI 10.1093/jn/133.5.1649S; World Anti-doping Agency, 2011, REQ PASSP OP INT STA; Zoller H, 2004, NUTRITION, V20, P615, DOI 10.1016/j.nut.2004.04.006	24	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55803	10.1371/journal.pone.0055803	http://dx.doi.org/10.1371/journal.pone.0055803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383348	gold, Green Submitted, Green Published			2022-12-27	WOS:000314597900055
J	Yong, MH; Allen, JC; Prakash, KM; Tan, EK				Yong, Ming-Hui; Allen, John C., Jr.; Prakash, Kumar M.; Tan, Eng-King			Differentiating Non-Motor Symptoms in Parkinson's Disease from Controls and Hemifacial Spasm	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE IMPAIRMENT; MULTICENTER; DYSFUNCTION; MANAGEMENT; DIAGNOSIS; SCALE	Background and Aims: Non-motor symptoms (NMS) are important manifestations of Parkinson's disease (PD) that reduce patients' health-related quality of life. Some NMS may also be caused by age-related changes, or manifested as a psychological reaction to a chronic neurological condition. This case-control study compared the NMS burden among PD patients, healthy controls and hemifacial spasm (HFS) patients. In addition, we determined the NMS that discriminated between PD and non-PD subjects. Methods: 425 subjects were recruited from a tertiary hospital in Singapore (200 PD patients, 150 healthy controls and 75 HFS patients). NMS burden in subjects was measured using the Non-Motor Symptoms Scale (NMSS). Results: NMSS total score was significantly higher in PD patients (37.9 +/- 2.6) compared to healthy controls (11.2 +/- 0.9) (p<0.0001) and HFS patients (18.0 +/- 2.1) (p<0.0001). In addition, NMSS total score was significantly higher in HFS patients compared to healthy controls (p = 0.003). PD patients experienced a higher NMS burden than healthy controls in all domains, and a higher NMS burden than HFS patients in all but attention/memory and urinary domains. NMS burden for HFS and healthy controls differed only in the sleep/fatigue and urinary domains. Using stepwise logistic regression, problems of 'constipation', 'restless legs', 'dribbling saliva', 'altered interest in sex' and 'change in taste or smell' were found to have significant discriminative power in differentiating between PD patients and healthy controls and between PD patients and HFS patients. Conclusion: PD patients experienced a greater overall NMS burden compared to both healthy controls and HFS patients. HFS patients demonstrated a higher NMS burden than controls, and some NMS may be common to chronic neurological conditions while others are more specific to PD. Differentiating patients using NMS domains may help refine the clinical management of NMS in PD patients.	[Yong, Ming-Hui; Prakash, Kumar M.; Tan, Eng-King] Natl Inst Neurosci, Dept Neurol, Singapore, Singapore; [Yong, Ming-Hui; Allen, John C., Jr.; Prakash, Kumar M.; Tan, Eng-King] Duke NUS Grad Med Sch, Singapore, Singapore	National Neuroscience Institute (NNI); National University of Singapore	Tan, EK (corresponding author), Natl Inst Neurosci, Dept Neurol, Singapore, Singapore.	gnrtek@sgh.com.sg			Duke Graduate Medical School; National Neuroscience Institute; Singapore Millennium Foundation	Duke Graduate Medical School; National Neuroscience Institute; Singapore Millennium Foundation(Singapore Millennium Foundation)	This work was supported in part by Duke Graduate Medical School, National Neuroscience Institute and Singapore Millennium Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Defazio G, 2008, ARCH NEUROL-CHICAGO, V65, P1191, DOI 10.1001/archneurol.2008.2; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Diederich NJ, 2010, MOVEMENT DISORD, V25, P882, DOI 10.1002/mds.22963; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Findley L, 2002, MOVEMENT DISORD, V17, P60; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jain S, 2011, PARKINSONISM RELAT D, V17, P77, DOI 10.1016/j.parkreldis.2010.08.022; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Kim HJ, 2009, J NEUROL SCI, V287, P200, DOI 10.1016/j.jns.2009.07.026; Krishnan S, 2011, MOVEMENT DISORD, V26, P2110, DOI 10.1002/mds.23826; KUA EH, 1992, ACTA PSYCHIAT SCAND, V85, P119, DOI 10.1111/j.1600-0447.1992.tb01454.x; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; Lim SY, 2010, MOVEMENT DISORD, V25, pS123, DOI 10.1002/mds.22786; Martinez-Martin P, 2009, NEUROLOGY, V73, P1584, DOI 10.1212/WNL.0b013e3181c0d416; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Pavese N, 2010, BRAIN, V133, P3434, DOI 10.1093/brain/awq268; Qin ZH, 2009, PARKINSONISM RELAT D, V15, P767, DOI 10.1016/j.parkreldis.2009.05.011; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Tan EK, 2006, MOVEMENT DISORD, V21, P2145, DOI 10.1002/mds.21150; Tan NC, 2002, QJM-INT J MED, V95, P493, DOI 10.1093/qjmed/95.8.493; Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Truong DD, 2008, J NEUROL SCI, V266, P216, DOI 10.1016/j.jns.2007.08.015; Wolters EC, 2009, PARKINSONISM RELAT D, V15, pS6, DOI 10.1016/S1353-8020(09)70770-9; Ziemssen T, 2007, PARKINSONISM RELAT D, V13, P323, DOI 10.1016/j.parkreldis.2006.12.014	33	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e49596	10.1371/journal.pone.0049596	http://dx.doi.org/10.1371/journal.pone.0049596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408927	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000001
J	De Marco, C; Rinaldo, N; Bruni, P; Malzoni, C; Zullo, F; Fabiani, F; Losito, S; Scrima, M; Zito Marino, F; Franco, R; Quintiero, A; Agosti, V; Viglietto, G				De Marco, Carmela; Rinaldo, Nicola; Bruni, Paola; Malzoni, Carmine; Zullo, Fulvio; Fabiani, Fernanda; Losito, Simona; Scrima, Marianna; Zito Marino, Federica; Franco, Renato; Quintiero, Alfina; Agosti, Valter; Viglietto, Giuseppe			Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma	PLOS ONE			English	Article							SIGNALING PATHWAY; PHOSPHORYLATED AKT; THERAPEUTIC TARGET; PROGNOSTIC VALUE; PIK3CA GENE; MUTATIONAL ANALYSIS; PROTEIN EXPRESSION; PTEN EXPRESSION; IN-VITRO; CANCER	The phosphatidylinositol 3-kinase (PI3K)/AKT pathway is activated in multiple cancers including ovarian carcinoma (OC). However, the relative contribution of the single components within the PI3K pathway to AKT activation in OC is still unclear. We examined 98 tumor samples from Italian OC patients for alterations in the members of the PI3K pathway. We report that AKT is significantly hyperactive in OC compared to normal tissue (n = 93; p<0.0001) and that AKT activation is preferentially observed in the elderly (>58 years old; n = 93; p<0.05). The most frequent alteration is the overexpression of the p110 alpha catalytic subunit of PI3K (63/93, similar to 68%); less frequent alterations comprise the loss of PTEN (24/89, 27%) and the overexpression of AKT1 (18/96, 19%) or AKT2 (11/88,12.5%). Mutations in the PIK3CA or KRAS genes were detected at lower frequency (12% and 10%, respectively) whereas mutations in AKT1 or AKT2 genes were absent. Although many tumors presented a single lesion (28/93, of which 23 overexpressed PIK3CA, 1 overexpressed AKT and 4 had lost PTEN), many OC (35/93) presented multiple alterations within the PI3K pathway. Apparently, aberrant PI3K signalling was mediated by activation of the canonical downstream AKT-dependent mTOR/S6K1/4EBP1 pathway and by regulation of expression of oncogenic transcription factors that include HMGA1, JUN-B, FOS and MYC but not by AKT-independent activation of SGK3. FISH analysis indicated that gene amplification of PIK3CA, AKT1 and AKT2 (but not of PI3KR1) and the loss of PTEN are common and may account for changes in the expression of the corresponding proteins. In conclusion, our results indicate that p110 alpha overexpression represents the most frequent alteration within the PI3K/AKT pathway in OC. However, p110 alpha overexpression may not be sufficient to activate AKT signalling and drive ovarian tumorigenesis since many tumors overexpressing PI3K presented at least one additional alteration.	[De Marco, Carmela; Zullo, Fulvio; Fabiani, Fernanda; Scrima, Marianna; Quintiero, Alfina; Agosti, Valter; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [De Marco, Carmela; Rinaldo, Nicola; Scrima, Marianna; Viglietto, Giuseppe] Inst Genet Res Gaetano Salvatore, Biogem Scarl, Avellino, Italy; [Bruni, Paola; Malzoni, Carmine] Casa Cura Malzoni Villa Platani, Avellino, Italy; [Losito, Simona; Zito Marino, Federica; Franco, Renato] Fdn G Pascale, NCI, Naples, Italy	Magna Graecia University of Catanzaro; IRCCS Fondazione Pascale	Viglietto, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	viglietto@unicz.it	scrima, marianna/ABE-3003-2021; scrima, marianna/J-7431-2016; losito, Nunzia/Y-6339-2018; Viglietto, Giuseppe/AAC-2852-2019; Marino, Federica ZMF Zito/K-8634-2016; De Marco, Carmela/J-6797-2015; Scrima, Marianna/S-3320-2017; Zullo, Fulvio/K-3396-2016	scrima, marianna/0000-0003-4636-7695; scrima, marianna/0000-0003-4636-7695; losito, Nunzia/0000-0001-9045-0328; Viglietto, Giuseppe/0000-0003-2327-7515; De Marco, Carmela/0000-0002-4893-4246; Scrima, Marianna/0000-0003-4636-7695; AGOSTI, Valter/0000-0001-6785-093X; Zullo, Fulvio/0000-0003-3726-7561; Zito Marino, Federica/0000-0002-1071-757X; Franco, Renato/0000-0002-8340-3184; Zullo, Fulvio/0000-0003-4006-3287	MIUR (PRIN) [20087FSFFP_001, PON_02782]; Fondazione per il Sud	MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione per il Sud	This work was supported by MIUR (PRIN, 20087FSFFP_001; PON_02782) to GV. CDM was supported by a fellowship from 'Fondazione per il Sud'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-51; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auner V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-111; Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Barda G, 2004, AM J OBSTET GYNECOL, V190, P1039, DOI 10.1016/j.ajog.2003.09.073; Bast RC, 2010, J CLIN ONCOL, V28, P3545, DOI 10.1200/JCO.2010.28.5791; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carvalho S, 2010, VIRCHOWS ARCH, V456, P235, DOI 10.1007/s00428-010-0881-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; de Graeff P, 2008, BRIT J CANCER, V99, P341, DOI 10.1038/sj.bjc.6604471; ENOMOTO T, 1991, AM J PATHOL, V139, P777; Fader AN, 2007, J CLIN ONCOL, V25, P2873, DOI 10.1200/JCO.2007.11.0932; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Fishman DA, 2001, CANC TREATMENT RES O, P3; Gemignani ML, 2003, GYNECOL ONCOL, V90, P378, DOI 10.1016/S0090-8258(03)00264-6; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hu LM, 2002, CANCER RES, V62, P1087; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kawano O, 2007, LUNG CANCER, V58, P159, DOI 10.1016/j.lungcan.2007.06.020; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Kirkegaard T, 2010, HISTOPATHOLOGY, V56, P203, DOI 10.1111/j.1365-2559.2009.03467.x; Kurose K, 2001, AM J PATHOL, V158, P2097, DOI 10.1016/S0002-9440(10)64681-0; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lee SH, 2002, APMIS, V110, P587, DOI 10.1034/j.1600-0463.2002.11007811.x; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Lin Y, 2009, ENDOCR-RELAT CANCER, V16, P301, DOI 10.1677/ERC-08-0167; Liu JF, 2010, WORLD J GASTROENTERO, V16, P4986, DOI 10.3748/wjg.v16.i39.4986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Mabuchi S, 2009, CLIN CANCER RES, V15, P5404, DOI 10.1158/1078-0432.CCR-09-0365; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Mayr D, 2006, GYNECOL ONCOL, V103, P883, DOI 10.1016/j.ygyno.2006.05.029; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; [Natioanl Institute of Health website National Library of Medicine], OV CANC; National Cancer Institute website, CANC TOP OV CANC; No JH, 2011, GYNECOL ONCOL, V121, P8, DOI 10.1016/j.ygyno.2010.12.364; Obata K, 1998, CANCER RES, V58, P2095; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; Philp AJ, 2001, CANCER RES, V61, P7426; Rimm DL, 2001, CANCER J, V7, P24; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Russel P, 1995, BLAUSTEINS PATHOLOGY, P705; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Sambrook J, 1992, MOL CLONING LAB MANU, V2; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; SATO T, 1991, CANCER RES, V51, P5118; Scrima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030427; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Trinh XB, 2009, BRIT J CANCER, V100, P971, DOI 10.1038/sj.bjc.6604921; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang GX, 2010, CLIN NEUROL NEUROSUR, V112, P324, DOI 10.1016/j.clineuro.2010.01.003; Wang Y, 2005, AM J CLIN PATHOL, V124, P392, DOI 10.1309/BL7EMW66LQX6GFRP; Willner J, 2007, HUM PATHOL, V38, P607, DOI 10.1016/j.humpath.2006.10.007; Woenckhaus J, 2007, VIRCHOWS ARCH, V450, P387, DOI 10.1007/s00428-006-0358-3; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yuan ZQ, 2000, ONCOGENE, V19, P2324, DOI 10.1038/sj.onc.1203598; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660; Zhang X, 2009, ONCOLOGY-BASEL, V77, P22, DOI 10.1159/000218201	71	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55362	10.1371/journal.pone.0055362	http://dx.doi.org/10.1371/journal.pone.0055362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408974	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200027
J	Elschot, M; Vermolen, BJ; Lam, MGEH; de Keizer, B; van den Bosch, MAAJ; de Jong, HWAM				Elschot, Mattijs; Vermolen, Bart J.; Lam, Marnix G. E. H.; de Keizer, Bart; van den Bosch, Maurice A. A. J.; de Jong, Hugo W. A. M.			Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; RECONSTRUCTION; DOSIMETRY; THERAPY; BIODISTRIBUTION; MALIGNANCIES; SURVIVAL; IMAGES; SIRT; CT	Background: After yttrium-90 (Y-90) microsphere radioembolization (RE), evaluation of extrahepatic activity and liver dosimetry is typically performed on Y-90 Bremsstrahlung SPECT images. Since these images demonstrate a low quantitative accuracy, Y-90 PET has been suggested as an alternative. The aim of this study is to quantitatively compare SPECT and state-of-the-art PET on the ability to detect small accumulations of Y-90 and on the accuracy of liver dosimetry. Methodology/Principal Findings: SPECT/CT and PET/CT phantom data were acquired using several acquisition and reconstruction protocols, including resolution recovery and Time-Of-Flight (TOF) PET. Image contrast and noise were compared using a torso-shaped phantom containing six hot spheres of various sizes. The ability to detect extra-and intrahepatic accumulations of activity was tested by quantitative evaluation of the visibility and unique detectability of the phantom hot spheres. Image-based dose estimates of the phantom were compared to the true dose. For clinical illustration, the SPECT and PET-based estimated liver dose distributions of five RE patients were compared. At equal noise level, PET showed higher contrast recovery coefficients than SPECT. The highest contrast recovery coefficients were obtained with TOF PET reconstruction including resolution recovery. All six spheres were consistently visible on SPECT and PET images, but PET was able to uniquely detect smaller spheres than SPECT. TOF PET-based estimates of the dose in the phantom spheres were more accurate than SPECT-based dose estimates, with underestimations ranging from 45% (10-mm sphere) to 11% (37-mm sphere) for PET, and 75% to 58% for SPECT, respectively. The differences between TOF PET and SPECT dose-estimates were supported by the patient data. Conclusions/Significance: In this study we quantitatively demonstrated that the image quality of state-of-the-art PET is superior over Bremsstrahlung SPECT for the assessment of the Y-90 microsphere distribution after radioembolization.	[Elschot, Mattijs; Vermolen, Bart J.; Lam, Marnix G. E. H.; de Keizer, Bart; van den Bosch, Maurice A. A. J.; de Jong, Hugo W. A. M.] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Elschot, M (corresponding author), Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands.	m.elschot@umcutrecht.nl	de Keizer, Bart/AAG-9733-2019; Elschot, Mattijs/AAD-4362-2021	de Keizer, Bart/0000-0002-6270-9483; Elschot, Mattijs/0000-0002-8056-9103	University Medical Center Utrecht	University Medical Center Utrecht	This work was funded by the University Medical Center Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadehfar H, 2010, EUR J NUCL MED MOL I, V37, pS264; Bailey D L, 2003, POSITRON EMISSION TO, P41; Bolch WE, 1999, J NUCL MED, V40, p11S; Cherry SR, 2003, PHYS NUCL MED, P290; Chiesa C, 2011, Q J NUCL MED MOL IM, V55, P168; CLARKE LP, 1992, J NUCL MED, V33, P161; Comtat C, 1998, IEEE T NUCL SCI, V45, P1083, DOI 10.1109/23.681983; Comtat C, 2004, IEEE NUCL SCI CONF R, P3492; D'Arienzo M, 2012, NUCL MED COMMUN, V33, P633, DOI 10.1097/MNM.0b013e3283524220; Elschot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026174; Fabbri C, 2009, CANCER BIOTHER RADIO, V24, P145, DOI 10.1089/cbr.2008.0543; Flamen P, 2008, PHYS MED BIOL, V53, P6591, DOI 10.1088/0031-9155/53/22/019; Garin E, 2012, J NUCL MED, V53, P255, DOI 10.2967/jnumed.111.094235; Gates VL, 2011, J NUCL MED, V52, P72, DOI 10.2967/jnumed.110.080986; Hendricks JS, 2005, LAUR052675 LOS AL NA; Hutton BF, 1997, EUR J NUCL MED, V24, P797; Ito S, 2009, ANN NUCL MED, V23, P257, DOI 10.1007/s12149-009-0233-9; Jakoby BW, 2011, PHYS MED BIOL, V56, P2375, DOI 10.1088/0031-9155/56/8/004; Kennedy A, 2007, INT J RADIAT ONCOL, V68, P13, DOI 10.1016/j.ijrobp.2006.11.060; Kennedy AS, 2010, CANCER J, V16, P163, DOI 10.1097/PPO.0b013e3181d7e8cf; Knesaurek K, 2010, TECHNOL CANCER RES T, V9, P253, DOI 10.1177/153303461000900304; LANGHOFF H, 1961, Z PHYS, V164, P166, DOI 10.1007/BF01377806; Lhommel R, 2010, EUR J NUCL MED MOL I, V37, P1654, DOI 10.1007/s00259-010-1470-9; Lhommel R, 2009, EUR J NUCL MED MOL I, V36, P1696, DOI 10.1007/s00259-009-1210-1; Lubberink M, 2011, EUR J NUCL MED MOL I, V38, P10, DOI 10.1007/s00259-011-1768-2; Mansberg R, 2007, EUR J NUCL MED MOL I, V34, P1887, DOI 10.1007/s00259-007-0536-9; Minarik D, 2008, PHYS MED BIOL, V53, P5689, DOI 10.1088/0031-9155/53/20/008; Minarik D, 2009, PHYS MED BIOL, V54, P5873, DOI 10.1088/0031-9155/54/19/014; Murthy R, 2007, J VASC INTERV RADIOL, V18, P553, DOI 10.1016/j.jvir.2007.02.002; National Electrical Manufacturers Assoc. Rosslyn VA USA, 2007, NEMA STAND PUBL NU; Nickles RJ, 2004, IEEE NUCL SCI CONF R, P3412; Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171; Riaz A, 2009, J VASC INTERV RADIOL, V20, P1121, DOI 10.1016/j.jvir.2009.05.030; Rong X, 2012, MED PHYS, V39, P2346, DOI 10.1118/1.3700174; ROSE A, 1948, J OPT SOC AM, V38, P196, DOI 10.1364/JOSA.38.000196; SHEN S, 1994, J NUCL MED, V35, P1381; Strigari L, 2010, J NUCL MED, V51, P1377, DOI 10.2967/jnumed.110.075861; TSUI BMW, 1988, IEEE T NUCL SCI, V35, P778, DOI 10.1109/23.12831; van Elmbt L, 2010, EUR J NUCL MED MOL I, V37, pS293; van Velden FHP, 2008, PHYS MED BIOL, V53, P3217, DOI 10.1088/0031-9155/53/12/010; Vente MAD, 2009, EUR RADIOL, V19, P951, DOI 10.1007/s00330-008-1211-7; Walrand S, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-20; Werner MK, 2010, EUR J NUCL MED MOL I, V37, P407, DOI 10.1007/s00259-009-1317-4	43	133	133	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55742	10.1371/journal.pone.0055742	http://dx.doi.org/10.1371/journal.pone.0055742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405207	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400152
J	Imbalzano, KM; Cohet, N; Wu, Q; Underwood, JM; Imbalzano, AN; Nickerson, JA				Imbalzano, Karen M.; Cohet, Nathalie; Wu, Qiong; Underwood, Jean M.; Imbalzano, Anthony N.; Nickerson, Jeffrey A.			Nuclear Shape Changes Are Induced by Knockdown of the SWI/SNF ATPase BRG1 and Are Independent of Cytoskeletal Connections	PLOS ONE			English	Article							DISRUPT MICROFILAMENT ORGANIZATION; CHROMATIN REMODELING COMPLEXES; INTERMEDIATE-FILAMENT NETWORKS; ACTIN-BINDING PROTEIN; SWI-SNF COMPLEX; BREAST-CARCINOMA; MEMBRANE PROTEIN; DYNAMIC ASPECTS; CULTURED-CELLS; CANCER-CELLS	Changes in nuclear morphology occur during normal development and have been observed during the progression of several diseases. The shape of a nucleus is governed by the balance of forces exerted by nuclear-cytoskeletal contacts and internal forces created by the structure of the chromatin and nuclear envelope. However, factors that regulate the balance of these forces and determine nuclear shape are poorly understood. The SWI/SNF chromatin remodeling enzyme ATPase, BRG1, has been shown to contribute to the regulation of overall cell size and shape. Here we document that immortalized mammary epithelial cells show BRG1-dependent nuclear shape changes. Specifically, knockdown of BRG1 induced grooves in the nuclear periphery that could be documented by cytological and ultrastructural methods. To test the hypothesis that the observed changes in nuclear morphology resulted from altered tension exerted by the cytoskeleton, we disrupted the major cytoskeletal networks and quantified the frequency of BRG1-dependent changes in nuclear morphology. The results demonstrated that disruption of cytoskeletal networks did not change the frequency of BRG1-induced nuclear shape changes. These findings suggest that BRG1 mediates control of nuclear shape by internal nuclear mechanisms that likely control chromatin dynamics.	[Imbalzano, Karen M.; Cohet, Nathalie; Wu, Qiong; Underwood, Jean M.; Imbalzano, Anthony N.; Nickerson, Jeffrey A.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Imbalzano, AN (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA.	Anthony.imbalzano@umassmed.edu; Jeffrey.nickerson@umassmed.edu			National Cancer Institute [P01 CA82834]; National Institute of Diabetes and Digestive and Kidney Diseases [5P30 DK32520]; National Institute of Biomedical Imaging and Bioengineering [R01 EB014869]; NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Cancer Institute grant P01 CA82834 (http://cancer.gov). A.N.I. is a member of the University of Massachusetts Diabetes Endocrinology Research Center, which is supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grant 5P30 DK32520 (http://www.niddk.nih.gov). J.A.N. acknowledges additional support from the National Institute of Biomedical Imaging and Bioengineering grant R01 EB014869 (http://www.nibib.nih.gov). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asp P, 2002, J CELL SCI, V115, P2735; Bank EM, 2011, BIOCHEM SOC T, V39, P1705, DOI 10.1042/BST20110603; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Beale LS, 1860, ARCH MED LOND, V2, P44; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; CARMOFONSECA M, 1988, EUR J CELL BIOL, V45, P282; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cohet N, 2010, J CELL PHYSIOL, V223, P667, DOI 10.1002/jcp.22072; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; DJABALI K, 1991, CELL, V64, P109, DOI 10.1016/0092-8674(91)90213-I; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Feoli F, 2008, ACTA CYTOL, V52, P145, DOI 10.1159/000325472; FEY EG, 1984, J CELL BIOL, V99, pS203, DOI 10.1083/jcb.99.1.203s; FRANKE WW, 1971, PROTOPLASMA, V73, P263, DOI 10.1007/BF01275600; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Giardina C, 1996, ANAL QUANT CYTOL, V18, P374; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Goulbourne CN, 2011, J CELL SCI, V124, P4253, DOI 10.1242/jcs.091009; Haroske G, 1996, HISTOCHEM CELL BIOL, V105, P479, DOI 10.1007/BF01457662; Heeboll S, 2008, HISTOL HISTOPATHOL, V23, P1069, DOI 10.14670/HH-23.1069; Hill DA, 2004, J CELL SCI, V117, P5847, DOI 10.1242/jcs.01502; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Javed A, 2005, P NATL ACAD SCI USA, V102, P1454, DOI 10.1073/pnas.0409121102; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Liu R, 2011, CHEMBIOCHEM, V12, P1813, DOI 10.1002/cbic.201100284; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; MARSHALL PN, 1983, MICROSC ACTA, V87, P233; Martin S, 2001, TELECONNECT, V19, P10; Mazumder A, 2010, METHOD CELL BIOL, V98, P221, DOI 10.1016/S0091-679X(10)98010-2; Mazumder A, 2010, J R SOC INTERFACE, V7, pS321, DOI 10.1098/rsif.2010.0039.focus; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Paesmans M, 2008, REV MAL RESPIR, V25, p3S99; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Saladi SV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-280; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Serber DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031346; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Shimi T, 2010, COLD SH Q B, V75, P525, DOI 10.1101/sqb.2010.75.045; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Strnad P, 2002, J CELL SCI, V115, P4133, DOI 10.1242/jcs.00096; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; VIKSTROM KL, 1989, P NATL ACAD SCI USA, V86, P549, DOI 10.1073/pnas.86.2.549; Wagner S, 2003, P NATL ACAD SCI USA, V100, P3269, DOI 10.1073/pnas.0438055100; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Watanabe T, 2011, BRIT J CANCER, V104, P146, DOI 10.1038/sj.bjc.6606018; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Zhen YY, 2002, J CELL SCI, V115, P3207; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	78	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55628	10.1371/journal.pone.0055628	http://dx.doi.org/10.1371/journal.pone.0055628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405182	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400127
J	Page, S; Birerdinc, A; Estep, M; Stepanova, M; Afendy, A; Petricoin, E; Younossi, Z; Chandhoke, V; Baranova, A				Page, Sandra; Birerdinc, Aybike; Estep, Michael; Stepanova, Maria; Afendy, Arian; Petricoin, Emanuel; Younossi, Zobair; Chandhoke, Vikas; Baranova, Ancha			Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; FAS LIGAND; ADIPOKINES; DISCOVERY; CIRRHOSIS	The discovery of biomarkers is often performed using high-throughput proteomics-based platforms and is limited to the molecules recognized by a given set of purified and validated antigens or antibodies. Knowledge-based, or systems biology, approaches that involve the analysis of integrated data, predominantly molecular pathways and networks may infer quantitative changes in the levels of biomolecules not included by the given assay from the levels of the analytes profiled. In this study we attempted to use a knowledge-based approach to predict biomarkers reflecting the changes in underlying protein phosphorylation events using Nonalcoholic Fatty Liver Disease (NAFLD) as a model. Two soluble biomarkers, CCL-2 and FasL, were inferred in silico as relevant to NAFLD pathogenesis. Predictive performance of these biomarkers was studied using serum samples collected from patients with histologically proven NAFLD. Serum levels of both molecules, in combination with clinical and demographic data, were predictive of hepatic fibrosis in a cohort of NAFLD patients. Our study suggests that (1) NASH-specific disruption of the kinase-driven signaling cascades in visceral adipose tissue lead to detectable changes in the levels of soluble molecules released into the bloodstream, and (2) biomarkers discovered in silico could contribute to predictive models for non-malignant chronic diseases.	[Page, Sandra; Birerdinc, Aybike; Stepanova, Maria; Petricoin, Emanuel; Chandhoke, Vikas; Baranova, Ancha] George Mason Univ, Coll Sci, Sch Syst Biol, Ctr Study Chron Metab Dis, Fairfax, VA 22030 USA; [Page, Sandra; Birerdinc, Aybike; Estep, Michael; Stepanova, Maria; Afendy, Arian; Younossi, Zobair; Baranova, Ancha] Inova Hlth Syst, Betty & Guy Beatty Liver & Obes Program, Falls Church, VA USA; [Estep, Michael; Afendy, Arian; Younossi, Zobair] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA; [Estep, Michael; Afendy, Arian; Younossi, Zobair] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA; [Petricoin, Emanuel] George Mason Univ, Coll Sci, Sch Syst Biol, Ctr Appl Prote & Mol Med, Fairfax, VA 22030 USA; [Baranova, Ancha] Res Ctr Med Genet RAMS, Moscow, Russia; [Page, Sandra] NIDDKD, Liver Dis Branch, NIH, Bethesda, MD 20892 USA	George Mason University; Inova Health System; Inova Fairfax Hospital; Inova Fairfax Hospital; George Mason University; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Baranova, A (corresponding author), George Mason Univ, Coll Sci, Sch Syst Biol, Ctr Study Chron Metab Dis, Fairfax, VA 22030 USA.	abaranov@gmu.edu	Baranova, Anna/HGB-3721-2022; , Ancha/B-4608-2012	, Ancha/0000-0001-6810-5982; Estep, J. Michael/0000-0001-7735-2133				Baranova A, 2008, HEPATOLOGY, V47, P373, DOI 10.1002/hep.22140; Baranova A, 2007, EXPERT REV MOL DIAGN, V7, P195, DOI 10.1586/14737159.7.2.195; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Bell LN, 2010, HEPATOLOGY, V51, P111, DOI 10.1002/hep.23271; Emanuel E, 2008, HEPATOLOGY, V48, P2086, DOI 10.1002/hep.22622; Fierbinteanu-Braticevici C, 2011, J GASTROINTEST LIVER, V20, P153; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Jarrar MH, 2008, ALIMENT PHARM THER, V27, P412, DOI 10.1111/j.1365-2036.2007.03586.x; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Ochs MF, 2010, BRIEF BIOINFORM, V11, P30, DOI 10.1093/bib/bbp044; Panasiuk A, 2005, WORLD J GASTROENTERO, V11, P7661, DOI 10.3748/wjg.v11.i48.7661; Sanchez-Carbayo M, 2011, METHODS MOL BIOL, V785, P159, DOI 10.1007/978-1-61779-286-1_11; Singhal S, 2009, BIOMARKERS, V14, P347, DOI 10.1080/13547500903013664; Song LH, 2004, J MED VIROL, V73, P244, DOI 10.1002/jmv.20082; Stephen S, 2012, EXPERT REV GASTROENT, V6, P163, DOI [10.1586/EGH.11.97, 10.1586/egh.11.97]; Szuster-Ciesielska A, 2005, TOXICOLOGY, V212, P124, DOI 10.1016/j.tox.2005.04.009; Tokar Jeffrey L., 2002, Curr Treat Options Gastroenterol, V5, P425, DOI 10.1007/s11938-002-0030-1; Wilson B, 2010, DIS MARKERS, V28, P225, DOI [10.1155/2010/240248, 10.3233/DMA-2010-0705]; Yilmaz Y, 2009, WORLD J GASTROENTERO, V15, P4387, DOI 10.3748/wjg.15.4387; Younossi ZM, 2010, J PROTEOME RES, V9, P3218, DOI 10.1021/pr100069e	20	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56009	10.1371/journal.pone.0056009	http://dx.doi.org/10.1371/journal.pone.0056009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405244	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400189
J	Su, CY; Lin, HC; Cheng, HC; Yen, AMF; Chen, YH; Kao, S				Su, Chen-Yi; Lin, Herng-Ching; Cheng, Hsin-Chung; Yen, Amy Ming-Fang; Chen, Yi-Hua; Kao, Senyeong			Pregnancy Outcomes of Anti-Hypertensives for Women with Chronic Hypertension: A Population-Based Study	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; ANTIHYPERTENSIVE DRUGS; FETAL-GROWTH; PRETERM DELIVERY; SOUTH-AUSTRALIA; BIRTH-WEIGHT; AGE; ATENOLOL; RISK; MALFORMATIONS	Background: The impact of anti-hypertensive treatment on fetus was unclear, and hence, remains controversial. We set out in this study to estimate the prevalence of adverse pregnancy outcomes, including low birth weight, preterm delivery and small for gestational age amongst women with chronic hypertension, and to determine whether the use of antihypertensive drugs increases the risk of such adverse pregnancy outcomes. Methodology/Principal Findings: A total of 2,727 hypertension mothers and 8,181 matched controls were identified from the population-based cohort. These hypertension women were divided into seven sub-groups according to different types of prescribed anti-hypertensive drugs. Multivariable logistic regressions were conducted to estimate the risk of low birth weight, preterm birth and small for gestational age. Increased risk of low birth weight (OR = 2.29, 95% CI = 1.95-2.68), preterm birth (OR = 2.18, 95% CI = 1.89-2.52) and small for gestational age (OR = 1.62, 95% CI = 1.45-1.81) were all discernible within the hypertension group after adjusting for potential confounding factors. The increased ORs were found to differ with different types of anti-hypertensive drugs. Women who received vasodilators were associated with the highest risk of low birth weight (OR = 2.96, 95% CI = 2.06-4.26), preterm birth (OR = 2.92 95% CI = 2.06-4.15) and small for gestational age (OR = 2.12, 95% CI = 1.60-2.82). Conclusions/Significance: This finding is important for practitioners, because it indicates the need for caution while considering the administration of anti-hypertensive drugs to pregnant women. These observations require confirmation in further studies that can better adjust for the severity of the underlying HTN.	[Su, Chen-Yi; Kao, Senyeong] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Cheng, Hsin-Chung] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Cheng, Hsin-Chung] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan; [Yen, Amy Ming-Fang] Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei, Taiwan; [Chen, Yi-Hua] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Kao, Senyeong] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; National Defense Medical Center	Kao, S (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	kao@mail.ndmctsgh.edu.tw		Kao, Senyeong/0000-0002-0209-240X				Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; Afifi Y, 2003, CURR PHARM DESIGN, V9, P1745, DOI 10.2174/1381612033454487; Allen Victoria M, 2004, BMC Pregnancy Childbirth, V4, P17, DOI 10.1186/1471-2393-4-17; ANANTH CV, 1995, EPIDEMIOLOGY, V6, P391, DOI 10.1097/00001648-199507000-00011; [Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002863; Bell R, 2012, DIABETOLOGIA, V55, P936, DOI 10.1007/s00125-012-2455-y; BUTTERS L, 1990, BMJ-BRIT MED J, V301, P587, DOI 10.1136/bmj.301.6752.587; Catov JM, 2008, OBSTET GYNECOL, V112, P290, DOI 10.1097/AOG.0b013e31817f589b; Chang CJ, 2000, DIABETES RES CLIN PR, V50, pS49, DOI 10.1016/S0168-8227(00)00179-0; Chen YH, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.025; CONSTANTINE G, 1987, BRIT J OBSTET GYNAEC, V94, P1136, DOI 10.1111/j.1471-0528.1987.tb02312.x; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Easterling TR, 2001, OBSTET GYNECOL, V98, P427, DOI 10.1016/S0029-7844(01)01477-6; FENAKEL K, 1991, OBSTET GYNECOL, V77, P331; Haelterman E, 1997, AM J EPIDEMIOL, V145, P689, DOI 10.1093/aje/145.8.689; HANSSENS M, 1991, OBSTET GYNECOL, V78, P128; Heard AR, 2004, AUST NZ J OBSTET GYN, V44, P404, DOI 10.1111/j.1479-828X.2004.00267.x; Hsieh T T, 1991, J Formos Med Assoc, V90, P382; JANNET D, 1994, OBSTET GYNECOL, V84, P354; Lee HC, 2010, J AFFECT DISORDERS, V121, P100, DOI 10.1016/j.jad.2009.05.019; Lennestal R, 2009, EUR J CLIN PHARMACOL, V65, P615, DOI 10.1007/s00228-009-0620-0; Li DK, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5931; Lin HC, 2010, BJOG-INT J OBSTET GY, V117, P585, DOI 10.1111/j.1471-0528.2010.02504.x; Ludford I, 2012, AUST NZ J OBSTET GYN, V52, P235, DOI 10.1111/j.1479-828X.2012.01442.x; Lydakis C, 1999, AM J HYPERTENS, V12, P541, DOI 10.1016/S0895-7061(99)00031-X; Magee LA, 1999, BMJ-BRIT MED J, V318, P1332, DOI 10.1136/bmj.318.7194.1332; Olesen C, 2001, BRIT J CLIN PHARMACO, V51, P153, DOI 10.1111/j.1365-2125.2001.01310.x; Parazzini F, 1998, BRIT J OBSTET GYNAEC, V105, P718; PLOUIN PF, 1990, BRIT J OBSTET GYNAEC, V97, P134, DOI 10.1111/j.1471-0528.1990.tb01738.x; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; Ray Joel G, 2001, BMC Pregnancy Childbirth, V1, P6, DOI 10.1186/1471-2393-1-6; REDMAN CWG, 1976, LANCET, V2, P753; RUBIN PC, 1983, LANCET, V1, P431; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P960, DOI 10.1016/0002-9378(90)91297-P; Sibai BM, 2000, AM J OBSTET GYNECOL, V183, P1520, DOI 10.1067/mob.2000.107621; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; WEITZ C, 1987, INT J GYNECOL OBSTET, V25, P35, DOI 10.1016/0020-7292(87)90181-0	37	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53844	10.1371/journal.pone.0053844	http://dx.doi.org/10.1371/journal.pone.0053844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405075	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400019
J	Wang, L; Pawlak, EA; Johnson, PJ; Belknap, JK; Eades, S; Stack, S; Cousin, H; Black, SJ				Wang, Le; Pawlak, Erica A.; Johnson, Philip J.; Belknap, James K.; Eades, Susan; Stack, Sharon; Cousin, Helene; Black, Samuel J.			Impact of Laminitis on the Canonical Wnt Signaling Pathway in Basal Epithelial Cells of the Equine Digital Laminae	PLOS ONE			English	Article							BETA-CATENIN; GENE-EXPRESSION; VERSICAN PROMOTER; INTEGRIN; HORSES; HEMIDESMOSOMES; TRANSITION; VIMENTIN; CLEAVAGE; MODEL	The digital laminae is a two layer tissue that attaches the distal phalanx to the inner hoof wall, thus suspending the horse's axial skeleton in the hoof capsule. This tissue fails at the epidermal: dermal junction in laminitic horses, causing crippling disease. Basal epithelial cells line the laminar epidermal: dermal junction, undergo physiological change in laminitic horses, and lose versican gene expression. Versican gene expression is purportedly under control of the canonical Wnt signaling pathway and is a trigger for mesenchymal-to-epithelial transition; thus, its repression in laminar epithelial cells of laminitic horses may be associated with suppression of the canonical Wnt signaling pathway and loss of the epithelial cell phenotype. In support of the former contention, we show, using laminae from healthy horses and horses with carbohydrate overload-induced laminitis, quantitative real-time polymerase chain reaction, Western blotting after sodium dodecylsulfate polyacrylamide gel electrophoresis, and immunofluorescent tissue staining, that positive and negative regulatory components of the canonical Wnt signaling pathway are expressed in laminar basal epithelial cells of healthy horses. Furthermore, expression of positive regulators is suppressed and negative regulators elevated in laminae of laminitic compared to healthy horses. We also show that versican gene expression in the epithelial cells correlates positively with that of beta-catenin and T-cell Factor 4, consistent with regulation by the canonical Wnt signaling pathway. In addition, gene and protein expression of beta-catenin correlates positively with that of integrin beta 4 and both are strongly suppressed in laminar basal epithelial cells of laminitic horses, which remain E-cadherin(+)/vimentin(-), excluding mesenchymal transition as contributing to loss of the adherens junction and hemidesmosome components. We propose that suppression of the canonical Wnt signaling pathway, and accompanying reduced expression of beta catenin and integrin beta 4 in laminar basal epithelial cells reduces cell: cell and cell: basement membrane attachment, thus, destabilizing the laminar epidermal: dermal junction.	[Wang, Le; Pawlak, Erica A.; Cousin, Helene; Black, Samuel J.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Johnson, Philip J.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Belknap, James K.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Eades, Susan] Louisiana State Sch Vet Med, Baton Rouge, LA USA; [Stack, Sharon] Univ Notre Dame, Notre Dame, IN 46556 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Missouri System; University of Missouri Columbia; Ohio State University; University of Notre Dame	Black, SJ (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	sblack@vasci.umass.edu	Black, Samuel/L-8429-2016; BELKNAP, JAMES K/A-9877-2013	BELKNAP, JAMES K/0000-0003-2682-4991	Morris Animal Foundation [D08EQ-054]; United States Department of Agriculture (USDA) National Research Initiative Cooperative State Research, Education, and Extension Service (CSREES) [2007-35204-18313]; USDA CSREES [MAS00907]; Lotta M. Crabtree Fellowship in Agriculture; National Institutes of Health [DE016289]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016289] Funding Source: NIH RePORTER	Morris Animal Foundation; United States Department of Agriculture (USDA) National Research Initiative Cooperative State Research, Education, and Extension Service (CSREES); USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Lotta M. Crabtree Fellowship in Agriculture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study was supported by D08EQ-054 from the Morris Animal Foundation (http://www.morrisanimalfoundation.org/), by 2007-35204-18313 from United States Department of Agriculture (USDA) National Research Initiative Cooperative State Research, Education, and Extension Service (CSREES) and by MAS00907 from USDA CSREES to SJB. EAP was supported by a Lotta M. Crabtree Fellowship in Agriculture. HC was supported by a grant from National Institutes of Health (DE016289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Coyne MJ, 2009, VET IMMUNOL IMMUNOP, V129, P231, DOI 10.1016/j.vetimm.2008.11.022; Crampton SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007841; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Eades SC, 2010, VET CLIN N AM-EQUINE, V26, P51, DOI 10.1016/j.cveq.2010.01.001; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Faleiros RR, 2011, J VET INTERN MED, V25, P107, DOI 10.1111/j.1939-1676.2010.0650.x; FERRIER AF, 1992, J CELL BIOCHEM, V50, P245, DOI 10.1002/jcb.240500305; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; French KR, 2004, EQUINE VET J, V36, P299, DOI 10.2746/0425164044877206; French KR, 2004, EQUINE VET J, V36, P242, DOI 10.2746/0425164044877134; French KR, 2004, EQUINE VET J, V36, P230, DOI 10.2746/0425164044877125; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; GARNER HE, 1975, AM J VET RES, V36, P441; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hatfield CL, 2001, AM J VET RES, V62, P1387, DOI 10.2460/ajvr.2001.62.1387; Heymering HW, 2010, VET CLIN N AM-EQUINE, V26, P1, DOI 10.1016/j.cveq.2009.12.004; Johnson PJ, 2000, EQUINE VET J, V32, P462, DOI 10.2746/042516400777584695; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Leise BS, 2011, EQUINE VET J, V43, P54, DOI 10.1111/j.2042-3306.2010.00122.x; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nourian AR, 2009, EQUINE VET J, V41, P671, DOI 10.2746/042516409X407648; OBEL NJ, 1948, ACTA PHARMACOL TOX, V4, P71; Oh DY, 2010, SCIENCE, V329, P397, DOI 10.1126/science.1193404; Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048; Pollitt CC, 2010, VET CLIN N AM-EQUINE, V26, P29, DOI 10.1016/j.cveq.2010.01.005; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Rahmani M, 2012, METHODS MOL BIOL, V836, P35, DOI 10.1007/978-1-61779-498-8_3; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2007, J CELL PHYSIOL, V211, P213, DOI 10.1002/jcp.20921; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Wang L, 2012, AM J VET RES, V73, P1047, DOI 10.2460/ajvr.73.7.1047; WYCKOFF M, 1977, ANAL BIOCHEM, V78, P459, DOI 10.1016/0003-2697(77)90107-5; Xu HX, 2010, PHOTODERMATOL PHOTO, V26, P198, DOI 10.1111/j.1600-0781.2010.00522.x	46	12	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56025	10.1371/journal.pone.0056025	http://dx.doi.org/10.1371/journal.pone.0056025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405249	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400194
J	Rosenthal, CR; Ng, TWC; Kennard, C				Rosenthal, Clive R.; Ng, Tammy W. C.; Kennard, Christopher			Generalisation of New Sequence Knowledge Depends on Response Modality	PLOS ONE			English	Article							INTERMANUAL TRANSFER; TIME-COURSE; SRT TASKS; IMPLICIT; EXPLICIT; STIMULUS; ATTENTION; DISSOCIATION; EXPRESSION; REPRESENTATIONS	New visuomotor skills can guide behaviour in novel situations. Prior studies indicate that learning a visuospatial sequence via responses based on manual key presses leads to effector- and response-independent knowledge. Little is known, however, about the extent to which new sequence knowledge can generalise, and, thereby guide behaviour, outside of the manual response modality. Here, we examined whether learning a visuospatial sequence either via manual (key presses, without eye movements), oculomotor (obligatory eye movements), or perceptual (covert reorienting of visuospatial attention) responses supported generalisation to direct and indirect tests administered either in the same (baseline conditions) or a novel response modality (transfer conditions) with respect to initial study. Direct tests measured the use of conscious knowledge about the studied sequence, whereas the indirect tests did not ostensibly draw on the study phase and measured response priming. Oculomotor learning supported the use of conscious knowledge on the manual direct tests, whereas manual learning supported generalisation to the oculomotor direct tests but did not support the conscious use of knowledge. Sequence knowledge acquired via perceptual responses did not generalise onto any of the manual tests. Manual, oculomotor, and perceptual sequence learning all supported generalisation in the baseline conditions. Notably, the manual baseline condition and the manual to oculomotor transfer condition differed in the magnitude of general skill acquired during the study phase; however, general skill did not predict performance on the post-study tests. The results demonstrated that generalisation was only affected by the responses used to initially code the visuospatial sequence when new knowledge was applied to a novel response modality. We interpret these results in terms of response-effect distinctiveness, the availability of integrated effector- and motor-plan based information, and discuss their implications for neurocognitive accounts of sequence learning.	[Rosenthal, Clive R.; Kennard, Christopher] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Ng, Tammy W. C.] Univ Coll London Hosp NHS Fdn Trust, Univ Coll London, Dept Anaesthet, London, England	University of Oxford; University College London Hospitals NHS Foundation Trust; University of London; University College London	Rosenthal, CR (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	clive.rosenthal@clneuro.ox.ac.uk			Wellcome Trust [073735]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford; NIHR London Biomedical Research Centre based at University College London Hospitals NHS Foundation Trust; University College London	Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford; NIHR London Biomedical Research Centre based at University College London Hospitals NHS Foundation Trust; University College London(General Electric)	The research was supported by the Wellcome Trust (C.K.; C.R.R) (073735), National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford (C.K.; C.R.R), and NIHR London Biomedical Research Centre and based at University College London Hospitals NHS Foundation Trust and University College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Ashe J, 2006, CURR OPIN NEUROBIOL, V16, P213, DOI 10.1016/j.conb.2006.03.008; Baars BJ, 1998, COGNITIVE THEORY CON; Bapi RS, 2000, EXP BRAIN RES, V132, P149, DOI 10.1007/s002219900332; Bischoff-Grethe A, 2004, J COGNITIVE NEUROSCI, V16, P127, DOI 10.1162/089892904322755610; Buchner A, 2001, PSYCHOL RES-PSYCH FO, V65, P71, DOI 10.1007/s004260000052; Clegg BA, 2005, Q J EXP PSYCHOL-A, V58, P1087, DOI 10.1080/02724980443000485; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; Curran T, 1997, PSYCHOL RES-PSYCH FO, V60, P24, DOI 10.1007/BF00419678; Deroost N, 2006, PSYCHOL RES-PSYCH FO, V70, P88, DOI 10.1007/s00426-004-0196-3; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Destrebecqz A., 2003, ADV CONSCIOUSNESS RE, V48, P181, DOI [10.1075/aicr.48.11des, DOI 10.1075/AICR.48.11DES]; Frensch PA, 1999, J EXP PSYCHOL LEARN, V25, P260, DOI 10.1037/0278-7393.25.1.260; Froehlich AL, 2004, J EXP PSYCHOL GEN, V133, P31, DOI 10.1037/0096-3445.133.1.31; Grafton S T, 1994, Hum Brain Mapp, V1, P221, DOI 10.1002/hbm.460010307; Grafton ST, 1998, J NEUROSCI, V18, P9420; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; Hazeltine E, 2002, ATTENTION PERFORM, V19, P673; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hoffmann J, 2003, PSYCHOL RES-PSYCH FO, V67, P160, DOI 10.1007/s00426-002-0117-2; HOLM S, 1979, SCAND J STAT, V6, P65; Ikegami T, 2010, J NEUROSCI, V30, P4515, DOI 10.1523/JNEUROSCI.3066-09.2010; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Japikse KC, 2003, EXP BRAIN RES, V148, P38, DOI 10.1007/s00221-002-1264-9; JORDAN MI, 1995, J MOTOR BEHAV, V27, P179, DOI 10.1080/00222895.1995.9941709; Sarvestani IK, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00013; KEELE SW, 1990, ATTENTION PERFORM, V8, P77; KEELE SW, 1995, J MOTOR BEHAV, V27, P17, DOI 10.1080/00222895.1995.9941696; Keele SW, 2003, PSYCHOL REV, V110, P316, DOI 10.1037/0033-295X.110.2.316; Keele SW, 1998, MOTOR BEHAVIOR AND HUMAN SKILL, P3; Kinder A, 2008, Q J EXP PSYCHOL, V61, P203, DOI 10.1080/17470210701557555; Knee R, 2007, MEM COGNITION, V35, P326, DOI 10.3758/BF03193453; Koch I, 2000, PSYCHOL RES-PSYCH FO, V63, P22, DOI 10.1007/PL00008165; Koch I, 2000, J EXP PSYCHOL LEARN, V26, P863, DOI 10.1037//0278-7393.26.4.863; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Lai Q, 2002, J MOTOR BEHAV, V34, P299, DOI 10.1080/00222890209601948; Lawrence BM, 2001, MEMORY, V9, P433, DOI 10.1080/09658210143000047; Lee D, 2000, COGNITIVE BRAIN RES, V9, P35, DOI 10.1016/S0926-6410(99)00040-3; Marcus DJ, 2006, MEM COGNITION, V34, P420, DOI 10.3758/BF03193419; Mayr U, 1996, J EXP PSYCHOL LEARN, V22, P350, DOI 10.1037/0278-7393.22.2.350; Nattkemper D, 1997, PSYCHOL RES-PSYCH FO, V60, P98, DOI 10.1007/BF00419683; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Park JH, 2005, Q J EXP PSYCHOL-A, V58, P387, DOI 10.1080/02724980343000918; Park JH, 2003, J MOTOR BEHAV, V35, P33, DOI 10.1080/00222890309602119; Park JH, 2002, J MOTOR BEHAV, V34, P253, DOI 10.1080/00222890209601944; Perez MA, 2007, CURR BIOL, V17, P1896, DOI 10.1016/j.cub.2007.09.058; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; PERRUCHET P, 1992, J EXP PSYCHOL LEARN, V18, P785, DOI 10.1037/0278-7393.18.4.785; Porta IB, 1593, REFRACTIONE OPTICS P; Posner MI, 1992, NEUROPSYCHOLOGY CONS, P91, DOI DOI 10.1016/B978-0-12-498045-7.50010-4; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Remillard G, 2003, J EXP PSYCHOL LEARN, V29, P581, DOI 10.1037/0278-7393.29.4.581; Remillard G, 2009, J EXP PSYCHOL LEARN, V35, P528, DOI 10.1037/a0014646; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; ROSENBAUM DA, 1983, J EXP PSYCHOL HUMAN, V9, P86, DOI 10.1037/0096-1523.9.1.86; Rosenthal CR, 2009, J NEUROSCI, V29, P15115, DOI 10.1523/JNEUROSCI.2603-09.2009; Russeler J, 2000, ACTA PSYCHOL, V104, P45, DOI 10.1016/S0001-6918(99)00053-0; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schvaneveldt RW, 1998, PSYCHOL RES-PSYCH FO, V61, P175, DOI 10.1007/s004260050023; Seidler RD, 2005, EXP BRAIN RES, V165, P114, DOI 10.1007/s00221-005-2284-z; Shanks DR, 2006, NEUROPSYCHOPHARMACOL, V31, P1768, DOI 10.1038/sj.npp.1300935; Shanks DR, 1999, J EXP PSYCHOL LEARN, V25, P1435, DOI 10.1037/0278-7393.25.6.1435; Shanks DR, 2005, PSYCHOL RES-PSYCH FO, V69, P369, DOI 10.1007/s00426-004-0211-8; Shanks DR, 2002, PSYCHON B REV, V9, P362, DOI 10.3758/BF03196294; Shanks DR, 2002, PSYCHOL RES-PSYCH FO, V66, P99, DOI 10.1007/s00426-001-0081-2; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Shin JC, 2002, J EXP PSYCHOL LEARN, V28, P445, DOI 10.1037//0278-7393.28.3.445; Song S, 2008, EXP BRAIN RES, V189, P145, DOI 10.1007/s00221-008-1411-z; STADLER MA, 1989, J EXP PSYCHOL LEARN, V15, P1061, DOI 10.1037/0278-7393.15.6.1061; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Stocker C, 2003, Q J EXP PSYCHOL-A, V56, P684, DOI 10.1080/02724980244000585; Tubau E, 2007, J EXP PSYCHOL GEN, V136, P43, DOI 10.1037/0096-3445.136.1.43; Verwey WB, 2005, PSYCHOL RES-PSYCH FO, V69, P242, DOI 10.1007/s00426-004-0181-x; VERWEY WB, 1994, ACTA PSYCHOL, V85, P245, DOI 10.1016/0001-6918(94)90038-8; Whitacre CA, 2002, RES Q EXERCISE SPORT, V73, P47, DOI 10.1080/02701367.2002.10608991; Wilkinson L, 2007, BRAIN RES, V1137, P117, DOI 10.1016/j.brainres.2006.12.051; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Willingham DB, 1999, MEM COGNITION, V27, P561, DOI 10.3758/BF03211549; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Willingham DB, 1999, CURR DIR PSYCHOL SCI, V8, P178, DOI 10.1111/1467-8721.00042; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Zirngibl C, 2002, EXP PSYCHOL, V49, P153, DOI 10.1027//1618-3169.49.2.153	88	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53990	10.1371/journal.pone.0053990	http://dx.doi.org/10.1371/journal.pone.0053990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086NV	23393553	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800007
J	Guidi, V; Lehner, A; Luthy, P; Tonolla, M				Guidi, Valeria; Lehner, Angelika; Luethy, Peter; Tonolla, Mauro			Dynamics of Bacillus thuringiensis var. israelensis and Lysinibacillus sphaericus Spores in Urban Catch Basins after Simultaneous Application against Mosquito Larvae	PLOS ONE			English	Article							IN-FIELD POPULATIONS; CULEX-QUINQUEFASCIATUS; SUBSP ISRAELENSIS; HIGH-LEVEL; POLLUTED WATER; SP NOV.; PERSISTENCE; RESISTANCE; STRAINS; TOXIN	Bacillus thuringiensis var. israelensis (Bti) and Lysinibacillus sphaericus (Lsph) are extensively used in mosquito control programs. These biocides are the active ingredients of a commercial larvicide. Quantitative data on the fate of both Bti and Lsph applied together for the control of mosquitoes in urban drainage structures such as catch basins are lacking. We evaluated the dynamics and persistence of Bti and Lsph spores released through their concomitant application in urban catch basins in southern Switzerland. Detection and quantification of spores over time in water and sludge samples from catch basins were carried out using quantitative real-time PCR targeting both cry4A and cry4B toxin genes for Bti and the binA gene for Lsph. After treatment, Bti and Lsph spores attained concentrations of 3.76 (+/- 0.08) and 4.13 (+/- 0.09) log ml(-1) in water, then decreased progressively over time, reaching baseline values. For both Bti and Lsph, spore levels in the order of 10(5) g(-1) were observed in the bottom sludge two days after the treatment and remained constant for the whole test period (275 days). Indigenous Lsph strains were isolated from previously untreated catch basins. A selection of those was genotyped using pulsed field gel electrophoresis of SmaI-digested chromosomal DNA, revealing that a subset of isolates were members of the clonal population of strain 2362. No safety issues related to the use of this biopesticide in the environment have been observed during this study, because no significant increase in the number of spores was seen during the long observation period. The isolation of native Lysinibacillus sphaericus strains belonging to the same clonal population as strain 2362 from catch basins never treated with Lsph-based products indicates that the use of a combination of Bti and Lsph for the control of mosquitoes does not introduce non-indigenous microorganisms in this area.	[Guidi, Valeria; Tonolla, Mauro] Univ Geneva, Microbiol Unit, Microbial Ecol Grp, Dept Plant Biol, Geneva, Switzerland; [Guidi, Valeria; Tonolla, Mauro] Inst Microbiol, Bellinzona, Switzerland; [Lehner, Angelika] Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Zurich, Switzerland; [Luethy, Peter] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tonolla, M (corresponding author), Univ Geneva, Microbiol Unit, Microbial Ecol Grp, Dept Plant Biol, Geneva, Switzerland.	mauro.tonolla@ti.ch	Lehner, Angelika/B-2363-2018	Lehner, Angelika/0000-0003-1863-5090; Tonolla, Mauro/0000-0002-8861-7763; Guidi, Valeria/0000-0001-5553-3136				Ahmed I, 2007, INT J SYST EVOL MICR, V57, P1117, DOI 10.1099/ijs.0.63867-0; Ali Arshad, 2000, Medical Entomology and Zoology, V51, P257; Ammons D, 2002, J INVERTEBR PATHOL, V79, P203, DOI 10.1016/S0022-2011(02)00018-6; Anderson JF, 2011, J AM MOSQUITO CONTR, V27, P45, DOI 10.2987/10-6079.1; Benagli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016424; BenDov E, 1997, APPL ENVIRON MICROB, V63, P4883, DOI 10.1128/AEM.63.12.4883-4890.1997; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; DAVIDSON EW, 1984, APPL ENVIRON MICROB, V47, P125, DOI 10.1128/AEM.47.1.125-129.1984; De Barjac H., 1990, Bacterial control of mosquitoes & black flies: biochemistry, genetics & applications of Bacillus thuringiensis israelensis and Bacillus sphaericus., P228; De Respinis S, 2006, LETT APPL MICROBIOL, V43, P495, DOI 10.1111/j.1472-765x.2006.01999.x; Delecluse A, 1995, BACILLUS THURINGIENS, P125; Dritz DA, 2011, J AM MOSQUITO CONTR, V27, P398, DOI 10.2987/11-6161.1; Ge Y, 2011, APPL ENVIRON MICROB, V77, P5553, DOI 10.1128/AEM.00207-11; Georghiou GP, 1997, APPL ENVIRON MICROB, V63, P1095, DOI 10.1128/AEM.63.3.1095-1101.1997; Guidi V, 2010, J APPL MICROBIOL, V109, P1209, DOI 10.1111/j.1365-2672.2010.04741.x; Guidi V, 2011, APPL ENVIRON MICROB, V77, P3663, DOI 10.1128/AEM.00132-11; Hajaij M, 2005, MICROB ECOL, V50, P475, DOI 10.1007/s00248-005-0247-3; Jahnz U, 1996, FEMS MICROBIOL ECOL, V20, P91; Joly P, 2006, APPL ENVIRON MICROB, V72, P2801, DOI 10.1128/AEM.72.4.2801-2808.2006; Jones GW, 2008, ENVIRON MICROBIOL, V10, P2418, DOI 10.1111/j.1462-2920.2008.01667.x; Jones GW, 2007, FASEB J, V21, P4112, DOI 10.1096/fj.07-8913com; KRYCH VK, 1980, INT J SYST BACTERIOL, V30, P476, DOI 10.1099/00207713-30-2-476; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lee CS, 2010, INT J SYST EVOL MICR, V60, P281, DOI 10.1099/ijs.0.013367-0; Logan NA., 2009, BERGEYS MANUAL SYSTE, P21; Mulla MS, 2003, J AM MOSQUITO CONTR, V19, P39; Mulla MS, 1999, J VECTOR ECOL, V24, P99; NICOLAS L, 1987, APPL MICROBIOL BIOT, V25, P341, DOI 10.1007/BF00252544; PEDERSEN JC, 1995, CAN J MICROBIOL, V41, P118, DOI 10.1139/m95-016; Poopathi S, 2010, J PHYSL PATHOPHYSIOL, V1, P22, DOI DOI 10.5897/JPAP; Priest FG, 2000, APPLIED MICROBIAL SYSTEMATICS, P165; PRIEST FG, 1992, J APPL BACTERIOL, V72, P357, DOI 10.1111/j.1365-2672.1992.tb01847.x; RAO DR, 1995, J AM MOSQUITO CONTR, V11, P1; SILAPANUNTAKUL S, 1983, J INVERTEBR PATHOL, V42, P387, DOI 10.1016/0022-2011(83)90179-9; SILVAFILHA MH, 1995, J ECON ENTOMOL, V88, P525, DOI 10.1093/jee/88.3.525; Skovmand O, 2000, J INVERTEBR PATHOL, V75, P243, DOI 10.1006/jipa.2000.4935; Smith RA, 1998, J INVERTEBR PATHOL, V71, P263, DOI 10.1006/jipa.1997.4738; Su TY, 2004, J AM MOSQUITO CONTR, V20, P405; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Cuyk S, 2011, APPL ENVIRON MICROB, V77, P7954, DOI 10.1128/AEM.05207-11; Vettori C, 2003, SOIL BIOL BIOCHEM, V35, P1635, DOI 10.1016/j.soilbio.2003.08.009; Wirth MC, 2004, J MED ENTOMOL, V41, P935, DOI 10.1603/0022-2585-41.5.935; YOUSTEN AA, 1969, J BACTERIOL, V100, P1229, DOI 10.1128/JB.100.3.1229-1236.1969; Yuan ZM, 2000, BIOCONTROL SCI TECHN, V10, P41, DOI 10.1080/09583150029378; Zahner V, 1998, SYST APPL MICROBIOL, V21, P162, DOI 10.1016/S0723-2020(98)80020-9; ZAHNER V, 1995, MEM I OSWALDO CRUZ, V90, P65, DOI [10.1590/S0074-02761995000100015, 10.1590/S0074-02761995000600021]	51	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55658	10.1371/journal.pone.0055658	http://dx.doi.org/10.1371/journal.pone.0055658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390547	Green Published, gold, Green Accepted			2022-12-27	WOS:000314691100063
J	Lucchetti, C; Caligiuri, I; Toffoli, G; Giordano, A; Rizzolio, F				Lucchetti, Chiara; Caligiuri, Isabella; Toffoli, Giuseppe; Giordano, Antonio; Rizzolio, Flavio			The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor alpha in Breast Cancer	PLOS ONE			English	Article							PHOSPHORYLATION SITES; HINGE REGION; DISEASE-FREE; ER-ALPHA; ACTIVATION; TRANSFORMATION; ISOMERIZATION; INACTIVATION; SURVIVAL; OUTCOMES	In hormone receptor-positive breast cancers, most tumors in the early stages of development depend on the activity of the estrogen receptor and its ligand, estradiol. Anti-estrogens, such as tamoxifen, have been used as the first line of therapy for over three decades due to the fact that they elicit cell cycle arrest. Unfortunately, after an initial period, most cells become resistant to hormonal therapy. Peptidylprolyl isomerase 1 (Pin1), a protein overexpressed in many tumor types including breast, has been demonstrated to modulate ERalpha activity and is involved in resistance to hormonal therapy. Here we show a new mechanism through which CDK2 drives an ERalpha-Pin1 interaction under hormone- and growth factor-free conditions. The PI3K/AKT pathway is necessary to activate CDK2, which phosphorylates ERalphaSer294, and mediates the binding between Pin1 and ERalpha. Site-directed mutagenesis demonstrated that ERalphaSer294 is essential for Pin1-ERalpha interaction and modulates ERalpha phosphorylation on Ser118 and Ser167, dimerization and activity. These results open up new drug treatment opportunities for breast cancer patients who are resistant to anti-estrogen therapy.	[Lucchetti, Chiara; Caligiuri, Isabella; Giordano, Antonio; Rizzolio, Flavio] Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Caligiuri, Isabella; Giordano, Antonio] Human Hlth Fdn, Terni, PG, Italy; [Caligiuri, Isabella; Giordano, Antonio] Human Hlth Fdn, Spoleto, PG, Italy; [Caligiuri, Isabella; Giordano, Antonio] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, SI, Italy; [Toffoli, Giuseppe; Rizzolio, Flavio] Natl Canc Inst, Div Expt & Clin Pharmacol, Dept Mol Biol & Translat Res, Aviano, PN, Italy; [Toffoli, Giuseppe; Rizzolio, Flavio] Ctr Mol Biomed, Aviano, PN, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena	Giordano, A (corresponding author), Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Coll Sci & Technol, Philadelphia, PA 19122 USA.	giordano@temple.edu; rizzolio@temple.edu	Toffoli, Giuseppe/F-6642-2018; Giordano, Antonio/F-1927-2010; Giordano, Antonio/AAU-1201-2020; Rizzolio, Flavio/K-2690-2018; Caligiuri, Isabella/J-9956-2016	Toffoli, Giuseppe/0000-0002-5323-4762; Giordano, Antonio/0000-0002-5959-016X; Giordano, Antonio/0000-0002-5959-016X; Rizzolio, Flavio/0000-0002-3400-4363; Caligiuri, Isabella/0000-0002-4355-5597	Associazione Italiana per la Ricerca sul Cancro (AIRC); Special Program Molecular Clinical Oncology, 5x1000 [12214]; European Research Council, Programme "Ideas'' [269051]; Italian Ministry of Education MIUR (FIRB) [RBAP11ETKA]; Sbarro Health Research Organization; Istituto Tumori Toscano ITT; Human Health Foundation; Commonwealth of Pennsylvania	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology, 5x1000; European Research Council, Programme "Ideas''; Italian Ministry of Education MIUR (FIRB)(Ministry of Education, Universities and Research (MIUR)); Sbarro Health Research Organization; Istituto Tumori Toscano ITT; Human Health Foundation; Commonwealth of Pennsylvania	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) (A.G.), Special Program Molecular Clinical Oncology, 5x1000, (number 12214) (G.T.), European Research Council, Programme "Ideas'', proposal number 269051 (F.R., G.T.), Italian Ministry of Education MIUR (FIRB prot. RBAP11ETKA (G.T.)), Sbarro Health Research Organization (A.G.), Istituto Tumori Toscano ITT (A.G.), Human Health Foundation (A.G.) and Commonwealth of Pennsylvania (A.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; ALLEGRA JC, 1979, CANCER TREAT REP, V63, P1271; Bao L, 2004, PREVALENT OVEREXPRES; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Burns KA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187773; Caligiuri I, 2012, J CELL PHYSIOL, V227, P2988, DOI 10.1002/jcp.24031; Chen D, 2002, PHOSPHORYLATION HUMA; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Henry MK, 2004, EXP CELL RES, V299, P257, DOI 10.1016/j.yexcr.2004.06.003; Jiang J, 2007, CLIN CANCER RES, V13, P5769, DOI 10.1158/1078-0432.CCR-07-0822; Khanal P, 2010, MOL CANCER THER, V9, P606, DOI 10.1158/1535-7163.MCT-09-0560; Kumar Raj, 2011, J Amino Acids, V2011, P812540, DOI 10.4061/2011/812540; Kumar R, 2012, ENDOCR REV, V33, P271, DOI 10.1210/er.2011-1033; Kuntz MA, 1997, J BIOL CHEM, V272, P27949, DOI 10.1074/jbc.272.44.27949; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lee KY, 2011, MOL CELLS, V32, P107, DOI 10.1007/s10059-011-0074-y; Liao Y, 2009, ONCOGENE, V28, P2436, DOI 10.1038/onc.2009.98; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Napoli M, 2011, ONCOTARGET, V2, P654; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Rizzolio F, 2012, CELL DEATH DIFFER, V19, P1152, DOI 10.1038/cdd.2011.202; Rizzolio F, 2009, J MED GENET, V46, P585, DOI 10.1136/jmg.2007.056093; Rizzolio F, 2012, J CELL PHYSL; Roberti A, 2011, CELL CYCLE, V10, P127, DOI 10.4161/cc.10.1.14446; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Skliris GP, 2010, ENDOCR-RELAT CANCER, V17, P589, DOI 10.1677/ERC-10-0030; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Takeda A, 2004, PANCREAS, V28, P353, DOI 10.1097/00006676-200404000-00026; Trowbridge JM, 1997, P NATL ACAD SCI USA, V94, P10132, DOI 10.1073/pnas.94.19.10132; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Vilgelm A, 2006, CANCER RES, V66, P3375, DOI 10.1158/0008-5472.CAN-05-4019; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wierod L, 2007, CELL PROLIFERAT, V40, P475, DOI 10.1111/j.1365-2184.2007.00451.x; Williams CC, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-36; WILLIAMS MR, 1987, BRIT J CANCER, V55, P67, DOI 10.1038/bjc.1987.14; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yamashita H, 2008, ENDOCR-RELAT CANCER, V15, P755, DOI 10.1677/ERC-08-0078; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	51	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55355	10.1371/journal.pone.0055355	http://dx.doi.org/10.1371/journal.pone.0055355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390529	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100045
J	Esse, R; Rocha, MS; Barroso, M; Florindo, C; Teerlink, T; Kok, RM; Smulders, YM; Rivera, I; Leandro, P; Koolwijk, P; Castro, R; Blom, HJ; de Almeida, IT				Esse, Ruben; Rocha, Monica S.; Barroso, Madalena; Florindo, Cristina; Teerlink, Tom; Kok, Robert M.; Smulders, Yvo M.; Rivera, Isabel; Leandro, Paula; Koolwijk, Pieter; Castro, Rita; Blom, Henk J.; de Almeida, Isabel Tavares			Protein Arginine Methylation Is More Prone to Inhibition by S-Adenosylhomocysteine than DNA Methylation in Vascular Endothelial Cells	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; HOMOCYSTEINE; PLASMA; ADENOSYLMETHIONINE; METABOLISM; SYNTHASE; HYPOMETHYLATION; IDENTIFICATION; MECHANISM; INCREASE	Methyltransferases use S-adenosylmethionine (AdoMet) as methyl group donor, forming S-adenosylhomocysteine (AdoHcy) and methylated substrates, including DNA and proteins. AdoHcy inhibits most methyltransferases. Accumulation of intracellular AdoHcy secondary to Hcy elevation elicits global DNA hypomethylation. We aimed at determining the extent at which protein arginine methylation status is affected by accumulation of intracellular AdoHcy. AdoHcy accumulation in human umbilical vein endothelial cells was induced by inhibition of AdoHcy hydrolase by adenosine-2,3-dialdehyde (AdOx). As a measure of protein arginine methylation status, the levels of monomethylarginine (MMA) and asymmetric and symmetric dimethylated arginine residues (ADMA and SDMA, respectively) in cell protein hydrolysates were measured by HPLC. A 10% decrease was observed at a 2.5-fold increase of intracellular AdoHcy. Western blotting revealed that the translational levels of the main enzymes catalyzing protein arginine methylation, protein arginine methyl transferases (PRMTs) 1 and 5, were not affected by AdoHcy accumulation. Global DNA methylation status was evaluated by measuring 5-methylcytosine and total cytosine concentrations in DNA hydrolysates by LC-MS/MS. DNA methylation decreased by 10% only when intracellular AdoHcy concentration accumulated to 6-fold of its basal value. In conclusion, our results indicate that protein arginine methylation is more sensitive to AdoHcy accumulation than DNA methylation, pinpointing a possible new player in methylation-related pathology.	[Esse, Ruben; Rocha, Monica S.; Barroso, Madalena; Florindo, Cristina; Rivera, Isabel; Leandro, Paula; Castro, Rita; de Almeida, Isabel Tavares] Univ Lisbon, Fac Pharm, Inst Med & Pharmaceut Sci IMed UL, P-1699 Lisbon, Portugal; [Esse, Ruben; Rocha, Monica S.; Teerlink, Tom; Kok, Robert M.; Blom, Henk J.] Vrije Univ Amsterdam, Med Ctr, Metab Unit, Dept Clin Chem, Amsterdam, Netherlands; [Teerlink, Tom; Smulders, Yvo M.; Koolwijk, Pieter; Blom, Henk J.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Amsterdam, Netherlands; [Smulders, Yvo M.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Rivera, Isabel; Leandro, Paula; Castro, Rita; de Almeida, Isabel Tavares] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal; [Koolwijk, Pieter] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Amsterdam, Netherlands	Universidade de Lisboa; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Universidade de Lisboa; Vrije Universiteit Amsterdam	de Almeida, IT (corresponding author), Univ Lisbon, Fac Pharm, Inst Med & Pharmaceut Sci IMed UL, P-1699 Lisbon, Portugal.	italmeida@ff.ul.pt	Rivera, Isabel/A-5863-2014; Leandro, Paula/A-8323-2014; Rivera, Isabel/AAS-3204-2021; Smulders, YM/AAG-7506-2021; de Almeida, Isabel Tavares/F-8319-2014; Castro, Rita/J-7672-2019; Barroso, Madalena/AAT-9916-2020; iMed.ULisboa, MetGen/B-5293-2014	Rivera, Isabel/0000-0001-6892-729X; Leandro, Paula/0000-0002-2946-9342; Rivera, Isabel/0000-0001-6892-729X; Castro, Rita/0000-0002-4585-0741; Barroso, Madalena/0000-0002-1600-890X; , Ruben/0000-0002-8381-0628; Blom, Henk/0000-0001-5202-9241; Florindo, Cristina/0000-0002-0664-5411; Tavares de Almeida, Isabel/0000-0002-4024-8305	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/SAU-ORG/112683/2009, SFRH/BD/48585/2008, SFRH/BD/41970/2007]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This work was partially supported by Fundacao para a Ciencia e a Tecnologia (FCT), Portugal (grants PTDC/SAU-ORG/112683/2009 to RC, SFRH/BD/48585/2008 to RE, SFRH/BD/41970/2007 to MSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Blom HJ, 2011, J INHERIT METAB DIS, V34, P75, DOI 10.1007/s10545-010-9177-4; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Boger RH, 2000, ARTERIOSCL THROM VAS, V20, P1557, DOI 10.1161/01.ATV.20.6.1557; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Castro R, 2005, J MOL MED, V83, P831, DOI 10.1007/s00109-005-0679-8; Choumenkovitch SF, 2002, J NUTR, V132, P2157, DOI 10.1093/jn/132.8.2157; Clarke R, 2011, J INHERIT METAB DIS, V34, P83, DOI 10.1007/s10545-010-9235-y; Clarke S., 2011, HOMOCYSTEINE HLTH DI, P63; de Jong S, 2006, ANAL BIOCHEM, V353, P287, DOI 10.1016/j.ab.2006.03.010; Fickling SA, 1993, ENDOTHELIUM, V1, P137; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Flynn J, 1998, BIOCHEMISTRY-US, V37, P15162, DOI 10.1021/bi9810609; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; GHOSH SK, 1988, J BIOL CHEM, V263, P19024; Green TJ, 2010, BRIT J NUTR, V103, P1629, DOI 10.1017/S0007114509993552; Grillo MA, 2008, AMINO ACIDS, V34, P187, DOI 10.1007/s00726-007-0500-9; Handy DE, 2011, CIRCULATION, V123, P2145, DOI 10.1161/CIRCULATIONAHA.110.956839; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; Kielstein JT, 2008, KIDNEY BLOOD PRESS R, V31, P259, DOI 10.1159/000142725; Kok RM, 2007, CLIN CHEM LAB MED, V45, P903, DOI 10.1515/CCLM.2007.137; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; Menon V, 2006, CIRCULATION, V113, P1572, DOI 10.1161/CIRCULATIONAHA.105.570127; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rocha MS, 2010, CLIN CHEM LAB MED, V48, P1793, DOI 10.1515/CCLM.2010.346; Smulders YM, 2011, J INHERIT METAB DIS, V34, P93, DOI 10.1007/s10545-010-9151-1; Struys EA, 2000, CLIN CHEM, V46, P1650; Teerlink T, 2007, J CHROMATOGR B, V851, P21, DOI 10.1016/j.jchromb.2006.07.024; UELAND PM, 1982, PHARMACOL REV, V34, P223; vanderMolen EF, 1997, THROMB HAEMOSTASIS, V78, P827; Wagner C, 2007, AM J CLIN NUTR, V86, P1581; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	40	16	17	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55483	10.1371/journal.pone.0055483	http://dx.doi.org/10.1371/journal.pone.0055483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408989	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300018
J	Gu, LW; Yue, JJ; Zheng, YL; Zheng, X; Wang, J; Wang, YZ; Li, JC; Jiang, YQ; Jiang, H				Gu, Liwei; Yue, Junjie; Zheng, Yuling; Zheng, Xin; Wang, Jun; Wang, Yanzi; Li, Jianchun; Jiang, Yongqiang; Jiang, Hua			Evaluation of a Recombinant Double Mutant of Staphylococcal Enterotoxin B (SEB-H32Q/K173E) with Enhanced Antitumor Activity Effects and Decreased Pyrexia	PLOS ONE			English	Article							RECEPTOR BETA-CHAIN; CLASS-II; BACTERIAL SUPERANTIGEN; TRANSGENIC MICE; CELL CARCINOMA; IN-VIVO; STRUCTURAL BASIS; CANCER; RESPONSES; IMMUNOTHERAPY	Background: Immunotherapy has been used to improve patient immune function, inhibit tumor growth and has become a highly promising method of cancer treatment. Highly agglutinative staphylococcin (HAS), a mixture of Staphylococcus aureus culture filtrates, which include staphylococcal enterotoxin (SE) C as the active ingredient, has been used clinically as an immunomodifier in the treatment of a number of tumors for many years. However, the use of HAS has been associated with some unavoidable side-effects such as fever. Previous studies have shown that SEB stimulates a more potent activation of T lymphocytes than SEC3, and mutations of the histidine residues eliminated the toxicity of SEB. SE mutants with decreased side-effects and/or more potent antitumor activities are required. Methodology/Principal Findings: We built a structural model of the MHC II-SEB-TCR complex and found that a mutation of SEB at Lys173 might decrease the repulsion force between the SEB-TCR, which would facilitate their interaction. From the above results, we designed SEB-H32Q/K173E (mSEB). Analysis of in vitro stimulation of the proliferation of human peripheral blood mononuclear cells (PBMCs), IFN-gamma secretion and inhibition of the growth of various tumor cell lines demonstrated that mSEB exhibited higher antitumor activity compared with wild-type SEB (wtSEB). Notably, mSEB inhibited the growth of various tumors at an extremely low concentration with little cytotoxicity against normal cells. Three animal tumor models (C57BL/6 mouse, New Zealand rabbit and a humanized NOD/SCID mouse) were used to evaluate the in vivo immunotherapeutic effects. Compared with wtSEB, mSEB significantly enhanced antitumor effect in more than one animal model with reduced pyrexia toxicity and prolonged the survival of tumor-bearing mice. Conclusions/Significance: Our results suggest that SEB-H32Q/K173E retains superantigen (SAg) characteristics	[Gu, Liwei; Zheng, Yuling; Zheng, Xin; Wang, Jun; Jiang, Yongqiang; Jiang, Hua] Acad Mil Med Sci, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Gu, Liwei; Li, Jianchun] Shenyang Pharmaceut Univ, Dept Tradit Chinese Med Pharmacol, Shenyang, Peoples R China; [Yue, Junjie] Beijing Inst Biotechnol, Beijing, Peoples R China; [Zheng, Xin; Wang, Jun] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China; [Wang, Yanzi] Jiangsu Prov Xuzhou Pharmaceut Vocat Coll, Dept Pharm, Xuzhou, Peoples R China	Academy of Military Medical Sciences - China; Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Li, JC (corresponding author), Shenyang Pharmaceut Univ, Dept Tradit Chinese Med Pharmacol, Shenyang, Peoples R China.	lijianchun0317@gmail.com; jiangyq@nic.bmi.ac.cn; weishengwuliuxingbing@hotmail.com		Yue, Junjie/0000-0002-2549-9261	Chinese State Key Project Specialized for new drugs [2009ZX09103-618]; National Natural Science Foundation of China [81071434]	Chinese State Key Project Specialized for new drugs; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Chinese State Key Project Specialized for new drugs (2009ZX09103-618) and the National Natural Science Foundation of China (81071434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaugh RK, 1998, CLIN CANCER RES, V4, P1903; BaoAn Ning, 2006, ANTITUMOR EFFECT SUP, P24; Buonpane RA, 2007, NAT MED, V13, P725, DOI 10.1038/nm1584; Cheng X, 2010, SCAND J IMMUNOL, V71, P169, DOI 10.1111/j.1365-3083.2009.02359.x; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; DOHLSTEN M, 1995, CANCER IMMUNOL IMMUN, V41, P162, DOI 10.1007/s002620050214; DOHLSTEN M, 1993, INT J CANCER, V54, P482, DOI 10.1002/ijc.2910540321; Egwuagu CE, 2006, ONCOGENE, V25, P3670, DOI 10.1038/sj.onc.1209402; Gampfer J, 2002, VACCINE, V20, P1354, DOI 10.1016/S0264-410X(01)00470-4; Gunther S, 2007, J MOL BIOL, V371, P210, DOI 10.1016/j.jmb.2007.05.038; HARRIS TO, 1993, INFECT IMMUN, V61, P3175, DOI 10.1128/IAI.61.8.3175-3183.1993; Holzer U, 1997, IMMUNOLOGY, V90, P74, DOI 10.1046/j.1365-2567.1997.00141.x; Ilback NG, 2003, TOXICOLOGY, V185, P161, DOI 10.1016/S0300-483X(02)00591-7; Jardetzky TS, 1994, 3 DIMENSIONAL STRUCT; Jie KG, 2007, CANCER BIOL THER, V6, P1584, DOI 10.4161/cbt.6.10.4724; JOHNSON HM, 1991, FASEB J, V5, P2706, DOI 10.1096/fasebj.5.12.1916093; Kominsky SL, 2001, INT J CANCER, V94, P834, DOI 10.1002/ijc.1551; Komisar JL, 2001, TOXICOL PATHOL, V29, P369, DOI 10.1080/019262301316905336; Korolev S, 2003, TOXICOLOGY, V187, P229, DOI 10.1016/S0300-483X(03)00049-0; Kou ZC, 1998, J IMMUNOL, V160, P5170; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Lu Da-Yong, 2004, BMC Pharmacology, V4, P32, DOI 10.1186/1471-2210-4-32; Moza B, 2007, EMBO J, V26, P1187, DOI 10.1038/sj.emboj.7601531; Perabo FG, 2005, INT J CANCER, V115, P591, DOI 10.1002/ijc.20941; Perabo FGE, 2005, ANTICANCER RES, V25, P3565; Rajagopalan G, 2008, TISSUE ANTIGENS, V71, P135, DOI 10.1111/j.1399-0039.2007.00986.x; Rajagopalan G, 2006, INFECT IMMUN, V74, P1284, DOI 10.1128/IAI.74.2.1284-1296.2006; Rajagopalan G, 2009, PHYSIOL GENOMICS, V37, P279, DOI 10.1152/physiolgenomics.90385.2008; RECK B, 1988, P NATL ACAD SCI USA, V85, P3170, DOI 10.1073/pnas.85.9.3170; Roy CJ, 2005, INFECT IMMUN, V73, P2452, DOI 10.1128/IAI.73.4.2452-2460.2005; Shaw DM, 2007, BRIT J CANCER, V96, P567, DOI 10.1038/sj.bjc.6603567; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Stohl W, 2001, INT IMMUNOL, V13, P1291, DOI 10.1093/intimm/13.10.1291; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; TORBETT BE, 1991, IMMUNOL REV, V124, P139, DOI 10.1111/j.1600-065X.1991.tb00620.x; Wang HR, 2010, CANC INVESTIGATION; Wang LJ, 2010, TRANSPL IMMUNOL, V24, P64, DOI 10.1016/j.trim.2010.09.001; Wang XG, 2009, CANCER IMMUNOL IMMUN, V58, P677, DOI 10.1007/s00262-008-0590-6; Xu M., 2008, ASIAN J PHARMCODYN P, V8, P83; Xu MK, 2011, CANCER IMMUNOL IMMUN, V60, P705, DOI 10.1007/s00262-011-0986-6	43	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55892	10.1371/journal.pone.0055892	http://dx.doi.org/10.1371/journal.pone.0055892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405232	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400177
J	Hori, M; Miki, T; Okamoto, M; Yazama, F; Konishi, H; Kaneko, H; Shimamoto, F; Ota, T; Temme, A; Tatsuka, M				Hori, Masato; Miki, Tomoharu; Okamoto, Mayumi; Yazama, Futoshi; Konishi, Hiroaki; Kaneko, Hiroshi; Shimamoto, Fumio; Ota, Takahide; Temme, Achim; Tatsuka, Masaaki			The Detergent-Soluble Cytoplasmic Pool of Survivin Suppresses Anoikis and Its Expression Is Associated with Metastatic Disease of Human Colon Cancer	PLOS ONE			English	Article							FOCAL ADHESION KINASE; X-LINKED INHIBITOR; WILD-TYPE P53; APOPTOSIS PROTEIN; COLORECTAL-CANCER; CELL-DIVISION; AURORA-B; IN-VIVO; CHROMOSOME CONDENSATION; SPINDLE CHECKPOINT	Survivin is a component of the chromosomal passenger complex (CPC) that is essential for accurate chromosome segregation. Interfering with the function of Survivin in mitosis leads to chromosome segregation errors and defective cytokinesis. Survivin contains a Baculovirus IAP Repeat (BIR) and therefore was originally classified as inhibitor of apopotosis protein (IAP), yet its role in apoptosis after cellular stress remains largely unknown. We demonstrate here, that Survivin predominantly suppresses anoikis, a form of programmed cell death induced by loss of cellular adhesion to extracellular matrix. Interestingly, cells ectopically overexpressing EGFP-Survivin showed after loss of cell-matrix-interaction a decreased expression of I kappa B-alpha. Subsequent subcellular protein fractionation and immunoprecipitation experiments revealed that XIAP interacts with detergent-soluble Survivin which is known to cooperatively activate NF-kappa B signaling. Examination of the expression levels of detergent soluble Survivin in colorectal cancer cell lines and in colorectal cancerous tissues revealed that detergent soluble cytoplasmic Survivin levels correlated inversely with anoikis susceptibility in colorectal cancer. Therefore, the detergent soluble cytoplasmic Survivin might be a promising predictive biomarker for lymph node and distant metastases of colorectal cancer. We conclude that an anti-apoptotic function of detergent-soluble Survivin in interphase cells experiencing anoikis is mediated at least via XIAP/I kappa B-alpha/NF-kappa B signaling.	[Hori, Masato; Miki, Tomoharu; Okamoto, Mayumi; Yazama, Futoshi; Konishi, Hiroaki; Tatsuka, Masaaki] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Dept Life Sci, Hiroshima, Japan; [Kaneko, Hiroshi; Shimamoto, Fumio] Prefectural Univ Hiroshima, Fac Human Culture & Sci, Dept Hlth Sci, Minami Ku, Hiroshima, Japan; [Ota, Takahide] Kanazawa Med Univ, Dept Life Sci, Med Res Inst, Uchinada, Ishikawa 92002, Japan; [Temme, Achim] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurosurg, D-01062 Dresden, Germany	Kanazawa Medical University; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Tatsuka, M (corresponding author), Prefectural Univ Hiroshima, Fac Life & Environm Sci, Dept Life Sci, Hiroshima, Japan.	tatsuka@pu-hiroshima.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [21591730]; Prefectural University of Hiroshima [GAKUNAI KYODO KENKYU H-24]; Prefectural University of Hiroshima Graduate School of Comprehensive Scientific Research [H-24]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Prefectural University of Hiroshima; Prefectural University of Hiroshima Graduate School of Comprehensive Scientific Research	This work was supported by grants from the Japan Society for the Promotion of Science (KAKENHI No. 21591730 for Masaaki Tatsuka) and Prefectural University of Hiroshima (Important Research Project, GAKUNAI KYODO KENKYU H-24 for Masaaki Tatsuka, Hiroaki Konishi, and Fumio Shimamoto), and Prefectural University of Hiroshima Graduate School of Comprehensive Scientific Research to Mayumi Okamoto and Guangying Qi (Research Associate Grant H-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Banks DP, 2000, BLOOD, V96, P4002, DOI 10.1182/blood.V96.12.4002.h8004000c_4002_4003; Beltrami E, 2004, J BIOL CHEM, V279, P2077, DOI 10.1074/jbc.M309479200; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Christmann M, 2005, ONCOGENE, V24, P8304, DOI 10.1038/sj.onc.1208994; Chu XY, 2012, J SURG ONCOL, V105, P520, DOI 10.1002/jso.22134; Conway EM, 2000, BLOOD, V95, P1435, DOI 10.1182/blood.V95.4.1435.004k01_1435_1442; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Fortugno P, 2002, J CELL SCI, V115, P575; Fraser AG, 1999, CURR BIOL, V9, P292, DOI 10.1016/S0960-9822(99)80137-7; Golubovskaya VM, 2003, MOL CANCER RES, V1, P755; Hendruschk S, 2011, NEURO-ONCOLOGY, V13, P1074, DOI 10.1093/neuonc/nor098; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jones G, 2000, J BIOL CHEM, V275, P22157, DOI 10.1074/jbc.M000369200; Kalliakmanis JG, 2010, DIGEST DIS SCI, V55, P2958, DOI 10.1007/s10620-009-1088-6; Kaur H, 2010, J CELL BIOCHEM, V111, P1291, DOI 10.1002/jcb.22853; Kawai H, 1998, RADIAT RES, V149, P41, DOI 10.2307/3579680; Kawasaki H, 1998, CANCER RES, V58, P5071; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kelly RJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-35; Lackinger D, 2001, MUTAGENESIS, V16, P233, DOI 10.1093/mutage/16.3.233; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; McNeish IA, 2005, EXP CELL RES, V302, P69, DOI 10.1016/j.yexcr.2004.08.029; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Miura K, 2011, SURG TODAY, V41, P175, DOI 10.1007/s00595-010-4390-1; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Okamoto M, 2010, MUTAT RES-FUND MOL M, V688, P78, DOI 10.1016/j.mrfmmm.2010.03.012; Ota T, 2002, CANCER RES, V62, P5168; Ota T, 2006, CLIN EXP METASTAS, V23, P323, DOI 10.1007/s10585-006-9041-y; Pavlyukov MS, 2011, J BIOL CHEM, V286, P23296, DOI 10.1074/jbc.M111.237586; Petersen J, 2003, CURR BIOL, V13, P590, DOI 10.1016/S0960-9822(03)00205-7; Qi GY, 2009, ONCOL REP, V22, P557, DOI 10.3892/or_00000471; Rajagopalan S, 2002, GENETICS, V160, P445; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sakurai S, 2002, BIOCHEM BIOPH RES CO, V293, P174, DOI 10.1016/S0006-291X(02)00192-4; Sarela AI, 2000, GUT, V46, P645, DOI 10.1136/gut.46.5.645; Sarela AI, 2001, ANN SURG ONCOL, V8, P305; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; SHIMIZU T, 1995, JPN J CANCER RES, V86, P546, DOI 10.1111/j.1349-7006.1995.tb02433.x; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Suzuki Y, 2001, J BIOL CHEM, V276, P27058, DOI 10.1074/jbc.M102415200; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tamm I, 1998, CANCER RES, V58, P5315; Tatsuka M, 1998, CANCER RES, V58, P4811; Temme A, 2005, HUM GENE THER, V16, P209, DOI 10.1089/hum.2005.16.209; Temme A, 2003, MOL BIOL CELL, V14, P78, DOI 10.1091/mbc.E02-04-0182; Tomicic MT, 2005, APOPTOSIS, V10, P1295, DOI 10.1007/s10495-005-1392-3; Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Xia F, 2006, CANCER RES, V66, P3392, DOI 10.1158/0008-5472.CAN-05-4537; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yang D, 2004, P NATL ACAD SCI USA, V101, P15100, DOI 10.1073/pnas.0406665101; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118	70	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55710	10.1371/journal.pone.0055710	http://dx.doi.org/10.1371/journal.pone.0055710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405201	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400146
J	Overcash, RF; Chappell, VA; Green, T; Geyer, CB; Asch, AS; Ruiz-Echevarria, MJ				Overcash, Ryan F.; Chappell, Vesna A.; Green, Thomas; Geyer, Christopher B.; Asch, Adam S.; Ruiz-Echevarria, Maria J.			Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the alpha Subunit of the Translation Initiation Factor 2	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; PROTEIN-SYNTHESIS; GENE-EXPRESSION; BLOOD-PRESSURE; RECEPTOR; GROWTH; DIHYDROTESTOSTERONE; EIF2-ALPHA; IDENTIFICATION; PROLIFERATION	The type I transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2), is expressed mainly in brain and prostate. Expression of TMEFF2 is deregulated in prostate cancer, suggesting a role in this disease, but the molecular mechanism(s) involved in this effect are not clear. Although androgens promote tmeff2 transcription, androgen delivery to castrated animals carrying CWR22 xenografts increases TMEFF2 protein levels in the absence of mRNA changes, suggesting that TMEFF2 may also be post-transcriptionally regulated. Here we show that translation of TMEFF2 is regulated by androgens. Addition of physiological concentrations of dihydrotestosterone (DHT) to prostate cancer cell lines increases translation of endogenous TMEFF2 or transfected TMEFF2-Luciferase fusions, and this effect requires the presence of upstream open reading frames (uORFs) in the 59-untranslated region (59-UTR) of TMEFF2. Using chemical and siRNA inhibition of the androgen receptor (AR), we show that the androgen effect on TMEFF2 translation is mediated by the AR. Importantly, DHT also promotes phosphorylation of the alpha subunit of the translation initiation factor 2 (eIF2 alpha) in an AR-dependent manner, paralleling the effect on TMEFF2 translation. Moreover, endoplasmic reticulum (ER) stress conditions, which promote eIF2 alpha phosphorylation, also stimulate TMEFF2 translation. These results indicate that androgen signaling promotes eIF2 alpha phosphorylation and subsequent translation of TMEFF2 via a mechanism that requires uORFs in the 59-UTR of TMEFF2.	[Overcash, Ryan F.] E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC USA; [Chappell, Vesna A.; Geyer, Christopher B.; Ruiz-Echevarria, Maria J.] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA; [Green, Thomas; Asch, Adam S.; Ruiz-Echevarria, Maria J.] E Carolina Univ, Brody Sch Med, Div Hematol Oncol, Dept Internal Med, Greenville, NC USA; [Asch, Adam S.; Ruiz-Echevarria, Maria J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill	Ruiz-Echevarria, MJ (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA.	ruizechevarriam@ecu.edu		Ruiz Echevarria, Maria Jesus/0000-0001-7133-9982	National Cancer Institute [1R15CA155873]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD072552] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R15CA155873] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant from the National Cancer Institute (1R15CA155873). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afar DEH, 2004, MOL CANCER THER, V3, P921; Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bennett NC, 2010, INT J BIOCHEM CELL B, V42, P813, DOI 10.1016/j.biocel.2009.11.013; Chen TR, 2012, BIOCHEM BIOPH RES CO, V425, P189, DOI 10.1016/j.bbrc.2012.07.064; Chen XF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193805; Clemens MJ, 2001, PROG MOLEC, V27, P57; Cuesta R, 2009, PROG MOL BIOL TRANSL, V90, P255, DOI 10.1016/S1877-1173(09)90007-2; Dai RY, 2012, J CELL BIOCHEM, V113, P1800, DOI 10.1002/jcb.24051; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; Esfahani A, 2010, IN VITRO CELL DEV-AN, V46, P856, DOI 10.1007/s11626-010-9351-x; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Floryk D, 2011, MOL CELL ENDOCRINOL, V345, P58, DOI 10.1016/j.mce.2011.07.011; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Gery S, 2002, ONCOGENE, V21, P4739, DOI 10.1038/sj.onc.1205142; Glynne-Jones E, 2001, INT J CANCER, V94, P178, DOI 10.1002/ijc.1450; Gregory CW, 2001, CANCER RES, V61, P4315; Hamdi MM, 2011, J PHYSIOL-LONDON, V589, P3623, DOI 10.1113/jphysiol.2011.207175; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haren MT, 2011, INT J ANDROL, V34, P55, DOI 10.1111/j.1365-2605.2010.01061.x; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Ikeda Y, 2012, J ENDOCRINOL, V214, P1, DOI 10.1530/JOE-12-0126; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kim HJ, 2006, TOXICOL IN VITRO, V20, P1159, DOI 10.1016/j.tiv.2006.03.003; Kinoshita H, 2000, CANCER RES, V60, P3623; Ko S, 2011, MOL ENDOCRINOL, V25, P433, DOI 10.1210/me.2010-0482; Kumarasamy S, 2011, HYPERTENS RES, V34, P1263, DOI 10.1038/hr.2011.116; LIANG T, 1975, P NATL ACAD SCI USA, V72, P706, DOI 10.1073/pnas.72.2.706; LIANG T, 1975, J STEROID BIOCHEM, V6, P549, DOI 10.1016/0022-4731(75)90033-3; Lin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018608; Liu SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011302; Lizotte E, 2009, CELL PHYSIOL BIOCHEM, V23, P75, DOI 10.1159/000204096; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lozon TI, 2011, AM J PHYSIOL-LUNG C, V300, pL422, DOI 10.1152/ajplung.00166.2010; Masek T, 2011, METHODS MOL BIOL, V703, P293, DOI 10.1007/978-1-59745-248-9_20; Mehraein-Ghomi F, 2008, PROSTATE, V68, P924, DOI 10.1002/pros.20737; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Mounir Z, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000389; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pan CL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S17; Pascall JC, 1997, J MOL ENDOCRINOL, V18, P177, DOI 10.1677/jme.0.0180177; Pausova Z, 2010, HYPERTENSION, V55, P706, DOI 10.1161/HYPERTENSIONAHA.109.146720; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Putluri N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021417; Quinkler M, 2005, HYPERTENSION, V46, P787, DOI 10.1161/01.HYP.0000184362.61744.c1; Rajabi H, 2011, PROSTATE, V71, P1299, DOI 10.1002/pros.21344; Ramberg H, 2008, PROSTATE, V68, P1133, DOI 10.1002/pros.20778; Ripple MO, 1999, ANTIOXID REDOX SIGN, V1, P71, DOI 10.1089/ars.1999.1.1-71; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; SRIVASTAVA SP, 1995, J BIOL CHEM, V270, P16619, DOI 10.1074/jbc.270.28.16619; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; Sun XY, 2001, CARCINOGENESIS, V22, P1775, DOI 10.1093/carcin/22.11.1775; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yoshioka M, 2006, J MOL ENDOCRINOL, V36, P247, DOI 10.1677/jme.1.01964; Zhao JC, 2012, GENOME RES, V22, P322, DOI 10.1101/gr.131508.111	65	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55257	10.1371/journal.pone.0055257	http://dx.doi.org/10.1371/journal.pone.0055257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405127	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400072
J	Ward, A; Quinn, KP; Bellas, E; Georgakoudi, I; Kaplan, DL				Ward, Andrew; Quinn, Kyle P.; Bellas, Evangelia; Georgakoudi, Irene; Kaplan, David L.			Noninvasive Metabolic Imaging of Engineered 3D Human Adipose Tissue in a Perfusion Bioreactor	PLOS ONE			English	Article							IN-VITRO; SILK FIBROIN; STEM-CELLS; MODEL	The efficacy and economy of most in vitro human models used in research is limited by the lack of a physiologically-relevant three-dimensional perfused environment and the inability to noninvasively quantify the structural and biochemical characteristics of the tissue. The goal of this project was to develop a perfusion bioreactor system compatible with two-photon imaging to noninvasively assess tissue engineered human adipose tissue structure and function in vitro. Three-dimensional (3D) vascularized human adipose tissues were engineered in vitro, before being introduced to a perfusion environment and tracked over time by automated quantification of endogenous markers of metabolism using two-photon excited fluorescence (TPEF). Depth-resolved image stacks were analyzed for redox ratio metabolic profiling and compared to prior analyses performed on 3D engineered adipose tissue in static culture. Traditional assessments with H&E staining were used to qualitatively measure extracellular matrix generation and cell density with respect to location within the tissue. The distribution of cells within the tissue and average cellular redox ratios were different between static and perfusion cultures, while the trends of decreased redox ratio and increased cellular proliferation with time in both static and perfusion cultures were similar. These results establish a basis for noninvasive optical tracking of tissue structure and function in vitro, which can be applied to future studies to assess tissue development or drug toxicity screening and disease progression.	[Ward, Andrew; Quinn, Kyle P.; Bellas, Evangelia; Georgakoudi, Irene; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	David.Kaplan@tufts.edu		Quinn, Kyle/0000-0002-6876-3608	National Institutes of Health (NIH) [P41 EB002520-05]; National Institute of Biomedical Imaging and Bioengineering/NIH [R01EB007542]; National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH [F32AR061933]; Armed Forces Institute of Regenerative Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520, R01EB007542] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Armed Forces Institute of Regenerative Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	All funding for this project was from the National Institutes of Health (NIH) (grant P41 EB002520-05 (Tissue Engineering Resource Center), R01EB007542 from National Institute of Biomedical Imaging and Bioengineering/NIH and F32AR061933 from National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH). The authors also thank Armed Forces Institute of Regenerative Medicine for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUCHER RC, 1980, J APPL PHYSIOL, V48, P169, DOI 10.1152/jappl.1980.48.1.169; Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]; Fournier R. L., 1999, BASIC TRANSPORT PHEN; Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]; Georgakoudi I, 2012, ANN REV BIOMED ENG; Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043; Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248; Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024; Hillel AT, 2009, TISSUE ENG PT A, V15, P479, DOI 10.1089/ten.tea.2007.0352; Job Charles K, 2003, Indian J Pathol Microbiol, V46, P541; Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051; Provenzano PP, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940365; Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024; Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003; Ren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012520; Rice WL, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823019; Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Soini E, 2000, BIOCHEM SOC T, V28, P70, DOI 10.1042/bst0280070; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013	26	27	28	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55696	10.1371/journal.pone.0055696	http://dx.doi.org/10.1371/journal.pone.0055696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405199	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400144
J	Geurts, L; Muccioli, GG; Delzenne, NM; Cani, PD				Geurts, Lucie; Muccioli, Giulio G.; Delzenne, Nathalie M.; Cani, Patrice D.			Chronic Endocannabinoid System Stimulation Induces Muscle Macrophage and Lipid Accumulation in Type 2 Diabetic Mice Independently of Metabolic Endotoxaemia	PLOS ONE			English	Article							HIGH-FAT DIET; HEPATIC CB1 RECEPTORS; GUT MICROBIOTA; CANNABINOID RECEPTORS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ENERGY-METABOLISM; INDUCED OBESITY; RISK-FACTORS; ACTIVATION	Aims: Obesity and type 2 diabetes are characterised by low-grade inflammation, metabolic endotoxaemia (i.e., increased plasma lipopolysaccharides [LPS] levels) and altered endocannabinoid (eCB)-system tone. The aim of this study was to decipher the specific role of eCB-system stimulation or metabolic endotoxaemia in the onset of glucose intolerance, metabolic inflammation and altered lipid metabolism. Methods: Mice were treated with either a cannabinoid (CB) receptor agonist (HU210) or low-dose LPS using subcutaneous mini-pumps for 6 weeks. After 3 weeks of the treatment under control (CT) diet, one-half of each group of mice were challenged with a high fat (HF) diet for the following 3-week period. Results: Under basal conditions (control diet), chronic CB receptor agonist treatment (i.e., 6 weeks) induced glucose intolerance, stimulated metabolic endotoxaemia, and increased macrophage infiltration (CD11c and F4/80 expression) in the muscles; this phenomenon was associated with an altered lipid metabolism (increased PGC-1 alpha expression and decreased CPT-1b expression) in this tissue. Chronic LPS treatment tended to increase the body weight and fat mass, with minor effects on the other metabolic parameters. Challenging mice with an HF diet following pre-treatment with the CB agonist exacerbated the HF diet-induced glucose intolerance, the muscle macrophage infiltration and the muscle's lipid content without affecting the body weight or the fat mass. Conclusion: Chronic CB receptor stimulation under basal conditions induces glucose intolerance, stimulates metabolic inflammation and alters lipid metabolism in the muscles. These effects worsen following the concomitant ingestion of an HF diet. Here, we highlight the central roles played by the eCB system and LPS in the pathophysiology of several hallmarks of obesity and type 2 diabetes.	[Geurts, Lucie; Delzenne, Nathalie M.; Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Lab, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Cani, PD (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.	patrice.cani@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016	Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Muccioli, Giulio/0000-0002-1600-9259	SFD (Societe Francophone du Diabete); FSR (Fonds Speciaux de Recherche, UCL (Universite catholique de Louvain); FRSM (Fonds de la Recherche Scientifique Medicale)	SFD (Societe Francophone du Diabete); FSR (Fonds Speciaux de Recherche, UCL (Universite catholique de Louvain); FRSM (Fonds de la Recherche Scientifique Medicale)(Fonds de la Recherche Scientifique - FNRS)	Sources of funding: SFD (Societe Francophone du Diabete); FSR (Fonds Speciaux de Recherche, UCL (Universite catholique de Louvain); FRSM (Fonds de la Recherche Scientifique Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamoruni A, 2012, BRIT J PHARMACOL, V165, P2598, DOI 10.1111/j.1476-5381.2011.01589.x; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Andre A, 2010, INT J BIOCHEM CELL B, V42, P1788, DOI 10.1016/j.biocel.2010.06.002; Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Bermudez-Siva FJ, 2006, EUR J PHARMACOL, V531, P282, DOI 10.1016/j.ejphar.2005.12.016; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bosier B, 2012, NEUROPHARMACOLOGY, V62, P2328, DOI 10.1016/j.neuropharm.2012.02.003; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2008, BRIT J PHARMACOL, V154, P915, DOI 10.1038/bjp.2008.170; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; Di Marzo V, 2009, BEST PRACT RES CL EN, V23, pVII, DOI 10.1016/j.beem.2008.12.005; Di Marzo V, 2008, DRUG DISCOV TODAY, V13, P1026, DOI 10.1016/j.drudis.2008.09.001; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Doyle ME, 2011, CURR OPIN ENDOCRINOL, V18, P153, DOI 10.1097/MED.0b013e32834455a8; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x; Lambert DM, 2007, CURR OPIN CLIN NUTR, V10, P735, DOI 10.1097/MCO.0b013e3282f00061; Li C, 2010, ISLETS, V2, P293, DOI 10.4161/isl.2.5.12729; Li C, 2011, PHARMACOL THERAPEUT, V129, P307, DOI 10.1016/j.pharmthera.2010.10.006; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Liu J, 2012, GASTROENTEROLOGY; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Ottani A, 2001, CNS DRUG REV, V7, P131; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Song D, 2011, DIABETOLOGIA, V54, P1181, DOI 10.1007/s00125-011-2082-z; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X	53	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55963	10.1371/journal.pone.0055963	http://dx.doi.org/10.1371/journal.pone.0055963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393605	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800060
J	Biraro, S; Ruzagira, E; Kamali, A; Whitworth, J; Grosskurth, H; Weiss, HA				Biraro, Samuel; Ruzagira, Eugene; Kamali, Anatoli; Whitworth, James; Grosskurth, Heiner; Weiss, Helen A.			HIV-1 Transmission within Marriage in Rural Uganda: A Longitudinal Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MALE-TO-FEMALE; DISCORDANT COUPLES; HIV-1-DISCORDANT COUPLES; SEXUAL TRANSMISSION; MALE CIRCUMCISION; DOUBLE-BLIND; VIRAL LOAD; INFECTION; RISK	Background: Early initiation of antiretroviral therapy reduces risk of transmission to the uninfected partner in HIV discordant couples, but there are relatively little observational data on HIV transmission within couples from non-trial settings. The aims of this paper are to estimate HIV incidence among HIV discordant couples using longstanding observational data from a rural Ugandan population and to identify factors associated with HIV transmission within couples, including the role of HSV-2 infection. Methods: Using existing data collected at population-wide annual serological and behavioural surveys in a rural district in southwest Uganda between 1989 and 2007, HIV discordant partners were identified. Stored serum samples were tested for HSV-2 serostatus using the Kalon ELISA test. HIV seroconversion rates and factors association with HIV seroconversion were analysed using Poisson regression. Results: HIV status of both partners was known in 2465 couples and of these 259 (10.5%) were HIV serodiscordant. At enrolment, HSV-2 prevalence was 87.3% in HIV positive partners and 71.5% in HIV negative partners. Of the 259 discordant couples, 62 converted to HIV (seroconversion rate 7.11/100 PYAR, 95% CI; 5.54, 9.11) with the rate decreasing from 10.89 in 1990-1994 to 4.32 in 2005-2007. Factors independently associated with HIV seroconversion were female sex, non-Muslim religion, greater age difference (man older than woman by more than 15 years), higher viral load in the positive partner and earlier calendar period. HSV-2 was not independently associated with HIV acquisition (HR 1.62, 95% CI; 0.57, 4.55) or transmission (HR 0.61, 95% CI; 0.24, 1.57). No transmissions occurred in the 29 couples where the index partner was on ART during follow up (872 person-years on ART). Discussion: HIV negative partners in serodiscordant couples have a high incidence of HIV if the index partner is not on antiretroviral therapy and should be provided with interventions such as couple counselling, condoms and antiretroviral treatment.	[Biraro, Samuel; Ruzagira, Eugene; Kamali, Anatoli; Grosskurth, Heiner] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Biraro, Samuel; Grosskurth, Heiner; Weiss, Helen A.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, London WC1, England; [Whitworth, James] Wellcome Trust Res Labs, London, England	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine	Biraro, S (corresponding author), Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda.	samuel.biraro@mrcuganda.org	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Ruzagira, Eugene/0000-0002-7291-1693; Grosskurth, Heiner/0000-0001-9960-7280	United Kingdom Medical Research Council; Medical Research Council [MR/K012126/1] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the United Kingdom Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chemaitelly H, 2012, AIDS; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Kairania RM, 2010, AIDS CARE, V22, P1041, DOI 10.1080/09540121003602226; Kalon Biologicals Ltd, 2008, KIT INS HSV TYP 2 IG; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Kumarasamy N, 2010, HIV MED, V11, P178, DOI 10.1111/j.1468-1293.2009.00760.x; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; [Ministry of Health Uganda ORC Macro], 2006, UG HIV AIDS SER SURV; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024037; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Seeley J, 2008, SOC SCI MED, V67, P1434, DOI 10.1016/j.socscimed.2008.07.001; SERWADDA D, 1995, AIDS, V9, P745, DOI 10.1097/00002030-199507000-00012; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Van der Paal L, 2007, TROP MED INT HEALTH, V12, P920, DOI [10.1111/j.1365-3156.2007.01873.x, 10.1111/j.1365-3156.2007.001873.x]; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wabwire-Mangen F, 2009, UGANDA HIV MODES TRA; Wald Anna, 2004, Herpes, V11, P70; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X	44	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55060	10.1371/journal.pone.0055060	http://dx.doi.org/10.1371/journal.pone.0055060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390512	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000314691100028
J	Couto, E; Sandin, S; Lof, M; Ursin, G; Adami, HO; Weiderpass, E				Couto, Elisabeth; Sandin, Sven; Lof, Marie; Ursin, Giske; Adami, Hans-Olov; Weiderpass, Elisabete			Mediterranean Dietary Pattern and Risk of Breast Cancer	PLOS ONE			English	Article							MENOPAUSAL HORMONE-THERAPY; HEALTH; MORTALITY; SURVIVAL; ALCOHOL; COHORT; WOMEN	Background: A Mediterranean diet has a recognized beneficial effect on health and longevity, with a protective influence on several cancers. However, its association with breast cancer risk remains unclear. Objective: We aimed to investigate whether adherence to a Mediterranean dietary pattern influences breast cancer risk. Design: The Swedish Women's Lifestyle and Health cohort study includes 49,258 women aged 30 to 49 years at recruitment in 1991-1992. Consumption of foods and beverages was measured at enrollment using a food frequency questionnaire. A Mediterranean diet score was constructed based on the consumption of alcohol, vegetables, fruits, legumes, cereals, fish, the ratio of unsaturated to saturated fat, and dairy and meat products. Relative risks (RR) for breast cancer and specific tumor characteristics (invasiveness, histological type, estrogen/progesterone receptor status, malignancy grade and stage) associated with this score were estimated using Cox regression controlling for potential confounders. Results: 1,278 incident breast cancers were diagnosed. Adherence to a Mediterranean dietary pattern was not statistically significantly associated with reduced risk of breast cancer overall, or with specific breast tumor characteristics. A RR (95% confidence interval) for breast cancer associated with a two-point increment in the Mediterranean diet score was 1.08 (1.00-1.15) in all women, and 1.10 (1.01-1.21) and 1.02 (0.91-1.15) in premenopausal and postmenopausal women, respectively. When alcohol was excluded from the Mediterranean diet score, results became not statistically significant. Conclusions: Adherence to a Mediterranean dietary pattern did not decrease breast cancer risk in this cohort of relatively young women.	[Couto, Elisabeth; Sandin, Sven; Adami, Hans-Olov; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Couto, Elisabeth; Ursin, Giske; Weiderpass, Elisabete] Canc Registry Norway, Oslo, Norway; [Couto, Elisabeth] Norwegian Knowledge Ctr Hlth Serv, Hlth Econ & Drug Unit, Oslo, Norway; [Lof, Marie] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lof, Marie] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Ursin, Giske] Univ Oslo, Dept Nutr, Oslo, Norway; [Ursin, Giske] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Dept Genet Epidemiol, Helsinki, Finland; [Weiderpass, Elisabete] Univ Tromso, Dept Community Med, Tromso, Norway	Karolinska Institutet; University of Oslo; Norwegian Knowledge Centre for Health Services; Linkoping University; Karolinska Institutet; University of Oslo; University of Southern California; Harvard University; Harvard T.H. Chan School of Public Health; Folkhalsan Research Center; UiT The Arctic University of Tromso	Weiderpass, E (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Elisabete.Weiderpass@ki.se	Löf, Marie/ABB-2697-2020; Weiderpass, Elisabete/AAP-2747-2021; Sandin, Sven/L-5357-2015; Weiderpass, Elisabete/M-4029-2016; Sandin, Sven/ABE-2959-2021; Löf, Marie/AAW-3323-2020; Ursin, Giske/U-6637-2017	Löf, Marie/0000-0002-2273-4430; Weiderpass, Elisabete/0000-0003-2237-0128; Sandin, Sven/0000-0001-6994-4884; Weiderpass, Elisabete/0000-0003-2237-0128; Sandin, Sven/0000-0001-6994-4884; Ursin, Giske/0000-0002-0835-9507	Swedish Research Council (Vetenskapsradet) [K2012-69X-22062-01-3]; Swedish Cancer Society	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society)	Supported by the Swedish Research Council (Vetenskapsradet) grant K2012-69X-22062-01-3 and by the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Benitez-Arciniega AA, 2011, PUBLIC HEALTH NUTR, V14, P2015, DOI 10.1017/S1368980011001212; Bergstrom L., 1991, Var Foda, V43, P439; Brinton LA, 2008, CANCER EPIDEM BIOMAR, V17, P3150, DOI 10.1158/1055-9965.EPI-08-0435; Cade JE, 2011, EUR J CLIN NUTR, V65, P920, DOI 10.1038/ejcn.2011.69; COLDITZ GA, 1992, CANCER CAUSE CONTROL, V3, P433, DOI 10.1007/BF00051356; Cottet V, 2009, AM J EPIDEMIOL, V170, P1257, DOI 10.1093/aje/kwp257; Couto E, 2011, BRIT J CANCER, V104, P1493, DOI 10.1038/bjc.2011.106; Edefonti V, 2009, NUTR REV, V67, P297, DOI 10.1111/j.1753-4887.2009.00203.x; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Fung TT, 2006, J NUTR, V136, P466, DOI 10.1093/jn/136.2.466; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Jacques PF, 2001, AM J CLIN NUTR, V73, P1, DOI 10.1093/ajcn/73.1.1; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kumle M, 2002, CANCER EPIDEM BIOMAR, V11, P1375; Lagiou P, 2006, BRIT J NUTR, V96, P384, DOI 10.1079/BJN20061824; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ma HY, 2006, BREAST CANCER RES, V8, DOI [10.1186/bcr1525, 10.1186/bcr1512]; Murtaugh MA, 2008, AM J CLIN NUTR, V87, P978, DOI 10.1093/ajcn/87.4.978; Saxena T, 2010, CANCER EPIDEM BIOMAR, V19, P2366, DOI 10.1158/1055-9965.EPI-10-0162; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Therneau TM, 2001, MODELING SURVIVAL DA; Thiebaut ACM, 2007, ANN INTERN MED, V146, P65, DOI 10.7326/0003-4819-146-1-200701020-00012; Trichopoulou A, 2004, PUBLIC HEALTH NUTR, V7, P943, DOI 10.1079/PHN2004558; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2010, AM J CLIN NUTR, V92, P620, DOI 10.3945/ajcn.2010.29619; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; United Nations Educational Scientific and Cultural Organization, 2011, INT HER LISTS MED DI; Wolk A, 1998, ARCH INTERN MED, V158, P41, DOI 10.1001/archinte.158.1.41; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu AH, 2009, AM J CLIN NUTR, V89, P1145, DOI 10.3945/ajcn.2008.26915	33	65	68	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55374	10.1371/journal.pone.0055374	http://dx.doi.org/10.1371/journal.pone.0055374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390532	gold, Green Published			2022-12-27	WOS:000314691100048
J	Lanyon, LJ; Barton, JJS				Lanyon, Linda J.; Barton, Jason J. S.			Visual Search and Line Bisection in Hemianopia: Computational Modelling of Cortical Compensatory Mechanisms and Comparison with Hemineglect	PLOS ONE			English	Article							OBJECT-BASED ATTENTION; VISION RESTORATION THERAPY; UNILATERAL SPATIAL NEGLECT; SHREW STRIATE CORTEX; HOMONYMOUS HEMIANOPIA; RESIDUAL VISION; CALLOSAL CONNECTIONS; EYE-MOVEMENT; FIELD DEFECTS; FUNCTIONAL SPECIFICITY	Hemianopia patients have lost vision from the contralateral hemifield, but make behavioural adjustments to compensate for this field loss. As a result, their visual performance and behaviour contrast with those of hemineglect patients who fail to attend to objects contralateral to their lesion. These conditions differ in their ocular fixations and perceptual judgments. During visual search, hemianopic patients make more fixations in contralesional space while hemineglect patients make fewer. During line bisection, hemianopic patients fixate the contralesional line segment more and make a small contralesional bisection error, while hemineglect patients make few contralesional fixations and a larger ipsilesional bisection error. Hence, there is an attentional failure for contralesional space in hemineglect but a compensatory adaptation to attend more to the blind side in hemianopia. A challenge for models of visual attentional processes is to show how compensation is achieved in hemianopia, and why such processes are hindered or inaccessible in hemineglect. We used a neurophysiology-derived computational model to examine possible cortical compensatory processes in simulated hemianopia from a V1 lesion and compared results with those obtained with the same processes under conditions of simulated hemineglect from a parietal lesion. A spatial compensatory bias to increase attention contralesionally replicated hemianopic scanning patterns during visual search but not during line bisection. To reproduce the latter required a second process, an extrastriate lateral connectivity facilitating form completion into the blind field: this allowed accurate placement of fixations on contralesional stimuli and reproduced fixation patterns and the contralesional bisection error of hemianopia. Neither of these two cortical compensatory processes was effective in ameliorating the ipsilesional bias in the hemineglect model. Our results replicate normal and pathological patterns of visual scanning, line bisection, and differences between hemianopia and hemineglect, and may explain why compensatory processes that counter the effects of hemianopia are ineffective in hemineglect.	[Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Ophthalmol, Vancouver, BC, Canada; [Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Lanyon, Linda J.] Karolinska Inst, Int Neuroinformat Coordinating Facil Secretariat, Stockholm, Sweden	University of British Columbia; University of British Columbia; University of British Columbia; Karolinska Institutet	Lanyon, LJ (corresponding author), Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada.	linda.lanyon@incf.org	Lanyon, Linda/L-9238-2019; Barton, Jason JS/A-6362-2012	Lanyon, Linda/0000-0002-0885-1825; 	Michael Smith Foundation for Health Research; Canadian Institute of Health Research; Canada Research Chair program	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs)	LL was supported by a Post Doctoral Fellowship from the Michael Smith Foundation for Health Research and by the Canadian Institute of Health Research. JB was supported by the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Anderson EJ, 2012, CEREB CORTEX, V22, P765, DOI 10.1093/cercor/bhr110; Axenfeld D, 1894, NEUROLOGISCHES CENTR, V13, P437; Barrett AM, 2006, J COGNITIVE NEUROSCI, V18, P1223, DOI 10.1162/jocn.2006.18.7.1223; Bartolomeo P, 2012, FRONTIERS HUMAN NEUR, V6; Barton JJS, 1998, BRAIN, V121, P1117, DOI 10.1093/brain/121.6.1117; Barton JJS, 1997, BRAIN, V120, P681, DOI 10.1093/brain/120.4.681; Barton JJS, 1998, J NEUROL NEUROSUR PS, V64, P660, DOI 10.1136/jnnp.64.5.660; Behrmann M, 2004, CORTEX, V40, P247, DOI 10.1016/S0010-9452(08)70120-5; Behrmann M, 1997, NEUROPSYCHOLOGIA, V35, P1445, DOI 10.1016/S0028-3932(97)00058-4; Berman R, 2009, VISION RES, V49, P1233, DOI 10.1016/j.visres.2008.06.017; BLYTHE IM, 1986, NATURE, V320, P619, DOI 10.1038/320619a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2000, J NEUROSCI, V20, P2346; BRADDICK O, 1992, NATURE, V360, P461, DOI 10.1038/360461a0; Chavane F, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00004; CHOUDHURY BP, 1965, Q J EXP PHYSIOL CMS, V50, P214, DOI 10.1113/expphysiol.1965.sp001783; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; Danckert J, 2005, NEUROSCI BIOBEHAV R, V29, P1035, DOI 10.1016/j.neubiorev.2005.02.001; Danziger S, 1998, J EXP PSYCHOL HUMAN, V24, P1467, DOI 10.1037/0096-1523.24.5.1467; Deco G, 2001, LECT NOTES ARTIF INT, V2036, P114; Farivar R, 2009, J NEUROSCI, V29, P5336, DOI 10.1523/JNEUROSCI.4978-08.2009; Faubert J, 2001, PROG BRAIN RES, V134, P399; Faubert J, 1999, VISION RES, V39, P149, DOI 10.1016/S0042-6989(98)00107-2; GASSEL MM, 1963, BRAIN, V86, P1, DOI 10.1093/brain/86.1.1; GASSEL MM, 1963, BRAIN, V86, P229, DOI 10.1093/brain/86.2.229; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GROSSBERG S, 1989, IEEE T BIO-MED ENG, V36, P65, DOI 10.1109/10.16450; Grossberg S, 2000, VISION RES, V40, P1413, DOI 10.1016/S0042-6989(99)00229-1; Heilman K M, 1977, Adv Neurol, V18, P93; Heilman K.M., 1985, INT J CLIN NEUROPSYC, V2nd, P243; Heilman K. M., 1987, NEUROPHYSIOLOGICAL N, V45, P115, DOI [DOI 10.1016/S0166-4115(08)61711-2, 10.1016/S0166-4115(08)61711-2]; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; HEILMAN KM, 1979, ANN NEUROL, V5, P166, DOI 10.1002/ana.410050210; HEILMAN KM, 1979, CLIN NEUROPSYCHOLOGY, P268, DOI DOI 10.1055/S-2008-1041551; HUBEL DH, 1967, J NEUROPHYSIOL, V30, P1561, DOI 10.1152/jn.1967.30.6.1561; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Husain M, 2001, BRAIN, V124, P941, DOI 10.1093/brain/124.5.941; ISHIAI S, 1987, NEUROPSYCHOLOGIA, V25, P675, DOI 10.1016/0028-3932(87)90058-3; ISHIAI S, 1989, BRAIN, V112, P1485, DOI 10.1093/brain/112.6.1485; Kasten E, 2006, NEUROCASE, V12, P98, DOI 10.1080/13554790600582562; Kasten E, 1998, J CLIN EXP NEUROPSYC, V20, P581, DOI 10.1076/jcen.20.5.581.1129; KENNEDY H, 1986, J COMP NEUROL, V247, P398, DOI 10.1002/cne.902470309; Kerkhoff G, 2008, CORTEX, V44, P200, DOI 10.1016/j.cortex.2006.07.002; King SM, 1996, VISUAL NEUROSCI, V13, P1, DOI 10.1017/S0952523800007082; Kinsbourne M, 1970, Trans Am Neurol Assoc, V95, P143; Kinsbourne M., 1987, NEUROPHYSIOLOGICAL N, P69, DOI DOI 10.1016/S0166-4115(08)61709-4; Kinsbourne M, 1993, UNILATERAL NEGLECT C, V6386; Klein RM, 1999, PSYCHOL SCI, V10, P346, DOI 10.1111/1467-9280.00166; Lanyon LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011128; Lanyon LJ, 2009, COGN NEURODYNAMICS, V3, P223, DOI 10.1007/s11571-008-9073-x; Lanyon LJ, 2004, NEURAL NETWORKS, V17, P873, DOI 10.1016/j.neunet.2004.03.012; LEPORE F, 1982, EXP BRAIN RES, V46, P413; Luaute J, 2006, NEUROSCI BIOBEHAV R, V30, P961, DOI 10.1016/j.neubiorev.2006.03.001; Machner B, 2009, J NEUROL, V256, P289, DOI 10.1007/s00415-009-0148-3; Mannan SK, 2010, J NEUROL, V257, P1812, DOI 10.1007/s00415-010-5615-3; Mazer JA, 2011, BIOL PSYCHIAT, V69, P1147, DOI 10.1016/j.biopsych.2011.03.014; McCarthy RA, 2006, NEUROPSYCHOLOGIA, V44, P1269, DOI 10.1016/j.neuropsychologia.2006.01.036; MEIENBERG O, 1981, ANN NEUROL, V9, P537, DOI 10.1002/ana.410090605; Milner A. D., 1995, VISUAL BRAIN ACTION; Mitra AR, 2010, NEUROPSYCHOLOGIA, V48, P1742, DOI 10.1016/j.neuropsychologia.2010.02.023; Motter BC, 1998, VISION RES, V38, P1805, DOI 10.1016/S0042-6989(97)00349-0; Nelles G, 2010, J NEUROL, V257, P1832, DOI 10.1007/s00415-010-5617-1; Nelles G, 2009, J NEUROL, V256, P726, DOI 10.1007/s00415-009-5005-x; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PERENIN MT, 1975, NEUROPSYCHOLOGIA, V13, P1, DOI 10.1016/0028-3932(75)90041-X; Poggel DA, 2004, NEUROLOGY, V63, P2069, DOI 10.1212/01.WNL.0000145773.26378.E5; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; POPPELREUTER W, 1917, PSYCHISCHEN SCHADIGU, V1; POSNER MI, 1984, J NEUROSCI, V4, P1863; RIDDOCH MJ, 1983, NEUROPSYCHOLOGIA, V21, P589, DOI 10.1016/0028-3932(83)90056-8; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Romano JG, 2008, J NEUROL SCI, V273, P70, DOI 10.1016/j.jns.2008.06.026; Rushmore RJ, 2006, BRAIN, V129, P1803, DOI 10.1093/brain/awl140; SANDERS MD, 1974, LANCET, V1, P707; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; Scharli H, 1999, J COGNITIVE NEUROSCI, V11, P52, DOI 10.1162/089892999563247; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Schmidt KE, 1997, J NEUROSCI, V17, P5480; Scialfa CT, 1998, PERCEPT PSYCHOPHYS, V60, P1067, DOI 10.3758/BF03211940; Simpson SA, 2011, RAPID ADAPTATION VIS; Stoerig P, 1996, NEUROREPORT, V7, P1990, DOI 10.1097/00001756-199608120-00027; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Stoerig P, 2007, CURR BIOL, V17, pR822, DOI 10.1016/j.cub.2007.07.016; Umilta C, 1988, HDB NEUROPSYCHOLOGY, P175; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van der Stigchel S, 2010, BRAIN COGNITION, V74, P66, DOI 10.1016/j.bandc.2010.06.006; Van der Stigchel S, 2008, J COGNITIVE NEUROSCI, V20, P2025, DOI 10.1162/jocn.2008.20145; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; Verlohr D, 2007, STRABISMUS, V15, P63, DOI 10.1080/09273970601180305; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WARRINGTON EK, 1962, J NEUROL NEUROSUR PS, V25, P208, DOI 10.1136/jnnp.25.3.208; WATSON RT, 1979, NEUROLOGY, V29, P690, DOI 10.1212/WNL.29.5.690; Weil RS, 2009, NEUROPSYCHOLOGIA, V47, P457, DOI 10.1016/j.neuropsychologia.2008.09.020; Weiskrantz L, 1996, CURR OPIN NEUROBIOL, V6, P215, DOI 10.1016/S0959-4388(96)80075-4; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WEISKRANTZ L, 1987, BRAIN, V110, P77, DOI 10.1093/brain/110.1.77; Wessinger CM, 1996, PROG BRAIN RES, V112, P405; Wessinger CM, 1996, NEUROPSYCHOLOGIA, V34, P1129, DOI 10.1016/0028-3932(96)00023-1; Williams DE, 2001, PSYCHON B REV, V8, P476, DOI 10.3758/BF03196182; Zihl J, 2009, NEUROPSYCHOLOGIA, V47, P2417, DOI 10.1016/j.neuropsychologia.2009.04.009	102	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54919	10.1371/journal.pone.0054919	http://dx.doi.org/10.1371/journal.pone.0054919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390506	Green Submitted, gold, Green Published			2022-12-27	WOS:000314691100022
J	Peter, JG; Theron, G; Dheda, K				Peter, Jonathan G.; Theron, Grant; Dheda, Keertan			Can Point-of-Care Urine LAM Strip Testing for Tuberculosis Add Value to Clinical Decision Making in Hospitalised HIV-Infected Persons?	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSTIC-ACCURACY; LOW-COST; LIPOARABINOMANNAN; ASSAY; ALGORITHM	Background: The urine lipoarabinomannan (LAM) strip-test (Determine (R)-TB) can rapidly rule-in TB in HIV-infected persons with advanced immunosuppression. However, given high rates of empiric treatment amongst hospitalised patients in high-burden settings (similar to 50%) it is unclear whether LAM can add any value to clinical decision making, or identify a subset of patients with unfavourable outcomes that would otherwise have been missed by empiric treatment. Methods: 281 HIV-infected hospitalised patients with suspected TB received urine LAM strip testing, and were categorised as definite (culture-positive), probable-, or non-TB. Both the proportion and morbidity of TB cases identified by LAM testing, early empiric treatment (initiated prior to test result availability) and a set of clinical predictors were compared across groups. Results: 187/281 patients had either definite- (n = 116) or probable-TB (n = 71). As a rule-in test for definite and probable-TB, LAM identified a similar proportion of TB cases compared to early empiric treatment (85/187 vs. 93/187, p = 0.4), but a greater proportion than classified by a set of clinical predictors alone (19/187; p<0.001). Thirty-nine of the 187 (21%) LAM-positive patients who had either definite- or probable-TB were missed by early empiric treatment, and of these 25/39 (64%) would also have been missed by smear microscopy. Thus, 25/187 (8%) of definite- or probable-TB patients with otherwise delayed initiation of TB treatment could be detected by the LAM strip test. LAM-positive patients missed by early empiric treatment had a lower median CD4 count (p = 0.008), a higher median illness severity score (p = 0.001) and increased urea levels (p = 0.002) compared to LAM-negative patients given early empiric treatment. Conclusions: LAM strip testing outperformed TB diagnosis based on clinical criteria but in day-to-day practice identified a similar proportion of patients compared to early empiric treatment. However, compared to empiric treatment, LAM identified a different subset of patients with more advanced immunosuppression and greater disease severity.	[Peter, Jonathan G.; Theron, Grant; Dheda, Keertan] Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Peter, Jonathan G.; Theron, Grant; Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] UCL, Sch Med, Dept Infect, London W1N 8AA, England	University of Cape Town; University of Cape Town; University of Cape Town; University of London; University College London; UCL Medical School	Dheda, K (corresponding author), Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	Keertan.Dheda@uct.ac.za	Theron, Grant/ABB-1167-2020	Theron, Grant/0000-0002-9216-2415; Peter, Jonathan/0000-0002-2658-0723	Carnegie Academic Fellowship; SAMA fellowship; EDCTP (TB-NEAT); South African National Research Foundation; Claude Leon Foundation; EDCTP (TB-NEAT, TESA); SA DST; SA NRF (SARChI)	Carnegie Academic Fellowship; SAMA fellowship; EDCTP (TB-NEAT); South African National Research Foundation(National Research Foundation - South Africa); Claude Leon Foundation; EDCTP (TB-NEAT, TESA); SA DST; SA NRF (SARChI)	JP is supported by a Carnegie Academic Fellowship, a SAMA fellowship and the EDCTP (TB-NEAT). GT is supported by the EDCTP (TB-NEAT), the South African National Research Foundation, and the Claude Leon Foundation. KD is supported by the EDCTP (TB-NEAT, TESA), the SA DST and the SA NRF (SARChI). Alere provided in kind co-funding in the form of ELISA and LAM strip tests free of charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakari M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-32; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Edginton ME, 2005, INT J TUBERC LUNG D, V9, P398; Gill CJ, 2005, BRIT MED J, V330, P1080, DOI 10.1136/bmj.330.7499.1080; Holtz TH, 2011, LANCET INFECT DIS, V11, P533, DOI 10.1016/S1473-3099(11)70057-3; Koole O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018502; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Pai NP, 2012, DISCOV MED, V13, P35; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Peter JG, 2012, EUR RESPIR MONOGR, P124, DOI 10.1183/1025448x.10023211; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Peter JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039966; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; Theron G, 2011, LANCET, V378, P481, DOI 10.1016/S0140-6736(11)61242-7; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Wilson D, 2011, INT J TUBERC LUNG D, V15, P919, DOI 10.5588/ijtld.10.0440	24	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54875	10.1371/journal.pone.0054875	http://dx.doi.org/10.1371/journal.pone.0054875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390504	gold, Green Submitted, Green Published			2022-12-27	WOS:000314691100020
J	Chavalarias, D; Cointet, JP				Chavalarias, David; Cointet, Jean-Philippe			Phylomemetic Patterns in Science Evolution-The Rise and Fall of Scientific Fields	PLOS ONE			English	Article							KNOWLEDGE DOMAIN; WORD; NETWORKS	We introduce an automated method for the bottom-up reconstruction of the cognitive evolution of science, based on big-data issued from digital libraries, and modeled as lineage relationships between scientific fields. We refer to these dynamic structures as phylomemetic networks or phylomemies, by analogy with biological evolution; and we show that they exhibit strong regularities, with clearly identifiable phylomemetic patterns. Some structural properties of the scientific fields - in particular their density -, which are defined independently of the phylomemy reconstruction, are clearly correlated with their status and their fate in the phylomemy (like their age or their short term survival). Within the framework of a quantitative epistemology, this approach raises the question of predictibility for science evolution, and sketches a prototypical life cycle of the scientific fields: an increase of their cohesion after their emergence, the renewal of their conceptual background through branching or merging events, before decaying when their density is getting too low.	[Chavalarias, David; Cointet, Jean-Philippe] Complex Syst Inst Paris Ile de France ISC PIF, Paris, France; [Chavalarias, David] CNRS EHESS, CAMS, Paris, France; [Cointet, Jean-Philippe] INRA, INRA SenS, Marne La Vallee, France	Centre National de la Recherche Scientifique (CNRS); INRAE	Chavalarias, D (corresponding author), Complex Syst Inst Paris Ile de France ISC PIF, Paris, France.	david.chavalarias@ehess.fr	cointet, jean-philippe/AAX-3720-2021	cointet, jean-philippe/0000-0002-3172-3960; Chavalarias, David/0000-0001-9485-1399	Paris Ile-de-France Complex Systems Institute (ISC-PIF); Ecole Polytechnique; Centre National de la Recherche Scientifique (CNRS); INRA (INRA-SenS); ADEME [1204C0003]	Paris Ile-de-France Complex Systems Institute (ISC-PIF); Ecole Polytechnique; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INRA (INRA-SenS); ADEME	This research has been supported by the Paris Ile-de-France Complex Systems Institute (ISC-PIF), the Ecole Polytechnique, the Centre National de la Recherche Scientifique (CNRS), the INRA (INRA-SenS) and the ADEME (grant no1204C0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijker WE, 2007, HANDBOOK OF SCIENCE AND TECHNOLOGY STUDIES, THIRD EDITION, pXI; Bonaccorsi A, 2008, MINERVA, V46, P285, DOI 10.1007/s11024-008-9101-3; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; CALLON M, 1983, SOC SCI INFORM, V22, P191, DOI 10.1177/053901883022002003; CALLON M, 1991, SCIENTOMETRICS, V22, P155, DOI 10.1007/BF02019280; Callon M, 1986, PUTTING TEXTS THEIR, P221; Callon M., 1986, MAPPING DYNAMICS SCI, P9; Chavalarias D, 2011, STREAMS MEDIA ISSUES; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Cui WW, 2011, IEEE T VIS COMPUT GR, V17, P2412, DOI 10.1109/TVCG.2011.239; Dawkins R, 2006, SELFISH GENE; GARFIELD E, 1964, SCIENCE, V144, P649, DOI 10.1126/science.144.3619.649; He Q, 1999, LIBR TRENDS, V48, P133; Herrera M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010355; Howe CJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001069; Kageura K., 1996, Terminology, V3, P259, DOI 10.1075/term.3.2.03kag; Kuhn T., 1970, STRUCTURE SCI REVOLU; Lakatos I., 1980, METHODOLOGY SCI RES, V1; Latour Bruno., 1986, LAB LIFE SOCIAL CONS; Newman MEJ, 2004, LECT NOTES PHYS, V650, P337; Nowotny H., 2001, RETHINKING SCI KNOWL; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE; Palla G, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/186; Popper K.R., 2002, CONJECTURES REFUTATI; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Simmel G., 1898, AM J SOCIOL, V3, P662, DOI DOI 10.1086/AJS.1898.3.ISSUE-5; Skupin A, 2004, P NATL ACAD SCI USA, V101, P5274, DOI 10.1073/pnas.0307654100; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; WHITTAKER J, 1989, SOC STUD SCI, V19, P473, DOI 10.1177/030631289019003004; Zitt M, 2006, INFORM PROCESS MANAG, V42, P1513, DOI 10.1016/j.ipm.2006.03.016	32	60	61	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54847	10.1371/journal.pone.0054847	http://dx.doi.org/10.1371/journal.pone.0054847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092DU	23408947	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000007
J	Raeven, P; Salibasic, A; Drechsler, S; Weixelbaumer, KM; Jafarmadar, M; van Griensven, M; Bahrami, S; Osuchowski, MF				Raeven, Pierre; Salibasic, Alma; Drechsler, Susanne; Weixelbaumer, Katrin Maria; Jafarmadar, Mohammad; van Griensven, Martijn; Bahrami, Soheyl; Osuchowski, Marcin Filip			A Non-Lethal Traumatic/Hemorrhagic Insult Strongly Modulates the Compartment-Specific PAI-1 Response in the Subsequent Polymicrobial Sepsis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; MULTIPLE ORGAN DYSFUNCTION; HIGH-DOSE ANTITHROMBIN; SEPTIC SHOCK; SOLUBLE THROMBOMODULIN; HEMORRHAGIC-SHOCK; TRAUMA PATIENTS; MORTALITY; EPIDEMIOLOGY; COAGULOPATHY	Introduction: Plasminogen activator inhibitor 1 (PAI-1) is a key factor in trauma-and sepsis-induced coagulopathy. We examined how trauma-hemorrhage (TH) modulates PAI-1 responses in subsequent cecal ligation and puncture (CLP)-induced sepsis, and the association of PAI-1 with septic outcomes. Methods: Mice underwent TH and CLP 48 h later in three separate experiments. In experiment 1, mice were sacrificed pre-and post-CLP to characterize the trajectory of PAI-1 in plasma (protein) and tissues (mRNA). Post-CLP dynamics in TH-CLP (this study) and CLP-Only mice (prior study) were then compared for modulatory effects of TH. In experiment 2, to relate PAI-1 changes to outcome, mice underwent TH-CLP and were sampled daily and followed for 14 days to compare non-survivors (DEAD) and survivors (SUR). In experiment 3, plasma and tissue PAI-1 expression were compared between mice predicted to die (P-DIE) and to live (P-LIVE). Results: In experiment 1, an early post-TH rise of circulating PAI-1 was contrasted by a delayed (post-TH) decrease of PAI-1 mRNA in organs. In the post-CLP phase, profiles of circulating PAI-1 were similar between TH-CLP and CLP-Only mice. Conversely, PAI-1 mRNA declined in the liver and heart of TH-CLP mice versus CLP-Only. In experiment 2, there were no DEAD/SUR differences in circulating PAI-1 prior to CLP. Post-CLP, circulating PAI-1 in DEAD was 2-4-fold higher than in SUR. PAI-1 increase heralded septic deaths up to 48 h prior but DEAD/SUR thrombomodulin (endothelial injury marker) levels were identical. In experiment 3, levels of circulating PAI-1 and its hepatic gene expression were higher in P-DIE versus P-LIVE mice and those increases closely correlated with liver dysfunction. Conclusions: Trauma modulated septic PAI-1 responses in a compartment-specific fashion. Only post-CLP increases in circulating PAI-1 predicted septic outcomes. In posttraumatic sepsis, pre-lethal release of PAI-1 was mostly of hepatic origin and was independent of endothelial injury.	[Raeven, Pierre; Salibasic, Alma; Drechsler, Susanne; Weixelbaumer, Katrin Maria; Jafarmadar, Mohammad; van Griensven, Martijn; Bahrami, Soheyl; Osuchowski, Marcin Filip] Trauma Res Ctr Allgemeine Unfallversicherungsanst, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria	Ludwig Boltzmann Institute	Osuchowski, MF (corresponding author), Trauma Res Ctr Allgemeine Unfallversicherungsanst, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.	Marcin.Osuchowski@trauma.lbg.ac.at	van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881; Drechsler, Susanne/0000-0002-0758-303X; Bahrami, Soheyl/0000-0002-4563-6251; Osuchowski, Marcin/0000-0002-1321-9883	WWTF Grant [LS07-065]	WWTF Grant	The study was funded by WWTF Grant LS07-065 (awarded to MFO and SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY GJ, 1980, J SURG RES, V29, P110, DOI 10.1016/0022-4804(80)90028-1; Barkhausen T, 2009, CRIT CARE, V13, DOI 10.1186/cc7963; Bochicchio GV, 2002, J TRAUMA, V53, P245, DOI 10.1097/00005373-200208000-00010; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brunnemer U, 2011, J ORTHOP TRAUMA, V25, P511, DOI 10.1097/BOT.0b013e3182251044; Cauvi DM, 2012, J BIOL CHEM, V287, P19804, DOI 10.1074/jbc.M112.359562; Claridge JA, 2002, CRIT CARE MED, V30, P1815, DOI 10.1097/00003246-200208000-00024; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Desai KH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001093; Drechsler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051457; Drechsler S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/357926; Ebong S, 1999, INFECT IMMUN, V67, P6603; Fan J, 2000, AM J RESP CELL MOL, V22, P412, DOI 10.1165/ajrcmb.22.4.3857; Ganopolsky JG, 2004, AM J PATHOL, V165, P1433, DOI 10.1016/S0002-9440(10)63401-3; Garcia-Segarra G, 2007, INTENS CARE MED, V33, P1354, DOI 10.1007/s00134-007-0695-y; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Ikegami K, 1998, J TRAUMA, V44, P789, DOI 10.1097/00005373-199805000-00008; Iskander KN, 2012, CRIT CARE MED; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; Kurosawa S, 2008, CRIT CARE MED, V36, P985, DOI 10.1097/CCM.0B013E318165FDA7; Kwak SH, 2006, THROMB HAEMOSTASIS, V95, P829, DOI 10.1160/TH05-12-0782; Lagoa CE, 2005, HEPATOLOGY, V42, P390, DOI 10.1002/hep.20797; Levi M, 2012, SEMIN IMMUNOPATHOL, V34, P167, DOI 10.1007/s00281-011-0283-7; Lijnen HR, 2005, J THROMB HAEMOST, V3, P35, DOI 10.1111/j.1538-7836.2004.00827.x; LORENTE JA, 1993, CHEST, V103, P1536, DOI 10.1378/chest.103.5.1536; Madach K, 2010, CRIT CARE, V14, DOI 10.1186/cc8992; Mailman D, 1999, SHOCK, V12, P208, DOI 10.1097/00024382-199909000-00007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Osuchowski MF, 2007, J IMMUNOL, V179, P623, DOI 10.4049/jimmunol.179.1.623; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Osuchowski MF, 2009, CRIT CARE MED, V37, P1567, DOI 10.1097/CCM.0b013e31819df06b; Park YJ, 2008, P NATL ACAD SCI USA, V105, P11784, DOI 10.1073/pnas.0801394105; Peden M, 2000, INJURY LEADING CAUSE; Pfeifer R, 2012, CYTOKINE; PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459; Raaphorst J, 2001, THROMB HAEMOSTASIS, V86, P543, DOI 10.1055/s-0037-1616084; Raeven P, 2012, THROMB RES, V129, pE238, DOI 10.1016/j.thromres.2012.02.004; REDL H, 1993, BEHR INST MITT, V92, P218; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schochl H, 2012, HAMOSTASEOLOGIE, V32, P22, DOI 10.5482/ha-1178; Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290; Shapiro NI, 2009, J VASC RES, V46, P495, DOI 10.1159/000210662; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Tarlowe MH, 2005, AM J RESP CRIT CARE, V171, P753, DOI 10.1164/rccm.200307-917OC; van der Poll T, 2011, CURR OPIN INFECT DIS, V24, P273, DOI 10.1097/QCO.0b013e328344c078; van Griensven M, 2002, EXP TOXICOL PATHOL, V54, P203, DOI 10.1078/0940-2993-00247; van Veen SQ, 2006, CRIT CARE MED, V34, P2799, DOI 10.1097/01.CCM.0000243795.04284.2A; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Waydhas C, 1998, J TRAUMA, V45, P931, DOI 10.1097/00005373-199811000-00015; Weixelbaumer KM, 2010, SHOCK, V34, P420, DOI 10.1097/SHK.0b013e3181dc0918; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; YAMASHITA M, 1995, AM J PHYSIOL-ENDOC M, V268, pE1065, DOI 10.1152/ajpendo.1995.268.6.E1065	61	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55467	10.1371/journal.pone.0055467	http://dx.doi.org/10.1371/journal.pone.0055467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408987	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300017
J	Hoch, T; Kreitz, S; Gaffling, S; Pischetsrieder, M; Hess, A				Hoch, Tobias; Kreitz, Silke; Gaffling, Simone; Pischetsrieder, Monika; Hess, Andreas			Manganese-Enhanced Magnetic Resonance Imaging for Mapping of Whole Brain Activity Patterns Associated with the Intake of Snack Food in Ad Libitum Fed Rats	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; BODY-WEIGHT; RECEPTOR ANTAGONIST; COCAINE-SEEKING; REM-SLEEP; NUCLEUS; ADDICTION; DOPAMINE; BEHAVIOR; REWARD	Non-homeostatic hyperphagia, which is a major contributor to obesity-related hyperalimentation, is associated with the diet's molecular composition influencing, for example, the energy content. Thus, specific food items such as snack food may induce food intake independent from the state of satiety. To elucidate mechanisms how snack food may induce non-homeostatic food intake, it was tested if manganese-enhanced magnetic resonance imaging (MEMRI) was suitable for mapping the whole brain activity related to standard and snack food intake under normal behavioral situation. Application of the MnCl2 solution by osmotic pumps ensured that food intake was not significantly affected by the treatment. After z-score normalization and a non-affine three-dimensional registration to a rat brain atlas, significantly different grey values of 80 predefined brain structures were recorded in ad libitum fed rats after the intake of potato chips compared to standard chow at the group level. Ten of these areas had previously been connected to food intake, in particular to hyperphagia (e.g. dorsomedial hypothalamus or the anterior paraventricular thalamic nucleus) or to the satiety system (e.g. arcuate hypothalamic nucleus or solitary tract); 27 areas were related to reward/addiction including the core and shell of the nucleus accumbens, the ventral pallidum and the ventral striatum (caudate and putamen). Eleven areas associated to sleep displayed significantly reduced Mn2+-accumulation and six areas related to locomotor activity showed significantly increased Mn2+-accumulation after the intake of potato chips. The latter changes were associated with an observed significantly higher locomotor activity. Osmotic pump-assisted MEMRI proved to be a promising technique for functional mapping of whole brain activity patterns associated to nutritional intake under normal behavior.	[Hoch, Tobias; Pischetsrieder, Monika] Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem Div, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Kreitz, Silke; Hess, Andreas] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Gaffling, Simone] Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91054 Erlangen, Germany; [Gaffling, Simone] Univ Erlangen Nurnberg, SAOT, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Pischetsrieder, M (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem Div, Emil Fischer Ctr, D-91054 Erlangen, Germany.	monika.pischetsrieder@lmchemie.uni-erlangen.de			Emerging Fields Initiative of the Friedrich-Alexander-University Erlangen-Nuremberg	Emerging Fields Initiative of the Friedrich-Alexander-University Erlangen-Nuremberg	The study is part of the Neurotrition Project, which is supported by the Emerging Fields Initiative of the Friedrich-Alexander-University Erlangen-Nuremberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard SM, 2005, J NEUROSCI, V25, P3578, DOI 10.1523/JNEUROSCI.4177-04.2005; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Bellinger LL, 2002, PHYSIOL BEHAV, V76, P431, DOI 10.1016/S0031-9384(02)00756-4; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Chase MH, 2008, SLEEP, V31, P1487, DOI 10.1093/sleep/31.11.1487; Daum V, 2012, MODEL CONSTRAINED NO; Denbleyker M, 2009, NEUROSCIENCE, V162, P224, DOI 10.1016/j.neuroscience.2009.04.071; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Epping-Jordan MP, 1998, BRAIN RES, V784, P105, DOI 10.1016/S0006-8993(97)01190-6; Eschenko O, 2010, NEUROIMAGE, V49, P2544, DOI 10.1016/j.neuroimage.2009.10.079; Fischer B, 2003, J MATH IMAGING VIS, V18, P81, DOI 10.1023/A:1021897212261; Glick SD, 2006, EUR J PHARMACOL, V537, P94, DOI 10.1016/j.ejphar.2006.03.045; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harris Cameron D, 2005, Respir Care Clin N Am, V11, P567; Harrold JA, 2012, NEUROPHARMACOLOGY, V63, P3, DOI 10.1016/j.neuropharm.2012.01.007; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Jenkins JB, 2006, PHYSIOL BEHAV, V87, P255, DOI 10.1016/j.physbeh.2005.10.010; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; Kawagoe T, 2007, NEUROREPORT, V18, P683, DOI 10.1097/WNR.0b013e3280bef9a6; Kelley AE, 2005, J COMP NEUROL, V493, P72, DOI 10.1002/cne.20769; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; Kranz GS, 2010, NEUROSCIENCE, V166, P1023, DOI 10.1016/j.neuroscience.2010.01.036; Lenard NR, 2008, OBESITY, V16, pS11, DOI 10.1038/oby.2008.511; Mansur SS, 2011, APPETITE, V57, P498, DOI 10.1016/j.appet.2011.06.017; Martin-Fardon R, 2008, NEUROPSYCHOPHARMACOL, V33, P1827, DOI 10.1038/sj.npp.1301589; McCrory MA, 2000, J NUTR, V130, p276S, DOI 10.1093/jn/130.2.276S; Morales L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036139; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Roncari CF, 2011, NEUROSCIENCE, V196, P147, DOI 10.1016/j.neuroscience.2011.08.042; Santis S, 2009, N-S ARCH PHARMACOL, V379, P181, DOI 10.1007/s00210-008-0346-z; Scopinho AA, 2008, BRIT J PHARMACOL, V155, P752, DOI 10.1038/bjp.2008.295; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2012, NEUROIMAGE, V62, P1009, DOI 10.1016/j.neuroimage.2012.01.008; Sirieix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028724; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Stratford TR, 2013, BRAIN RES, V1490, P128, DOI 10.1016/j.brainres.2012.10.043; Stucchi P, 2012, ENDOCRINOLOGY, V153, P690, DOI 10.1210/en.2011-1023; Sun WL, 2003, J NEUROSCI, V23, P10258; Tham WWP, 2009, BRAIN RES REV, V62, P109, DOI 10.1016/j.brainresrev.2009.09.007; Trepel M, 2003, NEUROANATOMIE STRUKT; Tzschentke TM, 1999, EUR J NEUROSCI, V11, P4099, DOI 10.1046/j.1460-9568.1999.00834.x; Valdes JL, 2006, EUR J NEUROSCI, V23, P1352, DOI 10.1111/j.1460-9568.2006.04659.x; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; Zheng HY, 2007, CURR OPIN PHARMACOL, V7, P607, DOI 10.1016/j.coph.2007.10.011	54	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55354	10.1371/journal.pone.0055354	http://dx.doi.org/10.1371/journal.pone.0055354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408973	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200026
J	Lu, SS; Liu, S; Zu, QQ; Xu, XQ; Yu, J; Wang, JW; Zhang, Y; Shi, HB				Lu, Shan-shan; Liu, Sheng; Zu, Qing-quan; Xu, Xiao-quan; Yu, Jing; Wang, Jian-wei; Zhang, Yu; Shi, Hai-bin			In Vivo MR Imaging of Intraarterially Delivered Magnetically Labeled Mesenchymal Stem Cells in a Canine Stroke Model	PLOS ONE			English	Article							MARROW STROMAL CELLS; CEREBRAL-ARTERY OCCLUSION; BONE-MARROW; ISCHEMIC-STROKE; TRANSPLANTATION; INJURY; RATS; INFARCTION; MIGRATION; BLOOD	Background: This study aimed to evaluate the feasibility of intraarterial (IA) delivery and in vivo MR imaging of superparamagnetic iron oxide (SPIO)-labeled mesenchymal stem cells (MSCs) in a canine stroke model. Methodology: MSCs harvested from beagles' bone marrow were labeled with home-synthesized SPIO. Adult beagle dogs (n = 12) were subjected to left proximal middle cerebral artery (MCA) occlusion by autologous thrombus, followed by two-hour left internal carotid artery (ICA) occlusion with 5 French vertebral catheter. One week later, dogs were classified as three groups before transplantation: group A: complete MCA recanalization, group B: incomplete MCA recanalization, group C: no MCA recanalization. 3x10(6) labeled-MSCs were delivered through left ICA. Series in vivo MRI images were obtained before cell grafting, one and 24 hours after transplantation and weekly thereafter until four weeks. MRI findings were compared with histological studies at the time point of 24 hours and four weeks. Principal Findings: Home-synthesized SPIO was useful to label MSCs without cell viability compromise. MSCs scattered widely in the left cerebral hemisphere in group A, while fewer grafted cells were observed in group B and no cell was detected in group C at one hour after transplantation. A larger infarction on the day of cell transplantation was associated with more grafted cells in the brain. Grafted MSCs could be tracked effectively by MRI within four weeks and were found in peri-infarction area by Prussian blue staining. Conclusion: It is feasible of IA MSCs transplantation in a canine stroke model. Both the ipsilateral MCA condition and infarction volume before transplantation may affect the amount of grafted cells in target brain. In vivo MR imaging is useful for tracking IA delivered MSCs after SPIO labeling.	[Lu, Shan-shan; Liu, Sheng; Zu, Qing-quan; Xu, Xiao-quan; Yu, Jing; Wang, Jian-wei; Shi, Hai-bin] Nanjing Med Univ, Dept Radiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Yu] Southeast Univ, State Key Lab Bioelect, Jiangsu Key Lab Biomat & Devices, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Shi, HB (corresponding author), Nanjing Med Univ, Dept Radiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	shihb@vip.sina.com			National Natural Science Foundation of China [30870710, 81000653]; foundation of Research and Innovation Program for postgraduates in Jiangsu Province [CXZZ11.0718]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation of Research and Innovation Program for postgraduates in Jiangsu Province	This study was supported by National Natural Science Foundation of China (30870710 to Hai-bin Shi, 81000653 to Sheng Liu) and foundation of Research and Innovation Program for postgraduates in Jiangsu Province (CXZZ11.0718 to Shan-shan Lu). http://www.nsfc.gov.cn/Portalo/default152.htm; http://www.ec.js.edu.cn/art/2011/6/11/art_4266_26988.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Ben-Hur T, 2003, GLIA, V41, P73, DOI 10.1002/glia.10159; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Criado FJ, 2002, J VASC SURG, V35, P430, DOI 10.1067/mva.2002.121209; Guzman R, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E14; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ju SH, 2006, MAGN RESON IMAGING, V24, P611, DOI 10.1016/j.mri.2005.12.017; Kang BT, 2007, J VET SCI, V8, P369, DOI 10.4142/jvs.2007.8.4.369; Kang BT, 2009, COMPARATIVE MED, V59, P459; Komatsu K, 2010, BRAIN RES, V1334, P84, DOI 10.1016/j.brainres.2010.04.006; Li L, 2006, J CEREBR BLOOD F MET, V26, P1366, DOI 10.1038/sj.jcbfm.9600288; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu S, 2012, J NEUROSCI METH, V209, P90, DOI 10.1016/j.jneumeth.2012.06.009; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Rice HE, 2007, AM J ROENTGENOL, V188, P1101, DOI 10.2214/AJR.06.0663; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Song M, 2009, NEUROSCI RES, V64, P235, DOI 10.1016/j.neures.2009.03.006; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Thu MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007218; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Weon YC, 2006, AM J ROENTGENOL, V186, P1148, DOI 10.2214/AJR.05.0683; Yocum GT, 2005, RADIOLOGY, V235, P547, DOI 10.1148/radiol.2352040383; Zhou B, 2010, MAGN RESON IMAGING, V28, P394, DOI 10.1016/j.mri.2009.12.005	34	37	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54963	10.1371/journal.pone.0054963	http://dx.doi.org/10.1371/journal.pone.0054963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408953	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200013
J	Zhang, HX; Zhou, F; Li, C; Kong, M; Liu, H; Zhang, P; Zhang, S; Cao, JL; Zhang, LC; Ma, H				Zhang, Hongxing; Zhou, Fang; Li, Chen; Kong, Min; Liu, He; Zhang, Peng; Zhang, Song; Cao, Junli; Zhang, Licai; Ma, Hong			Molecular Mechanisms Underlying the Analgesic Property of Intrathecal Dexmedetomidine and Its Neurotoxicity Evaluation: An In Vivo and In Vitro Experimental Study	PLOS ONE			English	Article							LOCAL-ANESTHETICS; MICE; APOPTOSIS; PAIN; INVOLVEMENT; MODULATION; RECEPTORS; INDUCTION; PROTEIN; ERK	Background: Dexmedetomidine (DEX) has been used under perioperative settings as an adjuvant to enhance the analgesic property of local anesthetics by some anesthesiologists. However, the analgesic mechanisms and neurotoxicity of DEX were poorly understood. This study examined the effect of DEX alone on inflammatory pain, and it also examined the underlying molecular mechanisms of DEX in the spinal cord. Furthermore, in vivo and in vitro experiments were performed to investigate the neurotoxicity of DEX on the spinal cord and cortical neurons. Methods: This study used adult, male Kunming mice. In the acute inflammatory model, the left hind-paws of mice were intradermally injected with pH 5.0 PBS while chronic constrictive injury (CCI) of the sciatic nerve was used to duplicate the neuropathic pain condition. Thermal paw withdrawal latency and mechanical paw withdrawal threshold were tested with a radiant heat test and the Von Frey method, respectively. Locomotor activity and motor coordination were evaluated using the inverted mesh test. Western blotting examined spinal ERK1/2, p-ERK1/2, caspase-3 and beta-actin expressions, while spinal c-Fos protein expression was realized with immunohistochemical staining. Hematoxylin eosin (HE) staining was used to examine the pathological impacts of intrathecal DEX on the spinal cord. DAPI (4',6-diamidino-2-phenylindole) staining was used to observe cell death under an immunofluorescence microscope. Results: Intra-plantar pH 5.0 PBS-induced acute pain required spinal ERK1/2 activation. Inhibition of spinal ERK1/2 signaling by intrathecal injection of DEX displayed a robust analgesia, via a alpha 2-receptor dependent manner. The analgesic properties of DEX were validated in CCI mice. In vivo studies showed that intrathecal DEX has no significant pathological impacts on the spinal cord, and in vitro experiments indicated that DEX has potential protective effects of lidocaine-induced neural cell death. Conclusion: Intrathecal injection of DEX alone or as an adjuvant might be potential for pain relief.	[Zhang, Hongxing; Zhou, Fang; Liu, He] China Med Univ, Clin Coll 1, Shenyang, Liaoning, Peoples R China; [Zhang, Hongxing; Ma, Hong] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China; [Zhou, Fang; Li, Chen; Kong, Min; Liu, He; Zhang, Peng; Zhang, Song; Cao, Junli; Zhang, Licai] Xuzhou Med Coll, Jiangsu Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Zhou, Fang] Xuzhou Med Coll, Sch Nursing, Xuzhou, Jiangsu, Peoples R China; [Cao, Junli] Xuzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Xuzhou, Jiangsu, Peoples R China	China Medical University; China Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Ma, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China.	mahong5466@hotmail.com	Liu, He/C-9799-2012	Liu, He/0000-0002-4103-312X; Cao, Jun-Li/0000-0002-8932-4743	National Nature Science Foundation of China [81230025, 81200862]; Jiangsu Province University Graduate Student Science and Technology Innovation Project [CXLX12_0997]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province University Graduate Student Science and Technology Innovation Project	The study was supported by National Nature Science Foundation of China (81230025 and 81200862); Jiangsu Province University Graduate Student Science and Technology Innovation Project (CXLX12_0997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummett Chad M, 2009, J Opioid Manag, V5, P175; Bruzzone A, 2008, BRIT J PHARMACOL, V155, P494, DOI 10.1038/bjp.2008.278; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Drizin I, 2006, BIOORGAN MED CHEM, V14, P4740, DOI 10.1016/j.bmc.2006.03.027; Gao Yong-Jing, 2009, Open Pain J, V2, P11; Grosu Irina, 2010, F1000 Med Rep, V2, P90, DOI 10.3410/M2-90; Guan XH, 2010, PHARMACOL BIOCHEM BE, V95, P315, DOI 10.1016/j.pbb.2010.02.007; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Hwang YP, 2011, MOL NUTR FOOD RES, V55, P594, DOI 10.1002/mnfr.201000292; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; KALSO EA, 1991, PHARMACOL TOXICOL, V68, P140, DOI 10.1111/j.1600-0773.1991.tb02052.x; Konakci S, 2008, EUR J ANAESTH, V25, P403, DOI 10.1017/S0265021507003079; Lee MJ, 2010, PHARMACOL BIOCHEM BE, V97, P198, DOI 10.1016/j.pbb.2010.07.018; Lee YJ, 2011, J NEUROCHEM, V119, P1262, DOI 10.1111/j.1471-4159.2011.07529.x; LESZCZYNSKA K, 1992, J PHARMACOL TOXICOL, V27, P85, DOI 10.1016/1056-8719(92)90026-W; Li LY, 2012, J MOL NEUROSCI; Liu H, 2011, PLOS ONE US; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Perez-Castro R, 2009, ANESTH ANALG, V108, P997, DOI 10.1213/ane.0b013e31819385e1; Ries CR, 2009, ANESTHESIOLOGY, V111, P122, DOI 10.1097/ALN.0b013e3181a9160e; Ruan JP, 2010, ANESTHESIOLOGY, V112, P1234, DOI 10.1097/ALN.0b013e3181d3e0df; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Sites BD, 2012, REGION ANESTH PAIN M, V37, P478, DOI 10.1097/AAP.0b013e31825cb3d6; Tashiro A, 2009, NEUROSCIENCE, V164, P1813, DOI 10.1016/j.neuroscience.2009.09.058; Werdehausen R, 2009, BRIT J ANAESTH, V103, P711, DOI 10.1093/bja/aep236; Werdehausen R, 2007, ANESTHESIOLOGY, V107, P136, DOI 10.1097/01.anes.0000268389.39436.66; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	30	42	42	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55556	10.1371/journal.pone.0055556	http://dx.doi.org/10.1371/journal.pone.0055556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409000	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200039
J	Arman, M; Adams, Y; Lindergard, G; Rowe, JA				Arman, Monica; Adams, Yvonne; Lindergard, Gabriella; Rowe, J. Alexandra			A Method for Positive and Negative Selection of Plasmodium falciparum Platelet-Mediated Clumping Parasites and Investigation of the Role of CD36	PLOS ONE			English	Article							RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; CEREBRAL MALARIA; PROTEIN-1; ADHESION; INHIBITION; MECHANISMS; ANTIBODIES; SECRETION; BINDING	Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes (IEs) is a frequently observed parasite adhesion phenotype. The importance of clumping in severe malaria and the molecular mechanisms behind this phenomenon are incompletely understood. Three platelet surface molecules have previously been identified as clumping receptors: CD36, globular C1q receptor (gC1qR/HABP1/p32), and P-selectin (CD62P), but the parasite ligands mediating this phenotype are unknown. The aim of this work was to develop a selection method to facilitate investigations of the molecular mechanisms of clumping in selected P. falciparum lines. Magnetic beads coated with anti-platelet antibodies were used to positively and negatively select clumping IEs from P. falciparum strains IT, HB3, 3D7 and Dd2. Clumping in all four positively selected parasite lines was abolished by antibodies to CD36, but was not affected by antibodies to gC1qR or P-selectin. Clumping positive lines showed significantly higher binding to CD36 than clumping negative lines in flow adhesion assays (strains IT, HB3 and 3D7, p<0.05 for all strains, paired t test) and static assays (strain Dd2, p<0.0001 paired t test). However, clumping negative lines IT, HB3 and 3D7 did show some binding to CD36 under flow conditions, indicating that CD36-binding is not sufficient for clumping. These data show that CD36-dependent clumping positive and negative lines can easily be selected from P. falciparum laboratory strains. CD36-binding is necessary but not sufficient for clumping, and the molecular differences between clumping positive and negative parasite lines responsible for the phenotype require further investigation.	[Arman, Monica; Adams, Yvonne; Lindergard, Gabriella; Rowe, J. Alexandra] Univ Edinburgh, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Rowe, JA (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	Alex.Rowe@ed.ac.uk	Adams, Yvonne/GRX-3572-2022; Adams, Yvonne/AAX-8901-2021	Adams, Yvonne/0000-0001-8041-6580; Rowe, Alexandra/0000-0002-7702-1892	Wellcome Trust [084226]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust Senior Fellowship in Basic Biomedical Science to JAR, grant number 084226. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman M, 2007, AM J TROP MED HYG, V77, P943, DOI 10.4269/ajtmh.2007.77.943; Arman M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-243; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Biswas AK, 2007, PLOS PATHOG, V3, P1271, DOI 10.1371/journal.ppat.0030130; CARLSON J, 1990, P NATL ACAD SCI USA, V87, P2511, DOI 10.1073/pnas.87.7.2511; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Cox D, 2011, J THROMB HAEMOST, V9, P1097, DOI 10.1111/j.1538-7836.2011.04264.x; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Dawood BB, 2007, PLATELETS, V18, P329, DOI 10.1080/09537100601024111; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; Frankland S, 2007, EUKARYOT CELL, V6, P1584, DOI 10.1128/EC.00063-07; Herricks T, 2009, CELL MICROBIOL, V11, P1340, DOI 10.1111/j.1462-5822.2009.01334.x; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANGRETH SG, 1979, EXP PARASITOL, V48, P213, DOI 10.1016/0014-4894(79)90101-2; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARSH K, 1988, EXP PARASITOL, V65, P202, DOI 10.1016/0014-4894(88)90123-3; Mayor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019422; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Perrotta PL, 2007, PLATELETS, 2ND EDITION, P1265, DOI 10.1016/B978-012369367-9/50831-4; PEYRON F, 1989, PARASITOLOGY, V99, P317, DOI 10.1017/S0031182000059011; POLOGE LG, 1986, NATURE, V322, P474, DOI 10.1038/322474a0; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 2002, AM J TROP MED HYG, V66, P458, DOI 10.4269/ajtmh.2002.66.458; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; TAYLOR DW, 1987, MOL BIOCHEM PARASIT, V25, P165, DOI 10.1016/0166-6851(87)90005-3; Wahlgren M, 1995, SCAND J IMMUNOL, V42, P626, DOI 10.1111/j.1365-3083.1995.tb03705.x; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Wassmer SC, 2008, J INFECT DIS, V197, P72, DOI 10.1086/523761; Winograd E, 2004, MOL BIOCHEM PARASIT, V136, P243, DOI 10.1016/j.molbiopara.2004.04.005	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55453	10.1371/journal.pone.0055453	http://dx.doi.org/10.1371/journal.pone.0055453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405153	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400098
J	Ironside, JE				Ironside, Joseph Edward			Diversity and Recombination of Dispersed Ribosomal DNA and Protein Coding Genes in Microsporidia	PLOS ONE			English	Article							RNA-POLYMERASE-II; NOSEMA TRICHOPLUSIAE; CHROMOSOMAL DNA; DEATH EVOLUTION; LARGEST SUBUNIT; BOMBUS SPP.; 5S RDNA; SEQUENCE; LEPIDOPTERA; VAIRIMORPHA	Microsporidian strains are usually classified on the basis of their ribosomal DNA (rDNA) sequences. Although rDNA occurs as multiple copies, in most non-microsporidian species copies within a genome occur as tandem arrays and are homogenised by concerted evolution. In contrast, microsporidian rDNA units are dispersed throughout the genome in some species, and on this basis are predicted to undergo reduced concerted evolution. Furthermore many microsporidian species appear to be asexual and should therefore exhibit reduced genetic diversity due to a lack of recombination. Here, DNA sequences are compared between microsporidia with different life cycles in order to determine the effects of concerted evolution and sexual reproduction upon the diversity of rDNA and protein coding genes. Comparisons of cloned rDNA sequences between microsporidia of the genus Nosema with different life cycles provide evidence of intragenomic variability coupled with strong purifying selection. This suggests a birth and death process of evolution. However, some concerted evolution is suggested by clustering of rDNA sequences within species. Variability of protein-coding sequences indicates that considerable intergenomic variation also occurs between microsporidian cells within a single host. Patterns of variation in microsporidian DNA sequences indicate that additional diversity is generated by intragenomic and/or intergenomic recombination between sequence variants. The discovery of intragenomic variability coupled with strong purifying selection in microsporidian rRNA sequences supports the hypothesis that concerted evolution is reduced when copies of a gene are dispersed rather than repeated tandemly. The presence of intragenomic variability also renders the use of rDNA sequences for barcoding microsporidia questionable. Evidence of recombination in the single-copy genes of putatively asexual microsporidia suggests that these species may undergo cryptic sexual reproduction, a possibility with profound implications for the evolution of virulence, host range and drug resistance in these species.	Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Ironside, JE (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	jei@aber.ac.uk		Ironside, Joseph/0000-0001-6292-4768	Royal Society [2004/R2]	Royal Society(Royal Society of London)	The research presented in this article was supported by a Royal Society research grant (Ref: 2004/R2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MD, 1994, J INVERTEBR PATHOL, V64, P100, DOI 10.1006/jipa.1994.1077; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Canning EU, 1999, PARASITOLOGY, V119, P273, DOI 10.1017/S0031182099004734; Cheney SA, 2001, J EUKARYOT MICROBIOL, V48, P111, DOI 10.1111/j.1550-7408.2001.tb00422.x; Choi Y, 2011, J INVERTEBR PATHOL, V107, P86, DOI 10.1016/j.jip.2011.02.005; Cordes N, 2012, J INVERTEBR PATHOL, V109, P209, DOI 10.1016/j.jip.2011.11.005; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001277; CREASE TJ, 1991, MOL BIOL EVOL, V8, P620; DOVER G, 1981, NATURE, V290, P731, DOI 10.1038/290731a0; Dunn AM, 1998, PARASITOLOGY, V117, P21, DOI 10.1017/S0031182098002753; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; Freire R, 2010, J MOL EVOL, V70, P413, DOI 10.1007/s00239-010-9341-3; Gatehouse HS, 1998, J INVERTEBR PATHOL, V71, P97, DOI 10.1006/jipa.1997.4737; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Goldman ASH, 1996, GENETICS, V144, P43; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Huang WF, 2008, J INVERTEBR PATHOL, V97, P9, DOI 10.1016/j.jip.2007.07.001; Huang WF, 2004, FUNGAL GENET BIOL, V41, P473, DOI 10.1016/j.fgb.2003.12.005; Iiyama K, 2004, J EUKARYOT MICROBIOL, V51, P598, DOI 10.1111/j.1550-7408.2004.tb00592.x; Ironside JE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-48; KAWAKAMI Y, 1994, APPL ENTOMOL ZOOL, V29, P120, DOI 10.1303/aez.29.120; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Lee SC, 2010, PLOS ONE, P5; Li JL, 2012, INT J PARASITOL, V42, P49, DOI 10.1016/j.ijpara.2011.10.005; Liu HD, 2008, J INVERTEBR PATHOL, V99, P235, DOI 10.1016/j.jip.2008.06.012; MALONE LA, 1993, J INVERTEBR PATHOL, V61, P203, DOI 10.1006/jipa.1993.1036; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McTaggart S, 2007, GENETICS, V175, P311, DOI 10.1534/genetics.105.050229; MUNDERLOH UG, 1990, J INVERTEBR PATHOL, V56, P243, DOI 10.1016/0022-2011(90)90107-H; Nassonova E, 2005, FOLIA PARASIT, V52, P145, DOI 10.14411/fp.2005.019; Negi MS, 2002, GENOME, V45, P1181, DOI 10.1139/G02-094; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; O'Mahony EM, 2007, J EUKARYOT MICROBIOL, V54, P103, DOI 10.1111/j.1550-7408.2006.00232.x; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pieniazek NJ, 1996, J INVERTEBR PATHOL, V67, P316, DOI 10.1006/jipa.1996.0049; PILLEY BM, 1976, J INVERTEBR PATHOL, V28, P177, DOI 10.1016/0022-2011(76)90119-1; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Rooney AP, 2004, MOL BIOL EVOL, V21, P1704, DOI 10.1093/molbev/msh178; Sagastume S, 2011, ENVIRON MICROBIOL, V13, P84, DOI 10.1111/j.1462-2920.2010.02311.x; Sak B, 2011, FOLIA PARASIT, V58, P81, DOI 10.14411/fp.2011.008; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Schoch CL, 2012, NUCL RIBOSO IN PRESS; SMITH JM, 1992, J MOL EVOL, V34, P126; STREETT DA, 1984, J PARASITOL, V70, P452, DOI 10.2307/3281586; TANABE AM, 1967, J INVERTEBR PATHOL, V9, P188, DOI 10.1016/0022-2011(67)90007-9; Tay WT, 2005, J EUKARYOT MICROBIOL, V52, P505, DOI 10.1111/j.1550-7408.2005.00057.x; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Vierna J, 2009, BIOCHEM GENET, V47, P635, DOI 10.1007/s10528-009-9255-1; Voigt K, 2011, APPL MICROBIOL BIOT, V90, P41, DOI 10.1007/s00253-011-3143-4; Vrba V, 2011, VET PARASITOL, V183, P47, DOI 10.1016/j.vetpar.2011.06.020; Weedall RT, 2006, INT J PARASITOL, V36, P749, DOI 10.1016/j.ijpara.2006.02.020; Wilkinson TJ, 2011, INT J PARASITOL, V41, P959, DOI 10.1016/j.ijpara.2011.04.002	59	41	44	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55878	10.1371/journal.pone.0055878	http://dx.doi.org/10.1371/journal.pone.0055878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405227	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400172
J	Ismaeil, I; Doury, G; Desouhant, E; Dubois, F; Prevost, G; Couty, A				Ismaeil, Ibrahim; Doury, Geraldine; Desouhant, Emmanuel; Dubois, Francoise; Prevost, Genevieve; Couty, Aude			Trans-Generational Effects of Mild Heat Stress on the Life History Traits of an Aphid Parasitoid	PLOS ONE			English	Article							TRICHOGRAMMA-BRASSICAE HYM; DROSOPHILA-MELANOGASTER; CLIMATE-CHANGE; TEMPERATURE; HYMENOPTERA; HOST; RESISTANCE; WASP; SURVIVORSHIP; REPRODUCTION	Temperature changes are common in nature and insects are particularly exposed and sensitive to such variations which can be potential stresses, ultimately affecting life history traits and overall fitness. Braconids have been widely used to study the effects of temperature on host-parasitoid interactions and the present work focused on the solitary endoparasitoid Aphidius ervi Haliday (Hymenoptera: Braconidae Aphidiidae), an efficient biological control agent commercially used against aphids such as the potato aphid Macrosiphum euphorbiae Thomas (Sternorrhyncha: Aphididae). Contrary to previous studies using heat shocks at extreme temperatures, we evaluated the effects of mild heat stresses by transferring young parasitoid adults from the constant temperature of 20 degrees C to either a warm (25 degrees C) or hot (28 degrees C) temperature, for either 1 h or 48 h. Such treatments are consistent with situations commonly experienced by parasitoids when moved from their rearing conditions to greenhouses or field conditions. The effects were evaluated both on the heat stressed A. ervi adults (G0) (immediate effects) and on their first generation (G1) progeny (trans-generational effects). G0 wasps' mortality was significantly affected by the temperature in interaction with the duration of the stress. Longevity of G0 wasps surviving the heat stress was negatively affected by the temperature and females lived longer than males. Heat stress applied to A. ervi parents also had consequences on their G1 progeny whose developmental time, rates of mummification and percentage of parasitoid completing total development were negatively affected. Surprisingly, the egg load at emergence of the G1 female progeny was increased when their mothers had been submitted to a mild heat stress of 25 degrees C or 28 degrees C. These results clearly demonstrate trans-generational phenotypic plasticity, showing that adaptation to thermal stresses may be achieved via maternal effects. This study also sheds light on the complexity of insect responses and underlying mechanisms to fluctuating conditions in their natural environment.	[Ismaeil, Ibrahim; Doury, Geraldine; Dubois, Francoise; Prevost, Genevieve; Couty, Aude] Univ Picardie Jules Verne, EA Ecol & Dynam Syst Anthropises 4698, Equipe Bioecol Insectes Phytophages & Entomophage, Amiens, France; [Desouhant, Emmanuel] Univ Lyon 1, CNRS, UMR Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Couty, A (corresponding author), Univ Picardie Jules Verne, EA Ecol & Dynam Syst Anthropises 4698, Equipe Bioecol Insectes Phytophages & Entomophage, Amiens, France.	aude.couty@u-picardie.fr		DESOUHANT, Emmanuel/0000-0003-0317-4463	Atomic Energy Commission of Syria	Atomic Energy Commission of Syria	This work was made possible by the financial support of the Atomic Energy Commission of Syria through a PhD scholarship for Ibrahim Ismaeil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat I, 2006, OECOLOGIA, V148, P153, DOI 10.1007/s00442-005-0332-9; Amice G, 2008, ECOL ENTOMOL, V33, P701, DOI 10.1111/j.1365-2311.2008.01019.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2010, R LANG ENV STAT COMP; Bell HA, 2003, J APPL ENTOMOL, V127, P332, DOI 10.1046/j.1439-0418.2003.00760.x; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; BERNAL J, 1993, ENTOMOL EXP APPL, V69, P173, DOI 10.1007/BF02380643; Bezemer TM, 1998, OECOLOGIA, V116, P128, DOI 10.1007/s004420050571; Boivin G, 2010, NEOTROP ENTOMOL, V39, P457, DOI 10.1590/S1519-566X2010000400001; Candolfi MP, 1999, CHEMOSPHERE, V39, P1357, DOI 10.1016/S0045-6535(98)00489-5; Chihrane J, 1996, BIOL CONTROL, V7, P95, DOI 10.1006/bcon.1996.0070; CHIHRANE J, 1993, ENTOMOPHAGA, V38, P185, DOI 10.1007/BF02372552; Colinet H, 2006, ENVIRON ENTOMOL, V35, P228, DOI 10.1603/0046-225X-35.2.228; Denlinger DL, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P7; Desneux N, 2006, ENVIRON TOXICOL CHEM, V25, P2675, DOI 10.1897/05-562R.1; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; DIGILIO M C, 1989, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V46, P59; Djawdan M, 1997, ECOLOGY, V78, P828, DOI 10.1890/0012-9658(1997)078[0828:DSFSRL]2.0.CO;2; Feder ME, 2000, OECOLOGIA, V123, P460, DOI 10.1007/s004420000334; Fox CW, 1999, EVOLUTION, V53, P552, DOI [10.2307/2640791, 10.1111/j.1558-5646.1999.tb03790.x]; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hagvar E.B., 1991, Biocontrol News and Information, V12, P13; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hoffmann AA, 2000, FUNCT ECOL, V14, P55, DOI 10.1046/j.1365-2435.2000.00388.x; Hoffmann AA, 1997, EXTREME ENV CHANGE E; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Joseph JR, 2011, PHYTOPARASITICA, V39, P35, DOI 10.1007/s12600-010-0134-4; KIRKPATRICK M, 1989, EVOLUTION, V43, P485, DOI 10.1111/j.1558-5646.1989.tb04247.x; KOEHN RK, 1989, BIOL J LINN SOC, V37, P157, DOI 10.1111/j.1095-8312.1989.tb02100.x; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; Levie A, 2005, J ECON ENTOMOL, V98, P704, DOI 10.1603/0022-0493-98.3.704; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu YH, 2002, ENVIRON ENTOMOL, V31, P418, DOI 10.1603/0046-225X-31.2.418; Lopez SN, 2005, BIOL CONTROL, V33, P123, DOI 10.1016/j.biocontrol.2004.11.003; MACKAUER M, 1986, J INSECT PHYSIOL, V32, P275, DOI 10.1016/0022-1910(86)90039-9; March PM, 1977, ENTOMOPHAGA, V22, P365; McCullagh P, 1989, GEN LINEAR MODELS; Mironidis GK, 2008, ENVIRON ENTOMOL, V37, P16, DOI 10.1603/0046-225X(2008)37[16:DSAROH]2.0.CO;2; Mironidis GK, 2010, J THERM BIOL, V35, P59, DOI 10.1016/j.jtherbio.2009.11.001; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pennacchio F, 1999, ARCH INSECT BIOCHEM, V40, P53, DOI 10.1002/(SICI)1520-6327(1999)40:1&lt;53::AID-ARCH6&gt;3.0.CO;2-J; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; SEQUEIRA R, 1992, EVOL ECOL, V6, P34, DOI 10.1007/BF02285332; SIBLY RM, 1989, BIOL J LINN SOC, V37, P101, DOI 10.1111/j.1095-8312.1989.tb02007.x; Speight MR, 1999, ECOLOGY INSECTS CONC; Stary P, 1962, ZOOL LISTY, V11, P285; THIREAU JC, 1995, ENTOMOL EXP APPL, V76, P67, DOI 10.1007/BF02382312; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022	51	17	18	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54306	10.1371/journal.pone.0054306	http://dx.doi.org/10.1371/journal.pone.0054306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405079	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400023
J	Kim, SC; Jung, Y; Park, J; Cho, S; Seo, C; Kim, J; Kim, P; Park, J; Seo, J; Kim, J; Park, S; Jang, I; Kim, N; Yang, JO; Lee, B; Rho, K; Jung, Y; Keum, J; Lee, J; Han, J; Kang, S; Bae, S; Choi, SJ; Kim, S; Lee, JE; Kim, W; Kim, J; Lee, S				Kim, Sang Cheol; Jung, Yeonjoo; Park, Jinah; Cho, Sooyoung; Seo, Chaehwa; Kim, Jaesang; Kim, Pora; Park, Jehwan; Seo, Jihae; Kim, Jiwoong; Park, Seongjin; Jang, Insu; Kim, Namshin; Yang, Jin Ok; Lee, Byungwook; Rho, Kyoohyoung; Jung, Yeonhwa; Keum, Juhee; Lee, Jinseon; Han, Jungho; Kang, Sangeun; Bae, Sujin; Choi, So-Jung; Kim, Sujin; Lee, Jong-Eun; Kim, Wankyu; Kim, Jhingook; Lee, Sanghyuk			A High-Dimensional, Deep-Sequencing Study of Lung Adenocarcinoma in Female Never-Smokers	PLOS ONE			English	Article							SOMATIC MUTATIONS; CANCER; FUSIONS; RET; PATHWAYS; KINASES; PROTEIN; GENOME; TARGET; GENE	Background: Deep sequencing techniques provide a remarkable opportunity for comprehensive understanding of tumorigenesis at the molecular level. As omics studies become popular, integrative approaches need to be developed to move from a simple cataloguing of mutations and changes in gene expression to dissecting the molecular nature of carcinogenesis at the systemic level and understanding the complex networks that lead to cancer development. Results: Here, we describe a high-throughput, multi-dimensional sequencing study of primary lung adenocarcinoma tumors and adjacent normal tissues of six Korean female never-smoker patients. Our data encompass results from exome-seq, RNA-seq, small RNA-seq, and MeDIP-seq. We identified and validated novel genetic aberrations, including 47 somatic mutations and 19 fusion transcripts. One of the fusions involves the c-RET gene, which was recently reported to form fusion genes that may function as drivers of carcinogenesis in lung cancer patients. We also characterized gene expression profiles, which we integrated with genomic aberrations and gene regulations into functional networks. The most prominent gene network module that emerged indicates that disturbances in G2/M transition and mitotic progression are causally linked to tumorigenesis in these patients. Also, results from the analysis strongly suggest that several novel microRNA-target interactions represent key regulatory elements of the gene network. Conclusions: Our study not only provides an overview of the alterations occurring in lung adenocarcinoma at multiple levels from genome to transcriptome and epigenome, but also offers a model for integrative genomics analysis and proposes potential target pathways for the control of lung adenocarcinoma.	[Kim, Sang Cheol; Park, Jinah; Seo, Chaehwa; Park, Jehwan; Seo, Jihae; Kim, Jiwoong; Park, Seongjin; Jang, Insu; Kim, Namshin; Yang, Jin Ok; Lee, Byungwook; Rho, Kyoohyoung; Lee, Sanghyuk] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr KOBIC, Taejon, South Korea; [Jung, Yeonjoo; Cho, Sooyoung; Kim, Jaesang; Kim, Pora; Seo, Jihae; Jung, Yeonhwa; Keum, Juhee; Kim, Wankyu; Lee, Sanghyuk] Ewha Womans Univ, ERCSB, Seoul, South Korea; [Jung, Yeonjoo; Cho, Sooyoung; Kim, Jaesang; Kim, Pora; Seo, Jihae; Jung, Yeonhwa; Keum, Juhee; Kim, Wankyu; Lee, Sanghyuk] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Jung, Yeonjoo; Cho, Sooyoung; Kim, Jaesang; Kim, Pora; Seo, Jihae; Jung, Yeonhwa; Keum, Juhee; Kim, Wankyu; Lee, Sanghyuk] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea; [Lee, Jinseon; Kang, Sangeun; Bae, Sujin; Choi, So-Jung; Kim, Jhingook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, SBRI, Seoul, South Korea; [Lee, Jinseon; Kang, Sangeun; Bae, Sujin; Choi, So-Jung; Kim, Jhingook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Canc Res Inst, Seoul, South Korea; [Han, Jungho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Bae, Sujin; Choi, So-Jung] DNA Link Inc, Seoul, South Korea; [Kim, Jhingook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; Ewha Womans University; Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; DNA Link, Inc.; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, SBRI, Seoul, South Korea.	jkimsmc@skku.edu; sanghyuk@ewha.ac.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; kim, wankyu/0000-0003-3181-0594	KRIBB Research Initiative Program; National Research Foundation of Korea [20110019747, 20110002321, 20110014992]; GIST Systems Biology Infrastructure Establishment Grant through ERCSB; RP-Grant of Ewha Womans University	KRIBB Research Initiative Program; National Research Foundation of Korea(National Research Foundation of Korea); GIST Systems Biology Infrastructure Establishment Grant through ERCSB; RP-Grant of Ewha Womans University	This work was funded by grants from the KRIBB Research Initiative Program (S. L.), National Research Foundation of Korea (grant numbers 20110019747 and 20110002321 to S. L. and grant number 20110014992 to WK), GIST Systems Biology Infrastructure Establishment Grant through ERCSB (SL and JK), and RP-Grant 2011 of Ewha Womans University (SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Cho WC, 2011, GASTRIC BREAST CANC, V11, P58; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Heneghan HM, 2010, CURR OPIN PHARMACOL, V10, P543, DOI 10.1016/j.coph.2010.05.010; Huang YT, 2011, P NATL ACAD SCI USA, V108, P16345, DOI 10.1073/pnas.1102769108; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Job B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015145; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Loayza-Puch F, 2010, ONCOGENE, V29, P2638, DOI 10.1038/onc.2010.23; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393	36	48	50	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55596	10.1371/journal.pone.0055596	http://dx.doi.org/10.1371/journal.pone.0055596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405175	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400120
J	Nilsson, L; Szymanowski, A; Swahn, E; Jonasson, L				Nilsson, Lennart; Szymanowski, Aleksander; Swahn, Eva; Jonasson, Lena			Soluble TNF Receptors Are Associated with Infarct Size and Ventricular Dysfunction in ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ISCHEMIA-REPERFUSION INJURY; FACTOR-ALPHA; ISCHEMIA/REPERFUSION INJURY; PEPTIDE B-BETA(15-42); SEGMENT ELEVATION; TRANSGENIC MICE; CELL-DEATH; APOPTOSIS; HEART	Objectives: The aim of the study was to investigate circulating markers of apoptosis in relation to infarct size, left ventricular dysfunction and remodeling in an ST-elevation myocardial infarction (STEMI) population undergoing primary percutaneous coronary intervention (PCI). Background: Immediate re-opening of the acutely occluded infarct-related artery via primary PCI is the treatment of choice in STEMI to limit ischemia injury. However, the sudden re-initiation of blood flow can lead to a local acute inflammatory response with further endothelial and myocardial damage, so-called reperfusion injury. Apoptosis is suggested to be a key event in ischemia-reperfusion injury, resulting in LV-dysfunction, remodeling and heart failure. Methods: The present study is a prespecified substudy of the F.I.R.E. trial. We included 48 patients with STEMI undergoing primary PCI. Blood samples were collected prior to PCI and after 24 hours. Plasma was separated for later analysis of soluble tumor necrosis factor receptor (sTNFR) 1, sTNFR2, sFas and sFas ligand (sFasL) by ELISA. Infarct size, left ventricular (LV) dysfunction and remodeling were assessed by cardiac magnetic resonance imaging at five days and four months after STEMI. Results: The levels of sTNFR1 at 24 h as well as the relative increases in sTNFR1 and sTNFR2 over 24 h showed consistent and significant correlations with infarct size and LV-dysfunction at four months. Moreover, both sTNFRs correlated strongly with Troponin I and matrix metalloproteinase (MMP)-2 measurements. Soluble Fas and sFasL did not overall correlate with measures of infarct size or LV-dysfunction. None of the apoptosis markers correlated significantly with measures of remodeling. Conclusions: In STEMI patients, circulating levels of sTNFR1 and sTNFR2 are associated with infarct size and LV dysfunction. This provides further evidence for the role of apoptosis in ischemia-reperfusion injury.	[Nilsson, Lennart; Szymanowski, Aleksander; Swahn, Eva; Jonasson, Lena] Linkoping Univ, Div Cardiol, Dept Med & Hlth Sci, Linkoping, Sweden; [Nilsson, Lennart; Szymanowski, Aleksander; Swahn, Eva; Jonasson, Lena] Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden	Linkoping University; Linkoping University	Nilsson, L (corresponding author), Linkoping Univ, Div Cardiol, Dept Med & Hlth Sci, Linkoping, Sweden.	lennart.nilsson@liu.se			Swedish Heart-Lung Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This project was supported by grants from the Swedish Heart-Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atar D, 2007, CARDIOLOGY, V108, P117, DOI 10.1159/000095982; Atar D, 2009, J AM COLL CARDIOL, V53, P720, DOI 10.1016/j.jacc.2008.12.017; Bach TL, 1998, J BIOL CHEM, V273, P30719, DOI 10.1074/jbc.273.46.30719; Belosjorow S, 2003, AM J PHYSIOL-HEART C, V284, pH927, DOI 10.1152/ajpheart.00374.2002; BEUTLER BA, 1985, J IMMUNOL, V135, P3972; BOCCI V, 1991, CLIN PHARMACOKINET, V21, P274, DOI 10.2165/00003088-199121040-00004; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Burchfield JS, 2010, CIRC-HEART FAIL, V3, P157, DOI 10.1161/CIRCHEARTFAILURE.109.899732; Dall'Armellina E, 2010, NAT REV CARDIOL, V7, P624, DOI 10.1038/nrcardio.2010.140; Dawn B, 2004, J MOL CELL CARDIOL, V37, P51, DOI 10.1016/j.yjmcc.2004.03.012; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Haudek SB, 2007, J CLIN INVEST, V117, P2692, DOI 10.1172/JCI29134; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kakkar AK, 2004, CURR OPIN PHARMACOL, V4, P154, DOI 10.1016/j.coph.2004.01.003; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; Labruto F, 2005, BASIC RES CARDIOL, V100, P198, DOI 10.1007/s00395-004-0509-0; Lacerda L, 2009, CARDIOVASC RES, V84, P201, DOI 10.1093/cvr/cvp274; Lecour S, 2002, J MOL CELL CARDIOL, V34, P509, DOI 10.1006/jmcc.2002.1533; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Nilsson L, 2012, HEART, V98, P31, DOI 10.1136/heartjnl-2011-300079; Ohtsuka T, 1999, CORONARY ARTERY DIS, V10, P221, DOI 10.1097/00019501-199906000-00003; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P2005, DOI 10.1006/jmcc.1996.0193; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Piper HM, 2003, ANN THORAC SURG, V75, pS644, DOI 10.1016/S0003-4975(02)04686-6; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Saraste A, 1997, CIRCULATION, V95, P320; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Sugano M, 2004, MOL CELL BIOCHEM, V266, P127, DOI 10.1023/B:MCBI.0000049149.03964.c9; Thatcher Jackson L, 2003, J Invasive Cardiol, V15, P693; Ueland T, 2005, J AM COLL CARDIOL, V46, P2018, DOI 10.1016/j.jacc.2005.08.039; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Weinlich R, 2010, CELL MOL LIFE SCI, V67, P1631, DOI 10.1007/s00018-010-0289-7; Wu E, 2008, HEART, V94, P730, DOI 10.1136/hrt.2007.122622; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	42	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55477	10.1371/journal.pone.0055477	http://dx.doi.org/10.1371/journal.pone.0055477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405158	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400103
J	Lenders, M; Duning, T; Schelleckes, M; Schmitz, B; Stander, S; Rolfs, A; Brand, SM; Brand, E				Lenders, Malte; Duning, Thomas; Schelleckes, Michael; Schmitz, Boris; Stander, Sonja; Rolfs, Arndt; Brand, Stefan-Martin; Brand, Eva			s Multifocal White Matter Lesions Associated with the D313Y Mutation of the alpha-Galactosidase A Gene	PLOS ONE			English	Article							FABRY-DISEASE; VARIANT; PREVALENCE; FREQUENCY; DIAGNOSIS; PLASMA; STROKE	White matter lesions (WML) are clinically relevant since they are associated with strokes, cognitive decline, depression, or epilepsy, but the underlying etiology in young adults without classical risk factors still remains elusive. Our aim was to elucidate the possible clinical diagnosis and mechanisms leading to WML in patients carrying the D313Y mutation in the alpha-galactosidase A (GLA) gene, a mutation that was formerly described as nonpathogenic. Pathogenic GLA mutations cause Fabry disease, a vascular endothelial glycosphingolipid storage disease typically presenting with a symptom complex of renal, cardiac, and cerebrovascular manifestations. We performed in-depths clinical, biochemical and genetic examinations as well as advanced magnetic resonance imaging analyses in a pedigree with the genetically determined GLA mutation D313Y. We detected exclusive neurologic manifestations of the central nervous system of the "pseudo''-deficient D313Y mutation leading to manifest WML in 7 affected adult family members. Furthermore, two family members that do not carry the mutation showed no WML. The D313Y mutation resulted in a normal GLA enzyme activity in leukocytes and severely decreased activities in plasma. In conclusion, our results provide evidence that GLA D313Y is potentially involved in neural damage with significant WML, demonstrating the necessity of evaluating patients carrying D313Y more thoroughly. D313Y might broaden the spectrum of hereditary small artery diseases of the brain, which preferably occur in young adults without classical risk factors. In view of the existing causal therapy regime, D313Y should be more specifically taken into account in these patients.	[Lenders, Malte; Schelleckes, Michael; Schmitz, Boris; Brand, Eva] Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany; [Duning, Thomas] Univ Hosp Muenster, Dept Neurol, Munster, Germany; [Schmitz, Boris; Brand, Stefan-Martin] Univ Hosp Muenster, Inst Sports Med Mol Genet & Cardiovasc Dis, Munster, Germany; [Stander, Sonja] Univ Hosp Muenster, Dept Dermatol, Munster, Germany; [Rolfs, Arndt] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Rostock	Brand, E (corresponding author), Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany.	Eva.Brand@ukmuenster.de	Schmitz, Boris/M-3205-2019	Schmitz, Boris/0000-0001-7041-7424; Stander, Sonja/0000-0003-3612-7786	Shire HGT; Genzyme Corporation	Shire HGT; Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	AR, EB and TD have received speaker fees and research support from both Shire HGT and Genzyme Corporation. This also does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Assareh A, 2011, CNS NEUROSCI THER, V17, P525, DOI 10.1111/j.1755-5949.2010.00181.x; Baptista MV, 2010, STROKE, V41, P431, DOI 10.1161/STROKEAHA.109.570499; Basile AM, 2006, CEREBROVASC DIS, V21, P315, DOI 10.1159/000091536; Buechner S, 2008, J NEUROL NEUROSUR PS, V79, P1249, DOI 10.1136/jnnp.2008.143693; de Groot JC, 2000, ARCH GEN PSYCHIAT, V57, P1071, DOI 10.1001/archpsyc.57.11.1071; de Groot JC, 2000, ANN NEUROL, V47, P145; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; ENG CM, 1993, AM J HUM GENET, V53, P1186; Enzinger C, 2007, J NEUROL SCI, V257, P5, DOI 10.1016/j.jns.2007.01.018; Froissart R, 2010, REV MED INTERNE, V31, pS275, DOI 10.1016/S0248-8663(10)70027-8; Froissart R, 2003, MOL GENET METAB, V80, P307, DOI 10.1016/S1096-7192(03)00136-7; Gaspar P, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-19; Hoffmann B, 2006, FABRY DIS PERSPECTIV; Hoffmann B, 2007, CLIN J PAIN, V23, P535, DOI 10.1097/AJP.0b013e318074c986; Lin HY, 2009, CIRC-CARDIOVASC GENE, V2, P450, DOI 10.1161/CIRCGENETICS.109.862920; Matsuzawa F, 2005, HUM GENET, V117, P317, DOI 10.1007/s00439-005-1300-5; Maxwell H, 2012, CLIN NEUROL IN PRESS; Mehta A, 2009, LANCET, V374, P1986, DOI 10.1016/S0140-6736(09)61493-8; Monserrat L, 2007, J AM COLL CARDIOL, V50, P2399, DOI 10.1016/j.jacc.2007.06.062; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Ringelstein EB, 2010, J NEUROL SCI, V299, P81, DOI 10.1016/j.jns.2010.08.037; Sachdev P, 2008, CURR OPIN PSYCHIATR, V21, P268, DOI 10.1097/YCO.0b013e3282f945d5; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Sims K, 2009, STROKE, V40, P788, DOI 10.1161/STROKEAHA.108.526293; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Sugawara K, 2008, J HUM GENET, V53, P812, DOI 10.1007/s10038-008-0316-9; Tetaud C, 2003, J BIOL CHEM, V278, P45200, DOI 10.1074/jbc.M303868200; Tolouian R, 2010, CLIN KIDNEY J, V3, P81, DOI 10.1093/ndtplus/sfp156; Wozniak MA, 2010, STROKE, V41, P78, DOI 10.1161/STROKEAHA.109.558320; Yasuda M, 2003, HUM MUTAT, V22, P486, DOI 10.1002/humu.10275; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5	32	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55565	10.1371/journal.pone.0055565	http://dx.doi.org/10.1371/journal.pone.0055565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393592	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800046
J	Ma, XC; Dang, YH; Jia, M; Ma, R; Wang, F; Wu, J; Gao, CG; Hashimoto, K				Ma, Xian-Cang; Dang, Yong-Hui; Jia, Min; Ma, Rui; Wang, Fen; Wu, Jin; Gao, Cheng-Ge; Hashimoto, Kenji			Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; D-ASPARTATE ANTAGONIST; INDUCED HYPERACTIVITY; DEPRESSION; GLUTAMATE; SENSITIZATION; INVOLVEMENT; EFFICACY; SYNAPSE; SYSTEM	Background: Clinical studies demonstrate that the N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, induces rapid antidepressant effects in patients with refractive major depressive disorder and bipolar depression. This rapid onset of action makes ketamine a highly attractive drug for patients, particularly those who do not typically respond to therapy. A recent study suggested that glycogen synthase kinase (GSK)-3 may underlie the rapid antidepressant action of ketamine, although the precise mechanisms are unclear. In this study, we examined the effects of ketamine and GSK-3 inhibitor SB216763 in the unpredictable, chronic mild stress (CMS) mouse model of mice. Methodology/Principal Findings: Adult C57/B6 male mice were divided into 2 groups, a non-stressed control group and the unpredictable CMS (35 days) group. Then, either vehicle, ketamine (10 mg/kg), or the established GSK-3 inhibitor, SB216763 (10 mg/kg), were administered into mice in the CMS group, while vehicle was administered to controls. In the open field test, there was no difference between the four groups (control+vehicle, CMS+vehicle, CMS+ketamine, CMS+SB216763). In the sucrose intake test, a 1% sucrose intake drop, seen in CMS mice, was significantly attenuated after a single dose of ketamine, but not SB216763. In the tail suspension test (TST) and forced swimming test (FST), the increased immobility time seen in CMS mice was significantly attenuated by a single dose of ketamine, but not SB216763. Interestingly, the ketamine-induced increase in the sucrose intake test persisted for 8 days after a single dose of ketamine. Furthermore, a single administration of ketamine, but not SB216763, significantly attenuated the immobility time of the TST and FST in the control (non-stressed) mice. Conclusions/Significance: These findings suggest that a single administration of ketamine, but not GSK-3 inhibitor SB216763, produces a long-lasting antidepressant action in CMS model mice.	[Ma, Xian-Cang; Jia, Min; Ma, Rui; Wang, Fen; Gao, Cheng-Ge] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Psychiat, Xian 710049, Peoples R China; [Dang, Yong-Hui] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis,Educ Minist, Key Lab,Hlth Minist Forens Med, Dept Forens Med,Sch Med, Xian 710049, Peoples R China; [Wu, Jin; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Xi'an Jiaotong University; Xi'an Jiaotong University; Chiba University	Gao, CG (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Psychiat, Xian 710049, Peoples R China.	yaogaow@163.com; hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	National Natural Science Foundation of China [81171256, 81171262]; Minister of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [24116006] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Minister of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the National Natural Science Foundation of China (# 81171256 and # 81171262) and a grant from the Minister of Education, Culture, Sports, Science, and Technology of Japan (to K. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAMURA CA, 1993, AM J PSYCHIAT, V150, P1731; Amar S, 2011, CURR PHARM DESIGN, V17, P2264; Auer DP, 2000, BIOL PSYCHIAT, V47, P305, DOI 10.1016/S0006-3223(99)00159-6; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Beurel E, 2011, MOL PSYCHIATR, V16, P1068, DOI 10.1038/mp.2011.47; Block W, 2009, INT J NEUROPSYCHOPH, V12, P415, DOI 10.1017/S1461145708009516; Chan MH, 2012, SCHIZOPHR RES, V136, P96, DOI 10.1016/j.schres.2012.01.024; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Elyaman W, 2002, EUR J NEUROSCI, V15, P651, DOI 10.1046/j.1460-9568.2002.01899.x; Enman NM, 2012, BEHAV BRAIN RES, V231, P217, DOI 10.1016/j.bbr.2012.03.027; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hashimoto K, 2011, PROG NEURO-PSYCHOPH, V35, P1558, DOI 10.1016/j.pnpbp.2010.06.013; Hashimoto K, 2011, EXPERT REV NEUROTHER, V11, P33, DOI [10.1586/ern.10.176, 10.1586/ERN.10.176]; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Jope RS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00016; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; KIM JS, 1982, ARCH PSYCHIAT NERVEN, V232, P299, DOI 10.1007/BF00345492; Krystal JH, 2010, ARCH GEN PSYCHIAT, V67, P1110, DOI 10.1001/archgenpsychiatry.2010.138; Lei G, 2008, NEUROPSYCHOPHARMACOL, V33, P1343, DOI 10.1038/sj.npp.1301511; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Luykx JJ, 2010, EUR NEUROPSYCHOPHARM, V20, P357, DOI 10.1016/j.euroneuro.2010.02.008; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; Machado-Vieira R, 2009, BIPOLAR DISORD, V11, P92, DOI 10.1111/j.1399-5618.2009.00714.x; Machado-Vieira R, 2009, PHARMACOL THERAPEUT, V123, P143, DOI 10.1016/j.pharmthera.2009.02.010; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mathew SJ, 2012, CNS DRUGS, V26, P189, DOI 10.2165/11599770-000000000-00000; Mayorga AJ, 2001, PSYCHOPHARMACOLOGY, V155, P110, DOI 10.1007/s002130100687; Miller JS, 2010, BRAIN RES BULL, V82, P184, DOI 10.1016/j.brainresbull.2010.03.005; Miller JS, 2009, NEUROPHARMACOLOGY, V56, P1116, DOI 10.1016/j.neuropharm.2009.03.006; Mitani H, 2006, PROG NEURO-PSYCHOPH, V30, P1155, DOI 10.1016/j.pnpbp.2006.03.036; Murrough JW, 2012, CLIN PHARMACOL THER, V91, P303, DOI 10.1038/clpt.2011.244; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Rosa AO, 2008, PROG NEURO-PSYCHOPH, V32, P1549, DOI 10.1016/j.pnpbp.2008.05.020; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Tokita K, 2012, PHARMACOL BIOCHEM BE, V100, P688, DOI 10.1016/j.pbb.2011.04.016; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zarate CA, 2012, BIOL PSYCHIAT, V71, P939, DOI 10.1016/j.biopsych.2011.12.010; Zarate C, 2010, HARVARD REV PSYCHIAT, V18, P293, DOI 10.3109/10673229.2010.511059	51	71	73	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e56053	10.1371/journal.pone.0056053	http://dx.doi.org/10.1371/journal.pone.0056053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390559	gold, Green Submitted, Green Published			2022-12-27	WOS:000314691100075
J	Nevalainen, N; Lundblad, M; Gerhardt, GA; Stromberg, I				Nevalainen, Nina; Lundblad, Martin; Gerhardt, Greg A.; Stromberg, Ingrid			Striatal Glutamate Release in L-DOPA-Induced Dyskinetic Animals	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; INDUCED MOTOR COMPLICATIONS; AMINO-ACID DECARBOXYLASE; RAT MODEL; SEROTONERGIC FIBERS; BASAL GANGLIA; MULTISITE MICROELECTRODES; NIGROSTRIATAL DOPAMINE; RECEPTOR ANTAGONISM; AMANTADINE	L-DOPA-induced dyskinesia is a common side effect developed after chronic treatment with 3,4-dihydroxyphenyl-L-alanine (L-DOPA) in Parkinson's disease. The biological mechanisms behind this side effect are not fully comprehended although involvement of dopaminergic, serotonergic, and glutamatergic systems has been suggested. The present study utilizes in vivo amperometry to investigate the impact from unilateral 6-hydroxydopamine lesions and L-DOPA (4 mg/kg, including benserazide 15 mg/kg) -induced dyskinetic behavior on striatal basal extracellular glutamate concentration and potassium-evoked glutamate release in urethane-anesthetized rats. Recordings were performed before and after local L-DOPA application in the striatum. In addition, effects from the 5-HT1A receptor agonist (2R)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide (8-OHDPAT; 1 mg/kg) was assessed on glutamate release and on dyskinetic behavior. The results revealed a bilateral similar to 30% reduction of basal extracellular glutamate concentration and attenuated potassium-evoked glutamate release after a unilateral dopamine-depletion in L-DOPA naive animals. In dyskinetic subjects, basal glutamate concentration was comparable to normal controls, although potassium-evoked glutamate release was reduced to similar levels as in drug naive dopamine-lesioned animals. Furthermore, acute striatal L-DOPA administration attenuated glutamate release in all groups, except in the dopamine-lesioned striatum of dyskinetic animals. Co-administration of 8-OHDPAT and L-DOPA decreased dyskinesia in dopamine-lesioned animals, but did not affect potassium-evoked glutamate release, which was seen in normal animals. These findings indicate altered glutamate transmission upon dopamine-depletion and dyskinesia.	[Nevalainen, Nina; Stromberg, Ingrid] Umea Univ, Umea, Sweden; [Lundblad, Martin] Lund Univ, Dept Expt Med Sci, Basal Ganglia Pathophysiol Unit, Neurosci Sect, Lund, Sweden; [Gerhardt, Greg A.] Univ Kentucky, Med Ctr, Lexington, KY USA	Umea University; Lund University; University of Kentucky	Stromberg, I (corresponding author), Umea Univ, Umea, Sweden.	ingrid.stromberg@histocel.umu.se	Lundblad, Martin/AIA-7458-2022	Lundblad, Martin/0000-0001-8623-3152	Swedish Research Council Grant [09917]; Umea University Medical Faculty Funds; Konung Gustav V and Drottning Victorias Fond, Sweden	Swedish Research Council Grant(Swedish Research Council); Umea University Medical Faculty Funds; Konung Gustav V and Drottning Victorias Fond, Sweden	This study was funded by the Swedish Research Council Grant #09917, The Umea University Medical Faculty Funds, and Konung Gustav V and Drottning Victorias Fond, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Ahmed I, 2011, BRAIN, V134, P979, DOI 10.1093/brain/awr028; Antonelli T, 2005, SYNAPSE, V58, P193, DOI 10.1002/syn.20195; Arai A, 2003, BRAIN RES, V972, P229, DOI 10.1016/S0006-8993(03)02531-9; Arai R, 1996, BRAIN RES, V706, P177, DOI 10.1016/0006-8993(95)01281-8; ARAI R, 1995, NEUROSCI LETT, V195, P195, DOI 10.1016/0304-3940(95)11817-G; Aubert I, 2005, ANN NEUROL, V57, P17, DOI 10.1002/ana.20296; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Bianchi L, 2003, EUR J NEUROSCI, V18, P856, DOI 10.1046/j.1460-9568.2003.02795.x; Bibbiani F, 2005, EXP NEUROL, V196, P422, DOI 10.1016/j.expneurol.2005.08.017; Bido S, 2011, J NEUROCHEM, V118, P1043, DOI 10.1111/j.1471-4159.2011.07376.x; Blanchet PJ, 1998, MOVEMENT DISORD, V13, P798, DOI 10.1002/mds.870130507; Breit S, 2008, J NEUROSCI RES, V86, P1388, DOI 10.1002/jnr.21588; Brotchie JA, 2005, MOVEMENT DISORD, V20, P919, DOI 10.1002/mds.20612; Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3; Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429; Burmeister JJ, 2000, ANAL CHEM, V72, P187, DOI 10.1021/ac9907991; Calon F, 2003, NEUROBIOL DIS, V14, P404, DOI 10.1016/j.nbd.2003.07.003; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Cenci MA, 2007, CURR PROTOC NEUROSCI; Chase TN, 2000, TRENDS NEUROSCI, V23, pS86, DOI 10.1016/S1471-1931(00)00018-5; Corsi C, 2003, EUR J PHARMACOL, V464, P33, DOI 10.1016/S0014-2999(03)01352-9; Darmopil S, 2009, BIOL PSYCHIAT, V66, P603, DOI 10.1016/j.biopsych.2009.04.025; Day BK, 2006, J NEUROCHEM, V96, P1626, DOI 10.1111/j.1471-4159.2006.03673.x; DeFelipe J, 2001, J COMP NEUROL, V433, P148, DOI 10.1002/cne.1132; Del Dotto P, 2001, MOVEMENT DISORD, V16, P515, DOI 10.1002/mds.1112; Dupre KB, 2008, PSYCHOPHARMACOLOGY, V199, P99, DOI 10.1007/s00213-008-1135-6; Dupre KB, 2011, EXP NEUROL, V229, P288, DOI 10.1016/j.expneurol.2011.02.012; Fiorentini C, 2006, MOL PHARMACOL, V69, P805, DOI 10.1124/mol.105.016667; FISHER RS, 1984, NEUROSCI LETT, V48, P369, DOI 10.1016/0304-3940(84)90066-1; GOODWIN GM, 1987, PSYCHOPHARMACOLOGY, V91, P506, DOI 10.1007/BF00216019; Hascup KN, 2007, FRONT NEUROENG, V1, P407; HOLLISTER AS, 1979, J PHARMACOL EXP THER, V208, P37; Holmer HK, 2005, NEUROSCIENCE, V136, P333, DOI 10.1016/j.neuroscience.2005.08.003; HORNYKIEWICZ O, 1975, Psychopharmacology Bulletin, V11, P34; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Iravani MM, 2006, J PHARMACOL EXP THER, V319, P1225, DOI 10.1124/jpet.106.110429; JENNER P, 1983, BRIT J CLIN PHARMACO, V15, pS277, DOI 10.1111/j.1365-2125.1983.tb05876.x; JONES EG, 1977, J COMP NEUROL, V173, P53, DOI 10.1002/cne.901730105; Jonkers N, 2002, BRAIN RES, V926, P149, DOI 10.1016/S0006-8993(01)03147-X; King JM, 2011, LIFE SCI, V89, P638, DOI 10.1016/j.lfs.2011.08.008; Kish SJ, 2008, BRAIN, V131, P120, DOI 10.1093/brain/awm239; Kobylecki C, 2010, J NEUROCHEM, V114, P499, DOI 10.1111/j.1471-4159.2010.06776.x; Konitsiotis S, 2000, NEUROLOGY, V54, P1589, DOI 10.1212/WNL.54.8.1589; LINDEFORS N, 1990, NEUROSCI LETT, V115, P248, DOI 10.1016/0304-3940(90)90463-J; Luginger E, 2000, MOVEMENT DISORD, V15, P873, DOI 10.1002/1531-8257(200009)15:5<873::AID-MDS1017>3.0.CO;2-I; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; Lundblad M, 2009, J NEUROCHEM, V108, P998, DOI 10.1111/j.1471-4159.2008.05848.x; Maeda T, 2005, BRAIN RES, V1046, P230, DOI 10.1016/j.brainres.2005.04.019; MCGEORGE AJ, 1987, BRAIN RES, V423, P318, DOI 10.1016/0006-8993(87)90855-9; Mela F, 2007, J NEUROCHEM, V101, P483, DOI 10.1111/j.1471-4159.2007.04456.x; Mela F, 2012, NEUROBIOL DIS, V45, P573, DOI 10.1016/j.nbd.2011.09.015; Meshul CK, 1999, NEUROSCIENCE, V88, P1, DOI 10.1016/S0306-4522(98)00189-4; Metman LV, 1998, NEUROLOGY, V50, P1323, DOI 10.1212/WNL.50.5.1323; Mignon LJ, 2005, NEUROREPORT, V16, P699, DOI 10.1097/00001756-200505120-00009; Morin N, 2010, NEUROPHARMACOLOGY, V58, P981, DOI 10.1016/j.neuropharm.2009.12.024; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Nahimi A, 2012, J NEUROCHEM, V120, P806, DOI 10.1111/j.1471-4159.2011.07598.x; Navailles S, 2011, NEUROBIOL DIS, V41, P585, DOI 10.1016/j.nbd.2010.11.007; Nevalainen N, 2011, J NEUROCHEM, V118, P12, DOI 10.1111/j.1471-4159.2011.07292.x; NG KY, 1970, SCIENCE, V170, P76, DOI 10.1126/science.170.3953.76; Oh JD, 1998, BRAIN RES, V813, P150, DOI 10.1016/S0006-8993(98)01049-X; Ostock CY, 2011, NEUROPHARMACOLOGY, V61, P753, DOI 10.1016/j.neuropharm.2011.05.021; Papa SM, 1996, ANN NEUROL, V39, P574, DOI 10.1002/ana.410390505; Paquette MA, 2010, NEUROPHARMACOLOGY, V58, P1002, DOI 10.1016/j.neuropharm.2010.01.003; PETER D, 1995, J NEUROSCI, V15, P6179; Robelet S, 2004, EUR J NEUROSCI, V20, P1255, DOI 10.1111/j.1460-9568.2004.03591.x; Rylander D, 2010, NEUROBIOL DIS, V39, P352, DOI 10.1016/j.nbd.2010.05.001; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Silverdale MA, 2010, SYNAPSE, V64, P177, DOI 10.1002/syn.20739; SPROUSE JS, 1987, SYNAPSE, V1, P3, DOI 10.1002/syn.890010103; Tahar AH, 2004, NEUROBIOL DIS, V15, P171, DOI 10.1016/j.nbd.2003.10.007; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Westin JE, 2007, BIOL PSYCHIAT, V62, P800, DOI 10.1016/j.biopsych.2006.11.032; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Yamada H, 2007, NEUROSCI RES, V59, P1, DOI 10.1016/j.neures.2007.05.002; YAMADA J, 1988, EUR J PHARMACOL, V154, P299, DOI 10.1016/0014-2999(88)90205-1	77	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55706	10.1371/journal.pone.0055706	http://dx.doi.org/10.1371/journal.pone.0055706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390548	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100064
J	Panchapakesan, U; Pegg, K; Gross, S; Komala, MG; Mudaliar, H; Forbes, J; Pollock, C; Mather, A				Panchapakesan, Usha; Pegg, Kate; Gross, Simon; Komala, Muralikrishna Gangadharan; Mudaliar, Harshini; Forbes, Josephine; Pollock, Carol; Mather, Amanda			Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); PPAR-GAMMA AGONISTS; HIGH GLUCOSE; GENE-EXPRESSION; STIMULATION; DISEASE; MATRIX	Sodium/glucose cotransporter 2 (SGLT2) inhibitors are oral hypoglycemic agents used to treat patients with diabetes mellitus. SGLT2 inhibitors block reabsorption of filtered glucose by inhibiting SGLT2, the primary glucose transporter in the proximal tubular cell (PTC), leading to glycosuria and lowering of serum glucose. We examined the renoprotective effects of the SGLT2 inhibitor empagliflozin to determine whether blocking glucose entry into the kidney PTCs reduced the inflammatory and fibrotic responses of the cell to high glucose. We used an in vitro model of human PTCs. HK2 cells (human kidney PTC line) were exposed to control 5 mM, high glucose (HG) 30 mM or the profibrotic cytokine transforming growth factor beta (TGF beta 1; 0.5 ng/ml) in the presence and absence of empagliflozin for up to 72 h. SGLT1 and 2 expression and various inflammatory/fibrotic markers were assessed. A chromatin immunoprecipitation assay was used to determine the binding of phosphorylated smad3 to the promoter region of the SGLT2 gene. Our data showed that TGF beta 1 but not HG increased SGLT2 expression and this occurred via phosphorylated smad3. HG induced expression of Toll-like receptor-4, increased nuclear deoxyribonucleic acid binding for nuclear factor kappa B (NF-kappa B) and activator protein 1, induced collagen IV expression as well as interleukin-6 secretion all of which were attenuated with empagliflozin. Empagliflozin did not reduce high mobility group box protein 1 induced NF-kappa B suggesting that its effect is specifically related to a reduction in glycotoxicity. SGLT1 and GLUT2 expression was not significantly altered with HG or empagliflozin. In conclusion, empagliflozin reduces HG induced inflammatory and fibrotic markers by blocking glucose transport and did not induce a compensatory increase in SGLT1/GLUT2 expression. Although HG itself does not regulate SGLT2 expression in our model, TGF beta increases SGLT2 expression through phosphorylated smad3.	[Panchapakesan, Usha; Pegg, Kate; Gross, Simon; Komala, Muralikrishna Gangadharan; Mudaliar, Harshini; Pollock, Carol; Mather, Amanda] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Dept Med,Renal Res Grp, St Leonards, NSW 2065, Australia; [Forbes, Josephine] Mater Med Res Inst, Glycat & Diabet Res Grp, Brisbane, Qld, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Mater Research	Panchapakesan, U (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Dept Med,Renal Res Grp, St Leonards, NSW 2065, Australia.	usha.panchapakesan@sydney.edu.au	Forbes, Josephine M/A-4569-2012; Gangadharan Komala, Muralikrishna/ABA-5078-2021; Gangadharan Komala, Muralikrishna/ABH-3183-2021	Forbes, Josephine M/0000-0002-5595-8174; Gangadharan Komala, Muralikrishna/0000-0003-0534-0584; 	National Health and Medical Council of Australia [1004926]	National Health and Medical Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors are grateful to the National Health and Medical Council of Australia for funding this study (1004926). The authors would like to thank Boehringer Ingelheim for providing the empagliflozin and funding for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires I, 2010, CURR OPIN INVEST DR, V11, P1182; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Ghosh RK, 2011, J CLIN PHARM; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; Isono M, 2000, J AM SOC NEPHROL, V11, P2222, DOI 10.1681/ASN.V11122222; Johnson DW, 1998, KIDNEY INT, V53, P1601, DOI 10.1046/j.1523-1755.1998.00916.x; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; Mudaliar H, 2011, NEPHROLOGY, V16, P31; Musso G, 2011, ANN MED; NAKAMURA T, 1995, DIABETES, V44, P895, DOI 10.2337/diabetes.44.8.895; Nicolle LE, 2012, CURR MED RES OPIN, V28, P1167, DOI 10.1185/03007995.2012.689956; Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005; Panchapakesan U, 2004, AM J PHYSIOL-RENAL, V287, pF528, DOI 10.1152/ajprenal.00445.2003; POLLOCK CA, 1991, AM J PHYSIOL, V260, pF946, DOI 10.1152/ajprenal.1991.260.6.F946; POLLOCK CA, 1991, PFLUG ARCH EUR J PHY, V418, P14, DOI 10.1007/BF00370446; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Qi W, 2006, AM J PHYSIOL-RENAL, V291, pF1070, DOI 10.1152/ajprenal.00013.2006; Sharma K, 1997, DIABETES, V46, P854, DOI 10.2337/diabetes.46.5.854; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Thomson SC, 2011, AM J PHYSL REGUL INT; Vallon V, 2010, CURR OPIN NEPHROL HY, V19, P425, DOI 10.1097/MNH.0b013e32833bec06; Wolf G, 1997, AM J KIDNEY DIS, V29, P153, DOI 10.1016/S0272-6386(97)90023-8; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; YANG CW, 1994, P NATL ACAD SCI USA, V91, P9436, DOI 10.1073/pnas.91.20.9436; ZIYADEH FN, 1994, J CLIN INVEST, V93, P536, DOI 10.1172/JCI117004	30	201	220	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54442	10.1371/journal.pone.0054442	http://dx.doi.org/10.1371/journal.pone.0054442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390498	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100014
J	Rizzetti, DA; Torres, JGD; Escobar, AG; Pecanha, FM; Santos, FW; Puntel, RL; Alonso, MJ; Briones, AM; Salaices, M; Vassallo, DV; Wiggers, GA				Rizzetti, Danize A.; Torres, Joao Guilherme D.; Escobar, Alyne G.; Pecanha, Franck M.; Santos, Francielli W.; Puntel, Robson L.; Alonso, Maria J.; Briones, Ana M.; Salaices, Mercedes; Vassallo, Dalton V.; Wiggers, Giulia A.			Apocynin Prevents Vascular Effects Caused by Chronic Exposure to Low Concentrations of Mercury	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OXIDATIVE STRESS; LIPID-PEROXIDATION; ENDOTHELIAL DYSFUNCTION; NAD(P)H OXIDASE; GLUTATHIONE-PEROXIDASE; INORGANIC MERCURY; IN-VITRO; RAT; METHYLMERCURY	Mercury increases the risk of cardiovascular disease and oxidative stress and alters vascular reactivity. This metal elicits endothelial dysfunction causing decreased NO bioavailability via increased oxidative stress and contractile prostanoid production. NADPH oxidase is the major source of reactive oxygen species (ROS) in the vasculature. Our aim was to investigate whether treatment with apocynin, an NADPH oxidase inhibitor, prevents the vascular effects caused by chronic intoxication with low concentrations of mercury. Three-month-old male Wistar rats were treated for 30 days with a) intramuscular injections (i.m.) of saline; b) HgCl2 (i.m. 1(st) dose: 4.6 mu g/kg, subsequent doses: 0.07 mu g/kg/day); c) Apocynin (1.5 mM in drinking water plus saline i.m.); and d) Apocynin plus HgCl2. The mercury treatment resulted in 1) an increased aortic vasoconstrictor response to phenylephrine and reduced endothelium-dependent responses to acetylcholine; 2) the increased involvement of ROS and vasoconstrictor prostanoids in response to phenylephrine, whereas the endothelial NO modulation of such responses was reduced; and 3) the reduced activity of aortic superoxide dismutase (SOD) and glutathione peroxidase (GPx) and increased plasma malondialdehyde (MDA) levels. Treatment with apocynin partially prevented the increased phenylephrine responses and reduced the endothelial dysfunction elicited by mercury treatment. In addition, apocynin treatment increased the NO modulation of vasoconstrictor responses and aortic SOD activity and reduced plasma MDA levels without affecting the increased participation of vasoconstrictor prostanoids observed in aortic segments from mercury-treated rats. Conclusions: Mercury increases the vasoconstrictor response to phenylephrine by reducing NO bioavailability and increasing the involvement of ROS and constrictor prostanoids. Apocynin protects the vessel from the deleterious effects caused by NADPH oxidase, but not from those caused by prostanoids, thus demonstrating a two-way action.	[Rizzetti, Danize A.; Torres, Joao Guilherme D.; Escobar, Alyne G.; Pecanha, Franck M.; Santos, Francielli W.; Puntel, Robson L.; Wiggers, Giulia A.] Univ Fed Pampa, Postgrad Program Biochem, Uruguaiana, RS, Brazil; [Vassallo, Dalton V.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Alonso, Maria J.] Univ Rey Juan Carlos, Dept Biochem Physiol & Mol Genet, Alcorcon, Spain; [Briones, Ana M.; Salaices, Mercedes] Univ Autonoma Madrid, Dept Pharmacol, Sch Med, Madrid, Spain	Universidade Federal do Pampa; Universidade Federal do Espirito Santo; Universidad Rey Juan Carlos; Autonomous University of Madrid	Wiggers, GA (corresponding author), Univ Fed Pampa, Postgrad Program Biochem, Uruguaiana, RS, Brazil.	giuliawp@yahoo.com	Wiggers, Giulia/AAG-2039-2019; Rizzetti, Danize Aparecida/D-9792-2014; Alonso, María/AAB-4309-2019; Cibin, Francielli/AAW-3973-2020; Vassallo, Dalton/K-8289-2016	Wiggers, Giulia/0000-0001-5401-828X; Alonso, María/0000-0003-4912-1121; Cibin, Francielli/0000-0003-2178-1857; Puntel, Robson/0000-0001-9047-2906; Salaices Sanchez, Mercedes/0000-0003-3323-1692; Vassallo, Dalton/0000-0002-4463-4174; Briones, Ana/0000-0001-8218-5579	CAPES; CNPq/FAPES/FUNCITEC, Brazil [39767531/07]; MICIIN [SAF 2009-07201, PHB2011-0001-PC]; Pro-reitoria de Pesquisa - Federal University of Pampa [20120307165228-111]; ISCIII, Spain [Red RECAVA RD06/0014/0011]; Ramon y Cajal program [RYC-2010-06473]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/FAPES/FUNCITEC, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MICIIN; Pro-reitoria de Pesquisa - Federal University of Pampa; ISCIII, Spain(Instituto de Salud Carlos III); Ramon y Cajal program(Spanish Government)	This study was supported by and by grants from CAPES and CNPq/FAPES/FUNCITEC (39767531/07), Brazil, MICIIN (SAF 2009-07201, PHB2011-0001-PC), Pro-reitoria de Pesquisa (N degrees 20120307165228-111) - Federal University of Pampa and ISCIII (Red RECAVA RD06/0014/0011), Spain. Ana M. Briones is supported through the Ramon y Cajal program (RYC-2010-06473). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, J PHARMACOL EXP THER, V321, P381, DOI 10.1124/jpet.106.115287; BENOV LC, 1990, CHEM-BIOL INTERACT, V76, P321, DOI 10.1016/0009-2797(90)90099-9; Beswick RA, 2001, HYPERTENSION, V37, P781, DOI 10.1161/01.HYP.37.2.781; Beswick RA, 2001, HYPERTENSION, V38, P1107, DOI 10.1161/hy1101.093423; Bulat P, 1998, INT ARCH OCC ENV HEA, V71, pS37; CARMIGNANI M, 1992, BRIT J IND MED, V49, P226; Chan EC, 2007, CARDIOVASC RES, V75, P710, DOI 10.1016/j.cardiores.2007.06.005; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; da Cunha V, 2000, ARCH ENVIRON CON TOX, V39, P124; Durak D, 2009, ENVIRON TOXICOL, V24, P235, DOI 10.1002/tox.20423; El-Demerdash FM, 2001, J ENVIRON SCI HEAL B, V36, P489, DOI 10.1081/PFC-100104191; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Furieri LB, 2011, BRIT J PHARMACOL, V162, P1819, DOI 10.1111/j.1476-5381.2011.01203.x; GSTRAUNTHALER G, 1983, BIOCHEM PHARMACOL, V32, P2969, DOI 10.1016/0006-2952(83)90404-5; Hamilton CA, 2002, HYPERTENSION, V40, P755, DOI 10.1161/01.HYP.0000037063.90643.0B; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Huang YL, 1996, BIOL TRACE ELEM RES, V52, P193, DOI 10.1007/BF02789461; Hussain S, 1999, J ENVIRON SCI HEAL B, V34, P645, DOI 10.1080/03601239909373219; Jin L, 2006, J PHYSIOL PHARMACOL, V57, P343; Kobal Alfred B., 2004, Journal of Trace Elements in Medicine and Biology, V17, P261, DOI 10.1016/S0946-672X(04)80028-2; Kobal AB, 2008, ENVIRON RES, V107, P115, DOI 10.1016/j.envres.2007.07.001; LUND BO, 1993, BIOCHEM PHARMACOL, V45, P2017, DOI 10.1016/0006-2952(93)90012-L; Martinez-Revelles S, 2012, ANTIOXID REDOX SIGNA; Massaroni L, 1995, PHARMACOL RES, V32, P27, DOI 10.1016/S1043-6618(95)80005-0; McKelvey W, 2007, ENVIRON HEALTH PERSP, V115, P1435, DOI 10.1289/ehp.10056; MISRA HP, 1972, J BIOL CHEM, V247, P3170; National Academy of Sciences, 2000, TOX EFF METH; Nyland JF, 2012, TOXICOL SCI, V125, P134, DOI 10.1093/toxsci/kfr264; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pecanha FM, 2010, J PHYSIOL PHARMACOL, V61, P29; PRABHU SD, 1990, ARCH BIOCHEM BIOPHYS, V277, P47, DOI 10.1016/0003-9861(90)90548-D; RHEE HM, 1989, EXP MOL PATHOL, V50, P281, DOI 10.1016/0014-4800(89)90038-5; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; Sancho P, 2011, FREE RADICAL BIO MED, V51, P1789, DOI 10.1016/j.freeradbiomed.2011.08.011; Tian XY, 2012, ANTIOXID REDOX SIGN, V16, P363, DOI 10.1089/ars.2010.3874; Virdis A, 2004, J HYPERTENS, V22, P535, DOI 10.1097/00004872-200403000-00016; Virtanen JK, 2005, ARTERIOSCL THROM VAS, V25, P228, DOI 10.1161/01.ATV.0000150040.20950.61; Wakisaka Y, 2008, J CEREBR BLOOD F MET, V28, P1175, DOI 10.1038/jcbfm.2008.7; WAKITA Y, 1987, TOXICOL APPL PHARM, V89, P144, DOI 10.1016/0041-008X(87)90185-2; Wendel A, 1981, Methods Enzymol, V77, P325; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Wiggers GA, 2008, COMP BIOCHEM PHYS C, V147, P252, DOI 10.1016/j.cbpc.2007.10.003; Yin ZB, 2007, BRAIN RES, V1131, P1, DOI 10.1016/j.brainres.2006.10.070; Zalups RK, 2000, PHARMACOL REV, V52, P113; Zemolin APP, 2012, TOXICOLOGY, V302, P60, DOI 10.1016/j.tox.2012.07.013; Zhang YB, 2011, TOXICOL SCI, V119, P270, DOI 10.1093/toxsci/kfq334	46	38	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55806	10.1371/journal.pone.0055806	http://dx.doi.org/10.1371/journal.pone.0055806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390552	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100068
J	Yuki, KE; Eva, MM; Richer, E; Chung, D; Paquet, M; Cellier, M; Canonne-Hergaux, F; Vaulont, S; Vidal, SM; Malo, D				Yuki, Kyoko E.; Eva, Megan M.; Richer, Etienne; Chung, Dudley; Paquet, Marilene; Cellier, Mathieu; Canonne-Hergaux, Francois; Vaulont, Sophie; Vidal, Silvia M.; Malo, Danielle			Suppression of Hepcidin Expression and Iron Overload Mediate Salmonella Susceptibility in Ankyrin 1 ENU-Induced Mutant	PLOS ONE			English	Article							CELLULAR-LOCALIZATION; MUTATIONS; MICE; FERROPORTIN; INFECTIONS; DEFICIENCY; METABOLISM; RESISTANCE; TRANSPORT; DISEASES	Salmonella, a ubiquitous Gram-negative intracellular bacterium, is a food borne pathogen that infects a broad range of hosts. Infection with Salmonella Typhimurium in mice is a broadly recognized experimental model resembling typhoid fever in humans. Using a N-ethyl-N-nitrosurea (ENU) mutagenesis recessive screen, we report the identification of lty16 (Immunity to Typhimurium locus 16), a locus responsible for increased susceptibility to infection. The position of lty16 was refined on chromosome 8 and a nonsense mutation was identified in the ankyrin 1 (Ank1) gene. ANK1 plays an important role in the formation and stabilization of the red cell cytoskeleton. The Ank1(lty16/lty16) mutation causes severe hemolytic anemia in uninfected mice resulting in splenomegaly, hyperbilirubinemia, jaundice, extramedullary erythropoiesis and iron overload in liver and kidneys. Ank1(lty16/lty16) mutant mice demonstrated low levels of hepcidin (Hamp) expression and significant increases in the expression of the growth differentiation factor 15 (Gdf15), erythropoietin (Epo) and heme oxygenase 1 (Hmox1) exacerbating extramedullary erythropoiesis, tissue iron deposition and splenomegaly. As the infection progresses in Ank1(lty16/lty16), the anemia worsens and bacterial load were high in liver and kidneys compared to wild type mice. Heterozygous Ank1(+/lty16) mice were also more susceptible to Salmonella infection although to a lesser extent than Ank1(lty16/lty16) and they did not inherently present anemia and splenomegaly. During infection, iron accumulated in the kidneys of Ank1(+/lty16) mice where bacterial loads were high compared to littermate controls. The critical role of HAMP in the host response to Salmonella infection was validated by showing increased susceptibility to infection in Hamp-deficient mice and significant survival benefits in Ank1(+/lty16) heterozygous mice treated with HAMP peptide. This study illustrates that the regulation of Hamp and iron balance are crucial in the host response to Salmonella infection in Ank1 mutants.	[Yuki, Kyoko E.; Eva, Megan M.; Richer, Etienne; Vidal, Silvia M.; Malo, Danielle] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Malo, Danielle] McGill Univ, Dept Med, Montreal, PQ, Canada; [Yuki, Kyoko E.; Eva, Megan M.; Richer, Etienne; Vidal, Silvia M.; Malo, Danielle] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Paquet, Marilene] McGill Univ, Comparat Med & Anim Resources Ctr, Montreal, PQ, Canada; [Chung, Dudley] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Cellier, Mathieu] Univ Quebec, Inst Armand Frappier, Ctr INRS, Laval, PQ, Canada; [Canonne-Hergaux, Francois] Fac Med Toulouse, INSERM, U1043, CPTP, F-31073 Toulouse, France; [Vaulont, Sophie] Inst Cochin, INSERM, U1016, Paris, France; [Canonne-Hergaux, Francois] CNRS, U5282, Toulouse, France; [Canonne-Hergaux, Francois] Univ Toulouse, UPS, CPTP, Toulouse, France	McGill University; McGill University; McGill University; McGill University; University of Victoria; University of Quebec; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Malo, D (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	danielle.malo@mcgill.ca	CANONNE-HERGAUX, François/AAC-2073-2020; Paquet, Marilene/L-3414-2019; Canonne-Hergaux, Francois/L-5363-2016; Vaulont, Sophie/O-6732-2017	CANONNE-HERGAUX, François/0000-0002-0621-2157; Paquet, Marilene/0000-0002-3562-4636; Canonne-Hergaux, Francois/0000-0002-0621-2157; Malo, Danielle/0000-0003-3980-6610	Team Program of the Canadian Institutes of Health Research [CTP-87520]; Faculty of Medicine Internal Studentship Award; Research Institute of the MUHC Studentship	Team Program of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Faculty of Medicine Internal Studentship Award; Research Institute of the MUHC Studentship	This work was supported by the Team Program of the Canadian Institutes of Health Research (CTP-87520) to DM and SMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KEY was a recipient of a Faculty of Medicine Internal Studentship Award and MME was a recipient of a Research Institute of the MUHC Studentship. SMV holds a Canada Research Chair and DM is a McGill Dawson Scholar.	BENNETT V, 1992, J BIOL CHEM, V267, P8703; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Birkenmeier Connie S, 2003, Hematol J, V4, P445, DOI 10.1038/sj.thj.6200307; Boguslawska DM, 2004, ANN HEMATOL, V83, P28, DOI 10.1007/s00277-003-0739-5; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Bustamante J, 2008, IMMUNOL ALLERGY CLIN, V28, P235, DOI 10.1016/j.iac.2008.01.009; Casanova JL, 2008, J INTERN MED, V264, P115, DOI 10.1111/j.1365-2796.2008.01971.x; Collins HL, 2002, J IMMUNOL, V168, P3458, DOI 10.4049/jimmunol.168.7.3458; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Delaunay J, 2002, ACTA HAEMATOL-BASEL, V108, P210, DOI 10.1159/000065657; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Ferguson CJ, 2001, AM J PHYSIOL-RENAL, V280, pF803, DOI 10.1152/ajprenal.2001.280.5.F803; Gallagher PG, 2005, BLOOD CELL MOL DIS, V35, P345, DOI 10.1016/j.bcmd.2005.08.008; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Gardenghi S, 2010, HEMATOL ONCOL CLIN N, V24, P1089, DOI 10.1016/j.hoc.2010.08.003; Gordeuk VR, 2011, BLOOD, V118, P5278, DOI 10.1182/blood-2011-03-345512; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Greth A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038999; Harris BS, 2009, NEW PALE LETHAL MOUS; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hughes MR, 2011, EXP HEMATOL, V39, P305, DOI 10.1016/j.exphem.2010.12.009; JONES RL, 1977, NATURE, V267, P63, DOI 10.1038/267063a0; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; Lakhal S, 2009, BLOOD, V113, P1555, DOI 10.1182/blood-2008-07-170431; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Mastroeni P., 2006, SALMONELLA INFECT CL; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; Perrotta S, 2008, LANCET, V372, P1411, DOI 10.1016/S0140-6736(08)61588-3; PETERS LL, 1993, SEMIN HEMATOL, V30, P85; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Rank G, 2009, BLOOD, V113, P3352, DOI 10.1182/blood-2008-08-172841; Richer E, 2010, J IMMUNOL, V185, P3593, DOI 10.4049/jimmunol.1000890; Roy MF, 2007, J EXP MED, V204, P2949, DOI 10.1084/jem.20062606; Rubtsov AM, 2000, FEBS LETT, V482, P1, DOI 10.1016/S0014-5793(00)01924-4; Sanchez-Lopez JY, 2003, BLOOD CELL MOL DIS, V31, P357, DOI 10.1016/S1079-9796(03)00207-9; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Team R. D. C, 2011, R LANG ENV STAT COMP; Vento S, 2006, LANCET INFECT DIS, V6, P226, DOI 10.1016/S1473-3099(06)70437-6; Veuthey T, 2008, AM J PHYSIOL-RENAL, V295, pF1213, DOI 10.1152/ajprenal.90216.2008; Viatte L, 2006, BLOOD, V107, P2952, DOI 10.1182/blood-2005-10-4071; VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382, DOI 10.1002/jlb.58.4.382; Walker EM, 2000, ANN CLIN LAB SCI, V30, P354; Wareing M, 2000, J PHYSIOL-LONDON, V524, P581, DOI 10.1111/j.1469-7793.2000.00581.x; Zhou XJ, 2000, LAB INVEST, V80, P1905, DOI 10.1038/labinvest.3780200	57	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55331	10.1371/journal.pone.0055331	http://dx.doi.org/10.1371/journal.pone.0055331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390527	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100043
J	Kim, JW; Glasgow, JN; Nakayama, M; Ak, F; Ugai, H; Curiel, DT				Kim, Julius W.; Glasgow, Joel N.; Nakayama, Masaharu; Ak, Ferhat; Ugai, Hideyo; Curiel, David T.			An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer	PLOS ONE			English	Article							POLY-N-ACETYLLACTOSAMINE; IN-VIVO; FIBER PROTEIN; CANCER-CELLS; CELLULAR RECEPTORS; UDP-GALACTOSE; BREAST-CANCER; EX-VIVO; GLYCOSYLATION; THERAPY	Background: Vectors based on human adenovirus serotype 5 (HAdV-5) continue to show promise as delivery vehicles for cancer gene therapy. Nevertheless, it has become clear that therapeutic benefit is directly linked to tumor-specific vector localization, highlighting the need for tumor-targeted gene delivery. Aberrant glycosylation of cell surface glycoproteins and glycolipids is a central feature of malignant transformation, and tumor-associated glycoforms are recognized as cancer biomarkers. On this basis, we hypothesized that cancer-specific cell-surface glycans could be the basis of a novel paradigm in HAdV-5-based vector targeting. Methodology/Principal Findings: As a first step toward this goal, we constructed a novel HAdV-5 vector encoding a unique chimeric fiber protein that contains the tandem carbohydrate binding domains of the fiber protein of the NADC-1 strain of porcine adenovirus type 4 (PAdV-4). This glycan-targeted vector displays augmented CAR-independent gene transfer in cells with low CAR expression. Further, we show that gene transfer is markedly decreased in cells with genetic glycosylation defects and by inhibitors of glycosylation in normal cells. Conclusions/Significance: These data provide the initial proof-of-concept for HAdV-5 vector-mediated gene delivery based on the presence of cell-surface carbohydrates. Further development of this new targeting paradigm could provide targeted gene delivery based on vector recognition of disease-specific glycan biomarkers.	[Kim, Julius W.; Ugai, Hideyo; Curiel, David T.] Washington Univ, Sch Med, Div Canc Biol, St Louis, MO 63130 USA; [Curiel, David T.] Washington Univ, Sch Med, Biol Therapeut Ctr, Dept Radiat Oncol, St Louis, MO USA; [Ak, Ferhat] Univ Groningen, Dept Pharm, Fac Math & Nat Sci, Groningen, Netherlands; [Nakayama, Masaharu] Kyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, Japan; [Glasgow, Joel N.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Washington University (WUSTL); Washington University (WUSTL); University of Groningen; Kyushu University; University of Alabama System; University of Alabama Birmingham	Curiel, DT (corresponding author), Washington Univ, Sch Med, Div Canc Biol, St Louis, MO 63130 USA.	dcuriel@radonc.wustl.edu	Ugai, Hideyo/K-4920-2017	Ugai, Hideyo/0000-0002-9121-8480; Glasgow, Joel/0000-0002-2842-7917	National Institutes of Health [SP50 10 CA101955]; NATIONAL CANCER INSTITUTE [P50CA101955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant SP50 10 CA101955 from the National Institutes of Health (DTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; [Anonymous], 2012, J GENE MED; Barrow H, 2011, INT J CANCER, V129, P1, DOI 10.1002/ijc.25945; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Battacharya M, 1968, HDB CANCER IMMUNOLOG, V4, P277; Belousova N, 2002, J VIROL, V76, P8621, DOI 10.1128/JVI.76.17.8621-8631.2002; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Connelly S, 1999, CURR OPIN MOL THER, V1, P565; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Davison E, 1997, J VIROL, V71, P6204, DOI 10.1128/JVI.71.8.6204-6207.1997; Dempsey E, 2012, ANN NY ACAD SCI, V1253, P122, DOI 10.1111/j.1749-6632.2011.06420.x; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DO KY, 1993, J BIOL CHEM, V268, P22028; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; ELBEIN AD, 1981, P NATL ACAD SCI-BIOL, V78, P7393, DOI 10.1073/pnas.78.12.7393; Fujishiro J, 2005, NEPHROL DIAL TRANSPL, V20, P1385, DOI 10.1093/ndt/gfh783; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Glasgow JN, 2004, VIROLOGY, V324, P103, DOI 10.1016/j.virol.2004.03.028; Guardado-Calvo P, 2010, J VIROL, V84, P10558, DOI 10.1128/JVI.00997-10; Guardado-Calvo P, 2009, ACTA CRYSTALLOGR F, V65, P1149, DOI 10.1107/S1744309109038287; Hakomori S, 1996, CANCER RES, V56, P5309; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Haviv YS, 2002, CANCER RES, V62, P4273; Heikkila P, 1996, GENE THER, V3, P21; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; HUARD J, 1995, GENE THER, V2, P107; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kanerva A, 2005, ANN MED, V37, P33, DOI 10.1080/07853890410018934; Kasono K, 1999, CLIN CANCER RES, V5, P2571; Kleiboeker SB, 1995, VIRUS RES, V39, P299, DOI 10.1016/0168-1702(95)00079-8; Krasnykh V, 1998, J VIROL, V72, P1844, DOI 10.1128/JVI.72.3.1844-1852.1998; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; Li HJ, 2009, CURR OPIN BIOTECH, V20, P678, DOI 10.1016/j.copbio.2009.10.009; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Miller CR, 1998, CANCER RES, V58, P5738; MOULLIER P, 1994, KIDNEY INT, V45, P1220, DOI 10.1038/ki.1994.162; Murakami M, 2009, PROSTATE; Murakami M, 2010, VIROLOGY, V407, P196, DOI 10.1016/j.virol.2010.08.010; Nagae M, 2009, GLYCOBIOLOGY, V19, P112, DOI 10.1093/glycob/cwn121; Nakayama M, 2006, VIROLOGY, V350, P103, DOI 10.1016/j.virol.2006.01.037; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; Noureddini SC, 2006, VIRUS RES, V116, P185, DOI 10.1016/j.virusres.2005.10.002; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Okegawa T, 2000, CANCER RES, V60, P5031; Okegawa T, 2001, CANCER RES, V61, P6592; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Paul CPL, 2008, CANCER BIOL THER, V7, P786, DOI 10.4161/cbt.7.5.5421; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Renaut L, 2004, VIROLOGY, V321, P189, DOI 10.1016/j.virol.2003.12.023; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Scott Ken, 2004, Glycoconjugate Journal, V19, P467; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Short JJ, 2009, MOL CANCER THER, V8, P2096, DOI 10.1158/1535-7163.MCT-09-0367; Smith TAG, 2003, HUM GENE THER, V14, P777, DOI 10.1089/104303403765255165; STANLEY P, 1985, MOL CELL BIOL, V5, P923, DOI 10.1128/MCB.5.5.923; Takeda S, 2004, NEPHRON EXP NEPHROL, V96, pE119, DOI 10.1159/000077378; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Ugai H, 2007, J MOL BIOL, V366, P1142, DOI 10.1016/j.jmb.2006.11.090; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; van Raaij MJ, 1999, VIROLOGY, V262, P333, DOI 10.1006/viro.1999.9849; Wesseling JG, 2001, CANCER GENE THER, V8, P990, DOI 10.1038/sj.cgt.7700403; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200; YU DH, 1993, CANCER RES, V53, P891	76	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55533	10.1371/journal.pone.0055533	http://dx.doi.org/10.1371/journal.pone.0055533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383334	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900041
J	Hamilton, NA; Tammen, I; Raadsma, HW				Hamilton, Natasha A.; Tammen, Imke; Raadsma, Herman W.			Multi-Species Comparative Analysis of the Equine ACE Gene Identifies a Highly Conserved Potential Transcription Factor Binding Site in Intron 16	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; OPTIMUM RACING DISTANCE; LINKAGE ANALYSIS; COMPUTATIONAL IDENTIFICATION; THOROUGHBRED RACEHORSES; MYOCARDIAL-INFARCTION; DELETION POLYMORPHISM; REGULATORY SEQUENCES; ATHLETIC PERFORMANCE; PHYSICAL PERFORMANCE	Angiotensin converting enzyme (ACE) is essential for control of blood pressure. The human ACE gene contains an intronic Alu indel (I/D) polymorphism that has been associated with variation in serum enzyme levels, although the functional mechanism has not been identified. The polymorphism has also been associated with cardiovascular disease, type II diabetes, renal disease and elite athleticism. We have characterized the ACE gene in horses of breeds selected for differing physical abilities. The equine gene has a similar structure to that of all known mammalian ACE genes. Nine common single nucleotide polymorphisms (SNPs) discovered in pooled DNA were found to be inherited in nine haplotypes. Three of these SNPs were located in intron 16, homologous to that containing the Alu polymorphism in the human. A highly conserved 18 bp sequence, also within that intron, was identified as being a potential binding site for the transcription factors Oct-1, HFH-1 and HNF-3 beta, and lies within a larger area of higher than normal homology. This putative regulatory element may contribute to regulation of the documented inter-individual variation in human circulating enzyme levels, for which a functional mechanism is yet to be defined. Two equine SNPs occurred within the conserved area in intron 16, although neither of them disrupted the putative binding site. We propose a possible regulatory mechanism of the ACE gene in mammalian species which was previously unknown. This advance will allow further analysis leading to a better understanding of the mechanisms underpinning the associations seen between the human Alu polymorphism and enzyme levels, cardiovascular disease states and elite athleticism.	[Hamilton, Natasha A.] Univ Sydney, Fac Vet Sci, ReproGen Anim Biosci Grp, Camperdown, NSW, Australia; [Tammen, Imke; Raadsma, Herman W.] Univ Sydney Camden, Fac Vet Sci, ReproGen Anim Biosci Grp, Sydney, NSW, Australia	University of Sydney; University of Sydney	Hamilton, NA (corresponding author), Univ Sydney, Fac Vet Sci, ReproGen Anim Biosci Grp, Camperdown, NSW, Australia.	natasha.hamilton@sydney.edu.au	Tammen, Imke/AFF-7998-2022	Tammen, Imke/0000-0002-5520-6597	NSW Racing Research Fund	NSW Racing Research Fund	This work was partly funded by the NSW Racing Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alvarez R, 2000, EUR J APPL PHYSIOL, V82, P117, DOI 10.1007/s004210050660; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Baudin B, 2002, CLIN CHEM LAB MED, V40, P256, DOI 10.1515/CCLM.2002.042; BELDENT V, 1995, J BIOL CHEM, V270, P28962, DOI 10.1074/jbc.270.48.28962; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Binns MM, 2010, ANIM GENET, V41, P154, DOI 10.1111/j.1365-2052.2010.02126.x; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; CAMBIEN F, 1994, CIRCULATION, V90, P669, DOI 10.1161/01.CIR.90.2.669; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Castellon R, 2007, CURR PHARM DESIGN, V13, P1191, DOI 10.2174/138161207780618902; Cavanagh JAL, 2005, ANIM GENET, V36, P452, DOI 10.1111/j.1365-2052.2005.01340.x; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Cole J, 2000, J Renin Angiotensin Aldosterone Syst, V1, P137, DOI 10.3317/jraas.2000.016; Coomer RPC, 2003, EQUINE VET J, V35, P96, DOI 10.2746/042516403775467487; Esther CR, 1997, LAB INVEST, V77, P483; EVANS AE, 1994, Q J MED, V87, P211; Folland J, 2000, EXP PHYSIOL, V85, P575, DOI 10.1017/S0958067000020571; Frank S, 1998, DNA CELL BIOL, V17, P679, DOI 10.1089/dna.1998.17.679; Fujisawa T, 1998, DIABETOLOGIA, V41, P47, DOI 10.1007/s001250050865; Gallagher PC, 1999, MAMM GENOME, V10, P140, DOI 10.1007/s003359900959; Gayagay G, 1998, HUM GENET, V103, P48, DOI 10.1007/s004390050781; Godard S, 1998, MAMM GENOME, V9, P633, DOI 10.1007/s003359900835; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Grabe N., 2002, SILICO BIOL, V2, P1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552; Hill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008645; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; HUBERT C, 1991, J BIOL CHEM, V266, P15377; Karjalainen J, 1999, J AM COLL CARDIOL, V34, P494, DOI 10.1016/S0735-1097(99)00199-0; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McGivney BA, 2012, ANIM GENET, V43, P810, DOI 10.1111/j.1365-2052.2012.02329.x; McKenzie CA, 2001, HUM MOL GENET, V10, P1077, DOI 10.1093/hmg/10.10.1077; MONTGOMERY GW, 1990, NEW ZEAL J AGR RES, V33, P437, DOI 10.1080/00288233.1990.10428440; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Myerson S, 1999, J APPL PHYSIOL, V87, P1313, DOI 10.1152/jappl.1999.87.4.1313; Nazarov IB, 2001, EUR J HUM GENET, V9, P797, DOI 10.1038/sj.ejhg.5200711; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nobrega MA, 2004, J PHYSIOL-LONDON, V554, P31, DOI 10.1113/jphysiol.2003.050948; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Overdier DG, 1997, J BIOL CHEM, V272, P13725, DOI 10.1074/jbc.272.21.13725; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rankinen T, 2000, J APPL PHYSIOL, V88, P1571, DOI 10.1152/jappl.2000.88.5.1571; Rausa FM, 1999, MECH DEVELOP, V89, P185, DOI 10.1016/S0925-4773(99)00209-9; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rosatto N, 1999, NEPHROL DIAL TRANSPL, V14, P868, DOI 10.1093/ndt/14.4.868; Schroder W, 2011, VET J, V190, P39, DOI 10.1016/j.tvjl.2010.09.029; SHAI SY, 1990, BIOCHEM BIOPH RES CO, V167, P1128, DOI 10.1016/0006-291X(90)90640-9; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129; Sonna LA, 2001, J APPL PHYSIOL, V91, P1355, DOI 10.1152/jappl.2001.91.3.1355; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Soubrier F, 2002, EUR J HUM GENET, V10, P553, DOI 10.1038/sj.ejhg.5200847; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suehiro T, 2004, HUM GENET, V115, P91, DOI 10.1007/s00439-004-1136-4; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Taylor RR, 1999, J APPL PHYSIOL, V87, P1035, DOI 10.1152/jappl.1999.87.3.1035; TESTUT P, 1993, BIOCHEM J, V293, P843, DOI 10.1042/bj2930843; TIRET L, 1992, AM J HUM GENET, V51, P197; Tozaki T, 2010, ANIM GENET, V41, P28, DOI 10.1111/j.1365-2052.2010.02095.x; Villard E, 1996, AM J HUM GENET, V58, P1268; Wang PX, 2010, ISLETS, V2, P46, DOI 10.4161/isl.2.1.10017; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Woodman ZL, 2000, BIOCHEM J, V347, P711, DOI 10.1042/0264-6021:3470711; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	84	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55434	10.1371/journal.pone.0055434	http://dx.doi.org/10.1371/journal.pone.0055434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408978	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300013
J	Esfandiarei, M; Fameli, N; Choi, YYH; Tehrani, AY; Hoskins, JG; van Breemen, C				Esfandiarei, Mitra; Fameli, Nicola; Choi, Yohan Y. H.; Tehrani, Arash Y.; Hoskins, Jeremy G.; van Breemen, Cornelis			Waves of Calcium Depletion in the Sarcoplasmic Reticulum of Vascular Smooth Muscle Cells: An Inside View of Spatiotemporal Ca2+ Regulation	PLOS ONE			English	Article							LUMINAL CA2+; INOSITOL 1,4,5-TRISPHOSPHATE; INDUCED CONTRACTION; RELEASE; CHANNEL; ACTIVATION; VISUALIZATION; OSCILLATIONS; MITOCHONDRIA; DYNAMICS	Agonist-stimulated smooth muscle Ca2+ waves regulate blood vessel tone and vasomotion. Previous studies employing cytoplasmic Ca2+ indicators revealed that these Ca2+ waves were stimulated by a combination of inositol 1,4,5trisphosphate- and Ca2+-induced Ca2+ release from the endo/sarcoplasmic reticulum. Herein, we present the first report of endothelin-1 stimulated waves of Ca2+ depletion from the sarcoplasmic reticulum of vascular smooth muscle cells using a calsequestrin-targeted Ca2+ indicator. Our findings confirm that these waves are due to regenerative Ca2+-induced Ca2+ release by the receptors for inositol 1,4,5-trisphosphate. Our main new finding is a transient elevation in SR luminal Ca2+ concentration ([Ca2+](SR)) both at the site of wave initiation, just before regenerative Ca2+ release commences, and at the advancing wave front, during propagation. This strongly suggests a role for [Ca2+](SR) in the activation of inositol 1,4,5-trisphosphate receptors during agonist-induced calcium waves. In addition, quantitative analysis of the gradual decrease in the velocity of the depletion wave, observed in the absence of external Ca2+, indicates continuity of the lumen of the sarcoplasmic reticulum network. Finally, our observation that the depletion wave was arrested by the nuclear envelope may have implications for selective Ca2+ signalling.	[Esfandiarei, Mitra; Fameli, Nicola; Choi, Yohan Y. H.; Tehrani, Arash Y.; Hoskins, Jeremy G.; van Breemen, Cornelis] Univ British Columbia, Child & Family Res Inst, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia	Esfandiarei, M (corresponding author), Univ British Columbia, Child & Family Res Inst, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	mesfandiarei@gmail.com	Esfandiarei, Mitra/R-9903-2019; Esfandiarei, Mitra/V-1258-2019; Fameli, Nicola/AAB-7934-2019	Esfandiarei, Mitra/0000-0003-3218-7781; Fameli, Nicola/0000-0002-2022-7048	Canadian Institutes of Health Research [84309]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the operating grant (FRN#84309) from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1994, MOL CELL ENDOCRINOL, V98, P119, DOI 10.1016/0303-7207(94)90129-5; BERRIDGE MJ, 1991, CELL CALCIUM, V12, P63, DOI 10.1016/0143-4160(91)90009-4; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gordienko DV, 2001, CELL CALCIUM, V29, P13, DOI 10.1054/ceca.2000.0180; IINO M, 1987, BIOCHEM BIOPH RES CO, V142, P47, DOI 10.1016/0006-291X(87)90449-9; IINO M, 1994, EMBO J, V13, P5026, DOI 10.1002/j.1460-2075.1994.tb06831.x; Iino M, 2010, P JPN ACAD B-PHYS, V86, P244, DOI 10.2183/pjab.86.244; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kumar B, 2006, CIRC RES, V98, P557, DOI 10.1161/01.RES.0000204724.29685.db; Lee CH, 2002, AM J PHYSIOL-HEART C, V282, pH1768, DOI 10.1152/ajpheart.00637.2001; Lee CH, 2002, AM J PHYSIOL-HEART C, V282, pH1571, DOI 10.1152/ajpheart.01035.2001; Lee CH, 2002, NOVART FDN SYMP, V246, P48; Lee Cheng-Han, 2002, Novartis Found Symp, V246, P26; LEIJTEN PAA, 1986, BRIT J PHARMACOL, V89, P739, DOI 10.1111/j.1476-5381.1986.tb11178.x; LoRusso A, 1996, BRIT J PHARMACOL, V118, P885; McCarron JG, 2008, J CELL SCI, V121, P86, DOI 10.1242/jcs.017541; McCarron JG, 2010, J CELL PHYSIOL, V224, P334, DOI 10.1002/jcp.22103; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; Dai JM, 2010, EUR J PHARMACOL, V629, P82, DOI 10.1016/j.ejphar.2009.11.055; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MISSIAEN L, 1992, J PHYSIOL-LONDON, V455, P623, DOI 10.1113/jphysiol.1992.sp019319; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; Missiaen L, 1996, CELL CALCIUM, V19, P91, DOI 10.1016/S0143-4160(96)90016-0; NEYLON CB, 1990, AM J PHYSIOL, V259, pC675, DOI 10.1152/ajpcell.1990.259.4.C675; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Poburko D, 2004, TRENDS PHARMACOL SCI, V25, P8, DOI 10.1016/j.tips.2003.10.011; Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612; Rainbow RD, 2009, CELL CALCIUM, V46, P313, DOI 10.1016/j.ceca.2009.09.001; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Shmygol A, 2005, CELL CALCIUM, V37, P215, DOI 10.1016/j.ceca.2004.10.002; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Swillens S, 1998, CELL CALCIUM, V23, P291, DOI 10.1016/S0143-4160(98)90025-2; Syyong HT, 2009, BRIT J PHARMACOL, V156, P587, DOI 10.1111/j.1476-5381.2008.00063.x; Takeda Y, 2011, AM J PHYSIOL-HEART C, V301, pH2285, DOI 10.1152/ajpheart.00488.2011; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Thomas D, 1998, J BIOL CHEM, V273, P27130, DOI 10.1074/jbc.273.42.27130; Vallot O, 2000, ARTERIOSCL THROM VAS, V20, P1225, DOI 10.1161/01.ATV.20.5.1225; van Breemen C, 2006, CIRC RES, V98, P446, DOI 10.1161/01.RES.0000214329.10320.fb; Wu GS, 2009, P NATL ACAD SCI USA, V106, P10829, DOI 10.1073/pnas.0903408106; Zhang F, 2010, AM J PHYSIOL-CELL PH, V298, pC1209, DOI 10.1152/ajpcell.00533.2009	49	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55333	10.1371/journal.pone.0055333	http://dx.doi.org/10.1371/journal.pone.0055333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408969	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200023
J	Vaneckova, P; Bambrick, H				Vaneckova, Pavla; Bambrick, Hilary			Cause-Specific Hospital Admissions on Hot Days in Sydney, Australia	PLOS ONE			English	Article							HEAT-RELATED MORTALITY; CASE-CROSSOVER; CARDIOVASCULAR-DISEASES; HIGH-TEMPERATURES; SOUTH-AUSTRALIA; AIR-POLLUTION; WAVE; RISK; DEATHS; PEOPLE	Background: While morbidity outcomes for major disease categories during extreme heat have received increasing research attention, there has been very limited investigation at the level of specific disease subcategories. Methodology/Principal Findings: We analyzed daily hospital admissions for cardiovascular (CVD), respiratory (RD), genitourinary (GU) and mental diseases (MD), diabetes (DIA), dehydration (DEH) and 'the effects of heat and light' (HEAT) in Sydney between 1991 and 2009. We further investigated the sensitivity to heat of subcategories within the major disease groups. We defined hot days as those with temperatures in the 95th and 99th percentiles within the study period. We applied time-stratified case-crossover analysis to compare the hospital admissions on hot days with those on non-hot days matched by day of the week. We calculated the odds ratios (OR) of admissions between the two types of days, accounting for other environmental variables (relative humidity, ozone and particulate matter) and non-environmental trends (public and school holidays). On hot days, hospital admissions increased for all major categories except GU. This increase was not shared homogeneously across all diseases within a major category: within RD, only 'other diseases of the respiratory system' (includes pleurisy or empyema) increased significantly, while admissions for asthma decreased. Within MD, hospital admissions increased only for psychoses. Admissions due to some major categories increased one to three days after a hot day (e.g., DIA, RD and CVD) and on two and three consecutive days (e.g., HEAT and RD). Conclusions/Significance: High ambient temperatures were associated with increased hospital admissions for several disease categories, with some within-category variation. Future analyses should focus on subgroups within broad disease categories to pinpoint medical conditions most affected by ambient heat.	[Vaneckova, Pavla; Bambrick, Hilary] Univ Western Sydney, Sch Med, Sydney, NSW, Australia	Western Sydney University	Vaneckova, P (corresponding author), Univ Western Sydney, Sch Med, Sydney, NSW, Australia.	p.vaneckova@uws.edu.au		Bambrick, Hilary/0000-0001-5361-950X; Vaneckova, Pavla/0000-0001-9213-8733	'Flagship: Urbanism, Climate Adaptation and Health Collaboration Cluster'; CSIRO Climate Adaptation	'Flagship: Urbanism, Climate Adaptation and Health Collaboration Cluster'; CSIRO Climate Adaptation	The CSIRO Climate Adaptation. This study was funded by the 'Flagship: Urbanism, Climate Adaptation and Health Collaboration Cluster' grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2012, 2001 CENS QUICKSTATS; Bark N, 1998, PSYCHIATR SERV, V49, P1088, DOI 10.1176/ps.49.8.1088; Barnett, 2010, ANAL SEASONAL HLTH D; Barnett AG, 2010, ENVIRON RES, V110, P604, DOI 10.1016/j.envres.2010.05.006; Batscha C L, 1997, J Psychosoc Nurs Ment Health Serv, V35, P12; Bayentin L, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-5; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton D, 2009, APPETITE, V53, P143, DOI 10.1016/j.appet.2009.05.006; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Bureau of Meteorology (BoM), 2012, CLIM DAT ONL; Carracedo-Martinez E, 2010, ENVIRON HEALTH PERSP, V118, P1173, DOI 10.1289/ehp.0901485; CSIRO, 2007, CLIM CHANG SYDN METR; Dematte JE, 1998, ANN INTERN MED, V129, P173, DOI 10.7326/0003-4819-129-3-199808010-00001; Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5; FAUNT JD, 1995, AUST NZ J MED, V25, P117, DOI 10.1111/j.1445-5994.1995.tb02822.x; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Green RS, 2010, INT J PUBLIC HEALTH, V55, P113, DOI 10.1007/s00038-009-0076-0; Hansen A, 2008, ENVIRON HEALTH PERSP, V116, P1369, DOI 10.1289/ehp.11339; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Johnson Helen, 2005, Health Stat Q, P6; Khalaj B, 2010, INT ARCH OCC ENV HEA, V83, P833, DOI 10.1007/s00420-010-0534-2; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; LAVIZZOMOUREY RJ, 1987, J NATL MED ASSOC, V79, P1033; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; Linares C, 2008, EUR J PUBLIC HEALTH, V18, P317, DOI 10.1093/eurpub/ckm108; Loughnan ME, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-42; Lu Y, 2008, EPIDEMIOLOGY, V19, P169, DOI 10.1097/EDE.0b013e3181632c24; Lu Y, 2007, BIOSTATISTICS, V8, P337, DOI 10.1093/biostatistics/kxl013; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Martin-Latry K, 2007, EUR PSYCHIAT, V22, P335, DOI 10.1016/j.eurpsy.2007.03.007; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Naughton MP, 2002, AM J PREV MED, V22, P221, DOI 10.1016/S0749-3797(02)00421-X; Nitschke M, 2007, MED J AUSTRALIA, V187, P662, DOI 10.5694/j.1326-5377.2007.tb01466.x; Nitschke M, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-42; Nordon C, 2009, AM J GERIAT PSYCHIAT, V17, P1059, DOI 10.1097/JGP.0b013e3181b7ef6e; Page LA, 2012, BRIT J PSYCHIAT, V200, P485, DOI 10.1192/bjp.bp.111.100404; Panagiotakos DB, 2004, INT J CARDIOL, V94, P229, DOI 10.1016/j.ijcard.2003.04.050; Pudpong N, 2011, SCI TOTAL ENVIRON, V409, P5260, DOI 10.1016/j.scitotenv.2011.09.005; Ren CZ, 2006, ENVIRON HEALTH PERSP, V114, P1690, DOI 10.1289/ehp.9266; Rydman R J, 1999, J Med Syst, V23, P41, DOI 10.1023/A:1020871528086; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Vaneckova P, 2011, J APPL METEOROL CLIM, V50, P1165, DOI 10.1175/2011JAMC2632.1; Wichmann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022904; Williams S, 2012, SCI TOTAL ENVIRON, V414, P126, DOI 10.1016/j.scitotenv.2011.11.038; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]	51	67	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55459	10.1371/journal.pone.0055459	http://dx.doi.org/10.1371/journal.pone.0055459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408986	gold, Green Submitted, Green Published			2022-12-27	WOS:000315157200032
J	Altman, J; Hedl, R; Szabo, P; Mazurek, P; Riedl, V; Mullerova, J; Kopecky, M; Dolezal, J				Altman, Jan; Hedl, Radim; Szabo, Peter; Mazurek, Petr; Riedl, Vladan; Muellerova, Jana; Kopecky, Martin; Dolezal, Jiri			Tree-Rings Mirror Management Legacy: Dramatic Response of Standard Oaks to Past Coppicing in Central Europe	PLOS ONE			English	Article							FAGUS-SYLVATICA; RADIAL-GROWTH; QUERCUS-ROBUR; CANOPY DISTURBANCE; FOREST; REGENERATION; SEEDLINGS; DENDROCHRONOLOGY; COMPETITION; SUCCESSION	Background: Coppicing was one of the most important forest management systems in Europe documented in prehistory as well as in the Middle Ages. However, coppicing was gradually abandoned by the mid-20th century, which has altered the ecosystem structure, diversity and function of coppice woods. Methodology/Principal Findings: Our aim was to disentangle factors shaping the historical growth dynamics of oak standards (i.e. mature trees growing through several coppice cycles) in a former coppice-with-standards in Central Europe. Specifically, we tried to detect historical coppicing events from tree-rings of oak standards, to link coppicing events with the recruitment of mature oaks, and to determine the effects of neighbouring trees on the stem increment of oak standards. Large peaks in radial growth found for the periods 1895-1899 and 1935-1939 matched with historical records of coppice harvests. After coppicing, the number of newly recruited oak standards markedly grew in comparison with the preceding or following periods. The last significant recruitment of oak standards was after the 1930s following the last regular coppicing event. The diameter increment of oak standards from 1953 to 2003 was negatively correlated with competition indices, suggesting that neighbouring trees (mainly resprouting coppiced Tilia platyphyllos) partly suppressed the growth of oak standards. Our results showed that improved light conditions following historical coppicing events caused significant increase in pulses of radial growth and most probably maintained oak recruitment. Conclusions/Significance: Our historical perspective carries important implications for oak management in Central Europe and elsewhere. Relatively intense cutting creating open canopy woodlands, either as in the coppicing system or in the form of selective cutting, is needed to achieve significant radial growth in mature oaks. It is also critical for the successful regeneration and long-term maintenance of oak populations.	[Altman, Jan; Hedl, Radim; Szabo, Peter; Mazurek, Petr; Riedl, Vladan; Muellerova, Jana; Kopecky, Martin; Dolezal, Jiri] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Altman, Jan; Mazurek, Petr; Dolezal, Jiri] Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Riedl, Vladan] Adm Palava Protected Landscape Area, Mikulov, Czech Republic; [Kopecky, Martin] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Charles University Prague	Altman, J (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	altman.jan@gmail.com	Hédl, Radim/A-5631-2011; Mullerova, Jana/A-7915-2012; Doležal, Jiří/H-1583-2014; Kopecký, Martin/A-1466-2009; Altman, Jan/B-4305-2015; Szabó, Péter/B-1736-2010	Mullerova, Jana/0000-0001-7331-3479; Kopecký, Martin/0000-0002-1018-9316; Szabó, Péter/0000-0002-2985-0717; Dolezal, Jiri/0000-0002-5829-4051	Grant Agency of the Academy of Sciences of the Czech Republic [AV0 IAA600050812]; Grant Agency of the Czech Republic [P504/12/1952]; EC; state budget of the Czech Republic;  [RVO 67985939];  [CZ.1.07/2.3.00/20.0267];  [GAJU 138/2010/P]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); EC(European CommissionEuropean Commission Joint Research Centre); state budget of the Czech Republic; ; ; 	This study was funded by long-term research development project no. RVO 67985939, research grants AV0 IAA600050812 of the Grant Agency of the Academy of Sciences of the Czech Republic, P504/12/1952 of the Grant Agency of the Czech Republic, CZ.1.07/2.3.00/20.0267 with the financial contribution of EC and the state budget of the Czech Republic, and GAJU 138/2010/P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakala T, 2011, J VEG SCI, V22, P322, DOI 10.1111/j.1654-1103.2010.01253.x; Altman J, 2013, GLOBAL CHANGE BIOL, V19, P498, DOI 10.1111/gcb.12067; Baeten L, 2009, APPL VEG SCI, V12, P187, DOI 10.1111/j.1654-109X.2009.01013.x; Bartet E, 1890, REV EAUX FORESTS, V29, P310; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Billamboz A, 2003, TREE RINGS WETLAND O; Birks HJB, 2005, TRENDS ECOL EVOL, V20, P154, DOI 10.1016/j.tree.2005.02.001; Black BA, 2003, ECOL APPL, V13, P1733, DOI 10.1890/02-5122; BRIDGE MC, 1986, J ECOL, V74, P1095, DOI 10.2307/2260236; Bridge MC, 2000, BOT J LINN SOC, V134, P61, DOI [10.1006/bojl.2000.0364, 10.1111/j.1095-8339.2000.tb02345.x]; Broome A, 2011, BIODIVERS CONSERV, V20, P729, DOI 10.1007/s10531-010-9974-y; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Busby PE, 2009, J VEG SCI, V20, P487, DOI 10.1111/j.1654-1103.2009.01056.x; Caquet B, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009086; CARTANSON M, 1992, VEGETATIO, V100, P61; Collet C, 2008, FORESTRY, V81, P135, DOI 10.1093/forestry/cpn004; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Dobrowolska D, 2008, FORESTRY, V81, P511, DOI 10.1093/forestry/cpn025; Dolezal J, 2004, ANN BOT-LONDON, V94, P333, DOI 10.1093/aob/mch149; Dolezal J, 2010, PRESLIA, V82, P289; Dolezal J, 2009, ECOL RES, V24, P281, DOI 10.1007/s11284-008-0505-1; Emborg J, 1998, FOREST ECOL MANAG, V106, P83, DOI 10.1016/S0378-1127(97)00299-5; Erdmann GG, 1973, RP100 SUDA NC FOR SE, P100; Fraver S, 2005, CAN J FOREST RES, V35, P1648, DOI 10.1139/X05-092; Fraver S, 2009, J ECOL, V97, P289, DOI 10.1111/j.1365-2745.2008.01474.x; Frelich L.E., 2002, FOREST DYNAMICS DIST, Vfirst; Fuller Robert J., 1995, P327; Gomez-Aparicio L, 2008, OIKOS, V117, P1683, DOI 10.1111/j.1600-0706.2008.16814.x; Haneca K, 2006, VEG HIST ARCHAEOBOT, V15, P137, DOI 10.1007/s00334-005-0022-x; Harmer R, 2007, FORESTRY, V80, P137, DOI 10.1093/forestry/cpm006; Hedl R., 2007, Acta Agronomica Hungarica, V55, P453, DOI 10.1556/AAgr.55.2007.4.6; Hedl R, 2005, SROVNANI STAVU LESNI; Hedl R, 2010, DIVERS DISTRIB, V16, P267, DOI 10.1111/j.1472-4642.2010.00637.x; Helama S, 2009, PLANT SOIL, V319, P163, DOI 10.1007/s11104-008-9858-z; Hilt DE, 1979, RES437 USDA NE FOR S, P437; Holscher D, 2002, FORSTWISS CENTRALBL, V121, P229, DOI 10.1046/j.1439-0337.2002.02031.x; Holscher D, 2002, FLORA, V197, P118, DOI 10.1078/0367-2530-00021; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Ito H, 2012, FOREST ECOL MANAG, V269, P99, DOI 10.1016/j.foreco.2011.12.017; Iverson LR, 2008, FOREST ECOL MANAG, V255, P3035, DOI 10.1016/j.foreco.2007.09.088; JONES EW, 1959, J ECOL, V47, P169, DOI 10.2307/2257253; Jung T, 2000, PLANT PATHOL, V49, P706, DOI 10.1046/j.1365-3059.2000.00521.x; Kelly DL, 2002, FOREST ECOL MANAG, V166, P207, DOI 10.1016/S0378-1127(01)00670-3; Konvicka M, 2005, BIOLOGIA, V60, P551; Kopecky M, 2013, J APPL ECOL, V50, P79, DOI 10.1111/1365-2664.12010; LORIMER CG, 1994, J ECOL, V82, P227, DOI 10.2307/2261291; LORIMER CG, 1989, CAN J FOREST RES, V19, P651, DOI 10.1139/x89-102; Luisi N., 1992, P INT C, P1; MITCHELL PL, 1987, J APPL ECOL, V24, P239, DOI 10.2307/2403801; NOAA, 2012, CONTR INT TREE RING; Nowacki GJ, 1997, ECOL MONOGR, V67, P225, DOI 10.1890/0012-9615(1997)067[0225:RGACFR]2.0.CO;2; Nunez V, 2012, J NAT CONSERV, V20, P1, DOI 10.1016/j.jnc.2011.07.001; Olano JM, 2009, ANN FOREST SCI, V66, P8; Oliver WW, 1986, R180 USDA PSW FOR SE, P180; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rackham O, 2003, ANCIENT WOODLAND ITS; Rackham O., 1975, HAYLEY WOOD ITS HIST; Rentch JS, 2002, CAN J FOREST RES, V32, P915, DOI [10.1139/x02-016, 10.1139/X02-016]; Rubino Darrin L., 2004, Dendrochronologia, V21, P97, DOI 10.1078/1125.7865.00047; Spiecker H., 2002, Dendrochronologia, V20, P191, DOI 10.1078/1125-7865-00016; Splechtna BE, 2005, J VEG SCI, V16, P511, DOI 10.1658/1100-9233(2005)16[511:DHOAEO]2.0.CO;2; Svoboda M, 2012, J VEG SCI, V23, P86, DOI 10.1111/j.1654-1103.2011.01329.x; Swaine MD, 2008, BIOTROPICA, V40, P370, DOI 10.1111/j.1744-7429.2007.00386.x; Szabo P, 2011, CONSERV BIOL, V25, P680, DOI 10.1111/j.1523-1739.2011.01710.x; Szabo P, 2010, FOREST ECOL MANAG, V259, P650, DOI 10.1016/j.foreco.2009.11.026; Valladares F, 2002, TREES-STRUCT FUNCT, V16, P395, DOI 10.1007/s00468.002.0184.4; von Lupke B, 1998, FOREST ECOL MANAG, V106, P19, DOI 10.1016/S0378-1127(97)00235-1; Webster CR, 2007, CAN J FOREST RES, V37, P682, DOI 10.1139/X06-267; Welander NT, 1998, FOREST ECOL MANAG, V107, P117, DOI 10.1016/S0378-1127(97)00326-5; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Zhang J, 2010, ACTA OECOL, V36, P29, DOI 10.1016/j.actao.2009.09.005; Zhang JW, 2006, FOREST ECOL MANAG, V223, P275, DOI 10.1016/j.foreco.2005.11.007	73	58	60	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55770	10.1371/journal.pone.0055770	http://dx.doi.org/10.1371/journal.pone.0055770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405213	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400158
J	Baker, DM; Weigt, L; Fogel, M; Knowlton, N				Baker, David M.; Weigt, Lee; Fogel, Marilyn; Knowlton, Nancy			Ancient DNA from Coral-Hosted Symbiodinium Reveal a Static Mutualism over the Last 172 Years	PLOS ONE			English	Article							ALGAL SYMBIONTS; REEF CORALS; MONTASTRAEA-ANNULARIS; SCLERACTINIAN CORALS; GORGONIA-VENTALINA; CARIBBEAN CORALS; SPECIFICITY; ZOOXANTHELLAE; DIVERSITY; ENDOSYMBIONTS	Ancient DNA (aDNA) provides powerful evidence for detecting the genetic basis for adaptation to environmental change in many taxa. Among the greatest of changes in our biosphere within the last century is rapid anthropogenic ocean warming. This phenomenon threatens corals with extinction, evidenced by the increasing observation of widespread mortality following mass bleaching events. There is some evidence and conjecture that coral-dinoflagellate symbioses change partnerships in response to changing external conditions over ecological and evolutionary timescales. Until now, we have been unable to ascertain the genetic identity of Symbiodinium hosted by corals prior to the rapid global change of the last century. Here, we show that Symbiodinium cells recovered from dry, century old specimens of 6 host species of octocorals contain sufficient DNA for amplification of the ITS2 subregion of the nuclear ribosomal DNA, commonly used for genotyping within this genus. Through comparisons with modern specimens sampled from similar locales we show that symbiotic associations among several species have been static over the last century, thereby suggesting that adaptive shifts to novel symbiont types is not common among these gorgonians, and perhaps, symbiotic corals in general.	[Baker, David M.] Smithsonian Inst, Marine Sci Network, Washington, DC 20560 USA; [Baker, David M.; Fogel, Marilyn] Carnegie Inst Sci, Geophys Lab, Washington, DC USA; [Weigt, Lee] Smithsonian Inst, Museum Support Ctr, Labs Analyt Biol, Suitland, MD USA; [Knowlton, Nancy] Smithsonian Inst, Dept Invertebrate Zool, Washington, DC 20560 USA	Smithsonian Institution; Carnegie Institution for Science; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Baker, DM (corresponding author), Smithsonian Inst, Marine Sci Network, Washington, DC 20560 USA.	dmbaker@hku.hk	Baker, David/B-2512-2010	Baker, David/0000-0002-0308-4954	Smithsonian's Marine Science Network Fellowship; Laboratories of Analytical Biology	Smithsonian's Marine Science Network Fellowship; Laboratories of Analytical Biology	This work was funded by the Smithsonian's Marine Science Network Fellowship and the Laboratories of Analytical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras JP, 2011, MOL ECOL, V20, P2525, DOI 10.1111/j.1365-294X.2011.05115.x; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2007, MAR ECOL PROG SER, V335, P237, DOI 10.3354/meps335237; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Drohan AF, 2005, B MAR SCI, V77, P257; Drummond AJ, 2010, GENEIOUS V5 3; Finney JC, 2010, MICROB ECOL, V60, P250, DOI 10.1007/s00248-010-9681-y; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Frenz-Ross JL, 2008, MAR BIOTECHNOL, V10, P572, DOI 10.1007/s10126-008-9095-8; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Goulet TL, 2008, MAR BIOL, V154, P795, DOI 10.1007/s00227-008-0972-5; Goulet TL, 2008, MAR ECOL PROG SER, V355, P45, DOI 10.3354/meps07214; Goulet TL, 2007, MAR ECOL PROG SER, V335, P243, DOI 10.3354/meps335243; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Goulet TL, 2004, CORAL REEFS, V23, P465, DOI 10.1007/s00338-004-0408-8; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Hannes AR, 2009, MAR ECOL PROG SER, V391, P65, DOI 10.3354/meps07990; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; Kirk NL, 2005, BIOL BULL-US, V209, P227, DOI 10.2307/3593112; LaJeunesse TC, 2005, CORAL REEFS, V24, P157, DOI 10.1007/s00338-004-0436-4; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Lasker HR, 2003, CORAL REEFS, V22, P23, DOI 10.1007/s00338-003-0276-7; Leverette CL, 2008, SPECTROCHIM ACTA A, V69, P1058, DOI 10.1016/j.saa.2007.07.018; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; PORTER JW, 1976, AM NAT, V110, P731, DOI 10.1086/283100; Prada C, 2010, CORAL REEFS, V29, P41, DOI 10.1007/s00338-009-0547-z; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Santos SR, 2004, MOL ECOL, V13, P459, DOI 10.1046/j.1365-294X.2003.02058.x; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Van Oppen MJH, 2005, MOL ECOL, V14, P2403, DOI 10.1111/j.1365-294X.2005.02545.x; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	47	6	6	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55057	10.1371/journal.pone.0055057	http://dx.doi.org/10.1371/journal.pone.0055057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405111	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400055
J	Jeon, SJ; Elzo, M; DiLorenzo, N; Lamb, GC; Jeong, KC				Jeon, Soo Jin; Elzo, Mauricio; DiLorenzo, Nicolas; Lamb, G. Cliff; Jeong, Kwang Cheol			Evaluation of Animal Genetic and Physiological Factors That Affect the Prevalence of Escherichia coli O157 in Cattle	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; RECTOANAL-JUNCTION; SECRETED PROTEINS; VIRULENCE FACTORS; BEEF-CATTLE; COLONIZATION; CALVES; CONTAMINATION; INOCULATION; SALMONELLA	Controlling the prevalence of Escherichia coli O157 in cattle at the pre-harvest level is critical to reduce outbreaks of this pathogen in humans. Multilayers of factors including the environmental and bacterial factors modulate the colonization and persistence of E. coli O157 in cattle that serve as a reservoir of this pathogen. Here, we report animal factors contributing to the prevalence of E. coli O157 in cattle. We observe the lowest number of E. coli O157 in Brahman breed when compared with other crosses in an Angus-Brahman multibreed herd, and bulls excrete more E. coli O157 than steers in the pens where cattle were housed together. The presence of super-shedders, cattle excreting > 10(5) CFU/rectal anal swab, increases the concentration of E. coli O157 in the pens; thereby super-shedders enhance transmission of this pathogen among cattle. Molecular subtyping analysis reveal only one subtype of E. coli O157 in the multibreed herd, indicating the variance in the levels of E. coli O157 in cattle is influenced by animal factors. Furthermore, strain tracking after relocation of the cattle to a commercial feedlot reveals farm-to-farm transmission of E. coli O157, likely via super-shedders. Our results reveal high risk factors in the prevalence of E. coli O157 in cattle whereby animal genetic and physiological factors influence whether this pathogen can persist in cattle at high concentration, providing insights to intervene this pathogen at the pre-harvest level.	[Jeon, Soo Jin; Elzo, Mauricio; DiLorenzo, Nicolas; Lamb, G. Cliff; Jeong, Kwang Cheol] Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA; [Jeon, Soo Jin; Jeong, Kwang Cheol] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [DiLorenzo, Nicolas; Lamb, G. Cliff] Univ Florida, Inst Food & Agr Sci, N Florida Res & Educ Ctr, Marianna, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jeong, KC (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA.	kcjeong@ufl.edu		Jeon, Soo Jin/0000-0001-7473-3184	Institute of Food and Agricultural Sciences; Emerging Pathogens Institute at University of Florida	Institute of Food and Agricultural Sciences; Emerging Pathogens Institute at University of Florida	This work was supported by the Institute of Food and Agricultural Sciences, and Emerging Pathogens Institute at University of Florida, grants to KCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1998, J EXP MED, V188, P1907, DOI 10.1084/jem.188.10.1907; Arthur TM, 2011, APPL ENVIRON MICROB, V77, P3002, DOI 10.1128/AEM.02238-10; Arthur TM, 2010, MEAT SCI, V86, P32, DOI 10.1016/j.meatsci.2010.04.019; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; Bai JF, 2010, J MICROBIOL METH, V82, P85, DOI 10.1016/j.mimet.2010.05.003; Barkocy-Gallagher GA, 2003, J FOOD PROTECT, V66, P1978, DOI 10.4315/0362-028X-66.11.1978; BESSER RE, 1993, JAMA-J AM MED ASSOC, V269, P2217, DOI 10.1001/jama.269.17.2217; Bretschneider G, 2007, VET MICROBIOL, V125, P381, DOI 10.1016/j.vetmic.2007.06.009; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Chase-Topping ME, 2007, J CLIN MICROBIOL, V45, P1594, DOI 10.1128/JCM.01690-06; CRAY WC, 1995, APPL ENVIRON MICROB, V61, P1586, DOI 10.1128/AEM.61.4.1586-1590.1995; Davis MA, 2006, APPL ENVIRON MICROB, V72, P3766, DOI 10.1128/AEM.72.5.3766-3770.2006; Dean-Nystrom EA, 1998, INFECT IMMUN, V66, P4560; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Elzo MA, 1998, J ANIM SCI, V76, P1810; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Franz E, 2008, J APPL MICROBIOL, V105, P1569, DOI 10.1111/j.1365-2672.2008.03915.x; Franz E, 2008, CRIT REV MICROBIOL, V34, P143, DOI [10.1080/10408410802357432, 10.1080/10408410802357432 ]; Heuvelink AE, 1998, J CLIN MICROBIOL, V36, P878, DOI 10.1128/JCM.36.4.878-882.1998; Jeong KC, 2007, VET MICROBIOL, V119, P339, DOI 10.1016/j.vetmic.2006.08.023; Jeong KC, 2011, APPL ENVIRON MICROB, V77, P2611, DOI 10.1128/AEM.02587-10; Keen JE, 2010, APPL ENVIRON MICROB, V76, P5278, DOI 10.1128/AEM.00400-10; Laegreid WW, 1999, EPIDEMIOL INFECT, V123, P291, DOI 10.1017/S0950268899002757; Lim JY, 2007, APPL ENVIRON MICROB, V73, P1380, DOI 10.1128/AEM.02242-06; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Riley DG, 2003, J FOOD PROTECT, V66, P1778, DOI 10.4315/0362-028X-66.10.1778; Sharma VK, 2012, INFECT IMMUN, V80, P1333, DOI 10.1128/IAI.05869-11; Sheng HQ, 2006, INFECT IMMUN, V74, P4685, DOI 10.1128/IAI.00406-06; Shere JA, 2002, APPL ENVIRON MICROB, V68, P1947, DOI 10.1128/AEM.68.4.1947-1954.2002; Shere JA, 1998, APPL ENVIRON MICROB, V64, P1390; Valadez AM, 2011, J FOOD PROTECT, V74, P228, DOI 10.4315/0362-028X.JFP-10-386; ZADIK PM, 1993, J MED MICROBIOL, V39, P155, DOI 10.1099/00222615-39-2-155; Zhao T, 1998, J CLIN MICROBIOL, V36, P641, DOI 10.1128/JCM.36.3.641-647.1998	39	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55728	10.1371/journal.pone.0055728	http://dx.doi.org/10.1371/journal.pone.0055728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405204	Green Published, gold			2022-12-27	WOS:000315153400149
J	Linares, E; Seixas, LV; dos Prazeres, JN; Ladd, FVL; Ladd, AABL; Coppi, AA; Augusto, O				Linares, Edlaine; Seixas, Luciana V.; dos Prazeres, Janaina N.; Ladd, Fernando V. L.; Ladd, Aliny A. B. L.; Coppi, Antonio A.; Augusto, Ohara			Tempol Moderately Extends Survival in a hSOD1(G93A) ALS Rat Model by Inhibiting Neuronal Cell Loss, Oxidative Damage and Levels of Non-Native hSOD1(G93A) Forms	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; MUTANT SOD1; CU,ZN-SUPEROXIDE DISMUTASE; INCREASED 3-NITROTYROSINE; GLUTAMATE TRANSPORTER; THERAPEUTIC TARGET; PROTEIN CARBONYLS; TRANSGENIC MICE; FREE-RADICALS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive dysfunction and death of motor neurons by mechanisms that remain unclear. Evidence indicates that oxidative mechanisms contribute to ALS pathology, but classical antioxidants have not performed well in clinical trials. Cyclic nitroxides are an alternative worth exploring because they are multifunctional antioxidants that display low toxicity in vivo. Here, we examine the effects of the cyclic nitroxide tempol (4-hydroxy-2,2,6,6-tetramethyl piperidine-1-oxyl) on ALS onset and progression in transgenic female rats over-expressing the mutant hSOD1(G93A). Starting at 7 weeks of age, a high dose of tempol (155 mg/day/rat) in the rats drinking water had marginal effects on the disease onset but decelerated disease progression and extended survival by 9 days. In addition, tempol protected spinal cord tissues as monitored by the number of neuronal cells, and the reducing capability and levels of carbonylated proteins and non-native hSOD1 forms in spinal cord homogenates. Intraperitoneal tempol (26 mg/rat, 3 times/week) extended survival by 17 days. This group of rats, however, diverted to a decelerated disease progression. Therefore, it was inconclusive whether the higher protective effect of the lower i.p. dose was due to higher tempol bioavailability, decelerated disease development or both. Collectively, the results show that tempol moderately extends the survival of ALS rats while protecting their cellular and molecular structures against damage. Thus, the results provide proof that cyclic nitroxides are alternatives worth to be further tested in animal models of ALS.	[Linares, Edlaine; Seixas, Luciana V.; dos Prazeres, Janaina N.; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Ladd, Fernando V. L.; Ladd, Aliny A. B. L.; Coppi, Antonio A.] Univ Sao Paulo, Coll Vet Med, Dept Surg, Lab Stochast Stereol & Chem Anat, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.	oaugusto@iq.usp.br	Augusto, Ohara/D-3839-2012; Ladd, Aliny/C-4130-2012; Linares, Edlaine/AAR-8753-2020	Augusto, Ohara/0000-0002-7220-4286; Linares, Edlaine/0000-0001-8164-3013; Coppi, Augusto/0000-0002-8656-0409	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). OA, EL and JNP are members of the INCT de Processos Redox em Biomedicina-Redoxoma (FAPESP/CNPq/CAPES) and of the NAP REDOXOMA (Pro Reitoria de Pesquisa/USP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrus PK, 1998, J NEUROCHEM, V71, P2041; Augusto O, 2008, AN ACAD BRAS CIENC, V80, P179, DOI 10.1590/S0001-37652008000100013; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Barbosa LF, 2010, BBA-MOL BASIS DIS, V1802, P462, DOI 10.1016/j.bbadis.2010.01.011; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Boillee S, 2008, J CLIN INVEST, V118, P474, DOI [10.1172/JC134613, 10.1172/JCI34613]; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Desnuelle C, 2001, AMYOTROPH LATERAL SC, V2, P9, DOI 10.1080/146608201300079364; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Fitzmaurice PS, 1996, MUSCLE NERVE, V19, P797; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gundersen HJG, 2002, J MICROSC-OXFORD, V207, P191, DOI 10.1046/j.1365-2818.2002.01054.x; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hahn SM, 1999, FREE RADICAL BIO MED, V27, P529, DOI 10.1016/S0891-5849(99)00099-4; Howard CV, 2010, UNBIASED STEREOLOGY, V2nd; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; JENSEN EBV, 1993, J MICROSC-OXFORD, V170, P35, DOI 10.1111/j.1365-2818.1993.tb03321.x; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jones DP, 2010, DIABETES OBES METAB, V12, P116, DOI 10.1111/j.1463-1326.2010.01266.x; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Linares E, 2008, FREE RADICAL BIO MED, V44, P1668, DOI 10.1016/j.freeradbiomed.2008.01.027; Ladd AABL, 2012, INT J DEV NEUROSCI, V30, P129, DOI 10.1016/j.ijdevneu.2011.12.002; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; Mead RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023244; Medinas DB, 2010, FREE RADICAL BIO MED, V49, P1046, DOI 10.1016/j.freeradbiomed.2010.06.018; MEHLHORN RJ, 1991, J BIOL CHEM, V266, P2724; Mitchell JB, 2003, FREE RADICAL BIO MED, V34, P93, DOI 10.1016/S0891-5849(02)01193-0; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Orrell RW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002829.pub4; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Poon HF, 2005, FREE RADICAL BIO MED, V39, P453, DOI 10.1016/j.freeradbiomed.2005.03.030; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Rao SD, 2004, TRENDS NEUROSCI, V27, P17, DOI 10.1016/j.tins.2003.11.001; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Samuni A, 2002, J AM CHEM SOC, V124, P8719, DOI 10.1021/ja017587h; Samuni Y, 2004, ANTIOXID REDOX SIGN, V6, P587, DOI 10.1089/152308604773934341; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Soule BP, 2007, FREE RADICAL BIO MED, V42, P1632, DOI 10.1016/j.freeradbiomed.2007.02.030; Steele C, 2006, CELL TISSUE RES, V326, P737, DOI 10.1007/s00441-006-0218-0; Takeuchi S, 2010, J NEUROPATH EXP NEUR, V69, P1044, DOI 10.1097/NEN.0b013e3181f4a90a; Thiemermann C, 2003, CRIT CARE MED, V31, pS76, DOI 10.1097/00003246-200301001-00011; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; Tsuhako MH, 2010, FREE RADICAL BIO MED, V48, P704, DOI 10.1016/j.freeradbiomed.2009.12.013; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; VasquezVivar J, 1996, BIOCHEM J, V314, P869, DOI 10.1042/bj3140869; Wang P, 2010, FREE RADICAL BIO MED, V49, P119, DOI 10.1016/j.freeradbiomed.2010.03.005; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85	68	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55868	10.1371/journal.pone.0055868	http://dx.doi.org/10.1371/journal.pone.0055868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405225	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400170
J	Milhomem, SSR; Scacchetti, PC; Pieczarka, JC; Ferguson-Smith, MA; Pansonato-Alves, JC; O'Brien, PCM; Foresti, F; Nagamachi, CY				Milhomem, Susana S. R.; Scacchetti, Priscilla C.; Pieczarka, Julio C.; Ferguson-Smith, Malcolm A.; Pansonato-Alves, Jose C.; O'Brien, Patricia C. M.; Foresti, Fausto; Nagamachi, Cleusa Y.			Are NORs Always Located on Homeologous Chromosomes? A FISH Investigation with rDNA and Whole Chromosome Probes in Gymnotus Fishes (Gymnotiformes)	PLOS ONE			English	Article							NUCLEOLUS ORGANIZER REGIONS; RIBOSOMAL-RNA GENES; ELECTRIC KNIFEFISH; SEX-CHROMOSOMES; TELEOSTEI; AMAZON; REARRANGEMENTS; STERNOPYGIDAE; POLYMORPHISM; GYMNOTOIDEI	Gymnotus (Gymnotiformes, Gymnotidae) is the most diverse known Neotropical electric knife fish genus. Cytogenetic studies in Gymnotus demonstrate a huge karyotypic diversity for this genus, with diploid numbers ranging from 34 to 54. The NOR are also variable in this genus, with both single and multiple NORs described. A common interpretation is that the single NOR pair is a primitive trait while multiple NORs are derivative. However this hypothesis has never been fully tested. In this report we checked if the NOR-bearing chromosome and the rDNA site are homeologous in different species of the genus Gymnotus: G. carapo (2n = 40, 42, 54), G. mamiraua (2n = 54), G. arapaima (2n = 44), G. sylvius (2n = 40), G. inaequilabiatus (2n = 54) and G. capanema (2n = 34), from the monophyletic group G. carapo (Gymnotidae-Gymnotiformes), as well as G. jonasi (2n = 52), belonging to the G1 group. They were analyzed with Fluorescence in situ hybridization (FISH) using 18S rDNA and whole chromosome probes of the NOR-bearing chromosome 20 (GCA20) of G. carapo (cytotype 2n = 42), obtained by Fluorescence Activated Cell Sorting. All species of the monophyletic G. carapo group show the NOR in the same single pair, confirmed by hybridization with CGA20 whole chromosome probe. In G. jonasi the NORs are multiple, and located on pairs 9, 10 and 11. In G. jonasi the GCA20 chromosome probe paints the distal half of the long arm of pair 7, which is not a NOR-bearing chromosome. Thus these rDNA sequences are not always in the homeologous chromosomes in different species thus giving no support to the hypothesis that single NOR pairs are primitive traits while multiple NORs are derived. The separation of groups of species in the genus Gymnotus proposed by phylogenies with morphologic and molecular data is supported by our cytogenetic data.	[Milhomem, Susana S. R.; Pieczarka, Julio C.; Nagamachi, Cleusa Y.] Fed Univ Para, Lab Citogenet, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Scacchetti, Priscilla C.; Pansonato-Alves, Jose C.; Foresti, Fausto] Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Morfol, Botucatu, SP, Brazil; [Ferguson-Smith, Malcolm A.; O'Brien, Patricia C. M.] Univ Cambridge, Cambridge Resource Ctr Comparat Genom, Dept Vet Med, Cambridge, England	Universidade Federal do Para; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; University of Cambridge	Nagamachi, CY (corresponding author), Fed Univ Para, Lab Citogenet, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	cleusa@ufpa.br	Pieczarka, Julio C/E-7585-2016; Nagamachi, Cleusa/AAV-8985-2021; Pansonato Alves, Jose Carlos/C-3062-2014	Pieczarka, Julio C/0000-0003-2951-8877; Pansonato Alves, Jose Carlos/0000-0003-3580-7384; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734	FAPESPA (Para Foundation for Supporting Science) through the National Excellence on Research Program (PRONEX) [TO 011/2008]; CNPq; CAPES; UFPA; FAPESPA; FAPESP; Wellcome Trust; CNPq-Brazil	FAPESPA (Para Foundation for Supporting Science) through the National Excellence on Research Program (PRONEX)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UFPA; FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Wellcome Trust(Wellcome TrustEuropean Commission); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Most of this research was supported by FAPESPA (Para Foundation for Supporting Science) through the National Excellence on Research Program (PRONEX, TO 011/2008) on a project coordinated by J. C. Pieczarka. Funding to the Brazilian authors was provided by CNPq, CAPES, UFPA, FAPESPA and FAPESP. Wellcome Trust provided a grant to M. A. Ferguson-Smith, the CNPq-Brazil provided Post-Doctoral scholarships to C. Y. Nagamachi and J. C. Pieczarka and a Doctoral scholarship to S. S. R. Milhomem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 1995, P BIOL SOC WASH, V108, P662; Albert JS., 2005, SYSTEM BIODIVERS, V4, P375, DOI DOI 10.1017/S1477200004001574; Almeida-Toledo LF, 1985, CIENC CULT, V3, P448; Artoni RF, 2002, HEREDITY, V89, P15, DOI 10.1038/sj.hdy.6800081; BERTOLLO L A C, 1978, Revista Brasileira de Genetica, V1, P103; Cardoso AL, 2011, REV FISH BIOL FISHER, V21, P613, DOI 10.1007/s11160-010-9196-0; Deiana AM, 2006, ITAL J ZOOL, V73, P1, DOI 10.1080/11250000500502038; DERGAM JA, 1990, REV BRAS GENET, V13, P755; Dumas F, 2005, CHROMOSOME RES, V13, P85, DOI 10.1007/s10577-005-7063-y; Ferguson-Smith Malcolm A., 1998, ILAR J, V39, P68; Fernandes FMC, 2005, ZOOTAXA, P1; Fernandes-Matioli FMC, 1998, CARYOLOGIA, V51, P221, DOI 10.1080/00087114.1998.10797414; Fernandes-Matioli FMC, 1997, CYTOGENET CELL GENET, V78, P236, DOI 10.1159/000134665; Ferro DAD, 2000, GENETICA, V110, P55; Fonteles SBA, 2008, GENET MOL BIOL, V31, P227, DOI 10.1590/S1415-47572008000200010; FORESTI F, 1981, CYTOGENET CELL GENET, V31, P137, DOI 10.1159/000131639; Geoffrey MC, 2002, CELULA ABORDAGEM MOL; GOLD JR, 1984, COPEIA, P133, DOI 10.2307/1445043; Hatanaka T, 2004, GENETICA, V122, P239, DOI 10.1007/s10709-004-2039-y; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; HSU TC, 1975, CHROMOSOMA, V53, P25, DOI 10.1007/BF00329388; Lovejoy NR, 2010, MOL PHYLOGENET EVOL, V54, P278, DOI 10.1016/j.ympev.2009.09.017; Machado MA, 2011, 14 S CIT GEN PEIX; Machado TC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-65; Margarido VP, 2007, J FISH BIOL, V70, P155, DOI 10.1111/j.1095-8649.2007.01365.x; Marques DK, 2006, NEOTROP ICHTHYOL, V4, P215, DOI 10.1590/S1679-62252006000200007; MartinsSantos IC, 1996, BRAZ J GENET, V19, P271; Milhomem SSR, 2012, J FISH BIOL, V80, P802, DOI 10.1111/j.1095-8649.2012.03219.x; Milhomem SSR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-75; Nagamachi CY, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-28; PENDAS AM, 1993, CYTOGENET CELL GENET, V63, P128, DOI 10.1159/000133517; Pieczarka JC, 2005, CHROMOSOME RES, V13, P339, DOI 10.1007/s10577-005-2886-0; Porto Jorge Ivan Rebelo, 1992, Revue d'Hydrobiologie Tropicale, V25, P287; Reed KM, 1997, CHROMOSOME RES, V5, P221, DOI 10.1023/A:1018411417816; Milhomem SSR, 2007, ZOOTAXA, P55; Milhomem SSR, 2012, REV FISH BIOL FISHER, V22, P485, DOI 10.1007/s11160-011-9239-1; Sanchez Sebastian, 2004, Cytologia (Tokyo), V69, P155, DOI 10.1508/cytologia.69.155; Scacchetti PC, 2011, COMP CYTOGENET, V5, P223, DOI 10.3897/CompCytogen.v5i3.1375; Sharma OP, 2002, SOME ASPECTS CHROMOS, P109; Silva DD, 2008, MICRON, V39, P1251, DOI 10.1016/j.micron.2008.04.001; Silva DS, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-74; Yang F, 1997, CHROMOSOMA, V106, P37, DOI 10.1007/s004120050222; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691	43	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55608	10.1371/journal.pone.0055608	http://dx.doi.org/10.1371/journal.pone.0055608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405178	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400123
J	Plominsky, AM; Larsson, J; Bergman, B; Delherbe, N; Osses, I; Vasquez, M				Plominsky, Alvaro M.; Larsson, John; Bergman, Birgitta; Delherbe, Nathalie; Osses, Igor; Vasquez, Monica			Dinitrogen Fixation Is Restricted to the Terminal Heterocysts in the Invasive Cyanobacterium Cylindrospermopsis raciborskii CS-505	PLOS ONE			English	Article							BLUE-GREEN-ALGA; NITROGEN-FIXATION; PATTERN-FORMATION; VEGETATIVE CELLS; ANABAENA; GENE; DIFFERENTIATION; GROWTH; PATA; IDENTIFICATION	The toxin producing nitrogen-fixing heterocystous freshwater cyanobacterium Cylindrospermopsis raciborskii recently radiated from its endemic tropical environment into sub-tropical and temperate regions, a radiation likely to be favored by its ability to fix dinitrogen (diazotrophy). Although most heterocystous cyanobacteria differentiate regularly spaced intercalary heterocysts along their trichomes when combined nitrogen sources are depleted, C. raciborskii differentiates only two terminal heterocysts (one at each trichome end) that can reach >100 vegetative cells each. Here we investigated whether these terminal heterocysts are the exclusive sites for dinitrogen fixation in C. raciborskii. The highest nitrogenase activity and NifH biosynthesis (western-blot) were restricted to the light phase of a 12/12 light/dark cycle. Separation of heterocysts and vegetative cells (sonication and two-phase aqueous polymer partitioning) demonstrated that the terminal heterocysts are the sole sites for nifH expression (RT-PCR) and NifH biosynthesis. The latter finding was verified by the exclusive localization of nitrogenase in the terminal heterocysts of intact trichomes (immunogold-transmission electron microscopy and in situ immunofluorescence-light microscopy). These results suggest that the terminal heterocysts provide the combined nitrogen required by the often long trichomes (>100 vegetative cells). Our data also suggests that the terminal-heterocyst phenotype in C. raciborskii may be explained by the lack of a patL ortholog. These data help identify mechanisms by which C. raciborskii and other terminal heterocyst-forming cyanobacteria successfully inhabit environments depleted in combined nitrogen.	[Plominsky, Alvaro M.; Delherbe, Nathalie; Osses, Igor; Vasquez, Monica] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Santiago, Chile; [Larsson, John; Bergman, Birgitta] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden	Pontificia Universidad Catolica de Chile; Stockholm University	Vasquez, M (corresponding author), Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Alameda 340, Santiago, Chile.	mvasquez@bio.puc.cl		M. Plominsky, Alvaro/0000-0003-0816-8580	FONDECYT [1050433, 1080075]; Proyecto Puente [10/2011, 13/2012 VRI-PUC]; Swedish Research Council Formas; K. and A. Wallenberg Foundation	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Puente; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); K. and A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This study was financially supported by FONDECYT 1050433 and 1080075, Proyecto Puente no. 10/2011 and no. 13/2012 VRI-PUC, the Swedish Research Council Formas and the K. and A. Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bar-Yosef Y, 2010, CURR BIOL, V20, P1557, DOI 10.1016/j.cub.2010.07.032; Bergman B, 1997, FEMS MICROBIOL REV, V19, P139, DOI 10.1016/S0168-6445(96)00028-9; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; Castro D, 2004, TOXICON, V44, P483, DOI 10.1016/j.toxicon.2004.06.005; Coute A, 1997, CRYPTOGAMIE ALGOL, V18, P57; Dokulil MT, 1996, ALGOLOGICAL STUDIES, V83, P179, DOI DOI 10.1127/ALG0L_STUD/83/1996/179; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELHAI J, 1990, EMBO J, V9, P3379, DOI 10.1002/j.1460-2075.1990.tb07539.x; Fan Q, 2005, MOL MICROBIOL, V58, P227, DOI 10.1111/j.1365-2958.2005.04818.x; Fiedler G, 1998, MOL MICROBIOL, V27, P1193, DOI 10.1046/j.1365-2958.1998.00762.x; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; FREDRIKSSON C, 1995, MICROBIOL-UK, V141, P2471, DOI 10.1099/13500872-141-10-2471; Hamilton PB, 2005, PHYCOLOGIA, V44, P17, DOI 10.2216/0031-8884(2005)44[17:TOOTCC]2.0.CO;2; Hess WR, 2011, CURR OPIN MICROBIOL, V14, P608, DOI 10.1016/j.mib.2011.07.024; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Klint J, 2007, J PLANT PHYSIOL, V164, P11, DOI 10.1016/j.jplph.2005.08.021; KRIENITZ L, 1996, LAUTERBORNIA, V26, P55; Lagos N, 1999, TOXICON, V37, P1359, DOI 10.1016/S0041-0101(99)00080-X; Larsson J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-187; Lawton L, 1999, TOXIC CYANOBACTERIA, P354; Liaimer A, 2011, ENV MICROBIOL REP, V3, P550, DOI 10.1111/j.1758-2229.2011.00258.x; LIANG J, 1992, P NATL ACAD SCI USA, V89, P5655, DOI 10.1073/pnas.89.12.5655; Liu JJ, 2011, J BACTERIOL, V193, P6070, DOI 10.1128/JB.05523-11; Lundgren P, 2003, J PHYCOL, V39, P310, DOI 10.1046/j.1529-8817.2003.02080.x; Makarova KS, 2006, BIOINFORMATICS, V22, P1297, DOI 10.1093/bioinformatics/btl096; Moisander PH, 2012, FEMS MICROBIOL ECOL, V79, P800, DOI 10.1111/j.1574-6941.2011.01264.x; Neilan BA, 2003, MOL ECOL, V12, P133, DOI 10.1046/j.1365-294X.2003.01709.x; Neunuebel MR, 2008, J BACTERIOL, V190, P6829, DOI 10.1128/JB.00701-08; Olmedo-Verd E, 2006, J BACTERIOL, V188, P6694, DOI 10.1128/JB.00509-06; Padisak J., 1997, ARCH HYDROBIOL, V107, P563; Plominsky AM, 2009, LETT APPL MICROBIOL, V49, P332, DOI 10.1111/j.1472-765X.2009.02665.x; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Popa R, 2007, ISME J, V1, P354, DOI 10.1038/ismej.2007.44; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; REDDY PM, 1974, NATURE, V249, P493, DOI 10.1038/249493a0; Risser DD, 2008, J BACTERIOL, V190, P7645, DOI 10.1128/JB.01110-08; Rucker J, 1997, HYDROBIOLOGIA, V342, P107, DOI 10.1023/A:1017013208039; Saker ML, 1999, J PHYCOL, V35, P599, DOI 10.1046/j.1529-8817.1999.3530599.x; Saker ML, 2003, ECOTOX ENVIRON SAFE, V55, P243, DOI 10.1016/S0147-6513(02)00043-X; Sambrook J., 2001, MOL CLONING LAB MANU; Sandh G, 2012, MICROBIOL-SGM, V158, P345, DOI 10.1099/mic.0.051268-0; Sandh G, 2011, PROTEOMICS, V11, P406, DOI 10.1002/pmic.201000382; SINGH PK, 1976, Z ALLG MIKROBIOL, V16, P453, DOI 10.1002/jobm.3630160606; SKUJA H., 1938, BOT REV, V4, P665, DOI 10.1007/BF02869845; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; THIEL T, 1995, P NATL ACAD SCI USA, V92, P9358, DOI 10.1073/pnas.92.20.9358; Thiel T, 2001, J BACTERIOL, V183, P280, DOI 10.1128/JB.183.1.280-286.2001; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Van Alstine JM, 2000, METH BIOTEC, V11, P119; VANDEWATER S, 1984, J GEN MICROBIOL, V130, P789; WEI TF, 1994, J BACTERIOL, V176, P4473, DOI 10.1128/JB.176.15.4473-4482.1994; Wiedner C, 2007, OECOLOGIA, V152, P473, DOI 10.1007/s00442-007-0683-5; WILCOX M, 1973, J CELL SCI, V12, P707; Wilson K, 1990, CURRENT PROTOCOLS MO; Wood SA, 2003, NEW ZEAL J MAR FRESH, V37, P821, DOI 10.1080/00288330.2003.9517211	58	24	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e51682	10.1371/journal.pone.0051682	http://dx.doi.org/10.1371/journal.pone.0051682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405062	Green Published, gold			2022-12-27	WOS:000315153400005
J	Shehab, A; Al-Dabbagh, B; AlHabib, KF; Alsheikh-Ali, AA; Almahmeed, W; Sulaiman, K; Al-Motarreb, A; Nagelkerke, N; Al Suwaidi, J; Hersi, A; Al Faleh, H; Asaad, N; Al Saif, S; Amin, H				Shehab, Abdulla; Al-Dabbagh, Bayan; AlHabib, Khalid F.; Alsheikh-Ali, Alawi A.; Almahmeed, Wael; Sulaiman, Kadhim; Al-Motarreb, Ahmed; Nagelkerke, Nicolaas; Al Suwaidi, Jassim; Hersi, Ahmad; Al Faleh, Hussam; Asaad, Nidal; Al Saif, Shukri; Amin, Haitham			Gender Disparities in the Presentation, Management and Outcomes of Acute Coronary Syndrome Patients: Data from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2)	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BASE-LINE CHARACTERISTICS; LONG-TERM OUTCOMES; SEX-DIFFERENCES; UNSTABLE ANGINA; CARDIAC-CATHETERIZATION; WOMEN; MEN; ANGIOPLASTY; CARDIOLOGY	Background: Gender-related differences in mortality of acute coronary syndrome (ACS) have been reported. The extent and causes of these differences in the Middle-East are poorly understood. We studied to what extent difference in outcome, specifically 1-year mortality are attributable to demographic, baseline clinical differences at presentation, and management differences between female and male patients. Methodology/Principal Findings: Baseline characteristics, treatment patterns, and 1-year mortality of 7390 ACS patients in 65 hospitals in 6 Arabian Gulf countries were evaluated during 2008-2009, as part of the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2). Women were older (61.3+/-11.8 vs. 55.6+/-12.4; P<0.001), more overweight (BMI: 28.1+/-6.6 vs. 26.7+/-5.1; P<0.001), and more likely to have a history of hypertension, hyperlipidemia or diabetes. Fewer women than men received angiotensin-converting enzyme inhibitors (ACE), aspirin, clopidogrel, beta blockers or statins at discharge. They also underwent fewer invasive procedures including angiography (27.0% vs. 34.0%; P<0.001), percutaneous coronary intervention (PCI) (10.5% vs. 15.6%; P<0.001) and reperfusion therapy (6.9% vs. 20.2%; P<0.001) than men. Women were at higher unadjusted risk for in-hospital death (6.8% vs. 4.0%, P<0.001) and heart failure (HF) (18% vs. 11.8%, P<0.001). Both 1-month and 1-year mortality rates were higher in women than men (11% vs. 7.4% and 17.3% vs. 11.4%, respectively, P<0.001). Both baseline and management differences contributed to a worse outcome in women. Together these variables explained almost all mortality disparities. Conclusions/Significance: Differences between genders in mortality appeared to be largely explained by differences in prognostic variables and management patterns. However, the origin of the latter differences need further study.	[Shehab, Abdulla; Al-Dabbagh, Bayan] United Arab Emirates Univ, Dept Internal Med, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [AlHabib, Khalid F.] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Riyadh 11461, Saudi Arabia; [Alsheikh-Ali, Alawi A.; Almahmeed, Wael] Sheikh Khalifa Med City, Inst Heart & Vasc, Abu Dhabi, U Arab Emirates; [Alsheikh-Ali, Alawi A.] Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Alsheikh-Ali, Alawi A.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Sulaiman, Kadhim] Royal Hosp, Dept Cardiol, Muscat, Oman; [Al-Motarreb, Ahmed] Sanas Univ, Fac Med, Sanaa, Yemen; [Nagelkerke, Nicolaas] United Arab Emirates Univ, Dept Community Med, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Al Suwaidi, Jassim; Asaad, Nidal] Hamad Med Corp, Dept Cardiol & Cardiovasc Surg, Doha, Qatar; [Hersi, Ahmad; Al Faleh, Hussam] King Saud Univ, Coll Med, Dept Cardiac Sci, Riyadh 11461, Saudi Arabia; [Al Saif, Shukri] Saud Al Babtain Cardiac Ctr, Dept Cardiol, Dammam, Saudi Arabia; [Amin, Haitham] Mohammed Bin Khalifa Cardiac Ctr, Dept Cardiol, Manama, Bahrain	United Arab Emirates University; King Saud University; Tufts University; The Royal Hospital, Sultanate of Oman; United Arab Emirates University; Hamad Medical Corporation; King Saud University	Shehab, A (corresponding author), United Arab Emirates Univ, Dept Internal Med, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	a.shehab@uaeu.ac.ae	AlSaif, Shukri/GZM-0822-2022; Hersi, Ahmad/ABC-9266-2020	AL-Motarreb, Ahmed/0000-0002-3696-5002; al suwaidi, MB, ChB, FACC, FESC, FSCAI, jassim/0000-0002-5299-9106; Alhabib, Khalid/0000-0002-6692-3874	GHA; Sanofi Aventis (Paris, France); College of Medicine Research Center at King Khalid University Hospital, King Saud University (Riyadh, Saudi Arabia); Sanofi Aventis	GHA; Sanofi Aventis (Paris, France)(Sanofi-Aventis); College of Medicine Research Center at King Khalid University Hospital, King Saud University (Riyadh, Saudi Arabia); Sanofi Aventis(Sanofi-Aventis)	Gulf RACE-2 is a Gulf Heart Association (GHA) project. The authors gratefully acknowledge the financial support of GHA, Sanofi Aventis (Paris, France) and the College of Medicine Research Center at King Khalid University Hospital, King Saud University (Riyadh, Saudi Arabia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the financial support of Sanofi Aventis. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alfredsson J, 2007, HEART, V93, P1357, DOI 10.1136/hrt.2006.102012; AlHabib KF, 2012, ANN SAUDI MED, V32, P9, DOI 10.5144/0256-4947.2012.9; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; BEARDEN D, 1994, J AM GERIATR SOC, V42, P1143, DOI 10.1111/j.1532-5415.1994.tb06979.x; Bugiardini R, 2010, CURR VASC PHARMACOL, V8, P276, DOI 10.2174/157016110790887018; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Claassen M, 2012, WORLD J CARDIOL, V4, P36, DOI 10.4330/wjc.v4.i2.36; DeVon HA, 2002, HEART LUNG, V31, P235, DOI 10.1067/mhl.2002.126105; El-Menyar A, 2009, AM J CARDIOL, V104, P1018, DOI 10.1016/j.amjcard.2009.06.003; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Ghali WA, 2002, ANN INTERN MED, V136, P723, DOI 10.7326/0003-4819-136-10-200205210-00007; Glaser R, 2002, JAMA-J AM MED ASSOC, V288, P3124, DOI 10.1001/jama.288.24.3124; Gottlieb S, 2000, CIRCULATION, V102, P2484, DOI 10.1161/01.CIR.102.20.2484; Grech ED, 2003, BRIT MED J, V326, P1259, DOI 10.1136/bmj.326.7401.1259; Hanratty B, 2000, J EPIDEMIOL COMMUN H, V54, P912, DOI 10.1136/jech.54.12.912; Heer T, 2002, AM J CARDIOL, V89, P511, DOI 10.1016/S0002-9149(01)02289-5; Heidenreich PA, 2002, AM J MED, V113, P200, DOI 10.1016/S0002-9343(02)01221-4; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; KAHN JK, 1992, AM J CARDIOL, V69, P1241, DOI 10.1016/0002-9149(92)90945-U; Kaplan KL, 2002, J THROMB THROMBOLYS, V13, P21, DOI 10.1023/A:1015312007648; Kim C, 2001, AM HEART J, V141, P73, DOI 10.1067/mhj.2001.111546; Lagerqvist B, 2001, J AM COLL CARDIOL, V38, P41, DOI 10.1016/S0735-1097(01)01308-0; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Mahon NG, 2000, AM J CARDIOL, V85, P921, DOI 10.1016/S0002-9149(99)00902-9; Perers E, 2005, INT J CARDIOL, V103, P120, DOI 10.1016/j.ijcard.2004.07.015; Rathore SS, 2002, ANN INTERN MED, V137, P487, DOI 10.7326/0003-4819-137-6-200209170-00008; Saha S, 1999, J GEN INTERN MED, V14, P122, DOI 10.1046/j.1525-1497.1999.00297.x; Shehab A, 2013, ANGIOLOGY, V64, P9, DOI 10.1177/0003319712443891; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; World Health Organization, 2008, TOP 10 CAUS DEATH, V310, P1	30	40	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55508	10.1371/journal.pone.0055508	http://dx.doi.org/10.1371/journal.pone.0055508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405162	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400107
J	Zhong, DB; Chang, XL; Zhou, GF; He, ZB; Fu, FY; Yan, ZT; Zhu, GD; Xu, TL; Bonizzoni, M; Wang, MH; Cui, LW; Zheng, B; Chen, B; Yan, GY				Zhong, Daibin; Chang, Xuelian; Zhou, Guofa; He, Zhengbo; Fu, Fengyang; Yan, Zhentian; Zhu, Guoding; Xu, Tielong; Bonizzoni, Mariangela; Wang, Mei-Hui; Cui, Liwang; Zheng, Bin; Chen, Bin; Yan, Guiyun			Relationship between Knockdown Resistance, Metabolic Detoxification and Organismal Resistance to Pyrethroids in Anopheles sinensis	PLOS ONE			English	Article							MALARIA VECTOR MOSQUITO; GATED SODIUM-CHANNEL; TRIATOMA-INFESTANS HEMIPTERA; IMPREGNATED BED NETS; INSECTICIDE RESISTANCE; AEDES-AEGYPTI; MOLECULAR CHARACTERIZATION; HAEMATOBIA-IRRITANS; CENTRAL-AFRICA; KDR MUTATION	Anopheles sinensis is the most important vector of malaria in Southeast Asia, including China. Currently, the most effective measure to prevent malaria transmission relies on vector control through the use of insecticides, primarily pyrethroids. Extensive use of insecticides poses strong selection pressure on mosquito populations for resistance. Resistance to insecticides can arise due to mutations in the insecticide target site (target site resistance), which in the case of pyrethroids is the para-type sodium channel gene, and/or the catabolism of the insecticide by detoxification enzymes before it reaches its target (metabolic detoxification resistance). In this study, we examined deltamethrin resistance in An. sinensis from China and investigated the relative importance of target site versus metabolic detoxification mechanisms in resistance. A high frequency (>85%) of nonsynonymous mutations in the para gene was found in populations from central China, but not in populations from southern China. Metabolic detoxification as measured by the activity of monooxygenases and glutathione S-transferases (GSTs) was detected in populations from both central and southern China. Monooxygenase activity levels were significantly higher in the resistant than the susceptible mosquitoes, independently of their geographic origin. Stepwise multiple regression analyses in mosquito populations from central China found that both knockdown resistance (kdr) mutations and monooxygenase activity were significantly associated with deltamethrin resistance, with monooxygenase activity playing a stronger role. These results demonstrate the importance of metabolic detoxification in pyrethroid resistance in An. sinensis, and suggest that different mechanisms of resistance could evolve in geographically different populations.	[Zhong, Daibin; Chang, Xuelian; Zhou, Guofa; Zhu, Guoding; Bonizzoni, Mariangela; Wang, Mei-Hui; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Coll Hlth Sci, Irvine, CA USA; [Chang, Xuelian] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Chang, Xuelian] Bengbu Med Coll, Dept Pathogen Biol, Bengbu, Anhui, Peoples R China; [He, Zhengbo; Fu, Fengyang; Yan, Zhentian; Chen, Bin] Chongqing Normal Univ, Inst Entomol & Mol Biol, Coll Life Sci, Chongqing, Peoples R China; [Zhu, Guoding] Jiangsu Inst Parasit Dis, Div Malaria Control, Wuxi, Peoples R China; [Xu, Tielong; Zheng, Bin] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	University of California System; University of California Irvine; Nanjing Medical University; Bengbu Medical College; Chongqing Normal University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zheng, B (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China.	chuner1997@yahoo.com; c_bin@hotmail.com; guiyuny@uci.edu	bonizzoni, mariangela/AAM-9035-2021; Zhong, Daibin/GRF-0564-2022	bonizzoni, mariangela/0000-0003-0568-8564; Tie-Long, Xu/0000-0001-9432-9584	National Institutes of Health [R01 AI050243, R03 TW008237, R01 AI095184, U19 AI089672]; FOGARTY INTERNATIONAL CENTER [R03TW008237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095184, R01AI050243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from the National Institutes of Health (R01 AI050243, R03 TW008237, R01 AI095184 and U19 AI089672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audino PG, 2004, MEM I OSWALDO CRUZ, V99, P335, DOI 10.1590/S0074-02762004000300018; Bouvier JC, 1998, ARCH INSECT BIOCHEM, V39, P55, DOI 10.1002/(SICI)1520-6327(1998)39:2&lt;55::AID-ARCH2&gt;3.0.CO;2-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Chandre F, 1999, B WHO, V77; Chareonviriyaphap Theeraphap, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P225; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; Corbel V, 2006, NEUROTOXICOLOGY, V27, P508, DOI 10.1016/j.neuro.2006.01.011; Cui F, 2007, PEST MANAG SCI, V63, P453, DOI 10.1002/ps.1356; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Enayati AA, 2003, MED VET ENTOMOL, V17, P138, DOI 10.1046/j.1365-2915.2003.00418.x; Fanello C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P323; Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081; Guerrero FD, 1997, INSECT BIOCHEM MOLEC, V27, P745, DOI 10.1016/S0965-1748(97)00057-X; [何大明 He Daming], 2005, [地球科学进展, Advance in Earth Sciences], V20, P338; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Jamroz RC, 1998, INSECT BIOCHEM MOLEC, V28, P1031, DOI 10.1016/S0965-1748(98)00094-0; Joshi D, 2010, MOL ECOL RESOUR, V10, P748, DOI 10.1111/j.1755-0998.2010.02835.x; Jung J, 2006, MOL ECOL NOTES, V6, P1272, DOI 10.1111/j.1471-8286.2006.01512.x; Jung J, 2007, AM J TROP MED HYG, V77, P310, DOI 10.4269/ajtmh.2007.77.310; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; Kang S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-151; Kang W, 1995, ANN TROP MED PARASIT, V89, P677, DOI 10.1080/00034983.1995.11813001; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Khambay BPS., 2010, INSECT CONTROL BIOL, P1; Kim H, 2007, PESTIC BIOCHEM PHYS, V87, P54, DOI 10.1016/j.pestbp.2006.06.009; LI ZZ, 1989, AM J TROP MED HYG, V40, P356; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu Nannan, 2006, Insect Science, V13, P159, DOI 10.1111/j.1744-7917.2006.00078.x; Liu XB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-221; Ma YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022219; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Munhenga G, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-247; Overgaard Hans J, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P152; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Picollo MI, 2005, J MED ENTOMOL, V42, P637, DOI 10.1603/0022-2585(2005)042[0637:HRTPIA]2.0.CO;2; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SEXTON JD, 1994, AM J TROP MED HYG, V50, P72, DOI 10.4269/ajtmh.1994.50.72; Singh OP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-59; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Syafruddin D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-315; Tan W-L, 2011, PLOS ONE, V7; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59; WHO, 2006, GLOB MAL PROGR US IN; WHO, 1998, WHOCDSCPCMAL9812; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; World Health Organization, 2005, MAL CONTR TOD CURR W	56	54	72	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55475	10.1371/journal.pone.0055475	http://dx.doi.org/10.1371/journal.pone.0055475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405157	Green Published, gold			2022-12-27	WOS:000315153400102
J	Bisconti, R; Canestrelli, D; Nascetti, G				Bisconti, Roberta; Canestrelli, Daniele; Nascetti, Giuseppe			Has Living on Islands Been So Simple? Insights from the Insular Endemic Frog Discoglossus montalentii	PLOS ONE			English	Article							LIZARD PODARCIS-TILIGUERTA; GENETIC DIVERSITY; SOFTWARE PACKAGE; POPULATION-SIZE; PHYLOGEOGRAPHY; EVOLUTIONARY; NEUTRALITY; AMPHIBIA; CORSICA; TESTS	Island populations have been extensively used as model systems in ecology, biogeography, conservation and evolutionary biology, owing to the several simplifying assumptions that they allow. Nevertheless, recent findings from intra-island phylogeographic studies are casting doubts on the generality of some of these underlying assumptions. We investigated the phylogeography, historical demography, and population genetic structure of the Corsican endemic frog, Discoglossus montalentii. In contrast with expectations based on its insular, restricted and continuous distribution, we found evidence of 3 phylogroups, whose rather ancient divergence (Early-Middle Pleistocene) was likely primed by climatic changes that occurred during the 'middle Pleistocene revolution'. Furthermore, their differentiation explained most (68%) of the overall genetic diversity that was observed. These results and the growing evidence from intra-island phylogeographies, suggest that island populations frequently may not conform to some long-standing assumptions, including long-term stability, range-wide panmixia and the correlation of effective population size to the island size. As a consequence, both for theoretical and for applied purposes, the extensive use of these assumptions in the study of island populations warrants a careful re-examination.	[Bisconti, Roberta; Canestrelli, Daniele; Nascetti, Giuseppe] Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy	Tuscia University	Canestrelli, D (corresponding author), Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy.	canestrelli@unitus.it	Canestrelli, Daniele/N-1724-2015; bisconti, roberta/AAA-8795-2020; Nascetti, Giuseppe/AAA-6396-2020	Canestrelli, Daniele/0000-0001-9351-4972; Nascetti, Giuseppe/0000-0002-1159-8103; Bisconti, Roberta/0000-0002-0600-7436	Tuscia University	Tuscia University	This work was supported by Tuscia University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barton N. H., 1998, P102; Bisconti R, 2012, MOL ECOL IN PRESS; Bisconti R, 2011, BIOL J LINN SOC, V103, P159, DOI 10.1111/j.1095-8312.2011.01643.x; Canestrelli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041754; Canestrelli D, 2012, BIOL J LINN SOC, V105, P42, DOI 10.1111/j.1095-8312.2011.01767.x; Capula M, 1996, HEREDITY, V77, P518, DOI 10.1038/hdy.1996.179; Delaugerre M., 1992, ATLAS REPARTITION BA; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Emerson BC, 2006, MOL ECOL, V15, P449, DOI 10.1111/j.1365-294X.2005.02786.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falchi A, 2009, MOL PHYLOGENET EVOL, V52, P538, DOI 10.1016/j.ympev.2009.04.002; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fu YX, 1997, GENETICS, V147, P915; Gasc J. P., 1997, COLLECTION PATRIMOIN; Gentile G, 2010, MOL PHYLOGENET EVOL, V54, P640, DOI 10.1016/j.ympev.2009.10.005; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Grant P.R., 2007, WHY SPECIES MULTIPLY; Grant PR, 1998, EVOLUTION ISLANDS; Harris DJ, 2005, AMPHIBIA-REPTILIA, V26, P401, DOI 10.1163/156853805774408676; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Head MJ, 2005, GEOL SOC SPEC PUBL, V247, P1, DOI 10.1144/GSL.SP.2005.247.01.01; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Holland BS, 2002, MOL ECOL, V11, P365, DOI 10.1046/j.1365-294X.2002.01464.x; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Ketmaier V, 2010, MALACOLOGIA, V52, P81, DOI 10.4002/040.052.0106; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kuhlemann J, 2008, SCIENCE, V321, P1338, DOI 10.1126/science.1157638; LANZA B, 1984, MONIT ZOOL ITAL, V18, P133; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MAC ARTHUR ROBERT H., 1967; Mannion, 2008, MEDITERRANEAN ISLAND; Miaud C, 2009, IUCN 2012 IUCN RED L; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mouillot F., 2008, V9, P220; Nei M., 1987, MOL EVOLUTIONARY GEN; Nevo E., 1984, Lecture Notes in Biomathematics, V53, P13; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Salvi D, 2010, MOL PHYLOGENET EVOL, V56, P690, DOI 10.1016/j.ympev.2010.03.017; Salvi D, 2009, BIOL J LINN SOC, V98, P661, DOI 10.1111/j.1095-8312.2009.01313.x; Stebbins G. Ledyard, 1942, MADRONO, V6, P241; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Thorpe Roger S., 1998, P67; Villacorta C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-7; Wallace AR, 1880, ISLAND LIFE PHENOMEN; Wallis GP, 2009, MOL ECOL, V18, P3548, DOI 10.1111/j.1365-294X.2009.04294.x; Waters JM, 2012, TRENDS ECOL IN PRESS; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Woolfit M, 2005, P ROY SOC B-BIOL SCI, V272, P2277, DOI 10.1098/rspb.2005.3217; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2011, MOL PHYLOGENET EVOL, V59, P342, DOI 10.1016/j.ympev.2011.01.017; Young AG, 2000, CONSERV BIOL SER, V4, P335; Zangari F, 2006, BIOL J LINN SOC, V87, P515	63	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55735	10.1371/journal.pone.0055735	http://dx.doi.org/10.1371/journal.pone.0055735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393599	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800053
J	Jiang, JS; Magilnick, N; Tsirulnikov, K; Abuladze, N; Atanasov, I; Ge, P; Narla, M; Pushkin, A; Zhou, ZH; Kurtz, I				Jiang, Jiansen; Magilnick, Nathaniel; Tsirulnikov, Kirill; Abuladze, Natalia; Atanasov, Ivo; Ge, Peng; Narla, Mohandas; Pushkin, Alexander; Zhou, Z. Hong; Kurtz, Ira			Single Particle Electron Microscopy Analysis of the Bovine Anion Exchanger 1 Reveals a Flexible Linker Connecting the Cytoplasmic and Membrane Domains	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE; TRANSPORT PROTEIN; BAND-3 PROTEIN; TILT; VISUALIZATION; PLASMODIUM; MECHANISM	Anion exchanger 1 (AE1) is the major erythrocyte membrane protein that mediates chloride/bicarbonate exchange across the erythrocyte membrane facilitating CO2 transport by the blood, and anchors the plasma membrane to the spectrin-based cytoskeleton. This multi-protein cytoskeletal complex plays an important role in erythrocyte elasticity and membrane stability. An in-frame AE1 deletion of nine amino acids in the cytoplasmic domain in a proximity to the membrane domain results in a marked increase in membrane rigidity and ovalocytic red cells in the disease Southeast Asian Ovalocytosis (SAO). We hypothesized that AE1 has a flexible region connecting the cytoplasmic and membrane domains, which is partially deleted in SAO, thus causing the loss of erythrocyte elasticity. To explore this hypothesis, we developed a new non-denaturing method of AE1 purification from bovine erythrocyte membranes. A three-dimensional (3D) structure of bovine AE1 at 2.4 nm resolution was obtained by negative staining electron microscopy, orthogonal tilt reconstruction and single particle analysis. The cytoplasmic and membrane domains are connected by two parallel linkers. Image classification demonstrated substantial flexibility in the linker region. We propose a mechanism whereby flexibility of the linker region plays a critical role in regulating red cell elasticity.	[Jiang, Jiansen; Atanasov, Ivo; Ge, Peng; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Jiang, Jiansen; Atanasov, Ivo; Ge, Peng; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Jiang, Jiansen; Zhou, Z. Hong] Baylor Coll Med, Struct Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Magilnick, Nathaniel; Tsirulnikov, Kirill; Abuladze, Natalia; Pushkin, Alexander; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Narla, Mohandas] New York Blood Ctr, New York, NY 10021 USA; [Kurtz, Ira] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York Blood Center; University of California System; University of California Los Angeles	Pushkin, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	apushkin@mednet.ucla.edu; Hong.Zhou@ucla.edu; ikurtz@mednet.ucla.edu	Jiang, Jiansen/J-2057-2015; Zhou, Z Hong/HDN-0747-2022	Jiang, Jiansen/0000-0002-1692-7906; Magilnick, Nathaniel/0000-0002-8515-4919	National Institutes of Health [DK077162, DK058563, GM071940]; American Heart Association Western State Affiliate grant [10GRNT4140074]; National Kidney Foundation Serving Southern California and Southern Nevada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R37DK026263, R01DK058563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Western State Affiliate grant; National Kidney Foundation Serving Southern California and Southern Nevada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health grants DK077162 and DK058563 (I.K.), and GM071940 (Z.H.Z.), and the American Heart Association Western State Affiliate grant 10GRNT4140074 (A.P.). Jiansen Jiang is a recipient of a postdoctoral fellowship from the National Kidney Foundation Serving Southern California and Southern Nevada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 2005, J PHYSIOL-LONDON, V565, P717, DOI 10.1113/jphysiol.2005.084988; Alberts B., 2008, MOL BIOL CELL, VFifth; Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; BENNETT V, 1979, NATURE, V280, P468, DOI 10.1038/280468a0; Butler J, 2008, BIOPHYS J, V95, P1826, DOI 10.1529/biophysj.108.129163; CASEY JR, 1991, J BIOL CHEM, V266, P15726; Colfen H, 1996, BIOPHYS J, V71, P1611, DOI 10.1016/S0006-3495(96)79364-5; Crandall IE, 2007, BIOCHEM PHARMACOL, V73, P632, DOI 10.1016/j.bcp.2006.10.030; DOLDER M, 1993, J MOL BIOL, V231, P119, DOI 10.1006/jmbi.1993.1261; Drew C, 2004, BIOELECTROCHEMISTRY, V62, P153, DOI 10.1016/j.bioelechem.2003.07.003; Ficarra S, 2009, J MEMBRANE BIOL, V228, P43, DOI 10.1007/s00232-009-9157-5; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GarciaRomeu F, 1996, CELL MOL BIOL, V42, P985; Ito D, 2006, J CELL SCI, V119, P3602, DOI 10.1242/jcs.03101; KANG D, 1992, J BIOL CHEM, V267, P19211; Kodippili GC, 2012, J BIOL CHEM, V287, P4129, DOI 10.1074/jbc.M111.294439; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lemieux MJ, 2002, J STRUCT BIOL, V137, P322; Leschziner AE, 2006, J STRUCT BIOL, V153, P284, DOI 10.1016/j.jsb.2005.10.012; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mgone CS, 1996, T ROY SOC TROP MED H, V90, P228, DOI 10.1016/S0035-9203(96)90223-0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MOHANDAS N, 1992, J CLIN INVEST, V89, P686, DOI 10.1172/JCI115636; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nakao M, 2002, CURR OPIN HEMATOL, V9, P127, DOI 10.1097/00062752-200203000-00008; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; SHEETZ MP, 1983, SEMIN HEMATOL, V20, P175; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; von Kalckreuth V, 2006, J INFECT DIS, V194, P949, DOI 10.1086/507430; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; WANG DN, 1993, EMBO J, V12, P2233, DOI 10.1002/j.1460-2075.1993.tb05876.x; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; Winograd E, 2004, MOL BIOCHEM PARASIT, V136, P243, DOI 10.1016/j.molbiopara.2004.04.005; WONG P, 1994, J THEOR BIOL, V171, P197, DOI 10.1006/jtbi.1994.1223; Yamaguchi T, 2010, J MOL BIOL, V397, P179, DOI 10.1016/j.jmb.2010.01.027; Zhang DC, 2000, BLOOD, V96, P2925; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P15115, DOI 10.1021/bi050931t	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55408	10.1371/journal.pone.0055408	http://dx.doi.org/10.1371/journal.pone.0055408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393575	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800029
J	Rugelj, D; Trontelj, JV; Strojnik, V				Rugelj, Darja; Trontelj, Joze V.; Strojnik, Vojko			The Influence of Light Hypothenar Contact during a Reaching Movement on the Centre of Pressure (COP) Forward Displacement	PLOS ONE			English	Article							POSTURAL CONTROL; FINGERTIP TOUCH; BALANCE; ORIENTATION; HEIGHT; SWAY; STABILIZATION; EQUILIBRIUM; STABILITY	The purpose of this study was to evaluate the effect of additional light hand contact (F<1 N) in the region of the hypothenar eminence on forward movement of the center of pressure (COP) and dominant hand. Subjects sled their hypothenar eminence on a vertically-oriented pressure sensitive board while reaching forward beyond their arm length. In the two separate experiments forty nine healthy, college-aged volunteers participated in the study. Thirty subjects (mean age of 22.2 +/- 2.4 years, 6 male and 24 female) participated in the experiment on level ground and nineteen subjects (22 +/- 2.6 years, 5 male and 14 female) in the experiment on an elevated surface. The forward displacement of the COP was significantly larger (p = 0.002) when subjects were allowed to slide with the hand as compared to no contact when the activity occurred on level ground (84 +/- 10 mm and 79 +/- 11 mm, respectively), and on a one meter elevated surface (71 +/- 17 mm and 65 +/- 21 mm, respectively). The maximal forward reach of the dominant hand was significantly greater when subjects were allowed to slide with the hypothenar eminence as compared to the no contact condition on the level ground (336 +/- 35 mm and 344 +/- 38 mm, respectively, p<0.02), and on the one meter elevated surface (298 +/- 58 mm and 307 +/- 58 mm, respectively, p<0.01). This data indicate that subjects were able to use additional haptic information from the hypothenar region to bring their COP and dominant hand further forward while standing on level ground as well as on a one m elevated surface.	[Rugelj, Darja] Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia; [Trontelj, Joze V.] Univ Clin Ctr, Inst Clin Neurophysiol, Ljubljana, Slovenia; [Strojnik, Vojko] Univ Ljubljana, Fac Sports, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Rugelj, D (corresponding author), Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia.	darja.rugelj@zf.uni-lj.si			Slovenian Research Agency [J3-0178-0382-08]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This research was partly supported by the Slovenian Research Agency, contract No. J3-0178-0382-08. http://www.arrs.gov.si The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adkin AL, 2000, GAIT POSTURE, V12, P87, DOI 10.1016/S0966-6362(00)00057-6; Adkin AL, 2002, EXP BRAIN RES, V143, P160, DOI 10.1007/s00221-001-0974-8; Albertsen IM, 2010, HUM MOVEMENT SCI, V29, P999, DOI 10.1016/j.humov.2010.07.013; Baccini M, 2007, AGE AGEING, V36, P30, DOI 10.1093/ageing/afl072; Bolton DAE, 2011, EXP BRAIN RES, V212, P279, DOI 10.1007/s00221-011-2728-6; Carpenter MG, 1999, J VESTIBUL RES-EQUIL, V9, P277; Carpenter MG, 2004, J NEUROPHYSIOL, V92, P3255, DOI 10.1152/jn.01139.2003; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Clapp S, 1999, EXP BRAIN RES, V125, P521, DOI 10.1007/s002210050711; Dickstein R, 2004, GAIT POSTURE, V20, P41, DOI 10.1016/S0966-6362(03)00091-2; Dickstein R, 2001, GAIT POSTURE, V14, P238, DOI 10.1016/S0966-6362(01)00161-8; DUNCAN PW, 1992, J GERONTOL, V47, pM93, DOI 10.1093/geronj/47.3.M93; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Holden M, 1994, J Vestib Res, V4, P285; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Huffman JL, 2009, GAIT POSTURE, V30, P528, DOI 10.1016/j.gaitpost.2009.08.001; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; Jeka JJ, 1996, PERCEPT PSYCHOPHYS, V58, P409, DOI 10.3758/BF03206817; Johannsen L, 2007, J NEUROPHYSIOL, V97, P2686, DOI 10.1152/jn.00038.2007; Johannsen L, 2012, J NEUROPHYSIOL, V107, P216, DOI 10.1152/jn.00149.2011; Johannsen L, 2009, J MOTOR BEHAV, V41, P397, DOI 10.3200/35-09-001; Jonsson E, 2003, J REHABIL MED, V35, P26, DOI 10.1080/16501970306099; Lackner JR, 1999, EXP BRAIN RES, V126, P459, DOI 10.1007/s002210050753; Massion J, 1993, J Vestib Res, V3, P275; Massion J, 2004, PROG BRAIN RES, V143, P13, DOI 10.1016/S0079-6123(03)43002-1; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McNevin NH, 2002, HUM MOVEMENT SCI, V21, P187, DOI 10.1016/S0167-9457(02)00095-7; Nagano A, 2006, MOTOR CONTROL, V10, P348, DOI 10.1123/mcj.10.4.348; Nakahara H, 2000, OTOLARYNG HEAD NECK, V123, P501, DOI 10.1067/mhn.2000.107316; Reginella RL, 1999, J VESTIBUL RES-EQUIL, V9, P103; Rugelj D, 2002, CELL MOL BIOL LETT, V7, P149; Schmidt RA, 2005, MOTOR CONTROL LEARNI, P432; Simeonov PI, 2005, HUM FACTORS, V47, P430, DOI 10.1518/0018720054679506; Stins JF, 2011, HUM MOVEMENT SCI, V30, P190, DOI 10.1016/j.humov.2010.05.013; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Zhang YF, 2007, GAIT POSTURE, V26, P263, DOI 10.1016/j.gaitpost.2006.09.007	36	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55360	10.1371/journal.pone.0055360	http://dx.doi.org/10.1371/journal.pone.0055360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393569	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800023
J	Schottner, S; Hoffmann, F; Cardenas, P; Rapp, HT; Boetius, A; Ramette, A				Schoettner, Sandra; Hoffmann, Friederike; Cardenas, Paco; Rapp, Hans Tore; Boetius, Antje; Ramette, Alban			Relationships between Host Phylogeny, Host Type and Bacterial Community Diversity in Cold-Water Coral Reef Sponges	PLOS ONE			English	Article							CHONDRILLA-NUCULA DEMOSPONGIAE; INTERGENIC SPACER ANALYSIS; VERTICAL TRANSMISSION; MICROBIAL DIVERSITY; LOPHELIA-PERTUSA; MARINE SPONGES; ORGANIC-CARBON; SYMBIOTIC BACTERIA; DEEP; PORIFERA	Cold-water coral reefs are known to locally enhance the diversity of deep-sea fauna as well as of microbes. Sponges are among the most diverse faunal groups in these ecosystems, and many of them host large abundances of microbes in their tissues. In this study, twelve sponge species from three cold-water coral reefs off Norway were investigated for the relationship between sponge phylogenetic classification (species and family level), as well as sponge type (high versus low microbial abundance), and the diversity of sponge-associated bacterial communities, taking also geographic location and water depth into account. Community analysis by Automated Ribosomal Intergenic Spacer Analysis (ARISA) showed that as many as 345 (79%) of the 437 different bacterial operational taxonomic units (OTUs) detected in the dataset were shared between sponges and sediments, while only 70 (16%) appeared purely sponge-associated. Furthermore, changes in bacterial community structure were significantly related to sponge species (63% of explained community variation), sponge family (52%) or sponge type (30%), whereas mesoscale geographic distances and water depth showed comparatively small effects (< 5% each). In addition, a highly significant, positive relationship between bacterial community dissimilarity and sponge phylogenetic distance was observed within the ancient family of the Geodiidae. Overall, the high diversity of sponges in cold-water coral reefs, combined with the observed sponge-related variation in bacterial community structure, support the idea that sponges represent heterogeneous, yet structured microbial habitats that contribute significantly to enhancing bacterial diversity in deep-sea ecosystems.	[Schoettner, Sandra; Hoffmann, Friederike; Boetius, Antje; Ramette, Alban] Max Planck Inst Marine Microbiol, HGF MPG Grp Deep Sea Ecol & Technol, Bremen, Germany; [Schoettner, Sandra] Univ Bergen, Marine Microbiol Grp, Dept Biol, Bergen, Norway; [Hoffmann, Friederike; Rapp, Hans Tore] Univ Bergen, Dept Biol, Ctr Geobiol, Bergen, Norway; [Cardenas, Paco] Univ Bergen, Dept Biol, Bergen High Technol Ctr, Bergen, Norway	Max Planck Society; University of Bergen; University of Bergen; University of Bergen	Ramette, A (corresponding author), Max Planck Inst Marine Microbiol, HGF MPG Grp Deep Sea Ecol & Technol, Bremen, Germany.	aramette@mpi-bremen.de	Boetius, Antje/D-5459-2013; Ramette, Alban/E-9197-2016	Boetius, Antje/0000-0003-2117-4176; Ramette, Alban/0000-0002-3437-4639	EU [GOCE-CT-2005-511234-1, 226354]; SPONGES [017800]; Deutsche Forschungsgemeinschaft (DFG) [HO 3293/1-1]; Norwegian Research Council [28630]; Max Planck Society	EU(European Commission); SPONGES; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was funded by the EU FP6 project HERMES (GOCE-CT-2005-511234-1), the EU FP7 project HERMIONE (contract no. 226354) and SPONGES (project 017800). FH was funded by the Deutsche Forschungsgemeinschaft (DFG project HO 3293/1-1). HTR was funded by the Norwegian Research Council through contract number 28630. This study was also supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Bruck WM, 2010, ISME J, V4, P686, DOI 10.1038/ismej.2009.149; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Cardebas Paco, 2012, Zootaxa, V3253, P1; Cardenas P, 2012, ADV MAR BIOL, V61, P79, DOI 10.1016/B978-0-12-387787-1.00010-6; Cardenas P, 2007, J MAR BIOL ASSOC UK, V87, P1511, DOI 10.1017/S0025315407058286; Cardenas P, 2010, ZOOL SCR, V39, P89, DOI 10.1111/j.1463-6409.2009.00402.x; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; de Goeij JM, 2007, LIMNOL OCEANOGR, V52, P2608, DOI 10.4319/lo.2007.52.6.2608; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Ereskovsky AV, 2005, MAR BIOL, V146, P869, DOI 10.1007/s00227-004-1489-1; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Freiwald Andre, 2004, P1; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Hansson L, 2009, MAR ECOL PROG SER, V397, P89, DOI 10.3354/meps08429; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hill M, 2006, MAR BIOL, V148, P1221, DOI 10.1007/s00227-005-0164-5; Hoffmann F, 2005, GEOMICROBIOL J, V22, P1, DOI 10.1080/01490450590922505; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; Hooper JNA, 2002, SYSTEMA PORIFERA GUI; JENSEN A, 1992, SARSIA, V77, P53, DOI 10.1080/00364827.1992.10413492; Jensen S, 2008, DEEP-SEA RES PT I, V55, P1554, DOI 10.1016/j.dsr.2008.06.008; Kamke J, 2010, ISME J, V4, P498, DOI 10.1038/ismej.2009.143; Kellogg CA, 2009, APPL ENVIRON MICROB, V75, P2294, DOI 10.1128/AEM.02357-08; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lee OO, 2009, APPL ENVIRON MICROB, V75, P3513, DOI 10.1128/AEM.00002-09; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pisera A, 2006, CAN J ZOOL, V84, P242, DOI 10.1139/Z05-169; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Reitner Joachim, 1995, Geologisch-Palaeontologische Mitteilungen, V20, P335; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schmitt S, 2007, APPL ENVIRON MICROB, V73, P2067, DOI 10.1128/AEM.01944-06; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; Schottner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032093; Schottner S, 2011, ENVIRON MICROBIOL, V13, P1815, DOI 10.1111/j.1462-2920.2011.02494.x; Schottner S, 2009, ISME J, V3, P756, DOI 10.1038/ismej.2009.15; SCISCIOLI M, 1991, MOL REPROD DEV, V28, P346, DOI 10.1002/mrd.1080280406; SCISCIOLI M, 1994, CAH BIOL MAR, V35, P471; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Thoms C, 2003, MAR BIOL, V142, P685, DOI 10.1007/s00227-002-1000-9; Van Soest RWM, 2005, MAR BIOL RES, V1, P338, DOI 10.1080/17451000500380322; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; Wichels A, 2006, FEMS MICROBIOL ECOL, V56, P102, DOI 10.1111/j.1574-6941.2006.00067.x; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Yakimov MM, 2006, DEEP-SEA RES PT I, V53, P62, DOI 10.1016/j.dsr.2005.07.005; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	76	62	64	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55505	10.1371/journal.pone.0055505	http://dx.doi.org/10.1371/journal.pone.0055505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393586	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800040
J	Wang, LF; Taneja, R; Wang, W; Yao, LJ; Veldhuizen, RAW; Gill, SE; Fortin, D; Inculet, R; Malthaner, R; Mehta, S				Wang, Lefeng; Taneja, Ravi; Wang, Wei; Yao, Li-Juan; Veldhuizen, Ruud A. W.; Gill, Sean E.; Fortin, Dalilah; Inculet, Richard; Malthaner, Richard; Mehta, Sanjay			Human Alveolar Epithelial Cells Attenuate Pulmonary Microvascular Endothelial Cell Permeability under Septic Conditions	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; NITRIC-OXIDE SYNTHASE; MURINE SEPSIS; PROTEIN LEAK; IN-VITRO; MIGRATION; KINASE; MODEL; PATHOGENESIS	Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), are characterised by high-protein pulmonary edema and severe hypoxaemic respiratory failure due to increased permeability of pulmonary microvascular endothelial cells (PMVEC). Alveolar epithelial cells (AEC) contribute importantly to normal alveolar function, and AEC dysfunction in ALI/ARDS is associated with worse outcomes. We hypothesized that AEC can modulate human PMVEC barrier function, and investigated the effects of AEC presence on human PMVEC barrier under septic conditions in vitro. PMVEC isolated from human lung were treated in vitro with septic stimulation (lipopolysaccharide [LPS], a mixture of clinically-relevant cytokines [cytomix], or plasma from patients with severe sepsis), and the trans-PMVEC leak of Evans Blue dye-labeled albumin assessed. PMVEC septic responses were compared in the presence/absence of co-cultured A549 epithelial cell line or primary human AEC. Septic stimulation with LPS, cytomix, or septic plasma induced marked PMVEC hyper-permeability (10.2 +/- 1.8, 8.9 +/- 2.2, and 3.7 +/- 0.2 fold-increase vs. control, respectively, p<0.01 for all). The presence of A549 cells or primary human AEC in a non-contact co-culture model attenuated septic PMVEC hyper-permeability by 39 +/- 4% to 100 +/- 3%, depending on the septic stimulation (p<0.05). Septic PMVEC hyper-permeability was also attenuated following treatment with culture medium conditioned by previous incubation with either naive or cytomix-treated A549 cells (p<0.05), and this protective effect of A549 cell-conditioned medium was both heat-stable and transferable following lipid extraction. Cytomix-stimulated PMN-dependent PMVEC hyper-permeability and trans-PMVEC PMN migration were also inhibited in the presence of A549 cells or A549 cell-conditioned medium (p<0.05). Human AEC appear to protect human PMVEC barrier function under septic conditions in vitro, through release of a soluble mediator(s), which are at least partly lipid in nature. This study suggests a scientific and potential clinical therapeutic importance of epithelial-endothelial cross talk in maintaining alveolar integrity in ALI/ARDS.	[Wang, Lefeng; Taneja, Ravi; Wang, Wei; Yao, Li-Juan; Veldhuizen, Ruud A. W.; Gill, Sean E.; Mehta, Sanjay] London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, Div Respirol, London, ON, Canada; [Wang, Lefeng; Wang, Wei; Veldhuizen, Ruud A. W.; Gill, Sean E.; Mehta, Sanjay] Univ Western Ontario, Schulich Fac Med & Dent, Dept Med, London, ON, Canada; [Taneja, Ravi] Univ Western Ontario, Schulich Fac Med & Dent, Dept Anesthesia, London, ON, Canada; [Taneja, Ravi; Fortin, Dalilah] Univ Western Ontario, Schulich Fac Med & Dent, Dept Crit Care Med, London, ON, Canada; [Fortin, Dalilah; Inculet, Richard; Malthaner, Richard] Univ Western Ontario, Schulich Fac Med & Dent, Dept Thorac Surg, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Mehta, S (corresponding author), London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, Div Respirol, London, ON, Canada.	Sanjay.Mehta@lhsc.on.ca	Veldhuizen, Ruud/G-3352-2011; Gill, Sean E/G-4057-2012; Mehta, Sanjay/G-3332-2011	Veldhuizen, Ruud/0000-0002-8802-1580; Mehta, Sanjay/0000-0002-7707-1056	Heart & Stroke Foundation of Ontario/Canada [T6461]; Ontario Thoracic Society; Lawson Health Research Institute; LHSC Department of Medicine Program of Experimental Medicine	Heart & Stroke Foundation of Ontario/Canada; Ontario Thoracic Society; Lawson Health Research Institute; LHSC Department of Medicine Program of Experimental Medicine	Funding support by Heart & Stroke Foundation of Ontario/Canada grant #T6461, Ontario Thoracic Society, Lawson Health Research Institute, LHSC Department of Medicine Program of Experimental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastarache JA, 2009, AM J PHYSIOL-LUNG C, V297, pL1035, DOI 10.1152/ajplung.00214.2009; Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Breslin JW, 2004, AM J PHYSIOL-HEART C, V286, pH1057, DOI 10.1152/ajpheart.00841.2003; Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002; Clerici C, 2011, AM J PHYSIOL-LUNG C, V301, pL20, DOI 10.1152/ajplung.00126.2011; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Ehrhardt Carsten, 2005, Methods Mol Med, V107, P207; Farley KS, 2006, AM J PHYSIOL-LUNG C, V290, pL1164, DOI 10.1152/ajplung.00248.2005; GORIN AB, 1979, J APPL PHYSIOL, V47, P1315, DOI 10.1152/jappl.1979.47.6.1315; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hermanns MI, 2009, CELL TISSUE RES, V336, P91, DOI 10.1007/s00441-008-0750-1; Jacobs ER, 2001, AM J PHYSIOL-HEART C, V280, pH1, DOI 10.1152/ajpheart.2001.280.1.H1; Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Moss M, 1996, CRIT CARE MED, V24, P1782, DOI 10.1097/00003246-199611000-00004; Ochoa CD, 2012, AM J PHYSIOL-LUNG C, V302, pL275, DOI [10.1152/ajplung.00215.2011., 10.1152/ajplung.00215.2011]; Orgeig S, 2010, RESP PHYSIOL NEUROBI, V173, pS43, DOI 10.1016/j.resp.2010.04.023; Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI 10.1586/ERS.10.92; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Razavi HM, 2005, CRIT CARE MED, V33, P1333, DOI 10.1097/01.CCM.0000165445.48350.4F; Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Shelton JL, 2008, MICROVASC RES, V76, P80, DOI 10.1016/j.mvr.2008.06.001; Shelton JL, 2007, MICROVASC RES, V74, P23, DOI 10.1016/j.mvr.2007.02.008; Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003; Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Wang LF, 2012, SHOCK, V37, P539, DOI 10.1097/SHK.0b013e31824dcb5a; Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017; Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weppler A, 2006, EXP LUNG RES, V32, P455, DOI 10.1080/01902140601059463; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	42	30	36	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55311	10.1371/journal.pone.0055311	http://dx.doi.org/10.1371/journal.pone.0055311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393568	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800022
J	Wood, MP; Cole, AL; Ruchala, P; Waring, AJ; Rohan, LC; Marx, P; Tarwater, PM; Gupta, P; Cole, AM				Wood, Matthew P.; Cole, Amy L.; Ruchala, Piotr; Waring, Alan J.; Rohan, Lisa C.; Marx, Preston; Tarwater, Patrick M.; Gupta, Phalguni; Cole, Alexander M.			A Compensatory Mutation Provides Resistance to Disparate HIV Fusion Inhibitor Peptides and Enhances Membrane Fusion	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RETROCYCLIN ANALOG RC-101; ENVELOPE GLYCOPROTEIN; TYPE-1 VARIANT; 6-HELIX BUNDLE; GP41; INFECTION; BINDING; MODEL; ENFUVIRTIDE	Fusion inhibitors are a class of antiretroviral drugs used to prevent entry of HIV into host cells. Many of the fusion inhibitors being developed, including the drug enfuvirtide, are peptides designed to competitively inhibit the viral fusion protein gp41. With the emergence of drug resistance, there is an increased need for effective and unique alternatives within this class of antivirals. One such alternative is a class of cyclic, cationic, antimicrobial peptides known as theta-defensins, which are produced by many non-human primates and exhibit broad-spectrum antiviral and antibacterial activity. Currently, the theta-defensin analog RC-101 is being developed as a microbicide due to its specific antiviral activity, lack of toxicity to cells and tissues, and safety in animals. Understanding potential RC-101 resistance, and how resistance to other fusion inhibitors affects RC-101 susceptibility, is critical for future development. In previous studies, we identified a mutant, R5-tropic virus that had evolved partial resistance to RC-101 during in vitro selection. Here, we report that a secondary mutation in gp41 was found to restore replicative fitness, membrane fusion, and the rate of viral entry, which were compromised by an initial mutation providing partial RC-101 resistance. Interestingly, we show that RC-101 is effective against two enfuvirtide-resistant mutants, demonstrating the clinical importance of RC-101 as a unique fusion inhibitor. These findings both expand our understanding of HIV drug-resistance to diverse peptide fusion inhibitors and emphasize the significance of compensatory gp41 mutations.	[Wood, Matthew P.; Cole, Amy L.; Cole, Alexander M.] Univ Cent Florida, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Ruchala, Piotr; Waring, Alan J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Rohan, Lisa C.; Gupta, Phalguni] Univ Pittsburgh, Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Magee Womens Res Inst, Pittsburgh, PA USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Marx, Preston] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Tarwater, Patrick M.] Texas Tech Univ, Dept Biostat, Hlth Sci Ctr, El Paso, TX USA	State University System of Florida; University of Central Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tulane University; Texas Tech University System; Texas Tech University	Cole, AM (corresponding author), Univ Cent Florida, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	acole@ucf.edu		RUCHALA, PIOTR/0000-0002-5574-2779; Wood, Matthew/0000-0001-6741-0088	National Institutes of Health [AI052017, AI082623, AI082693]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [P51 RR00164-50]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052017, R33AI082693, U19AI082623, R21AI082693, R56AI052017] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants AI052017 (to A.M.C.), AI082623 (to A.M.C., P.G., L.C.R., P.A.M., and P.M.T.), and AI082693 (to A.M.C.) from the National Institutes of Health (to A.M.C.). This project was supported by the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Grant Number P51 RR00164-50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Baldwin C, 2008, J VIROL, V82, P7735, DOI 10.1128/JVI.02524-07; Barrio AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S18; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Cole AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015111; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2007, IMMUNOLOGY, V121, P140, DOI 10.1111/j.1365-2567.2006.02553.x; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Eade CR, 2012, CURR HIV RES, V10, P61, DOI 10.2174/157016212799304580; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fuhrman CA, 2007, FEBS J, V274, P6477, DOI 10.1111/j.1742-4658.2007.06165.x; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Lamers RP, 2011, ANTIMICROB AGENTS CH, V55, P5338, DOI 10.1128/AAC.00619-11; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Micewicz ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014360; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Owen SM, 2004, AIDS RES HUM RETROV, V20, P1157, DOI 10.1089/aid.2004.20.1157; Poveda E, 2004, J MED VIROL, V74, P21, DOI 10.1002/jmv.20141; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Trivedi VD, 2003, PROTEIN ENG, V16, P311, DOI 10.1093/proeng/gzg036; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	32	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55478	10.1371/journal.pone.0055478	http://dx.doi.org/10.1371/journal.pone.0055478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393582	Green Accepted, gold, Green Published			2022-12-27	WOS:000314692800036
J	Siozios, S; Ioannidis, P; Klasson, L; Andersson, SGE; Braig, HR; Bourtzis, K				Siozios, Stefanos; Ioannidis, Panagiotis; Klasson, Lisa; Andersson, Siv G. E.; Braig, Henk R.; Bourtzis, Kostas			The Diversity and Evolution of Wolbachia Ankyrin Repeat Domain Genes	PLOS ONE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM ANKA; SEQUENCE TYPING SYSTEM; CYTOPLASMIC INCOMPATIBILITY; GENOME SEQUENCE; LEGIONELLA-PNEUMOPHILA; DNA-SEQUENCES; CULEX-PIPIENS; BRUGIA-MALAYI; RECOMBINATION; PROTEIN	Ankyrin repeat domain-encoding genes are common in the eukaryotic and viral domains of life, but they are rare in bacteria, the exception being a few obligate or facultative intracellular Proteobacteria species. Despite having a reduced genome, the arthropod strains of the alphaproteobacterium Wolbachia contain an unusually high number of ankyrin repeat domain-encoding genes ranging from 23 in wMel to 60 in wPip strain. This group of genes has attracted considerable attention for their astonishing large number as well as for the fact that ankyrin proteins are known to participate in protein-protein interactions, suggesting that they play a critical role in the molecular mechanism that determines host-Wolbachia symbiotic interactions. We present a comparative evolutionary analysis of the wMel-related ankyrin repeat domain-encoding genes present in different Drosophila-Wolbachia associations. Our results show that the ankyrin repeat domain-encoding genes change in size by expansion and contraction mediated by short directly repeated sequences. We provide examples of intragenic recombination events and show that these genes are likely to be horizontally transferred between strains with the aid of bacteriophages. These results confirm previous findings that the Wolbachia genomes are evolutionary mosaics and illustrate the potential that these bacteria have to generate diversity in proteins potentially involved in the symbiotic interactions.	[Siozios, Stefanos; Ioannidis, Panagiotis; Bourtzis, Kostas] Univ Western Greece, Dept Environm & Nat Resources Management, Agrinion, Greece; [Klasson, Lisa; Andersson, Siv G. E.] Uppsala Univ, Dept Mol Evolut, Uppsala, Sweden; [Braig, Henk R.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Bourtzis, Kostas] Biomed Sci Res Ctr Al Fleming, Vari, Greece; [Bourtzis, Kostas] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria	Uppsala University; Bangor University; Alexander Fleming Biomedical Sciences Research Center; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Bourtzis, K (corresponding author), Univ Western Greece, Dept Environm & Nat Resources Management, Agrinion, Greece.	K.Bourtzis@iaea.org	Ioannidis, Panagiotis/I-4281-2014; Braig, Henk/I-5477-2013	Ioannidis, Panagiotis/0000-0003-0939-6745; Braig, Henk/0000-0001-9592-1141; Klasson, Lisa/0000-0002-5874-7153; Siozios, Stefanos/0000-0002-1104-7061	European Community [203590]; EU COST Action [FA0701]	European Community(European Commission); EU COST Action(European Cooperation in Science and Technology (COST)European Commission)	This research was supported in part by the European Community's Seventh Framework Programme CSA-SA_REGPROT-2007-1 (under grant agreement no 203590 (KB). LK, SA, HRB and KB benefitted by travel grants in the frame of the EU COST Action FA0701 "Arthropod Symbiosis: from fundamental studies to pest and disease management". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Amiri H, 2003, MOL BIOL EVOL, V20, P1575, DOI 10.1093/molbev/msg175; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2005, J BACTERIOL, V187, P5406, DOI 10.1128/JB.187.15.5406-5418.2005; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Caturegli P, 2000, INFECT IMMUN, V68, P5277, DOI 10.1128/IAI.68.9.5277-5283.2000; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chafee ME, 2010, MOL BIOL EVOL, V27, P501, DOI 10.1093/molbev/msp275; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Cordaux R, 2008, MOL BIOL EVOL, V25, P1889, DOI 10.1093/molbev/msn134; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; Doudoumis V, 2012, J INVERTEBR PATHOL; DRUMMOND AJ, 2008, GENEIOUS V4 0; Duron O, 2005, MOL ECOL, V14, P1561, DOI 10.1111/j.1365-294X.2005.02495.x; Duron O, 2007, J BACTERIOL, V189, P4442, DOI 10.1128/JB.00142-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felix C, 2008, RES MICROBIOL, V159, P481, DOI 10.1016/j.resmic.2008.05.007; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Garcia-Garcia JC, 2009, INFECT IMMUN, V77, P2385, DOI 10.1128/IAI.00023-09; Gavotte L, 2007, MOL BIOL EVOL, V24, P427, DOI 10.1093/molbev/msl171; GIORDANO R, 1995, GENETICS, V140, P1307; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Habyarimana F, 2008, ENVIRON MICROBIOL, V10, P1460, DOI 10.1111/j.1462-2920.2007.01560.x; Hadfield SJ, 1999, NATURE, V402, P482, DOI 10.1038/45002; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; HOLDEN PR, 1993, MOL GEN GENET, V240, P213, DOI 10.1007/BF00277059; HOLMES DS, 1973, BIOCHEMISTRY-US, V12, P2330, DOI 10.1021/bi00736a023; Ijdo JW, 2007, CELL MICROBIOL, V9, P1284, DOI 10.1111/j.1462-5822.2006.00871.x; Ioannidis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-182; Ishmael N, 2009, MICROBIOLOGY, V106, P5725; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; Jiggins FM, 2002, MOL BIOL EVOL, V19, P1640, DOI 10.1093/oxfordjournals.molbev.a004228; Kent BN, 2010, TRENDS MICROBIOL, V18, P173, DOI 10.1016/j.tim.2009.12.011; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Leclercq S, 2011, MOL BIOL EVOL, V28, P685, DOI 10.1093/molbev/msq238; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; McGraw EA, 2001, P ROY SOC B-BIOL SCI, V268, P2565, DOI 10.1098/rspb.2001.1839; MERCOT H, 1995, GENETICS, V141, P1015; Metcalf JA, 2012, CURR OPIN MICROBIOL, V15, P546, DOI 10.1016/j.mib.2012.04.010; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nakayama K, 2008, DNA RES, V15, P185, DOI 10.1093/dnares/dsn011; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Papafotiou G, 2011, RES MICROBIOL, V162, P764, DOI 10.1016/j.resmic.2011.06.012; Paraskevopoulos C, 2006, CURR MICROBIOL, V53, P388, DOI 10.1007/s00284-006-0054-1; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Riegler M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S12; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P1886, DOI 10.1093/nar/30.9.1886; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Salzberg S. L., 2005, GENOME BIOL, V6; Salzberg SL, 2009, J BACTERIOL, V191, P1725, DOI 10.1128/JB.01731-08; Sambrook S, 1989, MOL CLONING LAB MANU; Saridaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019708; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sinkins SP, 2005, NATURE, V436, P257, DOI 10.1038/nature03629; SMITH JM, 1992, J MOL EVOL, V34, P126; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Tripp KW, 2004, J MOL BIOL, V344, P169, DOI 10.1016/j.jmb.2004.09.038; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Walker T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-39; Werden SJ, 2008, BBA-PROTEINS PROTEOM, V1784, P228, DOI 10.1016/j.bbapap.2007.08.001; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yamada R, 2011, INSECT MOL BIOL, V20, P75, DOI 10.1111/j.1365-2583.2010.01042.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zabalou S, 2004, GENETICS, V167, P827, DOI 10.1534/genetics.103.015990; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	106	55	55	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55390	10.1371/journal.pone.0055390	http://dx.doi.org/10.1371/journal.pone.0055390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390535	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100051
J	Wang, C; Wang, JY; Borer, JG; Li, X				Wang, Chen; Wang, JingYing; Borer, Joseph G.; Li, Xue			Embryonic Origin and Remodeling of the Urinary and Digestive Outlets	PLOS ONE			English	Article							EXTERNAL GENITALIA DEVELOPMENT; MAMMALIAN KIDNEY; SONIC-HEDGEHOG; HEAD INDUCTION; APOPTOSIS; MOUSE; SEPTATION; TUBERCLE; CATENIN; GROWTH	Separating digestive and urinary outlets is a critical step during mammalian embryogenesis. However, the natural history of these structures is poorly studied, and little is known about their embryonic origin. Here, we show that peri-cloacal mesenchymal (PCM) progenitors are the major source of these structures. Surprisingly, PCM progenitors also contribute to perineum, a structural barrier separating the urinary and digestive tracts, suggesting a potential role of PCM progenitors in establishing independent urinary and digestive outlets. We demonstrate that Six1 and Six2 are complementarily but asymmetrically expressed in the PCM progenitors. Deletion of these genes results in decreased cell survival and proliferation, and consequently in agenesis of the perineum and severe hypoplasia of the genital tubercle. Together, these findings suggest that PCM progenitors are the unexpected source of perineum and genital tubercle, and establish a basic framework for investigating normal and abnormal development of anorectal and genitourinary structures.	[Wang, Chen; Wang, JingYing; Borer, Joseph G.; Li, Xue] Boston Childrens Hosp, Dept Urol, Boston, MA USA; [Wang, JingYing; Li, Xue] Harvard Univ, Sch Med, Dept Surg & Pathol, Boston, MA USA; [Wang, JingYing; Li, Xue] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Li, X (corresponding author), Boston Childrens Hosp, Dept Urol, Boston, MA USA.	sean.li@childrens.harvard.edu	Wang, Jingying/G-5568-2012	Wang, Jingying/0000-0001-8692-6928	Harvard Stem Cell Institute; National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR) [1R01DE019823]; NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) [1R01DK091645-01A1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091645] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the Harvard Stem Cell Institute, National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR) (1R01DE019823, XL) and NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) (1R01DK091645-01A1, XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J ANAT; [Anonymous], J ANAT PHYSL; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Blaschko SD, 2012, DIFFERENTIATION; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; Hynes PJ, 2004, BRIT J PLAST SURG, V57, P27, DOI 10.1016/j.bjps.2003.08.019; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; KLUTH D, 1995, J PEDIATR SURG, V30, P1143, DOI 10.1016/0022-3468(95)90007-1; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Li X, 2002, SCIENCE, V297, P1180; Lin CX, 2008, DEVELOPMENT, V135, P2815, DOI 10.1242/dev.020586; Lin CX, 2009, DEVELOPMENT, V136, P3959, DOI 10.1242/dev.039768; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Miyagawa S, 2009, MOL ENDOCRINOL, V23, P871, DOI 10.1210/me.2008-0478; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Paidas CN, 1999, J PEDIATR SURG, V34, P877, DOI 10.1016/S0022-3468(99)90391-3; Penington EC, 2003, J PEDIATR SURG, V38, P1287, DOI 10.1016/S0022-3468(03)00384-1; Qi BQ, 2000, J PEDIATR SURG, V35, P1556, DOI 10.1053/jpsu.2000.18309; Rathke H, 1832, ABHANDLUNGEN BILDUNG; Rodriguez E, 2011, BIOL REPROD, V85, P1216, DOI 10.1095/biolreprod.111.091504; Sasaki C, 2004, ANAT REC PART A, V279A, P761, DOI 10.1002/ar.a.20062; Seifert AW, 2008, DEV BIOL, V318, P143, DOI 10.1016/j.ydbio.2008.03.017; Seifert AW, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1020; Seifert AW, 2009, DEVELOPMENT, V136, P3949, DOI 10.1242/dev.042291; Seifert AW, 2009, DEVELOPMENT, V136, P2643, DOI 10.1242/dev.036830; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki K, 2003, DEVELOPMENT, V130, P6209, DOI 10.1242/dev.00846; van der Putte SCJ, 2005, ADV ANAT EMBRYOL CEL, V177, P1; VANDERPUTTE SCJ, 1986, J PEDIATR SURG, V21, P434, DOI 10.1016/S0022-3468(86)80515-2; Wang C, 2011, DEV BIOL, V360, P186, DOI 10.1016/j.ydbio.2011.09.020; Weiss DA, 2012, MOL CELL ENDOCRINOL, V354, P94, DOI 10.1016/j.mce.2011.08.009; Wu XY, 2009, GENE EXPR PATTERNS, V9, P224, DOI 10.1016/j.gep.2008.12.005; Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536; Yucel S, 2004, ADV EXP MED BIOL, V545, P123	43	120	121	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55587	10.1371/journal.pone.0055587	http://dx.doi.org/10.1371/journal.pone.0055587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390542	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100058
J	Luger, R; Valookaran, S; Knapp, N; Vizzardelli, C; Dohnal, AM; Felzmann, T				Luger, Romana; Valookaran, Sneha; Knapp, Natalie; Vizzardelli, Caterina; Dohnal, Alexander M.; Felzmann, Thomas			Toll-Like Receptor 4 Engagement Drives Differentiation of Human and Murine Dendritic Cells from a Pro- into an Anti-Inflammatory Mode	PLOS ONE			English	Article							T-CELLS; IN-VIVO; TUMOR; IL-12; ANTIGEN; CANCER; INTERLEUKIN-12; ACTIVATION; GENERATION; MATURATION	The dendritic cell (DC) coordinates innate and adaptive immunity to fight infections and cancer. Our observations reveal that DCs exposed to the microbial danger signal lipopolysaccharide (LPS) in the presence of interferon-gamma (IFN-gamma) acquire a continuously changing activation/maturation phenotype. The DCs' initial mode of action is pro-inflammatory via up-regulation among others of the signaling molecule interleukin (IL) 12, which polarizes IFN-gamma secreting type 1 helper T-cells (Th1). Within 24 hours the same DC switches from the pro- into an anti-inflammatory phenotype. This is mediated by autocrine IL-10 release and secretion of soluble IL-2 receptor alpha (sIL-2RA) molecules. T-cells, when contacted with DCs during their anti-inflammatory phase loose their proliferative capacity and develop regulatory T-cell (Treg) -like anti-inflammatory functions indicated by IL-10 secretion and elevated FoxP3 levels. Studying the kinetics of IL-12 and IL-10 expression from LPS/IFN-gamma activated myeloid DCs on a single cell level confirmed these observations. When T-cells are separated from DCs within 24 hours, they are spared from the anti-inflammatory DC activity. We conclude that, in addition to differentiation of DCs into distinct subsets, the observed sequential functional phases of DC differentiation permit the fine-tuning of an immune response. A better understanding of time-kinetic DC features is required for optimally exploiting the therapeutic capacity of DCs in cancer immune therapy.	[Luger, Romana; Valookaran, Sneha; Knapp, Natalie; Vizzardelli, Caterina; Dohnal, Alexander M.; Felzmann, Thomas] Med Univ Vienna, Dept Pediat, Lab Tumor Immunol, St Anna Childrens Canc Res Inst, Vienna, Austria; [Felzmann, Thomas] Activartis Biotech GmbH, Vienna, Austria	Medical University of Vienna; Saint Anna Children's Hospital	Felzmann, T (corresponding author), Med Univ Vienna, Dept Pediat, Lab Tumor Immunol, St Anna Childrens Canc Res Inst, Vienna, Austria.	thomas.felzmann@activartis.com		Dohnal, Alexander/0000-0002-5844-7329; Vizzardelli, Caterina/0000-0001-9262-6710	St. Anna Children's Cancer Research Institute (CCRI); City of Vienna (Vienna Business Agency, WWFF/ZIT); Austrian government (Austrian Research Promotion Fund); Austrian government (FFG); Austrian government (FWF); EU (EU Framework Program 7); Activartis Biotech GmbH	St. Anna Children's Cancer Research Institute (CCRI); City of Vienna (Vienna Business Agency, WWFF/ZIT); Austrian government (Austrian Research Promotion Fund); Austrian government (FFG); Austrian government (FWF); EU (EU Framework Program 7); Activartis Biotech GmbH	The authors are grateful to the The St. Anna Children's Cancer Research Institute (CCRI) and its many private donors for financing this research project. The work was also supported by grants from the City of Vienna (Vienna Business Agency, WWFF/ZIT), the Austrian government (Austrian Research Promotion Fund, FFG and FWF), and the EU (EU Framework Program 7) awarded to the CCRI and to Activartis Biotech GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: As CEO of Activartis Biotech GmbH, a biotech company that develops a DC based cancer vaccine technology, T.F. discloses conflicting financial interests in the data presented in this paper. Activartis Biotech GmbH is a funder of this research. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials All other authors have no conflicting financial interests.	Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Battye FL, 2000, J IMMUNOL METHODS, V243, P25, DOI 10.1016/S0022-1759(00)00225-8; Benencia F, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-21; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Boullart ACI, 2008, CANCER IMMUNOL IMMUN, V57, P1589, DOI 10.1007/s00262-008-0489-2; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Camporeale A, 2003, CANCER RES, V63, P3688; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cobb A, 2011, J IMMUNOL METHODS, V365, P27, DOI 10.1016/j.jim.2010.11.002; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Dohnal AM, 2007, CYTOTHERAPY, V9, P755, DOI 10.1080/14653240701589221; Dohnal AM, 2009, J CELL MOL MED, V13, P1741, DOI 10.1111/j.1582-4934.2008.00584.x; Dohnal AM, 2009, J CELL MOL MED, V13, P125, DOI 10.1111/j.1582-4934.2008.00304.x; Driesen J, 2008, IMMUNOBIOLOGY, V213, P849, DOI 10.1016/j.imbio.2008.07.026; Felzmann T, 2005, CANCER IMMUNOL IMMUN, V54, P769, DOI 10.1007/s00262-004-0637-2; Felzmann T, 2003, CYTOTHERAPY, V5, P391, DOI 10.1080/14653240310003053; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Han TH, 2009, J IMMUNOTHER, V32, P399, DOI 10.1097/CJI.0b013e31819e1773; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Huttner KG, 2005, CANCER IMMUNOL IMMUN, V54, P67, DOI 10.1007/s00262-004-0571-3; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; Kaiser A, 2003, EUR J IMMUNOL, V33, P162, DOI 10.1002/immu.200390019; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lee JJ, 2008, J LEUKOCYTE BIOL, V84, P319, DOI 10.1189/jlb.1107737; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mitchell DA, 2011, BLOOD, V118, P3003, DOI 10.1182/blood-2011-02-334565; Mnasria K, 2008, J LEUKOCYTE BIOL, V84, P460, DOI 10.1189/jlb.1007712; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Roses RE, 2008, J IMMUNOL, V181, P5120, DOI 10.4049/jimmunol.181.7.5120; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saraiva M, 2010, NAT REV IMMUNOL; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Traxlmayr MW, 2010, J IMMUNOTHER, V33, P40, DOI 10.1097/CJI.0b013e3181b51447; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Wieckowski E, 2011, PROSTATE, V71, P125, DOI 10.1002/pros.21228; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zobywalski A, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-18	51	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54879	10.1371/journal.pone.0054879	http://dx.doi.org/10.1371/journal.pone.0054879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408948	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000008
J	Yan, HL; Xu, T; Zhao, HF; Lee, KC; Wang, HY; Zhang, Y				Yan, Hailiang; Xu, Tao; Zhao, Hongfeng; Lee, Kuo-Chieh; Wang, Hoau-Yan; Zhang, Yan			Isoflurane Increases Neuronal Cell Death Vulnerability by Downregulating miR-214	PLOS ONE			English	Article							NITROUS OXIDE ANESTHESIA; DEVELOPING RAT-BRAIN; ALZHEIMERS-DISEASE; GENERAL-ANESTHESIA; APOPTOSIS; OLIGOMERIZATION; SEVOFLURANE; EXPOSURE; HYPERPHOSPHORYLATION; ACQUISITION	Since accumulating evidence suggests the application of anesthetics may increase the risk of Alzheimer's disease (AD), we investigated the cytotoxicity of inhaled general anesthesia in neurons and its underlying mechanism. Using primary cultured rat hippocampal neurons as the study model, here we show that isoflurane increases vulnerability to intracellular or extracellular amyloid b with or without serum deprivation. This isoflurane-induced effect is mediated by the downregulation of miR-214 level that lead to an elevated expression of Bax, a prominent target for miR-214. We conclude that isoflurane increases cell death in the presence of amyloid b by increasing Bax level through downregulating miR-214. Our data provide a new insight for inhaled anesthetics toxicity and indicate a possible mechanistic link between anesthetic application and neurodegenration in AD.	[Yan, Hailiang; Xu, Tao; Zhang, Yan] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Lee, Kuo-Chieh; Wang, Hoau-Yan] CUNY, Sch Med, Sophie Davis Sch Biomed Educ, Dept Pharmacol Physiol & Neurosci, New York, NY 10031 USA; [Zhao, Hongfeng] Beijing 4 High Sch, Beijing, Peoples R China; [Yan, Hailiang; Xu, Tao; Zhang, Yan] Peking Univ Peoples Hosp, Dept Urol, Beijing, Peoples R China	Peking University; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education; Peking University	Zhang, Y (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	yanzhang@pku.edu.cn	Zhang, Yan/AAX-8786-2021		National Program of Basic Research; Ministry of Science and Technology of China [2009CB941301]; National Science Foundation of China (NSFC) [91132718]; Roche	National Program of Basic Research(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Roche(Roche Holding)	This work was supported by the National Program of Basic Research sponsored by the Ministry of Science and Technology of China (2009CB941301), National Science Foundation of China (NSFC) Major Research Grant (91132718) and Roche research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; BOHNEN NILJ, 1994, J AM GERIATR SOC, V42, P198, DOI 10.1111/j.1532-5415.1994.tb04952.x; BRETELER MMB, 1991, INT J EPIDEMIOL, V20, pS36, DOI 10.1093/ije/20.Supplement_2.S36; Carnini A, 2007, CURR ALZHEIMER RES, V4, P233; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Dong Yu-lin, 2012, PLoS One, V7, pe34435, DOI 10.1371/journal.pone.0034435; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Eckenhoff R G, 2001, Mol Interv, V1, P258; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Eckenhoff RG, 1997, PHARMACOL REV, V49, P343; Fodale V, 2006, BRIT J ANAESTH, V97, P445, DOI 10.1093/bja/ael233; Fodale V, 2003, ACTA ANAESTH SCAND, V47, P1180, DOI 10.1034/j.1399-6576.2003.00226.x; Gasparini M, 2002, NEUROL SCI, V23, P11, DOI 10.1007/s100720200017; Ghirlanda G, 2004, FEBS LETT, V578, P140, DOI 10.1016/j.febslet.2004.10.087; Hudson AE, 2011, BRIT J ANAESTH, V107, P30, DOI 10.1093/bja/aer122; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; Lee TA, 2005, J ALZHEIMERS DIS, V7, P319; Liang G, 2008, ANESTH ANALG, V106, P492, DOI 10.1213/ane.0b013e3181605b71; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Mallick B, 2011, RNA BIOL, V8, P665, DOI 10.4161/rna.8.4.15584; Mandal PK, 2009, BIOCHEM BIOPH RES CO, V379, P716, DOI 10.1016/j.bbrc.2008.12.092; Mandal PK, 2008, BBA-BIOMEMBRANES, V1778, P2633, DOI 10.1016/j.bbamem.2008.07.002; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MURAVCHICK S, 1995, ANESTHESIOLOGY, V82, P305, DOI 10.1097/00000542-199501000-00039; Olney JW, 2004, ANESTHESIOLOGY, V101, P273, DOI 10.1097/00000542-200408000-00004; Papon MA, 2011, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00272; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; Rodriguez JA, 2002, CELL MOL BIOL, V48, P103; Run XQ, 2010, J ALZHEIMERS DIS, V22, pS49, DOI 10.3233/JAD-2010-100813; Su DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027632; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Whittington RA, 2010, CURR ALZHEIMER RES, V7, P717; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2006, EXP GERONTOL, V41, P346, DOI 10.1016/j.exger.2006.01.014; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang B, 2008, J BIOL CHEM, V283, P11866, DOI 10.1074/jbc.M800199200; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zhang Y, 2003, J NEUROSCI, V23, P7385; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664; Zhen Y, 2009, ANESTHESIOLOGY, V111, P741, DOI 10.1097/ALN.0b013e3181b27fd4; Zuo CS, 2010, DEMENT GERIATR COGN, V29, P233, DOI 10.1159/000295114	53	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55276	10.1371/journal.pone.0055276	http://dx.doi.org/10.1371/journal.pone.0055276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408966	Green Published, gold			2022-12-27	WOS:000314660300009
J	Huerta-Quintanilla, R; Canto-Lugo, E; Viga-de Alva, D				Huerta-Quintanilla, Rodrigo; Canto-Lugo, Efrain; Viga-de Alva, Dolores			Modeling Social Network Topologies in Elementary Schools	PLOS ONE			English	Article							WORLD; COOPERATION; EMERGENCE	Complex networks are used to describe interactions in many real world systems, including economic, biological and social systems. An analysis was done of inter-student friendship, enmity and kinship relationships at three elementary schools by building social networks of these relationships and studying their properties. Friendship network measurements were similar between schools and produced a Poisson topology with a high clustering index. Enmity network measurements were also similar between schools and produced a power law topology. Spatial confinement and the sense of belonging to a social group played vital roles in shaping these networks. Two models were developed which generate complex friendship and enmity networks that reproduce the properties observed at the three studied elementary schools.	[Huerta-Quintanilla, Rodrigo; Canto-Lugo, Efrain] Inst Politecn Nacl, Dept Fis Aplicada, Ctr Invest & Estudios Avanzados, Unidad Merida, Merida, Yucatan, Mexico; [Viga-de Alva, Dolores] Inst Politecn Nacl, Dept Ecol Humana, Ctr Invest & Estudios Avanzados, Unidad Merida, Merida, Yucatan, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Huerta-Quintanilla, R (corresponding author), Inst Politecn Nacl, Dept Fis Aplicada, Ctr Invest & Estudios Avanzados, Unidad Merida, Merida, Yucatan, Mexico.	rhuerta@mda.cinvestav.mx						Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Balakrishnan H, 2006, P 44 ANN SE REG C AC, P280; Barabasi AL, 1999, PHYSICA A, V272, P173, DOI 10.1016/S0378-4371(99)00291-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2000, EUR PHYS J B, V13, P547, DOI 10.1007/s100510050067; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Capozza D, 2000, SOCIAL IDENTITY PROC; Casella G., 2002, STAT INFERENCE, V2nd; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cooley CH, 2005, SOCIAL ORG STUDY LAR; ERDOS P, 1960, B INT STATIST INST, V38, P343; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hartas D., 2010, ED RES INQUIRY QUALI, P257; Hock K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026652; Hogg MA., 1998, SOCIAL IDENTIFICATIO; Jackson MO, 1996, J ECON THEORY, V71, P44, DOI 10.1006/jeth.1996.0108; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Olmsted MS, 1963, THE SMALL GROUP; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Thas O, 2010, SPRINGER SER STAT, P1; Vega-Redondo F., 2007, COMPLEX SOCIAL NETWO, P268; Villas Boas PR, 2010, J STAT MECH-THEORY E, V3; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	33	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55371	10.1371/journal.pone.0055371	http://dx.doi.org/10.1371/journal.pone.0055371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408976	gold, Green Submitted, Green Published			2022-12-27	WOS:000315157200029
J	Ather, F; Hamidi, H; Fejzo, MS; Letrent, S; Finn, RS; Kabbinavar, F; Head, C; Wong, SG				Ather, Ferdows; Hamidi, Habib; Fejzo, Marlena S.; Letrent, Stephen; Finn, Richard S.; Kabbinavar, Fairooz; Head, Christian; Wong, Steven G.			Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RECEPTOR TYROSINE KINASE; HUMAN-BREAST-CANCER; METASTATIC COLORECTAL-CANCER; LUNG-CANCER; IN-VITRO; PROGNOSTIC-SIGNIFICANCE; PLUS CETUXIMAB; EGFR; LINES	Aberrant epidermal growth factor (EGF) signaling is associated with tumor growth in squamous cell carcinoma of the head and neck in humans (HNSCC), and is a major focus of targeted therapy. Cetuximab, a monoclonal antibody against EGFR, has been successful at prolonging survival but has only a 10% tumor shrinkage response rate in a clinical setting. The goal of this study was to compare dacomitinib (PF-00299804), a next generation small molecule tyrosine kinase inhibitor that irreversibly blocks multiple HER family receptors (HER-1 (EGFR), HER-2 and HER-4 tyrosine kinases), to cetuximab, the current FDA approved anti-EGFR medication for HNSCC and erlotinib, an EGFR specific small molecule tyrosine kinase inhibitor. Dacomitinib, erlotinib and cetuximab were tested in a panel of 27 HNSCC cell lines. Treatment with 100 ug/ml of cetuximab or 1 uM of erlotinib inhibited growth by at least 50% in 7/27 cell lines, while treatment with 1 uM of dacomitinib had similar growth inhibition in 17/27 lines. Cell lines representing three levels of sensitivity to dacomitinib were further examined using Western blots, cell cycle and apoptosis analysis. Treatment with 100 nM of dacomitinib reduced EGFR activity and downstream AKT and ERK pathways more effectively than treatment with 100 ug/ml of cetuximab in all ten tested lines. Although both compounds induced apoptosis at similar levels, dacomitinib caused greater G0/G1 arrest. Sensitivity to EGFR blockade was associated with levels of EGFR and ERK and was not associated with common oncogenic mutations and copy number variations. Phosphorylated and total EGFR and ERK levels correlate with sensitivity to both cetuximab and dacomitinib. Three of the four lines in the exquisitely sensitive group had the highest levels of phosphorylated and total EGFR and ERK among the ten lines selected, while the three resistant lines collectively had the lowest levels. Neither pAKT nor tAKT was associated with sensitivity.	[Ather, Ferdows; Hamidi, Habib; Fejzo, Marlena S.; Finn, Richard S.; Kabbinavar, Fairooz; Head, Christian; Wong, Steven G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Letrent, Stephen] Pfizer Oncol, Clin Dev & Med Affairs, San Diego, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pfizer	Hamidi, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	hhamidi@mednet.ucla.edu	Hamidi, Habib/H-8030-2016	Hamidi, Habib/0000-0003-0196-9852; Fejzo, Marlena/0000-0001-6800-687X				Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Britten CD, 2004, MOL CANCER THER, V3, P1335; Butowski Nicholas, 2005, Cancer Control, V12, P116; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; Demiral A, 2004, AURIS NASUS LARYNX, V31, P417, DOI 10.1016/j.anl.2004.05.003; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Garon EB, 2010, MOL CANCER THER, V9, P1985, DOI 10.1158/1535-7163.MCT-10-0037; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; Gonzales AJ, 2008, MOL CANCER THER, V7, P1880, DOI 10.1158/1535-7163.MCT-07-2232; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Herbst RS, 2002, CANCER-AM CANCER SOC, V94, P1593, DOI 10.1002/cncr.10372; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Janne PA, 2011, CLIN CANCER RES, V17, P1131, DOI 10.1158/1078-0432.CCR-10-1220; Janne P, 2009, J CLIN ONCOL, V27, pS; Kalous O, 2012, MOL CANCER THER, V11, P1978, DOI 10.1158/1535-7163.MCT-11-0730; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lammering G, 2003, ONCOGENE, V22, P5545, DOI 10.1038/sj.onc.1206788; Lee JW, 2005, CLIN CANCER RES, V11, P2879, DOI 10.1158/1078-0432.CCR-04-2029; LEONARD JH, 1991, INT J CANCER, V48, P511, DOI 10.1002/ijc.2910480406; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Maurizi M, 1996, BRIT J CANCER, V74, P1253, DOI 10.1038/bjc.1996.525; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Moyer JD, 1997, CANCER RES, V57, P4838; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Qiu WL, 2006, CLIN CANCER RES, V12, P1441, DOI 10.1158/1078-0432.CCR-05-2173; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Uphoff CC, 2002, LEUKEMIA, V16, P289, DOI 10.1038/sj.leu.2402365; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wainberg ZA, 2010, CLIN CANCER RES, V16, P1509, DOI 10.1158/1078-0432.CCR-09-1112; WARD WHJ, 1994, BIOCHEM PHARMACOL, V48, P659, DOI 10.1016/0006-2952(94)90042-6; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965	43	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56112	10.1371/journal.pone.0056112	http://dx.doi.org/10.1371/journal.pone.0056112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405260	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400206
J	Hsiao, NY; Stinson, K; Myer, L				Hsiao, Nei-Yuan; Stinson, Kathryn; Myer, Landon			Linkage of HIV-Infected Infants from Diagnosis to Antiretroviral Therapy Services across the Western Cape, South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESOURCE-LIMITED SETTINGS; HEALTH-CARE FACILITIES; TO-CHILD TRANSMISSION; BLOOD; MORTALITY; PROGRAM; TANZANIA; OUTCOMES; MALAWI	Introduction: Early infant diagnosis (EID) of HIV infection is an important service to reduce paediatric morbidity and mortality related to HIV/AIDS. Although South Africa has a national EID programme based on PCR testing, there are no population-wide data on the linkage of infants testing HIV PCR-positive to HIV care and treatment services. Methods: We conducted a retrospective analysis of all public sector laboratory data from across the Western Cape province between 2005 and 2011. We linked positive HIV PCR results to subsequent HIV viral load testing to determine the proportion of infants who were successfully linked to HIV care. Results: A total of 83 698 unique infant HIV PCR tests were documented, of which 6322 (8%) were PCR positive. The proportion of PCR-positive children declined from 12% in 2005 to 3% in 2011. Of the children testing PCR-positive, 4105 (65%) had subsequent viral load testing indicating successful linkage to care. The proportion of successfully linked infants increased from 54% in 2005 to 71% in 2010, while the median delay in days to successful linkage decreased from 146 days in 2005 to 33 days in 2010. Discussion: From 2005 to 2011 there has been a reduction in the proportion of children testing HIV PCR-positive, and an increase in the proportion of infected infants successfully linked to HIV care and treatment, in this setting. However a large proportion of infected infants remain unlinked to antiretroviral therapy services and there is a clear need for interventions to further strengthen EID programmes.	[Hsiao, Nei-Yuan] Univ Cape Town, Div Virol, ZA-7925 Cape Town, South Africa; [Hsiao, Nei-Yuan] Natl Hlth Lab Serv, Cape Town, South Africa; [Stinson, Kathryn; Myer, Landon] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Hsiao, NY (corresponding author), Univ Cape Town, Div Virol, ZA-7925 Cape Town, South Africa.	marvin.hsiao@nhls.ac.za			Elizabeth Glaser Pediatric AIDS Foundation	Elizabeth Glaser Pediatric AIDS Foundation	Landon Myer is funded by the Elizabeth Glaser Pediatric AIDS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Braun M, 2011, JAIDS-J ACQ IMM DEF, V56, pE122, DOI 10.1097/QAI.0b013e31820a7f2f; Chatterjee A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-553; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Creek TL, 2007, AM J OBSTET GYNECOL, V197, pS64, DOI 10.1016/j.ajog.2007.03.002; Dramowski A, 2012, S AFR J HIV MED, V12, P16; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goga A, 2012, EVALUATION EFFECTIVE; Grimwood A, 2012, SAMJ S AFR MED J, V102, P81, DOI 10.7196/SAMJ.5294; Hassan AS, 2012, AIDS BEHAV, V16, P5, DOI 10.1007/s10461-010-9877-7; Jangam SR, 2009, J CLIN MICROBIOL, V47, P2363, DOI 10.1128/JCM.r00092-09; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; McCollum ED, 2012, JAIDS-J ACQ IMM DEF, V60, pE107, DOI 10.1097/QAI.0b013e31825aa721; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Parpia ZA, 2010, JAIDS-J ACQ IMM DEF, V55, P413, DOI 10.1097/QAI.0b013e3181f1afbc; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Seidenberg P, 2012, B WORLD HEALTH ORGAN, V90, P348, DOI 10.2471/BLT.11.100032; Silal SP, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-120; Tejiokem MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021840; Vearey J, 2012, GLOB PUBLIC HEALTH, V7, P58, DOI [10.1080/17441692.2010.549494, 10.3402/gha.v4i0.5898]; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organisation The Joint United Nations Programme on HIV/AIDS and The United Nations Children's Fund, 2012, GLOB HIV AIDS RESP E; World Health Organisation The Joint United Nations Programme on HIV/AIDS and The United Nations Children's Fund, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2010, WHO REC DIAGN HIV IN	27	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55308	10.1371/journal.pone.0055308	http://dx.doi.org/10.1371/journal.pone.0055308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405133	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400078
J	Ou, YY; Chen, SA; Wu, SC				Ou, Yu-Yen; Chen, Shu-An; Wu, Sheng-Cheng			ETMB-RBF: Discrimination of Metal-Binding Sites in Electron Transporters Based on RBF Networks with PSSM Profiles and Significant Amino Acid Pairs	PLOS ONE			English	Article							BARREL MEMBRANE-PROTEINS; FUNCTION NEURAL-NETWORK; SUBCELLULAR-LOCALIZATION; CLEAVAGE SITES; WEB SERVER; PREDICTION; SEQUENCE; CLASSIFIER; MATRICES; SVM	Background: Cellular respiration is the process by which cells obtain energy from glucose and is a very important biological process in living cell. As cells do cellular respiration, they need a pathway to store and transport electrons, the electron transport chain. The function of the electron transport chain is to produce a trans-membrane proton electrochemical gradient as a result of oxidation-reduction reactions. In these oxidation-reduction reactions in electron transport chains, metal ions play very important role as electron donor and acceptor. For example, Fe ions are in complex I and complex II, and Cu ions are in complex IV. Therefore, to identify metal-binding sites in electron transporters is an important issue in helping biologists better understand the workings of the electron transport chain. Methods: We propose a method based on Position Specific Scoring Matrix (PSSM) profiles and significant amino acid pairs to identify metal-binding residues in electron transport proteins. Results: We have selected a non-redundant set of 55 metal-binding electron transport proteins as our dataset. The proposed method can predict metal-binding sites in electron transport proteins with an average 10-fold cross-validation accuracy of 93.2% and 93.1% for metal-binding cysteine and histidine, respectively. Compared with the general metal-binding predictor from A. Passerini et al., the proposed method can improve over 9% of sensitivity, and 14% specificity on the independent dataset in identifying metal-binding cysteines. The proposed method can also improve almost 76% sensitivity with same specificity in metal-binding histidine, and MCC is also improved from 0.28 to 0.88. Conclusions: We have developed a novel approach based on PSSM profiles and significant amino acid pairs for identifying metal-binding sites from electron transport proteins. The proposed approach achieved a significant improvement with independent test set of metal-binding electron transport proteins.	[Ou, Yu-Yen; Chen, Shu-An; Wu, Sheng-Cheng] Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan	Yuan Ze University	Ou, YY (corresponding author), Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan.	yien@csie.org	Ou, Yu-Yen/AAA-1716-2022	Ou, Yu-Yen/0000-0002-9894-926X	National Science Council (NSC) of Taiwan [NSC 101-2221-E-155-068]	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially supported by National Science Council (NSC) of Taiwan, NSC 101-2221-E-155-068 to Yu-Yen Ou. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Chen SA, 2011, BIOINFORMATICS, V27, P2062, DOI 10.1093/bioinformatics/btr340; Chen SA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-536; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017331; Li DD, 2010, PROTEIN PEPTIDE LETT, V17, P1566, DOI 10.2174/0929866511009011566; Lin CT, 2005, INT J NEURAL SYST, V15, P71, DOI 10.1142/S0129065705000116; Lippi M, 2008, BIOINFORMATICS, V24, P2094, DOI 10.1093/bioinformatics/btn371; Menchetti S, 2006, LECT NOTES COMPUT SC, V3909, P309, DOI 10.1007/11732990_26; Ou, 2005, QUICKRBF PACKAGE EFF; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; Ou YY, 2010, PROTEINS, V78, P1789, DOI 10.1002/prot.22694; Ou YY, 2010, J COMPUT CHEM, V31, P217, DOI 10.1002/jcc.21281; Ou YY, 2005, IEEE IJCNN, P1383; Passerini A, 2006, PROTEINS, V65, P305, DOI 10.1002/prot.21135; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz RM, 1978, ATLAS PROTEIN SEQ S3, P353; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Yang ZR, 2005, IEEE T NEURAL NETWOR, V16, P263, DOI 10.1109/TNN.2004.836196; Zhang GZ, 2004, J COMPUT AID MOL DES, V18, P797, DOI 10.1007/s10822-005-0578-7	32	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e46572	10.1371/journal.pone.0046572	http://dx.doi.org/10.1371/journal.pone.0046572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405059	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400002
J	Unick, GJ; Rosenblum, D; Mars, S; Ciccarone, D				Unick, George Jay; Rosenblum, Daniel; Mars, Sarah; Ciccarone, Daniel			Intertwined Epidemics: National Demographic Trends in Hospitalizations for Heroin- and Opioid-Related Overdoses, 1993-2009	PLOS ONE			English	Article							INJECTION-DRUG USERS; NALOXONE DISTRIBUTION; UNITED-STATES; MORTALITY; PREVENTION; DEATHS; ABUSE; HIV	The historical patterns of opiate use show that sources and methods of access greatly influence who is at risk. Today, there is evidence that an enormous increase in the availability of prescription opiates is fuelling a rise in addiction nationally, drawing in new initiates to these drugs and changing the geography of opiate overdoses. Recent efforts at supply-based reductions in prescription opiates may reduce harm, but addicted individuals may switch to other opiates such as heroin. In this analysis, we test the hypothesis that changes in the rates of Prescription Opiate Overdoses (POD) are correlated with changes in the rate of heroin overdoses (HOD). ICD9 codes from the Nationwide Inpatient Sample and population data from the Census were used to estimate overall and demographic specific rates of POD and HOD hospital admissions between 1993 and 2009. Regression models were used to test for linear trends and lagged negative binomial regression models were used to model the interrelationship between POD and HOD hospital admissions. Findings show that whites, women, and middle-aged individuals had the largest increase in POD and HOD rates over the study period and that HOD rates have increased in since 2007. The lagged models show that increases in a hospitals POD predict an increase in the subsequent years HOD admissions by a factor of 1.26 (p < 0.001) and that each increase in HOD admissions increase the subsequent years POD by a factor of 1.57 (p < 0.001). Our hypothesis of fungibility between prescription opiates and heroin was supported by these analyses. These findings suggest that focusing on supply-based interventions may simply lead to a shift in use to heroin rather minimizing the reduction in harm. The alternative approach of using drug abuse prevention resources on treatment and demand-side reduction is likely to be more productive at reducing opiate abuse related harm.	[Unick, George Jay] Univ Maryland, Sch Social Work, Baltimore, MD 21201 USA; [Rosenblum, Daniel] Dalhousie Univ, Dept Econ, Halifax, NS, Canada; [Mars, Sarah; Ciccarone, Daniel] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University System of Maryland; University of Maryland Baltimore; Dalhousie University; University of California System; University of California San Francisco	Unick, GJ (corresponding author), Univ Maryland, Sch Social Work, 525 W Redwood St, Baltimore, MD 21201 USA.	junick@ssw.umaryland.edu	Ciccarone, Daniel/I-5404-2013	Ciccarone, Daniel/0000-0002-2355-5477; Rosenblum, Daniel/0000-0003-0056-9734	National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA) [RO1DA2759]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027599, R01DA010164] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was support by The National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA), grant number RO1DA2759 to Daniel Ciccarone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; Barrett M, 2012, POPULATION DENOMINAT; Broz D, 2008, DRUG ALCOHOL DEPEN, V94, P221, DOI 10.1016/j.drugalcdep.2007.11.020; Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Centers for Disease Control, 2010, UN DRUG POIS US; Ciccarone D, 2009, INT J DRUG POLICY, V20, P392, DOI 10.1016/j.drugpo.2008.12.001; Cicero TJ, 2012, NEW ENGL J MED, V367, P187, DOI 10.1056/NEJMc1204141; Coben JH, 2010, AM J PREV MED, V38, P517, DOI 10.1016/j.amepre.2010.01.022; Colson J, 2012, PAIN PHYSICIAN, V15, pES231; Courtwright DT., 2001, DARK PARADISE HIST O, VEnl. ed., pxiii, 326; Daly EM, 2012, RISE YOUNG PAINKILLE; Darke S., 2007, MORTALITY ILLICIT DR; Denton JS, 2008, J FORENSIC SCI, V53, P452, DOI 10.1111/j.1556-4029.2008.00669.x; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Evans JL, 2012, AM J EPIDEMIOL, V175, P302, DOI 10.1093/aje/kwr318; FDA, 2009, JOINT M AN LIF SUPP; Frosch Dan, 2012, NY TIMES, P22; Galea S, 2006, ADDICT BEHAV, V31, P907, DOI 10.1016/j.addbeh.2005.07.020; Green TC, 2008, ADDICTION, V103, P979, DOI 10.1111/j.1360-0443.2008.02182.x; Hansen RN, 2011, CLIN J PAIN, V27, P194, DOI 10.1097/AJP.0b013e3181ff04ca; Havens JR, 2009, AM J DRUG ALCOHOL AB, V35, P18, DOI 10.1080/00952990802326298; HCUP, 1993, NAT INP SAMPL NIS; HCUP, 1993, NAT INP SAMPL TRENDS; Hickman T. A., 2004, ALTERING AM CONSCIOU, P182; IMS Institute for Healthcare Informatics, 2011, US MED US REV 2010; Kerlikowske R., 2012, COMMUNICATION; Khosla N, 2011, ADDICT BEHAV, V36, P1282, DOI 10.1016/j.addbeh.2011.07.046; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Manchikanti Laxmaiah, 2007, Pain Physician, V10, P399; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P287; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P215; Mars S, 2012, HARM RED C PORTL OR; Masson CL, 2002, DRUG ALCOHOL DEPEN, V66, P45, DOI 10.1016/S0376-8716(01)00182-X; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Paulozzi LJ, 2008, PHARMACOEPIDEM DR S, V17, P997, DOI 10.1002/pds.1626; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Peavy KM, 2012, J PSYCHOACTIVE DRUGS, V44, P259, DOI 10.1080/02791072.2012.704591; Piper Tinka Markham, 2007, Harm Reduct J, V4, P3, DOI 10.1186/1477-7517-4-3; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Roy E, 2011, SUBST USE MISUSE, V46, P1142, DOI 10.3109/10826084.2011.552932; Schneider EC, 2008, POLIT CULT MOD AM, P1; Scott G, 2007, J URBAN HEALTH, V84, P292, DOI 10.1007/s11524-007-9157-7; Seal KH, 2005, J URBAN HEALTH, V82, P303, DOI 10.1093/jurban/jti053; Semaan S, 2011, DRUG ALCOHOL DEPEN, V118, P100, DOI 10.1016/j.drugalcdep.2011.03.006; Shah NG, 2008, ADDICTION, V103, P126, DOI 10.1111/j.1360-0443.2007.02054.x; Tobin KE, 2009, INT J DRUG POLICY, V20, P131, DOI 10.1016/j.drugpo.2008.03.002; U.S. General Accounting Office, 2003, PRESCR DRUGS OXYCONT; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369; Walley A, 2012, FDA PUBL WORKSH SEP; Walley AY, 2013, J SUBST ABUSE TREAT, V44, P241, DOI 10.1016/j.jsat.2012.07.004; Wang CL, 2005, AIDS, V19, P935, DOI 10.1097/01.aids.0000171407.30866.22; Warner M, 2009, INCREASE FATAL POISO; Webster PC, 2012, CAN MED ASSOC J, V184, pE345, DOI 10.1503/cmaj.109-4158; Wheeler Eliza, 2012, Morbidity and Mortality Weekly Report, V61, P101	55	208	208	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54496	10.1371/journal.pone.0054496	http://dx.doi.org/10.1371/journal.pone.0054496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405084	Green Published, gold			2022-12-27	WOS:000315153400028
J	Wood, KA; Stillman, RA; Daunt, F; O'Hare, MT				Wood, Kevin A.; Stillman, Richard A.; Daunt, Francis; O'Hare, Matthew T.			Evaluating the Effects of Population Management on a Herbivore Grazing Conflict	PLOS ONE			English	Article							SWAN CYGNUS-OLOR; MUTE SWANS; OILSEED RAPE; STANDING CROP; WINTER CROPS; GEESE; DYNAMICS; CONSEQUENCES; ERADICATION; BRITAIN	Abundant herbivores can damage plants and so cause conflict with conservation, agricultural, and fisheries interests. Management of herbivore populations is a potential tool to alleviate such conflicts but may raise concerns about the economic and ethical costs of implementation, especially if the herbivores are 'charismatic' and popular with the public. Thus it is critical to evaluate the probability of achieving the desired ecological outcomes before proceeding to a field trial. Here we assessed the potential for population control to resolve a conflict of non-breeding swans grazing in river catchments. We used a mathematical model to evaluate the consequences of three population management strategies; (a) reductions in reproductive success, (b) removal of individuals, and (c) reduced reproductive success and removal of individuals combined. This model gave accurate projections of historical changes in population size for the two rivers for which data were available. Our model projected that the River Frome swan population would increase by 54%, from 257 to 397 individuals, over 17 years in the absence of population control. Removal of >= 60% of non-breeding individuals each year was projected to reduce the catchment population below the level for which grazing conflicts have been previously reported. Reducing reproductive success, even to 0 eggs per nest, failed to achieve the population reduction required. High adult and juvenile survival probabilities (>0.7) and immigration from outside of the catchment limited the effects of management on population size. Given the high, sustained effort required, population control does not represent an effective management option for preventing the grazing conflicts in river catchments. Our study highlights the need to evaluate the effects of different management techniques, both alone and in combination, prior to field trials. Population models, such as the one presented here, can provide a cost-effective and ethical means of such evaluations.	[Wood, Kevin A.; Daunt, Francis; O'Hare, Matthew T.] Ctr Ecol & Hydrol, Edinburgh, Midlothian, Scotland; [Wood, Kevin A.; Stillman, Richard A.] Bournemouth Univ, Sch Appl Sci, Poole BH12 5BB, Dorset, England	UK Centre for Ecology & Hydrology (UKCEH); Bournemouth University	Wood, KA (corresponding author), Ctr Ecol & Hydrol, Bush Estate, Edinburgh, Midlothian, Scotland.	kevinwoodecology@hotmail.co.uk	Daunt, Francis/K-6688-2012; Wood, Kevin/C-7312-2012; O'Hare, Matthew T/F-3648-2011	Daunt, Francis/0000-0003-4638-3388; Wood, Kevin/0000-0001-9170-6129; 	Centre for Ecology & Hydrology Algorithm (Natural Environment Research Council); Natural Environment Research Council [ceh010022] Funding Source: researchfish	Centre for Ecology & Hydrology Algorithm (Natural Environment Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded through a Centre for Ecology & Hydrology Algorithm (Natural Environment Research Council, http://www.nerc.ac.uk/) studentship awarded to Kevin Wood. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2007, J APPL ECOL, V44, P506, DOI 10.1111/j.1365-2664.2007.01314.x; Ash SJ, 2003, WILDLIFE SOC B, V31, P334; BAKER SJ, 1993, INT J PEST MANAGE, V39, P246, DOI 10.1080/09670879309371798; Birkhead M., 1986, MUTE SWAN; BOMFORD M, 1995, WILDLIFE SOC B, V23, P249; Bos D, 2011, WILDLIFE BIOL, V17, P143, DOI 10.2981/09-115; BROOKS RP, 1980, J WILDLIFE MANAGE, V44, P568, DOI 10.2307/3808004; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Caswell, 2000, MATRIX POPULATION MO; Coleman AE, 2001, ARDEA, V89, P123; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; COWAN PE, 1992, BIOL CONSERV, V61, P217, DOI 10.1016/0006-3207(92)91119-D; Duka Toni, 2005, Ecological Management & Restoration, V6, P172, DOI 10.1111/j.1442-8903.2005.00234.x; Ellis MM, 2007, J APPL ECOL, V44, P312, DOI 10.1111/j.1365-2664.2006.01265.x; Esselink Hans, 1991, Wildfowl, P110; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Federico P, 2005, ECOL MODEL, V186, P111, DOI 10.1016/j.ecolmodel.2005.01.011; FRYXELL JM, 1991, J WILDLIFE MANAGE, V55, P377, DOI 10.2307/3808963; GOSLING LM, 1989, BIOL J LINN SOC, V38, P39, DOI 10.1111/j.1095-8312.1989.tb01561.x; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Harrison JG, 1967, WILDFOWL, V18, P85; Harrison M. D. K., 1985, REPORT ASSESSMENT DA; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; Hein CL, 2007, FRESHWATER BIOL, V52, P1134, DOI 10.1111/j.1365-2427.2007.01741.x; Hodder KH, 1997, J APPL ECOL, V34, P547, DOI 10.2307/2404906; Hughes B., 1999, Wildfowl, V50, P77; IMBER MJ, 1968, J WILDLIFE MANAGE, V32, P256, DOI 10.2307/3798969; JENKINS D, 1976, Wildfowl, V27, P77; KIRBY J, 1994, HYDROBIOLOGIA, V279, P467, DOI 10.1007/BF00027878; Liley D, 2008, FOOTPRINT ECOLOGY PU; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; McCarthy MA, 1996, J APPL ECOL, V33, P45, DOI 10.2307/2405014; McKay HV, 2002, INT J PEST MANAGE, V48, P189, DOI 10.1080/09670870110102585; MIDDLETON DAJ, 1993, J APPL ECOL, V30, P1, DOI 10.2307/2404265; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Minteer BA, 2005, FRONT ECOL ENVIRON, V3, P332, DOI 10.1890/1540-9295(2005)003[0332:WWNAEE]2.0.CO;2; Moorhouse TP, 2011, FRESHWATER BIOL, V56, P993, DOI 10.1111/j.1365-2427.2010.02528.x; O'Hare MT, 2007, FRESHWATER BIOL, V52, P2463, DOI 10.1111/j.1365-2427.2007.01841.x; OWEN M, 1977, Biological Conservation, V11, P209, DOI 10.1016/0006-3207(77)90005-2; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Parrott D, 2001, CROP PROT, V20, P913, DOI 10.1016/S0261-2194(01)00041-2; Parrott D, 2008, CROP PROT, V27, P632, DOI 10.1016/j.cropro.2007.09.006; Perry D, 2008, CONSERV BIOL, V22, P27, DOI 10.1111/j.1523-1739.2007.00845.x; Pople AR, 2010, RANGELAND J, V32, P11, DOI 10.1071/RJ09053; REESE JG, 1975, J WILDLIFE MANAGE, V39, P280, DOI 10.2307/3799904; Sladen William J. L., 1991, Wildfowl, P368; Smith GC, 2008, J APPL ECOL, V45, P1675, DOI 10.1111/j.1365-2664.2008.01380.x; Spray C.J., 2002, Aspects of Applied Biology, V67, P67; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; TRUMP DPC, 1994, INT J PEST MANAGE, V40, P88, DOI 10.1080/09670879409371860; VICKERY JA, 1994, J APPL ECOL, V31, P371, DOI 10.2307/2404551; Warburton B, 2009, J WILDLIFE MANAGE, V73, P158, DOI 10.2193/2007-313; Ward Robin M., 2007, Wildfowl, V57, P3; Watola GV, 2003, J APPL ECOL, V40, P565, DOI 10.1046/j.1365-2664.2003.00811.x; Williams CK, 2007, J APPL ECOL, V44, P291, DOI 10.1111/j.1365-2664.2006.01264.x; Wood K.A, 2012, THESIS BOURNEMOUTH U; Wood KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049824; Wood KA, 2012, AQUAT BOT, V102, P28, DOI 10.1016/j.aquabot.2012.04.006; Wood Kevin A., 2012, P339; Wood KA, 2012, HYDROBIOLOGIA, V686, P157, DOI 10.1007/s10750-012-1007-2; Wright R. M., 1991, Wildfowl, V42, P42	62	11	11	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56287	10.1371/journal.pone.0056287	http://dx.doi.org/10.1371/journal.pone.0056287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405270	Green Accepted, gold, Green Published			2022-12-27	WOS:000315153400216
J	Bellieny-Rabelo, D; Oliveira, AEA; Venancio, TM				Bellieny-Rabelo, Daniel; Amancio Oliveira, Antonia Elenir; Venancio, Thiago Motta			Impact of Whole-Genome and Tandem Duplications in the Expansion and Functional Diversification of the F-Box Family in Legumes (Fabaceae)	PLOS ONE			English	Article							NATURAL-HISTORY; GLYCINE-MAX; UBIQUITIN; EVOLUTION; SEQUENCE; ATLAS; PROTEINS; GENES	F-box proteins constitute a large gene family that regulates processes from hormone signaling to stress response. F-box proteins are the substrate recognition modules of SCF E3 ubiquitin ligases. Here we report very distinct trends in family size, duplication, synteny and transcription of F-box genes in two nitrogen-fixing legumes, Glycine max (soybean) and Medicago truncatula (alfafa). While the soybean FBX genes emerged mainly through segmental duplications (including whole-genome duplications), M. truncatula genome is dominated by locally-duplicated (tandem) F-box genes. Many of these young FBX genes evolved complex transcriptional patterns, including preferential transcription in different tissues, suggesting that they have probably been recruited to important biochemical pathways (e.g. nodulation and seed development).	[Bellieny-Rabelo, Daniel; Amancio Oliveira, Antonia Elenir; Venancio, Thiago Motta] Univ Estadual N Fluminense Darcy Ribeiro, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil		Venancio, TM (corresponding author), Univ Estadual N Fluminense Darcy Ribeiro, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil.	thiago.venancio@gmail.com	Bellieny-Rabelo, Daniel/B-3871-2017; Oliveira, Antonia Elenir Amancio/AAS-3885-2021; Venancio, Thiago M/B-5003-2011	Bellieny-Rabelo, Daniel/0000-0003-2544-7899; Oliveira, Antonia Elenir Amancio/0000-0002-2618-8916; Venancio, Thiago M/0000-0002-2215-8082	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.236/2011, E-26/111.314/2011]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471929/201-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Universidade Estadual do Norte Fluminense Darcy Ribeiro	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Estadual do Norte Fluminense Darcy Ribeiro	The authors acknowledge Universidade Estadual do Norte Fluminense Darcy Ribeiro and the following Brazilian funding agencies for supporting their research: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (Grants E-26/110.236/2011 and E-26/111.314/2011), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant 471929/201-5) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2009, BIRTH DEFECTS RES C, V87, P143, DOI 10.1002/bdrc.20153; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Burroughs AM, 2012, FRONT BIOSCI-LANDMRK, V17, P1433, DOI 10.2741/3996; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hua ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016219; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Venancio TM, 2010, MOL BIOSYST, V6, P1475, DOI 10.1039/c002567b; Venancio TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r33; Venancio Thiago Motta, 2012, Frontiers in Genetics, V3, P47, DOI 10.3389/fgene.2012.00047; Vierstra RD, 2012, PLANT PHYSL; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Young ND, 2012, ANNU REV PLANT BIOL, V63, P283, DOI 10.1146/annurev-arplant-042110-103754; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	40	23	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55127	10.1371/journal.pone.0055127	http://dx.doi.org/10.1371/journal.pone.0055127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390519	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100035
J	Ivarsson, Y; Wawrzyniak, AM; Kashyap, R; Polanowska, J; Betzi, S; Lembo, F; Vermeiren, E; Chiheb, D; Lenfant, N; Morelli, X; Borg, JP; Reboul, J; Zimmermann, P				Ivarsson, Ylva; Wawrzyniak, Anna Maria; Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Vermeiren, Elke; Chiheb, Driss; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale			Prevalence, Specificity and Determinants of Lipid-Interacting PDZ Domains from an In-Cell Screen and In Vitro Binding Experiments	PLOS ONE			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; NMDA RECEPTOR SUBUNITS; GENOME-WIDE; PROTEIN INTERACTIONS; GUANYLATE KINASES; MEMBRANE; PHOSPHOINOSITIDE; SYNTENIN; LOCALIZATION; INHIBITOR	Background: PDZ domains are highly abundant protein-protein interaction modules involved in the wiring of protein networks. Emerging evidence indicates that some PDZ domains also interact with phosphoinositides (PtdInsPs), important regulators of cell polarization and signaling. Yet our knowledge on the prevalence, specificity, affinity, and molecular determinants of PDZ-PtdInsPs interactions and on their impact on PDZ-protein interactions is very limited. Methodology/Principal Findings: We screened the human proteome for PtdInsPs interacting PDZ domains by a combination of in vivo cell-localization studies and in vitro dot blot and Surface Plasmon Resonance (SPR) experiments using synthetic lipids and recombinant proteins. We found that PtdInsPs interactions contribute to the cellular distribution of some PDZ domains, intriguingly also in nuclear organelles, and that a significant subgroup of PDZ domains interacts with PtdInsPs with affinities in the low-to-mid micromolar range. In vitro specificity for the head group is low, but with a trend of higher affinities for more phosphorylated PtdInsPs species. Other membrane lipids can assist PtdInsPs-interactions. PtdInsPs-interacting PDZ domains have generally high pI values and contain characteristic clusters of basic residues, hallmarks that may be used to predict additional PtdInsPs interacting PDZ domains. In tripartite binding experiments we established that peptide binding can either compete or cooperate with PtdInsPs binding depending on the combination of ligands. Conclusions/Significance: Our screen substantially expands the set of PtdInsPs interacting PDZ domains, and shows that a full understanding of the biology of PDZ proteins will require a comprehensive insight into the intricate relationships between PDZ domains and their peptide and lipid ligands.	[Ivarsson, Ylva; Wawrzyniak, Anna Maria; Kashyap, Rudra; Vermeiren, Elke; Chiheb, Driss; Zimmermann, Pascale] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale] INSERM, CRCM, U1068, F-13258 Marseille, France; [Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale] Univ Aix Marseille, Marseille, France; [Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale] CNRS, CRCM, UMR7258, Marseille, France	KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Zimmermann, P (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium.	Pascale.Zimmermann@med.kuleuven.be	Zimmermann, Pascale/P-4190-2017; Polanowska, Jolanta/P-9117-2016; Betzi, Stephane/AAC-6103-2022; morelli, xavier/A-9218-2016; Reboul, Jerome/P-9103-2016; Ivarsson, Ylva/HGE-0283-2022; Borg, Jean-Paul/AAX-8096-2020; Kashyap, Rudra/ABD-3316-2020	Polanowska, Jolanta/0000-0001-7666-7010; Betzi, Stephane/0000-0001-5935-5058; morelli, xavier/0000-0001-8101-7901; Reboul, Jerome/0000-0002-5513-4546; Ivarsson, Ylva/0000-0002-7081-3846; Borg, Jean-Paul/0000-0001-8418-3382; Lenfant, Nicolas/0000-0002-0519-1120	Fund for Scientific Research - Flanders (FWO); Cell Imaging Core; Concerted Actions Program of K. U. Leuven; Hercules Foundation [AKUL005 HER/08/061]; Belgian Foundation against cancer; Ph.D. fellowship from FWO; La Ligue contre le Cancer	Fund for Scientific Research - Flanders (FWO)(FWO); Cell Imaging Core; Concerted Actions Program of K. U. Leuven; Hercules Foundation; Belgian Foundation against cancer; Ph.D. fellowship from FWO(FWO); La Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Fund for Scientific Research - Flanders (FWO), the Cell Imaging Core and the Concerted Actions Program of K. U. Leuven, the Hercules Foundation (AKUL005 HER/08/061) and the Belgian Foundation against cancer. AMW was supported by a Ph.D. fellowship from FWO, YI was an EMBO long-term fellow and PZ was an EMBO young investigator. JPB is supported by La Ligue contre le Cancer (Label 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Chang BH, 2011, CHEM BIOL, V18, P1143, DOI 10.1016/j.chembiol.2011.06.013; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Ivarsson Y, 2011, J BIOL CHEM, V286, P44669, DOI 10.1074/jbc.M111.285734; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jeynov B, 2006, FEBS LETT, V580, P5917, DOI 10.1016/j.febslet.2006.09.058; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lambaerts K, 2012, J CELL SCI, V125, P1129, DOI 10.1242/jcs.089987; Lemmon MA, 1997, TRENDS CELL BIOL, V7, P237, DOI 10.1016/S0962-8924(97)01065-9; Lenfant N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-671; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Meerschaert K, 2007, EXP CELL RES, V313, P1790, DOI 10.1016/j.yexcr.2007.03.014; Meerschaert K, 2009, CELL MOL LIFE SCI, V66, P3951, DOI 10.1007/s00018-009-0156-6; MICHALIK J, 1981, LIFE SCI, V28, P1371, DOI 10.1016/0024-3205(81)90411-2; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Niethammer M, 1996, J NEUROSCI, V16, P2157; Osborne SL, 2001, J CELL SCI, V114, P2501; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Velthuis AJWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016047; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Wawrzyniak AM, 2012, FEBS LETT, V586, P1445, DOI 10.1016/j.febslet.2012.04.024; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	60	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54581	10.1371/journal.pone.0054581	http://dx.doi.org/10.1371/journal.pone.0054581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390500	gold, Green Submitted, Green Published			2022-12-27	WOS:000314691100016
J	Verrier, ER; Dorson, M; Mauger, S; Torhy, C; Ciobotaru, C; Hervet, C; Dechamp, N; Genet, C; Boudinot, P; Quillet, E				Verrier, Eloi R.; Dorson, Michel; Mauger, Stephane; Torhy, Corinne; Ciobotaru, Celine; Hervet, Caroline; Dechamp, Nicolas; Genet, Carine; Boudinot, Pierre; Quillet, Edwige			Resistance to a Rhabdovirus (VHSV) in Rainbow Trout: Identification of a Major QTL Related to Innate Mechanisms	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; QUANTITATIVE TRAIT LOCI; SALMON SALMO-SALAR; SEPTICEMIA VIRUS-REPLICATION; MICROSATELLITE LINKAGE MAP; ONCORHYNCHUS-MYKISS; DISEASE RESISTANCE; HIV-1 INFECTION; FISH; SELECTION	Health control is a major issue in animal breeding and a better knowledge of the genetic bases of resistance to diseases is needed in farm animals including fish. The detection of quantitative trait loci (QTL) will help uncovering the genetic architecture of important traits and understanding the mechanisms involved in resistance to pathogens. We report here the detection of QTL for resistance to Viral Haemorrhagic Septicaemia Virus (VHSV), a major threat for European aquaculture industry. Two induced mitogynogenetic doubled haploid F2 rainbow trout (Oncorhynchus mykiss) families were used. These families combined the genome of susceptible and resistant F0 breeders and contained only fully homozygous individuals. For phenotyping, fish survival after an immersion challenge with the virus was recorded, as well as in vitro virus replication on fin explants. A bidirectional selective genotyping strategy identified seven QTL associated to survival. One of those QTL was significant at the genome-wide level and largely explained both survival and viral replication in fin explants in the different families of the design (up to 65% and 49% of phenotypic variance explained respectively). These results evidence the key role of innate defence in resistance to the virus and pave the way for the identification of the gene(s) responsible for resistance. The identification of a major QTL also opens appealing perspectives for selective breeding of fish with improved resistance.	[Verrier, Eloi R.; Mauger, Stephane; Ciobotaru, Celine; Hervet, Caroline; Dechamp, Nicolas; Genet, Carine; Quillet, Edwige] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Verrier, Eloi R.; Dorson, Michel; Torhy, Corinne; Boudinot, Pierre] INRA, Virol & Immunol Mol UR892, Jouy En Josas, France; [Verrier, Eloi R.] AgroParisTech, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech	Quillet, E (corresponding author), INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France.	edwige.quillet@jouy.inra.fr	boudinot, pierre/L-4246-2016; Verrier, Eloi/AAH-3249-2021	boudinot, pierre/0000-0002-7490-9677; Dechamp, Nicolas/0000-0003-3248-2182; Mauger, Stephane/0000-0002-8779-1516; Verrier, Eloi/0000-0002-9022-5611	European Community (IFOP); French Ministry of Research [2004/190]; European Community's Seventh Framework Programme (FP7), Research Infrastructures action [FP7-228394]; Animal Genetics and Animal Health Divisions of INRA	European Community (IFOP)(European Commission); French Ministry of Research(Ministry of Research, FranceEuropean Commission); European Community's Seventh Framework Programme (FP7), Research Infrastructures action; Animal Genetics and Animal Health Divisions of INRA	The research leading to these results has received co-funding from European Community (IFOP) and French Ministry of Research (grant agreement DPMA/CIPA/INRA No. 2004/190, AGENOP project) and funding from the European Community's Seventh Framework Programme (FP7, 2007-2013), Research Infrastructures action, under the grant agreement No. FP7-228394 (NADIR). E.R. VERRIER is a recipient of a PhD fellowship co-funded by Animal Genetics and Animal Health Divisions of INRA. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hussinee L, 2011, DIS AQUAT ORGAN, V93, P117, DOI 10.3354/dao02285; [Anonymous], 1997, GENETICS ANAL QUANTI; Ayoub M, 2002, GENOME, V45, P1116, DOI [10.1139/g02-089, 10.1139/G02-089]; Baerwald MR, 2011, HEREDITY, V106, P920, DOI 10.1038/hdy.2010.137; Bain MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010156; Bearzotti M, 1999, J VIROL, V73, P7703, DOI 10.1128/JVI.73.9.7703-7709.1999; Bishop SC, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P1, DOI 10.1079/9781845935559.0000; Bisset SA, 1996, INT J PARASITOL, V26, P857, DOI 10.1016/S0020-7519(96)80056-7; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Boudinot P, 2001, J IMMUNOL, V167, P6202, DOI 10.4049/jimmunol.167.11.6202; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Boussaha M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-238; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DITER A, 1993, J FISH BIOL, V42, P777, DOI 10.1111/j.1095-8649.1993.tb00383.x; DORSON M, 1993, J FISH DIS, V16, P403, DOI 10.1111/j.1365-2761.1993.tb00874.x; DORSON M, 1975, ANN INST PASTEUR MIC, VB126, P485; Elsen JM, 1999, GENET SEL EVOL, V31, P213, DOI 10.1051/gse:19990302; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Filangi O, 2010, P 9 WORLD C GEN APPL; Gilbey J, 2006, DIS AQUAT ORGAN, V71, P119, DOI 10.3354/dao071119; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; Guyomard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-302; Guyomard R, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-15; HARRELL FE, 1982, BIOMETRIKA, V69, P635; Heringstad B, 2000, LIVEST PROD SCI, V64, P95, DOI 10.1016/S0301-6226(99)00128-1; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Jorgensen HBH, 2011, MOL IMMUNOL, V48, P1046, DOI 10.1016/j.molimm.2011.01.014; LANDER ES, 1989, GENETICS, V121, P185; le Berre M, 1977, Bulletin Off int Epizoot, V87, P391; Le Roy P, 1998, 6 WORLD C GEN APPL L, V26, P257; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Massault C, 2011, ANIM GENET, V42, P191, DOI 10.1111/j.1365-2052.2010.02110.x; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; Moen T, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P166, DOI 10.1079/9781845935559.0166; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Moreno CR, 2005, GENET RES, V85, P139, DOI 10.1017/S0016672305007366; Navabi A, 2009, THEOR APPL GENET, V118, P347, DOI 10.1007/s00122-008-0904-2; O'Farrell C, 2002, J VIROL, V76, P8040, DOI 10.1128/JVI.76.16.8040-8049.2002; Odegard J, 2011, AQUAC RES, V42, P103, DOI 10.1111/j.1365-2109.2010.02669.x; Overturf K, 2010, J FISH DIS, V33, P321, DOI 10.1111/j.1365-2761.2009.01124.x; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Palti Y, 2010, DEV COMP IMMUNOL, V34, P219, DOI 10.1016/j.dci.2009.10.002; Penaranda MMD, 2009, J GEN VIROL, V90, P2172, DOI 10.1099/vir.0.012286-0; Pierce LR, 2012, MOL PHYLOGENET EVOL, V63, P327, DOI 10.1016/j.ympev.2011.12.024; PINCUS T, 1971, J EXP MED, V133, P1219, DOI 10.1084/jem.133.6.1219; Purcell MK, 2012, VIRUSES-BASEL, V4, P140, DOI 10.3390/v4010140; Purcell MK, 2010, FISH SHELLFISH IMMUN, V28, P98, DOI 10.1016/j.fsi.2009.10.005; Quillet E, 2007, PROD ANIM, V20, P239; QUILLET E, 1994, AQUACULTURE, V123, P223, DOI 10.1016/0044-8486(94)90061-2; Quillet E, 2001, DIS AQUAT ORGAN, V45, P171, DOI 10.3354/dao045171; Quillet E, 2007, DIS AQUAT ORGAN, V76, P7, DOI 10.3354/dao076007; Quillet E, 2007, FISH SHELLFISH IMMUN, V22, P510, DOI 10.1016/j.fsi.2006.07.002; Rodriguez-Ramilo ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-541; Sakamoto T, 2000, GENETICS, V155, P1331; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Seymour DK, 2012, P NATL ACAD SCI USA, V109, P4227, DOI 10.1073/pnas.1117277109; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Sun YP, 2010, MOL BREEDING, V26, P493, DOI 10.1007/s11032-010-9390-8; Tomar D, 2012, BBA-MOL CELL RES, V1823, P316, DOI 10.1016/j.bbamcr.2011.11.015; Trobridge GD, 2000, DIS AQUAT ORGAN, V40, P1, DOI 10.3354/dao040001; Verrier ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033935; Verrier ER, 2011, DEV COMP IMMUNOL, V35, P1204, DOI 10.1016/j.dci.2011.03.012; Villanueva B, 2011, J ANIM SCI, V89, P3433, DOI 10.2527/jas.2010-3814; Wahli T., 2011, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V6, P1, DOI 10.1079/PAVSNNR20116002; Wargo AR, 2012, VIRUS RES, V165, P71, DOI 10.1016/j.virusres.2012.01.010; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Winton JR, 1997, DEV BIOLOGICALS, V90, P211; WOOLASTON RR, 1992, INT J PARASITOL, V22, P947, DOI 10.1016/0020-7519(92)90052-M	73	36	36	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55302	10.1371/journal.pone.0055302	http://dx.doi.org/10.1371/journal.pone.0055302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390526	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100042
J	Zhang, QM; Lu, LY; Wang, WQ; Zhu, YX; Zhou, T				Zhang, Qian-Ming; Lu, Linyuan; Wang, Wen-Qiang; Zhu, Yu-Xiao; Zhou, Tao			Potential Theory for Directed Networks	PLOS ONE			English	Article								Uncovering factors underlying the network formation is a long-standing challenge for data mining and network analysis. In particular, the microscopic organizing principles of directed networks are less understood than those of undirected networks. This article proposes a hypothesis named potential theory, which assumes that every directed link corresponds to a decrease of a unit potential and subgraphs with definable potential values for all nodes are preferred. Combining the potential theory with the clustering and homophily mechanisms, it is deduced that the Bi-fan structure consisting of 4 nodes and 4 directed links is the most favored local structure in directed networks. Our hypothesis receives strongly positive supports from extensive experiments on 15 directed networks drawn from disparate fields, as indicated by the most accurate and robust performance of Bi-fan predictor within the link prediction framework. In summary, our main contribution is twofold: (i) We propose a new mechanism for the local organization of directed networks; (ii) We design the corresponding link prediction algorithm, which can not only testify our hypothesis, but also find out direct applications in missing link prediction and friendship recommendation.	[Zhang, Qian-Ming; Wang, Wen-Qiang; Zhu, Yu-Xiao; Zhou, Tao] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Web Sci Ctr, Chengdu 610054, Peoples R China; [Lu, Linyuan] Hangzhou Normal Univ, Alibaba Business Coll, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Lu, Linyuan] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland	University of Electronic Science & Technology of China; Hangzhou Normal University; University of Fribourg	Lu, LY (corresponding author), Hangzhou Normal Univ, Alibaba Business Coll, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China.	linyuan.lue@unifr.ch	zhou, tao/GQA-3572-2022	Zhou, Tao/0000-0003-0561-2316	National Natural Science Foundation of China [11075031, 11205042]; EU FET-Open project QLectives [231200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EU FET-Open project QLectives	This work is partially supported by the National Natural Science Foundation of China under grant numbers 11075031 and 11205042, and the EU FET-Open project QLectives under grant number 231200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Backstrom L., 2006, P SIGKDD, P44, DOI DOI 10.1145/1150402.1150412; Baird D, 1998, ESTUAR COAST SHELF S, V47, P329, DOI 10.1006/ecss.1998.0360; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Batagelj V., 2006, PAJEK DATASETS WEBSI; Bianconi G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118701; Brzoowski MJ, 2011, P 5 INT AAAI C WEBL, P458; Celli F, 2010, LECT NOTES COMPUT SC, V6007, P346, DOI 10.1007/978-3-642-12079-4_43; Cheng XQ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033019; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cui AX, 2011, ACTA PHYS SIN-CH ED, V60, DOI 10.7498/aps.60.038901; Currarini S, 2010, P NATL ACAD SCI USA, V107, P4857, DOI 10.1073/pnas.0911793107; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Farkas IJ, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/180; Garlaschelli D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268701; Gomez V., 2008, P 17 INT C WORLD WID, P645, DOI [10.1145/1367497.1367585, DOI 10.1145/1367497.1367585]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Itzkovitz S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026127; Karrer B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.128701; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kumpula JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228701; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Leskovec J., 2010, P 19 INT C WORLD WID, P641, DOI [10.1145/1772690.1772756, DOI 10.1145/1772690.1772756]; Leskovec J., 2008, P 14 ACM SIGKDD INT, P462, DOI DOI 10.1145/1401890.1401948; Leskovec J., 2008, P 17 INT C WORLD WID, P915, DOI [10.1145/1367497.1367620, DOI 10.1145/1367497.1367620]; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Marvel SA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198701; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mislove A., 2008, P 1 WORKSH ONL SOC N; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Mones E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033799; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Opsahl T., 2010, ARXIV10102141; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Palmer C., 2002, ACM SIGKDD INT C KNO, P81; Perotti JI, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108701; Pimm SL, 2002, FOOD WEBS; Richardson M, 2003, LECT NOTES COMPUT SC, V2870, P351; Szabo G, 2004, LECT NOTES PHYS, V650, P139; Ulanowicz RE, 2000, TS19199 MAR SYST CTR; Ulanowicz RE, 1998, 98123 UMCES CBL MAR; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yin DW, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P1235; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zafarani R., 2009, SOCIAL COMPUTING DAT; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648	57	85	98	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55437	10.1371/journal.pone.0055437	http://dx.doi.org/10.1371/journal.pone.0055437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408979	Green Published, gold, Green Submitted			2022-12-27	WOS:000315100000013
J	Liu, PP; Li, WJ; Lin, N; Li, XS				Liu, Ping-Ping; Li, Wei-Jun; Lin, Nan; Li, Xing-Shan			Do Chinese Readers Follow the National Standard Rules for Word Segmentation during Reading?	PLOS ONE			English	Article							EYE-MOVEMENT CONTROL; MODEL; PERCEPTION; ALGORITHM; TEXT	We conducted a preliminary study to examine whether Chinese readers' spontaneous word segmentation processing is consistent with the national standard rules of word segmentation based on the Contemporary Chinese language word segmentation specification for information processing (CCLWSSIP). Participants were asked to segment Chinese sentences into individual words according to their prior knowledge of words. The results showed that Chinese readers did not follow the segmentation rules of the CCLWSSIP, and their word segmentation processing was influenced by the syntactic categories of consecutive words. In many cases, the participants did not consider the auxiliary words, adverbs, adjectives, nouns, verbs, numerals and quantifiers as single word units. Generally, Chinese readers tended to combine function words with content words to form single word units, indicating they were inclined to chunk single words into large information units during word segmentation. Additionally, the "overextension of monosyllable words" hypothesis was tested and it might need to be corrected to some degree, implying that word length have an implicit influence on Chinese readers' segmentation processing. Implications of these results for models of word recognition and eye movement control are discussed.	[Liu, Ping-Ping; Li, Wei-Jun; Lin, Nan; Li, Xing-Shan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Liu, Ping-Ping] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, PP (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	liupp@psych.ac.cn; liwj88@gmail.com	Lin, Nan/ABN-3049-2022; Li, Xingshan/HHM-6328-2022		Chinese Academy Sciences [KSCX2-YW-BR-6]; National Natural Science Foundation of China [31070904, 31000505]	Chinese Academy Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the Knowledge Innovation Project of the Chinese Academy Sciences (No. KSCX2-YW-BR-6), and the National Natural Science Foundation of China (No. 31070904); and the National Natural Science Foundation of China (No. 31000505). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the article.	[Anonymous], 1992, 1371592 GBT; Bai XJ, 2008, J EXP PSYCHOL HUMAN, V34, P1277, DOI 10.1037/0096-1523.34.5.1277; Blythe HI, 2012, J MEM LANG, V67, P241, DOI 10.1016/j.jml.2012.05.004; Chen HC, 1999, READING CHINESE SCRIPT, P257; Chen JY, 1999, READING CHINESE SCRIPT, P239; CHENG CM, 1981, ACTA PSYCHOL TAIWAN, V23, P137; Gao J, 2006, COMPUT LINGUIST, V31, P531; Hoosain R, 1991, PSYCHOLINGUISTIC IMP; Hoosain R., 1992, LANGUAGE PROCESSING, P111, DOI [10.1016/S0166-4115(08)61889-0, DOI 10.1016/S0166-4115(08)61889-0]; Huang Borong., 2007, MODERN CHINESE; [黄昌宁 HUANG Changning], 2007, [中文信息学报, Journal of Chinese Information Processing], V21, P8; Inhoff AW, 2005, MEM COGNITION, V33, P1345, DOI 10.3758/BF03193367; Li Xiaoqi, 2003, GUIDE FUNCTION WORDS; Li XS, 2011, PSYCHON B REV, V18, P833, DOI 10.3758/s13423-011-0115-8; [李兴珊 LI XingShan], 2011, [心理科学进展, Advances in Psychological Science], V19, P459; Li XS, 2009, COGNITIVE PSYCHOL, V58, P525, DOI 10.1016/j.cogpsych.2009.02.003; Liu P, BRIT J PSYC IN PRESS; Liu Q, 2010, PART SPEECH TAGGING; Liu Yao-feng, 2010, Computer Engineering, V36, P17; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Nakagawa T, 2004, P COLING 04 P 20 INT; Peng R., 2004, CHINESE J PSYCHOL, V46, P49; Perfetti CA, 2005, PSYCHOL REV, V112, P43, DOI 10.1037/0033-295X.112.1.43; Pollatsek A, 2006, COGNITIVE PSYCHOL, V52, P1, DOI 10.1016/j.cogpsych.2005.06.001; Rayner K, 2005, PSYCHON B REV, V12, P1089, DOI 10.3758/BF03206448; Rayner K, 2007, COGNITIVE SCI, V31, P1021, DOI 10.1080/03640210701703824; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reich ED, 2012, PSYCHOL REV, V119, P155, DOI 10.1037/a0026473; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Reilly R, 2012, READ WRIT, V25, P935, DOI 10.1007/s11145-012-9369-4; SIMON HA, 1974, SCIENCE, V183, P482, DOI 10.1126/science.183.4124.482; Sproat R, 1996, COMPUT LINGUIST, V22, P377; Teahan WJ, 2000, COMPUT LINGUIST, V26, P375, DOI 10.1162/089120100561746; Wang Z, 1998, FUNCTION WORDS MODER; Winskel H, 2009, J MEM LANG, V61, P339, DOI 10.1016/j.jml.2009.07.002; Xu J, 2006, CONT CHINESE WORD RE; Xue N., 2003, COMPUT LINGUIST, V8, P29; Yan G, 2006, BRIT J PSYCHOL, V97, P259, DOI 10.1348/000712605X70066; Yan M, 2010, Q J EXP PSYCHOL, V63, P705, DOI 10.1080/17470210903114858; Yang HM, 1999, READING CHINESE SCRIPT, P207; Zhang B, 2006, FUNCTION WORDS MODER	42	19	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55440	10.1371/journal.pone.0055440	http://dx.doi.org/10.1371/journal.pone.0055440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23408981	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300015
J	Romero, MC; Van Dromme, ICL; Janssen, P				Romero, Maria C.; Van Dromme, Ilse C. L.; Janssen, Peter			The Role of Binocular Disparity in Stereoscopic Images of Objects in the Macaque Anterior Intraparietal Area	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; MONKEY PARIETAL CORTEX; 3-DIMENSIONAL SHAPE; INFEROTEMPORAL CORTEX; SURFACE-ORIENTATION; VISUAL CONTROL; HAND ACTION; NEURONS; REPRESENTATION; PERCEPTION	Neurons in the macaque Anterior Intraparietal area (AIP) encode depth structure in random-dot stimuli defined by gradients of binocular disparity, but the importance of binocular disparity in real-world objects for AIP neurons is unknown. We investigated the effect of binocular disparity on the responses of AIP neurons to images of real-world objects during passive fixation. We presented stereoscopic images of natural and man-made objects in which the disparity information was congruent or incongruent with disparity gradients present in the real-world objects, and images of the same objects where such gradients were absent. Although more than half of the AIP neurons were significantly affected by binocular disparity, the great majority of AIP neurons remained image selective even in the absence of binocular disparity. AIP neurons tended to prefer stimuli in which the depth information derived from binocular disparity was congruent with the depth information signaled by monocular depth cues, indicating that these monocular depth cues have an influence upon AIP neurons. Finally, in contrast to neurons in the inferior temporal cortex, AIP neurons do not represent images of objects in terms of categories such as animate-inanimate, but utilize representations based upon simple shape features including aspect ratio.	[Romero, Maria C.; Van Dromme, Ilse C. L.; Janssen, Peter] KULeuven, Lab Neuro & Psychofysiol, Louvain, Belgium	KU Leuven	Janssen, P (corresponding author), KULeuven, Lab Neuro & Psychofysiol, Louvain, Belgium.	Peter.Janssen@med.kuleuven.be	Romero, Maria/AAA-2826-2020	Romero, Maria C/0000-0001-7758-2211	Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0713.09]; Geconcerteerde Onderzoeksacties GOA [10/19]; Interuniversitaire Attractiepolen IUAP [P6/29];  [ERC-StG-260607];  [PFV10/008]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Geconcerteerde Onderzoeksacties GOA; Interuniversitaire Attractiepolen IUAP; ; 	This work was supported by Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0713.09), ERC-StG-260607, Programmafinanciering PFV10/008, Geconcerteerde Onderzoeksacties GOA 10/19, and Interuniversitaire Attractiepolen IUAP P6/29. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann MA, 2009, J NEUROSCI, V29, P6436, DOI 10.1523/JNEUROSCI.5479-08.2009; Durand JB, 2007, NEURON, V55, P493, DOI 10.1016/j.neuron.2007.06.040; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2008, J NEUROSCI, V28, P6679, DOI 10.1523/JNEUROSCI.0499-08.2008; Katsuyama N, 2010, NEUROSCIENCE, V167, P1, DOI 10.1016/j.neuroscience.2010.01.028; Keefe BD, 2009, EXP BRAIN RES, V194, P435, DOI 10.1007/s00221-009-1718-4; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Nelissen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008306; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Romero MC, 2012, EUR J NEUROSCI, V36, P2324, DOI 10.1111/j.1460-9568.2012.08135.x; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Sakuraba S, 2012, J NEUROSCI, V32, P3949, DOI 10.1523/JNEUROSCI.3973-11.2012; Srivastava S, 2009, J NEUROSCI, V29, P10613, DOI 10.1523/JNEUROSCI.6016-08.2009; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Theys T, 2012, J NEUROPHYSIOL, V107, P995, DOI 10.1152/jn.00248.2011; Todd JT, 2007, J VIS, V7, P91; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Verhoef BE, 2012, NEURON, V73, P171, DOI 10.1016/j.neuron.2011.10.031; Verhoef BE, 2011, J NEUROPHYSIOL, V105, P2030, DOI 10.1152/jn.00924.2010; Verhoef BE, 2010, CURR BIOL, V20, P909, DOI 10.1016/j.cub.2010.03.058; Watt SJ, 2003, J EXP PSYCHOL HUMAN, V29, P404, DOI 10.1037/0096-1523.29.2.404	27	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55340	10.1371/journal.pone.0055340	http://dx.doi.org/10.1371/journal.pone.0055340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408970	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000315157200024
J	Chang, KC; Hsu, CC; Liu, SH; Su, CC; Yen, CC; Lee, MJ; Chen, KL; Ho, TJ; Hung, DZ; Wu, CC; Lu, TH; Su, YC; Chen, YW; Huang, CF				Chang, Kai-Chih; Hsu, Ching-Cheng; Liu, Shing-Hwa; Su, Chin-Chuan; Yen, Cheng-Chieh; Lee, Ming-Jye; Chen, Kuo-Liang; Ho, Tsung-Jung; Hung, Dong-Zong; Wu, Chin-Ching; Lu, Tien-Hui; Su, Yi-Chang; Chen, Ya-Wen; Huang, Chun-Fa			Cadmium Induces Apoptosis in Pancreatic beta-Cells through a Mitochondria-Dependent Pathway: The Role of Oxidative Stress-Mediated c-Jun N-Terminal Kinase Activation	PLOS ONE			English	Article							BIOLOGICAL SAMPLES; INSULIN-SECRETION; URINARY CADMIUM; TOXIC METALS; EXPRESSION; GLUCOSE; DEATH; DYSFUNCTION; METABOLISM; P38	Cadmium (Cd), one of well-known highly toxic environmental and industrial pollutants, causes a number of adverse health effects and diseases in humans. The growing epidemiological studies have suggested a possible link between Cd exposure and diabetes mellitus (DM). However, the toxicological effects and underlying mechanisms of Cd-induced pancreatic beta-cell injury are still unknown. In this study, we found that Cd significantly decreased cell viability, and increased sub-G1 hypodiploid cells and annexin V-Cy3 binding in pancreatic beta-cell-derived RIN-m5F cells. Cd also increased intracellular reactive oxygen species (ROS) generation and malondialdehyde (MDA) production and induced mitochondrial dysfunction (the loss of mitochondrial membrane potential (MMP) and the increase of cytosolic cytochrome c release), the decreased Bcl-2 expression, increased p53 expression, poly (ADP-ribose) polymerase (PARP) cleavage, and caspase cascades, which accompanied with intracellular Cd accumulation. Pretreatment with the antioxidant N-acetylcysteine (NAC) effectively reversed these Cd-induced events. Furthermore, exposure to Cd induced the phosphorylations of c-jun N-terminal kinases (JNK), extracellular signal-regulated kinases (ERK) 1/2, and p38-mitogen-activated protein kinase (MAPK), which was prevented by NAC. Additionally, the specific JNK inhibitor SP600125 or JNK-specific small interference RNA (si-RNA) transfection suppressed Cd-induced beta-cell apoptosis and related signals, but not ERK1/2 and p38-MAPK inhibitors (PD98059 and SB203580) did not. However, the JNK inhibitor or JNK-specific si-RNA did not suppress ROS generation in Cd-treated cells. These results indicate that Cd induces pancreatic beta-cell death via an oxidative stress downstream-mediated JNK activation-triggered mitochondria-regulated apoptotic pathway.	[Chang, Kai-Chih; Hsu, Ching-Cheng; Lu, Tien-Hui; Chen, Ya-Wen] China Med Univ, Coll Med, Sch Med, Dept Physiol, Taichung, Taiwan; [Chang, Kai-Chih; Hsu, Ching-Cheng; Lu, Tien-Hui; Chen, Ya-Wen] China Med Univ, Coll Med, Sch Med, Grad Inst Basic Med Sci, Taichung, Taiwan; [Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Su, Chin-Chuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Changhua County, Taiwan; [Yen, Cheng-Chieh] Chung Shan Med Univ, Coll Hlth Care & Management, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Yen, Cheng-Chieh] Chung Shan Med Univ Hosp, Dept Occupat Med, Taichung, Taiwan; [Lee, Ming-Jye] Peng Hu Hosp, Dept Surg, Makung City, Taiwan; [Lee, Ming-Jye] Execut Yuan, Dept Hlth, Taipei, Taiwan; [Chen, Kuo-Liang] China Med Univ Hosp, Dept Urol, Taichung, Taiwan; [Ho, Tsung-Jung; Su, Yi-Chang; Huang, Chun-Fa] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Hung, Dong-Zong] China Med Univ Hosp, Div Toxicol, Trauma & Emergency Ctr, Taichung, Taiwan; [Wu, Chin-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; National Taiwan University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chen, YW (corresponding author), China Med Univ, Coll Med, Sch Med, Dept Physiol, Taichung, Taiwan.	ywc@mail.cmu.edu.tw; cfhuang@mail.cmu.edu.tw		HSU, CHING-CHENG/0000-0002-8804-6171	National Science Council of Taiwan [NSC 98-2314-B-039-015, NSC 98-2815-C-039-031-B, NSC 100-2314-B-039-023-]; China Medical University, Taichung, Taiwan [CMU100-TC-01]; Central Region Hospital Alliance, Department of Health, Executive Yuan [9919]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taichung, Taiwan(China Medical University); Central Region Hospital Alliance, Department of Health, Executive Yuan; Taiwan Department of Health Clinical Trial and Research Center of Excellence	This study was supported by research grants form the National Science Council of Taiwan (NSC 98-2314-B-039-015, NSC 98-2815-C-039-031-B, and NSC 100-2314-B-039-023-), the China Medical University, Taichung, Taiwan (CMU100-TC-01), the Central Region Hospital Alliance, Department of Health, Executive Yuan (9919), and also supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2008, DIABETES RES CLIN PR, V80, P280, DOI 10.1016/j.diabres.2007.12.021; Azevedo-Martins AK, 2006, TOXICOL IN VITRO, V20, P1106, DOI 10.1016/j.tiv.2006.02.007; Bagchi D, 2000, J BIOCHEM MOL TOXIC, V14, P33, DOI 10.1002/(SICI)1099-0461(2000)14:1<33::AID-JBT5>3.3.CO;2-P; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bernard A, 2008, INDIAN J MED RES, V128, P557; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHAPATWALA KD, 1982, DRUG CHEM TOXICOL, V5, P305, DOI 10.3109/01480548209041060; Chen YW, 2006, DIABETES, V55, P1614, DOI 10.2337/db06-0029; Chen YW, 2009, ISLETS, V1, P169, DOI 10.4161/isl.1.3.9262; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Edwards JR, 2009, TOXICOL APPL PHARM, V238, P289, DOI 10.1016/j.taap.2009.03.007; Galluzzi L, 2008, CELL CYCLE, V7, P1949, DOI 10.4161/cc.7.13.6222; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Gobe G, 2010, TOXICOL LETT, V198, P49, DOI 10.1016/j.toxlet.2010.04.013; Han JC, 2003, ARCH BIOCHEM BIOPHYS, V413, P213, DOI 10.1016/S0003-9861(03)00120-6; Haswell-Elkins M, 2008, ENVIRON RES, V106, P379, DOI 10.1016/j.envres.2007.10.004; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Inaba T, 2005, TOXICOL LETT, V159, P192, DOI 10.1016/j.toxlet.2005.05.011; IPCS, 1992, ENV HLTH CRIT 134; ITHAKISSIOS DS, 1975, TOXICOL APPL PHARM, V31, P143, DOI 10.1016/0041-008X(75)90062-9; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kaneto Hideaki, 2005, Am J Ther, V12, P529, DOI 10.1097/01.mjt.0000178773.31525.c2; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Kolachi NF, 2011, BIOL TRACE ELEM RES, V143, P196, DOI 10.1007/s12011-010-8879-7; Lei LJ, 2007, BIOMED ENVIRON SCI, V20, P295; Lei Li-jian, 2005, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V23, P45; Lei Li-jian, 2006, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V24, P3; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Lemarie A, 2004, FREE RADICAL BIO MED, V36, P1517, DOI 10.1016/j.freeradbiomed.2004.03.020; Liu Y, 2008, J CELL PHYSIOL, V217, P307, DOI 10.1002/jcp.21499; MERALI Z, 1980, BRIT J PHARMACOL, V69, P151, DOI 10.1111/j.1476-5381.1980.tb10895.x; Mokhtari D, 2008, ENDOCRINOLOGY, V149, P3046, DOI 10.1210/en.2007-0438; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pitocco Dario, 2010, Rev Diabet Stud, V7, P15, DOI 10.1900/RDS.2010.7.15; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Schwartz GG, 2003, DIABETES CARE, V26, P468, DOI 10.2337/diacare.26.2.468; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; World Health Organization, 1993, WHO TECHN REP SER, V837; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Yen CC, 2011, ARCH TOXICOL, V85, P565, DOI 10.1007/s00204-011-0709-y	49	117	123	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54374	10.1371/journal.pone.0054374	http://dx.doi.org/10.1371/journal.pone.0054374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405080	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400024
J	Gross, JB; Furterer, A; Carlson, BM; Stahl, BA				Gross, Joshua B.; Furterer, Allison; Carlson, Brian M.; Stahl, Bethany A.			An Integrated Transcriptome-Wide Analysis of Cave and Surface Dwelling Astyanax mexicanus	PLOS ONE			English	Article							ALPHA-TRANSDUCIN GNAT1; BLIND CAVEFISH; REGRESSIVE EVOLUTION; CONVERGENT EVOLUTION; GENE-EXPRESSION; GAMMARUS-MINUS; LENS; EYE; FASCIATUS; FISH	Numerous organisms around the globe have successfully adapted to subterranean environments. A powerful system in which to study cave adaptation is the freshwater characin fish, Astyanax mexicanus. Prior studies in this system have established a genetic basis for the evolution of numerous regressive traits, most notably vision and pigmentation reduction. However, identification of the precise genetic alterations that underlie these morphological changes has been delayed by limited genetic and genomic resources. To address this, we performed a transcriptome analysis of cave and surface dwelling Astyanax morphs using Roche/454 pyrosequencing technology. Through this approach, we obtained 576,197 Pachon cavefish-specific reads and 438,978 surface fish-specific reads. Using this dataset, we assembled transcriptomes of cave and surface fish separately, as well as an integrated transcriptome that combined 1,499,568 reads from both morphotypes. The integrated assembly was the most successful approach, yielding 22,596 high quality contiguous sequences comprising a total transcriptome length of 21,363,556 bp. Sequence identities were obtained through exhaustive blast searches, revealing an adult transcriptome represented by highly diverse Gene Ontology ( GO) terms. Our dataset facilitated rapid identification of sequence polymorphisms between morphotypes. These data, along with positional information collected from the Danio rerio genome, revealed several syntenic regions between Astyanax and Danio. We demonstrated the utility of this positional information through a QTL analysis of albinism in a surface x Pachon cave F-2 pedigree, using 65 polymorphic markers identified from our integrated assembly. We also adapted our dataset for an RNA-seq study, revealing many genes responsible for visual system maintenance in surface fish, whose expression was not detected in adult Pachon cavefish. Conversely, several metabolism-related genes expressed in cavefish were not detected in surface fish. This resource will enable powerful genetic and genomic analyses in the future that will better clarify the heritable genetic changes governing adaptation to the cave environment.	[Gross, Joshua B.; Furterer, Allison; Carlson, Brian M.; Stahl, Bethany A.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Gross, JB (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.	grossja@ucmail.uc.edu	Carlson, Brian/GVT-0987-2022	Carlson, Brian/0000-0002-0879-6600	Small Grant Program for New Investigators (NIH/NIDCR) [1R03DE022403-01]; University of Cincinnati Women in Science and Engineering (WISE) program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE022403] Funding Source: NIH RePORTER	Small Grant Program for New Investigators (NIH/NIDCR); University of Cincinnati Women in Science and Engineering (WISE) program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by the Small Grant Program for New Investigators (NIH/NIDCR Award Number 1R03DE022403-01) to JBG, and a 2011 summer fellowship awarded to AF from the University of Cincinnati Women in Science and Engineering (WISE) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-216; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; Aspiras AC, 2012, J EVOLUTION BIOL, V25, P995, DOI 10.1111/j.1420-9101.2012.02481.x; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barr T. C., 1968, Evolutionary Biology, V2, P35; Behrens M, 1998, GENE, V216, P319, DOI 10.1016/S0378-1119(98)00346-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowen ME, 2012, GENETICS, V190, P1017, DOI 10.1534/genetics.111.136069; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver DC, 1982, CAVE LIFE EVOLUTION; Cvekl A, 1996, BIOESSAYS, V18, P621, DOI 10.1002/bies.950180805; Darwin C, 1859, ORIGIN SPECIES MEANS; Dryja TP, 1997, INVEST OPHTH VIS SCI, V38, P1972; Eigenmann C. H., 1909, CAVE VERTEBRATES AM; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Friedrich M, 2011, J EXP BIOL, V214, P3532, DOI 10.1242/jeb.060368; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Gross JB, 2008, P NATL ACAD SCI USA, V105, P20106, DOI 10.1073/pnas.0806238105; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hervant F, 2000, CAN J ZOOL, V78, P1427, DOI 10.1139/cjz-78-8-1427; Hervant F, 1999, HYDROBIOLOGIA, V392, P197, DOI 10.1023/A:1003511416509; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; HOWARTH FG, 1993, AM NAT, V142, pS65, DOI 10.1086/285523; Huppop K., 1985, Bulletin of the National Speleological Society, V47, P136; HUPPOP K, 1986, ENVIRON BIOL FISH, V17, P299, DOI 10.1007/BF00001496; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Jeffery WR, 1998, AM ZOOL, V38, P685; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; LANGECKER TG, 1995, J ZOOL SYST EVOL RES, V33, P123; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NGO JT, 1993, GENOMICS, V18, P724, DOI 10.1016/S0888-7543(05)80384-2; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; OMURA Y, 1975, CELL TISSUE RES, V160, P99; Panaram K, 2005, COPEIA, P409; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; POULSON TL, 1969, SCIENCE, V165, P971; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas ME, 2011, P NATL ACAD SCI USA, V108, P5702, DOI 10.1073/pnas.1013850108; SADOGLU P, 1957, EXPERIENTIA, V13, P394, DOI 10.1007/BF02161111; SADOGLU P, 1969, J HERED, V60, P10, DOI 10.1093/oxfordjournals.jhered.a107917; Sadoglu P., 1957, VERH DTSCH ZOOL GES, P432; Salin K, 2010, COMP BIOCHEM PHYS A, V156, P451, DOI 10.1016/j.cbpa.2010.03.030; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Soares D, 2004, DEV NEUROSCI-BASEL, V26, P308, DOI 10.1159/000082272; Strickler AG, 2007, DEV BIOL, V311, P512, DOI 10.1016/j.ydbio.2007.08.050; Strickler AG, 2009, INTEGR ZOOL, V4, P99, DOI 10.1111/j.1749-4877.2008.00139.x; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Szabo V, 2007, HUM MUTAT, V28, P741, DOI 10.1002/humu.9499; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wilkens H, 2003, BIOL J LINN SOC, V80, P545, DOI 10.1111/j.1095-8312.2003.00230.x; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; WISTOW G, 1993, TRENDS BIOCHEM SCI, V18, P301, DOI 10.1016/0968-0004(93)90041-K; WISTOW G, 1991, J MOL EVOL, V32, P262, DOI 10.1007/BF02342749; WRIGHT S, 1964, AM NAT, V98, P65, DOI 10.1086/282301; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315	64	52	52	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55659	10.1371/journal.pone.0055659	http://dx.doi.org/10.1371/journal.pone.0055659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405189	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400134
J	Isolani, ME; Abril, JF; Salo, E; Deri, P; Bianucci, AM; Batistoni, R				Isolani, Maria Emilia; Abril, Josep F.; Salo, Emili; Deri, Paolo; Bianucci, Anna Maria; Batistoni, Renata			Planarians as a Model to Assess In Vivo the Role of Matrix Metalloproteinase Genes during Homeostasis and Regeneration	PLOS ONE			English	Article							EXTRINSIC APOPTOTIC PATHWAY; EXTRACELLULAR-MATRIX; STEM-CELLS; SCHMIDTEA-MEDITERRANEA; TISSUE INHIBITORS; PROTECTIVE ROLES; BASAL LAMINA; EXPRESSION; TRANSCRIPTOME; MEMBRANE	Matrix metalloproteinases (MMPs) are major executors of extracellular matrix remodeling and, consequently, play key roles in the response of cells to their microenvironment. The experimentally accessible stem cell population and the robust regenerative capabilities of planarians offer an ideal model to study how modulation of the proteolytic system in the extracellular environment affects cell behavior in vivo. Genome-wide identification of Schmidtea mediterranea MMPs reveals that planarians possess four mmp-like genes. Two of them (mmp1 and mmp2) are strongly expressed in a subset of secretory cells and encode putative matrilysins. The other genes (mt-mmpA and mt-mmpB) are widely expressed in postmitotic cells and appear structurally related to membrane-type MMPs. These genes are conserved in the planarian Dugesia japonica. Here we explore the role of the planarian mmp genes by RNA interference (RNAi) during tissue homeostasis and regeneration. Our analyses identify essential functions for two of them. Following inhibition of mmp1 planarians display dramatic disruption of tissues architecture and significant decrease in cell death. These results suggest that mmp1 controls tissue turnover, modulating survival of postmitotic cells. Unexpectedly, the ability to regenerate is unaffected by mmp1(RNAi). Silencing of mt-mmpA alters tissue integrity and delays blastema growth, without affecting proliferation of stem cells. Our data support the possibility that the activity of this protease modulates cell migration and regulates anoikis, with a consequent pivotal role in tissue homeostasis and regeneration. Our data provide evidence of the involvement of specific MMPs in tissue homeostasis and regeneration and demonstrate that the behavior of planarian stem cells is critically dependent on the microenvironment surrounding these cells. Studying MMPs function in the planarian model provides evidence on how individual proteases work in vivo in adult tissues. These results have high potential to generate significant information for development of regenerative and anti cancer therapies.	[Isolani, Maria Emilia; Deri, Paolo; Batistoni, Renata] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Isolani, Maria Emilia; Bianucci, Anna Maria] Univ Pisa, Dipartimento Sci Farmaceut, Pisa, Italy; [Abril, Josep F.; Salo, Emili] Univ Barcelona, Dept Genet, Barcelona, Catalonia, Spain; [Abril, Josep F.; Salo, Emili] Univ Barcelona, Inst Biomed, Barcelona, Catalonia, Spain	University of Pisa; University of Pisa; University of Barcelona; University of Barcelona	Batistoni, R (corresponding author), Univ Pisa, Dipartimento Biol, Pisa, Italy.	rbatistoni@biologia.unipi.it	Salo, Emili/M-3928-2014; Ferrando, Josep F Abril/B-3877-2014	Salo, Emili/0000-0001-5460-9223; Ferrando, Josep F Abril/0000-0001-7793-589X	Fondazione Cassa di Risparmio di Volterra; Ministerio de Educacion y Ciencia (MEC) [BFU2011-22786, BFU2009-09102]	Fondazione Cassa di Risparmio di Volterra; Ministerio de Educacion y Ciencia (MEC)(Spanish Government)	This work was supported by Fondazione Cassa di Risparmio di Volterra to RB. This work was also funded by grants BFU2011-22786 from the Ministerio de Educacion y Ciencia (MEC) to ES and BFU2009-09102 from the MEC to JFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2011, TRENDS CELL BIOL, V21, P304, DOI 10.1016/j.tcb.2011.01.005; Abril JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-731; Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110; Adell T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000505; Agata K, 2007, DEV GROWTH DIFFER, V49, P73, DOI 10.1111/j.1440-169x.2007.00919.x; Altincicek B, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-6; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Banchetti R, 1973, REND ACCAD NAZ LINCE, V55, P107; Beaucher M, 2007, DEV BIOL, V303, P625, DOI 10.1016/j.ydbio.2006.12.001; Biljana E, 2000, J CELL ANIM BIOL, V5, P113; Blythe MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015617; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Das A, 2003, NEUROPATHOLOGY, V23, P275, DOI 10.1046/j.1440-1789.2003.00512.x; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Fata JE, 2000, CELL MOL LIFE SCI, V57, P77, DOI 10.1007/s000180050500; Fernandez-Taboada E, 2010, DEVELOPMENT, V137, P1055, DOI 10.1242/dev.042564; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fu LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036707; Fu XY, 2008, SEMIN CELL DEV BIOL, V19, P2, DOI 10.1016/j.semcdb.2007.06.005; Fukushima K, 2007, BMC MUSCULOSKEL DIS, V28, P8; Gilles C, 2001, J CELL SCI, V114, P2967; Gondi CS, 2009, INT J ONCOL, V35, P851, DOI 10.3892/ijo_00000399; Gonzalez-Estevez C, 2007, P NATL ACAD SCI USA, V104, P13373, DOI 10.1073/pnas.0703588104; Gourevitch D, 2003, DEV DYNAM, V226, P377, DOI 10.1002/dvdy.10243; Guedelhoefer OC, 2012, DEVELOPMENT, V139, P3510, DOI 10.1242/dev.082099; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hayashi T, 2010, DEV GROWTH DIFFER, V52, P131, DOI 10.1111/j.1440-169X.2009.01157.x; Higuchi S, 2007, DEV GROWTH DIFFER, V49, P571, DOI 10.1111/j.1440-169X.2007.00947.x; HORI I, 1991, International Journal of Developmental Biology, V35, P101; HORI I, 1979, TISSUE CELL, V11, P611, DOI 10.1016/0040-8166(79)90018-1; HORI I, 1979, RADIAT RES, V77, P521, DOI 10.2307/3575163; HORI I, 1980, TISSUE CELL, V12, P513, DOI 10.1016/0040-8166(80)90040-3; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huxley-Jones J, 2008, DRUG DISCOV TODAY, V13, P685, DOI 10.1016/j.drudis.2008.05.005; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isolani ME, 2012, EUR J PHARMACOL, V686, P1, DOI 10.1016/j.ejphar.2012.03.036; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim YN, 2012, INT J CELL BIOL, V2012, P3068; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Knapinska A, 2012, CHEMBIOCHEM, V13, P2002, DOI 10.1002/cbic.201200298; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Leontovich AA, 2000, DEVELOPMENT, V127, P907; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu H, 2008, MED ONCOL, V25, P419, DOI 10.1007/s12032-008-9057-z; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; Mancini A, 2006, FRONT BIOSCI-LANDMRK, V11, P423, DOI 10.2741/1809; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Menze MA, 2010, APOPTOSIS, V15, P293, DOI 10.1007/s10495-009-0443-6; Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072; Mineta K, 2003, P NATL ACAD SCI USA, V100, P7666, DOI 10.1073/pnas.1332513100; Mitsiades N, 2001, CANCER RES, V61, P577; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Nogi T, 2005, DEV BIOL, V287, P314, DOI 10.1016/j.ydbio.2005.09.002; Oviedo NJ, 2008, DIS MODEL MECH, V1, P131, DOI 10.1242/dmm.000117; Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park IS, 1999, MOL CELLS, V9, P119; Peiris TH, 2012, BIOCH BIOPHYS ACTA; Pellettieri J, 2010, DEV BIOL, V338, P76, DOI 10.1016/j.ydbio.2009.09.015; Pontius J., 2003, NCBI HDB, P1; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Reddien PW, 2008, DEV DYNAM, V237, P3099, DOI 10.1002/dvdy.21623; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rieger MR, 1991, PLATYHELMINTHES NEME, V3, P7; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Salo E, 2006, BIOESSAYS, V28, P546, DOI 10.1002/bies.20416; Salvetti A, 2000, DEV DYNAM, V218, P603, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1016>3.0.CO;2-C; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Sarras MP, 2002, CELL RES, V12, P163, DOI 10.1038/sj.cr.7290123; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Sawada T, 1999, WOUND REPAIR REGEN, V7, P458, DOI 10.1046/j.1524-475X.1999.00458.x; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Sivakumar P, 1999, COMP BIOCHEM PHYS B, V123, P273, DOI 10.1016/S0305-0491(99)00067-X; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8; Tu KC, 2012, DEV BIOL, V365, P458, DOI 10.1016/j.ydbio.2012.03.010; Umesono Y, 1997, DEV GROWTH DIFFER, V39, P723; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vargo-Gogola T, 2002, CANCER RES, V62, P5559; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007; Wada K, 1998, GENE, V211, P57, DOI 10.1016/S0378-1119(98)00076-6; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yan L, 2000, DEV BIOL, V219, P115, DOI 10.1006/dbio.1999.9568; Yuan SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000906; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	119	31	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55649	10.1371/journal.pone.0055649	http://dx.doi.org/10.1371/journal.pone.0055649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405188	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400133
J	Liu, Y; Li, L; Qi, HY; Gao, Y; Liu, S; Xu, CA				Liu, Yan; Li, Lin; Qi, Haiyan; Gao, Yan; Liu, Sha; Xu, Chongan			Survivin-31G > C Polymorphism and Gastrointestinal Tract Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							SURVIVIN EXPRESSION; PROMOTER POLYMORPHISM; ESOPHAGEAL CANCER; POTENTIAL ROLE; GENE; ASSOCIATION; APOPTOSIS; SUSCEPTIBILITY; PROGNOSIS; HETEROGENEITY	Background: Emerging evidence showed that common functional -31G>C polymorphism (rs9904341 G>C) in the promoter region of the survivin gene is involved in the regulation of survivin expression, thus increasing an individual's susceptibility to gastrointestinal tract (GIT) cancer; but individually published results are inconclusive. The aim of this systematic review and meta-analysis was to derive a more precise estimation of the association between survivin -31G>C polymorphism and GIT cancer risk. Methods: A literature search of PubMed, Embase, Web of Science and CBM databases was conducted from inception through July 1st, 2012. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. Results: Nine case-control studies were included with a total of 2,231 GIT cancer cases and 2,287 healthy controls. The results indicated that survivin -31G>C polymorphism was associated with increased risk of GIT cancer. In the stratified analysis by cancer types, significant associations were observed between survivin -31G>C polymorphism and increased risk of colorectal and gastric cancers. However, the lack of association of survivin -31G>C polymorphism with esophageal cancer risk may be due to a lack of a sufficient number of eligible studies and the influence of different genetic and environmental factors. Conclusion: Results from the current meta-analysis suggests that survivin -31G>C polymorphism might increase the risk of GIT cancer, especially among gastric and colorectal cancers.	[Liu, Yan; Li, Lin; Qi, Haiyan; Gao, Yan; Liu, Sha; Xu, Chongan] China Med Univ, Affiliated Hosp 4, Dept Oncol, Shenyang, Peoples R China	China Medical University	Xu, CA (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Oncol, Shenyang, Peoples R China.	med_xca@126.com			Foundation of the Science and Technology Research Project of the Higher Education Department of Liaoning Province [L2010695]	Foundation of the Science and Technology Research Project of the Higher Education Department of Liaoning Province	This was funded by the Foundation of the Science and Technology Research Project of the Higher Education Department of Liaoning Province (No. L2010695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177; Antonacopoulou AG, 2010, ANAL CELL PATHOL, V33, P177, DOI [10.1155/2010/673592, 10.3233/ACP-CLO-2010-0537]; Borges BD, 2011, CLIN EXP MED, V11, P189, DOI 10.1007/s10238-010-0122-5; Cheng Zheng-Jiang, 2008, Ai Zheng, V27, P258; Cui YH, 2009, J DIGEST DIS, V10, P118, DOI 10.1111/j.1751-2980.2009.00373.x; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; Dabrowski A, 2004, FOLIA HISTOCHEM CYTO, V42, P169; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gazouli M, 2009, INT J COLORECTAL DIS, V24, P145, DOI 10.1007/s00384-008-0601-2; Grabowski P, 2003, BRIT J CANCER, V88, P115, DOI 10.1038/sj.bjc.6600696; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; [黄俊 HUANG Jun], 2010, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V31, P59; Ikeguchi M, 2003, TUMOR BIOL, V24, P40, DOI 10.1159/000070659; Ikeguchi M, 2002, BRIT J CANCER, V87, P883, DOI 10.1038/sj.bjc.6600546; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kato J, 2001, INT J CANCER, V95, P92; Krieg A, 2002, BRIT J CANCER, V86, P737, DOI 10.1038/sj.bjc.6600153; Lambert R, 2007, BEST PRACT RES CL GA, V21, P921, DOI 10.1016/j.bpg.2007.10.001; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lochhead P, 2011, GASTROENTEROLOGY, V140, P435, DOI 10.1053/j.gastro.2010.11.001; McCormack VA, 2011, ANN ONCOL, V22, P2349, DOI 10.1093/annonc/mdq763; Mondello C, 2010, SUBCELL BIOCHEM, V50, P307, DOI 10.1007/978-90-481-3471-7_16; Nemoto T, 2004, EXP MOL PATHOL, V76, P253, DOI 10.1016/j.yexmp.2004.01.001; Okada E, 2001, CANCER LETT, V163, P109, DOI 10.1016/S0304-3835(00)00677-7; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Rosato A, 2006, INT J CANCER, V119, P1717, DOI 10.1002/ijc.21923; Sarela AI, 2000, GUT, V46, P645, DOI 10.1136/gut.46.5.645; Sarela AI, 2001, ANN SURG ONCOL, V8, P305; Sato F, 2006, BIOCHEM BIOPH RES CO, V342, P465, DOI 10.1016/j.bbrc.2006.01.177; Shoeneman JK, 2012, CANCER RES, V72, P249, DOI 10.1158/0008-5472.CAN-11-2315; Song JH, 2009, NEOPLASMA, V56, P343, DOI 10.4149/neo_2009_04_343; Srivastava K, 2012, MOL BIOL REP, V39, P1509, DOI 10.1007/s11033-011-0889-9; Tu SP, 2003, CANCER RES, V63, P7724; Upadhyay R, 2011, ANN SURG ONCOL, V18, P880, DOI 10.1245/s10434-010-1371-y; Wang TT, 2007, WORLD J GASTROENTERO, V13, P2784, DOI 10.3748/wjg.v13.i20.2784; Wang XF, 2012, EUR J HUM GENET, V20, P790, DOI 10.1038/ejhg.2011.276; Yagihashi A, 2001, CLIN CHEM, V47, P1729; Yang L, 2009, DIGEST DIS SCI, V54, P1021, DOI 10.1007/s10620-008-0441-5; Yang LQ, 2004, WORLD J GASTROENTERO, V10, P22; Yang XY, 2009, J CANCER RES CLIN, V135, P1341, DOI 10.1007/s00432-009-0575-7; Zhang L, 2011, CLIN EXP RHEUMATOL, V29, P285; Zhu HJ, 2009, PHARMACERTICAL CLIN, V17, P9; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	48	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54081	10.1371/journal.pone.0054081	http://dx.doi.org/10.1371/journal.pone.0054081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405077	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400021
J	Wei, XL; Shi, X; Zhong, W; Zhao, YT; Tang, YA; Sun, WL; Yin, XM; Bogdanov, B; Kim, S; McClain, C; Zhou, ZX; Zhang, X				Wei, Xiaoli; Shi, Xue; Zhong, Wei; Zhao, Yantao; Tang, Yunan; Sun, Wenlong; Yin, Xinmin; Bogdanov, Bogdan; Kim, Seongho; McClain, Craig; Zhou, Zhanxiang; Zhang, Xiang			Chronic Alcohol Exposure Disturbs Lipid Homeostasis at the Adipose Tissue-Liver Axis in Mice: Analysis of Triacylglycerols Using High-Resolution Mass Spectrometry in Combination with In Vivo Metabolite Deuterium Labeling	PLOS ONE			English	Article							SERUM LEPTIN LEVELS; FATTY LIVER; PROTECTIVE ACTION; CHRONIC ETHANOL; PATHOGENESIS; ROSIGLITAZONE; NORMALIZATION; ADIPONECTIN; CONTRIBUTES; EXPRESSION	A method of employing high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling was developed in this study to investigate the effects of alcohol exposure on lipid homeostasis at the white adipose tissue (WAT)-liver axis in a mouse model of alcoholic fatty liver. In order to differentiate the liver lipids synthesized from the fatty acids that were transported back from adipose tissue and the lipids synthesized from other sources of fatty acids, a two-stage mouse feeding experiment was performed to incorporate deuterium into metabolites. Hepatic lipids extracted from mouse liver, epididymal white adipose tissue (eWAT) and subcutaneous white adipose tissue (sWAT) were analyzed. It was found that 13 and 10 triacylglycerols (TGs) incorporated with a certain number of deuterium were significantly increased in alcohol induced fatty liver at two and four weeks of alcohol feeding periods, respectively. The concentration changes of these TGs ranged from 1.7 to 6.3-fold increase. A total of 14 deuterated TGs were significantly decreased in both eWAT and sWAT at the two and four weeks and the fold-change ranged from 0.19 to 0.77. The increase of deuterium incorporated TGs in alcohol-induced fatty liver and their decrease in both eWAT and sWAT indicate that alcohol exposure induces hepatic influx of fatty acids which are released from WATs. The results of time course analysis further indicate a mechanistic link between adipose fat loss and hepatic fat gain in alcoholic fatty liver.	[Wei, Xiaoli; Shi, Xue; Sun, Wenlong; Yin, Xinmin; Bogdanov, Bogdan; Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA; [Zhao, Yantao; Tang, Yunan; McClain, Craig] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Kim, Seongho] Univ Louisville, Bioinformat & Biostat Dept, Louisville, KY 40292 USA; [McClain, Craig] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McClain, Craig] Univ Louisville, Alcohol Res Ctr, Louisville, KY 40292 USA; [McClain, Craig] Robley Rex Louisville VAMC, Louisville, KY USA; [Zhong, Wei; Zhou, Zhanxiang] Univ North Carolina Greensboro, Ctr Translat Biomed Res, Kannapolis, NC USA; [Zhong, Wei; Zhou, Zhanxiang] Univ North Carolina Greensboro, Dept Nutr, Kannapolis, NC USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro	Zhou, ZX (corresponding author), Univ North Carolina Greensboro, Ctr Translat Biomed Res, North Carolina Res Campus, Kannapolis, NC USA.	z_zhou@uncg.edu; xiang.zhang@louisville.edu	sun, wenlong/AAW-7486-2020; Shi, Xue/N-6907-2015; sun, wenlong/HCH-0574-2022	Shi, Xue/0000-0003-2040-7425; sun, wenlong/0000-0003-0164-8733	National Institutes of Health [1R01GM087735, R01AA018844, 1RC2AA019385, P01AA017103, P30AA019360, R01AA015970, R37AA010762, R01AA018016, R01AA018869, R01DK7071765]; Veteran's Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020212, R01AA018869, U01AA021901, R01AA018844, R01AA018016, RC2AA019385, P30AA019360, R37AA010762, R01AA015970, P01AA017103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants 1R01GM087735, R01AA018844, 1RC2AA019385, P01AA017103, P30AA019360, R01AA015970, R37AA010762, R01AA018016, R01AA018869, R01DK7071765, and Veteran's Affairs. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 1997, ALCOHOL CLIN EXP RES, V21, P962, DOI 10.1097/00000374-199709000-00003; Addolorato G, 1998, J INTERN MED, V244, P387; [Anonymous], 1932, STAT METHODS RES WOR; Astrand M, 2003, J COMPUT BIOL, V10, P95, DOI 10.1089/106652703763255697; Berk Paul D, 2005, Trans Am Clin Climatol Assoc, V116, P335; BERK PD, 2005, T AM CLIN CLIMAT ASS, V116, P345; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bradbury Michael W, 2004, Clin Liver Dis, V8, P639, DOI 10.1016/j.cld.2004.04.005; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Greco AV, 2000, J HEPATOL, V33, P38, DOI 10.1016/S0168-8278(00)80157-9; JANERO DR, 1984, J CELL BIOCHEM, V24, P131, DOI 10.1002/jcb.240240205; Kang L, 2007, J BIOL CHEM, V282, P28465, DOI 10.1074/jbc.M705503200; Kang L, 2006, ENDOCRINOLOGY, V147, P4330, DOI 10.1210/en.2006-0120; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Kharbanda KK, 2009, MOL CELL BIOCHEM, V327, P75, DOI 10.1007/s11010-009-0044-2; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Pouteau E, 2009, METHODS MOL BIOL, V579, P337, DOI 10.1007/978-1-60761-322-0_17; Santolaria F, 2003, ALCOHOL ALCOHOLISM, V38, P60, DOI 10.1093/alcalc/agg015; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Sozio MS, 2010, SEMIN LIVER DIS, V30, P378, DOI 10.1055/s-0030-1267538; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Sun XH, 2012, AM J PHYSIOL-GASTR L, V302, pG548, DOI 10.1152/ajpgi.00342.2011; Tahara M, 1999, J CLIN INVEST, V103, P313, DOI 10.1172/JCI4433; Tan XB, 2012, AM J PATHOL, V181, P1279, DOI 10.1016/j.ajpath.2012.06.013; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Wei XL, 2011, ANAL CHEM, V83, P7668, DOI 10.1021/ac2017025; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011; Yao Z, 2012, CURR OPIN LIPIDOL; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017; Zhou SL, 1998, HEPATOLOGY, V27, P1064, DOI 10.1002/hep.510270423	36	51	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55382	10.1371/journal.pone.0055382	http://dx.doi.org/10.1371/journal.pone.0055382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405143	gold, Green Published			2022-12-27	WOS:000315153400088
J	Colucci, R; Gambaccini, D; Ghisu, N; Rossi, G; Costa, F; Tuccori, M; De Bortoli, N; Fornai, M; Antonioli, L; Ricchiuti, A; Mumolo, MG; Marchi, S; Blandizzi, C; Bellini, M				Colucci, Rocchina; Gambaccini, Dario; Ghisu, Narcisa; Rossi, Giuseppe; Costa, Francesco; Tuccori, Marco; De Bortoli, Nicola; Fornai, Matteo; Antonioli, Luca; Ricchiuti, Angelo; Mumolo, Maria Gloria; Marchi, Santino; Blandizzi, Corrado; Bellini, Massimo			Influence of the Serotonin Transporter 5HTTLPR Polymorphism on Symptom Severity in Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; GENE-EXPRESSION; ASSOCIATION; DISTENSION; DEPRESSION; PROMOTER; PATHOPHYSIOLOGY; PATHOGENESIS; METAANALYSIS; ACTIVATION	5HTTLPR polymorphism of serotonin transporter yields short (S) and long (L) alleles. SS and LS genotypes are associated with reduced expression of serotonin transporter. This cross-sectional study investigated the association of 5HTTLPR with symptom severity of irritable bowel syndrome (IBS). Patients with IBS (Rome III) and healthy controls were included. Genomic DNA was extracted from saliva, and 5HTTLPR alleles were assessed by polymerase chain reaction. IBS symptom severity was evaluated by means of IBS-SSS questionnaire. Two hundreds and four IBS patients (159 females; mean age: 39.6 +/- 12.3 years; 106 with constipation: C-IBS; 98 with diarrhea: D-IBS) and 200 healthy controls (154 females; mean age: 40.4 +/- 15.8 years) were enrolled. The overall IBS-SSS value was higher in LS/SS than LL patients (319.0 +/- 71.5 versus 283.8 +/- 62.3; P = 0.0006). LS/SS patients had also higher values of abdominal pain (59.7 +/- 21.0 versus 51.0 +/- 18.8; P = 0.020) and bowel dissatisfaction (80.1 +/- 23.9 versus 70.5 +/- 22.8; P = 0.035). The overall IBS-SSS values in C-IBS and D-IBS patients were 317.2 +/- 68.3 and 296.1 +/- 71.4, respectively (P = 0.192), with significantly higher values for abdominal distension (65.0 +/- 24.4 versus 51.4 +/- 24.8; P = 0.0006), but not for bowel dissatisfaction (80.5 +/- 21.7 versus 72.9 +/- 25.7; P = 0.138). Frequencies of 5HTTLPR genotypes did not differ significantly when comparing IBS patients (overall or upon stratification in C-IBS and D-IBS) with healthy controls. In conclusion, the LS and SS genotypes are significantly correlated with IBS symptom severity, although their possible direct causal role remains to be proven. In addition, the present findings do not support an association of 5HTTLPR with IBS or its clinical presentation in terms of bowel habit predominance.	[Colucci, Rocchina; Ghisu, Narcisa; Tuccori, Marco; Fornai, Matteo; Antonioli, Luca; Blandizzi, Corrado] Univ Pisa, Dept Clin & Expt Med, Div Pharmacol & Chemotherapy, Pisa, Italy; [Gambaccini, Dario; Costa, Francesco; De Bortoli, Nicola; Ricchiuti, Angelo; Mumolo, Maria Gloria; Marchi, Santino; Bellini, Massimo] Univ Pisa, Gastroenterol Unit, Dept Translat Med, Pisa, Italy; [Rossi, Giuseppe] CNR, Inst Clin Physiol, Unit Epidemiol & Biostat, Pisa, Italy	University of Pisa; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Blandizzi, C (corresponding author), Univ Pisa, Dept Clin & Expt Med, Div Pharmacol & Chemotherapy, Pisa, Italy.	c.blandizzi@virgilio.it	Gambaccini, Dario/AAC-6716-2022; Blandizzi, Corrado/AAB-8736-2019; Rossi, Giuseppe/G-7838-2012; Tuccori, Marco/B-2113-2012	Gambaccini, Dario/0000-0002-6506-0253; DE BORTOLI, NICOLA/0000-0003-1995-1060; Costa, Francesco/0000-0002-9150-3345; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; bellini, massimo/0000-0002-6387-6443; FORNAI, MATTEO/0000-0002-0812-3959; BLANDIZZI, CORRADO/0000-0001-9927-5386	Italian Ministry of Education, University and Research (PRIN) [2007Z292XF_002]	Italian Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The present work was supported by a grant from the Italian Ministry of Education, University and Research (PRIN 2007, Project number 2007Z292XF_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B, 2007, NAT CLIN PRACT GASTR, V4, P102, DOI 10.1038/ncpgasthep0717; Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Camilleri M, 2008, AM J PHYSIOL-GASTR L, V295, pG219, DOI 10.1152/ajpgi.90202.2008; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V302, pG1075, DOI 10.1152/ajpgi.00537.2011; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen JX, 1998, AM J PHYSIOL-GASTR L, V275, pG433, DOI 10.1152/ajpgi.1998.275.3.G433; Colucci R, 2008, TRENDS MOL MED, V14, P295, DOI 10.1016/j.molmed.2008.05.001; Ford AC, 2009, GUT, V58, P367, DOI 10.1136/gut.2008.163162; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Fukudo S, 2009, NEUROIMAGE, V47, P946, DOI 10.1016/j.neuroimage.2009.04.083; Garrigues V, 2007, ALIMENT PHARM THER, V25, P323, DOI 10.1111/j.1365-2036.2006.03197.x; Gershon MD, 2005, J CLIN GASTROENTEROL, V39, pS184, DOI 10.1097/01.mcg.0000156403.37240.30; Gerson CD, 2008, EUR J GASTROEN HEPAT, V20, P659, DOI 10.1097/MEG.0b013e3282f53a24; Hamaguchi T, 2004, NEUROGASTROENT MOTIL, V16, P299, DOI 10.1111/j.1365-2982.2004.00498.x; Hasler WL, 2011, GASTROENTEROL CLIN N, V40, P21, DOI 10.1016/j.gtc.2010.12.004; Heils A, 1996, J NEUROCHEM, V66, P2621; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Kim DY, 2000, AM J GASTROENTEROL, V95, P2698, DOI 10.1016/S0002-9270(00)01970-5; Kim HJ, 2004, GUT, V53, P829, DOI 10.1136/gut.2003.030882; Kohen R, 2009, DIGEST DIS SCI, V54, P2663, DOI 10.1007/s10620-008-0666-3; Lee Dok Yong, 2004, Korean J Gastroenterol, V43, P18; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2001, EUR NEUROPSYCHOPHARM, V11, P457, DOI 10.1016/S0924-977X(01)00123-7; Li YY, 2007, DIGEST DIS SCI, V52, P2942, DOI 10.1007/s10620-006-9679-y; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mawe GM, 2006, ALIMENT PHARM THER, V23, P1067, DOI 10.1111/j.1365-2036.2006.02858.x; MAYER EA, 1994, GASTROENTEROLOGY, V107, P271, DOI 10.1016/0016-5085(94)90086-8; Mertz H, 2000, GASTROENTEROLOGY, V118, P842, DOI 10.1016/S0016-5085(00)70170-3; Niesler B, 2010, EUR J GASTROEN HEPAT, V22, P856, DOI 10.1097/MEG.0b013e32832e9d6b; Noskova T, 2008, PROG NEURO-PSYCHOPH, V32, P1735, DOI 10.1016/j.pnpbp.2008.07.012; Ohman L, 2007, DIGEST LIVER DIS, V39, P201, DOI 10.1016/j.dld.2006.10.014; Park JM, 2006, NEUROGASTROENT MOTIL, V18, P995, DOI 10.1111/j.1365-2982.2006.00829.x; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Saito YA, 2007, NEUROGASTROENT MOTIL, V19, P465, DOI 10.1111/j.1365-2982.2007.00905.x; Saito YA, 2011, GASTROENTEROL CLIN N, V40, P45, DOI 10.1016/j.gtc.2010.12.011; Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419; Sikander A, 2009, J CLIN GASTROENTEROL, V43, P957, DOI 10.1097/MCG.0b013e3181b37e8c; Smits KM, 2004, MOL PSYCHIATR, V9, P433, DOI 10.1038/sj.mp.4001488; Spiller R, 2007, LANCET, V369, P1586, DOI 10.1016/S0140-6736(07)60726-0; Van Kerkhoven LAS, 2007, ALIMENT PHARM THER, V26, P979, DOI 10.1111/j.1365-2036.2007.03453.x; Wang YM, 2012, NEUROGASTROENT MOTIL, V24, P560, DOI 10.1111/j.1365-2982.2012.01902.x; Yeo A, 2004, GUT, V53, P1452, DOI 10.1136/gut.2003.035451	43	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54831	10.1371/journal.pone.0054831	http://dx.doi.org/10.1371/journal.pone.0054831			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393559	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800013
J	Gaikwad, SM; Gunjal, L; Junutula, AR; Astanehe, A; Gambhir, SS; Ray, P				Gaikwad, Snehal M.; Gunjal, Lata; Junutula, Anitha R.; Astanehe, Arezoo; Gambhir, Sanjiv Sam; Ray, Pritha			Non-Invasive Imaging of Phosphoinositide-3-Kinase-Catalytic-Subunit-Alpha (PIK3CA) Promoter Modulation in Small Animal Models	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FUSION REPORTER GENE; LIVING SUBJECTS; OVARIAN-CANCER; FLUORESCENT PROTEINS; BREAST-CANCER; RESISTANCE; CELLS; PI3K; P53	Activation of the PI3K/Akt pathway, a critical step for survival in cancer cells is often associated with decreased sensitivity to several chemotherapeutic drugs. PIK3CA gene amplification is observed in 16-24% of epithelial ovarian cancer (EOC) patients in conjunction with p53 mutations. A 900 bp long PIK3CA promoter is shown to be negatively regulated by p53 in ovarian surface epithelial cells but the consequence of chemotherapeutic drug treatments on this promoter in ovarian cancer cells is largely unknown. We aim to study the modulation of this promoter by cisplatin using an improved fusion reporter in ovarian cancer cells and tumor xenografts by non-invasive imaging approach. A PIK3CA sensor was developed using a bi-fusion reporter from a newly constructed library of bi- and tri-fusion vectors comprising of two mutant far red fluorescent proteins (mcherry/mch and tdTomato/tdt), a mutant firefly luciferase (fluc2), and a PET reporter protein (ttk). In vivo imaging of mice implanted with 293T cells transiently expressing these bi- and tri-fusion reporters along with respective controls revealed comparable activity of each reporter in the fusion background and fluc2-tdt as the most sensitive one. Repression of the PIK3CA sensor by drugs was inversely proportional to cellular p53 level in a germline (PA1) and in an EOC (A2780) cell line but not in a p53 deficient EOC (SKOV3) cell line. Bioluminescence imaging of tumor xenografts stably expressing the PIK3CA sensor in PA1 and A2780 cells exhibited attenuating activity without any change in SKOV3 tumors expressing the PIK3CA sensor after cisplatin treatment. Sequential mutation at p53 binding sites showed gradual increase in promoter activity and decreased effects of the drugs. These newly developed PIK3CA-fluc2-tdt and the mutant reporter sensors thus would be extremely useful for screening new drugs and for functional assessment of PIK3CA expression from intact cells to living subjects.	[Gaikwad, Snehal M.; Gunjal, Lata; Ray, Pritha] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India; [Junutula, Anitha R.; Gambhir, Sanjiv Sam] Stanford Univ, Sch Med, Bio X Program,Mol Imaging Program Stanford, Dept Radiol,Dept Mat Sci & Engn, Palo Alto, CA 94304 USA; [Junutula, Anitha R.; Gambhir, Sanjiv Sam] Stanford Univ, Sch Med, Bio X Program, Dept Bioengn,Dept Mat Sci & Engn, Palo Alto, CA 94304 USA; [Astanehe, Arezoo] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Stanford University; Stanford University; University of British Columbia	Ray, P (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India.	pray@actrec.gov.in	Gaikwad, Snehal/K-2858-2019; Gaikwad, Snehal/AAJ-7984-2020	Gaikwad, Snehal/0000-0002-3366-4116	ACTREC [IRG-2698]; CSIR [27(232)/10]; NIH In Vivo Cellular and Molecular Imaging Centre grant (ICMIC) [P50CA114747]; Council of Scientific and Industrial Research (India); NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER	ACTREC; CSIR(Council of Scientific & Industrial Research (CSIR) - India); NIH In Vivo Cellular and Molecular Imaging Centre grant (ICMIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by ACTREC start up fund, IRG-2698 and CSIR 27(232)/10 (PR), NIH In Vivo Cellular and Molecular Imaging Centre grant (ICMIC grant P50CA114747) (SSG). SMG acknowledges fellowship funding from Council of Scientific and Industrial Research (India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini MR, 2009, ONCOGENE, P11; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; DeBlasio SL, 2010, BRIEF FUNCT GENOMICS, V9, P129, DOI 10.1093/bfgp/elp060; Doubrovin M, 2004, BIOCONJUGATE CHEM, V15, P1376, DOI 10.1021/bc0498572; Fraser Michael, 2003, Reprod Biol Endocrinol, V1, P66, DOI 10.1186/1477-7827-1-66; Gaikwad SM, 2012, AM J NUCL MED MOLEC, V2, P418; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Kolasa IK, 2009, CANCER BIOL THER, V8, P21, DOI 10.4161/cbt.8.1.7209; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Massoud TF, 2007, CURR OPIN BIOTECH, V18, P31, DOI 10.1016/j.copbio.2007.01.007; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Mayer-Kuckuk P, 2004, BIOL CHEM, V385, P353, DOI 10.1515/BC.2004.039; Min JJ, 2006, ANN NUCL MED, V20, P165, DOI 10.1007/BF03027425; Prasad SB, 2006, ASIAN J EXP SCI, V20, P55; Rakovitch E, 1999, INT J RADIAT ONCOL, V44, P1119, DOI 10.1016/S0360-3016(99)00109-1; Ray P, 2003, CANCER RES, V63, P1160; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; Ray P, 2001, SEMIN NUCL MED, V31, P312, DOI 10.1053/snuc.2001.26209; Ray P, 2008, CLIN CANCER RES, V14, P5801, DOI 10.1158/1078-0432.CCR-07-5244; Ray P, 2007, CANCER RES, V67, P3085, DOI 10.1158/0008-5472.CAN-06-2402; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shu CYJ, 2005, P NATL ACAD SCI USA, V102, P17412, DOI 10.1073/pnas.0508698102; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Winnard PT, 2006, NEOPLASIA, V8, P796, DOI 10.1593/neo.06304; Yaghoubi SS, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821415; Yang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001758; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	36	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55971	10.1371/journal.pone.0055971	http://dx.doi.org/10.1371/journal.pone.0055971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393606	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800061
J	Orman, MA; Ierapetritou, MG; Androulakis, IP; Berthiaume, F				Orman, Mehmet A.; Ierapetritou, Marianthi G.; Androulakis, Ioannis P.; Berthiaume, Francois			Effect of Fasting on the Metabolic Response of Liver to Experimental Burn Injury	PLOS ONE			English	Article							RAT-LIVER; GENE-EXPRESSION; AMINO-ACID; BALANCE ANALYSIS; PERFUSED LIVERS; FLUX ANALYSIS; HYPERMETABOLIC LIVERS; THERMAL-INJURY; GLUCOSE; MODEL	Liver metabolism is altered after systemic injuries such as burns and trauma. These changes have been elucidated in rat models of experimental burn injury where the liver was isolated and perfused ex vivo. Because these studies were performed in fasted animals to deplete glycogen stores, thus simplifying quantification of gluconeogenesis, these observations reflect the combined impact of fasting and injury on liver metabolism. Herein we asked whether the metabolic response to experimental burn injury is different in fed vs. fasted animals. Rats were subjected to a cutaneous burn covering 20% of the total body surface area, or to similar procedures without administering the burn, hence a sham-burn. Half of the animals in the burn and sham-burn groups were fasted starting on postburn day 3, and the others allowed to continue ad libitum. On postburn day 4, livers were isolated and perfused for 1 hour in physiological medium supplemented with 10% hematocrit red blood cells. The uptake/release rates of major carbon and nitrogen sources, oxygen, and carbon dioxide were measured during the perfusion and the data fed into a mass balance model to estimate intracellular fluxes. The data show that in fed animals, injury increased glucose output mainly from glycogen breakdown and minimally impacted amino acid metabolism. In fasted animals, injury did not increase glucose output but increased urea production and the uptake of several amino acids, namely glutamine, arginine, glycine, and methionine. Furthermore, sham-burn animals responded to fasting by triggering gluconeogenesis from lactate; however, in burned animals the preferred gluconeogenic substrate was amino acids. Taken together, these results suggest that the fed state prevents the burn-induced increase in hepatic amino acid utilization for gluconeogenesis. The role of glycogen stores and means to increase and/or maintain internal sources of glucose to prevent increased hepatic amino acid utilization warrant further studies.	[Orman, Mehmet A.; Ierapetritou, Marianthi G.; Androulakis, Ioannis P.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ USA; [Androulakis, Ioannis P.; Berthiaume, Francois] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Berthiaume, F (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA.	fberthia@rci.rutgers.edu	Ierapetritou, Marianthi/GVT-1369-2022; Berthiaume, Francois/ABD-2139-2020		National Institutes of Health [GM082974]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge the financial support from National Institutes of Health grant GM082974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon RR, 2008, J PHARMACOL EXP THER, V326, P700, DOI 10.1124/jpet.108.140186; Arai K, 2001, HEPATOLOGY, V34, P360, DOI 10.1053/jhep.2001.26515; Banta S, 2005, J SURG RES, V127, P93, DOI 10.1016/j.jss.2005.01.001; Banta S, 2007, BIOTECHNOL BIOENG, V97, P118, DOI 10.1002/bit.21200; BESSEY PQ, 1989, WORLD J SURG, V13, P465, DOI 10.1007/BF01660758; BIOLO G, 1997, NUTRITION S, V13, P52; Chan C, 2003, BIOTECHNOL BIOENG, V81, P33, DOI 10.1002/bit.10453; Chan C, 2003, METAB ENG, V5, P1, DOI 10.1016/S1096-7176(02)00011-3; Chen CY, 2003, FORTUNE, V148, P52; HERNDON DN, 1978, J SURG RES, V25, P394, DOI 10.1016/S0022-4804(78)80003-1; Herndon DN, 2004, LANCET, V363, P1895, DOI 10.1016/S0140-6736(04)16360-5; Hu RH, 1998, J SURG RES, V75, P153, DOI 10.1006/jsre.1998.5274; Izamis ML, 2011, BIOTECHNOL BIOENG, V108, P839, DOI 10.1002/bit.22998; Jeschke MG, 2001, ARCH SURG-CHICAGO, V136, P1301, DOI 10.1001/archsurg.136.11.1301; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Lee K, 2003, BIOTECHNOL BIOENG, V83, P400, DOI 10.1002/bit.10682; Lee K, 2000, METAB ENG, V2, P312, DOI 10.1006/mben.2000.0160; Lohmann R, 1999, AM J PHYSIOL-GASTR L, V276, pG743, DOI 10.1152/ajpgi.1999.276.3.G743; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; MORTIMORE GE, 1984, P NUTR SOC, V43, P161, DOI 10.1079/PNS19840039; Nguyen TT, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-279; Nolan RP, 2006, METAB ENG, V8, P30, DOI 10.1016/j.ymben.2005.08.004; Orman MA, 2012, J THEOR BIOL, V293, P101, DOI 10.1016/j.jtbi.2011.10.019; Orman MA, 2011, BIOTECHNOL BIOENG, V108, P2947, DOI 10.1002/bit.23261; Orman MA, 2011, J THEOR BIOL, V272, P131, DOI 10.1016/j.jtbi.2010.11.042; Orman MA, 2010, BIOTECHNOL BIOENG, V107, P825, DOI 10.1002/bit.22878; Ovacik MA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-540; Rutter MT, 2004, J MOL EVOL, V58, P218, DOI 10.1007/s00239-003-2546-y; Schwarz R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-135; Soares AF, 2010, METAB ENG, V12, P552, DOI 10.1016/j.ymben.2010.08.002; Soares AF, 2009, MAGN RESON MED, V61, P1, DOI 10.1002/mrm.21830; Vemula M, 2004, PHYSIOL GENOMICS, V18, P87, DOI 10.1152/physiolgenomics.00189.2003; WALKER HL, 1968, J TRAUM, V8, P1049, DOI 10.1097/00005373-196811000-00006; Wilmore DW, 2001, J NUTR, V131, p2543S, DOI 10.1093/jn/131.9.2543S; WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702; Yamaguchi Y, 1997, SURGERY, V121, P295, DOI 10.1016/S0039-6060(97)90358-5; Yang H, 2011, OMICS, V15, P449, DOI 10.1089/omi.2010.0070; Yang Q, 2011, J SURG RES; Yarmush DM, 1999, J BURN CARE REHABIL, V20, P292, DOI 10.1097/00004630-199907000-00004; Yu YM, 2001, AM J PHYSIOL-ENDOC M, V280, pE509, DOI 10.1152/ajpendo.2001.280.3.E509	40	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54825	10.1371/journal.pone.0054825	http://dx.doi.org/10.1371/journal.pone.0054825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393558	gold, Green Published			2022-12-27	WOS:000314692800012
J	Batalla, A; Bhattacharyya, S; Yucel, M; Fusar-Poli, P; Crippa, JA; Nogue, S; Torrens, M; Pujol, J; Farre, M; Martin-Santos, R				Batalla, Albert; Bhattacharyya, Sagnik; Yuecel, Murat; Fusar-Poli, Paolo; Crippa, Jose Alexandre; Nogue, Santiago; Torrens, Marta; Pujol, Jesus; Farre, Magi; Martin-Santos, Rocio			Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings	PLOS ONE			English	Review							CEREBRAL-BLOOD-FLOW; SPATIAL WORKING-MEMORY; VENTROMEDIAL PREFRONTAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; UNDERLYING COGNITIVE CONTROL; FREQUENT MARIJUANA USE; WHITE-MATTER; MAGNETIC-RESONANCE; DOPAMINE RELEASE; DECISION-MAKING	Background: The growing concern about cannabis use, the most commonly used illicit drug worldwide, has led to a significant increase in the number of human studies using neuroimaging techniques to determine the effect of cannabis on brain structure and function. We conducted a systematic review to assess the evidence of the impact of chronic cannabis use on brain structure and function in adults and adolescents. Methods: Papers published until August 2012 were included from EMBASE, Medline, PubMed and LILACS databases following a comprehensive search strategy and pre-determined set of criteria for article selection. Only neuroimaging studies involving chronic cannabis users with a matched control group were considered. Results: One hundred and forty-two studies were identified, of which 43 met the established criteria. Eight studies were in adolescent population. Neuroimaging studies provide evidence of morphological brain alterations in both population groups, particularly in the medial temporal and frontal cortices, as well as the cerebellum. These effects may be related to the amount of cannabis exposure. Functional neuroimaging studies suggest different patterns of resting global and brain activity during the performance of several cognitive tasks both in adolescents and adults, which may indicate compensatory effects in response to chronic cannabis exposure. Limitations: However, the results pointed out methodological limitations of the work conducted to date and considerable heterogeneity in the findings. Conclusion: Chronic cannabis use may alter brain structure and function in adult and adolescent population. Further studies should consider the use of convergent methodology, prospective large samples involving adolescent to adulthood subjects, and data-sharing initiatives.	[Batalla, Albert; Martin-Santos, Rocio] CIBERSAM, IDIBAPS, Hosp Clin, Inst Neurosci, Barcelona, Spain; [Batalla, Albert; Martin-Santos, Rocio] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Batalla, Albert; Yuecel, Murat] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Bhattacharyya, Sagnik; Fusar-Poli, Paolo] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Crippa, Jose Alexandre] Univ Sao Paulo, Neurosci & Cognit Behav Dept, BR-14049 Ribeirao Preto, Brazil; [Crippa, Jose Alexandre; Martin-Santos, Rocio] CNPq, INCT TM, Natl Sci & Technol Inst Translat Med, Ribeirao Preto, Brazil; [Nogue, Santiago] Univ Barcelona, IDIBAPS, Hosp Clin, Clin Toxicol Unit,Emergency Dept, Barcelona, Spain; [Torrens, Marta; Farre, Magi] Autonomous Univ Barcelona, Neurosci Program, Pharmacol Unit, Barcelona, Spain; [Torrens, Marta; Farre, Magi] Autonomous Univ Barcelona, Drug Addict Unit, IMIM INAD Parc Salut Mar, Barcelona, Spain; [Torrens, Marta; Farre, Magi] IMIM INAD Parc Salut Mar, Red Trastornos Adict RETIC, Barcelona, Spain; [Pujol, Jesus] Hosp Mar, CRC Mar, Inst Alta Tecnol PRBB, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Melbourne; University of London; King's College London; Universidade de Sao Paulo; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Martin-Santos, R (corresponding author), CIBERSAM, IDIBAPS, Hosp Clin, Inst Neurosci, Barcelona, Spain.	rmsantos@clinic.ub.es	Bhattacharyya, Sagnik/E-1893-2011; Yücel, Murat/AAY-8124-2020; Yucel, Murat/I-3004-2014; de Souza Crippa, José Alexandre/A-1215-2008; Batalla, Albert/I-4388-2014; Fusar-Poli, Paolo/D-8605-2011	Bhattacharyya, Sagnik/0000-0002-8688-8025; Yücel, Murat/0000-0002-4705-452X; Yucel, Murat/0000-0002-4705-452X; Batalla, Albert/0000-0002-5010-5121; Fusar-Poli, Paolo/0000-0003-3582-6788	Plan Nacional sobre Drogas, Ministerio de Sanidad y Consumo [PNSD/2011/050, PNSD2006/101]; Generalitat de Catalunya [SGR2009/1435]; Technology Institute for Translational Medicine (INCT-TM, Conselho Nacional de Desenvolvimiento CientA-fico e TecnolA2gico (CNPq), Brazil; Clinician Scientist award from the National Institute of Health Research, UK; CNPq (Brazil); Medical Research Council [G0501775] Funding Source: researchfish; National Institute for Health Research [NIHR-CS-011-001] Funding Source: researchfish; MRC [G0501775] Funding Source: UKRI	Plan Nacional sobre Drogas, Ministerio de Sanidad y Consumo; Generalitat de Catalunya(Generalitat de Catalunya); Technology Institute for Translational Medicine (INCT-TM, Conselho Nacional de Desenvolvimiento CientA-fico e TecnolA2gico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Clinician Scientist award from the National Institute of Health Research, UK; CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study has been done in part with Spanish grants: Plan Nacional sobre Drogas, Ministerio de Sanidad y Consumo PNSD/2011/050 and PNSD2006/101 (R. MartA-n-Santos); and the support of DIUE of Generalitat de Catalunya SGR2009/1435 (R. MartA-n-Santos, J.A. Crippa); and the Technology Institute for Translational Medicine (INCT-TM, Conselho Nacional de Desenvolvimiento CientA-fico e TecnolA2gico (CNPq), Brazil (J.A. Crippa, R. MartA-n-Santos); S. Bhattacharyya is supported by a Clinician Scientist award from the National Institute of Health Research, UK; and J.A. Crippa receives a CNPq (Brazil) productivity award (IC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLY J, 1993, ACTA NEUROL SCAND, V87, P210; Abdullaev Y, 2010, BEHAV BRAIN RES, V215, P45, DOI 10.1016/j.bbr.2010.06.023; Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Albrecht DS, 2012, DRUG ALCOHOL DEPEND; Amen DG, 1998, J PSYCHOACTIVE DRUGS, V30, P209; Arnone D, 2008, NEUROIMAGE, V41, P1067, DOI 10.1016/j.neuroimage.2008.02.064; Ashtari M, 2011, J PSYCHIATR RES, V45, P1055, DOI 10.1016/j.jpsychires.2011.01.004; Ashtari M, 2008, J PSYCHIATR RES, V43, P189, DOI 10.1016/j.jpsychires.2008.12.002; Barkus E, 2011, J PSYCHOPHARMACOL, V25, P1462, DOI 10.1177/0269881110382465; Bava S, 2010, BRAIN COGNITION, V72, P347, DOI 10.1016/j.bandc.2009.10.012; Bava S, 2009, PSYCHIAT RES-NEUROIM, V173, P228, DOI 10.1016/j.pscychresns.2009.04.005; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Becker B, 2010, PROG NEURO-PSYCHOPH, V34, P837, DOI 10.1016/j.pnpbp.2010.03.032; Becker B, 2010, PSYCHOPHARMACOLOGY, V209, P361, DOI 10.1007/s00213-010-1805-z; BELUE RC, 1995, NEUROTOXICOL TERATOL, V17, P25, DOI 10.1016/0892-0362(94)00053-G; Bhattacharyya S, 2009, CURR PHARM DESIGN, V15, P2603, DOI 10.2174/138161209788957465; Bhattacharyya S, 2012, MOL PSYCHIAT; Bhattacharyya S, 2012, CURR PHARM DESIGN, V18, P5045, DOI 10.2174/138161212802884636; Bhattacharyya S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00022; Bhattacharyya S, 2012, ARCH GEN PSYCHIAT, V69, P27, DOI 10.1001/archgenpsychiatry.2011.161; Bhattacharyya S, 2009, ARCH GEN PSYCHIAT, V66, P442, DOI 10.1001/archgenpsychiatry.2009.17; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Block RI, 2000, NEUROREPORT, V11, P749, DOI 10.1097/00001756-200003200-00019; Block RI, 2000, NEUROREPORT, V11, P491, DOI 10.1097/00001756-200002280-00013; Block RI, 2002, PHARMACOL BIOCHEM BE, V72, P237, DOI 10.1016/S0091-3057(01)00771-7; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Borgwardt SJ, 2008, BIOL PSYCHIAT, V64, P966, DOI 10.1016/j.biopsych.2008.05.011; Bossong MG, 2012, J COGNITIVE NEUROSCI, V24, P588, DOI 10.1162/jocn_a_00156; Bossong MG, 2010, PROG NEUROBIOL, V92, P370, DOI 10.1016/j.pneurobio.2010.06.010; Bossong MG, 2009, NEUROPSYCHOPHARMACOL, V34, P759, DOI 10.1038/npp.2008.138; Burns HD, 2007, P NATL ACAD SCI USA, V104, P9800, DOI 10.1073/pnas.0703472104; CAMPBELL AM, 1971, LANCET, V2, P1219; Chang L, 2006, BRAIN, V129, P1096, DOI 10.1093/brain/awl064; Chang L, 2007, NEUROSCIENTIST, V13, P422, DOI 10.1177/1073858406296601; Cheetham A, 2012, BIOL PSYCHIAT, V71, P684, DOI 10.1016/j.biopsych.2011.10.029; Chen CY, 2005, DRUG ALCOHOL DEPEN, V79, P11, DOI 10.1016/j.drugalcdep.2004.11.014; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Chung T, 2011, DRUG ALCOHOL DEPEN, V115, P43, DOI 10.1016/j.drugalcdep.2010.10.017; Churchwell JC, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00225; Clark DB, 2012, ADDICTION, V107, P206, DOI 10.1111/j.1360-0443.2011.03566.x; CO BT, 1977, JAMA-J AM MED ASSOC, V237, P1229, DOI 10.1001/jama.237.12.1229; Cohen M, 2011, INT J NEUROPSYCHOPH, V4, P1; Cornelius JR, 2010, ADDICT BEHAV, V35, P644, DOI 10.1016/j.addbeh.2010.02.004; Cousijn J, 2013, ADDICT BIOL, V18, P570, DOI 10.1111/j.1369-1600.2011.00417.x; Cousijn J, 2012, NEUROIMAGE, V59, P3845, DOI 10.1016/j.neuroimage.2011.09.046; Cowan RL, 2009, PHARMACOL BIOCHEM BE, V92, P105, DOI 10.1016/j.pbb.2008.10.022; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Crippa JAD, 2004, NEUROPSYCHOPHARMACOL, V29, P417, DOI 10.1038/sj.npp.1300340; D'Souza DC, 2009, EUR ARCH PSY CLIN N, V259, P413, DOI 10.1007/s00406-009-0024-2; Dekker N, 2010, PSYCHIAT RES-NEUROIM, V181, P51, DOI 10.1016/j.pscychresns.2009.06.003; Delisi Lynn E, 2006, Harm Reduct J, V3, P17, DOI 10.1186/1477-7517-3-17; Demirakca T, 2011, DRUG ALCOHOL DEPEN, V114, P242, DOI 10.1016/j.drugalcdep.2010.09.020; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Eldreth DA, 2004, NEUROIMAGE, V23, P914, DOI 10.1016/j.neuroimage.2004.07.032; European Monitoring Centre for Drugs and Drug Addiction, 2011, STAT DRUGS PROBL EUR; Fernandez-Artamendi S, 2011, ACTAS ESP PSIQUIATRI, V39, P180; Filbey FM, 2010, NEUROPSYCHOPHARMACOL, V35, P967, DOI 10.1038/npp.2009.200; Filbey FM, 2009, P NATL ACAD SCI USA, V106, P13016, DOI 10.1073/pnas.0903863106; Fusar-Poli P, 2010, INT J NEUROPSYCHOPH, V13, P421, DOI 10.1017/S1461145709990617; Fusar-Poli P, 2009, ARCH GEN PSYCHIAT, V66, P95, DOI 10.1001/archgenpsychiatry.2008.519; GAONI Y, 1971, J AM CHEM SOC, V93, P217, DOI 10.1021/ja00730a036; Glover GH, 2012, J MAGN RESON IMAGING, V36, P39, DOI 10.1002/jmri.23572; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gonzalez R, 2007, NEUROPSYCHOL REV, V17, P347, DOI 10.1007/s11065-007-9036-8; Gruber SA, 2005, COGNITIVE BRAIN RES, V23, P107, DOI 10.1016/j.cogbrainres.2005.02.016; Gruber SA, 2011, EXP CLIN PSYCHOPHARM, V19, P231, DOI 10.1037/a0023034; Gruber SA, 2009, DRUG ALCOHOL DEPEN, V105, P139, DOI 10.1016/j.drugalcdep.2009.06.019; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; HANNERZ J, 1983, ANN NEUROL, V13, P207, DOI 10.1002/ana.410130219; Harding IH, 2012, NEUROPSYCHOPHARMACOL, V37, P1923, DOI 10.1038/npp.2012.39; Hermann D, 2007, BIOL PSYCHIAT, V61, P1281, DOI 10.1016/j.biopsych.2006.08.027; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Hirvonen J, 2011, J NUCL MED, V52; Ho BC, 2011, SCHIZOPHR RES, V128, P66, DOI 10.1016/j.schres.2011.02.021; Hoffman AF, 2007, LEARN MEMORY, V14, P63, DOI 10.1101/lm.439007; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jacobsen LK, 2004, ANN NY ACAD SCI, V1021, P384, DOI 10.1196/annals.1308.053; Jacobus J, 2009, NEUROTOXICOL TERATOL, V31, P349, DOI 10.1016/j.ntt.2009.07.006; Jager G, 2006, PSYCHOPHARMACOLOGY, V185, P358, DOI 10.1007/s00213-005-0298-7; Jager G, 2007, EUR NEUROPSYCHOPHARM, V17, P289, DOI 10.1016/j.euroneuro.2006.10.003; Jager G, 2010, J AM ACAD CHILD PSY, V49, P561, DOI 10.1016/j.jaac.2010.02.001; Jager Gerry, 2008, Curr Drug Abuse Rev, V1, P114; James A, 2011, SCHIZOPHR RES, V128, P91, DOI 10.1016/j.schres.2011.02.014; Jernigan TL, 2005, NEUROBIOL AGING, V26, P1271, DOI 10.1016/j.neurobiolaging.2005.05.016; Kanayama G, 2004, PSYCHOPHARMACOLOGY, V176, P239, DOI 10.1007/s00213-004-1885-8; King GR, 2011, J NEUROSCI, V31, P17923, DOI 10.1523/JNEUROSCI.4148-11.2011; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; KUEHNLE J, 1977, JAMA-J AM MED ASSOC, V237, P1231, DOI 10.1001/jama.237.12.1231; Kumra S, 2012, J AM ACAD CHILD PSY, V51, P171, DOI 10.1016/j.jaac.2011.11.001; LANDFIELD PW, 1988, BRAIN RES, V443, P47, DOI 10.1016/0006-8993(88)91597-1; Leroy C, 2012, ADDICT BIOL, V17, P981, DOI 10.1111/j.1369-1600.2011.00356.x; Li CSR, 2005, PSYCHIAT RES-NEUROIM, V140, P271, DOI 10.1016/j.pscychresns.2005.09.002; Licata SC, 2010, ANN NY ACAD SCI, V1187, P148, DOI 10.1111/j.1749-6632.2009.05143.x; Lopez-Larson MP, 2011, BEHAV BRAIN RES, V220, P164, DOI 10.1016/j.bbr.2011.02.001; Lorenzetti V, 2010, SUBST USE MISUSE, V45, P1787, DOI 10.3109/10826084.2010.482443; Lundqvist T, 2001, NEUROTOXICOL TERATOL, V23, P437, DOI 10.1016/S0892-0362(01)00165-9; Martin-Santos R, 2010, PSYCHOL MED, V40, P383, DOI 10.1017/S0033291709990729; Mata I, 2010, BRAIN RES, V1317, P297, DOI 10.1016/j.brainres.2009.12.069; Mathew RJ, 1999, ACTA PSYCHIAT SCAND, V100, P67, DOI 10.1111/j.1600-0447.1999.tb10916.x; MATHEW RJ, 1992, J CEREBR BLOOD F MET, V12, P750, DOI 10.1038/jcbfm.1992.106; Mathew RJ, 1997, LIFE SCI, V60, P2075, DOI 10.1016/S0024-3205(97)00195-1; Mathew RJ, 1998, BRAIN RES, V797, P183, DOI 10.1016/S0006-8993(98)00375-8; MATHEW RJ, 1992, BIOL PSYCHIAT, V32, P164, DOI 10.1016/0006-3223(92)90019-V; Mathew RJ, 2002, PSYCHIAT RES-NEUROIM, V116, P173, DOI 10.1016/S0925-4927(02)00069-0; MATHEW RJ, 1993, LIFE SCI, V52, P757, DOI 10.1016/0024-3205(93)90239-Y; MATHEW RJ, 1989, ACTA PSYCHIAT SCAND, V79, P118, DOI 10.1111/j.1600-0447.1989.tb08579.x; Matochik JA, 2005, DRUG ALCOHOL DEPEN, V77, P23, DOI 10.1016/j.drugalcdep.2004.06.011; McQueeny T, 2011, BEHAV BRAIN RES, V224, P128, DOI 10.1016/j.bbr.2011.05.031; Medina KL, 2007, J CHILD PSYCHOL PSYC, V48, P592, DOI 10.1111/j.1469-7610.2007.01728.x; Medina KL, 2010, PSYCHIAT RES-NEUROIM, V182, P152, DOI 10.1016/j.pscychresns.2009.12.004; Medina KL, 2009, ADDICT BIOL, V14, P457, DOI 10.1111/j.1369-1600.2009.00166.x; Meier MH, 2012, P NATL ACAD SCI US; Milham MP, 2012, NEURON, V73, P214, DOI 10.1016/j.neuron.2011.11.004; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Morrison PD, 2011, NEUROPSYCHOPHARMACOL, V36, P827, DOI 10.1038/npp.2010.222; Morrison PD, 2009, SCHIZOPHRENIA BULL, V35, P668, DOI 10.1093/schbul/sbp049; Murphy K, 2006, AM J PSYCHIAT, V163, P1245, DOI 10.1176/appi.ajp.163.7.1245; Nestor L, 2008, NEUROIMAGE, V40, P1328, DOI 10.1016/j.neuroimage.2007.12.059; Nestor L, 2010, NEUROIMAGE, V49, P1133, DOI 10.1016/j.neuroimage.2009.07.022; O'Leary DS, 2007, HUM PSYCHOPHARM CLIN, V22, P135, DOI 10.1002/hup.832; O'Leary DS, 2000, NEUROREPORT, V11, P3835, DOI 10.1097/00001756-200011270-00047; O'Leary DS, 2003, NEUROREPORT, V14, P1145, DOI 10.1097/00001756-200306110-00009; O'Leary DS, 2002, NEUROPSYCHOPHARMACOL, V26, P802, DOI 10.1016/S0893-133X(01)00425-0; Okuda M, 2010, DRUG ALCOHOL DEPEN, V111, P177, DOI 10.1016/j.drugalcdep.2010.04.009; Padula CB, 2007, PSYCHOL ADDICT BEHAV, V21, P478, DOI 10.1037/0893-164X.21.4.478; Parkar Shubhangi R, 2011, Indian J Psychiatry, V53, P13, DOI 10.4103/0019-5545.75552; Parkar Shubhangi R, 2010, Indian J Psychiatry, V52, P236, DOI 10.4103/0019-5545.70976; Peters BD, 2009, PSYCHOPHARMACOL BULL, V42, P75; Phan KL, 2008, J NEUROSCI, V28, P2313, DOI 10.1523/JNEUROSCI.5603-07.2008; Pillay SS, 2004, DRUG ALCOHOL DEPEN, V76, P261, DOI 10.1016/j.drugalcdep.2004.05.009; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; Prescot AP, 2011, NEUROIMAGE, V57, P69, DOI 10.1016/j.neuroimage.2011.02.044; Quickfall J, 2006, J NEUROPSYCH CLIN N, V18, P318, DOI 10.1176/appi.neuropsych.18.3.318; Quinn HR, 2008, NEUROPSYCHOPHARMACOL, V33, P1113, DOI 10.1038/sj.npp.1301475; Rabinak CA, 2012, J NEURAL TRANSM, V119, P701, DOI 10.1007/s00702-011-0747-x; Rais M, 2010, EUR NEUROPSYCHOPHARM, V20, P855, DOI 10.1016/j.euroneuro.2010.08.008; Roberts GMP, 2010, NEUROIMAGE, V52, P429, DOI 10.1016/j.neuroimage.2010.04.192; Safont G, 2011, SCHIZOPHR RES, V129, P169, DOI 10.1016/j.schres.2011.03.012; SCALLET AC, 1987, BRAIN RES, V436, P193, DOI 10.1016/0006-8993(87)91576-9; Schneider M, 2003, NEUROPSYCHOPHARMACOL, V28, P1760, DOI 10.1038/sj.npp.1300225; Schneider M, 2008, ADDICT BIOL, V13, P253, DOI 10.1111/j.1369-1600.2008.00110.x; Schweinsburg AD, 2005, DRUG ALCOHOL DEPEN, V79, P201, DOI 10.1016/j.drugalcdep.2005.01.009; Schweinsburg AD, 2008, PSYCHIAT RES-NEUROIM, V163, P40, DOI 10.1016/j.pscychresns.2007.04.018; Schweinsburg AD, 2011, ADDICTION, V106, P564, DOI 10.1111/j.1360-0443.2010.03197.x; Schweinsburg AD, 2010, J PSYCHOACTIVE DRUGS, V42, P401, DOI 10.1080/02791072.2010.10400703; Sevy S, 2008, PSYCHOPHARMACOLOGY, V197, P549, DOI 10.1007/s00213-008-1075-1; Silveri MM, 2011, PSYCHIAT RES-NEUROIM, V191, P201, DOI 10.1016/j.pscychresns.2010.10.005; Smith AM, 2010, PSYCHOPHARMACOLOGY, V210, P429, DOI 10.1007/s00213-010-1841-8; Sneider JT, 2006, EXP CLIN PSYCHOPHARM, V14, P422, DOI 10.1037/1064-1297.14.4.422; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Solowij N, 2011, PSYCHOL MED, V41, P2349, DOI 10.1017/S003329171100050X; Solowij N, 2010, REV BRAS PSIQUIATR, V32, pS31; Solowij Nadia, 2008, Curr Drug Abuse Rev, V1, P81; Stokes PRA, 2012, J PSYCHOPHARMACOL, V26, P144, DOI 10.1177/0269881111414090; Stokes PRA, 2010, NEUROIMAGE, V52, P1521, DOI 10.1016/j.neuroimage.2010.04.274; Stokes PRA, 2009, NEUROIMAGE, V48, P186, DOI 10.1016/j.neuroimage.2009.06.029; Stone JM, 2012, MOL PSYCHIATR, V17, P568, DOI 10.1038/mp.2011.141; Stone JM, 2012, EUR NEUROPSYCHOPHARM, V22, P114, DOI 10.1016/j.euroneuro.2011.06.004; Sundram S, 2006, HUM PSYCHOPHARM CLIN, V21, P245, DOI 10.1002/hup.762; Takagi M, 2011, ADDICT BIOL; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tapert SF, 2007, PSYCHOPHARMACOLOGY, V194, P173, DOI 10.1007/s00213-007-0823-y; Tzilos GK, 2005, AM J ADDICTION, V14, P64, DOI 10.1080/10550490590899862; United Nations Office on Drugs and Crime, 2011, WORLD DRUG REP 2011; Urban NBL, 2012, BIOL PSYCHIAT, V71, P677, DOI 10.1016/j.biopsych.2011.12.018; Vaidya JG, 2012, NEUROPSYCHOPHARMACOL, V37, P618, DOI 10.1038/npp.2011.227; van Hell HH, 2012, PSYCHOPHARMACOLOGY, V219, P981, DOI 10.1007/s00213-011-2428-8; van Hell HH, 2011, INT J NEUROPSYCHOPH, V14, P1377, DOI 10.1017/S1461145711000526; van Hell HH, 2010, EUR NEUROPSYCHOPHARM, V20, P153, DOI 10.1016/j.euroneuro.2009.11.010; van Winkel R, 2011, ARCH GEN PSYCHIAT, V68, P148, DOI 10.1001/archgenpsychiatry.2010.152; VOLKOW ND, 1991, PSYCHIAT RES-NEUROIM, V40, P69, DOI 10.1016/0925-4927(91)90030-T; Volkow ND, 1996, PSYCHIAT RES-NEUROIM, V67, P29, DOI 10.1016/0925-4927(96)02817-X; Voruganti LNP, 2001, PSYCHIAT RES-NEUROIM, V107, P173, DOI 10.1016/S0925-4927(01)00104-4; Voytek B, 2005, SYNAPSE, V57, P113, DOI 10.1002/syn.20155; Ward PB, 2002, J PSYCHOPHARMACOL S3, V16; Weinstein A, 2008, PSYCHOPHARMACOLOGY, V196, P119, DOI 10.1007/s00213-007-0940-7; Welch KA, 2011, BRIT J PSYCHIAT, V199, P386, DOI 10.1192/bjp.bp.110.090175; Welch KA, 2011, SCHIZOPHRENIA BULL, V37, P1066, DOI 10.1093/schbul/sbq013; Wesley MJ, 2011, PSYCHIAT RES-NEUROIM, V191, P51, DOI 10.1016/j.pscychresns.2010.10.002; WIESBECK GA, 1991, EUR ARCH PSY CLIN N, V241, P88, DOI 10.1007/BF02191147; Wilson W, 2000, J ADDICT DIS, V19, P1, DOI 10.1300/J069v19n01_01; Winton-Brown TT, 2011, NEUROPSYCHOPHARMACOL, V36, P1340, DOI 10.1038/npp.2011.17; Wobrock T, 2009, EUR ARCH PSY CLIN N, V259, P28, DOI 10.1007/s00406-008-0831-x; Wolff V, 2011, STROKE, V42, P1778, DOI 10.1161/STROKEAHA.110.610915; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694; Yucel M, 2010, J PSYCHIATR NEUROSCI, V35, P409, DOI 10.1503/jpn.090177; Yurgelun-Todd D, 1998, NIDA RES MONOGR, P78; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136	193	251	254	2	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55821	10.1371/journal.pone.0055821	http://dx.doi.org/10.1371/journal.pone.0055821			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086NH	23390554	Green Published, gold			2022-12-27	WOS:000314691100070
J	Foster, PG; Bergo, ES; Bourke, BP; Oliveira, TMP; Nagaki, SS; Sant'Ana, DC; Sallum, MAM				Foster, Peter G.; Bergo, Eduardo S.; Bourke, Brian P.; Oliveira, Tatiane M. P.; Nagaki, Sandra S.; Sant'Ana, Denise C.; Sallum, Maria Anice M.			Phylogenetic Analysis and DNA-based Species Confirmation in Anopheles (Nyssorhynchus)	PLOS ONE			English	Article							MITOCHONDRIAL GENOME PHYLOGENY; INTERNAL TRANSCRIBED SPACER; DIPTERA-CULICIDAE; COMPLEX DIPTERA; MALARIA VECTOR; MYZORHYNCHELLA SECTION; PLASMODIUM-FALCIPARUM; ALBITARSIS COMPLEX; RIBOSOMAL DNA; NUCLEAR	Specimens of neotropical Anopheles (Nyssorhynchus) were collected and identified morphologically. We amplified three genes for phylogenetic analysis-the single copy nuclear white and CAD genes, and the COI barcode region. Since we had multiple specimens for most species we were able to test how well the single or combined genes were able to corroborate morphologically defined species by placing the species into exclusive groups. We found that single genes, including the COI barcode region, were poor at confirming species, but that the three genes combined were able to do so much better. This has implications for species identification, species delimitation, and species discovery, and we caution that single genes are not enough. Higher level groupings were partially resolved with some well-supported groupings, whereas others were found to be either polyphyletic or paraphyletic. There were examples of known groups, such as the Myzorhynchella Section, which were poorly supported with single genes but were well supported with combined genes. From this we can infer that more sequence data will be needed in order to show more higher-level groupings with good support. We got unambiguously good support (0.94-1.0 Bayesian posterior probability) from all DNA-based analyses for a grouping of An. dunhami with An. nuneztovari and An. goeldii, and because of this and because of morphological similarities we propose that An. dunhami be included in the Nuneztovari Complex. We obtained phylogenetic corroboration for new species which had been recognised by morphological differences; these will need to be formally described and named.	[Foster, Peter G.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Bergo, Eduardo S.] Secretaria Estado Saude Sao Paulo, Sao Paulo, Brazil; [Bourke, Brian P.; Oliveira, Tatiane M. P.; Nagaki, Sandra S.; Sant'Ana, Denise C.; Sallum, Maria Anice M.] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil	Natural History Museum London; Universidade de Sao Paulo	Foster, PG (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	p.foster@nhm.ac.uk	Bourke, Brian/A-9985-2012; Bergo, Eduardo/F-5374-2014; Oliveira, Tatiane/O-6518-2014; Sallum, Maria Anice Mureb/B-8537-2012; Nagaki, Sandra Sayuri/G-7069-2016	Bourke, Brian/0000-0002-2638-0967; Bergo, Eduardo/0000-0003-4928-0368; Sallum, Maria Anice Mureb/0000-0002-7051-2891; Nagaki, Sandra/0000-0001-5019-442X; Sant'Ana, Denise Cristina/0000-0001-6883-6611; Foster, Peter/0000-0003-0194-9237	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20397-7, 2005/53973-0]; Conselho Nacional de Desenvolvimento Tecnico e Cientifico (CNPq) [301666/2011-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Tecnico e Cientifico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This investigation was financially supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Grants no. 2011/20397-7; 2005/53973-0; http://www.fapesp.br/), and Conselho Nacional de Desenvolvimento Tecnico e Cientifico (CNPq BPP no. 301666/2011-3 to MAMS; http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besansky NJ, 1997, MOL BIOL EVOL, V14, P442, DOI 10.1093/oxfordjournals.molbev.a025780; Birney E, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P56; Birney E, 2012, WISE2; Bourke BP, 2010, ACTA TROP, V114, P88, DOI 10.1016/j.actatropica.2010.01.009; Bourke BP, 2011, MEM I OSWALDO CRUZ, V106, P705, DOI 10.1590/S0074-02762011000600010; Brochero HHL, 2007, AM J TROP MED HYG, V76, P1113, DOI 10.4269/ajtmh.2007.76.1113; Calado DC, 2008, MEM I OSWALDO CRUZ, V103, P791, DOI 10.1590/S0074-02762008000800009; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Causey O. R., 1945, JOUR NATION MALARIA SOC, V4, P231; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; CONN J, 1993, J AM MOSQUITO CONTR, V9, P294; CONN J, 1990, J AM MOSQUITO CONTR, V6, P400; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; da Rocha JAM, 2008, AM J TROP MED HYG, V78, P872, DOI 10.4269/ajtmh.2008.78.872; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DEARRUDA M, 1986, AM J TROP MED HYG, V35, P873, DOI 10.4269/ajtmh.1986.35.873; DEOLIVEIRAFERREIRA J, 1990, AM J TROP MED HYG, V43, P6, DOI 10.4269/ajtmh.1990.43.1.TM0430010006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faran M, 1980, CONTRIB AM ENTOMOL I, V15; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Flores-Mendoza C, 2004, J MED ENTOMOL, V41, P489, DOI 10.1603/0022-2585-41.3.489; Flores-Mendoza C, 2004, P ENTOMOL SOC WASH, V106, P118; Forattini OP, 1998, J AM MOSQUITO CONTR, V14, P256; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; GALVAO A. L. AYROZA, 1941, ARCH ZOOL SAO PAULO, V2, P505; Harbach RE, SUBGENUS NYSSORHYNCH; Harbach RE, 1902, SUBGENUS NYSSORHYNCH; Harbach RE, 1818, GENUS ANOPHELES MEIG; HAYES J, 1987, J AM MOSQUITO CONTR, V3, P418; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KITZMILLER JB, 1973, B WORLD HEALTH ORGAN, V48, P435; Krzywinski J, 2011, MOL PHYLOGENET EVOL, V58, P469, DOI 10.1016/j.ympev.2011.01.003; Linthicum K, 1988, TECHNICAL REPORT; Marrelli MT, 2006, MEM I OSWALDO CRUZ, V101, P817, DOI 10.1590/S0074-02762006000800002; Marrelli MT, 1999, J MED ENTOMOL, V36, P679, DOI 10.1093/jmedent/36.6.679; Motoki MT, 2011, J AM MOSQUITO CONTR, V27, P191, DOI 10.2987/10-6094.1; Motoki MT, 2009, MEM I OSWALDO CRUZ, V104, P823, DOI 10.1590/S0074-02762009000600004; Sallum MAM, 2010, J MED ENTOMOL, V47, P504, DOI 10.1603/ME09229; Nagaki SS, 2011, ANN ENTOMOL SOC AM, V104, P374, DOI 10.1603/AN10126; Nagaki SS, 2010, MEM I OSWALDO CRUZ, V105, P278, DOI 10.1590/S0074-02762010000300006; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quinones ML, 2006, MEM I OSWALDO CRUZ, V101, P617, DOI 10.1590/S0074-02762006000600007; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Reidenbach Kyanne R., 2009, BMC Evolutionary Biology, V9, DOI 10.1186/1471-2148-9-298; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Lopez F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-44; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sallum MAM, 2008, J MED ENTOMOL, V45, P970, DOI 10.1603/0022-2585(2008)45[970:IIANDC]2.0.CO;2; Sallum MAM, 2002, SYST ENTOMOL, V27, P361, DOI 10.1046/j.1365-3113.2002.00182.x; Sallum MAM, 2000, ANN ENTOMOL SOC AM, V93, P745, DOI 10.1603/0013-8746(2000)093[0745:POADCB]2.0.CO;2; Sierra DM, 2004, J MED ENTOMOL, V41, P302, DOI 10.1603/0022-2585-41.3.302; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva-Do-Nascimento TF, 2007, MEM I OSWALDO CRUZ, V102, P975, DOI 10.1590/S0074-02762007000800013; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Unti O, 1940, Ann; paulist Med Cirurg Sao Paulo, V40, P489; Unti O, 1941, SAO PAULO SERV PROFI, V33, P3; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; White BJ, 2011, ANNU REV ECOL EVOL S, V42, P111, DOI 10.1146/annurev-ecolsys-102710-145028; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Zapata MA, 2007, AM J TROP MED HYG, V77, P67, DOI 10.4269/ajtmh.2007.77.67	67	62	65	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54063	10.1371/journal.pone.0054063	http://dx.doi.org/10.1371/journal.pone.0054063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390494	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100010
J	Li, T; Gao, CQ; Cui, Y; Xie, Q; Bu, WJ				Li, Teng; Gao, Cuiqing; Cui, Ying; Xie, Qiang; Bu, Wenjun			The Complete Mitochondrial Genome of the Stalk-Eyed Bug Chauliops fallax Scott, and the Monophyly of Malcidae (Hemiptera: Heteroptera)	PLOS ONE			English	Article							A+T-RICH REGION; RIBOSOMAL-RNA; SECONDARY STRUCTURE; PHYLOGENETIC ANALYSIS; INSECTA; SEQUENCE; DNA; EVOLUTION; LEPIDOPTERA; MODEL	Chauliops fallax Scott, 1874 (Hemiptera: Heteroptera: Malcidae: Chauliopinae) is one of the most destructive insect pests of soybean and rice fields in Asia. Here we sequenced the complete mitochondrial genome of this pest. This genome is 15,739 bp long, with an A+T content of 73.7%, containing 37 typical animal mitochondrial genes and a control region. All genes were arranged in the same order as most of other Heteroptera. A remarkable strand bias was found for all nine protein coding genes (PCGs) encoded by the majority strand were positive AT-skew and negative GC-skew, whereas the reverse were found in the remaining four PCGs encoded by the minority strand and two rRNA genes. The models of secondary structures for the two rRNA genes of sequenced true bugs and Lygaeoidea were predicted. 16S rRNA consisted of six domains (domain III is absent as in other known arthropod mitochondrial genomes) and 45 helices, while three domains and 27 helices for 12S rRNA. The control region consists of five subregions: a microsatellite-like region, a tandem repeats region and other three motifs. The unusual intergenic spacer between tRNA-H and ND4 only found in the species of Lygaeoidea, not in other heteropteran species, may be the synapomorphy of this superfamily. Phylogenetic analyses were carried out based on all the 13 PCGs showed that Chauliopinae was the sister group of Malcinae and the monophyly of Lygaeoidea.	[Li, Teng; Gao, Cuiqing; Cui, Ying; Xie, Qiang; Bu, Wenjun] Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China	Nankai University	Bu, WJ (corresponding author), Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China.	wenjunbu@nankai.edu.cn		Li, Teng/0000-0002-3224-0477	National Science Foundation of China [31071959, 30970350]; National Education Project in Basic Science for Special Subjects (Insect Systematics) [J0930005]; Doctoral Fund of Ministry of Education of China [20100031110026]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Education Project in Basic Science for Special Subjects (Insect Systematics); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This project was supported by the National Science Foundation of China [No. 31071959, 30970350], the National Education Project in Basic Science for Special Subjects (Insect Systematics) [No. J0930005] and the Doctoral Fund of Ministry of Education of China 20100031110026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, ACTA ENT MUS NAT PRA; BARRETTE RJ, 1994, GENOME, V37, P858, DOI 10.1139/g94-121; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Breddin G, 1907, DTSCH ENTOMOLOGISCHE, V6, P34, DOI DOI 10.1002/MMND.48019070609; Buckley TR, 2000, INSECT MOL BIOL, V9, P565, DOI 10.1046/j.1365-2583.2000.00220.x; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CLARY DO, 1987, J MOL EVOL, V25, P116, DOI 10.1007/BF02101753; Comandi S, 2009, GENE, V439, P25, DOI 10.1016/j.gene.2009.02.020; Distant W. L., 1904, Entomologist, P278; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Henry TJ, 1997, ANN ENTOMOL SOC AM, V90, P275, DOI 10.1093/aesa/90.3.275; Hickson RE, 1996, MOL BIOL EVOL, V13, P150, DOI 10.1093/oxfordjournals.molbev.a025552; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Niehuis O, 2006, ORG DIVERS EVOL, V6, P17, DOI 10.1016/j.ode.2005.03.001; Niehuis O, 2006, MOL PHYLOGENET EVOL, V39, P812, DOI 10.1016/j.ympev.2006.01.007; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Page RDM, 2000, NUCLEIC ACIDS RES, V28, P3839, DOI 10.1093/nar/28.20.3839; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schuh RT, 2008, ANN ENTOMOL SOC AM, V101, P20, DOI 10.1603/0013-8746(2008)101[20:CANFOH]2.0.CO;2; Schuh RT, 1995, TRUE BUGS WORLD HEMI; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song N, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.7601; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Stys P, 1963, ACTA U CAROLINAE BIO, V1963, P209; Suzaki Y, 2011, APPL ENTOMOL ZOOL, V46, P429, DOI 10.1007/s13355-011-0057-7; SWEET MH, 1985, ANN ENTOMOL SOC AM, V78, P526, DOI 10.1093/aesa/78.4.526; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xie Q, 2005, MOL PHYLOGENET EVOL, V34, P448, DOI 10.1016/j.ympev.2004.10.015; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhao XY, 2000, J MOUNT AGR BIOL, V19, P321; Zhou JF, 2011, BIOINFORMATICS, V27, P1255, DOI 10.1093/bioinformatics/btr140; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	31	35	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55381	10.1371/journal.pone.0055381	http://dx.doi.org/10.1371/journal.pone.0055381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390534	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100050
J	Zhao, MF; Xiang, WH; Tian, DL; Deng, XW; Huang, ZH; Zhou, XL; Peng, CH				Zhao, Meifang; Xiang, Wenhua; Tian, Dalun; Deng, Xiangwen; Huang, Zhihong; Zhou, Xiaolu; Peng, Changhui			Effects of Increased Nitrogen Deposition and Rotation Length on Long-Term Productivity of Cunninghamia lanceolata Plantation in Southern China	PLOS ONE			English	Article							CLIMATE-CHANGE; FOREST ECOSYSTEMS; ATMOSPHERIC DEPOSITION; SUCCESSIVE ROTATIONS; CARBON SEQUESTRATION; SUBTROPICAL CHINA; FIR PLANTATIONS; N DEPOSITION; MODEL; STORAGE	Cunninghamia lanceolata (Lamb.) Hook. has been widely planted in subtropical China to meet increasing timber demands, leading to short-rotation practices that deplete soil nutrients. However, increased nitrogen (N) deposition offsets soil N depletion. While long-term experimental data investigating the coupled effects related to short rotation practices and increasing N deposition are scarce, applying model simulations may yield insights. In this study, the CenW3.1 model was validated and parameterized using data from pure C. lanceolata plantations. The model was then used to simulate various changes in long-term productivity. Results indicated that responses of productivity of C. lanceolata plantation to increased N deposition were more related to stand age than N addition, depending on the proportion and age of growing forests. Our results have also shown a rapid peak in growth and N dynamics. The peak is reached sooner and is higher under higher level of N deposition. Short rotation lengths had a greater effect on productivity and N dynamics than high N deposition levels. Productivity and N dynamics decreased as the rotation length decreased. Total productivity levels suggest that a 30-year rotation length maximizes productivity at the 4.9 kg N ha(-1) year(-1) deposition level. For a specific rotation length, higher N deposition levels resulted in greater overall ecosystem C and N storage, but this positive correlation tendency gradually slowed down with increasing N deposition levels. More pronounced differences in N deposition levels occurred as rotation length decreased. To sustain C. lanceolata plantation productivity without offsite detrimental N effects, the appropriate rotation length is about 20-30 years for N deposition levels below 50 kg N ha(-1) year(-1) and about 15-20 years for N deposition levels above 50 kg N ha(-1) year(-1). These results highlight the importance of assessing N effects on carbon management and the long-term productivity of forest ecosystems.	[Zhao, Meifang; Xiang, Wenhua; Tian, Dalun; Deng, Xiangwen; Huang, Zhihong; Peng, Changhui] Cent S Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China; [Zhou, Xiaolu; Peng, Changhui] Univ Quebec, Dept Biol Sci, Inst Environm Sci, Montreal, PQ H3C 3P8, Canada	Central South University of Forestry & Technology; University of Quebec; University of Quebec Montreal	Xiang, WH (corresponding author), Cent S Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China.	xiangwh2005@163.com		deng, xiang wen/0000-0002-9399-1231	Key Program of State Forestry Special Fund for Public Welfare Industry of China [2011432009]; Program of Introducing Advanced Technology (948 program) from the China State Forestry Administration [2010-4-03]; Furong Scholar Program	Key Program of State Forestry Special Fund for Public Welfare Industry of China; Program of Introducing Advanced Technology (948 program) from the China State Forestry Administration; Furong Scholar Program	This study was financially supported by the Key Program of State Forestry Special Fund for Public Welfare Industry of China (number 2011432009), the Program of Introducing Advanced Technology (948 program) from the China State Forestry Administration (number 2010-4-03), and the Furong Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; [Anonymous], [No title captured]; [Anonymous], 2001, ACTA ECOL SIN, DOI DOI 10.3321/J.ISSN:1000-0933.2001.12.006; Bi J, 2007, CAN J FOREST RES, V37, P1615, DOI 10.1139/X07-018; Chen R., 2010, HUNAN AGR SCI, V5, P125; Chen XY, 2007, SCI TOTAL ENVIRON, V378, P317, DOI 10.1016/j.scitotenv.2007.02.028; Chen XY, 2004, ENVIRON GEOCHEM HLTH, V26, P179, DOI 10.1023/B:EGAH.0000039580.79321.1a; Chen XY, 1989, J CENTRAL S FORESTRY, V9, P66; Clein JS, 2002, PLANT SOIL, V242, P15, DOI 10.1023/A:1019673420225; Davidson EA, 2007, NATURE, V447, P995, DOI 10.1038/nature05900; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Ding Y. X., 1995, Pedosphere, V5, P57; Fang JY., 1996, ACTA ECOL SIN, V16, P497, DOI DOI 10.1016/j.chnaes.2015.03.001; Fang X, 2002, J CENTRAL S FORESTRY, V22, P1; Fang YT, 2006, J ENVIRON SCI, V18, P756; FAO, 2006, PLANTED FORESTS TREE; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gu Feng-Xue, 2008, Zhiwu Shengtai Xuebao, V32, P1041, DOI 10.3773/j.issn.1005-264x.2008.05.009; Guo Jian-fen, 2009, Journal of Forestry Research (Harbin), V20, P49, DOI 10.1007/s11676-009-0009-z; Hakkila P, 2002, BIOENERGY SUSTAINABL; Heilman P, 1998, BIOMASS BIOENERG, V14, P361, DOI 10.1016/S0961-9534(97)10072-1; Helms JA, 1998, DICT FORESTRY; Hu ZY, 2007, PEDOSPHERE, V17, P360, DOI 10.1016/S1002-0160(07)60043-5; Hynynen J, 2005, FOREST ECOL MANAG, V207, P5, DOI 10.1016/j.foreco.2004.10.015; Kaipainen T, 2004, ENVIRON SCI POLICY, V7, P205, DOI 10.1016/j.envsci.2004.03.001; [康文星 KANG Wenxing], 2007, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V27, P1; Kirschbaum MUF, 1999, TELLUS B, V51, P871, DOI 10.1034/j.1600-0889.1999.t01-4-00002.x; Kirschbaum MUF, 2002, SOIL BIOL BIOCHEM, V34, P341, DOI 10.1016/S0038-0717(01)00189-4; Lei J F, 2005, FOREST RESOURCES CHI; Liu X.Z., 1993, LONG TERM LOCATED RE, P221; Lu XK, 2009, PEDOSPHERE, V19, P189, DOI 10.1016/S1002-0160(09)60108-9; Ma X. H., 1989, Acta Ecologica Sinica, V9, P15; Ma XQ, 2007, FOREST ECOL MANAG, V243, P61, DOI 10.1016/j.foreco.2007.02.018; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Miller R.E., 2004, NCASI TECHNICAL B 88; Moffat AS, 1998, SCIENCE, V279, P988, DOI 10.1126/science.279.5353.988; Morford SL, 2011, NATURE, V477, P78, DOI 10.1038/nature10415; Murty D, 2000, ECOL MODEL, V134, P185, DOI 10.1016/S0304-3800(00)00345-8; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; OVERPECK JT, 1990, NATURE, V343, P51, DOI 10.1038/343051a0; Pan W., 1989, J CENTRAL S FOR U, V9, P1; PASTOR J, 1988, NATURE, V334, P55, DOI 10.1038/334055a0; Peng CH, 2002, ECOL MODEL, V155, P177, DOI 10.1016/S0304-3800(02)00134-5; Pussinen A, 2002, FOREST ECOL MANAG, V158, P103, DOI 10.1016/S0378-1127(00)00675-7; Qian N, 1989, J NANJING FORESTRY U, V13, P75; Ren W, 2011, GLOBAL ECOL BIOGEOGR, V20, P391, DOI 10.1111/j.1466-8238.2010.00606.x; RUNNING SW, 1987, CAN J FOREST RES, V17, P472, DOI 10.1139/x87-081; RYAN MG, 1991, ECOL APPL, V1, P157, DOI 10.2307/1941808; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Tian DL, 2011, FORESTRY, V84, P411, DOI 10.1093/forestry/cpr029; Tian DL, 1993, LONG TERM LOCATED RE; Tian DL, 1989, J CENTRAL S FORESTRY, V9, P29; Wang SQ, 2011, J ENVIRON MANAGE, V92, P1651, DOI 10.1016/j.jenvman.2011.01.024; Weetman GF, 1992, U WASHINGTON CONTRIB, V73; Wei X, 2003, ECOL MODEL, V164, P239, DOI 10.1016/S0304-3800(03)00062-0; Wei XH, 2012, SCI TOTAL ENVIRON, V416, P351, DOI 10.1016/j.scitotenv.2011.11.087; Wen D., 1999, CHIN J PLANT ECOL, V23, P361; Wen SZ, 1993, LONG TERM LOCATED RE; Wu Z., 1984, CHINESE FIR; Xin ZanHong, 2011, Journal of Zhejiang A&F University, V28, P855; Xue L, 2005, CHINESE J PLANT ECOL, V29, P415; Yang YS, 2003, PEDOSPHERE, V13, P87; Yang YS, 2002, CHINESE J APPL ENV B, V8, P2230; Yin H, 2009, IMPROVEMENT CROWN IN; Zaehle S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041345; Zhang J, 2009, J ENVIRON SCI-CHINA, V21, P352, DOI 10.1016/S1001-0742(08)62276-7; Zhang XQ, 2004, FOREST ECOL MANAG, V202, P131, DOI 10.1016/j.foreco.2004.07.032; Zhao MF, 2009, FOREST ECOL MANAG, V257, P1520, DOI 10.1016/j.foreco.2008.12.025	70	15	17	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55376	10.1371/journal.pone.0055376	http://dx.doi.org/10.1371/journal.pone.0055376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390533	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100049
J	Travis, JMJ; Palmer, SCF; Coyne, S; Millon, A; Lambin, X				Travis, Justin M. J.; Palmer, Stephen C. F.; Coyne, Steven; Millon, Alexandre; Lambin, Xavier			Evolution of Predator Dispersal in Relation to Spatio-Temporal Prey Dynamics: How Not to Get Stuck in the Wrong Place!	PLOS ONE			English	Article							SPATIALLY-STRUCTURED POPULATIONS; TRAVELING-WAVES; CONDITIONAL DISPERSAL; DEPENDENT DISPERSAL; CYCLIC POPULATIONS; MICROTUS-AGRESTIS; FIELD VOLES; DISTANCE; ENVIRONMENTS; EMIGRATION	The eco-evolutionary dynamics of dispersal are recognised as key in determining the responses of populations to environmental changes. Here, by developing a novel modelling approach, we show that predators are likely to have evolved to emigrate more often and become more selective over their destination patch when their prey species exhibit spatio-temporally complex dynamics. We additionally demonstrate that the cost of dispersal can vary substantially across space and time. Perhaps as a consequence of current environmental change, many key prey species are currently exhibiting major shifts in their spatio-temporal dynamics. By exploring similar shifts in silico, we predict that predator populations will be most vulnerable when prey dynamics shift from stable to complex. The more sophisticated dispersal rules, and greater variance therein, that evolve under complex dynamics will enable persistence across a broader range of prey dynamics than the rules which evolve under relatively stable prey conditions.	[Travis, Justin M. J.; Palmer, Stephen C. F.; Coyne, Steven; Millon, Alexandre; Lambin, Xavier] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Millon, Alexandre] CNRS, Inst Mediterraneen Ecol & Paleoecol, Aix En Provence, France	University of Aberdeen; Centre National de la Recherche Scientifique (CNRS)	Travis, JMJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	justin.travis@abdn.ac.uk	Travis, Justin/B-8571-2014; Lambin, Xavier/E-8284-2011; Millon, Alexandre/AAF-8624-2020; Palmer, Steve/GSE-1103-2022; Millon, Alexandre/R-6464-2017	Travis, Justin/0000-0002-5785-4272; Lambin, Xavier/0000-0003-4643-2653; Millon, Alexandre/0000-0002-9475-4123; Millon, Alexandre/0000-0002-9475-4123	NERC [NE/E010660/1, NE/F021402/1]; BiodivERsA project "Ecocycle" NERC [NE/G002045/1]; NERC [NE/G002045/1] Funding Source: UKRI; Natural Environment Research Council [NE/E010660/1, NE/G002045/1, NE/F021402/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BiodivERsA project "Ecocycle" NERC; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NERC grants NE/E010660/1 and NE/F021402/1 and BiodivERsA project "Ecocycle" NERC NE/G002045/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1980, J ANIM ECOL, V49, P175, DOI 10.2307/4282; Baalen MV, 1999, AM NAT, V154, P69; Bach LA, 2007, EVOL ECOL RES, V9, P663; Barton KA, 2009, OIKOS, V118, P309, DOI 10.1111/j.1600-0706.2008.16936.x; Bierman SM, 2006, AM NAT, V167, P583, DOI 10.1086/501076; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bocedi G, 2012, AM NAT, V179, P606, DOI 10.1086/665004; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; COMINS HN, 1992, J ANIM ECOL, V61, P735, DOI 10.2307/5627; COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; CROWLEY PH, 1981, AM NAT, V118, P673, DOI 10.1086/283861; Dytham C, 2009, P ROY SOC B-BIOL SCI, V276, P1407, DOI 10.1098/rspb.2008.1535; Green DM, 2009, POPUL ECOL, V51, P253, DOI 10.1007/s10144-008-0131-3; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; HASSELL MP, 1976, THEOR POPUL BIOL, V9, P202, DOI 10.1016/0040-5809(76)90045-9; Henden JA, 2009, J ANIM ECOL, V78, P636, DOI 10.1111/j.1365-2656.2008.01510.x; Hiebeler D, 2004, THEOR POPUL BIOL, V66, P205, DOI 10.1016/j.tpb.2004.06.004; Holt RD, 1996, AM NAT, V148, P709, DOI 10.1086/285949; Holyoak M, 1996, J ANIM ECOL, V65, P640, DOI 10.2307/5743; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Johnson DM, 2004, ECOL LETT, V7, P967, DOI 10.1111/j.1461-0248.2004.00659.x; Kaitala V, 1998, ECOL LETT, V1, P186; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Lachmuth S, 2011, NEW PHYTOL, V192, P529, DOI 10.1111/j.1469-8137.2011.03808.x; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; Mathias A, 2001, EVOLUTION, V55, P246; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; NACHMAN G, 1987, J ANIM ECOL, V56, P267, DOI 10.2307/4814; North A, 2011, EVOLUTION, V65, P1739, DOI 10.1111/j.1558-5646.2011.01254.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Poethke HJ, 2011, J THEOR BIOL, V282, P93, DOI 10.1016/j.jtbi.2011.05.012; Poethke HJ, 2010, AM NAT, V175, P577, DOI 10.1086/651595; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Saitoh T, 2006, CLIM RES, V32, P109, DOI 10.3354/cr032109; Savill NJ, 1998, P ROY SOC B-BIOL SCI, V265, P25, DOI 10.1098/rspb.1998.0259; Schreiber SJ, 2009, AM NAT, V174, P68, DOI 10.1086/599296; Sherratt TN, 2000, J APPL ECOL, V37, P148, DOI 10.1046/j.1365-2664.2000.00472.x; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Snyder RE, 2011, P ROY SOC B-BIOL SCI, V278, P739, DOI 10.1098/rspb.2010.1549; Travis JMJ, 1998, P ROY SOC B-BIOL SCI, V265, P17, DOI 10.1098/rspb.1998.0258; Travis JMJ, 2001, ECOL RES, V16, P157, DOI 10.1046/j.1440-1703.2001.00381.x; Travis JMJ, 2012, METHODS ECOL EVOL, V3, P628, DOI 10.1111/j.2041-210X.2012.00193.x; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; ZEIGLER BP, 1977, J THEOR BIOL, V67, P687, DOI 10.1016/0022-5193(77)90255-7	49	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54453	10.1371/journal.pone.0054453	http://dx.doi.org/10.1371/journal.pone.0054453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408940	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000004
J	Kretschmer, S; Dethlefsen, I; Hagner-Benes, S; Marsh, LM; Garn, H; Konig, P				Kretschmer, Sarah; Dethlefsen, Ina; Hagner-Benes, Stefanie; Marsh, Leigh M.; Garn, Holger; Koenig, Peter			Visualization of Intrapulmonary Lymph Vessels in Healthy and Inflamed Murine Lung Using CD90/Thy-1 as a Marker	PLOS ONE			English	Article							THY-1 CD90; T-CELLS; EXPRESSION; ANTIGEN; SUBPOPULATIONS	Background: Lymphatic vessels play a pivotal role in fluid drainage and egress of immune cells from the lung. However, examining murine lung lymphatics is hampered by the expression of classical lymph endothelial markers on other cell types, which hinders the unambiguous identification of lymphatics. The expression of CD90/Thy-1 on lymph endothelium was recently described and we therefore examined its suitability to identify murine pulmonary lymph vessels under healthy and inflammatory conditions. Methodology/Principal Findings: Immunohistochemistry with a monoclonal antibody against CD90.2/Thy-1.2 on 200 mu thick precision cut lung slices labeled a vascular network that was distinct from blood vessels. Preembedding immunostaining and electron microscopy verified that the anti-CD90.2/Thy-1.2 antibody labeled lymphatic endothelium. Absence of staining in CD90.1/Thy-1.1 expressing FVB mice indicated that CD90/Thy-1 was expressed on lymph endothelium and labeling was not due to antibody cross reactivity. Double-labeling immunohistochemistry for CD90/Thy-1 and alpha-smooth muscle actin identified two routes for lymph vessel exit from the murine lung. One started in the parenchyma or around veins and left via venous blood vessels. The other began in the space around airways or in the space between airways and pulmonary arteries and left via the main bronchi. As expected from the pulmonary distribution of lymph vessels, intranasal application of house dust mite led to accumulation of T cells around veins and in the connective tissue between airways and pulmonary arteries. Surprisingly, increased numbers of T cells were also detected around intraacinar arteries that lack lymph vessels. This arterial T cell sheath extended to the pulmonary arteries where lymph vessels were located. Conclusions/Significance: These results indicate that CD90/Thy-1 is expressed on lymphatic endothelial cells and represents a suitable marker for murine lung lymph vessels. Combining CD90/Thy-1 labeling with precision cut lung slices allows visualizing the anatomy of the lymphatic system in normal and inflamed conditions.	[Kretschmer, Sarah; Dethlefsen, Ina; Koenig, Peter] Med Univ Lubeck, Inst Anat, Zentrum Med Struktur & Zellbiol, D-23538 Lubeck, Germany; [Hagner-Benes, Stefanie; Marsh, Leigh M.; Garn, Holger] Univ Marburg, Inst Lab Med & Pathobiochem, Marburg, Germany; [Marsh, Leigh M.] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria	University of Lubeck; Philipps University Marburg; Ludwig Boltzmann Institute	Konig, P (corresponding author), Med Univ Lubeck, Inst Anat, Zentrum Med Struktur & Zellbiol, D-23538 Lubeck, Germany.	koenig@anat.uni-luebeck.de	König, Peter/AAK-2021-2020; Marsh, Leigh/AAB-5125-2021	Marsh, Leigh/0000-0002-1754-9249; Garn, Holger/0000-0002-5178-4023	DFG (German Research Foundation) [Transergio 22 Z2, Z5]; section of Medicine of the University of Lubeck (Stipendium Exzellenzmedizin [E21-2008, PI-E11B-2009]	DFG (German Research Foundation)(German Research Foundation (DFG)); section of Medicine of the University of Lubeck (Stipendium Exzellenzmedizin	This work was funded by the DFG (German Research Foundation) (Transergio 22 Z2 to Holger Garn and Z5 to Peter Konig) and by the section of Medicine of the University of Lubeck (Stipendium Exzellenzmedizin to Ina Dethlefsen and E21-2008 and PI-E11B-2009 to Peter Konig). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Jurisic G, 2010, EXP CELL RES, V316, P2982, DOI 10.1016/j.yexcr.2010.06.013; LEDBETTER JA, 1980, J EXP MED, V152, P280, DOI 10.1084/jem.152.2.280; McDonald Donald M, 2011, Proc Am Thorac Soc, V8, P504, DOI 10.1513/pats.201102-022MW; MCINTOSH JC, 1994, EUR RESPIR J, V7, P2131, DOI 10.1183/09031936.94.07122131; Miserocchi G, 2009, EUR RESPIR REV, V18, P244, DOI 10.1183/09059180.00002709; Pabst R, 2004, PATHOBIOLOGY, V71, P287, DOI 10.1159/000081723; Pabst R, 2002, J ALLERGY CLIN IMMUN, V110, P209, DOI 10.1067/mai.2002.126836; Paddenberg R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-93; PHIPPS RP, 1990, EUR J IMMUNOL, V20, P1723, DOI 10.1002/eji.1830200815; SCHRADER JW, 1982, P NATL ACAD SCI-BIOL, V79, P4161, DOI 10.1073/pnas.79.13.4161; Schubert K, 2011, EUR J IMMUNOL, V41, P645, DOI 10.1002/eji.201041117; Sleeman JP, 2001, MICROSC RES TECHNIQ, V55, P61, DOI 10.1002/jemt.1157; Swartz MA, 2008, SEMIN IMMUNOL, V20, P147, DOI 10.1016/j.smim.2007.11.007; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Wandel E, 2012, J IMMUNOL, V188, P1442, DOI 10.4049/jimmunol.1003944; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Wetzel A, 2006, J INVEST DERMATOL, V126, P441, DOI 10.1038/sj.jid.5700072; Yao LC, 2010, AM J PATHOL, V176, P1525, DOI 10.2353/ajpath.2010.090909	24	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55201	10.1371/journal.pone.0055201	http://dx.doi.org/10.1371/journal.pone.0055201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408960	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300007
J	Ma, MX; Liu, JH; Song, YJ; Li, L; Li, YF				Ma Mingxiao; Liu Jinhua; Song Yingjin; Li Li; Li Yongfei			TaqMan MGB Probe Fluorescence Real-Time Quantitative PCR for Rapid Detection of Chinese Sacbrood Virus	PLOS ONE			English	Article							DEFORMED WING VIRUS; HONEYBEE	Sacbrood virus (SBV) is a picorna-like virus that affects honey bees (Apis mellifera) and results in the death of the larvae. Several procedures are available to detect Chinese SBV (CSBV) in clinical samples, but not to estimate the level of CSBV infection. The aim of this study was develop an assay for rapid detection and quantification of this virus. Primers and probes were designed that were specific for CSBV structural protein genes. A TaqMan minor groove binder (MGB) probe-based, fluorescence real-time quantitative PCR was established. The specificity, sensitivity and stability of the assay were assessed; specificity was high and there were no cross-reactivity with healthy larvae or other bee viruses. The assay was applied to detect CSBV in 37 clinical samples and its efficiency was compared with clinical diagnosis, electron microscopy observation, and conventional RT-PCR. The TaqMan MGB-based probe fluorescence real-time quantitative PCR for CSBV was more sensitive than other methods tested. This assay was a reliable, fast, and sensitive method that was used successfully to detect CSBV in clinical samples. The technology can provide a useful tool for rapid detection of CSBV. This study has established a useful protocol for CSBV testing, epidemiological investigation, and development of animal models.	[Ma Mingxiao; Li Li; Li Yongfei] Liaoning Med Univ, Dept Lab Anim Ctr, Jinzhou, Peoples R China; [Liu Jinhua] Jilin Entry Exit Inspect & Quarantine Bur, Changchun, Peoples R China; [Song Yingjin] Tianjin Univ, Agr & Biol Engn Coll, Tianjin 300072, Peoples R China	Jinzhou Medical University; Tianjin University	Ma, MX (corresponding author), Liaoning Med Univ, Dept Lab Anim Ctr, Jinzhou, Peoples R China.	nnxx8@yahoo.com.cn			National Natural Science Foundation of China [30972200]; Science and Technology Department of Liaoning Province of China [2011408004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province of China	This work was supported by grants from the National Natural Science Foundation of China (No. 30972200) and the Science and Technology Department of Liaoning Province of China (No. 2011408004). The funders had no role in study design, data collection and analysis, decision to publish.	ANDERSON DL, 1989, ANN APPL BIOL, V114, P1, DOI 10.1111/j.1744-7348.1989.tb06781.x; Bailey L, 1976, Adv Virus Res, V20, P271, DOI 10.1016/S0065-3527(08)60507-2; Bailey L., 1975, Bee World, V56, P55; Blanchard P, 2007, J VIROL METHODS, V141, P7, DOI 10.1016/j.jviromet.2006.11.021; Chantawannakul P, 2006, J INVERTEBR PATHOL, V91, P69, DOI 10.1016/j.jip.2005.11.001; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Kukielka D, 2008, J VIROL METHODS, V147, P275, DOI 10.1016/j.jviromet.2007.09.008; Kukielka D, 2009, J VIROL METHODS, V161, P240, DOI 10.1016/j.jviromet.2009.06.014; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Ma Ming-xiao, 2010, Chinese Journal of Biologicals, V23, P425; Ma MX, 2011, J VIROL METHODS, V176, P115, DOI 10.1016/j.jviromet.2011.05.028; Ritter W., 1996, DIAGNOSTIK BEKAMPFUN, P104; Sambrook J., 2001, MOL CLONING LAB MANU; WANG DI, 1970, J ECON ENTOMOL, V63, P1539, DOI 10.1093/jee/63.5.1539; Wernike K, 2010, DETECTION TYPING HIG; Yan X, 2009, SOCIOBIOLOGY, V53, P687	16	12	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e52670	10.1371/journal.pone.0052670	http://dx.doi.org/10.1371/journal.pone.0052670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408931	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300002
J	Fink, K; Busch, HJ; Bourgeois, N; Schwarz, M; Wolf, D; Zirlik, A; Peter, K; Bode, C; von zur Muhlen, C				Fink, Katrin; Busch, Hans-Joerg; Bourgeois, Natascha; Schwarz, Meike; Wolf, Dennis; Zirlik, Andreas; Peter, Karlheinz; Bode, Christoph; von zur Muhlen, Constantin			Mac-1 Directly Binds to the Endothelial Protein C-Receptor: A Link between the Protein C Anticoagulant Pathway and Inflammation?	PLOS ONE			English	Article							CD11B/CD18; ACTIVATION; EXPRESSION; INVOLVEMENT; APOPTOSIS; ADHESION; DISEASE; HEPARIN; SEPSIS; PLASMA	Objective: The endothelial protein C-receptor (EPCR) is an endothelial transmembrane protein that binds protein C and activated protein C (APC) with equal affinity, thereby facilitating APC formation. APC has anticoagulant, antiapoptotic and antiinflammatory properties. Soluble EPCR, released by the endothelium, may bind activated neutrophils, thereby modulating cell adhesion. EPCR is therefore considered as a possible link between the anticoagulant properties of protein C and the inflammatory response of neutrophils. In the present study, we aimed to provide proof of concept for a direct binding of EPCR to the beta(2)-integrin Mac-1 on monocytic cells under static and physiological flow conditions. Measurements and Main Results: Under static conditions, human monocytes bind soluble EPCR in a concentration dependent manner, as demonstrated by flow cytometry. Binding can be inhibited by specific antibodies (anti-EPCR and anti-Mac-1). Specific binding was confirmed by a static adhesion assay, where a transfected Mac-1 expressing CHO cell line (Mac-1+ cells) bound significantly more recombinant EPCR compared to Mac-1+ cells blocked by anti-Mac-1-antibody and native CHO cells. Under physiological flow conditions, monocyte binding to the endothelium could be significantly blocked by both, anti-EPCR and anti-Mac-1 antibodies in a dynamic adhesion assay at physiological flow conditions. Pre-treatment of endothelial cells with APC (drotrecogin alfa) diminished monocyte adhesion significantly in a comparable extent to antiEPCR. Conclusions: In the present study, we demonstrate a direct binding of Mac-1 on monocytes to the endothelial protein C receptor under static and flow conditions. This binding suggests a link between the protein C anticoagulant pathway and inflammation at the endothelium side, such as in acute vascular inflammation or septicaemia.	[Fink, Katrin; Bourgeois, Natascha; Schwarz, Meike; Wolf, Dennis; Zirlik, Andreas; Bode, Christoph; von zur Muhlen, Constantin] Univ Heart Ctr Freiburg, Dept Cardiol & Angiol 1, Freiburg, Germany; [Busch, Hans-Joerg] Univ Hosp Freiburg, Dept Emergency Med, Freiburg, Germany; [Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Universitats Herzzentrum Freiburg; University of Freiburg; Baker Heart and Diabetes Institute	Fink, K (corresponding author), Univ Heart Ctr Freiburg, Dept Cardiol & Angiol 1, Freiburg, Germany.	katrin.fink@universitaets-herzzentrum.de	Peter, Karlheinz/E-8772-2010; Wolf, Dennis/S-9217-2018; Wolf, Dennis/G-8299-2012; /S-2765-2019; Zirlik, Andreas/A-6400-2011	Peter, Karlheinz/0000-0002-8040-2258; Wolf, Dennis/0000-0003-1525-4348; /0000-0002-8040-2258; Zirlik, Andreas/0000-0001-6290-3297				ALTIERI DC, 1990, J BIOL CHEM, V265, P12119; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Eisenhardt SU, 2007, BLOOD, V109, P3521, DOI 10.1182/blood-2006-03-007179; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Franscini N, 2004, CIRCULATION, V110, P2903, DOI 10.1161/01.CIR.0000146344.49689.BB; FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571; Grinnell BW, 2001, CRIT CARE MED S, V53-0, P60; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kanse SM, 2004, ARTERIOSCL THROM VAS, V24, P2251, DOI 10.1161/01.ATV.0000146529.68729.8b; Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697; Laszik Z, 1997, CIRCULATION, V96, P3633; Mizutani A, 2000, BLOOD, V95, P3781; Murakami K, 1996, BLOOD, V87, P642, DOI 10.1182/blood.V87.2.642.bloodjournal872642; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; Schuler P, 2003, CELL COMMUN ADHES, V10, P17, DOI 10.1080/15419060302065; Schwarz M, 2002, THROMB RES, V107, P121, DOI 10.1016/S0049-3848(02)00207-4; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Xia Y, 1999, J IMMUNOL, V162, P2281; Xu J, 2000, J BIOL CHEM, V275, P6038, DOI 10.1074/jbc.275.8.6038	29	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e53103	10.1371/journal.pone.0053103	http://dx.doi.org/10.1371/journal.pone.0053103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408932	gold, Green Published			2022-12-27	WOS:000315157200005
J	Pietrosemoli, N; Garcia-Martin, JA; Solano, R; Pazos, F				Pietrosemoli, Natalia; Garcia-Martin, Juan A.; Solano, Roberto; Pazos, Florencio			Genome-Wide Analysis of Protein Disorder in Arabidopsis thaliana: Implications for Plant Environmental Adaptation	PLOS ONE			English	Article							INTRINSIC DISORDER; STRUCTURAL DISORDER; WEB SERVER; PREDICTION; SEQUENCE; RECOGNITION; COMPLEXITY; DOMAINS; REGIONS; LIGHT	Intrinsically Disordered Proteins/Regions (IDPs/IDRs) are currently recognized as a widespread phenomenon having key cellular functions. Still, many aspects of the function of these proteins need to be unveiled. IDPs conformational flexibility allows them to recognize and interact with multiple partners, and confers them larger interaction surfaces that may increase interaction speed. For this reason, molecular interactions mediated by IDPs/IDRs are particularly abundant in certain types of protein interactions, such as those of signaling and cell cycle control. We present the first large-scale study of IDPs in Arabidopsis thaliana, the most widely used model organism in plant biology, in order to get insight into the biological roles of these proteins in plants. The work includes a comparative analysis with the human proteome to highlight the differential use of disorder in both species. Results show that while human proteins are in general more disordered, certain functional classes, mainly related to environmental response, are significantly more enriched in disorder in Arabidopsis. We propose that because plants cannot escape from environmental conditions as animals do, they use disorder as a simple and fast mechanism, independent of transcriptional control, for introducing versatility in the interaction networks underlying these biological processes so that they can quickly adapt and respond to challenging environmental conditions.	[Pietrosemoli, Natalia; Pazos, Florencio] Natl Ctr Biotechnol CNB CSIC, Computat Syst Biol Grp, Madrid, Spain; [Garcia-Martin, Juan A.; Solano, Roberto] Natl Ctr Biotechnol CNB CSIC, Plant Mol Genet Dept, Madrid, Spain; [Pietrosemoli, Natalia] Rice Univ, Dept Bioengn, Houston, TX USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Rice University	Solano, R (corresponding author), Natl Ctr Biotechnol CNB CSIC, Plant Mol Genet Dept, Madrid, Spain.	rsolano@cnb.csic.es; fpazos@cnb.csic.es	Solano, Roberto/O-5908-2017; Garcia-Martin, Juan Antonio/K-5956-2017; Garcia-Martin, Juan Antonio/HDN-5951-2022	Solano, Roberto/0000-0001-5459-2417; Garcia-Martin, Juan Antonio/0000-0003-0993-4064; 	Spanish Ministry for Science and Innovation [BIO2010-22109, BIO2010-21739, CSD2007-00057, EUI2008- 03666]	Spanish Ministry for Science and Innovation(Spanish Government)	This project was funded by the Spanish Ministry for Science and Innovation grants BIO2010-22109 to FP and BIO2010-21739, CSD2007-00057, and EUI2008- 03666 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Casal JJ, 2004, TRENDS PLANT SCI, V9, P309, DOI 10.1016/j.tplants.2004.04.007; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Pentony MM, 2010, PROTEINS, V78, P212, DOI 10.1002/prot.22504; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; RHODES MJC, 1994, PLANT MOL BIOL, V24, P1, DOI 10.1007/BF00040570; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero P, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P90, DOI 10.1109/ICNN.1997.611643; Schad E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r120; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Seigler D.S., 1998, PLANT SECONDARY META, DOI 10.1007/978-1-4615-4913-0; Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tantos A, 2009, FEBS LETT, V583, P465, DOI 10.1016/j.febslet.2008.12.054; Thomas PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002386; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Wang HY, 2002, EMBO J, V21, P1339, DOI 10.1093/emboj/21.6.1339; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; Yruela I, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-165	56	47	48	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55524	10.1371/journal.pone.0055524	http://dx.doi.org/10.1371/journal.pone.0055524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408995	gold, Green Submitted, Green Published			2022-12-27	WOS:000315157200035
J	Chen, YH; Pizzolato, F; Cesari, P				Chen, Yin-Hua; Pizzolato, Fabio; Cesari, Paola			Observing Expertise-Related Actions Leads to Perfect Time Flow Estimations	PLOS ONE			English	Article							IMPLICIT-MOTION; STATIC IMAGES; MOTOR-SKILLS; PERCEPTION	The estimation of the time of exposure of a picture portraying an action increases as a function of the amount of movement implied in the action represented. This effect suggests that the perceiver creates an internal embodiment of the action observed as if internally simulating the entire movement sequence. Little is known however about the timing accuracy of these internal action simulations, specifically whether they are affected by the level of familiarity and experience that the observer has of the action. In this study we asked professional pianists to reproduce different durations of exposure (shorter or longer than one second) of visual displays both specific (a hand in piano-playing action) and non-specific to their domain of expertise (a hand in finger-thumb opposition and scrambled-pixels) and compared their performance with non-pianists. Pianists outperformed non-pianists independently of the time of exposure of the stimuli; remarkably the group difference was particularly magnified by the pianists' enhanced accuracy and stability only when observing the hand in the act of playing the piano. These results for the first time provide evidence that through musical training, pianists create a selective and self-determined dynamic internal representation of an observed movement that allows them to estimate precisely its temporal duration.	[Chen, Yin-Hua; Pizzolato, Fabio; Cesari, Paola] Univ Verona, Dept Neurol Neurophysiol Morphol & Movement Sci, I-37100 Verona, Italy	University of Verona	Cesari, P (corresponding author), Univ Verona, Dept Neurol Neurophysiol Morphol & Movement Sci, I-37100 Verona, Italy.	paola.cesari@univr.it		Chen, Yin-Hua/0000-0003-2481-1054; Cesari, Paola/0000-0002-1705-6065				Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; David AS, 2000, TRENDS COGN SCI, V4, P293, DOI 10.1016/S1364-6613(00)01511-4; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; KILLEEN PR, 1987, PSYCHOL REV, V94, P455, DOI 10.1037/0033-295X.94.4.455; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Lorteije JAM, 2006, J COGNITIVE NEUROSCI, V18, P158, DOI 10.1162/089892906775783732; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Moscatelli A, 2011, EXP BRAIN RES, V210, P25, DOI 10.1007/s00221-011-2598-y; Nather FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019818; Nather FC, 2011, PERCEPT MOTOR SKILL, V113, P157, DOI 10.2466/24.25.27.PMS.113.4.157-170; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; Wearden JH, 2008, Q J EXP PSYCHOL, V61, P569, DOI 10.1080/17470210701282576; Wearden JH, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P21; WEARDEN JH, 1991, Q J EXP PSYCHOL-B, V43, P59; Wollner C, 2010, PSYCHOL RES-PSYCH FO, V74, P579, DOI 10.1007/s00426-010-0280-9; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	35	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55294	10.1371/journal.pone.0055294	http://dx.doi.org/10.1371/journal.pone.0055294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405131	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400076
J	Conrad, KD; Giering, F; Erfurth, C; Neumann, A; Fehr, C; Meister, G; Niepmann, M				Conrad, K. Dominik; Giering, Florian; Erfurth, Corinna; Neumann, Angelina; Fehr, Carmen; Meister, Gunter; Niepmann, Michael			microRNA-122 Dependent Binding of Ago2 Protein to Hepatitis C Virus RNA Is Associated with Enhanced RNA Stability and Translation Stimulation	PLOS ONE			English	Article							LONG-RANGE RNA; 3'-UNTRANSLATED REGION; RIBOSOME; INITIATION; ELEMENT; IDENTIFICATION; STABILIZATION; ACTIVATION; REPRESSION; MECHANISM	Translation of Hepatitis C Virus (HCV) RNA is directed by an internal ribosome entry site (IRES) in the 5'-untranslated region (5'-UTR). HCV translation is stimulated by the liver-specific microRNA-122 (miR-122) that binds to two binding sites between the stem-loops I and II near the 5'-end of the 5'-UTR. Here, we show that Argonaute (Ago) 2 protein binds to the HCV 5'-UTR in a miR-122-dependent manner, whereas the HCV 3'-UTR does not bind Ago2. miR-122 also recruits Ago1 to the HCV 5'-UTR. Only miRNA duplex precursors of the correct length stimulate HCV translation, indicating that the duplex miR-122 precursors are unwound by a complex that measures their length. Insertions in the 5'-UTR between the miR-122 binding sites and the IRES only slightly decrease translation stimulation by miR-122. In contrast, partially masking the miR-122 binding sites in a stem-loop structure impairs Ago2 binding and translation stimulation by miR-122. In an RNA decay assay, also miR-122-mediated RNA stability contributes to HCV translation stimulation. These results suggest that Ago2 protein is directly involved in loading miR-122 to the HCV RNA and mediating RNA stability and translation stimulation.	[Conrad, K. Dominik; Giering, Florian; Erfurth, Corinna; Neumann, Angelina; Fehr, Carmen; Niepmann, Michael] Univ Giessen, Fac Med, Inst Biochem, D-35390 Giessen, Germany; [Meister, Gunter] Univ Regensburg, Inst Biochem, Fac Biol & Preclin Med, D-93053 Regensburg, Germany	Justus Liebig University Giessen; University of Regensburg	Niepmann, M (corresponding author), Univ Giessen, Fac Med, Inst Biochem, D-35390 Giessen, Germany.	michael.niepmann@biochemie.med.uni-giessen.de			Deutsche Forschungsgemeinschaft, Germany (DFG) [SFB 535, Ni 604/1-1, /2-1, GRK 1384]	Deutsche Forschungsgemeinschaft, Germany (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Germany (DFG) (SFB 535, Ni 604/1-1 and /2-1, GRK 1384) and the Universitatsklinikum Giessen und Marburg GmbH (KOOPV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beguiristain N, 2005, NUCLEIC ACIDS RES, V33, P5250, DOI 10.1093/nar/gki822; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Berezhna SY, 2011, RNA, V17, P1831, DOI 10.1261/rna.2523911; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Bung C, 2010, FEBS LETT, V584, P837, DOI 10.1016/j.febslet.2010.01.015; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Diaz-Toledano R, 2009, NUCLEIC ACIDS RES, V37, P5498, DOI 10.1093/nar/gkp553; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Ebhardt H Alexander, 2010, Silence, V1, P12, DOI 10.1186/1758-907X-1-12; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fehr C, 2012, CELL CYCLE, V11, P277, DOI 10.4161/cc.11.2.18699; Friebe P, 2009, J VIROL, V83, P11989, DOI 10.1128/JVI.01508-09; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Goergen D, 2012, VIRUS RES, V167, P343, DOI 10.1016/j.virusres.2012.05.022; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hoffman B, 2011, LIVER INT, V31, P1449, DOI 10.1111/j.1478-3231.2011.02543.x; Honda M, 1999, J VIROL, V73, P4941, DOI 10.1128/JVI.73.6.4941-4951.1999; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ito T, 1998, J VIROL, V72, P8789, DOI 10.1128/JVI.72.11.8789-8796.1998; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Junemann C, 2007, J BIOL CHEM, V282, P132, DOI 10.1074/jbc.M608750200; Juvvuna PK, 2012, NUCLEIC ACIDS RES, V40, P6808, DOI 10.1093/nar/gks293; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kim YK, 2003, RNA, V9, P599, DOI 10.1261/rna.2185603; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Niepmann M, 2009, BBA-GENE REGUL MECH, V1789, P529, DOI 10.1016/j.bbagrm.2009.05.002; Niepmann M, 2009, CELL CYCLE, V8, P1473, DOI 10.4161/cc.8.10.8349; Ochs K, 1999, J VIROL, V73, P7505, DOI 10.1128/JVI.73.9.7505-7514.1999; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Perrault M, 2009, BIOCHEM J, V423, P303, DOI 10.1042/BJ20091000; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Petri S, 2011, RNA, V17, P737, DOI 10.1261/rna.2348111; Poenisch M, 2010, SEMIN LIVER DIS, V30, P333, DOI 10.1055/s-0030-1267535; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shimakami T, 2012, J VIROL, V86, P7372, DOI 10.1128/JVI.00513-12; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Villanueva RA, 2010, ANTIVIR RES, V88, P119, DOI 10.1016/j.antiviral.2010.07.004; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wilson JA, 2011, J VIROL, V85, P2342, DOI 10.1128/JVI.02046-10; Zhang C, 2012, VIROLOGY, V433, P479, DOI 10.1016/j.virol.2012.08.039	57	64	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56272	10.1371/journal.pone.0056272	http://dx.doi.org/10.1371/journal.pone.0056272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405269	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400215
J	Donini, LM; Neri, B; De Chiara, S; Poggiogalle, E; Muscaritoli, M				Donini, Lorenzo Maria; Neri, Barbara; De Chiara, Stefania; Poggiogalle, Eleonora; Muscaritoli, Maurizio			Nutritional Care in a Nursing Home in Italy	PLOS ONE			English	Article							MALNUTRITION; UNDERNUTRITION; REHABILITATION; ANOREXIA; COMPLICATIONS; SATISFACTION; REPLACEMENT; COMORBIDITY; PREVALENCE; MORTALITY	Introduction: Malnutrition is a clinical condition due to the imbalance among needs, intake and use of nutrients, leading to the increase of morbidity and mortality, and to the impairment of quality of life. Even in industrialized countries undernutrition is becoming an alarming phenomenon, especially involving elderly institutionalized subjects. A multicentric study called PIMAI (Project Iatrogenic MAlnutrition in Italy), was carried out in Italy over 2005. The aims of this study were to determine the prevalence of malnutrition in hospitals and in nursing care homes (NH), to assess the level of nutritional attention and to measure the perceived quality in food and nutritional care. This paper represents a preliminary analysis of data collected in a NH included in the PIMAI project. Materials and methods: A total of 100 subjects (29 males and 71 females, aged 80.2 +/- 10 years), were recruited from January to June 2005 at the Clinical Rehabilitation Institute "Villa delle Querce'' in Nemi (Rome), among patients in the NH facility. All the participants underwent a multidimensional geriatric evaluation (considering nutritional, clinical, functional and cognitive parameters), and a survey on "perceived quality'' of nutritional care. Results and discussion: According to nutritional status defined by the Mini Nutritional Assessment (R), data analysis showed a high prevalence of malnutrition (36%) especially related to advanced age, chewing, cognitive and functional impairments. Patients seemed to consider nutrition to be important for their health; on the other hand, they were not thoroughly satisfied with the quality of food. Particularly, it was observed scarce attention to nutritional status from medical and nursing staff. Conclusions: Our study confirms the need to pay greater attention to nutritional status in elderly institutionalized subjects. Medical and nursing teams need to be aware of the importance to perform an evaluation of nutritional status in these subset of subjects.	[Donini, Lorenzo Maria; Neri, Barbara; De Chiara, Stefania; Poggiogalle, Eleonora] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Muscaritoli, Maurizio] Univ Roma La Sapienza, Dept Clin Med, Rome, Italy; [Donini, Lorenzo Maria] Rehabil Clin Inst Villa Querce, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Donini, LM (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	Lorenzomaria.donini@uniroma1.it	Donini, Lorenzo/AAS-3873-2020; Poggiogalle, Eleonora/AAB-9338-2019	Donini, Lorenzo/0000-0003-4692-4754; Poggiogalle, Eleonora/0000-0003-0862-5892	Nutricia (Milan, Italy); Nutricia	Nutricia (Milan, Italy)(Danone Nutricia); Nutricia(Danone Nutricia)	The PIMAI (Project: Iatrogenic MAlnutrition in Italy) study was partially supported by unrestricted grants by Nutricia (Milan, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This study was funded by Nutricia. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amaral TF, 2007, CLIN NUTR, V26, P778, DOI 10.1016/j.clnu.2007.08.002; Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Beck AM, 2003, CLIN NUTR, V20, P455; Bostrom AM, 2012, J AM MED DIR ASSOC, V13, P210, DOI 10.1016/j.jamda.2010.12.004; Bourdel-Marchasson I, 2009, NUTRITION, V25, P155, DOI 10.1016/j.nut.2008.07.016; Carrier N, 2009, J NUTR HEALTH AGING, V13, P565, DOI 10.1007/s12603-009-0108-8; Cereda E, 2010, EUR J CLIN NUTR, V64, P894, DOI 10.1038/ejcn.2010.85; Cereda E, 2011, J AM MED DIR ASSOC, V12, P174, DOI 10.1016/j.jamda.2010.11.013; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Crogan N L, 2000, J Nurses Staff Dev, V16, P216, DOI 10.1097/00124645-200009000-00004; Crogan NL, 2004, J GERONTOL A-BIOL, V59, P370; de Luis DA, 2011, EUR REV MED PHARMACO, V15, P259; Donini LM, 2008, CLIN NUTR, V27, P105, DOI 10.1016/j.clnu.2007.10.004; Donini L M, 2000, J Nutr Health Aging, V4, P72; Donini LM, 2011, J NUTR HEALTH AGING, V15, P586, DOI 10.1007/s12603-011-0030-8; Donini LM, 2005, MED SCI MONITOR, V11, pCR326; Donini LM, 2004, AGING CLIN EXP RES, V16, P132, DOI 10.1007/BF03324542; Donini LM, 2003, INT PSYCHOGERIATR, V15, P73, DOI 10.1017/S1041610203008779; Edington J, 2000, CLIN NUTR, V19, P191, DOI 10.1054/clnu.1999.0121; Fairbank J C, 1980, Physiotherapy, V66, P271; Ferry M, 2005, J NUTR HEALTH AGING, V9, P261; FRIED LP, 1992, AGING-CLIN EXP RES, V4, P251, DOI 10.1007/BF03324099; Friedmann JM, 1997, AM J CLIN NUTR, V65, P1714, DOI 10.1093/ajcn/65.6.1714; Garry PJ, 1994, GERIATRIC CLIN CHEM, P84; GREENFIELD S, 1993, MED CARE, V31, P141, DOI 10.1097/00005650-199302000-00005; Grieger Jessica A., 2009, Journal of Nutrition for the Elderly, V28, P47, DOI 10.1080/01639360802633979; Gunther CM, 2008, J HAND SURG-AM, V33A, P558, DOI 10.1016/j.jhsa.2008.01.008; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; Harris Connie L, 2004, Ostomy Wound Manage, V50, P54; Hassan Abdelmonem, 2009, Journal of Nutrition for the Elderly, V28, P313, DOI 10.1080/01639360903140353; Hassen TA, 2007, EUR J VASC ENDOVASC, V33, P696, DOI 10.1016/j.ejvs.2006.12.006; Hiesmayr M, 2009, CLIN NUTR, V28, P484, DOI 10.1016/j.clnu.2009.05.013; Hutton Brian, 2002, J Can Dent Assoc, V68, P182; INRAN-Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione, 2000, TABELLE COMPOSIZIONE; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kelly IE, 2000, QJM-MON J ASSOC PHYS, V93, P93, DOI 10.1093/qjmed/93.2.93; Kruizenga HM, 2005, AM J CLIN NUTR, V82, P1082, DOI 10.1093/ajcn/82.5.1082; Kubrak C, 2007, INT J NURS STUD, V44, P1036, DOI 10.1016/j.ijnurstu.2006.07.015; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lengyel Christina O., 2004, Journal of Nutrition for the Elderly, V24, P5, DOI 10.1300/J052v24n02_02; Lin LC, 2005, J ADV NURS, V51, P30, DOI 10.1111/j.1365-2648.2005.03457.x; Linee Guida SINPE per la Nutrizione artificiale ospedaliera, 2002, RIV IT NUT PARENT S, pS5; Lohman T. G., 1992, MANUALE RIFERIMENTO; Morley JE, 1996, DRUG AGING, V8, P134, DOI 10.2165/00002512-199608020-00007; Morley JE, 2001, NUTRITION, V17, P660, DOI 10.1016/S0899-9007(01)00574-3; Morrone A, 2011, Ann Ig, V23, P161; Oliveira MRM, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-54; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; PIKUL J, 1994, TRANSPLANTATION, V57, P469, DOI 10.1097/00007890-199402150-00030; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; Rai J, 2002, ORTHOPEDICS, V25, P417; Ramic Enisa, 2011, Med Arh, V65, P92; Rockwood K, 2000, DRUG AGING, V17, P295, DOI 10.2165/00002512-200017040-00005; Rozzini R, 2002, AGE AGEING, V31, P277, DOI 10.1093/ageing/31.4.277; Sanchez-Ayala A, 2010, IMPLANT DENT, V19, P196, DOI 10.1097/ID.0b013e3181d46903; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Schneider SM, 2004, BRIT J NUTR, V92, P105, DOI 10.1079/BJN20041152; Soto ME, 2005, J NUTR HEALTH AGING, V9, P158; Stratton RJ, 2006, BRIT J NUTR, V96, P870, DOI 10.1017/BJN20061852; Stratton RJ, 2003, DIS RELATED MALNUTRI; Sullivan DH, 2002, J GEN INTERN MED, V17, P923, DOI 10.1046/j.1525-1497.2002.10930.x; Szczygiel B, 2006, POL J FOOD NUTR SCI, V15-56, P43; Wojszel Z B, 2006, Adv Med Sci, V51, P168; Wright ORL, 2010, J NUTR HEALTH AGING, V14, P775, DOI 10.1007/s12603-010-0123-9; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	66	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55804	10.1371/journal.pone.0055804	http://dx.doi.org/10.1371/journal.pone.0055804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405217	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400162
J	Legrand, AJ; Choul-Li, S; Spriet, C; Idziorek, T; Vicogne, D; Drobecq, H; Dantzer, F; Villeret, V; Aumercier, M				Legrand, Arnaud J.; Choul-Li, Souhaila; Spriet, Corentin; Idziorek, Thierry; Vicogne, Dorothee; Drobecq, Herve; Dantzer, Francoise; Villeret, Vincent; Aumercier, Marc			The Level of Ets-1 Protein Is Regulated by Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Cancer Cells to Prevent DNA Damage	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ETS-1; BINDING-SITES; STROMELYSIN-1 PROMOTER; GENE-EXPRESSION; ANGIOTENSIN-II; ACTIVATION; INHIBITION; PROTOONCOGENE; CARCINOMA; OVEREXPRESSION	Ets-1 is a transcription factor that regulates many genes involved in cancer progression and in tumour invasion. It is a poor prognostic marker for breast, lung, colorectal and ovary carcinomas. Here, we identified poly(ADP-ribose) polymerase-1 (PARP-1) as a novel interaction partner of Ets-1. We show that Ets-1 activates, by direct interaction, the catalytic activity of PARP-1 and is then poly(ADP-ribosyl)ated in a DNA-independent manner. The catalytic inhibition of PARP-1 enhanced Ets-1 transcriptional activity and caused its massive accumulation in cell nuclei. Ets-1 expression was correlated with an increase in DNA damage when PARP-1 was inhibited, leading to cancer cell death. Moreover, PARP-1 inhibitors caused only Ets-1-expressing cells to accumulate DNA damage. These results provide new insight into Ets-1 regulation in cancer cells and its link with DNA repair proteins. Furthermore, our findings suggest that PARP-1 inhibitors would be useful in a new therapeutic strategy that specifically targets Ets-1-expressing tumours.	[Legrand, Arnaud J.; Spriet, Corentin; Vicogne, Dorothee; Villeret, Vincent; Aumercier, Marc] Univ Lille Nord France, Inst Rech Interdisciplinaire, CNRS, USR 3078,IFR 147, Villeneuve Dascq, France; [Choul-Li, Souhaila; Drobecq, Herve] Univ Lille Nord France, Inst Biol Lille, Inst Pasteur Lille, CNRS,UMR 8161,IFR 142, Lille, France; [Idziorek, Thierry] Univ Lille Nord France, Inst Rech Canc Lille, INSERM, U837,IFR 114, Lille, France; [Dantzer, Francoise] Univ Strasbourg, Ecole Super Biotechnol Strasbourg, Ecole Biotechnol Strasbourg, CNRS,UMR 7242,Inst Rech, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Aumercier, M (corresponding author), Univ Lille Nord France, Inst Rech Interdisciplinaire, CNRS, USR 3078,IFR 147, Campus CNRS Haute Borne,BP 70478, Villeneuve Dascq, France.	marc.aumercier@iri.univ-lille1.fr	Dantzer, Françoise/O-2126-2016; CHOUL-LI, Souhaila/ABA-2431-2020; Spriet, Corentin/ABE-4215-2021	CHOUL-LI, Souhaila/0000-0003-0682-4214; Spriet, Corentin/0000-0002-5805-3426; Villeret, Vincent/0000-0003-4504-056X; Drobecq, Herve/0000-0002-4081-1575; Legrand, Arnaud/0000-0002-9429-813X; Dantzer, Francoise/0000-0003-0945-8483; Aumercier, Marc/0000-0002-0370-3452	Centre National de la Recherche Scientifique (CNRS); la Ligue contre le Cancer, Comite du Pas-de-Calais; Ministere de la Recherche et de l'Enseignement Superieur; Fondation ARC pour la Recherche sur le cancer; CNRS; Conseil Regional du Nord-Pas-de-Calais	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); la Ligue contre le Cancer, Comite du Pas-de-Calais; Ministere de la Recherche et de l'Enseignement Superieur; Fondation ARC pour la Recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional du Nord-Pas-de-Calais(Region Hauts-de-FranceRegion Ile-de-France)	This work was supported by the Centre National de la Recherche Scientifique (CNRS) and by grants from la Ligue contre le Cancer, Comite du Pas-de-Calais. The Ministere de la Recherche et de l'Enseignement Superieur and the Fondation ARC pour la Recherche sur le cancer provided a PhD fellowship to Arnaud J. Legrand. The CNRS and the Conseil Regional du Nord-Pas-de-Calais provided a PhD fellowship (BDI) to Souhaila Choul-li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillat D, 2006, ONCOGENE, V25, P5764, DOI 10.1038/sj.onc.1209583; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; Brenner JC, 2012, CANCER RES, V72, P1608, DOI 10.1158/0008-5472.CAN-11-3648; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Choul-li S, 2009, BIOCHEM BIOPH RES CO, V390, P839, DOI 10.1016/j.bbrc.2009.10.059; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Davidson B, 2001, CLIN CANCER RES, V7, P551; de Nigris F, 2001, CANCER RES, V61, P2267; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gebhard C, 2011, BIOCHEM BIOPH RES CO, V414, P641, DOI 10.1016/j.bbrc.2011.09.029; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Higuchi T, 2007, MOL CELL BIOL, V27, P3353, DOI 10.1128/MCB.01871-06; Huang D, 2009, J MOL CELL CARDIOL, V46, P25, DOI 10.1016/j.yjmcc.2008.10.019; Ibrahim YH, 2012, CANC DISCOV; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kars MD, 2010, BIOMED PHARMACOTHER, V64, P458, DOI 10.1016/j.biopha.2010.01.008; Katayama S, 2005, HISTOL HISTOPATHOL, V20, P119, DOI 10.14670/HH-20.119; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kita D, 2001, CANCER RES, V61, P7985; Laitem C, 2009, ONCOGENE, V28, P2087, DOI 10.1038/onc.2009.72; Laitem C, 2008, PROTEIN EXPRES PURIF, V62, P53, DOI 10.1016/j.pep.2008.06.010; Ledford H, 2012, NATURE, V483, P519, DOI 10.1038/483519a; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Leprivier G, 2009, NUCLEIC ACIDS RES, V37, P4341, DOI 10.1093/nar/gkp307; Li M, 2004, BIOCHEM J, V382, P323, DOI 10.1042/BJ20040593; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Lulli V, 2006, CELL DEATH DIFFER, V13, P1064, DOI 10.1038/sj.cdd.4401811; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Madison DL, 2011, DNA REPAIR, V10, P1003, DOI 10.1016/j.dnarep.2011.07.006; Nakayama T, 2001, MODERN PATHOL, V14, P415, DOI 10.1038/modpathol.3880328; Ni W, 2007, CIRC RES, V101, P985, DOI 10.1161/CIRCRESAHA.107.152439; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raffetseder U, 2004, KIDNEY INT, V66, P622, DOI 10.1111/j.1523-1755.2004.00782.x; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Takanami I, 2001, TUMOR BIOL, V22, P205, DOI 10.1159/000050617; Taniguchi H, 2007, INT J CANCER, V121, P1609, DOI 10.1002/ijc.22870; Teruyama K, 2001, J CELL PHYSIOL, V188, P243, DOI 10.1002/jcp.1112; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang H, 2004, J BIOL CHEM, V279, P25241, DOI 10.1074/jbc.M401356200; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417	55	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55883	10.1371/journal.pone.0055883	http://dx.doi.org/10.1371/journal.pone.0055883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405229	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400174
J	Sammarco, PW; Strychar, KB				Sammarco, Paul W.; Strychar, Kevin B.			Responses to High Seawater Temperatures in Zooxanthellate Octocorals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SYMBIODINIUM-MICROADRIATICUM FREUDENTHAL; PROGRAMMED CELL-DEATH; CORAL-REEFS; SCLERACTINIAN CORALS; PHOTOSYNTHETIC PIGMENTS; ALGAL ENDOSYMBIONTS; BLEACHING RESPONSE; OXIDATIVE STRESS; SYMBIOTIC ALGAE	Increases in Sea Surface Temperatures (SSTs) as a result of global warming have caused reef-building scleractinian corals to bleach worldwide, a result of the loss of obligate endosymbiotic zooxanthellae. Since the 1980's, bleaching severity and frequency has increased, in some cases causing mass mortality of corals. Earlier experiments have demonstrated that zooxanthellae in scleractinian corals from three families from the Great Barrier Reef, Australia (Faviidae, Poritidae, and Acroporidae) are more sensitive to heat stress than their hosts, exhibiting differential symptoms of programmed cell death - apoptosis and necrosis. Most zooxanthellar phylotypes are dying during expulsion upon release from the host. The host corals appear to be adapted or exapted to the heat increases. We attempt to determine whether this adaptation/exaptation occurs in octocorals by examining the heat-sensitivities of zooxanthellae and their host octocoral alcyonacean soft corals - Sarcophyton ehrenbergi (Alcyoniidae), Sinularia lochmodes (Alcyoniidae), and Xenia elongata (Xeniidae), species from two different families. The soft coral holobionts were subjected to experimental seawater temperatures of 28, 30, 32, 34, and 36 degrees C for 48 hrs. Host and zooxanthellar cells were examined for viability, apoptosis, and necrosis (in hospite and expelled) using transmission electron microscopy (TEM), fluorescent microscopy (FM), and flow cytometry (FC). As experimental temperatures increased, zooxanthellae generally exhibited apoptotic and necrotic symptoms at lower temperatures than host cells and were expelled. Responses varied species-specifically. Soft coral hosts were adapted/exapted to higher seawater temperatures than their zooxanthellae. As with the scleractinians, the zooxanthellae appear to be the limiting factor for survival of the holobiont in the groups tested, in this region. These limits have now been shown to operate in six species within five families and two orders of the Cnidaria in the western Pacific. We hypothesize that this relationship may have taxonomic implications for other obligate zooxanthellate cnidarians subject to bleaching.	[Sammarco, Paul W.] Louisiana Univ Marine Consortium, Chauvin, LA 70344 USA; [Strychar, Kevin B.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI USA	Grand Valley State University	Sammarco, PW (corresponding author), Louisiana Univ Marine Consortium, Chauvin, LA 70344 USA.	psammarco@lumcon.edu						Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; ACHITUV Y, 1990, ECOSYSTEMS WORLD, V25, P1; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Ambariyanto, 1997, MAR BIOL, V129, P635; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Asada K., 1987, PHOTOINHIBITION, P228; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Banin E, 2000, APPL ENVIRON MICROB, V66, P3031, DOI 10.1128/AEM.66.7.3031-3036.2000; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BERNER T, 1987, SYMBIOSIS, V3, P23; Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4; BROWN BE, 1985, ADV MAR BIOL, V22, P1, DOI 10.1016/S0065-2881(08)60049-8; Buck BH, 2002, AQUAT LIVING RESOUR, V15, P107, DOI 10.1016/S0990-7440(02)01159-2; Cervino JM, 2004, SYMBIOSIS, V37, P63; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Davy SK, 2003, BIOL BULL-US, V205, P66, DOI 10.2307/1543446; DREW E A, 1972, Journal of Experimental Marine Biology and Ecology, V9, P71, DOI 10.1016/0022-0981(72)90008-1; Droop M. R, 1963, SYMBIOTIC ASSOCIATIO, V13, P171; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; FABRICIUS KE, 1995, MAR ECOL PROG SER, V126, P145, DOI 10.3354/meps126145; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; FITT WK, 1983, J CELL SCI, V64, P195; FITT WK, 1983, NEW PHYTOL, V94, P421, DOI 10.1111/j.1469-8137.1983.tb03456.x; FITT WK, 1981, BIOL BULL, V161, P213, DOI 10.2307/1540800; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; Freudenthal T., 1969, Utrecht Micropaleontological Bulletins, V1, P1; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Geddes P., 1882, NATURE, V25, P303; Ginsburg RN, 2006, CORAL REEF BACKGROUN; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Gomez E, 1998, REEF ENCOUNTER, V24, P19; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; GOREAU TF, 1979, SCI AM, V241, P124, DOI 10.1038/scientificamerican0879-124; GOREAU TF, 1971, BIOL BULL, V141, P247, DOI 10.2307/1540115; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Goulet TL, 2008, MAR ECOL PROG SER, V355, P45, DOI 10.3354/meps07214; Harithsa S, 2005, CORAL REEFS, V24, P463, DOI 10.1007/s00338-005-0008-2; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Haslun Joshua A., 2011, Journal of Marine Biology, V2011, P1; Hill M, 2012, BIOL REV IN PRESS; Hill R, 2009, B MAR SCI, V85, P223; Hochberg EJ, 2006, CORAL REEFS, V25, P99, DOI 10.1007/s00338-005-0071-8; Hoegh Guldberg O, 1994, CLIMATE IMPACTS SERI, V1; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoogenboom MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030167; Huang ZB, 2010, J EXP ZOOL PART A, V313A, P660, DOI 10.1002/jez.637; JEFFREY SW, 1968, BIOL BULL, V135, P149, DOI 10.2307/1539622; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Karako S, 2002, CELL OR EX, V4, P539; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KERVIN MJ, 1969, J PHYCOL, V5, P341, DOI 10.1111/j.1529-8817.1969.tb02624.x; Krueger T, 2012, J EXP MAR BIOL ECOL, V413, P169, DOI 10.1016/j.jembe.2011.12.002; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lupinkova L, 2004, PHOTOCHEM PHOTOBIOL, V79, P152, DOI 10.1562/0031-8655(2004)079<0152:OMOTPI>2.0.CO;2; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MCLAUGHLIN JJA, 1957, P SOC EXP BIOL MED, V95, P115; McLennan Deborah A., 2008, Evolution Education and Outreach, V1, P247, DOI 10.1007/s12052-008-0053-8; Miao W, 2005, J EUKARYOT MICROBIOL, V52, P11, DOI 10.1111/j.1550-7408.2005.3311r.x; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; MUSCATINE L, 1989, AM ZOOL, V29, P371; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Obura David, 2000, P65; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; PARDY RL, 1974, BIOL BULL, V147, P105, DOI 10.2307/1540572; Perez SF, 2001, J EXP MAR BIOL ECOL, V256, P1, DOI 10.1016/S0022-0981(00)00282-3; Podesta GP, 1997, J GEOPHYS RES-OCEANS, V102, P15749, DOI 10.1029/96JC03557; Rajasuriya Arjan, 2000, P95; Ralph PJ, 2005, J EXP MAR BIOL ECOL, V316, P17, DOI 10.1016/j.jembe.2004.10.003; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; RICHTER M, 1990, PHOTOSYNTH RES, V24, P237, DOI 10.1007/BF00032311; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P133, DOI 10.3354/meps001133; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Roth MS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00240; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sabourin Daryl T., 2013, International Journal of Biology, V5, P1; Salm RV, 2001, P WORKSH MIT COR BLE; Sammarco Paul W., 2009, Environmental Bioindicators, V4, P9, DOI 10.1080/15555270902905377; SAMMARCO PW, 1987, OECOLOGIA, V74, P93, DOI 10.1007/BF00377351; Sandeman I. M, 2006, Rev. biol. trop, V54, P79; Schleyer MH, 2008, MAR POLLUT BULL, V56, P493, DOI 10.1016/j.marpolbul.2007.11.011; Seipp S, 2001, DEVELOPMENT, V128, P4891; Smith Allan H., 2000, P315; Sokal R. R., 1981, BIOMETRY; Sotka EE, 2005, TRENDS ECOL EVOL, V20, P59, DOI 10.1016/j.tree.2004.11.015; Stambler N, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P87, DOI 10.1007/978-94-007-0114-4_7; Stambler N, 2010, CELL ORIG LIFE EXTRE, V17, P199, DOI 10.1007/978-90-481-9449-0_10; Stanley G. D. Jr., 2009, V205, P7; STANLEY GD, 1995, PALEOBIOLOGY, V21, P179, DOI 10.1017/S0094837300013191; STEELE RD, 1977, J ZOOL, V181, P421; Strychar KB, 2005, J EXP MAR BIOL ECOL, V320, P159, DOI 10.1016/j.jembe.2004.12.039; Strychar KB, 2004, PHYCOLOGIA, V43, P768, DOI 10.2216/i0031-8884-43-6-768.1; Strychar KB, 2004, J EXP MAR BIOL ECOL, V304, P99, DOI 10.1016/j.jembe.2003.11.023; Strychar KB, 2004, MAR FRESHWATER RES, V55, P135, DOI 10.1071/MF03080; Strychar KB, 2010, C INT SOC ENV IND; Strychar KB, 2002, THESIS CENTRAL QUEEN; Strychar KB, 2009, J EXP MAR BIOL ECOL, V369, P31, DOI 10.1016/j.jembe.2008.10.021; SUHARSONO, 1992, J EXP MAR BIOL ECOL, V158, P179, DOI 10.1016/0022-0981(92)90225-Y; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; TAYLOR CE, 1989, PROC R SOC SER B-BIO, V238, P277, DOI 10.1098/rspb.1989.0081; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Terahara K, 2008, CURR PHARM DESIGN, V14, P131, DOI 10.2174/138161208783378725; Thornhill DJ, 2006, J EXP MAR BIOL ECOL, V338, P50, DOI 10.1016/j.jembe.2006.06.032; Thurber RV, 2007, DEV BIOL, V303, P336, DOI 10.1016/j.ydbio.2006.11.018; Titlyanov EA, 1996, MAR ECOL PROG SER, V139, P167, DOI 10.3354/meps139167; Trench RK., 1987, BIOL DINOFLAGELLATES, P530; Tsubokawa R, 1999, DEV GENES EVOL, V209, P515, DOI 10.1007/s004270050284; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; Vivekanandan E, 2008, INDIAN COUNCIL AGR R, V1, P117; Vogt CI, 1842, UNTERSUCHUNGEN ENTWI; Wakefield TS, 2000, BIOL BULL-US, V199, P76, DOI 10.2307/1542709; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Wells S., 1992, GREENPEACE BOOK CORA; Welsh MF, 1936, BIOL BULL-US, V70, P282, DOI 10.2307/1537473; Wiens M, 2006, CAN J ZOOL, V84, P307, DOI 10.1139/Z05-165; Wijgerde T, 2012, CORAL REEFS GROW; Wilkinson Clive, 2000, P21; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Yonge C. M., 1930, Scientific Reports Great Barrier Reef Expedition, V1, P59; Yonge C. M., 1930, Scientific Reports Great Barrier Reef Expedition, V1, P13; Yonge CM, 1930, SCI REP GREAT BARRIE, V1, P83; Yonge CM, 1931, SCI REP GREAT BARRIE, V1928-29, P135; Zhang LL, 2011, DEV COMP IMMUNOL, V35, P603, DOI 10.1016/j.dci.2011.01.005	141	40	42	0	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54989	10.1371/journal.pone.0054989	http://dx.doi.org/10.1371/journal.pone.0054989			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405104	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400048
J	Sarikonda, G; Sachithanantham, S; Manenkova, Y; Kupfer, T; Posgai, A; Wasserfall, C; Bernstein, P; Straub, L; Pagni, PP; Schneider, D; Calvo, TR; Coulombe, M; Herold, K; Gill, RG; Atkinson, M; Nepom, G; Ehlers, M; Staeva, T; Garren, H; Steinman, L; Chan, AC; von Herrath, M				Sarikonda, Ghanashyam; Sachithanantham, Sowbarnika; Manenkova, Yulia; Kupfer, Tinalyn; Posgai, Amanda; Wasserfall, Clive; Bernstein, Philip; Straub, Laura; Pagni, Philippe P.; Schneider, Darius; Calvo, Teresa Rodriguez; Coulombe, Marilyne; Herold, Kevan; Gill, Ronald G.; Atkinson, Mark; Nepom, Gerald; Ehlers, Mario; Staeva, Teodora; Garren, Hideki; Steinman, Lawrence; Chan, Andrew C.; von Herrath, Matthias			Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; RECENT-ONSET; BETA-CELLS; LYMPHOCYTE DEPLETION; TYPE-1; ANTIGEN; EXPRESSION; PREVENTS; IMMUNOTHERAPY; DESTRUCTION	A recent type 1 diabetes (T1D) clinical trial of rituximab (a B cell-depleting anti-CD20 antibody) achieved some therapeutic benefit in preserving C-peptide for a period of approximately nine months in patients with recently diagnosed diabetes. Our previous data in the NOD mouse demonstrated that co-administration of antigen (insulin) with anti-CD3 antibody (a T cell-directed immunomodulator) offers better protection than either entity alone, indicating that novel combination therapies that include a T1D-related autoantigen are possible. To accelerate the identification and development of novel combination therapies that can be advanced into the clinic, we have evaluated the combination of a mouse anti-CD20 antibody with either oral insulin or a proinsulin-expressing DNA vaccine. Anti-CD20 alone, given once or on 4 consecutive days, produced transient B cell depletion but did not prevent or reverse T1D in the NOD mouse. Oral insulin alone (twice weekly for 6 weeks) was also ineffective, while proinsulin DNA (weekly for up to 12 weeks) showed a trend toward modest efficacy. Combination of anti-CD20 with oral insulin was ineffective in reversing diabetes in NOD mice whose glycemia was controlled with SC insulin pellets; these experiments were performed in three independent labs. Combination of anti-CD20 with proinsulin DNA was also ineffective in diabetes reversal, but did show modest efficacy in diabetes prevention (p = 0.04). In the prevention studies, anti-CD20 plus proinsulin resulted in modest increases in Tregs in pancreatic lymph nodes and elevated levels of proinsulin-specific CD4+ T-cells that produced IL-4. Thus, combination therapy with anti-CD20 and either oral insulin or proinsulin does not protect hyperglycemic NOD mice, but the combination with proinsulin offers limited efficacy in T1D prevention, potentially by augmentation of proinsulin-specific IL-4 production.	[Sarikonda, Ghanashyam; Sachithanantham, Sowbarnika; Manenkova, Yulia; Pagni, Philippe P.; Schneider, Darius; Calvo, Teresa Rodriguez; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA 92037 USA; [Kupfer, Tinalyn; Coulombe, Marilyne; Gill, Ronald G.] Univ Colorado Denver, Aurora, CO USA; [Posgai, Amanda; Wasserfall, Clive; Atkinson, Mark] Univ Florida, Gainesville, FL USA; [Bernstein, Philip; Straub, Laura; Ehlers, Mario] Immune Tolerance Network, San Francisco, CA USA; [Staeva, Teodora] JDRF Int, New York, NY USA; [Garren, Hideki; Steinman, Lawrence] Bayhill Therapeut, San Mateo, CA USA; [Steinman, Lawrence] Stanford Univ, Stanford, CA 94305 USA; [Chan, Andrew C.] Genentech Inc, San Francisco, CA 94080 USA; [Herold, Kevan] Yale Univ, New Haven, CT USA; [Nepom, Gerald] Benaroya Res Inst, Seattle, WA USA	La Jolla Institute for Immunology; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of Florida; Immune Tolerance Network; Stanford University; Roche Holding; Genentech; Yale University; Benaroya Research Institute	von Herrath, M (corresponding author), La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA 92037 USA.	matthias@liai.org	Gill, Ronald/GWM-5338-2022; Kupfer, Tinalyn M/P-1326-2018; Wasserfall, Clive/ABF-9385-2020; wasserfall, clive/J-9078-2012	Kupfer, Tinalyn M/0000-0001-8182-0235; Wasserfall, Clive/0000-0002-3522-8932; wasserfall, clive/0000-0002-3522-8932; Nepom, Gerald/0000-0002-8063-1464; Gill, Ronald/0000-0001-7520-4401; Steinman, Lawrence/0000-0002-2437-2250; Posgai, Amanda/0000-0002-9491-0958	University of Colorado, Denver (UCD) under NIH [5U19AI050864-08]; T1D center of San Diego Postdoctoral fellowship; ITN-JDRF (Immune Tolerence Network) Partnership; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864] Funding Source: NIH RePORTER	University of Colorado, Denver (UCD) under NIH; T1D center of San Diego Postdoctoral fellowship; ITN-JDRF (Immune Tolerence Network) Partnership; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a subaward from the University of Colorado, Denver (UCD) to MvH, issued under NIH award number 5U19AI050864-08 to UCD under the direction of Dr. George S. Eisenbarth, P. I. GS was a recipient of a T1D center of San Diego Postdoctoral fellowship; the ITN-JDRF (Immune Tolerence Network) Partnership supported members of the ITN-JDRF preclinical consortium, including TK, AP, CW, RG, MA, ME and MvH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bot A, 2001, J IMMUNOL, V167, P2950, DOI 10.4049/jimmunol.167.5.2950; Bour-Jordan H, 2007, J IMMUNOL, V179, P1004, DOI 10.4049/jimmunol.179.2.1004; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Coon B, 1999, J CLIN INVEST, V104, P189, DOI 10.1172/JCI7209; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Diabetes Prevention Trial Type Stu, 2005, DIABETES CARE, V28, P1068; Falcone M, 1998, J IMMUNOL, V161, P1163; Fourlanos S, 2011, DIABETES, V60, P1237, DOI 10.2337/db10-1360; Fousteri G, 2010, DIABETOLOGIA, V53, P1958, DOI 10.1007/s00125-010-1777-x; Gallagher MP, 2011, ANN NY ACAD SCI, V1243, P119, DOI 10.1111/j.1749-6632.2011.06321.x; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Homann D, 1999, J IMMUNOL, V163, P1833; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Huang HC, 2010, P NATL ACAD SCI USA, V107, P4658, DOI 10.1073/pnas.1001074107; Hulbert C, 2001, J IMMUNOL, V167, P5535, DOI 10.4049/jimmunol.167.10.5535; Martinez NR, 2003, J CLIN INVEST, V111, P1365, DOI 10.1172/JCI200317166; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nanto-Salonen K, 2008, LANCET; Noorchashm H, 1999, J IMMUNOL, V163, P743; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Orban T, 2010, J AUTOIMMUN, V34, P408, DOI 10.1016/j.jaut.2009.10.005; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Serreze DV, 2011, DIABETES, V60, P2914, DOI 10.2337/db11-0705; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; Solvason N, 2008, J IMMUNOL, V181, P8298, DOI 10.4049/jimmunol.181.12.8298; Thrower SL, 2009, CLIN EXP IMMUNOL, V155, P156, DOI 10.1111/j.1365-2249.2008.03814.x; von Herrath M, 2004, PEDIATR DIABETES, V5, P23, DOI 10.1111/j.1399-543X.2004.00076.x; vonHerrath MG, 1996, J CLIN INVEST, V98, P1324, DOI 10.1172/JCI118919; Waldron-Lynch F, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003401; Wong F Susan, 2005, Rev Diabet Stud, V2, P121, DOI 10.1900/RDS.2005.2.121; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yu S, 2012, INT IMMUNOL	36	29	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54712	10.1371/journal.pone.0054712	http://dx.doi.org/10.1371/journal.pone.0054712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405091	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400035
J	Syvaranta, J; Lensu, A; Marjomaki, TJ; Oksanen, S; Jones, RI				Syvaranta, Jari; Lensu, Anssi; Marjomaki, Timo J.; Oksanen, Sari; Jones, Roger I.			An Empirical Evaluation of the Utility of Convex Hull and Standard Ellipse Areas for Assessing Population Niche Widths from Stable Isotope Data	PLOS ONE			English	Article							COMMUNITY-WIDE MEASURES; TROPHIC POSITION; RATIOS PROVIDE; DELTA-N-15; DELTA-C-13; ECOLOGY; CARBON; N-15	Stable isotope analyses are increasingly employed to characterise population niche widths. The convex hull area (TA) in a delta C-13-delta N-15 biplot has been used as a measure of isotopic niche width, but concerns exist over its dependence on sample size and associated difficulties in among-population comparisons. Recently a more robust method was proposed for estimating and comparing isotopic niche widths using standard ellipse areas (SEA), but this approach has yet to be tested with empirical stable isotope data. The two methods measure different kind of isotopic niche areas, but both are now widely used to characterise isotopic niche widths of populations. We used simulated data and an extensive empirical dataset from two fish populations to test the influence of sample size on the observed isotopic niche widths (TA and SEA). We resampled the original datasets to generate 5000 new samples for different numbers of observations from 5 to 80 to examine the statistical distributions of niche area estimates for increasing sample size. Our results illustrate how increasing sample size increased the observed TA; even sample sizes much higher than n = 30 did not improve the precision for the TA method. SEA was less sensitive to sample size, but the natural variation in our empirical fish delta C-13 and delta N-15 data still resulted in considerable uncertainty around the mean estimates of niche width, reducing the precision particularly with sample sizes n<30. These results confirm that the TA method is less appropriate for estimating population isotopic niche areas using small samples, especially when considerable population level isotope variation is expected. The results also indicate a need for caution when using SEA as a measure of trophic niche widths for consumers, particularly with low sample sizes and when the distribution and range for population isotope values are not known.	[Syvaranta, Jari; Lensu, Anssi; Marjomaki, Timo J.; Oksanen, Sari; Jones, Roger I.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Jyvaskyla	Syvaranta, J (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	jari.syvaranta@jyu.fi	Jones, Roger I/C-7703-2011	Jones, Roger I/0000-0002-0835-8264; Lensu, Anssi/0000-0003-2182-7042	Maj and Tor Nessling Foundation; Kone Foundation; Academy of Finland [137671]	Maj and Tor Nessling Foundation; Kone Foundation; Academy of Finland(Academy of Finland)	This work was funded by the Maj and Tor Nessling Foundation, the Kone Foundation and the Academy of Finland (grant 137671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Eloranta AP, 2011, ECOL FRESHW FISH, V20, P558, DOI 10.1111/j.1600-0633.2011.00504.x; Elton C., 1927, ANIMAL ECOLOGY; Grey J, 2004, LIMNOL OCEANOGR, V49, P239, DOI 10.4319/lo.2004.49.1.0239; Hoeinghaus DJ, 2008, ECOLOGY, V89, P2353, DOI 10.1890/07-1143.1; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Leberfinger K, 2011, FRESHWATER BIOL, V56, P470, DOI 10.1111/j.1365-2427.2010.02512.x; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Olsson K, 2009, FRESHWATER BIOL, V54, P1731, DOI 10.1111/j.1365-2427.2009.02221.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; R Core Team, 2020, R LANG ENV STAT COMP; Ravinet M, 2010, OIKOS, V119, P409, DOI 10.1111/j.1600-0706.2009.17859.x; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Syvaranta J, 2010, AQUAT BIOL, V8, P137, DOI 10.3354/ab00220; Syvaranta J, 2008, FRESHWATER BIOL, V53, P425, DOI 10.1111/j.1365-2427.2007.01905.x; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Worton BJ, 1995, BIOMETRICS, V51, P1206, DOI 10.2307/2533254; Zambrano L, 2010, BIOL INVASIONS, V12, P3061, DOI 10.1007/s10530-010-9697-8	30	151	151	3	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56094	10.1371/journal.pone.0056094	http://dx.doi.org/10.1371/journal.pone.0056094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405254	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400200
J	Ma, HY; Hong, M; Duan, JN; Liu, P; Fan, XS; Shang, EX; Su, SL; Guo, JM; Qian, DW; Tang, YP				Ma, Hongyue; Hong, Min; Duan, Jinao; Liu, Pei; Fan, Xinsheng; Shang, Erxin; Su, Shulan; Guo, Jianming; Qian, Dawei; Tang, Yuping			Altered Cytokine Gene Expression in Peripheral Blood Monocytes across the Menstrual Cycle in Primary Dysmenorrhea: A Case-Control Study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; EPIDERMAL-GROWTH-FACTOR; BETA SUPERFAMILY; TGF-BETA; OXYTOCIN RECEPTOR; HUMAN ENDOMETRIUM; MESSENGER-RNA; STROMAL CELLS; INFLAMMATION; INTERLEUKIN-1-BETA	Primary dysmenorrhea is one of the most common gynecological complaints in young women, but potential peripheral immunologic features underlying this condition remain undefined. In this paper, we compared 84 common cytokine gene expression profiles of peripheral blood mononuclear cells (PBMCs) from six primary dysmenorrheic young women and three unaffected controls on the seventh day before (secretory phase), and the first (menstrual phase) and the fifth (regenerative phase) days of menstruation, using a real-time PCR array assay combined with pattern recognition and gene function annotation methods. Comparisons between dysmenorrhea and normal control groups identified 11 (nine increased and two decreased), 14 (five increased and nine decreased), and 15 (seven increased and eight decreased) genes with >= 2-fold difference in expression (P<0.05) in the three phases of menstruation, respectively. In the menstrual phase, genes encoding pro-inflammatory cytokines (IL1B, TNF, IL6, and IL8) were up-regulated, and genes encoding TGF-beta superfamily members (BMP4, BMP6, GDF5, GDF11, LEFTY2, NODAL, and MSTN) were down-regulated. Functional annotation revealed an excessive inflammatory response and insufficient TGF-beta superfamily member signals with anti-inflammatory consequences, which may directly contribute to menstrual pain. In the secretory and regenerative phases, increased expression of pro-inflammatory cytokines and decreased expression of growth factors were also observed. These factors may be involved in the regulation of decidualization, endometrium breakdown and repair, and indirectly exacerbate primary dysmenorrhea. This first study of cytokine gene expression profiles in PBMCs from young primary dysmenorrheic women demonstrates a shift in the balance between expression patterns of pro-inflammatory cytokines and TGF-beta superfamily members across the whole menstrual cycle, underlying the peripheral immunologic features of primary dysmenorrhea.	[Ma, Hongyue; Hong, Min; Duan, Jinao; Liu, Pei; Fan, Xinsheng; Shang, Erxin; Su, Shulan; Guo, Jianming; Qian, Dawei; Tang, Yuping] Nanjing Univ Chinese Med, Jiangsu Key Lab TCM Formulae Res, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Duan, JN (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab TCM Formulae Res, Nanjing, Jiangsu, Peoples R China.	dja@njutcm.edu.cn			Open Project Program of Traditional Chinese Medicine Department of Nanjing University of Chinese Medicine [YS2012ZYX311]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); National Natural Science Fund of China [81274199, 81073121]; National Science Fund for Distinguished Young Scholars [81102762]; National Basic Research Program of China (973 Program) [2011CB505300, 2011CB505303]	Open Project Program of Traditional Chinese Medicine Department of Nanjing University of Chinese Medicine; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Open Project Program of Traditional Chinese Medicine Department of Nanjing University of Chinese Medicine (YS2012ZYX311), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD), the National Natural Science Fund of China (81274199, 81073121) and the National Science Fund for Distinguished Young Scholars (81102762), and National Basic Research Program of China (973 Program) (2011CB505300, 2011CB505303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Ahnstedt H, 2012, ACTA PHYSIOL, V205, P266, DOI 10.1111/j.1748-1716.2011.02392.x; Akerlund M, 2002, PROG BRAIN RES, V139, P359; Aksu K, 2012, CURR PHARM DESIGN, V18, P1478; Arcuri F, 2009, REPROD SCI, V16, P453, DOI 10.1177/1933719108328609; Bany BM, 1998, BIOL REPROD, V59, P131, DOI 10.1095/biolreprod59.1.131; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Braundmeier AG, 2006, J CLIN ENDOCR METAB, V91, P2358, DOI 10.1210/jc.2005-0601; Catalano RD, 2007, MOL HUM REPROD, V13, P641, DOI 10.1093/molehr/gam021; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; Coco AS, 1999, AM FAM PHYSICIAN, V60, P489; Cornet PB, 2002, J BIOL CHEM, V277, P42496, DOI 10.1074/jbc.M201793200; Dams-Kozlowska H, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-8; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; Deepak P, 2010, INT IMMUNOL, V22, P53, DOI 10.1093/intimm/dxp114; Duncan WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023595; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Friebe-Hoffmann U, 2007, REGUL PEPTIDES, V142, P78, DOI 10.1016/j.regpep.2007.01.012; Friebe-Hoffmann U, 2001, AM J REPROD IMMUNOL, V46, P226, DOI 10.1034/j.1600-0897.2001.d01-6.x; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Guo D, 2012, MOL CELL BIOCHEM, V363, P179, DOI 10.1007/s11010-011-1170-1; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016840; Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015; Han S, 2011, BMB REP, V44, P129, DOI 10.5483/BMBRep.2011.44.2.129; Harel Z, 2008, ANN NY ACAD SCI, V1135, P185, DOI 10.1196/annals.1429.007; Hatakeyama Y, 2010, BONE TISSUE REGENERA, V3, P1; Henriet P, 2012, MOL CELL ENDOCRINOL, V358, P197, DOI 10.1016/j.mce.2011.07.042; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JC, 1998, J CLIN ENDOCR METAB, V83, P538, DOI 10.1210/jc.83.2.538; Hur J, 2009, BIOINFORMATICS, V25, P838, DOI 10.1093/bioinformatics/btp049; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; JEZIORSKA M, 1995, BIOL REPROD, V53, P312, DOI 10.1095/biolreprod53.2.312; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Kokabu S, 2012, MOL ENDOCRINOL, V26, P87, DOI 10.1210/me.2011-1168; LeBlanc MM, 2012, EQUINE VET J, V44, P8, DOI 10.1111/j.2042-3306.2011.00502.x; Lee CC, 2010, ONCOGENE, V29, P3110, DOI 10.1038/onc.2010.55; Lee HT, 2012, AM J PHYSIOL-RENAL, V303, pF1216, DOI 10.1152/ajprenal.00220.2012; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Liedman R, 2008, GYNECOL ENDOCRINOL, V24, P508, DOI 10.1080/09513590802306218; Lundvig DMS, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00081; MacDonald TT, 2011, BIOCHEM SOC T, V39, P1061, DOI 10.1042/BST0391061; Madhyastha H, 2012, CLIN EXP PHARMACOL P, V39, P13, DOI 10.1111/j.1440-1681.2011.05627.x; Maybin JA, 2011, MOL CELL ENDOCRINOL, V335, P42, DOI 10.1016/j.mce.2010.08.006; Oliveira MR, 2001, LEUKEMIA RES, V25, P711, DOI 10.1016/S0145-2126(01)00011-X; Plake C, 2006, BIOINFORMATICS, V22, P2444, DOI 10.1093/bioinformatics/btl408; Ponnampalam AP, 2004, MOL HUM REPROD, V10, P879, DOI 10.1093/molehr/gah121; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Rauk PN, 2001, AM J REPROD IMMUNOL, V45, P148, DOI 10.1111/j.8755-8920.2001.450305.x; Saiga K, 2010, BIOCHEM BIOPH RES CO, V402, P329, DOI 10.1016/j.bbrc.2010.10.026; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; SCAMBIA G, 1994, INT J CANCER, V58, P769, DOI 10.1002/ijc.2910580603; Sheares KKK, 2004, AM J PHYSIOL-LUNG C, V287, pL919, DOI 10.1152/ajplung.00012.2004; Sheridan BC, 1999, AM J PHYSIOL-LUNG C, V277, pL861, DOI 10.1152/ajplung.1999.277.5.L861; Shimizu T, 2010, PHYSIOL GENOMICS, V42A, P290, DOI 10.1152/physiolgenomics.00107.2010; Skarzynski DJ, 2000, BIOL REPROD, V62, P1116, DOI 10.1095/biolreprod62.5.1116; Strakova Z, 2002, J REPROD IMMUNOL, V55, P35, DOI 10.1016/S0165-0378(01)00141-3; STROMBERG P, 1984, ACTA OBSTET GYN SCAN, V63, P533, DOI 10.3109/00016348409156715; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Suresh PS, 2011, ENDOCR J, V58, P223, DOI 10.1507/endocrj.K11E-098; Szostek AZ, 2011, DOMEST ANIM ENDOCRIN, V41, P14, DOI 10.1016/j.domaniend.2011.01.007; Takano M, 2012, MOL CELL ENDOCRINOL, V348, P224, DOI 10.1016/j.mce.2011.08.027; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tang MY, 2010, ENDOCRINOLOGY, V151, P1320, DOI 10.1210/en.2009-1081; Terness P, 2001, INT IMMUNOPHARMACOL, V1, P119, DOI 10.1016/S0162-3109(00)00264-2; Terzidou V, 2011, BIOL REPROD, V84, P546, DOI 10.1095/biolreprod.110.086785; Thompson M, 2004, AM J PHYSIOL-ENDOC M, V287, pE1142, DOI 10.1152/ajpendo.00122.2004; Xu GX, 2004, J CLIN ENDOCR METAB, V89, P5523, DOI 10.1210/jc.2004-0893; Yan JD, 2009, FREE RADICAL BIO MED, V46, P1275, DOI 10.1016/j.freeradbiomed.2009.02.007; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; Yeh ML, 2004, LIFE SCI, V75, P669, DOI 10.1016/j.lfs.2003.11.034; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200	75	39	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55200	10.1371/journal.pone.0055200	http://dx.doi.org/10.1371/journal.pone.0055200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390521	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100037
J	Muller, N; Lorenz, I; Langguth, B; Weisz, N				Mueller, Nadia; Lorenz, Isabel; Langguth, Berthold; Weisz, Nathan			rTMS Induced Tinnitus Relief Is Related to an Increase in Auditory Cortical Alpha Activity	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; DORSAL COCHLEAR NUCLEUS; REPETITIVE TMS; GAMMA-OSCILLATIONS; CORTEX; EXCITABILITY; RESPONSES; ATTENTION; SCHIZOPHRENIA	Chronic tinnitus, the continuous perception of a phantom sound, is a highly prevalent audiological symptom. A promising approach for the treatment of tinnitus is repetitive transcranial magnetic stimulation (rTMS) as this directly affects tinnitus-related brain activity. Several studies indeed show tinnitus relief after rTMS, however effects are moderate and vary strongly across patients. This may be due to a lack of knowledge regarding how rTMS affects oscillatory activity in tinnitus sufferers and which modulations are associated with tinnitus relief. In the present study we examined the effects of five different stimulation protocols (including sham) by measuring tinnitus loudness and tinnitus-related brain activity with Magnetoencephalography before and after rTMS. Changes in oscillatory activity were analysed for the stimulated auditory cortex as well as for the entire brain regarding certain frequency bands of interest (delta, theta, alpha, gamma). In line with the literature the effects of rTMS on tinnitus loudness varied strongly across patients. This variability was also reflected in the rTMS effects on oscillatory activity. Importantly, strong reductions in tinnitus loudness were associated with increases in alpha power in the stimulated auditory cortex, while an unspecific decrease in gamma and alpha power, particularly in left frontal regions, was linked to an increase in tinnitus loudness. The identification of alpha power increase as main correlate for tinnitus reduction sheds further light on the pathophysiology of tinnitus. This will hopefully stimulate the development of more effective therapy approaches.	[Mueller, Nadia; Weisz, Nathan] Univ Trento, Ctr Mind Brain Sci, Mattarello, Italy; [Lorenz, Isabel] Univ Konstanz, Dept Psychol, Constance, Germany; [Langguth, Berthold] Univ Hosp Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Weisz, Nathan] Univ Konstanz, Constance, Germany	University of Trento; University of Konstanz; University of Regensburg; University of Konstanz	Muller, N (corresponding author), Univ Trento, Ctr Mind Brain Sci, Mattarello, Italy.	nadia.muller@unitn.it	Müller-Voggel, Nadia/ABB-6603-2020; Langguth, Berthold/AAP-2638-2021; Weisz, Nathan/K-3325-2015	Müller-Voggel, Nadia/0000-0002-6414-5669; Weisz, Nathan/0000-0001-7816-0037	Deutsche Forschungsgemeinschaft [4156/2-1]; Tinnitus Research Initiative	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tinnitus Research Initiative	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (grant number: 4156/2-1) and the Tinnitus Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; Baguley DM, 2002, CLIN OTOLARYNGOL, V27, P219, DOI 10.1046/j.1365-2273.2002.00566.x; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; De Ridder D, 2005, OTOL NEUROTOL, V26, P616, DOI 10.1097/01.mao.0000178146.91139.3c; Di Lazzaro V, 2011, J NEUROPHYSIOL, V105, P2150, DOI 10.1152/jn.00781.2010; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Dohrmann K, 2007, PROG BRAIN RES, V166, P473, DOI 10.1016/S0079-6123(07)66046-4; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Ferrarelli F, 2008, AM J PSYCHIAT, V165, P996, DOI 10.1176/appi.ajp.2008.07111733; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Folmer RL, 2006, ACTA OTO-LARYNGOL, V126, P96, DOI 10.1080/03655230600895465; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Fregni F, 2006, EUR J NEUROL, V13, P996, DOI 10.1111/j.1468-1331.2006.01414.x; Fuggetta G, 2012, EXPT NEUROLOGY; Gamboa OL, 2010, EXP BRAIN RES, V204, P181, DOI 10.1007/s00221-010-2293-4; GOEBEL G, 1994, HNO, V42, P166; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kaltenbach JA, 2006, ACTA OTO-LARYNGOL, V126, P20, DOI 10.1080/03655230600895309; Khedr EM, 2009, EUR J NEUROL, V16, P404, DOI 10.1111/j.1468-1331.2008.02522.x; Kleinjung T, 2007, PROG BRAIN RES, V166, P359, DOI 10.1016/S0079-6123(07)66034-8; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; Kleinjung Tobias, 2009, Int Tinnitus J, V15, P154; Kleinjung Tobias, 2008, Int Tinnitus J, V14, P112; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Langguth B, 2006, BRAIN TOPOGR, V18, P241, DOI 10.1007/s10548-006-0002-1; Langguth B, 2008, BRAIN STIMUL, V1, P192, DOI 10.1016/j.brs.2008.06.003; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Londero A, 2006, NEUROPHYSIOL CLIN, V36, P145, DOI 10.1016/j.neucli.2006.08.001; Lorenz I, 2010, J NEUROPHYSIOL, V104, P1497, DOI 10.1152/jn.00370.2010; Marcondes RA, 2010, EUR J NEUROL, V17, P38, DOI 10.1111/j.1468-1331.2009.02730.x; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moont R, 2011, PAIN, V60, P709; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ortmann M, 2011, EUR J NEUROSCI, V33, P568, DOI 10.1111/j.1460-9568.2010.07542.x; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Plewnia C, 2007, J NEUROL NEUROSUR PS, V78, P152, DOI 10.1136/jnnp.2006.095612; Plewnia C, 2003, ANN NEUROL, V53, P263, DOI 10.1002/ana.10468; Plewnia C, 2011, CNS NEUROSCI THER, V17, P449, DOI 10.1111/j.1755-5949.2010.00169.x; Poreisz C, 2008, EXP BRAIN RES, V185, P611, DOI 10.1007/s00221-007-1188-5; Poreisz C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-54; Pridmore S, 1998, J ECT, V14, P25; Quartarone A, 2005, EXP BRAIN RES, V161, P114, DOI 10.1007/s00221-004-2052-5; Rajan R, 1998, AUDIOL NEURO-OTOL, V3, P123, DOI 10.1159/000013786; Ramirez RR, 2009, IEEE ENG MED BIO, P1940, DOI 10.1109/IEMBS.2009.5333457; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Romei V, 2008, NEUROREPORT, V19, P203, DOI 10.1097/WNR.0b013e3282f454c4; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Sedley W, 2012, BRAIN, V135, P3089, DOI 10.1093/brain/aws220; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Soekadar SR, 2009, CNS SPECTRUMS, V14, P208, DOI 10.1017/S1092852900020228; Takano B, 2004, NEUROIMAGE, V23, P849, DOI 10.1016/j.neuroimage.2004.06.032; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Trippe J, 2009, EXPT BRAIN RES, V31, P1193; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Weiler Elmar W, 2002, Int Tinnitus J, V8, P87; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028; Worden MS, 2000, J NEUROSCI, V20; Wunderlich AP, 2010, AUDIOL NEURO-OTOL, V15, P137, DOI 10.1159/000241094; Zacharek MA, 2002, HEARING RES, V172, P137, DOI 10.1016/S0378-5955(02)00575-0	87	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55557	10.1371/journal.pone.0055557	http://dx.doi.org/10.1371/journal.pone.0055557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390539	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100055
J	Stegmaier, J; Skanda, D; Lebiedz, D				Stegmaier, Johannes; Skanda, Dominik; Lebiedz, Dirk			Robust Optimal Design of Experiments for Model Discrimination Using an Interactive Software Tool	PLOS ONE			English	Article							CRITERION; KINETICS; SYSTEMS	Mathematical modeling of biochemical processes significantly contributes to a better understanding of biological functionality and underlying dynamic mechanisms. To support time consuming and costly lab experiments, kinetic reaction equations can be formulated as a set of ordinary differential equations, which in turn allows to simulate and compare hypothetical models in silico. To identify new experimental designs that are able to discriminate between investigated models, the approach used in this work solves a semi-infinite constrained nonlinear optimization problem using derivative based numerical algorithms. The method takes into account parameter variabilities such that new experimental designs are robust against parameter changes while maintaining the optimal potential to discriminate between hypothetical models. In this contribution we present a newly developed software tool that offers a convenient graphical user interface for model discrimination. We demonstrate the beneficial operation of the discrimination approach and the usefulness of the software tool by analyzing a realistic benchmark experiment from literature. New robust optimal designs that allow to discriminate between the investigated model hypotheses of the benchmark experiment are successfully calculated and yield promising results. The involved robustification approach provides maximally discriminating experiments for the worst parameter configurations, which can be used to estimate the meaningfulness of upcoming experiments. A major benefit of the graphical user interface is the ability to interactively investigate the model behavior and the clear arrangement of numerous variables. In addition to a brief theoretical overview of the discrimination method and the functionality of the software tool, the importance of robustness of experimental designs against parameter variability is demonstrated on a biochemical benchmark problem. The software is licensed under the GNU General Public License and freely available at http://sourceforge.net/projects/mdtgui/.	[Stegmaier, Johannes; Skanda, Dominik] Univ Freiburg, Ctr Anal Biol Syst ZBSA, D-79106 Freiburg, Germany; [Stegmaier, Johannes] Karlsruhe Inst Technol, Inst Appl Comp Sci IAI, D-76021 Karlsruhe, Germany; [Lebiedz, Dirk] Univ Ulm, Inst Numer Math, D-89069 Ulm, Germany; [Lebiedz, Dirk] Univ Ulm, Ulm Ctr Sci Comp UZWR, D-89069 Ulm, Germany	University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology; Ulm University; Ulm University	Lebiedz, D (corresponding author), Univ Ulm, Inst Numer Math, D-89069 Ulm, Germany.	dirk.lebiedz@uni-ulm.de	Stegmaier, Johannes/ABA-4230-2021	Stegmaier, Johannes/0000-0003-4072-3759	Freiburg Initiative for Systems Biology (FRISYS), part of the BMBF FORSYS Systems Biology Initiative; Freiburg Excellence Cluster Centre for Biological Signalling Studies (BIOSS); Helmholtz Alliance Systems Biology of Cancer; Nephage Initiative (BMBF Gerontosys II - NephAge) [031 5896A]; German Research Foundation (DFG); Albert-Ludwigs-University Freiburg	Freiburg Initiative for Systems Biology (FRISYS), part of the BMBF FORSYS Systems Biology Initiative; Freiburg Excellence Cluster Centre for Biological Signalling Studies (BIOSS); Helmholtz Alliance Systems Biology of Cancer; Nephage Initiative (BMBF Gerontosys II - NephAge); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert-Ludwigs-University Freiburg	The authors gratefully acknowledge the Freiburg Initiative for Systems Biology (FRISYS), part of the BMBF FORSYS Systems Biology Initiative, the Freiburg Excellence Cluster Centre for Biological Signalling Studies (BIOSS), the Helmholtz Alliance Systems Biology of Cancer and the Nephage Initiative (BMBF Gerontosys II - NephAge (031 5896A)) for various support and funding. The article processing charge was funded by the German Research Foundation (DFG) and the Albert-Ludwigs-University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Bisswanger H., 2008, ENZYME KINETICS; Bock H.G., 1984, P 9 IFAC WORLD C BUD; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; COIN-OR, AUT DIFF SOFTW CPPAD; COONEY MJ, 1995, APPL MICROBIOL BIOT, V43, P826; Digia, QT CROSS PLATF APPL; Flassig RJ, 2012, BIOINFORMATICS; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; Hart J.D., 1997, NONPARAMETRIC SMOOTH; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; HSL, COLL FORTR COD LARG; Koudriavtsev A B, 2001, LAW MASS ACTION; Kremling A, 2004, GENOME RES, V14, P1773, DOI 10.1101/gr.1226004; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Lopez-Fidalgo J, 2007, J R STAT SOC B, V69, P231, DOI 10.1111/j.1467-9868.2007.00586.x; Lorenz S, 2007, J COMPUT CHEM, V28, P1384, DOI 10.1002/jcc.20674; Myung JI, 2009, PSYCHOL REV, V116, P499, DOI 10.1037/a0016104; Polak E., 1997, OPTIMIZATION ALGORIT; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rawlings JO, 1998, APPL REGRESSION ANAL, DOI 10.1007/b98890; RUBSAMEN H, 1974, H-S Z PHYSIOL CHEM, V355, P687, DOI 10.1515/bchm2.1974.355.1.687; Skanda D, 2012, THESIS A LUDWIGS U F; Skanda D, 2013, MATH PROGRAM, V141, P405, DOI 10.1007/s10107-012-0532-0; Skanda D, 2010, BIOINFORMATICS, V26, P939, DOI 10.1093/bioinformatics/btq074; Takors R, 1997, BIOTECHNOL BIOENG, V56, P564, DOI 10.1002/(SICI)1097-0290(19971205)56:5<564::AID-BIT10>3.0.CO;2-C; Timmer J, 2004, INT J BIFURCAT CHAOS, V14, P2069, DOI 10.1142/S0218127404010461; Torres N., 2005, PATHWAY ANAL OPTIMIZ; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Wachter A, 2002, THESIS CARNEGIE MELL; Wagenmakers EJ, 2003, J MATH PSYCHOL, V47, P580, DOI 10.1016/S0022-2496(03)00064-6	32	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55723	10.1371/journal.pone.0055723	http://dx.doi.org/10.1371/journal.pone.0055723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390549	Green Published, gold			2022-12-27	WOS:000314691100065
J	Heaton, MP; Kalbfleisch, TS; Petrik, DT; Simpson, B; Kijas, JW; Clawson, ML; Chitko-McKown, CG; Harhay, GP; Leymaster, KA				Heaton, Michael P.; Kalbfleisch, Theodore S.; Petrik, Dustin T.; Simpson, Barry; Kijas, James W.; Clawson, Michael L.; Chitko-McKown, Carol G.; Harhay, Gregory P.; Leymaster, Kreg A.		Int Sheep Genomics Consortium	Genetic Testing for TMEM154 Mutations Associated with Lentivirus Susceptibility in Sheep	PLOS ONE			English	Article							SMALL RUMINANT LENTIVIRUSES; TRANSMISSION; INFECTION; SEQUENCE	In sheep, small ruminant lentiviruses cause an incurable, progressive, lymphoproliferative disease that affects millions of animals worldwide. Known as ovine progressive pneumonia virus (OPPV) in the U. S., and Visna/Maedi virus (VMV) elsewhere, these viruses reduce an animal's health, productivity, and lifespan. Genetic variation in the ovine transmembrane protein 154 gene (TMEM154) has been previously associated with OPPV infection in U. S. sheep. Sheep with the ancestral TMEM154 haplotype encoding glutamate (E) at position 35, and either form of an N70I variant, were highly-susceptible compared to sheep homozygous for the K35 missense mutation. Our current overall aim was to characterize TMEM154 in sheep from around the world to develop an efficient genetic test for reduced susceptibility. The average frequency of TMEM154 E35 among 74 breeds was 0.51 and indicated that highly-susceptible alleles were present in most breeds around the world. Analysis of whole genome sequences from an international panel of 75 sheep revealed more than 1,300 previously unreported polymorphisms in a 62 kb region containing TMEM154 and confirmed that the most susceptible haplotypes were distributed worldwide. Novel missense mutations were discovered in the signal peptide (A13V) and the extracellular domains (E31Q, I74F, and I102T) of TMEM154. A matrix-assisted laser desorption/ionization-time-of flight mass spectrometry (MALDI-TOF MS) assay was developed to detect these and six previously reported missense and two deletion mutations in TMEM154. In blinded trials, the call rate for the eight most common coding polymorphisms was 99.4% for 499 sheep tested and 96.0% of the animals were assigned paired TMEM154 haplotypes (i.e., diplotypes). The widespread distribution of highly-susceptible TMEM154 alleles suggests that genetic testing and selection may improve the health and productivity of infected flocks.	[Heaton, Michael P.; Clawson, Michael L.; Chitko-McKown, Carol G.; Harhay, Gregory P.; Leymaster, Kreg A.] USDA ARS, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; [Kalbfleisch, Theodore S.] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Kalbfleisch, Theodore S.] Intrepid Bioinformat, Louisville, KY USA; [Petrik, Dustin T.; Simpson, Barry] GeneSeek, Lincoln, NE USA; [Kijas, James W.] CSIRO, Div Anim Food & Hlth Sci, Brisbane, Qld, Australia	United States Department of Agriculture (USDA); University of Louisville; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Heaton, MP (corresponding author), USDA ARS, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA.	mike.heaton@ars.usda.gov; ted.kalbfleisch@louisville.edu	Harhay, Gregory/AAC-5411-2022; Slate, Jon/D-2925-2012; Simianer, Henner/A-6574-2015; Kalbfleisch, Theodore/AAN-5407-2021; Dalrymple, Brian P/F-8721-2010; Kijas, James W/A-4656-2011; Barendse, William J/D-8608-2011; Coltman, David W/A-4453-2012	Harhay, Gregory/0000-0002-0129-6822; Slate, Jon/0000-0003-3356-5123; Simianer, Henner/0000-0002-7551-3797; Dalrymple, Brian P/0000-0003-3891-5233; Kijas, James W/0000-0002-1417-8278; Barendse, William J/0000-0002-5464-0658; Coltman, David W/0000-0002-1268-2307; Kalbfleisch, Theodore/0000-0002-2370-8189; Gupta, Vidya/0000-0002-6139-1346; Heaton, Michael/0000-0003-1386-1208; Clawson, Michael/0000-0002-3355-5390; ciani, elena/0000-0001-5673-0975; Drogemuller, Cord/0000-0001-9773-522X	United States Department of Agriculture, Agricultural Research Service	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this research was provided by the United States Department of Agriculture, Agricultural Research Service. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA. USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no current external funding sources for this study.	Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Birney E., 2009, NATURE, V461, P168, DOI DOI 10.1038/461168A; Blacklaws BA, 2004, VET MICROBIOL, V101, P199, DOI 10.1016/j.vetmic.2004.04.006; Gjerset B, 2009, VET MICROBIOL, V135, P231, DOI 10.1016/j.vetmic.2008.09.069; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Heaton MP, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-23; Keen JE, 1997, PREV VET MED, V30, P155, DOI 10.1016/S0167-5877(96)01101-4; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nomenclature for incompletely specified bases in nucleic acid sequences, 1986, P NATL ACAD SCI USA, V83, P4; Patel JR, 2012, VACCINE, V30, P1767, DOI 10.1016/j.vaccine.2012.01.014; Peterhans E, 2004, VET RES, V35, P257, DOI 10.1051/vetres:2004014; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SIGURDSSON B, 1952, J INFECT DIS, V90, P233, DOI 10.1093/infdis/90.3.233; Thormar H, 2005, AIDS REV, V7, P233; USDA, 2003, OV PROGR PNEUM AW MA; White SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047829	18	20	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55490	10.1371/journal.pone.0055490	http://dx.doi.org/10.1371/journal.pone.0055490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408992	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000315100000017
J	Haggar, FA; Pereira, G; Preen, DD; Holman, CDJ; Einarsdottir, K				Haggar, Fatima A.; Pereira, Gavin; Preen, David D.; Holman, C. D'Arcy J.; Einarsdottir, Kristjana			Cancer Survival and Excess Mortality Estimates among Adolescents and Young Adults in Western Australia, 1982-2004: A Population-Based Study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GERM-CELL TUMORS; CHILDHOOD; END; SEX	Background: Data are limited on cancer outcomes in adolescents and young adults. Methods: Based on data from the Western Australian Data Linkage System, this study modelled survival and excess mortality in all adolescents and young adults aged 15-39 years in Western Australia who had a diagnosis of cancer in the period 1982-2004. Relative survival and excess all-cause mortality for all cancers combined and for principal tumour subgroups were estimated, using the Ederer II method and generalised linear Poisson modelling, respectively. Results: A cancer diagnosis in adolescents and young adults conferred substantial survival decrement. However, overall outcomes improved over calendar period (excess mortality hazard ratio [HR], latest versus earliest diagnostic period: 0.52, trend p<0.0001). Case fatality varied according to age group (HR, oldest versus youngest: 1.38, trend p<0.0001), sex (HR, female versus male: 0.66, 95% confidence interval [CI] 0.62-0.71), ethnicity (HR, Aboriginal versus others: 1.47, CI 1.23-1.76), geographical area (HR, rural/remote versus urban: 1.13, CI 1.04-1.23) and residential socioeconomic status (HR, lowest versus highest quartile: 1.14, trend p<0.05). Tumour subgroups differed substantially in frequency according to age group and sex, and were critical outcome determinants. Conclusions: Marked progressive calendar-time improvement in overall outcomes was evident. Further research is required to disentangle the contributions of tumour biology and health service factors to outcome disparities between ethnodemographic, geographic and socioeconomic subgroups of adolescents and young adults with cancer.	[Haggar, Fatima A.; Preen, David D.; Holman, C. D'Arcy J.] Univ Western Australia, Ctr Hlth Serv Res, Sch Populat Hlth, Crawley, Australia; [Haggar, Fatima A.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Pereira, Gavin; Einarsdottir, Kristjana] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Pereira, Gavin] Yale Univ, Sch Publ Hlth, Yale Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT USA	University of Western Australia; University of Ottawa; Ottawa Hospital Research Institute; Telethon Kids Institute; University of Western Australia; Yale University	Haggar, FA (corresponding author), Univ Western Australia, Ctr Hlth Serv Res, Sch Populat Hlth, Crawley, Australia.	fhaggar@toh.on.ca	Pereira, Gavin/D-7136-2014; Preen, David B/H-5663-2014; Einarsdóttir, Kristjana/E-8337-2011; Holman, Cashel DJ/B-6173-2009	Pereira, Gavin/0000-0003-3740-8117; Preen, David B/0000-0002-2982-2169; Einarsdóttir, Kristjana/0000-0003-4931-7650; 	Cancer Council Western Australia; University of Western Australia; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Cancer Council Western Australia(Cancer Council Western Australia); University of Western Australia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Cancer Council Western Australia and The University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adolescent and Young Adult Oncology Progress Review Group Department of Health and Human Services National Institutes of Health National Cancer Institute, 2006, CLOSING THE GAP RESE; Australian Bureau of Statistics, 2008, AUSTRALIAN HISTORICA; Australian Bureau of Statistics, 2001, AUSTRALIAN STANDARD; Australian Bureau of Statistics ABS, 2006, INFORMATION PAPER CE; Australian Institute of Health Welfare, 2011, YOUNG AUSTRALIANS TH; Barr RD, 2006, CANCER, V106, P1425, DOI 10.1002/cncr.21773; Barry E, 2007, J CLIN ONCOL, V25, P813, DOI 10.1200/JCO.2006.08.6397; Bleyer A, 2005, CANCER-AM CANCER SOC, V103, P1891, DOI 10.1002/cncr.20995; BLEYER A, 2002, P AN M AM SOC CLIN, V21, pA389; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Clark A, 2010, AUST HEALTH REVIEW, V34; Cole CH, 2004, MED J AUSTRALIA, V180, P52, DOI 10.5694/j.1326-5377.2004.tb05795.x; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; de Giorgi V, 2011, J CLIN ONCOL, V29, pE94, DOI 10.1200/JCO.2010.33.1876; De P, 2011, CAN MED ASSOC J, V183, pE187, DOI 10.1503/CMAJ.100800; Department of Health WA, 2011, WESTERN AUSTRALIAN C; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Ederer F, 1961, THE RELATIVE SURVIVA; Fritz A, 2000, INT CLASSIFICATION D; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Hall Sonja, 2004, J Health Serv Res Policy, V9 Suppl 2, P10, DOI 10.1258/1355819042248116; Hopkins S, 1996, APPL EC, V28; Kent EE, 2009, CANCER CAUSE CONTROL, V20, P1409, DOI 10.1007/s10552-009-9367-2; Lasithiotakis K, 2008, CANCER, V112, P1795, DOI 10.1002/cncr.23359; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Morris M, 2007, MED J AUSTRALIA, V186, P296, DOI 10.5694/j.1326-5377.2007.tb00904.x; Nachman J, 2005, BRIT J HAEMATOL, V130, P166, DOI 10.1111/j.1365-2141.2005.05544.x; National Centre in HIV Epidemiology and Clinical Research, 2007, AUSTR HIV SURV REP O, P23; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Pui CH, 1999, J CLIN ONCOL, V17, P818, DOI 10.1200/JCO.1999.17.3.818; Ribera JM, 2008, J CLIN ONCOL, V26, P1843, DOI 10.1200/JCO.2007.13.7265; Ries LAG, 2003, ONCOLOGIST, V8, P541; Ries LAG, 2007, SEER SURVIVAL MONOGR; Sarfati D, 2010, INT J EPIDEMIOL, V39, P598, DOI 10.1093/ije/dyp392; SAS Inc, 2009, SAS SOFTWARE VERSION; SATHER H, 1981, LANCET, V1, P739; SEER, 2008, SEER ADOLESCENT YOUN; SHUGG D, 1994, INT J CANCER, V59, P765, DOI 10.1002/ijc.2910590610; Shuster JJ, 1998, J CLIN ONCOL, V16, P2854, DOI 10.1200/JCO.1998.16.8.2854; St. Jude Children's Research Hospital, 2011, THE CHILDHOOD CANCER; Threlfall T, 2010, CANCER INCIDENCE AND; van de Schans SAM, 2011, J CLIN ONCOL, V29, P192, DOI 10.1200/JCO.2010.28.6377; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302	45	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55630	10.1371/journal.pone.0055630	http://dx.doi.org/10.1371/journal.pone.0055630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405184	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400129
J	Hayashi, H; Tamura, A; Krishnan, D; Tsukita, S; Suzuki, Y; Kocinsky, HS; Aronson, PS; Orlowski, J; Grinstein, S; Alexander, RT				Hayashi, Hisayoshi; Tamura, Atsushi; Krishnan, Devishree; Tsukita, Sachiko; Suzuki, Yuichi; Kocinsky, Hetal S.; Aronson, Peter S.; Orlowski, John; Grinstein, Sergio; Alexander, R. Todd			Ezrin Is Required for the Functional Regulation of the Epithelial Sodium Proton Exchanger, NHE3	PLOS ONE			English	Article							PROTEIN-KINASE-A; RENAL PROXIMAL TUBULE; NA+/H+-EXCHANGER; ERM PROTEINS; APICAL MEMBRANE; CAMP; INHIBITION; PHOSPHORYLATION; ISOFORMS; CELLS	The sodium hydrogen exchanger isoform 3 (NHE3) mediates absorption of sodium, bicarbonate and water from renal and intestinal lumina. This activity is fundamental to the maintenance of a physiological plasma pH and blood pressure. To perform this function NHE3 must be present in the apical membrane of renal tubular and intestinal epithelia. The molecular determinants of this localization have not been conclusively determined, although linkage to the apical actin cytoskeleton through ezrin has been proposed. We set out to evaluate this hypothesis. Functional studies of NHE3 activity were performed on ezrin knockdown mice (Vil2(kd/kd)) and NHE3 activity similar to wild-type animals detected. Interpretation of this finding was difficult as other ERM (ezrin/radixin/moesin) proteins were present. We therefore generated an epithelial cell culture model where ezrin was the only detectable ERM. After knockdown of ezrin expression with siRNA, radixin and moesin expression remained undetectable. Consistent with the animal ultrastructural data, cells lacking ezrin retained an epithelial phenotype but had shortened and thicker microvilli. NHE3 localization was identical to cells transfected with non-targeting siRNA. The attachment of NHE3 to the apical cytoskeleton was unaltered as assessed by fluorescent recovery after photobleaching (FRAP) and the solubility of NHE3 in Triton X-100. Baseline NHE3 activity was unaltered, however, cAMP-dependent inhibition of NHE3 was largely lost even though NHE3 was phosphorylated at serines 552 and 605. Thus, ezrin is not necessary for the apical localization, attachment to the cytoskeleton, baseline activity or cAMP induced phosphrylation of NHE3, but instead is required for cAMP mediated inhibition.	[Hayashi, Hisayoshi; Suzuki, Yuichi] Univ Shizuoka, Sch Food & Nutr Sci, Physiol Lab, Shizuoka 4228526, Japan; [Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Biol Sci Lab, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Krishnan, Devishree; Alexander, R. Todd] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Kocinsky, Hetal S.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Aronson, Peter S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Aronson, Peter S.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Alexander, R. Todd] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Shizuoka; Osaka University; Osaka University; University of Alberta; Yale University; Yale University; Yale University; McGill University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta	Alexander, RT (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	todd2@ualberta.ca	Hayashi, Hisayoshi/K-5883-2013; Alexander, R. Todd/G-1373-2012	Orlowski, John/0000-0001-7371-175X	Canadian Institute of Health Research; Clinician Scientist Award from CIHR; Alberta Heritage Foundation for Medical Research (AHFMR); Grants-in-Aid for Scientific Research [23590334] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Clinician Scientist Award from CIHR; Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by The Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.T. Alexander is supported by a Clinician Scientist Award from CIHR and an Alberta Heritage Foundation for Medical Research (AHFMR) funded Clinical Investigator Award.	Alexander RT, 2007, J BIOL CHEM, V282, P7376, DOI 10.1074/jbc.M608557200; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 1997, J CELL SCI, V110, P3011; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Chalumeau C, 2001, AM J PHYSIOL-RENAL, V280, pF283, DOI 10.1152/ajprenal.2001.280.2.F283; Chiolero A, 2000, HYPERTENSION, V36, P631, DOI 10.1161/01.HYP.36.4.631; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Sole F, 2009, J AM SOC NEPHROL, V20, P1776, DOI 10.1681/ASN.2008121255; Dimke H, 2010, J AM SOC NEPHROL, V21, P1309, DOI 10.1681/ASN.2009111153; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Hayashi H, 2003, AM J PHYSIOL-GASTR L, V284, pG617, DOI 10.1152/ajpgi.00201.2002; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Hryciw DH, 2004, CLIN EXP PHARMACOL P, V31, P372, DOI 10.1111/j.1440-1681.2004.04001.x; Jaumouille V, 2011, CHANNELS, V5, P308, DOI 10.4161/chan.5.4.16548; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Kocinsky HS, 2007, AM J PHYSIOL-RENAL, V293, pF212, DOI 10.1152/ajprenal.00042.2007; Kocinsky HS, 2005, AM J PHYSIOL-RENAL, V289, pF249, DOI 10.1152/ajprenal.00082.2004; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Kurashima K, 1997, J BIOL CHEM, V272, P28672, DOI 10.1074/jbc.272.45.28672; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Minkoff C, 1999, CURR OPIN NEPHROL HY, V8, P603, DOI 10.1097/00041552-199909000-00012; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Szaszi K, 2000, CELL PHYSIOL BIOCHEM, V10, P265, DOI 10.1159/000016358; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Watts BA, 1999, J CLIN INVEST, V104, P1593, DOI 10.1172/JCI7332; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Weinman EJ, 2001, KIDNEY INT, V60, P450, DOI 10.1046/j.1523-1755.2001.060002450.x; Weinman EJ, 2000, AM J PHYSIOL-RENAL, V279, pF393, DOI 10.1152/ajprenal.2000.279.3.F393; Woodward AM, 2001, CELL BIOL INT, V25, P205, DOI 10.1006/cbir.2000.0635; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978; Zhao HR, 2004, P NATL ACAD SCI USA, V101, P9485, DOI 10.1073/pnas.0308400101; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	57	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55623	10.1371/journal.pone.0055623	http://dx.doi.org/10.1371/journal.pone.0055623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405179	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400124
J	Langer, MR; Weinmann, AE; Lotters, S; Bernhard, JM; Rodder, D				Langer, Martin R.; Weinmann, Anna E.; Loetters, Stefan; Bernhard, Joan M.; Roedder, Dennis			Climate-Driven Range Extension of Amphistegina (Protista, Foraminiferida): Models of Current and Predicted Future Ranges	PLOS ONE			English	Article							GLOBAL OCEAN CARBONATE; BENTHIC FORAMINIFERA; LARGER FORAMINIFERA; SEDIMENT PRODUCTION; COASTAL ECOSYSTEMS; INHACA ISLAND; AEGEAN SEA; ASSEMBLAGES; ORGANISMS; EXPANSION	Species-range expansions are a predicted and realized consequence of global climate change. Climate warming and the poleward widening of the tropical belt have induced range shifts in a variety of marine and terrestrial species. Range expansions may have broad implications on native biota and ecosystem functioning as shifting species may perturb recipient communities. Larger symbiont-bearing foraminifera constitute ubiquitous and prominent components of shallow water ecosystems, and range shifts of these important protists are likely to trigger changes in ecosystem functioning. We have used historical and newly acquired occurrence records to compute current range shifts of Amphistegina spp., a larger symbiont-bearing foraminifera, along the eastern coastline of Africa and compare them to analogous range shifts currently observed in the Mediterranean Sea. The study provides new evidence that amphisteginid foraminifera are rapidly progressing southwestward, closely approaching Port Edward (South Africa) at 31 degrees S. To project future species distributions, we applied a species distribution model (SDM) based on ecological niche constraints of current distribution ranges. Our model indicates that further warming is likely to cause a continued range extension, and predicts dispersal along nearly the entire southeastern coast of Africa. The average rates of amphisteginid range shift were computed between 8 and 2.7 km year 21, and are projected to lead to a total southward range expansion of 267 km, or 2.4 degrees latitude, in the year 2100. Our results corroborate findings from the fossil record that some larger symbiont-bearing foraminifera cope well with rising water temperatures and are beneficiaries of global climate change.	[Langer, Martin R.; Weinmann, Anna E.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Loetters, Stefan] Univ Trier, Biogeog Dept, Trier, Germany; [Bernhard, Joan M.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Roedder, Dennis] Museum Koenig, Zool Forsch Musem Alexander Koenig, Bonn, Germany	University of Bonn; Universitat Trier; Woods Hole Oceanographic Institution; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Langer, MR (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	martin.langer@uni-bonn.de	Rödder, Dennis/AAT-8644-2021; Weinmann, Anna E./AAS-7145-2021; Bernhard, Joan/M-3260-2013	Rödder, Dennis/0000-0002-6108-1639; Weinmann, Anna E./0000-0002-7999-0486; Bernhard, Joan/0000-0003-2121-625X	German Science Foundation (DFG) [LA 884/10-1, LA 884/5-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Science Foundation (DFG; www.dfg.de) to ML and SL (LA 884/10-1, LA 884/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABU TAIR N. K., 2011, THESIS RHEINISCHE FR; ALBANI A. D., 1965, CONTRIB CUSHMAN FOUND FORAMINIFERAL RES, V16, P60; Alory G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028044; [Anonymous], 1999, BEACH FIELD GUIDE LA; Banner F.T., 1981, P350; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Battistini R., 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Geologie, V8, P147; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Belderson RH, 1961, THESIS U NATAL DURBA; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Brady, 1884, ZOOLOGY, V9, P1; Braga J. M., 1961, Publicacoes do Instituto de Zoologia Dr Augusto Nobre, V77, P1; Cai WJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030380; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Chaproniere G.C.H., 1984, BUR MINERAL RESOUR G; CHAPRONIERE GCH, 1980, PALAEOGEOGR PALAEOCL, V31, P299, DOI 10.1016/0031-0182(80)90023-1; CHASENS S A, 1981, Journal of Foraminiferal Research, V11, P191; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark RM, 2010, INT J CLIMATOL, V30, P1599, DOI 10.1002/joc.2004; Cooper J.A.G., 1987, South African Journal of Geology, V90, P489; Cudmore TJ, 2010, J APPL ECOL, V47, P1036, DOI 10.1111/j.1365-2664.2010.01848.x; Dale DC, 1998, S AFR J SCI, V94, P319; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Dambach J, 2011, AQUAT CONSERV, V21, P92, DOI 10.1002/aqc.1160; dOrbigny A., 1826, ANN SCI NATURELLES, V7, P245; Egger JG, 1893, KONIGLICHE BAYERISCH, V18, P139; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fu Q, 2006, SCIENCE, V312, P1179, DOI 10.1126/science.1125566; Funk C, 2008, P NATL ACAD SCI USA, V105, P11081, DOI 10.1073/pnas.0708196105; Goldbeck EJ, 2009, SOC SEDIMENT GEOL SP, V93, P187; Goldstein ST, 1999, MODERN FORAMINIFERA, P37; Grosholz ED, 1996, ECOLOGY, V77, P1680, DOI 10.2307/2265773; Guarino L, 2001, DIVA GIS GEOGRAPHIC; HALLOCK P, 1981, Journal of Foraminiferal Research, V11, P40; HALLOCK P, 1981, J SEDIMENT PETROL, V51, P467; HALLOCK P, 1986, J FORAMIN RES, V16, P1, DOI 10.2113/gsjfr.16.1.1; Hallock P, 1999, MODERN FORAMINIFERA, P123; Hallock P., 2011, GSA ABSTRACTS PROGRA, P556; Hannah L, 2002, GLOBAL ECOL BIOGEOGR, V11, P485, DOI 10.1046/j.1466-822X.2002.00306.x; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Heron-Allen E., 1915, Transactions of the Zoological Society of London, V20; Hiddink JG, 2012, GLOBAL CHANGE BIOL, V18, P2161, DOI 10.1111/j.1365-2486.2012.02698.x; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hottinger L., 1977, Memoires Mus natn Hist nat Paris (Sci Terre), V40, P1; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kinlan BP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P381; Kintisch E, 2008, SCIENCE, V322, P182, DOI 10.1126/science.322.5899.182; Langer M.R., 2008, AQABA EILAT IMPROBAB, P399; LANGER M.R., 2006, ANUARIO I GEOCIENCIA, V29, P686; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Langer MR, 2012, J FORAMIN RES, V42, P234, DOI 10.2113/gsjfr.42.3.234; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Langer MR, 1997, J FORAMIN RES, V27, P271, DOI 10.2113/gsjfr.27.4.271; LARSEN AR, 1976, ISRAEL J EARTH SCI, V25, P1; Le Calvez Y, 1965, CAHIERS OFFICE RECHE, V11, P181; le Roux PC, 2008, GLOBAL CHANGE BIOL, V14, P2950, DOI 10.1111/j.1365-2486.2008.01687.x; LEE JJ, 1995, BIOSCIENCE, V45, P252, DOI 10.2307/1312418; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Levy A., 1982, Cahiers de Micropaleontologie Nouvelle Serie, V1982, P135; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luning K, 1990, SEAWEEDS THEIR ENV B, P527; McIntyre-Wressnig A, MAR ECOL PR IN PRESS; McMillan I.K., 1974, THESIS U COLL WALES; MCMILLAN IK, 1986, S AFR J SCI, V82, P66; Mobius K., 1880, BEITRAGE MEERESFAUNA, P65, DOI [10.1007/978-94-017-6608-1, DOI 10.1007/978-94-017-6608-1]; MONIER C, 1973, Tethys, V5, P241; MONTAGGIONI LF, 1981, ANN I OCEANOGR PARIS, V57, P41; Moura AR, 1965, REV ESTUDOS GERAIS 2, V2, P1; Murray JW, 1973, DISTRIBUTION ECOLOGY, P244; NEAGU T, 1982, Revista Espanola de Micropaleontologia, V14, P99; Oviatt CA, 2004, ESTUARIES, V27, P895, DOI 10.1007/BF02803416; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry M. L., 2007, CLIMATE CHANGE 2007; Pearce J, 2000, ECOL MODEL, V128, P127, DOI 10.1016/S0304-3800(99)00227-6; Pearson PN, 2010, SCIENCE, V330, P763, DOI 10.1126/science.1197894; Pereira CPG, 1979, THESIS U WALES ABERY; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Perry CT, 2005, SEDIMENT GEOL, V174, P161, DOI 10.1016/j.sedgeo.2004.12.003; Perry CT, 2003, CORAL REEFS, V22, P485, DOI 10.1007/s00338-003-0339-9; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Phleger F.B., 1976, Maritime Sediments Spec Publ, VNo. 1,A, P195; Phleger FB, 1976, ST LUC SCI ADV COUNC, P1; Pignatti J, 2012, ITAL J GEOSCI, V131, P47, DOI 10.3301/IJG.2011.22; Pujalte V, 2009, GEOL ACTA, V7, P161, DOI 10.1344/105.000000276; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Rogl Fred, 1993, Acta Geologica Polonica, V43, P121; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Scheibner C., 2008, eEarth, V3, P19; Scheibner C, 2008, EARTH-SCI REV, V90, P71, DOI 10.1016/j.earscirev.2008.07.002; Schmidt-Nielson K, 1990, ANIMAL PHYSL ADAPTAT, P217; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; SIMBERLOFF D, 2000, INTRO SPECIES THREAT; Solomon S., 2007, PHYS SCI BASIS WORKI; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Todd R., 1976, P382; Toefy R., 2005, African Invertebrates, V46, P1; Triantaphyllou MV, 2009, MEDITERR MAR SCI, V10, P73, DOI 10.12681/mms.111; Triantaphyllou MV, 2012, J FORAMIN RES, V42, P143, DOI 10.2113/gsjfr.42.2.143; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Vogel N, 2012, J EXP MAR BIOL ECOL, V424, P15, DOI 10.1016/j.jembe.2012.05.008; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Wright C.I., 1990, South African Journal of Geology, V93, P592; Wright E. P., 1876, Proceedings of the Royal Irish Academy, V(2), P586; Wright EP, 1877, J NAT HIST 4, V4, P40; Yamano H, 2000, CORAL REEFS, V19, P51, DOI 10.1007/s003380050226; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZMIRI A, 1974, J PROTOZOOL, V21, P133, DOI 10.1111/j.1550-7408.1974.tb03626.x	119	50	51	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54443	10.1371/journal.pone.0054443	http://dx.doi.org/10.1371/journal.pone.0054443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405081	Green Published, gold			2022-12-27	WOS:000315153400025
J	Lima, FD; Stamm, DN; Della-Pace, ID; Dobrachinski, F; de Carvalho, NR; Royes, LFF; Soares, FA; Rocha, JB; Gonzalez-Gallego, J; Bresciani, G				Lima, Frederico D.; Stamm, Daniel N.; Della-Pace, Iuri D.; Dobrachinski, Fernando; de Carvalho, Nelson R.; Royes, Luiz Fernando F.; Soares, Felix A.; Rocha, Joao B.; Gonzalez-Gallego, Javier; Bresciani, Guilherme			Swimming Training Induces Liver Mitochondrial Adaptations to Oxidative Stress in Rats Submitted to Repeated Exhaustive Swimming Bouts	PLOS ONE			English	Article							SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; PHYSICAL-EXERCISE; INTENSITY EXERCISE; ELECTRON-TRANSPORT; LIPID-PEROXIDATION; INSULIN-RESISTANCE; REGULAR EXERCISE; GENE-EXPRESSION; FREE-RADICALS	Background and Aims: Although acute exhaustive exercise is known to increase liver reactive oxygen species (ROS) production and aerobic training has shown to improve the antioxidant status in the liver, little is known about mitochondria adaptations to aerobic training. The main objective of this study was to investigate the effects of the aerobic training on oxidative stress markers and antioxidant defense in liver mitochondria both after training and in response to three repeated exhaustive swimming bouts. Methods: Wistar rats were divided into training (n = 14) and control (n = 14) groups. Training group performed a 6-week swimming training protocol. Subsets of training (n = 7) and control (n = 7) rats performed 3 repeated exhaustive swimming bouts with 72 h rest in between. Oxidative stress biomarkers, antioxidant activity, and mitochondria functionality were assessed. Results: Trained group showed increased reduced glutathione (GSH) content and reduced/oxidized (GSH/GSSG) ratio, higher superoxide dismutase (MnSOD) activity, and decreased lipid peroxidation in liver mitochondria. Aerobic training protected against exhaustive swimming ROS production herein characterized by decreased oxidative stress markers, higher antioxidant defenses, and increases in methyl-tetrazolium reduction and membrane potential. Trained group also presented higher time to exhaustion compared to control group. Conclusions: Swimming training induced positive adaptations in liver mitochondria of rats. Increased antioxidant defense after training coped well with exercise-produced ROS and liver mitochondria were less affected by exhaustive exercise. Therefore, liver mitochondria also adapt to exercise-induced ROS and may play an important role in exercise performance.	[Lima, Frederico D.; Stamm, Daniel N.; Della-Pace, Iuri D.; Royes, Luiz Fernando F.; Bresciani, Guilherme] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, BR-97119900 Santa Maria, RS, Brazil; [Dobrachinski, Fernando; de Carvalho, Nelson R.; Soares, Felix A.; Rocha, Joao B.] Univ Fed Santa Maria, CCNE, Dept Quim, BR-97119900 Santa Maria, RS, Brazil; [Gonzalez-Gallego, Javier] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain; [Gonzalez-Gallego, Javier] Univ Leon, Ctr Invest Biomed Red Enfermedades Hepat & Digest, E-24071 Leon, Spain	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidad de Leon; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de Leon	Bresciani, G (corresponding author), Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, BR-97119900 Santa Maria, RS, Brazil.	guilhermebresciani@gmail.com	Lima, Frederico Diniz/P-8479-2015; Dobrachinski, Fernando/C-4316-2014; Soares, Félix/AAE-6251-2020; royes, luiz/T-3581-2019; da Rocha, Joao Batista Teixeira/S-6813-2016; Soares, Félix AA/K-7611-2012; Rocha, João Batista Teixeira/AAI-5377-2021; Gonzalez-Gallego, Javier/D-8219-2012	Lima, Frederico Diniz/0000-0002-3298-2833; Dobrachinski, Fernando/0000-0002-3948-1273; Soares, Félix/0000-0002-6453-7902; da Rocha, Joao Batista Teixeira/0000-0003-3829-0595; Soares, Félix AA/0000-0002-6453-7902; Rocha, João Batista Teixeira/0000-0003-3829-0595; Gonzalez-Gallego, Javier/0000-0002-4386-9342; Stamm, Daniel Neis/0000-0003-2967-3391; Bresciani, Guilherme/0000-0003-1526-5573; Carvalho, Nelson/0000-0001-9882-2050; royes, luiz/0000-0003-4045-4827	Instituto de Salud Carlos III, Spain	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	CIBERehd is funded by the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Alessio HM, 2000, MED SCI SPORT EXER, V32, P1576; ALI SF, 1992, NEUROTOXICOLOGY, V13, P637; Arida RM, 1999, EPILEPSY RES, V37, P45, DOI 10.1016/S0920-1211(99)00032-7; Belardinelli P, 2007, NEUROIMAGE, V37, P1301, DOI 10.1016/j.neuroimage.2007.05.053; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; BHATTACHARYA SK, 1991, ANAL BIOCHEM, V192, P344, DOI 10.1016/0003-2697(91)90546-6; Botezelli JD, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-35; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cakir B, 2010, CELL BIOCHEM FUNCT, V28, P469, DOI 10.1002/cbf.1679; Clavel S, 2002, EUR J APPL PHYSIOL, V87, P193, DOI 10.1007/s00421-002-0612-6; Cobley JN, 2011, INT J SPORT NUTR EXE, V21, P451, DOI 10.1123/ijsnem.21.6.451; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; da Luz G, 2011, EUR J APPL PHYSIOL, V111, P2015, DOI 10.1007/s00421-010-1802-2; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; de Araujo GG, 2007, COMP BIOCHEM PHYS A, V148, P888, DOI 10.1016/j.cbpa.2007.09.002; De Minicis S, 2006, GASTROENTEROLOGY, V131, P272, DOI 10.1053/j.gastro.2006.05.048; Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Fogarty MC, 2011, ENVIRON MOL MUTAGEN, V52, P35, DOI 10.1002/em.20572; Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2; Gomez-Cabrera MC, 2009, PHYSICIAN SPORTSMED, V37, P116, DOI 10.3810/psm.2009.12.1749; Grassi B, 2011, EUR J APPL PHYSIOL, V111, P345, DOI 10.1007/s00421-010-1609-1; Gul M, 2002, SCAND J MED SCI SPOR, V12, P163, DOI 10.1034/j.1600-0838.2002.120307.x; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hoene M, 2010, DIABETOLOGIA, V53, P1131, DOI 10.1007/s00125-010-1666-3; Hoene M, 2010, EXERC IMMUNOL REV, V16, P163; Hollander J, 1999, AM J PHYSIOL-REG I, V277, pR856, DOI 10.1152/ajpregu.1999.277.3.R856; Huang CC, 2008, EXP GERONTOL, V43, P571, DOI 10.1016/j.exger.2008.03.002; Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149; Kiens B, 1998, AM J PHYSIOL-ENDOC M, V275, pE332, DOI 10.1152/ajpendo.1998.275.2.E332; Kiraly MA, 2005, INT J PSYCHIAT MED, V35, P75, DOI 10.2190/HX7L-4B40-PQNY-2A4P; Kiran TR, 2006, J COMP PHYSIOL B, V176, P749, DOI 10.1007/s00360-006-0096-5; Korivi M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/932165; Lazarevic G, 2006, DIABETES METAB, V32, P583, DOI 10.1016/S1262-3636(07)70312-9; Lee FT, 2009, AM J CHINESE MED, V37, P557, DOI 10.1142/S0192415X09007053; LEEUWENBURGH C, 1995, ARCH BIOCHEM BIOPHYS, V316, P941, DOI 10.1006/abbi.1995.1125; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; LEW H, 1985, FEBS LETT, V185, P262, DOI 10.1016/0014-5793(85)80919-4; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Linton S, 2001, EXP GERONTOL, V36, P1503, DOI 10.1016/S0531-5565(01)00136-X; Liu JK, 2000, J APPL PHYSIOL, V89, P21; Malaguti M, 2009, J APPL PHYSIOL, V107, P1028, DOI 10.1152/japplphysiol.00293.2009; Marquezi ML, 2003, INT J SPORT NUTR EXE, V13, P65, DOI 10.1123/ijsnem.13.1.65; Mastorakos G, 2005, HORM METAB RES, V37, P577, DOI 10.1055/s-2005-870426; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MRTENSSON J, 1991, P NATL ACAD SCI USA, V88, P4656, DOI 10.1073/pnas.88.11.4656; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Nikolaidis MG, 2008, SPORTS MED, V38, P579, DOI 10.2165/00007256-200838070-00005; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Packer L, 2007, FREE RADICAL RES, V41, P951, DOI 10.1080/10715760701490975; Pastor A, 1996, J HEPATOL, V24, P353, DOI 10.1016/S0168-8278(96)80016-X; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Radak Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje; Radak Z, 2000, ARCH BIOCHEM BIOPHYS, V383, P114, DOI 10.1006/abbi.2000.2042; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Rasmussen UF, 2001, PFLUG ARCH EUR J PHY, V443, P180, DOI 10.1007/s004240100689; Remedio RN, 2011, MICRON, V42, P484, DOI 10.1016/j.micron.2011.01.008; Sachdev S, 2008, FREE RADICAL BIO MED, V44, P215, DOI 10.1016/j.freeradbiomed.2007.07.019; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003; Veneroso C, 2009, J PINEAL RES, V47, P184, DOI 10.1111/j.1600-079X.2009.00699.x; VILLA JG, 1993, INT J SPORTS MED, V14, P179, DOI 10.1055/s-2007-1021160; WILLIS WT, 1994, MED SCI SPORT EXER, V26, P1347; Wilson DO, 2000, J APPL PHYSIOL, V88, P1791, DOI 10.1152/jappl.2000.88.5.1791; Yoshioka M, 2001, INT J OBESITY, V25, P332, DOI 10.1038/sj.ijo.0801554	71	56	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55668	10.1371/journal.pone.0055668	http://dx.doi.org/10.1371/journal.pone.0055668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405192	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400137
J	Merga, JY; Williams, NJ; Miller, WG; Leatherbarrow, AJH; Bennett, M; Hall, N; Ashelford, KE; Winstanley, C				Merga, J. Yvette; Williams, Nicola J.; Miller, William G.; Leatherbarrow, Andrew J. H.; Bennett, Malcolm; Hall, Neil; Ashelford, Kevin E.; Winstanley, Craig			Exploring the Diversity of Arcobacter butzleri from Cattle in the UK Using MLST and Whole Genome Sequencing	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; CAMPYLOBACTER SPP.; GENETIC DIVERSITY; HEALTHY CATTLE; RETAIL MEATS; PREVALENCE; IDENTIFICATION; ARTEMIS; SAMPLES	Arcobacter butzleri is considered to be an emerging human foodborne pathogen. The completion of an A. butzleri genome sequence along with microarray analysis of 13 isolates in 2007 revealed a surprising amount of diversity amongst A. butzleri isolates from humans, animals and food. In order to further investigate Arcobacter diversity, 792 faecal samples were collected from cattle on beef and dairy farms in the North West of England. Arcobacter was isolated from 42.5% of the samples and the diversity of the isolates was investigated using multilocus sequence typing. An A. butzleri whole genome sequence, obtained by 454 shotgun sequencing of an isolate from a clinically-healthy dairy cow, showed a number of differences when compared to the genome of a human-derived A. butzleri isolate. PCR-based prevalence assays for variable genes suggested some tentative evidence for source-related distributions. We also found evidence for phenotypic differences relating to growth capabilities between our representative human and cattle isolates. Our genotypic and phenotypic observations suggest that some level of niche adaptation may have occurred in A. butzleri.	[Merga, J. Yvette; Williams, Nicola J.; Leatherbarrow, Andrew J. H.; Bennett, Malcolm; Winstanley, Craig] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Miller, William G.] USDA, Produce Safety & Microbiol Res Unit, Albany, CA USA; [Hall, Neil; Ashelford, Kevin E.] Univ Liverpool, Inst Integrat Biol, Adv Genom Facil, Liverpool L69 3BX, Merseyside, England	University of Liverpool; United States Department of Agriculture (USDA); University of Liverpool	Merga, JY (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.	ysloane@liv.ac.uk	; Bennett, Malcolm/G-4004-2010	Merga, Yvette/0000-0002-0692-1455; Bennett, Malcolm/0000-0003-0475-390X; Hall, Neil/0000-0003-2808-0009; Williams, Nicola/0000-0003-4709-4190; Ashelford, Kevin/0000-0003-3217-2811; Bennett, Malcolm/0000-0002-5490-2910; Winstanley, Craig/0000-0002-2662-8053	Higher Education Funding Council for England (HEFCE); Department for Environment, Food and Rural Affairs; MRC [MR/K002279/1] Funding Source: UKRI; Medical Research Council [MR/K002279/1] Funding Source: researchfish	Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Higher Education Funding Council for England (HEFCE) and the Department for Environment, Food and Rural Affairs, as part of the Veterinary Training and Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Aydin F, 2007, J APPL MICROBIOL, V103, P27, DOI 10.1111/j.1365-2672.2006.03240.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Collado L, 2009, INT J SYST EVOL MICR, V59, P1391, DOI 10.1099/ijs.0.003749-0; De Smet S, 2011, INT J SYST EVOL MICR, V61, P356, DOI 10.1099/ijs.0.022665-0; Gonzalez A, 2007, CUADERNOS HISPANOAM, P85; Gonzalez I, 2000, LETT APPL MICROBIOL, V30, P207, DOI [10.1046/j.1472-765x.2000.00696.x, 10.1046/j.1472-765X.2000.00696.x]; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hamill S, 2008, J FOOD PROTECT, V71, P850, DOI 10.4315/0362-028X-71.4.850; Houf K, 2002, APPL ENVIRON MICROB, V68, P2172, DOI 10.1128/AEM.68.5.2172-2178.2002; Houf K, 2001, INT J FOOD MICROBIOL, V71, P189, DOI 10.1016/S0168-1605(01)00605-5; Houf K, 2000, FEMS MICROBIOL LETT, V193, P89, DOI 10.1111/j.1574-6968.2000.tb09407.x; Hume ME, 2001, J FOOD PROTECT, V64, P645, DOI 10.4315/0362-028X-64.5.645; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Kabeya H, 2004, INT J FOOD MICROBIOL, V90, P303, DOI 10.1016/S0168-1605(03)00322-2; Kemp R, 2005, APPL ENVIRON MICROB, V71, P1876, DOI 10.1128/AEM.71.4.1876-1882.2005; Merga Y, 2011, APPL ENVIRON MICROB, V75, P1646; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; Miller WG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-196; Ongor H, 2004, LETT APPL MICROBIOL, V38, P339, DOI 10.1111/j.1472-765X.2004.01494.x; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Rivas L, 2004, INT J FOOD MICROBIOL, V91, P31, DOI 10.1016/S0168-1605(03)00328-3; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scullion R, 2006, J FOOD PROTECT, V69, P1986, DOI 10.4315/0362-028X-69.8.1986; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toh H, 2011, J BACTERIOL, V193, P6411, DOI 10.1128/JB.06084-11; Van Driessche E, 2005, VET MICROBIOL, V105, P149, DOI 10.1016/j.vetmic.2004.11.002; Van Driessche E, 2004, RES MICROBIOL, V155, P662, DOI 10.1016/j.resmic.2004.04.011; Van Driessche E, 2003, FEMS MICROBIOL LETT, V229, P243, DOI 10.1016/S0378-1097(03)00840-1; VANDAMME P, 1992, J CLIN MICROBIOL, V30, P2335, DOI 10.1128/JCM.30.9.2335-2337.1992; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Vilar MJ, 2010, BERL MUNCH TIERARZTL, V123, P58, DOI 10.2376/0005-9366-123-58; Villarruel-Lopez A, 2003, J FOOD PROTECT, V66, P1374, DOI 10.4315/0362-028X-66.8.1374; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang GH, 2002, J CLIN MICROBIOL, V40, P4744, DOI 10.1128/JCM.40.12.4744-4747.2002; Wesley IV, 2000, APPL ENVIRON MICROB, V66, P1994, DOI 10.1128/AEM.66.5.1994-2000.2000	38	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55240	10.1371/journal.pone.0055240	http://dx.doi.org/10.1371/journal.pone.0055240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405126	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400071
J	Nyari, AS; Reddy, S				Nyari, Arpad S.; Reddy, Sushma			Comparative Phyloclimatic Analysis and Evolution of Ecological Niches in the Scimitar Babblers (Aves: Timaliidae: Pomatorhinus)	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTIONS; PLEISTOCENE REFUGIA; ALCIPPE-MORRISONIA; SPECIES-LIMITS; CONSERVATISM; DIVERSIFICATION; BIOGEOGRAPHY; PATTERNS; PHYLOGEOGRAPHY	We present the first extensive and integrative analysis of niche evolution based on climatic variables and a dated molecular phylogeny of a heterogeneous avian group of Southeast Asian scimitar babblers of the genus Pomatorhinus. The four main clades of scimitar babblers have species that co-occur in similar areas across southern Asia but some have diverged at different timeframes, with the most recently evolved clade harboring the highest number of species. Ecological niche models and analysis of contributing variables within a phylogenetic framework indicate instances of convergent evolution of members of different clades onto similar ecological parameter space, as well as divergent evolution of members from within clades. Pomatorhinus species from different clades occupying Himalayan foothills show convergence towards similar climatic tolerances, whereas within a clade, allopatric sister-species occurring in the Himalayas have diverged to occupy different climatic parameter spaces. Comparisons of climatic tolerances of Himalayan foothills taxa with species distributed further south in Assam/Burma and Burma/Thailand indicate convergence towards similar parameter spaces in several climatic variables. Niche overlap was observed to be lower among species of the youngest clade (ruficollis) and higher among species of older clades (ferruginosus). Analysis of accumulation of ecological disparity through time indicates rapid divergence within recent time frames. As a result, Himalayan taxa originating at different temporal scales within the four main scimitar babbler clades have differentiated ecologically only in recently diverged taxa. Our study suggests that the repeated orogenic and climatic fluctuations of the Pliocene and Pleistocene within mainland Southeast Asia served as an important ecological speciation driver within scimitar babblers, by providing opportunities for rapid geographic expansion and filling of novel environmental niches.	[Nyari, Arpad S.; Reddy, Sushma] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Nyari, Arpad S.] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA	Loyola University Chicago; Oklahoma State University System; Oklahoma State University - Stillwater	Nyari, AS (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	arpinyari@gmail.com		Reddy, Sushma/0000-0001-7263-0763	NSF [DEB-0962078]; Loyola University Chicago's Provost's Office	NSF(National Science Foundation (NSF)); Loyola University Chicago's Provost's Office	Funding for this research was provided by NSF DEB-0962078 and Loyola University Chicago's Provost's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anciaes M, 2009, J AVIAN BIOL, V40, P591, DOI 10.1111/j.1600-048X.2009.04597.x; [Anonymous], 2014, TRACER V1 6; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Brookfield ME, 1998, GEOMORPHOLOGY, V22, P285, DOI 10.1016/S0169-555X(97)00082-2; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Chen Y, 2007, CURRENT SCI, V92; Cibois A, 2003, AUK, V120, P35, DOI 10.1642/0004-8038(2003)120[0035:MDPOBT]2.0.CO;2; Collar NJ, 2007, HDB BIRDS WORLD, V12, P165; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eaton MD, 2008, BIOL J LINN SOC, V94, P869, DOI 10.1111/j.1095-8312.2008.01040.x; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Gelang M, 2009, ZOOL SCR, V38, P225, DOI 10.1111/j.1463-6409.2008.00374.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jakob SS, 2010, MOL ECOL, V19, P1423, DOI 10.1111/j.1365-294X.2010.04582.x; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Moyle RG, 2005, J AVIAN BIOL, V36, P96, DOI 10.1111/j.0908-8857.2005.03510.x; Moyle RG, 2012, SYST BIOL, V61, P631, DOI 10.1093/sysbio/sys027; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Nyari AS, 2009, MOL PHYLOGENET EVOL, V53, P613, DOI 10.1016/j.ympev.2009.06.014; Nyari AS, 2009, ZOOL SCR, V38, P553, DOI 10.1111/j.1463-6409.2009.00397.x; Ollier C., 2000, ORIGIN MOUNTAINS; Olsson U, 2005, MOL PHYLOGENET EVOL, V36, P261, DOI 10.1016/j.ympev.2005.01.012; Olsson U, 2006, MOL PHYLOGENET EVOL, V41, P556, DOI 10.1016/j.ympev.2006.05.009; Packert M, 2012, J BIOGEOGR, V39, P556, DOI 10.1111/j.1365-2699.2011.02606.x; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Peterson AT, 2007, ECOL MODEL, V203, P527, DOI 10.1016/j.ecolmodel.2006.12.023; Peterson A. Townsend, 2003, Bulletin of the British Ornithologists' Club, V123A, P186; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Peterson AT, 2009, FRONTIERS BIOGEOGRAP, V1, P19, DOI DOI 10.21425/F5FBG12232; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price TD, 2011, AM NAT, V178, pS97, DOI 10.1086/661926; Rangin C, 1995, TECTONOPHYSICS, V251, P179, DOI 10.1016/0040-1951(95)00006-2; Reddy S, 2008, MOL PHYLOGENET EVOL, V47, P54, DOI 10.1016/j.ympev.2008.01.014; Reddy S, 2011, BIOL J LINN SOC, V102, P846, DOI 10.1111/j.1095-8312.2010.01611.x; Rice NH, 2003, BIOL J LINN SOC, V80, P369, DOI 10.1046/j.1095-8312.2003.00242.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schidelko K, 2011, BIOL J LINN SOC, V102, P455, DOI 10.1111/j.1095-8312.2010.01570.x; Schnitzler J, 2012, J BIOGEOGR, V39, P2201, DOI 10.1111/jbi.12028; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Yesson C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-72; Zou FH, 2007, MOL PHYLOGENET EVOL, V44, P165, DOI 10.1016/j.ympev.2006.12.004	63	34	34	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55629	10.1371/journal.pone.0055629	http://dx.doi.org/10.1371/journal.pone.0055629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405183	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400128
J	Wang, JY; Zhang, Z; Wang, YL; Li, L; Chai, RY; Mao, XQ; Jiang, H; Qiu, HP; Du, XF; Lin, FC; Sun, GC				Wang, Jiaoyu; Zhang, Zhen; Wang, Yanli; Li, Ling; Chai, Rongyao; Mao, Xueqin; Jiang, Hua; Qiu, Haiping; Du, Xinfa; Lin, Fucheng; Sun, Guochang			PTS1 Peroxisomal Import Pathway Plays Shared and Distinct Roles to PTS2 Pathway in Development and Pathogenicity of Magnaporthe oryzae	PLOS ONE			English	Article							MEDIATED PLANT INFECTION; RICE BLAST FUNGUS; TARGETING SIGNAL TYPE-2; SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; PENICILLIUM-CHRYSOGENUM; COLLETOTRICHUM-LAGENARIUM; HANSENULA-POLYMORPHA; APPRESSORIUM TURGOR; YARROWIA-LIPOLYTICA	Peroxisomes participate in various important metabolisms and are required in pathogenicity of fungal plant pathogens. Peroxisomal matrix proteins are imported from cytoplasm into peroxisomes through peroxisomal targeting signal 1 (PTS1) or peroxisomal targeting signal 2 (PTS2) import pathway. PEX5 and PEX7 genes participate in the two pathways respectively. The involvement of PEX7 mediated PTS2 import pathway in fungal pathogenicity has been documented, while that of PTS1 remains unclear. Through null mutant analysis of MoPEX5, the PEX5 homolog in Magnaporthe oryzae, we report the crucial roles of PTS1 pathway in the development and host infection in the rice blast fungus, and compared with those of PTS2. We found that MoPEX5 disruption specifically blocked the PTS1 pathway. Delta mopex5 was unable to use lipids as sole carbon source and lost pathogenicity completely. Similar as Delta mopex7, Delta mopex5 exhibited significant reduction in lipid utilization and mobilization, appressorial turgor genesis and H2O2 resistance. Additionally, Delta mopex5 presented some distinct defects which were undetected in Delta mopex7 in vegetative growth, conidial morphogenesis, appressorial morphogenesis and melanization. The results indicated that the PTS1 peroxisomal import pathway, in addition to PTS2, is required for fungal development and pathogenicity of the rice blast fungus, and also, as a main peroxisomal import pathway, played a more predominant role than PTS2.	[Wang, Jiaoyu; Zhang, Zhen; Wang, Yanli; Li, Ling; Chai, Rongyao; Mao, Xueqin; Jiang, Hua; Qiu, Haiping; Du, Xinfa; Sun, Guochang] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect Microbiol, Hangzhou, Zhejiang, Peoples R China; [Lin, Fucheng] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang University	Sun, GC (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect Microbiol, Hangzhou, Zhejiang, Peoples R China.	sungc01@sina.com	Lin, Fucheng/ABE-7591-2021	Lin, Fucheng/0000-0002-4127-8143	Natural Science Foundation of China [30900933, 30970082, 31170136]; National Basic Research Program of China [2012CB722504]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the Natural Science Foundation of China (No: 30900933 to JW, 30970082 to GS and 31170136 to JW) and the National Basic Research Program of China (No: 2012CB722504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amano T, 2003, ANAL BIOCHEM, V314, P1, DOI 10.1016/S0003-2697(02)00653-X; Asakura M, 2006, APPL ENVIRON MICROB, V72, P6345, DOI 10.1128/AEM.00988-06; Asiegbu FO, 2004, FEMS MICROBIOL LETT, V230, P85, DOI 10.1016/S0378-1097(03)00858-9; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; COE JGS, 1994, MOL GEN GENET, V244, P661, DOI 10.1007/BF00282757; CRAWFORD MS, 1986, GENETICS, V114, P1111; Deng YZ, 2009, AUTOPHAGY, V5, P33, DOI 10.4161/auto.5.1.7175; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; Elgersma Y, 1996, BBA-REV BIOMEMBRANES, V1286, P269, DOI 10.1016/S0304-4157(96)00012-3; Fujihara N, 2010, MOL PLANT MICROBE IN, V23, P436, DOI 10.1094/MPMI-23-4-0436; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Hayashi M, 2005, J BIOL CHEM, V280, P14829, DOI 10.1074/jbc.M411005200; Hettema EH, 1999, BBA-MOL CELL RES, V1451, P17, DOI 10.1016/S0167-4889(99)00087-7; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kiel JAKW, 2004, FUNGAL GENET BIOL, V41, P708, DOI 10.1016/j.fgb.2004.02.006; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lee JR, 2006, PLANT J, V47, P457, DOI 10.1111/j.1365-313X.2006.02797.x; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Lu JP, 2005, FEMS MICROBIOL LETT, V245, P131, DOI 10.1016/j.femsle.2005.02.032; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; MIURA S, 1992, J BIOL CHEM, V267, P14405; Moser HW, 2000, FRONT BIOSCI, V5, pD298, DOI 10.2741/Moser; MULLER WH, 1991, EMBO J, V10, P489, DOI 10.1002/j.1460-2075.1991.tb07971.x; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; NOTTEGHEM JL, 1992, PHYTOPATHOLOGY, V82, P421, DOI 10.1094/Phyto-82-421; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Peraza-Reyes L, 2011, MOL MICROBIOL, V82, P365, DOI 10.1111/j.1365-2958.2011.07816.x; Purdue PE, 1998, J CELL BIOL, V143, P1859; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Rho HS, 2001, MOL CELLS, V12, P407; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SZILARD RK, 1995, J CELL BIOL, V131, P1453, DOI 10.1083/jcb.131.6.1453; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thoms S, 2006, BBA-MOL CELL RES, V1763, P1620, DOI 10.1016/j.bbamcr.2006.08.046; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17229, DOI 10.1074/jbc.270.29.17229; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P802, DOI 10.1631/jzus.B0860001; Wang Jiaoyu, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P129; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2005, BIOCHEM SOC T, V33, P384, DOI 10.1042/BST0330384; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; WOLOSHUK CP, 1983, PHYSIOL PLANT PATHOL, V22, P245; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65	67	14	22	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55554	10.1371/journal.pone.0055554	http://dx.doi.org/10.1371/journal.pone.0055554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405169	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400114
J	Xu, Q; Zhao, WM; Chen, Y; Tong, YY; Rong, GH; Huang, ZY; Zhang, Y; Chang, GB; Wu, XS; Chen, GH				Xu, Qi; Zhao, WenMing; Chen, Yang; Tong, YiYu; Rong, GuangHui; Huang, ZhengYang; Zhang, Yang; Chang, GuoBing; Wu, XinSheng; Chen, GuoHong			Transcriptome Profiling of the Goose (Anser cygnoides) Ovaries Identify Laying and Broodiness Phenotypes	PLOS ONE			English	Article							DIGITAL GENE-EXPRESSION; PROGESTERONE PRODUCTION; STAR	Background: The geese have strong broodiness and poor egg performance. These characteristics are the key issues that hinder the goose industry development. Yet little is known about the mechanisms responsible for follicle development due to lack of genomic resources. Hence, studies based on high-throughput sequencing technologies are needed to produce a comprehensive and integrated genomic resource and to better understand the biological mechanisms of goose follicle development. Methodology/Principal Findings: In this study, we performed de novo transcriptome assembly and gene expression analysis using short-read sequencing technology (Illumina). We obtained 67,315,996 short reads of 100 bp, which were assembled into 130,514 unique sequences by Trinity strategy (mean size = 753bp). Based on BLAST results with known proteins, these analyses identified 52,642 sequences with a cut-off E-value above 10(-5). Assembled sequences were annotated with gene descriptions, gene ontology and clusters of orthologous group terms. In addition, we investigated the transcription changes during the goose laying/broodiness period using a tag-based digital gene expression (DGE) system. We obtained a sequencing depth of over 4.2 million tags per sample and identified a large number of genes associated with follicle development and reproductive biology including cholesterol side-chain cleavage enzyme gene and dopamine beta-hydroxylas gene. We confirm the altered expression levels of the two genes using quantitative real-time PCR (qRT-PCR). Conclusions/Significance: The obtained goose transcriptome and DGE profiling data provide comprehensive gene expression information at the transcriptional level that could promote better understanding of the molecular mechanisms underlying follicle development and productivity.	[Xu, Qi; Zhao, WenMing; Chen, Yang; Tong, YiYu; Rong, GuangHui; Huang, ZhengYang; Zhang, Yang; Chang, GuoBing; Wu, XinSheng; Chen, GuoHong] Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Peoples R China	Yangzhou University	Chen, GH (corresponding author), Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Peoples R China.	ghchen@yzu.edu.cn	Huang, Zhengyang/J-6297-2013; XU, Qi/AID-2262-2022	Huang, Zhengyang/0000-0001-9197-6700; 	earmarked fund for Modern Agro-industry Technology Research System [CARS-43-3]; Priority Academic Program Development of Jiangsu Higher Education Institutions [[2011]137]	earmarked fund for Modern Agro-industry Technology Research System; Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-43-3) and Priority Academic Program Development of Jiangsu Higher Education Institutions [2011]137. Jiangsu Lihua Animal Husbandry CO. LTD provided the animal sample. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barbara R, 2007, STATE WORLDS ANIMAL, P252; Chen GH, 2004, CHINAS POULTRY GENET, P25; Cheng JH, 2009, COMPUTATIONAL SCI DI, P31; Cheng JinHua, 2011, Jiangsu Journal of Agricultural Sciences, V27, P818; Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Du XD, 2009, MRNA EXPRESSION PROF, P6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; [郭军 Guo Jun], 2011, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V42, P1477; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang B, 2009, POULTRY SCI, V88, P1975, DOI 10.3382/ps.2008-00519; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2010, GENOME RES, V20, P519, DOI 10.1101/gr.102129.109; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Rangel PL, 2009, REPRODUCTION, V138, P961, DOI 10.1530/REP-09-0071; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Sechman A, 2011, DOMEST ANIM ENDOCRIN, V41, P137, DOI 10.1016/j.domaniend.2011.05.007; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Toma SA, 2006, ANIMAL GENETICS, V8, P279; Wang BW, 2009, CHINA GOOSE IND, P25; Wei RH, 2009, MRNA EXPRESSION PROF, P9; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Zhang B, 2012, CHINESE POULTRY BREE, P25; Zhu P, 2009, MRNA EXPRESSION PROF, P10	34	48	56	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55496	10.1371/journal.pone.0055496	http://dx.doi.org/10.1371/journal.pone.0055496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405160	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400105
J	Okroglic, S; Widmann, CN; Urbach, H; Scheltens, P; Heneka, MT				Okroglic, Sandra; Widmann, Catherine N.; Urbach, Horst; Scheltens, Philip; Heneka, Michael T.			Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; WHITE-MATTER CHANGES; TYPE-2 DIABETES-MELLITUS; ISCHEMIC-STROKE; ROTTERDAM SCAN; COGNITIVE IMPAIRMENT; BRAIN; LEUKOARAIOSIS; LESIONS; LADIS	Objective: Although the clinical manifestation and risk factors of cerebral microangiopathy (CM) remain unclear, the number of diagnoses is increasing. Hence, patterns of association among lesion topography and severity, clinical symptoms and demographic and disease risk factors were investigated retrospectively in a cohort of CM patients. Methods: Patients treated at the Department of Neurology, University of Bonn for CM (n = 223; 98m, 125f; aged 77.32 +/- 9.09) from 2005 to 2010 were retrospectively enrolled. Clinical symptoms, blood chemistry, potential risk factors, demographic data and ratings of vascular pathology in the brain based on the Wahlund scale were analyzed using Pearson's chi square test and one-way ANOVA. Results: Progressive cognitive decline (38.1%), gait apraxia (27.8%), stroke-related symptoms and seizures (24.2%), TIA-symptoms (22%) and vertigo (17%) were frequent symptoms within the study population. Frontal lobe WMLs/lacunar infarcts led to more frequent presentation of progressive cognitive decline, seizures, gait apraxia, stroke-related symptoms, TIA, vertigo and incontinence. Parietooccipital WMLs/lacunar infarcts were related to higher frequencies of TIA, seizures and incontinence. Basal ganglia WMLs/lacunar infarcts were seen in patients with more complaints of gait apraxia, vertigo and incontinence. Age (p = .012), arterial hypertension (p<.000), obesity (p<.000) and cerebral macroangiopathy (p = .018) were positively related to cerebral lesion load. For increased glucose level, homocysteine, CRP and D-Dimers there was no association. Conclusion: This underlines the association of CM with neurological symptoms upon admission in a topographical manner. Seizures and vertigo are symptoms of CM which may have been missed in previous studies. In addition to confirming known risk factors such as aging and arterial hypertension, obesity appears to increase the risk as well. Since the incidence of CM is increasing, future studies should focus on the importance of prevention of vascular risk factors on its pathogenesis.	[Okroglic, Sandra; Widmann, Catherine N.; Heneka, Michael T.] Univ Bonn, Dept Neurol, Clin Neurosci Unit, Bonn, Germany; [Urbach, Horst] Univ Bonn, Dept Radiol, Neuroradiol Unit, Bonn, Germany; [Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands	University of Bonn; University of Bonn; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Heneka, MT (corresponding author), Univ Bonn, Dept Neurol, Clin Neurosci Unit, Bonn, Germany.	michael.heneka@ukb.uni-bonn.de	Heneka, Michael/AAE-8011-2019; Scheltens, Philip/AAL-9631-2020; Heneka, Michael/E-8072-2015	Scheltens, Philip/0000-0002-1046-6408; Heneka, Michael/0000-0003-4996-1630	Clinical Neuroscience Unit at the Department of Neurology, University of Bonn, Germany	Clinical Neuroscience Unit at the Department of Neurology, University of Bonn, Germany	Funding for this study was provided by the Clinical Neuroscience Unit at the Department of Neurology, University of Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Blahak C, 2009, J NEUROL NEUROSUR PS, V80, P608, DOI 10.1136/jnnp.2008.154633; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Brouns R, 2009, J NEUROL SCI, V285, P185, DOI 10.1016/j.jns.2009.06.032; de Lau LML, 2010, NEUROBIOL AGING, V31, P2020, DOI 10.1016/j.neurobiolaging.2008.10.004; De Reuck J, 2007, J NEUROL SCI, V263, P75, DOI 10.1016/j.jns.2007.06.004; Dufouil C, 2005, CIRCULATION, V112, P1644, DOI 10.1161/CIRCULATIONAHA.104.501163; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; INZITARI D, 1987, ARCH NEUROL-CHICAGO, V44, P42, DOI 10.1001/archneur.1987.00520130034014; Inzitari M, 2007, J NEUROL SCI, V257, P166, DOI 10.1016/j.jns.2007.01.026; Isenegger J, 2010, CEREBROVASC DIS, V29, P82, DOI 10.1159/000256652; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Jimenez-Conde J, 2010, STROKE, V41, P437, DOI 10.1161/STROKEAHA.109.563502; Karatas M, 2008, NEUROLOGIST, V14, P355, DOI 10.1097/NRL.0b013e31817533a3; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P818; Laloux P, 2004, ACTA NEUROL BELG, V104, P13; Lin HJ, 2007, J CLIN NEUROSCI, V14, P17, DOI 10.1016/j.jocn.2005.07.026; Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm; Miki Y, 1998, NEUROLOGY, V50, P1301, DOI 10.1212/WNL.50.5.1301; Mok VCT, 2009, J NEUROL, V256, P750, DOI 10.1007/s00415-009-5008-7; Oh SH, 2010, J NEUROL SCI, V293, P97, DOI 10.1016/j.jns.2010.02.025; Pantoni L, 1997, ANN NY ACAD SCI, V826, P92, DOI 10.1111/j.1749-6632.1997.tb48463.x; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Patel B, 2011, INT J STROKE, V6, P47, DOI 10.1111/j.1747-4949.2010.00552.x; Poggesi A, 2008, J AM GERIATR SOC, V56, P1638, DOI 10.1111/j.1532-5415.2008.01832.x; Reitz C, 2007, STROKE, V38, P2356, DOI 10.1161/STROKEAHA.107.482661; SCHREINER A, 1995, J NEUROL SCI, V130, P171, DOI 10.1016/0022-510X(95)00020-3; SPSS Statistics, 2008, SPSS STAT; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Teodorczuk A, 2010, PSYCHOL MED, V40, P603, DOI 10.1017/S0033291709990857; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; van Harten B, 2007, EUR NEUROL, V57, P70, DOI 10.1159/000098054; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Viana-Baptista M, 2008, J NEUROL, V255, P360, DOI 10.1007/s00415-008-0661-9; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318	35	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53455	10.1371/journal.pone.0053455	http://dx.doi.org/10.1371/journal.pone.0053455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393549	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800003
J	Sun, YL; Chen, JJ; Kumar, P; Chen, K; Sodani, K; Patel, A; Chen, YL; Chen, SD; Jiang, WQ; Chen, ZS				Sun, Yue-Li; Chen, Jun-Jiang; Kumar, Priyank; Chen, Kang; Sodani, Kamlesh; Patel, Atish; Chen, Yang-Lu; Chen, Si-Dong; Jiang, Wen-Qi; Chen, Zhe-Sheng			Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar	PLOS ONE			English	Article							P-GLYCOPROTEIN INHIBITOR; ABC TRANSPORTERS; PROTEIN-7 ABCC10; IN-VITRO; PHASE-I; XR9576; PACLITAXEL; MECHANISMS; EXPRESSION; SUBSTRATE	Multidrug resistance protein 7 (MRP7, ABCC10) is a recently discovered member of the ATP-binding cassette (ABC) family which are capable of conferring resistance to a variety of anticancer drugs, including taxanes and nucleoside analogs, in vivo. MRP7 is highly expressed in non-small cell lung cancer cells, and Mrp7-KO mice are highly sensitive to paclitaxel, making MRP7 an attractive chemotherapeutic target of non-small cell lung cancer. However, only a few inhibitors of MRP7 are currently identified, with none of them having progressed to clinical trials. We used MRP7-expressing cells to investigate whether tariquidar, a third generation inhibitor of P-glycoprotein, could inhibit MRP7-mediated multidrug resistance (MDR). We found that tariquidar, at 0.1 and 0.3 mu M, significantly potentiated the sensitivity of MRP7-transfected HEK293 cells to MRP7 substrates and increased the intracellular accumulation of paclitaxel. We further demonstrated that tariquidar directly impaired paclitaxel efflux and could downregulate MRP7 protein expression in a concentration-and time-dependent manner after prolonged treatment. Our findings suggest that tariquidar, at pharmacologically achievable concentrations, reverses MRP7-mediated MDR through inhibition of MRP7 protein expression and function, and thus represents a promising therapeutic agent in the clinical treatment of chemoresistant cancer patients.	[Sun, Yue-Li; Jiang, Wen-Qi] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Sun, Yue-Li; Jiang, Wen-Qi] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Yue-Li; Chen, Jun-Jiang; Kumar, Priyank; Sodani, Kamlesh; Patel, Atish; Chen, Yang-Lu; Chen, Zhe-Sheng] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY USA; [Chen, Jun-Jiang; Chen, Si-Dong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Chen, Kang] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Chen, Kang] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Bethesda, MD USA; [Chen, Yang-Lu] Montgomery High Sch, Skillman, NJ USA	Sun Yat Sen University; Saint John's University; Guangdong Pharmaceutical University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Jiang, WQ (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	wqjiang@yahoo.com; chenz@stjohns.edu	jiang, wen/GYI-9662-2022; Patel, Atish/J-4699-2014	Chen, Yanglu/0000-0002-6520-0412; Chen, Zhe-Sheng/0000-0002-8289-097X; Patel, Atish/0000-0002-5549-9166; Sodani, Kamlesh/0000-0003-4488-2984; Kumar, Priyank/0000-0002-4772-2073	National Institutes of Health [1R15CA143701]; St. John's University Research Seed Grant [579-1110-7002]; NATIONAL CANCER INSTITUTE [R15CA143701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. John's University Research Seed Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from National Institutes of Health (number 1R15CA143701) and St. John's University Research Seed Grant (number 579-1110-7002) to Z.S. Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2009, CLIN CANCER RES, V15, P3574, DOI 10.1158/1078-0432.CCR-08-0938; Ahmed-Belkacem A, 2006, ANTI-CANCER DRUG, V17, P239, DOI 10.1097/00001813-200603000-00001; Bauer F, 2010, BIOORGAN MED CHEM, V18, P5489, DOI 10.1016/j.bmc.2010.06.057; Borel F, 2012, HEPATOLOGY, V55, P821, DOI 10.1002/hep.24682; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen ZS, 2003, MOL PHARMACOL, V63, P351, DOI 10.1124/mol.63.2.351; Choi CH, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-30; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; Ferry DR, 1996, EUR J CANCER, V32A, P1070, DOI 10.1016/0959-8049(96)00091-3; Fox E, 2007, EXPERT REV ANTICANC, V7, P447, DOI 10.1586/14737140.7.4.447; Goler-Baron V, 2012, BIOCHEM PHARMACOL, V83, P1340, DOI 10.1016/j.bcp.2012.01.033; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Hopper-Borge E, 2004, CANCER RES, V64, P4927, DOI 10.1158/0008-5472.CAN-03-3111; Hopper-Borge E, 2009, CANCER RES, V69, P178, DOI 10.1158/0008-5472.CAN-08-1420; Hopper-Borge EA, 2011, CANCER RES, V71, P3649, DOI 10.1158/0008-5472.CAN-10-3623; Hubensack M, 2008, J CANCER RES CLIN, V134, P597, DOI 10.1007/s00432-007-0323-9; Kannan P, 2011, ACS CHEM NEUROSCI, V2, P82, DOI 10.1021/cn100078a; Kawamura K, 2010, ANN NUCL MED, V24, P403, DOI 10.1007/s12149-010-0373-y; Kelly RJ, 2011, CLIN CANCER RES, V17, P569, DOI 10.1158/1078-0432.CCR-10-1725; Kimura Y, 2007, CANCER SCI, V98, P1303, DOI 10.1111/j.1349-7006.2007.00538.x; Klinkhammer W, 2009, BIOORGAN MED CHEM, V17, P2524, DOI 10.1016/j.bmc.2009.01.072; Kuhnle M, 2009, J MED CHEM, V52, P1190, DOI 10.1021/jm8013822; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Malofeeva EV, 2012, CANC RES; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; Menefee ME, 2005, J CLIN ONCOL S, V23, P3093; Min W, 2010, APPL RADIAT ISOTOPES, V68, P1098, DOI 10.1016/j.apradiso.2010.02.008; Mistry P, 2001, CANCER RES, V61, P749; Muller H, 2008, BIOORGAN MED CHEM, V16, P2448, DOI 10.1016/j.bmc.2007.11.057; Oguri T, 2008, MOL CANCER THER, V7, P1150, DOI 10.1158/1535-7163.MCT-07-2088; Pajeva IK, 2009, AAPS J, V11, P435, DOI 10.1208/s12248-009-9118-z; Pick A, 2012, CHEMMEDCHEM, V7, P650, DOI 10.1002/cmdc.201100543; Pusztai L, 2005, CANCER-AM CANCER SOC, V104, P682, DOI 10.1002/cncr.21227; Robert J, 2003, J MED CHEM, V46, P4805, DOI 10.1021/jm030183a; Roe M, 1999, BIOORG MED CHEM LETT, V9, P595, DOI 10.1016/S0960-894X(99)00030-X; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Shi Z, 2006, CANCER BIOL THER, V5, P39, DOI 10.4161/cbt.5.1.2236; Smith AJ, 1998, J NATL CANCER I, V90, P1161, DOI 10.1093/jnci/90.15.1161; Stewart A, 2000, CLIN CANCER RES, V6, P4186; Takayanagi Shin-Ichiro, 2004, J Exp Ther Oncol, V4, P239; Tiwari AK, 2013, CANCER LETT, V328, P307, DOI 10.1016/j.canlet.2012.10.001; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; TWENTYMAN PR, 1990, BRIT J CANCER, V62, P89, DOI 10.1038/bjc.1990.235; Wagner CC, 2009, J NUCL MED, V50, P1954, DOI 10.2967/jnumed.109.063289; Walker J, 2004, EUR J CANCER, V40, P594, DOI 10.1016/j.ejca.2003.09.036; Wang Peng, 2009, Zhongguo Fei Ai Za Zhi, V12, P875, DOI 10.3779/j.issn.1009-3419.2009.08.08; Yu XH, 2012, CIRC J, V76, P1780, DOI 10.1253/circj.CJ-11-1338	50	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55576	10.1371/journal.pone.0055576	http://dx.doi.org/10.1371/journal.pone.0055576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393594	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800048
J	Honnuraiah, S; Narayanan, R				Honnuraiah, Suraj; Narayanan, Rishikesh			A Calcium-Dependent Plasticity Rule for HCN Channels Maintains Activity Homeostasis and Stable Synaptic Learning	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; INDEPENDENT COMPONENT ANALYSIS; RAT HIPPOCAMPAL-NEURONS; ACTIVATED CATION CHANNELS; LONG-TERM POTENTIATION; I-H; VISUAL-CORTEX; INFORMATION-TRANSMISSION; BIOPHYSICAL MODEL; NETWORK FUNCTION	Theoretical and computational frameworks for synaptic plasticity and learning have a long and cherished history, with few parallels within the well-established literature for plasticity of voltage-gated ion channels. In this study, we derive rules for plasticity in the hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, and assess the synergy between synaptic and HCN channel plasticity in establishing stability during synaptic learning. To do this, we employ a conductance-based model for the hippocampal pyramidal neuron, and incorporate synaptic plasticity through the well-established Bienenstock-Cooper-Munro (BCM)-like rule for synaptic plasticity, wherein the direction and strength of the plasticity is dependent on the concentration of calcium influx. Under this framework, we derive a rule for HCN channel plasticity to establish homeostasis in synaptically-driven firing rate, and incorporate such plasticity into our model. In demonstrating that this rule for HCN channel plasticity helps maintain firing rate homeostasis after bidirectional synaptic plasticity, we observe a linear relationship between synaptic plasticity and HCN channel plasticity for maintaining firing rate homeostasis. Motivated by this linear relationship, we derive a calcium-dependent rule for HCN-channel plasticity, and demonstrate that firing rate homeostasis is maintained in the face of synaptic plasticity when moderate and high levels of cytosolic calcium influx induced depression and potentiation of the HCN-channel conductance, respectively. Additionally, we show that such synergy between synaptic and HCN-channel plasticity enhances the stability of synaptic learning through metaplasticity in the BCM-like synaptic plasticity profile. Finally, we demonstrate that the synergistic interaction between synaptic and HCN-channel plasticity preserves robustness of information transfer across the neuron under a rate-coding schema. Our results establish specific physiological roles for experimentally observed plasticity in HCN channels accompanying synaptic plasticity in hippocampal neurons, and uncover potential links between HCN-channel plasticity and calcium influx, dynamic gain control and stable synaptic learning.	[Honnuraiah, Suraj; Narayanan, Rishikesh] Indian Inst Sci, Mol Biophys Unit, Cellular Neurophysiol Lab, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Narayanan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Cellular Neurophysiol Lab, Bangalore 560012, Karnataka, India.	rishi@mbu.iisc.ernet.in	Narayanan, Rishikesh/C-3191-2009	Honnuraiah, Suraj/0000-0002-6465-464X; Honnuraiah, Suraj/0000-0002-4949-676X; Narayanan, Rishikesh/0000-0002-1362-4635	International Human Frontier Science Program Organization	International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by a career development award to RN by the International Human Frontier Science Program Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2003, ZOOLOGY, V106, P365, DOI 10.1078/0944-2006-00133; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Ascoli GA, 2010, J NEUROSCI, V30, P6434, DOI 10.1523/JNEUROSCI.4066-09.2010; Banakar A, 2011, ISRN APPL MATH, V2011, P12; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Canavier CC, 1999, J COMPUT NEUROSCI, V6, P49, DOI 10.1023/A:1008809000182; Carnevale NT, 2006, NEURON BOOK; Castellani GC, 2001, P NATL ACAD SCI USA, V98, P12772, DOI 10.1073/pnas.201404598; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Dayan P, 2001, COMPUTATIONAL NEUROS; Dingledine R, 1999, PHARMACOL REV, V51, P7; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dyhrfjeld-Johnsen J, 2009, FRONT NEUROSCI-SWITZ, V3, P25, DOI 10.3389/neuro.01.005.2009; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Haykin S. O., 2008, NEURAL NETWORKS LEAR; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hyvarinen A, 1998, SIGNAL PROCESS, V64, P301, DOI 10.1016/S0165-1684(97)00197-7; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; JAHR CE, 1990, J NEUROSCI, V10, P3178; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Joshi P, 2009, RULES INFORM MAXIMIZ, P1456; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Legenstein R, 2011, J NEUROSCI, V31, P10787, DOI 10.1523/JNEUROSCI.5684-10.2011; Lerche H, 2012, J PHYSL; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 2001, J PHYSIOL-LONDON, V532, P285, DOI 10.1111/j.1469-7793.2001.0285f.x; Lujan R, 2009, NAT REV NEUROSCI, V10, P475, DOI 10.1038/nrn2668; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1998, J NEUROSCI, V18, P7613; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Narayanan R, 2012, J NEUROPHYSIOL, V108, P2343, DOI 10.1152/jn.00530.2012; Narayanan R, 2010, J NEUROPHYSIOL, V104, P1020, DOI 10.1152/jn.01129.2009; Pavlov I, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1202; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Rabinowitch I, 2008, TRENDS NEUROSCI, V31, P377, DOI 10.1016/j.tins.2008.05.005; Rathour RK, 2012, J PHYSIOL-LONDON, V590, P5629, DOI 10.1113/jphysiol.2012.239418; Rieke F., 1999, SPIKES EXPLORING NEU; Savin C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000757; Seng KP, 2002, IEEE T CIRCUITS SYST, V49, P6; Shah MM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003593; Shah MM, 2010, TRENDS NEUROSCI, V33, P307, DOI 10.1016/j.tins.2010.03.002; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Toyoizumi T, 2005, P NATL ACAD SCI USA, V102, P5239, DOI 10.1073/pnas.0500495102; Triesch J, 2007, NEURAL COMPUT, V19, P885, DOI 10.1162/neco.2007.19.4.885; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Yeung LC, 2004, P NATL ACAD SCI USA, V101, P14943, DOI 10.1073/pnas.0405555101; ZADOR A, 1990, P NATL ACAD SCI USA, V87, P6718, DOI 10.1073/pnas.87.17.6718	85	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55590	10.1371/journal.pone.0055590	http://dx.doi.org/10.1371/journal.pone.0055590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390543	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000314691100059
J	Huang, JY; Chiang, MT; Chau, LY				Huang, Jun-Yuan; Chiang, Ming-Tsai; Chau, Lee-Young			Adipose Overexpression of Heme Oxygenase-1 Does Not Protect against High Fat Diet-Induced Insulin Resistance in Mice	PLOS ONE			English	Article							MACROPHAGE POLARIZATION; APOLIPOPROTEIN-E; CARBON-MONOXIDE; SENSITIVITY; TISSUE; INFLAMMATION; OBESITY; ATHEROSCLEROSIS; DYSFUNCTION; MECHANISMS	Heme oxygenase-1 (HO-1) is a stress-responsive enzyme with potent anti-oxidant and anti-inflammatory activities. Previous studies have shown that systemic induction of HO-1 by chemical inducers reduces adiposity and improves insulin sensitivity. To dissect the specific function of HO-1 in adipose tissue, we generated transgenic mice with adipose HO-1 overexpression using the adipocyte-specific aP2 promoter. The transgenic (Tg) mice exhibit similar metabolic phenotype as wild type (WT) control under chow-fed condition. High fat diet (HFD) challenge significantly increased the body weights of WT and Tg mice to a similar extent. Likewise, HFD-induced glucose intolerance and insulin resistance were not much different between WT and Tg mice. Analysis of the adipose tissue gene expression revealed that the mRNA levels of adiponectin and interleukin-10 were significantly higher in chow diet-fed Tg mice as compared to WT counterparts, whereas HFD induced downregulation of adiponectin gene expression in both Tg and WT mice to a similar level. HFD-induced proinflammatory cytokine expression in adipose tissues were comparable between WT and transgenic mice. Nevertheless, immunohistochemistry and gene expression analysis showed that the number of infiltrating macrophages with preferential expression of M2 markers was significantly higher in the adipose tissue of obese Tg mice than WT mice. Further experiment demonstrated that myeloid cells from Tg mice expressed higher level of HO-1 and exhibited greater migration response toward chemoattractant in vitro. Collectively, these data indicate that HO-1 overexpression in adipocytes does not protect against HFD-induced obesity and the development of insulin resistance in mice.	[Huang, Jun-Yuan; Chau, Lee-Young] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Jun-Yuan; Chiang, Ming-Tsai; Chau, Lee-Young] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Chau, LY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	lyc@ibms.sinica.edu.tw	Chau, Lee-Young/N-7659-2018	Chau, Lee-Young/0000-0002-6316-2328	National Science Council of Taiwan [NSC-97-2320-B-001-010-MY3]; National Research Program for Genomic Medicine at the National Science Council of Taiwan [NSC97-3112-B001-025]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine at the National Science Council of Taiwan	This work was supported by a grant (NSC-97-2320-B-001-010-MY3) from the National Science Council of Taiwan (http://web1.nsc.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Taiwan Mouse Clinic Core (NSC97-3112-B001-025) funded by the National Research Program for Genomic Medicine at the National Science Council of Taiwan for technical support.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Bach FH, 2005, FASEB J, V19, P1216, DOI 10.1096/fj.04-3485cmt; Cao J, 2012, HYPERTENSION, V60, P467, DOI 10.1161/HYPERTENSIONAHA.112.193805; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038626; Johnson FK, 2006, AM J PHYSIOL-REG I, V290, pR601, DOI 10.1152/ajpregu.00308.2005; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2098, DOI 10.1210/en.2008-0239; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Soukas A, 2000, GENE DEV, V14, P963; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9	26	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55369	10.1371/journal.pone.0055369	http://dx.doi.org/10.1371/journal.pone.0055369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390531	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100047
J	Elliott, KL; Houston, DW; Fritzsch, B				Elliott, Karen L.; Houston, Douglas W.; Fritzsch, Bernd			Transplantation of Xenopus laevis Tissues to Determine the Ability of Motor Neurons to Acquire a Novel Target	PLOS ONE			English	Article							HAIR-CELLS; NICOTINIC RECEPTOR; TRAPEZIUS MUSCLE; EFFERENT SYSTEM; SPINAL-CORD; MOTONEURONS; EXPRESSION; EVOLUTION; INNERVATION; MICE	The evolutionary origin of novelties is a central problem in biology. At a cellular level this requires, for example, molecularly resolving how brainstem motor neurons change their innervation target from muscle fibers (branchial motor neurons) to neural crest-derived ganglia (visceral motor neurons) or ear-derived hair cells (inner ear and lateral line efferent neurons). Transplantation of various tissues into the path of motor neuron axons could determine the ability of any motor neuron to innervate a novel target. Several tissues that receive direct, indirect, or no motor innervation were transplanted into the path of different motor neuron populations in Xenopus laevis embryos. Ears, somites, hearts, and lungs were transplanted to the orbit, replacing the eye. Jaw and eye muscle were transplanted to the trunk, replacing a somite. Applications of lipophilic dyes and immunohistochemistry to reveal motor neuron axon terminals were used. The ear, but not somite-derived muscle, heart, or liver, received motor neuron axons via the oculomotor or trochlear nerves. Somite-derived muscle tissue was innervated, likely by the hypoglossal nerve, when replacing the ear. In contrast to our previous report on ear innervation by spinal motor neurons, none of the tissues (eye or jaw muscle) was innervated when transplanted to the trunk. Taken together, these results suggest that there is some plasticity inherent to motor innervation, but not every motor neuron can become an efferent to any target that normally receives motor input. The only tissue among our samples that can be innervated by all motor neurons tested is the ear. We suggest some possible, testable molecular suggestions for this apparent uniqueness.	[Elliott, Karen L.; Houston, Douglas W.; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu		Fritzsch, Bernd/0000-0002-4882-8398	NASA [NNX10AK63H];  [R01 DC055095590];  [P30 DC010362];  [R01 GM083999]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010362] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was in part supported by R01 DC055095590 and P30 DC010362 (Bernd Fritzsch) and R01 GM083999 (Douglas W. Houston). This material is based upon work supported by NASA under Grant No. NNX10AK63H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2008, NEUROIMAG CLIN N AM, V18, P261, DOI 10.1016/j.nic.2007.11.001; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BOORD RL, 1991, J MORPHOL, V207, P165, DOI 10.1002/jmor.1052070207; Borges A, 2010, EUR J RADIOL, V74, P323, DOI 10.1016/j.ejrad.2010.02.006; CANNATELLA DC, 1993, SYST BIOL, V42, P476, DOI 10.2307/2992485; Crook AC, 2006, AM MIDL NAT, V155, P417, DOI 10.1674/0003-0031(2006)155[417:AEOMAB]2.0.CO;2; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; Demer JL, 2007, INVEST OPHTH VIS SCI, V48, P194, DOI 10.1167/iovs.06-0632; Dudek A, 2011, POL J VET SCI, V14, P199, DOI 10.2478/v10181-011-0030-y; Dufour HD, 2006, P NATL ACAD SCI USA, V103, P8727, DOI 10.1073/pnas.0600805103; Eisen JS, 1999, TRENDS NEUROSCI, V22, P321, DOI 10.1016/S0166-2236(98)01370-8; Elliott KL, 2010, INT J DEV BIOL, V54, P1443, DOI 10.1387/ijdb.103061ke; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Franchini LF, 2006, MOL PHYLOGENET EVOL, V41, P622, DOI 10.1016/j.ympev.2006.05.042; FRITZSCH B, 1993, J NEUROSCI METH, V50, P95, DOI 10.1016/0165-0270(93)90060-5; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; FRITZSCH B, 1993, ACTA ANAT, V148, P96; Fritzsch B., 2007, P1; FRITZSCH B, 1990, NEUROSCI LETT, V114, P129, DOI 10.1016/0304-3940(90)90060-M; Fritzsch B, 1999, SING AUDIOL TEXTBK, P31; FRITZSCH B, 1995, J NEUROBIOL, V27, P457, DOI 10.1002/neu.480270403; FRITZSCH B, 1993, HEARING RES, V65, P51, DOI 10.1016/0378-5955(93)90200-K; Fritzsch B, 2007, INT J DEV BIOL, V51, P663, DOI 10.1387/ijdb.072367bf; Hellmann B, 1996, BRAIN BEHAV EVOLUT, V47, P185, DOI 10.1159/000113238; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Katz E, 2011, SPRINGER HANDB AUDIT, V38, P103, DOI 10.1007/978-1-4419-7070-1_5; Koppl C, 2011, SPRINGER HANDB AUDIT, V38, P217, DOI 10.1007/978-1-4419-7070-1_8; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; LEPERCHEY F, 1979, REV STOMATOL CHIR, V80, P45; Lipovsek M, 2012, P NATL ACAD SCI USA, V109, P4308, DOI 10.1073/pnas.1115488109; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Murakami Y, 2004, DEVELOPMENT, V131, P983, DOI 10.1242/dev.00986; NIKUNDIWE AM, 1983, J COMP NEUROL, V213, P199, DOI 10.1002/cne.902130207; Rossert C, 2011, J NEUROSCI, V31, P8359, DOI 10.1523/JNEUROSCI.6161-10.2011; Seipel K, 2004, DEV BIOL, V269, P331, DOI 10.1016/j.ydbio.2004.01.035; Sgard F, 2002, MOL PHARMACOL, V61, P150, DOI 10.1124/mol.61.1.150; Sienkiewicz W, 2010, VET MED-CZECH, V55, P242, DOI 10.17221/2994-VETMED; Simmons D, 2011, SPRINGER HANDB AUDIT, V38, P187, DOI 10.1007/978-1-4419-7070-1_7; Straka H, 2009, ANN NY ACAD SCI, V1164, P37, DOI 10.1111/j.1749-6632.2008.03740.x; Takano-Maruyama M, 2010, DEV DYNAM, V239, P1155, DOI 10.1002/dvdy.22273; Tonniges J, 2010, J MICROSCOPY, P9999; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tsunoyama K, 1998, MOL BIOL EVOL, V15, P518, DOI 10.1093/oxfordjournals.molbev.a025951; Vernino S, 2009, AUTON NEUROSCI-BASIC, V146, P3, DOI 10.1016/j.autneu.2008.09.005; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Vetter DE, 2007, P NATL ACAD SCI USA, V104, P20594, DOI 10.1073/pnas.0708545105; Zuo J, 1999, P NATL ACAD SCI USA, V96, P14100, DOI 10.1073/pnas.96.24.14100	51	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55541	10.1371/journal.pone.0055541	http://dx.doi.org/10.1371/journal.pone.0055541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383335	gold, Green Published, Green Submitted			2022-12-27	WOS:000314597900042
J	Svenson, U; Gronlund, E; Soderstrom, I; Sitaram, RT; Ljungberg, B; Roos, G				Svenson, Ulrika; Gronlund, Elisabeth; Soderstrom, Ingegerd; Sitaram, Raviprakash T.; Ljungberg, Borje; Roos, Goran			Telomere Length in Relation to Immunological Parameters in Patients with Renal Cell Carcinoma	PLOS ONE			English	Article							REGULATORY T-CELLS; PERIPHERAL-BLOOD; HEPATOCELLULAR-CARCINOMA; IMMUNE SUPPRESSION; MULTIPLE-MYELOMA; BREAST-CANCER; B-LYMPHOCYTES; UP-REGULATION; SURVIVAL; INTERLEUKIN-7	Over the last decade, telomere length (TL) has gained attention as a potential biomarker in cancer disease. We previously reported that long blood TL was associated with a poorer outcome in patients with breast cancer and renal cell carcinoma. Based on these findings, we hypothesized that certain immunological components may have an impact on TL dynamics in cancer patients. One aim of the present study was to investigate a possible association between serum cytokines and TL of peripheral blood cells, tumors and corresponding kidney cortex, in patients with clear cell renal cell carcinoma. For this purpose, a multiplex cytokine assay was used. Correlation analysis revealed significant positive correlations between tumor TL and peripheral levels of three cytokines (IL-7, IL-8 and IL-10). In a parallel patient group with various kidney tumors, TL was investigated in whole blood and in immune cell subsets in relation to peripheral levels of regulatory T cells (Tregs). A significant positive association was found between whole blood TL and Treg levels. However, the strongest correlation was found between Tregs and TL of the T lymphocyte fraction. Thus, patients with higher Treg levels displayed longer T cell telomeres, which might reflect a suppressed immune system with fewer cell divisions and hence less telomere shortening. These results are in line with our earlier observation that long blood TL is an unfavorable prognostic factor for cancer-specific survival. In summary, we here show that immunological components are associated with TL in patients with renal cell carcinoma, providing further insight into the field of telomere biology in cancer.	[Svenson, Ulrika; Roos, Goran] Umea Univ, Dept Med Biosci, Umea, Sweden; [Gronlund, Elisabeth] Univ Hosp, Hematopathol Lab, Umea, Sweden; [Soderstrom, Ingegerd] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Sitaram, Raviprakash T.; Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Roos, G (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	goran.roos@medbio.umu.se		Ljungberg, Borje/0000-0002-4121-3753	Swedish Cancer Society; Swedish Research Council; Lions Cancer Research Foundation in Umea; Umea University; European Community [200950]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Research Foundation in Umea; Umea University; European Community(European Commission)	This work was supported by grants from The Swedish Cancer Society (G. Roos and B. Ljungberg), The Swedish Research Council (G. Roos), Lions Cancer Research Foundation in Umea and Umea University (G. Roos and B. Ljungberg). The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2011 under grant agreement no. 200950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2002, CANCER RES, V62, P3876; Al-Rawi MAA, 2004, EUR J CANCER, V40, P494, DOI 10.1016/j.ejca.2003.10.016; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Ben-Baruch A, 2006, SEMIN CANCER BIOL, V16, P38, DOI 10.1016/j.semcancer.2005.07.006; Bisoffi M, 2006, INT J CANCER, V119, P2255, DOI 10.1002/ijc.22120; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Eichelberg C, 2009, EUR UROL, V55, P851, DOI 10.1016/j.eururo.2009.01.003; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Frankenberger B, 2007, SEMIN CANCER BIOL, V17, P330, DOI 10.1016/j.semcancer.2007.06.004; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffiths RW, 2007, CANCER IMMUNOL IMMUN, V56, P1743, DOI 10.1007/s00262-007-0318-z; Heaphy CM, 2011, J CELL MOL MED, V15, P1227, DOI 10.1111/j.1582-4934.2011.01284.x; Hirokawa K, 2009, MECH AGEING DEV, V130, P86, DOI 10.1016/j.mad.2008.05.001; Hoffmann J, 2009, EXP GERONTOL, V44, P363, DOI 10.1016/j.exger.2009.02.006; Hu BT, 1999, EUR J IMMUNOL, V29, P3745, DOI 10.1002/(SICI)1521-4141(199911)29:11<3745::AID-IMMU3745>3.0.CO;2-1; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Igarashi H, 1997, BLOOD, V89, P1299, DOI 10.1182/blood.V89.4.1299; Kaszubowska L, 2008, J PHYSIOL PHARMACOL, V59, P169; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Lambeck AJA, 2007, CLIN CANCER RES, V13, P2385, DOI 10.1158/1078-0432.CCR-06-1828; Liu HQ, 2012, CARCINOGENESIS, V33, P1040, DOI 10.1093/carcin/bgs098; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Menetrier-Caux C, 1999, BRIT J CANCER, V79, P119, DOI 10.1038/sj.bjc.6690021; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Nordfjall K, 2007, BIOCHEM BIOPH RES CO, V358, P215, DOI 10.1016/j.bbrc.2007.04.099; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Sellmann L, 2011, INT J HEMATOL, V93, P74, DOI 10.1007/s12185-010-0750-2; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Svenson U, 2009, CANCER RES, V69, P2896, DOI 10.1158/0008-5472.CAN-08-3513; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; Wallace DL, 2006, IMMUNOLOGY, V119, P243, DOI 10.1111/j.1365-2567.2006.02429.x; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Wittke F, 1999, BRIT J CANCER, V79, P1182, DOI 10.1038/sj.bjc.6690189; Wu KD, 2003, BLOOD, V101, P4982, DOI 10.1182/blood-2002-11-3451; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8	43	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55543	10.1371/journal.pone.0055543	http://dx.doi.org/10.1371/journal.pone.0055543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383336	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900043
J	Molyneux, S; Njue, M; Boga, M; Akello, L; Olupot-Olupot, P; Engoru, C; Kiguli, S; Maitland, K				Molyneux, Sassy; Njue, Maureen; Boga, Mwanamvua; Akello, Lilian; Olupot-Olupot, Peter; Engoru, Charles; Kiguli, Sarah; Maitland, Kathryn			'The Words Will Pass with the Blowing Wind': Staff and Parent Views of the Deferred Consent Process, with Prior Assent, Used in an Emergency Fluids Trial in Two African Hospitals	PLOS ONE			English	Article							CLINICAL-RESEARCH; INFORMED-CONSENT; DEVELOPING-COUNTRIES; COMMUNITY; CHILDREN; CARE; ILLNESS; IF	Objective: To document and explore the views and experiences of key stakeholders regarding the consent procedures of an emergency research clinical trial examining immediate fluid resuscitation strategies, and to discuss the implications for similar trials in future. Methods: A social science sub-study of the FEAST (Fluid Expansion As Supportive Therapy) trial. Interviews were held with trial team members (n = 30), health workers (n = 15) and parents (n = 51) from two purposively selected hospitals in Soroti, Uganda, and Kilifi, Kenya. Findings: Overall, deferred consent with prior assent was seen by staff and parents as having the potential to protect the interests of both patients and researchers, and to avoid delays in starting treatment. An important challenge is that the validity of verbal assent is undermined when inadequate initial information is poorly understood. This concern needs to be balanced against the possibility that full prior consent on admission potentially causes harm through introducing delays. Full prior consent also potentially imposes worries on parents that clinicians are uncertain about how to proceed and that clinicians want to absolve themselves of any responsibility for the child's outcome (some parents' interpretation of the need for signed consent). Voluntariness is clearly compromised for both verbal assent and full prior consent in a context of such vulnerability and stress. Further challenges in obtaining verbal assent were: what to do in the absence of the household decision-maker (often the father); and how medical staff handle parents not giving a clear agreement or refusal. Conclusion: While the challenges identified are faced in all research in low-income settings, they are magnified for emergency trials by the urgency of decision making and treatment needs. Consent options will need to be tailored to particular studies and settings, and might best be informed by consultation with staff members and community representatives using a deliberative approach.	[Molyneux, Sassy; Njue, Maureen] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Hlth Syst & Social Sci Res Grp, Kilifi, Kenya; [Molyneux, Sassy] Univ Oxford, Ctr Trop Med, Oxford, England; [Molyneux, Sassy] Univ Oxford, Dept Publ Hlth & Primary Hlth Care, Ethox Ctr, Oxford, England; [Boga, Mwanamvua; Maitland, Kathryn] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi Clin Trials Facil, Kilifi, Kenya; [Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Paediat, Wellcome Trust Ctr Clin Trop Med, London, England; [Kiguli, Sarah] Makerere Univ, Mulago Natl Referral Hosp, Dept Paediat, Kampala, Uganda; [Olupot-Olupot, Peter] Mbale Reg Referral Hosp, Mbale, Uganda; [Engoru, Charles] Soroti Reg Referral Hosp, Soroti, Uganda; [Akello, Lilian] Malaria Consortium, Kampala, Uganda	Kenya Medical Research Institute; University of Oxford; University of Oxford; Kenya Medical Research Institute; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Makerere University; Mulago National Referral Hospital	Molyneux, S (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Hlth Syst & Social Sci Res Grp, Kilifi, Kenya.	SMolyneux@kemri-wellcome.org	Molyneux, Catherine/HGB-8464-2022	Molyneux, Catherine/0000-0001-9522-416X; Maitland, Kathryn/0000-0002-0007-0645	Wellcome Trust, United Kingdom [WT085418]; Medical Research Council, United Kingdom [G0801439]; MRC [G0801439, G0601027] Funding Source: UKRI; Medical Research Council [G0801439, G0601027] Funding Source: researchfish	Wellcome Trust, United Kingdom(Wellcome Trust); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, United Kingdom (WT085418 to S.M.) (http://www.wellcome.ac.uk), and Medical Research Council, United Kingdom (G0801439 to K.M.) (http://www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmark P, 2006, J MED ETHICS, V32, P439, DOI 10.1136/jme.2005.013722; Boga M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001089; Brierley J, 2011, J MED ETHICS, V37, P429, DOI 10.1136/jme.2010.040667; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Chuma J, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-15; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Emanuel EJ, 2005, LANCET, V366, P336, DOI 10.1016/S0140-6736(05)66992-9; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Gamble C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039429, 10.1371/journal.pone.0035982]; Green J, 2009, QUALITATIVE METHODS; Jansen TC, 2007, INTENS CARE MED, V33, P894, DOI 10.1007/s00134-007-0580-8; Jansen TC, 2010, INTENS CARE MED, V36, P1962, DOI 10.1007/s00134-010-1988-0; Kamuya D, 2013, DEV WORLD B IN PRESS, V13; Lairumbi Geoffrey M, 2012, Philos Ethics Humanit Med, V7, P7, DOI 10.1186/1747-5341-7-7; Largent EA, 2010, ARCH INTERN MED, V170, P668, DOI 10.1001/archinternmed.2010.80; Lindegger G, 2000, S AFR J SCI, V96, P313; Luce JM, 2003, CRIT CARE MED, V31, pS153, DOI 10.1097/01.CCM.0000054901.80339.01; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Maitland K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-90; Manning DJ, 2000, J MED ETHICS, V26, P249, DOI 10.1136/jme.26.4.249; Marsh VM, 2011, PUBLIC HEALTH ETH-UK, V4, P26, DOI 10.1093/phe/phr007; Molyneux CS, 2005, SOC SCI MED, V61, P1463, DOI 10.1016/j.socscimed.2004.11.073; Molyneux CS, 2005, SOC SCI MED, V61, P443, DOI 10.1016/j.socscimed.2004.12.003; Molyneux CS, 2004, SOC SCI MED, V59, P2547, DOI 10.1016/j.socscimed.2004.03.037; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Molyneux S, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-13; Myburgh JA, 2011, NEW ENGL J MED, V364, P2543, DOI 10.1056/NEJMe1105490; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Van Loon K, 2009, INFORM CONSENT CLIN, P14; World Health Organization, 2005, EM TRIAG ASS TREATM	30	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54894	10.1371/journal.pone.0054894	http://dx.doi.org/10.1371/journal.pone.0054894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092DU	23408950	Green Published, gold, Green Submitted			2022-12-27	WOS:000315100000009
J	Toledo, JB; Da, X; Bhatt, P; Wolk, DA; Arnold, SE; Shaw, LM; Trojanowski, JQ; Davatzikos, C				Toledo, Jon B.; Da, Xiao; Bhatt, Priyanka; Wolk, David A.; Arnold, Steven E.; Shaw, Leslie M.; Trojanowski, John Q.; Davatzikos, Christos		Alzheimer's Dis Neuroimaging	Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CORTICOTROPIN-RELEASING-FACTOR; FRONTOTEMPORAL LOBAR DEGENERATION; NEUROIMAGING INITIATIVE ADNI; MEDIAL PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; AMYLOID-BETA; TAU PATHOLOGY; IN-VIVO; SYNAPTIC ALTERATIONS	Different inflammatory and metabolic pathways have been associated with Alzheimers disease (AD). However, only recently multi-analyte panels to study a large number of molecules in well characterized cohorts have been made available. These panels could help identify molecules that point to the affected pathways. We studied the relationship between a panel of plasma biomarkers (Human DiscoveryMAP (R)) and presence of AD-like brain atrophy patterns defined by a previously published index (SPARE-AD) at baseline in subjects of the ADNI cohort. 818 subjects had MRI-derived SPARE-AD scores, of these subjects 69% had plasma biomarkers and 51% had CSF tau and A beta measurements. Significant analyte-SPARE-AD and analytes correlations were studied in adjusted models. Plasma cortisol and chromogranin A showed a significant association that did not remain significant in the CSF signature adjusted model. Plasma macrophage inhibitory protein-1 alpha and insulin-like growth factor binding protein 2 showed a significant association with brain atrophy in the adjusted model. Cortisol levels showed an inverse association with tests measuring processing speed. Our results indicate that stress and insulin responses and cytokines associated with recruitment of inflammatory cells in MCI-AD are associated with its characteristic AD-like brain atrophy pattern and correlate with clinical changes or CSF biomarkers.	[Toledo, Jon B.; Shaw, Leslie M.; Trojanowski, John Q.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging,Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Da, Xiao; Bhatt, Priyanka; Davatzikos, Christos] Univ Penn, Dept Radiol, Sect Biomed Image Anal, Philadelphia, PA 19104 USA; [Wolk, David A.; Arnold, Steven E.] Univ Penn, Penn Memory Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Davatzikos, C (corresponding author), Univ Penn, Dept Radiol, Sect Biomed Image Anal, Philadelphia, PA 19104 USA.	christos@rad.upenn.edu	Davatzikos, Christos/ABE-2057-2021; Da, Xiao/F-8738-2015	Da, Xiao/0000-0001-9898-8130; Davatzikos, Christos/0000-0002-1025-8561; Toledo, Jon/0000-0003-4366-9268	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; Alfonso Martin Escudero foundation; Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; Takeda Pharmaceutical Company; NATIONAL INSTITUTE ON AGING [U01AG024904, P30AG010129, K01AG030514, U19AG010483, R01AG039478, R01AG014971] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Alfonso Martin Escudero foundation; Abbott(Abbott Laboratories); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca(AstraZeneca); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); BioClinica, Inc.; Biogen Idec Inc.(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals Inc.; Eli Lilly and Company(Eli Lilly); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Medpace, Inc.; Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Servier(Servier); Synarc Inc.; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (NIH) (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. JQT is the William Maul Measy-Truman G. Schnabel Jr. M. D. Professor of Geriatric Medicine and Gerontology. JBT's work was supported by a grant from the Alfonso Martin Escudero foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Baena N, 2011, LANCET NEUROL, V10, P213, DOI 10.1016/S1474-4422(10)70323-9; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bian H, 2008, NEUROLOGY, V70, P1827, DOI 10.1212/01.wnl.0000311445.21321.fc; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Britschgi M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008862; Brown SM, 2005, CEREB CORTEX, V15, P1714, DOI 10.1093/cercor/bhi048; Buchhave P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006294; Budas G, 1999, NEUROSCI LETT, V276, P61, DOI 10.1016/S0304-3940(99)00790-9; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Filipovych R, 2011, NEUROIMAGE, V55, P1109, DOI 10.1016/j.neuroimage.2010.12.066; Friedman B, 2005, J AM GERIATR SOC, V53, P1570, DOI 10.1111/j.1532-5415.2005.53461.x; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gold SM, 2005, J CLIN ENDOCR METAB, V90, P3262, DOI 10.1210/jc.2004-2181; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; Hoefer M, 2008, BRAIN, V131, P1646, DOI 10.1093/brain/awn082; Hoeflich A, 2001, ENDOCRINOLOGY, V142, P1889, DOI 10.1210/en.142.5.1889; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hooper C, 2009, FEBS LETT, V583, P3461, DOI 10.1016/j.febslet.2009.09.049; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Huang CW, 2009, J CLIN NEUROSCI, V16, P1283, DOI 10.1016/j.jocn.2008.12.026; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Joels M, 2007, FRONT NEUROENDOCRIN, V28, P72, DOI 10.1016/j.yfrne.2007.04.001; Kadir A, 2011, BRAIN, V134, P301, DOI 10.1093/brain/awq349; Kalaria RN, 2012, J NEUROL SCI; Kang JE, 2007, P NATL ACAD SCI USA, V104, P10673, DOI 10.1073/pnas.0700148104; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Kester M I, 2011, NEUROBIOL AGING; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Kiepe D, 2002, KIDNEY INT, V62, P1591, DOI 10.1046/j.1523-1755.2002.00603.x; Kling MA, 2012, ALZHEIMERS DEMENT; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; Li M, 2009, J IMMUNOL, V182, P5778, DOI 10.4049/jimmunol.0803013; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P356, DOI 10.1016/j.biopsych.2004.05.021; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; LUPIEN S, 1994, J NEUROSCI, V14, P2893, DOI 10.1523/jneurosci.14-05-02893.1994; MacDonald D.J., 1998, NEUROIMAGE, V7, pS717, DOI [10.1016/S1053-8119(18)31550-7, DOI 10.1016/S1053-8119(18)31550-7]; Man SM, 2007, NEUROBIOL AGING, V28, P485, DOI 10.1016/j.neurobiolaging.2006.02.013; MANCARDI GL, 1983, ACTA NEUROPATHOL, V61, P76, DOI 10.1007/BF00688390; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Rissman RA, 2007, J NEUROSCI, V27, P6552, DOI 10.1523/JNEUROSCI.5173-06.2007; Ryan J.J., 1992, CLIN NEUROPSYCHOL, V6, P53, DOI DOI 10.1080/; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; SCHEFF SW, 1993, ANN NEUROL, V33, P190, DOI 10.1002/ana.410330209; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shen X, 2012, MOL CELL BIOL; Soares HD, 2012, ARCH NEUROL-CHICAGO, P1, DOI DOI 10.1001/ARCHNEUROL.2012.1070; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; Sotiropoulos I, 2008, J NEUROCHEM, V107, P385, DOI 10.1111/j.1471-4159.2008.05613.x; Sotiropoulos I, 2011, J NEUROSCI, V31, P7840, DOI 10.1523/JNEUROSCI.0730-11.2011; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Thambisetty M, 2012, NEUROIMAGE, V59, P212, DOI 10.1016/j.neuroimage.2011.07.056; Toledo JB, 2012, ACTA NEUROPATHOL; Toledo JB, 2012, ALZHEIMERS DEMENT, V8, P483, DOI 10.1016/j.jalz.2011.08.008; Toledo JB, 2011, ACTA NEUROPATHOL, V122, P401, DOI 10.1007/s00401-011-0861-8; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Weisberg S., 2005, APPL LINEAR REGRESSI, DOI DOI 10.1002/0471704091; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Yau JLW, 2011, J NEUROSCI, V31, P4188, DOI 10.1523/JNEUROSCI.6145-10.2011; Young AH, 1999, PSYCHOPHARMACOLOGY, V145, P260, DOI 10.1007/s002130051057; Zozulya AL, 2007, J IMMUNOL, V178, P520, DOI 10.4049/jimmunol.178.1.520	102	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55531	10.1371/journal.pone.0055531	http://dx.doi.org/10.1371/journal.pone.0055531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408997	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300021
J	Tombline, G; Schwingel, JM; Lapek, JD; Friedman, AE; Darrah, T; Maguire, M; Van Alst, NE; Filiatrault, MJ; Iglewski, BH				Tombline, Gregory; Schwingel, Johanna M.; Lapek, John D., Jr.; Friedman, Alan E.; Darrah, Thomas; Maguire, Michael; Van Alst, Nadine E.; Filiatrault, Melanie J.; Iglewski, Barbara H.			Pseudomonas aeruginosa PA1006 Is a Persulfide-Modified Protein That Is Critical for Molybdenum Homeostasis	PLOS ONE			English	Article							ESCHERICHIA-COLI; CYSTEINE DESULFURASE; MOLYBDOPTERIN SYNTHASE; BIOSYNTHESIS; INSIGHTS; DATABASE; CLONING; YHHP; SCOP	A companion manuscript revealed that deletion of the Pseudomonas aeruginosa (Pae) PA1006 gene caused pleiotropic defects in metabolism including a loss of all nitrate reductase activities, biofilm maturation, and virulence. Herein, several complementary approaches indicate that PA1006 protein serves as a persulfide-modified protein that is critical for molybdenum homeostasis in Pae. Mutation of a highly conserved Cys22 to Ala or Ser resulted in a loss of PA1006 activity. Yeast-two-hybrid and a green-fluorescent protein fragment complementation assay (GFP-PFCA) in Pae itself revealed that PA1006 interacts with Pae PA3667/CsdA and PA3814/IscS Cys desulfurase enzymes. Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) "top-down" analysis of PA1006 purified from Pae revealed that conserved Cys22 is post-translationally modified in vivo in the form a persulfide. Inductively-coupled-plasma (ICP)-MS analysis of Delta PA1006 mutant extracts revealed that the mutant cells contain significantly reduced levels of molybdenum compared to wild-type. GFP-PFCA also revealed that PA1006 interacts with several molybdenum cofactor (MoCo) biosynthesis proteins as well as nitrate reductase maturation factor NarJ and component NarH. These data indicate that a loss of PA1006 protein's persulfide sulfur and a reduced availability of molybdenum contribute to the phenotype of a Delta PA1006 mutant.	[Tombline, Gregory; Schwingel, Johanna M.; Maguire, Michael; Van Alst, Nadine E.; Filiatrault, Melanie J.; Iglewski, Barbara H.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Lapek, John D., Jr.; Friedman, Alan E.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA; [Darrah, Thomas] Duke Univ, Nicholas Sch Environm, Div Earth & Ocean Sci, Durham, NC 27708 USA	University of Rochester; University of Rochester; Duke University	Tombline, G (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	gtombline@urmc.rochester.edu; Barbara_Iglewski@URMC.Rochester.edu	Friedman, Alan/Q-4858-2018; Darrah, Tom H/I-2253-2016	Friedman, Alan/0000-0002-4764-8168; 	NIH [5R37AI0337131, 1 UL1 RR024160-1]; Cystic Fibrosis Foundation [IGLEWS00V0]; NRSA Postdoctoral fellowship from the National Institutes of Health (NIH) [F32AI056825]; National Institute of Environmental Health Sciences [ES07026]; U of R start-up funds; National Institute of Environmental Health Sciences Training Center [ES01247]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI056825, R37AI033713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NRSA Postdoctoral fellowship from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U of R start-up funds; National Institute of Environmental Health Sciences Training Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant NIH 5R37AI033713 and the Cystic Fibrosis Foundation Therapeutics grant IGLEWS00V0 to B. H. I. M. J. F. performed this work as a postdoctoral fellow at the University of Rochester and was supported by a NRSA Postdoctoral fellowship from the National Institutes of Health (NIH) (F32AI056825). A. E. F. was funded by 1 UL1 RR024160-1 (NIH), National Institute of Environmental Health Sciences Training Grant ES07026, and Center Grant ES01247 and U of R start-up funds. J. L. was supported by a National Institute of Environmental Health Sciences Training Grant (ES07026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency USEP, 1991, AN SOILS SED IND COU; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Darrah TH, 2009, METALLOMICS, V1, P479, DOI 10.1039/b905145g; Filiatrault MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055594; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Hagen WR, 2011, COORDIN CHEM REV, V255, P1117, DOI 10.1016/j.ccr.2011.02.009; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; Jacob C, 2004, ORG BIOMOL CHEM, V2, P1953, DOI 10.1039/b406180b; Katoh E, 2000, J MOL BIOL, V304, P219, DOI 10.1006/jmbi.2000.4170; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; LONG GL, 1983, ANAL CHEM, V55, pA712, DOI 10.1021/ac00258a001; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; PASSADOR L, 1989, J BACTERIOL, V171, P6234, DOI 10.1128/jb.171.11.6234-6242.1989; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Rudolph MJ, 2003, J BIOL CHEM, V278, P14514, DOI 10.1074/jbc.M300449200; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; US Environmental Protection Agency OoRaD, 1994, DET TRAC EL WAT WAST; Wagner Victoria E., 2008, P129; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Yang Z, 2011, J STRUCT BIOL	43	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55593	10.1371/journal.pone.0055593	http://dx.doi.org/10.1371/journal.pone.0055593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409003	gold, Green Published, Green Submitted			2022-12-27	WOS:000314660300022
J	Eberhard, J; Grote, K; Luchtefeld, M; Heuer, W; Schuett, H; Divchev, D; Scherer, R; Schmitz-Streit, R; Langfeldt, D; Stumpp, N; Staufenbiel, I; Schieffer, B; Stiesch, M				Eberhard, Joerg; Grote, Karsten; Luchtefeld, Maren; Heuer, Wieland; Schuett, Harald; Divchev, Dimitar; Scherer, Ralph; Schmitz-Streit, Ruth; Langfeldt, Daniela; Stumpp, Nico; Staufenbiel, Ingmar; Schieffer, Bernhard; Stiesch, Meike			Experimental Gingivitis Induces Systemic Inflammatory Markers in Young Healthy Individuals: A Single-Subject Interventional Study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; C-REACTIVE PROTEIN; ATHEROSCLEROTIC PLAQUES; PERIODONTAL PATHOGENS; SUPRAGINGIVAL PLAQUE; MICROBIAL COMPLEXES; SUBGINGIVAL PLAQUE; RISK-FACTORS; DISEASE; IDENTIFICATION	Objectives: We here investigated whether experimental gingivitis enhances systemic markers of inflammation which are also known as surrogate markers of atherosclerotic plaque development. Background: Gingivitis is a low-level oral infection induced by bacterial deposits with a high prevalence within Western populations. A potential link between the more severe oral disease periodontitis and cardiovascular disease has already been shown. Methods: 37 non-smoking young volunteers with no inflammatory disease or any cardiovascular risk factors participated in this single-subject interventional study with an intra-individual control. Intentionally experimental oral inflammation was induced by the interruption of oral hygiene for 21 days, followed by a 21-days resolving phase after reinitiation of oral hygiene. Primary outcome measures at baseline, day 21 and 42 were concentrations of hsCRP, IL-6, and MCP-1, as well as adhesion capacity and oxLDL uptake of isolated blood monocytes. Results: The partial cessation of oral hygiene procedures was followed by the significant increase of gingival bleeding (34.0%, P<0.0001). This local inflammation was associated with a systemic increase in hsCRP (0.24 mg/L, P = 0.038), IL-6 (12.52 ng/L, P = 0.0002) and MCP-1 (9.10 ng/l, P = 0.124) in peripheral blood samples between baseline and day 21, which decreased at day 42. Monocytes showed an enhanced adherence to endothelial cells and increased foam cell formation after oxLDL uptake (P<0.050) at day 21 of gingivitis. Conclusions: Bacterial-induced gingival low-level inflammation induced a systemic increase in inflammatory markers. Dental hygiene almost completely reversed this experimental inflammatory process, suggesting that appropriate dental prophylaxis may also limit systemic markers of inflammation in subjects with natural gingivitis. International Clinical Trials Register Platform of the World Health Organization, registry number: DRKS00003366, URL: http://apps.who.int/trialsearch/Default.aspx.	[Eberhard, Joerg; Heuer, Wieland; Stumpp, Nico; Stiesch, Meike] Hannover Med Sch, Dept Prosthet Dent & Biomat Sci, Hannover, Germany; [Grote, Karsten; Luchtefeld, Maren; Schuett, Harald; Divchev, Dimitar; Schieffer, Bernhard] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Scherer, Ralph] Hannover Med Sch, Dept Med Stat, Hannover, Germany; [Staufenbiel, Ingmar] Hannover Med Sch, Dept Operat Dent & Periodontol, Hannover, Germany; [Schmitz-Streit, Ruth; Langfeldt, Daniela] Univ Kiel, Inst Microbiol, Kiel, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Kiel	Eberhard, J (corresponding author), Hannover Med Sch, Dept Prosthet Dent & Biomat Sci, Hannover, Germany.	eberhard.joerg@mh-hannover.de	Eberhard, Joerg/AAY-9034-2020; Eberhard, Jörg/G-1103-2012; Staufenbiel, Ingmar/K-7675-2018; Stefanadis, Christodoulos/ABH-2232-2020	Eberhard, Joerg/0000-0001-8060-2893; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829; Divchev, Dimitar/0000-0002-3062-3271; Grote, Karsten/0000-0001-7914-3159; Stefanadis, Christodoulos/0000-0001-5974-6454	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany [Eb 223/5-1]; Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was in part supported by the Deutsche Forschungsgemeinschaft DFG, Bonn, Germany (Eb 223/5-1). The authors acknowledge funding of the publication costs by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriankaja OM, 2009, J PERIODONTOL, V80, P307, DOI [10.1902/jop.2009.080385, 10.1902/jop.2009.080385 ]; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Baumgartner JC, 1999, J ENDODONT, V25, P413, DOI 10.1016/S0099-2399(99)80268-4; Boucelma M, 2011, INT ANGIOL, V30, P18; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; Conrads G, 1997, J ENDODONT, V23, P433, DOI 10.1016/S0099-2399(97)80297-X; Conrads G, 1996, J PERIODONTOL, V67, P994, DOI 10.1902/jop.1996.67.10.994; De Groot L, 2010, EUR J CLIN INVEST, V40, P835, DOI 10.1111/j.1365-2362.2010.02333.x; Demmer RT, 2010, PERIODONTOL 2000, V53, P28, DOI 10.1111/j.1600-0757.2009.00326.x; Drakopoulou M, 2009, ATHEROSCLEROSIS, V206, P335, DOI 10.1016/j.atherosclerosis.2009.01.041; Eberhard J, 2005, BIOMATERIALS, V26, P1545, DOI 10.1016/j.biomaterials.2004.05.005; Eberhard J, 2000, ANAL BIOCHEM, V280, P258, DOI 10.1006/abio.2000.4540; Elkaim R, 2008, J PERIODONTAL RES, V43, P224, DOI 10.1111/j.1600-0765.2007.01018.x; Elter JR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.002; Ericsson JS, 2009, SWED DENT J, V33, P131; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Gaetti-Jardim E, 2009, J MED MICROBIOL, V58, P1568, DOI 10.1099/jmm.0.013383-0; Haffajee AD, 2008, ORAL MICROBIOL IMMUN, V23, P196, DOI 10.1111/j.1399-302X.2007.00411.x; Haffajee AD, 2009, J PERIODONTAL RES, V44, P511, DOI 10.1111/j.1600-0765.2008.01154.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Honda T, 2006, CLIN EXP IMMUNOL, V144, P35, DOI 10.1111/j.1365-2249.2006.03028.x; Hoshino T, 2004, DIAGN MICR INFEC DIS, V48, P195, DOI 10.1016/j.diagmicrobio.2003.10.002; Igarashi E, 2009, ORAL MICROBIOL IMMUN, V24, P310, DOI 10.1111/j.1399-302X.2009.00513.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kim SG, 2005, J MICROBIOL, V43, P209; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Li YM, 2010, AM J DENT, V23, P9; Libby P, 1997, CIRCULATION, V96, P4095; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Lu QA, 2010, J CLIN PERIODONTOL, V37, P789, DOI 10.1111/j.1600-051X.2010.01600.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; SAGLIE FR, 1987, J PERIODONTOL, V58, P837, DOI 10.1902/jop.1987.58.12.837; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Slawik S, 2011, EUR J CLIN NUTR, V65, P857, DOI 10.1038/ejcn.2011.45; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Uno K, 2010, BIOMARK MED, V4, P361, DOI [10.2217/bmm.10.57, 10.2217/BMM.10.57]; Wahaidi VY, 2011, J CLIN PERIODONTOL, V38, P412, DOI 10.1111/j.1600-051X.2011.01710.x; Wohifeil M, 2009, CLIN CHIM ACTA, V401, P105, DOI 10.1016/j.cca.2008.11.017; Ylostalo PV, 2006, J CLIN PERIODONTOL, V33, P92, DOI 10.1111/j.1600-051X.2005.00875.x; Zee KY, 1996, J CLIN PERIODONTOL, V23, P1025, DOI 10.1111/j.1600-051X.1996.tb00532.x	46	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55265	10.1371/journal.pone.0055265	http://dx.doi.org/10.1371/journal.pone.0055265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408963	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200021
J	Ikenaka, K; Kawai, K; Katsuno, M; Huang, Z; Jiang, YM; Iguchi, Y; Kobayashi, K; Kimata, T; Waza, M; Tanaka, F; Mori, I; Sobue, G				Ikenaka, Kensuke; Kawai, Kaori; Katsuno, Masahisa; Huang, Zhe; Jiang, Yue-Mei; Iguchi, Yohei; Kobayashi, Kyogo; Kimata, Tsubasa; Waza, Masahiro; Tanaka, Fumiaki; Mori, Ikue; Sobue, Gen			dnc-1/dynactin 1 Knockdown Disrupts Transport of Autophagosomes and Induces Motor Neuron Degeneration	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; HUNTINGTONS-DISEASE; MUTANT DYNACTIN; SPINAL-CORD; LIFE-SPAN; DYNEIN; TUBULIN; PATHWAY; PROTEIN; CELLS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. We previously showed that the expression of dynactin 1, an axon motor protein regulating retrograde transport, is markedly reduced in spinal motor neurons of sporadic ALS patients, although the mechanisms by which decreased dynactin 1 levels cause neurodegeneration have yet to be elucidated. The accumulation of autophagosomes in degenerated motor neurons is another key pathological feature of sporadic ALS. Since autophagosomes are cargo of dynein/dynactin complexes and play a crucial role in the turnover of several organelles and proteins, we hypothesized that the quantitative loss of dynactin 1 disrupts the transport of autophagosomes and induces the degeneration of motor neuron. In the present study, we generated a Caenorhabditis elegans model in which the expression of DNC-1, the homolog of dynactin 1, is specifically knocked down in motor neurons. This model exhibited severe motor defects together with axonal and neuronal degeneration. We also observed impaired movement and increased number of autophagosomes in the degenerated neurons. Furthermore, the combination of rapamycin, an activator of autophagy, and trichostatin which facilitates axonal transport dramatically ameliorated the motor phenotype and axonal degeneration of this model. Thus, our results suggest that decreased expression of dynactin 1 induces motor neuron degeneration and that the transport of autophagosomes is a novel and substantial therapeutic target for motor neuron degeneration.	[Ikenaka, Kensuke; Kawai, Kaori; Katsuno, Masahisa; Huang, Zhe; Jiang, Yue-Mei; Iguchi, Yohei; Waza, Masahiro; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kobayashi, Kyogo; Kimata, Tsubasa; Mori, Ikue] Nagoya Univ, Grp Mol Neurobiol, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Sobue, Gen] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Sobue, G (corresponding author), Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	sobueg@med.nagoya-u.ac.jp	KATSUNO, MASAHISA/I-7502-2014	KATSUNO, MASAHISA/0000-0001-9453-9311; Kobayashi, Kyogo/0000-0002-2769-9646	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare; Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [25293207] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research and Global COE Program from the Ministry of Education, Culture, Sports, Science, and Technology, Grants-in-Aid for Scientific Research from the Ministry of Health, Labor, and Welfare, a Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology", and Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; BRENNER S, 1974, GENETICS, V77, P71; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Comley LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017639; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hall DH, 1997, J NEUROSCI, V17, P1033; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Ishigaki S, 2002, J NEUROCHEM, V82, P576, DOI 10.1046/j.1471-4159.2002.00998.x; Jiang YM, 2007, J NEUROPATH EXP NEUR, V66, P617, DOI 10.1097/nen.0b013e318093ece3; Katsumata K, 2010, AUTOPHAGY, V6, P378, DOI 10.4161/auto.6.3.11262; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Koushika SP, 2004, J NEUROSCI, V24, P3907, DOI 10.1523/JNEUROSCI.5039-03.2004; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Melendez Alicia, 2009, WormBook, P1, DOI 10.1895/wormbook.1.147.1; Miyara A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001384; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ohara S, 2004, EXP NEUROL, V187, P289, DOI 10.1016/j.expneurol.2004.03.002; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Paredez AR, 2008, PLANT PHYSIOL, V147, P1723, DOI 10.1104/pp.108.120196; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690; Sikorska B, 2004, INT J BIOCHEM CELL B, V36, P2563, DOI 10.1016/j.biocel.2004.04.014; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Stiernagle Theresa, 2006, WormBook, P1; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; Takada T, 2005, INT J DEV BIOL, V49, P891, DOI 10.1387/ijdb.052031tt; THOMAS JH, 1990, GENETICS, V124, P855; Welte MA, 2010, CURR BIOL, V20, pR410, DOI 10.1016/j.cub.2010.03.018; Yang Y, 2008, AUTOPHAGY, V4, P243, DOI 10.4161/auto.5431; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang X, 2011, AUTOPHAGY, V7	55	68	71	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54511	10.1371/journal.pone.0054511	http://dx.doi.org/10.1371/journal.pone.0054511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408943	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200009
J	Luiz, RD; Silva, KAS; Rampaso, RR; Antonio, EL; Montemor, J; Bocalini, DS; dos Santos, L; Moura, L; Tucci, PJF; de Abreu, NP; Schor, N				Luiz, Rafael da Silva; Santos Silva, Kleiton Augusto; Rampaso, Rodolfo Rosseto; Antonio, Ednei Luiz; Montemor, Jairo; Bocalini, Danilo Sales; dos Santos, Leonardo; Moura, Luiz; Ferreira Tucci, Paulo Jose; de Abreu, Nayda Parisio; Schor, Nestor			Exercise Attenuates Renal Dysfunction with Preservation of Myocardial Function in Chronic Kidney Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; 5/6 NEPHRECTOMIZED RATS; HEART-FAILURE; POSTEXERCISE HYPOTENSION; SUBTOTAL NEPHRECTOMY; SWIMMING EXERCISE; AEROBIC EXERCISE; NITRIC-OXIDE; PROGRESSION; THERAPY	Previous studies have suggested that exercise improves renal and cardiac functions in patients with chronic kidney disease. The aim of this study was to evaluate the effects of long-term aerobic swimming exercise with overload on renal and cardiac function in rats with 5/6 nefrectomy (5/6Nx). Eight Wistar rats were placed into 4 groups: Control (C), Control+Exercise (E), Sedentary 5/6Nx (NxS) and 5/6Nx+Exercise (NxE). The rats were subjected to swimming exercise sessions with overload for 30 min five days per week for five weeks. Exercise reduced the effect of 5/6Nx on creatinine clearance compared to the NxS group. In addition, exercise minimized the increase in mean proteinuria compared to the NxS group (96.9 +/- 10.0 vs. 51.4 +/- 9.9 mg/24 h; p<0.05). Blood pressure was higher in the NxS and NxE groups compared to the C and E groups (216 +/- 4 and 178 +/- 3 vs. 123 +/- 2 and 124 +/- 2 mm Hg, p<0.05). In the 200 glomeruli that were evaluated, the NxS group had a higher sclerosis index than did the NxE group (16% vs. 2%, p<0.05). Echocardiography demonstrated a higher anterior wall of the left ventricle (LV) in diastole in the NxS group compared with the C, E and NxE groups. The NxS group also had a higher LV posterior wall in diastole and systole compared with the E group. The developed isometric tension in Lmax of the heart papillary muscle was lower in the NxS group compared with the C, E and NxE groups. These results suggested that exercise in 5/6Nx animals might reduce the progression of renal disease and lessen the cardiovascular impact of a reduction in renal mass.	[Luiz, Rafael da Silva; Santos Silva, Kleiton Augusto; Rampaso, Rodolfo Rosseto; Moura, Luiz; de Abreu, Nayda Parisio; Schor, Nestor] Univ Fed Sao Paulo, UNIFESP EPM, Dept Med, Div Nephrol, Sao Paulo, Brazil; [Antonio, Ednei Luiz; Montemor, Jairo; Bocalini, Danilo Sales; Ferreira Tucci, Paulo Jose] Univ Fed Sao Paulo, Cardiophysiol & Pathophysiol Lab, Sao Paulo, Brazil; [dos Santos, Leonardo] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Luiz, RD (corresponding author), Univ Fed Sao Paulo, UNIFESP EPM, Dept Med, Div Nephrol, Sao Paulo, Brazil.	rafakarate@hotmail.com	Schor, Nestor/K-4364-2013; Bocalini, Danilo/J-1997-2014; Antonio, Ednei/AGG-9987-2022; dos Santos, Leonardo/B-6509-2013; Batista, Marcelo/K-4305-2013	Antonio, Ednei/0000-0002-8254-5762; dos Santos, Leonardo/0000-0002-4340-6364; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Oswaldo Ramos (FOR); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Ramos (FOR); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The present study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Oswaldo Ramos (FOR) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013; Antonio EL, 2009, J CARD FAIL, V15, P540, DOI 10.1016/j.cardfail.2009.01.007; Bellinghieri G, 2008, J RENAL NUTR, V18, P158, DOI 10.1053/j.jrn.2007.10.031; Bergamaschi CT, 1997, MED SCI SPORT EXER, V29, P169, DOI 10.1097/00005768-199702000-00001; Bocalini DS, 2010, EUR J APPL PHYSIOL, V109, P909, DOI 10.1007/s00421-010-1406-x; Bocalini DS, 2009, INT HEART J, V50, P643, DOI 10.1536/ihj.50.643; Bohm CJ, 2010, J NEPHROL, V23, P235; Burke SW, 2000, ADV RENAL REPLACE TH, V7, P210, DOI 10.1053/jarr.2000.8120; Chaykovska L, 2011, CLIN LAB, V57, P455; Coelho BLP, 2010, J RENAL NUTR, V20, P169, DOI 10.1053/j.jrn.2009.10.007; Deguchi T, 2005, J PHARMACOL EXP THER, V314, P932, DOI 10.1124/jpet.105.085613; Derumeaux G, 2002, CIRCULATION, V105, P1602, DOI 10.1161/01.CIR.0000012943.91101.D7; dos Santos L, 2010, CAN J PHYSIOL PHARM, V88, P724, DOI [10.1139/Y10-062, 10.1139/y10-062]; Evangelista FS, 2003, BRAZ J MED BIOL RES, V36, P1751, DOI 10.1590/S0100-879X2003001200018; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; GOLDBERG AP, 1986, NEPHRON, V42, P311, DOI 10.1159/000183694; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Gunduz F, 2003, J APPL PHYSIOL, V95, P1867, DOI 10.1152/japplphysiol.00599.2003; Halliwill JR, 2000, J APPL PHYSIOL, V89, P1830, DOI 10.1152/jappl.2000.89.5.1830; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Hayashi SY, 2006, NEPHROL DIAL TRANSPL, V21, P125, DOI 10.1093/ndt/gfi075; HEIFETS M, 1987, KIDNEY INT, V32, P815, DOI 10.1038/ki.1987.281; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Johansen KL, 2007, J AM SOC NEPHROL, V18, P1845, DOI 10.1681/ASN.2007010009; Kanazawa M, 2006, AM J HYPERTENS, V19, P80, DOI 10.1016/j.amjhyper.2005.07.009; KLAHR S, 1987, KIDNEY INT, V32, pS35; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; Knap B, 2005, THER APHER DIAL, V9, P211, DOI 10.1111/j.1774-9987.2005.00256.x; Kohzuki M, 2001, J HYPERTENS, V19, P1877, DOI 10.1097/00004872-200110000-00024; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; Moinuddin I, 2008, ADV CHRONIC KIDNEY D, V15, P83, DOI 10.1053/j.ackd.2007.10.004; Moraes MR, 2007, BIOL CHEM, V388, P533, DOI 10.1515/BC.2007.055; Henrique DMN, 2010, ARQ BRAS CARDIOL, V94, P823, DOI 10.1590/S0066-782X2010005000043; Noronha IL, 2002, NEPHROL DIAL TRANSPL, V17, P363, DOI 10.1093/ndt/17.3.363; OSATO S, 1990, NEPHRON, V55, P306, DOI 10.1159/000185980; Osorio RAL, 2003, COMP BIOCHEM PHYS A, V135, P605, DOI 10.1016/S1095-6433(03)00144-2; Paterno JC, 2008, KIDNEY BLOOD PRESS R, V31, P367, DOI 10.1159/000176189; Portes LA, 2009, CLIN EXP PHARMACOL P, V36, P394, DOI 10.1111/j.1440-1681.2008.05070.x; Remuzzi G, 2005, KIDNEY INT, V68, P57; Salgado JV, 2010, BRAZ J MED BIOL RES, V43, P528, DOI 10.1590/S0100-879X2010000600002; Serra AJ, 2010, J PHYSIOL-LONDON, V588, P2431, DOI 10.1113/jphysiol.2010.187310; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Sviglerova J, 2010, PHYSIOL RES, V59, pS81, DOI 10.33549/physiolres.932003; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Windt WAKM, 2008, NEPHROL DIAL TRANSPL, V23, P3103, DOI 10.1093/ndt/gfn233; Wu X M, 1999, Nihon Jinzo Gakkai Shi, V41, P35; Zelle DM, 2011, CLIN J AM SOC NEPHRO, V6, P898, DOI 10.2215/CJN.03340410	48	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55363	10.1371/journal.pone.0055363	http://dx.doi.org/10.1371/journal.pone.0055363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408975	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200028
J	Aggarwal, C; Labuz, J; Gabrys, H				Aggarwal, Chhavi; Labuz, Justyna; Gabrys, Halina			Phosphoinositides Play Differential Roles in Regulating Phototropin1-and Phototropin2-Mediated Chloroplast Movements in Arabidopsis	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-AND 4-PHOSPHATE; BLUE; LIGHT; CALCIUM; CA2+; 4,5-BISPHOSPHATE; CELLS; OSCILLATIONS; INCREASES; MECHANISM	Phototropins are UVA/blue-light receptors involved in controlling the light-dependent physiological responses which serve to optimize the photosynthetic activity of plants and promote growth. The phototropin-induced phosphoinositide (PI) metabolism has been shown to be essential for stomatal opening and phototropism. However, the role of PIs in phototropin-induced chloroplast movements remains poorly understood. The aim of this work is to determine which PI species are involved in the control of chloroplast movements in Arabidopsis and the nature of their involvement. We present the effects of the inactivation of phospholipase C (PLC), PI3-kinase (PI3K) and PI4-kinase (PI4K) on chloroplast relocations in Arabidopsis. The inhibition of the phosphatidylinositol 4,5-bisphospahte [PI(4,5)P2]-PLC pathway, using neomycin and U73122, suppressed the phot2-mediated chloroplast accumulation and avoidance responses, without affecting movement responses controlled by phot1. On the other hand, PI3K and PI4K activities are more restricted to phot1- and phot2-induced weak-light responses. The inactivation of PI3K and PI4K by wortmannin and LY294002 severely affected the weak blue-light-activated accumulation response but had little effect on the strong blue-light-activated avoidance response. The inhibitory effect observed with PI metabolism inhibitors is, at least partly, due to a disturbance in Ca-(c)(2+) signaling. Using the transgenic aequorin system, we show that the application of these inhibitors suppresses the blue-light-induced transient Ca-(c)(2+) rise. These results demonstrate the importance of PIs in chloroplast movements, with the PI(4,5)P2-PLC pathway involved in phot2 signaling while PI3K and PI4K are required for the phot1- and phot2-induced accumulation response. Our results suggest that these PIs modulate cytosolic Ca2+ signaling during movements.	[Aggarwal, Chhavi; Labuz, Justyna; Gabrys, Halina] Jagiellonian Univ, Dept Plant Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland	Jagiellonian University	Gabrys, H (corresponding author), Jagiellonian Univ, Dept Plant Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	halina.gabrys@uj.edu.pl		Labuz, Justyna/0000-0002-2612-1658	European Union (EU) [215174]; Polish National Science Center [211/03/N/NZ3/00224, 2011/01/N/NZ3/00280]; Jagiellonian University within the SET project; European Union [POIG.02.01.00-12-064/08]	European Union (EU)(CGIAREuropean Commission); Polish National Science Center; Jagiellonian University within the SET project; European Union(European Commission)	Chhavi Aggarwal was supported from European Union (EU) funds within the framework of FP7, Marie Curie ITN, grant no. 215174 "Chloroplast Signals'' (COSI) and from Polish National Science Center, grant no. 211/03/N/NZ3/00224. Justyna Labuz was supported by the grant of the Polish National Science Center, no. 2011/01/N/NZ3/00280 and funding from the Jagiellonian University within the SET project (co-financed by the European Union). The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is the beneficiary of structural funds from the European Union - grant No. POIG.02.01.00-12-064/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva Z, 2010, PLANTA, V232, P1263, DOI 10.1007/s00425-010-1256-0; Anielska-Mazur A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-64; Babourina O, 2002, P NATL ACAD SCI USA, V99, P2433, DOI 10.1073/pnas.042294599; Banas AK, 2012, J EXP BOT, V63, P1559, DOI 10.1093/jxb/err429; Baum G, 1999, P NATL ACAD SCI USA, V96, P13554, DOI 10.1073/pnas.96.23.13554; Bovet L, 2001, BIOCHEM BIOPH RES CO, V289, P269, DOI 10.1006/bbrc.2001.5969; Chen X, 2008, PLANT CELL, V20, P353, DOI 10.1105/tpc.107.052670; Choi Y, 2008, PLANT CELL ENVIRON, V31, P366, DOI 10.1111/j.1365-3040.2007.01769.x; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DeWald DB, 2001, PLANT PHYSIOL, V126, P759, DOI 10.1104/pp.126.2.759; Dowd PE, 2006, PLANT CELL, V18, P1438, DOI 10.1105/tpc.106.041582; Erneux C, 1998, BBA-MOL CELL BIOL L, V1436, P185, DOI 10.1016/S0005-2760(98)00132-5; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gonorazky G, 2010, J PLANT PHYSIOL, V167, P411, DOI 10.1016/j.jplph.2009.10.003; Grabalska M, 2004, PHOTOCHEM PHOTOBIOL, V79, P343, DOI 10.1562/LE-03-16.1; Harada A, 2003, P NATL ACAD SCI USA, V100, P8583, DOI 10.1073/pnas.1336802100; Harada A, 2009, PLANT CELL PHYSIOL, V50, P360, DOI 10.1093/pcp/pcn203; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Jung JY, 2002, PLANT CELL, V14, P2399, DOI 10.1105/tpc.004143; Kadota A, 2009, P NATL ACAD SCI USA, V106, P13106, DOI 10.1073/pnas.0906250106; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Kong SG, 2006, PLANT J, V45, P994, DOI 10.1111/j.1365-313X.2006.02667.x; Krzeszowiec W, 2007, BIOL CELL, V99, P251, DOI 10.1042/BC20060077; Lee Y, 2007, PLANT J, V52, P803, DOI 10.1111/j.1365-313X.2007.03277.x; Lemtiri-Chlieh F, 2003, P NATL ACAD SCI USA, V100, P10091, DOI 10.1073/pnas.1133289100; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Marten H, 2007, PLANT J, V50, P29, DOI 10.1111/j.1365-313X.2006.03026.x; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Munnik T, 2011, CURR OPIN PLANT BIOL, V14, P1; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Salinas-Mondragon RE, 2010, PLANT CELL ENVIRON, V33, P2041, DOI 10.1111/j.1365-3040.2010.02204.x; Silswal N, 2011, AM J PHYSIOL-HEART C, V300, pH2016, DOI 10.1152/ajpheart.01011.2010; Sousa E, 2008, PLANT CELL, V20, P3050, DOI 10.1105/tpc.108.058826; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Stoelzle S, 2003, P NATL ACAD SCI USA, V100, P1456, DOI 10.1073/pnas.0333408100; Sztatelman O, 2010, J PLANT PHYSIOL, V167, P709, DOI 10.1016/j.jplph.2009.12.015; Takac T, 2012, J PROTEOME RES, V11, P3127, DOI 10.1021/pr201111n; Tlalka M, 1999, PLANT J, V20, P461, DOI 10.1046/j.1365-313x.1999.00621.x; TLALKA M, 1993, PLANTA, V189, P491, DOI 10.1007/BF00198211; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vossen JH, 2010, PLANT J, V62, P224, DOI 10.1111/j.1365-313X.2010.04136.x; WALCZAK T, 1980, PHOTOSYNTHETICA, V14, P65; Wan YL, 2008, MOL PLANT, V1, P103, DOI 10.1093/mp/ssm011; YULE DI, 1992, J BIOL CHEM, V267, P13830; ZURZYCKI J., 1955, ACTA SOC BOT POLON, V24, P27	47	29	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55393	10.1371/journal.pone.0055393	http://dx.doi.org/10.1371/journal.pone.0055393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405144	Green Published, gold			2022-12-27	WOS:000315153400089
J	Cahoon, EK; Wheeler, DC; Kimlin, MG; Kwok, RK; Alexander, BH; Little, MP; Linet, MS; Freedman, DM				Cahoon, Elizabeth Khaykin; Wheeler, David C.; Kimlin, Michael G.; Kwok, Richard K.; Alexander, Bruce H.; Little, Mark P.; Linet, Martha S.; Freedman, Daryl Michal			Individual, Environmental, and Meteorological Predictors of Daily Personal Ultraviolet Radiation Exposure Measurements in a United States Cohort Study	PLOS ONE			English	Article							SUN EXPOSURE; VITAMIN-D; MEASUREMENT ERROR; CANCER INCIDENCE; MORTALITY-RATES; SKIN; RISK; REPRODUCIBILITY; LATITUDE; AUSTRALIA	Background: Individual exposure to ultraviolet radiation (UVR) is challenging to measure, particularly for diseases with substantial latency periods between first exposure and diagnosis of outcome, such as cancer. To guide the choice of surrogates for long-term UVR exposure in epidemiologic studies, we assessed how well stable sun-related individual characteristics and environmental/meteorological factors predicted daily personal UVR exposure measurements. Methods: We evaluated 123 United States Radiologic Technologists subjects who wore personal UVR dosimeters for 8 hours daily for up to 7 days (N = 837 days). Potential predictors of personal UVR derived from a self-administered questionnaire, and public databases that provided daily estimates of ambient UVR and weather conditions. Factors potentially related to personal UVR exposure were tested individually and in a model including all significant variables. Results: The strongest predictors of daily personal UVR exposure in the full model were ambient UVR, latitude, daily rainfall, and skin reaction to prolonged sunlight (R-2 = 0.30). In a model containing only environmental and meteorological variables, ambient UVR, latitude, and daily rainfall were the strongest predictors of daily personal UVR exposure (R-2 = 0.25). Conclusions: In the absence of feasible measures of individual longitudinal sun exposure history, stable personal characteristics, ambient UVR, and weather parameters may help estimate long-term personal UVR exposure.	[Cahoon, Elizabeth Khaykin; Little, Mark P.; Linet, Martha S.; Freedman, Daryl Michal] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Wheeler, David C.] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA; [Kimlin, Michael G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, AusSun Res Lab, Brisbane, Qld 4001, Australia; [Kwok, Richard K.] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Alexander, Bruce H.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Commonwealth University; Queensland University of Technology (QUT); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Minnesota System; University of Minnesota Twin Cities	Cahoon, EK (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	khaykine@mail.nih.gov	Kwok, Richard/B-6907-2017	Kwok, Richard/0000-0002-6794-8360; Kimlin, Michael/0000-0002-9536-8646; Little, Mark/0000-0003-0980-7567	Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services	Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LN, 2011, AM J EPIDEMIOL, V174, P293, DOI 10.1093/aje/kwr091; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Armstrong BK, 2006, INT J EPIDEMIOL, V35, P231, DOI 10.1093/ije/dyi292; BOICE JD, 1992, CANCER, V69, P586, DOI 10.1002/1097-0142(19920115)69:2<586::AID-CNCR2820690251>3.0.CO;2-3; Boscoe FP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-264; Chen ACH, 2008, J GEN VIROL, V89, P2891, DOI 10.1099/vir.0.2008/003665-0; Chodick G, 2008, PHOTOCHEM PHOTOBIOL, V84, P713, DOI 10.1111/j.1751-1097.2007.00236.x; Colli JL, 2010, INT UROL NEPHROL, V42, P659, DOI 10.1007/s11255-009-9655-5; Dadvand P, 2011, PHOTOCH PHOTOBIO SCI, V10, P1161, DOI 10.1039/c0pp00333f; Diffey B, 2008, PHOTOCHEM PHOTOBIOL, V84, P371, DOI 10.1111/j.1751-1097.2007.00271.x; Doody MM, 1998, CANCER CAUSE CONTROL, V9, P67, DOI 10.1023/A:1008801404245; English DR, 1998, CANCER EPIDEM BIOMAR, V7, P857; Freedman DM, 2010, J PHOTOCH PHOTOBIO B, V101, P321, DOI 10.1016/j.jphotobiol.2010.08.001; Grant WB, 2003, RECENT RESULTS CANC, V164, P371; Grant WB, 2002, CANCER-AM CANCER SOC, V94, P272, DOI 10.1002/cncr.10196; Grant WB, 2007, ASIAN PAC J CANCER P, V8, P236; Hall LM, 2010, J NUTR, V140, P542, DOI 10.3945/jn.109.115253; Handel AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014606; Hu S, 2004, CANCER EPIDEM BIOMAR, V13, P59, DOI 10.1158/1055-9965.EPI-03-0187; Hughes AM, 2011, PEDIAT ALLERG IMM-UK, V22, P327, DOI 10.1111/j.1399-3038.2010.01099.x; Karagas MR, 2007, AM J EPIDEMIOL, V165, P719, DOI 10.1093/aje/kwk055; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; Lin SW, 2012, INT J CANC; MacKie RM, 2006, PROG BIOPHYS MOL BIO, V92, P92, DOI 10.1016/j.pbiomolbio.2006.02.008; McCurdy T, 2003, J EXPO ANAL ENV EPID, V13, P294, DOI 10.1038/sj.jea.7500281; Musselman JRB, 2011, BRIT J CANCER, V104, P214, DOI 10.1038/sj.bjc.6606015; National Aeronautics and Space Administration, 2004, TOT OZ MAPP SPECTR D; National Oceanic and Atmospheric Administration, 2004, 3505 DSI NAT OC ATM; O'Riordan DL, 2000, PHOTOCHEM PHOTOBIOL, V71, P60, DOI 10.1562/0031-8655(2000)071<0060:CBRAMU>2.0.CO;2; Orton SM, 2011, NEUROLOGY, V76, P425, DOI 10.1212/WNL.0b013e31820a0a9f; PARISI AV, 1994, PHOTOCHEM PHOTOBIOL, V60, P470, DOI 10.1111/j.1751-1097.1994.tb05136.x; Rosso S, 2002, INT J EPIDEMIOL, V31, P439, DOI 10.1093/ije/31.2.439; Sayers A, 2009, INT J EPIDEMIOL, V38, P1681, DOI 10.1093/ije/dyp237; Snijders TAB, 1999, MULTILEVEL ANAL INTR, Vviii; Stanton WR, 2003, INT J BEHAV MED, V10, P285, DOI 10.1207/S15327558IJBM1004_1; Staples JA, 2003, ENVIRON HEALTH PERSP, V111, P518, DOI 10.1289/ehp.5941; Thieden E, 2001, PHOTODERMATOL PHOTO, V17, P249, DOI 10.1034/j.1600-0781.2001.170601.x; Thieden E, 2008, DAN MED BULL, V55, P47; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; Vajdic CM, 2003, INT J CANCER, V105, P117, DOI 10.1002/ijc.11057; Veierod MB, 2008, MELANOMA RES, V18, P1, DOI 10.1097/CMR.0b013e3282f120d2; Yaroch AL, 2006, HEALTH EDUC BEHAV, V33, P340, DOI 10.1177/1090198105285329; Yu GP, 2006, PHOTOCHEM PHOTOBIOL, V82, P1621, DOI 10.1562/2006-07-17-RA-970; Zhou XH, 2001, J ROY STAT SOC C-APP, V50, P303, DOI 10.1111/1467-9876.00235	44	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54983	10.1371/journal.pone.0054983	http://dx.doi.org/10.1371/journal.pone.0054983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405102	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400046
J	Coban, AY				Coban, Ahmet Yilmaz			Blood Agar Validation for Susceptibility Testing of Isoniazid, Rifampicin, Ethambutol, and Streptomycin to Mycobacterium tuberculosis Isolates	PLOS ONE			English	Article							ANTITUBERCULOUS DRUGS; 2ND-LINE; 1ST-LINE	In recent studies, it was shown that blood agar can be used at least as effectively as Lowenstein-Jensen medium for growing Mycobacterium tuberculosis. It was also shown that susceptibility testing can be performed on blood agar. Additional validation of blood agar was performed on regional M. tuberculosis isolates from Turkey to determine critical concentrations of isoniazid (INH), rifampicin (RIF), ethambutol (ETM), and streptomycin (STR). In the current study, 40 M. tuberculosis clinical isolates were tested. H37Rv, which is susceptible to all antituberculosis agents, ATCC 35822 (INH-resistant), ATCC 35838 (RIF-resistant), ATCC 35837 (ETM-resistant), and ATCC 35820 (STR-resistant) quality control strains were used as control strains. Proportion method on 7H11 agar was considered as gold standard in the study. MIC values of the control strains and clinical isolates were detected on blood and 7H11 agar. Categorical agreements were 100% for each antibiotic, and essential agreements were 100%, 97.5%, 82.5%, and 95% for INH, RIF, ETM, and STR, respectively. According to the data, 0.2 mu g/mL for INH, 1 mu g/mL for RIF, 4 mu g/mL for ETM, and 2 mu g/mL for STR were appropriate breakpoint values for susceptibility testing on blood agar. Blood agar may be recommended for use in both developed and developing countries for the susceptibility testing of M. tuberculosis isolates to primary antituberculosis drugs.	Ondokuz Mayis Univ, Sch Med, Dept Med Microbiol, Samsun, Turkey	Ondokuz Mayis University	Coban, AY (corresponding author), Ondokuz Mayis Univ, Sch Med, Dept Med Microbiol, Samsun, Turkey.	yilmazden@hotmail.com	Coban, Ahmet Y/I-9067-2017		Scientific and Technological Research Council of Turkey	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was supported by "The Scientific and Technological Research Council of Turkey''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto AMW, 2003, MEM I OSWALDO CRUZ, V98, P827, DOI 10.1590/S0074-02762003000600020; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2 CLSI; Coban AY, 2008, J CHEMOTHERAPY, V20, P388, DOI 10.1179/joc.2008.20.3.388; Coban AY, 2008, MIKROBIYOL BUL, V42, P477; Coban AY, 2011, MIKROBIYOL BUL, V45, P617; Coban AY, 2011, MEM I OSWALDO CRUZ, V106, P378, DOI 10.1590/S0074-02762011000300022; Coban AY, 2008, J CLIN MICROBIOL, V46, P4095, DOI 10.1128/JCM.01104-08; Coban AY, 2006, INT J TUBERC LUNG D, V10, P450; Coban AY, 2005, J CLIN MICROBIOL, V43, P1930, DOI 10.1128/JCM.43.4.1930-1931.2005; Drancourt M, 2003, J CLIN MICROBIOL, V41, P1710, DOI 10.1128/JCM.41.4.1710-1711.2003; Drancourt M, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000083; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Kent PT, 1985, PUBLIC HLTH MYCOBACT, P47; Kilicturgay K, 1977, Mikrobiyol Bul, V11, P29; Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304; Mathur ML, 2009, DAN MED BULL, V56, P208; Palomino JC, 2007, TUBERCULOSIS 2007, P635; Satana D, 2010, J CLIN MICROBIOL, V48, P4291, DOI 10.1128/JCM.00688-10; Yildiz C, 2007, SAUDI MED J, V28, P975	20	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55370	10.1371/journal.pone.0055370	http://dx.doi.org/10.1371/journal.pone.0055370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405140	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400085
J	Dayaram, T; Lemoine, FJ; Donehower, LA; Marriott, SJ				Dayaram, Tajhal; Lemoine, Francene J.; Donehower, Lawrence A.; Marriott, Susan J.			Activation of WIP1 Phosphatase by HTLV-1 Tax Mitigates the Cellular Response to DNA Damage	PLOS ONE			English	Article							VIRUS TYPE-I; NUCLEOTIDE EXCISION-REPAIR; ONCOGENE PRODUCT TAX; NF-KAPPA-B; TYPE-1 TAX; CYCLE PROGRESSION; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TRANSACTIVATOR TAX; HUMAN-LYMPHOCYTES	Genomic instability stemming from dysregulation of cell cycle checkpoints and DNA damage response (DDR) is a common feature of many cancers. The cancer adult T cell leukemia (ATL) can occur in individuals infected with human T cell leukemia virus type 1 (HTLV-1), and ATL cells contain extensive chromosomal abnormalities, suggesting that they have defects in the recognition or repair of DNA damage. Since Tax is the transforming protein encoded by HTLV-1, we asked whether Tax can affect cell cycle checkpoints and the DDR. Using a combination of flow cytometry and DNA repair assays we showed that Tax-expressing cells exit G(1) phase and initiate DNA replication prematurely following damage. Reduced phosphorylation of H2AX (gamma H2AX) and RPA2, phosphoproteins that are essential to properly initiate the DDR, was also observed in Tax-expressing cells. To determine the cause of decreased DDR protein phosphorylation in Tax-expressing cells, we examined the cellular phosphatase, WIP1, which is known to dephosphorylate gamma H2AX. We found that Tax can interact with Wip1 in vivo and in vitro, and that Tax-expressing cells display elevated levels of Wip1 mRNA. In vitro phosphatase assays showed that Tax can enhance Wip1 activity on a gamma H2AX peptide target by 2-fold. Thus, loss of gamma H2AX in vivo could be due, in part, to increased expression and activity of WIP1 in the presence of Tax. siRNA knockdown of WIP1 in Tax-expressing cells rescued gamma H2AX in response to damage, confirming the role of WIP1 in the DDR. These studies demonstrate that Tax can disengage the G(1)/S checkpoint by enhancing WIP1 activity, resulting in reduced DDR. Premature G(1) exit of Tax-expressing cells in the presence of DNA lesions creates an environment that tolerates incorporation of random mutations into the host genome.	[Dayaram, Tajhal; Donehower, Lawrence A.; Marriott, Susan J.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.; Marriott, Susan J.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Lemoine, Francene J.] NW State Univ Louisiana, Dept Biol Sci, Natchitoches, LA USA	Baylor College of Medicine; Baylor College of Medicine; University of Louisiana System; Northwestern State University of Louisiana	Marriott, SJ (corresponding author), Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA.	susanm@bcm.tmc.edu			United States Public Service Grant, National Cancer Institute, National Institutes of Health [CA-77371]; NATIONAL CANCER INSTITUTE [R01CA077371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	United States Public Service Grant, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the United States Public Service Grant CA-77371 from National Cancer Institute, National Institutes of Health, awarded to SJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADYA N, 1995, J VIROL, V69, P1834, DOI 10.1128/JVI.69.3.1834-1841.1995; Al-Mohanna MA, 2001, CARCINOGENESIS, V22, P573, DOI 10.1093/carcin/22.4.573; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Bullock SK, 2001, CARCINOGENESIS, V22, P233, DOI 10.1093/carcin/22.2.233; Cereseto A, 1996, BLOOD, V88, P1551, DOI 10.1182/blood.V88.5.1551.bloodjournal8851551; Chandhasin C, 2008, J VIROL, V2, P46; Chuman Y, 2008, PROTEIN PEPTIDE LETT, V15, P938, DOI 10.2174/092986608785849236; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074/jbc.M804931200; FRANKLIN AA, 1993, J BIOL CHEM, V268, P21225; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; GRASSMANN R, 1989, P NATL ACAD SCI USA, V86, P3551; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Haller K, 2002, MOL CELL BIOL, V22, P3327, DOI 10.1128/MCB.22.10.3327-3338.2002; Han HS, 2009, MOL CANCER RES, V7, P713, DOI 10.1158/1541-7786.MCR-08-0247; Haoudi A, 2003, VIROLOGY, V305, P229, DOI 10.1006/viro.2002.1642; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; HINRICHS SH, 1987, SCIENCE, V237, P1340, DOI 10.1126/science.2888191; Iwanaga R, 2001, ONCOGENE, V20, P2055, DOI 10.1038/sj.onc.1204304; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; KANNO T, 1994, MOL CELL BIOL, V14, P6443, DOI 10.1128/MCB.14.10.6443; Kao SY, 2000, J BIOL CHEM, V275, P35926, DOI 10.1074/jbc.M004397200; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; KORBER B, 1991, J VIROL, V65, P5471, DOI 10.1128/JVI.65.10.5471-5476.1991; Lemoine FJ, 2002, ONCOGENE, V21, P7230, DOI 10.1038/sj.onc.1205898; Lemoine FJ, 2001, J BIOL CHEM, V276, P31851, DOI 10.1074/jbc.M105195200; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LOW KG, 1994, MOL CELL BIOL, V14, P4958, DOI 10.1128/MCB.14.7.4958; Low KG, 1997, J VIROL, V71, P1956, DOI 10.1128/JVI.71.3.1956-1962.1997; Lowe JM, 2009, J BIOL CHEM; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2008, CELL CYCLE, V7, P164, DOI 10.4161/cc.7.2.5299; McDonald ER, 2001, ANN MED, V33, P113, DOI 10.3109/07853890109002066; Miyake H, 1999, VIROLOGY, V253, P155, DOI 10.1006/viro.1998.9500; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Mulloy JC, 1998, J VIROL, V72, P8852, DOI 10.1128/JVI.72.11.8852-8860.1998; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; Nakayama K, 2000, LEUKEMIA RES, V24, P299, DOI 10.1016/S0145-2126(99)00186-1; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; Neuveut C, 1998, MOL CELL BIOL, V18, P3620, DOI 10.1128/MCB.18.6.3620; Nguyen TA, 2010, DNA REPAIR, V9, P813, DOI 10.1016/j.dnarep.2010.04.005; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; Reddy TR, 1997, ONCOGENE, V14, P2785, DOI 10.1038/sj.onc.1201119; RIMSKY L, 1988, NATURE, V335, P738, DOI 10.1038/335738a0; Rossi M, 2008, NUCLEIC ACIDS RES, V36, P7168, DOI 10.1093/nar/gkn888; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; Schmitt I, 1998, J VIROL, V72, P633, DOI 10.1128/JVI.72.1.633-640.1998; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; SMITH MR, 1991, J CLIN INVEST, V88, P1038, DOI 10.1172/JCI115364; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; Suzuki T, 1999, VIROLOGY, V259, P384, DOI 10.1006/viro.1999.9760; Suzuki T, 1996, EMBO J, V15, P1607, DOI 10.1002/j.1460-2075.1996.tb00505.x; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; YAMAGUCHI K, 1983, BLOOD, V62, P758; YAMAOKA S, 1992, ONCOGENE, V7, P433; Zane L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-114	66	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55989	10.1371/journal.pone.0055989	http://dx.doi.org/10.1371/journal.pone.0055989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405243	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400188
J	Grezes, J; Philip, L; Chadwick, M; Dezecache, G; Soussignan, R; Conty, L				Grezes, Julie; Philip, Leonor; Chadwick, Michele; Dezecache, Guillaume; Soussignan, Robert; Conty, Laurence			Self-Relevance Appraisal Influences Facial Reactions to Emotional Body Expressions	PLOS ONE			English	Article							ELECTROMYOGRAPHIC RESPONSES; GAZE DIRECTION; SOCIAL-INTERACTION; TIME-COURSE; BEHAVIOR; AMYGDALA; MIMICRY; FACES; COGNITION; RECOGNITION	People display facial reactions when exposed to others' emotional expressions, but exactly what mechanism mediates these facial reactions remains a debated issue. In this study, we manipulated two critical perceptual features that contribute to determining the significance of others' emotional expressions: the direction of attention (toward or away from the observer) and the intensity of the emotional display. Electromyographic activity over the corrugator muscle was recorded while participants observed videos of neutral to angry body expressions. Self-directed bodies induced greater corrugator activity than other-directed bodies; additionally corrugator activity was only influenced by the intensity of anger expresssed by self-directed bodies. These data support the hypothesis that rapid facial reactions are the outcome of self-relevant emotional processing.	[Grezes, Julie; Philip, Leonor; Chadwick, Michele; Dezecache, Guillaume; Conty, Laurence] INSERM, U960, LNC, F-75005 Paris, France; [Grezes, Julie; Philip, Leonor; Chadwick, Michele; Dezecache, Guillaume; Conty, Laurence] ENS, IEC, F-75005 Paris, France; [Soussignan, Robert] Univ Bourgogne, CNRS, CSGA, UMR 6265,INRA 1324, F-21000 Dijon, France; [Conty, Laurence] Univ Paris 08, EA2027, LPN, F-93526 St Denis, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Universite Paris-VIII	Grezes, J (corresponding author), INSERM, U960, LNC, F-75005 Paris, France.	julie.grezes@ens.fr	Grèzes, Julie/E-5060-2016; Grezes, julie/I-3012-2019	Grèzes, Julie/0000-0002-5066-9154; Grezes, julie/0000-0002-5066-9154; Dezecache, Guillaume/0000-0002-9366-6287	Agence National of Research (ANR); INSERM	Agence National of Research (ANR)(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Agence National of Research (ANR) "Emotion(s), Cognition, Comportement'' 2011 program (Selfreademo) and by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; [Anonymous], 2000, SER AFFECTIVE SCI; Argyle M., 1975, BODILY COMMUNICATION; Aue T, 2011, BIOL PSYCHOL, V86, P65, DOI 10.1016/j.biopsycho.2010.10.008; Balconi M, 2011, NEUROSCI RES, V71, P251, DOI 10.1016/j.neures.2011.07.1833; Bindemann M, 2008, VIS COGN, V16, P733; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; BUCK R, 1994, BIOL PSYCHOL, V38, P95, DOI 10.1016/0301-0511(94)90032-9; BUSH L, 1986, PSYCHOPHYSIOLOGY, V23, P427; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Conty L, 2012, J NEUROSCI, V32, P4531, DOI 10.1523/JNEUROSCI.5636-11.2012; Cristinzio C, 2010, BRAIN, V133, P248, DOI 10.1093/brain/awp255; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Wied M, 2006, J PSYCHIAT RES, V40, P112, DOI 10.1016/j.jpsychires.2005.08.003; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Dimberg U, 2011, J PSYCHOPHYSIOL, V25, P26, DOI 10.1027/0269-8803/a000029; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Fischer AH., 2008, HDB EMOTIONS, P456, DOI DOI 10.2307/2076468; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Frijda NH, 2010, BIOL PSYCHOL, V84, P570, DOI 10.1016/j.biopsycho.2010.01.005; HESS U, 1995, J PERS SOC PSYCHOL, V69, P280, DOI 10.1037/0022-3514.69.2.280; Hess U, 1998, COGNITION EMOTION, V12, P509, DOI 10.1080/026999398379547; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hess U, 2007, MOTIV EMOTION, V31, P137, DOI 10.1007/s11031-007-9057-x; Hietanen JK, 1998, PSYCHOPHYSIOLOGY, V35, P530, DOI 10.1017/S0048577298970445; Keltner D, 2001, EMO SOC BEH, P192; Loveland KA, 2001, DEVELOPMENT OF AUTISM: PERSPECTIVES FROM THEORY AND RESEARCH, P17; Magnee MJCM, 2007, NEUROREPORT, V18, P369, DOI 10.1097/WNR.0b013e32801776e6; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31; Mojzisch A, 2006, SOC NEUROSCI-UK, V1, P184, DOI 10.1080/17470910600985621; Moody E.J., 2006, IMITATION SOCIAL MIN, P71; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Moody EJ, 2011, SOC PSYCHOL PERS SCI, V2, P679, DOI 10.1177/1948550611406741; N'Diaye K, 2009, EMOTION, V9, P798, DOI 10.1037/a0017845; Roseman I.J., 2001, APPRAISAL PROCESSES, P3, DOI DOI 10.1080/02699939108411034; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Sander D, 2007, EUR J COGN PSYCHOL, V19, P470, DOI 10.1080/09541440600757426; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schrammel F, 2009, PSYCHOPHYSIOLOGY, V46, P922, DOI 10.1111/j.1469-8986.2009.00831.x; SMITH CA, 1989, J PERS SOC PSYCHOL, V56, P339, DOI 10.1037/0022-3514.56.3.339; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Soussignan R, 2013, EMOTION, V13, P330, DOI 10.1037/a0029892; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Tiedens LZ, 2003, J PERS SOC PSYCHOL, V84, P558, DOI 10.1037/0022-3514.84.3.558; van der Schalk J, 2011, EMOTION, V2, P298; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6	55	26	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55885	10.1371/journal.pone.0055885	http://dx.doi.org/10.1371/journal.pone.0055885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405230	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400175
J	Heatherly, RD; Loukides, G; Denny, JC; Haines, JL; Roden, DM; Malin, BA				Heatherly, Raymond D.; Loukides, Grigorios; Denny, Joshua C.; Haines, Jonathan L.; Roden, Dan M.; Malin, Bradley A.			Enabling Genomic-Phenomic Association Discovery without Sacrificing Anonymity	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; PROTECTING PRIVACY; HEALTH DATA; REIDENTIFICATION; ANONYMIZATION; FRAMEWORK; BENEFITS; NETWORK; SUPPORT; SYSTEMS	Health information technologies facilitate the collection of massive quantities of patient-level data. A growing body of research demonstrates that such information can support novel, large-scale biomedical investigations at a fraction of the cost of traditional prospective studies. While healthcare organizations are being encouraged to share these data in a de-identified form, there is hesitation over concerns that it will allow corresponding patients to be re-identified. Currently proposed technologies to anonymize clinical data may make unrealistic assumptions with respect to the capabilities of a recipient to ascertain a patients identity. We show that more pragmatic assumptions enable the design of anonymization algorithms that permit the dissemination of detailed clinical profiles with provable guarantees of protection. We demonstrate this strategy with a dataset of over one million medical records and show that 192 genotype-phenotype associations can be discovered with fidelity equivalent to non-anonymized clinical data.	[Heatherly, Raymond D.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Loukides, Grigorios] Cardiff Univ, Sch Comp Sci & Informat, Cardiff CF10 3AX, S Glam, Wales; [Denny, Joshua C.] Vanderbilt Univ, Sch Med, Dept Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Haines, Jonathan L.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Dept Med, Nashville, TN 37212 USA; [Malin, Bradley A.] Vanderbilt Univ, Sch Med, Dept Elect Engn & Comp Sci, Dept Biomed Informat,Sch Engn, Nashville, TN 37212 USA	Vanderbilt University; Cardiff University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Heatherly, RD (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	r.heatherly@vanderbilt.edu	Denny, Josh/AAL-3359-2021; Haines, Jonathan/C-3374-2012; Roden, Dan/ABD-5412-2021	Denny, Josh/0000-0002-3049-7332; Haines, Jonathan/0000-0002-4351-4728; 	National Human Genome Research Institute [U01HG006385, U01HG006378]; National Library of Medicine [R01LM009989, R01LM010685]; Royal Academy of Engineering Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006385, R01HG006844, U01HG006378] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685, R01LM009989] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Royal Academy of Engineering Research Fellowship(Royal Academy of Engineering - UK); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was sponsored, in part, by grants U01HG006385 and U01HG006378 from the National Human Genome Research Institute and grants R01LM009989 and R01LM010685 from the National Library of Medicine. Dr. Loukides' research is supported by a Royal Academy of Engineering Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Nick, 2010, P 2010 WORKSH GOV TE, DOI [DOI 10.1145/1920320.1920323, 10.1145/1920320.1920323]; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Benitez K, 2010, J AM MED INFORM ASSN, V17, P169, DOI 10.1136/jamia.2009.000026; Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Crosslin D, 2011, HUM GENET, P1; Delaney J, 2011, CLIN PHARM THERAPEUT; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Department of Health and Human Services, 2011, FED REGISTER, V76, P44512; El Emam K, 2006, J MED INTERNET RES, V8; El Emam K, 2008, J AM MED INFORM ASSN, V15, P627, DOI 10.1197/jamia.M2716; El Emam K, 2009, J AM MED INFORM ASSN, V16, P670, DOI 10.1197/jamia.M3144; Elkin PL, 2012, ANN INTERN MED, V156, P11, DOI 10.7326/0003-4819-156-1-201201030-00003; Emam Khaled El, 2009, Can J Hosp Pharm, V62, P307; Fadly A, 2011, J BIOMEDICAL INFORM; Gionis A, 2008, PROC INT CONF DATA, P744, DOI 10.1109/ICDE.2008.4497483; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Jensen Peter, 2012, NATURE REV GENETICS; Kalra D, 2006, BRIT MED J, V333, P196, DOI 10.1136/bmj.333.7560.196; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Lazarus R, 2009, J AM MED INFORM ASSN, V16, P18, DOI 10.1197/jamia.M2848; Li FJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S12-S7; Loukides G, 2011, KNOWL INF SYST, V28, P251, DOI 10.1007/s10115-010-0354-4; Loukides G, 2010, J AM MED INFORM ASSN, V17, P322, DOI 10.1136/jamia.2009.002725; Loukides G, 2010, P NATL ACAD SCI USA, V107, P7898, DOI 10.1073/pnas.0911686107; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Malin B, 2004, J BIOMED INFORM, V37, P179, DOI 10.1016/j.jbi.2004.04.005; Malin B, 2011, HUM GENET, P1; Malin B, 2010, J INVEST MED, V58, P11, DOI 10.2310/JIM.0b013e3181c9b2ea; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Ohno-Machado L, 2012, J AM MED INFORM ASSN, V19, P196, DOI 10.1136/amiajnl-2011-000538; Pendergrass S, 2011, GENETIC EPIDEMIOLOGY; Piwowar HA, 2008, PLOS MED, V5, P1315, DOI 10.1371/journal.pmed.0050183; Ramirez-Nafarrate A, 2012, PHARMACOGENOMICS, P1; Roche PA, 2001, NAT REV GENET, V2, P392, DOI 10.1038/35072029; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273; Stone MA, 2005, BRIT J GEN PRACT, V55, P783; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; Terrovitis M, 2008, PROC VLDB ENDOW, V1, P115, DOI 10.14778/1453856.1453874; Vinterbo SA, 2012, J AM MED INFORM ASSN, V19, P750, DOI 10.1136/amiajnl-2011-000459; Walker L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002788; Wasserman L, 2010, J AM STAT ASSOC, V105, P375, DOI 10.1198/jasa.2009.tm08651; Weiner MG, 2009, ANN INTERN MED, V151, P359, DOI 10.7326/0003-4819-151-5-200909010-00141; Wylie JE, 2003, TRENDS BIOTECHNOL, V21, P113, DOI 10.1016/S0167-7799(02)00039-2	51	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53875	10.1371/journal.pone.0053875	http://dx.doi.org/10.1371/journal.pone.0053875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405076	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400020
J	Lin, GHY; Wortzman, ME; Girardin, SE; Philpott, DJ; Watts, TH				Lin, Gloria H. Y.; Wortzman, Michael E.; Girardin, Stephen E.; Philpott, Dana J.; Watts, Tania H.			T Cell Intrinsic NOD2 Is Dispensable for CD8 T Cell Immunity	PLOS ONE			English	Article							TOXOPLASMA-GONDII; PEPTIDOGLYCAN; HOMEOSTASIS; INFECTION; DISEASE	NOD2 is an intracellular pattern recognition receptor that provides innate sensing of bacterial muramyl dipeptide by host cells, such as dendritic cells, macrophages and epithelial cells. While NOD2's role as an innate pathogen sensor is well established, NOD2 is also expressed at low levels in T cells and there are conflicting data as to whether NOD2 plays an intrinsic role in T cell function. Here we show that following adoptive transfer into WT hosts, NOD2(-/-) OT-I T cells show a small decrease in the number of OVA-specific CD8 T cells recovered at the peak of the response to respiratory influenza virus infection. On the other hand, no such defect was observed upon intranasal immunization with a replication defective adenovirus carrying the OVA epitope recognized by OT-I, or when OVA was delivered with LPS subcutaneously, or when influenza-OVA was delivered intraperitoneally. Thus we observed a selective defect in NOD2-deficient T cell responses only during a live viral infection. Moreover, there was no apparent defect when NOD2(-/-) OT-I T cells were stimulated in vitro. Finally, this selective defect in recovery of NOD2-deficient CD8 T cells was not observed in a non-transgenic respiratory infection model in which mixed bone marrow chimeras were used such that the NOD2(-/-) T cells were allowed to develop and respond in a NOD2-sufficient host. Taken together our data indicate that T cell intrinsic NOD2 is not required for CD8 T cell responses to antigen delivered under a variety of conditions in vitro and in vivo. However, CD8 T cells that have developed in the absence of NOD2 show a selective and modest impairment in their response to live respiratory influenza infection.	[Lin, Gloria H. Y.; Wortzman, Michael E.; Philpott, Dana J.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto	Watts, TH (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tania.watts@utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP 84419]; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This research was funded by grant number MOP 84419 from the Canadian Institutes of Health Research (CIHR) to THW as well as CIHR grants to DJP and SEG. THW holds the Sanofi Pasteur chair in Human Immunology at the University of Toronto; GHYL was funded by a CIHR doctoral award. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscripts.	Barreau F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000523; Caetano BC, 2011, EUR J IMMUNOL, V41, P3627, DOI 10.1002/eji.201141876; COTTEY R, 2001, CURRENT PROTOCOLS IM, V4; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Lin GHY, 2009, J IMMUNOL, V182, P934, DOI 10.4049/jimmunol.182.2.934; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Yang TC, 2003, J VIROL, V77, P13407, DOI 10.1128/JVI.77.24.13407-13411.2003	13	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56014	10.1371/journal.pone.0056014	http://dx.doi.org/10.1371/journal.pone.0056014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405246	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400191
J	Marrakchi-Kacem, L; Delmaire, C; Guevara, P; Poupon, F; Lecomte, S; Tucholka, A; Roca, P; Yelnik, J; Durr, A; Mangin, JF; Lehericy, S; Poupon, C				Marrakchi-Kacem, Linda; Delmaire, Christine; Guevara, Pamela; Poupon, Fabrice; Lecomte, Sophie; Tucholka, Alan; Roca, Pauline; Yelnik, Jerome; Durr, Alexandra; Mangin, Jean-Francois; Lehericy, Stephane; Poupon, Cyril			Mapping Cortico-Striatal Connectivity onto the Cortical Surface: A New Tractography-Based Approach to Study Huntington Disease	PLOS ONE			English	Article							BASAL GANGLIA; CEREBRAL-CORTEX; FIBER TRACKING; DIFFUSION; MRI; CIRCUITS; SYSTEM; BRAIN	Huntington disease (HD) is associated with early and severe damage to the basal ganglia and particularly the striatum. We investigated cortico-striatal connectivity modifications occurring in HD patients using a novel approach which focuses on the projection of the connectivity profile of the basal ganglia onto the cortex. This approach consists in computing, for each subcortical structure, surface connectivity measures representing its strength of connections to the cortex and comparing these measures across groups. In this study, we focused on Huntington disease as an application of this new approach. First, surface cortico-striatal connectivity measures of a group of healthy subjects were averaged in order to infer the "normal" connectivity profile of the striatum to the cortex. Second, a statistical analysis was performed from the surface connectivity measures of healthy subjects and HD patients in order to detect the cortical gyri presenting altered cortico-striatal connectivity in HD. Lastly, percentage differences of connectivity between healthy subjects and patients were inferred, for each nucleus of the striatum, from the connectivity measures of the cortical gyri presenting a significant connectivity difference between the two groups. These percentage differences characterize the axonal disruptions between the striatum and the cortex occurring in HD. We found selective region-specific degeneration of cortical connections predominating for associative and primary sensorimotor connections and with relative preservation of limbic connections. Our method can be used to infer novel connectivity-based markers of HD pathological process.	[Marrakchi-Kacem, Linda; Guevara, Pamela; Poupon, Fabrice; Lecomte, Sophie; Roca, Pauline; Mangin, Jean-Francois; Poupon, Cyril] CEA, NeuroSpin, Gif Sur Yvette, France; [Marrakchi-Kacem, Linda; Guevara, Pamela; Poupon, Fabrice; Lecomte, Sophie; Roca, Pauline; Mangin, Jean-Francois; Poupon, Cyril] IFR49, Inst Federatif Rech, Gif Sur Yvette, France; [Delmaire, Christine] Ctr Hosp Reg & Univ Lille, Dept Neuroradiol, F-59037 Lille, France; [Delmaire, Christine; Lehericy, Stephane] Hop La Pitie Salpetriere, AP HP, CENIR, Ctr Neuroimagerie Rech, Paris, France; [Guevara, Pamela] Univ Concepcion, Concepcion, Chile; [Tucholka, Alan] Univ Montreal, Notre Dame Hosp, CHUM, Dept Radiol, Montreal, PQ H3C 3J7, Canada; [Yelnik, Jerome; Durr, Alexandra; Lehericy, Stephane] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Yelnik, Jerome; Durr, Alexandra; Lehericy, Stephane] INSERM, U975, Paris, France; [Yelnik, Jerome; Durr, Alexandra; Lehericy, Stephane] CNRS, UMR 7225, Paris, France; [Yelnik, Jerome; Durr, Alexandra; Lehericy, Stephane] ICM Inst Cerveau & Moelle Epiniere, Paris, France; [Yelnik, Jerome] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Ctr Invest Clin, Paris, France; [Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Paris, France	CEA; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidad de Concepcion; Universite de Montreal; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Marrakchi-Kacem, L (corresponding author), CEA, NeuroSpin, Gif Sur Yvette, France.	linda.marrakchi@gmail.com	Guevara, Pamela/AAZ-6221-2021; Guevara, Pamela/B-2300-2019; Mangin, Jean-Francois/AAI-8983-2020; Yelnik, Jérôme/F-7153-2013	Guevara, Pamela/0000-0001-9988-400X; Guevara, Pamela/0000-0001-9988-400X; Tucholka, Alan/0000-0002-8880-2707; YELNIK, Jerome/0000-0003-4814-708X; Roca, Pauline/0000-0003-2089-6636	Child Health and Development Institute CHDI/High Q Foundation; Ecole des Neurosciences Paris-Ile-de-France (NucleiPark project); NucleiPark project [ANR/MNP/2009]; Association France Parkinson	Child Health and Development Institute CHDI/High Q Foundation; Ecole des Neurosciences Paris-Ile-de-France (NucleiPark project); NucleiPark project; Association France Parkinson	TRACK-HD is supported by the Child Health and Development Institute CHDI/High Q Foundation, a not for profit organization dedicated to finding treatments for Huntington disease. This work was also supported by the Ecole des Neurosciences Paris-Ile-de-France (NucleiPark project), by the ANR/MNP/2009 (NucleiPark project) and by the Association France Parkinson (NucleiPark project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Backman L, 1997, BRAIN, V120, P2207, DOI 10.1093/brain/120.12.2207; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bohanna I, 2011, NEUROBIOL DIS; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Dubois J, 2010, PROCEEDINGS OF THE I; Guevara P, 2011, PROCEEDINGS OF THE I; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2004, CEREB CORTEX, V14, P1302, DOI 10.1093/cercor/bhh091; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marrakchi-Kacem L, 2010, I S BIOMED IMAGING, P61, DOI 10.1109/ISBI.2010.5490415; Nave RD, 2010, AM J NEURORADIOL, V31, P1675; Nopoulos PC, 2010, NEUROBIOL DIS, V40, P544, DOI 10.1016/j.nbd.2010.07.014; Perrin M, 2005, LECT NOTES COMPUT SC, V3565, P52; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Reading SAJ, 2005, PSYCHIAT RES-NEUROIM, V140, P55, DOI 10.1016/j.pscychresns.2005.05.011; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Roca P, 2009, LECT NOTES COMPUT SC, V5761, P935, DOI 10.1007/978-3-642-04268-3_115; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Rosas HD, 2010, NEUROIMAGE, V49, P2995, DOI 10.1016/j.neuroimage.2009.10.015; Rosas HD, 2005, NEUROLOGY, V65, P745, DOI 10.1212/01.wnl.0000174432.87383.87; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Solomon AC, 2008, MOVEMENT DISORD, V23, P1830, DOI 10.1002/mds.22097; Stoffers D, 2010, NEUROLOGY, V74, P1208, DOI 10.1212/WNL.0b013e3181d8c20a; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53135	10.1371/journal.pone.0053135	http://dx.doi.org/10.1371/journal.pone.0053135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405066	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400009
J	Ng, YK; Ehsaan, M; Philip, S; Collery, MM; Janoir, C; Collignon, A; Cartman, ST; Minton, NP				Ng, Yen Kuan; Ehsaan, Muhammad; Philip, Sheryl; Collery, Mark M.; Janoir, Clare; Collignon, Anne; Cartman, Stephen T.; Minton, Nigel P.			Expanding the Repertoire of Gene Tools for Precise Manipulation of the Clostridium difficile Genome: Allelic Exchange Using pyrE Alleles	PLOS ONE			English	Article							ESCHERICHIA-COLI; SYSTEM; TOXIN; EXPRESSION; PROTEINS; PHOSPHOENOLPYRUVATE; INTEGRATION; CHROMOSOME; SELECTION; PLASMIDS	Sophisticated genetic tools to modify essential biological processes at the molecular level are pivotal in elucidating the molecular pathogenesis of Clostridium difficile, a major cause of healthcare associated disease. Here we have developed an efficient procedure for making precise alterations to the C. difficile genome by pyrE-based allelic exchange. The robustness and reliability of the method was demonstrated through the creation of in-frame deletions in three genes (spo0A, cwp84, and mtlD) in the non-epidemic strain 630 Delta erm and two genes (spo0A and cwp84) in the epidemic PCR Ribotype 027 strain, R20291. The system is reliant on the initial creation of a pyrE deletion mutant, using Allele Coupled Exchange (ACE), that is auxotrophic for uracil and resistant to fluoroorotic acid (FOA). This enables the subsequent modification of target genes by allelic exchange using a heterologous pyrE allele from Clostridium sporogenes as a counter-/negative-selection marker in the presence of FOA. Following modification of the target gene, the strain created is rapidly returned to uracil prototrophy using ACE, allowing mutant phenotypes to be characterised in a PyrE proficient background. Crucially, wild-type copies of the inactivated gene may be introduced into the genome using ACE concomitant with correction of the pyrE allele. This allows complementation studies to be undertaken at an appropriate gene dosage, as opposed to the use of multicopy autonomous plasmids. The rapidity of the 'correction' method (5-7 days) makes pyrE(-) strains attractive hosts for mutagenesis studies.	[Ng, Yen Kuan; Ehsaan, Muhammad; Philip, Sheryl; Collery, Mark M.; Cartman, Stephen T.; Minton, Nigel P.] Univ Nottingham, Sch Life Sci, Ctr Biomol Sci, Clostridia Res Grp,NIHR Biomed Res Unit GI Dis, Nottingham NG7 2RD, England; [Janoir, Clare; Collignon, Anne] Univ Paris 11, Fac Pharm, Dept Microbiol, Unite EA 40 43, F-92290 Chatenay Malabry, France	University of Nottingham; UDICE-French Research Universities; Universite Paris Saclay	Minton, NP (corresponding author), Univ Nottingham, Sch Life Sci, Ctr Biomol Sci, Clostridia Res Grp,NIHR Biomed Res Unit GI Dis, Nottingham NG7 2RD, England.	Nigel.Minton@nottingham.ac.uk	Ehsaan, Muhammad/Z-3697-2019	Minton, Nigel/0000-0002-9277-1261; EHSAAN, MUHAMMAD/0000-0003-1393-5246	MRC [G0601176]; European Community [HEALTH-F3-2008-223585]; Biotechnology and Biological Sciences Research Council [BB/G016224/1]; TMO686 Renewables Ltd.; TMO Renewables Ltd.; University from TMO; Medical Research Council [G0601176] Funding Source: researchfish; BBSRC [BB/G016224/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); TMO686 Renewables Ltd.; TMO Renewables Ltd.; University from TMO; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge the financial support of the MRC (G0601176), the European Community's Seventh Framework Programme 'HYPERDIFF' (HEALTH-F3-2008-223585), the Biotechnology and Biological Sciences Research Council (BB/G016224/1), and TMO686 Renewables Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors, Muhammad Ehsaan is a PhD student sponsored by TMO Renewables Ltd. His stipend and fee is received by the University from TMO and administered by them. Neither he nor Nigel P. Minton have any other association with this company (neither in terms of salary, consultancy or shares). The work has not been patented. The funding of Muhammad Ehsaan's studentship does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Burns DA, 2010, J BACTERIOL, V192, P657, DOI 10.1128/JB.01209-09; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; CHAMBERS SP, 1988, GENE, V68, P139, DOI 10.1016/0378-1119(88)90606-3; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; de la Riva L, 2011, J BACTERIOL, V193, P3276, DOI 10.1128/JB.00248-11; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1321; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Henstra SA, 1996, J BACTERIOL, V178, P5586, DOI 10.1128/jb.178.19.5586-5591.1996; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; IWEN PC, 1989, J CLIN MICROBIOL, V27, P2105, DOI 10.1128/JCM.27.9.2105-2106.1989; Janoir C, 2007, J BACTERIOL, V189, P7174, DOI 10.1128/JB.00578-07; Kennedy CL, 2005, MOL MICROBIOL, V57, P1357, DOI 10.1111/j.1365-2958.2005.04774.x; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Knipfer N, 1997, PLASMID, V37, P129, DOI 10.1006/plas.1997.1286; Li JH, 2011, INFECT IMMUN, V79, P2451, DOI 10.1128/IAI.00169-11; Liyanage H, 2001, APPL ENVIRON MICROB, V67, P2004, DOI 10.1128/AEM.67.5.2004-2010.2001; MINTON N, 1981, J GEN MICROBIOL, V127, P325; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Rabinowitz J, 1972, Methods Enzymol, V24, P431; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; Sambrook J., 2001, MOL CLONING LAB MANU; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; SMITH CJ, 1981, ANTIMICROB AGENTS CH, V19, P997, DOI 10.1128/AAC.19.6.997; Takamizawa A, 2004, PROTEIN EXPRES PURIF, V36, P70, DOI 10.1016/j.pep.2004.03.004; Theys J, 2006, BRIT J CANCER, V95, P1212, DOI 10.1038/sj.bjc.6603367; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; WILLIAMS DR, 1990, J GEN MICROBIOL, V136, P819, DOI 10.1099/00221287-136-5-819	45	74	76	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56051	10.1371/journal.pone.0056051	http://dx.doi.org/10.1371/journal.pone.0056051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405251	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400196
J	Wen, AY; Landaw, EM; Ochoa, R; Cho, M; Chao, A; Lawson, G; Sakamoto, KM				Wen, Andy Y.; Landaw, Elliot M.; Ochoa, Rachel; Cho, Michelle; Chao, Alex; Lawson, Gregory; Sakamoto, Kathleen M.			Increased Abscess Formation and Defective Chemokine Regulation in CREB Transgenic Mice	PLOS ONE			English	Article							NF-KAPPA-B; MEDIATED TRANSCRIPTION; SIGNALING PATHWAYS; MONOCYTIC CELLS; BINDING PROTEIN; ACTIVATION; CAMP; PHOSPHORYLATION; INFLAMMATION; MACROPHAGES	Cyclic AMP-response element-binding protein (CREB) is a transcription factor implicated in growth factor-dependent cell proliferation and survival, glucose homeostasis, spermatogenesis, circadian rhythms, and synaptic plasticity associated with memory. To study the phenotype of CREB overexpression in vivo, we generated CREB transgenic (TG) mice in which a myeloid specific hMRP8 promoter drives CREB expression. CREB TG mice developed spontaneous skin abscesses more frequently than wild type (WT) mice. To understand the role of CREB in myeloid function and innate immunity, chemokine expression in bone marrow derived macrophages (BMDMs) from CREB TG mice were compared with BMDMs from WT mice. Our results demonstrated decreased Keratinocyte-derived cytokine (KC) in CREB TG BMDMs but not TNF alpha protein production in response to lipid A (LPA). In addition, mRNA expression of KC and IL-1 beta (Interleukin)-1 beta was decreased in CREB TG BMDMs; however, there was no difference in the mRNA expression of TNF alpha, MCP-1, IL-6 and IL-12p40. The mRNA expression of IL-1RA and IL-10 was decreased in response to LPA. Nuclear factor kappa B (NF kappa B) expression and a subset of its target genes were upregulated in CREB TG mouse BMDMs. Although neutrophil migration was the same in both CREB TG and WT mice, Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity was significantly increased in neutrophils from CREB TG mice. Taken together, CREB overexpression in myeloid cells results in increased abscess formation in vivo and aberrant cytokine and chemokine response, and neutrophil function in vitro.	[Wen, Andy Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Crit Care, Los Angeles, CA 90095 USA; [Landaw, Elliot M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Ochoa, Rachel; Cho, Michelle; Sakamoto, Kathleen M.] Stanford Univ, Sch Med, Lucile Packard Childrens Hosp, Div Pediat Hematol Oncol, Stanford, CA 94305 USA; [Chao, Alex] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Lawson, Gregory] Univ Calif Los Angeles, David Geffen Sch Med, Div Lab Anim Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lucile Packard Children's Hospital (LPCH); Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sakamoto, KM (corresponding author), Stanford Univ, Sch Med, Lucile Packard Childrens Hosp, Div Pediat Hematol Oncol, Stanford, CA 94305 USA.	kmsakamo@stanford.edu		Wen, Andy/0000-0001-8347-4364; Sakamoto, Kathleen/0000-0003-0494-8838	National Institutes of Health NIH [T32 HD007512, HL78526, HL097561]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007512] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561, R41HL078526] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by National Institutes of Health NIH T32 HD007512 Human and Molecular Development Training Grant (to A.Y.W.); HL78526, and HL097561 (to K. M. S.). K. M. S. is a Scholar of the Leukemia and Lymphoma Society. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; Bergamaschi A, 2006, CELL SIGNAL, V18, P1679, DOI 10.1016/j.cellsig.2006.01.006; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Chio CC, 2004, CELL SIGNAL, V16, P565, DOI 10.1016/j.cellsig.2003.10.003; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HONG CC, 1978, LAB ANIM SCI, V28, P317; Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016; Kotsias F., 2012, ANTIOXIDANTS REDOX S; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Parry GCN, 1997, J IMMUNOL, V159, P5450; Percy D, 2007, MOUSE PATHOLOGY LAB, P3; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Radaelli E, 2010, J AM ASSOC LAB ANIM, V49, P69; Sakai J, 2012, IMMUNITY; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Zhang JX, 2007, CHEM SENSES, V32, P293, DOI 10.1093/chemse/bjl058; Zhang Y, 2002, J BIOL CHEM, V277, P19042, DOI 10.1074/jbc.M112442200	27	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55866	10.1371/journal.pone.0055866	http://dx.doi.org/10.1371/journal.pone.0055866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405224	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400169
J	Yang, YF; Sun, L; Tala; Gao, JM; Li, DW; Zhou, J; Liu, M				Yang, Yunfan; Sun, Lei; Tala; Gao, Jinmin; Li, Dengwen; Zhou, Jun; Liu, Min			CYLD Regulates RhoA Activity by Modulating LARG Ubiquitination	PLOS ONE			English	Article							TUMOR-SUPPRESSOR CYLD; NF-KAPPA-B; NUCLEOTIDE-EXCHANGE FACTORS; MICROTUBULE DYNAMICS; NEGATIVE REGULATOR; GTPASES; CYTOKINESIS; MIGRATION	Rho family guanosine triphosphatases (GTPases), such as RhoA, Cdc42, and Rac1, play a fundamental role in various cellular processes. The activation of Rho proteins is catalyzed by guanine nucleotide-exchange factors (GEFs), which promote the exchange of GDP for GTP. The precise mechanisms regulating the activation of Rho proteins are not fully understood. Herein, we demonstrate that RhoA activity is regulated by cylindromatosis (CYLD), a deubiquitinase harboring multiple functions. In addition, we find that RhoA-mediated cytoskeletal rearrangement, chromosome separation, and cell polarization are altered in CYLD-depleted cells. Mechanistically, CYLD does not interact with RhoA; instead, it interacts with and deubiquitinates leukemia-associated RhoGEF (LARG). Our data further show that CYLD-mediated deubiquitination of LARG enhances its ability to stimulate the GDP/GTP exchange on RhoA. These data thus identify LARG as a new substrate of CYLD and provide novel insights into the regulation of RhoA activation. Our results also suggest that the LARG-RhoA signaling pathway may play a role in diverse CYLD-mediated cellular events.	[Yang, Yunfan; Sun, Lei; Tala; Gao, Jinmin; Li, Dengwen; Zhou, Jun] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Yang, Yunfan; Sun, Lei; Tala; Gao, Jinmin; Li, Dengwen; Zhou, Jun] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Liu, Min] Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin, Peoples R China; [Liu, Min] Tianjin Med Univ, Basic Med Coll, Dept Biochem, Tianjin, Peoples R China	Nankai University; Nankai University; Tianjin Medical University; Tianjin Medical University	Liu, M (corresponding author), Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin, Peoples R China.	queyuezhai@163.com	Zhou, Jun/D-4654-2017; Yang, Yunfan/AAN-9231-2020; Sun, Lei/N-4783-2018; Gao, Jinmin/J-8967-2015	Zhou, Jun/0000-0001-7858-8260; Yang, Yunfan/0000-0002-5266-7208; 	National Basic Research Program of China [2010CB912204, 2012CB945002]; National Natural Science Foundation of China [31170820, 31271437]; 111 project [B08011]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Basic Research Program of China (2010CB912204 and 2012CB945002), the National Natural Science Foundation of China (31170820 and 31271437), and the 111 project (B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Dutartre H, 1996, J CELL SCI, V109, P367; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Gao JM, 2010, BLOOD, V115, P4130, DOI 10.1182/blood-2009-10-248526; Goulimari P, 2008, MOL BIOL CELL, V19, P30, DOI 10.1091/mbc.E06-11-1045; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036389; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Shi XJ, 2012, CELL CYCLE, V11, P1554, DOI 10.4161/cc.19954; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Sun L, 2010, J PATHOL, V221, P425, DOI 10.1002/path.2723; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Vazquez-Prado J, 2004, METHOD ENZYMOL, V390, P259; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200	23	9	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55833	10.1371/journal.pone.0055833	http://dx.doi.org/10.1371/journal.pone.0055833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405219	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400164
J	Al-Kashi, A; Montero-Melendez, T; Moradi-Bidhendi, N; Gilligan, JP; Mehta, N; Perretti, M				Al-Kashi, Adam; Montero-Melendez, Trinidad; Moradi-Bidhendi, Niloufar; Gilligan, James P.; Mehta, Nozer; Perretti, Mauro			The Calcitonin and Glucocorticoids Combination: Mechanistic Insights into Their Class-Effect Synergy in Experimental Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SALMON-CALCITONIN; KAPPA-B; BONE; PREDNISOLONE; EFFICACY; RELEASE; SAFETY; MMP-2; NEUTROPHILS	Introduction: Previous work reported the anti-arthritic synergy afforded by combining calcitonin (CT) and glucocorticoids (GC). Here we focus on the pairing of elcatonin (eCT) and dexamethasone (Dex), querying whether: i) this was a class-effect action; ii) mechanistic insights could be unveiled; iii) the synergy affected canonical GC adverse effects. Methods: Using the rat collagen-induced arthritis model, different combinations of eCT and Dex, were administered from disease onset to peak (day 11 to 18). Macroscopic disease score was monitored throughout, with biochemical and histological analyses conducted on plasma and tissues at day 18. The effect on acute hyperglycaemia and liver enzyme message were also assessed. Results: Whilst eCT alone was inactive, it synergised at 1 mu g/kg with low doses of Dex (7.5 or 15 mu g/kg) to yield an anti-arthritic efficacy equivalent to a 4- to 7-fold higher Dex dose. Mechanistically, the anti-arthritic synergy corresponded to a marked attenuation in RA-relevant analytes. CXCL5 expression, in both plasma and joint, was markedly inhibited by the co-therapy. Finally, co-administration of eCT did not exacerbate metrics of GC adverse effects, and rescued some of them. Conclusions: We present evidence of a class-effect action for the anti-arthritic synergy of CT/GC combination, underpinned by the powerful inhibition of joint destruction markers. Furthermore, we identify CXCL5 as a marker for the combination therapy with potential diagnostic and prognostic utility. Substantial GC dose reduction, together with the absence of exacerbated adverse effects, indicated a significant clinical potential for this co-therapy in RA and beyond.	[Al-Kashi, Adam; Montero-Melendez, Trinidad; Moradi-Bidhendi, Niloufar; Perretti, Mauro] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England; [Gilligan, James P.] Tarsa Therapeut, Philadelphia, PA USA; [Mehta, Nozer] Unigene Corp, Fairfield, CT USA	University of London; Queen Mary University London	Perretti, M (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England.	m.perretti@qmul.ac.uk	Montero-Melendez, Trinidad/AAF-6345-2020	Montero-Melendez, Trinidad/0000-0002-3563-376X	Unigene Corporation of London; Queen Mary University of London; William Harvey Research Foundation	Unigene Corporation of London; Queen Mary University of London; William Harvey Research Foundation	This study was funded by a collaborative project between Unigene Corporation and Queen Mary University of London and, in part, by The William Harvey Research Foundation. The authors could operate freely in design the experiments, analyse data and prepare the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAHI SE, 1977, AGENTS ACTIONS, V7, P533, DOI 10.1007/BF02111126; AIDA S, 1993, CLIN EXP RHEUMATOL, V11, P503; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; Binkley N, 2009, OSTEOPOROSIS INT, V20, P1595, DOI 10.1007/s00198-008-0827-4; BODY JJ, 1990, J CLIN ENDOCR METAB, V71, P675, DOI 10.1210/jcem-71-3-675; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Buttgereit F, 2008, LANCET, V371, P205, DOI 10.1016/S0140-6736(08)60132-4; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Cidlowski John A, 2009, Retina, V29, pS21, DOI 10.1097/IAE.0b013e3181ad2636; COCHRAN M, 1970, BRIT MED J, V1, P135, DOI 10.1136/bmj.1.5689.135; COPP DH, 1961, SCIENCE, V134, P2038, DOI 10.1126/science.134.3495.2038; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Di Filippo C, 2004, J PHARMACOL EXP THER, V310, P1133, DOI 10.1124/jpet.104.068726; Edwards MR, 2006, AM J RESP CELL MOL, V34, P616, DOI 10.1165/rcmb.2005-0385OC; Fredin MF, 2005, PHARMACOL RES, V52, P422, DOI 10.1016/j.phrs.2005.06.003; Gannon C, 2010, PALLIATIVE MED, V24, P737, DOI 10.1177/0269216310377816; GRIEDER A, 1990, AGENTS ACTIONS, V29, P308, DOI 10.1007/BF01966462; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; Janckila AJ, 2009, CALCIFIED TISSUE INT, V85, P465, DOI 10.1007/s00223-009-9309-8; Joe B, 1999, MOL MED TODAY, V5, P367, DOI 10.1016/S1357-4310(99)01528-2; Karsdal MA, 2008, BIODRUGS, V22, P137, DOI 10.2165/00063030-200822030-00001; Karsdal MA, 2007, ANN NY ACAD SCI, V1117, P181, DOI 10.1196/annals.1402.041; Kim KS, 2011, RHEUMATOL INT, V31, P543, DOI 10.1007/s00296-010-1592-1; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; MACINTYRE I, 1980, ARTHRITIS RHEUM-US, V23, P1139, DOI 10.1002/art.1780231011; Mancini L, 2007, AM J PATHOL, V170, P1018, DOI 10.2353/ajpath.2007.060830; MITCHELL DR, 1990, J GERONTOL, V45, pM153, DOI 10.1093/geronj/45.5.M153; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Nathan RA, 2001, ANN ALLERG ASTHMA IM, V86, P203, DOI 10.1016/S1081-1206(10)62692-0; Paul-Clark M, 2000, BRIT J PHARMACOL, V131, P1345, DOI 10.1038/sj.bjp.0703704; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schacke H, 2002, E SCHERING RES FDN W, V40, P357; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Smith E, 2008, ARTHRITIS RHEUM, V58, P1968, DOI 10.1002/art.23545; Smith JB, 1997, METHOD ENZYMOL, V287, P250; Smolian H, 2001, BIOL CHEM, V382, P1491, DOI 10.1515/BC.2001.183; Sondergaard BC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-62; STUART JM, 1982, AGENTS ACTIONS, V12, P671, DOI 10.1007/BF01965077; van Wetering S, 2002, INFLAMM RES, V51, P8, DOI 10.1007/PL00000282; Whitworth JA, 2001, CLIN EXP PHARMACOL P, V28, P993, DOI 10.1046/j.1440-1681.2001.03584.x; YAMAGUCHI M, 1983, ACTA ENDOCRINOL-COP, V102, P572, DOI 10.1530/acta.0.1020572; YAMAGUCHI M, 1981, ENDOCRINOL JAPON, V28, P709; YAMAGUCHI M, 1981, ENDOCRINOL JAPON, V28, P51; ZAIDI M, 1988, Q J EXP PHYSIOL CMS, V73, P471, DOI 10.1113/expphysiol.1988.sp003168; Zimmermann GR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2602	50	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54299	10.1371/journal.pone.0054299	http://dx.doi.org/10.1371/journal.pone.0054299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393556	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800010
J	Bessonneau, V; Mosqueron, L; Berrube, A; Mukensturm, G; Buffet-Bataillon, S; Gangneux, JP; Thomas, O				Bessonneau, Vincent; Mosqueron, Luc; Berrube, Adele; Mukensturm, Gael; Buffet-Bataillon, Sylvie; Gangneux, Jean-Pierre; Thomas, Olivier			VOC Contamination in Hospital, from Stationary Sampling of a Large Panel of Compounds, in View of Healthcare Workers and Patients Exposure Assessment	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; ADSORPTION PERFORMANCE; CARBONYL-COMPOUNDS; ETHYL GLUCURONIDE; GLYCOL ETHERS; CARBOXEN 569; AIR-QUALITY; CARBOPACK X; INDOOR AIR; HAND RUBS	Background: We aimed to assess, for the first time, the nature of the indoor air contamination of hospitals. Methods and Findings: More than 40 volatile organic compounds (VOCs) including aliphatic, aromatic and halogenated hydrocarbons, aldehydes, alcohols, ketones, ethers and terpenes were measured in a teaching hospital in France, from sampling in six sampling sites - reception hall, patient room, nursing care, post-anesthesia care unit, parasitology-mycology laboratory and flexible endoscope disinfection unit - in the morning and in the afternoon, during three consecutive days. Our results showed that the main compounds found in indoor air were alcohols (arithmetic means +/- SD: 928 +/- 958 mu g/m(3) and 47.9 +/- 52.2 mu g/m(3) for ethanol and isopropanol, respectively), ethers (75.6 +/- 157 mu g/m(3) for ether) and ketones (22.6 +/- 20.6 mu g/m(3) for acetone). Concentrations levels of aromatic and halogenated hydrocarbons, ketones, aldehydes and limonene were widely variable between sampling sites, due to building age and type of products used according to health activities conducted in each site. A high temporal variability was observed in concentrations of alcohols, probably due to the intensive use of alcohol-based hand rubs in all sites. Qualitative analysis of air samples led to the identification of other compounds, including siloxanes (hexamethyldisiloxane, octamethyltrisiloxane, decamethylcyclopentasiloxane), anesthetic gases (sevoflurane, desflurane), aliphatic hydrocarbons (butane), esters (ethylacetate), terpenes (camphor, a-bisabolol), aldehydes (benzaldehyde) and organic acids (benzoic acid) depending on sites. Conclusion: For all compounds, concentrations measured were lower than concentrations known to be harmful in humans. However, results showed that indoor air of sampling locations contains a complex mixture of VOCs. Further multicenter studies are required to compare these results. A full understanding of the exposure of healthcare workers and patients to complex mixtures of chemical compounds can then be related to potential health outcomes.	[Bessonneau, Vincent; Thomas, Olivier] Adv Sch Publ Hlth, Environm & Hlth Res Lab, Rennes, France; [Bessonneau, Vincent; Gangneux, Jean-Pierre; Thomas, Olivier] Univ Rennes 1, Inst Res Environm & Occupat Hlth U 1085, Rennes, France; [Mosqueron, Luc; Berrube, Adele; Mukensturm, Gael] Veolia Environm Res & Innovat, Rueil Malmaison, France; [Buffet-Bataillon, Sylvie] Ctr Hosp Univ Rennes, Operat Staff Hosp Hyg, Rennes, France; [Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Parasitol Mycol Lab, Rennes, France	Universite de Rennes; Veolia; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Thomas, O (corresponding author), Adv Sch Publ Hlth, Environm & Hlth Res Lab, Rennes, France.	olivier.thomas@ehesp.fr	Bessonneau, Vincent/A-5642-2015; Gangneux, Jean-Pierre/J-2960-2015	Bessonneau, Vincent/0000-0003-3442-5026; Gangneux, Jean-Pierre/0000-0002-4974-5607	French Agency for Food, Environmental and Occupational Health and Safety (ANSES) [EST-2010/2/113]	French Agency for Food, Environmental and Occupational Health and Safety (ANSES)(French National Research Agency (ANR))	d This study was funded by the French Agency for Food, Environmental and Occupational Health and Safety (ANSES, project EST-2010/2/113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrube A, 2011, MEMOIRE INGENIEUR GE; Bessonneau V, 2012, INT J ENV RES PUB HE, V9, P868, DOI 10.3390/ijerph9030868; Bessonneau V, 2010, INT J ENV RES PUB HE, V7, P3038, DOI 10.3390/ijerph7083038; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Bruno P, 2008, INDOOR AIR, V18, P250, DOI 10.1111/j.1600-0668.2008.00528.x; Dascalaki EG, 2008, BUILD ENVIRON, V43, P1945, DOI 10.1016/j.buildenv.2007.11.015; Dascalaki EG, 2009, ENERG BUILDINGS, V41, P551, DOI 10.1016/j.enbuild.2008.11.023; Di Stefano F, 1999, ALLERGY, V54, P1105, DOI 10.1034/j.1398-9995.1999.00239.x; Dutch Expert Committee on Occupational Standards, 2006, ETH ETH ALC EV HLTH; Gallego E, 2011, TALANTA, V85, P662, DOI 10.1016/j.talanta.2011.04.043; Gallego E, 2010, TALANTA, V81, P916, DOI 10.1016/j.talanta.2010.01.037; Geiss O, 2011, ATMOS ENVIRON, V45, P3676, DOI 10.1016/j.atmosenv.2011.04.037; Ghasemkhani M, 2005, IND HEALTH, V43, P703, DOI 10.2486/indhealth.43.703; Glumbakaite E, 2003, INDOOR BUILT ENVIRON, V12, P105, DOI 10.1177/1420326X03012001017; Hellgren UM, 2008, SCAND J WORK ENV HEA, P58; Hellgren UM, 2011, INT J OCCUP MED ENV, V24, P48, DOI 10.2478/s13382-011-0011-5; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; ISIAQ (International Society of Indoor Air Quality and Climate), 2003, REV IND AIR QUAL HOS; Kang Moon-Soo, 2008, Korean Journal of Internal Medicine, V23, P111, DOI 10.3904/kjim.2008.23.3.111; Kirchner S, 2006, NATL SURVEY INDOOR A; Koda S, 1999, ACTA MED OKAYAMA, V53, P217; Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI [10.1080/10408440802291497, 10.1080/10408440802291497 ]; Kramer A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-117; Lu HX, 2006, SCI TOTAL ENVIRON, V368, P574, DOI 10.1016/j.scitotenv.2006.03.044; Lu Y, 2010, ENVIRON SCI TECHNOL, V44, P6081, DOI 10.1021/es101368n; Lu HX, 2010, J HAZARD MATER, V178, P673, DOI 10.1016/j.jhazmat.2010.01.138; Miller MA, 2006, AM J EMERG MED, V24, P815, DOI 10.1016/j.ajem.2006.05.006; Mosqueron L., 2004, INVENTAIRE DONNEES F; Norliana S., 2009, AM J PHARM TOXICOLOG, V4, P98, DOI [10.3844/ajptsp.2009.98.106, DOI 10.3844/ajptsp.2009.98.106, DOI 10.3844/AJPTSP.2009.98.106]; Ohura T, 2006, SCI TOTAL ENVIRON, V366, P485, DOI 10.1016/j.scitotenv.2005.10.005; Pacenti M, 2006, INDOOR BUILT ENVIRON, V15, P63, DOI 10.1177/1420326X06061706; Plieninger P, 2001, GEFAHRST REINHALT L, V61, P521; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Reisfield GM, 2011, J ANAL TOXICOL, V35, P264, DOI 10.1093/anatox/35.5.264; Reisfield GM, 2011, J ANAL TOXICOL, V35, P85, DOI 10.1093/anatox/35.2.85; Ribes A, 2007, J CHROMATOGR A, V1140, P44, DOI 10.1016/j.chroma.2006.11.062; Ras MR, 2009, TRAC-TREND ANAL CHEM, V28, P347, DOI 10.1016/j.trac.2008.10.009; Saad SG, 2003, INDOOR BUILT ENVIRON, V12, P93, DOI 10.1177/1420326X03012001015; Singer BC, 2006, INDOOR AIR, V16, P179, DOI 10.1111/j.1600-0668.2005.00414.x; Sobaszek A, 1999, J OCCUP ENVIRON MED, V41, P492, DOI 10.1097/00043764-199906000-00016; Takigawa T, 2004, ENVIRON TOXICOL, V19, P280, DOI 10.1002/tox.20035; Tsigonia A, 2010, INT J ENV RES PUB HE, V7, P314, DOI 10.3390/ijerph7010314; World Health Organization, 2010, WHO GUID IND AIR QUA; Xhauflaire-Uhoda Emmanuelle, 2008, J Occup Med Toxicol, V3, P15, DOI 10.1186/1745-6673-3-15; Zabiegala B, 2006, POL J ENVIRON STUD, V15, P383	45	53	53	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55535	10.1371/journal.pone.0055535	http://dx.doi.org/10.1371/journal.pone.0055535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393590	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800044
J	Promkan, M; Dakeng, S; Chakrabarty, S; Bogler, O; Patmasiriwat, P				Promkan, Moltira; Dakeng, Sumana; Chakrabarty, Subhas; Boegler, Oliver; Patmasiriwat, Pimpicha			The Effectiveness of Cucurbitacin B in BRCA1 Defective Breast Cancer Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; C-MYC; IN-VITRO; EXPRESSION; APOPTOSIS; SURVIVIN; PATHWAY; STAT3; PROLIFERATION; TRANSCRIPTION	Cucurbitacin B (CuB) is one of the potential agents for long term anticancer chemoprevention. Cumulative evidences has shown that cucurbitacin B provides potent cellular biological activities such as hepatoprotective, anti-inflammatory and antimicrobial effects, but the precise mechanism of this agent is not clearly understood. We examine the biological effects on cancer cells of cucurbitacin B extracted from a Thai herb, Trichosanthes cucumerina L. The wild type (wt) BRCA1, mutant BRCA1, BRCA1 knocked-down and BRCA1 overexpressed breast cancer cells were treated with the cucurbitacin B and determined for the inhibitory effects on the cell proliferation, migration, invasion, anchorage-independent growth. The gene expressions in the treated cells were analyzed for p21/(Waf1), p27(Kip1) and survivin. Our previous study revealed that loss of BRCA1 expression leads to an increase in survivin expression, which is responsible for a reduction in sensitivity to paclitaxel. In this work, we showed that cucurbitacin B obviously inhibited knocked-down and mutant BRCA1 breast cancer cells rather than the wild type BRCA1 breast cancer cells in regards to the cellular proliferation, migration, invasion and anchorage-independent growth. Furthermore, forcing the cells to overexpress wild type BRCA1 significantly reduced effectiveness of cucurbitacin B on growth inhibition of the endogenous mutant BRCA1 cells. Interestingly, cucurbitacin B promotes the expression of p21/(Waf1) and p27(Kip1) but inhibit the expression of survivin. We suggest that survivin could be an important target of cucurbitacin B in BRCA1 defective breast cancer cells.	[Promkan, Moltira; Dakeng, Sumana] Mahidol Univ, Fac Med Technol, Ctr Innovat Dev & Technol Transfer, Salaya, Nakhon Pathom, Thailand; [Promkan, Moltira; Chakrabarty, Subhas] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL USA; [Promkan, Moltira; Chakrabarty, Subhas] Simmons Canc Inst, Springfield, IL USA; [Dakeng, Sumana; Boegler, Oliver] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Patmasiriwat, Pimpicha] Mahidol Univ, Fac Med Technol, Dept Clin Microscopy, Salaya, Nakhon Pathom, Thailand	Mahidol University; Southern Illinois University System; Southern Illinois University; University of Texas System; UTMD Anderson Cancer Center; Mahidol University	Patmasiriwat, P (corresponding author), Mahidol Univ, Fac Med Technol, Dept Clin Microscopy, Salaya, Nakhon Pathom, Thailand.	mtppm@mahidol.ac.th		Bogler, Oliver/0000-0002-3700-0480	Mahidol University Research Fund (National Budget) [49439]; Simmons Cancer Institute, Southern Illinois; National Cancer Institute/National Institutes of Health grant [RO1CA128991]; NATIONAL CANCER INSTITUTE [R01CA128991] Funding Source: NIH RePORTER	Mahidol University Research Fund (National Budget); Simmons Cancer Institute, Southern Illinois; National Cancer Institute/National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by (1) Mahidol University Research Fund (National Budget), project # 49439 granted to PP; (2) SC was supported by Simmons Cancer Institute, Southern Illinois and (3) The National Cancer Institute/National Institutes of Health grant RO1CA128991 to OB, University of Texas M. D. Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agil A, 1999, PLANTA MED, V65, P673, DOI 10.1055/s-2006-960847; Atipairin A, 2011, BREAST CANCER-BASIC, V5, P201, DOI 10.4137/BCBCR.S8184; Blagosklonny MV, 2005, CELL DEATH DIFFER, V12, P592, DOI 10.1038/sj.cdd.4401610; Blaskovich MA, 2003, CANCER RES, V63, P1270; Brown AMC, 2001, BREAST CANCER RES, V3, P351, DOI 10.1186/bcr321; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Chan KT, 2010, CANCER LETT, V289, P46, DOI 10.1016/j.canlet.2009.07.015; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Dakeng S, 2012, J CELL BIOCHEM, V113, P49, DOI 10.1002/jcb.23326; Deng CX, 2003, HUM MOL GENET, V12, pR113, DOI 10.1093/hmg/ddg082; Duangmano S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-185; Duangmano S, 2010, INT J MOL SCI, V11, P5323, DOI 10.3390/ijms11125323; DUBIK D, 1987, CANCER RES, V47, P6517; Duncan KLK, 1996, BIOCHEM PHARMACOL, V52, P1553, DOI 10.1016/S0006-2952(96)00557-6; Efferth T, 2008, MOL CANCER THER, V7, P152, DOI 10.1158/1535-7163.MCT-07-0073; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fan WM, 1999, BIOCHEM PHARMACOL, V57, P1215; FARIAS MR, 1993, PLANTA MED, V59, P272, DOI 10.1055/s-2006-959668; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Foulkes WD, 2000, ANN ONCOL, V11, P307, DOI 10.1023/A:1008340723974; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; IRELAND CM, 1995, BIOCHEM PHARMACOL, V49, P1491, DOI 10.1016/0006-2952(95)00030-4; James CR, 2007, ONCOLOGIST, V12, P142, DOI 10.1634/theoncologist.12-2-142; Jiratchariyakul W, 1999, THAI J PHYTOPHARM, V6, P1; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Kongtun S, 2009, PLANTA MED, V75, P839, DOI 10.1055/s-0029-1185455; Lacroix M, 2005, BREAST CANCER RES TR, V89, P297, DOI 10.1007/s10549-004-2172-4; Lee DH, 2010, THESCIENTIFICWORLDJO, V10, P413, DOI 10.1100/tsw.2010.44; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Ma XH, 2009, DRUG DISCOV TODAY, V14, P1136, DOI 10.1016/j.drudis.2009.09.006; Patmasiriwat P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9049; Polakis P, 2000, GENE DEV, V14, P1837; Promkan M, 2011, CELL CALCIUM, V49, P79, DOI 10.1016/j.ceca.2011.01.003; Promkan M, 2009, INT J CANCER, V125, P2820, DOI 10.1002/ijc.24684; Reynolds S, 2000, CLIN EXP METASTAS, V18, P309, DOI 10.1023/A:1011071907047; Shimura T, 2004, CANCER RES, V64, P6363, DOI 10.1158/0008-5472.CAN-04-1816; Shimura T, 2005, CANCER RES, V65, P3535, DOI 10.1158/0008-5472.CAN-05-0104; Span PN, 2004, CLIN CHEM, V50, P1986, DOI 10.1373/clinchem.2004.039149; Sun CY, 2010, J CANCER RES CLIN, V136, P603, DOI 10.1007/s00432-009-0698-x; Sun JZ, 2005, ONCOGENE, V24, P3236, DOI 10.1038/sj.onc.1208470; Szabo CI, 2001, P AM ASS CANC RES, P42; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Thompson C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-62; Wakimoto N, 2008, CANCER SCI, V99, P1793, DOI 10.1111/j.1349-7006.2008.00899.x; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yang L, 2007, CANCER LETT, V256, P267, DOI 10.1016/j.canlet.2007.06.018; Yasuda S, 2010, MOL NUTR FOOD RES, V54, P559, DOI 10.1002/mnfr.200900165; Zhang MX, 2010, PANCREAS, V39, P923, DOI 10.1097/MPA.0b013e3181ce719e	58	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55732	10.1371/journal.pone.0055732	http://dx.doi.org/10.1371/journal.pone.0055732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393598	Green Published, gold, Green Submitted			2022-12-27	WOS:000314692800052
J	Raeder, MB; Birkeland, E; Trovik, J; Krakstad, C; Shehata, S; Schumacher, S; Zack, TI; Krohn, A; Werner, HMJ; Moody, SE; Wik, E; Stefansson, IM; Holst, F; Oyan, AM; Tamayo, P; Mesirov, JP; Kalland, KH; Akslen, LA; Simon, R; Beroukhim, R; Salvesen, HB				Raeder, Maria B.; Birkeland, Even; Trovik, Jone; Krakstad, Camilla; Shehata, Shyemaa; Schumacher, Steven; Zack, Travis I.; Krohn, Antje; Werner, Henrica M. J.; Moody, Susan E.; Wik, Elisabeth; Stefansson, Ingunn M.; Holst, Frederik; Oyan, Anne M.; Tamayo, Pablo; Mesirov, Jill P.; Kalland, Karl H.; Akslen, Lars A.; Simon, Ronald; Beroukhim, Rameen; Salvesen, Helga B.			Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers	PLOS ONE			English	Article							PROGNOSTIC IMPACT; GENE; MARKERS; BREAST; INHIBITION; EXPRESSION; CARCINOMA; STRATEGY; TARGETS; ANCCA	Chromosome 8q24 is the most commonly amplified region across multiple cancer types, and the typical length of the amplification suggests that it may target additional genes to MYC. To explore the roles of the genes most frequently included in 8q24 amplifications, we analyzed the relation between copy number alterations and gene expression in three sets of endometrial cancers (N = 252); and in glioblastoma, ovarian, and breast cancers profiled by TCGA. Among the genes neighbouring MYC, expression of the bromodomain-containing gene ATAD2 was the most associated with amplification. Bromodomain-containing genes have been implicated as mediators of MYC transcriptional function, and indeed ATAD2 expression was more closely associated with expression of genes known to be upregulated by MYC than was MYC itself. Amplifications of 8q24, expression of genes downstream from MYC, and overexpression of ATAD2 predicted poor outcome and increased from primary to metastatic lesions. Knockdown of ATAD2 and MYC in seven endometrial and 21 breast cancer cell lines demonstrated that cell lines that were dependent on MYC also depended upon ATAD2. These same cell lines were also the most sensitive to the histone deacetylase (HDAC) inhibitor Trichostatin-A, consistent with prior studies identifying bromodomain-containing proteins as targets of inhibition by HDAC inhibitors. Our data indicate high ATAD2 expression is a marker of aggressive endometrial cancers, and suggest specific inhibitors of ATAD2 may have therapeutic utility in these and other MYC-dependent cancers.	[Raeder, Maria B.; Birkeland, Even; Trovik, Jone; Krakstad, Camilla; Werner, Henrica M. J.; Wik, Elisabeth; Salvesen, Helga B.] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Raeder, Maria B.; Birkeland, Even; Trovik, Jone; Krakstad, Camilla; Werner, Henrica M. J.; Wik, Elisabeth; Salvesen, Helga B.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Raeder, Maria B.; Shehata, Shyemaa; Schumacher, Steven; Zack, Travis I.; Moody, Susan E.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Raeder, Maria B.; Shehata, Shyemaa; Schumacher, Steven; Zack, Travis I.; Moody, Susan E.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Schumacher, Steven; Zack, Travis I.; Moody, Susan E.; Tamayo, Pablo; Mesirov, Jill P.; Beroukhim, Rameen] Broad Inst, Cambridge, MA USA; [Zack, Travis I.] Harvard Univ, Dept Biophys, Boston, MA 02115 USA; [Krohn, Antje; Holst, Frederik; Simon, Ronald] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany; [Stefansson, Ingunn M.; Oyan, Anne M.; Kalland, Karl H.; Akslen, Lars A.] Univ Bergen, Gade Inst, Bergen, Norway; [Stefansson, Ingunn M.; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Oyan, Anne M.; Kalland, Karl H.] Haukeland Hosp, Dept Microbiol & Immunol, N-5021 Bergen, Norway; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	University of Bergen; Haukeland University Hospital; University of Bergen; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Raeder, MB (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway.	Maria.Rader@uib.no	Wik, E./AAA-9105-2020; Kalland, Karl-Henning/B-9445-2017; salvesen, Helga B/C-1187-2017; Mesirov, Jill/AGF-7626-2022; Schumacher, Steven/E-9821-2013; Akslen, Lars A/C-1202-2017; Krakstad, Camilla/AAB-5138-2020; Holst, Frederik/H-3149-2019; Akslen, Lars A./AAG-6097-2021; Werner, henrica/ABG-1235-2021	Kalland, Karl-Henning/0000-0003-4486-2334; salvesen, Helga B/0000-0002-4438-8831; Schumacher, Steven/0000-0002-6819-5647; Akslen, Lars A/0000-0003-2710-9543; Krakstad, Camilla/0000-0002-0174-8139; Holst, Frederik/0000-0002-5928-2175; Akslen, Lars A./0000-0003-2710-9543; Werner, henrica/0000-0001-5186-8369; Simon, Ronald/0000-0003-0158-4258	Helse Vest [990172, 911351, 911624, 911626]; University of Bergen; Norwegian Cancer Society; Research Council of Norway [205404, 193373]; National Cancer Institute [K08CA122833, U54CA143798]; V Foundation Scholarship; NATIONAL CANCER INSTITUTE [U54CA143798, K08CA122833, R01CA121941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024] Funding Source: NIH RePORTER	Helse Vest; University of Bergen; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support: Helse Vest Grants 990172 (MBR), 911351, 911624, and 911626 (HBS); the University of Bergen; the Norwegian Cancer Society; the Research Council of Norway Grants 205404 and 193373 (HBS); the National Cancer Institute (K08CA122833 and U54CA143798); and a V Foundation Scholarship (RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Caron C, 2010, ONCOGENE, V29, P5171, DOI 10.1038/onc.2010.259; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Engelsen IB, 2009, APMIS, V117, P693, DOI 10.1111/j.1600-0463.2009.02467.x; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Hsia EYC, 2010, MOL CANCER RES, V8, P183, DOI 10.1158/1541-7786.MCR-09-0095; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kalashnikova EV, 2010, CANCER RES, V70, P9402, DOI 10.1158/0008-5472.CAN-10-1199; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Ma O, 2009, CANCER RES, V69, P2559, DOI 10.1158/0008-5472.CAN-08-2929; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Rose PG, 1996, NEW ENGL J MED, V335, P640, DOI 10.1056/NEJM199608293350907; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Schwartz BE, 2011, CANCER RES, V71, P2686, DOI 10.1158/0008-5472.CAN-10-3513; Stefansson IM, 2004, J CLIN ONCOL, V22, P1242, DOI 10.1200/JCO.2004.09.034; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zitterbart K, 2011, J NEURO-ONCOL, V102, P25, DOI 10.1007/s11060-010-0289-3; Zou JX, 2007, P NATL ACAD SCI USA, V104, P18067, DOI 10.1073/pnas.0705814104	30	66	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54873	10.1371/journal.pone.0054873	http://dx.doi.org/10.1371/journal.pone.0054873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393560	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800014
J	Aarnoudse-Moens, CSH; Weisglas-Kuperus, N; Duivenvoorden, HJ; van Goudoever, JB; Oosterlaan, J				Aarnoudse-Moens, Cornelieke Sandrine Hanan; Weisglas-Kuperus, Nynke; Duivenvoorden, Hugo Joseph; van Goudoever, Johannes Bernard; Oosterlaan, Jaap			Executive Function and IQ Predict Mathematical and Attention Problems in Very Preterm Children	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; DEFICIT HYPERACTIVITY DISORDER; TESTING AUTOMATED BATTERY; WHITE-MATTER DAMAGE; WORKING-MEMORY; DEFICIT/HYPERACTIVITY DISORDER; RESPONSE-INHIBITION; NEUROPSYCHOLOGICAL FUNCTION; PRESCHOOL-CHILDREN; PROCESSING SPEED	Objective of this study was to examine the impact of executive function (EF) on mathematical and attention problems in very preterm (gestational age <= 30 weeks) children. Participants were 200 very preterm (mean age 8.2 +/- 2.5 years) and 230 term children (mean age 8.3 +/- 2.3 years) without severe disabilities, born between 1996 and 2004. EFs assessed included verbal fluency, verbal working memory, visuospatial span, planning, and impulse control. Mathematics was assessed with the Dutch Pupil Monitoring System and parents and teachers rated attention problems using standardized behavior questionnaires. The impact of EF was calculated over and above processing speed indices and IQ. Interactions with group (very preterm versus term birth status) were examined. Analyses were conducted separately for two subsamples: children in preschool and children in primary school. Very preterm children performed poorer on tests for mathematics and had more parent and teacher rated attention problems than term controls (beta(s) > .11, P-s < .01). IQ contributed unique variance to mathematics in preschool and in primary school (beta(s) > .16, P-s < .007). A significant interaction of group with IQ (beta = -.24, P = .02) showed that IQ contributed unique variance to attention problems as rated by teachers, but that effects were stronger for very preterm than for term infants. Over and above IQ, EF contributed unique variance to mathematics in primary school (beta = .13, P < .001), to parent rated inattention in preschool and in primary school (beta(s) > -.6, P-s < .04), and to teacher rated inattention in primary school (beta = -.19; beta = .19, P-s < .009). In conclusion, impaired EF is, over and above impaired IQ, an important predictor for poor mathematics and attention problems following very preterm birth.	[Aarnoudse-Moens, Cornelieke Sandrine Hanan; Weisglas-Kuperus, Nynke; Duivenvoorden, Hugo Joseph; van Goudoever, Johannes Bernard] Erasmus Univ, Med Ctr, Dept Paediat, Rotterdam, Netherlands; [Aarnoudse-Moens, Cornelieke Sandrine Hanan; van Goudoever, Johannes Bernard] Amsterdam Med Ctr, Dept Paediat, Amsterdam, Netherlands; [van Goudoever, Johannes Bernard] Vrije Univ Amsterdam, Med Ctr, Dept Paediat, Amsterdam, Netherlands; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Aarnoudse-Moens, CSH (corresponding author), Erasmus Univ, Med Ctr, Dept Paediat, Rotterdam, Netherlands.	c.aarnoudse-moens@amc.uva.nl	van Goudoever, Johannes Bernard/Y-4520-2018	van Goudoever, Johannes (Hans)/0000-0003-3960-1703				Aarnoudse-Moens CSH, 2012, DEV MED CHILD NEUROL, V54, P247, DOI 10.1111/j.1469-8749.2011.04150.x; Aarnoudse-Moens CSH, 2009, J ABNORM CHILD PSYCH, V37, P981, DOI 10.1007/s10802-009-9327-z; Aarnoudse-Moens CSH, 2011, J PEDIATR-US, V158, P15, DOI 10.1016/j.jpeds.2010.06.052; Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2000, MANUAL ASEBA SCH AGE; Altemeier L, 2006, DEV NEUROPSYCHOL, V29, P161, DOI 10.1207/s15326942dn2901_8; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Assel M.A., 2003, APPL DEV SCI, V7, P27, DOI DOI 10.1207/S1532480XADS0701_3; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; Aylward GP, 2003, JAMA-J AM MED ASSOC, V289, P752, DOI 10.1001/jama.289.6.752; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Campbell SB, 2009, J ABNORM CHILD PSYCH, V37, P1, DOI 10.1007/s10802-008-9270-4; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Clark CAC, 2010, DEV PSYCHOL, V46, P1176, DOI 10.1037/a0019672; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Kieviet JF, 2012, J PEDIATR-US, V161, P824, DOI 10.1016/j.jpeds.2012.05.010; de Zeeuw P, 2008, J AM ACAD CHILD PSY, V47, P808, DOI 10.1097/CHI.0b013e318172eee9; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Deutscher B, 2005, TOP EARLY CHILD SPEC, V25, P71, DOI 10.1177/02711214050250020401; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Edgin JO, 2008, J INT NEUROPSYCH SOC, V14, P90, DOI 10.1017/S1355617708080053; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Frye RE, 2009, DEV NEUROPSYCHOL, V34, P254, DOI 10.1080/87565640902805727; Goyen TA, 1998, DEV MED CHILD NEUROL, V40, P76, DOI 10.1111/j.1469-8749.1998.tb15365.x; Green S. M., 1989, DEV PSYCHOPATHOL, V1, P317, DOI DOI 10.1017/S095457940000050X; JANSSEN J, 2002, REKENEN WISKUNDE 200; Kalff AC, 2002, J ABNORM CHILD PSYCH, V30, P589, DOI 10.1023/A:1020859629994; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Krajewski K, 2009, J EXP CHILD PSYCHOL, V103, P516, DOI 10.1016/j.jecp.2009.03.009; Lawrence EJ, 2009, HUM BRAIN MAPP, V30, P1038, DOI 10.1002/hbm.20564; LEVIN BE, 1990, DEV NEUROPSYCHOL, V6, P95, DOI 10.1080/87565649009540453; LOEBER R, 1990, J CLIN CHILD PSYCHOL, V19, P136, DOI 10.1207/s15374424jccp1902_5; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Luciana M, 2002, DEV NEUROPSYCHOL, V22, P595, DOI 10.1207/S15326942DN2203_3; Luciana M, 2003, J CHILD PSYCHOL PSYC, V44, P649, DOI 10.1111/1469-7610.00152; Luoma L, 1998, DEV MED CHILD NEUROL, V40, P21, DOI 10.1111/j.1469-8749.1998.tb15352.x; Mahone EM, 2005, MENT RETARD DEV D R, V11, P216, DOI 10.1002/mrdd.20070; MCCORMICK MC, 1993, CLIN PERINATOL, V20, P263, DOI 10.1016/S0095-5108(18)30423-8; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mulder H, 2010, ARCH DIS CHILD-FETAL, V95, pF267, DOI 10.1136/adc.2009.167965; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Nadeau L, 2001, J DEV BEHAV PEDIATR, V22, P1, DOI 10.1097/00004703-200102000-00001; Nosarti C, 2011, HUM BRAIN MAPP, V32, P1615, DOI 10.1002/hbm.21133; Oosterlaan J, 2000, VRAGENLIJST GEDRAGSP; PALFREY JS, 1985, J DEV BEHAV PEDIATR, V6, P339; PELHAM WE, 1992, J AM ACAD CHILD PSY, V31, P210, DOI 10.1097/00004583-199203000-00006; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Rose SA, 2011, DEVELOPMENTAL SCI, V14, P1161, DOI 10.1111/j.1467-7687.2011.01068.x; Russell Vivienne A, 2006, Behav Brain Funct, V2, P30, DOI 10.1186/1744-9081-2-30; Sattler J., 1992, ASSESSMENT CHILDREN; Schachar R, 2000, J ABNORM CHILD PSYCH, V28, P227, DOI 10.1023/A:1005140103162; Scheres A, 2003, J ABNORM CHILD PSYCH, V31, P105, DOI 10.1023/A:1021729501230; Scope A, 2010, BRIT J DEV PSYCHOL, V28, P293, DOI 10.1348/026151009X410371; Sergeant JA, 2005, BIOL PSYCHIAT, V57, P1248, DOI 10.1016/j.biopsych.2004.09.010; Shum D, 2008, ARCH CLIN NEUROPSYCH, V23, P103, DOI 10.1016/j.acn.2007.08.006; Sonuga-Barke EJS, 2002, DEV NEUROPSYCHOL, V21, P255, DOI 10.1207/S15326942DN2103_3; Soria-Pastor S, 2008, INT J DEV NEUROSCI, V26, P647, DOI 10.1016/j.ijdevneu.2008.08.001; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor HG, 2006, J DEV BEHAV PEDIATR, V27, P459, DOI 10.1097/00004703-200612000-00002; Taylor HG, 2009, DEV DISABIL RES REV, V15, P52, DOI 10.1002/ddrr.51; Tillman CM, 2008, CHILD NEUROPSYCHOL, V14, P42, DOI 10.1080/09297040701249020; Tsujimoto S, 2007, EXP PSYCHOL, V54, P30, DOI 10.1027/1618-3169.54.1.30; Valo S, 2010, J CLIN CHILD ADOLESC, V39, P749, DOI 10.1080/15374416.2010.517172; VANKUYK JJ, 2001, ORDENEN OBSERVATIE H; Walhovd KB, 2007, NEUROPSYCHOLOGIA, V45, P2277, DOI 10.1016/j.neuropsychologia.2007.02.022; WECHSLER D, 1997, WECHSLER PRESCHOOL P; Wechsler D, 2005, WECHSLER INTELLIGENC; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	82	75	76	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55994	10.1371/journal.pone.0055994	http://dx.doi.org/10.1371/journal.pone.0055994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086NH	23390558	Green Submitted, Green Published, gold			2022-12-27	WOS:000314691100074
J	Hurst, DR; Xie, Y; Thomas, JW; Liu, JZ; Edmonds, MD; Stewart, MD; Welch, DR				Hurst, Douglas R.; Xie, Yi; Thomas, John W.; Liu, Jianzhong; Edmonds, Mick D.; Stewart, Mark D.; Welch, Danny R.			The C-Terminal Putative Nuclear Localization Sequence of BReast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression	PLOS ONE			English	Article							CARCINOMA METASTASIS; GENE-EXPRESSION; IDENTIFICATION; SIN3; MECHANISMS; COMMUNICATION; COREPRESSOR; MDA-MB-435; COMPONENT; PROTEINS	Breast cancer metastasis suppressor 1 (BRMS1) is a predominantly nuclear protein that suppresses metastasis in multiple human and murine carcinoma cell lines. BRMS1 interacts with several nuclear proteins including SIN3:HDAC chromatin remodeling complexes that are involved in repressing transcription. However, recent reports suggest BRMS1 may function in the cytoplasm. BRMS1 has two predicted nuclear localization sequences (NLS) that are located near the C-terminus (amino acids 198-205 and 238-244, NLS1 and NLS2 respectively). We hypothesized that nuclear localization sequences of BRMS1 were essential for BRMS1 mediated metastasis suppression. Replacement of NLS2 with NLS1 (BRMS1(NLS1,1)), truncation at 238 (BRMS1(Delta NLS2)), or switching the location of NLS1 and NLS2 (BRMS1(NLS2,1)) did not affect nuclear localization; but, replacement of NLS1 with NLS2 (BRMS1(NLS2,2)) or truncation at 197 (BRMS1(Delta NLS) which removes both NLS) promoted cytoplasmic localization. MDA-MB-231 human metastatic breast cancer cells transduced with BRMS1(NLS1,1), BRMS1(NLS2,2) or BRMS1(NLS2,1) were evaluated for metastasis suppression in an experimental xenograft mouse model. Interestingly, while NLS2 was not necessary for nuclear localization, it was found to be important for metastasis suppression since BRMS1(NLS2,2) suppressed metastasis by 85%. In contrast, BRMS1(NLS2,1) and BRMS1(NLS1,1) did not significantly suppress metastasis. Both BRMS1 and BRMS1(NLS2,2) co-immunoprecipitated with SIN3A in the nucleus and cytoplasm; however, BRMS1(NLS1,1) and BRMS1(NLS2,1) were associated with SIN3A in the nucleus only. Moreover, BRMS1 and BRMS1(NLS2,2), but not BRMS1(NLS1,1) and BRMS1(NLS2,1), down-regulated the pro-metastatic microRNA, miR-10b. Together, these data demonstrate an important role for NLS2 in the cytoplasm that is critical for metastasis suppression and is distinct from nuclear localization.	[Hurst, Douglas R.; Xie, Yi; Thomas, John W.; Liu, Jianzhong; Edmonds, Mick D.; Stewart, Mark D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Hurst, Douglas R.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL USA; [Welch, Danny R.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Kansas; University of Kansas Medical Center	Hurst, DR (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	DHurst@uab.edu; DWelch@kumc.edu	Welch, Danny R/B-7310-2009	Welch, Danny R/0000-0002-1951-4947; Hurst, Douglas/0000-0002-1296-2210	NIH [CA87728, CA134981]; National Foundation for Cancer Research; Susan G. Komen for the Cure [SAC11037]; American Cancer Society [RSG-11-259-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA134981, R01CA087728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants CA87728 and CA134981 (DRW), National Foundation for Cancer Research (DRW), Susan G. Komen for the Cure SAC11037 (DRW) and the American Cancer Society RSG-11-259-01-CSM (DRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027339; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bodenstine TM, 2010, CANCER RES, V70, P10002, DOI 10.1158/0008-5472.CAN-10-2606; Champine PJ, 2007, CLIN EXP METASTAS, V24, P551, DOI 10.1007/s10585-007-9092-8; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; Cicek M, 2009, CLIN EXP METASTAS, V26, P229, DOI 10.1007/s10585-009-9235-1; Cook LM, 2012, CLIN EXP METASTAS, V29, P315, DOI 10.1007/s10585-012-9452-x; DeWald DB, 2005, CANCER RES, V65, P713; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Edmonds MD, 2009, INT J CANCER, V125, P1778, DOI 10.1002/ijc.24616; Edmonds MD, 2009, CELL CYCLE, V8, P2673, DOI 10.4161/cc.8.17.9303; Frolova N, 2009, TUMOR BIOL, V30, P148, DOI 10.1159/000228908; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; Hurst DR, 2006, BIOCHEM BIOPH RES CO, V348, P1429, DOI 10.1016/j.bbrc.2006.08.005; Hurst DR, 2012, CANCER METAST REV, V31, P641, DOI 10.1007/s10555-012-9363-y; Hurst DR, 2011, FEBS LETT, V585, P3185, DOI 10.1016/j.febslet.2011.07.045; Hurst DR, 2011, INT REV CEL MOL BIO, V286, P107, DOI 10.1016/B978-0-12-385859-7.00003-3; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Hurst DR, 2009, CLIN EXP METASTAS, V26, P89, DOI 10.1007/s10585-008-9216-9; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Kapoor P, 2004, INT J CANCER, V111, P693, DOI 10.1002/ijc.20318; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; McDonel P, 2012, DEV BIOL, V363, P62, DOI 10.1016/j.ydbio.2011.12.019; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Phadke PA, 2008, AM J PATHOL, V172, P809, DOI 10.2353/ajpath.2008.070772; Riker AI, 2012, BMC MED, V10, DOI [10.1186/PREACCEPT-2032291833666638, 10.1186/1741-7015-10-19]; Rivera J, 2007, J PROTEOME RES, V6, P4006, DOI 10.1021/pr0703167; Rivera J, 2010, J CELL BIOCHEM, V111, P1464, DOI 10.1002/jcb.22874; Rivera J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006433; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Samant RS, 2001, CLIN EXP METASTAS, V18, P683, DOI 10.1023/A:1013124725690; Saunders MM, 2001, CANCER RES, V61, P1765; Seraj MJ, 2000, CANCER RES, V60, P2764; Shevde LA, 2002, EXP CELL RES, V273, P229, DOI 10.1006/excr.2001.5452; Shiio Y, 2006, MOL CELL BIOL, V26, P1386, DOI 10.1128/MCB.26.4.1386-1397.2006; Silveira AC, 2009, CANCER LETT, V276, P32, DOI 10.1016/j.canlet.2008.10.024; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Slipicevic A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-73; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Vaidya KS, 2008, J BIOL CHEM, V283, P28354, DOI 10.1074/jbc.M710068200; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x	49	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55966	10.1371/journal.pone.0055966	http://dx.doi.org/10.1371/journal.pone.0055966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390556	Green Submitted, gold, Green Published			2022-12-27	WOS:000314691100072
J	Lee, HK; Bier, A; Cazacu, S; Finniss, S; Xiang, CL; Twito, H; Poisson, LM; Mikkelsen, T; Slavin, S; Jacoby, E; Yalon, M; Toren, A; Rempel, SA; Brodie, C				Lee, Hae Kyung; Bier, Ariel; Cazacu, Simona; Finniss, Susan; Xiang, Cunli; Twito, Hodaya; Poisson, Laila M.; Mikkelsen, Tom; Slavin, Shimon; Jacoby, Elad; Yalon, Michal; Toren, Amos; Rempel, Sandra A.; Brodie, Chaya			MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor	PLOS ONE			English	Article							FACTOR CTGF; MALIGNANT GLIOMA; STEM-CELLS; CANCER; EXPRESSION; INVASION; MIR-145; SURVIVAL; DIFFERENTIATION; TUMORIGENICITY	Glioblastomas (GBM), the most common and aggressive type of malignant glioma, are characterized by increased invasion into the surrounding brain tissues. Despite intensive therapeutic strategies, the median survival of GBM patients has remained dismal over the last decades. In this study we examined the expression of miR-145 in glial tumors and its function in glioma cells. Using TCGA analysis and real-time PCR we found that the expression of miR-145/143 cluster was downregulated in astrocytic tumors compared to normal brain specimens and in glioma cells and glioma stem cells (GSCs) compared to normal astrocytes and neural stem cells. Moreover, the low expression of both miR-145 and miR-143 in GBM was correlated with poor patient prognosis. Transfection of glioma cells with miR-145 mimic or transduction with a lentivirus vector expressing pre-miR 145 significantly decreased the migration and invasion of glioma cells. We identified connective tissue growth factor (CTGF) as a novel target of miR-145 in glioma cells; transfection of the cells with this miRNA decreased the expression of CTGF as determined by Western blot analysis and the expression of its 3'-UTR fused to luciferase. Overexpression of a CTGF plasmid lacking the 3'-UTR and administration of recombinant CTGF protein abrogated the inhibitory effect of miR-145 on glioma cell migration. Similarly, we found that silencing of CTGF decreased the migration of glioma cells. CTGF silencing also decreased the expression of SPARC, phospho-FAK and FAK and overexpression of SPARC abrogated the inhibitory effect of CTGF silencing on cell migration. These results demonstrate that miR-145 is downregulated in glial tumors and its low expression in GBM predicts poor patient prognosis. In addition miR-145 regulates glioma cell migration by targeting CTGF which downregulates SPARC expression. Therefore, miR-145 is an attractive therapeutic target for anti-invasive treatment of astrocytic tumors.	[Lee, Hae Kyung; Cazacu, Simona; Finniss, Susan; Xiang, Cunli; Mikkelsen, Tom; Brodie, Chaya] Henry Ford Hosp, Dept Neurosurg, Hermelin Brain Tumor Ctr, Davidson Lab Cell Signaling & Tumorigenesis, Detroit, MI 48202 USA; [Bier, Ariel; Twito, Hodaya; Brodie, Chaya] Bar Ilan Univ, Everard & Mina Goodman Fac Life Sci, Ramat Gan, Israel; [Poisson, Laila M.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Slavin, Shimon] Int Ctr Cell Therapy & Canc Immunotherapy CTCI, Tel Aviv, Israel; [Jacoby, Elad; Yalon, Michal; Toren, Amos] Edmond & Lilly Safra Childrens Hosp, Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Jacoby, Elad; Yalon, Michal; Toren, Amos] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Rempel, Sandra A.] Henry Ford Hosp, Dept Neurosurg, Barbara Jane Levy Lab Mol Neurooncol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Bar Ilan University; Henry Ford Health System; Henry Ford Hospital; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Henry Ford Health System; Henry Ford Hospital	Brodie, C (corresponding author), Henry Ford Hosp, Dept Neurosurg, Hermelin Brain Tumor Ctr, Davidson Lab Cell Signaling & Tumorigenesis, Detroit, MI 48202 USA.	nscha@neuro.hfh.edu		Jacoby, Elad/0000-0003-1411-8942	William and Karen Davidson Fund; Lori and Alan Zekelman Fund	William and Karen Davidson Fund; Lori and Alan Zekelman Fund	This work was supported by the William and Karen Davidson and the Lori and Alan Zekelman Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; DeCarvalho AC, 2010, STEM CELLS, V28, P181, DOI 10.1002/stem.264; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Desjardins A, 2005, FRONT BIOSCI-LANDMRK, V10, P2645, DOI 10.2741/1727; Dhar A., 2010, Experimental Oncology, V32, P2; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Emdad L, 2012, FUTURE ONCOL, V8, P343, DOI [10.2217/FON.12.16, 10.2217/fon.12.16]; Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao P., 2012, ONCOGENE; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Golembieski WA, 2008, GLIA, V56, P1061, DOI 10.1002/glia.20679; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jia YS, 2012, ONCOL REP, V27, P1865, DOI 10.3892/or.2012.1701; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kwon S, 2007, INT J ONCOL, V31, P693; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Li XH, 2011, ONCOL REP, V26, P1431, DOI 10.3892/or.2011.1437; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Litofsky N S, 1997, Neurosurg Focus, V3, pe4; Liu DP, 2007, INT J ONCOL, V30, P865; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Lu Y, 2013, ONCOL REP, V29, P67, DOI 10.3892/or.2012.2084; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Maher EA, 2005, GENE DEV, V15, P1311; Noda SE, 2009, SEMIN RADIAT ONCOL, V19, P171, DOI 10.1016/j.semradonc.2009.02.005; Pan LH, 2002, NEUROL RES, V24, P677, DOI 10.1179/016164102101200573; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Quintavalle C, 2012, ONCOGENE, V31, P858, DOI 10.1038/onc.2011.280; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; Sachdeva M, 2012, NUCL ACIDS RES; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sala-Torra O, 2007, BLOOD, V109, P3080, DOI 10.1182/blood-2006-06-031096; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Schultz C, 2002, CANCER RES, V62, P6270; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suh SO, 2011, CARCINOGENESIS, V32, P772, DOI 10.1093/carcin/bgr036; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tan TW, 2009, J CELL BIOCHEM, V107, P345, DOI 10.1002/jcb.22132; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Wang JC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2973; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yin D, 2010, INT J CANCER, V127, P2257, DOI 10.1002/ijc.25257; Zaman MS, 2010, BRIT J CANCER, V103, P256, DOI 10.1038/sj.bjc.6605742; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang J, 2012, ONCOGENE; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531; Zhu L, 2011, AM J CANCER RES, V1, P574; Ziv-Av A, 2011, CELL SIGNAL, V23, P1936, DOI 10.1016/j.cellsig.2011.07.001	72	69	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54652	10.1371/journal.pone.0054652	http://dx.doi.org/10.1371/journal.pone.0054652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390502	gold, Green Published, Green Submitted			2022-12-27	WOS:000314691100018
J	Mouchnino, L; Blouin, J				Mouchnino, Laurence; Blouin, Jean			When Standing on a Moving Support, Cutaneous Inputs Provide Sufficient Information to Plan the Anticipatory Postural Adjustments for Gait Initiation	PLOS ONE			English	Article							PERTURBED STEP INITIATION; CEREBELLAR SUBJECTS; PARKINSONS-DISEASE; RESPONSES; HUMANS; TRANSLATION; THRESHOLDS; PERCEPTION; LOCOMOTION; AFFERENTS	Gait initiation is preceded by initial postural adjustments whose goal is to set up the condition required for the execution of the focal stepping movement. For instance, the step is preceded by a shift of the body's center of mass towards the stance foot unloading the stepping leg. This displacement is produced by exerting forces on the ground (i.e., thrust) while the body is still motionless. The purpose of this study was to identify whether the mere cutaneous inputs from the feet soles evoked by a lateral translation of the support could be used to scale the initial postural adjustments. Participants stood with their eyes closed on a force platform that could be moved laterally with a low acceleration (between 0.14 m/s(2) and 0.30 m/s(2)) to reach a constant velocity of 0.02 m/s. This translation resulted in a change in the somatosensory cues from the feet soles without modifying vestibular inputs. Participants were instructed to produce a step with the right foot as soon as they felt the platform start to move (on either side) or heard an auditory cue. In the latter case, the platform stayed stationary. We found that the thrust duration was lengthened when the platform moved towards the supporting foot. In this condition, the cutaneous stimulation provided information related to a body shift towards the stepping leg. This increased thrust duration likely helped overcoming the non-functional body shift perceived towards the stepping leg. This result highlights the accuracy with which the actual standing position can be determined from foot sole cutaneous cues in the absence of visual and vestibular or proprioceptive inputs.	[Mouchnino, Laurence; Blouin, Jean] Aix Marseille Univ, CNRS, Cognit Neurosci Lab, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Mouchnino, L (corresponding author), Aix Marseille Univ, CNRS, Cognit Neurosci Lab, Marseille, France.	laurence.mouchnino@univ-amu.fr		Blouin, Jean/0000-0002-8118-8994	Centre National d'Etudes Spatiales	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	This study was funded by the Centre National d'Etudes Spatiales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bent LR, 2002, EXP BRAIN RES, V143, P100, DOI 10.1007/s00221-001-0967-7; Bernier PM, 2009, CEREB CORTEX, V19, P2106, DOI 10.1093/cercor/bhn233; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3625, DOI 10.1152/jn.00496.2003; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; BRENIERE Y, 1991, J MOTOR BEHAV, V23, P235, DOI 10.1080/00222895.1991.9942034; BURLEIGH AL, 1994, J NEUROPHYSIOL, V72, P2892, DOI 10.1152/jn.1994.72.6.2892; Chapman CE, 2006, J NEUROPHYSIOL, V96, P1664, DOI 10.1152/jn.00214.2006; DO MC, 1990, EXP BRAIN RES, V79, P319, DOI 10.1007/BF00608241; Eils E, 2002, J BIOMECH, V35, P1307, DOI 10.1016/S0021-9290(02)00168-9; Fiolkowski P, 2002, NEUROSCI LETT, V323, P167, DOI 10.1016/S0304-3940(02)00158-1; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Gianna C, 1996, BRAIN RES BULL, V40, P443, DOI 10.1016/0361-9230(96)00140-2; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; INGLIS JT, 1994, EXP BRAIN RES, V101, P159; INGLIS JT, 1995, J NEUROPHYSIOL, V73, P1181, DOI 10.1152/jn.1995.73.3.1181; Kavounoudias A, 1998, NEUROREPORT, V9, P3247, DOI 10.1097/00001756-199810050-00021; Kelly LA, 2012, CLIN BIOMECH, V27, P46, DOI 10.1016/j.clinbiomech.2011.07.013; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Lowrey CR, 2012, J NEUROPHYS IN PRESS; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Mille ML, 2007, MOVEMENT DISORD, V22, P20, DOI 10.1002/mds.21139; Mille ML, 2009, J NEUROL PHYS THER, V33, P88, DOI 10.1097/NPT.0b013e3181a3360d; Mille ML, 1998, NEUROSCI LETT, V242, P61, DOI 10.1016/S0304-3940(98)00047-0; Mouchnino L, 2012, GAIT POSTURE, V35, P616, DOI 10.1016/j.gaitpost.2011.12.009; Nurse MA, 2001, CLIN BIOMECH, V16, P719, DOI 10.1016/S0268-0033(01)00090-0; Robinovitch SN, 2012, LANCET IN PRESS; Ruget H, 2008, NEUROSCIENCE, V155, P640, DOI 10.1016/j.neuroscience.2008.06.021; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; Timmann D, 1998, EXP BRAIN RES, V119, P73, DOI 10.1007/s002210050321; Timmann D, 2001, EXP BRAIN RES, V141, P110, DOI 10.1007/s002210100858; Tokuno CD, 2006, EXP BRAIN RES, V174, P19, DOI 10.1007/s00221-006-0414-x; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592	35	22	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55081	10.1371/journal.pone.0055081	http://dx.doi.org/10.1371/journal.pone.0055081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390513	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100029
J	Piratvisuth, T; Komolmit, P; Tanwandee, T; Sukeepaisarnjaroen, W; Chan, HLY; Pessoa, MG; Fassio, E; Ono, SK; Bessone, F; Daruich, J; Zeuzem, S; Cheinquer, H; Pathan, R; Dong, YH; Trylesinski, A				Piratvisuth, Teerha; Komolmit, Piyawat; Tanwandee, Tawesak; Sukeepaisarnjaroen, Wattana; Chan, Henry L. Y.; Pessoa, Mario G.; Fassio, Eduardo; Ono, Suzane K.; Bessone, Fernando; Daruich, Jorge; Zeuzem, Stefan; Cheinquer, Hugo; Pathan, Rashidkhan; Dong, Yuhong; Trylesinski, Aldo			52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B	PLOS ONE			English	Article							DISOPROXIL FUMARATE; ADEFOVIR DIPIVOXIL; RENAL SAFETY; E-ANTIGEN; LAMIVUDINE; THERAPY; DNA; ENTECAVIR; PREDICTION; NUCLEOSIDE	Background and Aims: The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. The efficacy and safety of this approach applied to telbivudine treatment has not been investigated. Methods: A multinational, phase IV, single-arm open-label study (ClinicalTrials.gov ID NCT00651209) was undertaken in HBeAg-positive, nucleoside-naive adult patients with chronic hepatitis B. Patients received telbivudine (600 mg once-daily) for 24 weeks, after which those with undetectable serum HBV DNA (<300 copies/mL) continued to receive telbivudine alone while those with detectable DNA received telbivudine plus tenofovir (300 mg once-daily). Outcomes were assessed at Week 52. Results: 105 patients commenced telbivudine monotherapy, of whom 100 were included in the efficacy analysis. Fifty-five (55%) had undetectable HBV DNA at Week 24 and continued telbivudine monotherapy; 45 (45%) received tenofovir intensification. At Week 52, the overall proportion of undetectable HBV DNA was 93% (93/100) by last-observation-carried-forward analysis (100% monotherapy group, 84% intensification group) and no virologic breakthroughs had occurred. ALT normalization occurred in 77% (87% monotherapy, 64% intensification), HBeAg clearance in 43% (65% monotherapy, 16% intensification), and HBeAg seroconversion in 39% (62% monotherapy, 11% intensification). Six patients had HBsAg clearance. Myalgia was more common in the monotherapy group (19% versus 7%). No decrease in the mean glomerular filtration rate occurred in either treatment group at Week 52. Conclusions: Telbivudine therapy with tenofovir intensification at Week 24, where indicated by the Roadmap strategy, appears effective and well tolerated for the treatment of chronic hepatitis B.	[Piratvisuth, Teerha] Prince Songkla Univ, Songklanagarind Hosp, NKC Inst Gastroenterol & Hepatol, Hat Yai, Songkhla, Thailand; [Komolmit, Piyawat] Chulalongkorn Univ, Dept Med, Div Gastroenterol, Bangkok, Thailand; [Tanwandee, Tawesak] Siriraj Hosp, Bangkok, Thailand; [Sukeepaisarnjaroen, Wattana] Khon Kaen Univ, Srinagarind Hosp, Dept Med, Khon Kaen, Thailand; [Chan, Henry L. Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Pessoa, Mario G.] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil; [Fassio, Eduardo] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Ono, Suzane K.] Univ Sao Paulo, Fac Med, Dept Gastroenterol, Sao Paulo, Brazil; [Bessone, Fernando] Univ Nacl Rosario, Catedra Clin Med, Rosario, Antigua & Barbu; [Daruich, Jorge] Univ Buenos Aires, Hosp Clin San Martin, Buenos Aires, DF, Argentina; [Zeuzem, Stefan] Univ Frankfurt Klinikum, Frankfurt, Germany; [Cheinquer, Hugo] Univ Fed Rio Grande do Sul, Div Gastroenterol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Pathan, Rashidkhan] Novartis Pharmaceut, E Hanover, NJ USA; [Dong, Yuhong; Trylesinski, Aldo] Novartis Pharma AG, Basel, Switzerland	Prince of Songkla University; Chulalongkorn University; Mahidol University; Khon Kaen University; Chinese University of Hong Kong; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Buenos Aires; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Universidade Federal do Rio Grande do Sul; Novartis; Novartis	Piratvisuth, T (corresponding author), Prince Songkla Univ, Songklanagarind Hosp, NKC Inst Gastroenterol & Hepatol, Hat Yai, Songkhla, Thailand.	teerha.p@psu.ac.th	Komolmit, Piyawat/AAD-1629-2020; Cheinquer, Hugo/U-2117-2019; Chan, Henry Lik-Yuen/B-9636-2008; Sukeepaisarnjaroen, Wattana/GQH-3065-2022; Tanwandee, Tawesak/AAR-6459-2020; Ono, Suzane K/I-3107-2012; Zeuzem, Stefan/AAE-7435-2019	Komolmit, Piyawat/0000-0002-1357-9547; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Tanwandee, Tawesak/0000-0001-7634-0843	Novartis Pharma AG	Novartis Pharma AG	The authors have read the journal's policy and have the following conflicts: RP, YD, and AT are all employees of Novartis, the funder of this study. The following employees of Novartis Pharma played key roles in the design, execution and analysis of the study and in the drafting of this manuscript: Efsevia Albanis, Patricia Lopez, Claudio Avila, and George Harb (study design and data analysis); Weibin Bao (data analysis); Michele Gysen, Joe Mostillo, Kevin Poirier (study operations); Mechthild Jung (study operations and manuscript preparation); Charles Koehne (manuscript preparation). Editorial assistance with the drafting of the manuscript in association with the authors was provided by a professional medical writer (Nicholas Fitch) with funding from Novartis Pharma AG. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andersson KL, 2009, HEPATOLOGY, V49, pS166, DOI 10.1002/hep.22899; [Anonymous], 2002, AM J KIDNEY DIS, V39, pS76; Chan HLY, 2007, ANN INTERN MED, V147, P745, DOI 10.7326/0003-4819-147-11-200712040-00183; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Gane EJ, 2010, J HEPATOL, V52, pS4, DOI 10.1016/S0168-8278(10)60009-8; Gane EJ, 2011, HEPATOLOGY, V54, p1044A; Gish RG, 2010, HEPATOLOGY, V52, p529A; Izzedine H, 2004, KIDNEY INT, V66, P1153, DOI 10.1111/j.1523-1755.2004.00866.x; Jia Ji-dong, 2007, Zhonghua Gan Zang Bing Za Zhi, V15, P342; Keeffe EB, 2007, CLIN GASTROENTEROL H, V5, P890, DOI 10.1016/j.cgh.2007.05.004; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Leung N, 2009, HEPATOLOGY, V49, P72, DOI 10.1002/hep.22658; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Mauss S, 2011, J HEPATOL, V55, P1235, DOI 10.1016/j.jhep.2011.03.030; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; Mommeja-Marin H, 2003, HEPATOLOGY, V37, P1309, DOI 10.1053/jhep.2003.50208; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Tenney DJ, 2004, ANTIMICROB AGENTS CH, V48, P3498, DOI 10.1128/AAC.48.9.3498-3507.2004; van Bommel F, 2009, 60 ANN M AM ASS STUD; Yang HL, 2005, ANTIVIR THER, V10, P625; Yuen MF, 2007, ANTIVIR THER, V12, P1295; Yuen MF, 2001, HEPATOLOGY, V34, P785, DOI 10.1053/jhep.2001.27563; Zeuzem S, 2009, J HEPATOL, V51, P11, DOI 10.1016/j.jhep.2008.12.019	30	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54279	10.1371/journal.pone.0054279	http://dx.doi.org/10.1371/journal.pone.0054279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390496	Green Submitted, gold, Green Published			2022-12-27	WOS:000314691100012
J	Sadique, MZ; Devlin, N; Edmunds, WJ; Parkin, D				Sadique, Md Z.; Devlin, Nancy; Edmunds, William J.; Parkin, David			The Effect of Perceived Risks on the Demand for Vaccination: Results from a Discrete Choice Experiment	PLOS ONE			English	Article							HEALTH; DETERMINANTS; DECISIONS; IMMUNIZATION; BEHAVIOR; PARENTS; INCOME	The demand for vaccination against infectious diseases involves a choice between vaccinating and not vaccinating, in which there is a trade-off between the benefits and costs of each option. The aim of this paper is to investigate these trade-offs and to estimate how the perceived prevalence and severity of both the disease against which the vaccine is given and any vaccine associated adverse events (VAAE) might affect demand. A Discrete Choice Experiment (DCE) was used to elicit stated preferences from a representative sample of 369 UK mothers of children below 5 years of age, for three hypothetical vaccines. Cost was included as an attribute, which enabled estimation of the willingness to pay for different vaccines having differing levels of the probability of occurrence and severity of both the infection and VAAE. The results suggest that the severity of the health effects associated with both the diseases and VAAEs exert an important influence on the demand for vaccination, whereas the probability of these events occurring was not a significant predictor. This has important implications for public health policy, which has tended to focus on the probability of these health effects as the main influence on decision making. Our results also suggest that anticipated regrets about the consequences of making the wrong decision also exert an influence on demand.	[Sadique, Md Z.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Devlin, Nancy] Off Hlth Econ, London, England; [Devlin, Nancy; Edmunds, William J.; Parkin, David] City Univ London, City Hlth Econ Ctr, London EC1V 0HB, England; [Edmunds, William J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; City University London; University of London; London School of Hygiene & Tropical Medicine	Sadique, MZ (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England.	zia.sadique@lshtm.ac.uk	Devlin, Nancy/M-3816-2014	Sadique, Zia/0000-0001-5814-0258	City Health Economics Centre, City University; Health Protection Agency, London	City Health Economics Centre, City University; Health Protection Agency, London	Data collection for this research was funded by a grant-in-aid provided by City Health Economics Centre, City University and the Health Protection Agency, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg D, 2011, J HEALTH ECON, V30, P515, DOI 10.1016/j.jhealeco.2011.01.009; [Anonymous], 2001, MISSING DATA; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P205, DOI 10.2105/AJPH.64.3.205; Brehaut JC, 2003, MED DECIS MAKING, V23, P281, DOI 10.1177/0272989X03256005; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Connolly T, 2003, ORGAN BEHAV HUM DEC, V91, P186, DOI 10.1016/S0749-5978(03)00057-8; Department of Health, 2002, HLTH SURV ENGL 2002; Essers BAB, 2010, PHARMACOECONOMICS, V28, P507, DOI 10.2165/11532240-000000000-00000; Gallagher S, 2006, J PUBLIC HEALTH-UK, V28, P139, DOI 10.1093/pubmed/fdl008; Geoffard P, INT EC REV, V37, P603; Hahn G.J., 1966, 66C165 GEN EL RES DE; Hall J, 2002, HEALTH ECON, V11, P457, DOI 10.1002/hec.694; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jinn J.-H., 1989, SOCIOL METHODOL, V19, P213, DOI DOI 10.2307/270953; KRINSKY I, 1986, REV ECON STAT, V68, P715, DOI 10.2307/1924536; Lancsar E, 2004, HEALTH ECON, V13, P901, DOI 10.1002/hec.870; Little R.J.A., 2002, STAT ANAL MISSING DA; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Louviere J, 1998, J TRANSP ECON POLICY, V22, P93; Meszaros JR, 1996, J CLIN EPIDEMIOL, V49, P697, DOI 10.1016/0895-4356(96)00007-8; Mullahy J, 1999, HEALTH ECON, V8, P9, DOI 10.1002/(SICI)1099-1050(199902)8:1<9::AID-HEC396>3.0.CO;2-X; Office of National Statistics, 2006, HLTH STAT Q, V36; Office of National Statistics, 2004, AG HOUS REF PERS HRP; Paulussen TGW, 2006, VACCINE, V24, P644, DOI 10.1016/j.vaccine.2005.08.053; Philipson T, 1996, J HUM RESOUR, V31, P611, DOI 10.2307/146268; Ratcliffe J, 2000, INT J TECHNOL ASSESS, V16, P270, DOI 10.1017/S0266462300161227; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; Ryan M, 2001, QUAL HEALTH CARE, V10, pI55; Ryan M, 1996, USING CONSUMER PREFE; Ryan M, 2003, APPL HLTH EC HLTH PO, V2; Sadique MZ, 2005, UNDERSTANDING INDIVI; Scott A, 1999, SCOT J POLIT ECON, V46, P111, DOI 10.1111/1467-9485.00124; Sturm LA, 2005, J DEV BEHAV PEDIATR, V26, P441, DOI 10.1097/00004703-200512000-00009; Vardavas R, 2007, PLOS COMPUT BIOL, V3, P796, DOI 10.1371/journal.pcbi.0030085; Yarwood J, 2005, VACCINE, V23, P5670, DOI 10.1016/j.vaccine.2004.11.081; Zeelenberg M, 2007, J CONSUM PSYCHOL, V17, P3, DOI 10.1207/s15327663jcp1701_3	40	54	54	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e54149	10.1371/journal.pone.0054149	http://dx.doi.org/10.1371/journal.pone.0054149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23408936	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000314660300004
J	Moraes, CB; Dorval, T; Contreras-Dominguez, M; Dossin, FD; Hansen, MAE; Genovesio, A; Freitas-Junior, LH				Moraes, Carolina B.; Dorval, Thierry; Contreras-Dominguez, Monica; Dossin, Fernando de M.; Hansen, Michael A. E.; Genovesio, Auguste; Freitas-Junior, Lucio H.			Transcription Sites Are Developmentally Regulated during the Asexual Cycle of Plasmodium falciparum	PLOS ONE			English	Article							RNA-POLYMERASE-II; MUTUALLY EXCLUSIVE EXPRESSION; ANTIGENIC VARIATION; VIRULENCE GENES; DNA-BINDING; PROTEIN; ORGANIZATION; COMPARTMENT; DISCOVERY; CLUSTERS	Increasing evidence shows that the spatial organization of transcription is an important epigenetic factor in eukaryotic gene regulation. The malaria parasite Plasmodium falciparum shows a remarkably complex pattern of gene expression during the erythrocytic cycle, paradoxically contrasting with the relatively low number of putative transcription factors encoded by its genome. The spatial organization of nuclear subcompartments has been correlated with the regulation of virulence genes. Here, we investigate the nuclear architecture of transcription during the asexual cycle of malaria parasites. As in mammals, transcription is organized into discrete nucleoplasmic sites in P. falciparum, but in a strikingly lower number of foci. An automated analysis of 3D images shows that the number and intensity of transcription sites vary significantly between rings and trophozoites, although the nuclear volume remains constant. Transcription sites are spatially reorganized during the asexual cycle, with a higher proportion of foci located in the outermost nuclear region in rings, whereas in trophozoites, foci are evenly distributed throughout the nucleoplasm. As in higher eukaryotes, transcription sites are predominantly found in areas of low chromatin density. Immunofluorescence analysis shows that transcription sites form an exclusive nuclear compartment, different from the compartments defined by the silenced or active chromatin markers. In conclusion, these data suggest that transcription is spatially contained in discrete foci that are developmentally regulated during the asexual cycle of malaria parasites and located in areas of low chromatin density.	[Moraes, Carolina B.; Contreras-Dominguez, Monica; Dossin, Fernando de M.; Freitas-Junior, Lucio H.] Inst Pasteur Korea, CND3, Gyeonggi Do, South Korea; [Dorval, Thierry] Inst Pasteur Korea, Cell Differentiat & Tox Grp, Gyeonggi Do, South Korea; [Hansen, Michael A. E.; Genovesio, Auguste] Inst Pasteur Korea, Image Min Grp, Gyeonggi Do, South Korea	Institut Pasteur Korea; Institut Pasteur Korea; Institut Pasteur Korea	Freitas-Junior, LH (corresponding author), Inst Pasteur Korea, CND3, Gyeonggi Do, South Korea.	freitasjunior@ip-korea.org	Hansen, Michael Adsetts Edberg/C-9028-2011; Moraes, Carolina Borsoi/I-4408-2014; Freitas-Junior, Lucio H/C-8677-2011; GENOVESIO, Auguste/I-1656-2017	Hansen, Michael Adsetts Edberg/0000-0001-7879-2106; Moraes, Carolina Borsoi/0000-0002-0689-2770; Freitas-Junior, Lucio H/0000-0002-8904-7897; Genovesio, Auguste/0000-0003-1877-5595	National Research Foundation of Korea (NRF); Korea government (MEST), Gyeonggi-do [2012-00011]; KISTI	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST), Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST - grant no. 2012-00011), Gyeonggi-do and KISTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bystricky K, 2009, MOL CELL BIOL, V29, P835, DOI 10.1128/MCB.01009-08; Callebaut I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-100; Cmarko D, 2000, HISTOCHEM CELL BIOL, V113, P181, DOI 10.1007/s004180050437; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Dorval T, 2009, I S BIOMED IMAGING, P1119, DOI 10.1109/ISBI.2009.5193253; Dossin FD, 2005, EUKARYOT CELL, V4, P960, DOI 10.1128/EC.4.5.960-970.2005; Dossin FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002313; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Eskiw CH, 2008, J CELL SCI, V121, P1999, DOI 10.1242/jcs.027250; Faro-Trindade I, 2006, MOL BIOL CELL, V17, P2910, DOI 10.1091/mbc.E05-11-1024; Figueiredo LM, 2005, NUCLEIC ACIDS RES, V33, P1111, DOI 10.1093/nar/gki260; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; Gopalakrishnan AM, 2009, EXP PARASITOL, V121, P46, DOI 10.1016/j.exppara.2008.09.016; GRITZMACHER CA, 1984, J BACTERIOL, V160, P1165, DOI 10.1128/JB.160.3.1165-1167.1984; Hazoume A, 2011, MOL BIOCHEM PARASIT, V176, P127, DOI 10.1016/j.molbiopara.2010.12.013; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Iborra FJ, 1996, J CELL SCI, V109, P1427; Issar N, 2009, MICROBES INFECT, V11, P403, DOI 10.1016/j.micinf.2008.12.010; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Kishore SP, 2009, J MOL EVOL, V68, P706, DOI 10.1007/s00239-009-9245-2; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Llinas M, 2008, TRENDS PARASITOL, V24, P551, DOI 10.1016/j.pt.2008.08.010; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mancio-Silva L, 2008, J CELL SCI, V121, P2046, DOI 10.1242/jcs.026427; Mancio-Silva L, 2010, P NATL ACAD SCI USA, V107, P15117, DOI 10.1073/pnas.1001045107; Marty AJ, 2006, MOL MICROBIOL, V62, P72, DOI 10.1111/j.1365-2958.2006.05364.x; Papantonis A, 2010, CURR OPIN CELL BIOL, V22, P271, DOI 10.1016/j.ceb.2010.03.004; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Ruvalcaba-Salazar OK, 2005, MOL BIOCHEM PARASIT, V140, P183, DOI 10.1016/j.molbiopara.2005.01.002; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Shiels C, 2007, PLOS COMPUT BIOL, V3, P1161, DOI 10.1371/journal.pcbi.0030138; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; Volz J, 2010, INT J PARASITOL, V40, P109, DOI 10.1016/j.ijpara.2009.09.002; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Zirbel RM, 1993, CHROMOSOME RES, V1, P93, DOI 10.1007/BF00710032	45	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55539	10.1371/journal.pone.0055539	http://dx.doi.org/10.1371/journal.pone.0055539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408998	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200037
J	Adkins, DE; Souza, RP; Aberg, K; Clark, SL; McClay, JL; Sullivan, PF; van den Oord, EJCG				Adkins, Daniel E.; Souza, Renan P.; Aberg, Karolina; Clark, Shaunna L.; McClay, Joseph L.; Sullivan, Patrick F.; van den Oord, Edwin J. C. G.			Genotype-Based Ancestral Background Consistently Predicts Efficacy and Side Effects across Treatments in CATIE and STAR*D	PLOS ONE			English	Article							NUCLEOTIDE-POLYMORPHISM PANEL; FALSE DISCOVERY RATE; GENOMEWIDE ASSOCIATION; SCHIZOPHRENIA; OUTCOMES; RACE; CARE	Only a subset of patients will typically respond to any given prescribed drug. The time it takes clinicians to declare a treatment ineffective leaves the patient in an impaired state and at unnecessary risk for adverse drug effects. Thus, diagnostic tests robustly predicting the most effective and safe medication for each patient prior to starting pharmacotherapy would have tremendous clinical value. In this article, we evaluated the use of genetic markers to estimate ancestry as a predictive component of such diagnostic tests. We first estimated each patient's unique mosaic of ancestral backgrounds using genome-wide SNP data collected in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) (n = 765) and the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) (n = 1892). Next, we performed multiple regression analyses to estimate the predictive power of these ancestral dimensions. For 136/89 treatment-outcome combinations tested in CATIE/STAR*D, results indicated 1.67/1.84 times higher median test statistics than expected under the null hypothesis assuming no predictive power (p<0.01, both samples). Thus, ancestry showed robust and pervasive correlations with drug efficacy and side effects in both CATIE and STAR*D. Comparison of the marginal predictive power of MDS ancestral dimensions and self-reported race indicated significant improvements to model fit with the inclusion of MDS dimensions, but mixed evidence for self-reported race. Knowledge of each patient's unique mosaic of ancestral backgrounds provides a potent immediate starting point for developing algorithms identifying the most effective and safe medication for a wide variety of drug-treatment response combinations. As relatively few new psychiatric drugs are currently under development, such personalized medicine offers a promising approach toward optimizing pharmacotherapy for psychiatric conditions.	[Adkins, Daniel E.; Souza, Renan P.; Aberg, Karolina; Clark, Shaunna L.; McClay, Joseph L.; van den Oord, Edwin J. C. G.] Virginia Commonwealth Univ, Med Coll Virginia, Sch Pharm, Ctr Biomarker Res & Personalized Med, Richmond, VA 23298 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	van den Oord, EJCG (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Sch Pharm, Ctr Biomarker Res & Personalized Med, Richmond, VA 23298 USA.	ejvandenoord@vcu.edu	Souza, Renan Pedra de/G-8394-2011; Aberg, Karolina/A-6772-2010; McClay, Joseph/C-9931-2009	Souza, Renan Pedra de/0000-0002-9479-4432; Aberg, Karolina/0000-0001-6103-5168; McClay, Joseph/0000-0002-3628-2447	National Institute of Mental Health (NIMH) [R01MH078069, K01MH093731, R01MH080403, MH080403]; Eli Lily; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078069, R01MH080403, K01MH093731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA021266] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eli Lily; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	EvdO is partially supported by grants R01MH078069, DEA by K01MH093731 and PFS by R01MH080403 from the National Institute of Mental Health (NIMH). Eli Lily funded part of the genotyping conducted in the CATIE sample. PFS reports receiving research funding from Eli Lilly. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. EvdO is partially supported by grants R01MH078069 and PFS by MH080403 from the National Institute of Mental Health (NIMH). Eli Lily funded part of the genotyping conducted in the CATIE sample. PFS reports receiving research funding from Eli Lilly. No additional external funding was received for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aberg K, 2010, PHARMACOGENOMICS J; Aberg K, 2010, BIOL PSYCHIAT, V67, P279, DOI 10.1016/j.biopsych.2009.08.036; Adkins DE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.57; Adkins DE, 2011, MOL PSYCHIATR, V16, P321, DOI 10.1038/mp.2010.14; Adkins DE, 2012, SCHIZOPHR RES, V135, P200, DOI 10.1016/j.schres.2011.11.002; Adkins Daniel E, 2010, Biol Psychiatry, V68, pe25, DOI 10.1016/j.biopsych.2010.05.018; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braff DL, 2008, AM J PSYCHIAT, V165, P952, DOI 10.1176/appi.ajp.2008.08050717; Clark SL, 2012, PSYCHOL MED, V42, P1151, DOI 10.1017/S003329171100239X; Clark SL, 2011, SCHIZOPHR RES, V132, P114, DOI 10.1016/j.schres.2011.07.031; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Couzin J, 2008, SCIENCE, V319, P274, DOI 10.1126/science.319.5861.274; Crowley JJ, 2009, PHARMACOGENOMICS, V10, P161, DOI 10.2217/14622416.10.2.161; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029; Holden C, 2003, SCIENCE, V302, P594, DOI 10.1126/science.302.5645.594; Karter AJ, 2003, INT J EPIDEMIOL, V32, P26, DOI 10.1093/ije/dyg033; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; McClay JL, 2011, MOL PSYCHIATR, V16, P76, DOI 10.1038/mp.2009.89; McClay JL, 2011, NEUROPSYCHOPHARMACOL, V36, P616, DOI 10.1038/npp.2010.193; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Paul D, 2008, ANN STAT, V36, P1595, DOI 10.1214/009053607000000578; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson G.K., 1991, STAT SCI, P15, DOI DOI 10.1214/SS/1177011926; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Simon GE, 2001, ARCH GEN PSYCHIAT, V58, P395, DOI 10.1001/archpsyc.58.4.395; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Stroup TS, 2003, SCHIZOPHRENIA BULL, V29, P15, DOI 10.1093/oxfordjournals.schbul.a006986; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; van den Oord EJCG, 2009, SCHIZOPHR RES, V107, P13, DOI 10.1016/j.schres.2008.09.009; Williams DR, 2010, J HEALTH SOC BEHAV, V51, pS15, DOI 10.1177/0022146510383838; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	43	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55239	10.1371/journal.pone.0055239	http://dx.doi.org/10.1371/journal.pone.0055239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405125	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400070
J	Callahan, DM; Umberger, BR; Kent-Braun, JA				Callahan, Damien M.; Umberger, Brian R.; Kent-Braun, Jane A.			A Computational Model of Torque Generation: Neural, Contractile, Metabolic and Musculoskeletal Components	PLOS ONE			English	Article							RATE CODING ORGANIZATION; HUMAN SKELETAL-MUSCLE; HUMAN MOTOR UNITS; TIBIALIS ANTERIOR; MOMENT ARM; MATHEMATICAL-MODEL; ATP SYNTHESIS; TIME-COURSE; FATIGUE; RECRUITMENT	The pathway of voluntary joint torque production includes motor neuron recruitment and rate-coding, sarcolemmal depolarization and calcium release by the sarcoplasmic reticulum, force generation by motor proteins within skeletal muscle, and force transmission by tendon across the joint. The direct source of energetic support for this process is ATP hydrolysis. It is possible to examine portions of this physiologic pathway using various in vivo and in vitro techniques, but an integrated view of the multiple processes that ultimately impact joint torque remains elusive. To address this gap, we present a comprehensive computational model of the combined neuromuscular and musculoskeletal systems that includes novel components related to intracellular bioenergetics function. Components representing excitatory drive, muscle activation, force generation, metabolic perturbations, and torque production during voluntary human ankle dorsiflexion were constructed, using a combination of experimentally-derived data and literature values. Simulation results were validated by comparison with torque and metabolic data obtained in vivo. The model successfully predicted peak and submaximal voluntary and electrically-elicited torque output, and accurately simulated the metabolic perturbations associated with voluntary contractions. This novel, comprehensive model could be used to better understand impact of global effectors such as age and disease on various components of the neuromuscular system, and ultimately, voluntary torque output.	[Callahan, Damien M.; Umberger, Brian R.; Kent-Braun, Jane A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Callahan, DM (corresponding author), Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA.	dmcallah@uvm.edu		Umberger, Brian/0000-0002-5780-2405	National Insitutes of Health [K02A6023582]; Faculty Research Grant, University of Massachusetts Amherst; NATIONAL INSTITUTE ON AGING [K02AG023582] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty Research Grant, University of Massachusetts Amherst; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided in part by the following funding sources: National Insitutes of Health K02A6023582 (JAKB) and a Faculty Research Grant, University of Massachusetts Amherst (BRU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHASIOTIS D, 1982, J APPL PHYSIOL, V53, P708, DOI 10.1152/jappl.1982.53.3.708; Connelly DM, 1999, J APPL PHYSIOL, V87, P843, DOI 10.1152/jappl.1999.87.2.843; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; Debold EP, 2008, AM J PHYSIOL-CELL PH, V295, pC173, DOI 10.1152/ajpcell.00172.2008; Debold EP, 2006, AM J PHYSIOL-CELL PH, V290, pC1041, DOI 10.1152/ajpcell.00342.2005; Ding J, 2002, IEEE T NEUR SYS REH, V10, P48, DOI 10.1109/TNSRE.2002.1021586; Dudel J, 2009, EUR J NEUROSCI, V30, P1219, DOI 10.1111/j.1460-9568.2009.06915.x; Fortune E, 2009, ANN BIOMED ENG, V37, P2105, DOI 10.1007/s10439-009-9756-4; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; Fuglevand AJ, 1997, J APPL PHYSIOL, V83, P1223, DOI 10.1152/jappl.1997.83.4.1223; Giat Y, 1996, J BIOMECH ENG-T ASME, V118, P357, DOI 10.1115/1.2796018; GUSTAFSSON B, 1984, J PHYSIOL-LONDON, V357, P453, DOI 10.1113/jphysiol.1984.sp015511; HANSON J, 1953, NATURE, V172, P530, DOI 10.1038/172530b0; HARRIS RC, 1974, SCAND J CLIN LAB INV, V33, P109; Hasson CJ, 2009, EXP BRAIN RES, V196, P413, DOI 10.1007/s00221-009-1865-7; HAWKINS DA, 1992, J BIOMECH, V25, P1467, DOI 10.1016/0021-9290(92)90059-A; HE JP, 1991, IEEE T AUTOMAT CONTR, V36, P322, DOI 10.1109/9.73565; HILL AV, 1949, PROC R SOC SER B-BIO, V136, P195, DOI 10.1098/rspb.1949.0019; HILL TL, 1983, BIOPHYS J, V44, P383, DOI 10.1016/S0006-3495(83)84312-4; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY HE, 1957, J BIOPHYS BIOCHEM CY, V3, P631, DOI 10.1083/jcb.3.5.631; Jeneson JAL, 2009, AM J PHYSIOL-ENDOC M, V297, pE774, DOI 10.1152/ajpendo.00370.2009; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kemp GJ, 2001, J PHYSIOL-LONDON, V535, P901, DOI 10.1111/j.1469-7793.2001.00901.x; Kent-Braun JA, 1999, J APPL PHYSIOL, V87, P22, DOI 10.1152/jappl.1999.87.1.22; Kent-Braun JA, 2000, J APPL PHYSIOL, V88, P662, DOI 10.1152/jappl.2000.88.2.662; Kent-Braun JA, COMPREHENSIVE PHYSL, P997; KENTBRAUN JA, 1993, J APPL PHYSIOL, V75, P573, DOI 10.1152/jappl.1993.75.2.573; Lanza IR, 2007, J PHYSIOL-LONDON, V583, P1093, DOI 10.1113/jphysiol.2007.138362; Lanza IR, 2005, J APPL PHYSIOL, V99, P1736, DOI 10.1152/japplphysiol.00566.2005; Lanza IR, 2006, J PHYSL; Linari M, 2010, P ROY SOC B-BIOL SCI, V277, P19, DOI 10.1098/rspb.2009.1498; Maganaris CN, 1999, CLIN BIOMECH, V14, P661, DOI 10.1016/S0268-0033(99)00018-2; Maganaris CN, 2004, J THEOR BIOL, V230, P89, DOI 10.1016/j.jtbi.2004.04.025; Maganaris CN, 2004, EUR J APPL PHYSIOL, V91, P130, DOI 10.1007/s00421-003-1033-x; MARTONOSI AN, 1984, PHYSIOL REV, V64, P1240, DOI 10.1152/physrev.1984.64.4.1240; MELZER W, 1984, BIOPHYS J, V45, P637, DOI 10.1016/S0006-3495(84)84203-4; MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P371, DOI 10.1113/jphysiol.1973.sp010193; MOON RB, 1973, J BIOL CHEM, V248, P7276; NARICI MV, 1989, EUR J APPL PHYSIOL O, V59, P310, DOI 10.1007/BF02388334; Oya T, 2009, J PHYSIOL-LONDON, V587, P4737, DOI 10.1113/jphysiol.2009.175695; Quinonez M, 2010, J MUSCLE RES CELL M, V31, P13, DOI 10.1007/s10974-009-9195-8; REN JM, 1988, ACTA PHYSIOL SCAND, V133, P101, DOI 10.1111/j.1748-1716.1988.tb08386.x; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; Shorten PR, 2007, J MUSCLE RES CELL M, V28, P293, DOI 10.1007/s10974-007-9125-6; Tevald MA, 2010, AM J PHYSIOL-REG I, V298, pR729, DOI 10.1152/ajpregu.00713.2009; TROUP JP, 1986, J APPL PHYSIOL, V60, P1743, DOI 10.1152/jappl.1986.60.5.1743; Umberger BR, 2011, P C INT SOC BIOM; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; VanCutsem M, 1997, CAN J APPL PHYSIOL, V22, P585, DOI 10.1139/h97-038; VANSOEST AJ, 1993, J BIOMECH, V26, P1, DOI 10.1016/0021-9290(93)90608-H; Walter G, 1999, J PHYSIOL-LONDON, V519, P901, DOI 10.1111/j.1469-7793.1999.0901n.x; Wexler AS, 1997, IEEE T BIO-MED ENG, V44, P337, DOI 10.1109/10.568909; Xia T, 2008, J BIOMECH, V41, P3046, DOI 10.1016/j.jbiomech.2008.07.013; Yoshitake Y, 2008, J NEUROSCI METH, V173, P271, DOI 10.1016/j.jneumeth.2008.06.022	56	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56013	10.1371/journal.pone.0056013	http://dx.doi.org/10.1371/journal.pone.0056013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405245	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400190
J	Castro, B; Sanchez, P; Torres, JM; Preda, O; del Moral, RG; Ortega, E				Castro, Beatriz; Sanchez, Pilar; Torres, Jesus M.; Preda, Ovidiu; del Moral, Raimundo G.; Ortega, Esperanza			Bisphenol A Exposure during Adulthood Alters Expression of Aromatase and 5 alpha-Reductase Isozymes in Rat Prostate	PLOS ONE			English	Article							ESTROGEN; HYPERPLASIA; MECHANISMS; CARCINOGENESIS; GLYCOSYLATION; DUTASTERIDE; INHIBITION; ESTRADIOL; CHEMICALS; DOLICHOL	The high incidence of prostate cancer (PCa) and benign prostatic hypertrophy (BPH) in elderly men is a cause of increasing public health concern. In recent years, various environmental endocrine disruptors, such as bisphenol A (BPA), have been shown to disrupt sexual organs, including the prostate gland. However, the mechanisms underlying these effects remain unclear. Because androgens and estrogens are important factors in prostate physiopathology, our objective was to examine in rat ventral prostate the effects of adult exposure to BPA on 5 alpha-Reductase isozymes (5 alpha-R types 1, 2, and 3) and aromatase, key enzymes in the biosynthesis of dihydrotestosterone and estradiol, respectively. Adult rats were subcutaneously injected for four days with BPA (25, 50, 300, or 600 mu g/Kg/d) dissolved in vehicle. Quantitative RT-PCR, western blot and immunohistochemical analyses showed lower mRNA and protein levels of 5 alpha-R1 and 5 alpha-R2 in BPA-treated groups versus controls but higher mRNA levels of 5 alpha-R3, recently proposed as a biomarker of malignancy. However, BPA treatment augmented mRNA and protein levels of aromatase, whose increase has been described in prostate diseases. BPA-treated rats also evidenced a higher plasma estradiol/testosterone ratio, which is associated with prostate disease. Our results may offer new insights into the role of BPA in the development of prostate disease and may be of great value for studying the prostate disease risk associated with exposure to BPA in adulthood.	[Castro, Beatriz; Sanchez, Pilar; Torres, Jesus M.; Ortega, Esperanza] Univ Granada, Sch Med, Dept Biochem & Mol Biol, Granada, Spain; [Torres, Jesus M.; Ortega, Esperanza] Univ Granada, Sch Med, Inst Neurosci, Granada, Spain; [Preda, Ovidiu; del Moral, Raimundo G.] Univ Granada, Sch Med, Dept Pathol, Granada, Spain; [Preda, Ovidiu; del Moral, Raimundo G.] Univ Granada, IBIMER, Granada, Spain	University of Granada; University of Granada; University of Granada; University of Granada	Ortega, E (corresponding author), Univ Granada, Sch Med, Dept Biochem & Mol Biol, Granada, Spain.	esortega@ugr.es	Torres, Jesus M/B-3634-2011		European Fund of Regional Development [FEDER-BFU2008-05340]	European Fund of Regional Development	The source of funding that has supported the work is European Fund of Regional Development (FEDER-BFU2008-05340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akingbemi BT, 2004, ENDOCRINOLOGY, V145, P592, DOI 10.1210/en.2003-1174; Arase S, 2011, BIOL REPROD, V84, P734, DOI 10.1095/biolreprod.110.087502; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Chitra KC, 2003, TOXICOLOGY, V185, P119, DOI 10.1016/S0300-483X(02)00597-8; Cooperberg MR, 2005, J CLIN ONCOL, V23, P8146, DOI 10.1200/JCO.2005.02.9751; De Flora S, 2011, TOXICOL SCI, V122, P45, DOI 10.1093/toxsci/kfr096; Ellem SJ, 2004, J CLIN ENDOCR METAB, V89, P2434, DOI 10.1210/jc.2003-030933; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Godoy A, 2011, PROSTATE, V71, P1033, DOI 10.1002/pros.21318; Goodson A, 2004, FOOD ADDIT CONTAM A, V21, P1015, DOI 10.1080/02652030400011387; Ho CKM, 2011, NAT REV UROL, V8, P29, DOI 10.1038/nrurol.2010.207; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Imamoto T, 2009, FUTURE ONCOL, V5, P1005, DOI 10.2217/FON.09.82; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Kamat A, 2002, TRENDS ENDOCRIN MET, V13, P122, DOI 10.1016/S1043-2760(02)00567-2; Kaplan SA, 2012, J UROLOGY, V187, P584, DOI 10.1016/j.juro.2011.10.106; Kwintkiewicz J, 2010, ENVIRON HEALTH PERSP, V118, P400, DOI 10.1289/ehp.0901161; Li J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025777, 10.1371/journal.pone.0028840, 10.1371/journal.pone.0027198]; Morava E, 2010, BRAIN, V133, P3210, DOI 10.1093/brain/awq261; Nelles JL, 2011, EXPERT REV ENDOCRINO, V6, P437, DOI 10.1586/EEM.11.20; Nicholson TM, 2011, DIFFERENTIATION, V82, P184, DOI 10.1016/j.diff.2011.04.006; Ogura Y, 2007, DIFFERENTIATION, V75, P745, DOI 10.1111/j.1432-0436.2007.00177.x; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; ORTEGA E, 1979, EXPERIENTIA, V35, P844, DOI 10.1007/BF01968288; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Ricke WA, 2008, FASEB J, V22, P1512, DOI 10.1096/fj.07-9526com; Rittmaster R, 2008, UROLOGY, V72, P808, DOI 10.1016/j.urology.2008.06.032; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SANTTI R, 1994, PROSTATE, V24, P67, DOI 10.1002/pros.2990240204; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Span PN, 1996, EUR J ENDOCRINOL, V134, P386, DOI 10.1530/eje.0.1340386; Takao T, 1999, LIFE SCI, V65, P2351, DOI 10.1016/S0024-3205(99)00502-0; Tan M. Ozgur, 2003, International Urology and Nephrology, V35, P357, DOI 10.1023/B:UROL.0000022909.57112.3e; Taylor JA, 2011, J STEROID BIOCHEM, V127, P83, DOI 10.1016/j.jsbmb.2011.07.005; Thomas LN, 2005, PROSTATE, V63, P231, DOI 10.1002/pros.20188; Torres JM, 2003, PROSTATE, V56, P74, DOI 10.1002/pros.10221; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; vomSaal FS, 1997, P NATL ACAD SCI USA, V94, P2056; Walker DM, 2011, NAT REV ENDOCRINOL, V7, P197, DOI 10.1038/nrendo.2010.215; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Xi W, 2011, REPROD TOXICOL, V31, P409, DOI 10.1016/j.reprotox.2010.12.002; Ye LP, 2011, TOXICOL LETT, V207, P137, DOI 10.1016/j.toxlet.2011.09.001	48	76	79	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55905	10.1371/journal.pone.0055905	http://dx.doi.org/10.1371/journal.pone.0055905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405234	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400179
J	Gianforcaro, A; Solomon, JA; Hamadeh, MJ				Gianforcaro, Alexandro; Solomon, Jesse A.; Hamadeh, Mazen J.			Vitamin D-3 at 50x AI Attenuates the Decline in Paw Grip Endurance, but Not Disease Outcomes, in the G93A Mouse Model of ALS, and Is Toxic in Females	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; RECEPTOR KNOCKOUT MICE; CENTRAL-NERVOUS-SYSTEM; 1,25-DIHYDROXYVITAMIN D-3; CALCIUM SUPPLEMENTATION; CALORIC RESTRICTION; MESSENGER-RNA; GROWTH-FACTOR	Background: We previously demonstrated that dietary vitamin D-3 at 10x the adequate intake (AI) attenuates the decline in functional capacity in the G93A mouse model of ALS. We hypothesized that higher doses would elicit more robust changes in functional and disease outcomes. Objective: To determine the effects of dietary vitamin D-3 at 50xAI on functional outcomes (motor performance, paw grip endurance) and disease severity (clinical score), as well as disease onset, disease progression and lifespan in the transgenic G93A mouse model of ALS. Methods: Starting at age 25 d, 100 G93A mice (55 M, 45 F) were provided ad libitum with either an adequate (AI; 1 IU D-3/g feed) or high (HiD; 50 IU D-3/g feed) vitamin D-3 diet. Results: HiD females consumed 9% less food corrected for body weight vs. AI females (P = 0.010). HiD mice had a 12% greater paw grip endurance over time between age 60-141 d (P = 0.015), and a 37% greater score during disease progression (P = 0.042) vs. AI mice. Although HiD females had a non-significant 31% greater CS prior to disease onset vs. AI females, they exhibited a significant 20% greater paw grip endurance AUC (P = 0.020) when corrected for clinical score. Conclusion: Dietary D-3 supplementation at 50x the adequate intake attenuated the decline in paw grip endurance, but did not influence age at disease onset, hindlimb paralysis or endpoint in the transgenic G93A mouse model of ALS. Furthermore, females may have reached the threshold for vitamin D-3 toxicity as evidence by reduced food intake and greater disease severity prior to disease onset.	[Gianforcaro, Alexandro; Solomon, Jesse A.; Hamadeh, Mazen J.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Gianforcaro, Alexandro; Solomon, Jesse A.; Hamadeh, Mazen J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Hamadeh, Mazen J.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	York University - Canada; York University - Canada; McMaster University	Hamadeh, MJ (corresponding author), York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	hamadeh@yorku.ca		Hamadeh, Mazen/0000-0002-3511-4345	Natural Sciences and Engineering Research Council of Canada [341445]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding provided by the Natural Sciences and Engineering Research Council of Canada - #341445. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIERI JG, 1977, J NUTR, V107, P1394; BIRGE SJ, 1975, J CLIN INVEST, V56, P1100, DOI 10.1172/JCI108184; Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844; Broe KE, 2007, J AM GERIATR SOC, V55, P234, DOI 10.1111/j.1532-5415.2007.01048.x; Burne THJ, 2006, BRAIN RES BULL, V69, P74, DOI 10.1016/j.brainresbull.2005.10.014; Burne THJ, 2005, BEHAV BRAIN RES, V157, P299, DOI 10.1016/j.bbr.2004.07.008; Cantorna MT, 1999, J NUTR, V129, P1966, DOI 10.1093/jn/129.11.1966; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cornet A, 1998, J NEUROSCI RES, V53, P742, DOI 10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#; Endo I, 2003, ENDOCRINOLOGY, V144, P5138, DOI 10.1210/en.2003-0502; Enomoto T, 2010, J BONE MINER METAB; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Fleet JC, 2008, J NUTR, V138, P1114, DOI 10.1093/jn/138.6.1114; Garcion E, 1997, MOL BRAIN RES, V45, P255, DOI 10.1016/S0169-328X(96)00260-4; Gianforcaro A, 2012, CNS NEUROSCI THER, V18, P547, DOI 10.1111/j.1755-5949.2012.00316.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Hamadeh MJ, 2006, MUSCLE NERVE, V34, P709, DOI 10.1002/mus.20630; Hamadeh MJ, 2005, MUSCLE NERVE, V31, P214, DOI 10.1002/mus.20255; Hamden K, 2009, J NUTR SCI VITAMINOL, V55, P215, DOI 10.3177/jnsv.55.215; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; HUGHES MR, 1977, ENDOCRINOLOGY, V100, P799, DOI 10.1210/endo-100-3-799; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Minasyan A, 2009, J STEROID BIOCHEM, V114, P161, DOI 10.1016/j.jsbmb.2009.01.020; Nashold FE, 2009, J IMMUNOL, V183, P3672, DOI 10.4049/jimmunol.0901351; Nataf S, 1996, J NEUROPATH EXP NEUR, V55, P904, DOI 10.1097/00005072-199608000-00006; National Research Council (NRC), 1995, NUTR REQ LAB AN, DOI [10.17226/4758, DOI 10.17226/4758]; Naveilhan P, 1996, NEUROREPORT, V7, P2171, DOI 10.1097/00001756-199609020-00023; NEVEU I, 1994, MOL BRAIN RES, V24, P70, DOI 10.1016/0169-328X(94)90119-8; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Patel BP, 2009, CLIN NUTR, V28, P604, DOI 10.1016/j.clnu.2009.06.002; Pfeifer M, 2009, OSTEOPOROSIS INT, V20, P315, DOI 10.1007/s00198-008-0662-7; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; Prufer K, 1999, J CHEM NEUROANAT, V16, P135, DOI 10.1016/S0891-0618(99)00002-2; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ross AC, 2011, J AM DIET ASSOC, V111, P524, DOI 10.1016/j.jada.2011.01.004; Rowling MJ, 2007, J NUTR, V137, P2608, DOI 10.1093/jn/137.12.2608; Sanchez B, 2002, MOL BRAIN RES, V108, P143, DOI 10.1016/S0169-328X(02)00545-4; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; SAPORITO MS, 1994, BRAIN RES, V633, P189, DOI 10.1016/0006-8993(94)91539-3; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; SILVA ME, 1993, COMP BIOCHEM PHYS A, V104, P175, DOI 10.1016/0300-9629(93)90026-Z; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029354; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020582; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Taniura H, 2006, J NEUROSCI RES, V83, P1179, DOI 10.1002/jnr.20824; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Veenstra TD, 1997, BIOCHEM BIOPH RES CO, V235, P15, DOI 10.1006/bbrc.1997.6718; Vieth R, 2000, J NUTR, V130, P578, DOI 10.1093/jn/130.3.578; Vucic S, 2009, CURR MOL MED, V9, P255, DOI 10.2174/156652409787847173; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Zhang ZL, 2011, ENDOCR RES, V36, P101, DOI 10.3109/07435800.2010.542415	56	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e30243	10.1371/journal.pone.0030243	http://dx.doi.org/10.1371/journal.pone.0030243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405058	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400001
J	Guasch, L; Sala, E; Mulero, M; Valls, C; Salvado, MJ; Pujadas, G; Garcia-Vallve, S				Guasch, Laura; Sala, Esther; Mulero, Miquel; Valls, Cristina; Josepa Salvado, Maria; Pujadas, Gerard; Garcia-Vallve, Santiago			Identification of PPARgamma Partial Agonists of Natural Origin (II): In Silico Prediction in Natural Extracts with Known Antidiabetic Activity	PLOS ONE			English	Article							INDUCED-DIABETIC-RATS; HYPOGLYCEMIC ACTIVITY; CRYPTOLEPIS-SANGUINOLENTA; ANGELICA-KEISKEI; PPAR-GAMMA; SCUTELLARIA-BAICALENSIS; SALVIA-MILTIORRHIZA; MEDICINAL-PLANTS; DRUG DISCOVERY; GLUCOSE-UPTAKE	Background: Natural extracts have played an important role in the prevention and treatment of diseases and are important sources for drug discovery. However, to be effectively used in these processes, natural extracts must be characterized through the identification of their active compounds and their modes of action. Methodology/Principal Findings: From an initial set of 29,779 natural products that are annotated with their natural source and using a previously developed virtual screening procedure (carefully validated experimentally), we have predicted as potential peroxisome proliferators-activated receptor gamma (PPAR gamma) partial agonists 12 molecules from 11 extracts known to have antidiabetic activity. Six of these molecules are similar to molecules with described antidiabetic activity but whose mechanism of action is unknown. Therefore, it is plausible that these 12 molecules could be the bioactive molecules responsible, at least in part, for the antidiabetic activity of the extracts containing them. In addition, we have also identified as potential PPAR gamma partial agonists 10 molecules from 16 plants with undescribed antidiabetic activity but that are related (i.e., they are from the same genus) to plants with known antidiabetic properties. None of the 22 molecules that we predict as PPAR gamma partial agonists show chemical similarity with a group of 211 known PPAR gamma partial agonists obtained from the literature. Conclusions/Significance: Our results provide a new hypothesis about the active molecules of natural extracts with antidiabetic properties and their mode of action. We also suggest plants with undescribed antidiabetic activity that may contain PPAR gamma partial agonists. These plants represent a new source of potential antidiabetic extracts. Consequently, our work opens the door to the discovery of new antidiabetic extracts and molecules that can be of use, for instance, in the design of new antidiabetic drugs or functional foods focused towards the prevention/treatment of type 2 Diabetes Mellitus.	[Guasch, Laura; Sala, Esther; Mulero, Miquel; Valls, Cristina; Josepa Salvado, Maria; Pujadas, Gerard; Garcia-Vallve, Santiago] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigenom, Tarragona, Catalonia, Spain; [Pujadas, Gerard; Garcia-Vallve, Santiago] CEICS, TECNIO, CTNS, Reus, Catalonia, Spain	Universitat Rovira i Virgili	Garcia-Vallve, S (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigenom, Tarragona, Catalonia, Spain.	santi.garcia-vallve@urv.cat	PUJADAS, GERARD/W-9348-2019; Garcia-Vallve, Santi/A-4226-2008; Sala, Esther/AAB-4997-2022; Valls-Bautista, Cristina/K-8769-2014; Salvado, M. Josepa/B-6062-2015; Pujadas, Gerard/B-1457-2010; Mulero, Miquel/L-4672-2014	PUJADAS, GERARD/0000-0003-2598-8089; Garcia-Vallve, Santi/0000-0002-0348-7497; Valls-Bautista, Cristina/0000-0001-5583-5695; Salvado, M. Josepa/0000-0003-3883-3326; Pujadas, Gerard/0000-0003-2598-8089; Mulero, Miquel/0000-0003-2545-2065; Sala, Esther/0000-0002-5149-1992; Guasch, Laura/0000-0003-4990-7765	"Ministerio de Educacion y Ciencia'' of the Spanish Government [AGL2008-00387/ALI, AGL2011-25831/ALI]; Generalitat de Catalunya [ACC1O (TECCT11-1-0012)]; XRQTC grant from the "Generalitat de Catalunya''	"Ministerio de Educacion y Ciencia'' of the Spanish Government(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); XRQTC grant from the "Generalitat de Catalunya''	This study was supported by grants AGL2008-00387/ALI and AGL2011-25831/ALI from the "Ministerio de Educacion y Ciencia'' of the Spanish Government and the ACC1O (TECCT11-1-0012) program and XRQTC grant from the "Generalitat de Catalunya''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor Gabriel A, 2007, Pak J Biol Sci, V10, P537, DOI 10.3923/pjbs.2007.537.544; ARAI K, 1981, CHEM PHARM BULL, V29, P1005; Arredondo MF, 2004, J ETHNOPHARMACOL, V91, P13, DOI 10.1016/j.jep.2003.11.012; Aslan M, 2007, J ETHNOPHARMACOL, V109, P54, DOI 10.1016/j.jep.2006.07.001; BASNET P, 1995, PLANTA MED, V61, P402, DOI 10.1055/s-2006-958124; BASNET P, 1994, PLANTA MED, V60, P507, DOI 10.1055/s-2006-959560; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bierer DE, 1998, J MED CHEM, V41, P2754, DOI 10.1021/jm970735n; BLASKO G, 1988, J ORG CHEM, V53, P6113, DOI 10.1021/jo00261a026; Bnouham M, 2006, INT J DIABETES METAB, V14, P1; BRIGGS LH, 1950, J CHEM SOC, P2376, DOI 10.1039/jr9500002376; Budantsev, 1993, CHEM NAT COMPD, V29, P133, DOI [DOI 10.1007/BF00631041, 10.1007/BF00631041]; CHANDRASEKAR B, 1990, INDIAN J EXP BIOL, V28, P616; Chang FR, 1998, PHYTOCHEMISTRY, V49, P2015, DOI 10.1016/S0031-9422(98)00376-8; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Christensen KB, 2009, PHYTOTHER RES, V23, P1316, DOI 10.1002/ptr.2782; Cousins KR, 2011, J AM CHEM SOC, V133, P8388, DOI 10.1021/ja204075s; Dewi Rizna T, 2007, Pak J Biol Sci, V10, P3131, DOI 10.3923/pjbs.2007.3131.3135; Dey D, 2003, METABOLISM, V52, P1012, DOI 10.1016/S0026-0495(03)00152-5; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Eidi M, 2005, J ETHNOPHARMACOL, V100, P310, DOI 10.1016/j.jep.2005.03.008; El-Lakany AM, 2003, PHARMAZIE, V58, P75; Enoki T, 2007, J AGR FOOD CHEM, V55, P6013, DOI 10.1021/jf070720q; Fakhrudin N, 2010, MOL PHARMACOL, V77, P559, DOI 10.1124/mol.109.062141; Feldman PL, 2008, CURR TOP MED CHEM, V8, P728, DOI 10.2174/156802608784535084; FERNANDO MR, 1990, GEN PHARMACOL, V21, P779, DOI 10.1016/0306-3623(90)91033-N; GHOSAL S, 1980, PHYTOCHEMISTRY, V19, P123, DOI 10.1016/0031-9422(80)85027-8; GLOMBITZA KW, 1981, TETRAHEDRON, V37, P3861, DOI 10.1016/S0040-4020(01)98884-2; GOMEZ F, 1985, PHYTOCHEMISTRY, V24, P1057, DOI 10.1016/S0031-9422(00)83182-9; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Guasch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050816; Guasch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044971; Guasch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044972; Guasch L, 2012, J MOL GRAPH MODEL, V36, P1, DOI 10.1016/j.jmgm.2012.03.001; Guasch L, 2011, J COMPUT AID MOL DES, V25, P717, DOI 10.1007/s10822-011-9446-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANSEL R, 1980, PHYTOCHEMISTRY, V19, P639, DOI 10.1016/0031-9422(80)87030-0; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; IKESHIRO Y, 1991, PHYTOCHEMISTRY, V30, P2791, DOI 10.1016/0031-9422(91)85147-R; IKESHIRO Y, 1989, PHYTOCHEMISTRY, V28, P3139, DOI 10.1016/0031-9422(89)80294-8; Jahan N, 2001, HETEROCYCLES, V55, P1951; JAKUPOVIC J, 1986, PHYTOCHEMISTRY, V25, P1133, DOI 10.1016/S0031-9422(00)81569-1; JIMENEZ J, 1986, PLANTA MED, P260, DOI 10.1055/s-2007-969146; Jung SH, 2009, PHYTOMEDICINE, V16, P327, DOI 10.1016/j.phymed.2008.12.017; Kamperdick C, 1997, PHYTOCHEMISTRY, V45, P1049, DOI 10.1016/S0031-9422(97)00059-9; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; KIMURA Y, 1991, AGR BIOL CHEM TOKYO, V55, P2673, DOI 10.1080/00021369.1991.10870996; Kinoshita T, 1996, CHEM PHARM BULL, V44, P1208, DOI 10.1248/cpb.44.1208; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; LAMELA M, 1989, J ETHNOPHARMACOL, V27, P35, DOI 10.1016/0378-8741(89)90075-5; Lenta BN, 2007, CHEM PHARM BULL, V55, P464, DOI 10.1248/cpb.55.464; Li M, 2001, J NAT PROD, V64, P971, DOI 10.1021/np000350z; Likhitwitayawuid K, 2000, PLANTA MED, V66, P275, DOI 10.1055/s-2000-8656; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Luo J, 1998, DIABETIC MED, V15, P367, DOI 10.1002/(SICI)1096-9136(199805)15:5<367::AID-DIA576>3.0.CO;2-G; Matsuura M, 2001, PLANTA MED, V67, P230, DOI 10.1055/s-2001-12011; MESQUITA AAL, 1986, PHYTOCHEMISTRY, V25, P1255, DOI 10.1016/S0031-9422(00)81599-X; Michihiro F, 2006, FOODS FOOD INGRED J, V211, P141; Modak M, 2007, J CLIN BIOCHEM NUTR, V40, P163, DOI 10.3164/jcbn.40.163; Negi JS, 2010, NAT PROD COMMUN, V5, P907; Nishimura R, 2007, BIOL PHARM BULL, V30, P1878, DOI 10.1248/bpb.30.1878; Nishioka T, 1998, J NAT PROD, V61, P1413, DOI 10.1021/np980163p; Pavana P, 2007, J ENVIRON BIOL, V28, P833; PERFUMI M, 1991, J ETHNOPHARMACOL, V34, P135, DOI 10.1016/0378-8741(91)90030-H; Petersen RK, 2011, J COMPUT AID MOL DES, V25, P107, DOI 10.1007/s10822-010-9398-5; Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379; Prabhakar PK, 2011, CHIN J INTEGR MED, V17, P563, DOI 10.1007/s11655-011-0810-3; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Rao YK, 2004, PHYTOCHEMISTRY, V65, P2317, DOI 10.1016/j.phytochem.2004.05.008; Sala E, 2011, EUR J MED CHEM, V46, P6098, DOI 10.1016/j.ejmech.2011.09.022; Sala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016903; Schuster D, 2010, CURR PHARM DESIGN, V16, P1666, DOI 10.2174/138161210791164072; Sharaf MHM, 1996, J HETEROCYCLIC CHEM, V33, P789, DOI 10.1002/jhet.5570330343; SHARAF MHM, 1995, MAGN RESON CHEM, V33, P767, DOI 10.1002/mrc.1260331003; Shirwaikar A, 2004, J ETHNOPHARMACOL, V91, P171, DOI 10.1016/j.jep.2003.12.017; Simmonds MSJ, 2005, TRADITIONAL MED MODE, P19; Stewart M, 1997, AUST J CHEM, V50, P341, DOI 10.1071/C96120; Tan Y, 2011, CLIN SCI, V120, P297, DOI 10.1042/CS20100441; Tian LY, 2010, PHYTOMEDICINE, V17, P533, DOI 10.1016/j.phymed.2009.10.007; Ulubelen A, 2002, PLANTA MED, V68, P818, DOI 10.1055/s-2002-34408; Waisundara VY, 2008, AM J CHINESE MED, V36, P517, DOI 10.1142/S0192415X08005953; Weidner C, 2012, P NATL ACAD SCI USA, V109, P7257, DOI 10.1073/pnas.1116971109; Wibudi Aris, 2008, Acta Med Indones, V40, P63; Yeo J, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-10; Zhang Y, 2009, ACTA PHARMACOL SIN, V30, P333, DOI 10.1038/aps.2009.5; Zsoldos Z, 2007, J MOL GRAPH MODEL, V26, P198, DOI 10.1016/j.jmgm.2006.06.002	88	22	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55889	10.1371/journal.pone.0055889	http://dx.doi.org/10.1371/journal.pone.0055889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405231	gold, Green Submitted, Green Published			2022-12-27	WOS:000315153400176
J	Loucoubar, C; Grange, L; Paul, R; Huret, A; Tall, A; Telle, O; Roussilhon, C; Faye, J; Diene-Sarr, F; Trape, JF; Mercereau-Puijalon, O; Sakuntabhai, A; Bureau, JF				Loucoubar, Cheikh; Grange, Laura; Paul, Richard; Huret, Augustin; Tall, Adama; Telle, Olivier; Roussilhon, Christian; Faye, Joseph; Diene-Sarr, Fatoumata; Trape, Jean-Francois; Mercereau-Puijalon, Odile; Sakuntabhai, Anavaj; Bureau, Jean-Francois			High Number of Previous Plasmodium falciparum Clinical Episodes Increases Risk of Future Episodes in a Sub-Group of Individuals	PLOS ONE			English	Article							NATURALLY ACQUIRED-IMMUNITY; COMBATING MALARIA; TRANSMISSION; AGE; SUSCEPTIBILITY; MECHANISMS; MORBIDITY; AREA	There exists great disparity in the number of clinical P. falciparum episodes among children of the same age and living in similar conditions. The epidemiological determinants of such disparity are unclear. We used a data-mining approach to explore a nineteen-year longitudinal malaria cohort study dataset from Senegal and identify variables associated with increased risk of malaria episodes. These were then verified using classical statistics and replicated in a second cohort. In addition to age, we identified a novel high-risk group of children in whom the history of P. falciparum clinical episodes greatly increased risk of further episodes. Age and a high number of previous falciparum clinical episodes not only play major roles in explaining the risk of P. falciparum episodes but also are risk factors for different groups of people. Combined, they explain the majority of falciparum clinical attacks. Contrary to what is widely believed, clinical immunity to P. falciparum does not de facto occur following many P. falciparum clinical episodes. There exist a sub-group of children who suffer repeated clinical episodes. In addition to posing an important challenge for population stratification during clinical trials, this sub-group disproportionally contributes to the disease burden and may necessitate specific prevention and control measures.	[Loucoubar, Cheikh; Grange, Laura; Paul, Richard; Telle, Olivier; Roussilhon, Christian; Sakuntabhai, Anavaj; Bureau, Jean-Francois] Inst Pasteur, Dept Genome & Genet, Unite Genet Fonct Malad Infect, Paris, France; [Loucoubar, Cheikh; Grange, Laura; Paul, Richard; Telle, Olivier; Roussilhon, Christian; Sakuntabhai, Anavaj; Bureau, Jean-Francois] Ctr Natl Rech Sci, Unite Rech Associee 3012, Paris, France; [Loucoubar, Cheikh; Tall, Adama; Faye, Joseph; Diene-Sarr, Fatoumata] Inst Pasteur, Unite Epidemiol Malad Infect, Dakar, Senegal; [Loucoubar, Cheikh] Univ Paris 05, Unite Mixte Rech Ctr Natl Rech Sci 8145, Paris, France; [Loucoubar, Cheikh] Ecole Hautes Etud Sante Publ, Rennes, France; [Huret, Augustin] Inst Hlth & Sci, Paris, France; [Trape, Jean-Francois] Inst Rech Dev, Unite Pathogenie Afrotrop, Unite Mixte Rech 198, Dakar, Senegal; [Mercereau-Puijalon, Odile] Inst Pasteur, Dept Parasitol, Unite Immunol Mol Parasites, Paris, France; [Sakuntabhai, Anavaj] Mahidol Univ, Fac Sci, Syst Biol Dis Unit, Bangkok 10400, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University	Sakuntabhai, A (corresponding author), Inst Pasteur, Dept Genome & Genet, Unite Genet Fonct Malad Infect, Paris, France.	anavaj@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020	Telle, Olivier/0000-0002-9473-8406; Bureau, Jean-Francois/0000-0003-1945-1883; Paul, Richard/0000-0002-0665-5089	Institut Pasteur, Paris; Institut Pasteur de Dakar; Institut de Recherche pour le Developpement; Institute of Health Science;  [ANR-11-BSV1-027-01]	Institut Pasteur, Paris; Institut Pasteur de Dakar; Institut de Recherche pour le Developpement; Institute of Health Science; 	Funding was provided by Institut Pasteur, Paris, Institut Pasteur de Dakar, Institut de Recherche pour le Developpement, and Institute of Health & Science. This article is linked to a project funded by ANR-11-BSV1-027-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Baird JK, 2003, ANN TROP MED PARASIT, V97, P557, DOI 10.1179/000349803225001472; BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Creasey A, 2004, PARASITOLOGY, V129, P263, DOI 10.1017/S0031182004005724; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Filion GJP, 2006, TRENDS PARASITOL, V22, P345, DOI 10.1016/j.pt.2006.06.005; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; HOGH B, 1994, ACTA TROP, V57, P265, DOI 10.1016/0001-706X(94)90072-8; Loucoubar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024085; Marsh K, 1997, PHILOS T R SOC B, V352, P1385, DOI 10.1098/rstb.1997.0124; Menendez C, 2006, CURR MOL MED, V6, P269, DOI 10.2174/156652406776055186; Mwangi TW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002196; PERIGNON JL, 1994, MEM I OSWALDO CRUZ, V89, P51, DOI 10.1590/S0074-02761994000600013; PLAYFAIR JHL, 1990, IMMUNOL TODAY, V11, P25; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Sergent Ed., 1935, Arch Inst Pasteur Alger, V13, P279; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith T, 2012, TRENDS PARASITOL, V28, P3, DOI 10.1016/j.pt.2011.09.002; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Sokhna CS, 2000, AM J TROP MED HYG, V62, P266, DOI 10.4269/ajtmh.2000.62.266; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Vazquez AI, 2010, J ANIM SCI, V88, P497, DOI 10.2527/jas.2009-1952; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; WILLIAMSON WA, 1978, LANCET, V1, P1328	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55666	10.1371/journal.pone.0055666	http://dx.doi.org/10.1371/journal.pone.0055666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405191	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400136
J	Nouchi, R; Taki, Y; Takeuchi, H; Hashizume, H; Nozawa, T; Kambara, T; Sekiguchi, A; Miyauchi, CM; Kotozaki, Y; Nouchi, H; Kawashima, R				Nouchi, Rui; Taki, Yasuyuki; Takeuchi, Hikaru; Hashizume, Hiroshi; Nozawa, Takayuki; Kambara, Toshimune; Sekiguchi, Atsushi; Miyauchi, Carlos Makoto; Kotozaki, Yuka; Nouchi, Haruka; Kawashima, Ryuta			Brain Training Game Boosts Executive Functions, Working Memory and Processing Speed in the Young Adults: A Randomized Controlled Trial	PLOS ONE			English	Article							COGNITIVE FUNCTIONS; READING ALOUD; LIFE-SPAN; PREFRONTAL CORTEX; PERMUTATION TESTS; REACTION-TIME; WHITE-MATTER; VIDEO GAMES; PERFORMANCE; PLASTICITY	Background: Do brain training games work? The beneficial effects of brain training games are expected to transfer to other cognitive functions. Yet in all honesty, beneficial transfer effects of the commercial brain training games in young adults have little scientific basis. Here we investigated the impact of the brain training game (Brain Age) on a wide range of cognitive functions in young adults. Methods: We conducted a double-blind (de facto masking) randomized controlled trial using a popular brain training game (Brain Age) and a popular puzzle game (Tetris). Thirty-two volunteers were recruited through an advertisement in the local newspaper and randomly assigned to either of two game groups (Brain Age, Tetris). Participants in both the Brain Age and the Tetris groups played their game for about 15 minutes per day, at least 5 days per week, for 4 weeks. Measures of the cognitive functions were conducted before and after training. Measures of the cognitive functions fell into eight categories (fluid intelligence, executive function, working memory, short-term memory, attention, processing speed, visual ability, and reading ability). Results and Discussion: Our results showed that commercial brain training game improves executive functions, working memory, and processing speed in young adults. Moreover, the popular puzzle game can engender improvement attention and visuo-spatial ability compared to playing the brain training game. The present study showed the scientific evidence which the brain training game had the beneficial effects on cognitive functions (executive functions, working memory and processing speed) in the healthy young adults. Conclusions: Our results do not indicate that everyone should play brain training games. However, the commercial brain training game might be a simple and convenient means to improve some cognitive functions. We believe that our findings are highly relevant to applications in educational and clinical fields.	[Nouchi, Rui; Takeuchi, Hikaru; Nozawa, Takayuki; Kotozaki, Yuka; Nouchi, Haruka; Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Nouchi, Rui; Kambara, Toshimune] Japanese Soc Promot Sci, Tokyo, Japan; [Taki, Yasuyuki; Hashizume, Hiroshi; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kambara, Toshimune; Sekiguchi, Atsushi; Miyauchi, Carlos Makoto; Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kambara, Toshimune] Tohoku Univ, IIARE, Sendai, Miyagi 980, Japan	Tohoku University; Japan Society for the Promotion of Science; Tohoku University; Tohoku University; Tohoku University	Nouchi, R (corresponding author), Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	rnouchi@idac.tohoku.ac.jp	Kotozaki, Yuka/ABA-2922-2020; Kotozaki, Yuka/ABA-2267-2020; Kambara, Toshimune/E-3336-2019; Nozawa, Takayuki/Y-9610-2019; Nouchi, Rui/GQH-1608-2022; Takeuchi, Hikaru/D-1057-2011	Kotozaki, Yuka/0000-0002-4659-1200; Kambara, Toshimune/0000-0002-6598-3365; Nozawa, Takayuki/0000-0001-6300-4373; Takeuchi, Hikaru/0000-0002-8022-9694; Nouchi, Rui/0000-0002-2078-9518	Japan Science and Technology Agency/Research Institute of Science and Technology for Society	Japan Science and Technology Agency/Research Institute of Science and Technology for Society(Japan Science & Technology Agency (JST))	This study was funded by Japan Science and Technology Agency/Research Institute of Science and Technology for Society (there are no particular numbers) (http://www.ristex.jp/EN/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2010, PSYCHOL AGING, V25, P753, DOI 10.1037/a0019277; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Belmonte M, 2001, IEEE T MED IMAGING, V20, P243, DOI 10.1109/42.918475; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger VW, 2012, J CLIN EPIDEMIOL, V65, P1236, DOI 10.1016/j.jclinepi.2012.04.016; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Borm GF, 2007, J CLIN EPIDEMIOL, V60, P1234, DOI 10.1016/j.jclinepi.2007.02.006; Bransford J. D, 1999, PEOPLE LEARN BRAIN M; Brehmer Y, 2007, DEV PSYCHOL, V43, P465, DOI 10.1037/0012-1649.43.2.465; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Camargo A, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-15; CARLSON JS, 1983, INTELLIGENCE, V7, P329, DOI 10.1016/0160-2896(83)90008-9; Carpenter PA, 2000, CURR OPIN NEUROBIOL, V10, P195, DOI 10.1016/S0959-4388(00)00074-X; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CLARK JE, 1987, J GERONTOL, V42, P82, DOI 10.1093/geronj/42.1.82; Cohen J.E., 1988, STAT POWER ANAL BEHA; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Forde EME, 2000, BRAIN COGNITION, V44, P214, DOI 10.1006/brcg.2000.1229; Genova HM, 2009, J INT NEUROPSYCH SOC, V15, P383, DOI 10.1017/S1355617709090535; Goldstein J, 1997, SOC BEHAV PERSONAL, V25, P345, DOI 10.2224/sbp.1997.25.4.345; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Graves WW, 2010, CEREB CORTEX, V20, P1799, DOI 10.1093/cercor/bhp245; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hair J.F., 1995, MULTIVARIATE DATA AN, V4th; Hakoda Y., 1990, KYOIKUSHINRIGAKUKENK, V38, P389, DOI DOI 10.5926/JJEP1953.38.4_; Hakoda Y, 2004, MANUAL NEW STROOP TE; Hatta T., 2000, D CAT MANUAL SCREENI; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hsu J., 1996, MULTIPLE COMP THEORY, DOI DOI 10.1007/978-1-4899-7180-7; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kawashima R, 2005, J GERONTOL A-BIOL, V60, P380, DOI 10.1093/gerona/60.3.380; Kawashima R, 2004, COGNITIVE BRAIN RES, V18, P227, DOI 10.1016/j.cogbrainres.2003.10.009; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Kherad-Pajouh S, 2010, COMPUT STAT DATA AN, V54, P1881, DOI 10.1016/j.csda.2010.02.015; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; KRUPSKI A, 1978, CHILD DEV, V49, P340, DOI 10.2307/1128696; Lovden M, 2010, PSYCHOL BULL, V136, P659, DOI 10.1037/a0020080; Ludbrook J, 1998, AM STAT, V52, P127, DOI 10.2307/2685470; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; MacPherson SE, 2002, PSYCHOL AGING, V17, P598, DOI 10.1037//0882-7974.17.4.598; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; MAY RB, 1993, CAN PSYCHOL, V34, P401, DOI 10.1037/h0078862; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; McDougall S, 2012, AGING NEUROPSYCHOL C, V19, P195, DOI 10.1080/13825585.2011.640656; Miller DJ, 2011, BRIT J EDUC TECHNOL, V42, P850, DOI 10.1111/j.1467-8535.2010.01114.x; Miller DJ, 2010, BRIT J EDUC TECHNOL, V41, P242, DOI 10.1111/j.1467-8535.2008.00918.x; Miura N, 2003, NEUROREPORT, V14, P1563, DOI 10.1097/00001756-200308260-00004; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; MURPHYBERMAN V, 1987, PERCEPT MOTOR SKILL, V64, P1139, DOI 10.2466/pms.1987.64.3c.1139; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nouchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029676; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Piper BJ, 2012, BEHAV RES METHODS, V44, P110, DOI 10.3758/s13428-011-0096-6; Raven J, 1998, SECTION 4 ADV PROGRE; Saltzman IJ, 1948, J PSYCHOL, V25, P227, DOI 10.1080/00223980.1948.9917373; Sano M, 1995, J Int Neuropsychol Soc, V1, P56; SCHAIE KW, 1994, AM PSYCHOL, V49, P304, DOI 10.1037/0003-066X.49.4.304; Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shing YL, 2008, J EXP PSYCHOL GEN, V137, P495, DOI 10.1037/0096-3445.137.3.495; SHUSTER JJ, 1979, J AM STAT ASSOC, V74, P379; Sims VK, 2002, APPL COGNITIVE PSYCH, V16, P97, DOI 10.1002/acp.759; Sweet LH, 2005, J INT NEUROPSYCH SOC, V11, P471, DOI 10.1017/S1355617705050575; Takeuchi H, 2011, NEUROPSYCHOLOGIA, V49, P3466, DOI 10.1016/j.neuropsychologia.2011.08.022; Takeuchi H, 2010, REV NEUROSCIENCE, V21, P427; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Uchida S, 2008, AGE, V30, P21, DOI 10.1007/s11357-007-9044-x; Usui N, 2009, NEUROSCI LETT, V463, P1, DOI 10.1016/j.neulet.2009.07.048; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 2010, WAIS 4 WECHSLER ADUL; Wesnes KA, 2000, PSYCHOPHARMACOLOGY, V152, P353, DOI 10.1007/s002130000533; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Zelinski EM, 2009, RESTOR NEUROL NEUROS, V27, P455, DOI 10.3233/RNN-2009-0495	90	123	129	3	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55518	10.1371/journal.pone.0055518	http://dx.doi.org/10.1371/journal.pone.0055518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405164	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400109
J	Segarra, G; Santpere, G; Elena, G; Trillas, I				Segarra, Guillem; Santpere, Gabriel; Elena, Georgina; Trillas, Isabel			Enhanced Botrytis cinerea Resistance of Arabidopsis Plants Grown in Compost May Be Explained by Increased Expression of Defense-Related Genes, as Revealed by Microarray Analysis	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; PATTERN-RECOGNITION RECEPTORS; ACQUIRED-RESISTANCE; DISEASE RESISTANCE; TRANSCRIPTION FACTORS; STRESS RESPONSES; SALICYLIC-ACID; ABSCISIC-ACID; HYPERSENSITIVE RESPONSE; CAMALEXIN BIOSYNTHESIS	Composts are the products obtained after the aerobic degradation of different types of organic matter waste and can be used as substrates or substrate/soil amendments for plant cultivation. There is a small but increasing number of reports that suggest that foliar diseases may be reduced when using compost, rather than standard substrates, as growing medium. The purpose of this study was to examine the gene expression alteration produced by the compost to gain knowledge of the mechanisms involved in compost-induced systemic resistance. A compost from olive marc and olive tree leaves was able to induce resistance against Botrytis cinerea in Arabidopsis, unlike the standard substrate, perlite. Microarray analyses revealed that 178 genes were differently expressed, with a fold change cut-off of 1, of which 155 were up-regulated and 23 were down-regulated in compost-grown, as against perlite-grown plants. A functional enrichment study of up-regulated genes revealed that 38 Gene Ontology terms were significantly enriched. Response to stress, biotic stimulus, other organism, bacterium, fungus, chemical and abiotic stimulus, SA and ABA stimulus, oxidative stress, water, temperature and cold were significantly enriched, as were immune and defense responses, systemic acquired resistance, secondary metabolic process and oxireductase activity. Interestingly, PR1 expression, which was equally enhanced by growing the plants in compost and by B. cinerea inoculation, was further boosted in compost-grown pathogen-inoculated plants. Compost triggered a plant response that shares similarities with both systemic acquired resistance and ABA-dependent/independent abiotic stress responses.	[Segarra, Guillem; Elena, Georgina; Trillas, Isabel] Univ Barcelona, Fac Biol, Dept Biol Vegetal, Unitat Fisiol Vegetal, Barcelona, Catalonia, Spain; [Santpere, Gabriel] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Catalonia, Spain; [Elena, Georgina] Inst Recerca & Tecnol Agroalimentaries Cabrils, Dept Patol Vegetal, Cabrils, Catalonia, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; IRTA	Segarra, G (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Vegetal, Unitat Fisiol Vegetal, Barcelona, Catalonia, Spain.	gsegarra@ub.edu	Trillas, M Isabel/L-8334-2014; Elena Jimenez, Georgina/M-3785-2014; Segarra, Guillem/R-1694-2018; Santpere, Gabriel/I-9437-2014	Elena Jimenez, Georgina/0000-0001-5053-4914; Segarra, Guillem/0000-0003-1634-9760; Santpere, Gabriel/0000-0001-5909-8637; Trillas Gay/0000-0001-9951-0972	Spanish Ministry of Science and Technology [AGL2010-21982-C02-02]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by the Spanish Ministry of Science and Technology (AGL2010-21982-C02-02). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Beck M, 2012, CURR OPIN PLANT BIOL, V15, P367, DOI 10.1016/j.pbi.2012.05.004; Bernoux M, 2011, CURR OPIN PLANT BIOL, V14, P512, DOI 10.1016/j.pbi.2011.05.005; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Borrero C, 2004, PHYTOPATHOLOGY, V94, P1094, DOI 10.1094/PHYTO.2004.94.10.1094; Chan ZL, 2012, GENOMICS, V100, P110, DOI 10.1016/j.ygeno.2012.06.004; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Doornbos RF, 2011, MOL PLANT MICROBE IN, V24, P395, DOI 10.1094/MPMI-05-10-0115; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Faulkner C, 2012, CURR OPIN PLANT BIOL, V15, P699, DOI 10.1016/j.pbi.2012.08.009; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hoitink HAJ, 1999, ANNU REV PHYTOPATHOL, V37, P427, DOI 10.1146/annurev.phyto.37.1.427; HOITINK HAJ, 1991, PLANT DIS, V75, P869, DOI 10.1094/PD-75-0869; Huang DQ, 2007, PLANT J, V50, P414, DOI 10.1111/j.1365-313X.2007.03056.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kavroulakis N, 2005, PHYSIOL MOL PLANT P, V66, P163, DOI 10.1016/j.pmpp.2005.06.003; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Litterick AM, 2004, CRIT REV PLANT SCI, V23, P453, DOI 10.1080/07352680490886815; MANTYLA E, 1995, PLANT PHYSIOL, V107, P141, DOI 10.1104/pp.107.1.141; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Noble R, 2005, BIOCONTROL SCI TECHN, V15, P3, DOI 10.1080/09583150400015904; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Povero G, 2011, J PLANT RES, V124, P619, DOI 10.1007/s10265-010-0399-1; Pozo MJ, 2008, NEW PHYTOL, V180, P511, DOI 10.1111/j.1469-8137.2008.02578.x; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Rogers EE, 1997, PLANT CELL, V9, P305, DOI 10.1105/tpc.9.3.305; Saga H, 2012, MOL PLANT MICROBE IN, V25, P684, DOI 10.1094/MPMI-09-11-0244; Sang MK, 2011, PHYTOPATHOLOGY, V101, P732, DOI 10.1094/PHYTO-10-10-0287; Segarra G, 2007, PROTEOMICS, V7, P3943, DOI 10.1002/pmic.200700173; Segarra G, 2007, EUR J PLANT PATHOL, V117, P393, DOI 10.1007/s10658-007-9108-x; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song JT, 2004, PLANT J, V40, P200, DOI 10.1111/j.1365-313X.2004.02200.x; Tsuchisaka A, 2009, GENETICS, V183, P979, DOI 10.1534/genetics.109.107102; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; Vallad GE, 2003, PHYSIOL MOL PLANT P, V63, P65, DOI 10.1016/j.pmpp.2003.10.003; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Wees SCM, 1999, PLANT MOL BIOL, V41, P537, DOI 10.1023/A:1006319216982; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Wan DL, 2012, PLANT CELL REP, V31, P1269, DOI 10.1007/s00299-012-1247-7; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Yogev A, 2010, BIOL CONTROL, V54, P46, DOI 10.1016/j.biocontrol.2010.03.004; Zhang W, 1998, PHYTOPATHOLOGY, V88, P450, DOI 10.1094/PHYTO.1998.88.5.450; Zheng MS, 2005, PLANT SCI, V168, P415, DOI 10.1016/j.plantsci.2004.09.016; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	70	26	27	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56075	10.1371/journal.pone.0056075	http://dx.doi.org/10.1371/journal.pone.0056075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405252	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400197
J	Berghoff, AS; Spanberger, T; Ilhan-Mutlu, A; Magerle, M; Hutterer, M; Woehrer, A; Hackl, M; Widhalm, G; Dieckmann, K; Marosi, C; Birner, P; Prayer, D; Preusser, M				Berghoff, Anna Sophie; Spanberger, Thomas; Ilhan-Mutlu, Ayseguel; Magerle, Manuel; Hutterer, Markus; Woehrer, Adelheid; Hackl, Monika; Widhalm, Georg; Dieckmann, Karin; Marosi, Christine; Birner, Peter; Prayer, Daniela; Preusser, Matthias			Preoperative Diffusion-Weighted Imaging of Single Brain Metastases Correlates with Patient Survival Times	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; TUMOR-STROMA RATIO; PROGNOSTIC VALUE; MRI; COEFFICIENT; CARCINOMA; CELLULARITY; DIAGNOSIS; PERFUSION; GLIOMAS	Background: MRI-based diffusion-weighted imaging (DWI) visualizes the local differences in water diffusion in vivo. The prognostic value of DWI signal intensities on the source images and apparent diffusion coefficient (ADC) maps respectively has not yet been studied in brain metastases (BM). Methods: We included into this retrospective analysis all patients operated for single BM at our institution between 2002 and 2010, in whom presurgical DWI and BM tissue samples were available. We recorded relevant clinical data, assessed DWI signal intensity and apparent diffusion coefficient (ADC) values and performed histopathological analysis of BM tissues. Statistical analyses including uni- and multivariate survival analyses were performed. Results: 65 patients (34 female, 31 male) with a median overall survival time (OS) of 15 months (range 0-99 months) were available for this study. 19 (29.2%) patients presented with hyper-, 3 (4.6%) with iso-, and 43 (66.2%) with hypointense DWI. ADCmean values could be determined in 32 (49.2%) patients, ranged from 456.4 to 1691.8*10(-6) mm(2)/s (median 969.5) and showed a highly significant correlation with DWI signal intensity. DWI hyperintensity correlated significantly with high amount of interstitial reticulin deposition. In univariate analysis, patients with hyperintense DWI (5 months) and low ADCmean values (7 months) had significantly worse OS than patients with iso/hypointense DWI (16 months) and high ADCmean values (30 months), respectively. In multivariate survival analysis, high ADCmean values retained independent statistical significance. Conclusions: Preoperative DWI findings strongly and independently correlate with OS in patients operated for single BM and are related to interstitial fibrosis. Inclusion of DWI parameters into established risk stratification scores for BM patients should be considered.	[Berghoff, Anna Sophie; Woehrer, Adelheid] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Spanberger, Thomas; Prayer, Daniela] Med Univ Vienna, Div Neuroradiol, Dept Radiol, Vienna, Austria; [Ilhan-Mutlu, Ayseguel; Magerle, Manuel; Marosi, Christine; Preusser, Matthias] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Hutterer, Markus] Univ Hosp Regensburg, Wilhelm Sander NeuroOncol Therapy Unit, Dept Neurol, Regensburg, Germany; [Hackl, Monika] Stat Austria, Austrian Natl Canc Registry, Vienna, Austria; [Widhalm, Georg] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Dieckmann, Karin] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria; [Birner, Peter] Med Univ Vienna, Clin Inst Clin Pathol, Vienna, Austria; [Berghoff, Anna Sophie; Spanberger, Thomas; Ilhan-Mutlu, Ayseguel; Magerle, Manuel; Woehrer, Adelheid; Widhalm, Georg; Dieckmann, Karin; Marosi, Christine; Birner, Peter; Prayer, Daniela; Preusser, Matthias] Med Univ Vienna, Ctr Comprehens Canc, CNS Tumors Unit, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Regensburg; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Preusser, M (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.	Matthias.preusser@meduniwien.ac.at	Widhalm, Georg/AFK-1669-2022; Preusser, Matthias/C-8530-2011; Hutterer, Markus/AAG-4535-2020	Widhalm, Georg/0000-0001-6014-0273; Preusser, Matthias/0000-0003-3541-2315; Berghoff, Anna Sophie/0000-0001-9379-6797; Woehrer, Adelheid/0000-0001-8435-8189	Austrian National Bank [13457]; scholarship program for scientific research of the city of Vienna [MA7-49139/13]	Austrian National Bank; scholarship program for scientific research of the city of Vienna	This study was supported by grant number 13457 of the Austrian National Bank (principle investigator: Matthias Preusser) and grant number MA7-49139/13 of the scholarship program for scientific research of the city of Vienna (recipient: Anna Sophie Berghoff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi T, 2012, EUR RADIOL, V22, P1172, DOI 10.1007/s00330-011-2359-0; Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Barajas RF, 2010, AM J NEURORADIOL, V31, P60, DOI 10.3174/ajnr.A1750; Berghoff AS, 2012, BRIT J CANCER, V107, P1454, DOI 10.1038/bjc.2012.440; Boxerman JL, 2010, AM J ROENTGENOL, V195, P720, DOI 10.2214/AJR.09.4128; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Curvo-Semedo L, 2012, J MAGN RESON IMAGING, V35, P1365, DOI 10.1002/jmri.23589; de Kruijf EM, 2011, BREAST CANCER RES TR, V125, P687, DOI 10.1007/s10549-010-0855-6; Duygulu G, 2010, EUR J RADIOL, V74, P117, DOI 10.1016/j.ejrad.2009.03.004; Fan GG, 2006, BRIT J RADIOL, V79, P652, DOI 10.1259/bjr/25349497; Frisk G, 2012, BRIT J CANCER, V106, P1850, DOI 10.1038/bjc.2012.163; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Gaspar L E, 2000, Radiology, V215 Suppl, P1105; Hayashida Y, 2006, AM J NEURORADIOL, V27, P1419; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Lee EK, 2012, ACTA RADIOL IN PRESS; Mesker WE, 2007, CELL ONCOL, V29, P387; Moorman AM, 2012, EJSO-EUR J SURG ONC, V38, P307, DOI 10.1016/j.ejso.2012.01.002; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; Ohno Y, 2012, AM J ROENTGENOL, V198, P75, DOI 10.2214/AJR.11.6525; Pillai S, 2011, CHILD NERV SYST, V27, P1407, DOI 10.1007/s00381-011-1499-5; Preusser M, 2012, EUR J CANC IN PRESS; Preusser M, 2012, CURR OPIN N IN PRESS; Preusser M, 2012, HISTOPATHOLOGY, V60, P885, DOI 10.1111/j.1365-2559.2011.04134.x; Sasaki M, 2008, RADIOLOGY, V249, P624, DOI 10.1148/radiol.2492071681; Schouten LJ, 2002, CANCER, V94, P2698, DOI 10.1002/cncr.10541; Silvera S, 2005, AM J NEURORADIOL, V26, P236; Soffietti R, 2006, EUR J NEUROL, V13, P674, DOI 10.1111/j.1468-1331.2006.01506.x; Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Wang S, 2011, AM J NEURORADIOL, V32, P507, DOI 10.3174/ajnr.A2333; Wohrer A, 2009, J NEURO-ONCOL, V95, P401, DOI 10.1007/s11060-009-9938-9	33	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55464	10.1371/journal.pone.0055464	http://dx.doi.org/10.1371/journal.pone.0055464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393579	gold, Green Published, Green Submitted			2022-12-27	WOS:000314692800033
J	Tapinos, A; Mendes, P				Tapinos, Avraam; Mendes, Pedro			A Method for Comparing Multivariate Time Series with Different Dimensions	PLOS ONE			English	Article							REPRESENTATION; COMPONENTS; SYSTEMS; MODELS; EEG	In many situations it is desirable to compare dynamical systems based on their behavior. Similarity of behavior often implies similarity of internal mechanisms or dependency on common extrinsic factors. While there are widely used methods for comparing univariate time series, most dynamical systems are characterized by multivariate time series. Yet, comparison of multivariate time series has been limited to cases where they share a common dimensionality. A semi-metric is a distance function that has the properties of non-negativity, symmetry and reflexivity, but not sub-additivity. Here we develop a semi-metric - SMETS - that can be used for comparing groups of time series that may have different dimensions. To demonstrate its utility, the method is applied to dynamic models of biochemical networks and to portfolios of shares. The former is an example of a case where the dependencies between system variables are known, while in the latter the system is treated (and behaves) as a black box.	[Tapinos, Avraam; Mendes, Pedro] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Tapinos, Avraam; Mendes, Pedro] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Mendes, Pedro] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	University of Manchester; University of Manchester; Virginia Polytechnic Institute & State University	Mendes, P (corresponding author), Univ Manchester, Sch Comp Sci, Manchester, Lancs, England.	pedro.mendes@manchester.ac.uk		Mendes, Pedro/0000-0001-6507-9168	National Institute for General Medical Sciences [GM080219]; European Union FP7 program [201142, 289434]; British Biotechnology and Biological Sciences Research Council [BB/J019259/1]; BBSRC [BB/J019259/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J019259/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080219] Funding Source: NIH RePORTER	National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); European Union FP7 program(European Commission); British Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Mendes lab is supported by grants from the National Institute for General Medical Sciences (GM080219), European Union FP7 program (201142, and 289434) and the British Biotechnology and Biological Sciences Research Council (BB/J019259/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, LNCS, V730, P69; Alon J, 2003, PROC CVPR IEEE, P375; [Anonymous], 2001, RIPPLES MATH DISCRET; Chakrabarti K, 2002, ACM T DATABASE SYST, V27, P188, DOI 10.1145/568518.568520; Chan KP, 1999, PROC INT CONF DATA, P126, DOI 10.1109/ICDE.1999.754915; Chin SC, 2005, SIGNAL PROCESS, V85, P1859, DOI 10.1016/j.sigpro.2005.03.014; Deza M. M., 2009, ENCY DISTANCES; Faloutsos C., 1994, SIGMOD Record, V23, P419, DOI 10.1145/191843.191925; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hart K.P., 2004, ENCY GEN TOPOLOGY, P259; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kalpakis K, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P273, DOI 10.1109/ICDM.2001.989529; Kemp B, 2000, IEEE T BIO-MED ENG, V47, P1185, DOI 10.1109/10.867928; Keogh E, 2003, DATA MIN KNOWL DISC, V7, P349, DOI 10.1023/A:1024988512476; Keogh E., 2001, Knowledge and Information Systems, V3, P263, DOI 10.1007/PL00011669; KRZANOWSKI WJ, 1979, J AM STAT ASSOC, V74, P703, DOI 10.2307/2286995; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Liao TW, 2005, PATTERN RECOGN, V38, P1857, DOI 10.1016/j.patcog.2005.01.025; Lin J, 2007, DATA MIN KNOWL DISC, V15, P107, DOI 10.1007/s10618-007-0064-z; MOURTAZAEV MS, 1995, SLEEP, V18, P557, DOI 10.1093/sleep/18.7.557; Rath TM, 2002, LOWER BOUNDING DYNAM; Shahabi C, 2003, P 9 INT C MULT MOD, P93; SHUMWAY RH, 2000, TIME SERIES ANAL ITS; Sutcliffe C., 2006, STOCK INDEX FUTURES; Veltkamp RC, 2001, INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, PROCEEDING, P188, DOI 10.1109/SMA.2001.923389; Vlachos M, 2002, PROC INT CONF DATA, P673, DOI 10.1109/ICDE.2002.994784; Vlachos M, 2003, P 9 ACM SIGKDD INT C, P216, DOI DOI 10.1145/956750.956777; Wei L., 2006, P 12 ACM SIGKDD INT, P748, DOI DOI 10.1145/1150402.1150498; Wilson WA, 1931, AM J MATH, V53, P361, DOI 10.2307/2370790; YANG K, 2004, P 2 ACM INT WORKSHOP, P65, DOI DOI 10.1145/1032604.1032616; Ye N., 2003, HDB DATA MINING	32	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54201	10.1371/journal.pone.0054201	http://dx.doi.org/10.1371/journal.pone.0054201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393554	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800008
J	Bunthi, C; Thamthitiwat, S; Baggett, HC; Akarasewi, P; Ruangchira-urai, R; Maloney, SA; Ungchusak, K				Bunthi, Charatdao; Thamthitiwat, Somsak; Baggett, Henry C.; Akarasewi, Pasakorn; Ruangchira-urai, Ruchira; Maloney, Susan A.; Ungchusak, Kumnuan			Influenza A(H1N1)pdm09-Associated Pneumonia Deaths in Thailand	PLOS ONE			English	Article							PANDEMIC H1N1 2009; CRITICALLY-ILL PATIENTS; RISK-FACTORS; UNITED-STATES; INFECTION; VIRUS; HOSPITALIZATION; A(H1N1)	Background: The first human infections with influenza A(H1N1)pdm09 virus were confirmed in April 2009. We describe the clinical and epidemiological characteristics of influenza A(H1N1)pdm09-associated pneumonia deaths in Thailand from May 2009-January 2010. Methods: We identified influenza A(H1N1)pdm09-associated pneumonia deaths from a national influenza surveillance system and performed detailed reviews of a subset. Results: Of 198 deaths reported, 49% were male and the median age was 37 years; 146 (73%) were 20-60 years. Among 90 deaths with records available for review, 46% had no identified risk factors for severe influenza. Eighty-eight patients (98%) received antiviral treatment, but only 16 (18%) initiated therapy within 48 hours of symptom onset. Conclusions: Most influenza A(H1N1)pdm09 pneumonia fatalities in Thailand occurred in adults aged 20-60 years. Nearly half lacked high-risk conditions. Antiviral treatment recommendations may be especially important early in a pandemic before vaccine is available. Treatment should be considered as soon as influenza is suspected.	[Bunthi, Charatdao; Thamthitiwat, Somsak; Baggett, Henry C.; Maloney, Susan A.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Global Dis Detect Reg Ctr, Int Emerging Infect Program, Nonthaburi, Thailand; [Akarasewi, Pasakorn; Ungchusak, Kumnuan] Thailand Minist Publ Hlth, Bur Epidemiol, Nonthaburi, Thailand; [Ruangchira-urai, Ruchira] Mahidol Univ, Dept Pathol, Siriraj Hosp, Bangkok 10700, Thailand	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University	Bunthi, C (corresponding author), US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Global Dis Detect Reg Ctr, Int Emerging Infect Program, Nonthaburi, Thailand.	charatdaob@th.cdc.gov			Thailand Ministry Of Public Health; U.S. Centers for Disease Control and Prevention (CDC)	Thailand Ministry Of Public Health; U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded primarily by the Thailand Ministry Of Public Health with additional support from the U.S. Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO REC PAND H1N1 20; Bassetti M, 2011, CLIN MICROBIOL INFEC, V17, P247, DOI 10.1111/j.1469-0691.2010.03275.x; Bassetti M, 2010, CLIN MICROBIOL INFEC; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P435; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Champunot R, 2010, JPN J INFECT DIS, V63, P251; Cox CM, 2011, CLIN INFECT DIS, V52, pS69, DOI 10.1093/cid/ciq011; Cui W, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-145; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESILVA UC, 2009, EURO SURVEILL, V14; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Dulyachai W, 2010, EMERG INFECT DIS, V16, P343, DOI 10.3201/eid1602.091733; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fowlkes AL, 2011, CLIN INFECT DIS, V52, pS60, DOI 10.1093/cid/ciq022; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Iamsirithaworn S., 2011, Siriraj Medical Journal, V63, P64; Ismail HIM, 2011, EMERG INFECT DIS, V17, P708, DOI 10.3201/eid1704.101212; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Lee C, 2011, HAEMOPHILIA, V17, P1, DOI 10.1111/j.1365-2516.2010.02478.x; Lees CH, 2011, EMERG INFECT DIS, V17, P1479, DOI 10.3201/eid1708.101914; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Cortes JMM, 2010, REV ESP SALUD PUBLIC, V84, P517, DOI 10.1590/S1135-57272010000500006; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Palache A, 2011, VACCINE, V29, P9459, DOI 10.1016/j.vaccine.2011.10.030; Pebody RG, 2010, EUROSURVEILLANCE, V15; Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5; Restrepo Marcos I, 2010, Arch Bronconeumol, V46 Suppl 2, P13, DOI 10.1016/S0300-2896(10)70015-6; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Peralta PS, 2010, REV ESP SALUD PUBLIC, V84, P547, DOI [10.1590/S1135-57272010000500008, 10.1590/s1135-57272010000500008]; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Tutuncu EE, 2010, SAUDI MED J, V31, P993; Ungchusak K, 2012, EMERG INFECT DIS, V18, P1058, DOI 10.3201/eid1807.110976; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; World Health Organization, 2009, CLIN MAN HUM INF PAN; Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233; Yokoyama T, 2010, INTERNAL MED, V49, P427, DOI 10.2169/internalmedicine.49.3022	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54946	10.1371/journal.pone.0054946	http://dx.doi.org/10.1371/journal.pone.0054946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390508	Green Published, Green Submitted, gold			2022-12-27	WOS:000314691100024
J	Naushad, HS; Gupta, RS				Naushad, Hafiz Sohail; Gupta, Radhey S.			Phylogenomics and Molecular Signatures for Species from the Plant Pathogen-Containing Order Xanthomonadales	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSIS; STENOTROPHOMONAS-MALTOPHILIA; PROTEIN SEQUENCES; EVOLUTIONARY RELATIONSHIPS; CONSERVED INDELS; GENE-TRANSFER; XYLELLA; BACTERIA; STRAINS; INSIGHTS	The species from the order Xanthomonadales, which harbors many important plant pathogens and some human pathogens, are currently distinguished primarily on the basis of their branching in the 16S rRNA tree. No molecular or biochemical characteristic is known that is specific for these bacteria. Phylogenetic and comparative analyses were conducted on 26 sequenced Xanthomonadales genomes to delineate their branching order and to identify molecular signatures consisting of conserved signature indels (CSIs) in protein sequences that are specific for these bacteria. In a phylogenetic tree based upon sequences for 28 proteins, Xanthomonadales species formed a strongly supported clade with Rhodanobacter sp. 2APBS1 as its deepest branch. Comparative analyses of protein sequences have identified 13 CSIs in widely distributed proteins such as GlnRS, TypA, MscL, LysRS, LipA, Tgt, LpxA, TolQ, ParE, PolA and TyrB that are unique to all species/strains from this order, but not found in any other bacteria. Fifteen additional CSIs in proteins (viz. CoxD, DnaE, PolA, SucA, AsnB, RecA, PyrG, LigA, MutS and TrmD) are uniquely shared by different Xanthomonadales except Rhodanobacter and in a few cases by Pseudoxanthomonas species, providing further support for the deep branching of these two genera. Five other CSIs are commonly shared by Xanthomonadales and 1-3 species from the orders Chromatiales, Methylococcales and Cardiobacteriales suggesting that these deep branching orders of Gammaproteobacteria might be specifically related. Lastly, 7 CSIs in ValRS, CarB, PyrE, GlyS, RnhB, MinD and X001065 are commonly shared by Xanthomonadales and a limited number of Beta-or Gamma-proteobacteria. Our analysis indicates that these CSIs have likely originated independently and they are not due to lateral gene transfers. The Xanthomonadales-specific CSIs reported here provide novel molecular markers for the identification of these important plant and human pathogens and also as potential targets for development of drugs/agents that specifically target these bacteria.	[Naushad, Hafiz Sohail; Gupta, Radhey S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Gupta, RS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	gupta@mcmaster.ca		Naushad, Sohail/0000-0001-8219-1717	NSERC (Natural Science and Engineering Research Council of Canada) [249924]	NSERC (Natural Science and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	NSERC (Natural Science and Engineering Research Council of Canada) 249924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bhattacharyya A, 2002, P NATL ACAD SCI USA, V99, P12403, DOI 10.1073/pnas.132393999; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Chen J, 2010, J BACTERIOL, V192, P4534, DOI 10.1128/JB.00651-10; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Comas I, 2006, MOL BIOL EVOL, V23, P2049, DOI 10.1093/molbev/msl075; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Cutino-Jimenez AM, 2010, MOL PHYLOGENET EVOL, V54, P524, DOI 10.1016/j.ympev.2009.09.026; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Doddapaneni H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-225; Dutilh BE, 2004, J MOL EVOL, V58, P527, DOI 10.1007/s00239-003-2575-6; Gao BL, 2012, ANTON LEEUW INT J G, V101, P45, DOI 10.1007/s10482-011-9663-1; Gao B, 2009, INT J SYST EVOL MICR, V59, P234, DOI 10.1099/ijs.0.002741-0; Gao BL, 2005, INT J SYST EVOL MICR, V55, P2401, DOI 10.1099/ijs.0.63785-0; Griffiths E, 2006, INT J SYST EVOL MICR, V56, P99, DOI 10.1099/ijs.0.63927-0; Griffiths E, 2002, MICROBIOL-SGM, V148, P2541, DOI 10.1099/00221287-148-8-2541; Griffiths E, 2006, J MOL EVOL, V63, P283, DOI 10.1007/s00239-005-0286-x; Gupta Radhey S., 2001, International Microbiology, V4, P187, DOI 10.1007/s10123-001-0037-9; Gupta RS, 2011, ANTON LEEUW INT J G, V100, P171, DOI 10.1007/s10482-011-9616-8; Gupta RS, 2010, PHOTOSYNTH RES, V104, P357, DOI 10.1007/s11120-010-9553-9; Gupta RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-24; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P2510, DOI 10.1099/ijs.0.005678-0; Gupta RS, 2007, J MOL EVOL, V64, P90, DOI 10.1007/s00239-006-0082-2; Gupta RS, 2002, THEOR POPUL BIOL, V61, P423, DOI 10.1006/tpbi.2002.1589; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; Handy J, 1999, J MOL EVOL, V49, P709, DOI 10.1007/PL00006592; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Imhoff J.F., 2005, BERGEYS MANUAL SYSTE, VVolume 2 (The Proteobacteria), P587, DOI DOI 10.1007/0-387-29298-5; Jalan N, 2011, J BACTERIOL, V193, P6342, DOI 10.1128/JB.05777-11; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Lee SH, 2012, J BACTERIOL, V194, P544, DOI 10.1128/JB.06436-11; Lima WC, 2008, J MOL EVOL, V66, P266, DOI 10.1007/s00239-008-9082-8; Lima WC, 2008, FEMS MICROBIOL LETT, V281, P87, DOI 10.1111/j.1574-6968.2008.01083.x; Lima WC, 2009, MOL BIOL EVOL, V26, P399, DOI 10.1093/molbev/msn261; Lima WC, 2005, OMICS, V9, P160, DOI 10.1089/omi.2005.9.160; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Martins-Pinheiro M, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-29; Monteiro-Vitorello CB, 2005, OMICS, V9, P146, DOI 10.1089/omi.2005.9.146; Naushad HS, 2012, ANTON LEEUW INT J G, V101, P105, DOI 10.1007/s10482-011-9628-4; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0; Parkinson N, 2007, INT J SYST EVOL MICR, V57, P2881, DOI 10.1099/ijs.0.65220-0; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; SADDLER G, 2005, BERGEYS MANUAL SYSTE, V2; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Schreiber HL, 2010, SOUTHWEST ENTOMOL, V35, P479, DOI 10.3958/059.035.0336; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Waters V, 2011, AM J RESP CRIT CARE, V183, P635, DOI 10.1164/rccm.201009-1392OC; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004	67	36	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55216	10.1371/journal.pone.0055216	http://dx.doi.org/10.1371/journal.pone.0055216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408961	gold, Green Published, Green Submitted			2022-12-27	WOS:000314660300008
J	Vidal-Donet, JM; Carcel-Trullols, J; Casanova, B; Aguado, C; Knecht, E				Manuel Vidal-Donet, Jose; Carcel-Trullols, Jaime; Casanova, Bonaventura; Aguado, Carmen; Knecht, Erwin			Alterations in ROS Activity and Lysosomal pH Account for Distinct Patterns of Macroautophagy in LINCL and JNCL Fibroblasts	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSES; BATTEN-DISEASE; AUTOPHAGIC VACUOLES; MOUSE MODELS; CLN3; DEGRADATION; PROTEINS; BIOSYNTHESIS; TRAFFICKING; PROTEASOMES	Neuronal Ceroid Lipofuscinoses (NCL) are lysosomal storage disorders characterized by the accumulation of lipofuscin within lysosomes. Late infantile (LINCL) and juvenile (JNCL) are their most common forms and are caused by loss-of-function mutations in tripeptidyl peptidase 1 (TPP1), a lysosomal endopeptidase, and CLN3 protein (CLN3p), whose location and function is still controversial. LINCL patients suffer more severely from NCL consequences than JNCL patients, in spite of having in common an abnormal accumulation of material with a similar composition in the lysosomes. To identify distinctive characteristics that could explain the differences in the severity of LINCL and JNCL pathologies, we compared the protein degradation mechanisms in patients fibroblasts. Pulse-chase experiments show a significant decrease in protein degradation by macroautophagy in fibroblasts bearing TPP1 (CLN2) and CLN3p (CLN3) mutations. In CLN2 fibroblasts, LC3-II levels and other procedures indicate an impaired formation of autophagosomes, which confirms the pulse-chase experiments. This defect is linked to an accumulation of Reactive Oxygen Species (ROS), an upregulation of the Akt-mTOR signalling pathway and increased activities of the p38 alpha and ERK1/2 MAPKs. In CLN3 fibroblasts, LC3-II analysis indicates impairment in autophagosome maturation and there is also a defect in fluid phase endocytosis, two alterations that can be related to an observed increase of 0.5 units in lysosomal pH. CLN3 fibroblasts also accumulate ROS but to a lower extent than CLN2. TPP1 activity is completely abrogated in CLN2 and partially diminished in CLN3 fibroblasts. TPP1 cleaves small hydrophobic proteins like subunit c of mitochondrial ATP synthase and the lack or a lower activity of this enzyme can contribute to lipofuscin accumulation. These alterations in TPP1 activity lead to an increased ROS production, especially in CLN2 in which it is aggravated by a decrease in catalase activity. This could explain the earlier appearance of the symptoms in the LINCL form.	[Manuel Vidal-Donet, Jose; Carcel-Trullols, Jaime; Aguado, Carmen; Knecht, Erwin] Ctr Invest Principe Felipe, Lab Cellular Biol, Valencia, Spain; [Aguado, Carmen; Knecht, Erwin] CIBERER, Valencia, Spain; [Casanova, Bonaventura] Hosp La Fe, Dept Neurol, E-46009 Valencia, Spain	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe	Knecht, E (corresponding author), Ctr Invest Principe Felipe, Lab Cellular Biol, Valencia, Spain.	knecht@cipf.es	Knecht, Erwin/K-2432-2014; Aguado, Carmen/K-4354-2014; Casanova, Bonaventura/AAY-1027-2020; Knecht, Erwin/A-9366-2014	Knecht, Erwin/0000-0002-7208-3832; Aguado, Carmen/0000-0002-3113-4269; 	Spanish Ministry of Science and Innovation [BFU2011-22630]; Generalitat Valenciana [PROMETEO/2012/061]; Fundacio Marato TV3 [100130]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Spanish Ministry of Science and Innovation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacio Marato TV3; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation (BFU2011-22630), Generalitat Valenciana (PROMETEO/2012/061), Fundacio Marato TV3 (Grant number 100130) and the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER). JMVD holds a fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Chattopadhyay S, 2000, J BACTERIOL, V182, P6418, DOI 10.1128/JB.182.22.6418-6423.2000; de Llano JJM, 2000, ANAL CHEM, V72, P2406, DOI 10.1021/ac991287p; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Esteban I, 2007, FEBS LETT, V581, P3415, DOI 10.1016/j.febslet.2007.06.043; Esteve JM, 2010, EXP CELL RES, V316, P2618, DOI 10.1016/j.yexcr.2010.06.019; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Ghislat G, 2012, J CELL SCI, V125, P92, DOI 10.1242/jcs.086728; Golabek AA, 2003, J BIOL CHEM, V278, P7135, DOI 10.1074/jbc.M211872200; Golabek AA, 2000, MOL GENET METAB, V70, P203, DOI 10.1006/mgme.2000.3006; Hofmann SL, 1997, NEUROPEDIATRICS, V28, P27, DOI 10.1055/s-2007-973661; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Jarvela I, 1999, HUM MOL GENET, V8, P1091, DOI 10.1093/hmg/8.6.1091; Jarvela I, 1998, HUM MOL GENET, V7, P85, DOI 10.1093/hmg/7.1.85; Jolly RD, 2002, NEUROCHEM INT, V40, P565, DOI 10.1016/S0197-0186(01)00128-0; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kim Y, 2003, P NATL ACAD SCI USA, V100, P15458, DOI 10.1073/pnas.2136651100; KNECHT E, 1984, EXP CELL RES, V154, P224, DOI 10.1016/0014-4827(84)90682-7; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Luellmann-Rauch Renate, 2005, P1; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Pal A, 2009, J BIOL CHEM, V284, P3976, DOI 10.1074/jbc.M806947200; Pearce DA, 1999, NAT GENET, V22, P55, DOI 10.1038/8861; Persaud-Sawin DA, 2004, PEDIATR RES, V56, P449, DOI 10.1203/01.PDR.0000136152.54638.95; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; Ramachandran N, 2009, CELL, V137, P235, DOI 10.1016/j.cell.2009.01.054; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Scherz-Shouval R, 2019, EMBO J, V38, DOI 10.15252/embj.2019101812; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; Shamsi FA, 2001, INVEST OPHTH VIS SCI, V42, P3041; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Uusi-Rauva K, 2012, CELL MOL LIFE SCI, V69, P2075, DOI 10.1007/s00018-011-0913-1; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Weimer JM, 2002, NEUROMOL MED, V1, P111, DOI 10.1385/NMM:1:2:111; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010	49	63	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55526	10.1371/journal.pone.0055526	http://dx.doi.org/10.1371/journal.pone.0055526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408996	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200036
J	Schilling, B; Harasymczuk, M; Schuler, P; Egan, J; Ferrone, S; Whiteside, TL				Schilling, Bastian; Harasymczuk, Malgorzata; Schuler, Patrick; Egan, James; Ferrone, Soldano; Whiteside, Theresa L.			IRX-2, a Novel Immunotherapeutic, Enhances Functions of Human Dendritic Cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MONOCLONAL-ANTIBODIES; T-CELLS; EFFECTOR-CELLS; FLOW-CYTOMETRY; TUMOR-CELLS; IN-VIVO; CANCER; ANTIGEN; MATURATION	Background: In a recent phase II clinical trial for HNSCC patients, IRX-2, a cell-derived biologic, promoted T-cell infiltration into the tumor and prolonged overall survival. Mechanisms responsible for these IRX-2-mediated effects are unknown. We hypothesized that IRX-2 enhanced tumor antigen-(TA)-specific immunity by up-regulating functions of dendritic cells (DC). Methodology/Principal Findings: Monocyte-derived DC obtained from 18 HNSCC patients and 12 healthy donors were matured using IRX-2 or a mix of TNF-alpha, IL-1 beta and IL-6 ("conv. mix''). Multicolor flow cytometry was used to study the DC phenotype and antigen processing machinery (APM) component expression. ELISPOT and cytotoxicity assays were used to evaluate tumor-reactive cytotoxic T lymphocytes (CTL). IL-12p70 and IL-10 production by DC was measured by Luminex (R) and DC migration toward CCL21 was tested in transwell migration assays. IRX-2-matured DC functions were compared with those of conv. mix-matured DC. IRX-2-matured DC expressed higher levels (p<0.05) of CD11c, CD40, CCR7 as well as LMP2, TAP1, TAP2 and tapasin than conv. mix-matured DC. IRX-2-matured DC migrated significantly better towards CCL21, produced more IL-12p70 and had a higher IL12p70/IL-10 ratio than conv. mix-matured DC (p<0.05 for all). IRX-2-matured DC carried a higher density of tumor antigen-derived peptides, and CTL primed with these DC mediated higher cytotoxicity against tumor targets (p<0.05) compared to the conv. mix-matured DC. Conclusion: Excellent ability of IRX-2 to induce ex vivo DC maturation in HNSCC patients explains, in part, its clinical benefits and emphasizes its utility in ex vivo maturation of DC generated for therapy.	[Schilling, Bastian; Harasymczuk, Malgorzata; Schuler, Patrick; Ferrone, Soldano; Whiteside, Theresa L.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Schilling, Bastian; Harasymczuk, Malgorzata; Schuler, Patrick; Ferrone, Soldano; Whiteside, Theresa L.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Egan, James] IRX Therapeut Inc, Farmingdale, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whiteside, TL (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	whitesidetl@upmc.edu	Schilling, Bastian/AAY-8646-2020	Schilling, Bastian/0000-0001-8859-4103	National Institutes of Health [PO-1 CA 109688]; NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research described in this article was supported in part by National Institutes of Health grant PO-1 CA 109688 to TLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Ahmadi M, 2008, CANCER RES, V68, P7520, DOI 10.1158/0008-5472.CAN-08-1060; Almand B, 2000, CLIN CANCER RES, V6, P1755; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bandoh N, 2005, TISSUE ANTIGENS, V66, P185, DOI 10.1111/j.1399-0039.2005.00462.x; Berinstein NL, 2012, CANCER IMMUNOL IMMUN, V61, P771, DOI 10.1007/s00262-011-1134-z; Butterfield LH, 2008, J IMMUNOTHER, V31, P89, DOI 10.1097/CJI.0b013e318158fce0; Chaux P, 1996, LAB INVEST, V74, P975; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Egan JE, 2007, J IMMUNOTHER, V30, P624, DOI 10.1097/CJI.0b013e3180691593; Frasca L, 2008, J IMMUNOL, V180, P1471, DOI 10.4049/jimmunol.180.3.1471; Gabrilovich DI, 1997, CLIN CANCER RES, V3, P483; HEO DS, 1989, CANCER RES, V49, P5167; Hoffmann TK, 2000, J IMMUNOL, V165, P5938, DOI 10.4049/jimmunol.165.10.5938; Hoffmann TK, 2001, J IMMUNOTHER, V24, P162, DOI 10.1097/00002371-200103000-00011; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalinski P, 2009, CURR OPIN INVEST DR, V10, P526; Kim GG, 2007, J IMMUNOL METHODS, V325, P51, DOI 10.1016/j.jim.2007.05.013; Kirkwood JM, 2009, CLIN CANCER RES, V15, P1443, DOI 10.1158/1078-0432.CCR-08-1231; LANGLADEDEMOYEN P, 1994, INT IMMUNOL, V6, P1759, DOI 10.1093/intimm/6.11.1759; Lopez-Abaitero A, 2009, J IMMUNOTHER, V32, P465, DOI 10.1097/CJI.0b013e3181a1c24e; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Muthuswamy R, 2010, BLOOD, V116, P1454, DOI 10.1182/blood-2009-12-258038; Ogino T, 2003, TISSUE ANTIGENS, V62, P385, DOI 10.1034/j.1399-0039.2003.00114.x; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Pinzon-Charry A, 2005, IMMUNOL CELL BIOL, V83, P451, DOI 10.1111/j.1440-1711.2005.01371.x; Poon IKH, 2010, J LEUKOCYTE BIOL, V88, P559, DOI 10.1189/jlb.0210087; Procko E, 2009, CURR OPIN IMMUNOL, V21, P84, DOI 10.1016/j.coi.2009.02.003; Rapidis AD, 2009, J ONCOL, V2009, DOI 10.1155/2009/346345; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680; Schilling B, 2012, J MOL MED, V90, P139, DOI 10.1007/s00109-011-0813-8; TEMPONI M, 1989, HYBRIDOMA, V8, P85, DOI 10.1089/hyb.1989.8.85; Visus C, 2007, CANCER RES, V67, P10538, DOI 10.1158/0008-5472.CAN-07-1346; Wang XH, 2005, J IMMUNOL METHODS, V299, P139, DOI 10.1016/j.jim.2005.02.006; Whiteside TL, 2012, CANCER IMMUNOL IMMUN, V61, P783, DOI 10.1007/s00262-011-1136-x; Whiteside TL, 2004, J IMMUNOL, V173, P1526, DOI 10.4049/jimmunol.173.3.1526; Wolf GT, 2011, HEAD NECK-J SCI SPEC, V33, P1666, DOI 10.1002/hed.21660; Young MRI, 1997, INT J CANCER, V74, P69, DOI 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D	41	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e47234	10.1371/journal.pone.0047234	http://dx.doi.org/10.1371/journal.pone.0047234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408925	gold, Green Accepted, Green Published			2022-12-27	WOS:000315157200002
J	Boscoe, FP; Schymura, MJ; Zhang, XL; Kramer, RA				Boscoe, Francis P.; Schymura, Maria J.; Zhang, Xiuling; Kramer, Rachel A.			Heuristic Algorithms for Assigning Hispanic Ethnicity	PLOS ONE			English	Article							MEDICARE ADMINISTRATIVE DATA; RACE; DISPARITIES; IDENTIFICATION; RACE/ETHNICITY; WHITE	We compared several techniques for assigning Hispanic ethnicity to records in data systems where this information may be missing, variously making use of country of origin, surname, race, and county of residence. We considered an algorithm in use by the North American Association of Central Cancer Registries (NAACCR), a variation of this developed by the authors, a "fast and frugal'' algorithm developed with the aid of recursive partitioning methods, and conventional logistic regression. With the exception of logistic regression, each approach was rule-based: if specific criteria were met, an ethnicity assignment was made; otherwise, the next criterion was considered, until all records were assigned. We evaluated the algorithms on a sample of over 500,000 female clients from the New York State Cancer Services Program for whom self-reported Hispanic ethnicity was known. We found that all approaches yielded similarly high accuracy, sensitivity, and positive predictive value in all parts of the state, from areas with very low to very high Hispanic populations. An advantage of the fast and frugal method is that it consists of a small number of easily remembered steps.	[Boscoe, Francis P.; Schymura, Maria J.; Zhang, Xiuling] New York State Dept Hlth, New York State Canc Registry, Albany, NY 12201 USA; [Kramer, Rachel A.] New York State Dept Hlth, New York State Canc Serv Program, Albany, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) System	Boscoe, FP (corresponding author), New York State Dept Hlth, New York State Canc Registry, Albany, NY 12201 USA.	fpb01@health.state.ny.us			Centers for Disease Control and Prevention's Cooperative Agreement [U58/DP000783]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000783] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention's Cooperative Agreement; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported in part by the Centers for Disease Control and Prevention's Cooperative Agreement U58/DP000783 (http://www.cdc.gov/), awarded to the New York State Department of Health through the National Program of Cancer Registries. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 2011, J PUBLIC HEALTH MAN, V17, P167, DOI 10.1097/PHH.0b013e3181f5426c; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Comstock RD, 2004, AM J EPIDEMIOL, V159, P611, DOI 10.1093/aje/kwh084; COOK EF, 1984, J CHRON DIS, V37, P721, DOI 10.1016/0021-9681(84)90041-9; Czerlinski Jean, 1999, SIMPLE HEURISTICS MA, P97, DOI DOI 10.1002/(SICI)1099-0771(200004/06)13:2<161::AID-BDM348>3.0.CO;2-P; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Elliott MN, 2008, HEALTH SERV RES, V43, P1722, DOI 10.1111/j.1475-6773.2008.00854.x; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P75; Lin SS, 2000, EPIDEMIOL REV, V22, P187, DOI 10.1093/oxfordjournals.epirev.a018032; Ma IWY, 2007, J CLIN EPIDEMIOL, V60, P572, DOI 10.1016/j.jclinepi.2006.11.009; Marrow H, 2003, ETHNICITIES, V3, P427, DOI DOI 10.1177/1468796803003004001; McAlpine DD, 2007, HEALTH SERV RES, V42, P2373, DOI 10.1111/j.1475-6773.2007.00771.x; Morgan RO, 2004, MED CARE, V42, P810, DOI 10.1097/01.mlr.0000132392.49176.5a; NAACCR Race and Ethnicity Work Group, 2011, NAACCR GUID ENH HISP; NAACCR Race and Ethnicity Work Group, 2010, NAACCR AS PAC ISL ID; National Research Council, 2004, ELIMINATING HLTH DIS, DOI [10.17226/10979, DOI 10.17226/10979]; North American Association of Central Cancer Registries, 2012, CINA DEL AN FIL; Passel Jeffrey, 2009, WHOS HISPANIC; Perkins RC., 1993, EVALUATING PASSEL WO; Rebbeck TR, 2006, J CLIN ONCOL, V24, P2164, DOI 10.1200/JCO.2005.05.1656; Smith DP, 2006, AM J PUBLIC HEALTH, V96, P1686, DOI 10.2105/AJPH.2003.035378; Stroupe KT, 2010, J REHABIL RES DEV, V47, P781, DOI 10.1682/JRRD.2009.08.0122; Thornton M, 2009, STANDARDS CANC REGIS, VII; Wei II, 2006, HEALTH SERV RES, V41, P1469, DOI 10.1111/j.1475-6773.2006.00550.x; Word DL, 2007, FREQUENTLY OCCURRING	26	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55689	10.1371/journal.pone.0055689	http://dx.doi.org/10.1371/journal.pone.0055689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405197	Green Published, gold			2022-12-27	WOS:000315153400142
J	Chiodin, M; Borve, A; Berezikov, E; Ladurner, P; Martinez, P; Hejnol, A				Chiodin, Marta; Borve, Aina; Berezikov, Eugene; Ladurner, Peter; Martinez, Pedro; Hejnol, Andreas			Mesodermal Gene Expression in the Acoel Isodiametra pulchra Indicates a Low Number of Mesodermal Cell Types and the Endomesodermal Origin of the Gonads	PLOS ONE			English	Article							SEA-URCHIN EMBRYO; CNIDARIAN NEMATOSTELLA-VECTENSIS; LEFT-RIGHT ASYMMETRY; MUSCLE LIM PROTEIN; STEM-CELLS; TRANSCRIPTION FACTORS; FOX GENES; DEVELOPMENTAL EXPRESSION; INDEPENDENT EVOLUTION; AMPHIOXUS DEVELOPMENT	Acoelomorphs are bilaterally symmetric small marine worms that lack a coelom and possess a digestive system with a single opening. Two alternative phylogenetic positions of this group within the animal tree are currently debated. In one view, Acoelomorpha is the sister group to all remaining Bilateria and as such, is a morphologically simple stepping stone in bilaterian evolution. In the other, the group is a lineage within the Deuterostomia, and therefore, has derived a simple morphology from a more complex ancestor. Acoels and the closely related Nemertodermatida and Xenoturbellida, which together form the Acoelomorpha, possess a very limited number of cell types. To further investigate the diversity and origin of mesodermal cell types we describe the expression pattern of 12 orthologs of bilaterian mesodermal markers including Six1/2, Twist, FoxC, GATA4/5/6, in the acoel Isodiametra pulchra. All the genes are expressed in stem cells (neoblasts), gonads, and at least subsets of the acoel musculature. Most are expressed in endomesodermal compartments of I. pulchra developing embryos similar to what has been described in cnidarians. Our molecular evidence indicates a very limited number of mesodermal cell types and suggests an endomesodermal origin of the gonads and the stem cell system. We discuss our results in light of the two prevailing phylogenetic positions of Acoelomorpha.	[Chiodin, Marta; Martinez, Pedro] Univ Barcelona, Dept Genet, Barcelona, Spain; [Borve, Aina; Hejnol, Andreas] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Ladurner, Peter] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Ladurner, Peter] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Berezikov, Eugene] Hubrecht Inst, Utrecht, Netherlands; [Martinez, Pedro] ICREA, Barcelona, Spain	University of Barcelona; University of Bergen; University of Innsbruck; University of Innsbruck; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); ICREA	Hejnol, A (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway.	andreas.hejnol@sars.uib.no	Martinez, Pedro/O-5025-2014; Berezikov, Eugene/D-3363-2013; Hejnol, Andreas/C-5577-2012	Martinez, Pedro/0000-0003-3956-7541; Berezikov, Eugene/0000-0002-1145-2884; Hejnol, Andreas/0000-0003-2196-8507; Ladurner, Peter/0000-0002-0323-9266	FP7 Marie Curie International Re-integration Grant (IRG) [246450]; Spanish Ministry of Science and Innovation [BFU2006-00898/BMC]; Austrian Science Fund (FWF) [18099]; ICREA Funding Source: Custom	FP7 Marie Curie International Re-integration Grant (IRG); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ICREA(ICREA)	The work was supported by the following funding agencies: FP7 Marie Curie International Re-integration Grant (IRG) "Mesoderm Evolution" (246450) to AH (http://tinyurl.com/9covbsz); the Spanish Ministry of Science and Innovation to MC and PM (BFU2006-00898/BMC) (http://www.idi.mineco.gob.es); Austrian Science Fund (FWF) (http://www.fwf.ac.at) 18099 to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arenas-Mena C, 2008, J EXP ZOOL PART B, V310B, P567, DOI 10.1002/jez.b.21225; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Ax P, 1996, MULTICELLULAR ANIMAL; Azzaria M, 1996, DEV BIOL, V178, P289, DOI 10.1006/dbio.1996.0219; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Boone M, 2010, ACTA ZOOLOGICA, V92, P101; Boone M, 2011, ZOOMORPHOLOGY, V130, P273, DOI 10.1007/s00435-011-0137-9; Boorman CJ, 2002, EVOL DEV, V4, P354, DOI 10.1046/j.1525-142X.2002.02021.x; Boyer BC, 1996, DEV BIOL, V179, P329, DOI 10.1006/dbio.1996.0264; Boyle MJ, 2008, EVOL DEV, V10, P89, DOI 10.1111/j.1525-142X.2007.00216.x; Boyle MJ, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-2; Bresslau E., 1909, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V19; Burton PM, 2008, J EXP ZOOL PART B, V310B, P5, DOI 10.1002/jez.b.21150; Cannon HG, 1925, NATURE, V115, P458, DOI 10.1038/115458a0; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Chiodin M, 2011, J EXP ZOOL PART B, V316B, P427, DOI 10.1002/jez.b.21416; Ciglar L, 2009, CURR OPIN CELL BIOL, V21, P754, DOI 10.1016/j.ceb.2009.10.001; Clark R. B., 1964, DYNAMICS METAZOAN EV; Croce J, 2001, MECH DEVELOP, V107, P159, DOI 10.1016/S0925-4773(01)00470-1; De Mulder K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-69; De Mulder K, 2009, DEV BIOL, V334, P198, DOI 10.1016/j.ydbio.2009.07.019; De-Leon SBT, 2010, P NATL ACAD SCI USA, V107, P10103, DOI 10.1073/pnas.1004824107; Dolmatov IY, 2007, CELL TISSUE RES, V327, P371, DOI 10.1007/s00441-006-0314-1; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Egger B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005502; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; FRANSEN ME, 1980, ZOOMORPHOLOGIE, V95, P235, DOI 10.1007/BF00998124; Fritzenwanker JH, 2004, DEV BIOL, V275, P389, DOI 10.1016/j.ydbio.2004.08.014; Gardiner EG, 1895, J MORPHOL, V11, P155; Genikhovich G, 2011, DEVELOPMENT, V138, P4911, DOI 10.1242/dev.068122; Graff Ludwig von, 1891, ORG TURBELLARIA ACOE; Gschwentner R, 2001, CELL TISSUE RES, V304, P401, DOI 10.1007/s004410100375; Harada Y, 1996, MECH DEVELOP, V60, P163, DOI 10.1016/S0925-4773(96)00608-9; Haszprunar G, 1996, J ZOOL SYST EVOL RES, V34, P41; Hejnol A, 2008, NATURE, V456, P382, DOI 10.1038/nature07309; Hejnol A, 2008, PHILOS T R SOC B, V363, P1493, DOI 10.1098/rstb.2007.2239; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Henry JQ, 2000, DEV BIOL, V220, P285, DOI 10.1006/dbio.2000.9628; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Hooge MD, 2005, J ZOOL SYST EVOL RES, V43, P100, DOI 10.1111/j.1439-0469.2005.00301.x; Hooge MD, 2002, MOL PHYLOGENET EVOL, V24, P333, DOI 10.1016/S1055-7903(02)00236-1; Hooge MD, 2001, J MORPHOL, V249, P171, DOI 10.1002/jmor.1048; Horton AC, 2002, J EXP ZOOL, V294, P112, DOI 10.1002/jez.10151; Hyman LH, 1951, PLATYHELMINTHES RHYN; Jondelius U, 2011, SYST BIOL, V60, P845, DOI 10.1093/sysbio/syr073; Koinuma S, 2000, GENE, V259, P171, DOI 10.1016/S0378-1119(00)00426-1; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Kozmik Z, 2007, DEV BIOL, V306, P143, DOI 10.1016/j.ydbio.2007.03.009; Ladurner P, 2000, DEV BIOL, V222, P359, DOI 10.1006/dbio.2000.9715; Lee PY, 2007, DEV BIOL, V307, P434, DOI 10.1016/j.ydbio.2007.05.005; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Martin-Duran JM, 2010, DEV BIOL, V340, P145, DOI 10.1016/j.ydbio.2010.01.018; Martindale MQ, 1999, DEV BIOL, V214, P243, DOI 10.1006/dbio.1999.9427; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Mazet F, 2006, CURR BIOL, V16, pR314, DOI 10.1016/j.cub.2006.03.088; Moreno E, 2010, EVOL DEV, V12, P258, DOI 10.1111/j.1525-142X.2010.00411.x; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Obst M, 2011, ACTA ZOOL-STOCKHOLM, V92, P109, DOI 10.1111/j.1463-6395.2010.00496.x; Pfister D, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-9; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Remane A., 1950, VERH DTSCH ZOOL GES, V14, P16; Remane A., 1963, LOWER METAZOA, P78; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Rieger R, 1985, ORIGINS RELATIONSHIP, P101; RIEGER RM, 1987, ZOOMORPHOLOGY, V107, P191, DOI 10.1007/BF00312261; Rieger RM, 2005, HYDROBIOLOGIA, V535, P127, DOI 10.1007/s10750-004-4381-6; Rieger RM, 2003, INTEGR COMP BIOL, V43, P47, DOI 10.1093/icb/43.1.47; Rieger RM, 1991, MICROSCOPIC ANATOMY, V3, P7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Ruppert EE, 1991, MICROSCOPIC ANATOMY, V4, P1; Salvini-Plawen L, 1978, J ZOOL SYST EVOL, P16; SALVINIPLAWEN LV, 1979, Z ZOOL SYST EVOL, V17, P10; Satoh G, 2002, J EXP ZOOL, V294, P136, DOI 10.1002/jez.10149; Schmidt-Rhaesa A, 2007, EVOLUTION ORGAN SYST; Scholz CB, 2003, DEV GENES EVOL, V212, P563, DOI 10.1007/s00427-002-0272-x; SCHUCHERT P, 1990, ACTA ZOOL-STOCKHOLM, V71, P5, DOI 10.1111/j.1463-6395.1990.tb01175.x; Seipel K, 2005, DEV BIOL, V282, P14, DOI 10.1016/j.ydbio.2005.03.032; Seipel K, 2004, INT J DEV BIOL, V48, P1, DOI 10.1387/ijdb.15005568; Seipel K, 2006, INT J DEV BIOL, V50, P589, DOI 10.1387/ijdb.062150ks; Semmler H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-14; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shankland M., 1997, EMBRYOLOGY CONSTRUCT; Shimeld SM, 2010, DEV BIOL, V340, P234, DOI 10.1016/j.ydbio.2010.01.015; SMITH JPS, 1991, T AM MICROSC SOC, V110, P12; SMITH PR, 1986, J MORPHOL, V188, P257, DOI 10.1002/jmor.1051880302; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; Stach T, 2002, ACTA ZOOL-STOCKHOLM, V83, P25, DOI 10.1046/j.1463-6395.2002.00097.x; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018; STORCH V, 1989, T AM MICROSC SOC, V108, P245, DOI 10.2307/3226343; Stronach BE, 1999, MOL BIOL CELL, V10, P2329, DOI 10.1091/mbc.10.7.2329; Tagawa K, 2000, J EXP ZOOL, V288, P23, DOI 10.1002/(SICI)1097-010X(20000415)288:1<23::AID-JEZ3>3.0.CO;2-H; Technau U, 2003, INT J DEV BIOL, V47, P531; Tu Q, 2006, DEV BIOL, V300, P49, DOI 10.1016/j.ydbio.2006.09.031; Tyler S, 1999, ZOOMORPHOLOGY, V119, P127, DOI 10.1007/s004350050087; Tyler S, 2001, INTERRELATIONSHIPS P, P3; Tyler S, 1985, ORIGINS RELATIONSHIP, P123; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Wang YY, 2010, GENE DEV, V24, P2081, DOI 10.1101/gad.1951010; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529; Wotton KR, 2008, DEV DYNAM, V237, P1590, DOI 10.1002/dvdy.21553; Yankura KA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-143; Yasui K, 1998, DEV BIOL, V195, P49, DOI 10.1006/dbio.1997.8834; Yasui K, 2000, DEVELOPMENT, V127, P187; Zhang Y, 2007, SCI CHINA SER C, V50, P637, DOI 10.1007/s11427-007-0082-5	113	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55499	10.1371/journal.pone.0055499	http://dx.doi.org/10.1371/journal.pone.0055499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405161	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400106
J	Lachaud, CC; Pezzolla, D; Dominguez-Rodriguez, A; Smani, T; Soria, B; Hmadcha, A				Claude Lachaud, Christian; Pezzolla, Daniela; Dominguez-Rodriguez, Alejandro; Smani, Tarik; Soria, Bernat; Hmadcha, Abdelkrim			Functional Vascular Smooth Muscle-like Cells Derived from Adult Mouse Uterine Mesothelial Cells	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; IN-VITRO; IMMUNOHISTOCHEMICAL MARKERS; DIFFERENTIAL EXPRESSION; SEROSAL MESOTHELIUM; PERITONEAL-DIALYSIS; EPICARDIAL CELLS; H-CALDESMON; STEM-CELLS; MYOFIBROBLASTS	In mammalian visceral organs, vascular smooth muscle cells (VSMCs) originate from an epithelial-to-mesenchymal transition (EMT) of embryonic mesothelial cells (MCs). The ability of adult MCs to recapitulate EMT and to acquire smooth muscle (SM) markers upon provasculogenic culture suggested they might retain embryonic vasculogenic differentiation potential. However, it remains unknown whether adult MCs-derived SM-like cells may acquire specific vascular SM lineage markers and the functionality of differentiated contractile VSMCs. Here, we describe how a gentle trypsinization of adult mouse uterine cords could selectively detach their outermost uterine mesothelial layer cells. As other MCs; uterine MCs (UtMCs) uniformly expressed the epithelial markers beta-catenin, ZO-1, E-cadherin, CD54, CD29, and CK18. When cultured in a modified SM differentiation media (SMDM) UtMCs initiated a loss of epithelial characteristics and gained markers expression of EMT (Twist, Snail, and Slug), stem and progenitor (Nanog, Sox2, C-kit, Gata-4, Isl-1, and nestin), SM (alpha-SMA, calponin, caldesmon, SM22 alpha, desmin, SM-MHC, and smoothelin-B) and cardiac (BMP2, BMP4, ACTC1, sACTN, cTnI, cTnT, ANF, Cx43, and MLC2a). UtMCs repeatedly subcultured in SMDM acquired differentiated VSM-like characteristics and expressed smoothelin-B in the typical stress-fiber pattern expression of contractile VSMCs. Relevantly, UtMCs-derived VSM-like cells could generate "mechanical force" to compact collagen lattices and displayed in diverse degree voltage (K+) and receptor (endothelin-1, oxytocin, norepinephrine, carbachol and vasopressin)-induced [Ca2+](i) rises and contraction. Thus, we show for the first time that UtMCs could recapitulate in vitro differentiative events of early cardiovascular differentiation and transdifferentiate in cells exhibiting molecular and functional characteristics of VSMCs.	[Claude Lachaud, Christian; Pezzolla, Daniela; Soria, Bernat; Hmadcha, Abdelkrim] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Dominguez-Rodriguez, Alejandro; Smani, Tarik] Inst Biomed Sevilla Fisiopatol Cardiovasc, Seville, Spain; [Soria, Bernat; Hmadcha, Abdelkrim] CIBER Diabet & Enfermedades Metabol Asociadas CIB, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Soria, B (corresponding author), Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain.	bernat.soria@cabimer.es; karim.hmadcha@cabimer.es	Lachaud, Christian Claude/C-2036-2017; IBIS, CARDIOVASCULAR/P-3910-2015; , Bernat/AAL-6470-2021; Hmadcha, Abdelkrim/T-1173-2019; Hajami, Tarik Smani/D-5372-2016	Lachaud, Christian Claude/0000-0001-8698-4589; Hmadcha, Abdelkrim/0000-0002-4105-3702; Hajami, Tarik Smani/0000-0002-1877-7438; , Daniela/0000-0001-8060-3706; Dominguez Rodriguez, Alejandro/0000-0002-3508-8538; Soria, Bernat/0000-0002-2356-0380	Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia [PI-0022/2008]; Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia [CTS-6505, INP-2011-1615-900000]; FEDER; Instituto de Salud Carlos III [RD06/0010/0025, PI10/00964]; Ministry of Health and Consumer Affairs [TRA-120]	Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); FEDER(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministry of Health and Consumer Affairs	Authors are supported by the Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia (Grant PI-0022/2008); Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia (Grant CTS-6505; INP-2011-1615-900000); FEDER co-funded grants from Instituto de Salud Carlos III (Red TerCel-Grant RD06/0010/0025; PI10/00964) and the Ministry of Health and Consumer Affairs (Advanced Therapies Program Grant TRA-120). CIBERDEM is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Boselli C, 2002, J UROLOGY, V168, P2672, DOI 10.1016/S0022-5347(05)64242-5; Brown DJ, 2005, J VASC SURG, V41, P509, DOI 10.1016/j.jvs.2004.12.024; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Ceballos KM, 2000, AM J CLIN PATHOL, V114, P746, DOI 10.1309/K5JP-A9EN-UWN7-B5GG; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Chen YL, 1999, EUR J PHARMACOL, V376, P45, DOI 10.1016/S0014-2999(99)00351-9; Chiavegato A, 1999, J MUSCLE RES CELL M, V20, P133, DOI 10.1023/A:1005411201187; Comin CE, 2007, AM J SURG PATHOL, V31, P1139, DOI 10.1097/PAS.0b013e318033e7a8; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; Deruiter MC, 2001, DEV DYNAM, V221, P460, DOI 10.1002/dvdy.1156; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; FUKURODA T, 1994, BRIT J PHARMACOL, V113, P336, DOI 10.1111/j.1476-5381.1994.tb16901.x; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Hegde SS, 1997, BRIT J PHARMACOL, V120, P1409, DOI 10.1038/sj.bjp.0701048; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; Ijpenberg A, 2007, DEV BIOL, V312, P157, DOI 10.1016/j.ydbio.2007.09.014; Jain M, 1996, J CLIN INVEST, V98, P877; Jankowski M, 2000, P NATL ACAD SCI USA, V97, P6207, DOI 10.1073/pnas.110137497; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Kawaguchi M, 2007, DEV DYNAM, V236, P2973, DOI 10.1002/dvdy.21334; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Kim MR, 2009, STEM CELLS, V27, P191, DOI 10.1634/stemcells.2008-0363; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Liu JD, 2010, CIRC RES, V106, P1818, DOI 10.1161/CIRCRESAHA.110.217950; Liu QH, 2008, PERITON DIALYSIS INT, V28, pS88; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Masaki T, 2004, TRENDS PHARMACOL SCI, V25, P219, DOI 10.1016/j.tips.2004.02.008; Matsubara D, 2009, MODERN PATHOL, V22, P776, DOI 10.1038/modpathol.2009.27; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mutsaers S E, 2007, Cancer Treat Res, V134, P1; Mutsaers SE, 1997, EUR J CELL BIOL, V72, P24; Nasreen N, 2009, AM J PHYSIOL-LUNG C, V297, pL115, DOI 10.1152/ajplung.90587.2008; Oikawa H, 2010, EXP CELL RES, V316, P940, DOI 10.1016/j.yexcr.2009.10.025; Oishi K, 2000, AM J PHYSIOL-CELL PH, V279, pC1432, DOI 10.1152/ajpcell.2000.279.5.C1432; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pacini S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009861; Patel P, 2010, MATRIX BIOL, V29, P97, DOI 10.1016/j.matbio.2009.10.004; Patel P, 2010, KIDNEY INT, V77, P319, DOI 10.1038/ki.2009.436; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Qiu XF, 2008, HUM PATHOL, V39, P846, DOI 10.1016/j.humpath.2007.10.010; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rensen SS, 2008, CIRCULATION, V118, P828, DOI 10.1161/CIRCULATIONAHA.107.743690; Schlueter J, 2006, DEV BIOL, V295, P546, DOI 10.1016/j.ydbio.2006.03.036; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2007, CIRC RES, V101, P1194, DOI 10.1161/CIRCRESAHA.107.159053; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; Vedernikov YP, 2006, AM J OBSTET GYNECOL, V194, P252, DOI 10.1016/j.ajog.2005.05.006; Wada AM, 2003, CIRC RES, V92, P525, DOI 10.1161/01.RES.0000060484.11032.0B; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	68	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55181	10.1371/journal.pone.0055181	http://dx.doi.org/10.1371/journal.pone.0055181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405120	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400064
J	Gai, SP; Zhang, YX; Liu, CY; Zhang, Y; Zheng, GS				Gai, Shupeng; Zhang, Yuxi; Liu, Chunying; Zhang, Yang; Zheng, Guosheng			Transcript Profiling of Paoenia ostii during Artificial Chilling Induced Dormancy Release Identifies Activation of GA Pathway and Carbohydrate Metabolism	PLOS ONE			English	Article							HISTONE H2B MONOUBIQUITINATION; BUD DORMANCY; GENE-EXPRESSION; LEAFY SPURGE; CROWN BUDS; CELL-CYCLE; GIBBERELLIN BIOSYNTHESIS; PAEONIA-SUFFRUTICOSA; HYDROGEN CYANAMIDE; RESPONSE PATHWAYS	Endo-dormant flower buds must pass through a period of chilling to reinitiate growth and subsequent flowering, which is a major obstacle to the forcing culture of tree peony in winter. Customized cDNA microarray (8x15 K element) was used to investigate gene expression profiling in tree peony 'Feng Dan Bai' buds during 24 d chilling treatment at 0-4 degrees C. According to the morphological changes after the whole plants were transferred to green house, endo-dormancy was released after 18 d chilling treatment, and prolonged chilling treatment increased bud break rate. Pearson correlation hierarchical clustering of sample groups was highly consistent with the dormancy transitions revealed by morphological changes. Totally 3,174 significantly differentially-expressed genes (P<0.05) were observed through endo-dormancy release process, of which the number of up-regulated (1,611) and that of down-regulated (1,563) was almost the same. Functional annotation of differentially-expressed genes revealed that cellular process, metabolic process, response to stimulus, regulation of biological process and development process were well-represented. Hierarchical clustering indicated that activation of genes involved in carbohydrate metabolism (Glycolysis, Citrate cycle and Pentose phosphate pathway), energy metabolism and cell growth. Based on the results of GO analysis, totally 51 probes presented in the microarray were associated with GA response and GA signaling pathway, and 22 of them were differently expressed. The expression profiles also revealed that the genes of GA biosynthesis, signaling and response involved in endo-dormancy release. We hypothesized that activation of GA pathway played a central role in the regulation of dormancy release in tree peony.	[Gai, Shupeng; Zhang, Yuxi; Liu, Chunying; Zhang, Yang; Zheng, Guosheng] Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Univ Shandong Prov, Qingdao, Peoples R China	Qingdao Agricultural University	Zheng, GS (corresponding author), Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Univ Shandong Prov, Qingdao, Peoples R China.	gszheng@qau.edu.cn			National Natural Science Foundation of China [30871728, 31071828, 31101577]; National Natural Science Foundation of Shandong province [ZR2009DM002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shandong province	This work was supported by grants from National Natural Science Foundation of China (30871728, 31071828 and 31101577) and National Natural Science Foundation of Shandong province (ZR2009DM002). The funders have very important role in material collection and reserve, study design, data collection and analysis, amending of the manuscript and decision to publish.	Anderson JV, 2005, PLANT CELL ENVIRON, V28, P1567, DOI 10.1111/j.1365-3040.2005.01393.x; Bonhomme M, 2000, TREE PHYSIOL, V20, P615; Campbell MA, 1996, PHYSIOL PLANTARUM, V98, P743, DOI 10.1111/j.1399-3054.1996.tb06680.x; DEVITT ML, 1995, PLANT MOL BIOL, V29, P255, DOI 10.1007/BF00043650; Dogramaci M, 2010, PLANT MOL BIOL, V73, P207, DOI 10.1007/s11103-010-9621-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erez A, 1995, ACTA HORTIC, P81, DOI 10.17660/ActaHortic.1995.395.7; Espinosa-Ruiz A, 2004, PLANT J, V38, P603, DOI 10.1111/j.1365-313X.2004.02070.x; Santamaria ME, 2011, ANN BOT-LONDON, V108, P485, DOI 10.1093/aob/mcr185; FLORE JA, 1996, PHOTOASSIMILATE DIST, P797; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Francis D, 2001, PLANT GROWTH REGUL, V33, P1, DOI 10.1023/A:1010762111585; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Halaly T, 2008, PLANTA, V228, P79, DOI 10.1007/s00425-008-0720-6; Hartweck LM, 2008, PLANTA, V229, P1, DOI 10.1007/s00425-008-0830-1; Hedley PE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-202; Hewezi T, 2006, J EXP BOT, V57, P3109, DOI 10.1093/jxb/erl080; Horvath DP, 2006, WEED SCI, V54, P821, DOI 10.1614/WS-06-06R1.1; Horvath DP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-536; Horvath DP, 2002, PLANT PHYSIOL, V128, P1439, DOI 10.1104/pp.010885; Huang X, 2008, ACTA PHYSIOL PLANT, V30, P797, DOI 10.1007/s11738-008-0184-0; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jiang C, 2007, CURR OPIN PLANT BIOL, V10, P461, DOI 10.1016/j.pbi.2007.08.011; Keilin T, 2007, PLANT SCI, V173, P446, DOI 10.1016/j.plantsci.2007.07.004; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; LANG GA, 1987, HORTSCIENCE, V22, P371; Liu Bo, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P1635; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Luo YR, 2008, J HEFEI U, V18, P78; Marquat C, 1999, SCI HORTIC-AMSTERDAM, V79, P151, DOI 10.1016/S0304-4238(98)00203-9; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Ophir R, 2009, PLANT MOL BIOL, V71, P403, DOI 10.1007/s11103-009-9531-9; Or E, 2000, PLANT MOL BIOL, V43, P483, DOI 10.1023/A:1006450516982; Or E., 2009, GRAPEVINE MOL PHYSL, P1, DOI DOI 10.1007/978-90-481-2305-6_1; Pang XQ, 2007, J EXP BOT, V58, P3249, DOI 10.1093/jxb/erm172; Panneerselvam R, 2007, COLLOID SURFACE B, V59, P59, DOI 10.1016/j.colsurfb.2007.04.006; Perez FJ, 2007, FUNCT PLANT BIOL, V34, P624, DOI 10.1071/FP06272; Rinne PLH, 2011, PLANT CELL, V23, P130, DOI 10.1105/tpc.110.081307; Rodrigo MJ, 2006, J EXP BOT, V57, P633, DOI 10.1093/jxb/erj048; Rohde A, 2000, FOR SCI, V64, P89; Ruonala R, 2006, PLANT J, V46, P628, DOI 10.1111/j.1365-313X.2006.02722.x; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Smalle J, 1997, PHYSIOL PLANTARUM, V100, P593, DOI 10.1034/j.1399-3054.1997.1000322.x; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sozzi G. O., 2004, Ciencia e Investigacion Agraria, V31, P101; Walton EF, 2009, J EXP BOT, V60, P3835, DOI 10.1093/jxb/erp231; WANG SY, 1991, PHYSIOL PLANTARUM, V82, P231, DOI 10.1111/j.1399-3054.1991.tb00086.x; Wang ZongZheng, 1996, Acta Horticulturae Sinica, V23, P307; Wu CT, 2001, PLANT PHYSIOL, V126, P1299, DOI 10.1104/pp.126.3.1299; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Zheng GuoSheng, 2009, Scientia Silvae Sinicae, V45, P48; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	64	47	60	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55297	10.1371/journal.pone.0055297	http://dx.doi.org/10.1371/journal.pone.0055297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405132	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400077
J	Goldenberg, DM; Gold, DV; Loo, M; Liu, DL; Chang, CH; Jaffe, ES				Goldenberg, David M.; Gold, David V.; Loo, Meiyu; Liu, Donglin; Chang, Chien-Hsing; Jaffe, Elaine S.			Horizontal Transmission of Malignancy: In-Vivo Fusion of Human Lymphomas with Hamster Stroma Produces Tumors Retaining Human Genes and Lymphoid Pathology	PLOS ONE			English	Article							REED-STERNBERG CELLS; HODGKINS-DISEASE; NUDE-MICE; B-CELL; METASTATIC PHENOTYPE; HOST-CELLS; CANCER; TRANSFORMATION; CHROMOSOME; BIOLOGY	We report the in-vivo fusion of two Hodgkin lymphomas with golden hamster cheek pouch cells, resulting in serially transplanted (over 5-6 years) GW-532 and GW-584 heterosynkaryon tumor cells displaying both human and hamster DNA (by FISH), lymphoma-like morphology, aggressive metastasis, and retention of 7 human genes (CD74, CXCR4, CD19, CD20, CD71, CD79b, and VIM) out of 24 tested by PCR. The prevalence of B-cell restricted genes (CD19, CD20, and CD79b) suggests that this uniform population may be the clonal initiating (malignant) cells of Hodgkin lymphoma, despite their not showing translation to their respective proteins by immunohistochemical analysis. This is believed to be the first report of in-vivo cell-cell fusion of human lymphoma and rodent host cells, and may be a method to disclose genes regulating both organoid and metastasis signatures, suggesting that the horizontal transfer of tumor DNA to adjacent stromal cells may be implicated in tumor heterogeneity and progression. The B-cell gene signature of the hybrid xenografts suggests that Hodgkin lymphoma, or its initiating cells, is a B-cell malignancy.	[Goldenberg, David M.; Gold, David V.] Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ USA; [Loo, Meiyu; Liu, Donglin; Chang, Chien-Hsing] Immunomedics Inc, Morris Plains, NJ USA; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Immunomedics Inc; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Goldenberg, DM (corresponding author), Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ USA.	dmg.gscancer@att.net	Jaffe, Elaine/G-8981-2014	Jaffe, Elaine/0000-0003-4632-0301	National Cancer Institute, National Institutes of Health; National Institutes of Health [CA11327]; NATIONAL CANCER INSTITUTE [ZIASC000550] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the intramural research program of the National Cancer Institute, National Institutes of Health (ESJ), and USPHS grant CA11327 from the National Institutes of Health (DMG) for establishing the original GW-532 and GW-584 tumors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2007, J PATHOL, V211, P10, DOI 10.1002/path.2078; Apolant, 1905, BERL KLIN WSCHR, V42, P871; BERNSTEIN SC, 1985, P NATL ACAD SCI USA, V82, P1726, DOI 10.1073/pnas.82.6.1726; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Brauninger A, 2006, INT J CANCER, V118, P1853, DOI 10.1002/ijc.21716; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; DIEHL V, 1982, CANCER TREAT REP, V66, P615; DOHNER H, 1992, GENE CHROMOSOME CANC, V5, P392, DOI 10.1002/gcc.2870050415; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; EPSTEIN AL, 1976, CANCER, V37, P2158, DOI 10.1002/1097-0142(197605)37:5<2158::AID-CNCR2820370503>3.0.CO;2-F; FIDLER IJ, 1986, CANCER METAST REV, V5, P29, DOI 10.1007/BF00049529; FISHER ER, 1970, CANCER-AM CANCER SOC, V25, P1286, DOI 10.1002/1097-0142(197006)25:6<1286::AID-CNCR2820250606>3.0.CO;2-U; Garcia-Olmo DC, 2012, EXPERT OPIN BIOL TH, V12, pS199, DOI 10.1517/14712598.2012.681370; Garcia-Olmo DC, 2010, CANCER RES, V70, P560, DOI 10.1158/0008-5472.CAN-09-3513; GOLDENBE.DM, 1971, EXP MOL PATHOL, V14, P134, DOI 10.1016/0014-4800(71)90059-1; Goldenberg DM, 2012, EXPERT OPIN BIOL TH, V12, pS133, DOI 10.1517/14712598.2012.671807; Goldenberg DM, 2012, INT J CANCER, V131, P49, DOI 10.1002/ijc.26327; GOLDENBERG DM, 1974, NATURE, V250, P649, DOI 10.1038/250649a0; GOLDENBERG DM, 1971, CANCER RES, V31, P1148; GOLDENBERG DM, 1977, CANCER LETT, V2, P195, DOI 10.1016/S0304-3835(77)80021-9; GOLDENBERG DM, 1981, SCIENCE, V212, P65, DOI 10.1126/science.7209521; GOTZ H, 1968, EXPERIENTIA, V24, P957, DOI 10.1007/BF02138681; GREENE HSN, 1952, CANCER, V5, P24, DOI 10.1002/1097-0142(195201)5:1<24::AID-CNCR2820050106>3.0.CO;2-O; Hartmann S, 2008, HAEMATOL-HEMATOL J, V93, P1318, DOI 10.3324/haematol.12875; Holmgren L, 2002, VOX SANG, V83, P305, DOI 10.1111/j.1423-0410.2002.tb05323.x; Jacobsen BM, 2006, CANCER RES, V66, P8274, DOI 10.1158/0008-5472.CAN-06-1456; JONASSON J, 1977, J CELL SCI, V24, P217; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; KAPLAN HS, 1977, INT J CANCER, V19, P511, DOI 10.1002/ijc.2910190412; KAPLAN HS, 1977, P NATL ACAD SCI USA, V74, P2564, DOI 10.1073/pnas.74.6.2564; KAPP U, 1993, BLOOD, V82, P1247; KOVACS G, 1985, INT J CANCER, V36, P637, DOI 10.1002/ijc.2910360602; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; LAGARDE AE, 1985, BIOCHIM BIOPHYS ACTA, V823, P81, DOI 10.1016/0304-419X(85)90008-3; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Moinfar F., 2000, CANCER RES, V60, P2652; NEWCOM SR, 1988, INT J CELL CLONING, V6, P417, DOI 10.1002/stem.5530060606; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pelham RJ, 2006, P NATL ACAD SCI USA, V103, P19848, DOI 10.1073/pnas.0609635104; ROBERTS AN, 1978, CANCER RES, V38, P3033; RUDDLE FH, 1981, NATURE, V294, P115, DOI 10.1038/294115a0; SCHOUTEN HC, 1989, BLOOD, V73, P2149; STOLER A, 1985, P NATL ACAD SCI USA, V82, P570, DOI 10.1073/pnas.82.2.570; TILLY H, 1991, BLOOD, V77, P1298; Ushmorov A, 2006, BLOOD, V107, P2493, DOI 10.1182/blood-2005-09-3765; Watanabe K, 2000, HISTOPATHOLOGY, V36, P353; Yan Y, 1996, BLOOD, V88, P3137, DOI 10.1182/blood.V88.8.3137.bloodjournal8883137	49	14	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55324	10.1371/journal.pone.0055324	http://dx.doi.org/10.1371/journal.pone.0055324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405135	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400080
J	Melbourne-Thomas, J; Constable, A; Wotherspoon, S; Raymond, B				Melbourne-Thomas, Jessica; Constable, Andrew; Wotherspoon, Simon; Raymond, Ben			Testing Paradigms of Ecosystem Change under Climate Warming in Antarctica	PLOS ONE			English	Article							KRILL EUPHAUSIA-SUPERBA; SOUTH SHETLAND ISLANDS; SEA-ICE EXTENT; QUALITATIVE-ANALYSIS; PENINSULA REGION; FOOD-WEB; PENGUIN POPULATIONS; MARINE; VARIABILITY; GROWTH	Antarctic marine ecosystems have undergone significant changes as a result of human activities in the past and are now responding in varied and often complicated ways to climate change impacts. Recent years have seen the emergence of large-scale mechanistic explanations-or "paradigms of change"-that attempt to synthesize our understanding of past and current changes. In many cases, these paradigms are based on observations that are spatially and temporally patchy. The West Antarctic Peninsula (WAP), one of Earth's most rapidly changing regions, has been an area of particular research focus. A recently proposed mechanistic explanation for observed changes in the WAP region relates changes in penguin populations to variability in krill biomass and regional warming. While this scheme is attractive for its simplicity and chronology, it may not account for complex spatio-temporal processes that drive ecosystem dynamics in the region. It might also be difficult to apply to other Antarctic regions that are experiencing some, though not all, of the changes documented for the WAP. We use qualitative network models of differing levels of complexity to test paradigms of change for the WAP ecosystem. Importantly, our approach captures the emergent effects of feedback processes in complex ecological networks and provides a means to identify and incorporate uncertain linkages between network elements. Our findings highlight key areas of uncertainty in the drivers of documented trends, and suggest that a greater level of model complexity is needed in devising explanations for ecosystem change in the Southern Ocean. We suggest that our network approach to evaluating a recent and widely cited paradigm of change for the Antarctic region could be broadly applied in hypothesis testing for other regions and research fields.	[Melbourne-Thomas, Jessica; Constable, Andrew; Raymond, Ben] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Constable, Andrew; Wotherspoon, Simon; Raymond, Ben] Australian Antarctic Div, Dept Sustainabil Environm Water Populat & Communi, Kingston, Tas, Australia; [Wotherspoon, Simon] Univ Tasmania, Inst Marine & Antarct Studies, Hobart, Tas, Australia	Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian Antarctic Division; University of Tasmania	Melbourne-Thomas, J (corresponding author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia.	Jessica.MelbourneThomas@utas.edu.au	Melbourne-Thomas, Jess/N-2437-2019; Wotherspoon, Simon J/B-2390-2013	Melbourne-Thomas, Jess/0000-0001-6585-876X; Wotherspoon, Simon J/0000-0002-6947-4445	Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystems Cooperative Research Centre (ACE CRC); Pew Fellowship in Marine Conservation	Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystems Cooperative Research Centre (ACE CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Pew Fellowship in Marine Conservation	This work was supported by the Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystems Cooperative Research Centre (ACE CRC; http://www.acecrc.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Thank you to Stuart Corney, Louise Emmerson, So Kawaguchi and Colin Southwell for helpful comments on model formulation, and on the manuscript (S. Corney). AJC was supported in part by a Pew Fellowship in Marine Conservation.	Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; Atkinson A, 2006, LIMNOL OCEANOGR, V51, P973, DOI 10.4319/lo.2006.51.2.0973; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barbosa A, 2012, POLAR BIOL, V35, P1453, DOI 10.1007/s00300-012-1196-1; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Bernard KS, 2012, DEEP-SEA RES PT I, V62, P111, DOI 10.1016/j.dsr.2011.12.015; Branch T. A., 2011, Journal of Cetacean Research and Management, P53; Chapman EW, 2011, MAR ECOL PROG SER, V436, P273, DOI 10.3354/meps09242; CROXALL JP, 1992, PHILOS T ROY SOC B, V338, P319, DOI 10.1098/rstb.1992.0152; Daly KL, 2004, POLAR BIOL, V28, P72, DOI 10.1007/s00300-004-0660-y; Dambacher JM, 2005, MATH BIOSCI, V197, P1, DOI 10.1016/j.mbs.2005.06.001; Dambacher JM, 1999, OIKOS, V84, P530, DOI 10.2307/3546432; Ducklow Hugh, 2012, P121; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; FRASER WR, 1992, POLAR BIOL, V11, P525; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Hinke JT, 2012, MAR ECOL PROG SER, V454, P91, DOI 10.3354/meps09633; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027331; Hucke-Gaete R, 2004, POLAR BIOL, V27, P304, DOI 10.1007/s00300-003-0587-8; Kravchenko VO, 2011, ANTARCT SCI, V23, P614, DOI 10.1017/S0954102011000423; LEVINS R, 1974, ANN NY ACAD SCI, V231, P123, DOI 10.1111/j.1749-6632.1974.tb20562.x; Liu JP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018732; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lynch HJ, 2012, MAR ECOL PROG SER, V454, P135, DOI 10.3354/meps09252; Marschoff ER, 2012, FISH RES, V125, P206, DOI 10.1016/j.fishres.2012.02.017; Marzloff MP, 2011, ECOL MODEL, V222, P2651, DOI 10.1016/j.ecolmodel.2011.03.040; McClintock J, 2008, AM SCI, V96, P302; Melbourne-Thomas J, 2012, ECOL MONOGR, V82, P505, DOI 10.1890/12-0207.1; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Naveen R, 2012, POLAR BIOL, V35, P1879, DOI 10.1007/s00300-012-1230-3; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Puccia C.J., 1985, QUALITATIVE MODELING; Raymond B, 2011, J APPL ECOL, V48, P181, DOI 10.1111/j.1365-2664.2010.01916.x; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Ross RM, 2008, DEEP-SEA RES PT II, V55, P2086, DOI 10.1016/j.dsr2.2008.04.037; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Smith RC, 2001, ANN GLACIOL-SER, V33, P493, DOI 10.3189/172756401781818662; Thorpe SE, 2007, DEEP-SEA RES PT I, V54, P792, DOI 10.1016/j.dsr.2007.01.008; Trathan PN, 2012, ECOGRAPHY, V35, P983, DOI 10.1111/j.1600-0587.2012.07330.x; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Wiedenmann J, 2009, LIMNOL OCEANOGR, V54, P799, DOI 10.4319/lo.2009.54.3.0799	48	31	32	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55093	10.1371/journal.pone.0055093	http://dx.doi.org/10.1371/journal.pone.0055093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405116	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400060
J	Saraiya, AA; Li, W; Wang, CC				Saraiya, Ashesh A.; Li, Wei; Wang, Ching C.			Transition of a microRNA from Repressing to Activating Translation Depending on the Extent of Base Pairing with the Target	PLOS ONE			English	Article							GIARDIA-LAMBLIA; PROTEIN-STRUCTURE; MESSENGER-RNA; HUMAN ARGONAUTE2; STRUCTURAL BASIS; GENE-EXPRESSION; HUMAN CANCERS; UP-REGULATION; RECOGNITION; CLEAVAGE	MicroRNAs are major post-transcriptional regulators of gene expression. Here we show in the ancient protozoan Giardia lamblia a snoRNA-derived 26-nucleotide microRNA, miR3, which represses the translation of histone H2A mRNA containing an imperfect target but enhances translation when the target is made fully complementary. A stepwise mutational analysis of the fully complementary target showed that the activating effect of miR3 was significantly reduced when a single nucleotide at the 5'-end of the target was altered. The effect of miR3 became repressive when 12 of the nucleotides lost their complementation to miR3 with maximum repression reached when only 8 base-pairs remained between the miR3 seed sequence and the target. A synthetic 8-nucleotide RNA oligomer of the miR3 seed sequence was found capable of exerting a similar Argonaute-dependent translational repression. This is the first report showing a correlation between the extent of base-pairing with the target and a change in miRNA function.	[Saraiya, Ashesh A.; Li, Wei; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wang, CC (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu			National Institutes of Health [AI30475]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [AI30475 to CCW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; Houzet L, 2012, NUCLEIC ACIDS RES, V40, P11684, DOI 10.1093/nar/gks912; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LEBLANCQ SM, 1994, PARASITOL TODAY, V10, P177, DOI 10.1016/0169-4758(94)90021-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li W, 2012, CELL MICROBIOL, V14, P1455, DOI 10.1111/j.1462-5822.2012.01811.x; Li W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001338; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Saraiya AA, 2011, RNA, V17, P2152, DOI 10.1261/rna.028118.111; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; Sun CH, 2000, MOL BIOCHEM PARASIT, V105, P51, DOI 10.1016/S0166-6851(99)00163-2; Triana O, 2001, J CELL BIOCHEM, V82, P573, DOI 10.1002/jcb.1159; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Upcroft JA, 1996, MOL BIOCHEM PARASIT, V76, P135, DOI 10.1016/0166-6851(95)02554-5; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	52	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55672	10.1371/journal.pone.0055672	http://dx.doi.org/10.1371/journal.pone.0055672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405193	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400138
J	Trombetta, DM; Cardoso, SC; Facure, A; da Silva, AX; da Rosa, LAR				Trombetta, Debora M.; Cardoso, Simone C.; Facure, Alessandro; da Silva, Ademir X.; da Rosa, Luiz Antonio R.			Influence of the Presence of Tissue Expanders on Energy Deposition for Post-Mastectomy Radiotherapy	PLOS ONE			English	Article							BREAST RECONSTRUCTION; POSTOPERATIVE RADIOTHERAPY; CANCER; COMPLICATIONS; PHANTOMS; IMPLANT	An increasing number of studies have shown that post-mastectomy radiotherapy presents benefits associated with the patients survival and a significant fraction of the treated patients makes use of tissue expanders for breast reconstruction. Some models of tissue expanders have a magnetic disk on their surface that constitutes heterogeneity in the radiation field, which can affect the dose distribution during the radiotherapy treatment. In this study, the influence of a metallic heterogeneity positioned in a breast tissue expander was evaluated by means of Monte Carlo simulations using the MCNPX code and using Eclipse treatment planning system. Deposited energy values were calculated in structures which have clinical importance for the treatment. Additionally, the effect in the absorbed energy due to backscattering and attenuation of the incident beam caused by the heterogeneity, as well as due to the expansion of the prosthesis, was evaluated in target structures for a 6 MV photon beam by simulations. The dose distributions for a breast treatment were calculated using a convolution/superposition algorithm from the Eclipse treatment planning system. When compared with the smallest breast expander volume, underdosage of 7% was found for the largest volume of breast implant, in the case of frontal irradiation of the chest wall, by Monte Carlo simulations. No significant changes were found in dose distributions for the presence of the heterogeneity during the treatment planning of irradiation with an opposed pair of beams. Even considering the limitation of the treatment planning system, the results obtained with its use confirm those ones found by Monte Carlo simulations for a tangent beam irradiation. The presence of a heterogeneity didnt alters the dose distributions on treatment structures. The underdosage of 7% observed with Monte Carlo simulations were found for irradiation at 0 degrees, not used frequently in a clinical routine.	[Trombetta, Debora M.; da Silva, Ademir X.] Univ Fed Rio de Janeiro, Programa Engn Nucl, Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, Rio De Janeiro, RJ, Brazil; [Trombetta, Debora M.; Cardoso, Simone C.] Univ Fed Rio de Janeiro, Inst Fis, Lab Fis Radica Gama, Rio De Janeiro, RJ, Brazil; [Facure, Alessandro] Comissao Nacl Energia Nucl CNEN, Rio De Janeiro, RJ, Brazil; [da Rosa, Luiz Antonio R.] Comissao Nacl Energia Nucl CNEN, IRD, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Comissao Nacional de Energia Nuclear (CNEN); Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria	Cardoso, SC (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Lab Fis Radica Gama, Rio De Janeiro, RJ, Brazil.	simone@if.ufrj.br	Cardoso, Simone/AAH-4274-2021; Cardoso, Simone/V-2514-2019	Montano Trombetta, Debora/0000-0002-3473-3750; cardoso, simone/0000-0001-6216-202X	National Counsel of Technological and Scientific Development (CNPq); Rio de Janeiro Research Assistance Foundation (FAPERJ)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro Research Assistance Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by National Counsel of Technological and Scientific Development (CNPq) and Rio de Janeiro Research Assistance Foundation (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ECL ALG REF GUID P N; [Anonymous], 2008, ALD PHANT; Chatzigiannis C, 2005, J APPL CLIN MED PHYS, V12, P58; Damast S, 2006, INT J RADIAT ONCOL, V66, P305, DOI 10.1016/j.ijrobp.2006.05.017; Dang J, 2009, IEEE NUCL SCI CONF R, P3088, DOI 10.1109/NSSMIC.2009.5401670; Freedma GM, 2005, BREAST CANC ONLINE, V8, pe44; ICRU, 1992, J INT COMM RAD UN ME, P1; Krueger EA, 2000, INT J RADIAT ONCOL, V3, P713; Lai CJ, 2007, MED PHYS, V34, P2995, DOI 10.1118/1.2745921; McCarthy CM, 2005, PLAST RECONSTR SURG, V116, P1642, DOI 10.1097/01.prs.0000187794.79464.23; Moni Janaki, 2004, Med Dosim, V29, P49, DOI 10.1016/j.meddos.2003.10.005; Nahabedian MY, 2003, PLAST RECONSTR SURG, V112, P467, DOI 10.1097/01.PRS.0000070727.02992.54; Nava MB, 2011, PLAST RECONSTR SURG, V128, P353, DOI 10.1097/PRS.0b013e31821e6c10; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Ozden BC, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-44; Pelowitz D. B., 2005, LACP050369 LOS AL NA; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; RAMON Y, 1991, Harefuah, V121, P1; Raylman RR, 2001, J NUCL MED, V42, P960; Rodrigues ASHV, 2011, THESIS U TECNICA LIS; Schechter NR, 2005, AM J CLIN ONCOL-CANC, V28, P485, DOI 10.1097/01.coc.0000170582.38634.b6; Senkus-Konefka E, 2004, CANCER TREAT REV, V30, P671, DOI 10.1016/j.ctrv.2004.06.008; Sheikh-Bagheri D, 2002, MED PHYS, V29, P391, DOI 10.1118/1.1445413; Tallet AV, 2003, INT J RADIAT ONCOL, V57, P136, DOI 10.1016/S0360-3016(03)00526-1; Thompson RCA, 2005, MED PHYS, V32, P1640, DOI 10.1118/1.1914545; Trombetta DM, 2010, REV BRAS FIS, V4, P7; Weinstein SP, 2002, RADIOLOGY, V224, P265, DOI 10.1148/radiol.2241010511	28	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55430	10.1371/journal.pone.0055430	http://dx.doi.org/10.1371/journal.pone.0055430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405149	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400094
J	Vincent-Chong, VK; Anwar, A; Karen-Ng, LP; Cheong, SC; Yang, YH; Pradeep, PJ; Rahman, ZAA; Ismail, SM; Zaini, ZM; Prepageran, N; Kallarakkal, TG; Ramanathan, A; Mohayadi, NABM; Rosli, NSBM; Mustafa, WMW; Abraham, MT; Tay, KK; Zain, RB				Vincent-Chong, Vui King; Anwar, Arif; Karen-Ng, Lee Peng; Cheong, Sok Ching; Yang, Yi-Hsin; Pradeep, Padmaja Jayaprasad; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Zaini, Zuraiza Mohamad; Prepageran, Narayanan; Kallarakkal, Thomas George; Ramanathan, Anand; Mohayadi, Nur Aaina Binti Mohd; Rosli, Nurul Shielawati Binti Mohamed; Mustafa, Wan Mahadzir Wan; Abraham, Mannil Thomas; Tay, Keng Kiong; Zain, Rosnah Binti			Genome Wide Analysis of Chromosomal Alterations in Oral Squamous Cell Carcinomas Revealed over Expression of MGAM and ADAM9	PLOS ONE			English	Article							COPY NUMBER; GENE-EXPRESSION; CANCER; ARRAY; HYBRIDIZATION; MICROARRAY; AMPLIFICATION; INSTABILITY; PROGRESSION; MIGRATION	Despite the advances in diagnosis and treatment of oral squamous cell carcinoma (OSCC), mortality and morbidity rates have not improved over the past decade. A major drawback in diagnosis and treatment of OSCC is the lack of knowledge relating to how genetic instability in oral cancer genomes affects oral carcinogenesis. Hence, the key aim of this study was to identify copy number alterations (CNAs) that may be cancer associated in OSCC using high-resolution array comparative genomic hybridization (aCGH). To our knowledge this is the first study to use ultra-high density aCGH microarrays to profile a large number of OSCC genomes (n = 46). The most frequently amplified CNAs were located on chromosome 11q11(52%), 2p22.3(52%), 1q21.3-q22(54%), 6p21.32(59%), 20p13(61%), 7q34(52% and 72%), 8p11.23-p11.22(80%), 8q11.1-q24.4(54%), 9q13-q34.3(54%), 11q23.3-q25(57%); 14q21.3-q31.1(54%); 14q31.3-q32.33(57%), 20p13-p12.3(54%) and 20q11.21-q13.33(52%). The most frequently deleted chromosome region was located on 3q26.1 (54%). In order to verify the CNAs from aCGH using quantitative polymerase chain reaction (qPCR), the three top most amplified regions and their associated genes, namely ADAM5P (8p11.23-p11.22), MGAM (7q34) and SIRPB1 (20p13.1), were selected in this study. The ADAM5P locus was found to be amplified in 39 samples and deleted in one; MGAM (24 amplifications and 3 deletions); and SIRPB1 (12 amplifications, others undetermined). On the basis of putative cancer-related annotations, two genes, namely ADAM metallopeptidase domain 9 (ADAM9) and maltase-glucoamylase alpha-glucosidase (MGAM), that mapped to CNA regions were selected for further evaluation of their mRNA expression using reverse transcriptase qPCR. The over-expression of MGAM was confirmed with a 6.6 fold increase in expression at the mRNA level whereas the fold change in ADAM9 demonstrated a 1.6 fold increase. This study has identified significant regions in the OSCC genome that were amplified and resulted in consequent over-expression of the MGAM and ADAM9 genes that may be utilized as biological markers for OSCC.	[Vincent-Chong, Vui King; Karen-Ng, Lee Peng; Pradeep, Padmaja Jayaprasad; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Zaini, Zuraiza Mohamad; Prepageran, Narayanan; Kallarakkal, Thomas George; Ramanathan, Anand; Zain, Rosnah Binti] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia; [Vincent-Chong, Vui King; Cheong, Sok Ching; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah] Univ Malaya, Fac Dent, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Anwar, Arif; Mohayadi, Nur Aaina Binti Mohd; Rosli, Nurul Shielawati Binti Mohamed] Sengen Sdn Bhd, Petaling Jaya, Selangor Darul, Malaysia; [Cheong, Sok Ching] Canc Res Initiat Fdn, Oral Canc Res Team, Selangor Darul Ehsan, Malaysia; [Yang, Yi-Hsin] Kaohsiung Med Univ, Coll Dent Med, Dept Dent Hyg, Kaohsiung, Taiwan; [Zaini, Zuraiza Mohamad; Kallarakkal, Thomas George; Ramanathan, Anand; Zain, Rosnah Binti] Univ Malaya, Fac Dent, Dept Oral Pathol Oral Med & Periodontol, Kuala Lumpur, Malaysia; [Prepageran, Narayanan] Univ Malaya, Fac Med, Dept Otorhinolaringol, Kuala Lumpur, Malaysia; [Mustafa, Wan Mahadzir Wan; Abraham, Mannil Thomas; Tay, Keng Kiong] Minist Hlth, Oral Hlth Div, Putrajaya, Malaysia	Universiti Malaya; Universiti Malaya; Kaohsiung Medical University; Universiti Malaya; Universiti Malaya; Kementerian Kesihatan Malaysia	Zain, RB (corresponding author), Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia.	rosnahbz12@yahoo.com	ABDUL RAHMAN, ZAINAL ARIFF/C-1120-2010; Ramanathan, Anand/J-2943-2014; Narayanan, Prepageran A/L/P-2359-2014; Karen-Ng, Lee Peng/AAD-3810-2020; Prepageran, Narayanan/ABC-7933-2021; Yang, Yi-Hsin/D-6471-2012; Zain, Rosnah/B-8054-2010; George, Thomas/B-7774-2010; Zaini, Zuraiza/B-5375-2010	Ramanathan, Anand/0000-0001-6496-7139; Karen-Ng, Lee Peng/0000-0002-3511-4791; Yang, Yi-Hsin/0000-0002-9581-2778; George, Thomas/0000-0002-5986-6170; Prepageran, Narayanan/0000-0001-5670-9340; Zaini, Zuraiza/0000-0002-9160-9625	University of Malaya High Impact Research Grant [J-00000-73561]; Ministry of Higher Education High Impact Research Grant [H-18001-00-C000008]; Ministry of Science, Technology and Innovation E-science grant [02-01-03SF0385]	University of Malaya High Impact Research Grant; Ministry of Higher Education High Impact Research Grant; Ministry of Science, Technology and Innovation E-science grant	This study was supported by a University of Malaya High Impact Research Grant (J-00000-73561), a Ministry of Higher Education High Impact Research Grant (H-18001-00-C000008) and a Ministry of Science, Technology and Innovation E-science grant (02-01-03SF0385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Ambatipudi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017250; Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; Bhatnagar R, 2012, ORAL ONCOL, V48, P831, DOI 10.1016/j.oraloncology.2012.03.007; Birnbaum D, 2003, LANCET ONCOL, V4, P639, DOI 10.1016/S1470-2045(03)01225-7; Bronstad I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-111; Bueno R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010612; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Choi P, 2008, ARCH OTOLARYNGOL, V134, P539, DOI 10.1001/archotol.134.5.539; Chu SH, 2012, MOL BIOL RE IN PRESS; Cooke SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-288; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Flossbach L, 2012, INT J CANC IN PRESS; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Garnis C, 2004, ORAL ONCOL, V40, P511, DOI 10.1016/j.oraloncology.2003.10.006; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Hamada T, 2012, CANCER IN PRESS; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Hossini AM, 2008, BIOCHEM PHARMACOL, V76, P1612, DOI 10.1016/j.bcp.2008.08.013; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Kohn KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035716; Kornberg LJ, 1998, HEAD NECK-J SCI SPEC, V20, P745, DOI 10.1002/(SICI)1097-0347(199812)20:8<745::AID-HED14>3.0.CO;2-Z; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Li Jian, 2010, BMC Res Notes, V3, P321, DOI 10.1186/1756-0500-3-321; Liu CJ, 2006, MOL CARCINOGEN, V45, P721, DOI 10.1002/mc.20213; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohavanichbutr P, 2009, ARCH OTOLARYNGOL, V135, P180, DOI 10.1001/archoto.2008.540; Lopez-Nieva P, 2012, CARCINOGENESIS, V33, P452, DOI 10.1093/carcin/bgr271; Martin-Ezquerra G, 2011, HISTOL HISTOPATHOL, V26, P71, DOI 10.14670/HH-26.71; Miller DA, 2008, FILM QUART, V62, P12, DOI 10.1525/FQ.2008.62.2.12; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Nagaraj NS, 2007, TOXICOL LETT, V170, P134, DOI 10.1016/j.toxlet.2007.02.014; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Przybytkowski E, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-16; Ramsay AG, 2007, CANCER RES, V67, P5275, DOI 10.1158/0008-5472.CAN-07-0318; Reshmi SC, 2005, J DENT RES, V84, P107, DOI 10.1177/154405910508400203; Romer MU, 2012, MOL ONCOL IN PRESS; Rotger M, 2007, PHARMACOGENET GENOM, V17, P885, DOI 10.1097/FPC.0b013e3282ef5cd1; Roymans D, 2001, EUR J BIOCHEM, V268, P487, DOI 10.1046/j.1432-1327.2001.01936.x; Shah JP, 2003, ORAL CANC, P3; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Sparano A, 2006, LARYNGOSCOPE, V116, P735, DOI 10.1097/01.mlg.0000205141.54471.7f; Sriram KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030398; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tan DSP, 2007, LAB INVEST, V87, P737, DOI 10.1038/labinvest.3700593; Thean LF, 2010, GENE CHROMOSOME CANC, V49, P99, DOI 10.1002/gcc.20724; Trebinska A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-76; Tsui IFL, 2010, HEAD NECK-J SCI SPEC, V32, P1143, DOI 10.1002/hed.21311; Tsui IFL, 2009, INT J CANCER, V125, P2219, DOI 10.1002/ijc.24611; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Viet CT, 2010, HEAD NECK-J SCI SPEC, V32, P1246, DOI 10.1002/hed.21358; Vincent-Chong VK, 2012, ORAL DIS, V18, P469, DOI 10.1111/j.1601-0825.2011.01894.x; Visani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027560; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Yang SH, 2007, INT J MOL MED, V20, P225; Zain RB, 2012, CELL TISSUE IN PRESS; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	69	20	20	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54705	10.1371/journal.pone.0054705	http://dx.doi.org/10.1371/journal.pone.0054705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405089	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400033
J	Wu, YX; Wang, L; Lin, C; Lin, Y; Zhou, M; Chen, L; Connolly, B; Zhang, YQ; Chen, TB; Shaw, C				Wu, Yuxin; Wang, Lei; Lin, Chen; Lin, Yan; Zhou, Mei; Chen, Liang; Connolly, Brian; Zhang, Yingqi; Chen, Tianbao; Shaw, Chris			Vasorelaxin: A Novel Arterial Smooth Muscle-Relaxing Eicosapeptide from the Skin Secretion of the Chinese Piebald Odorous Frog (Odorrana schmackeri)	PLOS ONE			English	Article							TRYPSIN-INHIBITOR; AMPHIBIAN SKIN; PEPTIDES; RECEPTORS; SCORPION; RELEASE; TOAD	The defensive skin secretions of amphibians are a rich resource for the discovery of novel, bioactive peptides. Here we report the identification of a novel vascular smooth muscle-relaxing peptide, named vasorelaxin, from the skin secretion of the Chinese piebald odorous frog, Odorrana schmackeri. Vasorelaxin consists of 20 amino acid residues, SRVVKCSGFRPGSPDSREFC, with a disulfide-bridge between Cys-6 and Cys-20. The structure of its biosynthetic precursor was deduced from cloned skin cDNA and consists of 67 amino acid residues encoding a single copy of vasorelaxin (vasorelaxin, accession number: HE860494). Synthetic vasorelaxin caused a profound relaxation of rat arterial smooth muscle with an EC50 of 6.76 nM.	[Wu, Yuxin; Wang, Lei; Lin, Chen; Lin, Yan; Zhou, Mei; Chen, Liang; Connolly, Brian; Zhang, Yingqi; Chen, Tianbao; Shaw, Chris] Queens Univ, Sch Pharm, Nat Drug Discovery Grp, Belfast, Antrim, North Ireland; [Zhang, Yingqi] Tangshan Gongren Hosp, Tangshan City, Hebei Province, Peoples R China	Queens University Belfast	Zhang, YQ (corresponding author), Queens Univ, Sch Pharm, Nat Drug Discovery Grp, Belfast, Antrim, North Ireland.	zhangyingqi08@sina.com; chris.shaw@qub.ac.uk	Wu, Yuxin/E-5612-2014	Wu, Yuxin/0000-0002-2657-8498; Wang, Lei/0000-0002-8811-8489				Almaaytah A, 2012, PEPTIDES, V35, P291, DOI 10.1016/j.peptides.2012.03.016; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Chen H, 2011, MOL IMMUNOL, V48, P442, DOI 10.1016/j.molimm.2010.09.018; Chen TB, 2002, EUR J BIOCHEM, V269, P4693, DOI 10.1046/j.1432-1033.2002.03174.x; Conlon JM, 1999, REGUL PEPTIDES, V79, P71, DOI 10.1016/S0167-0115(98)00160-8; Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828; Erspamer V., 1994, AMPHIBIAN BIOL, V1, P179; Galas L, 2009, GEN COMP ENDOCR, V164, P40, DOI 10.1016/j.ygcen.2009.05.003; Gale EAM, 2001, LANCET, V357, P1870, DOI 10.1016/S0140-6736(00)04960-6; LAZARUS LH, 1993, PROG NEUROBIOL, V41, P473, DOI 10.1016/0301-0082(93)90027-P; Li RJ, 2012, BIOCHIMIE, V94, P1376, DOI 10.1016/j.biochi.2012.03.009; Li XH, 2011, BIOCHIMIE, V93, P1537, DOI 10.1016/j.biochi.2011.05.009; Liu L, 2005, PEPTIDES, V26, P1369, DOI 10.1016/j.peptides.2005.03.027; Pal Sanjoy Kumar, 2002, Indian Journal of Experimental Biology, V40, P1353; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Patlak M, 2004, FASEB J, V18, DOI 10.1096/fj.03-1398bkt; Raufman JP, 1996, REGUL PEPTIDES, V61, P1, DOI 10.1016/0167-0115(96)00135-8; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Spindel ER, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P277, DOI 10.1016/B978-012369442-3/50045-3; Srinivasan KN, 2002, TOXICON, V40, P23, DOI 10.1016/S0041-0101(01)00182-9; TYLER MJ, 1992, J PHARMACOL TOXICOL, V28, P199, DOI 10.1016/1056-8719(92)90004-K; Wang H, 2012, BIOCHIMIE, V94, P891, DOI 10.1016/j.biochi.2011.12.008; Wang L, 2009, BIOCHEM BIOPH RES CO, V383, P240, DOI 10.1016/j.bbrc.2009.04.003; Wang M, 2012, PEPTIDES, V33, P245, DOI 10.1016/j.peptides.2012.01.003; WOLL PJ, 1988, P NATL ACAD SCI USA, V85, P1859, DOI 10.1073/pnas.85.6.1859; Wu YJ, 2011, BIOCHIMIE, V93, P981, DOI 10.1016/j.biochi.2011.03.003	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55739	10.1371/journal.pone.0055739	http://dx.doi.org/10.1371/journal.pone.0055739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405205	gold, Green Published, Green Submitted			2022-12-27	WOS:000315153400150
J	Cohen, D; Bogeat-Triboulot, MB; Vialet-Chabrand, S; Merret, R; Courty, PE; Moretti, S; Bizet, F; Guilliot, A; Hummel, I				Cohen, David; Bogeat-Triboulot, Marie-Beatrice; Vialet-Chabrand, Silvere; Merret, Remy; Courty, Pierre-Emmanuel; Moretti, Sebastien; Bizet, Francois; Guilliot, Agnes; Hummel, Irene			Developmental and Environmental Regulation of Aquaporin Gene Expression across Populus Species: Divergence or Redundancy?	PLOS ONE			English	Article							INTRINSIC PROTEINS; PLANT AQUAPORINS; WATER TRANSPORT; POPLAR LEAVES; DROUGHT; GENOME; TRICHOCARPA; EVOLUTION; LOCALIZATION; SUBFAMILY	Aquaporins (AQPs) are membrane channels belonging to the major intrinsic proteins family and are known for their ability to facilitate water movement. While in Populus trichocarpa, AQP proteins form a large family encompassing fifty-five genes, most of the experimental work focused on a few genes or subfamilies. The current work was undertaken to develop a comprehensive picture of the whole AQP gene family in Populus species by delineating gene expression domain and distinguishing responsiveness to developmental and environmental cues. Since duplication events amplified the poplar AQP family, we addressed the question of expression redundancy between gene duplicates. On these purposes, we carried a meta-analysis of all publicly available Affymetrix experiments. Our in-silico strategy controlled for previously identified biases in cross-species transcriptomics, a necessary step for any comparative transcriptomics based on multispecies design chips. Three poplar AQPs were not supported by any expression data, even in a large collection of situations (abiotic and biotic constraints, temporal oscillations and mutants). The expression of 11 AQPs was never or poorly regulated whatever the wideness of their expression domain and their expression level. Our work highlighted that PtTIP1;4 was the most responsive gene of the AQP family. A high functional divergence between gene duplicates was detected across species and in response to tested cues, except for the root-expressed PtTIP2;3/PtTIP2;4 pair exhibiting 80% convergent responses. Our meta-analysis assessed key features of aquaporin expression which had remained hidden in single experiments, such as expression wideness, response specificity and genotype and environment interactions. By consolidating expression profiles using independent experimental series, we showed that the large expansion of AQP family in poplar was accompanied with a strong divergence of gene expression, even if some cases of functional redundancy could be suspected.	[Cohen, David; Bogeat-Triboulot, Marie-Beatrice; Vialet-Chabrand, Silvere; Merret, Remy; Bizet, Francois; Guilliot, Agnes; Hummel, Irene] INRA, Ecol & Ecophysiol Forestieres UMR1137, Champenoux, France; [Cohen, David; Bogeat-Triboulot, Marie-Beatrice; Vialet-Chabrand, Silvere; Merret, Remy; Bizet, Francois; Guilliot, Agnes; Hummel, Irene] Univ Lorraine, Ecol & Ecophysiol Forestieres UMR1137, Fac Sci, Vandoeuvre Les Nancy, France; [Courty, Pierre-Emmanuel] Univ Basel, Inst Bot, Zurich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; [Moretti, Sebastien] SIB Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland; [Moretti, Sebastien] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	INRAE; Universite de Lorraine; Universite de Lorraine; University of Basel; Swiss Institute of Bioinformatics; University of Lausanne	Bogeat-Triboulot, MB (corresponding author), INRA, Ecol & Ecophysiol Forestieres UMR1137, Champenoux, France.	triboulo@nancy.inra.fr	MERRET, Rémy/J-6512-2019; Vialet-Chabrand, Silvere/Y-1642-2019	Vialet-Chabrand, Silvere/0000-0002-2105-2825; MERRET, Remy/0000-0002-3790-1115; Cohen, David/0000-0002-0320-8865; Bogeat-Triboulot, Marie-Beatrice/0000-0003-3015-488X; Moretti, Sebastien/0000-0003-3947-488X; COURTY, Pierre-Emmanuel/0000-0003-2789-7818	Laboratory of Excellence ARBRE [ANR-11-LABX-02-01]; French Research Agency [POPSEC] [ANR-Genoplante GPLA06028G]; Region Lorraine [12000158]; European Regional Development Fund [3709]	Laboratory of Excellence ARBRE; French Research Agency [POPSEC]; Region Lorraine(Region Grand-Est); European Regional Development Fund(European Commission)	This work was supported by the Laboratory of Excellence ARBRE [ANR-11-LABX-02-01], the French Research Agency [POPSEC-project number ANR-Genoplante GPLA06028G] and the Region Lorraine [grant number 12000158]. DC was supported by the European Regional Development Fund [project number 3709]. PEC is an Ambizione fellow of the Swiss National Science Foundation [PZ00P3_136651]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Almeida-Rodriguez AM, 2010, PHYSIOL PLANTARUM, V140, P321, DOI 10.1111/j.1399-3054.2010.01405.x; Almeida-Rodriguez AM, 2011, PLANT CELL ENVIRON, V34, P1318, DOI 10.1111/j.1365-3040.2011.02331.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; Bae EK, 2011, GENE, V483, P43, DOI 10.1016/j.gene.2011.05.015; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Besse M, 2011, J EXP BOT, V62, P4127, DOI 10.1093/jxb/err175; Bienert GP, 2011, SIGNAL COMMUN PLANTS, P3, DOI 10.1007/978-3-642-14369-4_1; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gattolin S, 2011, MOL PLANT, V4, P180, DOI 10.1093/mp/ssq051; Gehring CA, 2006, OECOLOGIA, V149, P158, DOI 10.1007/s00442-006-0437-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Goue N, 2008, NEW PHYTOL, V180, P45, DOI 10.1111/j.1469-8137.2008.02556.x; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Hacke UG, 2010, TREE PHYSIOL, V30, P1016, DOI 10.1093/treephys/tpq058; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janz D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-150; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; JOHNSON KD, 1989, PLANT PHYSIOL, V91, P1006, DOI 10.1104/pp.91.3.1006; Kohler A, 2003, FEBS LETT, V542, P37, DOI 10.1016/S0014-5793(03)00334-X; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Lopez D, 2012, J EXP BOT, V63, P2217, DOI 10.1093/jxb/err404; Luu DT, 2005, PLANT CELL ENVIRON, V28, P85, DOI 10.1111/j.1365-3040.2004.01295.x; Madsen SS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00056; MAESHIMA M, 1994, PLANT PHYSIOL, V106, P61, DOI 10.1104/pp.106.1.61; Marjanovic Z, 2005, PLANTA, V222, P258, DOI 10.1007/s00425-005-1539-z; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Oliviusson P, 2001, PLANT MOL BIOL, V46, P289, DOI 10.1023/A:1010611605142; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Quesada T, 2008, NEW PHYTOL, V180, P408, DOI 10.1111/j.1469-8137.2008.02586.x; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; Raldua D, 2008, AM J PHYSIOL-REG I, V294, pR993, DOI 10.1152/ajpregu.00695.2007; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; Rodgers-Melnick E, 2012, GENOME RES, V22, P95, DOI 10.1101/gr.125146.111; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Schneider A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-134; Secchi F, 2010, PLANT CELL ENVIRON, V33, P1285, DOI 10.1111/j.1365-3040.2010.02147.x; Secchi F, 2009, TREE PHYSIOL, V29, P1467, DOI 10.1093/treephys/tpp060; Siemens JA, 2008, MYCORRHIZA, V18, P393, DOI 10.1007/s00572-008-0193-2; Song DL, 2011, PLANT MOL BIOL, V76, P97, DOI 10.1007/s11103-011-9771-3; Soto G, 2010, PLANT J, V64, P1038, DOI 10.1111/j.1365-313X.2010.04395.x; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; Street NR, 2011, ENVIRON POLLUT, V159, P45, DOI 10.1016/j.envpol.2010.09.027; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Vander Willigen C, 2006, PLANT CELL PHYSIOL, V47, P1241, DOI 10.1093/pcp/pcj094; Voicu MC, 2011, TREES-STRUCT FUNCT, V25, P485, DOI 10.1007/s00468-010-0524-8; Wilkins O, 2009, PLANT J, V60, P703, DOI 10.1111/j.1365-313X.2009.03993.x; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	62	29	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55506	10.1371/journal.pone.0055506	http://dx.doi.org/10.1371/journal.pone.0055506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393587	Green Submitted, Green Published, gold			2022-12-27	WOS:000314692800041
J	Camacho, EF; Boszczowski, I; Freire, MP; Pinto, FCG; Guimaraes, T; Teixeira, MJ; Costa, SF				Camacho, Eduardo Fernandes; Boszczowski, Icaro; Freire, Maristela Pinheiro; Gomes Pinto, Fernando Campos; Guimaraes, Thais; Teixeira, Manuel Jacobsen; Costa, Silvia Figueiredo			Impact of an Educational Intervention Implanted in a Neurological Intensive Care Unit on Rates of Infection Related to External Ventricular Drains	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; RISK-FACTORS	Background: Studies on the implantation of care routines showed reduction on EVD catheter-related infections rates; however zero tolerance is difficult to be achieved. The objective of this study was to assess the impact of an educational intervention on the maximal reduction on rates of EVD-related infections. Methodology/Principal Findings: The quasi-experimental (before-after intervention) study occurred in two phases: pre-intervention, from April 2007 to July 2008, and intervention, from August 2008 to July 2010. Patients were followed for 30 days after the removal of the EVD, and EVD-related infections were considered as only those with laboratorial confirmation in the CSF. Observations were made of the care of the EVD and compliance with Hygiene of the Hands (HH), a routine of care was drawn up, training was given, and intervention was made to reduce the time the EVD catheter remained in place. Results: during the study, 178 patients were submitted to 194 procedures, corresponding to 1217 EVD catheters-day. Gram-negative agents were identified in 71.4% of the infections during the pre-intervention period and in 60% during the intervention period. During the study, EVD-related infection rates were reduced from 9.5% to 4.8% per patient, from 8.8% to 4.4% per procedure, and the incidence density dropped from 14.0 to 6.9 infections per 1000 catheters-day (p = 0.027). The mortality reduced 12% (from 42% to 30%). Conclusions/Significance: During one year after the fourth intervention, no microbiologically identified infection was documented. In light of these results, educational intervention proved to be a useful tool in reducing these rates and showed also impact on mortality.	[Camacho, Eduardo Fernandes; Boszczowski, Icaro; Freire, Maristela Pinheiro; Guimaraes, Thais; Costa, Silvia Figueiredo] Univ Sao Paulo, Sch Med, Hosp Clin, Div Infect Dis, Sao Paulo, Brazil; [Gomes Pinto, Fernando Campos; Teixeira, Manuel Jacobsen] Univ Sao Paulo, Sch Med, Hosp Clin, Div Neurosurg, Sao Paulo, Brazil; [Costa, Silvia Figueiredo] Univ Sao Paulo, Sch Med, Med Res Lab LIM 54, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Costa, SF (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Div Infect Dis, Sao Paulo, Brazil.	costasilviaf@ig.com.br	Boszczowski, Icaro/AAF-9675-2022; Costa, Silvia F/K-4768-2012; Freire, Maristela P/B-5262-2014; Figueiredo Costa, silvia/ABC-7704-2021; Boszczowski, Icaro/ACH-0889-2022; Pinto, Fernando Gomes/F-6094-2012; Teixeira, Manuel AC/AAZ-7251-2020; Guimarães, Thais/C-7134-2014	Costa, Silvia F/0000-0003-1087-752X; Figueiredo Costa, silvia/0000-0003-1087-752X; Teixeira, Manuel AC/0000-0002-1959-0624; Guimarães, Thais/0000-0002-7282-5453; PINTO, FERNANDO/0000-0003-2384-2190; freire, maristela p/0000-0002-9691-192X	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superor)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superor)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superor). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabi Y, 2005, AM J INFECT CONTROL, V33, P137, DOI 10.1016/j.ajic.2004.11.008; BOGDAHN U, 1992, NEUROSURGERY, V31, P898, DOI 10.1227/00006123-199211000-00011; Bota DP, 2005, J NEUROSURG, V103, P468, DOI 10.3171/jns.2005.103.3.0468; Chi H, 2010, INT J INFECT DIS, V14, pE216, DOI 10.1016/j.ijid.2009.04.006; Clinical and Laboratory Standards Institute (CLSI), 2014, CLIN LAB STANDARDS I; Dasic D, 2006, BRIT J NEUROSURG, V20, P296, DOI 10.1080/02688690600999901; Girao E, 2008, INT J INFECT DIS, V12, pE145, DOI 10.1016/j.ijid.2008.03.011; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Honda H, 2010, INFECT CONT HOSP EP, V31, P1078, DOI 10.1086/656377; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Kro V, 2009, J HOSP INFECT, V71, P176, DOI 10.1016/j.jhin.2008.09.018; Leverstein-van Hall MA, 2010, J NEUROSURG, V112, P345, DOI 10.3171/2009.6.JNS09223; Levin AS, 1999, CLIN INFECT DIS, V28, P1008, DOI 10.1086/514732; Lietard C, 2008, J NEUROSURG, V109, P729, DOI 10.3171/JNS/2008/109/10/0729; Lobo RD, 2005, AM J INFECT CONTROL, V33, P83, DOI 10.1016/j.ajic.2004.05.003; Lobo RD, 2010, AM J INFECT CONTROL, V38, P440, DOI 10.1016/j.ajic.2009.09.013; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Schade RP, 2005, J NEUROSURG, V102, P229, DOI 10.3171/jns.2005.102.2.0229	25	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e50708	10.1371/journal.pone.0050708	http://dx.doi.org/10.1371/journal.pone.0050708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390486	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100002
J	Wu, K; Taki, Y; Sato, K; Hashizume, H; Sassa, Y; Takeuchi, H; Thyreau, B; He, Y; Evans, AC; Li, XB; Kawashima, R; Fukuda, H				Wu, Kai; Taki, Yasuyuki; Sato, Kazunori; Hashizume, Hiroshi; Sassa, Yuko; Takeuchi, Hikaru; Thyreau, Benjamin; He, Yong; Evans, Alan C.; Li, Xiaobo; Kawashima, Ryuta; Fukuda, Hiroshi			Topological Organization of Functional Brain Networks in Healthy Children: Differences in Relation to Age, Sex, and Intelligence	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; GRAY-MATTER VOLUME; SMALL-WORLD; CORTICAL NETWORKS; DEVELOPMENTAL TRAJECTORIES; UNDERLYING INTELLIGENCE; CONNECTIVITY PATTERNS; ANATOMICAL NETWORKS; STRUCTURAL NETWORKS; LOW-FREQUENCY	Recent studies have demonstrated developmental changes of functional brain networks derived from functional connectivity using graph theoretical analysis, which has been rapidly translated to studies of brain network organization. However, little is known about sex- and IQ-related differences in the topological organization of functional brain networks during development. In this study, resting-state fMRI (rs-fMRI) was used to map the functional brain networks in 51 healthy children. We then investigated the effects of age, sex, and IQ on economic small-world properties and regional nodal properties of the functional brain networks. At a global level of whole networks, we found significant age-related increases in the small-worldness and local efficiency, significant higher values of the global efficiency in boys compared with girls, and no significant IQ-related difference. Age-related increases in the regional nodal properties were found predominately in the frontal brain regions, whereas the parietal, temporal, and occipital brain regions showed age-related decreases. Significant sex- related differences in the regional nodal properties were found in various brain regions, primarily related to the default mode, language, and vision systems. Positive correlations between IQ and the regional nodal properties were found in several brain regions related to the attention system, whereas negative correlations were found in various brain regions primarily involved in the default mode, emotion, and language systems. Together, our findings of the network topology of the functional brain networks in healthy children and its relationship with age, sex, and IQ bring new insights into the understanding of brain maturation and cognitive development during childhood and adolescence.	[Wu, Kai; Taki, Yasuyuki; Sato, Kazunori; Fukuda, Hiroshi] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Thyreau, Benjamin; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Wu, Kai] S China Univ Technol, Dept Biomed Engn, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Evans, Alan C.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Li, Xiaobo] Yeshiva Univ Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10461 USA	Tohoku University; Tohoku University; Tohoku University; Tohoku University; South China University of Technology; Beijing Normal University; McGill University; Yeshiva University; Albert Einstein College of Medicine	Wu, K (corresponding author), Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	kai.wu.22@gmail.com	He, Yong/C-2161-2009; wu, kai/G-1229-2014; Evans, Alan C/B-2373-2013; Takeuchi, Hikaru/D-1057-2011; He, Yong/Q-5756-2018	wu, kai/0000-0003-4467-1597; Evans, Alan C/0000-0003-3841-6098; He, Yong/0000-0002-7039-2850; Takeuchi, Hikaru/0000-0002-8022-9694	Ministry of Education, Culture, Sports, Science and Technology [20790875, 24103701, 23240056]; Tohoku University Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Centre''; Guangdong Natural Science Foundation, China [S2012040007743]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tohoku University Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Centre''(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Guangdong Natural Science Foundation, China(National Natural Science Foundation of Guangdong Province)	This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (20790875, 24103701, and 23240056) and the 2007 Tohoku University Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Centre''. This study was also supported by Guangdong Natural Science Foundation (S2012040007743), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bussey K, 1999, PSYCHOL REV, V106, P676, DOI 10.1037/0033-295X.106.4.676; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Clayden JD, 2012, CEREB CORTEX, V22, P1738, DOI 10.1093/cercor/bhr243; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Cohen RZ, 1999, AM J PSYCHIAT, V156, P1059; CORBETTA M, 1993, J NEUROSCI, V13, P1202; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Fangmeier T, 2006, J COGNITIVE NEUROSCI, V18, P320, DOI 10.1162/jocn.2006.18.3.320; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Fujita K, 2006, JAPANESE WECHSLER AD; Gao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025278; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Ikeda Y, 2010, PROG NEURO-PSYCHOPH, V34, P244, DOI 10.1016/j.pnpbp.2009.10.010; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Milham M F X, 2012, 18 ANN M ORG HUM BRA; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schmithorst VJ, 2007, NEUROIMAGE, V35, P406, DOI 10.1016/j.neuroimage.2006.11.046; Schmithorst VJ, 2006, NEUROIMAGE, V31, P1366, DOI 10.1016/j.neuroimage.2006.01.010; Schmithorst VJ, 2009, INTELLIGENCE, V37, P164, DOI 10.1016/j.intell.2008.07.001; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Sporns Olaf, 2001, Complexity, V7, P28, DOI 10.1002/cplx.10015; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Taki Y, 2012, NEUROIMAGE, V60, P471, DOI 10.1016/j.neuroimage.2011.11.072; Taki Y, 2012, NEUROIMAGE, V59, P1023, DOI 10.1016/j.neuroimage.2011.08.092; Taki Y, 2011, NEUROIMAGE, V58, P709, DOI 10.1016/j.neuroimage.2011.07.020; Taki Y, 2011, HUM BRAIN MAPP, V32, P1973, DOI 10.1002/hbm.21163; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Ueno K, 1998, WECHSLER INTELLIGENC, V3rd; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	112	106	107	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55347	10.1371/journal.pone.0055347	http://dx.doi.org/10.1371/journal.pone.0055347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390528	Green Published, gold, Green Submitted			2022-12-27	WOS:000314691100044
J	Cafri, G; Sharbi-Yunger, A; Tzehoval, E; Eisenbach, L				Cafri, Gal; Sharbi-Yunger, Adi; Tzehoval, Esther; Eisenbach, Lea			Production of LacZ Inducible T Cell Hybridoma Specific for Human and Mouse gp100(25-33) Peptides	PLOS ONE			English	Article							CLASS-I; ANTIGEN; ACTIVATION; EXPRESSION	Identification and quantification of immunogenic peptides and tumor-derived epitopes presented on MHC-I molecules are essential for basic studies and vaccines generation. Although lymphocytes derived from transgenic mice can serve as sensitive detectors of processes of antigen presentation and recognition, they are not always available. The use of cell lines might be extremely useful. In this study, we generated a lacZ inducible CD8(+) hybridoma (BUSA14) capable of recognizing both human and mouse gp100(25-33) melanoma antigens presented on dendritic and tumor cell lines. This hybridoma expresses a variety of membranal T cell markers and secretes IL-2 and TNF alpha. Thus, BUSA14 offers a quantifiable, cheap and straightforward tool for studying peptide presentation by MHC-I molecules on the cell surface.	[Cafri, Gal; Sharbi-Yunger, Adi; Tzehoval, Esther; Eisenbach, Lea] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Eisenbach, L (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	lea.eisenbach@weizmann.ac.il		Eisenbach, Lea R/0000-0002-4816-1968; Cafri, Gal/0000-0002-9427-0479				DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KATZ A, 1992, J IMMUNOL METHODS, V149, P255, DOI 10.1016/0022-1759(92)90257-T; Malarkannan S, 2000, METH MOL B, V156, P265; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; PORGADOR A, 1995, CANCER RES, V55, P4941; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shen ZH, 1997, J IMMUNOL, V158, P2723	11	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55583	10.1371/journal.pone.0055583	http://dx.doi.org/10.1371/journal.pone.0055583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383339	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900046
J	Davis, AR; Coleman, D; Broad, A; Byrne, M; Dworjanyn, SA; Przeslawski, R				Davis, Andrew R.; Coleman, Daniel; Broad, Allison; Byrne, Maria; Dworjanyn, Symon A.; Przeslawski, Rachel			Complex Responses of Intertidal Molluscan Embryos to a Warming and Acidifying Ocean in the Presence of UV Radiation	PLOS ONE			English	Article							LIFE-HISTORY STAGES; CLIMATE-CHANGE; ULTRAVIOLET-RADIATION; ACIDIFICATION; TEMPERATURE; FERTILIZATION; LARVAE; STRESSORS; MORTALITY; EXPOSURE	Climate change and ocean acidification will expose marine organisms to synchronous multiple stressors, with early life stages being potentially most vulnerable to changing environmental conditions. We simultaneously exposed encapsulated molluscan embryos to three abiotic stressors-acidified conditions, elevated temperate, and solar UV radiation in large outdoor water tables in a multifactorial design. Solar UV radiation was modified with plastic filters, while levels of the other factors reflected IPCC predictions for near-future change. We quantified mortality and the rate of embryonic development for a mid-shore littorinid, Bembicium nanum, and low-shore opisthobranch, Dolabrifera brazieri. Outcomes were consistent for these model species with embryos faring significantly better at 26 degrees C than 22 degrees C. Mortality sharply increased at the lowest temperature (22 degrees C) and lowest pH (7.6) examined, producing a significant interaction. Under these conditions mortality approached 100% for each species, representing a 2- to 4-fold increase in mortality relative to warm (26 degrees C) non-acidified conditions. Predictably, development was more rapid at the highest temperature but this again interacted with acidified conditions. Development was slowed under acidified conditions at the lowest temperature. The presence of UV radiation had minimal impact on the outcomes, only slowing development for the littorinid and not interacting with the other factors. Our findings suggest that a warming ocean, at least to a threshold, may compensate for the effects of decreasing pH for some species. It also appears that stressors will interact in complex and unpredictable ways in a changing climate.	[Davis, Andrew R.; Coleman, Daniel; Broad, Allison; Przeslawski, Rachel] Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia; [Byrne, Maria] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia	University of Wollongong; University of Sydney; University of Sydney; Southern Cross University	Davis, AR (corresponding author), Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia.	adavis@uow.edu.au	Broad, Allison/AAY-5852-2021; Davis, Andy/H-3607-2011; Byrne, Maria/K-6355-2016; Dworjanyn, Symon A/O-5633-2017	Broad, Allison/0000-0002-1402-6098; Davis, Andy/0000-0002-8146-7424; Byrne, Maria/0000-0002-8902-9808; Dworjanyn, Symon A/0000-0002-6690-8033; Przeslawski, Rachel/0000-0003-0269-3755; Coleman, Daniel/0000-0002-2472-9993	Australian Research Council	Australian Research Council(Australian Research Council)	The authors gratefully acknowledge the financial support of the Australian Research Council (to MB and ARD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D. T., 1961, PROC LINN SOC N S WALES, V86, P203; Australian Radiation Protection and Nuclear Safety Agency, 2012, AUSTR UV IND MOD SYD; Benkendorff K, 2004, AQUAT CONSERV, V14, P263, DOI 10.1002/aqc.604; Breitburg DL, 1999, LIMNOL OCEANOGR, V44, P837, DOI 10.4319/lo.1999.44.3_part_2.0837; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DCWDS, 2010, DCWDS; Deschaseaux ESM, 2010, J EXP MAR BIOL ECOL, V383, P130, DOI 10.1016/j.jembe.2009.12.013; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Edgar GJ, 2000, AUSTR MARINE LIFE; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Grant KP, 1995, CAN J ZOOL, V73, P2292, DOI 10.1139/z95-271; Gutowska MA, 2010, J COMP PHYSIOL B, V180, P323, DOI 10.1007/s00360-009-0412-y; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HEARST JE, 1995, SCIENCE, V268, P1858, DOI 10.1126/science.7604259; Hoffman JR, 2003, J PHYCOL, V39, P268, DOI 10.1046/j.1529-8817.2003.01111.x; Hofmann DJ, 1999, SCI ASSESSMENT OZONE; *INT PAN CLIM CHAN, 2007, 4 IPCC; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Lough J. M., 2009, NCCARF PUBLICATION, V05/09; MORRIS S, 1983, ESTUAR COAST SHELF S, V17, P339, DOI 10.1016/0272-7714(83)90026-4; Moulin L, 2011, MAR POLLUT BULL, V62, P48, DOI 10.1016/j.marpolbul.2010.09.012; Nguyen HD, 2012, GLOBAL CHANGE BIOL, V18, P2466, DOI 10.1111/j.1365-2486.2012.02714.x; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pechenik J.A., 1987, P551; Pelletier E, 2006, PHOTOCHEM PHOTOBIOL, V82, P981, DOI 10.1562/2005-09-18-RA-688.1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Przeslawski R, 2007, MAR BIOL, V152, P991, DOI 10.1007/s00227-007-0748-3; Przeslawski R, 2005, MAR ECOL PROG SER, V298, P169, DOI 10.3354/meps298169; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Przeslawski R, 2004, MAR ECOL PROG SER, V268, P151, DOI 10.3354/meps268151; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; Przeslawski R, 2011, MOLLUSCAN RES, V31, P152; Rudman WB, 2010, SEASLUG FORUM; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; SPIGHT TM, 1975, OECOLOGIA, V21, P1, DOI 10.1007/BF00345889; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Tevini M., 1993, EFFECTS HUMANS ANIMA; TRUCHOT JP, 1980, RESP PHYSIOL, V39, P241, DOI 10.1016/0034-5687(80)90056-0; van Uitregt VO, 2007, GLOBAL CHANGE BIOL, V13, P1114, DOI 10.1111/j.1365-2486.2007.01353.x; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wraith J, 2006, J CHEM ECOL, V32, P993, DOI 10.1007/s10886-006-9054-7; Zippay ML, 2010, MAR BIOL, V157, P707, DOI 10.1007/s00227-009-1354-3	55	70	70	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55939	10.1371/journal.pone.0055939	http://dx.doi.org/10.1371/journal.pone.0055939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23741396	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400183
J	Yamamoto, R; Noiri, Y; Yamaguchi, M; Asahi, Y; Maezono, H; Kuboniwa, M; Hayashi, M; Ebisu, S				Yamamoto, Reiko; Noiri, Yuichiro; Yamaguchi, Mikiyo; Asahi, Yoko; Maezono, Hazuki; Kuboniwa, Masae; Hayashi, Mikako; Ebisu, Shigeyuki			The sinR Ortholog PGN_0088 Encodes a Transcriptional Regulator That Inhibits Polysaccharide Synthesis in Porphyromonas gingivalis ATCC 33277 Biofilms	PLOS ONE			English	Article							HUMAN PERIODONTAL POCKETS; BACILLUS-SUBTILIS; BACTERIAL BIOFILMS; MASTER REGULATOR; GENE-EXPRESSION; AMYLOID FIBERS; ARG-GINGIPAIN; MATRIX; LOCALIZATION; FIMBRIAE	Biofilm-forming cells are distinct from well characterized planktonic cells and aggregate in the extracellular matrix, the so-called extracellular polymeric substances (EPS). The sinR gene of Bacillus subtilis encodes a transcriptional regulator that is known to be involved in the biosynthesis of EPS in biofilms. Porphyromonas gingivalis inhabits the subgingival and extraradicular biofilm of humans and is one of the primary pathogens that cause progressive marginal and refractory apical periodontitis. Furthermore, P. gingivalis possesses PGN_0088, which encodes a putative ortholog of B. subtilis sinR. Here, we investigated the role of PGN_0088 (sinR) on biofilm formation. P. gingivalis strains formed biofilms on saliva-coated glass surfaces in phosphate buffered saline. Quantitative analysis indicated that the biofilm of the sinR null mutant consisted of dense exopolysaccharide. Microscopic observations showed that the increased levels of exopolysaccharide produced by the sinR mutant changed the morphology of the EPS to a mesh-liked structure. Furthermore, physical analyses suggested that the enrichment of exopolysaccharide in the EPS enhanced the resistance of the biofilm to hydrodynamic shear force. The results presented here demonstrate sinR plays important roles in the ability of P. gingivalis strain ATCC 33277 to act as a negative mediator of exopolysaccharide accumulation and is indirectly associated with the structure of the EPS and the force of its adhesion to surfaces.	[Yamamoto, Reiko; Noiri, Yuichiro; Yamaguchi, Mikiyo; Asahi, Yoko; Maezono, Hazuki; Hayashi, Mikako; Ebisu, Shigeyuki] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka, Japan; [Kuboniwa, Masae] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka, Japan	Osaka University; Osaka University	Noiri, Y (corresponding author), Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka, Japan.	noiri@dent.osaka-u.ac.jp	Noiri, Yuichiro/AAA-4871-2021	MAEZONO, Hazuki/0000-0002-1929-2045; Kuboniwa, Masae/0000-0002-3332-2431; Asahi, Yoko/0000-0001-9443-5790	Japan Society for the Promotion of Science [20249076, 24390424, 24890118]; Grants-in-Aid for Scientific Research [24390425] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research (20249076, 24390424 and 24890118) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi Y, 2012, J APPL MICROBIOL, V112, P404, DOI 10.1111/j.1365-2672.2011.05194.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Dasanayake Ananda P, 2003, Dent Clin North Am, V47, P115, DOI 10.1016/S0011-8532(02)00056-3; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Genco RJ, 1996, J PERIODONTOL, V67, P1041, DOI 10.1902/jop.1996.67.10s.1041; Gibson FC, 2006, J DENT RES, V85, P106, DOI 10.1177/154405910608500202; Hedge J.E., 1962, METHODS CARBOHYDRATE, P380; Inoue T, 2003, MICROBIOL IMMUNOL, V47, P877, DOI 10.1111/j.1348-0421.2003.tb03454.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kuboniwa M, 2004, ORAL MICROBIOL IMMUN, V19, P168, DOI 10.1111/j.0902-0055.2004.00135.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Morrison HI, 1999, J CARDIOVASC RISK, V6, P7; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Noguchi N, 2005, APPL ENVIRON MICROB, V71, P8738, DOI 10.1128/AEM.71.12.8738-8743.2005; Noiri Y, 2004, J DENT RES, V83, P941, DOI 10.1177/154405910408301210; Noiri Y, 2002, J ENDODONT, V28, P679, DOI 10.1097/00004770-200210000-00001; Noiri Y, 1997, J PERIODONTAL RES, V32, P598, DOI 10.1111/j.1600-0765.1997.tb00937.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Winkelman JT, 2009, J BACTERIOL, V191, P3981, DOI 10.1128/JB.00278-09; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yamamoto R, 2011, APPL ENVIRON MICROB, V77, P6733, DOI 10.1128/AEM.00746-11	44	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56017	10.1371/journal.pone.0056017	http://dx.doi.org/10.1371/journal.pone.0056017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	24312461	Green Published, Green Submitted, gold			2022-12-27	WOS:000315153400192
J	Liu, HP; Liu, ZH; Chen, JX; Chen, L; He, X; Zheng, RJ; Yang, H; Song, P; Weng, D; Hu, HL; Fan, L; Xiao, HP; Kaufmann, SHE; Ernst, J; Ge, BX				Liu, Haipeng; Liu, Zhonghua; Chen, Jianxia; Chen, Ling; He, Xin; Zheng, Ruijuan; Yang, Hong; Song, Peng; Weng, Dong; Hu, Haili; Fan, Lin; Xiao, Heping; Kaufmann, Stefan H. E.; Ernst, Joel; Ge, Baoxue			Induction of CCL8/MCP-2 by Mycobacteria through the Activation of TLR2/PI3K/Akt Signaling Pathway	PLOS ONE			English	Article							TUBERCULOUS PLEURAL EFFUSIONS; HELPER T-CELLS; INTERFERON-GAMMA; DIAGNOSTIC UTILITY; UP-REGULATION; HOST DISEASE; PLASMA CCL8; EXPRESSION; MCP-2; RECRUITMENT	Pleural tuberculosis (TB), together with lymphatic TB, constitutes more than half of all extrapulmonary cases. Pleural effusions (PEs) in TB are representative of lymphocytic PEs which are dominated by T cells. However, the mechanism underlying T lymphocytes homing and accumulation in PEs is still incompletely understood. Here we performed a comparative analysis of cytokine abundance in PEs from TB patients and non-TB patients by protein array analysis and observed that MCP-2/CCL8 is highly expressed in the TB-PEs as compared to peripheral blood. Meanwhile, we observed that CCR5, the primary receptor used by MCP-2/CCL8, is mostly expressed on pleural CD4(+) T lymphocytes. Furthermore, we found that infection with either Mycobacterium bovis Bacillus Calmette-Guerin (BCG) or Mycobacterium tuberculosis H37Rv induced production of MCP-2/CCL8 at both transcriptional and protein level in Raw264.7 and THP-1 macrophage cells, mouse peritoneal macrophages as well as human PBMC monocyte-derived macrophages (MDMs). The induction of MCP-2/CCL8 by mycobacteria is dependent on the activation of TLR2/PI3K/Akt and p38 signaling pathway. We conclude that accumulation of MCP-2/CCL8 in TB-PEs may function as a biomarker for TB diagnosis.	[Liu, Haipeng; Liu, Zhonghua; Chen, Jianxia; Zheng, Ruijuan; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai 200092, Peoples R China; [Liu, Haipeng; Yang, Hong; Song, Peng; Weng, Dong; Ge, Baoxue] Tongji Univ, Sch Med, Dept Microbiol & Immunol, Shanghai 200092, Peoples R China; [Liu, Haipeng; Chen, Jianxia; Chen, Ling; He, Xin; Yang, Hong; Song, Peng; Weng, Dong; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Clin Translat Res Ctr, Shanghai 200092, Peoples R China; [Hu, Haili; Fan, Lin; Xiao, Heping] Tongji Univ, Sch Med, Shanghai Pulm Hosp, TB Dept, Shanghai 200092, Peoples R China; [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Ernst, Joel] NYU, Sch Med, Div Infect Dis, New York, NY USA	Tongji University; Tongji University; Tongji University; Tongji University; Max Planck Society; New York University	Ge, BX (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai 200092, Peoples R China.	baoxue_ge@tongji.edu.cn	; Kaufmann, Stefan HE/I-5454-2014	Liu, Haipeng/0000-0002-3338-6291; Kaufmann, Stefan HE/0000-0001-9866-8268	National Natural Science Foundation of China [81200003]; National Basic Research Program of China (973 Program) [2012CB518700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported in part by a grant from the National Natural Science Foundation of China (81200003); in part by a grant from the National Basic Research Program of China (973 Program 2012CB518700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameglio F, 2005, INT J TUBERC LUNG D, V9, P98; ANTONY VB, 1985, J CLIN INVEST, V76, P1514, DOI 10.1172/JCI112131; ANTONY VB, 1983, ACTA CYTOL, V27, P355; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; BARNES PF, 1989, J IMMUNOL, V142, P1114; Baumann MH, 2007, CHEST, V131, P1125, DOI 10.1378/chest.06-2352; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; BOSSINK AWJ, 1995, BLOOD, V86, P3841, DOI 10.1182/blood.V86.10.3841.bloodjournal86103841; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Hamm H, 1997, EUR RESPIR J, V10, P1150, DOI 10.1183/09031936.97.10051150; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Kohmo S, 2012, TUBERCULOSIS, V92, P248, DOI 10.1016/j.tube.2012.01.001; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; Maddocks S, 2009, TUBERCULOSIS, V89, P285, DOI 10.1016/j.tube.2009.05.003; Mege JL, 2011, CURR OPIN INFECT DIS, V24, P230, DOI 10.1097/QCO.0b013e328344b73e; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Ota A, 2009, EXP HEMATOL, V37, P525, DOI 10.1016/j.exphem.2008.12.006; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Pokkali S, 2008, CYTOKINE, V41, P307, DOI 10.1016/j.cyto.2007.12.009; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Ruffing N, 1998, CELL IMMUNOL, V189, P160, DOI 10.1006/cimm.1998.1379; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sun XG, 2006, INFECT IMMUN, V74, P5943, DOI 10.1128/IAI.00082-06; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; VANDAMME J, 1994, J IMMUNOL, V152, P5495; Villena V, 2002, ARCH BRONCONEUMOL, V38, P21, DOI 10.1016/S0300-2896(02)75142-9; Wang Ting-ting, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P592; WANGOO A, 1993, CLIN EXP IMMUNOL, V94, P43; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Yamamoto M, 2011, EXP HEMATOL, V39, P1101, DOI 10.1016/j.exphem.2011.07.006; Yang WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040450; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC	46	58	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56815	10.1371/journal.pone.0056815	http://dx.doi.org/10.1371/journal.pone.0056815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418602	Green Published, gold			2022-12-27	WOS:000315970300195
J	Zhang, WW; Li, ZZ				Zhang, Weiwei; Li, Zhenzhong			The Effects of Target Skeletal Muscle Cells on Dorsal Root Ganglion Neuronal Outgrowth and Migration In Vitro	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN; PRIMARY SENSORY NEURONS; GAP-43 MESSENGER-RNA; SPINAL-CORD; NEUROMUSCULAR-JUNCTION; NMDA RECEPTOR; EXPRESSION; RAT; INJURY; PHOSPHORYLATION	Targets of neuronal innervations play a vital role in regulating the survival and differentiation of innervating neurotrophin-responsive neurons. During development, neurons extend axons to their targets, and then their survival become dependent on the trophic substances secreted by their target cells. Sensory endings were present on myoblasts, myotubes, and myofibers in all intrafusal bundles regardless of age. The interdependence of sensory neurons and skeletal muscle (SKM) cells during both embryonic development and the maintenance of the mature functional state has not been fully understood. In the present study, neuromuscular cocultures of organotypic dorsal root ganglion (DRG) explants and dissociate SKM cells were established. Using this culture system, the morphological relationship between DRG neurons and SKM cells, neurites growth and neuronal migration were investigated. The migrating neurons were determined by fluorescent labeling of microtubule-associated protein-2 (MAP-2) and neurofilament 200 (NF-200) or growth-associated protein 43 (GAP-43). The expression of NF-200 and GAP-43 and their mRNAs was evaluated by Western blot assay and real time-PCR analysis. The results reveal that DRG explants showed more dense neurites outgrowth in neuromuscular cocultures as compared with that in the culture of DRG explants alone. The number of total migrating neurons (the MAP-2-expressing neurons) and the percentage NF-200-immunoreactive (IR) and GAP-43-IR neurons increased significantly in the presence of SKM cells. The levels of NF-200 and GAP-43 and their mRNAs increased significantly in neuromuscular cocultures as compared with that in the culture of DRG explants alone. These results suggested that target SKM cells play an important role in regulating neuronal protein synthesis, promoting neuritis outgrowth and neuronal migration of DRG explants in vitro. These results not only provide new clues for a better understanding of the association of SKM cells with DRG sensory neurons during development, they may also have implications for axonal regeneration after nerve injury.	[Zhang, Weiwei; Li, Zhenzhong] Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China	Shandong University	Li, ZZ (corresponding author), Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China.	zli@sdu.edu.cn			National Natural Science Foundation of China [30973051]; Natural Science Foundation of Shandong Province of China [ZR2010HM027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (No. 30973051) and the Natural Science Foundation of Shandong Province of China (ZR2010HM027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER L, 1993, J CELL BIOL, V123, P417, DOI 10.1083/jcb.123.2.417; Albright MJ, 2007, J NEUROPHYSIOL, V98, P1610, DOI 10.1152/jn.00219.2007; Anand U, 2008, J NEURO-ONCOL, V89, P1, DOI 10.1007/s11060-008-9585-6; Anderson KD, 2003, EXP NEUROL, V183, P100, DOI 10.1016/S0014-4886(03)00103-1; Baird DH, 1996, J NEUROSCI, V16, P2642; Bergman E, 1999, BRAIN RES, V832, P63, DOI 10.1016/S0006-8993(99)01469-9; Buddle M, 2003, BRAIN RES, V978, P38, DOI 10.1016/S0006-8993(03)02758-6; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Daniels MP, 2000, MICROSC RES TECHNIQ, V49, P26, DOI 10.1002/(SICI)1097-0029(20000401)49:1<26::AID-JEMT4>3.0.CO;2-8; Dehmelt L, 2003, J NEUROSCI, V23, P9479; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Di Stefano G, 2001, J HISTOCHEM CYTOCHEM, V49, P1065, DOI 10.1177/002215540104900818; El-Nour H, 2006, IMMUNOPHARM IMMUNOT, V28, P621, DOI 10.1080/08923970601067136; Ettorre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031451; Gotow Takahiro, 2000, Medical Electron Microscopy, V33, P173, DOI 10.1007/s007950000019; Gupta SK, 2009, CELL DEATH DIFFER, V16, P624, DOI 10.1038/cdd.2008.188; Hall AK, 1997, J NEUROSCI, V17, P2775; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kato N, 2003, NEUROSCI RES, V45, P297, DOI 10.1016/S0168-0102(02)00234-1; Kato N, 2001, J Orthop Sci, V6, P419, DOI 10.1007/s007760170008; Kesavapany S, 2003, NEUROSIGNALS, V12, P252, DOI 10.1159/000074627; Keswani SC, 2004, J NEUROSCI METH, V136, P193, DOI 10.1016/j.jneumeth.2004.01.004; Liu YL, 2003, ADV ANAT PATHOL, V10, P101, DOI 10.1097/00125480-200303000-00005; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lu JJ, 2001, NEUROSCI RES, V41, P355, DOI 10.1016/S0168-0102(01)00293-0; Manzini MC, 2006, J NEUROSCI, V26, P6040, DOI 10.1523/JNEUROSCI.4815-05.2006; Mars T, 2001, PFLUG ARCH EUR J PHY, V442, pR177, DOI 10.1007/s004240100015; Mason CA, 1997, PERSPECT DEV NEUROBI, V5, P69; Mechsner S, 2007, FERTIL STERIL, V88, P581, DOI 10.1016/j.fertnstert.2006.12.087; Murata R, 2006, AUTON NEUROSCI-BASIC, V128, P96, DOI 10.1016/j.autneu.2006.04.003; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Silver L, 2005, DNA CELL BIOL, V24, P438, DOI 10.1089/dna.2005.24.438; Tabernero A, 2002, J NEUROCHEM, V81, P881, DOI 10.1046/j.1471-4159.2002.00843.x; Tanaka H, 2000, J MUSCLE RES CELL M, V21, P507, DOI 10.1023/A:1026561120566; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Torres-Benito L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026164; Tsai SY, 2007, J NEUROSCI RES, V85, P321, DOI 10.1002/jnr.21119; Tsai SY, 2002, NEUROSCIENCE, V114, P55, DOI 10.1016/S0306-4522(02)00261-0; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; Umbach JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036049; VALMIER J, 1993, MUSCLE NERVE, V16, P397, DOI 10.1002/mus.880160409; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wang LH, 2009, ANAT REC, V292, P107, DOI 10.1002/ar.20777; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Yabe JT, 2001, CELL MOTIL CYTOSKEL, V50, P1, DOI 10.1002/cm.1037; Zhao CN, 2004, J NEUROTRAUM, V21, P1468, DOI 10.1089/neu.2004.21.1468	52	92	105	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52849	10.1371/journal.pone.0052849	http://dx.doi.org/10.1371/journal.pone.0052849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23405095	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400022
J	Geraldi, NR; Macreadie, PI				Geraldi, Nathan R.; Macreadie, Peter I.			Restricting Prey Dispersal Can Overestimate the Importance of Predation in Trophic Cascades	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; FOOD-WEB; ECOSYSTEM FUNCTION; FIELD EVIDENCE; OYSTER REEFS; BEHAVIOR; ECOLOGY; DENSITY; DRIFT; FISH	Predators can affect prey populations and, via trophic cascades, predators can indirectly impact resource populations (2 trophic levels below the predator) through consumption of prey (density-mediated indirect effects; DMIEs) and by inducing predator-avoidance behavior in prey (trait-mediated indirect effects; TMIEs). Prey often employ multiple predator-avoidance behaviors, such as dispersal or reduced foraging activity, but estimates of TMIEs are usually on individual behaviors. We assessed direct and indirect predator effects in a mesocosm experiment using a marine food chain consisting of a predator (toadfish - Opsanus tau), prey (mud crab - Panopeus herbstii) and resource (ribbed mussel - Geukensia demissa). We measured dispersal and foraging activity of prey separately by manipulating both the presence and absence of the predator, and whether prey could or could not disperse into a predator-free area. Consumption of prey was 9 times greater when prey could not disperse, probably because mesocosm boundaries increased predator capture success. Although predator presence did not significantly affect the number of crabs that emigrated, the presence of a predator decreased resource consumption by prey, which resulted in fewer resources consumed for each prey that emigrated in the presence of a predator, and reduced the overall TMIE. When prey were unable to disperse, TMIEs on mussel survival were 3 times higher than the DMIEs. When prey were allowed to disperse, the TMIEs on resource survival increased to 11-times the DMIEs. We found that restricting the ability of prey to disperse, or focusing on only one predator-avoidance behavior, may be underestimating TMIEs. Our results indicate that the relative contribution of behavior and consumption in food chain dynamics will depend on which predator-avoidance behaviors are allowed to occur and measured.	[Geraldi, Nathan R.] Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; [Macreadie, Peter I.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	University of North Carolina; University of North Carolina Chapel Hill; University of Technology Sydney	Macreadie, PI (corresponding author), Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia.	geraldi@email.unc.edu	Geraldi, Nathan/AAA-3645-2020	Geraldi, Nathan/0000-0002-2669-3867	North Carolina Coastal Recreational Fishing License Grant; National Estuary Research Reserve Fellowship; Cooperative Insitute for Coastal and Esturine Environnmetal Technology; NOAA Ecological Effects of Sea Level Rise Program; American Australian Association; UTS International Researcher Development Grant	North Carolina Coastal Recreational Fishing License Grant; National Estuary Research Reserve Fellowship; Cooperative Insitute for Coastal and Esturine Environnmetal Technology; NOAA Ecological Effects of Sea Level Rise Program; American Australian Association; UTS International Researcher Development Grant	Funding was provided by a North Carolina Coastal Recreational Fishing License Grant, National Estuary Research Reserve Fellowship, Cooperative Insitute for Coastal and Esturine Environnmetal Technology, NOAA Ecological Effects of Sea Level Rise Program, the American Australian Association, and a UTS International Researcher Development Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2008, EVOL ECOL RES, V10, P333; Abrams PA, 2007, ECOLOGY, V88, P2555, DOI 10.1890/06-1381.1; Beckerman AP, 2010, FUNCT ECOL, V24, P1, DOI 10.1111/j.1365-2435.2009.01673.x; Belovsky GE, 2011, ECOL LETT, V14, P335, DOI 10.1111/j.1461-0248.2011.01591.x; Beschta RL, 2007, WEST N AM NATURALIST, V67, P613, DOI 10.3398/1527-0904(2007)67[613:IWHANY]2.0.CO;2; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; CARPENTER SR, 1988, BIOSCIENCE, V38, P764, DOI 10.2307/1310785; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Cronin JT, 2004, ECOLOGY, V85, P2134, DOI 10.1890/03-0591; DIEHL S, 1993, OIKOS, V68, P151, DOI 10.2307/3545321; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Eggleston DB, 1998, J EXP MAR BIOL ECOL, V223, P111, DOI 10.1016/S0022-0981(97)00154-8; Englund G, 1997, ECOLOGY, V78, P2316; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; FORRESTER GE, 1994, ECOLOGY, V75, P1208, DOI 10.2307/1937447; FRASER DF, 1992, ECOLOGY, V73, P959, DOI 10.2307/1940172; Grabowski JH, 2005, ECOLOGY, V86, P1312, DOI 10.1890/04-1216; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; GRAY GA, 1961, ECOLOGY, V42, P274, DOI 10.2307/1932079; Griffin CAM, 2006, ECOL LETT, V9, P335, DOI 10.1111/j.1461-0248.2005.00880.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HUANG CF, 1991, OECOLOGIA, V85, P530, DOI 10.1007/BF00323765; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Laundre JW, 2010, ECOLOGY, V91, P2995, DOI 10.1890/08-2345.1; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Macreadie PI, 2012, MAR ECOL PROG SER, V466, P145, DOI 10.3354/meps09986; Macreadie PI, 2011, MAR ECOL PROG SER, V429, P87, DOI 10.3354/meps09115; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; MCDONALD J, 1982, MAR ECOL PROG SER, V8, P173, DOI 10.3354/meps008173; McIntosh AR, 2002, FRESHWATER BIOL, V47, P1497, DOI 10.1046/j.1365-2427.2002.00889.x; McIntosh AR, 1999, OECOLOGIA, V118, P256, DOI 10.1007/s004420050726; Micheli F, 1999, CONSERV BIOL, V13, P869, DOI 10.1046/j.1523-1739.1999.98233.x; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Okuyama T, 2007, ECOL LETT, V10, P264, DOI 10.1111/j.1461-0248.2007.01019.x; Orrock JL, 2008, ECOLOGY, V89, P2426, DOI 10.1890/07-1024.1; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Peckarsky BL, 1996, ECOLOGY, V77, P1888, DOI 10.2307/2265792; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Ripple WJ, 2006, FOREST ECOL MANAG, V230, P96, DOI 10.1016/j.foreco.2006.04.023; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Schmitz OJ, 2008, ECOLOGY, V89, P2436, DOI 10.1890/07-1030.1; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; SIH A, 1994, ECOLOGY, V75, P1199, DOI 10.2307/1937446; Stachowicz JJ, 1999, MAR ECOL PROG SER, V188, P169, DOI 10.3354/meps188169; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Toscano BJ, 2012, MAR ECOL PROG SER, V445, P65, DOI 10.3354/meps09461; Trussell GC, 2002, ECOL LETT, V5, P241, DOI 10.1046/j.1461-0248.2002.00304.x; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Winkelmann C, 2008, AQUAT ECOL, V42, P483, DOI 10.1007/s10452-007-9101-7; Wirsing AJ, 2011, FRONT ECOL ENVIRON, V9, P335, DOI 10.1890/090226	61	60	60	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55100	10.1371/journal.pone.0055100	http://dx.doi.org/10.1371/journal.pone.0055100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408957	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200017
J	Liu, Y; Luo, HS; Liang, CB; Xia, H; Xu, WJ; Chen, JH; Chen, MK				Liu, Ying; Luo, Hesheng; Liang, Chengbo; Xia, Hong; Xu, Wenjuan; Chen, Jihong; Chen, Mingkai			Actions of Hydrogen Sulfide and ATP-Sensitive Potassium Channels on Colonic Hypermotility in a Rat Model of Chronic Stress	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IRRITABLE-BOWEL-SYNDROME; ENTERIC NERVOUS-SYSTEM; K+ CHANNELS; GASTROINTESTINAL-TRACT; VISCERAL HYPERSENSITIVITY; CALCIUM-CHANNELS; IN-VITRO; MOTILITY; COLITIS	Objective: To investigate the potential role of hydrogen sulphide (H2S) and ATP-sensitive potassium (K-ATP) channels in chronic stress-induced colonic hypermotility. Methods: Male Wistar rats were submitted daily to 1 h of water avoidance stress (WAS) or sham WAS (SWAS) for 10 consecutive days. Organ bath recordings, H2S production, immunohistochemistry and western blotting were performed on rat colonic samples to investigate the role of endogenous H2S in repeated WAS-induced hypermotility. Organ bath recordings and western blotting were used to detect the role of K-ATP channels in repeated WAS. Results: Repeated WAS increased the number of fecal pellets per hour and the area under the curve of the spontaneous contractions of colonic strips, and decreased the endogenous production of H2S and the expression of H2S-producing enzymes in the colon devoid of mucosa and submucosa. Inhibitors of H2S-producing enzymes increased the contractile activity of colonic strips in the SWAS rats. NaHS concentration-dependently inhibited the spontaneous contractions of the strips and the NaHS IC50 for the WAS rats was significantly lower than that for the SWAS rats. The inhibitory effect of NaHS was significantly reduced by glybenclamide. Repeated WAS treatment resulted in up-regulation of Kir6.1 and SUR2B of K-ATP channels in the colon devoid of mucosa and submucosa. Conclusion: The colonic hypermotility induced by repeated WAS may be associated with the decreased production of endogenous H2S. The increased expression of the subunits of K-ATP channels in colonic smooth muscle cells may be a defensive response to repeated WAS. H2S donor may have potential clinical utility in treating chronic stress-induced colonic hypermotility.	[Liu, Ying; Luo, Hesheng; Liang, Chengbo; Xia, Hong; Xu, Wenjuan; Chen, Jihong; Chen, Mingkai] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Liu, Ying] Guilin Med Coll, Affiliated Hosp, Dept Gastroenterol, Guilin, Peoples R China	Wuhan University; Guilin Medical University	Luo, HS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China.	xhkhsluo@126.com		Chen, Mingkai/0000-0001-6771-0523; Chen, Mingkai/0000-0003-2652-6863	National Natural Science Foundation of China [81070297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81070297). The URL of the funder's website is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataka K, 2012, AM J PHYSIOL-GASTR L, V303, pG519, DOI 10.1152/ajpgi.00390.2011; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Bulbul M, 2012, AM J PHYSIOL-GASTR L, V302, pG702, DOI 10.1152/ajpgi.00447.2011; Choudhury BK, 2009, AM J PHYSIOL-GASTR L, V296, pG1238, DOI 10.1152/ajpgi.90712.2008; Dhaese I, 2010, EUR J PHARMACOL, V628, P179, DOI 10.1016/j.ejphar.2009.11.024; Dhaese I, 2009, EUR J PHARMACOL, V606, P180, DOI 10.1016/j.ejphar.2009.01.011; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P1306, DOI 10.1111/j.1365-2982.2008.01201.x; Gil V, 2011, BRIT J PHARMACOL, V164, P485, DOI 10.1111/j.1476-5381.2011.01431.x; Hansen MB, 2003, PHARMACOL TOXICOL, V92, P249, DOI 10.1034/j.1600-0773.2003.920601.x; Hennig B, 2009, BRIT J PHARMACOL, V158, P1263, DOI 10.1111/j.1476-5381.2009.00385.x; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jimenez M, 2010, NEUROGASTROENT MOTIL, V22, P1149, DOI 10.1111/j.1365-2982.2010.01600.x; Jin XC, 2004, AM J PHYSIOL-GASTR L, V287, pG274, DOI 10.1152/ajpgi.00472.2003; Jun JY, 2001, AM J PHYSIOL-CELL PH, V281, pC857, DOI 10.1152/ajpcell.2001.281.3.C857; Kasparek MS, 2012, J SURG RES, V175, P234, DOI 10.1016/j.jss.2011.03.069; Koh SD, 1998, BIOPHYS J, V75, P1793, DOI 10.1016/S0006-3495(98)77621-0; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; Leffler CW, 2006, J APPL PHYSIOL, V100, P1065, DOI 10.1152/japplphysiol.00793.2005; Li QJ, 2011, AM J PHYSIOL-GASTR L, V300, pG154, DOI 10.1152/ajpgi.00393.2010; Liang CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031774; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Linden DR, 2010, ANTIOXID REDOX SIGN, V12, P1135, DOI 10.1089/ars.2009.2885; Martin GR, 2010, DIGEST LIVER DIS, V42, P103, DOI 10.1016/j.dld.2009.05.016; Paravicini TM, 2003, CLIN EXP PHARMACOL P, V30, P855, DOI 10.1046/j.1440-1681.2003.03920.x; Pluja L, 1998, CAN J PHYSIOL PHARM, V76, P1166, DOI 10.1139/cjpp-76-12-1166; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Tian XY, 2006, BRAIN RES, V1088, P101, DOI 10.1016/j.brainres.2006.03.014; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Xu GY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-44; Zhang M, 2010, NEUROGASTROENT MOTIL, V22, pe162, DOI 10.1111/j.1365-2982.2009.01467.x; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014	38	130	141	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55853	10.1371/journal.pone.0055853	http://dx.doi.org/10.1371/journal.pone.0055853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23437170	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400167
J	Boillot, A; Zoungas, S; Mitchell, P; Klein, R; Klein, B; Ikram, MK; Klaver, C; Wang, JJ; Gopinath, B; Tai, ES; Neubauer, AS; Hercberg, S; Brazionis, L; Saw, SM; Wong, TY; Czernichow, S				Boillot, Adrien; Zoungas, Sophia; Mitchell, Paul; Klein, Ronald; Klein, Barbara; Ikram, Mohammad Kamran; Klaver, Caroline; Wang, Jie Jin; Gopinath, Bamini; Tai, E. Shyong; Neubauer, Aljoscha Steffen; Hercberg, Serge; Brazionis, Laima; Saw, Seang-Mei; Wong, Tien-Yin; Czernichow, Sebastien		META-EYE Study Grp	Obesity and the Microvasculature: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RETINAL VASCULAR CALIBER; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; ATHEROSCLEROSIS RISK; VESSEL DIAMETERS; BLOOD-PRESSURE; DIABETIC-RETINOPATHY; INSULIN-RESISTANCE; METABOLIC SYNDROME	Background: Overweight and obesity are thought to significantly influence a person's risk of cardiovascular disease, possibly via its effect on the microvasculature. Retinal vascular caliber is a surrogate marker of microvascular disease and a predictor of cardiovascular events. The aim of this systematic review and meta-analysis was to determine the association between body mass index (BMI) and retinal vascular caliber. Methods and Findings: Relevant studies were identified by searches of the MEDLINE and EMBASE databases from 1966 to August 2011. Standardized forms were used for data extraction. Among over 44,000 individuals, obese subjects had narrower arteriolar and wider venular calibers when compared with normal weight subjects, independent of conventional cardiovascular risk factors. In adults, a 1 kg/m(2) increase in BMI was associated with a difference of 0.07 mm [95% CI: -0.08; -0.06] in arteriolar caliber and 0.22 mu m [95% CI: 0.21; 0.23] in venular caliber. Similar results were found for children. Conclusions: Higher BMI is associated with narrower retinal arteriolar and wider venular calibers. Further prospective studies are needed to examine whether a causative relationship between BMI and retinal microcirculation exists.	[Boillot, Adrien] Univ Paris 07, Dept Periodontol, Paris, France; [Boillot, Adrien; Czernichow, Sebastien] Hop Ambroise Pare, Dept Nutr, Boulogne, France; [Zoungas, Sophia; Brazionis, Laima] George Inst Global Hlth, Dept Vasc Sci & Med, Melbourne, Vic, Australia; [Mitchell, Paul; Wang, Jie Jin] Westmead Millennium Inst, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW, Australia; [Klein, Ronald; Klein, Barbara] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Ikram, Mohammad Kamran; Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Ikram, Mohammad Kamran; Klaver, Caroline] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Ikram, Mohammad Kamran; Tai, E. Shyong; Saw, Seang-Mei; Wong, Tien-Yin] Singapore Eye Res Inst, Dept Ophthalmol, Singapore, Singapore; [Gopinath, Bamini] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Neubauer, Aljoscha Steffen] Univ Munich, Dept Ophthalmol, Munich, Germany; [Hercberg, Serge] Univ Sorbone Paris Cite, Univ Paris 13, INSERM,Inst Natl Rech Agron,Unite Rech Epidemiol, Unite U557,Avicenne Hosp,Conservatoire Arts & Met, Bobigny, France; [Czernichow, Sebastien] Univ Versailles St Quentin, Dept Nutr, Versailles, France; [Czernichow, Sebastien] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; George Institute for Global Health; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Wisconsin System; University of Wisconsin Madison; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; National University of Singapore; Singapore National Eye Center; University of Melbourne; University of Munich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Czernichow, S (corresponding author), Hop Ambroise Pare, Dept Nutr, Boulogne, France.	sebastien.czernichow@apr.aphp.fr	Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Klaver, Caroline C.W./A-2013-2016; Wang, Jie Jin/P-1499-2014; Serge, Hercberg/F-3038-2017; HERCBERG, Serge/B-4429-2008; Tai, E Shyong/J-9831-2013; Gopinath, Bamini/K-4286-2019; Mitchell, Paul/P-1498-2014; Dodds, Peter/C-9119-2014; Mitchell, Lewis/W-1312-2018	Wong, Tien Yin/0000-0002-8448-1264; Wang, Jie Jin/0000-0001-9491-4898; Serge, Hercberg/0000-0002-3168-1350; HERCBERG, Serge/0000-0002-3168-1350; Gopinath, Bamini/0000-0003-3573-359X; Tai, E Shyong/0000-0003-2929-8966; Dodds, Peter/0000-0003-1973-8614; Zoungas, Sophia/0000-0003-2672-0949; Klein, Ronald/0000-0002-4428-6237; Mitchell, Lewis/0000-0001-8191-1997; Ikram, Mohammad Kamran/0000-0003-0173-9571; /0000-0001-9487-9359	National Health and Medical Research Council [124317, 396414, 209057]; National Heart Foundation; Centre for Clinical Research Excellence in Clinical Science in Diabetes	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia); Centre for Clinical Research Excellence in Clinical Science in Diabetes	Funding was provided by the National Health and Medical Research Council (#124317, #396414, #209057), the National Heart Foundation, and the Centre for Clinical Research Excellence in Clinical Science in Diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Berni A, 2011, ATHEROSCLEROSIS, V216, P109, DOI 10.1016/j.atherosclerosis.2011.01.034; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Cardillo C, 2002, CIRCULATION, V106, P1783, DOI 10.1161/01.CIR.0000032260.01569.64; Cheung N, 2007, OBESITY, V15, P209, DOI 10.1038/oby.2007.576; Clerk LH, 2006, DIABETES, V55, P1436, DOI 10.2337/db05-1373; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Czernichow S, 2010, HYPERTENS RES, V33, P293, DOI 10.1038/hr.2009.228; Czernichow S, 2010, J HYPERTENS, V28, P325, DOI 10.1097/HJH.0b013e328333d1fc; de Jongh RT, 2004, CIRCULATION, V109, P2529, DOI 10.1161/01.CIR.0000129772.26647.6F; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fortunato G, 2003, ATHEROSCLEROSIS, V167, P141, DOI 10.1016/S0021-9150(02)00423-9; Frisbee JC, 2002, AM J PHYSIOL-HEART C, V283, pH2160, DOI 10.1152/ajpheart.00379.2002; Gopinath B, 2011, INT J PEDIATR OBES, V6, pE353, DOI 10.3109/17477166.2010.500390; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hodnett BL, 2007, MICROCIRCULATION, V14, P273, DOI 10.1080/10739680701282143; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Hughes A, 2009, MICROCIRCULATION, V16, P159, DOI 10.1080/10739680802353868; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Jeganathan VSE, 2009, HYPERTENS RES, V32, P975, DOI 10.1038/hr.2009.130; Kato K, 2009, ENVIRON SCI TECHNOL, V43, P2641, DOI 10.1021/es803156p; Klein R, 2003, OPHTHALMOLOGY, V110, P2118, DOI 10.1016/S0161-6420(03)00863-7; Klein R, 2006, OPHTHALMOLOGY, V113, P1488, DOI 10.1016/j.ophtha.2006.03.028; Knudson JD, 2007, MICROCIRCULATION, V14, P317, DOI 10.1080/10739680701282887; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kotsis VT, 2006, OBESITY, V14, P1708, DOI 10.1038/oby.2006.196; Liew G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1404, DOI 10.1001/archopht.126.10.1404; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; Stapleton Phoebe A, 2008, Pathophysiology, V15, P79, DOI 10.1016/j.pathophys.2008.04.007; Stepp DW, 2007, AM J PHYSIOL-HEART C, V293, pH2537, DOI 10.1152/ajpheart.01081.2006; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun C, 2008, INVEST OPHTH VIS SCI, V49, P1784, DOI 10.1167/iovs.07-1450; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Taylor B, 2007, INT J OBESITY, V31, P1527, DOI 10.1038/sj.ijo.0803674; Wang JJ, 2006, OBESITY, V14, P206, DOI 10.1038/oby.2006.27; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Wong TY, 2004, BMJ-BRIT MED J, V329, P79, DOI 10.1136/bmj.38124.682523.55; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Zebekakis PE, 2005, J HYPERTENS, V23, P1839, DOI 10.1097/01.hjh.0000179511.93889.e9	43	131	138	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e52708	10.1371/journal.pone.0052708	http://dx.doi.org/10.1371/journal.pone.0052708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405065	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400008
J	Liu, HJ; Xu, YF; Lin, XJ; Shi, J; Chen, SY				Liu, Hongjie; Xu, Yongfang; Lin, Xinjin; Shi, Jian; Chen, Shiyi			Associations between Perceived HIV Stigma and Quality of Life at the Dyadic Lvel: The Actor-Partner Interdependence Model	PLOS ONE			English	Article							YOUNG ADOLESCENTS; CAREGIVERS; SCHIZOPHRENIA; INDIVIDUALISM; COLLECTIVISM; PERSPECTIVES; SEROSTATUS; INFECTION; HIV/AIDS; DISEASE	Background: Few studies have investigated the relationship between HIV-related stigma and quality life at the dyadic level. The objective of this study was to examine the actor and partner effects of stigma that was perceived by people living with HIV/AIDS (PLWHAs) and caregivers on quality of life at the dyadic level. Method: A survey was conducted among 148 dyads consisting of one PLWHA and one caregiver (296 participants) in Nanning, China. The interdependent relationship between a pair of dyadic members that influences the associations between stigma and quality of life was analyzed, using an innovative dyadic analysis technique: the Actor-Partner Interdependence Model (APIM). Results: We found in this dyadic analysis that (1) PLWHAs compared to their caregivers exhibited a higher level of perceived HIV stigma and lower level of quality of life measured in four domains; (2) both PLWHAs' and caregivers' perceived HIV stigma influenced their own quality of life; (3) The quality of life was not substantially influenced by their partners' perceived stigma; and (4) Both actor and partner effects of stigma on quality of life were similar among PLWHAs and their caregivers. Conclusion: As HIV stigma and quality of life are complex phenomena rooted in cultures, intervention programs should be carefully planned based on social or cognitive theories and should be culturally adopted.	[Liu, Hongjie] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Xu, Yongfang; Lin, Xinjin; Shi, Jian; Chen, Shiyi] Nanning Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China	University System of Maryland; University of Maryland College Park	Liu, HJ (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.	hliu1210@umd.edu	; Kaufmann, Stefan HE/I-5454-2014	Liu, Haipeng/0000-0002-3338-6291; Kaufmann, Stefan HE/0000-0001-9866-8268	National Institutes of Health-National Institute of Child Health and Human Development [R01 HD068305-01]; Virginia Commonwealth University School of Medicine	National Institutes of Health-National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Virginia Commonwealth University School of Medicine	This work was partially supported by a research grant (R01 HD068305-01) from the National Institutes of Health-National Institute of Child Health and Human Development and a research grant from the Virginia Commonwealth University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasiubong F, 2011, AIDS CARE, V23, P494, DOI 10.1080/09540121.2010.516340; Andrinopoulos K, 2011, AIDS EDUC PREV, V23, P367, DOI 10.1521/aeap.2011.23.4.367; Aranda-Naranjo B, 2004, J ASSOC NURSE AIDS C, V15, p20S, DOI 10.1177/1055329004269183; Boyer L, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-42; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Caqueo-Urizar A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-84; Chinese Ministry of Health, 2012, CHIN AIDS RESP PROGR; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Feaster DJ, 2002, PSYCHOL HEALTH, V17, P339, DOI 10.1080/08870440290029584; Flaskerud J H, 1998, Health Care Women Int, V19, P23, DOI 10.1080/073993398246557; Goffman E., 1968, STIGMA NOTES MANAGEM; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Group W, 1996, WHOQOL BREF INTR ADM; Ha TH, 2012, AIDS CARE, V24, P39, DOI 10.1080/09540121.2011.592820; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Holzemer WL, 2009, J ASSOC NURSE AIDS C, V20, P161, DOI 10.1016/j.jana.2009.02.002; HUI CH, 1986, J CROSS CULT PSYCHOL, V17, P225, DOI 10.1177/0022002186017002006; Kelley H. H, 1978, INTERPERSONAL RELATI; Kenny D. A., 2006, DYADIC DATA ANAL; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Laursen B, 2005, INT J BEHAV DEV, V29, P97, DOI 10.1080/01650250444000450; Lee SJ, 2007, AM J PUBLIC HEALTH, V97, P1820, DOI 10.2105/AJPH.2005.084871; Li Li, 2008, Fam Syst Health, V26, P431; Li XH, 2011, AIDS PATIENT CARE ST, V25, P665, DOI 10.1089/apc.2011.0174; Lin T. Y., 1981, NORMAL ABNORMAL BEHA, P387, DOI DOI 10.1007/978-94-017-4986-2_20; Liu H, 2009, SEX TRANSM INFECT, V85, P65, DOI 10.1136/sti.2008.032714; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Liu HJ, 2002, SEX TRANSM DIS, V29, P335, DOI 10.1097/00007435-200206000-00005; Liu HJ, 2012, AIDS PATIENT CARE ST, V26, P565, DOI 10.1089/apc.2012.0227; Liu Hongjie, 2011, Stigma Res Action, V1, P27; Liu HJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-563; Mitchell MM, 2009, AIDS PATIENT CARE ST, V23, P611, DOI 10.1089/apc.2008.0279; Muth?n L.K., 2010, MPLUS USERS GUIDE V; Nelms TP, 2002, J FAMILY NURSING, V8, P282; Poindexter CC, 1999, SOC WORK, V44, P46, DOI 10.1093/sw/44.1.46; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Scambler G, 1998, LANCET, V352, P1054, DOI 10.1016/S0140-6736(98)08068-4; Shan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021839; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; WHOQOL Group, 2004, WHO QUAL LIF WHOQOL; Wight RG, 2006, SOC SCI MED, V62, P444, DOI 10.1016/j.socscimed.2005.06.004; Yang LH, 2008, SOC SCI MED, V67, P398, DOI 10.1016/j.socscimed.2008.03.011; Zendjidjian X, 2012, J AFFECT DISORDERS, V136, P660, DOI 10.1016/j.jad.2011.10.011	45	58	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55680	10.1371/journal.pone.0055680	http://dx.doi.org/10.1371/journal.pone.0055680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085EU	23418602	gold, Green Submitted, Green Published			2022-12-27	WOS:000314597900050
J	Park, SG; Long, MX; Kang, JA; Kim, WS; Lee, CR; Im, SH; Strickland, I; Schulze-Luehrmann, J; Hayden, MS; Ghosh, S				Park, Sung-Gyoo; Long, Meixiao; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog; Strickland, Ian; Schulze-Luehrmann, Jan; Hayden, Matthew S.; Ghosh, Sankar			The Kinase PDK1 Is Essential for B-Cell Receptor Mediated Survival Signaling	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE; ANTIGEN-RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; ACTIVATION; PHOSPHORYLATION; IMMUNODEFICIENCY; PROLIFERATION; REGULATOR; RICTOR	Phosphoinositide-dependent kinase 1 (PDK1) plays an important role in integrating the T cell antigen receptor (TCR) and CD28 signals to achieve efficient NF-kappa B activation. PDK1 is also an important regulator of T cell development, mediating pre-TCR induced proliferation signals. However, the role of PDK1 in B cell antigen receptor (BCR) signaling and B cell development remains largely unknown. In this study we provide genetic evidence supporting the role of PDK1 in B cell survival. We found PDK1 is required for BCR mediated survival in resting B cells, likely through regulation of Foxo activation. PDK1-dependent signaling to NF-kappa B is not crucial to resting B cell viability. However, PDK1 is necessary for triggering NF-kappa B during B cell activation and is required for activated B cell survival. Together these studies demonstrate that PDK1 is essential for BCR-induced signal transduction to Foxo and NF-kappa B and is indispensable for both resting and activated B cell survival.	[Park, Sung-Gyoo; Long, Meixiao; Strickland, Ian; Schulze-Luehrmann, Jan; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10027 USA; [Park, Sung-Gyoo; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog] GIST, Sch Life Sci, Kwangju, South Korea; [Park, Sung-Gyoo; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog] GIST, Immune Synapse Res Ctr, Kwangju, South Korea; [Hayden, Matthew S.] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY USA	Columbia University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Columbia University	Park, SG (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10027 USA.	sgpark@gist.ac.kr; sg2715@columbia.edu	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013; Park, Sung-Gyoo/H-8652-2019	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Hayden, Matthew/0000-0003-1670-6430; Park, Sung-Gyoo/0000-0003-3702-5765	National Institutes of Health [NIH R37-AI33443, RO1-AI068977]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0029942, 2011-0005477]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI068977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work in this study was supported by grants from the National Institutes of Health (NIH R37-AI33443 and RO1-AI068977) and by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0029942 and 2011-0005477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; delPeso L, 1997, SCIENCE, V278, P687; Donahue AC, 2004, SEMIN CELL DEV BIOL, V15, P183, DOI 10.1016/j.semcdb.2003.12.024; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hayashi T, 2007, P NATL ACAD SCI USA, V104, P18619, DOI 10.1073/pnas.0709261104; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hess KL, 2004, EUR J IMMUNOL, V34, P2968, DOI 10.1002/eji.200425326; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki Y, 2007, ADV EXP MED BIOL, V596, P149; SCHRIEVER F, 1989, J EXP MED, V169, P2043, DOI 10.1084/jem.169.6.2043; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	33	64	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55378	10.1371/journal.pone.0055378	http://dx.doi.org/10.1371/journal.pone.0055378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23437331	Green Published, Green Submitted, gold			2022-12-27	WOS:000314692800025
J	Wang, PH; Gu, ZH; Wan, DH; Zhu, WB; Qiu, W; Weng, SP; Yu, XQ; He, JG				Wang, Pei-Hui; Gu, Zhi-Hua; Wan, Ding-Hui; Zhu, Wei-Bin; Qiu, Wei; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			Litopenaeus vannamei Sterile-Alpha and Armadillo Motif Containing Protein (LvSARM) Is Involved in Regulation of Penaeidins and antilipopolysaccharide factors	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE GENES; TOLL SIGNALING PATHWAY; SHRIMP PENAEUS-MONODON; BLACK TIGER SHRIMP; INNATE IMMUNITY; CAENORHABDITIS-ELEGANS; DROSOPHILA; SARM; INFECTION; RECEPTORS	The Toll-like receptor (TLR)-mediated NF-kappa B pathway is tightly controlled because overactivation may result in severe damage to the host, such as in the case of chronic inflammatory diseases and cancer. In mammals, sterile-alpha and armadillo motif-containing protein (SARM) plays an important role in negatively regulating this pathway. While Caenorhabditis elegans SARM is crucial for an efficient immune response against bacterial and fungal infections, it is still unknown whether Drosophila SARM participates in immune responses. Here, Litopenaeus vannamei SARM (LvSARM) was cloned and functionally characterized. LvSARM shared signature domains with and exhibited significant similarities to mammalian SARM. Real-time quantitative PCR analysis indicated that the expression of LvSARM was responsive to Vibrio alginolyticus and white spot syndrome virus (WSSV) infections in the hemocyte, gill, hepatopancreas and intestine. In Drosophila S2 cells, LvSARM was widely distributed in the cytoplasm and could significantly inhibit the promoters of the NF-kappa B pathway-controlled antimicrobial peptide genes (AMPs). Silencing of LvSARM using dsRNA-mediated RNA interference increased the expression levels of Penaeidins and antilipopolysaccharide factors, which are L. vannamei AMPs, and increased the mortality rate after V. alginolyticus infection. Taken together, our results reveal that LvSARM may be a novel component of the shrimp Toll pathway that negatively regulates shrimp AMPs, particularly Penaeidins and antilipopolysaccharide factors.	[Wang, Pei-Hui; Gu, Zhi-Hua; Wan, Ding-Hui; Zhu, Wei-Bin; Qiu, Wei; Weng, Shao-Ping; He, Jian-Guo] Sch Life Sci, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	Wang, PH (corresponding author), Sch Life Sci, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	wph326@gmail.com; lsshjg@mail.sysu.edu.cn	YU, XiaoQiang/GRJ-1077-2022; Wang, Pei-Hui/F-7682-2014; YU, XIAO-QIANG/AAL-1797-2021	Wang, Pei-Hui/0000-0001-6853-2423; YU, XIAO-QIANG/0000-0003-1419-9009; Munthe, Else/0000-0003-3859-1582	National Natural Science Foundation of China [U1131002]; National High Technology Research and Development Program of China (973 Program) [2012CB114401]; China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest [201103034]; Foundation of Administration of Ocean and Fisheries of Guangdong Province [A201101B02]; Open Project of the State Key Laboratory of Biocontrol [SKLBC09K04]; Foundation of Science and Technology Bureau of Guangdong Province [2011A 020102002, 2009A 020102002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; Foundation of Administration of Ocean and Fisheries of Guangdong Province; Open Project of the State Key Laboratory of Biocontrol; Foundation of Science and Technology Bureau of Guangdong Province	This research was supported by the National Natural Science Foundation of China under Grant No. U1131002, the National High Technology Research and Development Program of China (973 Program) 2012CB114401, the China Agriculture Research System, the Special Fund for Agro-scientific Research in the Public Interest 201103034, the Foundation of Administration of Ocean and Fisheries of Guangdong Province A201101B02, the Open Project of the State Key Laboratory of Biocontrol (SKLBC09K04) and the Foundation of Science and Technology Bureau of Guangdong Province (2011A 020102002 and 2009A 020102002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Bachere E, 2000, AQUACULTURE, V191, P3, DOI 10.1016/S0044-8486(00)00413-0; Belinda LWC, 2008, MOL IMMUNOL, V45, P1732, DOI 10.1016/j.molimm.2007.09.030; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Cuthbertson BJ, 2008, DEV COMP IMMUNOL, V32, P167, DOI 10.1016/j.dci.2007.06.009; de la Vega E, 2008, MOL IMMUNOL, V45, P1916, DOI 10.1016/j.molimm.2007.10.039; de Lorgeril J, 2008, MOL IMMUNOL, V45, P3438, DOI 10.1016/j.molimm.2008.04.002; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho SH, 2009, FISH SHELLFISH IMMUN, V27, P73, DOI 10.1016/j.fsi.2009.05.001; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kadowaki T, 2011, IN VIVO, V25, P741; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Labreuche Y, 2009, DEV COMP IMMUNOL, V33, P806, DOI 10.1016/j.dci.2009.02.005; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leu JH, 2009, CURR TOP MICROBIOL, V328, P197; Li CY, 2010, FISH SHELLFISH IMMUN, V29, P1044, DOI 10.1016/j.fsi.2010.08.020; Li CY, 2010, FISH SHELLFISH IMMUN, V28, P1, DOI 10.1016/j.fsi.2009.09.003; Li FH, 2010, DEV COMP IMMUNOL, V34, P874, DOI 10.1016/j.dci.2010.03.008; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang KCHC, 2010, DEV COMP IMMUNOL, V34, P49, DOI 10.1016/j.dci.2009.08.003; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2012, DEV COMP IMMUNOL, V36, P39, DOI 10.1016/j.dci.2011.06.002; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Woramongkolchai N, 2011, DEV COMP IMMUNOL, V35, P530, DOI 10.1016/j.dci.2010.12.016; Yuan SC, 2010, J IMMUNOL, V184, P6874, DOI 10.4049/jimmunol.0903675; Zhang Q, 2011, DEV COMP IMMUNOL, V35, P461, DOI 10.1016/j.dci.2010.11.013	51	112	112	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e52088	10.1371/journal.pone.0052088	http://dx.doi.org/10.1371/journal.pone.0052088			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405063	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400006
J	Miller, CT; Fraser, SF; Levinger, I; Straznicky, NE; Dixon, JB; Reynolds, J; Selig, SE				Miller, Clint T.; Fraser, Steve F.; Levinger, Itamar; Straznicky, Nora E.; Dixon, John B.; Reynolds, John; Selig, Steve E.			The Effects of Exercise Training in Addition to Energy Restriction on Functional Capacities and Body Composition in Obese Adults during Weight Loss: A Systematic Review	PLOS ONE			English	Review							FAT-FREE MASS; PHYSICAL-ACTIVITY; MUSCLE STRENGTH; POSTMENOPAUSAL WOMEN; CALORIC RESTRICTION; SKELETAL-MUSCLE; OLDER PERSONS; ABDOMINAL FAT; RISK-FACTORS; HIGH-PROTEIN	Background: Obesity is associated with impairments of physical function, cardiovascular fitness, muscle strength and the capacity to perform activities of daily living. This review examines the specific effects of exercise training in relation to body composition and physical function demonstrated by changes in cardiovascular fitness, and muscle strength when obese adults undergo energy restriction. Methods: Electronic databases were searched for randomised controlled trials comparing energy restriction plus exercise training to energy restriction alone. Studies published to May 2013 were included if they used multi-component methods for analysing body composition and assessed measures of fitness in obese adults. Results: Fourteen RCTs met the inclusion criteria. Heterogeneity of study characteristics prevented meta-analysis. Energy restriction plus exercise training was more effective than energy restriction alone for improving cardiovascular fitness, muscle strength, and increasing fat mass loss and preserving lean body mass, depending on the type of exercise training. Conclusion: Adding exercise training to energy restriction for obese middle-aged and older individuals results in favourable changes to fitness and body composition. Whilst weight loss should be encouraged for obese individuals, exercise training should be included in lifestyle interventions as it offers additional benefits.	[Miller, Clint T.; Fraser, Steve F.; Selig, Steve E.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Exercise & Sports Sci, Melbourne, Vic, Australia; [Levinger, Itamar] Victoria Univ, Sch Sport & Exercise Sci, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Straznicky, Nora E.] Baker IDI Heart & Diabet Inst, Human Neurotransmitters Lab, Melbourne, Vic, Australia; [Dixon, John B.] Baker IDI Heart & Diabet Inst, Clin Obes Res Lab, Melbourne, Vic, Australia; [Reynolds, John] Deakin Univ, Fac Hlth, Biostat Unit, Melbourne, Vic, Australia	Deakin University; Victoria University; Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Deakin University	Selig, SE (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Ctr Exercise & Sports Sci, Melbourne, Vic, Australia.	steve.selig@deakin.edu.au	Dixon, John B/A-5318-2011; Wrighton, Kelly C/ABD-6621-2021; Reynolds, John/D-2591-2013	Dixon, John B/0000-0001-5391-4082; Wrighton, Kelly C/0000-0003-0434-4217; Reynolds, John/0000-0002-8825-8625; Fraser, Steve F/0000-0003-0202-9619; Miller, Clint/0000-0001-7743-6986; Banfield, Jill/0000-0001-8203-8771; Miller, Christopher/0000-0002-9448-8144; Handley, Kim/0000-0003-0531-3009; Levinger, Itamar/0000-0001-9194-2033	Heart Foundation [G11M5892]; Diabetes Australia Millennium Grant	Heart Foundation; Diabetes Australia Millennium Grant	Dr. Itamar Levinger is a Heart Foundation Research Fellow (PR 11M 6086 and Prof John Dixon is an NHMRC Senior Research Fellow. Dr. Nora Straznicky is funded by a Heart Foundation Grant-in-Aid (G11M5892) and a Diabetes Australia Millennium Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Alvarez VP, 2007, OBES SURG, V17, P211, DOI 10.1007/s11695-007-9032-3; Amati F, 2008, J APPL PHYSIOL, V105, P825, DOI 10.1152/japplphysiol.90384.2008; Anandacoomarasamy A, 2009, CURR OPIN RHEUMATOL, V21, P71, DOI 10.1097/BOR.0b013e32831bc0d7; Beavers KM, 2011, AM J CLIN NUTR, V94, P767, DOI 10.3945/ajcn.110.004895; Beckman LM, 2010, J AM DIET ASSOC, V110, P571, DOI 10.1016/j.jada.2009.12.023; Blazer DG, 2006, J AM GERIATR SOC, V54, P502, DOI 10.1111/j.1532-5415.2005.00607.x; Bouchard DR, 2011, METAB SYNDR RELAT D, V9, P225, DOI 10.1089/met.2010.0101; Bouchard DR, 2009, MENOPAUSE, V16, P66, DOI 10.1097/gme.0b013e31817dacf7; BRAY GA, 1988, WESTERN J MED, V149, P429; Byrne NM, 2003, AM J CLIN NUTR, V77, P1368, DOI 10.1093/ajcn/77.6.1368; Campbell KL, 2012, J CLIN ONCOL, V30, P2314, DOI 10.1200/JCO.2011.37.9792; Capodaglio P, 2010, INT J OCCUP SAF ERGO, V16, P507, DOI 10.1080/10803548.2010.11076863; Chaston TB, 2007, INT J OBESITY, V31, P743, DOI 10.1038/sj.ijo.0803483; Chmelo E, 2012, J PHYS ACT HEALTH; Clemes SA, 2010, OCCUP MED-OXFORD, V60, P101, DOI 10.1093/occmed/kqp127; Coulson JC, 2008, INT J WORKPLACE HEAL, V1, P176, DOI 10.1108/17538350810926534; Craig BN, 2006, AM J IND MED, V49, P249, DOI 10.1002/ajim.20290; Daly RM, 2005, OSTEOPOROSIS INT, V16, P1703, DOI 10.1007/s00198-005-1906-4; Das SK, 2005, CURR OPIN CLIN NUTR, V8, P602, DOI 10.1097/01.mco.0000171122.60665.5f; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Duvigneaud N, 2008, J SPORT MED PHYS FIT, V48, P201; Fields DA, 2005, CURR OPIN CLIN NUTR, V8, P624, DOI 10.1097/01.mco.0000171127.44525.07; Formiguera X, 2004, BEST PRACT RES CL GA, V18, P1125, DOI [10.1016/S1521-6918(04)00091-5, 10.1016/j.bpg.2004.06.030]; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Frimel TN, 2008, MED SCI SPORT EXER, V40, P1213, DOI 10.1249/MSS.0b013e31816a85ce; Fruhbeck G, 2004, NEW ENGL J MED, V350, P308, DOI 10.1056/NEJM200401153500323; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GARROW JS, 1995, EUR J CLIN NUTR, V49, P1; GENAIDY AM, 1992, ERGONOMICS, V35, P1081, DOI 10.1080/00140139208967384; Glasziou P.P., 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1017/CBO9780511543500; GOING SB, 1993, AM J CLIN NUTR, V57, P845, DOI 10.1093/ajcn/57.6.845; Guyenet SJ, 2012, J CLIN ENDOCR METAB, V97, P745, DOI 10.1210/jc.2011-2525; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; He XXZ, 2004, AM J PUBLIC HEALTH, V94, P1567, DOI 10.2105/AJPH.94.9.1567; Hills A P, 2002, Obes Rev, V3, P35, DOI 10.1046/j.1467-789X.2002.00054.x; Himes CL, 2000, DEMOGRAPHY, V37, P73, DOI 10.2307/2648097; Hulens M, 2003, SCAND J MED SCI SPOR, V13, P98, DOI 10.1034/j.1600-0838.2003.10273.x; Hulens M, 2001, INT J OBESITY, V25, P676, DOI 10.1038/sj.ijo.0801560; Ismail I, 2012, OBES REV, V13, P68, DOI 10.1111/j.1467-789X.2011.00931.x; Janssen I, 1999, INT J OBESITY, V23, P1035, DOI 10.1038/sj.ijo.0801038; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Janssen I, 2011, J OBES, V2011, DOI 10.1155/2011/531403; Jebb SA, 1999, MED SCI SPORT EXER, V31, pS534, DOI 10.1097/00005768-199911001-00008; Kaila B, 2008, CAN J GASTROENTEROL, V22, P61, DOI 10.1155/2008/609039; Kraemer WJ, 2001, MED SCI SPORT EXER, V33, P1011, DOI 10.1097/00005768-200106000-00022; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; Leone N, 2011, OBESITY; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; Manini TM, 2010, OBESITY, V18, P1168, DOI 10.1038/oby.2009.317; Marks BL, 1996, SPORTS MED, V22, P273, DOI 10.2165/00007256-199622050-00001; Messier V, 2010, J SPORT SCI, V28, P83, DOI 10.1080/02640410903390105; Miller GD, 2006, OBESITY, V14, P1219, DOI 10.1038/oby.2006.139; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Monteiro Maria Silvia, 2011, Rev. esc. enferm. USP, V45, P1177; Nicklas BJ, 2009, AM J CLIN NUTR, V89, P1043, DOI 10.3945/ajcn.2008.26938; Payne RW, 2011, GUIDE GENSTAT RELEAS; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rice B, 1999, DIABETES CARE, V22, P684, DOI 10.2337/diacare.22.5.684; Ruiz JR, 2010, J PEDIATR-US, V157, P917, DOI 10.1016/j.jpeds.2010.06.026; Stenholm S, 2009, INT J OBESITY, V33, P635, DOI 10.1038/ijo.2009.62; Stenholm S, 2013, J GERONTOL A, P1079; Straznicky NE, 2010, DIABETES, V59, P71, DOI 10.2337/db09-0934; Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429; Vargas CB, 2013, OBES SURG, V23, P1590, DOI 10.1007/s11695-013-0924-0; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Vieira ER, 2008, INT J IND ERGONOM, V38, P143, DOI 10.1016/j.ergon.2006.02.001; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Vingard E, 2009, WORK, V34, P339, DOI 10.3233/WOR-2009-0932; WEBSTER JD, 1984, HUM NUTR-CLIN NUTR, V38C, P299; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; Weiss EP, 2007, J APPL PHYSIOL, V102, P634, DOI 10.1152/japplphysiol.00853.2006; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d; Woodrow G, 2007, PERITON DIALYSIS INT, V27, pS245; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321; Wycherley TP, 2010, DIABETES CARE, V33, P969, DOI 10.2337/dc09-1974	82	194	199	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81692	10.1371/journal.pone.0081692	http://dx.doi.org/10.1371/journal.pone.0081692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	23405248	gold, Green Published, Green Accepted			2022-12-27	WOS:000327543500119
J	Miller, CS; Handley, KM; Wrighton, KC; Frischkorn, KR; Thomas, BC; Banfield, JF				Miller, Christopher S.; Handley, Kim M.; Wrighton, Kelly C.; Frischkorn, Kyle R.; Thomas, Brian C.; Banfield, Jillian F.			Short-Read Assembly of Full-Length 16S Amplicons Reveals Bacterial Diversity in Subsurface Sediments	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; MICROBIAL DIVERSITY; RARE BIOSPHERE; ENVIRONMENTAL SURVEYS; SPECIES RICHNESS; BODY HABITATS; DEEP-SEA; SEQUENCE; COMMUNITIES; URANIUM	In microbial ecology, a fundamental question relates to how community diversity and composition change in response to perturbation. Most studies have had limited ability to deeply sample community structure (e.g. Sanger-sequenced 16S rRNA libraries), or have had limited taxonomic resolution (e. g. studies based on 16S rRNA hypervariable region sequencing). Here, we combine the higher taxonomic resolution of near-full-length 16S rRNA gene amplicons with the economics and sensitivity of short-read sequencing to assay the abundance and identity of organisms that represent as little as 0.01% of sediment bacterial communities. We used a new version of EMIRGE optimized for large data size to reconstruct near-full-length 16S rRNA genes from amplicons sheared and sequenced with Illumina technology. The approach allowed us to differentiate the community composition among samples acquired before perturbation, after acetate amendment shifted the predominant metabolism to iron reduction, and once sulfate reduction began. Results were highly reproducible across technical replicates, and identified specific taxa that responded to the perturbation. All samples contain very high alpha diversity and abundant organisms from phyla without cultivated representatives. Surprisingly, at the time points measured, there was no strong loss of evenness, despite the selective pressure of acetate amendment and change in the terminal electron accepting process. However, community membership was altered significantly. The method allows for sensitive, accurate profiling of the "long tail'' of low abundance organisms that exist in many microbial communities, and can resolve population dynamics in response to environmental change.	[Miller, Christopher S.; Handley, Kim M.; Wrighton, Kelly C.; Frischkorn, Kyle R.; Thomas, Brian C.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Miller, CS (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	christopher.s.miller@ucdenver.edu	Dixon, John B/A-5318-2011; Wrighton, Kelly C/ABD-6621-2021; Reynolds, John/D-2591-2013	Dixon, John B/0000-0001-5391-4082; Wrighton, Kelly C/0000-0003-0434-4217; Reynolds, John/0000-0002-8825-8625; Fraser, Steve F/0000-0003-0202-9619; Miller, Clint/0000-0001-7743-6986; Banfield, Jill/0000-0001-8203-8771; Miller, Christopher/0000-0002-9448-8144; Handley, Kim/0000-0003-0531-3009; Levinger, Itamar/0000-0001-9194-2033	IFRC, Subsurface Biogeochemical Research Program; Office of Science, Biological and Environmental Research, US Department of Energy (DOE) [DE-AC02-05CH11231]	IFRC, Subsurface Biogeochemical Research Program; Office of Science, Biological and Environmental Research, US Department of Energy (DOE)	Funding was provided by the IFRC, Subsurface Biogeochemical Research Program and the Knowledgebase Program (DE-AC02-05CH11231), Office of Science, Biological and Environmental Research, US Department of Energy ( DOE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-490; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Beman JM, 2012, LIMNOL OCEANOGR, V57, P711, DOI 10.4319/lo.2012.57.3.0711; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Goltsman DSA, 2009, APPL ENVIRON MICROB, V75, P4599, DOI 10.1128/AEM.02943-08; Handley KM, 2012, FEMS MICROBIOL ECOL, V81, P188, DOI 10.1111/j.1574-6941.2012.01363.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harismendy O, 2009, BIOTECHNIQUES, V46, P229, DOI 10.2144/000113082; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Holmes DE, 2007, ISME J, V1, P663, DOI 10.1038/ismej.2007.85; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Kauserud H, 2012, MYCORRHIZA, V22, P309, DOI 10.1007/s00572-011-0403-1; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Li L, 2010, J CONTAM HYDROL, V112, P45, DOI 10.1016/j.jconhyd.2009.10.006; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Mueller RS, 2011, ENVIRON MICROBIOL, V13, P2279, DOI 10.1111/j.1462-2920.2011.02486.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spring S, 2009, STAND GENOMIC SCI, V1, P242, DOI 10.4056/sigs.39508; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrionis HA, 2005, APPL ENVIRON MICROB, V71, P6308, DOI 10.1128/AEM.71.10.6308-6318.2005; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	67	194	199	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56018	10.1371/journal.pone.0056018	http://dx.doi.org/10.1371/journal.pone.0056018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405248	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400193
J	Yang, DY; Baumgartner, RN; Slattery, ML; Wang, CX; Giuliano, AR; Murtaugh, MA; Risendal, BC; Byers, T; Baumgartner, KB				Yang, Dongyan; Baumgartner, Richard N.; Slattery, Martha L.; Wang, Chenxi; Giuliano, Anna R.; Murtaugh, Maureen A.; Risendal, Betsy C.; Byers, Tim; Baumgartner, Kathy B.			Dietary Intake of Folate, B-Vitamins and Methionine and Breast Cancer Risk among Hispanic and Non-Hispanic White Women	PLOS ONE			English	Article							ONE-CARBON METABOLISM; SOUTHWESTERN UNITED-STATES; ESTROGEN-RECEPTOR STATUS; MTHFR POLYMORPHISMS; BODY-SIZE; POSTMENOPAUSAL WOMEN; GENE POLYMORPHISMS; COLON-CANCER; ALCOHOL; NUTRIENTS	Background: Low dietary folate intake is associated with several neoplasias, but reports are inconsistent for breast cancer. Additionally, the association of folate with breast cancer estrogen receptor (ER) status is not well established. Objective: To determine if dietary intakes of folate, B-vitamins (B-2, B-6, B-12) and methionine are associated with breast cancer risk and ER status in Hispanic, and non-Hispanic White women in the southwestern US. Materials and Methods: Primary breast cancer cases (n = 2,325) in the 4-Corners region (Arizona, Colorado, New Mexico and Utah), diagnosed between October 1999 and May 2004, were identified through state cancer registries. Controls (n = 2,525) were frequency-matched by ethnicity and age (+/- 5 years). Dietary intake, physical activity and other exposures were assessed using in-person interviews. Risk was assessed through multivariable and multinomial logistic regression with adjustment for relevant covariates. Result: While there was no overall association with breast cancer, the highest quartile of folate intake was marginally inversely associated with ER- breast cancer (Odds Ratio (OR) = 0.50, 95% CI 0.25-1.00, p for trend = 0.07). Vitamin B-12 intake was inversely associated with breast cancer also (OR = 0.73, 95% CI 0.53-1.00, p for trend = 0.06), particularly for the highest quartile of ER+ breast cancer (OR = 0.67, 95% CI 0.46-0.99, p for trend = 0.06), among NHW women (OR = 0.49, 95% CI 0.29-0.81, p for trend = 0.01) and invasive breast cancer (OR = 0.63; 95% CI: 0.42, 0.93, P-trend = 0.01). Methionine intake was also inversely associated with ER+ breast cancer (OR for 4th quartile = 0.83, 95% CI 0.66-1.03, p for trend = 0.04), primarily among Hispanic women (OR = 0.71, 95% CI 0.47-1.06, and P for trend = 0.02). Conclusion: Higher intake of folate is marginally associated with a lower risk for ER- breast cancer, and higher intakes of vitamin B-12 and methionine are marginally associated with a lower risk of ER+ breast cancer.	[Yang, Dongyan; Baumgartner, Richard N.; Wang, Chenxi; Baumgartner, Kathy B.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA; [Slattery, Martha L.; Murtaugh, Maureen A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Giuliano, Anna R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Risendal, Betsy C.; Byers, Tim] Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA	University of Louisville; Utah System of Higher Education; University of Utah; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Yang, DY (corresponding author), Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA.	d0yang01@louisville.edu	Lv, Yuanjie/AER-0767-2022; Murtaugh, Maureen/AAN-6225-2020; Wang, Wei Eric/AAE-9504-2022; peng, yu/GXW-2071-2022; Wang, Wei Eric/AFE-0795-2022	Murtaugh, Maureen/0000-0001-5281-0302; 	National Cancer Institute [CA 078682, CA 078762, CA078552, CA078802, N01-PC-67000]; Utah Cancer Registry; State of Utah Department of Health	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Utah Cancer Registry; State of Utah Department of Health	This research was supported by the grants from the National Cancer Institute (CA 078682, CA 078762, CA078552, and CA078802). This research also was supported by the Utah Cancer Registry, which is funded by Contract #N01-PC-67000 from the National Cancer Institute, and with additional support from the State of Utah Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Baumgartner Kathy B., 2002, Ethnicity & Disease, V12, P460; Buechley RW, 1976, GEN USEFUL ETHNIC SE; Chen J, 2005, CANCER RES, V65, P1606, DOI 10.1158/0008-5472.CAN-04-2630; Cho EY, 2007, CANCER EPIDEM BIOMAR, V16, P2787, DOI 10.1158/1055-9965.EPI-07-0683; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; DuBose Katrina D, 2007, J Phys Act Health, V4, P343; Durnitrescu RG, 2005, ALCOHOL, V35, P213, DOI 10.1016/j.alcohol.2005.04.005; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; Ericson U, 2007, AM J CLIN NUTR, V86, P434, DOI 10.1093/ajcn/86.2.434; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Hines LM, 2008, CANCER EPIDEM BIOMAR, V17, P2700, DOI 10.1158/1055-9965.EPI-08-0504; HOWARD CA, 1983, AM J EPIDEMIOL, V117, P27, DOI 10.1093/oxfordjournals.aje.a113512; Institute of Medicine, 1998, DIET REF INT THIAM R, P1; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; JEWELL N. P., 2004, STAT EPIDEMIOLOGY; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kim YI, 2006, NUTR REV, V64, P468, DOI 10.1301/nr.2006.oct.468-475; Koutros S, 2008, AM J EPIDEMIOL, V167, P287, DOI 10.1093/aje/kwm307; Lajous M, 2006, CANCER EPIDEM BIOMAR, V15, P443, DOI 10.1158/1055-9965.EPI-05-0532; Lajous M, 2006, CANCER CAUSE CONTROL, V17, P1209, DOI 10.1007/s10552-006-0053-3; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Levi F, 2001, INT J CANCER, V91, P260, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1041&gt;3.3.CO;2-R; Lewis SJ, 2006, JNCI-J NATL CANCER I, V98, P1607, DOI 10.1093/jnci/djj440; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Maruti SS, 2009, AM J CLIN NUTR, V89, P624, DOI 10.3945/ajcn.2008.26568; Mason JB, 2005, ALCOHOL, V35, P235, DOI 10.1016/j.alcohol.2005.03.012; Moore CE, 2005, J NUTR, V135, P2478, DOI 10.1093/jn/135.10.2478; Murtaugh MA, 2008, AM J CLIN NUTR, V87, P978, DOI 10.1093/ajcn/87.4.978; Murtaugh MA, 2007, J AM DIET ASSOC, V107, P1311, DOI 10.1016/j.jada.2007.05.008; Murtaugh MA, 2007, CANCER CAUSE CONTROL, V18, P153, DOI 10.1007/s10552-006-0099-2; Negri E, 2000, J NATL CANCER I, V92, P1270, DOI 10.1093/jnci/92.15.1270-a; Osborne CK, 1991, BREAST DIS, P301; Prinz-Langenohl R, 2001, EUR J NUTR, V40, P98, DOI 10.1007/PL00007387; Risendal B, 2008, CANC CAUSES CONTROL; Rogers A, 2004, AM J EPIDEMIOL, V160, P85, DOI 10.1093/aje/kwh176; Rohan TE, 2000, J NATL CANCER I, V92, P266, DOI 10.1093/jnci/92.3.266; Rollison DE, 2008, AM J EPIDEMIOL, V167, P447, DOI 10.1093/aje/kwm322; Satia-Abouta J, 2003, CANCER EPIDEM BIOMAR, V12, P747; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Sellers TA, 2002, CANCER EPIDEM BIOMAR, V11, P1104; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shrubsole MJ, 2011, AM J EPIDEMIOL, V173, P1171, DOI 10.1093/aje/kwq491; Shrubsole MJ, 2004, CANCER EPIDEM BIOMAR, V13, P190, DOI 10.1158/1055-9965.EPI-03-0273; Shrubsole MJ, 2001, CANCER RES, V61, P7136; Slattery ML, 2007, BREAST CANCER RES TR, V104, P197, DOI 10.1007/s10549-006-9403-9; Slattery ML, 2008, BREAST CANCER RES TR, V109, P101, DOI 10.1007/s10549-007-9629-1; Slattery ML, 2008, OBESITY, V16, P339, DOI 10.1038/oby.2007.44; Slattery ML, 2007, BREAST CANCER RES TR, V105, P327, DOI 10.1007/s10549-006-9453-z; Slattery ML, 2007, ANN EPIDEMIOL, V17, P342, DOI 10.1016/j.annepidem.2006.10.017; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P747, DOI 10.1158/1055-9965.EPI-06-0667; Slattery ML, 2007, BREAST CANCER RES TR, V102, P85, DOI 10.1007/s10549-006-9292-y; SLATTERY ML, 1994, J AM DIET ASSOC, V94, P761, DOI 10.1016/0002-8223(94)91944-5; Slattery ML, 2005, CANCER CAUSE CONTROL, V16, P1147, DOI 10.1007/s10552-005-0318-2; STANFORD JL, 1989, AM J PUBLIC HEALTH, V79, P71, DOI 10.2105/AJPH.79.1.71; Steffen AD, 2008, CANCER EPIDEM BIOMAR, V17, P447, DOI 10.1158/1055-9965.EPI-07-2576; Stevens VL, 2010, AM J CLIN NUTR, V91, P1708, DOI 10.3945/ajcn.2009.28553; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Suitor CW, 2000, J AM DIET ASSOC, V100, P88, DOI 10.1016/S0002-8223(00)00027-4; Suzuki T, 2008, CARCINOGENESIS, V29, P356, DOI 10.1093/carcin/bgm295; Sweeney C, 2008, CANCER CAUSE CONTROL, V19, P391, DOI 10.1007/s10552-007-9098-1; Sweeney C, 2007, AM J EPIDEMIOL, V166, P1210, DOI 10.1093/aje/kwm192; Sweeney C, 2007, CANCER EPIDEM BIOMAR, V16, P142, DOI 10.1158/1055-9965.EPI-06-0706; Ulrich CM, 2006, NUTRIENT-GENE INTERACTIONS IN CANCER, P75, DOI 10.1201/9781420004847.ch5; Ulrich CM, 2007, AM J CLIN NUTR, V86, P271, DOI 10.1093/ajcn/86.2.271; Wang C, 2008, BREAST CANC RES TREA; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 2012, NUTR EPIDEMIOLOGY; Word DL, 1996, 13 US BUR CENS POP D, P1; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632; Zhu KM, 1998, CANCER CAUSE CONTROL, V9, P615, DOI 10.1023/A:1008819210777	78	222	229	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54495	10.1371/journal.pone.0054495	http://dx.doi.org/10.1371/journal.pone.0054495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23667467	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000006
J	Yang, DZ; Wang, W; Li, LP; Peng, YL; Chen, P; Huang, HY; Guo, YL; Xia, XW; Wang, YY; Wang, HY; Wang, WE; Zeng, CY				Yang, Dezhong; Wang, Wei; Li, Liangpeng; Peng, Yulan; Chen, Peng; Huang, Haiyun; Guo, Yanli; Xia, Xuewei; Wang, Yuanyuan; Wang, Hongyong; Wang, Wei Eric; Zeng, Chunyu			The Relative Contribution of Paracine Effect versus Direct Differentiation on Adipose-Derived Stem Cell Transplantation Mediated Cardiac Repair	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FUNCTIONAL IMPROVEMENT; REGENERATIVE MEDICINE; PARACRINE MECHANISMS; CONDITIONED MEDIUM; STROMAL CELLS; IN-VITRO; HEART; THERAPY; DISEASE	Background: Recent studies have demonstrated that transplantation of adipose-derived stem cell (ADSC) can improve cardiac function in animal models of myocardial infarction (MI). However, the mechanisms underlying the beneficial effect are not fully understood. In this study, we characterized the paracrine effect of transplanted ADSC and investigated its relative importance versus direct differentiation in ADSC transplantation mediated cardiac repair. Methodology/Principal Findings: MI was experimentally induced in mice by ligation of the left anterior descending coronary artery. Either human ADSC, conditioned medium (CM) collected from the same amount of ADSC or control medium was injected into the peri-infarct region immediately after MI. Compared with the control group, both ADSC and ADSC-CM significantly reduced myocardial infarct size and improved cardiac function. The therapeutic efficacy of ADSC was moderately superior to ADSC-CM. ADSC-CM significantly reduced cardiomyocyte apoptosis in the infarct border zone, to a similar degree with ADSC treatment. ADSC enhanced angiogenesis in the infarct border zone, but to a stronger degree than that seen in the ADSC-CM treatment. ADSC was able to differentiate to endothelial cell and smooth muscle cell in post-MI heart; these ADSC-derived vascular cells amount to about 9% of the enhanced angiogenesis. No cardiomyocyte differentiated from ADSC was found. Conclusions: ADSC-CM is sufficient to improve cardiac function of infarcted hearts. The therapeutic function of ADSC transplantation is mainly induced by paracrine-mediated cardioprotection and angiogenesis, while ADSC differentiation contributes a minor benefit by being involved in angiogenesis. Highlights 1 ADSC-CM is sufficient to exert a therapeutic potential. 2. ADSC was able to differentiate to vascular cells but not cardiomyocyte. 3. ADSC derived vascular cells amount to about 9% of the enhanced angiogenesis. 4. Paracrine effect is the major mechanism of ADSC therapeutic function for MI.	[Yang, Dezhong; Wang, Wei; Li, Liangpeng; Peng, Yulan; Chen, Peng; Xia, Xuewei; Wang, Hongyong; Wang, Wei Eric; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Huang, Haiyun; Guo, Yanli] Third Mil Med Univ, Southwest Hosp, Dept Ultrasonog, Chongqing, Peoples R China; [Wang, Yuanyuan] Third Mil Med Univ, Daping Hosp, Dept Plast Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Wang, WE (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	wangw28@gmail.com; cyzeng1@hotmail.com	Lv, Yuanjie/AER-0767-2022; Murtaugh, Maureen/AAN-6225-2020; Wang, Wei Eric/AAE-9504-2022; peng, yu/GXW-2071-2022; Wang, Wei Eric/AFE-0795-2022	Murtaugh, Maureen/0000-0001-5281-0302; 	National Natural Science Foundation of China [31130029, 81100111, 30925018]; Natural Science Foundation Project of CQ CSTC (CSTC) [2009BA5044]; National Basic Research Program of China (973 Program) [2008CB517308, 2012CB517801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC (CSTC)(Natural Science Foundation Project of CQ CSTC); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the grants from the National Natural Science Foundation of China (31130029, 81100111, 30925018), Natural Science Foundation Project of CQ CSTC (CSTC, 2009BA5044), and National Basic Research Program of China (973 Program, 2008CB517308, 2012CB517801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Christoffels V, 2011, NATURE, V474, P585, DOI 10.1038/474585a; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Deveza L, 2013, STEM CELLS DEV, V22, P483, DOI 10.1089/scd.2012.0201; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li XH, 2007, J MOL CELL CARDIOL, V42, P295, DOI 10.1016/j.yjmcc.2006.07.002; Li YX, 2011, CIRCULATION, V123, P866, DOI 10.1161/CIRCULATIONAHA.110.947531; Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Ramkisoensing AA, 2012, STEM CELLS, V30, P1236, DOI 10.1002/stem.1086; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sanchez PL, 2010, EUR HEART J, V31, P394, DOI 10.1093/eurheartj/ehp403; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xiong DZ, 2010, J MOL CELL CARDIOL, V48, P211, DOI 10.1016/j.yjmcc.2009.07.003; Yang JJ, 2012, TOHOKU J EXP MED, V226, P231, DOI 10.1620/tjem.226.231; Zhang HY, 2010, CIRC RES, V107, P800, DOI 10.1161/CIRCRESAHA.110.219220	40	222	229	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59020	10.1371/journal.pone.0059020	http://dx.doi.org/10.1371/journal.pone.0059020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23667467	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100066
J	Yu, HC; Hou, DR; Liu, CY; Lin, CS; Shiau, CW; Cheng, AL; Chen, KF				Yu, Hui-Chuan; Hou, Duen-Ren; Liu, Chun-Yu; Lin, Chen-Si; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Kuen-Feng			Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TUMOR-SUPPRESSOR; CIP2A EXPRESSION; CELL-SURVIVAL; PP2A; UBIQUITIN; AKT; APOPTOSIS; PHOSPHORYLATION	Previously, we reported that cancerous inhibitor of protein phosphatase 2A (CIP2A) mediates the apoptotic effect of bortezomib in hepatocellular carcinoma (HCC). Here, we report a proteasome-independent mechanism by which bortezomib induces autophagy in HCC. Our data indicate that bortezomib activated autophagy in a dose-and time-dependent manner in HCC cell lines including Huh-7, Sk-Hep1, and Hep3B. Bortezomib downregulated CIP2A, phospho-Akt (P-Akt) and phospho-4EBP1 (P-4EBP1) in a dose-and time-dependent manner in all tested HCC cells. Ectopic expression of CIP2A abolished the effect of bortezomib on autophagy. Co-treatment of bortezomib and calyculin A, a PP2A inhibitor, reduced the effect of bortezomib on P-Akt, P-4EBP1, and autophagy. Increased phosphorylation of either Akt or 4EBP1 by ectopic overexpression protected cells from bortezomib-induced autophagy. Furthermore, we examined the effect of Delta Btz, a bortezomib derivative that closely resembles bortezomib structurally but has no proteasome activity, in HCC. Interestingly, Delta Btz demonstrated similar effects to bortezomib on autophagy, CIP2A, P-Akt and P-4EBP1, suggesting that the effect of bortezomib on autophagy is independent of proteasome inhibition. Moreover, our in vivo data showed that both bortezomib and Delta Btz inhibited tumor growth, downregulated CIP2A, P-Akt and induced autophagy in Huh-7 tumors. In conclusion, bortezomib induces autophagy in HCC through a CIP2A-PP2A-Akt-4EBP1 pathway.	[Yu, Hui-Chuan; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yu, Hui-Chuan; Cheng, Ann-Lii; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Lin, Chen-Si; Chen, Kuen-Feng] Natl Taiwan Univ, Sch Vet Med, Taipei 10764, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Hou, Duen-Ren] Natl Cent Univ, Dept Chem, Tao Yuan, Taiwan; [Liu, Chun-Yu] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Shiau, Chung-Wai] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, KF (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan.	kfchen1970@ntu.edu.tw	Lin, Chen-Si/AAD-3733-2019	Lin, Chen-Si/0000-0003-2254-8344; Chen, Kuen-Feng/0000-0002-4686-7019; HOU, Duen-Ren/0000-0003-1072-2915; Yu, Hongbo/0000-0002-3384-7772; Liu, Jinting/0000-0003-2136-8560; Cheng, Ann-Lii/0000-0002-9152-6512; Suiyi, Zhu/0000-0002-9784-2698	National Taiwan University Hospital [NTUH 101P01]; National Science Council, Taiwan [NSC99-2314-B-002-017-MY2, NSC100-2325-B- 002-036]	National Taiwan University Hospital(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by grants, NTUH 101P01 (KFC) from National Taiwan University Hospital; NSC99-2314-B-002-017-MY2 (KFC), and NSC100-2325-B- 002-036 (KFC) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Eskelinen EL, 2005, CELL DEATH DIFFER, V12, P1468, DOI 10.1038/sj.cdd.4401721; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katz J, 2010, CANCER BIOL THER, V10, P694, DOI 10.4161/cbt.10.7.12895; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Li CY, 2012, CANCER LETT, V314, P102, DOI 10.1016/j.canlet.2011.09.020; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Ling YH, 2002, MOL CANCER THER, V1, P841; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Qu W, 2010, MED ONCOL; Richardson Paul G, 2003, Cancer Control, V10, P361; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Roy S, 2010, SEMIN IMMUNOPATHOL, V32, P383, DOI 10.1007/s00281-010-0213-0; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Verslype C, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp281; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Wang J, 2011, INT J LAB HEMATOL, V33, P290, DOI 10.1111/j.1751-553X.2010.01288.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhu Keyi, 2009, Proceedings of the American Association for Cancer Research Annual Meeting, V50, P451, DOI 10.1038/onc.2009.343	50	88	89	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55705	10.1371/journal.pone.0055705	http://dx.doi.org/10.1371/journal.pone.0055705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23799106	Green Submitted, gold, Green Published			2022-12-27	WOS:000314597900052
